PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Douillard, FP; Mora, D; Eijlander, RT; Wels, M; de Vos, WM				Douillard, Francois P.; Mora, Diego; Eijlander, Robyn T.; Wels, Michiel; de Vos, Willem M.			Comparative genomic analysis of the multispecies probiotic-marketed product VS L#3 (vol 13, e0192452, 2018)	PLOS ONE			English	Correction																		Douillard FP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192452	1	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203548	10.1371/journal.pone.0203548	http://dx.doi.org/10.1371/journal.pone.0203548			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161239	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900131
J	Lalani, T; Tisdale, MD; Liu, J; Mitra, I; Philip, C; Odundo, E; Reyes, F; Simons, MP; Fraser, JA; Hutley, E; Connor, P; Swierczewski, BE; Houpt, E; Tribble, DR; Riddle, MS				Lalani, Tahaniyat; Tisdale, Michele D.; Liu, Jie; Mitra, Indrani; Philip, Cliff; Odundo, Elizabeth; Reyes, Faviola; Simons, Mark P.; Fraser, Jamie A.; Hutley, Emma; Connor, Patrick; Swierczewski, Brett E.; Houpt, Eric; Tribble, David R.; Riddle, Mark S.			Comparison of stool collection and storage on Whatman FTA Elute cards versus frozen stool for enteropathogen detection using the TaqMan Array Card PCR assay	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; TRAVELERS DIARRHEA; COLONIZATION FACTOR; ETIOLOGY; SAMPLES; MEXICO; VIRUS; ETEC	The use of Polymerase Chain Reaction (PCR) assays for pathogen detection in travelers' diarrhea (TD) field studies is limited by the on-site processing and storage requirements for fecal specimens. The objectives of this investigation were to i) characterize the pathogen distribution in deployed military personnel with TD using the TaqMan (R) Array Card PCR (TAC) on frozen stool and diarrheal smears on Whatman FTA Elute cards (FTA cards), and to ii) compare TAC detection of enteropathogen targets using smeared FTA cards and frozen stool, using TAC on frozen stool as the 'reference standard'. Stool samples, obtained from active duty personnel with acute TD enrolled in a field trial, were smeared onto FTA cards and stored at room temperature. A corresponding aliquot of stool was frozen in a cryovial. FTA cards and frozen stool samples were tested at a central lab, using a customized TAC for detection of TD pathogens. 187 paired frozen stool samples and smeared FTA cards were stored fora median of 712 days (IQR 396-750) before testing. Overall detection rates were 78.6% for frozen stool and 73.2% for FTA cards. Diarrheagenic Escherichia coli were the most common bacteria identified. Using the TAC results on frozen stool as the reference, the overall sensitivity and specificity of TAC on FTA cards was 72.9% and 98.0% respectively. TAC on FTA cards demonstrated a decrease in sensitivity with increasing frozen stool quantification cycle (Cq) (90.0% in FTA cards with a corresponding frozen stool Cq < 30, and 72.9% in samples with a corresponding frozen stool Cq < 35). Our findings support the use and further development of FTA cards in combination with a quantitative PCR assay for enteropathogen detection in TD field studies.	[Lalani, Tahaniyat; Tisdale, Michele D.; Mitra, Indrani; Fraser, Jamie A.; Tribble, David R.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Infect Dis Clin Res Program, Rockville, MD USA; [Lalani, Tahaniyat; Tisdale, Michele D.; Mitra, Indrani; Fraser, Jamie A.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Lalani, Tahaniyat; Tisdale, Michele D.] Naval Med Ctr, Div Infect Dis, Portsmouth, VA 23708 USA; [Liu, Jie; Houpt, Eric] Univ Virginia, Charlottesville, VA USA; [Philip, Cliff; Odundo, Elizabeth] US Army Med Res Unit Kenya, Kericho, Kenya; [Reyes, Faviola] Joint Task Force Bravo, Soto Cano Air Base, Honduras; [Simons, Mark P.] Naval Med Res Ctr, Silver Spring, MD USA; [Hutley, Emma; Connor, Patrick] Royal Ctr Def Med, Dept Mil Med, Birmingham, W Midlands, England; [Swierczewski, Brett E.] Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Riddle, Mark S.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of Virginia; Naval Medical Research Center (NMRC); Royal Centre for Defence Medicine; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Uniformed Services University of the Health Sciences - USA	Lalani, T (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Infect Dis Clin Res Program, Rockville, MD USA.; Lalani, T (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.; Lalani, T (corresponding author), Naval Med Ctr, Div Infect Dis, Portsmouth, VA 23708 USA.	tlalani@idcrp.org	Lalani, Tahaniyat/HCI-8313-2022; Riddle, Mark/R-8788-2019	Lalani, Tahaniyat/0000-0002-9361-2991; Riddle, Mark/0000-0002-0607-7880	Bureau of Medicine and Surgery [HU0001-11-1-0022, G187V2]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [Y1-AI-5072]	Bureau of Medicine and Surgery; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by Bureau of Medicine and Surgery to the Uniformed Services University of the Health Sciences (USU Grant Agreement-HU0001-11-1-0022; USU Project No: G187V2) and from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under Inter-Agency Agreement Y1-AI-5072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruijnesteijn van Coppenraet L E S, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.02.007; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; GE Healthcare, REC EXTR DNA STOR WH; Grimes KA, 2008, J CLIN MICROBIOL, V46, P2227, DOI 10.1128/JCM.00073-08; Isidean SD, 2011, VACCINE, V29, P6167, DOI 10.1016/j.vaccine.2011.06.084; Kabayiza JC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-447; Laaveri T, 2016, CLIN MICROBIOL INFEC, V22, P535, DOI 10.1016/j.cmi.2016.02.011; Lalani T, 2015, DIAGN MICR INFEC DIS, V83, P18, DOI 10.1016/j.diagmicrobio.2015.05.011; Lau H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01736; Linhares DCL, 2012, J VET DIAGN INVEST, V24, P328, DOI 10.1177/1040638711429492; Liu J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176882; Liu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158199; Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Platts-Mills JA, 2013, MUCOSAL IMMUNOL, V6, P876, DOI 10.1038/mi.2013.50; Riddle MS, 2006, AM J TROP MED HYG, V74, P891, DOI 10.4269/ajtmh.2006.74.891; Riddle MS, 2017, CLIN INFECT DIS, V65, P2008, DOI 10.1093/cid/cix693; Sack DA, 2007, VACCINE, V25, P4392, DOI 10.1016/j.vaccine.2007.03.034; Steffen R, 2015, JAMA-J AM MED ASSOC, V313, P71, DOI 10.1001/jama.2014.17006; Taniuchi M, 2013, J INFECT DIS, V208, P1794, DOI 10.1093/infdis/jit507; Vila J, 2017, J TRAVEL MED, V24, pS23, DOI 10.1093/jtm/taw071; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Zboromyrska Y, 2016, EXPERT REV MOL DIAGN, V16, P631, DOI 10.1586/14737159.2016.1167599	23	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202178	10.1371/journal.pone.0202178	http://dx.doi.org/10.1371/journal.pone.0202178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30165370	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900023
J	Langeslag, SJE				Langeslag, Sandra J. E.			Effects of organization and disorganization on pleasantness, calmness, and the frontal negativity in the event-related potential	PLOS ONE			English	Article							SYMMETRY; ERP	A preference for organization is associated with several disorders, but is widespread in the general population as well. It remains unclear whether organization and various degrees of disorganization elicit pleasant or unpleasant feelings (i.e., valence), calming or arousing feelings (i.e., arousal), and a frontal negativity in the event-related potential (ERP) related to cognitive control. This study tested how organization, slight disorganization, and total disorganization affect valence, arousal, and the frontal negativity. Participants passively viewed organized, slightly disorganized, totally disorganized, and control pictures while their electroencephalogram was recorded. They also rated the valence and arousal elicited by each picture and completed questionnaires assessing desire for order and organization behavior. Organized pictures made participants feel most pleasant, control pictures made participants feel less pleasant, slightly disorganized pictures made participants feel even less pleasant, and totally disorganized pictures made participants feel least pleasant. There were no significant effects on arousal. Totally disorganized pictures elicited a frontal negativity in the ERP between 200-2000 ms after stimulus onset, which might reflect inhibition of rearranging behavior. Individual differences in desire for order and organization behavior did not correlate with valence, arousal, or the frontal negativity. The current study design and findings could be a starting point for examining the differences between adaptive and maladaptive preferences for organization and aversions to disorganization.	[Langeslag, Sandra J. E.] Univ Missouri, Dept Psychol Sci, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Langeslag, SJE (corresponding author), Univ Missouri, Dept Psychol Sci, St Louis, MO 63121 USA.	langeslags@umsl.edu	Langeslag, Sandra/GRE-6148-2022					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Borod J. C., 1993, NEUROPSYCHOLOGY, V7, P427; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bryden M. P., 1982, LATERALITY FUNCTIONA; de Vries FE, 2013, CNS SPECTRUMS, V18, P34, DOI 10.1017/S1092852912000703; Evans DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038966; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hajcak G., 2012, OXFORD HDB EVENT REL, P441, DOI 10.1093/oxfordhb/9780195374148.013.0222; Hofmann SG, 2008, CLIN PSYCHOL REV, V28, P1, DOI 10.1016/j.cpr.2007.09.003; HOLM S, 1979, SCAND J STAT, V6, P65; Jackson JJ, 2010, J RES PERS, V44, P501, DOI 10.1016/j.jrp.2010.06.005; Kalat J., 2012, EMOTION; LeDoux J. E., 1996, EMOTIONAL BRAIN; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Radomsky AS, 2004, BEHAV RES THER, V42, P893, DOI 10.1016/j.brat.2003.07.001; Rodriguez NM, 2013, J INTELLECT DEV DIS, V38, P242, DOI 10.3109/13668250.2013.812192; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Sari BA, 2017, COGNITION EMOTION, V31, P995, DOI 10.1080/02699931.2016.1170668; Shepherd K, 2011, PERCEPTION, V40, P1254, DOI 10.1068/p7057; Tullett AM, 2015, SOC COGN AFFECT NEUR, V10, P628, DOI 10.1093/scan/nsu097	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202726	10.1371/journal.pone.0202726	http://dx.doi.org/10.1371/journal.pone.0202726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161183	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900040
J	Meng, J; Chen, YPP				Meng, Jing; Chen, Yi-Ping Phoebe			A database of simulated tumor genomes towards accurate detection of somatic small variants in cancer	PLOS ONE			English	Article							MUTATION IDENTIFICATION; PERFORMANCE; SIGNATURES; REVEALS	Somatic mutations promote the transformation of normal cells to cancer. Accurate identification of such mutations facilitates cancer diagnosis and treatment, but biological and technological noises, including intra-tumor heterogeneity, sample contamination, uncertainties in base sequencing and read alignment, pose a big challenge to somatic mutation discovery. A number of callers have been developed to predict them from paired tumor/normal or unpaired tumor sequencing data. However, the small size of currently available experimentally validated somatic sites limits evaluation and then improvement of callers. Fortunately, NIST reference material NA12878 genome has been well-characterized with publicly available high-confidence genotype calls, and biological and technological noises can be computationally generalized to the number of sub-clones, the VAFs, the sequencing and mapping qualities. We used BAMSurgeon to create simulated tumors by introducing somatic small variants (SNVs and small indels) into homozygous reference or wildtype sites of NA12878. We generated 135 simulated tumors from 5 pre-tumors/normals. These simulated tumors vary in sequencing and subsequent mapping error profiles, read length, the number of subclones, the VAF, the mutation frequency across the genome and the genomic context. Furthermore, these pure tumor/normal pairs can be mixed at desired ratios within each pair to simulate sample contamination. This database (a total size of 15 terabytes) will be of great use to benchmark somatic small variant callers and guide their improvement.	[Meng, Jing; Chen, Yi-Ping Phoebe] La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia	La Trobe University	Meng, J (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia.	jing.mengrabbit@gmail.com	Chen, Yi-Ping Phoebe/B-8844-2008	Chen, Yi-Ping Phoebe/0000-0002-4122-3767	La Trobe University	La Trobe University	This work was supported by La Trobe University full fee scholarship.	Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Behjati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12605; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bradley G, 2017, ORAL DIS; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Eberle MA, 2017, GENOME RES, V27, P157, DOI 10.1101/gr.210500.116; Ewing AD, 2015, NAT METHODS, V12, P623, DOI [10.1038/NMETH.3407, 10.1038/nmeth.3407]; Fang LT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0758-2; Fu Y, 2016, CANCER RES, V76, P5954, DOI 10.1158/0008-5472.CAN-15-3457; Griffith M, 2015, CELL SYST, V1, P210, DOI 10.1016/j.cels.2015.08.015; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kalatskaya I, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0446-9; Kim S., BIORXIV; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Korthauer KD, 2015, BIOINFORMATICS, V31, P1526, DOI 10.1093/bioinformatics/btu858; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mwenifumbo JC, 2013, NAT REV GENET, V14, P321, DOI 10.1038/nrg3445; Narzisi G, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0023-9; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Poplin R., BIORXIV; Prasetyanti PR, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0600-4; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Secrier M, 2016, NAT GENET, V48, P1131, DOI 10.1038/ng.3659; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tokheim CJ, 2016, P NATL ACAD SCI USA, V113, P14330, DOI 10.1073/pnas.1616440113; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; You SY, 2016, CANCER RES, V76, P4948, DOI 10.1158/0008-5472.CAN-16-0902; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202982	10.1371/journal.pone.0202982	http://dx.doi.org/10.1371/journal.pone.0202982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161165	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900060
J	Siriussawakul, A; Maboonyanon, P; Kueprakone, S; Samankatiwat, S; Komoltri, C; Thanakiattiwibun, C				Siriussawakul, Arunotai; Maboonyanon, Patcharee; Kueprakone, Subongkot; Samankatiwat, Suthasinee; Komoltri, Chulaluk; Thanakiattiwibun, Chayanan			Predictive performance of a multivariable difficult intubation model for obese patients	PLOS ONE			English	Article							THYROMENTAL DISTANCE; TRACHEAL INTUBATION; NECK CIRCUMFERENCE; LARYNGOSCOPY; AIRWAY; VALIDATION; RATIO; RISK; REGRESSION; SURGERY	Background A predictive model of scores of difficult intubation (DI) may help physicians screen for airway difficulty to reduce morbidity and mortality in obese patients. The present study aimed to set up and evaluate the predictive performance of a newly developed, practical, multivariate DI model for obese patients. Methods A prospective multi-center study was undertaken on adults with a body mass index (BMI) of 30 kg/m(2) or more who were undergoing conventional endotracheal intubation. The BMI and 10 preoperative airway tests (namely, malformation of the teeth in the upper jaw, the modified Mallampati test [MMT], the upper lip bite test, neck mobility testing, the neck circumference [NC], the length of the neck, the interincisor gap, the hyomental distance, the thyromental distance [TM] and the sternomental distance) were examined. A DI was defined as one with an intubation difficulty scale (IDS) score >= 5. Results The 1,015 patients recruited for the study had a mean BMI of 34.2 (standard deviation: 4.3 kg/m(2)). The proportions for easy intubation, slight DI and DI were 81%, 15.8% and 3.2%, respectively. Drawing on the results of a multivariate analysis, clinically meaningful variables related to obesity (namely, BMI, MMT, and the ratio of NC to TM) were used to build a predictive model for DI. Nevertheless, the best model only had a fair predictive performance. The area under the receiver operating characteristic curve (AUC) was 0.71 (95% confidence interval 0.68-0.84). Conclusions The predictive performance of the selected model showed limited benefit for preoperative screening to predict DI among obese patients.	[Siriussawakul, Arunotai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anesthesiol, Bangkok, Thailand; [Maboonyanon, Patcharee] Phahonpolpayuhasena Hosp, Div Anesthesiol, Kanchanaburi, Thailand; [Kueprakone, Subongkot] Taksin Hosp, Div Anesthesiol, Bangkok, Thailand; [Samankatiwat, Suthasinee] Ratchaburi Hosp, Div Anesthesiol, Ratchaburi, Thailand; [Komoltri, Chulaluk] Mahidol Univ, Siriraj Hosp, Fac Med, Div Clin Epidemiol,Dept Res Dev, Bangkok, Thailand; [Thanakiattiwibun, Chayanan] Mahidol Univ, Siriraj Hosp, Fac Med, Integrated Perioperat Geriatr Excellent Res Ctr, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University	Siriussawakul, A (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anesthesiol, Bangkok, Thailand.	arunotai.sir@mahidol.ac.th			Siriraj Research Development Fund, Siriraj Hospital, Bangkok, Thailand [R2R13AS00014/048/13]	Siriraj Research Development Fund, Siriraj Hospital, Bangkok, Thailand	The study was supported by Siriraj Research Development Fund (managed by Routine to Research [R2R]), Siriraj Hospital, Bangkok, Thailand on May 12, 2014. Grant number is R2R13AS00014/048/13 to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnet F, 1997, ANESTHESIOLOGY, V87, P1290, DOI 10.1097/00000542-199712000-00005; Arne J, 1998, BRIT J ANAESTH, V80, P140, DOI 10.1093/bja/80.2.140; Brodsky JB, 2002, ANESTH ANALG, V94, P732, DOI 10.1097/00000539-200203000-00047; Carlson JN, 2017, WEST J EMERG MED, V18, P662, DOI 10.5811/westjem.2017.1.32938; Cook TM, 2011, BRIT J ANAESTH, V106, P617, DOI 10.1093/bja/aer058; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; De Jong A, 2013, AM J RESP CRIT CARE, V187, P832, DOI 10.1164/rccm.201210-1851OC; Gerds TA, 2008, BIOMETRICAL J, V50, P457, DOI 10.1002/bimj.200810443; Gonzalez H, 2008, ANESTH ANALG, V106, P1132, DOI 10.1213/ane.0b013e3181679659; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Hawkins JL, 1995, SEMIN ANESTH, V14, P204; Hosmer DW, 2005, APPL LOGISTIC REGRES, P203; Huh J, 2009, ANESTH ANALG, V108, P544, DOI 10.1213/ane.0b013e31818fc347; Jacobsen J, 1996, ACTA ANAESTH SCAND, V40, P421, DOI 10.1111/j.1399-6576.1996.tb04463.x; Kim WH, 2011, BRIT J ANAESTH, V106, P743, DOI 10.1093/bja/aer024; Knottnerus JA, 2002, BMJ-BRIT MED J, V324, P477, DOI 10.1136/bmj.324.7335.477; Krobbuaban B, 2005, ANESTH ANALG, V101, P1542, DOI 10.1213/01.ANE.0000181000.43971.1E; Merah NA, 2005, CAN J ANAESTH, V52, P291, DOI 10.1007/BF03016066; Naguib M, 2006, ANESTH ANALG, V102, P818, DOI 10.1213/01.ane.0000196507.19771.b2; Pearce A, 2005, BEST PRACT RES-CLIN, V19, P559, DOI 10.1016/j.bpa.2005.07.004; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Punjasawadwong Y, 2017, ASIAN BIOMEDICINE; Reynolds J, 2009, EUR SPINE J, V18, P863, DOI 10.1007/s00586-009-0894-z; ROSE DK, 1994, CAN J ANAESTH, V41, P372, DOI 10.1007/BF03009858; Shiga T, 2005, ANESTHESIOLOGY, V103, P429, DOI 10.1097/00000542-200508000-00027; Simundic Ana-Maria, 2009, EJIFCC, V19, P203; Siriussawakul A, 2016, J CLIN ANESTH, V33, P86, DOI 10.1016/j.jclinane.2016.03.016; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Voyagis GS, 1998, EUR J ANAESTH, V15, P330, DOI 10.1097/00003643-199805000-00015; WILSON ME, 1988, BRIT J ANAESTH, V61, P211, DOI 10.1093/bja/61.2.211; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zeng N, 2010, NESUG P HLTH CARE LI	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203142	10.1371/journal.pone.0203142	http://dx.doi.org/10.1371/journal.pone.0203142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161197	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900084
J	Fittler, A; Vida, RG; Radics, V; Botz, L				Fittler, Andras; Vida, Robert Gyorgy; Radics, Valter; Botz, Lajos			A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs	PLOS ONE			English	Article							PRESCRIPTION DRUGS; PATIENT SAFETY; UNITED-STATES; AVAILABILITY; PHARMACIES; IMPACT; MONEY; CALL	Introduction Drug shortages mean a challenge to healthcare systems. Exposed patients or health care providers may seek alternative resources for these products online. The purpose of our study was to analyze the online availability of oncology shortage drugs at national and at international levels in 2014 and 2016. Methods We tested the online accessibility of oncology shortage drugs by simulating the Internet search method of patients. Search results were evaluated according to operational, distributional, and patient safety characteristics. Results In 2014 and 2016 all (100%) antineoplastic agents affected by shortages were available on the Internet without medical prescription. The number of relevant websites among search engine results has decreased from 112 to 98, while online vendors actually offering oncology shortage drugs for sale has risen from 66.1% to 80.6% within relevant websites in the two evaluated years. None of the online sellers were classified as legitimate or accredited by LegitScript and VIPPS online pharmacy verification databases. Conclusion According to our findings shortage oncology drugs are widely available online. To manage shortages and illegal Internet trade national and international standardized shortage reporting and information systems, regularly updated Internet pharmacy verification databases are needed. As well, institutional procurement and medication use review policies are required.	[Fittler, Andras] Univ Pecs, Fac Pharm, Dept Pharmaceut, Pecs, Hungary; Univ Pecs, Fac Pharm, Cent Clin Pharm, Pecs, Hungary	University of Pecs; University of Pecs	Fittler, A (corresponding author), Univ Pecs, Fac Pharm, Dept Pharmaceut, Pecs, Hungary.	fittler.andras@pte.hu	Vida, Róbert György/AAC-5740-2019; Fittler, András/O-1768-2019	Vida, Róbert György/0000-0003-1176-0251; Fittler, András/0000-0002-8243-6179	European Union; European Social Fund	European Union(European Commission); European Social Fund(European Social Fund (ESF))	The project has been supported by the European Union, co-financed by the European Social Fund within the framework of Comprehensive Development for Implementing Smart Specialization Strategies at the University of PeAcs.	Alsheikh Mona, 2016, Hosp Pharm, V51, P370, DOI 10.1310/hpj5105-370; Alwon BM, 2015, INT J CLIN PHARM-NET, V37, P148, DOI 10.1007/s11096-014-0056-1; Anna Gu, 2011, INNOVATIONS PHARM, V2; ASHP Expert Panel on Drug Product Shortages, 2009, Am J Health Syst Pharm, V66, P1399, DOI 10.2146/ajhp090026; Bauters T, 2016, J ONCOL PHARM PRACT, V22, P766, DOI 10.1177/1078155215610915; Blackstone EA, 2014, AM HEALTH DRUG BENEF, V7, P216; Butterfield Lindsay, 2015, J Pediatr Pharmacol Ther, V20, P149, DOI 10.5863/1551-6776-20.2.149; Cancer medicines shortages in Europe, 2017, REP EC INT UNIT SUPP; Caulder Celeste R, 2015, Hosp Pharm, V50, P279, DOI 10.1310/hpj5004-279; Center for Drug Evaluation and Research FDA, 2006, MAN POL PROC DRUG SH, P2; de Lemos ML, 2016, J ONCOL PHARM PRACT, V22, P566, DOI 10.1177/1078155215589980; De Weerdt E, 2017, APPL HEALTH ECON HEA, V15, P441, DOI 10.1007/s40258-016-0264-z; De Weerdt E, 2015, FRONT PHARMACOL, V6, DOI [10.3329/fphar.2015.00253, 10.3389/fphar.2015.00253]; European Association of Hospital Pharmacists, 2012, EAHP STAT MED SHORT; European Association of Hospital Pharmacists, 2014, EAHPS 2014 SURV MED; European Association of Hospital Pharmacists, 2013, MED SHORT EUR HOSP; European Federation of Pharmaceutical Industries and Associations, 2014, EFPIA GOOD PRACT REV; European Medicines Agency, 2012, EMA5907452012; Fittler A, 2014, EUROPEAN J HOSP PHAR, V21, pA67; Fittler A, 2013, J MED INTERNET RES, V15, P227, DOI 10.2196/jmir.2606; Food and Drug Administration, FDA ACTS PREV MOR DR; Food and Drug Administration, FDA DRUG SHORT CURR; Fox ER, 2014, MAYO CLIN PROC, V89, P361, DOI 10.1016/j.mayocp.2013.11.014; Gabay Michael, 2015, Hosp Pharm, V50, P681, DOI 10.1310/hpj5008-681; GAO, 2016, GAO16595; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Goldsack JC, 2014, AM J HEALTH-SYST PH, V71, P571, DOI 10.2146/ajhp130569; Gray A, 2012, B WORLD HEALTH ORGAN, V90, P158, DOI 10.2471/BLT.11.101303; Hawley KL, 2016, ACAD EMERG MED, V23, P63, DOI 10.1111/acem.12838; Holloway Kathleen, DRUG THERAPEUTICS PR, P1; Hughes Kaitlin M, 2015, J Pediatr Pharmacol Ther, V20, P453, DOI 10.5863/1551-6776-20.6.453; Huys Isabelle, 2013, Int J Pharm Pract, V21, P1, DOI 10.1111/ijpp.12012; IMS Institute for Healthcare Informatics, 2011, DRUG SHORT CLOS LOOK; Institute for Safe Medication Practices, 2014, DRUG SHORT SUMM; Institute for Safe Medication Practices (ISMP), 2010, ISMP MED SAFETY ALER, V15, P1; International Pharmaceutical Federation, 2013, REP INT SUMM MED SHO; International Pharmaceutical Federation, 2011, FIP CALLS ATT MED SH; INTERPOL, OP PANG COMB SAL ILL; ISPE, 2013, REP ISPE DRUG SHORT; Iyengar S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0674-7; Kaposy C, 2014, J BIOETHIC INQ, V11, P85, DOI 10.1007/s11673-013-9494-z; Kehl KL, 2015, J ONCOL PRACT, V11, pE154, DOI 10.1200/JOP.2014.000380; Lagan BM, 2014, PHARMACOEPIDEM DR S, V23, P411, DOI 10.1002/pds.3565; Levaggi R, 2012, HEALTH POLICY, V106, P241, DOI 10.1016/j.healthpol.2012.05.003; Levaggi R, 2009, HEALTH POLICY, V92, P187, DOI 10.1016/j.healthpol.2009.03.010; Liang BA, 2012, NAT REV UROL, V9, P480, DOI 10.1038/nrurol.2012.148; Liang BA, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1999; Liang BA, 2012, VACCINE, V30, P105, DOI 10.1016/j.vaccine.2011.11.016; Liang BA, 2009, AM J LAW MED, V35, P125, DOI 10.1177/009885880903500104; Link MP, 2012, J CLIN ONCOL, V30, P692, DOI 10.1200/JCO.2011.41.0936; Mackey Tim K, 2016, Br Med Bull, V118, P110, DOI 10.1093/bmb/ldw016; Mackey T, 2015, INT J CLIN PHARM-NET, V37, P1076, DOI 10.1007/s11096-015-0154-8; Mackey TK, 2012, J ONCOL PRACT, V8, P341, DOI 10.1200/JOP.2012.000579; Mackey TK, 2011, J PHARM SCI-US, V100, P4571, DOI 10.1002/jps.22679; Malone C, 2016, Ulster Med J, V85, P174; Mazer-Amirshahi M, 2017, J CRIT CARE, V41, P283, DOI 10.1016/j.jcrc.2017.06.005; McKeever AE, 2013, CLIN J ONCOL NURS, V17, P490, DOI 10.1188/13.CJON.490-495; McLaughlin M, 2013, J MANAGE CARE PHARM, V19, P783, DOI 10.18553/jmcp.2013.19.9.783; McLaughlin MM, 2014, AM J HEALTH-SYST PH, V71, P2074, DOI 10.2146/ajhp140116; Monteith S, 2016, J AFFECT DISORDERS, V193, P59, DOI 10.1016/j.jad.2015.12.043; National Association of Boards of Pharmacy, 2016, PHARM GEN TOP LEV DO; National Institute of Pharmacy and Nutrition, TEMP DUG SHORT; Nyaka Bernadett, 2016, J HUNGARIAN INTERDIS, V15, P42; Orizio G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1795; Orizio G, 2009, EUR J PUBLIC HEALTH, V19, P375, DOI 10.1093/eurpub/ckn146; Parsons HM, 2016, J ONCOL PRACT, V12, pE289, DOI 10.1200/JOP.2015.007237; Pauwels K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119322; Pauwels K, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-438; Quadri F, 2015, CLIN INFECT DIS, V60, P1737, DOI 10.1093/cid/civ201; Reed BN, 2016, AM HEART J, V175, P130, DOI 10.1016/j.ahj.2016.02.004; Ridley DB, 2016, HEALTH AFFAIR, V35, P235, DOI 10.1377/hlthaff.2015.0420; Romito Bryan, 2015, Hosp Pharm, V50, P798, DOI 10.1310/hpj5009-798; Schweitzer SO, 2013, AM J PUBLIC HEALTH, V103, pE10, DOI 10.2105/AJPH.2013.301239; Stephens Martin, 2011, HOSP PHARM 11 STRAT, P181; Taylor Phil, 2012, DRUG SHORTAGES RAISI; US Government Accountability Office, 2014, GAO14194; Valgus J, 2013, J ONCOL PRACT, V9, pE21, DOI 10.1200/JOP.2012.000779; Verified Internet Pharmacy Practice Sites (VIPPS) National Association of Boards of Pharmacy, VIPPS ACCR PHARM LIS; Vida RG, 2017, INT J CLIN PHARM-NET, V39, P78, DOI 10.1007/s11096-016-0398-y; Woodcock J, 2013, CLIN PHARMACOL THER, V93, P170, DOI 10.1038/clpt.2012.220; Yang CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165183	81	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203185	10.1371/journal.pone.0203185	http://dx.doi.org/10.1371/journal.pone.0203185			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153304	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700049
J	Watanabe, M; Masieri, S; Costantini, D; Tozzi, R; De Giorgi, F; Gangitano, E; Tuccinardi, D; Poggiogalle, E; Mariani, S; Basciani, S; Petrangeli, E; Gnessi, L; Lubrano, C				Watanabe, Mikiko; Masieri, Simonetta; Costantini, Daniela; Tozzi, Rossella; De Giorgi, Francesca; Gangitano, Elena; Tuccinardi, Dario; Poggiogalle, Eleonora; Mariani, Stefania; Basciani, Sabrina; Petrangeli, Elisa; Gnessi, Lucio; Lubrano, Carla			Overweight and obese patients with nickel allergy have a worse metabolic profile compared to weight matched non-allergic individuals	PLOS ONE			English	Article							GROWTH-HORMONE; INSULIN-RESISTANCE; PATCH-TEST; INFLAMMATION; HEALTH; HYPERSENSITIVITY; PROLACTIN; SECRETION; IMPACT; AXIS	Background A lack of balance between energy intake and expenditure due to overeating or reduced physical activity does not seem to explain entirely the obesity epidemic we are facing, and further factors are therefore being evaluated. Nickel (Ni) is a ubiquitous heavy metal implied in several health conditions. Regarding this, the European Food Safety Authority has recently released an alert on the possible deleterious effects of dietary Ni on human health given the current levels of Ni dietary intake in some countries. Pre-clinical studies have also suggested its role as an endocrine disruptor and have linked its exposure to energy metabolism and glucose homeostasis dysregulation. Ni allergy is common in the general population, but preliminary data suggest it being even more widespread among overweight patients. Objectives The aim of this study has been to evaluate the presence of Ni allergy and its association with the metabolic and endocrine profile in overweight and obese individuals. Methods We have evaluated 1128 consecutive overweight and obese outpatients. 784 were suspected of being allergic to Ni and 666 were assessed for it. Presence of Ni allergy and correlation with body mass index (BMI), body composition, metabolic parameters and hormonal levels were evaluated. Results We report that Ni allergy is more frequent in presence of weight excess and is associated with worse metabolic parameters and impaired Growth Hormone secretion. Conclusions We confirm that Ni allergy is more common in obese patients, and we report for the first time its association with worse metabolic parameters and impaired function of the GH-IGF1 axis in human subjects.	[Watanabe, Mikiko; Costantini, Daniela; Tozzi, Rossella; De Giorgi, Francesca; Gangitano, Elena; Poggiogalle, Eleonora; Mariani, Stefania; Basciani, Sabrina; Petrangeli, Elisa; Gnessi, Lucio; Lubrano, Carla] Sapienza Univ Rome, Dept Expt Med, Sect Med Pathophysiol Food Sci & Endocrinol, Rome, Italy; [Masieri, Simonetta] Sapienza Univ Rome, Dept Sensory Organs, Rome, Italy; [Tuccinardi, Dario] Univ Campus Biomed Rome, Dept Endocrinol & Diabet, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University Campus Bio-Medico - Rome Italy	Watanabe, M (corresponding author), Sapienza Univ Rome, Dept Expt Med, Sect Med Pathophysiol Food Sci & Endocrinol, Rome, Italy.	mikiko.watanabe@uniroma1.it	Gnessi, Lucio/K-8025-2016; Poggiogalle, Eleonora/AAB-9338-2019; watanabe, Mikiko/AAL-6316-2020; Tozzi, Rossella/AAB-9253-2019; Tuccinardi, Dario/AAN-9540-2020; Tuccinardi, Dario/AAB-8423-2019	Gnessi, Lucio/0000-0001-8217-2372; watanabe, Mikiko/0000-0003-2225-8814; Tuccinardi, Dario/0000-0002-9139-7159; MASIERI, Simonetta/0000-0003-0423-9505; Gangitano, Elena/0000-0003-1044-2278				Ahlstrom MG, 2017, CONTACT DERMATITIS, V77, P193, DOI 10.1111/cod.12846; Antico A, 1999, ALLERGY ASTHMA PROC, V20, P235, DOI 10.2500/108854199778338991; Benford D, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4002; Braga M, 2013, INT J IMMUNOPATH PH, V26, P707, DOI 10.1177/039463201302600314; Bunt SNW, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2759-1; Buyukozturk S, 2015, INT IMMUNOPHARMACOL, V26, P92, DOI 10.1016/j.intimp.2015.03.012; CARLSON HE, 1984, LIFE SCI, V35, P1747, DOI 10.1016/0024-3205(84)90271-6; Chen YW, 2009, ISLETS, V1, P169, DOI 10.4161/isl.1.3.9262; Christensen O B, 1975, Contact Dermatitis, V1, P136, DOI 10.1111/j.1600-0536.1975.tb05354.x; Cook DM, 2009, ENDOCR PRACT S2, P1, DOI DOI 10.4158/EP.15.S2.1; Das KK, 2008, INDIAN J MED RES, V128, P412; Di Tola M, 2014, BIOL TRACE ELEM RES, V159, P81, DOI 10.1007/s12011-014-9991-x; DORMER RL, 1974, BIOCHEM J, V140, P135, DOI 10.1042/bj1400135; Dzugkoeva FS, 2016, B EXP BIOL MED+, V162, P199, DOI 10.1007/s10517-016-3575-z; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Grottoli S, 2003, CLIN ENDOCRINOL, V58, P220, DOI 10.1046/j.1365-2265.2003.01699.x; Gupta S, 2000, NITRIC OXIDE-BIOL CH, V4, P129, DOI 10.1006/niox.2000.0278; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ihlebaek C, 2002, SCAND J PUBLIC HEALT, V30, P20, DOI 10.1080/140349401753481547; Jacob SE, 2015, PEDIATR DERMATOL, V32, P779, DOI 10.1111/pde.12639; LABELLA FS, 1973, NATURE, V245, P330, DOI 10.1038/245330a0; Lachapelle J.-M., 2012, PATCH TESTING PRICK; Lanzi R, 1999, METABOLISM, V48, P1152, DOI 10.1016/S0026-0495(99)90130-0; Lin YC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014215; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Lusi EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123265; Maccario M, 2000, INT J OBESITY, V24, pS96, DOI 10.1038/sj.ijo.0801289; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nijhawan RI, 2009, DERMATOL CLIN, V27, P355, DOI 10.1016/j.det.2009.05.005; Patriarca M, 1997, AM J CLIN NUTR, V66, P616, DOI 10.1093/ajcn/66.3.616; Pizzutelli S, 2011, EUR ANN ALLERGY CLIN, V43, P5; Rietschel RL, 2008, DERMATITIS, V19, P16, DOI 10.2310/6620.2008.06062; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Saito M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020202; Saraswathi V, 2013, METABOLISM, V62, P1673, DOI 10.1016/j.metabol.2013.07.007; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schmidt M, 2011, J MOL MED, V89, P961, DOI 10.1007/s00109-011-0780-0; Seetho IW, 2013, CLIN ENDOCRINOL, V79, P163, DOI 10.1111/cen.12256; Tol J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-582; Wolfe Brenda L, 2002, Eat Disord, V10, P115, DOI 10.1080/10640260290081687; Xu XH, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-40	41	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202683	10.1371/journal.pone.0202683	http://dx.doi.org/10.1371/journal.pone.0202683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153310	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700021
J	Degli Esposti, M; Taylor, J; Humphreys, DK; Bowes, L				Degli Esposti, Michelle; Taylor, Jonathan; Humphreys, David K.; Bowes, Lucy			iCoverT: A rich data source on the incidence of child maltreatment over time in England and Wales	PLOS ONE			English	Article								Child maltreatment is a major public health problem, which is plagued with research challenges. Good epidemiological data can help to establish the nature and scope of past and present child maltreatment, and monitor its progress going forward. However, high quality data sources are currently lacking for England and Wales. We employed systematic methodology to harness pre-existing datasets (including non-digitalised datasets) and develop a rich data source on the incidence of Child maltreatment over Time (iCoverT) in England and Wales. The iCoverT consists of six databases and accompanying data documentation: Child Protection Statistics, Children In Care Statistics, Criminal Statistics, Homicide Index, Mortality Statistics and NSPCC Statistics. Each database is a unique indicator of child maltreatment incidence with 272 data variables in total. The databases span from 1858 to 2016 and therefore extends current data sources by over 80 years. We present a proof-of-principle analysis of a subset of the data to show how time series methods may be used to address key research challenges. This example demonstrates the utility of iCoverT and indicates that it will prove to be a valuable data source for researchers, clinicians and policymakers concerned with child maltreatment. The iCoverT is freely available at the Open Science Framework (osf.io/cf7mv).	[Degli Esposti, Michelle; Bowes, Lucy] Univ Oxford, Dept Expt Psychol, Oxford, England; [Taylor, Jonathan] Univ Oxford, Fac Hist, Oxford, England; [Humphreys, David K.] Univ Oxford, Dept Social Policy & Intervent, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Degli Esposti, M (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.	mdesposti@gmail.com	Taylor, Jonathan/HDO-0216-2022; Degli Esposti, Michelle/AAK-2936-2021	Taylor, Jonathan/0000-0003-1790-7699; Bowes, Lucy/0000-0001-5645-3875	Oxford Research Centre in the Humanities (TORCH, UK) via Mellon-Clarendon Doctoral Studentship (Andrew W. Mellon Foundation (New York, US)); Oxford Research Centre in the Humanities (TORCH, UK) via Mellon-Clarendon Doctoral Studentship (Clarendon (Oxford, UK))	Oxford Research Centre in the Humanities (TORCH, UK) via Mellon-Clarendon Doctoral Studentship (Andrew W. Mellon Foundation (New York, US)); Oxford Research Centre in the Humanities (TORCH, UK) via Mellon-Clarendon Doctoral Studentship (Clarendon (Oxford, UK))	This work was supported by The Oxford Research Centre in the Humanities (TORCH, UK) via two Mellon-Clarendon Doctoral Studentships (Andrew W. Mellon Foundation (New York, US), Clarendon (Oxford, UK)). MDE and JT were the two recipients of these Studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain MRS, 1997, J PUBLIC HEALTH MED, V19, P413, DOI 10.1093/oxfordjournals.pubmed.a024670; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bentley H., 2016, SAFE ARE OUR CHILDRE; Euser S, 2013, CHILD ABUSE NEGLECT, V37, P841, DOI 10.1016/j.chiabu.2013.07.004; Fallon B, 2010, CHILD ABUSE NEGLECT, V34, P70, DOI 10.1016/j.chiabu.2009.08.008; Furniss, 2006, PREVENTING CHILD MAL; Gilbert R, 2012, LANCET, V379, P758, DOI 10.1016/S0140-6736(11)61087-8; Gilbert R, 2009, LANCET, V373, P167, DOI 10.1016/S0140-6736(08)61707-9; Hardelid P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068323; Hyndman RobJ., 2018, FORECASTING PRINCIPL; Joubert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064592; Jud A, 2016, CHILD ADOL PSYCH MEN, V10, DOI 10.1186/s13034-016-0105-8; KINARD EM, 1994, CHILD ABUSE NEGLECT, V18, P645, DOI 10.1016/0145-2134(94)90014-0; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Morgan R, 2012, OXFORD HDB CRIMINOLO; Munro ER, 2011, SAFEGUARDING CHILDRE; NHS Digital, 2017, HOSP ADM PAT CAR ACT; Office for National Statistics, 2017, Q MORT REP; Rao C, 2005, B WORLD HEALTH ORGAN, V83, P618; Sedlak AJ, 1996, WESTAT EXECUTIVE SUM; Sidebotham P, 2012, ARCH DIS CHILD, V97, P193, DOI 10.1136/adc.2010.207647; Trocme NM, 2001, CAN J PUBLIC HEALTH, V92, P259, DOI 10.1007/BF03404956	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0201223	10.1371/journal.pone.0201223	http://dx.doi.org/10.1371/journal.pone.0201223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148834	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200001
J	Meneguz, M; Gasco, L; Tomberlin, JK				Meneguz, Marco; Gasco, Laura; Tomberlin, Jeffery K.			Impact of pH and feeding system on black soldier fly (Hermetia illucens, L; Diptera: Stratiomyidae) larval development	PLOS ONE			English	Article							GROWTH-PERFORMANCE; FLIES DIPTERA; HOUSE-FLIES; DIET PH; SUPPLEMENT; CONVERSION; BACTERIA; AMMONIA; MANURE; WATER	Black soldier fly (BSF) is a generalist species able to reduce large quantities of organic substrates and is thus considered as an interesting solution for waste management. Moreover, as BSF larvae accumulate high quantities of nutrients during their growth, they are valued because of their potential to produce products such as protein meal or fat for livestock feeds. Abiotic factors can influence larva growth, and a more detailed knowledge and control of these parameters can lead to the development of mass BSF breeding for the production of innovative products for animal feeds. As little information is available on the effects of the pH of substrates and feeding systems, the aim of this study was to evaluate the impact of these two factors on the activities of BSF larvae, prepupae, and adults. An experiment was performed with two fixed factors: i) pH (4.0; 6.1; 7.5; 9.5) and ii) feeding system (batch feeding system (TFS) or daily feeding system (DFS)). The pH treatments impacted larval weight on the first, third, and fifth day, but not at the end of the trial. Larval activity increased pH values from the fourth day onward, with final values of around 8.9-9.4 in all the treatments. The weight of the prepupae ranged from between 0.094 and 0.100 g. The final weight of the larvae and pupae, sex ratio, ingested food, larval mortality, percentage of emergence, and time to reach the pupa stadium were all affected by the feeding system. DFS showed the heaviest final larval weight (0.149 g), but required a longer time (11.3 d) than TFS to reach the prepupa stadium. The findings of this research could be useful for the mass production of BSF. Evaluation of an appropriate feeding system and initial pH value of the substrate are important parameters to reduce the time and to increase the weight in the production of larvae.	[Meneguz, Marco; Gasco, Laura] Univ Turin, Dept Agr Forestry & Food Sci, Turin, Italy; [Tomberlin, Jeffery K.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	University of Turin; Texas A&M University System; Texas A&M University College Station	Gasco, L (corresponding author), Univ Turin, Dept Agr Forestry & Food Sci, Turin, Italy.	laura.gasco@unito.it	menegeuz, marco/L-1083-2019; Meneguz, Marco/AAX-8043-2021	menegeuz, marco/0000-0001-8007-2044; GASCO, Laura/0000-0002-1829-7936				Alattar AM, 2012, THESIS; Alexandratos N., 2012, WORLD AGR 2030 2050, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; Alpas H, 2000, INT J FOOD MICROBIOL, V60, P33, DOI 10.1016/S0168-1605(00)00324-X; [Anonymous], 1972, LIMITS GROWTH; BENJAMIN MM, 1995, APPL ENVIRON MICROB, V61, P1669, DOI 10.1128/AEM.61.4.1669-1672.1995; Booth IR, 2007, NOVART FDN SYMP, P19, DOI [10.1002/9780470515631.ch3, DOI 10.1002/9780470515631.CH3]; Cammack JA, 2017, INSECTS, V8, DOI 10.3390/insects8020056; CHAN HT, 1995, J ECON ENTOMOL, V88, P569, DOI 10.1093/jee/88.3.569; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chaudhury MF, 2009, J ECON ENTOMOL, V102, P799, DOI 10.1603/029.102.0242; Choi Youngcheol, 2009, International Journal of Industrial Entomology, V19, P171; Clark TM, 2004, J EXP BIOL, V207, P2297, DOI 10.1242/jeb.01021; Diener S, 2011, WASTE BIOMASS VALORI, V2, P357, DOI 10.1007/s12649-011-9079-1; DREW RAI, 1983, OECOLOGIA, V60, P279, DOI 10.1007/BF00376839; Erickson MC, 2004, J FOOD PROTECT, V67, P685, DOI 10.4315/0362-028X-67.4.685; Gasco L, 2018, SPRBRIEF MOLEC SCI, P1, DOI 10.1007/978-3-319-77941-6_1; Gasco L, 2016, ANIM FEED SCI TECH, V220, P34, DOI 10.1016/j.anifeedsci.2016.07.003; Henry M, 2015, ANIM FEED SCI TECH, V203, P1, DOI 10.1016/j.anifeedsci.2015.03.001; HOGSETTE JA, 1992, J ECON ENTOMOL, V85, P2291, DOI 10.1093/jee/85.6.2291; Holman BWB, 2013, J ANIM PHYSIOL AN N, V97, P615, DOI 10.1111/j.1439-0396.2012.01328.x; Holmes LA, 2012, ENVIRON ENTOMOL, V41, P971, DOI 10.1603/EN12054; Jeon H, 2011, CURR MICROBIOL, V62, P1390, DOI 10.1007/s00284-011-9874-8; Kim W, 2011, J ASIA-PAC ENTOMOL, V14, P11, DOI 10.1016/j.aspen.2010.11.003; Lam K, 2009, ENTOMOL EXP APPL, V133, P292, DOI 10.1111/j.1570-7458.2009.00928.x; Lam K, 2009, NATURWISSENSCHAFTEN, V96, P1127, DOI 10.1007/s00114-009-0574-1; LECLERCQ M, 1969, Bulletin des Recherches Agronomiques de Gembloux, V4, P139; Leong SY, 2016, WASTE MANAGE, V47, P84, DOI 10.1016/j.wasman.2015.03.030; Ma JH, 2018, ENVIRON ENTOMOL, V47, P159, DOI 10.1093/ee/nvx186; Marono S, 2017, POULTRY SCI, V96, P1783, DOI 10.3382/ps/pew461; MENDONCA AF, 1994, APPL ENVIRON MICROB, V60, P4009, DOI 10.1128/AEM.60.11.4009-4014.1994; Meneguz M, 2018, J SCI FOOD AGR, V98, P5776, DOI 10.1002/jsfa.9127; Nguyen TTX, 2015, ENVIRON ENTOMOL, V44, P406, DOI 10.1093/ee/nvv002; Nguyen TTX, 2013, J MED ENTOMOL, V50, P898, DOI 10.1603/ME12260; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nitayavardhana S, 2010, BIORESOURCE TECHNOL, V101, P9078, DOI 10.1016/j.biortech.2010.07.048; Oonincx DGAB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144601; Paz ASP, 2015, WASTE BIOMASS VALORI, V6, P1059, DOI 10.1007/s12649-015-9418-8; Popa R, 2012, J ECON ENTOMOL, V105, P374, DOI 10.1603/EC11192; Renna M, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0191-3; Roncarati A, 2015, J INSECTS FOOD FEED, V1, P233, DOI 10.3920/JIFF2014.0006; Schiavone A, 2018, ANIMAL, V12, P2032, DOI 10.1017/S1751731117003743; Schiavone A, 2017, ITAL J ANIM SCI, V16, P93, DOI 10.1080/1828051X.2016.1249968; Schiavone A, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0181-5; Sheppard DC, 2002, J MED ENTOMOL, V39, P695, DOI 10.1603/0022-2585-39.4.695; Tinder AC, 2017, J INSECTS FOOD FEED, V3, P121, DOI 10.3920/JIFF2016.0048; Tomberlin JK, 2009, ENVIRON ENTOMOL, V38, P930, DOI 10.1603/022.038.0347; Tomberlin JK, 2002, ANN ENTOMOL SOC AM, V95, P379, DOI 10.1603/0013-8746(2002)095[0379:SLHTOB]2.0.CO;2; Tschirner M, 2015, J INSECTS FOOD FEED, V1, P249, DOI 10.3920/JIFF2014.0008; TURNBULL PC, 1973, AVIAN DIS, V17, P72, DOI 10.2307/1588921; van Broekhoven S, 2015, J INSECT PHYSIOL, V73, P1, DOI 10.1016/j.jinsphys.2014.12.005; Van Huis A, 2013, EDIBLE INSECTS FUTUR; Villas-Boas SG, 2002, ANIM FEED SCI TECH, V98, P1, DOI 10.1016/S0377-8401(02)00017-2; Wissinger SA, 2004, WETLANDS, V24, P777, DOI 10.1672/0277-5212(2004)024[0777:TROLCI]2.0.CO;2; Yu GH, 2011, ENVIRON ENTOMOL, V40, P30, DOI 10.1603/EN10126; Zheng LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02563; Zhu FX, 2012, BIORESOURCE TECHNOL, V116, P485, DOI 10.1016/j.biortech.2012.04.008	56	52	57	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202591	10.1371/journal.pone.0202591	http://dx.doi.org/10.1371/journal.pone.0202591			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148867	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200016
J	Osiecki, MJ; McElwain, SDL; Lott, WB				Osiecki, Michael J.; McElwain, Sean D. L.; Lott, William B.			Modelling mesenchymal stromal cell growth in a packed bed bioreactor with a gas permeable wall	PLOS ONE			English	Article							STEM-CELLS; PERFUSION BIOREACTOR; IN-VITRO; MATHEMATICAL-MODEL; OXYGEN-TRANSPORT; CULTURE-SYSTEM; SHEAR-STRESS; SOLID TUMOR; EXPANSION; TISSUE	A mathematical model was developed for mesenchymal stromal cell (MSC) growth in a packed bed bioreactor that improves oxygen availability by allowing oxygen diffusion through a gas-permeable wall. The governing equations for oxygen, glucose and lactate, the inhibitory waste product, were developed assuming Michaelis-Menten kinetics, together with an equation for the medium flow based on Darcy's Law. The conservation law for the cells includes the effects of inhibition as the cells reach confluence, nutrient and waste product concentrations, and the assumption that the cells can migrate on the scaffold. The equations were solved using the finite element package, COMSOL. Previous experimental results collected using a packed bed bioreactor with gas permeable walls to expand MSCs produced a lower cell yield than was obtained using a traditional cell culture flask. This mathematical model suggests that the main contributors to the observed low cell yield were a non-uniform initial cell seeding profile and a potential lag phase as cells recovered from the initial seeding procedure. Lactate build-up was predicted to have only a small effect at lower flow rates. Thus, the most important parameters to optimise cell expansion in the proliferation of MSCs in a bioreactor with gas permeable wall are the initial cell seeding protocol and the handling of the cells during the seeding process. The mathematical model was then used to identify and characterise potential enhancements to the bioreactor design, including incorporating a central gas permeable capillary to further enhance oxygen availability to the cells. Finally, to evaluate the issues and limitations that might be encountered scale-up of the bioreactor, the mathematical model was used to investigate modifications to the bioreactor design geometry and packing density.	[Osiecki, Michael J.; McElwain, Sean D. L.; Lott, William B.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Osiecki, Michael J.; Lott, William B.] Queensland Univ Technol, Sci & Engn Fac, Sch Chem Phys & Mech Engn, Brisbane, Qld, Australia; [McElwain, Sean D. L.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Osiecki, MJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.; Osiecki, MJ (corresponding author), Queensland Univ Technol, Sci & Engn Fac, Sch Chem Phys & Mech Engn, Brisbane, Qld, Australia.	m.osiecki@hdr.qut.edu.au						Andrade PZ, 2015, J TISSUE ENG REGEN M, V9, P1172, DOI 10.1002/term.1731; BALTZ JM, 1991, MOL REPROD DEV, V28, P351, DOI 10.1002/mrd.1080280407; Bear J, 1988, DYNAMICS FLUIDS PORO; Campolo M, 2013, AICHE J, V59, P3131, DOI 10.1002/aic.14084; Chen JP, 2006, J BIOSCI BIOENG, V102, P41, DOI 10.1263/jbb.102.41; Chung CA, 2007, BIOTECHNOL BIOENG, V97, P1603, DOI 10.1002/bit.21378; Coletti F, 2006, IND ENG CHEM RES, V45, P8158, DOI 10.1021/ie051144v; Craven S, 2013, BIOTECHNOL PROGR, V29, P186, DOI 10.1002/btpr.1664; David B, 2011, TISSUE ENG PART C-ME, V17, P505, DOI [10.1089/ten.tec.2010.0468, 10.1089/ten.TEC.2010.0468]; De Napoli IE, 2011, J MEMBRANE SCI, V379, P341, DOI 10.1016/j.memsci.2011.06.001; Donato D, 2014, PROCESSES, V2, P34, DOI 10.3390/pr2010034; dos Santos F, 2011, TISSUE ENG PART C-ME, V17, P1201, DOI 10.1089/ten.tec.2011.0255; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Green DW., 2007, PERRYS CHEM ENG HDB; GREENSPAN HP, 1972, STUD APPL MATH, V51, P317; Higuera G, 2009, TISSUE ENG PT A, V15, P2653, DOI [10.1089/ten.tea.2008.0328, 10.1089/ten.TEA.2008.0328]; Housler GJ, 2012, TISSUE ENG PART C-ME, V18, P133, DOI [10.1089/ten.tec.2011.0305, 10.1089/ten.TEC.2011.0305]; Kim MC, 2013, MICROFLUID NANOFLUID, V15, P285, DOI 10.1007/s10404-013-1142-8; Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874; Kitagawa T, 2006, BIOTECHNOL BIOENG, V93, P947, DOI 10.1002/bit.20797; KLEINSTREUER C, 1986, BIOTECHNOL BIOENG, V28, P1233, DOI 10.1002/bit.260280815; Lanfrey PY, 2010, CHEM ENG SCI, V65, P1891, DOI 10.1016/j.ces.2009.11.011; Lewis MC, 2005, BIOTECHNOL BIOENG, V91, P607, DOI 10.1002/bit.20508; Li DQ, 2009, TISSUE ENG PT A, V15, P2773, DOI [10.1089/ten.tea.2008.0540, 10.1089/ten.TEA.2008.0540]; Li M, 2012, J TISSUE ENG REGEN M, V6, P369, DOI 10.1002/term.439; Li Y, 2003, CYTOTECHNOLOGY, V41, P23, DOI 10.1023/A:1024283521966; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; MCELWAIN DLS, 1977, MATH BIOSCI, V35, P267, DOI 10.1016/0025-5564(77)90028-1; MILLER WM, 1988, BIOTECHNOL BIOENG, V32, P947, DOI 10.1002/bit.260320803; Mizukami A, 2013, BIOTECHNOL PROGR, V29, P568, DOI 10.1002/btpr.1707; Mohebbi-Kalhori D, 2012, J ARTIF ORGANS, V15, P250, DOI 10.1007/s10047-012-0649-1; Nold P, 2013, BIOCHEM BIOPH RES CO, V430, P325, DOI 10.1016/j.bbrc.2012.11.001; Osiecki MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144941; OYAAS J, 1995, BIOTECHNOL BIOENG, V47, P492, DOI 10.1002/bit.260470411; Pattappa G, 2011, J CELL PHYSIOL, V226, P2562, DOI 10.1002/jcp.22605; Polinkovsky M, 2009, LAB CHIP, V9, P1073, DOI 10.1039/b816191g; Sarkar S, 2011, ANN BIOMED ENG, V39, P2346, DOI 10.1007/s10439-011-0337-y; Schop D, 2009, TISSUE ENG PT A, V15, P1877, DOI 10.1089/ten.tea.2008.0345; Shakeel M, 2013, MATH MED BIOL, V30, P21, DOI 10.1093/imammb/dqr022; Shakeel M, 2013, MATH BIOSCI, V242, P86, DOI 10.1016/j.mbs.2012.12.004; Timmins NE, 2012, BIOTECHNOL BIOENG, V109, P1817, DOI 10.1002/bit.24425; Weber C, 2010, ADV BIOCHEM ENG BIOT, V123, P143, DOI 10.1007/10_2009_25; Weber C, 2010, INT J ARTIF ORGANS, V33, P512, DOI 10.1177/039139881003300802; Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759; Yeatts AB, 2013, BBA-GEN SUBJECTS, V1830, P2470, DOI 10.1016/j.bbagen.2012.06.007; Zeng AP, 1998, BIOTECHNOL PROGR, V14, P434, DOI 10.1021/bp9800337; Zhao F, 2005, BIOTECHNOL PROGR, V21, P1269, DOI 10.1021/bp0500664; Zhao F, 2007, BIOTECHNOL BIOENG, V96, P584, DOI 10.1002/bit.21184; Zhu XH, 2010, CHEM ENG SCI, V65, P2108, DOI 10.1016/j.ces.2009.12.006	51	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202079	10.1371/journal.pone.0202079	http://dx.doi.org/10.1371/journal.pone.0202079			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148832	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200007
J	Berg, AO; Jorgensen, KN; Nerhus, M; Athanasiu, L; Popejoy, AB; Bettella, F; Norbom, LCB; Gurholt, TP; Dahl, SR; Andreassen, OA; Djurovic, S; Agartz, I; Melle, I				Berg, Akiah Ottesen; Jorgensen, Kjetil N.; Nerhus, Mari; Athanasiu, Lavinia; Popejoy, Alice B.; Bettella, Francesco; Norbom, Linn Christin Bonaventure; Gurholt, Tiril P.; Dahl, Sandra R.; Andreassen, Ole A.; Djurovic, Srdjan; Agartz, Ingrid; Melle, Ingrid			Vitamin D levels, brain volume, and genetic architecture in patients with psychosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; D DEFICIENCY; D-RECEPTOR; MULTIPLE-SCLEROSIS; CALCIUM-METABOLISM; BIPOLAR DISORDER; D INSUFFICIENCY; SOCIAL STRESS; ANIMAL-MODEL; OLDER-ADULTS	Background Lower vitamin D levels are found in people with schizophrenia and depressive disorders, and also associated with neuroimaging abnormalities such as reduced brain volume in both animals and humans. Reduced whole brain and increased ventricular volume are also systematically reported in schizophrenia. Even though vitamin D deficiency has been proposed as a risk mechanism for schizophrenia there exist no studies to date of the association between vitamin D levels and brain volume in this population. Therefore, we investigated the relationship between vitamin D levels and brain phenotypes in psychotic disorders, and assessed possible interactions with genetic variants in vitamin D receptor (VDR) and other genetic variants that play a role in vitamin D levels in the body. Methods Our sample consisted of 83 psychosis patients and 101 healthy controls. We measured vitamin D levels as serum 25-hydroxyvitamin D. All participants were genotyped and neuroimaging conducted by structural magnetic resonance imaging. Results Vitamin D levels were significantly positively associated with peripheral grey matter volume in patients (beta 860.6; 95% confidence interval (CI) 333.4 +/- 1466, p<.003). A significant interaction effect of BSML marker (rs1544410) was observed to mediate the association between patient status and both white matter volume (beta 23603.3; 95% CI 2732.8 +/- 48708.6, p<.05) and whole brain volume (beta 46670.6, 95% CI 8817.8 +/- 93888.3, p<.04). Vitamin D did not predict ventricular volume, which rather was associated with patient status (beta 4423.3, 95% CI 1583.2 +/- 7267.8p < .002) and CYP24A1 marker (rs6013897) (beta 2491.5, 95% CI 269.7 +/- 4978.5, p < .04). Conclusions This is the first study of the association between vitamin D levels and brain volume in patients with psychotic disorders that takes into account possible interaction with genetic polymorphisms. The present findings warrant replication in independent samples.	[Berg, Akiah Ottesen; Jorgensen, Kjetil N.; Nerhus, Mari; Athanasiu, Lavinia; Popejoy, Alice B.; Bettella, Francesco; Norbom, Linn Christin Bonaventure; Andreassen, Ole A.; Agartz, Ingrid; Melle, Ingrid] Univ Oslo, Norwegian Ctr Mental Disorders Res NORMENT, KG Jebsen Ctr Psychosis Res, Inst Clin Med, Oslo, Norway; [Berg, Akiah Ottesen; Nerhus, Mari; Athanasiu, Lavinia; Popejoy, Alice B.; Bettella, Francesco; Norbom, Linn Christin Bonaventure; Andreassen, Ole A.; Melle, Ingrid] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Jorgensen, Kjetil N.; Norbom, Linn Christin Bonaventure; Gurholt, Tiril P.; Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Nerhus, Mari] Akershus Univ Hosp, Div Mental Hlth, Lorenskog, Norway; [Popejoy, Alice B.] Univ Washington, Inst Publ Hlth Genet, Seattle, WA 98195 USA; [Dahl, Sandra R.] Oslo Univ Hosp, Dept Med Biochem, Hormone Lab, Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan] Univ Bergen, KG Jebsen Ctr Psychosis Res, Dept Clin Sci, NORMENT, Bergen, Norway; [Agartz, Ingrid] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden	University of Oslo; University of Oslo; Diakonhjemmet Hospital; University of Oslo; University of Washington; University of Washington Seattle; University of Oslo; University of Oslo; University of Bergen; Karolinska Institutet	Berg, AO (corresponding author), Univ Oslo, Norwegian Ctr Mental Disorders Res NORMENT, KG Jebsen Ctr Psychosis Res, Inst Clin Med, Oslo, Norway.; Berg, AO (corresponding author), Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway.	a.o.berg@medisin.uio.no	Andreassen, Ole A./AAY-7531-2020; Gurholt, Tiril/S-1457-2019	Gurholt, Tiril/0000-0002-1272-7616; Djurovic, Srdjan/0000-0002-8140-8061; Nerhus, Mari/0000-0002-0468-4230	KG Jebsen Stiftelsen [SKGJ-MED-008]; Research Council of Norway [223273, 181831]; South-Eastern Norway Regional Health Authority [2017-112, 2006-258]	KG Jebsen Stiftelsen; Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	Funding for this study was provided to the Norwegian Centre for Mental Health Research by the KG Jebsen Stiftelsen (Grant #SKGJ-MED-008; http://stiftkgj.no/what-we-do/k-g-jebsen-centres-of-medical-research/?lang=en), the Research Council of Norway (Grants #223273 and #181831; https://www.forskningsradet.no/en/Home_page/1177315753906) and the South-Eastern Norway Regional Health Authority (Grants #2017-112 and #2006-258; https://www.helse-sorost.no/helsefaglig/forskning). Neither had any role in study design, data collection, analysis and interpretation, writing of the report, or the decision to submit the paper for publication.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Al-Diwani AAJ, 2017, IMMUNOLOGY, V152, P388, DOI 10.1111/imm.12795; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; Annweiler C, 2015, EXP GERONTOL, V63, P41, DOI 10.1016/j.exger.2015.01.049; Annweiler C, 2014, MATURITAS, V78, P30, DOI 10.1016/j.maturitas.2014.02.013; Annweiler C, 2013, MOL NUTR FOOD RES, V57, P267, DOI 10.1002/mnfr.201200418; Annweiler C, 2011, GERIATR PSYCHOL NEUR, V9, P259, DOI 10.1684/pnv.2011.0288; Berg AO, 2010, J CLIN PSYCHIAT, V71, P1598, DOI 10.4088/JCP.09m05299yel; Berger Gregor E, 2003, Psychopharmacol Bull, V37, P79; Berk M, 2007, MED HYPOTHESES, V69, P1316, DOI 10.1016/j.mehy.2007.04.001; Beydoun MA, 2012, AM J CLIN NUTR, V95, P163, DOI 10.3945/ajcn.111.017137; Bowman GL, 2012, NEUROLOGY, V78, P241, DOI 10.1212/WNL.0b013e3182436598; Buell JS, 2010, NEUROLOGY, V74, P18, DOI 10.1212/WNL.0b013e3181beecb7; Burton GJ, 2016, PHYSIOL REV, V96, P1509, DOI 10.1152/physrev.00029.2015; Calvello R, 2017, J NEUROIMMUNE PHARM, V12, P327, DOI 10.1007/s11481-016-9720-7; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; Chung Y, 2015, J NERV MENT DIS, V203, P336, DOI 10.1097/NMD.0000000000000286; Corporation I, IBM SPSS STAT WINDOW; Crews M, 2013, SCHIZOPHR RES, V150, P533, DOI 10.1016/j.schres.2013.08.036; Dealberto MJ, 2007, MED HYPOTHESES, V68, P259, DOI 10.1016/j.mehy.2006.07.040; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D W, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS247, DOI 10.1016/j.psyneuen.2009.04.015; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Fang Y, 2007, J CLIN ENDOCR METAB, V92, P1491, DOI 10.1210/jc.2006-1134; Farid K, 2012, NUCL MED COMMUN, V33, P1048, DOI 10.1097/MNM.0b013e32835674c4; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; FIRST MB, 1996, STRUCTURAL CLIN INTE; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Gracious BL, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-38; Groves NJ, 2017, PSYCHONEUROENDOCRINO, V86, P53, DOI 10.1016/j.psyneuen.2017.09.003; Gurholt TP, 2017, SCHIZOPHRENIA BULL, V43, pS241; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Handoko H, 2006, AM J HUM BIOL, V18, P415, DOI 10.1002/ajhb.20504; Harms LR, 2008, BEHAV BRAIN RES, V187, P343, DOI 10.1016/j.bbr.2007.09.032; Holvik K, 2005, EUR J CLIN NUTR, V59, P57, DOI 10.1038/sj.ejcn.1602033; Jorde R, 2012, ANN HUM GENET, V76, P200, DOI 10.1111/j.1469-1809.2012.00703.x; Karakis I, 2016, J ALZHEIMERS DIS, V51, P451, DOI 10.3233/JAD-150991; Kinney DK, 2010, MED HYPOTHESES, V74, P555, DOI 10.1016/j.mehy.2009.09.040; Lambrinoudaki I, 2013, NEUROL SCI, V34, P1433, DOI 10.1007/s10072-012-1259-7; LEMAY M, 1984, AM J ROENTGENOL, V143, P383, DOI 10.2214/ajr.143.2.383; Lemos MC, 2008, HUM IMMUNOL, V69, P134, DOI 10.1016/j.humimm.2008.01.008; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Mizrahi R, 2016, NEUROPSYCHOPHARMACOL, V41, P666, DOI 10.1038/npp.2015.274; Mosekilde L, 2005, CLIN ENDOCRINOL, V62, P265, DOI 10.1111/j.1365-2265.2005.02226.x; Mowry EM, 2016, EUR J NEUROL, V23, P327, DOI 10.1111/ene.12844; Mowry EM, 2011, J NEUROL SCI, V311, P19, DOI 10.1016/j.jns.2011.06.035; National Centre for Biotechnology Information, 2017, CYP24A1 CYT P450 FAM, DOI [10.1016/j.bbr.2007.09.032, DOI 10.1016/J.BBR.2007.09.032]; Nerhus M, 2017, J CLIN PSYCHIAT; Nerhus M, 2016, SCHIZOPHR RES, V178, P44, DOI 10.1016/j.schres.2016.08.024; Nerhus M, 2015, PSYCHIAT RES, V230, P616, DOI 10.1016/j.psychres.2015.10.015; Plozer E, 2015, NUTR NEUROSCI, V18, P37, DOI 10.1179/1476830514Y.0000000109; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rehn AE, 2004, NEUROSCIENCE, V129, P381, DOI 10.1016/j.neuroscience.2004.07.047; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sferruzzi-Perri AN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00033; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shin JS, 2010, PLACENTA, V31, P1027, DOI 10.1016/j.placenta.2010.08.015; Shivakumar V, 2015, PSYCHIAT RES-NEUROIM, V233, P175, DOI 10.1016/j.pscychresns.2015.06.006; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tolppanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041575; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Valipour G, 2014, J CLIN ENDOCR METAB, V99, P3863, DOI 10.1210/jc.2014-1887; van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63; van Os J, 2005, CURR OPIN PSYCHIATR, V18, P141, DOI 10.1097/00001504-200503000-00006; Virani A., 2012, CLIN HDB PSYCHOTROPI; Walhovd KB, 2014, NEUROBIOL AGING, V35, P1055, DOI 10.1016/j.neurobiolaging.2013.11.011; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Weinstock-Guttman B, 2011, J NEUROL NEUROSUR PS, V82, P189, DOI 10.1136/jnnp.2010.227942; WMA, 2008, 59 WMA; Xiong DH, 2005, J MED GENET, V42, P228, DOI 10.1136/jmg.2004.024083; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou Y, 2014, J STEROID BIOCHEM, V144, P207, DOI 10.1016/j.jsbmb.2013.10.004; Zivadinov R, 2013, J NEUROL NEUROSUR PS, V84, P1075, DOI 10.1136/jnnp-2012-304661	80	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0200250	10.1371/journal.pone.0200250	http://dx.doi.org/10.1371/journal.pone.0200250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142216	gold, Green Published, Green Submitted			2022-12-27	WOS:000442722500001
J	Tan, ZF; Meng, H; Dong, DW; Zhao, Y; Xu, AD				Tan, Zefeng; Meng, Heng; Dong, Dawei; Zhao, Ying; Xu, Anding			Blood pressure variability estimated by ARV is a predictor of poor short-term outcomes in a prospective cohort of minor ischemic stroke	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; TIME RATE; PLASMINOGEN-ACTIVATOR; IMPACT; CLASSIFICATION; COMPLICATIONS; THROMBOLYSIS; PROFILES; CHINA; INDEX	Prior studies have shown that patients with minor ischemic stroke have substantial disability rates at hospital discharge. We sought to determine whether blood pressure variability (BPV) estimated by average real variability (ARV) is one of the predictors of poor outcome at 90 days. Four hundred fifty-one consecutive patients with ischemic stroke treated within 7 days after onset were enrolled prospectively. Baseline magnetic resonance imaging (MRI) was performed on all subjects. Blood pressure was measured for all recruited patients every 2 hours in the first 24 hours after admission, followed by measurements collected every 4 hours from day 2 to day 7 after admission. ARV was used to estimate BPV. A total of 192 patients with minor ischemic stroke were enrolled, and 11 of them (5.7%) had poor outcomes. Univariate regression analysis showed that early neurological deterioration (X-2 = 21.44, P = 0.000), severe symptomatic large artery stenosis or occlusion (X-2 = 9.260, P = 0.000), large artery atherosclerotic stroke (X-2 = 7.14, P = 0.002), total cholesterol (TC), and D2-7 SBP-ARV (t = 5.449, P = 0.001) of the poor outcome group were significantly higher than those of the good outcome group. Multivariate logistic regression analysis showed that early neurological deterioration (OR 4.369, 95% CI 3.54, 15.65; P = 0.001), severe symptomatic large artery stenosis or occlusion (OR 5.56, 95% CI 3.56, 13.65; P = 0.000), large artery atherosclerotic stroke (OR 3.56, 95% CI 1.45, 7.48; P = 0.004), and D2-7 SBP-ARV (OR 3.96, 95% CI 1.90, 20.18, P = 0.008) were significantly related to poor outcomes. In conclusion, approximately 5.7% of minor ischemic stroke patients had poor outcomes. D2-7 SBP-ARV, early neurologic deterioration, severe symptomatic artery stenosis or occlusion, and large atherosclerotic stroke were the independent risk factors of poor short-term outcomes.	[Tan, Zefeng; Meng, Heng; Dong, Dawei; Zhao, Ying; Xu, Anding] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Jinan University	Xu, AD (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	tlil@jnu.edu.cn		Tan, Zefeng/0000-0001-8284-612X	Natural Science Foundation of Guangdong Province [2014A030313384]; Cultivation and Innovation Fund of Jinan University [2161533]; Medical Scientific Research Foundation of Guangdong Province [201512316463467]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Cultivation and Innovation Fund of Jinan University; Medical Scientific Research Foundation of Guangdong Province	This work was supported by Natural Science Foundation of Guangdong Province (No.2014A030313384), the Cultivation and Innovation Fund of Jinan University (grant No. 2161533), Medical Scientific Research Foundation of Guangdong Province, (No. 201512316463467), http://kyjj.gdwskj.cn/.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Aslanyan S, 2003, STROKE, V34, P2420, DOI 10.1161/01.STR.0000091233.04524.0C; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bilo G, 2007, J HYPERTENS, V25, P2058, DOI 10.1097/HJH.0b013e32829c6a60; Castillo J, 2004, STROKE, V35, P520, DOI 10.1161/01.STR.0000109769.22917.B0; Chalmers J, 1999, J HYPERTENS, V17, P151; Delgado-Mederos R, 2008, NEUROLOGY, V71, P552, DOI 10.1212/01.wnl.0000318294.36223.69; Dolan E, 2010, HYPERTENSION, V56, P179, DOI 10.1161/HYPERTENSIONAHA.110.154708; Endo K, 2013, STROKE, V44, P816, DOI 10.1161/STROKEAHA.112.681007; Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b; Fink JN, 2001, NEUROLOGY, V57, P1739, DOI 10.1212/WNL.57.9.1739; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI [10.1161/HYPERTENSIONAHA.109.140798, 10.1161/HYP.0b013e3181dfc0ad]; Ishitsuka K, 2014, HYPERTENSION, V63, P54, DOI 10.1161/HYPERTENSIONAHA.113.02189; Kang J, 2012, NEUROLOGY, V79, P2018, DOI 10.1212/WNL.0b013e3182749eb8; Kikuya M, 2000, HYPERTENSION, V36, P901, DOI 10.1161/01.HYP.36.5.901; Li Y, 2006, HYPERTENSION, V47, P359, DOI 10.1161/01.HYP.0000200695.34024.4c; MacWilliam JA, 1914, BRIT MED J, V1914, P693, DOI 10.1136/bmj.1.2778.693; Mancia G, 1997, HDB HYPERTENSION PAT, V17, P117; Manios E, 2011, J HYPERTENS, V29, P1109, DOI 10.1097/HJH.0b013e3283454ff4; Manning LS, 2015, STROKE, V46, P2482, DOI 10.1161/STROKEAHA.115.010075; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; Ohkubo T, 2007, J EPIDEMIOL, V17, P109, DOI 10.2188/jea.17.109; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; Pierdomenico SD, 2006, AM J HYPERTENS, V19, P991, DOI 10.1016/j.amjhyper.2006.03.009; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Saeed NP, 2013, CEREBROVASC DIS, V35, P257, DOI 10.1159/000347075; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Sare GM, 2009, STROKE, V40, P2098, DOI 10.1161/STROKEAHA.108.539155; Sato S, 2014, NEUROLOGY, V83, P174, DOI 10.1212/WNL.0000000000000572; Schillaci G, 2014, HYPERTENSION, V63, P217, DOI 10.1161/HYPERTENSIONAHA.113.02436; Smith EE, 2005, STROKE, V36, P2497, DOI 10.1161/01.STR.0000185798.78817.f3; Smith EE, 2011, STROKE, V42, P3110, DOI 10.1161/STROKEAHA.111.613208; Stamatelopoulos KS, 2010, J HYPERTENS, V28, P51, DOI 10.1097/HJH.0b013e328331b6c8; Stead LG, 2006, NEUROLOGY, V66, P1878, DOI 10.1212/01.wnl.0000219628.78513.b5; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tomii Y, 2011, STROKE, V42, P3511, DOI 10.1161/STROKEAHA.111.628586; Verdecchia P, 2007, AM J HYPERTENS, V20, P154, DOI 10.1016/j.amjhyper.2006.07.017; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wu LY, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0505-z; Yamamoto H, 1998, ARCH NEUROL-CHICAGO, V55, P481, DOI 10.1001/archneur.55.4.481; Yong M, 2005, STROKE, V36, P2619, DOI 10.1161/01.STR.0000189998.74892.24; Yong M, 2008, STROKE, V39, P366, DOI 10.1161/STROKEAHA.107.492330; Zakopoulos NA, 2005, HYPERTENSION, V45, P505, DOI 10.1161/01.HYP.0000158306.87582.43; Zakopoulos NA, 2006, J HYPERTENS, V24, P2071, DOI 10.1097/01.hjh.0000244957.47114.88; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807	50	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202317	10.1371/journal.pone.0202317	http://dx.doi.org/10.1371/journal.pone.0202317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142202	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500009
J	Tran, VT; Djima, MM; Messou, E; Moisan, J; Gregoire, JP; Ekouevi, DK				Viet-Thi Tran; Djima, Mariam Mama; Messou, Eugene; Moisan, Jocelyne; Gregoire, Jean-Pierre; Ekouevi, Didier K.			Avoidable workload of care for patients living with HIV infection in Abidjan, Cote d'Ivoire: A cross-sectional study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; ADHERENCE; TIME; REGIMENS; IMPROVE; QUALITY; BURDEN; HEALTH; MODEL	Objective People living with HIV infection (PLWHIV) in Sub-Saharan Africa cope with an increasing workload of care (doctor visits, lab tests, medication management, refills, etc.) in a context of poor health service organization. We aimed to describe the workload of care for PLWHIV in Sub-Saharan Africa and assess to what extent simple adjustments in care organization could reduce this workload of care. Methods Adult PLWHIV under antiretroviral treatment for at least 1 year were recruited in three centers (two public, one private) in Abidjan, Cote d'Ivoire. Using methods inspired from sociology, we precisely described all health-related activities (HRAs) performed by patients, in 1 month, in terms of time, money and opportunity costs. Then, we assessed the theoretical avoidable workload of care if patients' visits and tests had been grouped on the same days. Results We enrolled 476 PLWHIV in the study. Patients devoted 6.7 hours (SD = 6.3), on average, in HRAs per month and spent 5% (SD = 11) of their monthly revenue, on average, on health activities. However, we found great inter-patient heterogeneity in the mixture of activities performed (managing medications; dietary recommendations; visits, tests, support groups; administrative tasks; etc.) and their time allocation, temporal dispersion and opportunity costs (personal, familial, social or professional costs). For 22% of patients, grouping activities on the same days could reduce both time and cost requirements by 20%. Conclusion PLWHIV in Cote d'Ivoire have a heavy workload of care. Grouping visits and tests on the same days may be a simple and feasible way to reduce patients' investment of time and money in their care.	[Viet-Thi Tran; Djima, Mariam Mama; Messou, Eugene; Ekouevi, Didier K.] Programme PAC CI, Abidjan, Cote Ivoire; [Viet-Thi Tran] Ctr Rech Epidemiol & Stat Sorbonne Paris Cite, METHODS Team, CRESS, UMR1153, Paris, France; [Djima, Mariam Mama] Inst Pasteur, Abidjan, Cote Ivoire; [Djima, Mariam Mama; Moisan, Jocelyne; Gregoire, Jean-Pierre] Laval Univ, Fac Pharm, Quebec City, PQ, Canada; [Ekouevi, Didier K.] Bordeaux Populat Hlth UMR1219, Bordeaux, France	UDICE-French Research Universities; Universite Paris Cite; Laval University	Tran, VT (corresponding author), Programme PAC CI, Abidjan, Cote Ivoire.; Tran, VT (corresponding author), Ctr Rech Epidemiol & Stat Sorbonne Paris Cite, METHODS Team, CRESS, UMR1153, Paris, France.	thi-tran-viet@aphp.fr	EKOUEVI, Didier K/E-7960-2014; Tran, Viet-Thi/Q-2789-2019; Tran, Viet-Thi/F-1023-2018	Tran, Viet-Thi/0000-0003-1863-6739; Tran, Viet-Thi/0000-0003-1863-6739	French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales - ANRS) [12365]; Fondation pour la Recherche Medicale [40284]	French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales - ANRS); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales - ANRS) [grant number 12365]; and the "Fondation pour la Recherche Medicale" [grant number 40284 to Viet-Thi Tran]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213; Belli RF, 1998, MEMORY, V6, P383, DOI 10.1080/741942610; Bezabhe WM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003361; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Croome N, 2017, AIDS, V31, P995, DOI 10.1097/QAD.0000000000001416; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; du Vaure CB, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010119; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Ellman T, 2015, NEW ENGL J MED, V372, P303, DOI 10.1056/NEJMp1414730; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Gandhi RT, 2012, CLIN INFECT DIS, V54, P733, DOI 10.1093/cid/cir933; Haas AD, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25084; Haas AD, 2015, LANCET HIV, V2, pE271, DOI 10.1016/S2352-3018(15)00087-9; Hirschhorn Lisa R, 2012, AIDS, V26 Suppl 1, pS65; Hoffmann CJ, 2016, AIDS EDUC PREV, V28, P351, DOI 10.1521/aeap.2016.28.4.351; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Jacqmin-Gadda H, 2007, COMPUT STAT DATA AN, V51, P5142, DOI 10.1016/j.csda.2006.05.021; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Jowsey T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1044; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kwena ZA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19876; Lazarus JV, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0640-4; Mabuto T, 2018, AIDS BEHAV, V22, P3751, DOI 10.1007/s10461-018-2089-2; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Ministere de la Lutte contre le Sida. Suivi de la declaration d'engagement sur le VIH/SIDA (UNGASS), 2008, SUIV DECL ENG VIH SI; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; Naidoo L, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i1.1084; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Russell LB, 2005, J FAM PRACTICE, V54, P52; Sebaaly JC, 2017, ANN PHARMACOTHER, V51, P332, DOI 10.1177/1060028016682531; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Sidorkiewicz S, 2016, ANN FAM MED, V14, P415, DOI 10.1370/afm.1965; Sidorkiewicz S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010510; Siedner MJ, 2013, AIDS, V27, P1503, DOI 10.1097/QAD.0b013e32835fd873; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Tran VT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0356-x; Tran VT, 2016, MOTUHS BOT STUDY PRO; UNAIDS, 2014, 90 90 90 AMB TREATM; Vrijens B, 2005, STAT MED, V24, P2719, DOI 10.1002/sim.2130; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011	43	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202911	10.1371/journal.pone.0202911	http://dx.doi.org/10.1371/journal.pone.0202911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142165	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500048
J	Bradway, M; Pfuhl, G; Joakimsen, R; Ribu, L; Grottland, A; Arsand, E				Bradway, Meghan; Pfuhl, Gerit; Joakimsen, Ragnar; Ribu, Lis; Grottland, Astrid; Arsand, Eirik			Analysing mHealth usage logs in RCTs: Explaining participants' interactions with type 2 diabetes self-management tools	PLOS ONE			English	Article							HABIT FORMATION; BEHAVIOR; INTERVENTION; INDIVIDUALS; OUTCOMES; IMPACT	Background The Introduction of mobile health (mHealth) devices to health intervention studies challenges us as researchers to adapt how we analyse the impact of these technologies. For interventions involving chronic illness self-management, we must consider changes in behaviour in addition to changes in health. Fortunately, these mHealth technologies can record participants' interactions via usage-logs during research interventions. Objective The objective of this paper is to demonstrate the potential of analysing mHealth usage-logs by presenting an in-depth analysis as a preliminary study for using behavioural theories to contextualize the user-recorded results of mHealth intervention studies. We use the logs collected by persons with type 2 diabetes during a randomized controlled trial (RCT) as a use-case. Methods The Few Touch Application was tested in a year-long intervention, which allowed participants to register and review their blood glucose, diet and physical activity, goals, and access general disease information. Usage-logs, i.e. logged interactions with the mHealth devices, were collected from participants (n = 101) in the intervention groups. HbA1c was collected (baseline, 4- and 12-months). Usage logs were categorized into registrations or navigations. Results There were n = 29 non-mHealth users, n = 11 short-term users and n = 61 long-term users. Non-mHealth users increased (+0.33%) while Long-term users reduced their HbA1c (0.86%), which was significantly different (P = .021). Long-term users significantly decreased their usage over the year (P < .001). K-means clustering revealed two clusters: one dominated by diet/exercise interactions (n = 16), and one dominated by BG interactions and navigations in general (n = 40). The only significant difference between these two clusters was that the first cluster spent more time on the goals functionalities than the second (P < .001). Conclusion By comparing participants based upon their usage-logs, we were able to discern differences in HbA1c as well as usage patterns. This approach demonstrates the potential of analysing usage-logs to better understand how participants engage during mHealth intervention studies.	[Bradway, Meghan; Grottland, Astrid; Arsand, Eirik] Univ Hosp North Norway, Norwegian Ctr E Hlth Res, Tromso, Norway; [Bradway, Meghan; Joakimsen, Ragnar; Arsand, Eirik] UiT Arctic Univ Norway, Dept Clin Med, Tromso, Norway; [Pfuhl, Gerit] UiT Arctic Univ Norway, Dept Psychol, Tromso, Norway; [Joakimsen, Ragnar] Univ Hosp North Norway, Dept Internal Med, Tromso, Norway; [Ribu, Lis] Oslo Metropolitan Univ, Dept Nursing & Hlth Promot, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Oslo Metropolitan University (OsloMet)	Bradway, M (corresponding author), Univ Hosp North Norway, Norwegian Ctr E Hlth Res, Tromso, Norway.; Bradway, M (corresponding author), UiT Arctic Univ Norway, Dept Clin Med, Tromso, Norway.	meghan.bradway@healthresearch.no	Pfuhl, Gerit/AAY-2940-2020; Pfuhl, Gerit/AAY-2976-2020	Pfuhl, Gerit/0000-0002-3271-6447; Pfuhl, Gerit/0000-0002-3271-6447; Joakimsen, Ragnar Martin/0000-0002-2125-8081	Competitiveness and Innovation Framework Programme [250487]; Research Council of Norway [196364]; UiT The Arctic University of Norway [551011];  [247974/O70]	Competitiveness and Innovation Framework Programme; Research Council of Norway(Research Council of Norway); UiT The Arctic University of Norway; 	The EU's ICT Policy Support Programme as part of the Competitiveness and Innovation Framework Programme (http://ec.europa.eu/cip/) (No. 250487) and The Research Council of Norway (norges forskningsrad, https://www.forskningsradet.no/no/Forsiden/1173185591033) (No. 196364) funded the study design and data collection and analysis through the REgioNs of Europe WorkINg toGether for HEALTH (RENEWING HEALTH) project (https://cordis.europa.eu/project/rcn/191719_en.html), led by Lis Ribu and Eirik Arsand. The Research Council of Norway (norges forskningsrad, https://www.forskningsradet.no/no/Forsiden/1173185591033) funded the preparation of the manuscript and decision to publish through the <feminine ordinal indicator "Full Flow of Health Data Between Patients and Health Care Systems" project (https://ehealthresearch.no/en/projects/fullflow) (grant number 247974/O70), led by Eirik A rsand. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway (https://uit.no/ub/forskningsstotte/art?p_document_id=449104) (No. 551011), led by Meghan Bradway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, FULL FLOW HLTH DAT P; Arsand E, 2016, TAILORING TYPE 2 DIA; Arsand Eirik, 2010, J Diabetes Sci Technol, V4, P328; Attwood S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4358-9; Brousselle A, 2011, EVAL PROGRAM PLANN, V34, P69, DOI 10.1016/j.evalprogplan.2010.04.001; Carter MC, 2017, WEIGHT LOSS ASS DIFF, V5, pe8, DOI [10.2196/mhealth.4520, DOI 10.2196/MHEALTH.4520]; Chen H.T., 2012, EVALUATION PROGRAMME, P17, DOI [10.1007/978-3-531-19009-9_2, DOI 10.1007/978-3-531-19009-9_2]; Coryn CLS, 2011, AM J EVAL, V32, P199, DOI 10.1177/1098214010389321; Everett E, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9723; Gamito P, 2017, METHOD INFORM MED, V56, P156, DOI 10.3414/ME16-02-0012; Gardner B, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0135-7; Gardner B, 2012, BRIT J GEN PRACT, V62, P664, DOI 10.3399/bjgp12X659466; Holmen H, MOBILE HLTH INTERV 2, V2, pe57, DOI [10.2196/mhealth.3882, DOI 10.2196/MHEALTH.3882]; Holmen H, 2016, BMJ OPEN DIABETES RE, V4, DOI [10.2196/mental.584310.1136/bmjdrc-2016-000193, DOI 10.2196/MENTAL.584310.1136/BMJDRC-2016-000193]; Holmen H, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3882; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Laursen Ditte Hjorth, 2017, BMC Res Notes, V10, P213, DOI 10.1186/s13104-017-2536-6; Lee LT, 2017, JNP-J NURSE PRACT, V13, P265, DOI 10.1016/j.nurpra.2016.07.013; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Mohn J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013295; Mulvaney SA, 2012, HEALTH PSYCHOL, V31, P43, DOI 10.1037/a0025543; Nilsen P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-53; O'Hea EL, 2009, J BEHAV MED, V32, P106, DOI 10.1007/s10865-008-9188-x; Parchman ML, 2010, ANN FAM MED, V8, P410, DOI 10.1370/afm.1161; Quinn CC, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9265; Rahman QA, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7871; Rey Lynda, 2011, Can J Program Eval, V26, P61; Ribu L, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2768; Rothman AJ, 2009, ANN BEHAV MED, V38, pS4, DOI 10.1007/s12160-009-9118-3; Sheeran P, 2017, ANNU REV PSYCHOL, V68, P573, DOI 10.1146/annurev-psych-010416-044007; Skrovseth SO, 2012, DIABETES TECHNOL THE, V14, P1098, DOI 10.1089/dia.2012.0160; Song M, 2015, RES THEOR NURS PRACT, V29, P94, DOI 10.1891/1541-6577.29.2.94; The JASP Team, 2017, JASP VERS 0 8 2; Torbjornsen A, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3535	35	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203202	10.1371/journal.pone.0203202	http://dx.doi.org/10.1371/journal.pone.0203202			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161248	gold, Green Submitted, Green Published			2022-12-27	WOS:000443388900089
J	Ries, D; Carriquiry, A; Shook, R				Ries, Daniel; Carriquiry, Alicia; Shook, Robin			Modeling energy balance while correcting for measurement error via free knot splines	PLOS ONE			English	Article							DOUBLY LABELED WATER; CONDITIONALLY HETEROSCEDASTIC MEASUREMENT; RANDOMIZED CONTROLLED-TRIAL; NUTRITIONAL EPIDEMIOLOGY; CALORIE RESTRICTION; ACTIVITY MONITORS; WEARABLE DEVICES; BODY-COMPOSITION; IDENTICAL-TWINS; WEIGHT-GAIN	Measurements of energy balance components (energy intake, energy expenditure, changes in energy stores) are often plagued with measurement error. Doubly-labeled water can measure energy intake (EI) with negligible error, but is expensive and cumbersome. An alternative approach that is gaining popularity is to use the energy balance principle, by measuring energy expenditure (EE) and change in energy stores (ES) and then back-calculate EI. Gold standard methods for EE and ES exist and are known to give accurate measurements, albeit at a high cost. We propose a joint statistical model to assess the measurement error in cheaper, non-intrusive measures of EE and ES. We let the unknown true EE and ES for individuals be latent variables, and model them using a bivariate distribution. We try both a bivariate Normal as well as a Dirichlet Process Mixture Model, and compare the results via simulation. Our approach, is the first to account for the dependencies that exist in individuals' daily EE and ES. We employ semiparametric regression with free knot splines for measurements with error, and linear components for error free covariates. We adopt a Bayesian approach to estimation and inference and use Reversible Jump Markov Chain Monte Carlo to generate draws from the posterior distribution. Based on the semiparameteric regression, we develop a calibration equation that adjusts a cheaper, less reliable estimate, closer to the true value. Along with this calibrated value, our method also gives credible intervals to assess uncertainty. A simulation study shows our calibration helps produce a more accurate estimate. Our approach compares favorably in terms of prediction to other commonly used models.	[Ries, Daniel] Sandia Natl Labs, Stat Sci Dept, POB 5800, Albuquerque, NM 87185 USA; [Ries, Daniel; Carriquiry, Alicia] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Shook, Robin] Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO USA	United States Department of Energy (DOE); Sandia National Laboratories; Iowa State University	Ries, D (corresponding author), Sandia Natl Labs, Stat Sci Dept, POB 5800, Albuquerque, NM 87185 USA.; Ries, D (corresponding author), Iowa State Univ, Dept Stat, Ames, IA 50011 USA.	dries@sandia.gov		Ries, Daniel/0000-0002-5029-4647	NIH [HL091024]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by NIH grant HL091024. There was no additional external funding received for this study. This paper describes objective technical results and analysis. Any subjective views or opinions that might be expressed in the paper do not necessarily represent the views of the U.S. Department of Energy or the United States Government.	alger K., 2014, WEARABLE TECHNOLOGY; [Anonymous], 2007, PROJECT REPROT; Berry SM, 2002, J AM STAT ASSOC, V97, P160, DOI 10.1198/016214502753479301; Bouchard C, 1996, METABOLISM, V45, P1042, DOI 10.1016/S0026-0495(96)90277-2; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Bouchard C, 1994, Obes Res, V2, P400; Bouten CVC, 1996, J APPL PHYSIOL, V81, P1019, DOI 10.1152/jappl.1996.81.2.1019; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Caroll R, MEASUREMENT ERROR NO; de Boor C., 2001, APPL MATH SCI, V27; de Jonge L, 2007, AM J CLIN NUTR, V85, P73, DOI 10.1093/ajcn/85.1.73; Denison DGT, 1998, J ROY STAT SOC B, V60, P333, DOI 10.1111/1467-9868.00128; DiMatteo I, 2001, BIOMETRIKA, V88, P1055, DOI 10.1093/biomet/88.4.1055; Fuller W.A., 2009, MEASUREMENT ERROR MO; Gelman A., 2021, BAYESIAN DATA ANAL; Gilmore LA, 2014, AM J CLIN NUTR, V100, P806, DOI 10.3945/ajcn.114.087122; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.1093/biomet/82.4.711; Hall KD, 2011, AM J CLIN NUTR, V94, P66, DOI 10.3945/ajcn.111.014399; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Kipnis V, 2016, BIOMETRICS, V72, P106, DOI 10.1111/biom.12377; Kipnis V, 2009, BIOMETRICS, V65, P1003, DOI 10.1111/j.1541-0420.2009.01223.x; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; Lee JM, 2014, MED SCI SPORT EXER, V46, P1840, DOI 10.1249/MSS.0000000000000287; Leitenstorfer F, 2007, BIOSTATISTICS, V8, P654, DOI 10.1093/biostatistics/kxl036; Murakami H, 2016, JAMA INTERN MED, V176, P702, DOI 10.1001/jamainternmed.2016.0152; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; Pharm FEAB, 2015, HEALTHC INFORM RES, V21, P315, DOI 10.4258/hir.2015.21.4.315; Racette SB, 2012, AM J PHYSIOL-ENDOC M, V302, pE441, DOI 10.1152/ajpendo.00290.2011; Sanghvi A, 2015, AM J CLIN NUTR, V102, P353, DOI 10.3945/ajcn.115.111070; Sarkar A, 2014, BIOMETRICS, V70, P823, DOI 10.1111/biom.12197; Sarkar A, 2014, J COMPUT GRAPH STAT, V23, P1101, DOI 10.1080/10618600.2014.899237; Shook RP, 2018, J NUTR, V148, P490, DOI 10.1093/jn/nxx029; Sinha S, 2010, BIOMETRICS, V66, P444, DOI 10.1111/j.1541-0420.2009.01309.x; Takezawa K, 2006, INTRODUCTION TO NONPARAMETRIC REGRESSION, P1; Thomas DM, 2014, AM J CLIN NUTR, V100, P787, DOI 10.3945/ajcn.113.079822; Thomas Diana M., 2011, Journal of Biological Dynamics, V5, P579, DOI 10.1080/17513758.2010.508541; Tooze JA, 2002, STAT METHODS MED RES, V11, P341, DOI 10.1191/0962280202sm291ra; vonHelmholtz H., 1847, ERHALTUNG KRAFT ERHA; Wang W, 2015, AM STAT, V69, P28, DOI 10.1080/00031305.2014.969445	39	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201892	10.1371/journal.pone.0201892	http://dx.doi.org/10.1371/journal.pone.0201892			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161152	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900016
J	Aziz, F; Arof, H; Mokhtar, N; Shah, NM; Khairuddin, ASM; Hanafi, E; Abu Talip, MS				Aziz, Fayeem; Arof, Hamzah; Mokhtar, Norrima; Shah, Noraisyah M.; Khairuddin, Anis S. M.; Hanafi, Effariza; Abu Talip, Mohamad Sofian			Waste level detection and HMM based collection scheduling of multiple bins	PLOS ONE			English	Article							VEHICLE-ROUTING PROBLEM; DEVELOPING-COUNTRIES; MANAGEMENT-SYSTEMS; TIME WINDOWS; CLASSIFICATION; CHALLENGES; FACILITIES; NETWORK; DESIGN; CITIES	In this paper, an image-based waste collection scheduling involving a node with three waste bins is considered. First, the system locates the three bins and determines the waste level of each bin using four Laws Masks and a set of Support Vector Machine (SVM) classifiers. Next, a Hidden Markov Model (HMM) is used to decide on the number of days remaining before waste is collected from the node. This decision is based on the HMM's previous state and current observations. The HMM waste collection scheduling seeks to maximize the number of days between collection visits while preventing waste contamination due to late collection. The proposed system was trained using 100 training images and then tested on 100 test images. Each test image contains three bins that might be shifted, rotated, occluded or toppled over. The upright bins could be empty, partially full or full of garbage of various shapes and sizes. The method achieves bin detection, waste level classification and collection day scheduling rates of 100%, 99.8% and 100% respectively.	[Aziz, Fayeem; Arof, Hamzah; Mokhtar, Norrima; Shah, Noraisyah M.; Khairuddin, Anis S. M.; Hanafi, Effariza; Abu Talip, Mohamad Sofian] Univ Malaya, Fac Engn, Kuala Lumpur, Malaysia; [Aziz, Fayeem] Univ Newcastle, Sch Elect Engn & Comp, Callaghan, NSW, Australia	Universiti Malaya; University of Newcastle	Arof, H (corresponding author), Univ Malaya, Fac Engn, Kuala Lumpur, Malaysia.	ahamzah@um.edu.my	Hanafi, Effariza/N-1534-2015; Aziz, Fayeem/AAD-6804-2020; AROF, HAMZAH/ABI-1052-2020; ABU TALIP, MOHAMAD SOFIAN/B-9030-2010; mokhtar, norrima/B-9395-2010; KHAIRUDDIN, ANIS SALWA MOHD/B-5340-2010; Shah, Noraisyah Mohamed/B-9338-2010	Hanafi, Effariza/0000-0001-6384-0435; Aziz, Fayeem/0000-0001-7542-8990; ABU TALIP, MOHAMAD SOFIAN/0000-0003-1111-5770; KHAIRUDDIN, ANIS SALWA MOHD/0000-0002-9873-4779; Shah, Noraisyah Mohamed/0000-0002-1320-8711	Ministry of Higher Education, Malaysia [D000016-16001]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This research is fully funded by High Impact Research Grant Scheme (D000016-16001) under the Ministry of Higher Education, Malaysia.	Amponsah SK, 2004, WASTE MANAGE, V24, P711, DOI 10.1016/j.wasman.2004.01.008; Anagnostopoulos T, 2017, IEEE T SUST COMPUT, V2, P275, DOI 10.1109/TSUSC.2017.2691049; Angelelli E, 2002, EUR J OPER RES, V137, P233, DOI 10.1016/S0377-2217(01)00206-5; Aziz F, 2015, MEASUREMENT, V65, P19, DOI 10.1016/j.measurement.2014.12.027; Bautista J, 2008, COMPUT OPER RES, V35, P3020, DOI 10.1016/j.cor.2007.01.029; Beltrami E.J., 1974, NETWORKS, V4, P65, DOI [10.1002/net.3230040106, DOI 10.1002/NET.3230040106]; Benjamin AM, 2010, COMPUT OPER RES, V37, P2270, DOI 10.1016/j.cor.2010.03.019; Catania V, 2014, PROC CONF OPEN INNOV, P24, DOI 10.1109/FRUCT.2014.6872422; Chang NB, 1997, J ENVIRON ENG-ASCE, V123, P901, DOI 10.1061/(ASCE)0733-9372(1997)123:9(901); Chang NB, 1997, EUR J OPER RES, V99, P303, DOI 10.1016/S0377-2217(96)00024-0; Dash S, 2018, J APPL RES TECHNOLOG; de Figueiredo JN, 2008, TRANSPORT RES E-LOG, V44, P731, DOI 10.1016/j.tre.2007.04.002; Fuchs A, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/2/025201; Guerrero LA, 2013, WASTE MANAGE, V33, P220, DOI 10.1016/j.wasman.2012.09.008; Hannan MA, 2015, WASTE MANAGE, V43, P509, DOI 10.1016/j.wasman.2015.05.033; Hannan MA, 2012, WASTE MANAGE, V32, P2229, DOI 10.1016/j.wasman.2012.06.002; Islam MS, 2014, WASTE MANAGE, V34, P281, DOI 10.1016/j.wasman.2013.10.030; Jiu Huang, 2010, 2010 Proceedings of 3rd International Congress on Image and Signal Processing (CISP 2010), P1657, DOI 10.1109/CISP.2010.5647729; Johansson OM, 2006, WASTE MANAGE, V26, P875, DOI 10.1016/j.wasman.2005.09.004; Kim BI, 2006, COMPUT OPER RES, V33, P3624, DOI 10.1016/j.cor.2005.02.045; Laws KI, 1980, TEXTURED IMAGE SEGME; Lee DH, 2008, TRANSPORT RES E-LOG, V44, P455, DOI 10.1016/j.tre.2006.11.003; Leitao PO, 2009, ISWA APESB2009 WORLD; Lin YQ, 2011, PROC CVPR IEEE, P1689, DOI 10.1109/CVPR.2011.5995477; Liu P, 2017, SOFT COMPUT, V21, P7053, DOI [10.1007/s00500-016-2247-2, DOI 10.1007/s00500-016-2247-2]; McLeod F, 2013, TRANSPORT RES REC, P65, DOI 10.3141/2378-07; McLeod FN, 2011, INT J LOGIST-RES APP, V14, P399, DOI 10.1080/13675567.2011.641526; Nuortio T, 2006, EXPERT SYST APPL, V30, P223, DOI 10.1016/j.eswa.2005.07.009; Paksoy T, 2011, TRANSPORT RES E-LOG, V47, P532, DOI 10.1016/j.tre.2010.12.001; Reverter F, 2003, IEEE SENSOR, P7; Rovetta A, 2009, WASTE MANAGE, V29, P2939, DOI 10.1016/j.wasman.2009.08.016; Sanaee SA, 2009, ULTRASOUND MONITORIN; Scholkopf Bernhard., 2002, LEARNING KERNELS SUP; Schuster-Bockler B, 2007, CURRENT PROTOCOLS BI, V18, P1; Schweiger K, 2013, TRANSPORT RES E-LOG, V50, P98, DOI 10.1016/j.tre.2012.10.006; Shenbagavalli R., 2011, BONFRING INT J ADV I, V1, P15, DOI DOI 10.9756/BIJAIP.1004; Shih LH, 2001, ENVIRON MODEL ASSESS, V6, P261, DOI 10.1023/A:1013342102025; Teixeira J, 2004, EUR J OPER RES, V158, P543, DOI 10.1016/S0377-2217(03)00379-5; Tung DV, 2000, EUR J OPER RES, V125, P449, DOI 10.1016/S0377-2217(99)00408-7; Vicentini F, 2009, WASTE MANAGE, V29, P1467, DOI 10.1016/j.wasman.2008.10.017; Wilson DC, 2007, WASTE MANAGE RES, V25, P198, DOI 10.1177/0734242X07079149; Wright LA, 2011, CARBON MANAG, V2, P49, DOI 10.4155/CMT.10.41; Yiran Zhao, 2017, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, V1, DOI 10.1145/3132027; Zhu M., 2009, RESOUR SCI, V9, P025; Zhu MH, 2009, WASTE MANAGE, V29, P1227, DOI 10.1016/j.wasman.2008.07.016	45	6	6	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202092	10.1371/journal.pone.0202092	http://dx.doi.org/10.1371/journal.pone.0202092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157219	gold, Green Published, Green Submitted			2022-12-27	WOS:000443071400035
J	Bruchmann, K; Koopmann-Holm, B; Scherer, A				Bruchmann, Kathryn; Koopmann-Holm, Birgit; Scherer, Aaron			Seeing beyond political affiliations: The mediating role of perceived moral foundations on the partisan similarity-liking effect	PLOS ONE			English	Article							COMPETENCE; STEREOTYPES; ATTRACTION; PREJUDICE; IDEOLOGY; PREDICT; CONSERVATIVES; ORIENTATION; SOCIABILITY; PERCEPTIONS	Decades of research have demonstrated that we like people who are more similar to us. The present research tested a potential mechanism for this similarity-liking effect in the domain of politics: the stereotype that people's political orientation reflects their morals. People believe that Democrats are more likely to endorse individualizing morals like fairness and Republicans are more likely to endorse binding morals like obedience to authority. Prior to the 2016 election, American participants (N = 314) viewed an ostensible Facebook profile that shared an article endorsing conservative ideals (pro-Trump or pro-Republican), or liberal ideals (pro-Clinton or pro-Democrat). Participants rated the favorability of the profileowner, and completed the Moral Foundations Questionnaire for the profile-owner and themselves. As predicted, participants liked the profile-owner more when they shared political beliefs, and used political stereotypes to infer the moral foundations of the profile-owner. Additionally, the perceived moral foundation endorsement of the profile owner differentially mediated the relationship between the ideology and evaluations of the profile owner based on the party affiliation of the participant: perceived individualizing foundations mediated the relationship for Democratic participants and perceived binding foundations mediated the relationship for Republican participants. In other words, people liked their in-group members more because they thought that the profile-owner endorsed a specific type of morals. In Study 2 (N = 486), we ruled out the potential explanation that any political stereotype can account for the similarity-liking effect, replicating the results of Study 1 even when controlling for perceptions of other personality differences. Taken together, these studies highlight that there may be something unique about the perceived type of morality of political in-group and out-group members that may be contributing to the similarity-liking effect in politics.	[Bruchmann, Kathryn; Koopmann-Holm, Birgit] Santa Clara Univ, Dept Psychol, Santa Clara, CA 95053 USA; [Scherer, Aaron] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	Santa Clara University; University of Iowa	Bruchmann, K (corresponding author), Santa Clara Univ, Dept Psychol, Santa Clara, CA 95053 USA.	kbruchmann@scu.edu		Scherer, Aaron M/0000-0002-4134-9300; Bruchmann, Kathryn/0000-0003-4623-5297	Santa Clara University [14015]	Santa Clara University	This work was supported by Santa Clara University, Dean's Grant #14015, $1500, KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford JR, 2011, J POLIT, V73, P362, DOI 10.1017/S0022381611000016; Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Ben-Ner A, 2009, J ECON BEHAV ORGAN, V72, P153, DOI 10.1016/j.jebo.2009.05.007; Bhatia S, 2018, SOC PSYCHOL PERS SCI, V9, P123, DOI 10.1177/1948550617751584; Blake A., 2016, WASHINGTON POST; Brambilla M, 2013, J EXP SOC PSYCHOL, V49, P811, DOI 10.1016/j.jesp.2013.04.005; Brambilla M, 2012, BRIT J SOC PSYCHOL, V51, P149, DOI 10.1111/j.2044-8309.2010.02011.x; Brambilla M, 2011, EUR J SOC PSYCHOL, V41, P135, DOI 10.1002/ejsp.744; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; BRYNE D, 1964, PSYCHON SCI, V1, P93; BYRNE D, 1969, HUM RELAT, V22, P251, DOI 10.1177/001872676902200305; Byrne D, 1997, J SOC PERS RELAT, V14, P417, DOI 10.1177/0265407597143008; BYRNE D, 1961, HUM RELAT, V14, P283, DOI 10.1177/001872676101400305; Byrne D., 1971, ATTRACTION PARADIGM, V1st ed.; Chambers JR, 2006, PERS SOC PSYCHOL B, V32, P1295, DOI 10.1177/0146167206289979; Chambers JR, 2013, PSYCHOL SCI, V24, P140, DOI 10.1177/0956797612447820; Chambers JR, 2006, PSYCHOL SCI, V17, P38, DOI 10.1111/j.1467-9280.2005.01662.x; Cho WKT, 2013, ANN ASSOC AM GEOGR, V103, P856, DOI 10.1080/00045608.2012.720229; Chopik WJ, 2016, SOC PSYCHOL PERS SCI, V7, P759, DOI 10.1177/1948550616658096; Clifford S, 2013, J POLIT, V75, P659, DOI 10.1017/S0022381613000492; Collisson B, 2014, J SOC PSYCHOL, V154, P384, DOI 10.1080/00224545.2014.914882; Crawford JT, 2011, PERS SOC PSYCHOL B, V37, P529, DOI 10.1177/0146167211399473; Duckitt J, 2002, J PERS SOC PSYCHOL, V83, P75, DOI 10.1037//0022-3514.83.1.75; Duggan M., 2016, POLITICAL ENV SOCIAL; Ellemers N, 2008, J PERS SOC PSYCHOL, V95, P1397, DOI 10.1037/a0012628; Eriksson K, 2015, POLIT PSYCHOL, V36, P341, DOI 10.1111/pops.12093; Franks AS, 2015, ANAL SOC ISS PUB POL, V15, P213, DOI 10.1111/asap.12074; Frimer JA, 2017, J EXP SOC PSYCHOL, V72, P1, DOI 10.1016/j.jesp.2017.04.003; Goodwin GP, 2014, J PERS SOC PSYCHOL, V106, P148, DOI 10.1037/a0034726; Gosling SD, 2002, J PERS SOC PSYCHOL, V82, P379, DOI 10.1037//0022-3514.82.3.379; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Inbar Y, 2012, PERSPECT PSYCHOL SCI, V7, P496, DOI 10.1177/1745691612448792; Iyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042366; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; Jones JT, 2004, J PERS SOC PSYCHOL, V87, P665, DOI 10.1037/0022-3514.87.5.665; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; JUDD CM, 1993, PSYCHOL REV, V100, P109, DOI 10.1037/0033-295X.100.1.109; Kay AC, 2003, J PERS SOC PSYCHOL, V85, P823, DOI 10.1037/0022-3514.85.5.823; Koleva SP, 2012, J RES PERS, V46, P184, DOI 10.1016/j.jrp.2012.01.006; Landy JF, 2016, PERS SOC PSYCHOL B, V42, P1272, DOI 10.1177/0146167216655984; Leach CW, 2007, J PERS SOC PSYCHOL, V93, P234, DOI 10.1037/0022-3514.93.2.234; Levordashka A, 2017, SOC PSYCHOL PERS SCI, V8, P93, DOI 10.1177/1948550616663803; Mallinas SR, 2018, J SOC POLIT PSYCHOL, V6, P49, DOI 10.5964/jspp.v6i1.747; McAdams DP, 2008, J PERS SOC PSYCHOL, V95, P978, DOI 10.1037/a0012650; McDermott R, 2014, AM J POLIT SCI, V58, P997, DOI 10.1111/ajps.12133; McDonald I, 2011, AM POLIT RES, V39, P512, DOI 10.1177/1532673X10396303; McLaughlin B, 2018, J MEDIA PSYCHOL-GER, V30, P41, DOI 10.1027/1864-1105/a000176; Montoya RM, 2008, J SOC PERS RELAT, V25, P889, DOI 10.1177/0265407508096700; Motyl M., 2016, SOCIAL PSYCHOL POLIT, P7; Motyl M, 2014, J EXP SOC PSYCHOL, V51, P1, DOI 10.1016/j.jesp.2013.10.010; MULLEN B, 1992, EUR J SOC PSYCHOL, V22, P103, DOI 10.1002/ejsp.2420220202; Nilsson A, 2016, J RES PERS, V65, P22, DOI 10.1016/j.jrp.2016.07.001; Olivola CY, 2012, SOC PSYCHOL PERS SCI, V3, P605, DOI 10.1177/1948550611432770; Pagliaro S, 2013, J BUS ETHICS, V117, P37, DOI 10.1007/s10551-012-1508-y; Pagliaro S, 2011, PERS SOC PSYCHOL B, V37, P1117, DOI 10.1177/0146167211406906; Pew Research Center, 2016, PARTISANSHIP POLITIC; Pietraszewski D, 2015, COGNITION, V140, P24, DOI 10.1016/j.cognition.2015.03.007; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Reid CA, 2013, J SOC PSYCHOL, V153, P700, DOI 10.1080/00224545.2013.824404; Riva P, 2016, BRIT J SOC PSYCHOL, V55, P88, DOI 10.1111/bjso.12114; ROBINSON RJ, 1995, J PERS SOC PSYCHOL, V68, P404, DOI 10.1037/0022-3514.68.3.404; Roets A, 2011, PERS INDIV DIFFER, V50, P90, DOI 10.1016/j.paid.2010.09.004; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Rutchick AM, 2009, ANAL SOC ISS PUB POL, V9, P269, DOI 10.1111/j.1530-2415.2009.01183.x; Sawaoka T, 2014, SOC COGNITION, V32, P360, DOI 10.1521/soco.2014.32.4.360; SCHACHTER S, 1951, J ABNORM SOC PSYCH, V46, P190, DOI 10.1037/h0062326; Scherer AM, 2015, SOC PSYCHOL PERS SCI, V6, P201, DOI 10.1177/1948550614549385; Shkurko AV, 2015, J THEOR SOC BEHAV, V45, P188, DOI 10.1111/jtsb.12063; Tskhay KO, 2015, EMOTION, V15, P812, DOI 10.1037/emo0000077; TURNER JC, 1979, EUR J SOC PSYCHOL, V9, P187, DOI 10.1002/ejsp.2420090207; Vainio A, 2016, J AGR ENVIRON ETHIC, V29, P265, DOI 10.1007/s10806-016-9601-3; van Leeuwen F, 2009, PERS INDIV DIFFER, V47, P169, DOI 10.1016/j.paid.2009.02.017; WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049; Wells GL, 1999, PERS SOC PSYCHOL B, V25, P1115, DOI 10.1177/01461672992512005; Wilson JP, 2014, PLOS ONE, V9, P1; Winterich KP, 2012, INT J RES MARK, V29, P346, DOI 10.1016/j.ijresmar.2012.05.002; Wojciszke B, 1998, PERS SOC PSYCHOL B, V24, P1251, DOI 10.1177/01461672982412001; Young AI, 2014, PSYCHOL SCI, V25, P503, DOI 10.1177/0956797613510717	80	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202101	10.1371/journal.pone.0202101	http://dx.doi.org/10.1371/journal.pone.0202101			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157213	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400036
J	Qian, D; Zhang, TT; Tan, XP; Zheng, PY; Liang, ZR; Xie, JM; Jiang, J; Situ, B				Qian, Dan; Zhang, Tiantian; Tan, Xiangping; Zheng, Peiying; Liang, Zhuoru; Xie, Jingmei; Jiang, Jie; Situ, Bing			Comparison of antidiabetic drugs added to sulfonylurea monotherapy in patients with type 2 diabetes mellitus: A network meta-analysis	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; IMPROVES GLYCEMIC CONTROL; JAPANESE PATIENTS; ADD-ON; DOUBLE-BLIND; PARALLEL-GROUP; BETA-CELL; EFFICACY; PLACEBO; HYPOGLYCEMIA	Aims This study aimed to investigate the efficacy and safety of dual therapy comprising sulfonylurea (SU) plus antidiabetic drugs for the treatment of type 2 diabetes mellitus (T2DM). Methods We searched the PubMed, Cochrane library, and Embase databases for randomized clinical trials (>= 24 weeks) published up to December 28, 2017. Subsequently, we conducted pair-wise and network meta-analyses to calculate the odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals (Cls) of the outcomes. Results The final analyses included 24 trials with a total of 10,032 patients. Compared with placebo, all treatment regimens were associated with a significantly higher risk of hypoglycemia, except the combinations of SU plus sodium-glucose co-transporter-2 inhibitor (SGLT-2i) [OR, 1.35 (95% CI: 0.81 to 2.25)] or alpha-glucosidase inhibitor (AGI) [OR, 1.16 (95% CI: 0.55 to 2.44)]. Notably, the combination of SU plus glucagon-like peptide-1 receptor agonist (GLP-1 RA) was associated with the most significant increase in the risk of hypoglycemia. Furthermore, all SU-based combination regimens reduced the glycated hemoglobin (HbA1c) and fasting plasma glucose levels (FPG). However, only combinations containing SGLT-2i [MD, -1.00 kg (95% CI: -1.73 to -0.27)] and GLP-1 RA [MD, -0.56 kg (95% CI: -1.10 to -0.02)] led to weight loss. Conclusions Our findings highlight the importance of considering the risk of hypoglycemia when selecting antidiabetic drugs to be administered concomitantly with SU. Although all classes of antidiabetic drugs improved glucose control when administered in combination with SU, SGLT-2i might be the best option with respect to factors such as hypoglycemia and body weight.	[Qian, Dan; Tan, Xiangping; Zheng, Peiying; Situ, Bing] Guangzhou Med Univ, Dept Pharm, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Zhang, Tiantian; Liang, Zhuoru; Xie, Jingmei; Jiang, Jie] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Jinan University	Situ, B (corresponding author), Guangzhou Med Univ, Dept Pharm, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China.; Jiang, J (corresponding author), Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China.	lilyst@126.com; jiangjie@jnu.edu.cn						[Anonymous], 2014, DIABETES RES CLIN PR, V104, P1, DOI 10.1016/j.diabres.2012.10.001; Araki E, 2015, DIABETES OBES METAB, V17, P665, DOI 10.1111/dom.12464; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Ba JM, 2017, J DIABETES, V9, P667, DOI 10.1111/1753-0407.12456; Bachmann W, 2003, CLIN DRUG INVEST, V23, P679, DOI 10.2165/00044011-200323100-00007; Bakatselos SO, 2011, DIABETES RES CLIN PR, V93, pS92, DOI 10.1016/S0168-8227(11)70020-1; Barnett AH, 2010, INT J CLIN PRACT, V64, P1121, DOI 10.1111/j.1742-1241.2009.02332.x; Barnett AH, 2013, LANCET, V382, P1413, DOI 10.1016/S0140-6736(13)61500-7; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chacra AR, 2009, INT J CLIN PRACT, V63, P1395, DOI 10.1111/j.1742-1241.2009.02143.x; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Davidson JA, 2007, CLIN THER, V29, P1900, DOI 10.1016/j.clinthera.2007.09.011; Del Prato S, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.02.003; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Dungan KM, 2016, DIABETES OBES METAB, V18, P475, DOI 10.1111/dom.12634; Forst T, 2015, CURR MED RES OPIN, V31, P1079, DOI 10.1185/03007995.2015.1039936; Frier BM, 2014, NAT REV ENDOCRINOL, V10, P711, DOI 10.1038/nrendo.2014.170; Gantz I, 2017, DIABETES THER, V8, P793, DOI 10.1007/s13300-017-0270-7; Garber AJ, 2008, DIABETES OBES METAB, V10, P1047, DOI 10.1111/j.1463-1326.2008.00859.x; Goto A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4533; Guisasola FA, 2008, DIABETES OBES METAB, V10, P25, DOI 10.1111/j.1463-1326.2008.00882.x; Hermansen K, 2007, DIABETES OBES METAB, V9, P733, DOI 10.1111/j.1463-1326.2007.00744.x; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hsieh SH, 2011, ACTA DIABETOL, V48, P71, DOI 10.1007/s00592-010-0220-6; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Kaku K, 2010, DIABETES OBES METAB, V12, P341, DOI 10.1111/j.1463-1326.2009.01194.x; Kay S, 2017, DIABETES THER, V8, P251, DOI 10.1007/s13300-017-0245-8; Keus F, 2009, AM J GASTROENTEROL, V104, P546, DOI 10.1038/ajg.2008.22; Kobayashi K, 2014, DIABETES OBES METAB, V16, P761, DOI 10.1111/dom.12264; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Pratley RE, 2009, DIABETES OBES METAB, V11, P167, DOI 10.1111/j.1463-1326.2008.01016.x; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salvo F, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2231; Scheen AJ, 2009, DIABETIC MED, V26, P1242, DOI 10.1111/j.1464-5491.2009.02857.x; Seufert J, 2008, DIABETES RES CLIN PR, V79, P453, DOI 10.1016/j.diabres.2007.11.014; Strojek K, 2014, DIABETES THER, V5, P267, DOI 10.1007/s13300-014-0072-0; Thule PM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0473-5; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Vilsboll T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7771; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; Wolffenbuttel BHR, 2000, DIABETIC MED, V17, P40, DOI 10.1046/j.1464-5491.2000.00224.x; Yale JF, 2017, CLIN THER, V39, P2230, DOI 10.1016/j.clinthera.2017.10.003; Yang WY, 2015, J DIABETES, V7, P174, DOI 10.1111/1753-0407.12169; Zhu X-X, 2003, Diabetes Technol Ther, V5, P33, DOI 10.1089/152091503763816445	55	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202563	10.1371/journal.pone.0202563	http://dx.doi.org/10.1371/journal.pone.0202563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148851	Green Submitted, Green Published, gold			2022-12-27	WOS:000442804200015
J	Schmidt, FA; Connolly, F; Maas, MB; Grittner, U; Harms, L; Brandt, A; Paull, F; Schreiber, S; Ruprecht, K				Schmidt, Felix A.; Connolly, Florian; Maas, Matthew B.; Grittner, Ulrike; Harms, Lutz; Brandt, Alexander; Paull, Friedemann; Schreiber, Stephan; Ruprecht, Klemens			Objective assessment of a relative afferent pupillary defect by B-mode ultrasound	PLOS ONE			English	Article							OPTICA SPECTRUM DISORDERS; VISUAL-SYSTEM DAMAGE; MULTIPLE-SCLEROSIS; NEURITIS; CRITERIA	Purpose To evaluate B-mode ultrasound as a novel method for objective and quantitative assessment of a relative afferent pupillary defect (RAPD) in a prospective case-control study. Methods Seventeen patients with unilateral optic neuropathy and a clinically detectable RAPD and 17 age and sex matched healthy controls were examined with B-mode ultrasound using an Esaote-Mylab25 system according to current guidelines for orbital insonation. The swinging flashlight test was performed during ultrasound assessment with a standardized light stimulus using a penlight. Results B-mode ultrasound RAPD examination was doable in approximately 5 minutes only and was well tolerated by all participants. Compared to the unaffected contralateral eyes, eyes with RAPD showed lower absolute constriction amplitude of the pupillary diameter (mean [SD] 0.8 [0.4] vs. 2.1 [0.4] mm; p = 0.009) and a longer pupillary constriction time after ipsilateral light stimulus (mean [SD] 1240 [180] vs. 710 [200] ms; p= 0.008). In eyes affected by RAPD, visual acuity correlated with the absolute constriction amplitude (r= 0.75, p = 0.001). Conclusions B-mode ultrasound enables fast, easy and objective quantification of a RAPD and can thus be applied in clinical practice to document a RAPD.	[Schmidt, Felix A.; Connolly, Florian; Harms, Lutz; Brandt, Alexander; Paull, Friedemann; Ruprecht, Klemens] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Schmidt, Felix A.; Connolly, Florian; Grittner, Ulrike; Harms, Lutz; Brandt, Alexander; Paull, Friedemann; Ruprecht, Klemens] Berlin Inst Hlth, Neurocure Cluster Excellence, Berlin, Germany; [Schmidt, Felix A.; Brandt, Alexander; Paull, Friedemann] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany; [Schmidt, Felix A.] BIH, Berlin, Germany; [Maas, Matthew B.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Grittner, Ulrike] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Biostat & Clin Epidemiol, Berlin, Germany; [Paull, Friedemann] Max Delbrueck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Paull, Friedemann] Charite Univ Med Berlin, Berlin, Germany; [Schreiber, Stephan] Asklepios Fachklinikum Brandenburg, Dept Neurol, Brandenburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Northwestern University; Feinberg School of Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmidt, FA (corresponding author), Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Neurol, Berlin, Germany.; Schmidt, FA (corresponding author), Berlin Inst Hlth, Neurocure Cluster Excellence, Berlin, Germany.; Schmidt, FA (corresponding author), Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany.; Schmidt, FA (corresponding author), BIH, Berlin, Germany.	felix.schmidt@charite.de	Grittner, Ulrike/I-2026-2019	Grittner, Ulrike/0000-0003-2595-0224; paul, friedemann/0000-0002-6378-0070; Schreiber, Stephan J./0000-0003-0902-3447				Bennett JL, 2015, MULT SCLER J, V21, P678, DOI 10.1177/1352458514567216; Bennett JL, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000104; Bremner FD, 2004, EYE, V18, P1175, DOI 10.1038/sj.eye.6701560; Cayless A, 2016, Z MED PHYS, V26, P143, DOI 10.1016/j.zemedi.2015.10.001; Cree BAC, 2016, MULT SCLER J, V22, P862, DOI 10.1177/1352458515620934; Di Maggio G, 2014, MULT SCLER J, V20, P1342, DOI 10.1177/1352458514524293; Galetta SL, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000135; Kalaboukhova L, 2007, ACTA OPHTHALMOL SCAN, V85, P519, DOI 10.1111/j.1600-0420.2007.00863.x; Kidd DP, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000270; Kuchling J, 2017, EPMA J, V8, P279, DOI 10.1007/s13167-017-0102-x; Lankaranian Dara, 2005, Trans Am Ophthalmol Soc, V103, P200; LOEWENFELD IE, 1974, AM J OPHTHALMOL, V78, P304, DOI 10.1016/0002-9394(74)90093-2; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Martinez-Lapiscina EH, 2016, LANCET NEUROL, V15, P574, DOI 10.1016/S1474-4422(16)00068-5; MCGRAW P, 1995, BRIT MED J, V310, P1481, DOI 10.1136/bmj.310.6993.1481; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/530305; Oertel FC, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000334; Pache F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0720-6; Petzold A, 2014, NAT REV NEUROL, V10, P447, DOI 10.1038/nrneurol.2014.108; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; RIDGE SE, 1993, J CLIN MICROBIOL, V31, P1256, DOI 10.1128/JCM.31.5.1256-1261.1993; Schippling S, 2015, MULT SCLER J, V21, P163, DOI 10.1177/1352458514538110; Schmidt F, 2017, MULT SCLER RELAT DIS, V11, P45, DOI 10.1016/j.msard.2016.11.008; Schmidt FA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189016; Sepulveda M, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000225; THOMPSON HS, 1981, SURV OPHTHALMOL, V26, P39, DOI 10.1016/0039-6257(81)90124-7; Trier H G, 1982, Ultraschall Med, V3, P164, DOI 10.1055/s-2007-1010120; Volpe NJ, 2000, OPHTHALMOLOGY, V107, P1913, DOI 10.1016/S0161-6420(00)00354-7; Waldman AT, NEUROL NEUROIMMUNOL, V4; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202774	10.1371/journal.pone.0202774	http://dx.doi.org/10.1371/journal.pone.0202774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148895	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000442804200022
J	Lu, ZY; Li, JS; Shen, Q; Zhang, B; Zhang, H; Zhang, FF; Wang, SL				Lu, Zhaoyi; Li, Junsheng; Shen, Qian; Zhang, Bing; Zhang, Hao; Zhang, Fangfang; Wang, Shenglei			Modification of 6SV to remove skylight reflected at the air-water interface: Application to atmospheric correction of Landsat 8 OLI imagery in inland waters	PLOS ONE			English	Article							TOTAL SUSPENDED MATTER; LAKE TAIHU; CORRECTION ALGORITHM; LEAVING RADIANCE; TM IMAGE; SATELLITE; VALIDATION; RETRIEVAL; QUALITY; SEAWIFS	During the atmospheric correction of remote sensing data in inland waters, the original Second Simulation of the Satellite Signal in the Solar Spectrum-Vector version (6SV) model does not eliminate the specular reflection of downward skylight radiance at the air-water interface. Thus, we propose a modified version of the 6SV model (M6SV) that does remove reflected skylight at the air-water interface. We apply the new model to the atmospheric correction of a Landsat 8 Operational Land Imager (OLI) image over Taihu Lake, China, where the aerosol optical depth is known. In situ reflectance measurements acquired concurrently with the L8/OLI image are used to validate the performance of the new M6SV algorithm. To further analyze the merits and demerits of M6SV, the model is compared with two short-wave infrared (SWIR)-based atmospheric correction models: the Sea-Viewing Wide Field-of-View Sensor Data Analysis System short-wave infrared (SD-SWIR) model and the Vanhellemont & Ruddick short-wave infrared with a per scene fixed aerosol type (VR-SWIR-F) model. Comparisons of results from all three L8/OLI image atmospheric corrections with the in situ remote sensing reflectance data show that M6SV produces reliable atmospheric corrections in the green and red spectral bands and is an effective alternative for Landsat 8 OLI atmospheric correction in inland waters.	[Lu, Zhaoyi; Li, Junsheng; Shen, Qian; Zhang, Bing; Zhang, Hao; Zhang, Fangfang; Wang, Shenglei] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing, Peoples R China; [Lu, Zhaoyi] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shen, Q (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Key Lab Digital Earth Sci, Beijing, Peoples R China.	shenqian@radi.ac.cn		Lu, Zhao Y/0000-0003-0417-4190	National Key Research and Development Program of China [2016YFB0501502]; High Resolution Earth Observation Systems of the National Science and Technology Major Projects [41-Y20A31-9003-15/17]; National Natural Science Foundation of China [91638201, 41571361, 41471308]	National Key Research and Development Program of China; High Resolution Earth Observation Systems of the National Science and Technology Major Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was jointly supported by the National Key Research and Development Program of China (2016YFB0501502), the High Resolution Earth Observation Systems of the National Science and Technology Major Projects (41-Y20A31-9003-15/17 to J.L.), the National Natural Science Foundation of China (No. 91638201 to B.Z., 41571361 to Q.S., 41471308 to J.L.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara E, 2016, REMOTE SENS LETT, V7, P661, DOI 10.1080/2150704X.2016.1177242; ANGSTROM A, 1964, TELLUS, V16, P64, DOI 10.1111/j.2153-3490.1964.tb00144.x; Chen J, 2017, IEEE T GEOSCI REMOTE, V55, P2201, DOI 10.1109/TGRS.2016.2638828; Chen J, 2014, IEEE T GEOSCI REMOTE, V52, P3959, DOI 10.1109/TGRS.2013.2278340; Chen J, 2013, ADV SPACE RES, V51, P1750, DOI 10.1016/j.asr.2012.11.032; Chen J, 2013, INT J REMOTE SENS, V34, P3787, DOI 10.1080/01431161.2012.761740; Chen J, 2011, IEEE J-STARS, V4, P882, DOI 10.1109/JSTARS.2011.2154300; Concha Javier A., 2014, 2014 IEEE Geoscience and Remote Sensing Symposium. (IGARSS). Proceedings, P4458, DOI 10.1109/IGARSS.2014.6947481; Franz BA, 2015, J APPL REMOTE SENS, V9, DOI 10.1117/1.JRS.9.096070; Gitelson AA, 2007, REMOTE SENS ENVIRON, V109, P464, DOI 10.1016/j.rse.2007.01.016; Gong SQ, 2008, INT J REMOTE SENS, V29, P2199, DOI 10.1080/01431160701422262; GORDON HR, 1994, APPL OPTICS, V33, P443, DOI 10.1364/AO.33.000443; Gordon HR, 1999, NAS503163 NASA; HARRINGTON JA, 1992, REMOTE SENS ENVIRON, V39, P15, DOI 10.1016/0034-4257(92)90137-9; Irons JR, 2012, REMOTE SENS ENVIRON, V122, P11, DOI 10.1016/j.rse.2011.08.026; Kloiber SN, 2002, REMOTE SENS ENVIRON, V82, P38, DOI 10.1016/S0034-4257(02)00022-6; Kotchenova SY, 2006, APPL OPTICS, V45, P6762, DOI 10.1364/AO.45.006762; Li JS, 2014, AQUAT ECOSYST HEALTH, V17, P280, DOI 10.1080/14634988.2014.941776; Lv CG, 2015, REMOTE SENS INFO, V30, P43; MAYO M, 1995, INT J REMOTE SENS, V16, P175, DOI 10.1080/01431169508954386; Mobley CD, 1999, APPL OPTICS, V38, P7442, DOI 10.1364/AO.38.007442; Mobley CD, 2015, APPL OPTICS, V54, P4828, DOI 10.1364/AO.54.004828; Nazeer M, 2014, INT J REMOTE SENS, V35, P6271, DOI 10.1080/01431161.2014.951742; Oyama Y, 2009, ISPRS J PHOTOGRAMM, V64, P73, DOI 10.1016/j.isprsjprs.2008.04.005; Pahlevan N, 2014, REMOTE SENS ENVIRON, V154, P272, DOI 10.1016/j.rse.2014.08.001; Ruddick K., OCEAN COLOUR REMOTE; Salama S, 2002, INT S OPT SCI TECHN; Solar Light Company Inc, 2001, MTP05 SOL LIGHT CO I; [唐军武 Tang Junwu], 2004, [遥感学报, Journal of Remote Sensing], V8, P37; Tian LQ, 2010, SCI CHINA TECHNOL SC, V53, P191, DOI 10.1007/s11431-010-3221-3; Vanhellemont Q, 2014, ESA SPECIAL PUBLICAT, P726; Vanhellemont Q, 2015, REMOTE SENS ENVIRON, V161, P89, DOI 10.1016/j.rse.2015.02.007; Vermote E., 2006, 2 SIMULATION SATELLI; Wang D, 2007, CHINESE GEOGR SCI, V17, P364, DOI 10.1007/s11769-007-0364-7; Wang MH, 2011, REMOTE SENS ENVIRON, V115, P841, DOI 10.1016/j.rse.2010.11.012; Wang MH, 2002, INT J REMOTE SENS, V23, P2693, DOI 10.1080/01431160110115591; Wu CQ, 2010, SCI CHINA EARTH SCI, V53, P45, DOI 10.1007/s11430-010-4129-2; Zhang B, 2008, ENVIRON MONIT ASSESS, V145, P339, DOI 10.1007/s10661-007-0043-2; Zhang B, 2012, HYPERSPECTRAL REMOTE, P131; Zhang FF, 2015, IEEE J-STARS, V8, P350, DOI 10.1109/JSTARS.2014.2333540; Zhang MW, 2014, IEEE T GEOSCI REMOTE, V52, P4686, DOI 10.1109/TGRS.2013.2283523	41	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202883	10.1371/journal.pone.0202883	http://dx.doi.org/10.1371/journal.pone.0202883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142203	Green Submitted, Green Published, gold			2022-12-27	WOS:000442722500045
J	Maier, IL; Scalzo, F; Leyhe, JR; Schregel, K; Behme, D; Tsogkas, I; Psychogios, MN; Liebeskind, DS				Maier, Ilko L.; Scalzo, Fabien; Leyhe, Johanna R.; Schregel, Katharina; Behme, Daniel; Tsogkas, Ioannis; Psychogios, Marios-Nikos; Liebeskind, David S.			Validation of collateral scoring on flat-detector multiphase CT angiography in patients with acute ischemic stroke	PLOS ONE			English	Article							ONE-STOP MANAGEMENT; INTERVENTIONAL MANAGEMENT; ENDOVASCULAR TREATMENT; III TRIAL; TIME; REPERFUSION; OUTCOMES; FEASIBILITY; PERFUSION; SUITE	Background The pivotal impact of collateral circulation on outcomes in endovascular therapy has fueled the development of numerous CTA collateral scales, yet synchronized validation with conventional angiography has never occurred. We validated multiphase flat-detector CTA (mpFDCTA) for collateral imaging in patients undergoing endovascular stroke treatment. Materials and methods Consecutive acute ischemic stroke patient data, including mpFDCTA shortly followed by digital subtraction angiography (DSA), in the setting of acute ICA- or MCA-occlusions were analyzed. An independent core lab scored mpFDCTA with an established collateral scale and separately graded American Society of Interventional and Therapeutic Neuroradiology (ASITN) collateral score on DSA, blind to all other data. Results 24 consecutive cases (age 76.7 +/- 7.3 years; 58.3% women; baseline NIHSS median 17 (4-23)) of acute ICA- or MCA-occlusion were analyzed. Time from mpFDCTA to intracranial DSA was 23.04 +/- 7.6 minutes. Median mpFDCTA collateral score was 3 (0-5) and median DSA ASITN collateral score was 2 (0-3), including the full range of potential collateral grades. mpFDCTA and ASITN collateral score were strongly correlated (r = 0.86, p<0.001). mpFDCTA provided more complete collateral data compared to selective DSA injections in cases of ICA-occlusion. ROC analyses for prediction of clinical outcomes revealed an AUC of 0.76 for mpFDCTA- and 0.70 for DSA ASITN collaterals. Conclusions mpFDCTA in the angiography suite provides a validated measure of collaterals, offering distinct advantages over conventional angiography. Direct patient transfer to the angiography suite and mpFDCTA collateral grading provides a novel and reliable triage paradigm for acute ischemic stroke.	[Maier, Ilko L.] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Scalzo, Fabien; Liebeskind, David S.] Neurovasc Imaging Res Core, Los Angeles, CA USA; [Leyhe, Johanna R.; Schregel, Katharina; Behme, Daniel; Tsogkas, Ioannis; Psychogios, Marios-Nikos] Univ Med Ctr Gottingen, Dept Neuroradiol, Gottingen, Germany	University of Gottingen; University of Gottingen	Psychogios, MN (corresponding author), Univ Med Ctr Gottingen, Dept Neuroradiol, Gottingen, Germany.	m.psychogios@med.uni-goettingen.de	Scalzo, Fabien/AAM-6328-2020; Behme, Daniel/H-4551-2019	Scalzo, Fabien/0000-0001-9755-8104; 	Niedersachsische Ministerium fur Wissenschaft und Kultur [11-76251-99-52/14]	Niedersachsische Ministerium fur Wissenschaft und Kultur	This work was supported by the "Niedersachsische Ministerium fur Wissenschaft und Kultur" (grant number 11-76251-99-52/14 to I.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amans MR, 2015, AUSTIN J CEREBROVASC, V2, P1036; Bang OY, 2008, J NEUROL NEUROSUR PS, V79, P625, DOI 10.1136/jnnp.2007.132100; Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Higashida Randall, 2003, J Vasc Interv Radiol, V14, pS493; Janes H, 2008, AM J EPIDEMIOL, V168, P89, DOI 10.1093/aje/kwn099; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Leyhe JR, 2017, J NEUROINTERV SURG, V9, P1253, DOI 10.1136/neurintsurg-2016-012866; Liebeskind DS, 2014, STROKE, V45, P759, DOI 10.1161/STROKEAHA.113.004072; Liebeskind DS, 2011, J CEREBR BLOOD F MET, V31, P1293, DOI 10.1038/jcbfm.2010.224; Maas MB, 2009, STROKE, V40, P3001, DOI 10.1161/STROKEAHA.109.552513; Maier IL, AJNR AM J NEURORADIO; Menon BK, 2011, AM J NEURORADIOL, V32, P1640, DOI 10.3174/ajnr.A2564; Menon BK, 2016, CIRCULATION, V133, P2279, DOI 10.1161/CIRCULATIONAHA.115.019983; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Psychogios MN, 2010, AM J NEURORADIOL, V31, P1226, DOI 10.3174/ajnr.A2086; Psychogios MN, 2018, STROKE, V49; Psychogios MN, 2017, STROKE, V48, P3152, DOI 10.1161/STROKEAHA.117.018077; Psychogios MN, 2017, CLIN NEURORADIOL, V27, P389, DOI 10.1007/s00062-017-0574-z; Sallustio F, 2017, J NEUROINTERV SURG, V9, P940, DOI 10.1136/neurintsurg-2016-012628; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Schregel K, 2018, JOVE-J VIS EXP, DOI 10.3791/56397; Vagal A, 2016, STROKE, V47, P535, DOI 10.1161/STROKEAHA.115.011461; Yang P, 2017, AM J NEURORADIOL, V38, P747, DOI 10.3174/ajnr.A5072	25	10	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202592	10.1371/journal.pone.0202592	http://dx.doi.org/10.1371/journal.pone.0202592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142167	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500020
J	Santos, SS; Augusto, DG; Alves, PAC; Pereira, JS; Duarte, LMB; Melo, PC; Gross, E; Kaneto, CM; Silva, A; Santos, JL				Santos, Simone S.; Augusto, Danillo G.; Casaes Alves, Patricia A.; Pereira, Julia S.; Duarte, Larissa M. B.; Melo, Poliana C.; Gross, Eduardo; Kaneto, Carla M.; Silva, Aline; Santos, Jane L.			Trichoderma asperelloides ethanolic extracts efficiently inhibit Staphylococcus growth and biofilm formation	PLOS ONE			English	Article							FOOD-CONTACT SURFACES; ENDOPHYTIC FUNGUS; AUREUS; EPIDERMIDIS; RESISTANCE; FERMENTATION; TEMPERATURE; SENSITIVITY; METABOLITES; EXPRESSION	Fungi from the widely distributed genus Trichoderma are of great biotechnological interest, being currently used in a vast range of applications. Here, we report that high-molecular weight fraction (HWF) derived from Trichoderma asperelloides ethanolic extract exhibits antibiotic activity against staphylococcal biofilms. The antibacterial and anti-biofilm properties of T. asperelloides extracts were evaluated by well-established assays in Staphylococcus aureus ATCC strains (29213 and 6538) and in one clinical isolate from bovine mastitis. The HWF from T. asperelloides eradicated S. aureus by causing substantial matrix de-structuring and biomass reduction (p < 10(-5)) at concentrations as low as 2.3 mu g mL(-1). Additionally, we present ultra-structure analysis by the use of scanning electron microscopy as well as transmission microscopy, which showed that T. asperelloides killed cells through cell wall and membrane disturbance. Remarkably, the HWF from T. asperelloides killed S. aureus and eradicated its biofilms in a greater performance than gentamicin (p < 10(-5)), a known potent antibiotic against S. aureus. Our results indicate that extract from T. asperelloides may represent a promising candidate for the development of new antibiotics against gram-positive bacteria.	[Santos, Simone S.; Augusto, Danillo G.; Kaneto, Carla M.; Santos, Jane L.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Lab Imunobiol, Ilheus, Brazil; [Augusto, Danillo G.] Univ Fed Parana, Lab Genet Mol Humana, Curitiba, Parana, Brazil; [Casaes Alves, Patricia A.; Gross, Eduardo] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ctr Microscopia Eletron, Ilheus, Brazil; [Pereira, Julia S.; Duarte, Larissa M. B.] Ctr Fed Educ Tecnol Minas Gerais, Dept Engn Mat, Belo Horizonte, MG, Brazil; [Melo, Poliana C.] Univ Estadual Santa Cruz, Dept Ciencias Agr, Hosp Vet, Ilheus, Brazil; [Silva, Aline] Univ Estadual Santa Cruz, Dept Ciencias Biol, Lab Microbiol, Ilheus, Brazil	Universidade Estadual de Santa Cruz; Universidade Federal do Parana; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz	Santos, JL (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Lab Imunobiol, Ilheus, Brazil.	jlsantos@uesc.br	Gross, Eduardo/B-9738-2017; Augusto, Danillo G/H-8179-2019; Avaliação, PPGCS/ABF-2467-2020	Gross, Eduardo/0000-0002-1057-0432; Augusto, Danillo G/0000-0001-5665-8547; Santos Pereira, Julia/0000-0001-7987-1594; Batista Duarte, Larissa Mara/0000-0002-3870-3786; Setubal dos Santos, Simone/0000-0002-5848-8198	Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the following: Fundacao de Amparo a Pesquisa do Estado da Bahia - J.L.S.; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - S.S.S.	Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; Ansari MA, 2015, INDIAN J MED MICROBI, V33, P101, DOI 10.4103/0255-0857.148402; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V9th; Meira QGD, 2012, FOOD CONTROL, V25, P469, DOI 10.1016/j.foodcont.2011.11.030; de Souza EL, 2014, BRAZ J MICROBIOL, V45, P67, DOI 10.1590/S1517-83822014000100010; Del Pozo JL, 2008, INT J ARTIF ORGANS, V31, P786, DOI 10.1177/039139880803100906; Di Ciccio P, 2015, FOOD CONTROL, V50, P930, DOI 10.1016/j.foodcont.2014.10.048; Ding G, 2012, CHEM BIODIVERS, V9, P1205, DOI 10.1002/cbdv.201100185; Dos Santos Andrea G, 2017, Front Microbiol, V8, P1681, DOI 10.3389/fmicb.2017.01681; Feresin GE, 2001, J ETHNOPHARMACOL, V78, P103, DOI 10.1016/S0378-8741(01)00322-1; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; GOULARD C, 1995, J ANTIBIOT, V48, P1248, DOI 10.7164/antibiotics.48.1248; Guzman-Guzman P, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0481-y; Harman GE, 2000, PLANT DIS, V84, P377, DOI 10.1094/PDIS.2000.84.4.377; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Kundu A., 2008, Asian Journal of Experimental Sciences, V22, P373; Leite B, 2013, ENFERM INFEC MICR CL, V31, P655, DOI 10.1016/j.eimc.2012.11.011; Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Massey RC, 2006, NAT REV MICROBIOL, V4, P953, DOI 10.1038/nrmicro1551; Melo PD, 2014, PESQUI VET BRASIL, V34, P109, DOI 10.1590/S0100-736X2014000200002; Oh SU, 2002, J ANTIBIOT, V55, P557, DOI 10.7164/antibiotics.55.557; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Pleszczynska M, 2015, INT J BIOL MACROMOL, V79, P761, DOI 10.1016/j.ijbiomac.2015.05.052; Rode TM, 2007, INT J FOOD MICROBIOL, V116, P372, DOI 10.1016/j.ijfoodmicro.2007.02.017; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Sadykova V S, 2015, Prikl Biokhim Mikrobiol, V51, P340; Samuels GJ, 2010, MYCOLOGIA, V102, P944, DOI 10.3852/09-243; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Shale K, 2005, FOOD MICROBIOL, V22, P433, DOI 10.1016/j.fm.2004.09.007; Susi P, 2011, J ENVIRON MANAGE, V92, P1681, DOI 10.1016/j.jenvman.2011.03.004; Vandecasteele SJ, 2003, J INFECT DIS, V188, P730, DOI 10.1086/377452; Vazquez-Sanchez D, 2014, FOOD CONTROL, V39, P8, DOI 10.1016/j.foodcont.2013.09.029; Wang YH, 2012, PHYTOMEDICINE, V19, P364, DOI 10.1016/j.phymed.2011.10.011; Wiater A, 2013, INT J BIOL MACROMOL, V58, P199, DOI 10.1016/j.ijbiomac.2013.03.063; Yano A, 2010, APPL MICROBIOL BIOT, V86, P615, DOI 10.1007/s00253-009-2323-y; Zhang JC, 2017, NAT PROD RES, V31, P2745, DOI 10.1080/14786419.2017.1295235	38	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202828	10.1371/journal.pone.0202828	http://dx.doi.org/10.1371/journal.pone.0202828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142222	gold, Green Published, Green Submitted			2022-12-27	WOS:000442722500039
J	Knezevic, A; Stajic, M; Sofrenic, I; Stanojkovic, T; Milovanovic, I; Tesevic, V; Vukojevic, J				Knezevic, Aleksandar; Stajic, Mirjana; Sofrenic, Ivana; Stanojkovic, Tatjana; Milovanovic, Ivan; Tesevic, Vele; Vukojevic, Jelena			Antioxidative, antifungal, cytotoxic and antineurodegenerative activity of selected Trametes species from Serbia	PLOS ONE			English	Article							RAPID COLORIMETRIC ASSAY; IN-VITRO; GROWTH; MUSHROOM; EXTRACT; CELLS; LEUKEMIA; FUNGI	In a last few decades mushrooms are increasingly attracting attention as functional food and sources of biologically active compounds. Several Trametes species have been used for centuries in traditional medicine of East Asia cultures, but only T. versicolorwas studied sufficiently while there are less substantial data about medicinal properties of other species. Trametes versicolor, T. hirsuta and T. gibbosa were the species tested for biological activities. Antifungal potentials of extracts were assessed for clinical strains of selected Candida and Aspergillus species. ABTS and FRAP assays were used to evaluate antioxidant capacities of studied extracts. Cytotoxic activity was determined against human cervix and lung adenocarcinoma and colon carcinoma cell lines. Antineurodegenerative activity was assessed by determining the rate of acetylcholinesterase and tyrosinase activity. The presence of metabolites in extracts of mycelia and basidiocarps of studied Trametes species was analyzed by H-1 NMR spectroscopy. Studied extracts showed low antifungal potential in comparison with ketoconazole. Basidiocarp extracts were more effective ABTS(+) scavengers and Fe2+ reducers than mycelium ones but less effective in comparison with L-ascorbic acid. Results showed that mycelium extracts had stronger cytotoxic effects against three cancer cell lines than basidiocarp ones, and that cervix adenocarcinoma cells were the most sensitive to the extracts and commercial cytostatics. T. versicolor mycelium extract was the most effective inhibitor of acetylcholinesterase activity but double weaker than galantamine, and T. gibbosa mycelium extract was significantly better inhibitor of tyrosinase activity than kojic acid for 40.9%. Chemical analysis indicated strong synergistic action of triterpenes, sugars and polyphenols in applied assays. The results suggest that tested Trametes species have significant medicinal potentials which could be attributed to antioxidative and cytotoxic activity. Additionally both, basidiocarps and mycelia extracts can strongly inhibit activity of acetylcholinesterase and tyrosinase.	[Knezevic, Aleksandar; Stajic, Mirjana; Milovanovic, Ivan; Vukojevic, Jelena] Univ Belgrade, Fac Biol, Belgrade, Serbia; [Sofrenic, Ivana; Tesevic, Vele] Univ Belgrade, Fac Chem, Studentski Trg, Belgrade, Serbia; [Stanojkovic, Tatjana] Inst Oncol & Radiol Serbia, Belgrade, Serbia	University of Belgrade; University of Belgrade; Institute for Oncology & Radiology of Serbia (IORS)	Knezevic, A (corresponding author), Univ Belgrade, Fac Biol, Belgrade, Serbia.	knezevica@bio.bg.ac.rs	Sofrenić, Ivana/W-2421-2018; Stanojkovic, Tatjana/AHA-7955-2022; Tesevic, Vele/Q-6093-2016	Sofrenić, Ivana/0000-0002-9799-670X; Knezevic, Aleksandar/0000-0002-2776-9675; Tesevic, Vele/0000-0001-7060-9055; Milovanovic, Ivan/0000-0002-5772-4355	Ministry of Education, Science and Technological Development (Republic of Serbia) [173032, 172053]	Ministry of Education, Science and Technological Development (Republic of Serbia)	This work was supported by Ministry of Education, Science and Technological Development (Republic of Serbia), Grant No. 173032, AK, MS, IM, JV; Ministry of Education, Science and Technological Development (Republic of Serbia), Grant No. 172053, IS, VT.	Abd El Hady F., 2014, INT J PHARM SCI REV, V26, P338; Alves MJ, 2013, J APPL MICROBIOL, V115, P346, DOI 10.1111/jam.12196; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; [Anonymous], 1998, M38P NCCLS; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Brakhage AA, 2005, MED MYCOL, V43, pS75, DOI 10.1080/13693780400028967; Cheng K.F., 2008, CANC THER, V6, P117; Courtecuisse R, 1999, MUSHROOMS BRITAIN EU; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; de Billerbeck VG, 2001, CAN J MICROBIOL, V47, P9, DOI 10.1139/cjm-47-1-9; El-Hady F.K.A., 2014, INT J PHARM SCI REV, V26, P301; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ferreira ICFR, 2009, CURR MED CHEM, V16, P1543, DOI 10.2174/092986709787909587; Gan C. H., 2013, International Food Research Journal, V20, P1095; Harhaji L, 2008, FOOD CHEM TOXICOL, V46, P1825, DOI 10.1016/j.fct.2008.01.027; Hleba L., 2014, Scientific Papers: Animal Science and Biotechnologies, V47, P89; Hsieh TC, 2002, J ALTERN COMPLEM MED, V8, P591, DOI 10.1089/107555302320825101; Jamila N, 2015, J ENZYM INHIB MED CH, V30, P133, DOI 10.3109/14756366.2014.895720; Janjusevic L, 2018, NAT PROD RES, V32, P963, DOI 10.1080/14786419.2017.1366484; Janjusevic L, 2017, J ENZYM INHIB MED CH, V32, P355, DOI 10.1080/14756366.2016.1252759; Johnsy G., 2011, Journal of Pharmacy Research, V4, P3939; Karaman M, 2010, PHYTOTHER RES, V24, P1473, DOI 10.1002/ptr.2969; Kim Seong-Eun, 2012, Mycobiology, V40, P134, DOI 10.5941/MYCO.2012.40.2.134; Knezevic A, 2015, BOOK OF ABSTRACTS OF, P198; Knezevic Aleksandar, 2015, ScientificWorldJournal, V2015, P146378, DOI 10.1155/2015/146378; Lau CBS, 2004, LIFE SCI, V75, P797, DOI 10.1016/j.lfs.2004.04.001; Likhitwitayawuid K, 2001, J NAT PROD, V64, P1457, DOI 10.1021/np0101806; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Mau JL, 2002, J AGR FOOD CHEM, V50, P6072, DOI 10.1021/jf0201273; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mossier DB, 1993, DERMATOLOGY GEN MED, P949; Ng TB, 1998, GEN PHARMACOL, V30, P1, DOI 10.1016/S0306-3623(97)00076-1; OHNO M, 1991, J IMMUNOL METHODS, V145, P199, DOI 10.1016/0022-1759(91)90327-C; Otsuka Y., 2013, INT J NUTR FOOD SCI, V2, P85, DOI DOI 10.11648/j.ijnfs.20130202.19; PACKER L, 2004, OXIDAT STRESS DIS, pR7; Palacios I, 2011, FOOD CHEM, V128, P674, DOI 10.1016/j.foodchem.2011.03.085; Park YK, 1997, ARQ BIOL TECNOL, V40, P97; Patoka J., 2012, MILIT MED SCI LETT, V81, P40; Phillips R, 1981, FOLIA GEOBOT; Picman AK, 1995, BIOCHEM SYST ECOL, V23, P683, DOI 10.1016/0305-1978(95)00081-X; Pop RM, 2018, NOT BOT HORTI AGROBO, V46, P343, DOI 10.15835/nbha46211132; Ren G, 2006, FITOTERAPIA, V77, P408, DOI 10.1016/j.fitote.2006.05.004; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Scarpari M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171412; Senol FS, 2010, FOOD CHEM, V120, P34, DOI 10.1016/j.foodchem.2009.09.066; Sheikh I.A., 2014, INT J PHARM PHARM SC, V6, P679; Shnyreva AV, 2018, INT J MED MUSHROOMS, V20, P1, DOI 10.1615/IntJMedMushrooms.2018025250; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sivaprakasam E., 2011, International Journal of Pharmaceutical Sciences and Drug Research, V3, P219; Souza NAB, 2010, BRAZ J PHARM SCI, V46, P499, DOI 10.1590/S1984-82502010000300013; Stajic M, 2013, CURR TOP MED CHEM, V13, P2660, DOI 10.2174/15680266113136660192; TAKEUCHI T, 1969, J ANTIBIOT, V22, P215, DOI 10.7164/antibiotics.22.215; Wasser Solomon P, 2014, Biomed J, V37, P345, DOI 10.4103/2319-4170.138318; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; Yamac M, 2006, PHARM BIOL, V44, P660, DOI 10.1080/13880200601006897	58	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203064	10.1371/journal.pone.0203064	http://dx.doi.org/10.1371/journal.pone.0203064			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169542	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400019
J	Eriksen, A; Wabakken, P; Maartmann, E; Zimmermann, B				Eriksen, Ane; Wabakken, Petter; Maartmann, Erling; Zimmermann, Barbara			Den site selection by male brown bears at the population's expansion front	PLOS ONE			English	Article							URSUS-ARCTOS; HABITAT; RANGE; SEX; SCANDINAVIA; PERIPHERY; MOVEMENTS; PREDATION; NORTHERN; BEHAVIOR	Brown bears (Ursus arctos) spend about half of the year in winter dens. In order to preserve energy, bears may select denning locations that minimize temperature loss and human disturbance. In expanding animal populations, demographic structure and individual behavior at the expansion front can differ from core areas. We conducted a non-invasive study of male brown bear den sites at the male-biased, low-density western expansion front of the Scandinavian brown bear population, comparing den locations to the available habitat. Compared to the higher-density population core in which intraspecific avoidance may affect den site selection of subordinate bears, we expected resource competition in the periphery to be low, and all bears to be able to select optimal den sites. In addition, bears in the periphery had access to free-ranging domestic sheep during summer. We found that males in the periphery denned on high-elevation slopes, probably providing good drainage, longer periods of consistent, insulating snow cover and fewer melting-freezing events. Forests were the principal denning habitat and no dens were found in alpine areas. The Scandinavian brown bears have a history of intense harvest, including culling at the den. This may have exerted a selection pressure to avoid denning in open alpine habitat which compared to forests provide little cover. The bears denned away from main roads and in steep, rugged terrain, probably limiting human access. The odds for finding a bear den decreased with increasing distance to the population core where females could be found. Previous studies have documented directed movement of male brown bears from the male-biased population periphery toward the core areas during the mating season. In this way, denning males may be trading off between low resource competition and access to sheep in the low-density periphery, and mating opportunities in the higher-density population core.	[Eriksen, Ane; Wabakken, Petter; Maartmann, Erling; Zimmermann, Barbara] Inland Norway Univ Appl Sci, Dept Forestry & Wildlife Management, Evenstad, Norway	Inland Norway University of Applied Sciences	Eriksen, A (corresponding author), Inland Norway Univ Appl Sci, Dept Forestry & Wildlife Management, Evenstad, Norway.	ane.eriksen@inn.no	Eriksen, Ane/H-2773-2013; Zimmermann, Barbara/AAA-2631-2019	Eriksen, Ane/0000-0002-9073-8812; Zimmermann, Barbara/0000-0001-5133-9379	Hedmark; Norwegian Environment Agency; Inland Norway (INN) University of Applied Sciences; INN University	Hedmark; Norwegian Environment Agency; Inland Norway (INN) University of Applied Sciences; INN University	The study was funded by the County Governor of Hedmark (www.fylkesmannen.no/en/Hedmark/) to PW. DNA analyses were financed and made publicly available by the Norwegian Environment Agency (http://www.miljodirektoratet.no) to PW. Further financial support was provided by Inland Norway (INN) University of Applied Sciences (www.inn.no) to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Norwegian Nature Inspectorate (SNO) for assistance with field work, to everybody who reported bear tracks and dens throughout the study period, and to Juuli Vanni for useful discussions. The study was funded by the County Governor of Hedmark. DNA analyses were performed by the Norwegian Institute of Bioeconomy (NIBIO), and financed and made publicly available by the Norwegian Environment Agency. Further financial support was provided by INN University.	Aames SG, 2016, 56 NORSK I BIOOK NIB; [Anonymous], 2021, LANG ENV STAT COMP; Bischof R, 2016, CONSERV LETT, V9, P122, DOI 10.1111/conl.12183; Blanchard B.M., 1987, BEARS THEIR BIOL MAN, V7, P99, DOI [10.2307/3872615, DOI 10.2307/3872615]; Blix AS, 2016, J EXP BIOL, V219, P1093, DOI 10.1242/jeb.120477; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; BREITENMOSER U, 1993, J WILDLIFE MANAGE, V57, P135, DOI 10.2307/3809010; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; CRAIGHEAD F C JR, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P84; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Dahle B, 2003, J ANIM ECOL, V72, P660, DOI 10.1046/j.1365-2656.2003.00737.x; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; Dahle B, 2013, WILDLIFE BIOL, V19, P165, DOI 10.2981/10-113; Delgado MM, 2014, PLOS ONE, V9, P8; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eiken HG, 2009, FORENS SCI INT-GEN S, V2, P273, DOI 10.1016/j.fsigss.2009.07.007; Elfstrom M, 2008, WILDLIFE BIOL, V14, P176, DOI 10.2981/0909-6396(2008)14[176:SODHBS]2.0.CO;2; Elfstrom M, 2009, URSUS, V20, P85, DOI 10.2192/09GR005.1; ELOWE KD, 1989, J WILDLIFE MANAGE, V53, P962, DOI 10.2307/3809596; Evans AL, 2016, ECOPHYSIOLOGY BROWN; EVANS AL, 2012, PLOS ONE, V7, P8; Fox J., 2019, R COMPANION APPL REG, V.; Friebe A, 2001, URSUS-SERIES, V12, P37; Goldstein MI, 2010, J WILDLIFE MANAGE, V74, P35, DOI 10.2193/2008-490; Groff C, 1998, URSUS-SERIES, V10, P275; Henriksen S., 2015, NORSK RODLISTE ARTER; HUBER D, 1993, ACTA THERIOL, V38, P151, DOI 10.4098/AT.arch.93-13; Hudina S, 2015, BIOL INVASIONS, V17, P3101, DOI 10.1007/s10530-015-0936-x; Jerina K, 2008, J MAMMAL, V89, P1491, DOI 10.1644/07-MAMM-A-357.1; Jerina K, 2013, EUR J WILDLIFE RES, V59, P459, DOI 10.1007/s10344-013-0690-2; Johnsen K, 2018, ANN ZOOL FENN, V55, P173, DOI 10.5735/086.055.0604; Johnsen K, 2017, ECOL EVOL, V7, P115, DOI 10.1002/ece3.2635; Kojola L, 2003, URSUS-SERIES, V14, P17; Krofel M, 2010, URSUS, V21, P23, DOI 10.2192/09SC015.1; Linnell JDC, 2000, WILDLIFE SOC B, V28, P400; Manchi S, 2005, WILDLIFE BIOL, V11, P123, DOI 10.2981/0909-6396(2005)11[123:DBOSBB]2.0.CO;2; Manel S, 2004, MOL ECOL, V13, P1327, DOI 10.1111/j.1365-294X.2004.02074.x; Manly BFL., 2007, RESOURCE SELECTION A; Matson G., 1993, LAB MANUAL CEMENTUM; May R, 2008, J APPL ECOL, V45, P1382, DOI 10.1111/j.1365-2664.2008.01527.x; Mikle N, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1467; Nicholson KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150333; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Petram W, 2004, BIOL CONSERV, V119, P129, DOI 10.1016/j.biocon.2003.07.021; Pigeon KE, 2016, J WILDLIFE MANAGE, V80, P884, DOI 10.1002/jwmg.1069; PULLIAINEN ERKKI, 1965, ANN ZOOL FENNICI, V2, P215; Raby CR, 2009, BEHAV PROCESS, V80, P314, DOI 10.1016/j.beproc.2008.12.005; ROGERS L, 1981, NAT HIST, V90, P64; Rovbase, ROVB; RStudio Team, 2012, INTEGRATED DEV R; Ruf T, 2015, BIOL REV, V90, P891, DOI 10.1111/brv.12137; Sahlen E, 2011, URSUS, V22, P152, DOI 10.2192/URSUS-D-10-00007.1; Sahlen V, 2006, SKANDINAVISKA BJORNP, V2006-4, P43; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Schoen JW, 1987, INT C BEAR RES MANAG, V7, P293, DOI DOI 10.2307/3872636; Schregel J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180701; Sheriff MJ, 2009, J MAMMAL, V90, P761, DOI 10.1644/08-MAMM-A-247R.1; SOBYE E, 2014, HEIMEN, V51, P3; Stenset NE, 2016, WILDLIFE BIOL, V22, P107, DOI 10.2981/wlb.00194; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Storaas T, 2005, PROJECT MOOSE TRAFFI; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; SWENSON JE, 1994, BIOL CONSERV, V70, P9, DOI 10.1016/0006-3207(94)90293-3; Swenson JE, 2001, BROWN BEAR PREDATION; Swenson JE, 1996, UTREDNING FORETATT I; Swenson JE, 2007, OECOLOGIA, V153, P37, DOI 10.1007/s00442-007-0715-1; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Swenson Jon E., 1994, NINA Forskningsrapport, V53, P1; Swenson JE, 1997, WILDLIFE BIOL, V3, P35, DOI 10.2981/wlb.1997.005; Taranger A, 1915, NON TRADITIONAL REF, pVIII; Wabakken P, 1994, SLUTTRAPPORT SAUPROS; Wabakken P, 1992, SVENSK NORSKE BJORNE	74	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202653	10.1371/journal.pone.0202653	http://dx.doi.org/10.1371/journal.pone.0202653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161161	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900035
J	Maskew, M; Jamieson, L; Mohomi, G; Long, L; Mongwenyana, C; Nyoni, C; Mokaba, D; Fox, MP; Sanne, I; Rosen, S				Maskew, Mhairi; Jamieson, Lise; Mohomi, Given; Long, Lawrence; Mongwenyana, Constance; Nyoni, Cynthia; Mokaba, Dorah; Fox, Matthew P.; Sanne, Ian; Rosen, Sydney			Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care	PLOS ONE			English	Article							JOHANNESBURG; THERAPY	Introduction Initiating and retaining pregnant women on antiretroviral therapy (ART) to prevent motherto-child HIV transmission (PMTCT) remains a major challenge facing African HIV programs, particularly during the critical final months prior to delivery. In 2013, South Africa implemented its "Option B" PMTCT regimen (three-drug ART throughout pregnancy and breastfeeding, regardless of maternal CD4 count) and introduced once-daily fixed-dose combinations and lifelong ART. Currently, the uptake of Option B and its possible impact on adherence to PMTCT during the critical final months of pregnancy is unclear. Materials and methods We prospectively collected visit data from a cohort of adult, HIV-infected, pregnant women between July 2013-August 2014 to estimate three models of adherence to PMTCT during the final 16 weeks immediately preceding delivery. Adherence was defined according to possession of antiretroviral drugs, which was inferred from clinic visit records under varying assumptions in each model. We describe uptake of the PMTCT regimen, gestational age at initiation, and model possible scenarios of adherence through delivery after the implementation of Option B. Results Among 138 women enrolled (median (IQR) age 28 years (24-32), median CD4 count 378 cells/mm(3)), median (IQR) gestational age at initiation was 22 weeks (16-26). Estimates of adherence during the final 16 weeks of pregnancy prior to delivery ranged from 75% (52-89%) under the best case scenario assumptions to 52% (30-75%) under the worst case scenario assumptions. Estimates of the proportion of women who would achieve 80% adherence to PMTCT were <50% across all models. Conclusions Despite the switch to Option B and once-daily dosing, South African women continue to initiate PMTCT late in pregnancy, and estimations of regimen adherence, as modelled using PMTCT visit attendance data, is poor, with <50% of women reaching 80% adherence during final months of pregnancy across all models. Further guideline changes and interventions are needed to achieve vertical transmission goals.	[Maskew, Mhairi; Jamieson, Lise; Mohomi, Given; Long, Lawrence; Mongwenyana, Constance; Nyoni, Cynthia; Fox, Matthew P.; Sanne, Ian; Rosen, Sydney] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Long, Lawrence; Sanne, Ian; Rosen, Sydney] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Mokaba, Dorah] City Johannesburg, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA USA	University of Witwatersrand; Boston University; Boston University	Maskew, M (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa.	mmaskew@heroza.org	Sanne, Ian/ABH-2231-2020; Fox, Matthew/K-2004-2019	Long, Lawrence/0000-0003-4986-4988; MASKEW, MHAIRI/0000-0003-4238-0200	President's Emergency Program For AIDS Relief; NIH Office of AIDS Research, through NIH from the National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI100015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100015] Funding Source: NIH RePORTER	President's Emergency Program For AIDS Relief; NIH Office of AIDS Research, through NIH from the National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the President's Emergency Program For AIDS Relief and the NIH Office of AIDS Research, through NIH grant number U01 AI100015 to Boston University, from the National Institute of Allergy and Infectious Diseases (NIAID). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clouse K, 2017, J ACQUIR IMMUNE DEFI, V74; Clouse K, 2013, TROP MED INT HEAL, V18; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Genberg B, 2011, 6 INT C HIV TREATM P; Goga AE, 2016, AIDS 2016; Goga AE, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020405; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Henegar CE, 2015, AIDS BEHAV, V19, P612, DOI 10.1007/s10461-014-0953-2; Hoenigl M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32947; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Leach-lemens C, 2016, AIDS MAP, P2; McMahon SA, 2016, AIDS BEHAV, P1; Myer L, 2016, HIV MED, P1; National Department of Health, 2013, S AFR ANT TREATM GUI; National Department of Health (South Africa), 2014, NAT CONS GUID PREV M; Nkomo P, 2015, S AFR J HIV MED, V16, P100, DOI 10.4102/sajhivmed.v16i1.386; PEPFAR, 2003, PEPFAR DASHB; Rustagi AS, 2016, INT J STD AIDS; Schnippel K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0778-2; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Woelk GB, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20837	22	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201955	10.1371/journal.pone.0201955	http://dx.doi.org/10.1371/journal.pone.0201955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161147	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900018
J	Seekaew, P; Pengnonyang, S; Jantarapakde, J; Sungsing, T; Rodbumrung, P; Trachunthong, D; Cheng, CL; Nakpor, T; Reankhomfu, R; Lingjongrat, D; Janyam, S; Charoenying, S; Mills, S; Cassell, M; Phanuphak, P; Vannakit, R; Phanuphak, N				Seekaew, Pich; Pengnonyang, Supabhorn; Jantarapakde, Jureeporn; Sungsing, Thanthip; Rodbumrung, Piyanee; Trachunthong, Deondara; Cheng, Chun-liang; Nakpor, Thitiyanun; Reankhomfu, Ratchadej; Lingjongrat, Danai; Janyam, Surang; Charoenying, Sutinee; Mills, Stephen; Cassell, Michael; Phanuphak, Praphan; Vannakit, Ravipa; Phanuphak, Nittaya			Characteristics and HIV epidemiologic profiles of men who have sex with men and transgender women in key population-led test and treat cohorts in Thailand	PLOS ONE			English	Article								Men who have sex with men (MSM) and Transgender Women (TGW) in Thailand contribute to more than half of all new HIV infections annually. This cross-sectional study describes epidemiologic profiles of these key populations (KP) in Key Population-led Test and Treat study. Baseline data were collected using self-administered questionnaires and HIV/STI testing from MSM and TGW aged >18 years enrolled in a cohort study in six community sites in Thailand between October 2015 and February 2016. Factors associated with HIV prevalence were determined by logistic regression. TGW in the cohorts had lower education and income levels than MSM. TGW also engaged in sex work more, though similar proportions between MSM and TGW reported to have multiple sexual partners and STI diagnosis at baseline. HIV prevalence was 15.0% for MSM and 8.8% for TGW in the cohorts. HIV prevalence among TGW was more associated with sociodemographic characteristics, whereas factors related to behavioral risks were determined to be associated with HIV prevalence among MSM. TGW and MSM in the cohorts also had high prevalence of STI. Key Population-driven HIV services are able to capture harder-to-reach key populations who are at heightened risk for HIV.	[Seekaew, Pich; Pengnonyang, Supabhorn; Jantarapakde, Jureeporn; Sungsing, Thanthip; Rodbumrung, Piyanee; Trachunthong, Deondara; Cheng, Chun-liang; Phanuphak, Praphan; Phanuphak, Nittaya] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Nakpor, Thitiyanun] Sisters Fdn, Chon Buri, Thailand; [Reankhomfu, Ratchadej] Caremat Org, Chiang Mai, Thailand; [Lingjongrat, Danai] Rainbow Sky Assoc Thailand, Bangkok, Thailand; [Janyam, Surang] Serv Workers Grp Fdn, Bangkok, Thailand; [Charoenying, Sutinee; Mills, Stephen] FHI 360, Bangkok, Thailand; [Charoenying, Sutinee; Mills, Stephen] USAID LINKAGES Project, Bangkok, Thailand; [Cassell, Michael; Vannakit, Ravipa] US Agcy Int Dev Reg Dev Mission Asia, Off Publ Hlth, Bangkok, Thailand	Thai Red Cross Society; United States Agency for International Development (USAID)	Seekaew, P (corresponding author), Thai Red Cross AIDS Res Ctr, Bangkok, Thailand.	pich@trcarc.org	Fazli, Ghazal/AAE-8320-2022; Phanuphak, Nittaya/AAA-8579-2019; Seekaew, Pich/GPJ-9576-2022		USAID/PEPFAR's LINKAGES [FHI360]	USAID/PEPFAR's LINKAGES(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by USAID/PEPFAR's LINKAGES project through FHI360.	Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Bockting WO, 2005, AIDS CARE, V17, P289, DOI 10.1080/09540120412331299825; Bureau of Epidemiology and Thailand MOPH-US CDC Collaboration (TUC), 2016, EST SIZ KEY POP RISK; Chhim S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015390; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Colby D, 2016, AIDS BEHAV, V20, pS379, DOI 10.1007/s10461-016-1485-8; Kilmarx PH, 2000, AIDS, V14, P2731, DOI 10.1097/00002030-200012010-00013; Macdonald V, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21658; National AIDS Committee, 2015, THAIL AIDS RESP PROG; Nelson KE, 1996, NEW ENGL J MED, V335, P297, DOI 10.1056/NEJM199608013350501; Pattanasin S., 2017, INT J STD AIDS; Pawa D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077113; Poteat T, 2016, GLOB PUBLIC HEALTH, V11, P835, DOI 10.1080/17441692.2015.1134615; Thailand Working group on HIV/AIDS projection, 2015, AIDS EP MOD AEM; Thienkrua W, 2017, AIDS BEHAV; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2016, GLOB AIDS UPD; Wickersham JA, 2017, SEX TRANSM DIS, V44, P663, DOI 10.1097/OLQ.0000000000000662	19	29	30	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203294	10.1371/journal.pone.0203294	http://dx.doi.org/10.1371/journal.pone.0203294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161226	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900104
J	Tahmooresnejad, L; Beaudry, C				Tahmooresnejad, Leila; Beaudry, Catherine			Do patents of academic funded researchers enjoy a longer life? A study of patent renewal decisions	PLOS ONE			English	Article							BAYH-DOLE ACT; QUALITY; CITATIONS; INNOVATION; UNIVERSITIES; INDICATORS	This paper assesses the extent to which patent renewal data is associated with government funding in a university context by focusing on the relationship between the funded patentees and renewal decisions of their patents. The aim of this paper is to show whether receiving funding from government contributes to high-value patents as measured by the patent renewal decisions made by their owners. Our observations of academic nanotechnology patents in Canada discovered a positive relationship between funded researchers and the rate of patent renewal after 4 years. Further analysis is also undertaken into the relative impact on patent renewal after 8 years and 12 years. Our results suggest that the length of patent renewal in numbers of years can be related to levels of government funding received by their inventors.	[Tahmooresnejad, Leila; Beaudry, Catherine] Polytech Montreal, Dept Math & Ind Engn, Montreal, PQ, Canada	Universite de Montreal; Polytechnique Montreal	Tahmooresnejad, L (corresponding author), Polytech Montreal, Dept Math & Ind Engn, Montreal, PQ, Canada.	leila.tahmooresnejad@polymtl.ca		Beaudry, Catherine/0000-0002-2110-3151	Social Science and Humanities Research Council of Canada	Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work received financial support from the Social Science and Humanities Research Council of Canada.	Allison JR, 2004, GEORGETOWN LAW J, V92, P435; Anderson TW, 1984, INTRO MULTIVARIATE S; [Anonymous], 2010, SANTA CLARA HIGH TEC; Bakker J., 2016, RELATION PATENT CITA; Baron J, 2012, SCIENTOMETRICS, V90, P581, DOI 10.1007/s11192-011-0532-5; Bessen J, 2008, RES POLICY, V37, P932, DOI 10.1016/j.respol.2008.02.005; CARPENTER MP, 1980, RES MANAGE, V23, P30, DOI 10.1080/00345334.1980.11756595; Council of Canadian Academies, 2018, COMP GLOB INN EC CUR; Gay C, 2005, ECON INNOV NEW TECH, V14, P333, DOI 10.1080/1043859042000307310; Geuna A, 2001, J ECON ISSUES, V35, P607, DOI 10.1080/00213624.2001.11506393; Gittelman M, 2008, ACAD MANAGE PERSPECT, V22, P21, DOI 10.5465/AMP.2008.34587992; Grimaldi M, 2015, TECHNOL FORECAST SOC, V94, P286, DOI 10.1016/j.techfore.2014.10.013; Hall B. H, 2000, W7741 NAT BUR EC RES; Hall BH, 2005, RAND J ECON, V36, P16; Harhoff D, 1999, REV ECON STAT, V81, P511, DOI 10.1162/003465399558265; Harhoff D, 2016, AM ECON REV, V106, P193, DOI 10.1257/aer.p20161093; Hegde D, 2009, ECON LETT, V105, P287, DOI 10.1016/j.econlet.2009.08.019; Henderson R, 2005, AM ECON REV, V95, P461, DOI 10.1257/0002828053828644; Huang Z, 2006, J NANOPART RES, V8, P859, DOI 10.1007/s11051-006-9147-9; Lanjouw JO, 2004, ECON J, V114, P441, DOI 10.1111/j.1468-0297.2004.00216.x; Lanjouw JO, 2001, RAND J ECON, V32, P129, DOI 10.2307/2696401; Lanjouw JO, 1998, J IND ECON, V46, P405, DOI 10.1111/1467-6451.00081; Lanjouw JO, 1998, REV ECON STUD, V65, P671; LERNER J, 1994, RAND J ECON, V25, P319, DOI 10.2307/2555833; Lissoni F, 2012, CAHIERS DU GRETHA; Maurseth PB, 2005, ECON INNOV NEW TECH, V14, P351, DOI 10.1080/1043859042000307338; MCDONALD JF, 1980, REV ECON STAT, V62, P318, DOI 10.2307/1924766; Meyer MS, 2007, SCIENTOMETRICS, V70, P415, DOI 10.1007/s11192-007-0210-9; Mogee ME, 1997, TECHNOLOGY TRANSFER; Moore K., 2005, BERKELEY TECH LJ, V20, P1521; Mowery DC, 2001, RES POLICY, V30, P99, DOI 10.1016/S0048-7333(99)00100-6; Mowery DC, 2002, RES POLICY, V31, P399, DOI 10.1016/S0048-7333(01)00116-0; NARIN F, 1987, RES POLICY, V16, P143, DOI 10.1016/0048-7333(87)90028-X; PAKES A, 1986, ECONOMETRICA, V54, P755, DOI 10.2307/1912835; PAKES A, 1989, BROOKINGS PAP ECO AC, P331; Pakes A., 1984, R D PATENTS PRODUCTI, P73; Roco M.C, 2000, NANOTECHNOLOGY RES D; Roco MC, 2001, J NANOPART RES, V3, P5, DOI 10.1023/A:1011429917892; Sampat B.N., 2004, HDB QUANTITATIVE SCI, DOI [10.1007/1-4020-2755-9_13, DOI 10.1007/1-4020-2755-9_13]; Sampat Bhaven, 2004, J TECHNOLOGY TRANSFE, V30, P115, DOI DOI 10.1007/S10961-004-4361-Z; Sampat BN, 2003, INT J IND ORGAN, V21, P1371, DOI 10.1016/S0167-7187(03)00087-0; Schankerman M, 1998, RAND J ECON, V29, P77, DOI 10.2307/2555817; SCHANKERMAN M, 1986, ECON J, V96, P1052, DOI 10.2307/2233173; Squicciarini M., 2013, OECD STI WORKING PAP, V2013/03; Tahmooresnejad L, 2019, J TECHNOL TRANSFER, V44, P741, DOI 10.1007/s10961-017-9615-7; Thursby JG, 2011, RES POLICY, V40, P1077, DOI 10.1016/j.respol.2011.05.009; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; TONG XS, 1994, RES POLICY, V23, P133, DOI 10.1016/0048-7333(94)90050-7; Trajtenberg M., 2002, PATENTS CITATIONS IN, P25; Trappey AJC, 2012, ADV ENG INFORM, V26, P26, DOI 10.1016/j.aei.2011.06.005; Yasukawa S, 2014, SCIENTOMETRICS, V99, P895, DOI 10.1007/s11192-013-1195-1; Zhang YG, 2013, J NANOPART RES, V15, P1, DOI 10.1007/s11051-013-2007-5	52	2	2	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202643	10.1371/journal.pone.0202643	http://dx.doi.org/10.1371/journal.pone.0202643			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157218	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000443071400066
J	Dalrymple, KA; Wall, N; Spezio, M; Hazlett, HC; Piven, J; Elison, JT				Dalrymple, Kirsten A.; Wall, Natalie; Spezio, Michael; Hazlett, Heather C.; Piven, Joseph; Elison, Jed T.			Rapid face orienting in infants and school-age children with and without autism: Exploring measurement invariance in eye-tracking	PLOS ONE			English	Article							SPECTRUM DISORDER; INDIVIDUALS; RECOGNITION; INFORMATION; ATTENTION; STIMULI; BUBBLES	Questions concerning the ontogenetic stability of autism have recently received increased attention as long-term longitudinal studies have appeared in the literature. Most experimental measures are designed for specific ages and functioning levels, yet developing experimental tasks appropriate for a wide range of ages and functioning levels is critical for future long-term longitudinal studies, and treatment studies implemented at different ages. Accordingly, we designed an eye-tracking task to measure preferential orienting to facial features and implemented it with groups of participants with varying levels of functioning: infants, and school-age children with and without autism. All groups fixated eyes first, revealing an early and stable orienting bias. This indicates common bias towards the eyes across participants regardless of age or diagnosis. We also demonstrate that this eye-tracking task can be used with diverse populations who range in age and cognitive functioning. Our developmental approach has conceptual implications for future work focused on task development and particularly new experimental measures that offer measurement equivalence across broad age ranges, intellectual functioning and verbal abilities.	[Dalrymple, Kirsten A.; Wall, Natalie; Elison, Jed T.] Univ Minnesota, Inst Child Dev, 51 E River Rd, Minneapolis, MN 55455 USA; [Spezio, Michael] Scripps Coll, Psychol & Neurosci, Claremont, CA 91711 USA; [Spezio, Michael] Eppendorf, Univ Med Ctr, Inst Syst Neurosci, Hamburg, Germany; [Hazlett, Heather C.; Piven, Joseph] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27515 USA	University of Minnesota System; University of Minnesota Twin Cities; Claremont Colleges; Scripps College; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of North Carolina; University of North Carolina Chapel Hill	Dalrymple, KA (corresponding author), Univ Minnesota, Inst Child Dev, 51 E River Rd, Minneapolis, MN 55455 USA.	kad@umn.edu		Dalrymple, Kirsten/0000-0001-8772-7787	National Institute of Mental Health [NIMH RO1 MH104324]; National Institute of Child Health and Human Development [NICHD P30 HD03110]; Autism Speaks [2099]; Canadian Institutes of Health Research [201211BPF-295776-233239]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Autism Speaks; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by a National Institute of Mental Health (www.nimh.nih.gov) award to JTE (NIMH RO1 MH104324), a National Institute of Child Health and Human Development (www.nichd.nih.gov) award to JP (NICHD P30 HD03110), an Autism Speaks (act.autismspeaks.org) award to HCH (award number 2099), and a Banting Postdoctoral Fellowship through the Canadian Institutes of Health Research (banting.fellowships-bourses.gc.ca) to KAD (201211BPF-295776-233239).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2008, CURR BIOL, V18, P1090, DOI 10.1016/j.cub.2008.06.073; Anderson DK, 2014, J CHILD PSYCHOL PSYC, V55, P485, DOI 10.1111/jcpp.12178; Canfield RL, 1997, MONOGRAPHS SOC RES C, pi; Chawarska K, 2009, J AUTISM DEV DISORD, V39, P1663, DOI 10.1007/s10803-009-0803-7; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; Dawson G, 2012, J AM ACAD CHILD PSY, V51, P1150, DOI 10.1016/j.jaac.2012.08.018; Duku E, 2013, J CHILD PSYCHOL PSYC, V54, P1346, DOI 10.1111/jcpp.12103; Falck-Ytter T, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-28; Fein D, 2013, J CHILD PSYCHOL PSYC, V54, P195, DOI 10.1111/jcpp.12037; Flanagan HE, 2015, J AUTISM DEV DISORD, V45, P2691, DOI 10.1007/s10803-015-2433-6; Georgiades S, 2014, J AUTISM DEV DISORD, V44, P3045, DOI 10.1007/s10803-014-2167-x; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Guillon Q, 2014, NEUROSCI BIOBEHAV R, V42, P279, DOI 10.1016/j.neubiorev.2014.03.013; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Hazlett HC, 2011, ARCH GEN PSYCHIAT, V68, P467, DOI 10.1001/archgenpsychiatry.2011.39; Humphreys K, 2006, INFANT BEHAV DEV, V29, P471, DOI 10.1016/j.infbeh.2006.02.002; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; LANGDELL T, 1978, J CHILD PSYCHOL PSYC, V19, P255, DOI 10.1111/j.1469-7610.1978.tb00468.x; Levy J, 2012, BIOL LETT; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C, 2015, AMERICAN J MEDICAL G; Lundqvist D., 1998, KAROLINSKA DIRECTED; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Rice K, 2012, J AM ACAD CHILD PSY, V51, P238, DOI 10.1016/j.jaac.2011.12.017; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Shah P, 2013, CURR BIOL, V23, pR1087, DOI 10.1016/j.cub.2013.10.034; Shic F, 2008, P 2009 S EYE TRACK R; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; Szatmari P, 2015, JAMA PSYCHIAT, V72, P276, DOI 10.1001/jamapsychiatry.2014.2463; Wass SV, 2014, INFANCY, V19, P427, DOI 10.1111/infa.12055	34	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202875	10.1371/journal.pone.0202875	http://dx.doi.org/10.1371/journal.pone.0202875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153278	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700029
J	Park, S; Kang, J; Choi, S; Park, H; Hwang, E; Kang, Y; Kim, A; Holzapfel, W; Ji, Y				Park, Soyoung; Kang, Jihee; Choi, Sanghaeng; Park, Haryung; Hwang, Eunchong; Kang, Yoongu; Kim, Aram; Holzapfel, Wilhelm; Ji, Yosep			Cholesterol-lowering effect of Lactobacillus rhamnosus BFE5264 and its influence on the gut microbiome and propionate level in a murine model	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; PROBIOTICS; DIET; MILK; MODULATION	Thanks to recent scientific progress a relationship between the intestinal microbiota and metabolic diseases could be established. A deeper understanding of underlying mechanisms has opened ways towards new approaches for alleviating conditions associated with metabolic diseases. Dysbiosis appears to be a major underlying factor associated with metabolic syndrome and related adverse health conditions. A major focus has therefore shifted to controlling of the gut microbiota through administration of functional lactic acid bacteria (LAB). The scope for health promotion and/or support by probiotics such as LAB has thereby been widened beyond the improving of intestinal health, also to include anti-obesity, anti-diabetic and cholesterol-lowering effects. In this study we investigated the cholesterol-lowering and microbiota modulatory potential of a LAB strain, Lactobacillus rhamnosus BFE5264, isolated from Maasai fermented milk. A mouse model receiving a high-cholesterol diet served as model for evaluating its functionality. The administration of L. rhamnosus BFE5264 resulted in a significant reduction of the serum cholesterol level that was accompanied by changes in intestinal microbiota and the production of short chain fatty acid (SCFA) in comparison to the control group. This strain also beneficially influenced the regulation of cholesterol metabolism in the liver in a pattern similar to that resulting from statin treatment, a drug inhibiting cholesterol biosynthesis in the liver.	[Park, Soyoung; Park, Haryung; Hwang, Eunchong; Holzapfel, Wilhelm; Ji, Yosep] Handong Global Univ, Adv Green Energy & Environm, Pohang, Gyungbuk, South Korea; [Kang, Jihee; Choi, Sanghaeng] AtoGen Co Ltd, Daejeon, South Korea; [Kang, Yoongu; Kim, Aram] Handong Global Univ, Life Sci, Pohang, Gyungbuk, South Korea	Handong Global University; Handong Global University	Ji, Y (corresponding author), Handong Global Univ, Adv Green Energy & Environm, Pohang, Gyungbuk, South Korea.	jiyosep@gmail.com	Park, Grace/U-1673-2018		Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [916001-2]; AtoGen Co. Ltd.	Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; AtoGen Co. Ltd.	Funding for this work was provided by the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (as part of the (multi-ministerial) Genome Technology to Business Translation Program). The grant number is 916001-2. The funder (AtoGen Co. Ltd.) provided support in the form of salaries for authors [JK, SC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Funding for this work was provided by the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea (as part of the (multi-ministerial) Genome Technology to Business Translation Program). The grant number is 916001-2.	Anandaraja S, 2005, INT J CARDIOL, V102, P117, DOI 10.1016/j.ijcard.2004.05.009; Arora T, 2016, J INTERN MED, V280, P339, DOI 10.1111/joim.12508; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Bueld JE, 1996, PHARMACOL TOXICOL, V78, P229, DOI 10.1111/j.1600-0773.1996.tb00210.x; Butel MJ, 2014, MED MALADIES INFECT, V44, P1, DOI 10.1016/j.medmal.2013.10.002; Cammarota G, 2014, INTERN EMERG MED, V9, P365, DOI 10.1007/s11739-014-1069-4; Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032; DEMIGNE C, 1995, BRIT J NUTR, V74, P209, DOI 10.1079/BJN19950124; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; EICHHOLZER M, 1993, INT J VITAM NUTR RES, V63, P159; Hippe B, 2015, SCFA PRODUCING GUT M, P181; Kasubuchi M, 2015, NUTRIENTS, V7, P2839, DOI 10.3390/nu7042839; Kumar M, 2012, EXP DIABETES RES, DOI 10.1155/2012/902917; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MANN GV, 1974, AM J CLIN NUTR, V27, P464, DOI 10.1093/ajcn/27.5.464; Mathara JM, 2008, INT J FOOD MICROBIOL, V126, P57, DOI 10.1016/j.ijfoodmicro.2008.04.027; MORA S, 2015, FASEB J S1, V29; Ooi LG, 2010, INT J MOL SCI, V11, P2499, DOI 10.3390/ijms11062499; Patrignani F, 2006, INT J FOOD MICROBIOL, V107, P1, DOI 10.1016/j.ijfoodmicro.2005.08.004; Remely M, 2014, GENE, V537, P85, DOI 10.1016/j.gene.2013.11.081; Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Weitkunat K, 2016, MOL NUTR FOOD RES, V60, P2611, DOI 10.1002/mnfr.201600305; Yoon HS, 2013, J SCI FOOD AGR, V93, P781, DOI 10.1002/jsfa.5797; Yoon HS, 2011, PROBIOTICS ANTIMICRO, V3, P194, DOI 10.1007/s12602-011-9086-3	28	36	38	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203150	10.1371/journal.pone.0203150	http://dx.doi.org/10.1371/journal.pone.0203150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153290	gold, Green Submitted, Green Published			2022-12-27	WOS:000443001700048
J	Ross, A; Wu, J; Carlock, C; Glass, W; Lou, YH				Ross, April; Wu, Jean; Carlock, Colin; Glass, William, II; Lou, Ya-Huan			Inter-molecular epitope spreading does not lead to extension of autoimmunity beyond target tissue in autoimmune glomerulonephritis	PLOS ONE			English	Article							T-CELL EPITOPE; PEPTIDE; ANTIGEN; ANTIBODY; DISEASE; AUTOANTIBODIES; IDENTIFICATION; MECHANISM; CHAIN; RATS	Inter-molecular epitope spreading during autoimmune pathogenesis leads to generation of new pathogenic epitopes on other autoantigens beyond the original one. It raises an important question as whether autoimmunity extends beyond the target tissues if new epitopes are on the molecules shared with other tissues. This study is aimed addressing this question in a rat anti-glomerular basement membrane (GBM) glomerulonephritis model induced by a T cell epitope of glomerulus-specific collagen4 alpha 3. We have demonstrated inter-molecular B cell epitope spreading. Four novel epitopes were first identified by screening a phage display random peptide library against autoantibodies isolated from the GBM of immunized rats. All four epitopes were derived from GBM proteins with three from laminins and one from collagen4 alpha 4. Three out of four synthetic peptides were nephritogenic. Importantly, two peptides from lamininal and laminin beta 1, respectively, induced severe inflammation in glomeruli but not in the interstitial tissues, despite the presence of more abundant laminins in the tubular basement membranes. Our study suggests that surrounding tissues may display a lower or altered susceptibility to autoimmune inflammation. Thus, preventing extension of autoimmune inflammation beyond the original target tissue.	[Ross, April; Wu, Jean; Carlock, Colin; Lou, Ya-Huan] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost Sci, Houston, TX 77030 USA; [Glass, William, II] Univ Texas Hlth Sci Ctr Houston, McGoven Med Sch, Dept Pathol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Lou, YH (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost Sci, Houston, TX 77030 USA.	Yahuan.Lou@uth.tmc.EDU			National Institute of Diabetes and Digestive and Kidney Diseases - NIH [R01-DK60029, R01-DK077857, R01-DK077857S4]	National Institute of Diabetes and Digestive and Kidney Diseases - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institute of Diabetes and Digestive and Kidney Diseases - NIH (https://www.niddk.nih.gov/) R01-DK60029 YLOU, R01-DK077857 YLOU, NIH supplement R01-DK077857S4 AROSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2003, KIDNEY INT, V63, P826, DOI 10.1046/j.1523-1755.2003.00800.x; Bolton WK, 2005, J AM SOC NEPHROL, V16, P2657, DOI 10.1681/ASN.2004100823; Brooks-Worrell B, 2001, J IMMUNOL, V166, P5265, DOI 10.4049/jimmunol.166.8.5265; Cameron JS, 1999, J AM SOC NEPHROL, V10, P413; Chen LL, 2006, J AM SOC NEPHROL, V17, P3076, DOI 10.1681/ASN.2006070688; Deshmukh US, 2005, CLIN IMMUNOL, V117, P112, DOI 10.1016/j.clim.2005.07.002; Dromey JA, 2004, J IMMUNOL, V172, P4084, DOI 10.4049/jimmunol.172.7.4084; Gianani R, 1996, P NATL ACAD SCI USA, V93, P2257, DOI 10.1073/pnas.93.6.2257; Gordon FL, 2001, J NEUROIMMUNOL, V112, P15, DOI 10.1016/S0165-5728(00)00341-6; HUDSON BG, 1989, LAB INVEST, V61, P256; JAMES JA, 1995, J EXP MED, V181, P453, DOI 10.1084/jem.181.2.453; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Lou YH, 1996, J IMMUNOL, V156, P3535; LOU YH, 1995, J IMMUNOL, V155, P3667; LOU YH, 1993, J IMMUNOL, V151, P5790; Mamula MJ, 1998, IMMUNOL REV, V164, P231, DOI 10.1111/j.1600-065X.1998.tb01223.x; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Ooi JD, 2013, J AM SOC NEPHROL, V24, P419, DOI 10.1681/ASN.2012070705; Patel SD, 1997, P NATL ACAD SCI USA, V94, P8082, DOI 10.1073/pnas.94.15.8082; Putcha BDK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129216; RHIM SH, 1992, J CLIN INVEST, V89, P28, DOI 10.1172/JCI115572; Robertson J, 2005, J AM SOC NEPHROL, V16, P3256, DOI 10.1681/ASN.2005040421; Robertson J, 2005, KIDNEY INT, V68, P1061, DOI 10.1111/j.1523-1755.2005.00498.x; SERCARZ EE, 1994, CURR OPIN IMMUNOL, V6, P875, DOI 10.1016/0952-7915(94)90007-8; SUGISAKI T, 1980, CLIN IMMUNOL IMMUNOP, V15, P33, DOI 10.1016/0090-1229(80)90018-5; Talken BL, 2001, J IMMUNOL, V167, P562, DOI 10.4049/jimmunol.167.1.562; WILSON CB, 1974, ANNU REV MED, V25, P83, DOI 10.1146/annurev.me.25.020174.000503; Wu J, 2004, J IMMUNOL, V172, P4567, DOI 10.4049/jimmunol.172.7.4567; Wu J, 2003, KIDNEY INT, V64, P1292, DOI 10.1046/j.1523-1755.2003.00227.x; Wu J, 2002, J CLIN INVEST, V109, P517, DOI 10.1172/JCI200213876; Wu J, 2001, J IMMUNOL, V167, P2388, DOI 10.4049/jimmunol.167.4.2388; Zhou C, 2010, AM J NEPHROL, V32, P324, DOI 10.1159/000319490	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202988	10.1371/journal.pone.0202988	http://dx.doi.org/10.1371/journal.pone.0202988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153280	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700035
J	Cao, JMD; Prieto, A; Lopez, G; Fernandez-Antonio, R; Diaz, P; Lopez, C; Remesar, S; Diez-Banos, P; Fernandez, G				Diaz Cao, Jose Manuel; Prieto, Alberto; Lopez, Gonzalo; Fernandez-Antonio, Ricardo; Diaz, Pablo; Lopez, Ceferino; Remesar, Susana; Diez-Banos, Pablo; Fernandez, Gonzalo			Molecular assessment of visitor personal protective equipment contamination with the Aleutian mink disease virus and porcine circovirus-2 in mink and porcine farms	PLOS ONE			English	Article							BIOSECURITY MEASURES; PIG HERDS; FOMITES; TYPE-2; DISINFECTANTS; TRANSMISSION; RECOVERY; EFFICACY; SPAIN	Personal protective equipment (PPE) is an element of biosecurity intended to prevent the access or spread of diseases in farms. Nevertheless, to date no extensive reports exist about the effectiveness of different available PPE on farms. Thus, our aim was to estimate the degree of protection of PPE from viral contamination during farm visits. Two farms, infected with Aleutian mink disease virus and porcine circovirus-2 respectively, were visited by six visitors wearing different combinations of PPE: coveralls with hood and bootcovers, both with a certified barrier to infective agents (certified PPE group) and non-certified bootcover and coverall without hood (non-certified PPE group). Seventy-two swab samples from PPE and both hair and street clothes under PPE were taken after the visit and analysed by qPCR. Our results reveal viral exposure during visits, and the external protections of body and shoes were contaminated in all cases (24/24). In addition, protection from viral contamination varied noticeably according to the biosecurity elements used. A higher number of positives were detected in the non-certified PPE group than in the certified PPE group, both in elements under external protections (14/18 vs 3/18) and also in hair (4/6 vs 0/6). In fact, non-certified bootcovers broke during visits, resulting in viral contamination of the internal elements under them; these are consequently not suitable for using with wrinkled surfaces usually found in farm facilities. Thus, certified coveralls should be used in order to prevent contaminations, and workers and personnel of farms should be trained in their proper use. qPCR is a useful tool in the risk management of biosecurity programmes, and our results may serve as a model to evaluate different biosecurity measures.	[Diaz Cao, Jose Manuel; Prieto, Alberto; Lopez, Gonzalo; Fernandez-Antonio, Ricardo; Diaz, Pablo; Lopez, Ceferino; Remesar, Susana; Diez-Banos, Pablo; Fernandez, Gonzalo] Univ Santiago de Compostela, Fac Vet Sci, INVESAGA Grp, Dept Anim Pathol, Lugo, Spain; [Fernandez-Antonio, Ricardo] Galician Assoc Mink Breeders AGAVI, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Prieto, A (corresponding author), Univ Santiago de Compostela, Fac Vet Sci, INVESAGA Grp, Dept Anim Pathol, Lugo, Spain.	alberto.prieto@usc.es	Fernández, Pablo Díaz/J-8631-2012; Remesar, Susana/T-8577-2018; Cao, Jose Manuel Diaz/L-9217-2014; Sández, Ceferino M. López/A-6269-2010; Baños, Pablo Díez/E-1467-2012; fernandez, gonzalo/I-1644-2015	Fernández, Pablo Díaz/0000-0003-2445-1095; Remesar, Susana/0000-0002-8071-3806; Cao, Jose Manuel Diaz/0000-0002-8119-7057; Sández, Ceferino M. López/0000-0002-9151-3180; Baños, Pablo Díez/0000-0002-5236-5680; fernandez, gonzalo/0000-0002-7902-2995; Fernandez Antonio, Ricardo/0000-0002-3934-9061; Lopez Lorenzo, Gonzalo/0000-0001-8047-0413	program Consolidacio y Estructuracion de Grupos de Referencia Competitiva [GRC2015/003]	program Consolidacio y Estructuracion de Grupos de Referencia Competitiva	This work was funded by the program Consolidacio y Estructuracion de Grupos de Referencia Competitiva (GRC2015/003, Xunta de Galicia, Spain). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allepuz A, 2007, VET REC, V160, P398, DOI 10.1136/vr.160.12.398; Allerson MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067293; [Anonymous], 2016, SUGG PRIOR RES HOR 2; Barrington GM, 2002, VET CLIN N AM-FOOD A, V18, P7, DOI 10.1016/S0749-0720(02)00005-1; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Brennan ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028139; Callan RJ, 2002, VET CLIN N AM-FOOD A, V18, P57, DOI 10.1016/S0749-0720(02)00004-X; Casal J, 2007, PREV VET MED, V82, P138, DOI 10.1016/j.prevetmed.2007.05.012; Casanova L, 2009, J APPL MICROBIOL, V106, P1244, DOI 10.1111/j.1365-2672.2008.04093.x; Centers for Disease Control and Prevention, 2016, PROT HEALTHC PRES; Farid AH, 2012, PREV VET MED, V106, P332, DOI 10.1016/j.prevetmed.2012.03.010; Filippitzi ME, 2018, TRANSBOUND EMERG DIS, V65, P381, DOI 10.1111/tbed.12758; Ganime AC, 2015, J VIROL METHODS, V217, P24, DOI 10.1016/j.jviromet.2015.02.009; HAHN EC, 1977, ARCH VIROL, V55, P315, DOI 10.1007/BF01315053; Julian TR, 2011, APPL ENVIRON MICROB, V77, P6918, DOI 10.1128/AEM.05709-11; Kim HB, 2009, VET REC, V164, P599, DOI 10.1136/vr.164.19.599; Laanen M, 2013, VET J, V198, P508, DOI 10.1016/j.tvjl.2013.08.029; Martin H, 2008, VET J, V177, P388, DOI 10.1016/j.tvjl.2007.06.016; Neira V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146616; Noremark M, 2016, FRONT VET SCI, V3, DOI [10.3389/fvets.2016.00046, 10.3389/fvets.2015.00054]; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; O'Dea MA, 2008, J VIROL METHODS, V147, P61, DOI 10.1016/j.jviromet.2007.07.029; Pitkin A, 2009, CAN J VET RES, V73, P298; Prieto A, 2017, VET MICROBIOL, V204, P59, DOI 10.1016/j.vetmic.2017.04.013; Prieto A, 2014, VET MICROBIOL, V173, P355, DOI 10.1016/j.vetmic.2014.07.024; Simon-Grife M, 2013, PREV VET MED, V110, P223, DOI 10.1016/j.prevetmed.2012.11.028; Themudo GE, 2012, PREV VET MED, V107, P134, DOI 10.1016/j.prevetmed.2012.05.009; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Tomas ME, 2015, JAMA INTERN MED, V175, P1904, DOI 10.1001/jamainternmed.2015.4535; Verreault D, 2010, VET MICROBIOL, V141, P224, DOI 10.1016/j.vetmic.2009.09.013; Villarroel A, 2007, JAVMA-J AM VET MED A, V230, P808, DOI 10.2460/javma.230.6.808; World Health Organization, 2014, REC US PERS PROT EQ, P25	32	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203144	10.1371/journal.pone.0203144	http://dx.doi.org/10.1371/journal.pone.0203144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148883	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200049
J	Borba, JVVB; Tauhata, SBF; de Oliveira, CMA; Marques, MF; Bailao, AM; Soares, CMD; Pereira, M				Verde Bastos Borba, Joyce Villa; Ferreira Tauhata, Sinji Borges; Alves de Oliveira, Cecilia Maria; Marques, Monique Ferreira; Bailao, Alexandre Melo; de Almeida Soares, Celia Maria; Pereira, Maristela			Chemoproteomic identification of molecular targets of antifungal prototypes, thiosemicarbazide and a camphene derivative of thiosemicarbazide, in Paracoccidioides brasiliensis	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; BIOLOGICAL EVALUATION; YEAST-CELLS; EXPRESSION; PROTEIN; SPECIATION; COMPLEXES; SYNTHASE; GROWTH; VIEW	Paracoccidioidomycosis (PCM) is a neglected human systemic disease caused by species of the genus Paracoccidioides. The disease attacks the host's lungs and may disseminate to many other organs. Treatment involves amphotericin B, sulfadiazine, trimethoprim-sulfamethoxazole, itraconazole, ketoconazole, or fluconazole. The treatment duration is usually long, from 6 months to 2 years, and many adverse effects may occur in relation to the treatment; co-morbidities and poor treatment adherence have been noted. Therefore, the discovery of more effective and less toxic drugs is needed. Thiosemicarbazide (TSC) and a camphene derivative of thiosemicarbazide (TSC-C) were able to inhibit P. brasiliensis growth at a low dosage and were not toxic to fibroblast cells. In order to investigate the mode of action of those compounds, we used a chemoproteomic approach to determine which fungal proteins were bound to each of these compounds. The compounds were able to inhibit the activities of the enzyme formamidase and interfered in P. brasiliensis dimorphism. In comparison with the transcriptomic and proteomic data previously obtained by our group, we determined that TSC and TSC-C were multitarget compounds that exerted effects on the electron-transport chain and cell cycle regulation, increased ROS formation, inhibited proteasomes and peptidases, modulated glycolysis, lipid, protein and carbohydrate metabolisms, and caused suppressed the mycelium to yeast transition.	[Verde Bastos Borba, Joyce Villa; Ferreira Tauhata, Sinji Borges; Bailao, Alexandre Melo; de Almeida Soares, Celia Maria; Pereira, Maristela] Univ Fed Goias, Inst Ciencias Biol, Lab Biol Mol, Goiania, Go, Brazil; [Alves de Oliveira, Cecilia Maria; Marques, Monique Ferreira] Univ Fed Goias, Inst Quim, Lab Prod Nat, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Pereira, M (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Lab Biol Mol, Goiania, Go, Brazil.	maristelaufg@gmail.com	Borba, Joyce V. B./S-7813-2018; Pereira, Maristela/AAT-5765-2021; de Oliveira, Cecilia M A/C-5830-2013; Bailao, Alexandre Melo/H-1272-2013	Borba, Joyce V. B./0000-0002-2663-5173; de Oliveira, Cecilia M A/0000-0003-3339-5363; Bailao, Alexandre Melo/0000-0001-7754-4047; Tauhata, Sinji/0000-0002-6617-4244	MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FINEP (Financiadora de Estudos e Projetos); INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica); PRONEX (Programa de Apoio a Nucleos de Excelencia); CNPq	MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico); FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP (Financiadora de Estudos e Projetos)(Financiadora de Inovacao e Pesquisa (Finep)); INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica); PRONEX (Programa de Apoio a Nucleos de Excelencia); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work performed at Universidade Federal de Goias was supported by MCTI/CNPq (Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), FNDCT (Fundo Nacional de Desenvolvimento Cientifico e Tecnologico), FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), FINEP (Financiadora de Estudos e Projetos), INCT-IF (Instituto Nacional de Ciencia e Tecnologia para Inovacao Farmaceutica) and PRONEX (Programa de Apoio a Nucleos de Excelencia). Additionally, JVBB was supported by fellowship from CNPq.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Parente AFA, 2013, FUNGAL BIOL-UK, V117, P399, DOI 10.1016/j.funbio.2013.04.004; [Anonymous], ARG CIR CLIN EXP, V18, P197; Araujo FS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004309; Bailao AM, 2007, FEMS IMMUNOL MED MIC, V51, P43, DOI 10.1111/j.1574-695X.2007.00277.x; Bailao AM, 2006, MICROBES INFECT, V8, P2686, DOI 10.1016/j.micinf.2006.07.019; Bantscheff M, 2009, DRUG DISCOV TODAY, V14, P1021, DOI 10.1016/j.drudis.2009.07.001; Bastos KP, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-29; Bocca AL, 2013, FUTURE MICROBIOL, V8, P1177, DOI 10.2217/fmb.13.68; Borges CL, 2010, FEMS YEAST RES, V10, P104, DOI 10.1111/j.1567-1364.2009.00594.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang HY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.504; Costa FG, 2015, ANTIMICROB AGENTS CH, V59, P5581, DOI 10.1128/AAC.04711-14; Cruz-Monteagudo M, 2017, DRUG DISCOV TODAY, V22, P994, DOI 10.1016/j.drudis.2017.02.004; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Dimou M, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2330-6; do Prado RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094832; Dzitko K, 2014, 1 4 DISUBSTITUTED TH, P9926, DOI [10.3390/molecules19079926, DOI 10.3390/MOLECULES19079926]; El-Gammal OA, 2014, SPECTROCHIM ACTA A, V127, P530, DOI 10.1016/j.saa.2014.02.001; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; FRANCO M, 1987, J MED VET MYCOL, V25, P5; Gravi ET, 2012, MED MYCOL, V50, P81, DOI 10.3109/13693786.2011.590825; Hahn RC, 2003, MYCOSES, V46, P342; Karapandzova M, 2014, NAT PROD COMMUN, V9, P1623; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Li YJ, 2009, GLYCOBIOLOGY, V19, P624, DOI 10.1093/glycob/cwp029; Liu SD, 2015, BIOCHEM J, V468, P167, DOI 10.1042/BJ20150197; Marques SA, 2013, AN BRAS DERMATOL, V88, P700, DOI 10.1590/abd1806-4841.20132463; Menezes VM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004967.pub2; Murad AM, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-82; Murad AM, 2011, J SEP SCI, V34, P2618, DOI 10.1002/jssc.201100238; Nevagi RJ, 2014, BIOORG CHEM, V54, P68, DOI 10.1016/j.bioorg.2014.04.002; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; Nunes LR, 2005, EUKARYOT CELL, V4, P2115, DOI 10.1128/EC.4.12.2115-2128.2005; Patel SR, 2014, EUR J MED CHEM, V85, P255, DOI 10.1016/j.ejmech.2014.07.100; Prado RS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00616; Rastelli G, 2015, FRONT PHARMACOL, V6, P1, DOI [10.3389/fphar.2015.00001, DOI 10.3389/FPHAR.2015.00001]; Reiter WD, 2008, CURR OPIN PLANT BIOL, V11, P236, DOI 10.1016/j.pbi.2008.03.009; RESTREPO A, 1980, J CLIN MICROBIOL, V12, P279, DOI 10.1128/JCM.12.2.279-281.1980; Rezende TCV, 2011, J PROTEOMICS, V75, P572, DOI 10.1016/j.jprot.2011.08.020; Salomon AR, 2001, CHEM BIOL, V8, P71, DOI 10.1016/S1074-5521(00)00057-0; Santos GD, 2007, MED MYCOL, V45, P609, DOI 10.1080/13693780701502108; Scharfstein J, 2007, SCAND J IMMUNOL, V66, P128, DOI 10.1111/j.1365-3083.2007.01983.x; Serra S, 2014, EUR J MED CHEM, V82, P96, DOI 10.1016/j.ejmech.2014.05.044; Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017; Shikanai-Yasuda MA, 2017, REV SOC BRAS MED TRO, V50, P715, DOI 10.1590/0037-8682-0230-2017; Silva LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130703; Siwek A, 2011, MED CHEM, V7, P690, DOI 10.2174/157340611797928406; Skagia A, 2017, GENES CELLS, V22, P810, DOI 10.1111/gtc.12514; Skouloubris S, 1997, MOL MICROBIOL, V25, P989, DOI 10.1111/j.1365-2958.1997.mmi536.x; Slinski SL, 2015, PHYTOPATHOLOGY, V105, P119, DOI 10.1094/PHYTO-02-14-0027-R; Sousa-Pereira D, 2013, REV VIRTUAL QUIM, V5, P770, DOI 10.5935/1984-6835.20130055; Talevi A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00205; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Turissini DA, 2017, FUNGAL GENET BIOL, V106, P9, DOI 10.1016/j.fgb.2017.05.007; Weber SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052470; Yamaguchi MU, 2009, MOLECULES, V14, P1796, DOI 10.3390/molecules14051796; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524; Zambuzzi-Carvalho PF, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-227	60	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0201948	10.1371/journal.pone.0201948	http://dx.doi.org/10.1371/journal.pone.0201948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148835	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200004
J	Mori, S; Arima, N; Ito, M; Fujiyama, S; Kamo, Y; Ueki, Y				Mori, Shunsuke; Arima, Nobuyuki; Ito, Masahiro; Fujiyama, Shigetoshi; Kamo, Yasuhiro; Ueki, Yukitaka			Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment	PLOS ONE			English	Article							FATTY LIVER; RISK-FACTORS; AUTOIMMUNE HEPATITIS; PSORIATIC-ARTHRITIS; AMERICAN-COLLEGE; SCORING SYSTEM; FIBROSIS STAGE; DISEASE; PREVALENCE; CRITERIA	Objective The mechanism of liver injury with low-dose methotrexate (MTX) is incompletely understood. This study was designed to evaluate the association between non-alcoholic fatty liver disease (NAFLD) and liver injury during MTX treatment for rheumatoid arthritis (RA). Methods Between October 2014 and May 2015, we enrolled all MTX users for RA and monitored participant serum hepatic transaminase levels for 1 year. All patients had normal transaminase levels before the first MTX prescription. Using diagnostic criteria for non-alcoholic steatohepatitis (NASH), we performed histological analyses for patients presenting persistent transaminitis, defined as elevations of hepatic transaminases in four of six determinations during the follow-up period. Possible risk factors for persistent transaminitis were also examined. Results We followed 846 RA patients with a mean cumulative MTX dose of 2.48 g and identified 51 patients presenting persistent transaminitis. According to multivariate logistic regression analysis, obesity (odds ratio [OR] 3.23, p < 0.001), type 2 diabetes (OR 3.52, p = 0.001), hypercholesterolemia (OR 2.56, p = 0.004), and hyperuricemia (OR 3.52, p = 0.019), which are recognized as risk factors for NAFLD, were independently associated with a risk of persistent transaminitis. Among patients with persistent transaminitis, 42 showed fatty liver at ultrasonography. These patients had no evidence of alcoholic fatty liver, chronic viral hepatitis, autoimmune liver diseases, or hereditary liver diseases. Biopsy specimens were obtained from 32 patients, and we found that a NASH-like pattern was the most prevalent histological abnormality. There was no significant impact of MTX dose and duration on the histological severity. Conclusion Risk factors and histological findings are similar between NAFLD/NASH and liver injury during low-dose MTX treatment for RA, which suggests a strong association between both entities. NAFLD/NASH may be an underlying condition causing persistent transaminitis in MTX-treated RA patients. The results of this study illustrate the need for monitoring liver injury in RA patients with NAFLD risk factors during MTX treatment.	[Mori, Shunsuke] NHO Kumamoto Saishunsou Natl Hosp, Clin Res Ctr Rheumat Dis, Dept Rheumatol, Kumamoto, Japan; [Arima, Nobuyuki] Kumamoto Shinto Gen Hosp, Dept Pathol, Kumamoto, Japan; [Ito, Masahiro] NHO Nagasaki Med Ctr, Clin Res Ctr, Dept Pathol, Omura, Nagasaki, Japan; [Fujiyama, Shigetoshi] Kumamoto Shinto Gen Hosp, Dept Gastroenterol & Hepatol, Kumamoto, Japan; [Kamo, Yasuhiro] Sasebo Chuo Hosp, Gastrointestinal Endoscopy Ctr, Sasebo, Nagasaki, Japan; [Ueki, Yukitaka] Sasebo Chuo Hosp, Rheumat & Collagen Dis Ctr, Sasebo, Nagasaki, Japan		Mori, S (corresponding author), NHO Kumamoto Saishunsou Natl Hosp, Clin Res Ctr Rheumat Dis, Dept Rheumatol, Kumamoto, Japan.	moris@saisyunsou1.hosp.go.jp		Mori, Shunsuke/0000-0001-7972-4252	National Hospital Organization, Japan	National Hospital Organization, Japan	This study was supported by research funds from the National Hospital Organization, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2004, AM J GASTROENTEROL, V99, P1316, DOI 10.1111/j.1572-0241.2004.30444.x; Aithal GP, 2004, ALIMENT PHARM THER, V19, P391, DOI 10.1046/j.1365-2036.2004.01819.x; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Berends MAM, 2006, ALIMENT PHARM THERAP, V24, P805, DOI 10.1111/j.1365-2036.2006.03047.x; Braun J, 2011, THER ADV MUSCULOSKEL, V3, P151, DOI 10.1177/1759720X11408635; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Colli A, 2003, RADIOLOGY, V227, P89, DOI 10.1148/radiol.2272020193; Curtis JR, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2008.101378; Dawwas MF, 2014, ALIMENT PHARM THER, V40, P938, DOI 10.1111/apt.12912; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; ERICKSON AR, 1995, ARTHRITIS RHEUM, V38, P1115, DOI 10.1002/art.1780380814; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Golabi P, 2016, EXPERT REV GASTROENT, V10, P63, DOI 10.1586/17474124.2016.1099433; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Iwasaki M, 2004, TRANSPLANTATION, V78, P1501, DOI 10.1097/01.TP.0000140499.23683.0D; Jacobs JWG, 2012, RHEUMATOLOGY, V51, piv27, DOI 10.1093/rheumatology/kes084; Kent PD, 2004, J RHEUMATOL, V31, P1727; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kremer JM, 1996, J RHEUMATOL, V23, P459; KREMER JM, 1994, ARTHRITIS RHEUM-US, V37, P316, DOI 10.1002/art.1780370304; Kumada S, 2015, JPN J MED ULTRASON, V42, P201; Langman G, 2001, J GASTROEN HEPATOL, V16, P1395, DOI 10.1046/j.1440-1746.2001.02644.x; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Lohse AW, 2007, HEPATOL RES, V37, pS509, DOI 10.1111/j.1872-034X.2007.00289.x; Malatjalian DA, 1996, CAN J GASTROENTEROL, V10, P369, DOI 10.1155/1996/213596; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Mori S, 2017, CLIN RHEUMATOL, V36, P2673, DOI 10.1007/s10067-017-3804-5; Nishiura T, 2005, BRIT J RADIOL, V78, P189, DOI 10.1259/bjr/75208448; Ogdie A, 2018, J INVEST DERMATOL, V138, P760, DOI 10.1016/j.jid.2017.10.024; Pincus T, 2003, CLIN EXP RHEUMATOL, V21, pS179; Quintin E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3085; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; ROENIGK HH, 1982, J AM ACAD DERMATOL, V6, P145, DOI 10.1016/S0190-9622(82)80064-9; Ros S, 2002, SCAND J RHEUMATOL, V31, P330, DOI 10.1080/030097402320817040; Rosenberg P, 2007, J HEPATOL, V46, P1111, DOI 10.1016/j.jhep.2007.01.024; Rouhi A, 2017, CLIN EXP RHEUMATOL, V35, P1029; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Salliot C, 2009, ANN RHEUM DIS, V68, P1100, DOI 10.1136/ard.2008.093690; Schmajuk G, 2014, ARTHRIT CARE RES, V66, P1159, DOI 10.1002/acr.22294; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Stepanova M, 2013, DIGEST DIS SCI, V58, P3017, DOI 10.1007/s10620-013-2743-5; Suzuki Y, 1999, SCAND J RHEUMATOL, V28, P273; Uslusoy HS, 2009, WORLD J GASTROENTERO, V15, P1863, DOI 10.3748/wjg.15.1863; Visser K, 2009, CLIN EXP RHEUMATOL, V27, P1017; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; Watanabe S, 2015, J GASTROENTEROL, V50, P364, DOI 10.1007/s00535-015-1050-7; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; YAJIMA Y, 1983, TOHOKU J EXP MED, V139, P43, DOI 10.1620/tjem.139.43; Yatsuji S, 2005, J GASTROENTEROL, V40, P1130, DOI 10.1007/s00535-005-1711-z; Yoneda M, 2008, DIGEST LIVER DIS, V40, P371, DOI 10.1016/j.dld.2007.10.019; Yoneda M, 2013, J GASTROENTEROL, V48, P1051, DOI 10.1007/s00535-012-0704-y; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	61	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0203084	10.1371/journal.pone.0203084	http://dx.doi.org/10.1371/journal.pone.0203084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142184	gold, Green Published, Green Submitted			2022-12-27	WOS:000442722500062
J	Vernelen, K; Barbe, B; Gillet, P; Van Esbroeck, M; China, B; Jacobs, J				Vernelen, Kris; Barbe, Barbara; Gillet, Philippe; Van Esbroeck, Marjan; China, Bernard; Jacobs, Jan			Photo-based External Quality Assessment of Malaria rapid diagnostic tests in a non-endemic setting	PLOS ONE			English	Article							TRAVELERS	Introduction In non-endemic settings, expertise in malaria microscopy is limited and rapid diagnostic tests (RDTs) are an adjunct to malaria diagnosis. Aim We performed an External Quality Assessment (EQA) on reading and interpretation of malaria RDTs in a non-endemic setting. Methods Participants were medical laboratories in Belgium and the Grand Duchy of Luxembourg using malaria RDTs; they received (i) 10 high-resolution photographs presenting test line combinations of RDTs with interpretations listed in a multiple choice format and (ii) a questionnaire about their practices of malaria diagnosis. Results Among 135 subscribing laboratories, 134 (99.3%) used 139 RDT products (11 different products from 8 brands). After exclusion of the results of one laboratory, analysis was done for 133 laboratories using 137 RDT products. Scores of 10/10, 9/10 and 8/10 were achieved for 58.4%, 13.1% and 8.0% of 137 RDT products respectively. For three-band P. falciparum-pan-Plasmodium RDTs (113 (82.5%) products, 6 brands), most frequent errors were (1) disregarding faint test lines (18.6%), (2) reporting invalid instead of P. falciparum (16.8%) and (3) reporting "Plasmodium spp., no further differentiation possible" without mentioning the presence or absence of P. falciparum (11.5%). For four-band RDTs (21 (15.3%) products, 1 brand), errors were (4) disregarding faint P. vivaxtest lines (47.6%) and (5) reporting "Plasmodium spp., no further differentiation possible" without mentioning the presence of P. falciparum and P. vivax (28.6%). Instructions for use (IFU) of only 4 out of 10 RDT products mentioned to interpret faint-intensity test lines as positive (conducive to errors 1 and 4) and IFU of 2 products displayed incorrect information (conducive to errors 2 and 5). Outside of office hours, 36.1% of participants relied on RDTs as the initial diagnostic test; 13.9% did not perform microscopic confirmation. Conclusion Reading and interpretation of malaria RDTs was satisfactory, but errors were embedded in the instructions for use of the products. Relying on RDTs alone for malaria diagnosis (about one third of participants) is not a recommended practice.	[Vernelen, Kris; China, Bernard] Sciensano, Qual Med Labs, Inst Publ Hlth, Brussels, Belgium; [Barbe, Barbara; Gillet, Philippe; Van Esbroeck, Marjan; Jacobs, Jan] Inst Trop Med, Antwerp, Belgium; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium	Sciensano; Institute of Tropical Medicine (ITM); KU Leuven	Vernelen, K (corresponding author), Sciensano, Qual Med Labs, Inst Publ Hlth, Brussels, Belgium.	Kris.Vernelen@sciensano.be	China, Bernard/AAJ-3243-2021; Jacobs, Jan/GRX-7316-2022; Vernelen, Kris/GSO-1844-2022	China, Bernard/0000-0001-5717-478X; gillet, philippe/0000-0001-5878-6446; Van Esbroeck, Marjan/0000-0002-7294-6319	budget of the Scientific Institute of Public Health	budget of the Scientific Institute of Public Health	This work was supported by the budget of the Scientific Institute of Public Health dedicated to external quality assessment in medical laboratories.	Abanyie FA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-340; [Anonymous], 2009, US RAP DIAGN TEST RD; Askling HH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-328; Bailey JW, 2013, BRIT J HAEMATOL, V163, P573, DOI 10.1111/bjh.12572; Behrens RH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0666-7; Bobenchik A, 2013, J CLIN MICROBIOL, V51, P379, DOI 10.1128/JCM.02509-12; Bronner U, 2011, APMIS, V119, P88, DOI 10.1111/j.1600-0463.2010.02696.x; Chilton D, 2006, J CLIN PATHOL, V59, P862, DOI 10.1136/jcp.2005.032904; DiMaio MA, 2012, J CLIN MICROBIOL, V50, P2877, DOI 10.1128/JCM.01013-12; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-166; Gillet P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-359; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; Houze S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075486; Jacobs J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-505; Kurth F, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1673-z; Lalloo DG, 2016, J INFECTION, V72, P635, DOI 10.1016/j.jinf.2016.02.001; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P408, DOI 10.1111/1469-0691.12152; Millar SB, 2015, CLIN MICROBIOL INFEC, V21, P640, DOI 10.1016/j.cmi.2015.03.017; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Moulin F, 2009, ARCH PEDIATR, V19, P89; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Mukadi P, 2015, MALARIA J, V14, P2637; Mukadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071442; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Rossi IA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-377; Santos L, 2015, J INFECT DEV COUNTR, V9, P321, DOI 10.3855/jidc.5454; WHO, 2016, WORLD MAL REP 2016	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0201622	10.1371/journal.pone.0201622	http://dx.doi.org/10.1371/journal.pone.0201622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169508	gold, Green Submitted, Green Published			2022-12-27	WOS:000443374400005
J	Giroux, M; Barra, J; Zrelli, IE; Barraud, PA; Cian, C; Guerraz, M				Giroux, Marion; Barra, Julien; Zrelli, Issam-Eddine; Barraud, Pierre-Alain; Cian, Corinne; Guerraz, Michel			The respective contributions of visual and proprioceptive afferents to the mirror illusion in virtual reality	PLOS ONE			English	Article							ONE ARM; INTEGRATION; POSITION; FEEDBACK; HAND; DISPLACEMENT; PERCEPTION; MOVEMENT; STIMULUS	The reflection of passive arm displacement in a mirror is a powerful means of inducing a kinaesthetic illusion in the static arm hidden behind the mirror. Our recent research findings suggest that this illusion is not solely visual in origin but results from the combination of visual and proprioceptive signals from the two arms. To determine the respective contributions of visual and proprioceptive signals to this illusion, we reproduced the mirror paradigm in virtual reality. As in the physical version of the mirror paradigm, one of the participant's arms (the left arm, in our study) could be flexed or extended passively. This movement was combined with displacements of the avatar's left and right forearms, as viewed in a first-person perspective through a virtual reality headset. In order to distinguish between visual and proprioceptive contributions, two unimodal conditions were applied separately: displacement of the avatar's forearms in the absence of physical displacement of the left arm (the visual condition), and displacement of the left forearm while the avatar's forearms were masked (the proprioceptive condition). Of the 34 female participants included in the study, 28 experienced a kinaesthetic mirror illusion in their static (right) arm. The strength of the illusion (expressed in terms of speed and duration) evoked by the bimodal condition was much higher than that observed in either of the two unimodal conditions. Our present results confirm that the involvement of visual signals in the mirror illusion-often considered as a prototypic visual illusion-has been overstated. The mirror illusion also involves non-visual signals (bilateral proprioceptive-somaesthetic signals, in fact) that interact with the visual signals and strengthen the kinaesthetic effect.	[Giroux, Marion; Barra, Julien; Zrelli, Issam-Eddine; Cian, Corinne; Guerraz, Michel] Univ Grenoble Alpes, Univ Savoie Mont Blanc, CNRS, LPNC, Grenoble, France; [Barraud, Pierre-Alain] Univ Grenoble Alpes, Univ Savoie Mont Blanc, CNRS, CHU Grenoble Aloes,Grenoble INP,TIMC IMAG, Grenoble, France; [Cian, Corinne] Inst Rech Biomed Armees, Bretigny Sur Orge, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Gustave-Eiffel; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel	Guerraz, M (corresponding author), Univ Grenoble Alpes, Univ Savoie Mont Blanc, CNRS, LPNC, Grenoble, France.	michel.guerraz@univ-smb.fr		GUERRAZ, Michel/0000-0002-4267-6995	University Savoie Mont Blanc (France)	University Savoie Mont Blanc (France)	This work was supported through funding from the University Savoie Mont Blanc (France).	Ambron E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00067; Blanchard C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062475; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bresciani JP, 2008, SPRINGER TRAC ADV RO, V45, P61, DOI 10.1007/978-3-540-79035-8_5; Brun C, 2015, NEUROSCIENCE, V310, P268, DOI 10.1016/j.neuroscience.2015.09.052; Brun C, 2015, NEUROSCIENCE, V285, P343, DOI 10.1016/j.neuroscience.2014.11.036; Brunner I, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0186-z; Chancel M, 2016, J NEUROPHYSIOL, V116, P1522, DOI 10.1152/jn.00883.2015; Chancel M, 2017, NEUROSCIENCE, V362, P118, DOI 10.1016/j.neuroscience.2017.08.036; Chancel M, 2016, EXP BRAIN RES, V234, P1459, DOI 10.1007/s00221-015-4549-5; Cordo PJ, 2000, EXP BRAIN RES, V132, P1, DOI 10.1007/s002219900319; Deconinck FJA, 2015, NEUROREHAB NEURAL RE, V29, P349, DOI 10.1177/1545968314546134; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; Dietz V, 2015, CEREB CORTEX, V25, P948, DOI 10.1093/cercor/bht285; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dohle C, 2009, NEUROREHAB NEURAL RE, V23, P209, DOI 10.1177/1545968308324786; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Guerraz M, 2012, NEUROSCIENCE, V223, P258, DOI 10.1016/j.neuroscience.2012.07.059; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; Hakuta N, 2014, EXP BRAIN RES, V232, P2197, DOI 10.1007/s00221-014-3911-3; HAY JC, 1965, PSYCHON SCI, V2, P215, DOI 10.3758/BF03343413; Izumizaki M, 2010, J PHYSIOL-LONDON, V588, P2789, DOI 10.1113/jphysiol.2010.192336; Kuehn E, 2015, EXP BRAIN RES, V233, P1273, DOI 10.1007/s00221-015-4205-0; Laboissiere R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186431; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Lee SH, 2018, ARCH PHYS MED REHAB, V99, P1447, DOI 10.1016/j.apmr.2018.01.030; Marasco PD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6990; Metral M, 2015, EXP BRAIN RES, V233, P1463, DOI 10.1007/s00221-015-4220-1; Metral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080360; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Ridderikhoff A, 2006, NEUROSCI LETT, V399, P71, DOI 10.1016/j.neulet.2006.01.026; Seno T, 2012, SEEING PERCEIVING, V25, P631, DOI 10.1163/18784763-00002394; TARDYGERVET MF, 1984, BEHAV BRAIN RES, V11, P171, DOI 10.1016/0166-4328(84)90139-6; Touzalin-Chretien P, 2010, CEREB CORTEX, V20, P2007, DOI 10.1093/cercor/bhp271; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Wong JD, 2014, J NEUROPHYSIOL, V111, P1362, DOI 10.1152/jn.00537.2013; Zampini M, 2004, J NEUROL NEUROSUR PS, V75, P1626, DOI 10.1136/jnnp.2003.028589	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203086	10.1371/journal.pone.0203086	http://dx.doi.org/10.1371/journal.pone.0203086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161207	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900080
J	Fontes, PK; Ereno, RL; Peixoto, AR; Carvalho, RF; Scarano, WR; Trinca, LA; Barros, CM; Castilho, ACD				Fontes, Patricia Kubo; Ereno, Ronaldo Luis; Peixoto, Andre Rebello; Carvalho, Robson Francisco; Scarano, Wellerson Rodrigo; Trinca, Luzia Aparecida; Barros, Ciro Moraes; de Souza Castilho, Anthony Cesar			Can the antral follicular count modulate the gene expression of bovine oviducts in Aberdeen Angus and Nelore heifers?	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; CILIARY BEAT FREQUENCY; FOLLICLES GREATER-THAN-OR-EQUAL-TO-3 MM; HUMAN FALLOPIAN-TUBE; ALPHA-L-FUCOSIDASES; IN-VITRO; EPITHELIAL-CELLS; ESTROUS-CYCLE; BOS-INDICUS; CONDITIONED MEDIUM	The number of visible ovarian antral follicles (antral follicle count D AFC) is repeatable in bovine individuals, but highly variable between animals, and with differences between Bos taurus and Bos indicus breeds. Several studies have tried to determine the correlation between AFC and increased fertility in cattle. While the impacts of AFC on embryo production, hormonal levels, and pregnancy rates have been described, the molecular effects of AFC on bovine oviducts have not yet been investigated. Here, the aim was to investigate the impact of breeds, such as Aberdeen Angus and Nelore heifer with high or low AFC, on abundance of transcripts and protein related to oviductal transport, sperm reservoir formation, monospermy control, and gamete interaction in the oviducts. In summary, the ovulation side was the major factor that affected transcript abundance on bovine oviducts. However, a discreet effect among AFC and cattle breeds was also observed. Based on this, we concluded and reinforced here that differential microenvironments between ipsilateral and contralateral oviducts have a major effect on modulating the transcripts related to oviductal transport, sperm reservoir formation, monospermy control, and gamete interaction. However, we cannot exclude that there is minimal effect of AFC or breed on regulation of some genes (such as AGTR1, ACE1, FUCA1, and VEGFA) in bovine oviducts.	[Fontes, Patricia Kubo; Ereno, Ronaldo Luis; Barros, Ciro Moraes] Univ Estadual Paulista UNESP, Inst Biosci, Dept Pharmacol, Botucatu, SP, Brazil; [Peixoto, Andre Rebello; Carvalho, Robson Francisco; Scarano, Wellerson Rodrigo] Univ Estadual Paulista UNESP, Inst Biosci, Dept Morphol, Botucatu, SP, Brazil; [Trinca, Luzia Aparecida] Univ Estadual Paulista UNESP, Inst Biosci, Dept Biostat, Botucatu, SP, Brazil; [de Souza Castilho, Anthony Cesar] Univ Western Sao Paulo UNOESTE, Dept Anim Sci, Presidente Prudente, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade do Oeste Paulista	Castilho, ACD (corresponding author), Univ Western Sao Paulo UNOESTE, Dept Anim Sci, Presidente Prudente, SP, Brazil.	castilho.anthony@gmail.com	Carvalho, Robson Francisco/AAE-4134-2020; Carvalho, Robson Francisco/E-1161-2012; Scarano, Wellerson Rodrigo/T-7792-2019; Fontes, Patricia Kubo/R-8362-2017; Castilho, Anthony/AAS-2147-2021; Trinca, Luzia/C-7849-2012	Carvalho, Robson Francisco/0000-0002-4901-7714; Carvalho, Robson Francisco/0000-0002-4901-7714; Scarano, Wellerson Rodrigo/0000-0002-6682-2934; Fontes, Patricia Kubo/0000-0002-4280-9575; Castilho, Anthony/0000-0003-1666-7021; Trinca, Luzia/0000-0003-1106-8505	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/50514-8, 2011/50964-0, 2012/09498-9, 2013/08629-5, 2013/114803]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We confirm the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, the present work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br/) grants #2012/50514-8 and 2011/50964-0 (CMB), scholarships #2012/09498-9 and 2013/08629-5 (PKF), and 2013/114803 (ASC).	Aldarmahi A, 2014, REPROD FERT DEVELOP, V26, P358, DOI 10.1071/RD12222; ANDERSON SH, 1994, BIOL REPROD, V51, P795, DOI 10.1095/biolreprod51.4.795; Batista EOS, 2014, REPROD DOMEST ANIM, V49, P448, DOI 10.1111/rda.12304; Bauersachs S, 2004, J MOL ENDOCRINOL, V32, P449, DOI 10.1677/jme.0.0320449; Besenfelder U, 2012, REPROD DOMEST ANIM, V47, P156, DOI 10.1111/j.1439-0531.2012.02070.x; Boilard M, 2004, BIOL REPROD, V71, P1879, DOI 10.1095/biolreprod.103.026849; Boni R, 1997, THERIOGENOLOGY, V48, P277, DOI 10.1016/S0093-691X(97)84075-7; BOTTARI SP, 1993, FRONT NEUROENDOCRIN, V14, P123, DOI 10.1006/frne.1993.1005; Buhi WC, 2002, REPRODUCTION, V123, P355, DOI 10.1530/rep.0.1230355; Burns DS, 2005, BIOL REPROD, V73, P54, DOI 10.1095/biolreprod.104.036277; Bylander A, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-48; Carrasco LC, 2008, REPROD FERT DEVELOP, V20, P808, DOI 10.1071/RD08113; Carvalho JBP, 2008, THERIOGENOLOGY, V69, P167, DOI 10.1016/j.theriogenology.2007.08.035; Cebrian-Serrano A, 2013, REPROD DOMEST ANIM, V48, P331, DOI 10.1111/j.1439-0531.2012.02157.x; Chang HX, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096578; Coy P, 2008, P NATL ACAD SCI USA, V105, P15809, DOI 10.1073/pnas.0804422105; Croxatto Horacio B, 2002, Reprod Biomed Online, V4, P160; ELLINGTON JE, 1993, BIOL REPROD, V48, P851, DOI 10.1095/biolreprod48.4.851; EYESTONE WH, 1989, J REPROD FERTIL, V85, P715, DOI 10.1530/jrf.0.0850715; Fazeli A, 2004, BIOL REPROD, V71, P60, DOI 10.1095/biolreprod.103.026815; Figueiredo RA, 1997, THERIOGENOLOGY, V47, P1489, DOI 10.1016/S0093-691X(97)00156-8; Georgiou AS, 2007, J PROTEOME RES, V6, P4656, DOI 10.1021/pr070349m; Goncalves PB, 2012, REPRODUCTION, V143, P11, DOI 10.1530/REP-11-0192; Gonella-Diaza AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145321; GRIPPO AA, 1995, J REPROD FERTIL, V105, P57; HALBERT SA, 1976, SCIENCE, V191, P1052, DOI 10.1126/science.1251215; HARPER MJK, 1980, AM J PHYSIOL, V238, pE157, DOI 10.1152/ajpendo.1980.238.2.E157; Haxel BR, 2001, EUR ARCH OTO-RHINO-L, V258, P230, DOI 10.1007/s004050100339; Hermoso M, 2001, PFLUG ARCH EUR J PHY, V442, P336, DOI 10.1007/s004240100550; HUNTER RHF, 1984, REPROD NUTR DEV, V24, P597, DOI 10.1051/rnd:19840508; Ignotz GG, 2007, BIOL REPROD, V77, P906, DOI 10.1095/biolreprod.107.062505; Ireland J, 2007, HUM REPROD, V22, P1687, DOI 10.1093/humrep/dem071; Jimenez-Krassel F, 2009, BIOL REPROD, V80, P1272, DOI 10.1095/biolreprod.108.075093; JOHNSON SW, 1991, COMP BIOCHEM PHYS B, V99, P479, DOI 10.1016/0305-0491(91)90327-A; Kodithuwakku SP, 2007, REPRODUCTION, V133, P1087, DOI 10.1530/REP-06-0201; Kolle S, 2009, BIOL REPROD, V81, P267, DOI 10.1095/biolreprod.108.073874; LEFEBVRE R, 1995, BIOL REPROD, V53, P1066, DOI 10.1095/biolreprod53.5.1066; Lefebvre R, 1997, BIOL REPROD, V56, P1198, DOI 10.1095/biolreprod56.5.1198; Lin P, 2012, THERIOGENOLOGY, V78, P1824, DOI 10.1016/j.theriogenology.2012.07.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOMBARD L, 1950, J MORPHOL, V86, P1, DOI 10.1002/jmor.1050860102; Loureiro B, 2016, THERIOGENOLOGY, V86, P523, DOI 10.1016/j.theriogenology.2016.02.001; Lyons RA, 2006, HUM REPROD UPDATE, V12, P363, DOI 10.1093/humupd/dml012; Lyons RA, 2006, HUM REPROD, V21, P52, DOI 10.1093/humrep/dei306; Marin-Briggiler CI, 2010, FERTIL STERIL, V93, P1574, DOI 10.1016/j.fertnstert.2008.12.132; McNeel AK, 2017, ANIM REPROD SCI, V179, P1, DOI 10.1016/j.anireprosci.2017.01.004; Menezo Y, 1997, EUR J OBSTET GYN R B, V73, P99, DOI 10.1016/S0301-2115(97)02729-2; Mollo M.R., 2007, ACTA SCI VET, V35, P958; Mondejar I, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111385; Mossa F, 2012, J DAIRY SCI, V95, P2355, DOI 10.3168/jds.2011-4325; Mossa F, 2010, REPRODUCTION, V140, P713, DOI 10.1530/REP-10-0214; Mossa F, 2010, REPROD FERT DEVELOP, V22, P550, DOI 10.1071/RD09100; Nagai K, 2016, BIOMED RES-TOKYO, V37, P63, DOI 10.2220/biomedres.37.63; Nishimura A, 2010, EXP PHYSIOL, V95, P819, DOI 10.1113/expphysiol.2010.052555; Phopin K, 2013, MOL REPROD DEV, V80, P273, DOI 10.1002/mrd.22164; Ponnampalam AP, 2006, MOL HUM REPROD, V12, P661, DOI 10.1093/molehr/gal075; Romero-Aguirregomezcorta J, 2015, VET J, V203, P109, DOI 10.1016/j.tvjl.2014.11.006; RUCKEBUSCH Y, 1975, J REPROD FERTIL, V43, P23, DOI 10.1530/jrf.0.0430023; Saridogan E, 1996, J CLIN ENDOCR METAB, V81, P2719, DOI 10.1210/jc.81.7.2719; Sartori R, 2011, ANIM REPROD SCI, V124, P244, DOI 10.1016/j.anireprosci.2011.02.006; SAVIO JD, 1988, J REPROD FERTIL, V83, P663, DOI 10.1530/jrf.0.0830663; Schatz G, 2013, CELLS TISSUES ORGANS, V198, P457, DOI 10.1159/000360155; SEGERSON EC, 1984, J ANIM SCI, V59, P1026, DOI 10.2527/jas1984.5941026x; Silva-Santos KC, 2014, REPROD DOMEST ANIM, V49, P228, DOI 10.1111/rda.12255; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 2002, REPROD DOMEST ANIM, V37, P140, DOI 10.1046/j.1439-0531.2002.00346.x; Suarez SS, 2016, CELL TISSUE RES, V363, P185, DOI 10.1007/s00441-015-2244-2; Talbot P, 1999, MOL BIOL CELL, V10, P5, DOI 10.1091/mbc.10.1.5; Tanghe S, 2004, MOL REPROD DEV, V68, P492, DOI 10.1002/mrd.20095; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venditti JJ, 2010, BIOL REPROD, V82, P572, DOI 10.1095/biolreprod.109.076695; Wijayagunawardane MPB, 1998, THERIOGENOLOGY, V49, P607, DOI 10.1016/S0093-691X(98)00011-9; Wijayagunawardane MPB, 2005, MOL REPROD DEV, V72, P511, DOI 10.1002/mrd.20379; Wijayagunawardane MPB, 2004, J CARDIOVASC PHARM, V44, pS248, DOI 10.1097/01.fjc.0000166253.66486.4f; Wijayagunawardane MPB, 2004, J REPROD DEVELOP, V50, P57, DOI 10.1262/jrd.50.57; Wijayagunawardane MPB, 1999, THERIOGENOLOGY, V52, P791, DOI 10.1016/S0093-691X(99)00172-7; Wijayagunawardane MPB, 2003, BIOL REPROD, V69, P1341, DOI 10.1095/biolreprod.103.017327; Wijayagunawardane MPB, 2001, BIOL REPROD, V65, P799, DOI 10.1095/biolreprod65.3.799; Wijayagunawardane MPB, 2001, J ENDOCRINOL, V168, P117, DOI 10.1677/joe.0.1680117; Wolfenson D, 2004, THERIOGENOLOGY, V62, P1042, DOI 10.1016/j.theriogenology.2003.12.020; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yaniz JL, 2000, ANAT REC, V260, P268, DOI 10.1002/1097-0185(20001101)260:3<268::AID-AR60>3.0.CO;2-L; Yeste M, 2014, MOL REPROD DEV, V81, P805, DOI 10.1002/mrd.22350	83	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202017	10.1371/journal.pone.0202017	http://dx.doi.org/10.1371/journal.pone.0202017			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157205	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400027
J	Porzycki, J; Schmidt-Polonczyk, N; Was, J				Porzycki, Jakub; Schmidt-Polonczyk, Natalia; Was, Jaroslaw			Pedestrian behavior during evacuation from road tunnel in smoke condition - Empirical results	PLOS ONE			English	Article							RAIL TUNNELS; SPEED; DYNAMICS; MODELS	Five evacuation experiments were performed in a road tunnel in order to test how pedestrians react when exposed to reduced visibility, how the decision making process is carried out, and finally what is the impact of various circumstances like: different level of smokiness, competitive behavior or learning effect on an evacuation process. In four experiments pedestrians were exposed to artificial, non-toxic smoke. During evacuation of a group of people gathered in low and moderate level of smokiness (when Cs < 0.5m(-1)) we observed multi-line patterns created by pedestrians. Decision making was engaged in only by the first group of passengers, while under heavy smokiness Cs > 0.7m(-1) we have observed decision making by small groups and characteristic double-lines patterns. In four experiments the same group of participants was involved, and a learning effect was observed: increasingly shorter pre-movement time and decreasing time required to leave the main tunnel. We show, that movement speed in smoke is influenced by the evacuees' attitude and familiarity with environment and evacuation procedures and not only by the visibility level.	[Porzycki, Jakub; Was, Jaroslaw] AGH Univ Sci & Technol, Fac Elect Engn Automat Comp Sci & Biomed Engn, Al Mickiewicza 30, PL-30059 Krakow, Poland; [Schmidt-Polonczyk, Natalia] AGH Univ Sci & Technol, Fac Min & Geoengn, Al Mickiewicza 30, PL-30059 Krakow, Poland	AGH University of Science & Technology; AGH University of Science & Technology	Porzycki, J (corresponding author), AGH Univ Sci & Technol, Fac Elect Engn Automat Comp Sci & Biomed Engn, Al Mickiewicza 30, PL-30059 Krakow, Poland.	porzycki@agh.edu.pl	; Porzycki, Jakub/A-2424-2017; Was, Jaroslaw/B-5835-2012	Schmidt-Polonczyk, Natalia/0000-0003-0674-9680; Porzycki, Jakub/0000-0001-9077-9836; Was, Jaroslaw/0000-0003-2964-745X	AGH University of Science and Technology [11.11.120.859, 15.11.100.078]	AGH University of Science and Technology	The work was supported by AGH University of Science and Technology grant no 11.11.120.859 and 15.11.100.078. There was no additional external funding received for this study.	Abulhassan Y, 2018, SAFETY SCI, V108, P203, DOI 10.1016/j.ssci.2017.07.017; Abulhassan Y, 2016, SAFETY SCI, V89, P249, DOI 10.1016/j.ssci.2016.06.021; Beard A., 2012, HDB TUNNEL FIRE SAFE, DOI [10.1680/htfs.41530, DOI 10.1680/HTFS.41530]; DONALD I, 1992, EUR J SOC PSYCHOL, V22, P203, DOI 10.1002/ejsp.2420220302; Frantzich H, 2000, EXPT UTVARDERING MOG; Frantzich H, 2004, EVACUATION EXPT SMOK; Frantzich H, 2003, UTRYMNING GENOM TAT; Fridolf K, 2013, FIRE TECHNOL, V49, P451, DOI 10.1007/s10694-011-0217-x; Fridolf K, 2014, SAFETY SCI, V62, P515, DOI 10.1016/j.ssci.2013.10.008; Fridolf K, 2013, FIRE SAFETY J, V59, P8, DOI 10.1016/j.firesaf.2013.03.007; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Jin T., 1985, FIRE SCI TECHNOLOGY, V5, P79, DOI [10.3210/fst.5.79, DOI 10.3210/FST.5.79]; Jin T, 1976, VISIBILITY FIRE SMOK; Kinateder M, 2013, TRANSPORT RES F-TRAF, V17, P20, DOI 10.1016/j.trf.2012.09.001; Kirchner A, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/10/P10011; Lovreglio R, 2015, PHYSICA A, V438, P308, DOI 10.1016/j.physa.2015.06.040; Lubas R, 2016, J SUPERCOMPUT, V72, P2170, DOI 10.1007/s11227-016-1718-7; Mikame Y, 2014, STUDY SAFETY RELATIV; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Mu N, 2014, PROCEDIA ENGINEER, V71, P333, DOI 10.1016/j.proeng.2014.04.048; Nilsson, 2016, WAY FINDING LIGHTING, V8; Nilsson D., 2009, EXIT CHOICE FIRE EME; Nilsson D, 2018, FIRE SAFETY J, V97, P119, DOI 10.1016/j.firesaf.2017.07.001; Nilsson D, 2009, FIRE SAFETY J, V44, P458, DOI 10.1016/j.firesaf.2008.09.009; Oswald M, 2007, FULL SCALE EVACUATIO, P41, DOI [10.1007/978-3-540-47064-9_4, DOI 10.1007/978-3-540-47064-9_4]; Oswald M, 2011, ADV RES WORKSH EV HU; Oswald M, 2010, PEDESTRIAN AND EVACUATION DYNAMICS 2008, P67, DOI 10.1007/978-3-642-04504-2_5; Porzycki J, 2016, GRANULARITY PREMOVEM, P305, DOI [10.1007/978-3-319-33482-0_39, DOI 10.1007/978-3-319-33482-0_39]; Purser D., 2009, P FIR PROT LIF SAF B, P23; Ronchi E, 2013, FIRE TECHNOL, V49, P411, DOI 10.1007/s10694-012-0280-y; Ronchi E., 2010, P 12 INT INT 2010 C, P837; Ronchi E, 2018, FIRE SAFETY J, V97, P126, DOI 10.1016/j.firesaf.2017.06.002; Ronchi E, 2016, FIRE TECHNOL, V52, P623, DOI 10.1007/s10694-015-0462-5; Ronchi E, 2012, FIRE TECHNOL, V48, P961, DOI 10.1007/s10694-012-0256-y; Seike M, 2012, EXPT INVESTIGATIONS; Seike M, 2017, FIRE SAFETY J, V91, P901, DOI 10.1016/j.firesaf.2017.04.034; Seike M, 2016, TUNN UNDERGR SP TECH, V53, P61, DOI 10.1016/j.tust.2016.01.003; Voeltzel ADix A, 2004, COMP ANAL MONT BLANC	38	14	14	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201732	10.1371/journal.pone.0201732	http://dx.doi.org/10.1371/journal.pone.0201732			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157277	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400013
J	Rath, EM; Cheng, YY; Pinese, M; Sarun, KH; Hudson, AL; Weir, C; Wang, YD; Hakansson, AP; Howell, VM; Liu, GJ; Reid, G; Knott, RB; Duff, AP; Church, WB				Rath, Emma M.; Cheng, Yuen Yee; Pinese, Mark; Sarun, Kadir H.; Hudson, Amanda L.; Weir, Christopher; Wang, Yiwei D.; Hakansson, Anders P.; Howell, Viive M.; Liu, Guo Jun; Reid, Glen; Knott, Robert B.; Duff, Anthony P.; Church, W. Bret			BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state	PLOS ONE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; HUMAN ALPHA-LACTALBUMIN; MITOCHONDRIAL PERMEABILITY TRANSITION; SMALL-ANGLE SCATTERING; PROTEIN-LIPID COMPLEX; HUMAN-MILK PROTEIN; X-RAY-SCATTERING; TUMOR-CELLS; ATP SYNTHASE; FATTY-ACID	Malignant pleural mesothelioma is an aggressive cancer with poor prognosis. Here we have investigated in vitro efficacy of BAMLET and BLAGLET complexes (anti-cancer complexes consisting of oleic acid and bovine alpha-lactalbumin or beta-lactoglobulin respectively) in killing mesothelioma cells, determined BAMLET and BLAGLET structures, and investigated possible biological mechanisms. We performed cell viability assays on 16 mesothelioma cell lines. BAMLET and BLAGLET having increasing oleic acid content inhibited human and rat mesothelioma cell line proliferation at decreasing doses. Most of the non-cancer primary human fibroblasts were more resistant to BAMLET than were human mesothelioma cells. BAMLET showed similar cytotoxicity to cisplatin-resistant, pemetrexed-resistant, vinorelbine-resistant, and parental rat mesothelioma cells, indicating the BAMLET anti-cancer mechanism may be different to drugs currently used to treat mesothelioma. Cisplatin, pemetrexed, gemcitabine, vinorelbine, and BAMLET, did not demonstrate a therapeutic window for mesothelioma compared with immortalised non-cancer mesothelial cells. We demonstrated by quantitative PCR that ATP synthase is downregulated in mesothelioma cells in response to regular dosing with BAMLET. We sought structural insight for BAMLET and BLAGLET activity by performing small angle X-ray scattering, circular dichroism, and scanning electron microscopy. Our results indicate the structural mechanism by which BAMLET and BLAGLET achieve increased cytotoxicity by holding increasing amounts of oleic acid in an active cytotoxic state encapsulated in increasingly unfolded protein. Our structural studies revealed similarity in the molecular structure of the protein components of these two complexes and in their encapsulation of the fatty acid, and differences in the microscopic structure and structural stability. BAMLET forms rounded aggregates and BLAGLET forms long fibre-like aggregates whose aggregation is more stable than that of BAMLET due to intermolecular disulphide bonds. The results reported here indicate that BAMLET and BLAGLET may be effective second-line treatment options for mesothelioma.	[Rath, Emma M.; Church, W. Bret] Univ Sydney, Fac Pharm, Sydney, NSW, Australia; [Cheng, Yuen Yee; Sarun, Kadir H.; Reid, Glen] ADRI, Concord, NSW, Australia; [Cheng, Yuen Yee; Reid, Glen] Univ Sydney, Sydney, NSW, Australia; [Pinese, Mark] Kinghorn Canc Ctr, Sydney, NSW, Australia; [Pinese, Mark] Garvan Inst Med Res, Sydney, NSW, Australia; [Hudson, Amanda L.; Howell, Viive M.] Univ Sydney, Kolling Inst, Bill Walsh Translat Canc Res Lab, Sydney, NSW, Australia; [Weir, Christopher] Univ Sydney, Kolling Inst, Northern Blood Res Ctr, Sydney, NSW, Australia; [Wang, Yiwei D.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Burns Res, Concord, NSW, Australia; [Hakansson, Anders P.] Lund Univ, Div Expt Infect Med, Lund, Sweden; [Liu, Guo Jun; Knott, Robert B.; Duff, Anthony P.] ANSTO, New Illawarra Rd, Lucas Heights, NSW, Australia; [Liu, Guo Jun] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Liu, Guo Jun] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia	University of Sydney; University of Sydney; Garvan Institute of Medical Research; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Kolling Institute of Medical Research; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Lund University; Australian Nuclear Science & Technology Organisation; University of Sydney; University of Sydney	Church, WB (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW, Australia.; Cheng, YY (corresponding author), ADRI, Concord, NSW, Australia.; Cheng, YY (corresponding author), Univ Sydney, Sydney, NSW, Australia.	yuen.cheng@sydney.edu.au; bret.church@sydney.edu.au	Cheng, Yuen/AAU-2402-2020; Research Institute, ANZAC/CAE-9030-2022; Hakansson, Anders P/AAX-1225-2020	Hakansson, Anders P/0000-0002-2834-6009; Duff, Anthony/0000-0003-3586-360X; Rath, Emma/0000-0002-8430-5236; Liu, Guo-Jun/0000-0002-4278-8372; Sarun, Kadir/0000-0003-4592-0671	Australian Postgraduate Research Award; Bill Walsh Translational Cancer Research Laboratory; Swedish Medical Research Council (VR)	Australian Postgraduate Research Award; Bill Walsh Translational Cancer Research Laboratory; Swedish Medical Research Council (VR)(Swedish Medical Research Council (SMRC)Swedish Research Council)	Author EMR received support from an Australian Postgraduate Research Award. ALH and VMH received support from the Bill Walsh Translational Cancer Research Laboratory. APH was funded through Swedish Medical Research Council (VR) grants. Neither these funders nor any past or current employers of all authors had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; ALBERTS AS, 1988, J CLIN ONCOL, V6, P527, DOI 10.1200/JCO.1988.6.3.527; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; Altschul S.F., 1997, NUCLEIC ACIDS RES, V25, P3389, DOI DOI 10.1093/NAR/25.17; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Alvarellos ML, 2014, PHARMACOGENET GENOM, V24, P564, DOI 10.1097/FPC.0000000000000086; ARONSON JF, 1981, IN VITRO CELL DEV B, V17, P61, DOI 10.1007/BF02618032; BOWMAN R V, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P611; Brinkmann CR, 2011, FEBS J, V278, P1955, DOI 10.1111/j.1742-4658.2011.08112.x; Britten CD, 1999, CANCER CHEMOTH PHARM, V44, P105, DOI 10.1007/s002800050953; BRODERSEN R, 1990, EUR J BIOCHEM, V189, P343, DOI 10.1111/j.1432-1033.1990.tb15495.x; Bueno R, 2001, J THORAC CARDIOV SUR, V121, P225, DOI 10.1067/mtc.2001.111176; CHAHINIAN AP, 1984, CANCER RES, V44, P1688; Cheng YY, 2013, J THORAC ONCOL, V8, P1317, DOI 10.1097/JTO.0b013e3182a0840a; Clementi EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080649; Clementi EA, 2012, J BIOL CHEM, V287, P27168, DOI 10.1074/jbc.M112.371070; CRAIGHEAD JE, 1987, AM J PATHOL, V129, P448; Delgado Y, 2015, FEBS OPEN BIO, V5, P397, DOI 10.1016/j.fob.2015.04.010; Driscoll T, 2005, AM J IND MED, V48, P419, DOI 10.1002/ajim.20209; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Fang B, 2015, J DAIRY SCI, V98, P2898, DOI 10.3168/jds.2014-8993; Fang B, 2014, BBA-MOL CELL BIOL L, V1841, P535, DOI 10.1016/j.bbalip.2013.12.008; Fang B, 2012, PROTEIN J, V31, P564, DOI 10.1007/s10930-012-9434-5; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Fontana A, 2013, BBA-PROTEINS PROTEOM, V1834, P1125, DOI 10.1016/j.bbapap.2013.02.041; Frislev HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15003-6; Frislev HS, 2016, BBA-PROTEINS PROTEOM, V1864, P847, DOI 10.1016/j.bbapap.2016.04.003; Furlow B, 2016, LANCET RESP MED, V4, P545, DOI 10.1016/S2213-2600(16)30144-8; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; GLATTER O, 1977, ACTA PHYS AUSTRIACA, V47, P83; Guinier A, 1938, CR HEBD ACAD SCI, V206, P1374; Gultekin KE, 2013, GENET MOL RES, V12, P5405, DOI 10.4238/2013.November.11.2; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hallgren O, 2006, APOPTOSIS, V11, P221, DOI 10.1007/s10495-006-3607-7; HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; Ho J, 2015, J MOL BIOL, V427, P1866, DOI 10.1016/j.jmb.2015.01.024; Ho CSJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053051; Hoda MA, 2012, BRIT J CANCER, V107, P1978, DOI 10.1038/bjc.2012.519; HOLIAT SM, 1981, CANCER TREAT REP, V65, P1113; Hudson AL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06152; Hughes A, 2002, J CLIN ONCOL, V20, P3533, DOI 10.1200/JCO.2002.10.073; Kamijima T, 2008, BIOCHEM BIOPH RES CO, V376, P211, DOI 10.1016/j.bbrc.2008.08.127; Kaspersen JD, 2014, CHEMBIOCHEM, V15, P2693, DOI 10.1002/cbic.201402407; Kataev AA, 2013, BIOCHEM MOSC SUPPL S, V7, P141, DOI 10.1134/S1990747812030105; KE Y, 1989, AM J PATHOL, V134, P979; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Knyazeva EL, 2008, BIOCHEMISTRY-US, V47, P13127, DOI 10.1021/bi801423s; Kohler C, 1999, EXP CELL RES, V249, P260, DOI 10.1006/excr.1999.4472; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kondola S, 2016, THER ADV RESPIR DIS, V10, P275, DOI 10.1177/1753465816628800; KRARUPHANSEN A, 1991, CANCER CHEMOTH PHARM, V28, P319, DOI 10.1007/BF00685684; Kryeziu K, 2013, MOL CANCER THER, V12, P1073, DOI 10.1158/1535-7163.MCT-13-0065; Le GV, 2011, RESPIROLOGY, V16, P767, DOI 10.1111/j.1440-1843.2011.01975.x; Leigh J, 2003, INT J OCCUP ENV HEAL, V9, P206, DOI 10.1179/oeh.2003.9.3.206; Li W, 2017, INT J ONCOL, V50, P1312, DOI 10.3892/ijo.2017.3878; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liskova K, 2011, EUR J LIPID SCI TECH, V113, P1207, DOI 10.1002/ejlt.201100109; Liskova K, 2010, J AGR FOOD CHEM, V58, P4421, DOI 10.1021/jf903901j; Liskova Kamila, 2011, THESIS; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marks LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063158; Marks LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043514; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mercer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026093; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moriya M, 2014, ONCOL REP, V31, P1109, DOI 10.3892/or.2013.2948; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; Nadeem A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16432; Nielsen SB, 2010, J MOL BIOL, V398, P351, DOI 10.1016/j.jmb.2010.03.012; Nowak AK, 2012, ANN CARDIOTHORAC SUR, V1, P508, DOI 10.3978/j.issn.2225-319X.2012.10.05; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; Permyakov SE, 2004, BIOCHEMISTRY-US, V43, P5575, DOI 10.1021/bi049584y; Permyakov SE, 2011, BIOCHIMIE, V93, P1495, DOI 10.1016/j.biochi.2011.05.002; Permyakovz SE, 2012, BIOL CHEM, V393, P85, DOI 10.1515/BC-2011-230; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puthia M, 2014, GUT, V63, P131, DOI 10.1136/gutjnl-2012-303715; Rammer P, 2010, MOL CANCER THER, V9, P24, DOI 10.1158/1535-7163.MCT-09-0559; Rath EM, 2017, PROTEINS, V85, P1371, DOI 10.1002/prot.25298; Rath EM, 2015, J PHARM PHARM SCI, V18, P773, DOI 10.18433/J3G60C; Rath EM, 2014, PROTEINS, V82, P1400, DOI 10.1002/prot.24508; Relan V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058132; Remon J, 2013, CANCER TREAT REV, V39, P584, DOI 10.1016/j.ctrv.2012.12.005; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1973, NATURWISSENSCHAFTEN, V60, P399, DOI 10.1007/BF00623551; SAMSON MK, 1979, CANCER TREAT REP, V63, P2027; Scagliotti G., 2001, European Journal of Cancer, V37, pS20, DOI 10.1016/S0959-8049(01)80558-X; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schultz RM, 1999, SEMIN ONCOL, V26, P68; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Spolaore B, 2010, BIOCHEMISTRY-US, V49, P8658, DOI 10.1021/bi1012832; Storm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058578; Sullivan L. M., 2013, Food Digestion, V4, P7; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Team RC., 2013, R LANG ENV STAT COMP; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; Trulsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017179; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; von Seggern D.H., 2007, CRC STANDARD CURVES, V2nd ed.; Vukojevic V, 2010, LANGMUIR, V26, P14782, DOI 10.1021/la1026416; Wang WJ, 2012, CLIN EXP MED, V12, P3, DOI 10.1007/s10238-011-0133-x; Wang YW, 2015, ADV HEALTHC MATER, V4, P577, DOI 10.1002/adhm.201400571; Wen H., 2011, J BIOANAL BIOMED S, V5; Wen HZ, 2015, J MOL BIOL, V427, P3177, DOI 10.1016/j.jmb.2015.08.009; Wen HZ, 2013, BBA-BIOMEMBRANES, V1828, P2691, DOI 10.1016/j.bbamem.2013.07.026; Xiao ZW, 2013, BJU INT, V112, pE201, DOI 10.1111/j.1464-410X.2012.11737.x; Zhang X, 2008, ACTA PHARMACOL SIN, V29, P942, DOI 10.1111/j.1745-7254.2008.00830.x; Zhao WL, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-92; Zherelova OM, 2009, J BIOENERG BIOMEMBR, V41, P229, DOI 10.1007/s10863-009-9222-x	126	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203003	10.1371/journal.pone.0203003	http://dx.doi.org/10.1371/journal.pone.0203003			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157247	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400082
J	Hsu, YP; Hsu, CW; Bai, CH; Cheng, SW; Chen, KC; Chen, C				Hsu, Yuan-Pin; Hsu, Chin-Wang; Bai, Chyi-Huey; Cheng, Sheng-Wei; Chen, Kuan-Chou; Chen, Chiehfeng			Silodosin versus tamsulosin for medical expulsive treatment of ureteral stones: A systematic review and meta-analysis	PLOS ONE			English	Review							TRIAL SEQUENTIAL-ANALYSIS; ALPHA-1-ADRENOCEPTOR SUBTYPES; NETWORK METAANALYSIS; COMPARING TAMSULOSIN; ALPHA-BLOCKERS; THERAPY; CALCULI; UROLITHIASIS; EFFICACY; MANAGEMENT	Silodosin, a recently introduced selective a-blocker, has a much higher selectivity for the alpha-1A receptor. The efficacy and safety of silodosin compared to tamsulosin in medical expulsive therapy (MET) are controversial. The objective of this study was to assess the efficacy and safety of silodosin compared to tamsulosin for treating ureteral stones < 10 mm in diameter. We systematically searched the PubMed, EMBASE, Cochrane library, and Scopus databases from their inception to May 2018. We included randomized controlled studies (RCTs) and observational studies, which investigated stone expulsion rates using silodosin compared to tamsulosin. Data were synthesized using a random-effects model. Sixteen studies with 1824 patients were eligible for inclusion. Silodosin achieved significantly higher expulsion rates than tamsulosin (pooled risk difference (RD): 0.13, 95% confidence interval (CI): 0.09 to 0.18, GRADE: high). A subgroup analyses showed that silodosin has a significantly higher expulsion rate on stone sizes of 5 +/- 10 mm than tamsulosin (pooled RD: 0.14, 95% CI: 0.06 to 0.22, I-2 = 0%). The superior effect was not observed on stone sizes < 5 mm. A multivariate regression showed that the RD was negatively associated with the control expulsion rate after adjusting for age and gender (coefficient -0.658, p = 0.01). A sensitivity analysis showed that our findings were robust. Patients receiving silodosin also probably had a significantly shorter expulsion time (pooled mean difference (MD): -2.55 days, 95% CI: -4.06 to -1.04, I-2 = 85%, GRADE: moderate) and may have fewer pain episodes (pooled MD: -0.3, 95% CI: -0.51 to -0.09, GRADE: low) but a higher incidence of retrograde ejaculation by 5% compared to those receiving tamsulosin. In conclusion, compared to tamsulosin, silodosin provided significantly better stone passage for patients with ureteral stones (particularly for sizes of 5 similar to 10 mm), shorter expulsion times, and fewer pain episodes but caused a higher incidence of retrograde ejaculation.	[Hsu, Yuan-Pin; Hsu, Chin-Wang] Taipei Med Univ, Wan Fang Hosp, Emergency Dept, Taipei, Taiwan; [Hsu, Yuan-Pin; Cheng, Sheng-Wei; Chen, Kuan-Chou; Chen, Chiehfeng] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Hsu, Yuan-Pin; Hsu, Chin-Wang] Taipei Med Univ, Sch Med, Dept Emergency, Coll Med, Taipei, Taiwan; [Bai, Chyi-Huey; Chen, Chiehfeng] Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan; [Cheng, Sheng-Wei] Taipei Med Univ, Wan Fang Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Chen, Kuan-Chou] Taipei Med Univ, Dept Urol, Shuang Ho Hosp, Taipei, Taiwan; [Chen, Chiehfeng] Taipei Med Univ, Cochrane Taiwan, Taipei, Taiwan; [Chen, Chiehfeng] Taipei Med Univ, Wan Fang Hosp, Div Plast Surg, Dept Surg, Taipei, Taiwan; [Chen, Chiehfeng] Taipei Med Univ, Wan Fang Hosp, Evidence Based Med Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, C (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Chen, C (corresponding author), Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan.; Chen, C (corresponding author), Taipei Med Univ, Cochrane Taiwan, Taipei, Taiwan.; Chen, C (corresponding author), Taipei Med Univ, Wan Fang Hosp, Div Plast Surg, Dept Surg, Taipei, Taiwan.; Chen, C (corresponding author), Taipei Med Univ, Wan Fang Hosp, Evidence Based Med Ctr, Taipei, Taiwan.	clifchen@tmu.edu.tw	Hsu, Yuan-Pin/ABB-4709-2020	Chen, Chiehfeng/0000-0002-1595-6553	Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan [106-eva-18]	Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan	The authors, Yuan-Pin Hsu and Chiehfeng Chen, are very grateful for financial support from project no. 106-eva-18 of Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.	Albert AS, 2016, INT SURG J, V3, P578, DOI DOI 10.18203/2349-2902.ISJ20161125; Antony DA., 2017, J MED SCI CLIN RES, V5, DOI [10.18535/jmscr/v5i12.106, DOI 10.18535/JMSCR/V5I12.106]; Arda E, 2017, CUREUS, V9, DOI 10.7759/cureus.1848; Bensalah K, 2008, EUR UROL, V53, P411, DOI 10.1016/j.eururo.2007.09.012; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Coll DM, 2002, AM J ROENTGENOL, V178, P101, DOI 10.2214/ajr.178.1.1780101; Dell'Atti L, 2015, UROLOGIA J, V82, P54, DOI 10.5301/uro.5000083; Ding H, 2016, RENAL FAILURE, V38, P1311, DOI 10.1080/0886022X.2016.1215221; Elgalaly H, 2016, ARAB J UROL, V14, P12, DOI 10.1016/j.aju.2015.11.004; Fahmy A, 2017, J UROLOGY, V197, pE1217, DOI 10.1016/j.juro.2017.02.2837; Furyk JS, 2016, ANN EMERG MED, V67, P86, DOI 10.1016/j.annemergmed.2015.06.001; Fwu CW, 2013, KIDNEY INT, V83, P479, DOI 10.1038/ki.2012.419; Georgescu D, 2015, FARMACIA, V63, P184; Gupta S, 2013, J CLIN DIAGN RES, V7, P1672, DOI 10.7860/JCDR/2013/6141.3241; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hollingsworth JM, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6112; Huang W, 2016, BRIT J CLIN PHARMACO, V81, P13, DOI 10.1111/bcp.12737; Imperatore V, 2014, ARCH ITAL UROL ANDRO, V86, P103, DOI 10.4081/aiua.2014.2.103; Itoh Y, 2007, INT J UROL, V14, P749, DOI 10.1111/j.1442-2042.2007.01812.x; Jung JH, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012615.pub2; Kumar A, 2010, J ENDOUROL, V24, P2059, DOI 10.1089/end.2010.0066; Kumar S, 2015, UROLOGY, V85, P59, DOI 10.1016/j.urology.2014.09.022; Liu XJ, 2018, UROLITHIASIS, V46, P211, DOI 10.1007/s00240-017-0974-1; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Ozsoy M, 2016, UROLITHIASIS, V44, P491, DOI 10.1007/s00240-016-0872-y; Pickard R, 2015, LANCET, V386, P341, DOI 10.1016/S0140-6736(15)60933-3; Priyanka P, 2017, J EVOLUTION MED DENT, V6, P6766, DOI [10.14260/jemds/2017/1465, DOI 10.14260/JEMDS/2017/1465]; Rahman MJ, 2018, ARAB J UROL, V16, P245, DOI 10.1016/j.aju.2017.11.012; Rathi S, 2014, INDIAN J UROLOGY S1, V30, pS83; Reddy S, 2016, J EVOL MED DENT SCI-, V5, P4108, DOI 10.14260/jemds/2016/939; Romero Victoriano, 2010, Rev Urol, V12, pe86; Senturk AB, 2018, ARCH ITAL UROL ANDRO, V90, P25, DOI 10.4081/aiua.2018.1.25; Sharma G, 2016, J EVIDENCE BASED MED, V3, P4647, DOI [10.18410/jebmh/2016/979, DOI 10.18410/JEBMH/2016/979]; Skolarikos A, 2017, EUR UROL FOCUS, V3, P27, DOI 10.1016/j.euf.2017.05.002; Sridharan K, 2018, EXPERT REV CLIN PHAR, V11, P291, DOI 10.1080/17512433.2018.1424537; Sridharan K, 2017, EXPERT OPIN PHARMACO, V18, P1421, DOI 10.1080/14656566.2017.1362393; Tomiyama Y, 2007, EUR J PHARMACOL, V573, P201, DOI 10.1016/j.ejphar.2007.06.056; Tsuzaka Y, 2011, INT J UROL, V18, P792, DOI 10.1111/j.1442-2042.2011.02850.x; Turk C, 2016, EUR UROL, V69, P468, DOI 10.1016/j.eururo.2015.07.040; Wells G.A., 2011, NEWCASTLE OTTAWA SCA; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Yang DD, 2016, BMC UROL, V16, DOI 10.1186/s12894-016-0141-y; Ye ZQ, 2018, EUR UROL, V73, P385, DOI 10.1016/j.eururo.2017.10.033	46	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203035	10.1371/journal.pone.0203035	http://dx.doi.org/10.1371/journal.pone.0203035			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153301	Green Submitted, Green Published, gold			2022-12-27	WOS:000443001700039
J	Dominguez, JM; Dominguez, JH; Xie, DH; Kelly, KJ				Dominguez, James M., II; Dominguez, Jesus H.; Xie, Danhui; Kelly, K. J.			Human extracellular microvesicles from renal tubules reverse kidney ischemia-reperfusion injury in rats	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; CELL TRANSPLANTATION; IN-VIVO; FAILURE; PROGRESSION; HYPOXIA; AKI; TRANSITION; MORTALITY; EXOSOMES	Hypoxic acute kidney injury, a major unresolved problem, initiates, or aggravates, renal functional and structural decline. There is no treatment for hypoxic acute renal injury and its sequelae. We tested the hypothesis that human kidney tubular cells, or their extracellular vesicles (exosomes), prevent renal injury when infused intravenously 24 hours after 50 minutes of bilateral renal ischemia in Nude rats. Cells and their exosomes were from harvested human kidneys declined for transplantation. Injections of either cells or exosomes, given after 24 and 48 hours of reperfusion, preserved renal function and structure in both treatment groups. However, exosomes were superior to cells; and maintained renal vascular and epithelial networks, prevented renal oxidant stress, and apoptosis; and restrained activation of pro-inflammatory and pro-fibrogenic pathways. Exosomes worked in 24 hours, consistent with functional rather than regenerative activity. Comprehensive proteomic analysis identified 6152 renal proteins from all cellular compartments; and 628 were altered by ischemia at all cell levels, while 377 were significantly improved by exosome infusions. We conclude that renal damage from severe ischemia was broad, and human renal exosomes prevented most protein alterations. Thus, exosomes seem to acutely correct a critical and consequential abnormality during reperfusion. In their absence, renal structure and cells transition to a chronic state of fibrosis and extensive renal cell loss.	[Dominguez, James M., II; Dominguez, Jesus H.; Xie, Danhui; Kelly, K. J.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Dominguez, Jesus H.; Kelly, K. J.] Roudebush VA Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Dominguez, JH (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.; Dominguez, JH (corresponding author), Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.	jhdoming@iu.edu			NIH [R01 DK 082739]; Paul Teschan Research Fund of Dialysis Clinics, Inc.; U.S. Department of Veterans Affairs (Merit Review Grant); University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center; Indiana Clinical and Translational Sciences Institute; DCI Paul Teschan Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul Teschan Research Fund of Dialysis Clinics, Inc.; U.S. Department of Veterans Affairs (Merit Review Grant); University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center; Indiana Clinical and Translational Sciences Institute; DCI Paul Teschan Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by NIH grant R01 DK 082739, Paul Teschan Research Fund of Dialysis Clinics, Inc., U.S. Department of Veterans Affairs (Merit Review Grant), University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center, Indiana Clinical and Translational Sciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by Merit Review Grant to JHD, NIH grant R01 DK 082739, Indiana Clinical and Translational Sciences Institute, and research grant from DCI Paul Teschan Research and from University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center to KJK. We thank Dr. Tim E. Taber for supporting the human kidney donations and Indiana Donor Network staff for their contribution with rejected kidneys. We are also grateful to Jennifer Nelson and Dr. Sarah Tersey, from the Islet and Physiology Core of the Center for Diabetes and Metabolic Diseases at Indiana University, for conducting exosome analysis.	Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Basile DP, 2011, AM J PHYSIOL-RENAL, V300, pF721, DOI 10.1152/ajprenal.00546.2010; BERTRAM JF, 1992, CELL TISSUE RES, V270, P37, DOI 10.1007/BF00381877; Bonventre JV, 2002, CURR OPIN NEPHROL HY, V11, P43, DOI 10.1097/00041552-200201000-00007; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; Brodsky SV, 2002, AM J PHYSIOL-RENAL, V282, pF1140, DOI 10.1152/ajprenal.00329.2001; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Collino F, 2015, J AM SOC NEPHROL, V26, P2349, DOI 10.1681/ASN.2014070710; Dominguez JH, 2017, J AM SOC NEPHROL, V28, P3533, DOI 10.1681/ASN.2016121278; Heyman SN, 2008, AM J NEPHROL, V28, P998, DOI 10.1159/000146075; Islam CF, 1997, BRIT J UROL, V79, P842, DOI 10.1046/j.1464-410X.1997.00209.x; Jonker SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150863; Kelly KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131677; Kelly KJ, 2013, PHYSIOL GENOMICS, V45, P710, DOI 10.1152/physiolgenomics.00028.2013; Kelly KJ, 2009, AM J PHYSIOL-RENAL, V297, pF923, DOI 10.1152/ajprenal.00205.2009; Kelly KJ, 2015, AM J NEPHROL, V41, P48, DOI 10.1159/000371426; Kelly KJ, 2013, AM J PHYSIOL-RENAL, V305, pF1804, DOI 10.1152/ajprenal.00097.2013; Kelly KJ, 2012, AM J PHYSIOL-RENAL, V303, pF357, DOI 10.1152/ajprenal.00680.2011; Kelly KJ, 2010, AM J PHYSIOL-RENAL, V299, pF453, DOI 10.1152/ajprenal.00050.2010; Kelly KJ, 2009, AM J PHYSIOL-RENAL, V296, pF1355, DOI 10.1152/ajprenal.90622.2008; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Koritzinsky EH, 2017, J CELL PHYSIOL, V232, P1587, DOI 10.1002/jcp.25387; Kourembanas S, 2015, ANNU REV PHYSIOL, V77, P13, DOI 10.1146/annurev-physiol-021014-071641; Oosthuyzen W, 2016, J AM SOC NEPHROL, V27, P3345, DOI 10.1681/ASN.2015050568; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Reese PP, 2016, J AM SOC NEPHROL, V27, P973, DOI 10.1681/ASN.2015010023; Rolstad B, 2001, IMMUNOL REV, V184, P136, DOI 10.1034/j.1600-065x.2001.1840113.x; Tanaka S, 2014, AM J PHYSIOL-RENAL, V307, pF1187, DOI 10.1152/ajprenal.00425.2014; Wang CJ, 2017, HUM IMMUNOL, V78, P9, DOI 10.1016/j.humimm.2016.08.007; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	33	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202550	10.1371/journal.pone.0202550	http://dx.doi.org/10.1371/journal.pone.0202550			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148844	Green Submitted, Green Published, gold			2022-12-27	WOS:000442804200014
J	Golestaneh, L; Bellin, E; Neugarten, J; Lo, YT				Golestaneh, Ladan; Bellin, Eran; Neugarten, Joel; Lo, Yungtai			Avoidable visits to the emergency department (ED) and their association with sex, age and race in a cohort of low socio-economic status patients on hemodialysis in the Bronx	PLOS ONE			English	Article							INCIDENT DIALYSIS PATIENTS; PATIENTS APPROACHING ESRD; PSYCHOSOCIAL FACTORS; MAINTENANCE HEMODIALYSIS; BEHAVIORAL COMPLIANCE; SOCIAL SUPPORT; RENAL-DISEASE; MORTALITY; OUTCOMES; CARE	Background In national samples drawn from the USRDS, female patients utilize the hospital ED and inpatient services at a higher rate than their male counterparts and have a higher rate of re-hospitalization. We wanted to explore the association of sex with avoidable ED visits made by a cohort of patients on hemodialysis in a mostly minority, lower socioeconomic status (SES), population in the Bronx to test the applicability of the USRDS findings. Methods We used Montefiore's clinical database to build a cohort of patients on hemodialysis with a first ED visit between 2013 and 2017. All ED visits after the index ED visit and those within one year prior to the index visit were recorded. None of the ED visits resulted in a hospitalization and were thus labeled "avoidable". Bivariate analysis tested the association of demographic and clinical variables with sex. We used negative binomial regression to test the association of each variable with avoidable ED visit count. The multivariate model used negative binomial regression with avoidable ED visit count as outcome and sex as the exposure variable and included ancestral variables age and race. Potential mediators were added to the model to measure their effects on the association of sex with avoidable ED visits. Results Four thousand six hundred and seventy three subjects on hemodialysis were identified as having at least one avoidable ED visit, in the period of 2013-2017 at one of four ED sites affiliated with Montefiore Medical Center in the Bronx. Over 5 years (2012-2017), the median number of ED visits made by the study sample was 4 (25-75% IQR: 2-8). Female patients on hemodialysis in our cohort were older, more commonly black, had lower SES scores, less commonly had commercial insurance and were less commonly married than their male counterparts. Female sex was not significantly associated with a higher rate of avoidable ED visits in the total cohort.(1.053(0.99-1.12) Female sex was significantly associated with outcome in non-Hispanic whites only and in those subjects younger than 44 years old.(IRR 1.30(1.06-1.69), 1.17(1.00-1.38) in non-Hispanic White and younger age group, respectively.) Marital status, SES and hemoglobin levels possibly mediated the association of sex and outcome in our population. (>25% change in the coefficient for sex with respect to outcome when variable added to the model). Conclusion In this single center study of a lower-socioeconomic status, mostly minority dialysis population, the association of female sex with avoidable ED visits was not significant. These results suggest the association of sex with hospitalization outcomes, described by national datasets that determine quality indicators, are not consistent across different types of populations with some mediation possible by SES and marital status in poorer neighborhoods.	[Golestaneh, Ladan; Neugarten, Joel] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Renal Div, Bronx, NY 10467 USA; [Bellin, Eran; Lo, Yungtai] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Golestaneh, L (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Renal Div, Bronx, NY 10467 USA.	lgolesta@montefiore.org		Golestaneh, Ladan/0000-0003-1848-582X				Adams SV, 2017, J AM SOC NEPHROL, V28, P2721, DOI 10.1681/ASN.2016090986; Beberashvili I, 2009, J RENAL NUTR, V19, P238, DOI 10.1053/j.jrn.2008.11.007; Bellin E, 2015, RIDDLES ACCOUNTABLE; Bellin E, 2010, ACAD MED, V85, P1362, DOI 10.1097/ACM.0b013e3181df0f3b; BILLINGS J, 1993, HEALTH AFFAIR, V12, P162, DOI 10.1377/hlthaff.12.1.162; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleland V, 2010, SOC SCI MED, V70, P2011, DOI 10.1016/j.socscimed.2010.02.028; Borges MCC, 2017, CLIN NUTR ESPEN, V17, P63, DOI 10.1016/j.clnesp.2016.10.006; Hakim RM, 2014, J AM SOC NEPHROL, V25, P1891, DOI 10.1681/ASN.2014030270; Hecking M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001750; Huang J., 2015, CHIN RURAL EC, V2015, P10, DOI DOI 10.1016/j.agrformet.2015.10.013; Johns TS, 2014, J AM SOC NEPHROL, V25, P2649, DOI 10.1681/ASN.2013111207; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1343, DOI 10.1053/ajkd.2001.29250; Kalbfleisch J, 2015, J AM SOC NEPHROL, V26, P2641, DOI 10.1681/ASN.2014050512; Kimmel PL, 2000, AM J KIDNEY DIS, V35, pS132, DOI 10.1016/S0272-6386(00)70240-X; Kimmel PL, 2003, ADV RENAL REPLACE TH, V10, P61, DOI 10.1053/jarr.2003.50000; Kimmel PL, 1998, KIDNEY INT, V54, P245, DOI 10.1046/j.1523-1755.1998.00989.x; KIMMEL PL, 1995, J AM SOC NEPHROL, V5, P1826; Komenda P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195323; Lovasik BP, 2016, JAMA INTERN MED, V176, P1563, DOI 10.1001/jamainternmed.2016.4975; Martin M, 2015, ATHEROSCLEROSIS, V241, P264, DOI 10.1016/j.atherosclerosis.2015.02.048; Newman KL, 2017, TRANSPLANTATION, V101, P2913, DOI 10.1097/TP.0000000000001839; Norris KC, 2017, SEMIN DIALYSIS, V30, P213, DOI 10.1111/sdi.12589; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P1480, DOI 10.2215/CJN.01240210; Ronksley PE, 2016, CLIN J AM SOC NEPHRO, V11, P2022, DOI 10.2215/CJN.04690416; Ronksley PE, 2017, CLIN J AM SOC NEPHRO, V12, P304, DOI 10.2215/CJN.06280616; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Services CfMaM, 2017, ESRD QUAL INC PROGR; Services CfMaM, 2017, FIN PY 2018 CLIN MEA; Services CfMaM, END STAG REN DIS ESR, P1017; Sturm G, 2010, NEPHROL DIAL TRANSPL, V25, P2715, DOI 10.1093/ndt/gfq101; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; United States Renal Data S, 2016, ESRD US, P2; United States Renal Data S, 2017, US REN DAT S ANN REP; United States Renal Data S, 2013, EC COSTS ESRD; United States Renal Data S, 2017, ANN DAT REP HIGHL; Untas A, 2011, CLIN J AM SOC NEPHRO, V6, P142, DOI 10.2215/CJN.02340310; USRDS, 2017, USRDS ANN DAT REP, V23, DOI [10.1681/ASN.2016090986, DOI 10.1681/ASN.2016090986]; Wiebe N, 2014, AM J KIDNEY DIS, V64, P230, DOI 10.1053/j.ajkd.2014.03.012; Yan GF, 2015, CLIN J AM SOC NEPHRO, V10, P1979, DOI 10.2215/CJN.02800315; Yan GF, 2014, CLIN J AM SOC NEPHRO, V9, P1402, DOI 10.2215/CJN.12621213; Yan GF, 2013, CLIN J AM SOC NEPHRO, V8, P610, DOI 10.2215/CJN.07780812	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202697	10.1371/journal.pone.0202697	http://dx.doi.org/10.1371/journal.pone.0202697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142175	gold, Green Submitted, Green Published			2022-12-27	WOS:000442722500025
J	Lee, M; Kang, YS; Seok, J				Lee, Minhyeok; Kang, Yeong Seon; Seok, Junhee			The estimation of probability distribution for factor variables with many categorical values	PLOS ONE			English	Article							POLYA TREE DISTRIBUTIONS; DENSITY-ESTIMATION; KERNEL ESTIMATORS; CANCER	With recent developments of data technology in biomedicine, factor data such as diagnosis codes and genomic features, which can have tens to hundreds of discrete and unorderable categorical values, have emerged. While considered as a fundamental problem in statistical analyses, the estimation of probability distribution for such factor variables has not studied much because the previous studies have mainly focused on continuous variables and discrete factor variables with a few categories such as sex and race. In this work, we propose a nonparametric Bayesian procedure to estimate the probability distribution of factors with many categories. The proposed method was demonstrated through simulation studies under various conditions and showed significant improvements on the estimation errors from the previous conventional methods. In addition, the method was applied to the analysis of diagnosis data of intensive care unit patients, and generated interesting medical hypotheses. The overall results indicate that the proposed method will be useful in the analysis of biomedical factor data.	[Lee, Minhyeok; Seok, Junhee] Korea Univ, Sch Elect Engn, Seoul, South Korea; [Kang, Yeong Seon] Univ Seoul, Dept Business Adm, Seoul, South Korea	Korea University; University of Seoul	Seok, J (corresponding author), Korea Univ, Sch Elect Engn, Seoul, South Korea.	jseok14@korea.ac.kr	Lee, Minhyeok/AAD-6000-2019	Lee, Minhyeok/0000-0003-2562-172X; Seok, Junhee/0000-0002-6475-8457	National Research Foundation of Korea - Korea government [NRF-2016R1D1A1B03931077]; Institute for Information & communications Technology Promotion(IITP) grant - Korea government(MSIT) [2017-0-00053]; Korea Evaluation Institute of Industrial Technology [10073166]	National Research Foundation of Korea - Korea government(National Research Foundation of KoreaKorean Government); Institute for Information & communications Technology Promotion(IITP) grant - Korea government(MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Korea Evaluation Institute of Industrial Technology	This research was supported by grants from National Research Foundation of Korea (http://www.nrf.re.kr) funded by the Korea government (NRF-2016R1D1A1B03931077 to J.S.), Institute for Information & communications Technology Promotion(IITP) grant funded by the Korea government(MSIT) (No.2017-0-00053, A Technology Development of Artificial Intelligence Doctors for Cardiovascular Disease), and Korea Evaluation Institute of Industrial Technology (10073166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolo A, 2012, PULM MED, V2012, DOI 10.1155/2012/952741; Bhattacharya A, 2012, J AM STAT ASSOC, V107, P362, DOI 10.1080/01621459.2011.646934; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Dunson DB, 2009, J AM STAT ASSOC, V104, P1042, DOI 10.1198/jasa.2009.tm08439; FERGUSON TS, 1974, ANN STAT, V2, P615, DOI 10.1214/aos/1176342752; Friedman C, 2001, Bioinformatics, V17 Suppl 1, pS74; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; GRUND B, 1993, J MULTIVARIATE ANAL, V46, P283, DOI 10.1006/jmva.1993.1062; GRUND B, 1993, J MULTIVARIATE ANAL, V44, P321, DOI 10.1006/jmva.1993.1019; Jiang H, 2015, J COMPUTATIONAL GRAP; Kim J, 2012, J MACH LEARN RES, V13, P2529; LAVINE M, 1992, ANN STAT, V20, P1222, DOI 10.1214/aos/1176348767; LAVINE M, 1994, ANN STAT, V22, P1161, DOI 10.1214/aos/1176325623; LO AY, 1984, ANN STAT, V12, P351, DOI 10.1214/aos/1176346412; Ma L, 2011, J AM STAT ASS, V106; Manchikanti L, 2011, PAIN PHYSICIAN, V14, pE405; Motomura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050039; Rajagopala SV, 2014, NAT BIOTECHNOL, V32, P285, DOI 10.1038/nbt.2831; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Scott DJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-9; Seok J, 2014, BIOSTATISTICS, V15, P182, DOI 10.1093/biostatistics/kxt025; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; SIMONOFF JS, 1995, J STAT PLAN INFER, V47, P41, DOI 10.1016/0378-3758(94)00121-B; TITTERINGTON DM, 1980, TECHNOMETRICS, V22, P259, DOI 10.2307/1268466; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wong WH, 2010, ANN STAT, V38, P1433, DOI 10.1214/09-AOS755	32	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202547	10.1371/journal.pone.0202547	http://dx.doi.org/10.1371/journal.pone.0202547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142178	gold, Green Published, Green Submitted			2022-12-27	WOS:000442722500018
J	Pan, XY; Wenzel, A; Jensen, LJ; Gorodkin, J				Pan, Xiaoyong; Wenzel, Anne; Jensen, Lars Juhl; Gorodkin, Jan			Genome-wide identification of clusters of predicted microRNA binding sites as microRNA sponge candidates	PLOS ONE			English	Article							CERNA HYPOTHESIS; NONCODING RNAS; CIRCULAR RNAS; MIRNA; DATABASE; BIOGENESIS; TARGETS	The number of discovered natural miRNA sponges in plants, viruses, and mammals is increasing steadily. Some sponges like ciRS-7 for miR-7 contain multiple nearby miRNA binding sites. We hypothesize that such clusters of miRNA binding sites on the genome can function together as a sponge. No systematic effort has been made in search for clusters of miRNA targets. Here, we, to our knowledge, make the first genome-wide target site predictions for clusters of mature human miRNAs. For each miRNA, we predict the target sites on a genome-wide scale, build a graph with edge weights based on the pairwise distances between sites, and apply Markov clustering to identify genomic regions with high binding site density. Significant clusters are then extracted based on cluster size difference between real and shuffled genomes preserving local properties such as the GC content. We then use conservation and binding energy to filter a final set of miRNA target site clusters or sponge candidates. Our pipeline predicts 3673 sponge candidates for 1250 miRNAs, including the experimentally verified miR-7 sponge ciRS-7. In addition, we point explicitly to 19 high-confidence candidates overlapping annotated genomic sequence. The full list of candidates is freely available at http://rth.dk/resources/mirnasponge, where detailed properties for individual candidates can be explored, such as alignment details, conservation, accessibility and target profiles, which facilitates selection of sponge candidates for further context specific analysis.	[Pan, Xiaoyong; Wenzel, Anne; Jensen, Lars Juhl; Gorodkin, Jan] Univ Copenhagen, Dept Vet & Anim Sci, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark; [Pan, Xiaoyong; Jensen, Lars Juhl] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dis Syst Biol Program, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Jensen, LJ; Gorodkin, J (corresponding author), Univ Copenhagen, Dept Vet & Anim Sci, Ctr Noncoding RNA Technol & Hlth, Frederiksberg, Denmark.; Jensen, LJ (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dis Syst Biol Program, Copenhagen, Denmark.	lars.juhl.jensen@cpr.ku.dk; gorodkin@rth.dk	ravegnini, gloria/K-1330-2016; Jensen, Lars Juhl/C-6492-2008	ravegnini, gloria/0000-0002-7774-402X; Jensen, Lars Juhl/0000-0001-7885-715X; Wenzel, Anne/0000-0001-6187-4156; Gorodkin, Jan/0000-0001-5823-4000	University of Copenhagen; Novo Nordisk Foundation [NNF14CC0001]; Danish Center for Scientific Computing (DCSC/DEiC); Innovation Fund Denmark (Programme Commission on Strategic Growth Technologies) [0603-00320B]	University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Center for Scientific Computing (DCSC/DEiC); Innovation Fund Denmark (Programme Commission on Strategic Growth Technologies)	This project was mainly financed by University of Copenhagen with additional support from the Novo Nordisk Foundation [NNF14CC0001], the Danish Center for Scientific Computing (DCSC/DEiC), and Innovation Fund Denmark (Programme Commission on Strategic Growth Technologies) [0603-00320B].	Alkan F, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1325; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthon C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-459; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernhart SH, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-3; Cheng EC, 2013, DEV CELL, V25, P1, DOI 10.1016/j.devcel.2013.03.020; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098965; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gerlach W, 2006, BIOINFORMATICS, V22, P762, DOI 10.1093/bioinformatics/btk041; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Guo JN, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0482-3; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Holohan Kelly N., 2013, Frontiers in Genetics, V3, P323, DOI 10.3389/fgene.2012.00323; Jiang MH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-192; Junge A, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw167; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kluiver J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029275; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lange SJ, 2012, NUCLEIC ACIDS RES, V40, P5215, DOI 10.1093/nar/gks181; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mork S, 2014, BIOINFORMATICS, V30, P392, DOI 10.1093/bioinformatics/btt677; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarver AL, 2012, BIOINFORMATION, V8, P731, DOI 10.6026/97320630008731; Smit A, 1996, REPEATMASKER OPEN 30; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thomas LF, 2014, BIOINFORMATICS, V30, P2243, DOI 10.1093/bioinformatics/btu257; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Le TY, 2017, BRIEF BIOINFORM, V18, P577, DOI 10.1093/bib/bbw042; Van Dongen S., 2000, THESIS; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Wenzel A, 2012, BIOINFORMATICS, V28, P2738, DOI 10.1093/bioinformatics/bts519; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zhang XO, 2016, GENOME RES, V26, P1277, DOI 10.1101/gr.202895.115	52	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202369	10.1371/journal.pone.0202369	http://dx.doi.org/10.1371/journal.pone.0202369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142196	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500012
J	Song, L; Ouedraogo, JP; Kolbusz, M; Nguyen, TTM; Tsang, A				Song, Letian; Ouedraogo, Jean-Paul; Kolbusz, Magdalena; Thi Truc Minh Nguyen; Tsang, Adrian			Efficient genome editing using tRNA promoter-driven CRISPR/Cas9 gRNA in Aspergillus niger	PLOS ONE			English	Article							POLYMERASE-III; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS FUNGI; TRANSCRIPTION; GENES; CRISPR-CAS9; REPAIR; TRANSFORMATION; EXPRESSION; SEQUENCES	As a powerful tool for fast and precise genome editing, the CRISPR/Cas9 system has been applied in filamentous fungi to improve the efficiency of genome alteration. However, the method of delivering guide RNA (gRNA) remains a bottleneck in performing CRISPR mutagenesis in Aspergillus species. Here we report a gRNA transcription driven by endogenous tRNA promoters which include a tRNA gene plus 100 base pairs of upstream sequence. Co-transformation of a cas9-expressing plasmid with a linear DNA coding for gRNA demonstrated that 36 of the 37 tRNA promoters tested were able to generate the intended mutation in A. niger. When gRNA and cas9 were expressed in a single extra-chromosomal plasmid, the efficiency of gene mutation was as high as 97%. Co-transformation with DNA template for homologous recombination, the CRISPR/Cas9 system resulted similar to 42% efficiency of gene replacement in a strain with a functioning non-homologous end joining machinery (kusA(+)), and an efficiency of >90% gene replacement in a kusA-background. Our results demonstrate that tRNA promoter-mediated gRNA expressions are reliable and efficient in genome editing in A. niger.	[Song, Letian; Ouedraogo, Jean-Paul; Kolbusz, Magdalena; Thi Truc Minh Nguyen; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	Concordia University - Canada	Ouedraogo, JP (corresponding author), Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada.	jean-paul.ouedraogo@concordia.ca		Ouedraogo, Jean-Paul/0000-0002-9735-6235; Nguyen, Thi Truc Minh/0000-0003-4696-166X	NSERC Strategic Industrial Biocatalysis Network	NSERC Strategic Industrial Biocatalysis Network	This work was supported by NSERC Strategic Industrial Biocatalysis Network. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksenko A, 1996, MOL MICROBIOL, V19, P565, DOI 10.1046/j.1365-2958.1996.400937.x; Andersen MR, 2014, BRIEF FUNCT GENOMICS, V13, P451, DOI 10.1093/bfgp/elu029; Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P2543, DOI 10.1002/bit.25662; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BALLANCE DJ, 1985, GENE, V36, P321, DOI 10.1016/0378-1119(85)90187-8; Bellaiche Y, 1999, GENETICS, V152, P1037; Bennett J. W., 1991, MORE GENE MANIPULATI, P441; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; GOOSEN T, 1987, CURR GENET, V11, P499, DOI 10.1007/BF00384612; Hamada M, 2000, J BIOL CHEM, V275, P29076, DOI 10.1074/jbc.M003980200; HANG YD, 1984, BIOTECHNOL LETT, V6, P763, DOI 10.1007/BF00133071; Hopper AK, 2010, FEBS LETT, V584, P310, DOI 10.1016/j.febslet.2009.11.053; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Jorgensen TR, 2011, FUNGAL GENET BIOL, V48, P544, DOI 10.1016/j.fgb.2011.01.005; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kruszka K, 2003, EMBO J, V22, P621, DOI 10.1093/emboj/cdg040; Kudo, 2000, GENOME INFORM, V11, P301, DOI [10.11234/gi1990.11.301, DOI 10.11234/GI1990.11.301]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li YR, 2011, J AM CHEM SOC, V133, P15773, DOI 10.1021/ja206906d; Liu Q, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0693-9; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MALE G, 2015, NAT COMMUN, V6, DOI DOI 10.1038/NC0MMS8387; Matsu-Ura Toru, 2015, Fungal Biol Biotechnol, V2, P4, DOI 10.1186/s40694-015-0015-1; Meyer V, 2008, BIOTECHNOL ADV, V26, P177, DOI 10.1016/j.biotechadv.2007.12.001; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Meyer V, 2015, ADV BIOCHEM ENG BIOT, V149, P91, DOI 10.1007/10_2014_297; Meyer V, 2011, APPL ENVIRON MICROB, V77, P2975, DOI 10.1128/AEM.02740-10; Nodvig CS, 2018, FUNGAL GENET BIOL, V115, P78, DOI 10.1016/j.fgb.2018.01.004; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Ouedraogo JP, 2016, J BIOTECHNOL, V222, P25, DOI 10.1016/j.jbiotec.2016.02.012; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; SHARP S, 1981, NUCLEIC ACIDS RES, V9, P5867, DOI 10.1093/nar/9.22.5867; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Storms R, 2005, PLASMID, V53, P191, DOI 10.1016/j.plasmid.2004.10.001; Sugahara J, 2007, RNA, V13, P671, DOI 10.1261/rna.309507; Sugano SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00883-5; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Weyda I, 2017, J MICROBIOL METH, V135, P26, DOI 10.1016/j.mimet.2017.01.015; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; YOUNG LS, 1991, MOL CELL BIOL, V11, P1382, DOI 10.1128/MCB.11.3.1382; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007; Zhang JX, 2011, CURR MICROBIOL, V62, P1342, DOI 10.1007/s00284-010-9853-5; Zhang T, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2148	66	54	57	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202868	10.1371/journal.pone.0202868	http://dx.doi.org/10.1371/journal.pone.0202868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142205	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000442722500044
J	Bridges, D; Kawamura, H; Kanai, T				Bridges, Daniel; Kawamura, Hidemasa; Kanai, Tatsuaki			Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation	PLOS ONE			English	Article							RADIOTHERAPY	Purpose This observational study investigates the influence of interfractional motion on clinical target volume (CTV) coverage, planning target volume (PTV) margins, and rectum tissue sparing in carbon ion radiation therapy (CIRT). It reports dose coverage to target structures and organs at risk in the presence of interfractional motion, investigates rectal tissue sparing, and provides recommendations for lowering the rate of toxicity. We also propose probabilistic DVH based on cone-beam computed tomography (CBCT) table shifts from photon therapy for consideration in bone-matching CIRT treatment planning to represent probable dose to our CIRT patient population. Methods At Gunma University Hospital intensity-modulated x-ray therapy (IMXT, aka IMRT) prostate cancer patients are positioned on a table which is shifted twice based on CBCT to align bones and then align prostate tissue to isocenter. These shifts thereby contain interfractional motion. A total of 1306 such table shifts from 85 patients were collected. Normal probability distributions were fit to the difference between bone-matching and prostate-matching CBCT-to-planning CT table shifts (i.e. interfractional motion). Between 2011 and 2016 CIRT prostate patients were treated with three beams to PTV1 (lateral-opposing and anterior) one per day for 9 fractions and two beams for a boost PTV2 (lateral-opposing) one per day for 7 fractions for a prescribed total of 57.6 Gy(RBE) as follows: PTV1 extends the prostate contour by 10/10, 5/10, 6/6 mm in the right/left, posterior/anterior, and superior/inferior directions, respectively, and the proximal seminal vesicles contour by 5 mm superiorly and inferiorly, 3 mm right and left. PTV2 reduces PTV1 posteriorly along a straight line to exclude the rectum and reduces the superior and inferior margins by 6 mm. Probable interfractional motion for 40 patients was simulated using each patient's own beam data as follows: The previously fit normal probability distributions were randomly sampled 2000 times per patient, and the five beams were shifted and summed with the same relative weighting as in the 16fraction regimen. The resulting dose distribution was then scaled back down by 16/2000 to match the prescribed number of fractions. We then analyzed the resulting doses to contoured structures. Results Probable dose to rectum is substantially less than planned: For example, mean+-standard deviation D2% for planned and probable DVH is 51+-1.9 and 45+-2.4, respectively. Cumulative DVH show mean CTV fraction receiving a given probable dose is less than the mean fraction receiving the corresponding planned dose for doses larger than 52 Gy(RBE), up to 19% less at 57.4 Gy(RBE). Our PTV1 margins generally cover 95% of interfractional motion but seminal vesicles and inferior prostate receive less dose than planned due to insufficient PTV2 margins. Conclusion Assuming rigidly shifting interfractional motion around the prostate region and neglecting minor changes in soft tissue stopping power, interfractional motion resulted in target underdosing but better tissue sparing in all cases. Given our low rates of relapse and recurrence, it appears less curative dose is needed than previously thought or else current planning target margins may be excessive: Planning target volumes should be reconsidered with the adoption of dose verification methods. Our probable dose distributions quantify expected dose for future dose verification studies.	[Bridges, Daniel; Kawamura, Hidemasa; Kanai, Tatsuaki] Gunma Univ, Grad Sch Med, Maebashi, Gunma, Japan; [Kawamura, Hidemasa] Gunma Univ, Heavy Ion Med Ctr, Maebashi, Gunma, Japan; [Kanai, Tatsuaki] Osaka Heavy Ion Therapy Ctr, Osaka, Osaka, Japan	Gunma University; Gunma University	Bridges, D (corresponding author), Gunma Univ, Grad Sch Med, Maebashi, Gunma, Japan.	m14702069@gunma-u.ac.jp		, Daniel/0000-0002-5840-0299	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Daniel Bridges received a scholarship from the Ministry of Education, Culture, Sports, Science and Technology of Japan (accessible at http://www.mext.go.jp/en/) from April 2014 through September 2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry JF, 2004, INT J RADIAT ONCOL, V60, P30, DOI 10.1016/j.ijrobp.2004.02.045; Dong L, 2013, PROTON CARBON ION TH, P127; Elmpt W, 2018, PHYS IMAGING RAD ONC, V6, P12; Ishikawa H, 2015, ANTICANCER RES, V35, P5559; Jakel O, 2001, PHYS MED BIOL, V46, P1101, DOI 10.1088/0031-9155/46/4/314; Jakel O., 2012, ION BEAM THERAPY FUN; Jelen U, 2012, INT J RADIAT ONCOL, V84, pE257, DOI 10.1016/j.ijrobp.2012.03.058; Kanematsu N, 2003, PHYS MED BIOL, V48, P1053, DOI 10.1088/0031-9155/48/8/307; Kershaw L, 2017, INT J RADIAT ONCOL, V100, P68, DOI [10.1016/j.ijrobp.2017.08.044, DOI 10.1016/J.IJR0BP.2017.08.044]; Koide A, 2017, NUCL INSTRUM METHO A; Krimmer J, 2018, NUCL INSTRUM METH A, V878, P58, DOI 10.1016/j.nima.2017.07.063; Kubota Y, 2016, PLOS ONE; Kubota Y, 2018, J APPL CLIN MED PHYS, V19, P144, DOI 10.1002/acm2.12261; Kubota Y, 2015, J APPL CLIN MED PHYS, V16, P100, DOI 10.1120/jacmp.v16i4.5400; Lomax T., 2013, PROTON CARBON ION TH, P151; Marchant TE, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aab0f0; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; Nakahara R, 2018, INT J MED PHYS CLIN, V07, P47; Nomiya T, 2016, RADIOTHER ONCOL, V121, P288, DOI 10.1016/j.radonc.2016.10.009; Paganetti H, 2012, PHYS MED BIOL, V57, pR99, DOI 10.1088/0031-9155/57/11/R99; Tondel H, 2018, RADIOTHER ONCOL, V126, P229, DOI 10.1016/j.radonc.2017.10.029; Yan D, 2005, SEMIN RADIAT ONCOL, V15, P168, DOI 10.1016/j.semradonc.2005.01.007; Yang Y, 2007, PHYS MED BIOL, V52, P685, DOI 10.1088/0031-9155/52/3/011	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203289	10.1371/journal.pone.0203289	http://dx.doi.org/10.1371/journal.pone.0203289			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169520	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400033
J	Jabrayilov, R; van Asselt, ADI; Vermeulen, KM; Volger, S; Detzel, P; Dainelli, L; Krabbe, PFM				Jabrayilov, Ruslan; van Asselt, Antoinette D. I.; Vermeulen, Karin M.; Volger, Sheri; Detzel, Patrick; Dainelli, Livia; Krabbe, Paul F. M.		Pediat Expert Grp	A descriptive system for the Infant health-related Quality of life Instrument (IQI): Measuring health with a mobile app	PLOS ONE			English	Article							VALIDITY; RELIABILITY; SCALES	Background The assessment of health-related quality of life (HRQoL) is important for health outcomes research, disease modeling studies and comparisons of different healthcare interventions. Yet, only a few tools are available to assess HRQoL in 0-1-year-old infants. Furthermore, there is a need for an instrument able to assess HRQoL with a single, standardized, overall score in the first year of life. Here we described the development of the Infant health-related Quality of life Instrument (IQI), a generic, preference-based instrument that can be administered through a mobile application for assessing HRQoL in 0-1-year-old infants. Methods A multi-step development process began by extracting candidate health concepts from relevant measures identified by two literature searches. Next, three panels, with experts from Asia, Europe, New Zealand and United States of America, and two surveys, with primary caregivers in New Zealand, Singapore, and the United Kingdom, evaluated the relevance of the candidate health concepts, organized them into attributes based on their similarities, explored alternative attributes and generated response scales. Additional interviews assessed the cross-cultural interpretability, parents' understanding of health attributes, and the usability of the mobile application. Results The final list of 7 health attributes included in the IQI consisted of sleeping, feeding, breathing, stooling/poo, mood, skin, and interaction. The users' experiences with the mobile application were generally positive. Conclusions The IQI is the first generic, preference-based, instrument designed to assess overall HRQoL in 0-1-year old infants. It is short and easy-to-administer through a mobile PLOS application. Moreover, close attention was paid to the opinions of the infants' primary caregivers during the instrument and mobile application development process.	[Jabrayilov, Ruslan; van Asselt, Antoinette D. I.; Vermeulen, Karin M.; Krabbe, Paul F. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Volger, Sheri] Janssen Inc, Spring House, PA USA; [Detzel, Patrick; Dainelli, Livia] Nestle, Nestle Res Ctr, Lausanne, Switzerland	University of Groningen; Johnson & Johnson; Janssen Pharmaceuticals; Nestle SA	Krabbe, PFM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	p.f.m.krabbe@umcg.nl	Krabbe, Paul/B-2563-2013; Krabbe, Paul/AAO-6590-2020	Krabbe, Paul/0000-0001-6042-1243; Krabbe, Paul/0000-0001-6042-1243; van Asselt, Antoinette/0000-0001-7705-9906; volger, sheri/0000-0002-1689-1173	Nestec Ltd	Nestec Ltd	This study has been funded by Nestec Ltd to finance the research activities of RJ, AvA, KV, and PK. PD and LD are employed at Nestle Research Center. SV was employed at Nestle Research Center until the completion of this study and is now employed by Janssen Inc. The funder provided support in the form of salaries for authors [RJ, AvA, KV, SV, PD, LD, PK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Janssen did not provide any funding for this study and played no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	APGAR V, 1953, Curr Res Anesth Analg, V32, P260; Attema AE, 2013, EUR J HEALTH ECON, V14, pS53, DOI 10.1007/s10198-013-0508-x; Black N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f167; Brazier J, 2017, MEASURING VALUING HL, V2nd; Brazier JE, 2009, PHARMACOECONOMICS, V27, P705, DOI 10.2165/11314840-000000000-00000; Bunge EM, 2005, ARCH DIS CHILD, V90, P351, DOI 10.1136/adc.2003.048645; Chen G, 2015, PHARMACOECONOMICS, V33, P1013, DOI 10.1007/s40273-015-0286-7; Fekkes M, 2000, QUAL LIFE RES, V9, P961, DOI 10.1023/A:1008981603178; Food and Drug Administration, 2009, GUID IND US MED PROD; Groothuis-Oudshoorn CGM, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0516-8; Krabbe P., 2016, MEASUREMENT HLTH HLT; Krabbe PFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079494; Krabbe PFM, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-31; Krabbe PFM, 2015, HDB MEASUREMENTS BEN; Landgraf JM, 2013, QUAL LIFE RES, V22, P635, DOI 10.1007/s11136-012-0177-8; Manificat S, 2000, ARCH PEDIATRIE, V7, P605, DOI 10.1016/S0929-693X(00)80127-X; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; Nord E, 2010, HEALTH ECON, V19, P596, DOI 10.1002/hec.1497; Papuga MO, 2016, SPINE, V41, P1153, DOI 10.1097/BRS.0000000000001518; Raat H, 2007, QUAL LIFE RES, V16, P445, DOI 10.1007/s11136-006-9134-8; Reneman ME, 2018, PHYS THER, V98, P616, DOI 10.1093/ptj/pzy040; Salomon J.A., 2014, ENCYCL HLTH EC, V2, P454; Stevens K, 2012, VALUE HEALTH, V15, P991, DOI 10.1016/j.jval.2012.08.2204; Stevens K, 2012, PHARMACOECONOMICS, V30, P729, DOI 10.2165/11599120-000000000-00000; Varni JW, 2011, QUAL LIFE RES, V20, P45, DOI 10.1007/s11136-010-9730-5; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006	26	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203276	10.1371/journal.pone.0203276	http://dx.doi.org/10.1371/journal.pone.0203276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2JK	30169510	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400031
J	Landes, R; Illanes, A; Goeppner, D; Gollnick, H; Friebe, M				Landes, Rainer; Illanes, Alfredo; Goeppner, Daniela; Gollnick, Harald; Friebe, Michael			A study of concentration changes of Protoporphyrin IX and Coproporphyrin III in mixed samples mimicking conditions inside cancer cells for Photodynamic Therapy	PLOS ONE			English	Article							DOSE ESTIMATION; MLL CELLS	Photodynamic Therapy (PDT) using Aminolevulinic acid (ALA) could be an effective and minimally invasively applicable way to treat many different types of tumors without radiation and large incisions by just applying a light pulse. However the PDT process is difficult to observe, control and optimize and the dynamical relationships between the variables involved in the process is complex and still hardly understood. One of the main variables affecting the outcome of the process is the determination of the interval of time between ALA inoculation and starting of light delivery. This interval, better known as drug-light interval, should ensure that enough Protoporphyrin IX (PPIX) is located in the vicinity of functional structures inside the cells for the greatest damage during the PDT procedure. One route to better estimate this time interval would be by predicting PPIX from the dynamical changes of its precursors. For that purpose, in this work a novel optical setup (OS) is proposed for differentiating fluorescence emitted by Coproporphyrin III (CPIII) and PPIX itself in samples composed of mixed solutions. The OS is tested using samples with different concentrations in mixed solutions of PPIX and the precursor CPIII as well as with a Polymethyl methacrylate test sample as additional reference. Results show that emitted fluorescence of the whole process can be measured independently for PPIX and its precursor, which can enable future developments on PPIX prediction from the dynamical changes of its precursor for subject-dependent drug-light interval assessment.	[Landes, Rainer; Illanes, Alfredo; Friebe, Michael] Otto Von Guericke Univ, Inst Med Tech, Magdeburg, Saxony Anhalt, Germany; [Goeppner, Daniela] Justus Liebig Univ, Clin Dermatol & Allergol, Giessen, Hesse, Germany; [Gollnick, Harald] Univ Hosp Magdeburg, Magdeburg, Saxony Anhalt, Germany	Otto von Guericke University; Justus Liebig University Giessen; University Hospital Magdeburg	Landes, R (corresponding author), Otto Von Guericke Univ, Inst Med Tech, Magdeburg, Saxony Anhalt, Germany.	rainer.landes@ovgu.de	Friebe, Michael/E-3187-2015	Friebe, Michael/0000-0002-8624-0800; Illanes, Alfredo/0000-0002-0118-0483				Cohen DK, 2016, CANCERS, V8, DOI 10.3390/cancers8100090; Dysart JS, 2006, PHOTOCH PHOTOBIO SCI, V5, P73, DOI 10.1039/b511807g; Dysart JS, 2005, PHYS MED BIOL, V50, P2597, DOI 10.1088/0031-9155/50/11/011; Hillemanns P, 2000, CANCER, V88, P2275, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2275::AID-CNCR11>3.0.CO;2-B; Hindmarsh JT, 1999, CLIN BIOCHEM, V32, P609, DOI 10.1016/S0009-9120(99)00067-3; Huang W, 2010, TALANTA, V82, P1516, DOI 10.1016/j.talanta.2010.07.034; Inoue H, 2007, J NEURO-ONCOL, V83, P223, DOI 10.1007/s11060-006-9325-8; Ji ZY, 2006, J PHOTOCH PHOTOBIO B, V84, P213, DOI 10.1016/j.jphotobiol.2006.03.006; Landes R, 2018, RESULTS PHYS, V8, P1232, DOI 10.1016/j.rinp.2018.01.059; Morton C, 2015, EUR J DERMATOL, V25, P296, DOI 10.1684/ejd.2015.2570; Nakayama T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36478; Pilny A J, 2015, BIOPROTOCOL, V5; Rapozzi V, 2014, RESISTANCE TO TARGET, P3, DOI [10.1007/978-3-319-12730-9_1, DOI 10.1007/978-3-319-12730-9_1]; Sailer R, 2007, PHOTOCH PHOTOBIO SCI, V6, P145, DOI 10.1039/b611715e; Swietach P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0099	15	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202349	10.1371/journal.pone.0202349	http://dx.doi.org/10.1371/journal.pone.0202349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169536	Green Published, Green Submitted, gold			2022-12-27	WOS:000443374400011
J	Nha, KW; Shon, OJ; Kong, BS; Shin, YS				Nha, Kyung-Wook; Shon, Oog-Jin; Kong, Byung-Sic; Shin, Young-Soo			Gait comparison of unicompartmental knee arthroplasty and total knee arthroplasty during level walking	PLOS ONE			English	Article							IN-VIVO DETERMINATION; IMPLANT; KINEMATICS; STRENGTH; EXTENSOR; OUTCOMES; SPEED	This meta-analysis compared the gait patterns of unicompartmental knee arthroplasty (UKA) patients and total knee arthroplasty (TKA) patients during level walking by evaluating the kinetics, kinematics, and spatiotemporal parameters. Studies were included in the metaanalysis if they assessed the vertical ground reaction force (GRF), joint moment at stance, flexion at initial contact, flexion at swing, overall range of motion (ROM), coronal knee angle at stance, walking speed, cadence, and stride length in UKA patients or TKA patients. Seven non-randomized studies met the criteria for inclusion in this meta-analysis. UKA patients and TKA patients were similar in terms of vertical GRF (95% CI: -0.36 to 0.20; P = 0.60), joint moment (95% CI: -0.55 to 0.63; P = 0.90), kinematic outcomes (95% CI: -0.72 to 1.02; P = 0.74), walking speed (95% CI: -0.27 to 0.81; P = 0.32), and cadence (95% CI: -0.14 to 0.68; P = 0.20). In contrast, the stride length (95% CI: 0.01 to 0.80; P = 0.04) differed significantly between groups. Subgroup analyses revealed that the pooled data were similar between the groups: 1st maximum (heel strike), -0.18 BW (P = 0.53); 1st minimum (midstance), -0.43 BW (P = 0.08); and 2nd maximum (toe off), -0.03 BW (P = 0.87). On gait analysis, there were no significant differences in vertical GRF, joint moment at stance, overall kinematics, walking speed, or cadence between UKA patients and TKA patients during level walking. However, the TKA group had significantly shorter stride length than UKA patients. Although the comparison was inconclusive in determining which types of knee arthroplasty offered the closest approximation to normal gait, we consider it important to provide better rehabilitation programs to reduce the abnormal stride length in TKA patients compared to UKA patients.	[Nha, Kyung-Wook] Inje Univ, Ilsan Paik Hosp, Dept Orthopaed Surg, Goyang, South Korea; [Shon, Oog-Jin] Yeungnam Univ, Coll Med, Dept Orthoped Surg, Daegu, South Korea; [Kong, Byung-Sic] Masan Med Ctr, Dept Orthoped Surg, Masan, South Korea; [Shin, Young-Soo] Vet Hlth Serv Med Ctr, Dept Orthoped Surg, Seoul, South Korea	Inje University; Yeungnam University; Veterans Health Service Medical Center	Shin, YS (corresponding author), Vet Hlth Serv Med Ctr, Dept Orthoped Surg, Seoul, South Korea.	sysoo3180@naver.com						Akizuki S, 2009, J ARTHROPLASTY, V24, P963, DOI 10.1016/j.arth.2008.06.013; Argenson JNA, 2002, J ARTHROPLASTY, V17, P1049, DOI 10.1054/arth.2002.34527; Barker KL, 2012, KNEE, V19, P360, DOI 10.1016/j.knee.2011.05.006; Braito M, 2016, J ARTHROPLASTY, V31, P1711, DOI 10.1016/j.arth.2016.01.045; Calliess T, 2014, SENSORS-BASEL, V14, P15953, DOI 10.3390/s140915953; Collier MB, 2006, J ARTHROPLASTY, V21, P108, DOI 10.1016/j.arth.2006.04.012; Fetzer GB, 2002, J ARTHROPLASTY, V17, P961, DOI 10.1054/arth.2002.34824; Hanlon M, 2006, GAIT POSTURE, V24, P280, DOI 10.1016/j.gaitpost.2005.10.007; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Jones GG, 2016, BONE JOINT J, V98B, P16, DOI 10.1302/0301-620X.98B10.BJJ.2016.0473.R1; Jung MC, 2014, KNEE SURG SPORT TR A, V22, P1879, DOI 10.1007/s00167-014-3064-8; 최원식, 2007, [Journal of the Korean Orthopaedic Association, 대한정형외과학회지], V42, P505; Kim Kyung Tae, 2018, Knee Surg Relat Res, V30, P1, DOI 10.5792/ksrr.18.014; Kim Kyung Tae, 2016, Knee Surg Relat Res, V28, P46, DOI 10.5792/ksrr.2016.28.1.46; Kim MK, 2018, KNEE SURG SPORT TR A, V26, P3280, DOI 10.1007/s00167-018-4863-0; Kim Yeong-Joon, 2017, Knee Surg Relat Res, V29, P122, DOI 10.5792/ksrr.16.045; Ko Young-Bong, 2015, Knee Surg Relat Res, V27, P141, DOI 10.5792/ksrr.2015.27.3.141; Komnik I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168566; Lyons MC, 2012, CLIN ORTHOP RELAT R, V470, P84, DOI 10.1007/s11999-011-2144-z; Mahomed N, 2011, ARTHRITIS, DOI 10.1155/2011/591253; Manal K, 2000, GAIT POSTURE, V11, P38, DOI 10.1016/S0966-6362(99)00042-9; Mir SM, 2014, J PHYS THER SCI, V26, P1515, DOI 10.1589/jpts.26.1515; Mochizuki T, 2013, J ORTHOP SCI, V18, P54, DOI 10.1007/s00776-012-0322-9; Mundermann A, 2004, ARTHRITIS RHEUM-US, V50, P1172, DOI 10.1002/art.20132; Muro-de-la-Herran A, 2014, SENSORS-BASEL, V14, P3362, DOI 10.3390/s140203362; Rosenberger RE, 2008, KNEE SURG SPORT TR A, V16, P1133, DOI 10.1007/s00167-008-0618-7; Rossi MD, 2006, AM J PHYS MED REHAB, V85, P737, DOI 10.1097/01.phm.0000233178.22621.a5; Saccomanni B, 2010, CLIN RHEUMATOL, V29, P339, DOI 10.1007/s10067-009-1354-1; Stacoff A, 2007, GAIT POSTURE, V26, P48, DOI 10.1016/j.gaitpost.2006.07.015; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Valenzuela GA, 2013, J ARTHROPLASTY, V28, P463, DOI 10.1016/j.arth.2012.09.001; Wiik AV, 2013, J ARTHROPLASTY, V28, P176, DOI 10.1016/j.arth.2013.07.036; Yoshida Y, 2008, CLIN BIOMECH, V23, P320, DOI 10.1016/j.clinbiomech.2007.10.008; Zambianchi F, 2015, KNEE SURG SPORT TR A, V23, P2074, DOI 10.1007/s00167-014-2958-9; Zeni JA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-86	35	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203310	10.1371/journal.pone.0203310	http://dx.doi.org/10.1371/journal.pone.0203310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161216	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900107
J	Peng, ZL; Huang, LW; Yin, J; Zhang, KN; Xiao, K; Qing, GZ				Peng, Zheng-Liang; Huang, Liang-Wei; Yin, Jian; Zhang, Ke-Na; Xiao, Kang; Qing, Guo-Zhong			Association between early serum cholinesterase activity and 30-day mortality in sepsis-3 patients: A retrospective cohort study	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; INTERNATIONAL CONSENSUS DEFINITIONS; BUTYRYLCHOLINESTERASE ACTIVITY; SEPTIC SHOCK; PROGNOSTIC MARKER; VARIANTS; NERVE	Low serum cholinesterase (SCHE) activity has been associated with poor prognoses in a variety of conditions, including sepsis. However, such an association has not been well characterized since the Third International Consensus Definitions Task Force modified the definition of sepsis to "life-threatening organ dysfunction due to a dysregulated host response to infection" (known as sepsis-3) in 2016. In the current retrospective cohort study, we examined whether 30-day mortality in sepsis-3 patients is associated with SCHE activity. A total of 166 sepsis-3 patients receiving treatment at an emergency intensive care unit (EICU) were included. The 30-day death rate was 33.1% (55/166). SCHE activity upon EICU admission was lower in nonsurvivors (3.3 vs. 4.5 KU/L in survivors, p = 0.0002). Subjects with low SCHE activity (defined as <4 KU/L) had higher 30-day mortality rates than subjects with normal SCHE activity (45.5%, 40/88 vs. 19.2%, 15/78; p<0.001). A multivariate logistic regression analysis revealed an association between 30-day mortality and lower SCHE activity after adjustments for relevant factors, such as acute multiple organ dysfunction. The odds ratio (OR) for every unit decrease in SCHE activity was 2.11 (95% confidence interval (CI), 1.37-3.27; p = 0.0008). The area under the curve (AUC) of SCHE activity for predicting 30-day mortality was 0.67 (95% CI 0.59-0.74), and the AUC of lactate for predicting 30-day mortality was 0.64 (95% CI 0.57-0.70). Using a combination of SCHE and lactate, the AUC was 0.74 (95% CI 0.69-0.83). These data suggest that lower SCHE activity is an independent risk factor for 30-day mortality in sepsis-3 patients.	[Peng, Zheng-Liang; Huang, Liang-Wei; Yin, Jian; Zhang, Ke-Na; Xiao, Kang; Qing, Guo-Zhong] Univ South China, Affiliated Hosp 1, EICU, Hengyang, Hunan, Peoples R China	University of South China	Peng, ZL; Qing, GZ (corresponding author), Univ South China, Affiliated Hosp 1, EICU, Hengyang, Hunan, Peoples R China.	pengzhl-2001@163.com; gzqing9923@163.com			Health and Family Planning Commission of Hunan Province Research Project [B2015-54]	Health and Family Planning Commission of Hunan Province Research Project	The study was funded by the Health and Family Planning Commission of Hunan Province Research Project (B2015-54; to Zheng L Peng). The funder had no role in study design, data collection, analysis, interpretation, or manuscript writing.	ALKASSAB AS, 1995, EUR J CLIN CHEM CLIN, V33, P11; Arbel Y, 2014, MOL MED, V20, P38, DOI 10.2119/molmed.2013.00139; Ba L, 2014, J ZHEJIANG UNIV-SC B, V15, P1023, DOI 10.1631/jzus.B1400129; Bahloul M, 2017, J INTENSIVE CARE MED, V32, P346, DOI 10.1177/0885066616636549; Ben Assayag E, 2010, MOL MED, V16, P278, DOI 10.2119/molmed.2010.00015; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Calderon-Margalit R, 2006, CLIN CHEM, V52, P845, DOI 10.1373/clinchem.2005.059857; Chiarla C, 2011, MINERVA CHIR, V66, P323; Coopersmith CM, 2017, SHOCK, V47, P264, DOI 10.1097/SHK.0000000000000763; Das UN, 2007, MED SCI MONITOR, V13, pRA214; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Feng WM, 2013, HEPATO-GASTROENTEROL, V60, P1001, DOI 10.5754/hge13141; Goliasch G, 2012, CLIN CHEM, V58, P1055, DOI 10.1373/clinchem.2011.175984; Jin QH, 2011, CHINESE MED J-PEKING, V124, P2692, DOI 10.3760/cma.j.issn.0366-6999.2011.17.023; Johnson G, 2012, NEUROCHEM INT, V61, P783, DOI 10.1016/j.neuint.2012.06.016; Kanai S, 2008, J CLIN LAB ANAL, V22, P66, DOI 10.1002/jcla.20205; Kanashiro A, 2017, PHARMACOL RES, V117, P1, DOI 10.1016/j.phrs.2016.12.014; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Lampon N, 2012, ANN HEPATOL, V11, P356, DOI 10.1016/S1665-2681(19)30932-9; Lockridge O, 2015, PHARMACOL THERAPEUT, V148, P34, DOI 10.1016/j.pharmthera.2014.11.011; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Pereira MR, 2016, J CELL PHYSIOL, V231, P1862, DOI 10.1002/jcp.25307; Santarpia L, 2013, J CACHEXIA SARCOPENI, V4, P31, DOI 10.1007/s13539-012-0083-5; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sun LM, 2016, CLIN LAB, V62, P1093, DOI 10.7754/Clin.Lab.2015.151013; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; WHITTAKER M, 1980, ANAESTHESIA, V35, P174, DOI 10.1111/j.1365-2044.1980.tb03800.x; Williams JM, 2017, CHEST, V151, P586, DOI 10.1016/j.chest.2016.10.057; Yamano S, 2016, J CRIT CARE, V31, P36, DOI 10.1016/j.jcrc.2015.09.033; Zhang QH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129082	33	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203128	10.1371/journal.pone.0203128	http://dx.doi.org/10.1371/journal.pone.0203128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161257	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900082
J	Pule, HT; Tjelele, JT; Tedder, MJ				Pule, Hosia T.; Tjelele, Julius T.; Tedder, Michelle J.			The effects of abiotic factors in South African semi-arid grassland communities on Seriphium plumosum L density and canopy size	PLOS ONE			English	Article							WOODY PLANT ENCROACHMENT; SHRUB ENCROACHMENT; SOIL; VEGETATION; LANDSCAPE; INVASION; COVER; DESERTIFICATION; EVOLUTION; RAINFALL	Most studies suggest that multiple factors are responsible for woody plant encroachment, but are inconclusive on its causes. Woody plant encroachment is modified by local patterns of disturbance, topography, soil texture and fertility, and their relative importance and interaction strength varies among locations. We used grassland communities, Carletonville Dolomite Grassland (CDG), Rand Highveld Grassland (RHG) and abiotic factors (Soil Organic Carbon (SOC), Total nitrogen (TN), Phosphorus (P), Potassium (K), Sodium (Na), Calcium (Ca), Magnesium (Mg) and pH) to investigate habitat preferences of Seriphium plumosum L. in South African semi-arid grassland. Grassland community had a significant effect on S. plumosum density, canopy size, and on components of soil fertility (P<0.05). Slope position had a significant effect on S. plumosum density and canopy size (P< 0.05). Seriphium plumosum density was significantly lower (23 plants/50 m(2) +/- 2.39 (SE)) in CDG than in RHG (40 plants/50 m(2) +/- 4.19). By contrast, S. plumosum canopy size was significantly higher (1.39 m(2) +/- 0.11) at CDG than at the RHG (1.06 m(2) +/- 0.08). The interaction of grassland community and slope position had a significant effect on S. plumosum density and soil sodium content (P< 0.05). Bottom slope regions in RHG (59.00 plants/50 m(2) +/- 8.62) had higher S. plumosum density than bottom slope regions (19.75 plants/50 m(2) +/- 3.01) in CDG. Soil sodium content was similar in CDG slopes and higher than in RHG slopes. Seriphium plumosum density was positively related to components of soil fertility; P (r(2) = 0.1270; P 0.0036), K (r(2) = 0.0786; P 0.0237), Na (r(2) = 0.0686; P 0.0350), Ca (r(2) = 0.0681; P 0.0358), and SOC content (r(2) = 0.0669; P 0.0374). However, Seriphium plumosum canopy size did not show any relationship with components of soil fertility. This study revealed that S. plumosum density in grassland communities increased with increasing soil texture and fertility.	[Pule, Hosia T.; Tjelele, Julius T.] Agr Res Council, Anim Prod Inst, Irene, South Africa; [Pule, Hosia T.; Tedder, Michelle J.] Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Life Sci, Scottsville, South Africa	Agricultural Research Council of South Africa; Animal Production Research Institute, Agricultural Research Council; University of Kwazulu Natal	Pule, HT (corresponding author), Agr Res Council, Anim Prod Inst, Irene, South Africa.; Pule, HT (corresponding author), Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Life Sci, Scottsville, South Africa.	Gpule@arc.agric.za	Tedder, Michelle/F-4633-2010; Tedder, Michelle/S-6373-2019	Tedder, Michelle/0000-0001-8021-0929; Tedder, Michelle/0000-0001-8021-0929; Pule, Hosia/0000-0001-8576-5296	South African Science Services for Climate Change and Adaptive Land Management (SASSCAL) [229]; National Research Foundation (NRF), South Africa [TTK150608118921]	South African Science Services for Climate Change and Adaptive Land Management (SASSCAL); National Research Foundation (NRF), South Africa(National Research Foundation - South Africa)	The study was funded by South African Science Services for Climate Change and Adaptive Land Management (SASSCAL), award number: ID 229 and The National Research Foundation (NRF), South Africa, award number: TTK150608118921 to JTT. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SR, 2017, SPRINGER SER ENV MAN, P25, DOI 10.1007/978-3-319-46709-2_2; Ben Wu X, 2005, LANDSCAPE ECOL, V20, P733, DOI 10.1007/s10980-005-0996-x; BENSHAHAR R, 1990, VEGETATIO, V89, P69, DOI 10.1007/BF00134435; Bond WJ, 2003, GLOBAL CHANGE BIOL, V9, P973, DOI 10.1046/j.1365-2486.2003.00577.x; Bond WJ, 2000, GLOBAL CHANGE BIOL, V6, P865, DOI 10.1046/j.1365-2486.2000.00365.x; Browning DM, 2008, ECOL APPL, V18, P928, DOI 10.1890/07-1559.1; Coetzee BWT, 2008, AFR J ECOL, V46, P449, DOI 10.1111/j.1365-2028.2007.00842.x; du Toit JCO, 2012, AFR J RANGE FOR SCI, V29, P85, DOI 10.2989/10220119.2012.705325; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Fensham RJ, 2005, J ECOL, V93, P596, DOI 10.1111/j.1365-2745.2005.00998.x; Getzin S, 2007, FOREST ECOL MANAG, V242, P165, DOI 10.1016/j.foreco.2007.01.009; GROVER HD, 1990, CLIMATIC CHANGE, V17, P305, DOI 10.1007/BF00138373; Hagos MG, 2005, J ARID ENVIRON, V61, P47, DOI 10.1016/j.jaridenv.2004.08.003; HANNA AY, 1982, AGRON J, V74, P999, DOI 10.2134/agronj1982.00021962007400060016x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jia JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059315; Kerley GIH, 2009, J ARID ENVIRON, V73, P651, DOI 10.1016/j.jaridenv.2009.01.001; KNOOP WT, 1985, J ECOL, V73, P235, DOI 10.2307/2259780; Koekemoer M, 2001, THESIS; Ludwig JA, 1999, LANDSCAPE ECOL, V14, P557, DOI 10.1023/A:1008112122193; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; MCAULIFFE JR, 1994, ECOL MONOGR, V64, P111, DOI 10.2307/2937038; MEA (Millennium Ecosystem Assessment), 2005, MILL EC ASS EC HUM W; Morgan JA, 2007, P NATL ACAD SCI USA, V104, P14724, DOI 10.1073/pnas.0703427104; Mucina L, 2006, VEGETATION SO AFRICA; Oba G, 2000, LANDSCAPE ECOL, V15, P535, DOI 10.1023/A:1008106625096; OCONNOR TG, 1995, OECOLOGIA, V103, P214, DOI 10.1007/BF00329083; Price JN, 2008, AUSTRAL ECOL, V33, P278, DOI 10.1111/j.1442-9993.2007.01815.x; Pugnaire FI, 2011, J ARID ENVIRON, V75, P1310, DOI 10.1016/j.jaridenv.2011.01.016; Ratajczak Z, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00212.1; Roux E., 1969, GRASS STORY FRANKENW, P153; SAS Institute, 2001, SAS STAT US GGGUID V; Schlesinger WH, 1998, BIOGEOCHEMISTRY, V42, P169, DOI 10.1023/A:1005939924434; Schmidt E, 2002, TREE SHRUBS MPUMALAN; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Shaver GR, 2001, ECOLOGY, V82, P3163, DOI 10.1890/0012-9658(2001)082[3163:SCIWFT]2.0.CO;2; SMITH TM, 1986, BIOTROPICA, V18, P219, DOI 10.2307/2388488; Snyman H. A., 2012, South African Journal of Plant and Soil, V29, P157, DOI 10.1080/02571862.2012.745905; Snyman HA, 2012, S AFR J BOT, V81, P34, DOI 10.1016/j.sajb.2012.05.001; Snyman HA, 2009, NEWSLETTER GRASSLAND, V9, P29; Stevens N, 2017, GLOBAL CHANGE BIOL, V23, P235, DOI 10.1111/gcb.13409; Tjelele J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117788; Tjelele JT, 2012, RANGELAND ECOL MANAG, V65, P105, DOI 10.2111/REM-D-09-00161.1; Trollope W.S.W., 1984, Ecological Studies, V48, P149; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; van Wilgen BW, 2009, S AFR J SCI, V105, P335; Walker B. H., 1982, Ecology of tropical savannas, P556; WALKER BH, 1981, J ECOL, V69, P473, DOI 10.2307/2259679; Ward D., 2005, African Journal of Range & Forage Science, V22, P101, DOI 10.2989/10220110509485867; Ward D, 2013, S AFR J BOT, V86, P141, DOI [10.1016/j.sajb.2013.02.016, 10.1007/s00442-012-2538-y]; Ward D, 2014, AFR J RANGE FOR SCI, V31, P107, DOI 10.2989/10220119.2014.914974; Whitford WG, 2020, ECOLOGY OF DESERT SYSTEMS, 2ND EDITION, P343, DOI 10.1016/B978-0-12-815055-9.00011-4; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wingley BJ, 2009, GLOBAL CHANGE BIOL, V16, P964, DOI [10.1111/j.1365-2486.2009.02030.x, DOI 10.1111/J.1365-2486.2009.02030.X]	56	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202809	10.1371/journal.pone.0202809	http://dx.doi.org/10.1371/journal.pone.0202809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161189	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900045
J	Zhao, L; Yamaguchi, Y; Shen, WJ; Morser, J; Leung, LLK				Zhao, Lei; Yamaguchi, Yasuto; Shen, Wen-Jun; Morser, John; Leung, Lawrence L. K.			Dynamic and tissue-specific proteolytic processing of chemerin in obese mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; BARIATRIC SURGERY; GENE-EXPRESSION; RECEPTOR CCRL2; SERUM CHEMERIN; FATTY LIVER; WEIGHT-LOSS; EX-VIVO; ACTIVATION	Chemerin is a chemoattractant involved in immunity as well as an adipokine, whose activity is regulated by successive proteolytic cleavages at its C-terminus. Chemerin's C-terminal sequence and its proteolytic cleavage sites are highly conserved between human and mouse, as well as in other species. We produced, purified and characterized different mouse chemerin forms. Ca2+ mobilization assay showed that the EC50 values for mchem161T and mchem157R were 135.8 +/- 158 nM and 71.2 +/- 55.4 nM, respectively, whereas mchem156S and mchem155F had a 20-fold higher potency with an EC50 of 4.6 +/- 1.8 nM and 3.6 +/- 3.0 nM, respectively, likely representing the two physiologically active forms of chemerin. No agonist activity was found for mchem154A. Similar results were obtained in a chemotaxis assay. To identify and quantify the in vivo mouse chemerin forms in biological samples, we developed specific ELISAs for mchem162K, mchem157R, mchem156S, mchem155F and mchem154A, using antibodies raised against peptides from the C-terminus of the different mouse chemerin forms. The prochemerin form, mchem162K, was the major chemerin form in plasma with its increase matching the increase of total plasma chemerin in obese mice. During the onset of obesity in high-fat diet fed mice, mchem156S was elevated in plasma. In contrast, mchem155F was the dominant form in epididymal fat extracts. Our study provides the first direct evidence that mouse chemerin undergoes extensive, dynamic and tissue-specific proteolytic processing in vivo, similar to human chemerin, underlining the importance of measuring individual chemerin forms in studies of chemerin biology in mouse models.	[Zhao, Lei; Yamaguchi, Yasuto; Morser, John; Leung, Lawrence L. K.] Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Zhao, Lei; Yamaguchi, Yasuto; Shen, Wen-Jun; Morser, John; Leung, Lawrence L. K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Shen, Wen-Jun] Stanford Univ, Dept Med, Div Endocrinol, Sch Med, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Morser, J (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA.; Morser, J (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	jmorser@stanford.edu		Morser, John/0000-0003-3376-8692	National Heart Lung and Blood Institute [R01 HL057530]; United States Department of Veterans Affairs [I01BX001959]; Veterans Affairs [I01BX001959] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by the National Heart Lung and Blood Institute grant R01 HL057530 (https://www.nhlbi.nih.gov) to LLKL and the United States Department of Veterans Affairs grant I01BX001959 (https://www.research.va.gov/funding) to LLKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altintas MM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-198; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bondue B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040043; Bondue B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002358; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bueno AA, 2008, PFLUG ARCH EUR J PHY, V455, P701, DOI 10.1007/s00424-007-0330-3; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Chang SS, 2016, OBESITY, V24, P1522, DOI 10.1002/oby.21534; Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761; De Henau O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164179; Dogru T, 2010, SCAND J GASTROENTERO, V45, P1000, DOI 10.3109/00365521003749826; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; Einstein FH, 2005, DIABETES, V54, P672, DOI 10.2337/diabetes.54.3.672; Einstein FH, 2008, FASEB J, V22, P3450, DOI 10.1096/fj.08-109041; Einstein FH, 2010, J GERONTOL A-BIOL, V65, P800, DOI 10.1093/gerona/glq078; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-00014; Ernst MC, 2012, ENDOCRINOLOGY, V153, P672, DOI 10.1210/en.2011-1490; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Galvez-Prieto B, 2008, J ENDOCRINOL, V197, P55, DOI 10.1677/JOE-07-0284; Ge XM, 2018, BLOOD, V131, P353, DOI 10.1182/blood-2017-07-792580; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Guillabert A, 2008, J LEUKOCYTE BIOL, V84, P1530, DOI 10.1189/jlb.0508322; Haberl EM, 2018, CYTOKINE, V104, P42, DOI 10.1016/j.cyto.2018.02.004; Hansen IR, 2014, BBA-MOL CELL BIOL L, V1841, P1691, DOI 10.1016/j.bbalip.2014.09.003; Helfer G, 2018, J ENDOCRINOL; Hu WC, 2011, DIABETES RES CLIN PR, V91, P159, DOI 10.1016/j.diabres.2010.11.016; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Issa ME, 2012, AM J PHYSIOL-CELL PH, V302, pC1621, DOI 10.1152/ajpcell.00187.2011; John H, 2007, ANAL BIOCHEM, V362, P117, DOI 10.1016/j.ab.2006.12.001; Kappes A, 2000, HORM METAB RES, V32, P548, DOI 10.1055/s-2007-978684; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Otero K, 2010, BLOOD, V116, P2942, DOI 10.1182/blood-2009-12-259903; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Ress C, 2010, EUR J CLIN INVEST, V40, P277, DOI 10.1111/j.1365-2362.2010.02255.x; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Rourke JL, 2014, J ENDOCRINOL, V222, P201, DOI 10.1530/JOE-14-0069; Schultz S, 2013, BIOCHEM J, V452, P271, DOI 10.1042/BJ20121880; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Takahashi M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00123; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Toulany J, 2016, ENDOCR CONNECT, V5, P70, DOI 10.1530/EC-16-0065; Ukkola O, 2002, J MOL MED, V80, P696, DOI 10.1007/s00109-002-0378-7; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamaguchi Y, 2011, J BIOL CHEM, V286, P39510, DOI 10.1074/jbc.M111.258921; Yang ML, 2010, J INVEST MED, V58, P883, DOI 10.231/JIM.0b013e3181ec5db2; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011; Zhao L, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1615-y; Zhao L, 2011, J BIOL CHEM, V286, P39520, DOI 10.1074/jbc.M111.258954	56	13	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202780	10.1371/journal.pone.0202780	http://dx.doi.org/10.1371/journal.pone.0202780			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161155	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900043
J	Cesarini, E; Cerioni, L; Canonico, B; Di Sario, G; Guidarelli, A; Lattanzi, D; Savelli, D; Guescini, M; Nasoni, MG; Bigini, N; Cuppini, R; Stocchi, V; Ambrogini, P; Papa, S; Luchetti, F				Cesarini, Erica; Cerioni, Liana; Canonico, Barbara; Di Sario, Gianna; Guidarelli, Andrea; lattanzi, DaviDe; Savelli, David; Guescini, Michele; Nasoni, Maria Gemma; Bigini, Noemi; Cuppini, Riccardo; Stocchi, Vilberto; Ambrogini, Patrizia; Papa, Stefano; Luchetti, Francesca			Melatonin protects hippocampal HT22 cells from the effects of serum deprivation specifically targeting mitochondria	PLOS ONE			English	Article							ANION CHANNELS VDAC; AUTOPHAGY; APOPTOSIS; DYNAMICS; FISSION; PREVENTS; DRP1; MECHANISMS; MORPHOLOGY; MITOPHAGY	Neurons contain a high number of mitochondria, these neuronal cells produce elevated levels of oxidative stress and live for a long time without proliferation; therefore, mitochondrial homeostasis is crucial to their health. Investigations have recently focused on mitochondrial dynamics revealing the ability of these organelles to change their distribution and morphology. It is known that mitochondrial fission is necessary for the transmission of mitochondria to daughter cells during mitosis and mitochondrial fragmentation has been used as an indicator of cell death and mitochondrial dysfunction. Oxidative stress is a trigger able to induce changes in the mitochondrial network. The aim of the present study was to determine the effects of melatonin on the mitochondrial network in HT22 serum-deprived cells. Our results showed that serum deprivation increased reactive oxygen species (ROS) content, promoted the activation of plasma membrane voltage-dependent anion channels (VDACs) and affected the expression of pDRP1 and DRP1 fission proteins. Moreover, parallel increases in apoptotic and autophagic features were found. Damaged and dysfunctional mitochondria are deleterious to the cell; hence, the degradation of such mitochondria through mitophagy is crucial to cell survival. Our results suggest that melatonin supplementation reduces cell death and restores mitochondrial function through the regulation of autophagy.	[Cesarini, Erica; Cerioni, Liana; Canonico, Barbara; Di Sario, Gianna; Guidarelli, Andrea; lattanzi, DaviDe; Savelli, David; Guescini, Michele; Nasoni, Maria Gemma; Bigini, Noemi; Cuppini, Riccardo; Stocchi, Vilberto; Ambrogini, Patrizia; Papa, Stefano; Luchetti, Francesca] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy	University of Urbino	Luchetti, F (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.	francesca.luchetti@uniurb.it	Guescini, Michele/L-1297-2019	Guescini, Michele/0000-0001-9372-7038; Canonico, Barbara/0000-0003-3383-715X; Di Sario, Gianna/0000-0003-1919-6050; Savelli, David/0000-0003-4686-5758				Akanda N, 2008, CELL CYCLE, V7, P3225, DOI 10.4161/cc.7.20.6831; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; BENZ I, 1994, J MEMBRANE BIOL, V142, P309; Bialik S, 1999, CIRC RES, V85, P403, DOI 10.1161/01.RES.85.5.403; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Calo L, 2013, CURR PHARM DESIGN, V19, P6848, DOI 10.2174/138161281939131127110701; Canonico B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165780; Cantoni O, 2008, METHOD ENZYMOL, V441, P73, DOI 10.1016/S0076-6879(08)01205-6; Carretero M, 2009, J PINEAL RES, V47, P192, DOI 10.1111/j.1600-079X.2009.00700.x; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chu CT, 2014, AUTOPHAGY, V10, P376, DOI 10.4161/auto.27191; Chuang JI, 2016, J PINEAL RES, V61, P230, DOI 10.1111/jpi.12343; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Herrera F, 2007, J NEUROCHEM, V100, P736, DOI 10.1111/j.1471-4159.2006.04228.x; Hung CHL, 2018, REDOX BIOL, V14, P7, DOI 10.1016/j.redox.2017.08.010; Huo XK, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12390; Iqbal S, 2014, AM J PHYSIOL-CELL PH, V306, pC1176, DOI 10.1152/ajpcell.00017.2014; Jahanban-Esfahlan R, 2017, BR J PHARM; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Luchetti F, 2007, TOXICOL IN VITRO, V21, P293, DOI 10.1016/j.tiv.2006.08.003; Luchetti F, 2009, FREE RADICAL BIO MED, V46, P339, DOI 10.1016/j.freeradbiomed.2008.09.017; Luchetti F, 2015, STEROIDS, V99, P204, DOI 10.1016/j.steroids.2015.02.008; Ma Z, 2017, CELL MOL LIFE SCI; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Mauro-Lizcano M, 2015, AUTOPHAGY, V11, P833, DOI 10.1080/15548627.2015.1034403; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Purnell PR, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-86; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004; Reiter RJ, 2002, J PHARM PHARMACOL, V54, P1299, DOI 10.1211/002235702760345374; Reiter RJ, 2017, CELL MOL LIFE SCI; ROBINSON J, 1970, ANAL BIOCHEM, V33, P390, DOI 10.1016/0003-2697(70)90310-6; Sanchez-Barcelo EJ, 2017, CURR MED CHEM; Sanchez-Sanchez AM, 2011, FREE RADICAL RES, V45, P1333, DOI 10.3109/10715762.2011.623700; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374; Steiger-Barraissoul S, 2009, APOPTOSIS, V14, P1274, DOI 10.1007/s10495-009-0396-9; Tan D.X., 2016, INT J MOL SCI, V17; Thinnes FP, 2014, MOL GENET METAB, V111, P439, DOI 10.1016/j.ymgme.2014.02.001; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; van der Valk J, 2004, TOXICOL IN VITRO, V18, P1, DOI 10.1016/j.tiv.2003.08.009; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wang L, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12429; Xu SC, 2016, J PINEAL RES, V60, P291, DOI 10.1111/jpi.12310; Yamashita S, 2016, J CELL BIOL, V215, P649, DOI 10.1083/jcb.201605093; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhang ZY, 2012, AUTOPHAGY, V8, P1531, DOI 10.4161/auto.21213; Zhuge J, 2006, FREE RADICAL BIO MED, V40, P63, DOI 10.1016/j.freeradbiomed.2005.08.012; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	67	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203001	10.1371/journal.pone.0203001	http://dx.doi.org/10.1371/journal.pone.0203001			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157259	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400081
J	Degen, J; Hovestadt, T; Storms, M; Menzel, R				Degen, Jacqueline; Hovestadt, Thomas; Storms, Mona; Menzel, Randolf			Exploratory behavior of re-orienting foragers differs from other flight patterns of honeybees	PLOS ONE			English	Article							ORIENTATION FLIGHTS; HARMONIC RADAR; SPATIAL MEMORY; COGNITIVE MAP; NAVIGATION; BEES	Honeybees, Apis mellifera, perform re-orientation flights to learn about the new surroundings of the hive when their hive is transported to a new location. Since the pattern of re-orientation flights has not yet been studied, we asked whether this form of exploratory behavior differs from the well described exploratory orientation flights performed by young honeybees before they start foraging. We also investigated whether the exploratory components of re-orientation flights differ from foraging flights and if so how. We recorded re-orientation flights using harmonic radar technology and compared the patterns and flight parameters of these flights with the first exploratory orientation flights of young honeybees and foraging flights of experienced foragers. Just as exploratory orientation flights of young honeybees, re-orientation flights can be classified into short- and long-range flights, and most short-range re-orientation flights were performed under unfavorable weather conditions. This indicates that bees adapt the flight pattern of their re-orientation and orientation flights to changing weather conditions in a similar way. Unlike exploratory orientation flights, more than one sector of the landscape was explored during a long-range re-orientation flight, and significantly longer flight durations and flight distances were observed. Thus, re-orienting bees explored a larger terrain than bees performing their first exploratory orientation flight. By displacing some bees after their first re-orientation flight, we could demonstrate that a single re-orientation flight seems to be sufficient to learn the new location of the hive. The flight patterns of re-orientation flights differed clearly from those of foraging flights. Thus, re-orientation flights represent a special exploratory behavior that is triggered by a change in the location of the hive.	[Degen, Jacqueline; Storms, Mona; Menzel, Randolf] Free Univ Berlin, Dept Biol, Berlin, Germany; [Hovestadt, Thomas] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Wurzburg, Germany; [Degen, Jacqueline] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Wurzburg, Germany	Free University of Berlin; University of Wurzburg; University of Wurzburg	Degen, J (corresponding author), Free Univ Berlin, Dept Biol, Berlin, Germany.; Degen, J (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Wurzburg, Germany.	jacqueline.degen@uni-wuerzburg.de		Hovestadt, Thomas/0000-0001-7368-6013; Storms, Mona/0000-0001-8594-6572	Deutsche Forschungsgemeinschaft e.V. [Me 365/34-2]; Deutsche Forschungsgemeinschaft e.V., Collaborative Research Center [SFB 1047]	Deutsche Forschungsgemeinschaft e.V.(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft e.V., Collaborative Research Center	The experiments were supported by the Deutsche Forschungsgemeinschaft e.V. (http://www.dfg.de), grant Me 365/34-2. T.H. gratefully acknowledges financial support by the Deutsche Forschungsgemeinschaft e.V. (http://www.dfg.de), Collaborative Research Center SFB 1047 "Insect timing", Project C6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absconding Hepburn H., 2006, LIFE CYCLES SOCIAL I, P121; Agostinelli C, 2013, CIRCULAR STAT VERSIO; [Anonymous], 1927, Z VERGL PHYSIOL, V6, P221, DOI [10.1007/BF00339256, DOI 10.1007/BF00339256]; BECKER L, 1958, Z VERGL PHYSIOL, V41, P1; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Birke L.I.A., 1983, P1; Boccia M, 2014, NEUROPSYCHOL REV, V24, P236, DOI 10.1007/s11065-014-9247-8; Capaldi EA, 1999, J EXP BIOL, V202, P1655; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Cheeseman JF, 2014, P NATL ACAD SCI USA, V111, pE4398, DOI 10.1073/pnas.1415738111; Cheeseman JF, 2014, P NATL ACAD SCI USA, V111, P8949, DOI 10.1073/pnas.1408039111; Cheung A, 2014, P NATL ACAD SCI USA, V111, pE4396, DOI 10.1073/pnas.1413581111; Degen J, 2016, CURR BIOL, V26, P2800, DOI 10.1016/j.cub.2016.08.013; Degen J, 2015, ANIM BEHAV, V102, P45, DOI 10.1016/j.anbehav.2014.12.030; DYER FC, 1993, ANIM BEHAV, V46, P813, DOI 10.1006/anbe.1993.1260; FREE J. B., 1958, BEE WORLD, V39, P109; FREE J. B., 1958, ANIMAL BEHAVIOUR, V6, P219, DOI 10.1016/0003-3472(58)90054-X; LAUGHLIN SB, 1971, Z VERGL PHYSIOL, V74, P329, DOI 10.1007/BF00297733; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2012, APIDOLOGIE, V43, P229, DOI 10.1007/s13592-012-0127-z; Menzel R, 2011, CURR BIOL, V21, P645, DOI 10.1016/j.cub.2011.02.039; Menzel R, 2010, NATURWISSENSCHAFTEN, V97, P763, DOI 10.1007/s00114-010-0690-y; Osborne JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078681; R Core Team, 2012, R LANG ENV STAT COMP; Renner M. J., 1988, INT J COMP PSYCHOL, V2, P43; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; ROBINSON GE, 1993, ANIM BEHAV, V46, P311, DOI 10.1006/anbe.1993.1192; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; von Frisch K., 1967, DANCE LANGUAGE ORIEN, DOI [10.1007/s00114-010-0690-y, DOI 10.1007/S00114-010-0690-Y]; Wehner R, 1981, COMP PHYS EVOLUTION, VVII/ 6C, P287, DOI DOI 10.1007/978-3642-67868-4; Wiener Jan, 2011, P51; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	33	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202171	10.1371/journal.pone.0202171	http://dx.doi.org/10.1371/journal.pone.0202171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157186	Green Published, gold			2022-12-27	WOS:000443071400042
J	Geffen, N; Scholz, SM				Geffen, Nathan; Scholz, Stefan Michael			How various design decisions on matching individuals in relationships affect the outcomes of microsimulations of sexually transmitted infection epidemics	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; TRANSMISSION; PREVENTION; SIMULATION; BEHAVIOR; SPREAD; RISK	Microsimulations are increasingly used to estimate the prevalence of sexually transmitted infections (STIs). These models consist of agents which represent a sexually active population. Matching agents into sexual relationships is computationally intensive and presents modellers with difficult design decisions: how to select which partnerships between agents break up, which agents enter a partnership market, and how to pair agents in the partnership market. The aim of this study was to analyse the effect of these design decisions on STI prevalence. We compared two strategies for selecting which agents enter a daily partnership market and which agent partnerships break up: random selection in which agents are treated homogenously versus selection based on data from a large German longitudinal data set that accounts for sex, sexual orientation and age heterogeneity. We also coupled each of these strategies with one of several recently described algorithms for pairing agents and compared their speed and outcomes. Additional design choices were also considered, such as the number of agents used in the model, increasing the heterogeneity of agents' sexual behaviour, and the proportion of relationships which are casual sex encounters. Approaches which account for agent heterogeneity estimated lower prevalence than less sophisticated approaches which treat agents homogeneously. Also, in simulations with nonrandom pairing of agents, as the risk of infection increased, incidence declined as the number of agents increased. Our algorithms facilitate the execution of thousands of simulations with large numbers of agents quickly. Fast pair-matching algorithms provide a practical way for microsimulation modellers to account for varying sexual behaviour within the population they are studying. For STIs with high infection rates modellers may need to experiment with different population sizes.	[Geffen, Nathan] Univ Cape Town, Ctr Social Sci Res, Cape Town, South Africa; [Scholz, Stefan Michael] Univ Bielefeld, Dept Publ Hlth, Bielefeld, Germany; [Scholz, Stefan Michael] Leibniz Univ Hannover, Ctr Hlth Econ Res Hannover CHERH, Hannover, Germany	University of Cape Town; University of Bielefeld; Leibniz University Hannover	Geffen, N (corresponding author), Univ Cape Town, Ctr Social Sci Res, Cape Town, South Africa.	nathangeffen@gmail.com	Scholz, Stefan/W-9109-2019	Scholz, Stefan/0000-0002-8421-8829	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This paper uses data from the German Family Panel pairfam, coordinated by Josef Bruederl, Karsten Hank, Johannes Huinink, Bernhard Nauck, Franz Neyer, and Sabine Walper. pairfam is funded as long-term project by the German Research Foundation (DFG).	ALEXANDER LJ, 1949, ARCH DERMATOL SYPH, V59, P1; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Beck EC, 2015, JAIDS-J ACQ IMM DEF, V70, P186, DOI 10.1097/QAI.0000000000000733; Brookmeyer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112668; Burchell AN, 2006, AM J EPIDEMIOL, V163, P534, DOI 10.1093/aje/kwj077; Burchell AN, 2011, J INFECT DIS, V204, P1723, DOI 10.1093/infdis/jir644; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; EDMONDS J, 1965, J RES NATL BUR STAND, VB 69, P125, DOI 10.6028/jres.069B.013; Escobar Erik, 2015, Online J Public Health Inform, V7, pe224, DOI 10.5210/ojphi.v7i3.6104; Geffen N, 2017, JASSS-J ARTIF SOC S, V20, DOI 10.18564/jasss.3485; Goldhaber-Fiebert Jeremy D, 2007, Popul Health Metr, V5, P11, DOI 10.1186/1478-7954-5-11; Gray RT, 2011, SEX TRANSM DIS, V38, P1151, DOI 10.1097/OLQ.0b013e318238b85d; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Huinink J, 2011, Z FAMILIENCORSCH, V23, P77; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; Johnson LF, 2016, SEX TRANSM DIS, V43, P139, DOI 10.1097/OLQ.0000000000000412; Kolmogorov V, 2009, MATH PROGRAM COMPUT, V1, P43, DOI 10.1007/s12532-009-0002-8; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Kretzschmar M, 1996, AM J EPIDEMIOL, V144, P306; Kretzschmar M., 2000, MATH POPUL STUD, V8, P109, DOI [10.1080/08898480009525478, DOI 10.1080/08898480009525478]; Nauck B., 2014, GERMAN FAMILY PANEL; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202516	10.1371/journal.pone.0202516	http://dx.doi.org/10.1371/journal.pone.0202516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157216	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400058
J	Liao, YJ; Tang, PC; Chen, YH; Chu, FH; Kang, TC; Chen, LR; Yang, JR				Liao, Yu-Jing; Tang, Pin-Chi; Chen, Yu-Hsin; Chu, Feng-Hsiang; Kang, Ting-Chieh; Chen, Lih-Ren; Yang, Jenn-Rong			Porcine induced pluripotent stem cell-derived osteoblast-like cells prevent glucocorticoid-induced bone loss in Lanyu pigs	PLOS ONE			English	Article							ANIMAL-MODELS; OSTEOGENIC DIFFERENTIATION; OSTEOPOROSIS RESEARCH; BODY-WEIGHT; FOOD-INTAKE; IN-VITRO; MINIPIGS; TURNOVER; THERAPY; CALCIUM	The application of appropriate animal models and techniques for the study of osteoporosis is important. Lanyu pigs, a local miniature breed, have been widely used in various biomedical studies in Taiwan. This study aimed to induce bone loss in Lanyu pigs and to examine whether porcine induced pluripotent stem cell (piPSC)-derived osteoblast-like cells could recover bone mass of tibiae via local cell transplantation. piPSCs were directed to differentiate into osteoblast-like cells using osteogenic medium, and differentiated cells expressed osteogenic markers and phenotypes. Twenty mature female Lanyu pigs were divided into four groups, including control (C, 1% calcium diet), treatment 1 (T1, ovariectomy + 1% calcium diet), treatment 2 (T2, ovariectomy + 0.5% calcium diet), and treatment 3 (T3, ovariectomy + 0.5% calcium diet + 1 mg/kg of prednisolone) and were subjected to bone loss induction for twelve months. Micro-CT images revealed that the lowest trabecular bone parameters, such as trabecular bone volume, thickness, separation, number, and total porosity, were detected in the T3 group. The lowest proportions of cortical bone in the proximal metaphysis, proximal diaphysis, and distal diaphysis were also found in the T3 group. These results indicate that ovariectomy, calcium restriction, and prednisolone administration can be applied to induce proper bone loss in Lanyu pigs. After bone loss induction, pigs were subjected to cell transplantation in the left tibiae and were maintained for another six months. Results showed that transplanted piPSC-derived osteoblast-like cells significantly improved trabecular bone structures at transplanted sites and maintained cortical bone structures in the proximal metaphysis. In conclusion, the therapeutic potential of piPSCderived osteoblast-like cells was confirmed via cell transplantation in the left tibiae of Lanyu pigs. These findings reveal the therapeutic potential of piPSCs for glucocorticoid-induced bone loss in pig models.	[Liao, Yu-Jing; Chen, Yu-Hsin; Chu, Feng-Hsiang; Chen, Lih-Ren; Yang, Jenn-Rong] Council Agr, Livestock Res Inst, Div Physiol, Tainan, Taiwan; [Liao, Yu-Jing; Tang, Pin-Chi] Natl Chung Hsing Univ, Dept Anim Sci, Taichung, Taiwan; [Tang, Pin-Chi] Natl Chung Hsing Univ, IEGG, Taichung, Taiwan; [Tang, Pin-Chi] Natl Chung Hsing Univ, Anim Biotechnol Ctr, Taichung, Taiwan; [Tang, Pin-Chi] Natl Chung Hsing Univ, Ctr Integrat & Evolutionary Galliformes Genom, Taichung, Taiwan; [Chen, Yu-Hsin] Natl Chiayi Univ, Dept Anim Sci, Chiayi, Taiwan; [Kang, Ting-Chieh] Council Agr, Hengchun Branch, Livestock Res Inst, Tainan, Taiwan; [Kang, Ting-Chieh] Natl Pingtung Univ Sci & Technol, Grad Inst Bioresources, Pingtung, Taiwan; [Chen, Lih-Ren] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan	Taiwan Livestock Research Institute; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chiayi University; Taiwan Livestock Research Institute; National Pingtung University Science & Technology; National Cheng Kung University	Yang, JR (corresponding author), Council Agr, Livestock Res Inst, Div Physiol, Tainan, Taiwan.	jryang@mail.tlri.gov.tw		Liao, Yu Jing/0000-0003-0421-3268	Livestock Research Institute, Council of Agriculture [105AS-2.7.6-LI-L1]	Livestock Research Institute, Council of Agriculture	This research was supported from the grants of 105AS-2.7.6-LI-L1 by the Livestock Research Institute, Council of Agriculture.	Antebi B, 2014, CURR OSTEOPOROS REP, V12, P41, DOI 10.1007/s11914-013-0184-x; AOAC International, 2016, OFFICIAL METHODS ANA; Arpornmaeklong P, 2010, CELL REPROGRAM, V12, P377, DOI 10.1089/cell.2009.0079; Birkebaek NH, 1995, ARCH DIS CHILD, V73, P524, DOI 10.1136/adc.73.6.524; Borah B, 2002, J BONE MINER RES, V17, P1139, DOI 10.1359/jbmr.2002.17.7.1139; Bouchard GF, 1996, ADVANCES IN SWINE IN BIOMEDICAL RESEARCH, VOLS 1 AND 2, P647; Bouvard B, 2010, CLIN REV BONE MINER, V8, P15, DOI 10.1007/s12018-009-9051-9; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Creedon A, 2001, BRIT J NUTR, V86, P453, DOI 10.1079/BJN2001419; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; Gao X, 2014, INT J CLIN EXP PATHO, V7, P5123; Gluer CC, 2007, BONE, V40, P645, DOI 10.1016/j.bone.2006.10.019; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Ikeda S, 2003, BONE, V33, P779, DOI 10.1016/S8756-3282(03)00263-1; Kiernan J, 2016, STEM CELL TRANSL MED, V5, P683, DOI 10.5966/sctm.2015-0231; Kim Sang-Woo, 2013, Lab Anim Res, V29, P174, DOI 10.5625/lar.2013.29.3.174; Kimmel DB, 1996, OSTEOPOROSIS, V2, P29; Larsen T, 2000, CAN J ANIM SCI, V80, P547, DOI 10.4141/A00-024; Lee JH, 2012, CLIN INTERV AGING, V7, P303, DOI 10.2147/CIA.S32513; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Li BF, 2010, ACTA ORTHOP, V81, P396, DOI 10.3109/17453674.2010.483986; Li FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147810; Liao YJ, 2018, REGEN MED; Liao YJ, 2014, J STEM CELL RES THER, V4, P208; Liu XY, 2011, EXP THER MED, V2, P977, DOI 10.3892/etm.2011.292; Liu Y, 2014, CLIN EXP MED, V14, P13, DOI 10.1007/s10238-012-0218-1; Lysdahl H, 2014, BIORESEARCH OPEN ACC, V3, P278, DOI 10.1089/biores.2014.0044; MILLER SC, 1995, BONE, V17, pS117, DOI 10.1016/8756-3282(95)00284-K; MOSEKILDE L, 1993, BONE, V14, P379, DOI 10.1016/8756-3282(93)90167-9; MOSEKILDE L, 1995, BONE, V17, pS343, DOI 10.1016/8756-3282(95)00312-2; RODGERS JB, 1993, BONE, V14, P369, DOI 10.1016/8756-3282(93)90166-8; SAS, 2016, US GUID STAT; Scholz-Ahrens KE, 2007, AM J PHYSIOL-ENDOC M, V293, pE385, DOI 10.1152/ajpendo.00627.2006; Seto H, 1999, BONE, V25, P687, DOI 10.1016/S8756-3282(99)00229-X; Sottile V, 2003, CLONING STEM CELLS, V5, P149, DOI 10.1089/153623003322234759; STELLON AJ, 1985, GASTROENTEROLOGY, V89, P1078, DOI 10.1016/0016-5085(85)90212-4; Sui BD, 2016, STEM CELL TRANSL MED, V5, P1238, DOI 10.5966/sctm.2015-0347; Szulc P, 2000, OSTEOPOROSIS INT, V11, P281, DOI 10.1007/s001980070116; Taiani JT, 2014, BONE, V64, P263, DOI 10.1016/j.bone.2014.04.019; Teitelbaum SL, 2010, CELL STEM CELL, V7, P553, DOI 10.1016/j.stem.2010.10.004; Turner A. Simon, 2001, European Cells & Materials, V1, P66; Wu CY, 2007, ANIM GENET, V38, P499, DOI 10.1111/j.1365-2052.2007.01646.x	42	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202155	10.1371/journal.pone.0202155	http://dx.doi.org/10.1371/journal.pone.0202155			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157199	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400041
J	Diaz, LM; Ricaurte, J; Tovar, E; Cajiao, C; Teran, H; Grajales, M; Polania, J; Rao, I; Beebe, S; Raatz, B				Milena Diaz, Lucy; Ricaurte, Jaumer; Tovar, Eduardo; Cajiao, Cesar; Teran, Henry; Grajales, Miguel; Polania, Jose; Rao, Idupulapati; Beebe, Stephen; Raatz, Bodo			QTL analyses for tolerance to abiotic stresses in a common bean (Phaseolus vulgaris L.) population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ROOT ARCHITECTURE TRAITS; DROUGHT TOLERANCE; PLANT-GROWTH; YIELD; PHOSPHORUS; RESISTANCE; SELECTION; MAP; ACQUISITION	Common bean productivity is reduced by several abiotic stress factors like drought and low soil fertility, leading to yield losses particularly in low input smallholder farming systems in the tropics. To understand the genetics of stress tolerance, and to improve adaptation of common bean to adverse environments, the BAT 881 x G21212 population of 95 recombinant inbred lines (RILs) was evaluated under different abiotic stress conditions in 15 trials across four locations in Colombia, representing two higher altitude (Darien ,Popayan) and two lower altitude (Palmira, Quilichao) locations. Stress vs non-stress treatments showed that yields were reduced in drought trials in Palmira by 13 and 31%, respectively, and observed yield reductions in low phosphorus stress were 39% in Quilichao, 16% in Popayan, and 71% in Darien, respectively. Yield components and biomass traits were also reduced. Traits linked to dry matter redistribution from stems, leaves and pods to seed, such as pod harvest index and total non-structural carbohydrates, were found to be important factors contributing to yield in all conditions. In contrast, early maturity was correlated with improved yield only in lower altitude locations, whereas in higher altitudes delayed maturity promoted yield. Superior RILs that combine stress tolerance and high cross-location productivity were identified. Lines that showed good yield under strong stress conditions also performed well under non-stress conditions, indicating that breeder's selection can be applied for both conditions at the same time. Quantitative trait loci (QTL) analyses revealed a stable yield QTL on chromosome Pv04, detected individually in all locations, several stress treatments and in best linear unbiased predictions (BLUPs) across all trials. Furthermore, two QTL hotspots for maturity traits were identified on Pv01 and Pv08, which are the most stable QTL. The constitutive yield QTL could serve as a good candidate for marker development and could be used in marker assisted selection. Increased understanding of the physiology of abiotic stress tolerance, combined with the availability of superior germplasm and molecular tools, will aid breeding efforts for further improvement of these plant traits.	[Milena Diaz, Lucy; Ricaurte, Jaumer; Cajiao, Cesar; Grajales, Miguel; Polania, Jose; Rao, Idupulapati; Beebe, Stephen; Raatz, Bodo] Int Ctr Trop Agr CIAT, Biotechnol Unit, Cali, Valle, Colombia; [Milena Diaz, Lucy; Ricaurte, Jaumer; Cajiao, Cesar; Grajales, Miguel; Polania, Jose; Rao, Idupulapati; Beebe, Stephen; Raatz, Bodo] Int Ctr Trop Agr CIAT, Bean Program, Cali, Valle, Colombia; [Tovar, Eduardo] Inst Invest Recursos Biol Alexander von Humboldt, Bogota, Colombia; [Teran, Henry] DuPont Pioneer, Salinas, PR USA; [Raatz, Bodo] CIAT Int Ctr Trop Agr, Cali, Colombia; [Rao, Idupulapati] ARS, Plant Polymer Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL USA	Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT; United States Department of Agriculture (USDA)	Raatz, B (corresponding author), Int Ctr Trop Agr CIAT, Biotechnol Unit, Cali, Valle, Colombia.; Raatz, B (corresponding author), Int Ctr Trop Agr CIAT, Bean Program, Cali, Valle, Colombia.; Raatz, B (corresponding author), CIAT Int Ctr Trop Agr, Cali, Colombia.	b.raatz@cgiar.org	Polania, Jose/Q-2745-2017	Polania, Jose/0000-0002-1186-0503; raatz, bodo/0000-0003-0556-0691	Bill & Melinda Gates Foundation [OPPGD1392, OPP1114827]; CGIAR research program on Grain Legumes; Generation Challenge Program (GCP); Tropical Legumes I (TL-I) project; BMZ-GIZ, Germany	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); CGIAR research program on Grain Legumes(CGIAR); Generation Challenge Program (GCP); Tropical Legumes I (TL-I) project; BMZ-GIZ, Germany	Thanks to the Generation Challenge Program (GCP, www.generationcp.org/). And particularly its component Tropical Legume I (TL-I) project (funded by the Bill & Melinda Gates Foundation, OPPGD1392) continued by the TL3 project (http://tropicallegumes.icrisat.org/, OPP1114827). The authors also acknowledge the financial support from the CGIAR research program on Grain Legumes (http://grainlegumes.cgiar.org/), assumed by USAID (https://www.usaid.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge M. Otero, J. Molina, L. A. Lopez, R. Garcia, C. X. Rojas, C. Ceron, G. Vieira, A. Hoyos, O. Joaqui, J. Loboa, G. Mezu A, J. B. Cuasquer, M. Rivera, and F. de la Hoz for their technical support, statistical analysis and suggestions. We are grateful to the Generation Challenge Program (GCP), the Tropical Legumes I (TL-I) project (funded by the Bill & Melinda Gates Foundation), and BMZ-GIZ, Germany for financial support for SNP genotyping and field evaluation. The authors also acknowledge the financial support from the CGIAR research program on Grain Legumes. We would also like to thank all donors who supported this work through their contributions to the CGIAR Fund.	Abdel-Haleem H, 2011, THEOR APPL GENET, V122, P935, DOI 10.1007/s00122-010-1500-9; ACOSTAGALLEGOS JA, 1995, CROP SCI, V35, P199, DOI 10.2135/cropsci1995.0011183X003500010037x; Afanador L.K., 1993, ANN REP BEAN IMPROV, V36, P10; Araujo SS, 2015, CRIT REV PLANT SCI, V34, P237, DOI 10.1080/07352689.2014.898450; Asfaw A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00733; Assefa T, 2017, PLANT BREEDING, V136, P548, DOI 10.1111/pbr.12496; Assefa T, 2013, FIELD CROP RES, V148, P24, DOI 10.1016/j.fcr.2013.04.008; BASNET B, 1974, AGRON J, V66, P531, DOI 10.2134/agronj1974.00021962006600040016x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Batjes N., 1997, SOIL USE MANAG; Beaver JS, 2009, EUPHYTICA, V168, P145, DOI 10.1007/s10681-009-9911-x; Beebe S., 2012, Plant Breeding Reviews, V36, P357; Beebe SE, 2006, CROP SCI, V46, P413, DOI 10.2135/cropsci2005.0226; Beebe SE, 2008, CROP SCI, V48, P582, DOI 10.2135/cropsci2007.07.0404; Beebe SE, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00035; Berger JD, 2011, EUPHYTICA, V180, P1, DOI 10.1007/s10681-011-0391-4; Blair M, 2008, THEOR APPL GENET, V118, P91, DOI 10.1007/s00122-008-0879-z; Blair MW, 2012, MOL BREEDING, V29, P71, DOI 10.1007/s11032-010-9527-9; Blair MW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-100; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Burt AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139450; Cichy KA, 2015, CROP SCI, V55, P2149, DOI 10.2135/cropsci2014.09.0653; Cichy KA, 2009, CROP SCI, V49, P59, DOI 10.2135/cropsci2008.03.0142; Cichy KA, 2009, EUPHYTICA, V165, P257, DOI 10.1007/s10681-008-9778-2; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Da Silva DA, 2014, SCI AGR, V71, P232, DOI 10.1590/S0103-90162014000300008; Diaz LM, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0673-1; Ehlers JD, 1997, FIELD CROP RES, V53, P187, DOI 10.1016/S0378-4290(97)00031-2; Erskine W, 2011, FOOD SECUR, V3, P127, DOI 10.1007/s12571-011-0124-5; Frei A, 2005, CROP SCI, V45, P379, DOI 10.2135/cropsci2005.0379; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Kamfwa K, 2015, THEOR APPL GENET, V128, P1999, DOI 10.1007/s00122-015-2562-5; Kamfwa K, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.09.0059; Kang JH, 1995, WHITE CLOVER MORPHOL, p264 ; Keller B, 2015, THEOR APPL GENET, V128, P813, DOI 10.1007/s00122-015-2472-6; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Li R, 1996, CROP SCI, V36, P617, DOI 10.2135/cropsci1996.0011183X003600030016x; Liu FL, 2004, FIELD CROP RES, V86, P1, DOI 10.1016/S0378-4290(03)00165-5; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed., DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Miklas PN, 2001, CROP SCI, V41, P309, DOI 10.2135/cropsci2001.412309x; Mukeshimana G, 2014, CROP SCI, V54, P923, DOI 10.2135/cropsci2013.06.0427; Nidhi Gupta, 2013, American Journal of Plant Sciences, V4, P21; Polania J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00296; Polania J, 2016, EUPHYTICA, V210, P17, DOI 10.1007/s10681-016-1691-5; Polania JA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00660; Porch TG, 2009, J AGRON CROP SCI, V195, P328, DOI 10.1111/j.1439-037X.2009.00375.x; R Core Team, 2015, R LANGUAGE ENV STAT; Ramaekers L, 2010, FIELD CROP RES, V117, P169, DOI 10.1016/j.fcr.2010.03.001; Rao I., 2013, African Crop Science Journal, V21, P265; Rao IM, 2017, J AGR SCI-CAMBRIDGE, V155, P857, DOI 10.1017/S0021859616000915; Rao I.M., 2014, HDB PLANT CROP PHYSL, Vthird, P847, DOI [10.1201/b16675-49, DOI 10.1201/B16675-49]; Rao I.M., 2001, HDB PLANT CROP PHYSL, P583; Rao IM, 2016, ANN BOT-LONDON, V118, P593, DOI 10.1093/aob/mcw073; RAO IM, 1995, J PLANT NUTR, V18, P2135, DOI 10.1080/01904169509365052; Rao IM, 2006, ANN REPORT, P19; Resende MDV., 2002, GENETICA BIOMETRICA, P975; Rojo H, 2009, CADENAS DE MARKOV, V21, P265; Rosales-Serna R, 2004, FIELD CROP RES, V85, P203, DOI 10.1016/S0378-4290(03)00161-8; Salinas JG, 1985, METODOS QUIMICOS ANA; SAS- Institute. SAS Institute Inc, 2011, SAS 9 3 SYST OPT REF; Song QJ, 2015, G3-GENES GENOM GENET, V5, P2285, DOI 10.1534/g3.115.020594; Thung M, 1999, INTEGRATED MANAGEMEN, P331; Trapp JJ, 2015, CROP SCI, V55, P1596, DOI 10.2135/cropsci2014.11.0792; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Urrea CA, 2009, CROP SCI, V49, P2005, DOI 10.2135/cropsci2008.12.0694; Wang J., 2014, USERS MANUAL QTL ICI; WHITE JW, 1991, EUPHYTICA, V55, P15, DOI 10.1007/BF00022554; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wortmann CS, 1998, ATLAS COMMON BEAN PR; Yu K, 2000, J HERED, V91, P429, DOI 10.1093/jhered/91.6.429; ZHANG MM, 2016, ANN BOT, P1, DOI DOI 10.1093/AOB/MCW062	73	28	28	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202342	10.1371/journal.pone.0202342	http://dx.doi.org/10.1371/journal.pone.0202342			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157265	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400054
J	Theart, RP; Loos, B; Powrie, YSL; Niesler, TR				Theart, Rensu P.; Loos, Ben; Powrie, Yigael S. L.; Niesler, Thomas R.			Improved region of interest selection and colocalization analysis in three-dimensional fluorescence microscopy samples using virtual reality	PLOS ONE			English	Article							CONFOCAL MICROSCOPY; AXONAL-TRANSPORT; VISUALIZATION; DISEASE; CELLS; BETA; DNA	Although modern fluorescence microscopy produces detailed three-dimensional (3D) datasets, colocalization analysis and region of interest (ROI) selection is most commonly performed two-dimensionally (2D) using maximum intensity projections (MIP). However, these 2D projections exclude much of the available data. Furthermore, 2D ROI selections cannot adequately select complex 3D structures which may inadvertently lead to either the exclusion of relevant or the inclusion of irrelevant data points, consequently affecting the accuracy of the colocalization analysis. Using a virtual reality (VR) enabled system, we demonstrate that 3D visualization, sample interrogation and analysis can be achieved in a highly controlled and precise manner. We calculate several key colocalization metrics using both 2D and 3D derived super-resolved structured illumination-based data sets. Using a neuronal injury model, we investigate the change in colocalization between Tau and acetylated a-tubulin at control conditions, after 6 hours and again after 24 hours. We demonstrate that performing colocalization analysis in 3D enhances its sensitivity, leading to a greater number of statistically significant differences than could be established when using 2D methods. Moreover, by carefully delimiting the 3D structures under analysis using the 3D VR system, we were able to reveal a time dependent loss in colocalization between the Tau and microtubule network as an early event in neuronal injury. This behavior could not be reliably detected using a 2D based projection. We conclude that, using 3D colocalization analysis, biologically relevant samples can be interrogated and assessed with greater precision, thereby better exploiting the potential of fluorescence-based image analysis in biomedical research.	[Theart, Rensu P.; Niesler, Thomas R.] Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, Western Cape, South Africa; [Loos, Ben; Powrie, Yigael S. L.] Stellenbosch Univ, Dept Physiol Sci, Stellenbosch, Western Cape, South Africa	Stellenbosch University; Stellenbosch University	Niesler, TR (corresponding author), Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, Western Cape, South Africa.	trn@sun.ac.za	Powrie, Yigael SL/R-1094-2018	Powrie, Yigael SL/0000-0001-8044-9390; Theart, Rensu/0000-0003-0508-1690; Loos, Ben/0000-0002-5517-373X	NVIDIA corporation	NVIDIA corporation	NVIDIA corporation sponsored the GPU that was used in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA J, 1992, LIFE SCI, V50, P327, DOI 10.1016/0024-3205(92)90433-P; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Comeau JWD, 2008, MOL BIOSYST, V4, P672, DOI 10.1039/b719826d; Dan P, 2003, AM J PHYSIOL-HEART C, V284, pH1295, DOI 10.1152/ajpheart.00781.2002; Demandolx D, 1997, J MICROSC-OXFORD, V185, P21, DOI 10.1046/j.1365-2818.1997.1470704.x; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Dutartre H, 1996, J CELL SCI, V109, P367; Engel K., 2006, REAL TIME VOLUME GRA; Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006; FOX MH, 1991, J CELL SCI, V99, P247; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Lee S., 2012, INT J ALZHEIMERS DIS; Lee S, 2011, AUTOPHAGY, V7, P1562, DOI 10.4161/auto.7.12.17956; Lifshitz L. M., 1994, Proceedings of the IEEE Workshop on Biomedical Image Analysis (Cat. No.94TH0624-7), P166, DOI 10.1109/BIA.1994.315854; Lumkwana D, 2017, PROG NEUROBIOL, V153, P64, DOI 10.1016/j.pneurobio.2017.03.006; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Mietelska-Porowska A, 2014, INT J MOL SCI, V15, P4671, DOI 10.3390/ijms15034671; Movania MM, 2013, OPENGL DEV COOKBOOK, Vfirst; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Rodriguez-Martin T, 2013, NEUROBIOL AGING, V34, P2146, DOI 10.1016/j.neurobiolaging.2013.03.015; Scriven DRL, 2005, BIOPHYS J, V89, P1893, DOI 10.1529/biophysj.105.064212; Theart RP, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1446-2; Torres Manuel, 2012, Mol Neurodegener, V7, P59, DOI 10.1186/1750-1326-7-59; van der Voort H. T. M., 1993, Bioimaging, V1, P20, DOI 10.1002/1361-6374(199303)1:1<20::AID-BIO5>3.3.CO;2-U; VANDERVOORT HTM, 1989, J MICROSC-OXFORD, V153, P123; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037	32	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201965	10.1371/journal.pone.0201965	http://dx.doi.org/10.1371/journal.pone.0201965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157239	Green Published, gold			2022-12-27	WOS:000443071400022
J	Wu, XD; Chen, SS; Li, SZ; Zhang, J; Luan, D; Zhao, SC; Chu, ZH; Xu, Y				Wu, Xiaodong; Chen, Shuangshuang; Li, Shizun; Zhang, Ji; Luan, Di; Zhao, Shoucai; Chu, Zhaohu; Xu, Yang			Oxygen therapy in patients with retinal artery occlusion: A meta-analysis	PLOS ONE			English	Article							HYPERBARIC-OXYGEN; VEIN OCCLUSION; VISUAL-LOSS; MANAGEMENT	Background Oxygen therapy has been widely used for RAO (retinal artery occlusion) patients; however, inconsistent results have been reported. Methods PubMed, Web of Science, EMBASE, Medline (OvidSP), Cochrane, China National Knowledge Infrastructure (CNKI), and Wanfang Database were examined. The primary endpoint was visual acuity (VA), and RevMan software 5.3 was used to statistically analyze the outcomes. Results Seven randomized controlled trials (RCTs) met the inclusion criteria. Patients who received oxygen therapy exhibited probability of visual improvement about 5.61 times compared with the control group who did not receive oxygen therapy (OR = 5.61; 95% CI, 3.60-8.73; p < 0.01). No statistically significant difference was observed between oxygen inhalation methods (Chi 2 = 0.18, df = 1, p = 0.67), combined therapy (Chi 2 = 0.21, df = 1, p = 0.64), or RAO type (Chi 2 = 0.06, df = 1, p = 0.81). Conversely, 100% oxygen (Chi 2 = 4.55, df = 1, p < 0.05) and hyperbaric oxygen (Chi 2 = 4.55, df = 1, p < 0.05) significantly improved VA in RAO patients. Better effect was showed in period within 3 months (Chi 2 = 5.76, df = 1, p < 0.05). The most effective treatment length was over 9 hours (Chi 2 = 6.58, df = 1, p < 0.05). Conclusion Oxygen therapy demonstrated beneficial effects in improving VA in RAO patients, particularly when patients were treated with 100% hyperbaric oxygen and for over 9 hours.	[Wu, Xiaodong; Chen, Shuangshuang; Li, Shizun; Zhang, Ji; Luan, Di; Zhao, Shoucai; Chu, Zhaohu; Xu, Yang] Yijishan Hosp, Affiliated Hosp 1, Wannan Med Coll, Dept Neurol, Wuhu, Peoples R China; [Xu, Yang] Yijishan Hosp, Affiliated Hosp 1, Wannan Med Coll, Cent Lab, Wuhu, Peoples R China	Wannan Medical College; Wannan Medical College	Chu, ZH; Xu, Y (corresponding author), Yijishan Hosp, Affiliated Hosp 1, Wannan Med Coll, Dept Neurol, Wuhu, Peoples R China.; Xu, Y (corresponding author), Yijishan Hosp, Affiliated Hosp 1, Wannan Med Coll, Cent Lab, Wuhu, Peoples R China.	chuzhaohu878@163.com; southtv@163.com	Yang, Xu/AGR-8189-2022	Yang, Xu/0000-0001-8778-3885; Wu, Xiaodong/0000-0001-8407-8398	National Natural Science Foundation of China [81701161]; Scientifc Research Fund Project for Talent Introduction of Yijishan Hospital, Wannan Medical College, Anhui, China [YR201802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientifc Research Fund Project for Talent Introduction of Yijishan Hospital, Wannan Medical College, Anhui, China	This study was funded by the National Natural Science Foundation of China (81701161) and the Scientifc Research Fund Project for Talent Introduction of Yijishan Hospital, Wannan Medical College, Anhui, China (Grant Nos. YR201802).	Agarwal N, 2016, VASC ENDOVASC SURG, V50, P579, DOI 10.1177/1538574416682158; Aisenbrey S, 2000, OPHTHALMOLOGE, V97, P461, DOI 10.1007/s003470070075; Atebara NH, 1995, OPHTHALMOLOGY, V102, P2029, DOI 10.1016/S0161-6420(95)30758-0; Beiran I, 2001, EUR J OPHTHALMOL, V11, P345, DOI 10.1177/112067210101100405; Beiran I, 1993, Eur J Ophthalmol, V3, P89; Canan H, 2014, J MED CASE REPORTS, V8, P1; Celebi ARC, 2016, DIVING HYPERB MED, V46, P50; Chen YY, 2014, CHINESE MED J-PEKING, V127, P1434, DOI 10.3760/cma.j.issn.0366-6999.20133254; Chen YC, 2018, FACIAL PLAST SURG, V34, pE1, DOI 10.1055/s-0038-1656550; Cope A, 2011, DIVING HYPERB MED, V41, P135; Dattilo M, 2017, NEUROL CLIN, V35, P83, DOI 10.1016/j.ncl.2016.08.013; Dumitrascu OM, 2017, NEUROLOGIST, V22, P153, DOI 10.1097/NRL.0000000000000129; Elkordy Alaa Mohammed, 2016, NMC Case Rep J, V3, P71, DOI 10.2176/nmccrj.cr.2015-0243; Fraser SG, 2009, COCHRANE DB SYST REV, V1; Gaydar V, 2011, INVEST OPHTH VIS SCI, V52, P7514, DOI 10.1167/iovs.11-7574; Gokce G, 2014, HIGH ALT MED BIOL, V15, P84, DOI 10.1089/ham.2013.1086; Graefe AV, ARCH OPHTHALMOLOGIE, V5, P136; Green HS, 2008, N-S ARCH PHARMACOL, V5, pS38; Hayreh SS, 2009, OPHTHALMOLOGY, V116, P1928, DOI 10.1016/j.ophtha.2009.03.006; Hayreh SS, 2009, OPHTHALMOLOGY, V116, P1188, DOI 10.1016/j.ophtha.2009.01.015; Hayreh SS, 2005, AM J OPHTHALMOL, V140, P376, DOI 10.1016/j.ajo.2005.03.038; He Y., 2009, WORLD HLTH DIGEST, V6, P61; Hertzog LM, 1992, CENTRAL RETINAL ARTE; Hong JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177663; Hsiao SF, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-120; Hwang K., 2016, J CRANIOFAC SURG, V27, P1, DOI [10.1097/SCS.0000000000002387, DOI 10.1097/SCS.0000000000002387]; Jung Young Ho, 2016, Korean J Ophthalmol, V30, P352; Lemos JA, 2015, CASE REP OPHTHALM, V6, P462, DOI 10.1159/000442788; Li HK, 1996, OPHTHALMOLOGY, V103, P2091, DOI 10.1016/S0161-6420(96)30384-9; Lu CH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1401-6; Man V, 2017, GRAEF ARCH CLIN EXP, V255, P1869, DOI 10.1007/s00417-017-3777-8; Menzel-Severing J, 2012, AM J OPHTHALMOL, V153, P454, DOI 10.1016/j.ajo.2011.08.009; Murphy-Lavoie H, 2012, UNDERSEA HYPERBAR M, V39, P943; PERKINS SA, 1987, ANN OPHTHALMOL, V19, P3; Soares A, 2017, BMJ CASE REP, V2017; STONE R, 1977, ANN OPHTHALMOL, V9, P445; WALLYN CR, 1985, INVEST OPHTH VIS SCI, V26, P1155; Wang L., 2016, CHINA HLTH CARE NUTR, V26; Weinberger AWA, 2002, KLIN MONATSBL AUGENH, V219, P728, DOI 10.1055/s-2002-35687; Weiss JN, 2009, UNDERSEA HYPERBAR M, V36, P401; Zhang X., 2000, CHINESE J CRITICAL C, V20, P32	41	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202154	10.1371/journal.pone.0202154	http://dx.doi.org/10.1371/journal.pone.0202154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157206	gold, Green Published, Green Submitted			2022-12-27	WOS:000443071400040
J	Sieverding, M; Eib, C; Neubauer, AB; Stahl, T				Sieverding, Monika; Eib, Constanze; Neubauer, Andreas B.; Stahl, Thomas			Can lifestyle preferences help explain the persistent gender gap in academia? The "mothers work less" hypothesis supported for German but not for US early career researchers	PLOS ONE			English	Article							PUBLICATION PRODUCTIVITY; WOMEN; PREDICTORS; SCIENCE; ATTITUDES; MARRIAGE; JOB	Do lifestyle preferences contribute to the remaining gender gap in higher positions in academia with highly qualified women-especially those with children-deliberately working fewer hours than men do? We tested the "mothers work less" hypothesis in two samples of early career researchers employed at universities in Germany (N = 202) and in the US (N = 197). Early career researchers in the US worked on average 6.3 hours more per week than researchers in Germany. In Germany, female early career researchers with children had drastically reduced work hours (around 8 hours per week) compared to male researchers with children and compared to female researchers without children, whereas we found no such effect for U.S. researchers. In addition, we asked how long respondents would ideally want to work (ideal work hours), and results revealed similar effects for ideal work hours. Results support the "mothers work less" hypothesis for German but not for U.S. early career researchers.	[Sieverding, Monika; Neubauer, Andreas B.; Stahl, Thomas] Heidelberg Univ, Dept Psychol, Heidelberg, Germany; [Eib, Constanze] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Neubauer, Andreas B.] German Inst Int Educ Res DIPF, Frankfurt, Germany; [Neubauer, Andreas B.] Ctr Res Individual Dev & Adapt Educ Children Risk, Frankfurt, Germany	Ruprecht Karls University Heidelberg; Uppsala University; German Institute for International Educational Research	Sieverding, M (corresponding author), Heidelberg Univ, Dept Psychol, Heidelberg, Germany.	monika.sieverding@psychologie.uni-heidelberg.de	Neubauer, Andreas B./I-9475-2019	Neubauer, Andreas B./0000-0003-0515-1126; Eib, Constanze/0000-0002-4921-4865	Deutsche Forschungsgemeinschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	We acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding programme Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg.	Abele AE, 2011, INT J BEHAV DEV, V35, P225, DOI 10.1177/0165025411398181; Allmendinger J, 2012, 2013002 WZB; Baker M, 2010, J COMP FAM STUD, V41, P1; Bell LA, 2001, LABOUR ECON, V8, P181, DOI 10.1016/S0927-5371(01)00030-6; Bendels MHK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189136; Bennhold K, 2010, NY TIMES; Bick A, 2016, 10179 IZA I STUD LAB; Braun M, 2011, PERCEIVED CONSEQUENC; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Clinton ME, 2017, J OCCUP HEALTH PSYCH, V22, P28, DOI 10.1037/ocp0000025; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COLE JR, 1987, SCI AM, V256, P119, DOI 10.1038/scientificamerican0287-119; Correll SJ, 2007, AM J SOCIOL, V112, P1297, DOI 10.1086/511799; Eagly AH, 2016, PERSPECT PSYCHOL SCI, V11, P899, DOI 10.1177/1745691616663918; Ecklund EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022590; Evers A, 2015, J APPL SOC PSYCHOL, V45, P158, DOI 10.1111/jasp.12285; Evers A, 2014, PSYCHOL WOMEN QUART, V38, P93, DOI 10.1177/0361684313498071; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferriman K, 2009, J PERS SOC PSYCHOL, V97, P517, DOI 10.1037/a0016030; FOX MF, 1985, SOCIOL QUART, V26, P537, DOI 10.1111/j.1533-8525.1985.tb00243.x; Fox MF, 2005, SOC STUD SCI, V35, P131, DOI 10.1177/0306312705046630; Friesenhahn I, 2014, PROJ PAP RECOMM; HALLER M, 1994, INT SOCIOL, V9, P87, DOI 10.1177/026858094009001006; Helmer M, 2017, ELIFE, V6, DOI 10.7554/eLife.21718; Hunter LA, 2010, SOC STUD SCI, V40, P433, DOI 10.1177/0306312709358472; Jacobs JA, 2004, ANN AM ACAD POLIT SS, V596, P104, DOI 10.1177/0002716204268185; Jacobs JA., 2004, COMMUNITY WORK FAMIL, V7, P143, DOI DOI 10.1080/1366880042000245443; Jaksztat S, 2017, Z SOZIOL, V46, P347, DOI 10.1515/zfsoz-2017-1019; King EB, 2008, HUM RELAT, V61, P1677, DOI 10.1177/0018726708098082; Kleiner S, 2015, J HEALTH SOC BEHAV, V56, P98, DOI 10.1177/0022146514568348; Kyvik S, 1996, SCI TECHNOL HUM VAL, V21, P54, DOI 10.1177/016224399602100103; Lubinski D, 2006, PSYCHOL SCI, V17, P194, DOI 10.1111/j.1467-9280.2006.01685.x; Lubinski D, 2004, J PERS SOC PSYCHOL, V86, P96, DOI 10.1037/0022-3514.86.1.96; Lubinski D, 2006, PERSPECT PSYCHOL SCI, V1, P316, DOI 10.1111/j.1745-6916.2006.00019.x; Lubinski D, 2014, PSYCHOL SCI, V25, P2217, DOI 10.1177/0956797614551371; Marks G, 2002, WORK EMPLOY SOC, V16, P523, DOI 10.1177/095001702762217470; Martinez ED, 2007, EMBO REP, V8, P977, DOI 10.1038/sj.embor.7401110; Mason MA, 2004, ACADEME, V90, P10, DOI 10.2307/40252699; Mason MA, 2004, ANN AM ACAD POLIT SS, V596, P86, DOI 10.1177/0002716204268744; Mason MA, 2007, GENDER EQUITY STRENG; Mason MA, 2009, WHY GRADUATE STUDENT, P11; National Center for Education Statistics, 2015, FULL TIM FAC DEGR GR; Ng TWH, 2005, PERS PSYCHOL, V58, P367, DOI 10.1111/j.1744-6570.2005.00515.x; Settles IH, 2006, PSYCHOL WOMEN QUART, V30, P47, DOI 10.1111/j.1471-6402.2006.00261.x; Sieverding M., 1990, PSYCHOL BARRIEREN BE; Statistisches Bundesamt, 2015, FRAU AKAD LAUFB; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; UNESCO Institute for Statistics, 2014, ISCED FIELDS ED TRAI; van Buuren S, 2011, J STAT SOFTW, V45, P1; van den Besselaar P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183301; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Wilson E. O., 1998, CONSILIENCE UNITY KN; Wrzesniewski A, 1997, J RES PERS, V31, P21, DOI 10.1006/jrpe.1997.2162	55	11	11	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202728	10.1371/journal.pone.0202728	http://dx.doi.org/10.1371/journal.pone.0202728			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153285	gold, Green Published, Green Submitted			2022-12-27	WOS:000443001700023
J	Aguilera-Manrique, G; Marquez-Hernandez, VV; Alcaraz-Cordoba, T; Granados-Gamez, G; Gutierrez-Puertas, V; Gutierrez-Puertas, L				Aguilera-Manrique, Gabriel; Marquez-Hernandez, Veronica V.; Alcaraz-Cordoba, Tania; Granados-Gamez, Genoveva; Gutierrez-Puertas, Vanesa; Gutierrez-Puertas, Lorena			The relationship between nomophobia and the distraction associated with smartphone use among nursing students in their clinical practicum	PLOS ONE			English	Article							SOCIAL MEDIA; ADDICTION; NURSES; QUESTIONNAIRE; PHONE; WORK; PREVALENCE; VALIDATION; SETTINGS; USAGE	Background The increasing concern about the adverse effects of overuse of smartphones during clinical practicum implies the need for policies restricting smartphone use while attending to patients. It is important to educate health personnel about the potential risks that can arise from the associated distraction. Objective The aim of this study was to analyze the relationship between the level of nomophobia and the distraction associated with smartphone use among nursing students during their clinical practicum. Methods A cross-sectional study was carried out on 304 nursing students. The nomophobia questionnaire (NMP-Q) and a questionnaire about smartphone use, the distraction associated with it, and opinions about phone restriction policies in hospitals were used. Results A positive correlation between the use of smartphones and the total score of nomophobia was found. In the same way, there was a positive correlation between opinion about smartphone restriction polices with each of the dimensions of nomophobia and the total score of the questionnaire. Conclusions Nursing students who show high levels of nomophobia also regularly use their smartphones during their clinical practicum, although they also believe that the implementation of policies restricting smartphone use while working is necessary.	[Aguilera-Manrique, Gabriel; Marquez-Hernandez, Veronica V.; Alcaraz-Cordoba, Tania; Granados-Gamez, Genoveva; Gutierrez-Puertas, Vanesa; Gutierrez-Puertas, Lorena] Univ Almeria, Fac Hlth Sci, Dept Nursing Physiotherapy & Med, Almeria, Spain; [Aguilera-Manrique, Gabriel; Marquez-Hernandez, Veronica V.; Granados-Gamez, Genoveva] Univ Almeria, Res Grp Hlth Sci CTS 451, Almeria, Spain	Universidad de Almeria; Universidad de Almeria	Marquez-Hernandez, VV (corresponding author), Univ Almeria, Fac Hlth Sci, Dept Nursing Physiotherapy & Med, Almeria, Spain.; Marquez-Hernandez, VV (corresponding author), Univ Almeria, Res Grp Hlth Sci CTS 451, Almeria, Spain.	vmh380@ual.es	Márquez-Hernández, Verónica V./ABE-7896-2020; Gutiérrez-Puertas, Lorena/ABG-4135-2020; Aguilera Manrique, Gabriel/M-7347-2015	Márquez-Hernández, Verónica V./0000-0003-1163-4394; Gutiérrez-Puertas, Lorena/0000-0003-3565-7881; Gutierrez-Puertas, Vanesa/0000-0001-7580-4474; Aguilera Manrique, Gabriel/0000-0002-1945-9626				Aggarwal M., 2012, J PSYCHOL, V15, P50; Alsos OA, 2012, INT J MED INFORM, V81, P12, DOI 10.1016/j.ijmedinf.2011.09.004; Argumosa-Villar L, 2017, J ADOLESCENCE, V56, P127, DOI 10.1016/j.adolescence.2017.02.003; Arpaci I, 2019, INFORM DEV, V35, P96, DOI 10.1177/0266666917730119; Ayar D, 2018, CIN-COMPUT INFORM NU, V36, P589, DOI 10.1097/CIN.0000000000000458; Barton AJ, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-46; Bautista JR, 2016, INT J MED INFORM, V95, P71, DOI 10.1016/j.ijmedinf.2016.09.002; Cagan O, 2014, PROCD SOC BEHV, V114, P831, DOI 10.1016/j.sbspro.2013.12.793; Cho S, 2016, NURS EDUC TODAY, V40, P128, DOI 10.1016/j.nedt.2016.02.021; Cho S, 2015, CIN-COMPUT INFORM NU, V33, P216, DOI 10.1097/CIN.0000000000000132; Cohen TN, 2018, PERIOPER CARE OPERAT, V10, P10, DOI [10.1016/j.pcorm.2017.12.001, DOI 10.1016/J.PCORM.2017.12.001]; Flynn GAH, 2018, CIN-COMPUT INFORM NU, V36, P120, DOI 10.1097/CIN.0000000000000400; Gill PS, 2012, RISK MANAG HEALTHC P, V5, P105, DOI 10.2147/RMHP.S34813; Gokcearslan S, 2016, COMPUT HUM BEHAV, V63, P639, DOI 10.1016/j.chb.2016.05.091; Griffiths M.D., 2005, J SUBST USE, V10, P191, DOI [DOI 10.1080/14659890500114359, 10.1080/14659890500114359]; Gutierrez-Puertas L, 2016, CIN-COMPUT INFORM NU, V34, P470, DOI 10.1097/CIN.0000000000000268; Haug S, 2015, J BEHAV ADDICT, V4, P299, DOI 10.1556/2006.4.2015.037; International Telecommunications Union, MEAS INF SOC REP INT; Jones C, 2013, J CLIN NURS, V22, P1495, DOI 10.1111/jocn.12239; Junco R, 2012, COMPUT HUM BEHAV, V28, P2236, DOI 10.1016/j.chb.2012.06.031; Katz-Sidlow RJ, 2012, J HOSP MED, V7, P595, DOI 10.1002/jhm.1950; Kaur A, 2015, INT J PSYCHIAT NURS, V1, P1, DOI DOI 10.5958/2395-180X.2015.00051.1; King Anna Lucia Spear, 2014, Clin Pract Epidemiol Ment Health, V10, P28, DOI 10.2174/1745017901410010028; Kung YM, 2014, CIN-COMPUT INFORM NU, V32, P64, DOI 10.1097/CIN.0000000000000033; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056936; Lee S, 2017, APPL COGNITIVE PSYCH, V31, P360, DOI 10.1002/acp.3323; Lin SC, 2013, J ADV NURS, V69, P374, DOI 10.1111/j.1365-2648.2012.06016.x; McBride DL, 2015, J ADV NURS, V71, P2020, DOI 10.1111/jan.12674; McBride DL, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4001; McBride DL, 2012, J PEDIATR NURS, V27, P275, DOI 10.1016/j.pedn.2012.02.002; McNally G, 2017, NURSE EDUC PRACT, V23, P1, DOI 10.1016/j.nepr.2016.12.004; Mobasheri M.H., 2015, BMJ INNOV, V1, P174, DOI [DOI 10.1136/BMJINNOV-2015-000062, 10.1136/bmjinnov-2015-000062]; Oulasvirta A, 2012, PERS UBIQUIT COMPUT, V16, P105, DOI 10.1007/s00779-011-0412-2; Polit DF., 2008, NURSING RES GENERATI; Przybylski AK, 2013, COMPUT HUM BEHAV, V29, P1841, DOI 10.1016/j.chb.2013.02.014; Sebri I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165714; SecurEnvoy, 2012, 66 POP SUFF NOM FEAR; Sergeeva A, 2016, HEALTH INFORM J, V22, P1101, DOI 10.1177/1460458215598637; Smith T, 2011, PERFUSION-UK, V26, P375, DOI 10.1177/0267659111409969; Yildirim C, 2016, INFORM DEV, V32, P1322, DOI 10.1177/0266666915599025; Yildirim C, 2015, COMPUT HUM BEHAV, V49, P130, DOI 10.1016/j.chb.2015.02.059	41	52	53	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202953	10.1371/journal.pone.0202953	http://dx.doi.org/10.1371/journal.pone.0202953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148870	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200037
J	Kelm, NQ; Beare, JE; Yuan, FP; George, M; Shofner, CM; Keller, BB; Hoying, JB; LeBlanc, AJ				Kelm, Natia Q.; Beare, Jason E.; Yuan, Fangping; George, Monika; Shofner, Charles M.; Keller, Bradley B.; Hoying, James B.; LeBlanc, Amanda J.			Adipose-derived cells improve left ventricular diastolic function and increase microvascular perfusion in advanced age	PLOS ONE			English	Article							STROMAL-VASCULAR FRACTION; CORONARY FLOW RESERVE; STEM-CELLS; ARTERY-DISEASE; HEART-FAILURE; BLOOD-FLOW; DYSFUNCTION; RESISTANCE; RATS; ARTERIOLES	An early manifestation of coronary artery disease in advanced age is the development of microvascular dysfunction leading to deficits in diastolic function. Our lab has previously shown that epicardial treatment with adipose-derived stromal vascular fraction (SVF) preserves microvascular function following coronary ischemia in a young rodent model. Followup studies showed intravenous (i.v.) delivery of SVF allows the cells to migrate to the walls of small vessels and reset vasomotor tone. Therefore we tested the hypothesis that the i.v. cell injection of SVF would reverse the coronary microvascular dysfunction associated with aging in a rodent model. Fischer 344 rats were divided into 4 groups: young control (YC), old control (OC), old + rat aortic endothelial cells (O+EC) and old + GFP(+) SVF cells (O+SVF). After four weeks, cardiac function and coronary flow reserve (CFR) were measured via echocardiography, and hearts were explanted either for histology or isolation of coronary arterioles for vessel reactivity studies. In a subgroup of animals, microspheres were injected during resting and dobutamine-stimulated conditions to measure coronary blood flow. GFP(+) SVF cells engrafted and persisted in the myocardium and coronary vasculature four weeks following i.v. injection. Echocardiography showed age-related diastolic dysfunction without accompanying systolic dysfunction; diastolic function was improved in old rats after SVF treatment. Ultrasound and microsphere data both showed increased stimulated coronary blood flow in O+SVF rats compared to OC and O+EC, while isolated vessel reactivity was mostly unchanged. I. v.-injected SVF cells were capable of incorporating into the vasculature of the aging heart and are shown in this study to improve CFR and diastolic function in a model of advanced age. Importantly, SVF injection did not lead to arrhythmias or increased mortality in aged rats. SVF cells provide an autologous cell therapy option for treatment of microvascular and cardiac dysfunction in aged populations.	[Kelm, Natia Q.; Beare, Jason E.; Yuan, Fangping; Keller, Bradley B.; Hoying, James B.; LeBlanc, Amanda J.] Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; [Beare, Jason E.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [George, Monika; Shofner, Charles M.; Hoying, James B.; LeBlanc, Amanda J.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA; [Keller, Bradley B.] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	LeBlanc, AJ (corresponding author), Univ Louisville, Cardiovasc Innovat Inst, Louisville, KY 40292 USA.; LeBlanc, AJ (corresponding author), Univ Louisville, Dept Physiol, Louisville, KY 40292 USA.	amanda.leblanc@louisville.edu	Beare, Jason E/D-2870-2016	Beare, Jason E/0000-0003-3988-1223; LeBlanc, Amanda/0000-0003-2507-1203	National Institutes of Health [AG053585, P30 GM103507]; Jewish Heritage Fund for Excellence; Gheen's Foundation; NATIONAL INSTITUTE ON AGING [R01AG053585] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jewish Heritage Fund for Excellence; Gheen's Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (AG053585 to AJL and P30 GM103507 to UofL), Jewish Heritage Fund for Excellence and Gheen's Foundation to AJL.	Aird AL, 2015, EXP GERONTOL, V63, P18, DOI 10.1016/j.exger.2015.01.044; Anwar MA, 2013, VASC PHARMACOL, V58, P140, DOI 10.1016/j.vph.2012.10.007; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Briones AM, 2014, CURR VASC PHARMACOL, V12, P427, DOI 10.2174/1570161112666140423221319; Cheng K, 2012, CELL TRANSPLANT, V21, P1121, DOI 10.3727/096368911X627381; CHILIAN WM, 1986, AM J PHYSIOL, V251, pH779, DOI 10.1152/ajpheart.1986.251.4.H779; CZERNIN J, 1993, CIRCULATION, V88, P62, DOI 10.1161/01.CIR.88.1.62; De Barros S, 2013, MOL THER, V21, P399, DOI 10.1038/mt.2012.213; Dryer K, 2018, AM J PHYSIOL-HEART C, V314, pH1033, DOI 10.1152/ajpheart.00680.2017; Feisst V, 2015, STEM CELLS CLONING, V8, P149, DOI 10.2147/SCCAA.S64373; Ferreira RG, 2014, PERIOPERATIVE TRANSE, P90; Gir P, 2012, PLAST RECONSTR SURG, V130, P249, DOI 10.1097/PRS.0b013e318254b4d3; Gould KL, 2013, J AM COLL CARDIOL, V62, P1639, DOI 10.1016/j.jacc.2013.07.076; HACHAMOVITCH R, 1989, AM J PHYSIOL, V256, pH66, DOI 10.1152/ajpheart.1989.256.1.H66; HANLEY FL, 1984, CIRC RES, V54, P760, DOI 10.1161/01.RES.54.6.760; Hassan EA, 2015, J EQUINE VET SCI, V35, P283, DOI 10.1016/j.jevs.2015.01.016; Hill MA, 2009, TRENDS PHARMACOL SCI, V30, P363, DOI 10.1016/j.tips.2009.04.008; Hirleman Emily D, 2008, J Extra Corpor Technol, V40, P10; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hsiao ST, 2013, STEM CELLS DEV, V22, P1614, DOI 10.1089/scd.2012.0602; James AW, 2012, STEM CELL TRANSL MED, V1, P510, DOI 10.5966/sctm.2012-0002; Kang LS, 2011, AM J PHYSIOL-HEART C, V300, pH2105, DOI 10.1152/ajpheart.00349.2010; Kitzman Dalane W., 2000, Cardiology Clinics, V18, P597, DOI 10.1016/S0733-8651(05)70164-8; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Larson D F, 2000, J Extra Corpor Technol, V32, P142; LeBlanc AJ, 2013, STEM CELL TRANSL MED, V2, P896, DOI 10.5966/sctm.2013-0046; Leblanc AJ, 2013, MICROCIRCULATION, V20, P365, DOI 10.1111/micc.12028; LeBlanc AJ, 2012, AM J PHYSIOL-HEART C, V302, pH973, DOI 10.1152/ajpheart.00735.2011; LeBlanc AJ, 2009, AM J PHYSIOL-REG I, V297, pR1713, DOI 10.1152/ajpregu.00178.2009; Lee JM, 2016, J AM COLL CARDIOL, V67, P1158, DOI 10.1016/j.jacc.2015.12.053; Liu HZ, 2002, CLIN EXP PHARMACOL P, V29, P405, DOI 10.1046/j.1440-1681.2002.03676.x; Marinescu MA, 2015, JACC-CARDIOVASC IMAG, V8, P210, DOI 10.1016/j.jcmg.2014.12.008; Morris ME, 2015, STEM CELL TRANSL MED, V4, P369, DOI 10.5966/sctm.2014-0252; Neely CF, 1996, CIRCULATION, V94, P376; Nevitt C, 2016, AM J PHYSIOL-HEART C, V310, pH1842, DOI 10.1152/ajpheart.00086.2016; Pantos C, 2003, EUR J PHARMACOL, V460, P155, DOI 10.1016/S0014-2999(02)02927-8; Reis SE, 2001, AM HEART J, V141, P735, DOI 10.1067/mhj.2001.114198; Rengo G, 2012, CIRC-HEART FAIL, V5, P385, DOI 10.1161/CIRCHEARTFAILURE.112.966895; Songstad NT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102147; Suga H, 2014, ANN PLAS SURG, V72, P234, DOI 10.1097/SAP.0b013e318264fd6a; Taqueti VR, 2018, EUR HEART J, V39, P840, DOI 10.1093/eurheartj/ehx721; Taqueti VR, 2016, CURR OPIN CARDIOL, V31, P662, DOI 10.1097/HCO.0000000000000339; Taqueti VR, 2015, CIRCULATION, V131, P528, DOI 10.1161/CIRCULATIONAHA.114.009716; Walker EM, 2006, ANN CLIN LAB SCI, V36, P427; Yuan FP, 2006, HUM REPROD, V21, P936, DOI 10.1093/humrep/dei433; Yuill KH, 2011, ANTIOXID REDOX SIGN, V14, P1625, DOI 10.1089/ars.2010.3279; Zhao Z, 2014, AM J PHYSIOL-HEART C, V306, pH628, DOI 10.1152/ajpheart.00859.2013; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813	48	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202934	10.1371/journal.pone.0202934	http://dx.doi.org/10.1371/journal.pone.0202934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142193	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500049
J	Cheng, XJ; Chen, T; Yang, Y; Yang, J; Wang, DY; Hu, GQ; Shu, YL				Cheng, Xunjie; Chen, Tao; Yang, Yang; Yang, Jing; Wang, Dayan; Hu, Guoqing; Shu, Yuelong			Using an innovative method to develop the threshold of seasonal influenza epidemic in China	PLOS ONE			English	Article							LABORATORY-CONFIRMED INFLUENZA; SURVEILLANCE; PREDICTORS	Background Proper early warning thresholds for defining seasonal influenza epidemics are crucial for timely engagement of intervention strategies, but are currently not well established in China. We propose a novel moving logistic regression method (MLRM) to determine epidemic thresholds and validate them with the Chinese influenza surveillance data. Methods For each province, historical epidemic waves are formed as weekly percentages of laboratory-confirmed patients among all clinically diagnosed influenza cases. For each epidemic curve that is approximately symmetric, a series of logistic curves are fitted to increasing temporal range of the epidemic, and the threshold is determined based on the best-fitting logistic curve. Results Using surveillance data of seasonal influenza collected during 2010-2014 in 30 provinces of China, we screened 153 epidemic waves and identified 100 as approximately symmetric; and 85 of the 100 waves were satisfactorily fitted. Compared to two published approaches, the MLRM identified lower thresholds of seasonal influenza epidemics, leading to about three weeks earlier detection of onset and about four weeks later detection of closure of the epidemics. The potential misclassification proportion of influenza epidemic waves was 6% for the MLRM, comparable to that for the two published approaches. Conclusions The MLRM offers an alternative to existing methods for defining early warning thresholds for the surveillance of seasonal influenza, and can be readily generalized to other countries and other infectious agents. The thresholds we identified can be used for early detection of future influenza epidemics in China.	[Cheng, Xunjie; Hu, Guoqing] Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Chen, Tao; Yang, Jing; Wang, Dayan; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China; [Chen, Tao; Yang, Jing; Wang, Dayan; Shu, Yuelong] Natl Hlth & Family Planning Commiss, Key Lab Med Virol, Beijing, Peoples R China; [Yang, Yang] Univ Florida, Dept Biostat, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Yang, Yang] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Central South University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hu, GQ (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.; Shu, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China.; Shu, YL (corresponding author), Natl Hlth & Family Planning Commiss, Key Lab Med Virol, Beijing, Peoples R China.	huguoqing009@gmail.com; yshu@cnic.org.cn		Hu, Guoqing/0000-0002-5002-8015				[Anonymous], 2011, THE NATIONAL; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Blyth CC, 2016, EURO SURVEILL, V21; Chinese Center for Disease Control and Prevention, 2014, SURV REP NOT INF DIS; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Du XJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1710; Gravetter F.J., 2014, ESSENTIALS STAT BEHA, P249; Jia HP, 2011, NAT MED, V17, P520, DOI 10.1038/nm0511-520a; Miller MR, 2015, J INFECT DIS, V212, P1604, DOI 10.1093/infdis/jiv264; National Health and Family Planning Commission of the People's Republic of China, 2010, NOT OFF MIN HLTH ISS; OBrien SJ, 1997, PUBLIC HEALTH, V111, P255, DOI 10.1016/S0033-3506(97)00044-9; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Shah SC, 2015, INFECT CONT HOSP EP, V36, P241, DOI 10.1017/ice.2014.64; Shu Yue-Long, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P334; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; Singh BK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-726; Unkel S, 2012, J R STAT SOC A STAT, V175, P49, DOI 10.1111/j.1467-985X.2011.00714.x; Vega T, 2015, INFLUENZA OTHER RESP, V9, P234, DOI 10.1111/irv.12330; Wang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119923; WHO, 2014, INFL SEAS; World Health Organization, 2014, WHO GLOB EP SURV STA; Yang P, 2009, EMERG INFECT DIS, V15, P1603, DOI 10.3201/eid1510.081040; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Zou JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058434	24	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202880	10.1371/journal.pone.0202880	http://dx.doi.org/10.1371/journal.pone.0202880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169543	gold, Green Submitted, Green Published			2022-12-27	WOS:000443374400015
J	Rodriguez-Alonso, L; Rodriguez-Moranta, F; Arajol, C; Gilabert, P; Serra, K; Martin, A; Ibanez-Sanz, G; Moreno, V; Guardiola, J				Rodriguez-Alonso, Lorena; Rodriguez-Moranta, Francisco; Arajol, Claudia; Gilabert, Pau; Serra, Katja; Martin, Albert; Ibanez-Sanz, Gemma; Moreno, Victor; Guardiola, Jordi			Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients	PLOS ONE			English	Article							OCCULT BLOOD-TESTS; CANCER; POPULATION; COLONOSCOPY; OVERGROWTH; HEMOGLOBIN; INJURY	Background The faecal immunochemical test (FIT) is used in colorectal cancer (CRC) screening and for the detection of advanced colorectal neoplasia (AN) in symptomatic patients, but its accuracy could be improved. Our objective was to assess the impact of proton pump inhibitors (PPI) on the accuracy of the FIT in the detection of AN, namely advanced colorectal adenoma and CRC. Methods and findings We performed a prospective study of 1002 individuals referred for a diagnostic colonoscopy at Bellvitge University Hospital from September 2011 through to October 2012. An exhaustive interview was performed by a gastroenterologist, prescription drug dispensing database was reviewed and the patient was given a FIT prior to colonoscopy. The positivity threshold of FIT used was >= 20 mu g Hb/g feces and the main outcome was AN. AN was detected in 13.2% (133) of patients. The accuracy of FIT for detecting AN in the PPI users and non-PPI users were: sensitivity 43.0% vs 65.6%, P = 0.009; specificity 86.9% vs 92.3%, P = 0.010; and, predictive positive value 34.4% vs 55.5%, P = 0.007, respectively. In multivariate analysis, adjusting for potential confounders, PPIs were associated with false positives in AN detection by FIT (OR 1.63 CI 95% 1.02-2.59, P < 0.037). The ROC curve for the FIT in the detection of AN in the PPI users and non-PPI users was 0.68 (CI 95% 0.61-0.76) and 0.85 (CI 95% 0.79-0.90). Conclusions PPI therapy reduces the accuracy of FIT for detecting AN in symptomatic patients.	[Rodriguez-Alonso, Lorena; Rodriguez-Moranta, Francisco; Arajol, Claudia; Gilabert, Pau; Serra, Katja; Martin, Albert; Ibanez-Sanz, Gemma; Guardiola, Jordi] Univ Hosp Bellvitge IDIBELL, Dept Gastroenterol & Hepatol, Barcelona, Spain; [Ibanez-Sanz, Gemma; Moreno, Victor] IDIBELL, Catalan Inst Oncol, Canc Prevent & Control Programme, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Guardiola, J (corresponding author), Univ Hosp Bellvitge IDIBELL, Dept Gastroenterol & Hepatol, Barcelona, Spain.	jguardiola@bellvitgehospital.cat	Rodriguez-Moranta, Francisco/AAB-8082-2019; Moreno, Victor/A-1697-2010	Rodriguez-Moranta, Francisco/0000-0003-4025-5510; Moreno, Victor/0000-0002-2818-5487; MARTIN-CARDONA, ALBERT/0000-0002-7090-0106; Guardiola, Jordi/0000-0002-0464-241X; Rodriguez Alonso, Lorena/0000-0003-0498-4804; Ibanez Sanz, Gemma/0000-0001-6071-7343	Societat Catalana de Digestolologia (SCD), Catalonia, Spain; Instituto de Salud Carlos III, FIS grants [PI11/01439, PI11/01593]	Societat Catalana de Digestolologia (SCD), Catalonia, Spain; Instituto de Salud Carlos III, FIS grants	This work was supported by a grant from the Societat Catalana de Digestolologia (SCD), Catalonia, Spain. Also the Instituto de Salud Carlos III, FIS grants PI11/01439 and PI11/01593. The sponsor of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Abraham NS, 2012, CURR OPIN GASTROEN, V28, P615, DOI 10.1097/MOG.0b013e328358d5b9; Allison JE, 2014, GUT LIVER, V8, P117, DOI 10.5009/gnl.2014.8.2.117; Cordoba Rodrigo, 2014, Aten Primaria, V46 Suppl 4, P16, DOI 10.1016/S0212-6567(14)70048-4; Cubiella J, 2014, COLORECTAL DIS, V16, pO273, DOI 10.1111/codi.12569; de Wijkerslooth TR, 2012, AM J GASTROENTEROL, V107, P1570, DOI 10.1038/ajg.2012.249; Foltz E, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12269; Freedberg DE, 2014, CLIN LAB MED, V34, P771, DOI 10.1016/j.cll.2014.08.008; Godber IM, 2016, CLIN CHEM LAB MED, V54, P595, DOI 10.1515/cclm-2015-0617; Graser A, 2009, GUT, V58, P241, DOI 10.1136/gut.2008.156448; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Jacobs C, 2013, ALIMENT PHARM THER, V37, P1103, DOI 10.1111/apt.12304; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Lombardo L, 2010, CLIN GASTROENTEROL H, V8, P504, DOI 10.1016/j.cgh.2009.12.022; Auge JM, 2016, CLIN CHEM LAB MED, V54, P125, DOI 10.1515/cclm-2015-0388; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; National Institute for Health and Care Excellence, 2011, DIAGN MAN COL CANC; Pallarito K., 2009, US NEWS WORLD REPORT; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rodriguez-Alonso L, 2015, DIGEST LIVER DIS, V47, P797, DOI 10.1016/j.dld.2015.05.004; Sanz G, 2016, DIGEST LIVER DIS, V48, P1249, DOI [10.1016/j.dld.2016.06.011, DOI 10.1016/J.DLD.2016.06.011]; Schoenfeld AJ, 2016, JAMA INTERN MED, V176, P172, DOI 10.1001/jamainternmed.2015.7927; Symonds EL, 2015, J MED SCREEN, V22, P187, DOI 10.1177/0969141315584783; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; VERDU E, 1994, GUT, V35, P455, DOI 10.1136/gut.35.4.455; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126432; Washio E, 2016, CLIN GASTROENTEROL H, V14, P809, DOI 10.1016/j.cgh.2015.10.022; Westwood M, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21330; Wilschut JA, 2011, GASTROENTEROLOGY, V141, P1648, DOI 10.1053/j.gastro.2011.07.020; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9	30	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203359	10.1371/journal.pone.0203359	http://dx.doi.org/10.1371/journal.pone.0203359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169524	Green Submitted, Green Published, gold			2022-12-27	WOS:000443374400036
J	Carretero, GPB; Vicente, EF; Cilli, EM; Alvarez, CM; Jenssen, H; Schreier, S				Carretero, Gustavo P. B.; Vicente, Eduardo F.; Cilli, Eduardo M.; Alvarez, Carlos M.; Jenssen, Havard; Schreier, Shirley			Dissecting the mechanism of action of actinoporins. Role of the N-terminal amphipathic alpha-helix in membrane binding and pore activity of sticholysins I and II	PLOS ONE			English	Article							ANEMONE STICHODACTYLA-HELIANTHUS; CYTOLYSIN EQUINATOXIN-II; MINIPROTEIN STRUCTURE PREDICTION; SEA-ANEMONE; FORMING TOXIN; LIPID-MEMBRANES; INFRARED-SPECTROSCOPY; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; HEMOLYTIC-ACTIVITY	Actinoporins sticholysin I and sticholysin II (St I, St II) are proposed to lyse model and biomembranes via toroidal pore formation by their N-terminal domain. Based on the hypothesis that peptide fragments can reproduce the structure and function of this domain, the behavior of peptides containing St I residues 12-31 (StI(12)(-)(31)), St II residues 11-30 (StII(11)(-)(30)), and its TOAC-labeled analogue (N-TOAC-StII(11)(-)(30)) was examined. Molecular modeling showed a good match with experimental structures, indicating amphipathic alpha-helices in the same regions as in the toxins. CD spectra revealed that the peptides were essentially unstructured in aqueous solution, acquiring alpha-helical conformation upon interaction with micelles and large unilamellar vesicles (LUV) of variable lipid composition. Fluorescence quenching studies with NBD-containing lipids indicated that N-TOAC-StII(11)(-)(30)'s nitroxide moiety is located in the membranes polar head group region. Pyrene-labeled phospholipid inter-leaflet redistribution suggested that the peptides form toroidal pores, according to the mechanism of action proposed for the toxins. Binding occurred only to negatively charged LUV, indicating the importance of electrostatic interactions; in contrast the peptides bound to both negatively charged and zwitterionic micelles, pointing to a lesser influence of these interactions. In addition, differences between bilayers and micelles in head group packing and in curvature led to differences in peptide-membrane interaction. We propose that the peptides topography in micelles resembles that of the toxins in the toroidal pore. The peptides mimicked the toxins permeabilizing activity, St II peptides being more effective than StI(12)(-)(31). To our knowledge, this is the first demonstration that differences in the toxins N-terminal amphipathic alpha-helix play a role in the difference between St I and St II activities.	[Carretero, Gustavo P. B.; Schreier, Shirley] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Carretero, Gustavo P. B.; Jenssen, Havard] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Vicente, Eduardo F.] State Univ Sao Paulo, Fac Sci & Engn, Tupa, Brazil; [Cilli, Eduardo M.] State Univ Sao Paulo, Inst Chem, Araraquara, Brazil; [Alvarez, Carlos M.] Univ Havana, Ctr Prot Studies, Havana, Cuba	Universidade de Sao Paulo; Roskilde University; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidad de la Habana	Schreier, S (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.	schreier@iq.usp.br	Cilli, Eduardo Maffud/K-1857-2019; Cilli, Eduardo Maffud/B-9130-2012; Schreier, Shirley/F-7001-2014; Vicente, Eduardo Festozo/Y-2439-2019; Carretero, Gustavo/M-5352-2018	Cilli, Eduardo Maffud/0000-0002-4767-0904; Cilli, Eduardo Maffud/0000-0002-4767-0904; Vicente, Eduardo Festozo/0000-0002-9154-3574; Carretero, Gustavo/0000-0001-7776-6256; Jenssen, Havard/0000-0003-0007-0335	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by grants to Shirley Schreier and to Eduardo M. Cilli from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br), to Shirley Schreier and to Eduardo M. Cilli from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), to Shirley Schreier from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) through a Program between the Brazilian and Cuban Ministries of Education to support the visits of the Cuban researcher, Dr. Carlos M. Alvarez, to Havard Jenssen from Teknologi og Produktion, Det Frie Forskningsrad. Ph.D. fellowships were awarded to Gustavo P.B. Carretero and Eduardo F. Vicente by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br). Gustavo P.B. Carretero was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) to do part of his doctorate in the laboratory of Dr. Havard Jenssen.	Alegre-Cebollada J, 2007, BIOPHYS J, V93, P3191, DOI 10.1529/biophysj.106.102566; Almeida PF, 2012, BBA-BIOMEMBRANES, V1818, P178, DOI 10.1016/j.bbamem.2011.07.019; Alvarez C, 2003, CHEM PHYS LIPIDS, V122, P97, DOI 10.1016/S0009-3084(02)00181-0; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1997, PROTEIN ENG, V10, P751, DOI 10.1093/protein/10.7.751; Antonini V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110824; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Atherton E, 1989, F MOC SOLID PHASE PE; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bozelli JC, 2012, CHEM PHYS LIPIDS, V165, P365, DOI 10.1016/j.chemphyslip.2011.12.005; Carretero GPB, 2018, BBA-BIOMEMBRANES, V1860, P1502, DOI 10.1016/j.bbamem.2018.05.003; Casallanovo F, 2006, BIOPOLYMERS, V84, P169, DOI 10.1002/bip.20374; Castrillo I, 2010, PROTEINS, V78, P1959, DOI 10.1002/prot.22712; Cilli EM, 2007, TOXICON, V50, P1201, DOI 10.1016/j.toxicon.2007.07.013; de los Rios V, 1999, FEBS LETT, V455, P27, DOI 10.1016/S0014-5793(99)00846-7; de Oliveira AL, 2018, PEPTIDE SCI, V110, DOI 10.1002/bip.23097; Drechsler A, 2006, BIOCHEMISTRY-US, V45, P1818, DOI 10.1021/bi052166o; Drechsler A, 2009, EUR BIOPHYS J BIOPHY, V39, P121, DOI 10.1007/s00249-009-0445-x; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Ghosh T, 2003, BIOPHYS J, V85, P3187, DOI 10.1016/S0006-3495(03)74736-5; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Gutierrez-Aguirre I, 2004, BIOCHEM J, V384, P421, DOI 10.1042/BJ20040601; Haldar S, 2011, J PHYS CHEM B, V115, P5693, DOI 10.1021/jp200255e; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Huerta V, 2001, TOXICON, V39, P1253, DOI 10.1016/S0041-0101(00)00247-6; Hunter HN, 2005, ANTIMICROB AGENTS CH, V49, P3387, DOI 10.1128/AAC.49.8.3387-3395.2005; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kristan K, 2007, FEBS J, V274, P539, DOI 10.1111/j.1742-4658.2006.05608.x; Kumar P, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010004; Lanio ME, 2001, TOXICON, V39, P187, DOI 10.1016/S0041-0101(00)00106-9; LONDON E, 1981, BIOCHEMISTRY-US, V20, P1932, DOI 10.1021/bi00510a032; Lopez-Castilla A, 2014, PROTEINS, V82, P1022, DOI 10.1002/prot.24475; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; MANCHENO JM, 2011, BIOCHIM BIOPHYS ACTA, V1545, P122; Manzini MC, 2014, BBA-BIOMEMBRANES, V1838, P1985, DOI 10.1016/j.bbamem.2014.04.004; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Menestrina G, 1999, BIOCHEM BIOPH RES CO, V254, P174, DOI 10.1006/bbrc.1998.9898; Miles AJ, 2008, BBA-BIOMEMBRANES, V1778, P2091, DOI 10.1016/j.bbamem.2008.04.001; Mojsoska B, 2015, PHARMACEUTICALS-BASE, V8, P366, DOI 10.3390/ph8030366; Muller P, 2000, CHEM PHYS LIPIDS, V106, P89, DOI 10.1016/S0009-3084(00)00134-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355; Rojko N, 2016, BBA-BIOMEMBRANES, V1858, P446, DOI 10.1016/j.bbamem.2015.09.007; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Ros U, 2015, BIOCHIMIE, V116, P70, DOI 10.1016/j.biochi.2015.06.024; Ros U, 2013, BIOPOLYMERS, V100, P337, DOI 10.1002/bip.22211; Ros U, 2011, J BIOSCIENCES, V36, P781, DOI 10.1007/s12038-011-9156-4; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Santos TL, 2016, BIOPHYS J, V111, P2676, DOI 10.1016/j.bpj.2016.10.034; Schreier Shirley, 2012, Biophys Rev, V4, P45, DOI 10.1007/s12551-011-0064-5; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Tanaka K, 2015, NAT COMMUN, V6; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Walther TH, 2014, CURR OPIN STRUC BIOL, V27, P63, DOI 10.1016/j.sbi.2014.05.003	64	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202981	10.1371/journal.pone.0202981	http://dx.doi.org/10.1371/journal.pone.0202981			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161192	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900059
J	Lynn, H; Sun, XG; Ayshiev, D; Siegler, JH; Rizzo, AN; Karnes, JH; Garay, MG; Wang, T; Casanova, N; Camp, SM; Ellis, NA; Garcia, JGN				Lynn, Heather; Sun, Xiaoguang; Ayshiev, Djanybek; Siegler, Jessica H.; Rizzo, Alicia N.; Karnes, Jason H.; Garay, Manuel Gonzales; Wang, Ting; Casanova, Nancy; Camp, Sara M.; Ellis, Nathan A.; Garcia, Joe G. N.			Single nucleotide polymorphisms in the MYLKP1 pseudogene are associated with increased colon cancer risk in African Americans	PLOS ONE			English	Article							LIGHT-CHAIN-KINASE; COLORECTAL-CANCER; ENDOGENOUS RNA; GENE; EXPRESSION; MOUSE; CELLS; PROMOTER; VARIANT; 8Q24	Introduction Pseudogenes are paralogues of functional genes historically viewed as defunct due to either the lack of regulatory elements or the presence of frameshift mutations. Recent evidence, however, suggests that pseudogenes may regulate gene expression, although the functional role of pseudogenes remains largely unknown. We previously reported that MYLKP1, the pseudogene of MYLK that encodes myosin light chain kinase (MLCK), is highly expressed in lung and colon cancer cell lines and tissues but not in normal lung or colon. The MYLKP1 promoter is minimally active in normal bronchial epithelial cells but highly active in lung adenocarcinoma cells. In this study, we further validate MYLKP1as an oncogene via elucidation of the functional role of MYLKP1 genetic variants in colon cancer risk. Methods Proliferation and migration assays were performed in MYLKP/-transfected colon and lung cancer cell lines (H441, A549) and commercially-available normal lung and colon cells. Fourteen MYLKP1 SNPs (MAFs >0.01) residing within the 4 kb MYLKP1 promoter region, the core 1.4 kb of MYLKP1 gene, and a 4 kb enhancer region were selected and genotyped in a colorectal cancer cohort. MYLKP1 SNP influences on activity of MYLKP1 promoter (2kb) was assessed by dual luciferase reporter assay. Results Cancer cell lines, H441 and A549, exhibited increased MYLKP1 expression, increased MYLKP1 luciferase promoter activity, increased proliferation and migration. Genotyping studies identified two MYLKP1 SNPs (rs12490683; rs12497343) that significantly increase risk of colon cancer in African Americans compared to African American controls. Rs12490683 and rs12497343 further increase MYLKP1 promoter activity compared to the wild type MYLKP1 promoter. Conclusion MYLKP1 is a cancer-promoting pseudogene whose genetic variants differentially enhance cancer risk in African American populations.	[Lynn, Heather; Sun, Xiaoguang; Garay, Manuel Gonzales; Wang, Ting; Casanova, Nancy; Camp, Sara M.; Garcia, Joe G. N.] Univ Arizona Hlth Sci, Dept Med, Tucson, AZ 85721 USA; [Lynn, Heather; Garcia, Joe G. N.] Univ Arizona, Grad Interdisciplinary Program Physiol Sci, Tucson, AZ 85721 USA; [Ayshiev, Djanybek; Siegler, Jessica H.; Rizzo, Alicia N.] Univ Illinois, Dept Med, Chicago, IL USA; [Karnes, Jason H.] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA; [Ellis, Nathan A.] Univ Arizona Hlth Sci, Dept Cell & Mol Med, Tucson, AZ USA	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Arizona; University of Arizona Health Sciences	Garcia, JGN (corresponding author), Univ Arizona Hlth Sci, Dept Med, Tucson, AZ 85721 USA.; Garcia, JGN (corresponding author), Univ Arizona, Grad Interdisciplinary Program Physiol Sci, Tucson, AZ 85721 USA.	skipgarcia@email.arizona.edu	Casanova, Nancy Gonzalez/L-5228-2019; Casanova, Nancy/ABA-6498-2020	Lynn, Heather/0000-0001-8259-2326; Gonzalez-Garay, Manuel/0000-0003-3412-0353	NHLBI NIH HHS [P01 HL126609, R01 HL091889] Funding Source: Medline; NIEHS NIH HHS [P30 ES006694] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL126609, R01HL091889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahuja N, 2007, ANN SURG ONCOL, V14, P411, DOI 10.1245/s10434-006-9130-9; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bosia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066609; Brand-Arpon V, 1999, GENOMICS, V56, P98, DOI 10.1006/geno.1998.5690; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; Christie JD, 2008, CRIT CARE MED, V36, P2794, DOI 10.1097/CCM.0b013e318186b843; Cui WJ, 2010, ACTA PHARMACOL SIN, V31, P725, DOI 10.1038/aps.2010.56; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Esposito F, 2014, ONCOTARGET, V5, P8341, DOI 10.18632/oncotarget.2202; Falush D, 2003, GENETICS, V164, P1567; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Garcia Joe G. N., 1996, Seminars in Thrombosis and Hemostasis, V22, P309, DOI 10.1055/s-2007-999025; Giorgi D, 2001, GENOMICS, V75, P49, DOI 10.1006/geno.2001.6571; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Han YJ, 2012, J MOL MED, V90, P299, DOI 10.1007/s00109-011-0820-9; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Kessler MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12521; Khan I, 2015, ELIFE, V4, DOI [10.7554/eLife.08245, DOI 10.7554/ELIFE.08245]; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kupfer SS, 2009, CARCINOGENESIS, V30, P1353, DOI 10.1093/carcin/bgp123; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; Liu JN, 2017, SCI REP-UK, V7, DOI 10.1038/srep41179; Sayagues JM, 2016, ONCOTARGET, V7, P72908, DOI 10.18632/oncotarget.12140; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Matsumura F, 2001, CELL STRUCT FUNCT, V26, P639, DOI 10.1247/csf.26.639; Matsushita I, 2002, J CLIN GASTROENTEROL, V35, P29, DOI 10.1097/00004836-200207000-00008; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Muro EM, 2011, BIOCHIMIE, V93, P1916, DOI 10.1016/j.biochi.2011.07.024; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2011, J INVEST DERMATOL, V131, P2497, DOI 10.1038/jid.2011.232; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Purcell S, AM J HUMAN GENETICS, V81; Robbins C, 2007, GENOME RES, V17, P1717, DOI 10.1101/gr.6782707; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tan X, 2014, TUMOR BIOL, V35, P12189, DOI 10.1007/s13277-014-2527-3; Verin AD, 1998, AM J RESP CELL MOL, V19, P767, DOI 10.1165/ajrcmb.19.5.3126; Wen YZ, 2012, RNA BIOL, V9, P27, DOI 10.4161/rna.9.1.18277; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; Yu G, 2014, MOL CANCER THER, V13, P3086, DOI 10.1158/1535-7163.MCT-14-0245; Zhang H, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691418; Zheng LF, 2015, BREAST CANCER RES TR, V150, P105, DOI 10.1007/s10549-015-3298-2; Zhou SG, 2014, J CANCER RES CLIN, V140, P1989, DOI 10.1007/s00432-014-1699-y; Zhou T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094325	49	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0200916	10.1371/journal.pone.0200916	http://dx.doi.org/10.1371/journal.pone.0200916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161129	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900005
J	Mirzaeimoghri, M; Martinez, AM; Panna, A; Bennett, EE; Lucotte, BM; DeVoe, DL; Wen, H				Mirzaeimoghri, Mona; Martinez, Alejandro Morales; Panna, Alireza; Bennett, Eric E.; Lucotte, Bertrand M.; DeVoe, Don L.; Wen, Han			Nano-printed miniature compound refractive lens for desktop hard x-ray microscopy	PLOS ONE			English	Article								Hard x-ray lenses are useful elements in x-ray microscopy and in creating focused illumination for analytical applications such as x-ray fluorescence imaging. Recently, polymer compound refractive lenses for focused illumination in the soft x-ray regime (< 10 keV) have been created with nano-printing. However, there are no such lenses yet for hard x-rays, particularly of short focal lengths for benchtop microscopy. We report the first instance of a nano-printed lens for hard x-ray microscopy, and evaluate its imaging performance. The lens consists of a spherically focusing compound refractive lens designed for 22 keV photon energy, with a tightly packed structure to provide a short total length of 1.8 mm and a focal length of 21.5 mm. The resulting lens technology was found to enable benchtop microscopy at 74x magnification and 1.1 pm de-magnified image pixel size at the object plane. It was used to image and evaluate the focal spots of tungsten-anode micro-focus x-ray sources. The overall system resolution with broadband illumination from a tungsten-anode x-ray tube at 30 kV and 10 mm focal distance was measured to be 2.30 +/- 0.22 mu m.	[Mirzaeimoghri, Mona; Martinez, Alejandro Morales; Panna, Alireza; Bennett, Eric E.; Wen, Han] NHLBI, Imaging Phys Lab, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Mirzaeimoghri, Mona; DeVoe, Don L.] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Lucotte, Bertrand M.] NHLBI, Cardiac Energet Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wen, H (corresponding author), NHLBI, Imaging Phys Lab, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	han.wen@nih.gov	DeVoe, Don L/A-2891-2011; Bennett, Eric/Q-6451-2019; Bennett, Eric E/F-1070-2018	DeVoe, Don L/0000-0002-7740-9993; Bennett, Eric/0000-0001-6577-9869; Bennett, Eric E/0000-0001-6577-9869; Lucotte, Bertrand/0000-0002-1646-1384	Intramural Research Program of the National Heart, Lung and Blood Institute, National Institutes of Health; A. James Clark School of Engineering, Department of Mechanical Engineering, University of Maryland, College Park; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006171] Funding Source: NIH RePORTER	Intramural Research Program of the National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); A. James Clark School of Engineering, Department of Mechanical Engineering, University of Maryland, College Park; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work is funded by the Intramural Research Program of the National Heart, Lung and Blood Institute, National Institutes of Health, and the A. James Clark School of Engineering, Department of Mechanical Engineering, University of Maryland, College Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipov S, 2016, J SYNCHROTRON RADIAT, V23, P163, DOI 10.1107/S1600577515020639; Aristov V, 2000, APPL PHYS LETT, V77, P4058, DOI 10.1063/1.1332401; Aristov VV, 2000, OPT COMMUN, V177, P33, DOI 10.1016/S0030-4018(00)00580-0; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; Dudchik YI, 1999, NUCL INSTRUM METH A, V421, P361, DOI 10.1016/S0168-9002(98)01269-8; Dudchik YI, 2007, SPECTROCHIM ACTA B, V62, P598, DOI 10.1016/j.sab.2007.05.009; Gary CK, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734895; GIBSON SF, 1989, J OPT SOC AM A, V6, P1357, DOI 10.1364/JOSAA.6.001357; Jach T, INT SOC OPTICS PHOTO, P38; Lengeler B, 2005, J PHYS D APPL PHYS, V38, pA218, DOI 10.1088/0022-3727/38/10A/042; Nohammer B, 2003, J SYNCHROTRON RADIAT, V10, P168, DOI 10.1107/S0909049502019532; Petrov AK, 2017, OPT EXPRESS, V25, P3256; Schroer CG, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2053350; Schroer CG, 2002, P SOC PHOTO-OPT INS, V4783, P10, DOI 10.1117/12.451013; Snigirev A, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012072; Snigirev A, 1996, NATURE, V384, P49, DOI 10.1038/384049a0; Terentyev S, 2017, J SYNCHROTRON RADIAT, V24, P103, DOI 10.1107/S1600577516017331	17	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203319	10.1371/journal.pone.0203319	http://dx.doi.org/10.1371/journal.pone.0203319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161240	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900111
J	Koussemou, M; Lorenz, K; Klotz, KN				Koussemou, Marthe; Lorenz, Kristina; Klotz, Karl-Norbert			The A(2B) adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1	PLOS ONE			English	Article							TUMOR-GROWTH INHIBITION; MEDIATED INHIBITION; PROTEIN-KINASE; CAMP; TARGET; SIGNAL; EXPRESSION; APOPTOSIS; THERAPY; CALCIUM	It was previously shown that the estrogen-receptor negative breast cancer cell line MBA-MD-231 expresses high levels of A(2B) adenosine receptors as the sole adenosine receptor subtype. These receptors couple to both, stimulation of adenylyl cyclase and a Ca2+ signal. In order to establish a potential role of A(2B) adenosine receptors in tumor growth and development MAPK signaling was investigated in these breast cancer cells. Although it is known that A(2B) adenosine receptors may stimulate MAPK it was found that in MBA-MD-231 cells ERK1/2 phosphorylation is reduced upon agonist-stimulation of A(2B) adenosine receptors. This reduction is also triggered by forskolin, but abolished by the PKA inhibitor H89, suggesting an important role for the cAMP-PKA pathway. Likewise, a role for intracellular Ca2+ was established as the Ca2+ chelator 1,2-bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid, tetraacetoxymethyl ester (BAPTA-AM) abolished the reduction of ERK1/2 phosphorylation triggered by A(2B) stimulation. It was shown that various pathways downstream from A(2B) adenosine receptors resulted in a stimulation of MAPK phosphatase-1 (MKP-1) which dephosphorylates phospho ERK1/2, and thus plays a critical role in the regulation of the phosphorylation state of ERK1/2. The reduction of ERK1/2 phosphorylation mediated by A(2B) adenosine receptors might provide an interesting approach for adjuvant treatment leading to reduced growth of certain tumors expressing the A(2B) subtype.	[Koussemou, Marthe; Lorenz, Kristina; Klotz, Karl-Norbert] Univ Wurzburg, Inst Pharmakol & Toxikol, Wurzburg, Germany; [Lorenz, Kristina] Leibniz Inst Analyt Wissensch ISAS eV, Bunsen Dortmund, Germany; [Lorenz, Kristina] West German Heart & Vasc Ctr Essen, Essen, Germany	University of Wurzburg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS)	Klotz, KN (corresponding author), Univ Wurzburg, Inst Pharmakol & Toxikol, Wurzburg, Germany.	klotz@toxi.uni-wuerzburg.de	Lorenz, Kristina/F-3522-2016	Lorenz, Kristina/0000-0002-5747-2207; Klotz, Karl-Norbert/0000-0003-3553-3205				Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brion L, 2011, ENDOCRINOLOGY, V152, P2665, DOI 10.1210/en.2011-0021; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Fishman P, 2009, Handb Exp Pharmacol, P399, DOI 10.1007/978-3-540-89615-9_14; Fredholm B. B., 2001, PHARMACOL REV, V63, P1; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Fredholm BB, 2010, EXP CELL RES, V316, P1284, DOI 10.1016/j.yexcr.2010.02.004; Galaz-Montoya M, 2017, J BIOL CHEM, V292, P9967, DOI 10.1074/jbc.M117.787119; Gessi S, 2011, ADV PHARMACOL, V61, P41, DOI 10.1016/B978-0-12-385526-8.00002-3; Gessi S, 2011, BBA-BIOMEMBRANES, V1808, P1400, DOI 10.1016/j.bbamem.2010.09.020; Haneda M, 1996, KIDNEY INT, V50, P384, DOI 10.1038/ki.1996.327; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Li RC, 2004, CIRC RES, V94, P759, DOI 10.1161/01.RES.0000121568.40692.97; Madi L, 2003, J BIOL CHEM, V278, P42121, DOI 10.1074/jbc.M301243200; Madi L, 2004, CLIN CANCER RES, V10, P4472, DOI 10.1158/1078-0432.CCR-03-0651; Merighi S, 2003, PHARMACOL THERAPEUT, V100, P31, DOI 10.1016/S0163-7258(03)00084-6; Naviglio S, 2009, CANCER BIOL THER, V8, P1183, DOI 10.4161/cbt.8.12.8562; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Ohana G, 2001, J CELL PHYSIOL, V186, P19, DOI 10.1002/1097-4652(200101)186:1<19::AID-JCP1011>3.0.CO;2-3; Pandey KN, 2000, BIOCHEM BIOPH RES CO, V271, P374, DOI 10.1006/bbrc.2000.2627; Panjehpour M, 2005, BRIT J PHARMACOL, V145, P211, DOI 10.1038/sj.bjp.0706180; Ruppert C, 2013, P NATL ACAD SCI USA, V110, P7440, DOI 10.1073/pnas.1221999110; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Scimeca JC, 1997, ONCOGENE, V15, P717, DOI 10.1038/sj.onc.1201231; Tuglu MM, 2018, MOL MED REP, V17, P2033, DOI 10.3892/mmr.2017.8092	27	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202914	10.1371/journal.pone.0202914	http://dx.doi.org/10.1371/journal.pone.0202914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157211	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400075
J	McNairy, ML; Jannat-Khah, D; Pape, JW; Marcelin, A; Joseph, P; Mathon, JE; Koenig, S; Wells, M; Fitzgerald, DW; Evans, A				McNairy, Margaret L.; Jannat-Khah, Deanna; Pape, Jean W.; Marcelin, Adias; Joseph, Patrice; Mathon, Jean Edward; Koenig, Serena; Wells, Martin; Fitzgerald, Daniel W.; Evans, Arthur			Predicting death and lost to follow-up among adults initiating antiretroviral therapy in resource-limited settings: Derivation and external validation of a risk score in Haiti	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORD; ADVANCED HIV-INFECTION; SUB-SAHARAN AFRICA; TREATMENT OUTCOMES; MORTALITY; CARE; TUBERCULOSIS; AIDS; PREVENTION; IMPACT	Background Over 18 million adults have initiated life-saving antiretroviral therapy (ART) in resource-poor settings; however, mortality and lost-to-follow-up rates continue to be high among patients in their first year after treatment start. Clinical decision tools are needed to identify patients at high risk for poor outcomes in order to provide individualized risk assessment and intervention. This study aimed to develop and externally validate risk prediction tools that estimate the probability of dying or of being lost to follow-up (LTF) during the year after starting ART. Methods We used a derivation cohort of 7,031 adults age 15-70 years initiating ART from 2007 to 2013 at 6 clinics in Haiti; 242 (3.5%) had documented death and 1,521 (21.6%) were LTF at 1 year after starting ART. The following routinely collected data were used as predictors in two logistic regression models (one to predict death and another to predict LTF): age, gender, weight, CD4 count, WHO Stage, and diagnosis of tuberculosis (TB). The validation cohort consisted of 1,835 adults initiating ART at a different HIV clinic in Haiti during 2012. We assessed model discrimination by measuring the C-statistic, and measured model calibration by how closely the predicted probabilities approximated actual probabilities of the two outcomes. We derived a nomogram and a point-based risk score from the predictive models. Findings The model predicting death within the year after starting ART had a C-statistic of 0.75 (95% CI 0.74 to 0.81). There was no evidence for significant overfitting and the predictions were well calibrated. The strongest predictors of 1-year mortality were male gender, low weight, low CD4 count, advanced WHO stage, and the absence of TB. In the validation cohort, the C-statistic was 0.69 (95% CI 0.59 to 0.77). A point-based risk score for death had a C-statistic 0.73 (95% CI 0.69 to 0.76) and categorizes patients as low risk (< 2% risk of death), average risk (3-4%), and high-risk (8-10%) and very high-risk (14-19%) with likelihood ratios to be used in settings where the baseline risk is different from our study population. The model predicting LTF did not discriminate well (C-statistic 0.59). Conclusions A simple risk-score using routinely collected data can predict 1-year mortality after ART initiation for HIV-positive adults in Haiti. However, predicting lost to follow-up using routinely collected data was not as successful. The next step is to assess whether use of this risk score can identify patients who need tailored services to reduce mortality in resource-poor settings such as Haiti.	[McNairy, Margaret L.; Jannat-Khah, Deanna; Evans, Arthur] Weill Cornell Med, Div Gen Internal Med, New York, NY 10065 USA; [McNairy, Margaret L.; Fitzgerald, Daniel W.] Weill Cornell Med, Ctr Global Hlth, New York, NY 10065 USA; [Pape, Jean W.; Marcelin, Adias; Joseph, Patrice; Mathon, Jean Edward] Haitian Grp Study Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti; [Koenig, Serena] Harvard Med Sch, Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA USA; [Wells, Martin] Cornell Univ, Dept Stat Sci, Ithaca, NY USA	Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University	McNairy, ML (corresponding author), Weill Cornell Med, Div Gen Internal Med, New York, NY 10065 USA.; McNairy, ML (corresponding author), Weill Cornell Med, Ctr Global Hlth, New York, NY 10065 USA.	mam9365@med.cornell.edu	Jannat-Khah, Deanna/L-9701-2019	Jannat-Khah, Deanna/0000-0002-1091-379X; Wells, Martin/0000-0002-9750-9529	FIC NIH HHS [D43 TW010062] Funding Source: Medline; NIAID NIH HHS [K24 AI098627] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI098627] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal M, 2016, JAIDS-J ACQ IMM DEF, V73, pE33, DOI 10.1097/QAI.0000000000001117; Balkus JE, 2016, JAIDS-J ACQ IMM DEF, V72, P333, DOI 10.1097/QAI.0000000000000974; Bassett IV, 2010, CLIN INFECT DIS, V51, P823, DOI 10.1086/656282; Bengtson AM, 2016, AIDS CARE, V28, P1035, DOI 10.1080/09540121.2016.1144869; Boulle A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001718; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brown ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092606; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; Ellman T, 2015, NEW ENGL J MED, V372, P303, DOI 10.1056/NEJMp1414730; Fitzgerald DW, 2000, LANCET, V356, P1470, DOI 10.1016/S0140-6736(00)02870-1; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Hakim J, 2017, NEW ENGL J MED, V377, P233, DOI 10.1056/NEJMoa1615822; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Irungu EM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1899-y; Justice AC, 2013, JAIDS-J ACQ IMM DEF, V62, P149, DOI 10.1097/QAI.0b013e31827df36c; Kahle EM, 2013, JAIDS-J ACQ IMM DEF, V62, P339, DOI 10.1097/QAI.0b013e31827e622d; Koenig SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146903; Koenig SP, 2012, JAIDS-J ACQ IMM DEF, V59, pE60, DOI 10.1097/QAI.0b013e318245d3c1; Koenig SP, 2009, CLIN INFECT DIS, V48, P829, DOI 10.1086/597098; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Leger P, 2009, NEW ENGL J MED, V361, P828, DOI 10.1056/NEJMc0809485; Marcelin A, 2015, STUD HEALTH TECHNOL, V216, P883, DOI 10.3233/978-1-61499-564-7-883; Matheson AI, 2012, INT J MED INFORM, V81, P244, DOI 10.1016/j.ijmedinf.2012.01.011; McNairy ML, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002278; McNairy ML, 2015, JAIDS-J ACQ IMM DEF, V70, pE44, DOI 10.1097/QAI.0000000000000745; McNairy ML, 2012, AIDS, V26, P1735, DOI 10.1097/QAD.0b013e328355d67b; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Mocroft A, 2007, AIDS, V21, P1867, DOI 10.1097/QAD.0b013e328270b877; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Pierre S, 2016, NEW ENGL J MED, V374, P397, DOI 10.1056/NEJMc1508934; Puttkammer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112261; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Robbins GK, 2010, CLIN INFECT DIS, V50, P779, DOI 10.1086/650537; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; UNAIDS, 2014, UNAIDS COUNTR REP; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2006, AN THER HIV INT AD A; World Health Organization, 2015, CONS GUID US ANT DRU; World Health Organization, 2009, RAP ADV ANT THER HIV	48	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201945	10.1371/journal.pone.0201945	http://dx.doi.org/10.1371/journal.pone.0201945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157197	gold, Green Published, Green Submitted			2022-12-27	WOS:000443071400021
J	O'Brien, TG; Kinnaird, MF; Ekwanga, S; Wilmers, C; Williams, T; Oriol-Cotterill, A; Rubenstein, D; Frank, LG				O'Brien, Timothy G.; Kinnaird, Margaret F.; Ekwanga, Steven; Wilmers, Christopher; Williams, Terrie; Oriol-Cotterill, Alayne; Rubenstein, Daniel; Frank, Laurence G.			Resolving a conservation dilemma: Vulnerable lions eating endangered zebras	PLOS ONE			English	Article							PREY; DYNAMICS; YELLOWSTONE; CARNIVORES; PREDATORS; LANDSCAPE; LIVESTOCK; WILDLIFE; ECOLOGY; NEED	When predators are removed or suppressed for generations, prey populations tend to increase and when predators are re-introduced, prey densities should fall back to pre-control levels. In cases of apparent competition where there are alternate abundant and rare prey species, rare species may decline further than expected or disappear altogether. Recently, concern about the impact of recovering predator populations on wildlife in Laikipia County, Kenya, has led to questions of whether lions (Panthera leo, IUCN Red List Vulnerable) exert top-down pressure on Grevy's zebra (Equus grevyi, IUCN Red List Endangered). We examined effects of lion predation on Plain's zebra (E. quagga, IUCN Red List Near Threatened) and Grevy's zebra populations in a 2,105 km(2) area defined by lion movements. We used line transect surveys to estimate density of Grevy's (0.71/km(2)) and Plain's (15.9/ km(2)) zebras, and satellite telemetry to measure movements for lions and both zebras. We tracked lions to potential feeding sites to estimate predation rates on zebras. We compared field-based estimates of predation rates on both zebras to random gas models of encounters that result in predation to ask if lions prey preferentially on Grevy's zebra at a sufficient rate to drive population declines. Lions preyed on Grevy's zebra significantly less than expected in 15 of 16 (94%) scenarios considered and lions preyed on Plain's zebras as expected or significantly less than expected in 15 of 16 scenarios. Population trend of Grevy's zebra indicates that the Kenya population may be stabilizing. Recruitment rate to the population has tripled since 2004, making it unlikely that lions are having an impact on Grevy's zebras. In Laikipia County, competitive displacement by livestock (Livestock: Grevy's zebra ratio = 864: 1) and interference competition for grass with Plain's zebra (Plain's zebra: Grevy's zebra ratio = 22: 1) are most likely the predominant threats to Grevy's Zebra recovery.	[O'Brien, Timothy G.] Wildlife Conservat Soc, Global Programs, Bronx, NY 10460 USA; [O'Brien, Timothy G.; Kinnaird, Margaret F.; Rubenstein, Daniel] Mpala Res Ctr, Nanyuki, Kenya; [Ekwanga, Steven; Frank, Laurence G.] Living Lions, Nanyuki, Kenya; [Wilmers, Christopher] Univ Calif Santa Cruz, Dept Environm Studies, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Williams, Terrie] Univ Calif Santa Cruz, Ctr Ocean Hlth, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Oriol-Cotterill, Alayne] Ewaso Lions, Nairobi, Kenya; [Oriol-Cotterill, Alayne] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, England; [Rubenstein, Daniel] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Frank, Laurence G.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Wildlife Conservation Society; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Oxford; Princeton University; University of California System; University of California Berkeley	O'Brien, TG (corresponding author), Wildlife Conservat Soc, Global Programs, Bronx, NY 10460 USA.; O'Brien, TG (corresponding author), Mpala Res Ctr, Nanyuki, Kenya.	tobrien@wcs.org			NSF [DBI:0963022, DBI:1255913, IOB:9874523, IIS:0705822, IBN:030923]; Chester Zoo; Cleveland Metroparks Zoo; Disney Foundation; San Francisco Zoo; Meeker Family Fund; Banovich Wildscapes Foundation; Zeitz Foundation; Donald and Maureen Green Foundation; Wildlife Conservation Society; Australian 60 Minutes	NSF(National Science Foundation (NSF)); Chester Zoo; Cleveland Metroparks Zoo; Disney Foundation; San Francisco Zoo; Meeker Family Fund; Banovich Wildscapes Foundation; Zeitz Foundation; Donald and Maureen Green Foundation; Wildlife Conservation Society; Australian 60 Minutes	Funding was provided by: NSF grants DBI:0963022, DBI:1255913, IOB:9874523, IIS:0705822 and IBN:030923, Chester Zoo, Cleveland Metroparks Zoo, Disney Foundation, San Francisco Zoo, Meeker Family Fund, Banovich Wildscapes Foundation, Zeitz Foundation, Donald and Maureen Green Foundation, the Wildlife Conservation Society, Australian 60 Minutes, Bruce Ludwig, Frank Levinson, and Cindy Calderon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Anderson JJ, 2005, ECOL MODEL, V186, P196, DOI 10.1016/j.ecolmodel.2005.01.014; Anderson TM, 2010, ECOLOGY, V91, P1519, DOI 10.1890/09-0739.1; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; DENNEY RN, 1972, J RANGE MANAGE, V25, P415, DOI 10.2307/3896997; DOBSON AP, 1989, CONSERV BIOL, V3, P362, DOI 10.1111/j.1523-1739.1989.tb00242.x; ELLIOTT JP, 1977, CAN J ZOOL, V55, P1811, DOI 10.1139/z77-235; Ford AT, 2015, ECOLOGY, V96, P2705, DOI 10.1890/14-2056.1.sm; Ford AT, 2014, SCIENCE, V346, P346, DOI 10.1126/science.1252753; Frank L, 2003, WILDLIFE SOC B, V31, P309; Frank L., 2011, SMITHSONIAN CONTRIBU, V632; Georgiadis NJ, 2007, BIOL CONSERV, V137, P473, DOI 10.1016/j.biocon.2007.03.006; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; Hayward MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023607; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; IUCN, 2017, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.en2, DOI 10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.EN2]; Kinnaird M, 2012, SAMPLE COUNT AERIAL; Kinnaird MF, 2012, CONSERVATION BIOL; Kinnaird MF, 2000, MOVE WHY ANIMALS TRA; Kruuk H., 1972, THE SPOTTED HYENA; Lotka AJ, 1924, ELEMENTS PHYS BIOL; MILLS MGL, 1992, J ANIM ECOL, V61, P693, DOI 10.2307/5624; MITANI JC, 1991, ANIM BEHAV, V42, P33, DOI 10.1016/S0003-3472(05)80603-7; Napao MI, 2016, THESIS; Ng'weno CC, 2017, J MAMMAL, V98, P1078, DOI 10.1093/jmammal/gyx040; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; Oriol-Cotterill A, 2015, ANIM BEHAV, V101, P27, DOI 10.1016/j.anbehav.2014.11.020; PULLIAM HR, 1974, AM NAT, V108, P59, DOI 10.1086/282885; Ripple WJ, 2007, BIOL CONSERV, V138, P514, DOI 10.1016/j.biocon.2007.05.006; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rubenstein D.I., 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T7950A89624491.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T7950A89624491.EN]; Rubenstein DI, 2010, ADV STUD BEHAV, V42, P231, DOI 10.1016/S0065-3454(10)42007-0; Schaller G. B., 1972, SERENGETI LION STUDY; SKELLAM JG, 1958, BIOMETRICS, V14, P385, DOI 10.2307/2527881; Springer AM, 2008, MAR MAMMAL SCI, V24, P414, DOI 10.1111/j.1748-7692.2008.00185.x; Stephens D.W., 1986, pi; Terborgh J., 2010, TROPHIC CASCADES PRE; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; US Fish and Wildlife Service, 2007, REC PLAN SIERR NEV B; van Orsdal KG, 1984, AFRICAN J ECOLOGY, V22, P159; WASER PM, 1976, AM NAT, V110, P911, DOI 10.1086/283117; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; Young TP, 2007, OECOLOGIA, V109, P98	51	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201983	10.1371/journal.pone.0201983	http://dx.doi.org/10.1371/journal.pone.0201983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157200	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400023
J	Touquet, B; Pelissier, L; Cavailles, P; Yi, W; Bellini, V; Mercier, C; Cesbron-Delauw, MF; Boumendjel, A; Aldebert, D				Touquet, Bastien; Pelissier, Leonie; Cavailles, Pierre; Yi, Wei; Bellini, Valeria; Mercier, Corinne; Cesbron-Delauw, Marie-France; Boumendjel, Ahcene; Aldebert, Delphine			High-content imaging assay to evaluate Toxoplasma gondii infection and proliferation: A multiparametric assay to screen new compounds	PLOS ONE			English	Article							INHIBITION; DRUGS	Toxoplasma gondii is an intracellular protozoan parasite widely distributed in animals and humans. Infection of host cells and parasite proliferation are essential steps in Toxoplasma pathology. The objective of this study was to develop and validate a novel automatic High Content Imaging (HCI) assay to study T. gondii infection and proliferation. We tested various fluorescent markers and strategies of image analysis to obtain an automated method providing results comparable to those from gold standard infection and proliferation assays. No significant difference was observed between the results obtained from the HCI assay and the standard assays (manual fluorescence microscopy and incorporation of [ 3 H]-uracil). We developed here a robust and time-saving assay. This automated technology was then used to screen a library of compounds belonging to four classes of either natural compounds or synthetic derivatives. Inhibition of parasite proliferation and host cell toxicity were measured in the same assay and led to the identification of one hit, a thiosemicarbazone that allows important inhibition of Toxoplasma proliferation while being relatively safe for the host cells.	[Touquet, Bastien] Univ Grenoble Alpes, CNRS UMR 5309, INSERM U1209, Inst Adv Biosci,Team Membrane Dynam Parasite Host, Grenoble, France; [Pelissier, Leonie; Aldebert, Delphine] Univ Grenoble Alpes, CNRS UMR 5525, Equipe TheREx, Unite Tech Ingn Med & Complexite Informat Math &, Grenoble, France; [Pelissier, Leonie; Yi, Wei; Boumendjel, Ahcene] Univ Grenoble Alpes, CNRS UMR 5063, Dept Pharmacochim Mol, Grenoble, France; [Cavailles, Pierre] Univ Grenoble Alpes, CNRS UMR 5525, Equipe BNI, Unite Tech Ingn Med & Complexite Informat Math &, Grenoble, France; [Bellini, Valeria] Univ Grenoble Alpes, CNRS UMR 5309, INSERM U1209, Inst Adv Biosci,Team Host Pathogen Interact & Imm, Grenoble, France; [Mercier, Corinne] Univ Grenoble Alpes, CNRS UMR 5525, Equipe GEM, Unite Tech Ingn Med & Complexite Informat Math &, Grenoble, France; [Pelissier, Leonie] Univ Geneva, Ecole Pharm Geneve Lausanne, Sect Sci Pharmaceut, Phytochim & Prod Nat Bioactifs, Geneva, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); University of Geneva	Aldebert, D (corresponding author), Univ Grenoble Alpes, CNRS UMR 5525, Equipe TheREx, Unite Tech Ingn Med & Complexite Informat Math &, Grenoble, France.	delphine.aldebert@univ-grenoble-alpes.fr	Boumendjel, Ahcene/AFN-9621-2022; Touquet, Bastien/F-4757-2019; Touquet, Bastien/AAO-9681-2020; cavaillès, pierre/R-8756-2017; Aldebert, Delphine/C-2807-2019	Touquet, Bastien/0000-0002-2619-9818; Touquet, Bastien/0000-0002-2619-9818; cavaillès, pierre/0000-0001-5559-8634; Bellini, Valeria/0000-0003-2066-9206; Aldebert, Delphine/0000-0002-4939-0367	CNRS (Centre National de la Recheche Scientifique); UGA (Universite Grenoble, Alpes); ANR (Agence Nationale pour la Recherche); Labex Arcane [ANR-11-LABX-0003-01]; Fondation pour la Recherche Medicale-;  [Labex Parafrap-ANR-11-LABX-0024-]	CNRS (Centre National de la Recheche Scientifique); UGA (Universite Grenoble, Alpes); ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); Labex Arcane; Fondation pour la Recherche Medicale-(Fondation pour la Recherche Medicale); 	This work was supported by CNRS (Centre National de la Recheche Scientifique), UGA (Universite Grenoble, Alpes), ANR (Agence Nationale pour la Recherche) and Labex Arcane (ANR-11-LABX-0003-01), Fondation pour la Recherche Medicale- and Labex Parafrap-ANR-11-LABX-0024-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alday PH, 2017, DRUG DES DEV THER, V11, P273, DOI 10.2147/DDDT.S60973; Alonso-Padilla J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003493; Boccard J, 2009, EUR J PHARM SCI, V36, P254, DOI 10.1016/j.ejps.2008.09.009; Boumendjel A, 2008, J MED CHEM, V51, P2307, DOI 10.1021/jm0708331; Boveia V, 2009, USING Z FACTOR COEFF, P1; CESBRONDELAUW MF, 1989, P NATL ACAD SCI USA, V86, P7537, DOI 10.1073/pnas.86.19.7537; Dimier IH, 1997, IMMUNOL CELL BIOL, V75, P511, DOI 10.1038/icb.1997.80; Gaji RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064693; Haudecoeur R, 2011, J MED CHEM, V54, P5395, DOI 10.1021/jm200242p; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Jin C, 2012, EXPERT OPIN DRUG DIS, V7, P195, DOI 10.1517/17460441.2012.660479; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Moon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061812; Nicolle E, 2011, CURR MED CHEM, V18, P2661, DOI 10.2174/092986711795933777; Nohara LL, 2010, PARASITOL INT, V59, P565, DOI 10.1016/j.parint.2010.07.007; Siqueira-Neto JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001671; Valdameri G, 2012, J MED CHEM, V55, P966, DOI 10.1021/jm201404w; Yazdanparast E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002850; Yi W, 2011, EUR J MED CHEM, V46, P4330, DOI 10.1016/j.ejmech.2011.07.003	20	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201678	10.1371/journal.pone.0201678	http://dx.doi.org/10.1371/journal.pone.0201678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157171	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400010
J	Wenzel, MA; Douglas, A; Piertney, SB				Wenzel, Marius A.; Douglas, Alex; Piertney, Stuart B.			Microbiome composition within a sympatric species complex of intertidal isopods (Jaera albifrons)	PLOS ONE			English	Article							WIDESPREAD WOLBACHIA INFECTION; BACTERIAL COMMUNITIES; REPRODUCTIVE ISOLATION; EVOLUTION; ENDOSYMBIONT; SPECIATION; DIVERSITY; PHYLOGENY; CRUSTACEA; ECOLOGY	The increasingly recognised effects of microbiomes on the eco-evolutionary dynamics of their hosts are promoting a view of the "hologenome" as an integral host-symbiont evolutionary entity. For example, sex-ratio distorting reproductive parasites such as Wolbachia are well-studied pivotal drivers of invertebrate reproductive processes, and more recent work is highlighting novel effects of microbiome assemblages on host mating behaviour and developmental incompatibilities that underpin or reinforce reproductive isolation processes. However, examining the hologenome and its eco-evolutionary effects in natural populations is challenging because microbiome composition is considerably influenced by environmental factors. Here we illustrate these challenges in a sympatric species complex of intertidal isopods (Jaera albifrons spp.) with pervasive sex-ratio distortion and ecological and behavioural reproductive isolation mechanisms. We deep-sequence the bacterial 16S rRNA gene among males and females collected in spring and summer from two coasts in north-east Scotland, and examine microbiome composition with a particular focus on reproductive parasites. Microbiomes of all species were diverse (overall 3,317 unique sequences among 3.8 million reads) and comprised mainly Proteobacteria and Bacteroidetes taxa typical of the marine intertidal zone, in particular Vibrio spp. However, we found little evidence of the reproductive parasites Wolbachia, Rickettsia, Spiroplasma and Cardinium, suggesting alternative causes of sex-ratio distortion. Notwithstanding, a significant proportion of the variance in microbiome composition among samples was explained by sex (14.1 %), nested within geographic (26.9 %) and seasonal (39.6 %) variance components. The functional relevance of this sex signal was difficult to ascertain given the absence of reproductive parasites, the ephemeral nature of the species assemblages and substantial environmental variability. These results establish the Jaera albifrons species complex as an intriguing system for examining the effects of microbiomes on reproductive processes and speciation, and highlight the difficulties associated with snapshot assays of microbiome composition in dynamic and complex environments.	[Wenzel, Marius A.; Douglas, Alex; Piertney, Stuart B.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	University of Aberdeen	Wenzel, MA (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland.	marius.wenzel@abdn.ac.uk		Wenzel, Marius Alexander/0000-0003-0093-368X; Douglas, Alex/0000-0001-6606-1058	UK Natural Environment Research Council (NERC) [NE/M015661/1]; University of Aberdeen; NERC [NE/M015661/1, NBAF010002, NBAF010003] Funding Source: UKRI	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Aberdeen; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the UK Natural Environment Research Council (NERC), grant NE/M015661/1, awarded to SBP and AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to Heather Ritchie and Laura Howell for fieldwork assistance. We acknowledge the computational support of the Maxwell HPC cluster funded by the University of Aberdeen.	Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; [Anonymous], R LANG ENV STAT COMP; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Bahrndorff S, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/5304028; Baldini F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4985; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bierlich KC, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02574-17; BOCQUET C, 1954, SYST ZOOL, V3, P148, DOI 10.2307/2411376; Bolhuis H., 2016, MARINE MICROBIOME, P3, DOI [10.1007/978-3-319-33000-6, DOI 10.1007/978-3-319-33000-6_1, 10.1007/978-3-319-33000-6_1, DOI 10.1007/978-3-319-33000-6]; Bordenstein SR, 2007, HEREDITY, V99, P278, DOI 10.1038/sj.hdy.6800994; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Brooks AW, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000225; Brucker RM, 2013, SCIENCE, V341, P667, DOI 10.1126/science.1240659; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Carman KR, 1997, MICROSC RES TECHNIQ, V37, P116, DOI 10.1002/(SICI)1097-0029(19970415)37:2<116::AID-JEMT2>3.0.CO;2-M; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Chistoserdov AY, 2012, J SHELLFISH RES, V31, P449, DOI 10.2983/035.031.0205; Cordaux R, 2012, ZOOKEYS, P123, DOI 10.3897/zookeys.176.2284; Esposti MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176573; Dittmer J, 2014, MOL ECOL, V23, P2619, DOI 10.1111/mec.12760; Dittmer J, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw063; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Edgar RC, 2017, UPDATING 97 BIORXIV; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fitzpatrick CR, 2018, P NATL ACAD SCI USA; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Gilbert SF, 2015, NAT REV GENET, V16, P611, DOI 10.1038/nrg3982; Gromek SM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01342; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Hakim JA, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw146; Hazra S., 2014, THESIS; Heuschele J, 2014, J PLANKTON RES, V36, P895, DOI 10.1093/plankt/fbu025; Hird SM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00725; Hjerde E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-616; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Ishak HD, 2011, SCI REP-UK, V1, DOI 10.1038/srep00204; Jackel R, 2013, MOL ECOL, V22, P4241, DOI 10.1111/mec.12389; Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325; Jing XF, 2014, MOL ECOL, V23, P1433, DOI 10.1111/mec.12637; Jones M.B., 1972, Journal of exp mar Biol Ecol, V9, P231, DOI 10.1016/0022-0981(72)90035-4; JONES MB, 1971, J ZOOL, V165, P183; Kageyama D, 2017, EVOL LETT, V1, P232, DOI 10.1002/evl3.28; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kessner L, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00148-16; King GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051475; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Larsen AM, 2015, MICROB ECOL, V70, P534, DOI 10.1007/s00248-015-0578-7; Lokesh J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19707; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; Mariadassou M., 2016, GITHUB REPOSITORY; Martin MO, 2010, SYMBIOSIS, V51, P97, DOI 10.1007/s13199-010-0078-y; McFall-Ngai MJ, 2014, ANNU REV MICROBIOL, V68, P177, DOI 10.1146/annurev-micro-091313-103654; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mee PT, 2015, APPL ENVIRON MICROB, V81, P6177, DOI 10.1128/AEM.01239-15; Mengoni A, 2013, ESTUAR COAST SHELF S, V131, P75, DOI 10.1016/j.ecss.2013.08.011; Merilaita S, 1997, ANIM BEHAV, V54, P769, DOI 10.1006/anbe.1996.0490; Mifsud DV, 2011, THESIS; Moisander PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138967; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Nakayama T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-35; NAYLOR E, 1966, J ANIM ECOL, V35, P209, DOI 10.2307/2697; Naylor E., 1972, BRIT MARINE ISOPODS; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pavloudi C, 2017, PEERJ, V5, DOI 10.7717/peerj.3687; Pennings SC, 2000, CAN J ZOOL, V78, P1918, DOI 10.1139/cjz-78-11-1918; Piertney SB, 1996, J MAR BIOL ASSOC UK, V76, P825, DOI 10.1017/S0025315400031490; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ribardiere A, 2018, J EXP MAR BIOL UNPUB; Ribardiere A, 2017, ECOL EVOL, V7, P5352, DOI 10.1002/ece3.3106; Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015; Rogers EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106215; Rosenberg E, 2016, MBIO, V7, DOI 10.1128/mBio.01395-15; Saage A, 2009, J SEA RES, V62, P16, DOI 10.1016/j.seares.2009.01.002; Schuelke T, 2018, MOL ECOL, V27, P1930, DOI 10.1111/mec.14539; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shropshire JD, 2016, MBIO, V7, DOI 10.1128/mBio.01785-15; Simhadri RK, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00287-17, 10.1128/msphere.00287-17]; Smith JE, 2009, PARASITOLOGY, V136, P1901, DOI 10.1017/S0031182009991818; SOLIGNAC M, 1981, SYST ZOOL, V30, P387, DOI 10.2307/2413051; STANHOPE MJ, 1992, J CHEM ECOL, V18, P1871, DOI 10.1007/BF02751110; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sutton R, 2005, J CHEM ECOL, V31, P1865, DOI 10.1007/s10886-005-5931-8; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Venables WN., 2002, MODERN APPL STAT S; VEUILLE M, 1980, BIOL J LINN SOC, V13, P89, DOI 10.1111/j.1095-8312.1980.tb00072.x; Viver T, 2017, ENVIRON MICROBIOL, V19, P3039, DOI 10.1111/1462-2920.13763; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weigel BL, 2016, APPL ENVIRON MICROB, V82, P650, DOI 10.1128/AEM.02980-15; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Winters AD, 2015, CAN J MICROBIOL, V61, P72, DOI 10.1139/cjm-2014-0434; Yong HS, 2017, META GENE, V14, P6, DOI 10.1016/j.mgene.2017.07.007; Young VB, 2017, BMJ, V356; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	100	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202212	10.1371/journal.pone.0202212	http://dx.doi.org/10.1371/journal.pone.0202212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157257	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400044
J	Baker, JM; Bruno, JL; Gundran, A; Hosseini, SMH; Reiss, AL				Baker, Joseph M.; Bruno, Jennifer L.; Gundran, Andrew; Hosseini, S. M. Hadi; Reiss, Allan L.			fNIRS measurement of cortical activation and functional connectivity during a visuospatial working memory task (vol 13, e0201486, 2018)	PLOS ONE			English	Correction													Hosseini, Hadi/AAF-7095-2020	Bruno, Jennifer/0000-0001-7705-2456; Hosseini, Hadi/0000-0001-5186-7008	NATIONAL INSTITUTE ON AGING [K25AG050759] Funding Source: NIH RePORTER; NIA NIH HHS [K25 AG050759] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baker JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201486	1	1	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0203233	10.1371/journal.pone.0203233	http://dx.doi.org/10.1371/journal.pone.0203233			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142212	Green Submitted, gold, Green Published			2022-12-27	WOS:000442722500065
J	Da, W; Li, XM; Qiao, S; Zhou, YJ; Shen, ZY				Da, Wendi; Li, Xiaoming; Qiao, Shan; Zhou, Yuejiao; Shen, Zhiyong			Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China	PLOS ONE			English	Article							MEDICATION ADHERENCE; ANTIRETROVIRAL ADHERENCE; THERAPY; RECOMMENDATIONS; INSTRUMENTS	Objectives Self-report antiretroviral therapy (ART) adherence has been consistently associated with clinical outcomes. This study aims to compare the accuracy of self-report ART adherence measures with varying recall timeframes or item contents to predict virological response. Methods Data from a cross-sectional study among 2146 participants on ART in Guangxi, China were used. Detectable viral load was defined as viral load > 50 copies/ml. Adherence was measured using the number of days on which all doses were taken in the past month (i.e., the "one-month days taken" measure), the number of days on which any dose was missed in the past month (i.e., the "one-month days missed" measure), missed doses over the past 3 days, and missed days over the past weekend. Each adherence measure was dichotomized at an empirically determined cut-off to determine poor vs. good adherence. Accuracy of using each dichotomized adherence measure to predict detectable viral load was assessed by sensitivity, specificity, and the area under the receiver-operating characteristic (AUROC) curve. Logistic regressions were used to calculate the association between poor adherence and detectable viral load. Results All four measures had sensitivity below 10.0%, specificity above 90.0%, and AUROC slightly above 0.50. In univariate logistic regression, detectable viral load was statistically significantly associated with poor adherence determined by the one-month days taken measure (OR = 1.98, 95% CI 1.15-3.42), the 3-day measure (OR = 2.18, 95% CI 1.10-4.34), and the weekend measure (OR = 2.86, 95% CI 1.54-5.34). After adjusting for covariates, statistically significant association persisted only for the weekend measure (OR = 2.57, 95% CI 1.33-4.99). Conclusions Adherence measures asking about days on which all doses were taken might work better than items asking about days on which respondents missed their doses, and weekend measures should be included to comprehensively capture adherence behaviors. Further studies looking at intermediate timeframes are also needed to capture patients' dose-missing patterns that may better predict detectable viral load.	[Da, Wendi; Li, Xiaoming; Qiao, Shan] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Zhou, Yuejiao; Shen, Zhiyong] Guangxi Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China	University of South Carolina System; University of South Carolina Columbia	Da, W (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA.	wendi@mailbox.sc.edu	Li, Xiaoming/AAF-1362-2019	Li, Xiaoming/0000-0002-5555-9034	National Institute on Alcohol Abuse and Alcoholism [R01AA018090]; National Institute of Child and Human Development [R01HD074221]; National Natural Science Foundation of China [NSF71673146]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD074221] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Child and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research was funded by the National Institute on Alcohol Abuse and Alcoholism Grant R01AA018090, the National Institute of Child and Human Development Grant R01HD074221, and the National Natural Science Foundation of China Grant NSF71673146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS C, 2015, RESP PROGR REP; Berg KM, 2012, AIDS BEHAV, V16, P461, DOI 10.1007/s10461-010-9864-z; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Crane HM, 2016, AIDS BEHAV, P1, DOI [10.1007/s10461-015-1193-9, DOI 10.1007/S10461-015-1193-9]; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Ekstrand ML, 2011, INT HEALTH, V3, P27, DOI 10.1016/j.inhe.2010.11.003; Group A others. Society of Infectious Disease Chinese Medical Association, 2011, CHIN J CLIN INFECT D, V4, P231; Huang P, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007508; Levi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010; Lu M, 2008, AIDS BEHAV, V12, P86, DOI 10.1007/s10461-007-9261-4; Made F, 2016, VALIDATION SELF REPO; Mannheimer S, 2008, AIDS CARE, V20, P161, DOI 10.1080/09540120701534699; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pearson CR, 2007, AIDS BEHAV, V11, P161, DOI 10.1007/s10461-006-9133-3; Qiao Shan, 2015, AIDS, V29 Suppl 1, pS25, DOI 10.1097/QAD.0000000000000670; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sangeda RZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1035; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Stirratt MJ, 2015, TRANSL BEHAV MED, V5, P470, DOI 10.1007/s13142-015-0315-2; The Joint United Nation Programme on HIV/AIDS, 2014, 90 90 90 AMB TREATM; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Williams AB, 2013, AIDS BEHAV, V17, P284, DOI 10.1007/s10461-012-0172-7; Wilson Ira B, 2009, Curr HIV/AIDS Rep, V6, P177, DOI 10.1007/s11904-009-0024-x; Wilson IB, 2014, AIDS BEHAV, V18, P2349, DOI 10.1007/s10461-013-0610-1	25	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203032	10.1371/journal.pone.0203032	http://dx.doi.org/10.1371/journal.pone.0203032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161177	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900071
J	Cafiero, JH; Lamberti, YA; Surmann, K; Vecerek, B; Rodriguez, ME				Hilario Cafiero, Juan; Andrea Lamberti, Yanina; Surmann, Kristin; Vecerek, Branislav; Eugenia Rodriguez, Maria			A Bordetella pertussis MgtC homolog plays a role in the intracellular survival	PLOS ONE			English	Article							EPITHELIAL-CELLS; PROTEOMICS; PATHOGENICITY; PARAPERTUSSIS; ACIDIFICATION; MODULATION; INVASION; ATPASE	Bordetella pertussis, the causative agent of whooping cough, has the capability to survive inside the host cells. This process requires efficient adaptation of the pathogen to the intracellular environment and the associated stress. Among the proteins produced by the intracellular B. pertussis we identified a protein (BP0414) that shares homology with MgtC, a protein which was previously shown to be involved in the intracellular survival of other pathogens. To explore if BP0414 plays a role in B. pertussis intracellular survival a mutant strain defective in the production of this protein was constructed. Using standard in vitro growth conditions we found that BP0414 is required for B. pertussis growth under low magnesium availability or low pH, two environmental conditions that this pathogen might face within the host cell. Intracellular survival studies showed that MgtC is indeed involved in B. pertussis viability inside the macrophages. The use of bafilomycin A1, which inhibits phagosome acidification, abolished the survival defect of the mgtC deficient mutant strain suggesting that in intracellular B. pertussis the role of MgtC protein is mainly related to the bacterial adaptation to the acidic conditions found inside the of phagosomes. Overall, this work provides an insight into the importance of MgtC in B. pertussis pathogenesis and its contribution to bacterial survival within immune cells.	[Hilario Cafiero, Juan; Andrea Lamberti, Yanina; Eugenia Rodriguez, Maria] Univ Nacl La Plata, Fac Ciencias Exactas, CINDEFI UNLP CONICET La Plata, La Plata, Buenos Aires, Argentina; [Surmann, Kristin] Univ Med Greifswald, Dept Funct Genom, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Vecerek, Branislav] Inst Microbiol ASCR, Vvi, Lab Mol Biol Bacterial Pathogens, Prague, Czech Republic; [Vecerek, Branislav] Inst Microbiol ASCR, Vvi, Lab Posttranscript Control Gene Express, Prague, Czech Republic	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Greifswald Medical School; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Rodriguez, ME (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, CINDEFI UNLP CONICET La Plata, La Plata, Buenos Aires, Argentina.	mer@quimica.unlp.edu.ar	Vecerek, Branislav/H-2545-2014	Vecerek, Branislav/0000-0001-9520-6324	National Agency for Scientific and Technological Promotion (ANPCyT, MINCyT) [PICT 2013-1937, PICT 2016-2363]; CONICET-DFG-MINCYT 2016 [DFG: 357058152]; Czech Science Foundation [16-34825L]	National Agency for Scientific and Technological Promotion (ANPCyT, MINCyT); CONICET-DFG-MINCYT 2016; Czech Science Foundation(Grant Agency of the Czech Republic)	This work was partially supported by the National Agency for Scientific and Technological Promotion (ANPCyT, MINCyT) (www.agencia.mincyt.gob.ar/) grants PICT 2013-1937 and PICT 2016-2363 to MER, CONICET-DFG-MINCYT 2016, DFG: 357058152 to MER, KS, and YL, and the Czech Science Foundation (www.gacr.cz) grant 16-34825L to BV. MER and YAL are members of the Scientific Career of CONICET. JHC is a doctoral fellow of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix E, 2007, TRENDS MICROBIOL, V15, P252, DOI 10.1016/j.tim.2007.03.007; Amman F, 2018, RNA BIOL, V15, P967, DOI 10.1080/15476286.2018.1462655; Bassinet L, 2000, INFECT IMMUN, V68, P1934, DOI 10.1128/IAI.68.4.1934-1941.2000; Belon C, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00052; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Freue GVC, 2012, CIRC-CARDIOVASC GENE, V5, pO10, DOI 10.1161/CIRCGENETICS.111.959528; FRIEDMAN RL, 1992, INFECT IMMUN, V60, P4578, DOI 10.1128/IAI.60.11.4578-4585.1992; Gorgojo J, 2014, INFECT IMMUN, V82, P5175, DOI 10.1128/IAI.02553-14; Groisman EA, 2013, ANNU REV GENET, V47, P625, DOI 10.1146/annurev-genet-051313-051025; Hellwig SMM, 1999, FEMS IMMUNOL MED MIC, V26, P203, DOI 10.1111/j.1574-695X.1999.tb01391.x; Hellwig SMM, 2001, J INFECT DIS, V183, P871, DOI 10.1086/319266; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Kitteringham NR, 2009, J CHROMATOGR B, V877, P1229, DOI 10.1016/j.jchromb.2008.11.013; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lamberti Y, 2016, J PROTEOMICS, V136, P55, DOI 10.1016/j.jprot.2016.02.002; Lamberti Y, 2013, PATHOG DIS, V69, P194, DOI 10.1111/2049-632X.12072; Lamberti Y, 2008, MICROB PATHOGENESIS, V44, P501, DOI 10.1016/j.micpath.2008.01.002; Lamberti YA, 2010, INFECT IMMUN, V78, P907, DOI 10.1128/IAI.01031-09; LEE CK, 1990, INFECT IMMUN, V58, P2516, DOI 10.1128/IAI.58.8.2516-2522.1990; Lee EJ, 2013, CELL, V154, P146, DOI 10.1016/j.cell.2013.06.004; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MAGUIRE ME, 1992, J BIOENERG BIOMEMBR, V24, P319; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pontes MH, 2015, J MOL BIOL, V427, P2586, DOI 10.1016/j.jmb.2015.06.021; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Tang HY, 2011, J PROTEOME RES, V10, P4005, DOI 10.1021/pr2002098; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zlamy M, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00052	38	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203204	10.1371/journal.pone.0203204	http://dx.doi.org/10.1371/journal.pone.0203204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161230	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900090
J	Kruk, B; Liebe, R; Milkiewicz, M; Wunsch, E; Raszeja-Wyszomirska, J; Lammert, F; Milkiewicz, P; Krawczyk, M				Kruk, Beata; Liebe, Roman; Milkiewicz, Malgorzata; Wunsch, Ewa; Raszeja-Wyszomirska, Joanna; Lammert, Frank; Milkiewicz, Piotr; Krawczyk, Marcin			PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; PRIMARY SCLEROSING CHOLANGITIS; GENOME-WIDE ASSOCIATION; SUPERFAMILY MEMBER 2; GENETIC-VARIATION; STEATOSIS; RISK; FIBROSIS; SUSCEPTIBILITY; REDUCTION	Background The adiponutrin (PNPLA3) p.1148M and transmembrane 6 superfamily member 2 (TM6SF2) p.E167K variants represent major genetic risk factors for progressive liver injury in nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD) and chronic viral hepatitis. The aim of this study was to find out whether these variants have a detrimental impact on the progression of chronic liver disease in patients with prolonged cholestasis induced by primary sclerosing cholangitis (PSC). Methods We prospectively recruited 178 PSC patients (112 male, age range 17-75 years, 55 with liver cirrhosis, 94 with ulcerative colitis, 48 transplanted during follow-up). PNPLA3 rs738409 and TM6SF2 rs58542926 polymorphisms were genotyped using dedicated TaqMan assays. Associations between genotypes, biochemical and clinical phenotypes were analyzed using contingency tables. Results Allele and genotype distribution of both variants were consistent with Hardy-Weinberg equilibrium. No significant differences in the genotype distribution of PNPLA3 (P = 0.90) or TM6SF2 (P = 0.72) were observed between patients with cirrhosis and patients without cirrhosis. Serum liver enzyme activities were not modified by the presence of PNPLA3 (ALT P = 0.88, AST P = 0.77) or TM6SF2 (ALT P = 0.92, AST P = 0.49) risk variants. Increasing number of risk alleles had no impact on serum liver enzyme activities, as demonstrated by a separate analysis of patients carrying 0 (n = 99), 1 (n = 64), 2 (n = 12) or 3 (n = 3) risk alleles P>0.05). No impact of PNPLA3 or TM6SF2 risk variants was detectable in patients with PSC and ulcerative colitis, and none of the variants increased the odds of transplantation. Conclusions Neither PNPLA3 nor TM6SF2 polymorphisms seem to contribute significantly towards an increased risk for deterioration of liver function in patients with PSC. These results underscore the divergent mechanisms of liver damage in cholestatic conditions as compared to metabolic and viral liver diseases.	[Kruk, Beata; Krawczyk, Marcin] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Ctr Preclin Res, Lab Metab Liver Dis, Warsaw, Poland; [Liebe, Roman; Lammert, Frank; Krawczyk, Marcin] Saarland Univ, Saarland Univ Med Ctr, Dept Med 2, Homburg, Germany; [Milkiewicz, Malgorzata] Pomeranian Med Univ, Dept Med Biol, Szczecin, Poland; [Wunsch, Ewa; Milkiewicz, Piotr] Pomeranian Med Univ, Translat Med Grp, Szczecin, Poland; [Raszeja-Wyszomirska, Joanna; Milkiewicz, Piotr] Med Univ Warsaw, Liver & Internal Med Unit, Warsaw, Poland	Medical University of Warsaw; Universitatsklinikum des Saarlandes; Pomeranian Medical University; Pomeranian Medical University; Medical University of Warsaw	Krawczyk, M (corresponding author), Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Ctr Preclin Res, Lab Metab Liver Dis, Warsaw, Poland.; Krawczyk, M (corresponding author), Saarland Univ, Saarland Univ Med Ctr, Dept Med 2, Homburg, Germany.	marcin.krawczyk@uks.eu	Krawczyk, Marcin/AAG-4356-2020	Krawczyk, Marcin/0000-0002-0113-0777; Milkiewicz, Malgorzata/0000-0002-2064-0545; Liebe, Roman/0000-0002-3199-5595; Milkiewicz, Piotr/0000-0002-1817-0724				Arslanow A, 2016, LIVER INT, V36, P418, DOI 10.1111/liv.12937; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; Cai T, 2011, J HEPATOL, V55, P529, DOI 10.1016/j.jhep.2010.12.020; Friedrich K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058734; Goode EC, 2017, GUT; Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022; Krawczyk M, 2017, ANN HEPATOL, V16, P830, DOI 10.5604/01.3001.0010.5271; Krawczyk M, 2017, SCAND J GASTROENTERO, V52, P1407, DOI 10.1080/00365521.2017.1370009; Krawczyk M, 2017, J LIPID RES, V58, P247, DOI 10.1194/jlr.P067454; Krawczyk M, 2016, SURG OBES RELAT DIS, V12, P1838, DOI 10.1016/j.soard.2016.06.004; Krawczyk M, 2016, DIGESTION, V93, P139, DOI 10.1159/000441185; Krawczyk M, 2011, J HEPATOL, V55, P299, DOI 10.1016/j.jhep.2010.10.042; LEE YM, 1995, NEW ENGL J MED, V332, P924, DOI 10.1056/NEJM199504063321406; Mancina RM, 2016, INFLAMM BOWEL DIS, V22, P134, DOI 10.1097/MIB.0000000000000569; Mehal WZ, 2011, NAT MED, V17, P552, DOI 10.1038/nm0511-552; Milano M, 2015, HEPATOLOGY, V62, P111, DOI 10.1002/hep.27811; Pirola CJ, 2015, HEPATOLOGY, V62, P1742, DOI 10.1002/hep.28142; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sookoian S, 2015, HEPATOLOGY, V61, P515, DOI 10.1002/hep.27556; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Vigano M, 2013, HEPATOLOGY, V58, P1245, DOI 10.1002/hep.26445; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202942	10.1371/journal.pone.0202942	http://dx.doi.org/10.1371/journal.pone.0202942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161167	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900052
J	Kurdyukov, S; Eccles, CA; Desai, AKA; Gonzalez-Garay, M; Yuan, JXJ; Garcia, JGN; Rafikova, O; Rafikov, R				Kurdyukov, Sergey; Eccles, Cody A.; Desai, An Kit A.; Gonzalez-Garay, Manuel; Yuan, Jason X-J; Garcia, Joe G. N.; Rafikova, Olga; Rafikov, Ruslan			New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; HEMOLYSIS; MODEL	Pulmonary Arterial Hypertension (PAH) is a fatal disorder with limited treatment options and reduced life expectancy after diagnosis. Complex genetic backgrounds in PAH complicates identification of causative mutations that is essential for an understanding of the disease diagnostics and etiology especially for idiopathic PAH (iPAH). Hemolysis has been implicated as contributing to the pathobiology of PAH. Glucose-6-Phosphate Dehydrogenase (G6PD) expression and activity define erythrocyte's antioxidant capacity, and its decrease contributes to erythrocyte fragility. As G6PD deficiency was previously reported in a limited number of PAH cases, we tested whether iPAH patients exhibit underlying G6PD alterations in erythrocytes. A cohort of 22 PAH patients and 8 non-PAH patients were recruited for this study. DNA isolated from Peripheral Blood Mononuclear Cells (PBMC) was used for detection of mutations in the coding region of the G6PD gene. RNA isolated from PBMC was used for determination of G6PD mRNA expression level. G6PD activity was measured in Red Blood Cell (RBC) pellets. Three patients had missense mutations in G6PD (Val291 Met, Asn126Asp, Asp194Glu), however, only one mutation (Val291Met) results in a severe G6PD deficiency. A single patient with mutation (Asn126Asp) showed a 21% decrease in G6PD activity, two subjects showed G6PD deficiency without mutations, and one patient had a decreased level of G6PD mRNA and reduced enzyme levels. This study demonstrates that a moderate decrease in G6PD activity is associated with PAH. Screening for G6PD activity and mutations in the G6PD gene may provide early detection of individuals predisposed to PAH.	[Kurdyukov, Sergey; Eccles, Cody A.; Rafikova, Olga; Rafikov, Ruslan] Univ Arizona, Coll Med, Dept Med, Div Endocrinol, Tucson, AZ 85721 USA; [Desai, An Kit A.] Univ Arizona, Coll Med, Dept Med, Div Cardiol, Tucson, AZ USA; [Gonzalez-Garay, Manuel; Yuan, Jason X-J] Univ Arizona, Coll Med, Dept Med, Div Translat & Regenerat Med, Tucson, AZ USA; [Garcia, Joe G. N.] Univ Arizona, Coll Med, Dept Med, Div Pulm & Crit Care Med, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Rafikova, O; Rafikov, R (corresponding author), Univ Arizona, Coll Med, Dept Med, Div Endocrinol, Tucson, AZ 85721 USA.	orafikova@email.arizona.edu; ruslanrafikov@email.arizona.edu	Kurdyukov, Sergey/AAF-2311-2020; Rafikov, Ruslan/AAG-9352-2019	Kurdyukov, Sergey/0000-0001-5824-0443; Desai, Ankit/0000-0001-6427-616X; Rafikov, Ruslan/0000-0001-5950-4076; Gonzalez-Garay, Manuel/0000-0003-3412-0353	NIH [R01HL133085]; Arizona Health Sciences Center Career Development Award [R01HL132918, R01HL136603]; Scientist Development Grant [14SDG20480354]; National Heart Lung and Blood Institute (PVDOMICS) [HL125208-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL125208, R01HL132918, R35HL135807, R01HL133085, R01HL136603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Health Sciences Center Career Development Award; Scientist Development Grant; National Heart Lung and Blood Institute (PVDOMICS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants R01HL133085 (to OR) and Arizona Health Sciences Center Career Development Award (to OR); R01HL132918 (to RR); R01HL136603 (to AAD); Scientist Development Grant 14SDG20480354 (to RR). RNAseq was supported by the U01 grant HL125208-01 from the National Heart Lung and Blood Institute (PVDOMICS) (to JXJY).	BATTISTUZZI G, 1977, AM J HUM GENET, V29, P31; Boonyuen U, 2016, MOL GENET METAB, V118, P84, DOI 10.1016/j.ymgme.2016.03.008; Chen LYC, 2010, AM J HEMATOL, V85, P124, DOI 10.1002/ajh.21584; Chun Kook-Jin, 2001, Korean Journal of Internal Medicine, V16, P75; David G., 2017, J APPL LAB MED, V2, P1, DOI DOI 10.1373/JALM.2017.024935; Demir AY, 2009, BLOOD, V113, P2118, DOI 10.1182/blood-2008-12-194746; Fonseca G, 2015, CURR OPIN PULM MED, V21, P432, DOI 10.1097/MCP.0000000000000200; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Garcia-Rivas G, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0440-5; Hu WG, 2010, BLOOD, V116, P1613, DOI 10.1182/blood-2010-01-267112; Karamanian VA, 2014, PULM CIRC, V4, P269, DOI 10.1086/675990; Kerstjens-Frederikse WS, 2013, J MED GENET, V50, P500, DOI 10.1136/jmedgenet-2012-101152; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Mathew R, 2016, WORLD J CARDIOL, V8, P703, DOI 10.4330/wjc.v8.i12.703; NANCE WE, 1977, AM J HUM GENET, V29, P537; Newman JH, 2001, NEW ENGL J MED, V345, P319, DOI 10.1056/NEJM200108023450502; Paulin R, 2014, CELL METAB, V20, P827, DOI 10.1016/j.cmet.2014.08.011; Potoka KP, 2015, AM J PHYSIOL-LUNG C, V308, pL314, DOI 10.1152/ajplung.00252.2014; Rafikova O, 2018, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2017-0308OC, DOI 10.1165/RCMB.2017-03080C]; Rybicki AC, 1998, BLOOD, V92, P2594, DOI 10.1182/blood.V92.7.2594.2594_2594_2596; Shah SS, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0093-6; Taniguchi Misako, 2016, ScientificWorldJournal, V2016, P6382467, DOI 10.1155/2016/6382467; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224	23	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203493	10.1371/journal.pone.0203493	http://dx.doi.org/10.1371/journal.pone.0203493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161219	gold, Green Submitted, Green Published			2022-12-27	WOS:000443388900130
J	Myhre, JB; Johansen, AMW; Hjartaker, A; Andersen, LF				Myhre, Jannicke Borch; Johansen, Anne Marte Wetting; Hjartaker, Anette; Andersen, Lene Frost			Relative validation of a pre-coded food diary in a group of Norwegian adults - Comparison of underreporters and acceptable reporters	PLOS ONE			English	Article							ENERGY-INTAKE; NUTRITIONAL EPIDEMIOLOGY; REPORT INSTRUMENTS; PHYSICAL-ACTIVITY; GOLDBERG CUTOFF; DIET; NUTRIENT; CHILDREN; ADOLESCENTS; EXPENDITURE	Estimating dietary intake is important for both epidemiological and clinical studies. In large studies, a balance has to be achieved between methods with high accuracy and methods that are easy to use. The aim of the present study was to compare results from a pre-coded scanable food diary (PFD) with results from a weighed record (WR) in a group of Norwegian adults. We also explored differences in day-to-day energy intake and the distribution of energy intake across the day in acceptable reporters (ARs) and underreporters (URs). Participants (n = 114, mean age 35 years, 68% women) recorded dietary intake with the PFD for 7 consecutive days. One week after completing the PFD, participants completed a 7 days WR. No difference in mean energy intake was seen between methods. Few differences were seen for the macronutrients, the most noticeable difference being the percentage of energy (E%) from carbohydrates which was significantly lower with the PFD (47 E%) than with the WR (49 E%). For the micronutrients, intakes of calcium and vitamin A were both significantly higher with the PFD than with the WR. Pearson's correlation coefficient ranged from 0.47 (tocopherol) to 0.76 (E% carbohydrates) for all nutrients. Bread intake was significantly lower with the PFD while the intakes of edible fats, cheese and beverages were higher. Twenty-eight percent of the participants were found to be URs with the PFD. No clear pattern of underreporting at certain recording days or times of the day was seen. In conclusion, the results showed similar energy intakes and few differences in food and nutrient intakes between the PDF and the WR at the group level. Somewhat larger differences between the methods were seen at the individual level. Because of the reduced work load on both participants and researchers, the PFD seems a suitable alternative to the WR.	[Myhre, Jannicke Borch; Johansen, Anne Marte Wetting; Hjartaker, Anette; Andersen, Lene Frost] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway	University of Oslo	Myhre, JB (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway.	j.b.myhre@medisin.uio.no	Andersen, Lene/ABC-1337-2021	Myhre, Jannicke Borch/0000-0003-0797-8522	Throne-Holst Foundation	Throne-Holst Foundation	The Throne-Holst Foundation supported the writing of the article, but had no role the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LF, 2005, PUBLIC HEALTH NUTR, V8, P1315, DOI 10.1079/PHN2005751; Andersen LF, 2003, EUR J CLIN NUTR, V57, P279, DOI 10.1038/sj.ejcn.1601519; BARRETTCONNOR E, 1991, AM J CLIN NUTR, V54, pS182, DOI 10.1093/ajcn/54.1.182S; BASIOTIS PP, 1987, J NUTR, V117, P1638, DOI 10.1093/jn/117.9.1638; Becker W., 1998, Scandinavian Journal of Nutrition/Naringsforskning, V42, P145; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; Bingham SA, 2003, LANCET, V362, P212, DOI 10.1016/S0140-6736(03)13913-X; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Black AE, 2001, J AM DIET ASSOC, V101, P70, DOI 10.1016/S0002-8223(01)00018-9; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Freedman LS, 2014, AM J EPIDEMIOL, V180, P172, DOI 10.1093/aje/kwu116; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; HANKIN JH, 1991, AM J EPIDEMIOL, V133, P616, DOI 10.1093/oxfordjournals.aje.a115934; HARTMAN AM, 1990, AM J EPIDEMIOL, V132, P999, DOI 10.1093/oxfordjournals.aje.a115743; Hustvedt BE, 2004, BRIT J NUTR, V92, P1001, DOI 10.1079/BJN20041272; Keogh RH, 2014, STAT MED, V33, P2137, DOI 10.1002/sim.6095; Kipnis V, 2002, PUBLIC HEALTH NUTR, V5, P915, DOI 10.1079/PHN2002383; Knudsen VK, 2011, PUBLIC HEALTH NUTR, V14, P2110, DOI 10.1017/S1368980011001650; Lillegaard ITL, 2007, EUR J CLIN NUTR, V61, P61, DOI 10.1038/sj.ejcn.1602487; Lillegaard ITL, 2005, EUR J CLIN NUTR, V59, P611, DOI 10.1038/sj.ejcn.1602119; Lissner L, 2007, INT J OBESITY, V31, P956, DOI 10.1038/sj.ijo.0803527; Lombard MJ, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0027-y; NELSON M, 1989, AM J CLIN NUTR, V50, P155, DOI 10.1093/ajcn/50.1.155; Nydahl Margaretha, 2009, Food Nutr Res, V53, DOI 10.3402/fnr.v53i0.1889; Overby N.C.A., 2002, UNGKOST 2000 NATL RE; Overby NC, 2004, PUBLIC HEALTH NUTR, V7, P285, DOI 10.1079/PHN2003515; Stea TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102029; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; WHO, 1985, EN PROT REQ; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001; Zhan J, 2017, CRIT REV FOOD SCI, V57, P1650, DOI 10.1080/10408398.2015.1008980	33	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202907	10.1371/journal.pone.0202907	http://dx.doi.org/10.1371/journal.pone.0202907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161252	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900050
J	Rooney-Varga, JN; Sterman, JD; Fracassi, E; Franck, T; Kapmeier, F; Kurker, V; Johnston, E; Jones, AP; Rath, K				Rooney-Varga, J. N.; Sterman, J. D.; Fracassi, E.; Franck, T.; Kapmeier, F.; Kurker, V; Johnston, E.; Jones, A. P.; Rath, K.			Combining role-play with interactive simulation to motivate informed climate action: Evidence from the World Climate simulation	PLOS ONE			English	Article							RISK PERCEPTION; COMMUNICATION; POLICY; PARIS; CHALLENGES; SUPPORT	Climate change communication efforts grounded in the information deficit model have largely failed to close the gap between scientific and public understanding of the risks posed by climate change. In response, simulations have been proposed to enable people to learn for themselves about this complex and politically charged topic. Here we assess the impact of a widely-used simulation, World Climate, which combines a socially and emotionally engaging role-play with interactive exploration of climate change science through the CROADS climate simulation model. Participants take on the roles of delegates to the UN climate negotiations and are challenged to create an agreement that meets international climate goals. Their decisions are entered into C-ROADS, which provides immediate feedback about expected global climate impacts, enabling them to learn about climate change while experiencing the social dynamics of negotiations. We assess the impact of World Climate by analyzing pre- and post-survey results from >2,000 participants in 39 sessions in eight nations. We find statistically significant gains in three areas: (i) knowledge of climate change causes, dynamics and impacts; (ii) affective engagement including greater feelings of urgency and hope; and (iii) a desire to learn and do more about climate change. Contrary to the deficit model, gains in urgency were associated with gains in participants' desire to learn more and intent to act, while gains in climate knowledge were not. Gains were just as strong among American participants who oppose government regulation of free markets-a political ideology that has been linked to climate change denial in the US-suggesting the simulation's potential to reach across political divides. The results indicate that World Climate offers a climate change communication tool that enables people to learn and feel for themselves, which together have the potential to motivate action informed by science.	[Rooney-Varga, J. N.; Kurker, V] Univ Massachusetts Lowell, UMass Lowell Climate Change Initiat, Lowell, MA 01854 USA; [Rooney-Varga, J. N.; Kurker, V] Univ Massachusetts Lowell, Dept Environm Earth & Atmospher Sci, Lowell, MA 01854 USA; [Sterman, J. D.] MIT, Syst Dynam Grp, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Fracassi, E.] Escuela Ingn & Gest, Inst Tecnol Buenos Aires, Buenos Aires, DF, Argentina; [Franck, T.; Johnston, E.; Jones, A. P.] Climate Interact, Washington, DC USA; [Kapmeier, F.] ESB Business Sch, Reutlingen, Germany; [Rath, K.] SageFox Consulting Grp, Amherst, MA USA	University of Massachusetts System; University of Massachusetts Lowell; University of Massachusetts System; University of Massachusetts Lowell; Massachusetts Institute of Technology (MIT)	Rooney-Varga, JN (corresponding author), Univ Massachusetts Lowell, UMass Lowell Climate Change Initiat, Lowell, MA 01854 USA.; Rooney-Varga, JN (corresponding author), Univ Massachusetts Lowell, Dept Environm Earth & Atmospher Sci, Lowell, MA 01854 USA.	Juliette_RooneyVarga@uml.edu		Kapmeier, Florian/0000-0002-7567-4873	National Science Foundation [DUE-124558, ICER-1701062]; SageFox Consulting Group	National Science Foundation(National Science Foundation (NSF)); SageFox Consulting Group	Author KR is employed by SageFox Consulting Group, which provided support in the form of KR's salary, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of author KR are articulated in the 'author contributions' section. This work was supported by the National Science Foundation under grants DUE-124558 and ICER-1701062.	Anderson S, 2017, J ENERGY NAT RESO LA, V35, P221, DOI 10.1080/02646811.2017.1321263; Barros V.R., 2014, CLIM CHANG 2014 IMP, P688, DOI DOI 10.1017/CBO9781107415324; Bartholomew D, 2011, WILEY SER PROBAB ST, P1, DOI 10.1002/9781119970583; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chung KC, 2017, INT SYST DYN C CAMBR; Clemencon R, 2016, J ENVIRON DEV, V25, P3, DOI 10.1177/1070496516631362; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; Cronin MA, 2009, ORGAN BEHAV HUM DEC, V108, P116, DOI 10.1016/j.obhdp.2008.03.003; Doherty KL, 2016, NAT CLIM CHANGE, V6, P879, DOI 10.1038/NCLIMATE3025; Dunlap RE, 2016, ENVIRONMENT, V58, P4, DOI 10.1080/00139157.2016.1208995; Feinberg M, 2011, PSYCHOL SCI, V22, P34, DOI 10.1177/0956797610391911; Figueres C, 2017, NATURE, V546, P593, DOI 10.1038/546593a; Fischhoff B, 2007, ENVIRON SCI TECHNOL, V41, P7204, DOI 10.1021/es0726411; Gold AU, 2012, J GEOSCI ED, V60, P295, DOI [10.5408/12-324.11234011, DOI 10.5408/12-324.11234011, DOI 10.5408/12-324.1]; GOODMAN E, 2001, PEDIATRICS, V108; Goodman E, 2015, PEDIATRICS, V136, pE633, DOI 10.1542/peds.2015-1300; Halford GS, 2005, PSYCHOL SCI, V16, P70, DOI 10.1111/j.0956-7976.2005.00782.x; Harvey D, 1997, INTERGOVERNMENTAL PA; Hays RT, 1992, MIL PSYCHOL, V4, P63, DOI DOI 10.1207/S15327876MP0402_1; Heath Y, 2006, ENVIRON BEHAV, V38, P48, DOI 10.1177/0013916505277998; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Homer J, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140130; Hornsey MJ, 2016, GLOBAL ENVIRON CHANG, V39, P26, DOI 10.1016/j.gloenvcha.2016.04.003; Iyer A, 2007, PERS SOC PSYCHOL B, V33, P572, DOI 10.1177/0146167206297402; Kahan D, 2012, NATURE, V488, P255, DOI 10.1038/488255a; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kintisch E, 2015, SCIENCE, V350, P1018, DOI 10.1126/science.350.6264.1018; Kluge A, 2009, THEOR ISS ERGON SCI, V10, P489, DOI 10.1080/14639220902982192; Lattanzio R.K., 2014, INT CLIMATE CHANGE F; Ledley T.S., 2017, OXFORD RES ENCY ENV, V1, DOI [10.1093/acrefore/9780199389414.013.56, DOI 10.1093/ACREFORE/9780199389414.013.56]; Lee TM, 2015, NAT CLIM CHANGE, V5, P1014, DOI 10.1038/NCLIMATE2728; Leiserowitz A, 2011, AM TEENSKNOWLEDGE CL, P2; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Marx SM, 2007, GLOBAL ENVIRON CHANG, V17, P47, DOI 10.1016/j.gloenvcha.2006.10.004; Minestere de l'education nationale, 2015, ORG SIM NEG CHANG CL; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; Osgood E. E., 1957, MEASUREMENT MEANING; Pearce W, 2015, WIRES CLIM CHANGE, V6, P613, DOI 10.1002/wcc.366; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Robinson S, 2002, SIMUL MODEL PRACT TH, V10, P513, DOI 10.1016/S1569-190X(02)00117-X; Sanderson BM, 2017, NAT CLIM CHANGE, V7, P92; Shi J, 2016, NAT CLIM CHANGE, V6, P759, DOI [10.1038/NCLIMATE2997, 10.1038/nclimate2997]; Smith N, 2014, RISK ANAL, V34, P937, DOI 10.1111/risa.12140; Stage EK, 2013, SCIENCE, V340, P276, DOI 10.1126/science.1234011; Sterman J, 2012, SUSTAINABILITY SCI E; Sterman J, 2015, SIMULAT GAMING, V46, P348, DOI 10.1177/1046878113514935; Sterman J, 2012, SYST DYNAM REV, V28, P295, DOI 10.1002/sdr.1474; Sterman JD, 2008, SCIENCE, V322, P532, DOI 10.1126/science.1162574; Sterman JD, 2013, ENVIRON MODELL SOFTW, V44, P122, DOI 10.1016/j.envsoft.2012.06.004; Sterman JD, 2011, CLIMATIC CHANGE, V108, P811, DOI 10.1007/s10584-011-0189-3; Stokes B., 2015, GLOBAL CLIMATE CHANG; Sweeney LB, 2000, SYST DYNAM REV, V16, P249, DOI 10.1002/sdr.198; Tollefson J, 2017, NATURE, V546, P198, DOI 10.1038/nature.2017.22096; United Nations Secretary-General, 2021, ASS REP 6 WORK GROUP; van der Linden S, 2014, EUR J SOC PSYCHOL, V44, P430, DOI 10.1002/ejsp.2008; Weber EU, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0013; Weber EU, 2011, AM PSYCHOL, V66, P315, DOI 10.1037/a0023253; Weber EU, 2010, PERSPECT PSYCHOL SCI, V5, P410, DOI 10.1177/1745691610375556	62	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202877	10.1371/journal.pone.0202877	http://dx.doi.org/10.1371/journal.pone.0202877			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161185	Green Published, gold			2022-12-27	WOS:000443388900048
J	Marzen, S				Marzen, Sarah			Infinitely large, randomly wired sensors cannot predict their input unless they are close to deterministic	PLOS ONE			English	Article							COMPLEXITY; INFERENCE; NOISE	Building predictive sensors is of paramount importance in science. Can we make a randomly wired sensor "good enough" at predicting its input simply by making it larger? We show that infinitely large, randomly wired sensors are nonspecific for their input, and therefore nonpredictive of future input, unless they are close to deterministic. Nearly deterministic, randomly wired sensors can capture similar to 10% of the predictive information of their inputs for "typical" environments.	[Marzen, Sarah] MIT, Dept Phys, Phys Living Syst Grp, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Marzen, S (corresponding author), MIT, Dept Phys, Phys Living Syst Grp, Cambridge, MA 02139 USA.	semarzen@mit.edu		, Sarah/0000-0001-5386-1101	MIT Physics of Living Systems Fellowship	MIT Physics of Living Systems Fellowship	The author was funded by an MIT Physics of Living Systems Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara PM, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.022143; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bialek W, 2001, NEURAL COMPUT, V13, P2409, DOI 10.1162/089976601753195969; Bialek W, 2001, PHYSICA A, V302, P89, DOI 10.1016/S0378-4371(01)00444-7; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Cover T.M., 2006, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Horowitz JM, 2017, P NATL ACAD SCI USA, V114, P7565, DOI 10.1073/pnas.1700617114; Jaeger H., 2001, TECH REP 148, V148; James RG, 2011, CHAOS, V21, DOI 10.1063/1.3637494; Lukosevicius M, 2012, KUNSTL INTELL, V26, P365, DOI 10.1007/s13218-012-0204-5; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maas W., 2011, COMPUTABILITY CONTEX, P275, DOI 10.1142/9781848162778_0008; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Marzen S, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.032308; Marzen S, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.060101; Marzen SE, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0166; Marzen SE, 2016, J STAT PHYS, V163, P1312, DOI 10.1007/s10955-016-1520-1; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Nemenman I, 2002, ADV NEUR IN, V14, P471; Schrauwen B., 2009, 22 ANN C NEURAL INFO, P1425; Shalizi CR, 2001, J STAT PHYS, V104, P817, DOI 10.1023/A:1010388907793; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202333	10.1371/journal.pone.0202333	http://dx.doi.org/10.1371/journal.pone.0202333			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157215	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400053
J	Smith, A; Mullooly, M; Murphy, L; Barron, TI; Bennett, K				Smith, Amelia; Mullooly, Maeve; Murphy, Laura; Barron, Thomas Ian; Bennett, Kathleen			Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial	PLOS ONE			English	Article							INVOLVEMENT; SURVIVORS; COHORT; WOMEN	Introduction There is evidence suggesting that smoking and obesity prior to a breast cancer diagnosis is associated with poorer outcomes. In this study, we investigate the associations between smoking and obesity prior to a breast cancer diagnosis and the presence of lymph node metastases at diagnosis. Methods Women with stage I-III breast cancer (n = 3,304) were identified from the National Cancer Institute's Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Univariable and multivariable log-binomial models were used to estimate relative risks (RR) and 95% confidence intervals (CIs) for associations between lymph node positive breast cancer and; i) smoking, and ii) obesity prior to diagnosis. Results Pre-diagnostic smoking/obesity was not associated with lymph node metastasis at diagnosis in multivariable analyses; (RR 0.82, 95% CI 0.61, 1.10) and (RR 0.95, 95% CI 0.81, 1.12), respectively. Conclusion Obesity and smoking information was recorded a number of years prior to breast cancer diagnosis, therefore these findings should to be replicated in a larger cohort of women, with more detailed smoking and obesity information.	[Smith, Amelia; Barron, Thomas Ian] St James Hosp, Dept Pharmacol & Therapeut, Trinity Ctr Hlth Sci, Dublin, Ireland; [Mullooly, Maeve] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Mullooly, Maeve] NCI, Canc Prevent Fellowship Program, Div Canc Prevent, Bethesda, MD 20892 USA; [Mullooly, Maeve; Murphy, Laura; Bennett, Kathleen] Royal Coll Surgeons Ireland, Div Populat Hlth Sci, Dublin, Ireland; [Barron, Thomas Ian] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Trinity College Dublin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Royal College of Surgeons - Ireland; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Smith, A (corresponding author), St James Hosp, Dept Pharmacol & Therapeut, Trinity Ctr Hlth Sci, Dublin, Ireland.	smitha25@tcd.ie		Bennett, Kathleen/0000-0002-2861-7665	Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT [CCRC13GAL]; Health Research Board Ireland [RLA/2015/1579]	Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT; Health Research Board Ireland	This work was supported by the Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT (https://www.cancer.ie/) [CCRC13GAL to K Bennett, TI Barron]. L Murphy and A Smith's positions are funded by the Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT [CCRC13GAL]. K Bennett's [RLA/2015/1579] position was funded by the Health Research Board Ireland (http://www.hrb.ie/home/). The Health Research Board Ireland and the Irish Cancer Society had no role in the study design, collection, analysis, and interpretation of data, writing of the report, or the decision to submit for publication.	Abdessalam SF, 2001, AM J SURG, V182, P316, DOI 10.1016/S0002-9610(01)00719-X; Barron TI, 2014, CANCER RES, V74, P4065, DOI 10.1158/0008-5472.CAN-13-2679; Bennett JM, 2013, PSYCHONEUROENDOCRINO, V38, P179, DOI 10.1016/j.psyneuen.2012.05.012; Berube S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3646; Chan DSM, 2014, ANN ONCOL, V25, P1901, DOI 10.1093/annonc/mdu042; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Feigelson HS, 2000, BREAST CANCER RES, V2, P277, DOI 10.1186/bcr69; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Howland NK, 2013, J SURG RES, V185, P697, DOI 10.1016/j.jss.2013.06.048; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Majid S, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1353-2; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mattes MD, 2015, J BREAST CANCER, V18, P143, DOI 10.4048/jbc.2015.18.2.143; McTiernan A, 2003, J CLIN ONCOL, V21, P1961, DOI 10.1200/JCO.2003.07.057; Nandi P, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-3018-2; Porter GA, 2006, ANN SURG ONCOL, V13, P327, DOI 10.1245/ASO.2006.03.049; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Qiu SQ, 2018, EJSO-EUR J SURG ONC, V44, P700, DOI 10.1016/j.ejso.2017.12.008; Qiu SQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21196; Reynolds P, 2013, J MAMMARY GLAND BIOL, V18, P15, DOI 10.1007/s10911-012-9269-x; Utada Y, 1999, JPN J CLIN ONCOL, V29, P63, DOI 10.1093/jjco/29.2.63; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372	23	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202291	10.1371/journal.pone.0202291	http://dx.doi.org/10.1371/journal.pone.0202291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157224	gold, Green Submitted, Green Published			2022-12-27	WOS:000443071400050
J	Dur, M; Bruckner, V; Oberleitner-Leeb, C; Fuiko, R; Matter, B; Berger, A				Duer, Mona; Brueckner, Victoria; Oberleitner-Leeb, Christiane; Fuiko, Renate; Matter, Barbara; Berger, Angelika			Clinical relevance of activities meaningful to parents of preterm infants with very low birth weight: A focus group study	PLOS ONE			English	Article							NEONATAL INTENSIVE-CARE; QUALITY-OF-LIFE; COGNITIVE-DEVELOPMENT; RHEUMATOID-ARTHRITIS; CHRONIC ILLNESS; TIME-USE; IMPACT; INTERVENTION; CHILDREN; MOTHERS	Introduction Parents have a major impact on the outcome of health care of preterm infants. Parents' engagement in meaningful activities could have an impact on their own health and wellbeing and therefore be relevant in neonatal intensive care. The aim of this study was to explore meaningful activities of parents of very low birth weight (VLBW) preterm infants with the purpose to further the understanding of their clinical relevance and to foster their consideration in clinical practice and research of neonatal intensive care. Methods A total of 36 parents of preterm infants born prior to complete 37 weeks of gestation with VLBW (<= 1.500 grams) were asked to participate in a focus group interview. Interview transcripts were used to analyse the content of the focus group interviews using meaning condensation method by Steinar Kvale. Results Thirty-six parents participated in a total of twelve focus groups. Parents reported that the meaning of certain activities changed due to preterm birth. Meaningful activities, like bathing the baby and gardening, could foster a transition from a feeling of parental immaturity to a feeling of maturity, following health care instructions to possessing health care skills, and a functioning-only state to a balance of activities. Conclusions In neonatal intensive care, nurses contribute to delivering parental education and thereby facilitate experiences of being a mature parent and of possessing health care skills. Occupational therapy could be used to help re-engage in meaningful activities and maintain a balance of activities in parents of VLBW preterm infants.	[Duer, Mona; Brueckner, Victoria; Oberleitner-Leeb, Christiane; Fuiko, Renate; Berger, Angelika] Med Univ Vienna, Dept Pediat & Adolescent Med, Div Neonatol Pediat Intens Care & Neuropediat, Vienna, Austria; [Duer, Mona] IMC Univ Appl Sci Krems, Master Degree Programme Appl Hlth Sci & Bachelor, Dept Hlth Sci, Krems, Austria; [Matter, Barbara] Wilhelminenspital Stadt Wien, Div Neonatol, Dept Pediat & Adolescent Med, Vienna, Austria	Medical University of Vienna; Wilhelminenspital	Dur, M (corresponding author), Med Univ Vienna, Dept Pediat & Adolescent Med, Div Neonatol Pediat Intens Care & Neuropediat, Vienna, Austria.; Dur, M (corresponding author), IMC Univ Appl Sci Krems, Master Degree Programme Appl Hlth Sci & Bachelor, Dept Hlth Sci, Krems, Austria.	mona.duer@meduniwien.ac.at		Dur, Mona/0000-0003-4438-0933; Berger, Angelika/0000-0001-8775-2405	Association of Austrian Pharmaceutical Manufacturers; Austrian Social Security	Association of Austrian Pharmaceutical Manufacturers; Austrian Social Security	This work is supported by the Common Health Targets funds of the Rahmen-Pharmavertrag, a cooperation between the Association of Austrian Pharmaceutical Manufacturers and the Austrian Social Security; FP 1, (http://www.pharmig.at/uploads/gefrderte_Projekte_2014_Stand_Dezember_2015_13012_DE.pdf). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard Hanne, 2015, JBI Database System Rev Implement Rep, V13, P123, DOI 10.11124/jbisrir-2015-2287; Albritton T, 2014, FAM PROCESS, V53, P686, DOI 10.1111/famp.12088; AlS HDS, 2011, CURR WOMENS HEALTH R, V7, P288, DOI 10.2174/157340411796355216; Altimier L, 2016, NEWBORN INFANT NURS, V16, P230, DOI 10.1053/j.nainr.2016.09.030; Apter G, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0820-8; Ashworth P., 2008, QUALITATIVE PSYCHOL; ATLAS.ti GmbH, 2015, ATLAS TI QUAL DAT AN; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Bradbury-Jones C, 2009, J ADV NURS, V65, P663, DOI 10.1111/j.1365-2648.2008.04922.x; Bradford AB, 2017, J MARITAL FAM THER, V43, P291, DOI 10.1111/jmft.12190; Cho ES, 2016, J PEDIATR NURS, V31, P430, DOI 10.1016/j.pedn.2016.02.007; Chung J C, 2001, Am J Alzheimers Dis Other Demen, V16, P85, DOI 10.1177/153331750101600204; Clark GJF, 2013, AM J OCCUP THER, V67, P425, DOI 10.5014/ajot.2013.006163; Coenen M, 2012, QUAL LIFE RES, V21, P359, DOI 10.1007/s11136-011-9943-2; Crowe TK, 2006, AM J OCCUP THER, V60, P194, DOI 10.5014/ajot.60.2.194; Distelberg BJ, 2016, J MARITAL FAM THER, V42, P371, DOI 10.1111/jmft.12166; Dur M, 2016, PSYCHONEUROENDOCRINO, V65, P138, DOI 10.1016/j.psyneuen.2015.12.015; Dur M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-45; Dur M, 2014, DO PATIENT REP UNPUB; Dur M, 2014, OCCUPATIONAL BALANCE; Eakman AM, 2013, OTJR-OCCUP PART HEAL, V33, P100, DOI 10.3928/15394492-20130222-02; Gibbs D, 2015, BRIT J OCCUP THER, V78, P475, DOI 10.1177/0308022615586799; Gibbs DP, 2016, CAN J OCCUP THER, V83, P91, DOI 10.1177/0008417415625421; Gooding JS, 2011, SEMIN PERINATOL, V35, P20, DOI 10.1053/j.semperi.2010.10.004; Haijes HA, 2016, PEDIATR RES, V79, P676, DOI 10.1038/pr.2015.279; Hodgetts S, 2014, OTJR-OCCUP PART HEAL, V34, P81, DOI 10.3928/15394492-20130109-01; Horne J, 2005, J OCCUP SCI, V12, P176, DOI 10.1080/14427591.2005.9686561; Hunt E, 2015, QUAL LIFE RES, V24, P1303, DOI 10.1007/s11136-014-0863-9; Ionio C, 2016, EUR J PSYCHOL, V12, P604, DOI 10.5964/ejop.v12i4.1093; Jonsson H., 2000, J OCCUP SCI, V7, P29, DOI DOI 10.1080/14427591.2000.9686462; Kvale S., 2007, INTERVIEWS INTRO QUA; Landsem IP, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0221-9; Lee SY, 2012, ARCH WOMEN MENT HLTH, V15, P185, DOI 10.1007/s00737-012-0275-1; Linsell L, 2015, JAMA PEDIATR, V169, P1162, DOI 10.1001/jamapediatrics.2015.2175; Litt JS, 2016, ACAD PEDIATR, V16, P350, DOI 10.1016/j.acap.2015.12.009; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lu YYF, 2016, J NURS SCHOLARSHIP, V48, P334, DOI 10.1111/jnu.12214; Montirosso R, 2017, CHILD DEV PERSPECT, V11, P9, DOI 10.1111/cdep.12208; Peek L, 2009, QUAL RES, V9, P31, DOI 10.1177/1468794108098029; Pickering JA, 2017, FAM PROCESS, V56, P105, DOI 10.1111/famp.12173; Premji SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174419; Provenzi L, 2016, JOGNN-J OBST GYN NEO, V45, P528, DOI 10.1016/j.jogn.2016.04.004; Quach J, 2015, ACAD PEDIATR, V15, P89, DOI 10.1016/j.acap.2014.08.004; Seidman G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125643; Spittle AJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1363; Stamm TA, 2010, MUSCULOSKELET CARE, V8, P78, DOI 10.1002/msc.168; Stewart D., 2015, FOCUS GROUPS THEORY, Ved 3; Treherne SC, 2017, JOGNN-J OBST GYN NEO, V46, P737, DOI 10.1016/j.jogn.2017.07.005; Treyvaud K, 2014, J PEDIATR-US, V164, P515, DOI 10.1016/j.jpeds.2013.11.001; Vergara Elise, 2006, Am J Occup Ther, V60, P659; Yerxa E J, 1990, Occup Ther Health Care, V6, P1, DOI 10.1080/J003v06n04_04	51	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202189	10.1371/journal.pone.0202189	http://dx.doi.org/10.1371/journal.pone.0202189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153266	gold, Green Published, Green Submitted			2022-12-27	WOS:000443001700008
J	Bastiaansen, JA; Bennik, EC; Marsman, JBC; Ormel, J; Aleman, A; Oldehinkel, AJ				Bastiaansen, Jojanneke A.; Bennik, Elise C.; Marsman, Jan Bernard C.; Ormel, Johan; Aleman, Andre; Oldehinkel, Albertine J.			Prefrontal cortex activation during a cognitive reappraisal task is associated with real-life negative affect reactivity	PLOS ONE			English	Article							FOCUSED EMOTION REGULATION; INDIVIDUAL-DIFFERENCES; NEURAL BASES; SEX-DIFFERENCES; SUPPRESSION; PREDICT; FMRI; METAANALYSIS; EXPERIENCE; AMYGDALA	The neural substrate of cognitive reappraisal has been well-mapped. Individuals who successfully downregulate negative affect (NA) by reshaping their thoughts about a potentially emotional situation show augmented activity in the prefrontal cortex (PFC), with attenuated activity in the amygdala. We performed functional neuroimaging with experience sampling to determine whether individual differences in brain activation correspond to differences in real-life NA. While being scanned, 69 female students (aged 18-25 years) were asked to perform a cognitive reappraisal task. In addition, repeated assessments (5/day, 14 days) of affect and minor events in real-life were conducted. Individual t-maps were created for an instructed downregulation contrast (downregulate negative-attend negative) and an uninstructed regulation contrast (attend negative-attend neutral). Mean beta values were extracted from a priori defined regions of interest in the bilateral amygdala and PFC and were correlated with three daily life NA measures: baseline (mean) NA, NA variability, and NA reactivity to negative events. Only one out of twelve correlations for the amygdalae was nominally significant, which did not survive correction for multiple comparisons. PFC activation in the instructed and uninstructed regulation contrasts explained approximately 10% of the variance in NA reactivity; stronger recruitment during the attend-negative condition was correlated with lower reactivity levels. The degree to which individuals spontaneously engage frontal clusters may be a critical aspect of real-life emotional reactivity. The findings of this study provide a partial external validation of the cognitive reappraisal task, suggesting that frontal brain activation during implicit task conditions may have the strongest connection with real-life behaviors.	[Bastiaansen, Jojanneke A.; Ormel, Johan; Aleman, Andre; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, Groningen, Netherlands; [Bastiaansen, Jojanneke A.] Friesland Mental Hlth Care Serv, Dept Educ & Res, Leeuwarden, Netherlands; [Bennik, Elise C.; Aleman, Andre] Univ Groningen, Dept Psychol, Groningen, Netherlands; [Marsman, Jan Bernard C.; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Dept Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Oldehinkel, AJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Dept Psychiat, Groningen, Netherlands.	a.j.oldehinkel@umcg.nl	ormel, johan/AAC-5584-2019; Bastiaansen, Jojanneke/F-4849-2013	ormel, johan/0000-0002-5463-037X; Bastiaansen, Jojanneke/0000-0003-4831-6402	University Medical Center Groningen	University Medical Center Groningen	This work was supported by personal grants for excellent research from the University Medical Center Groningen to JO and AJO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkman ET, 2013, CURR DIR PSYCHOL SCI, V22, P45, DOI 10.1177/0963721412469394; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Chen SD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00073-3; Csikszentmihalyi M., 1983, NEW DIRECTIONS METHO, V15, P41, DOI DOI 10.1007/978-94-017-9088-8_2; David SP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23976-1; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Drabant EM, 2009, BIOL PSYCHIAT, V65, P367, DOI 10.1016/j.biopsych.2008.09.007; Ehring T, 2010, EMOTION, V10, P563, DOI 10.1037/a0019010; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Hoekstra H. A., 1996, HANDLEIDING NEO PERS; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Kohn N, 2014, NEUROIMAGE, V87, P345, DOI 10.1016/j.neuroimage.2013.11.001; Kong F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097071; Koole SL, 2011, COGNITION EMOTION, V25, P389, DOI 10.1080/02699931.2010.550505; Kuppens P, 2010, J PERS SOC PSYCHOL, V99, P1042, DOI 10.1037/a0020962; Lang PJ, 2008, A8 U FLOR, DOI [10.1016/j.neuroimage.2011.10.018, DOI 10.1016/J.NEUROIMAGE.2011.10.018]; Lopez RB, 2014, PSYCHOL SCI, V25, P1337, DOI 10.1177/0956797614531492; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Nikolova YS, 2012, BIOL PSYCHIAT, V72, P157, DOI 10.1016/j.biopsych.2012.03.014; Nolen-Hoeksema S, 2012, ANNU REV CLIN PSYCHO, V8, P161, DOI 10.1146/annurev-clinpsy-032511-143109; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Oinonen KA, 2002, J AFFECT DISORDERS, V70, P229, DOI 10.1016/S0165-0327(01)00356-1; Parker G, 2010, INT REV PSYCHIATR, V22, P429, DOI 10.3109/09540261.2010.492391; Paul S, 2013, BIOL PSYCHOL, V94, P136, DOI 10.1016/j.biopsycho.2013.05.019; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Silvers JA, 2015, SOC COGN AFFECT NEUR, V10, P10, DOI 10.1093/scan/nsu016; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van Roekel E, 2016, J ABNORM CHILD PSYCH, V44, P999, DOI 10.1007/s10802-015-0090-z; Vanderhasselt MA, 2013, BIOL PSYCHOL, V92, P433, DOI 10.1016/j.biopsycho.2012.03.005; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; Williams LE, 2009, EMOTION, V9, P847, DOI 10.1037/a0017745; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yuan JJ, 2015, COGNITION EMOTION, V29, P1042, DOI 10.1080/02699931.2014.965663; Yuan JJ, 2015, SCI CHINA LIFE SCI, V58, P480, DOI 10.1007/s11427-014-4739-6; Yuan JJ, 2009, HUM BRAIN MAPP, V30, P3676, DOI 10.1002/hbm.20796	46	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202888	10.1371/journal.pone.0202888	http://dx.doi.org/10.1371/journal.pone.0202888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142170	Green Submitted, Green Published, gold			2022-12-27	WOS:000442722500046
J	Krusi, A; Renville, F; Gurney, L; Lyons, T; Shoveller, J; Shannon, K				Krusi, Andrea; Renville, Flo; Gurney, Lulu; Lyons, Tara; Shoveller, Jean; Shannon, Kate			Positive sexuality: HIV disclosure, gender, violence and the law-A qualitative study	PLOS ONE			English	Article							SEROPOSITIVE STATUS DISCLOSURE; CRIMINAL PROSECUTIONS; SEROSTATUS DISCLOSURE; TRANSGENDER WOMEN; RISK BEHAVIORS; INFECTED WOMEN; SEX WORKERS; TRANSMISSION; PREVENTION; PARTNERS	While a growing body of research points to the shortcomings of the criminal law in governing HIV transmission, there is limited understanding of how cis and trans women living with HIV (WLWH) negotiate their sexuality and HIV disclosure in a criminalized environment. Given the ongoing criminalization of HIV non-disclosure and prevalence of gender-based violence, there is a critical need to better understand the dynamics of negotiating sexual relationships and HIV disclosure among WLWH. We conducted 64 qualitative interviews with cis and trans WLWH in Vancouver, Canada between 2015 and 2017. The interviews were conducted by three experienced researchers, including a cis and a trans WLWH using a semi-structured interview guide. Drawing on a feminist analytical framework and concepts of structural violence, the analysis sought to characterize the negotiation of sexual relationships and HIV disclosure among WLWH in a criminalized setting. For many participants their HIV diagnosis initially symbolized the end of their sexuality due to fear of rejection and potential legal consequences. WLWH recounted that disclosing their HIV status shifted the power dynamics in sexual relationships and many feared rejection, violence, and being outed as living with HIV. Participants' narratives also highlighted that male condom refusal was common and WLWH were not only subjected to the gendered interpersonal violence of male condom refusal but also to the structural violence of legislation that requires condom use but fails to account for the gendered power imbalance that shapes condom negotiation. Despite frequently being represented as a law that 'protects' women, our findings indicate that the criminalization of HIV non-disclosure constitutes a form of gendered structural violence that exacerbates risk for interpersonal violence among WLWH. In line with recommendations by, the WHO and UNAIDS these findings demonstrate the negative impacts of regulating HIV prevention through the use of criminal law for WLWH.	[Krusi, Andrea; Renville, Flo; Gurney, Lulu; Lyons, Tara; Shannon, Kate] Gender & Sexual Hlth Initiat, Vancouver, BC, Canada; [Krusi, Andrea; Shannon, Kate] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Lyons, Tara] Kwantlen Polytech Univ, Surrey, BC, Canada; [Shoveller, Jean; Shannon, Kate] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Krusi, A (corresponding author), Gender & Sexual Hlth Initiat, Vancouver, BC, Canada.; Krusi, A (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	gshi@cfenet.ubc.ca			Canadian Institutes of Health Research [384667, FDN-143349]; Michael Smith Foundation for Health Research; Canada Research Chair in Global Sexual Health and HIV/AIDS; Michael Smith Foundation for Health Research Scholar Award; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028648] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Research Chair in Global Sexual Health and HIV/AIDS; Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Canadian Institutes of Health Research through a Community-based Research Grant (384667) and a Foundation Grant (FDN-143349). AK is supported through a Michael Smith Foundation for Health Research Scholar Award. KS is partially supported by a Canada Research Chair in Global Sexual Health and HIV/AIDS and Michael Smith Foundation for Health Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BD, 2014, SEX RES SOC POLICY, V11, P39, DOI 10.1007/s13178-013-0131-8; Allard P., 2014, WOMEN HIV PREVENTION, P195; [Anonymous], 2017, CRIM JUST SYST RESP, P1; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barreto D, HIV DISCLOSURE CONSE; Bernard EJ, 2012, CRIMINALIZTION HIV N; Bernard EJ, 2016, ADV HIV JUSTICE2 BUI; Bingham B, 2014, CULT HEALTH SEX, V16, P440, DOI 10.1080/13691058.2014.888480; Borwein A, 2014, AIDS CARE, V26, P587, DOI 10.1080/09540121.2013.844763; Bourassa C, 2004, CANADIAN WOMAN STUDI, V24; Bourgois P, 2004, HUM ORGAN, V63, P253, DOI 10.17730/humo.63.3.h1phxbhrb7m4mlv0; Brady S, 2002, AIDS PATIENT CARE ST, V16, P121, DOI 10.1089/108729102317330463; Burris S., 2007, ARIZONA STATE LAW J, V2007, P1; Canadian HIV/AIDS Legal Network, 2014, CRIM LAW HIV NOND CA; CATIE, 2012, HIV CAN PRIM SERV PR; Cohen M, 2000, AM J PUBLIC HEALTH, V90, P560, DOI 10.2105/AJPH.90.4.560; Colombini M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20766; Culhane D., 2003, AM INDIAN Q, V27, P593, DOI [10.1353/aiq.2004.0073, DOI 10.1353/AIQ.2004.0073]; Deering KN, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2014.301909; Dodds C, 2006, INT J STD AIDS, V17, P315, DOI 10.1258/095646206776790114; Dodds C, 2008, AIDS CARE, V20, P509, DOI 10.1080/09540120701867131; Dunkle KL, 2013, AM J REPROD IMMUNOL, V69, P20, DOI 10.1111/aji.12039; Farmer P.E, 2001, INFECT INEQUALITIES; Galletly CL, 2009, INT J STD AIDS, V20, P613, DOI 10.1258/ijsa.2008.008417; Galletly CL, 2012, AM J PUBLIC HEALTH, V102, P2135, DOI 10.2105/AJPH.2012.300664; GALTUNG J, 1990, J PEACE RES, V27, P291, DOI 10.1177/0022343390027003005; Hankivsky O, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-5; Harrington EK, 2016, CULT HEALTH SEX, V18, P453, DOI 10.1080/13691058.2015.1091507; Hastings C., 2017, HIV CRIMINALIZATION; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; HEISE LL, 1995, SOC SCI MED, V40, P931, DOI 10.1016/0277-9536(94)00165-P; Holmes C, 2015, ACME, V14, P539; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kennedy CE, 2015, J INT AIDS SOC, V18, P74, DOI 10.7448/IAS.18.6.20292; Krusi A, 2017, MED ANTHR THEORY, V4; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Loutfy M, 2014, CAN J INFECT DIS MED, V25, P135, DOI 10.1155/2014/498459; Mazanderani F, 2015, SOC SCI MED, V131, P66, DOI 10.1016/j.socscimed.2015.02.041; McGrath JW, 2014, MED ANTHROPOL, V33, P303, DOI 10.1080/01459740.2014.892483; Melendez RM, 2007, CULT HEALTH SEX, V9, P233, DOI 10.1080/13691050601065909; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Moyer E, 2014, MED ANTHROPOL, V33, P263, DOI 10.1080/01459740.2014.890618; Moyer E, 2012, CULT HEALTH SEX, V14, pS67, DOI 10.1080/13691058.2012.662524; Mykhalovskiy E, 2004, SOC SCI MED, V59, P1059, DOI 10.1016/j.socscimed.2003.12.002; Mykhalovskiy E, 2012, CAN J LAW SOC, V27, P31, DOI 10.3138/cjls.27.1.031; O'Byrne P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-94; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Onu CC, 2017, JAIDS-J ACQ IMM DEF, V74, P52, DOI 10.1097/QAI.0000000000001135; Ostrach B, 2012, HEALTH SOCIOL REV, V21, P258, DOI 10.5172/hesr.2012.21.3.258; Otto-Salaj LL, 2010, J SEX RES, V47, P539, DOI 10.1080/00224490903216763; Palys T, 2002, SOCIOL METHODOL, V32, P1, DOI 10.1111/1467-9531.00107; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Patterson Sophie, 2016, CMAJ Open, V4, pE169, DOI 10.9778/cmajo.20150106; Patton C., 2002, GLOBALIZING AIDS, DOI [10.2105/AJPH.2014.301909, DOI 10.2105/AJPH.2014.301909]; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Quesada J, 2011, MED ANTHROPOL, V30, P339, DOI 10.1080/01459740.2011.576725; Sales JM, 2008, ARCH PEDIAT ADOL MED, V162, P432, DOI 10.1001/archpedi.162.5.432; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Siegel K, 2005, WOMEN HEALTH, V41, P63, DOI 10.1300/J013v41n04_04; Silverman JG, 2011, PERSPECT SEX REPRO H, V43, P60, DOI 10.1363/4306011; Smith LR, 2017, JAIDS-J ACQ IMM DEF, V75, P408, DOI 10.1097/QAI.0000000000001423; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Statistics Canada, 2015, AUD CORR STAT CAN 20; The Truth and Reconciliation Commission of Canada, 2015, HON TRUTH REC FUT SU; Trickey A, 2017, LANCET HIV; UNAIDS, 2007, GREAT INV PEOPL LIV; Varcoe C, 2008, JOURNAL DE LA SANTE; Zierler S, 2000, AM J PUBLIC HEALTH, V90, P208, DOI 10.2105/AJPH.90.2.208	72	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202776	10.1371/journal.pone.0202776	http://dx.doi.org/10.1371/journal.pone.0202776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142220	gold, Green Submitted, Green Published			2022-12-27	WOS:000442722500032
J	Jakubec, D; Kratochvil, M; Vymetal, J; Vondrasek, J				Jakubec, David; Kratochvil, Miroslav; Vymetal, Jiri; Vondrasek, Jiri			Widespread evolutionary crosstalk among protein domains in the context of multi- domain proteins	PLOS ONE			English	Article							RESIDUE COEVOLUTION; SEQUENCE; INFORMATION; IDENTIFICATION; SIGNALS	Domains are distinct units within proteins that typically can fold independently into recognizable three-dimensional structures to facilitate their functions. The structural and functional independence of protein domains is reflected by their apparent modularity in the context of multi-domain proteins. In this work, we examined the coupling of evolution of domain sequences co-occurring within multi-domain proteins to see if it proceeds independently, or in a coordinated manner. We used continuous information theory measures to assess the extent of correlated mutations among domains in multi-domain proteins from organisms across the tree of life. In all multi-domain architectures we examined, domains co-occurring within protein sequences had to some degree undergone concerted evolution. This finding challenges the notion of complete modularity and independence of protein domains, providing new perspective on the evolution of protein sequence and function.	[Jakubec, David; Kratochvil, Miroslav; Vymetal, Jiri; Vondrasek, Jiri] Czech Acad Sci, Inst Organ Chem & Biochem, Dept Bioinformat, Prague 16610 6, Czech Republic; [Jakubec, David] Charles Univ Prague, Dept Phys & Macromol Chem, Fac Sci, Prague 12843 2, Czech Republic; [Kratochvil, Miroslav] Charles Univ Prague, Dept Software Engn, Fac Math & Phys, CR-11800 Prague 1, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; Charles University Prague	Vondrasek, J (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Dept Bioinformat, Prague 16610 6, Czech Republic.	jiri.vondrasek@uochb.cas.cz	Kratochvíl, Miroslav/AAR-3520-2021; Vymětal, Jiří/R-1167-2017	Kratochvíl, Miroslav/0000-0001-7356-4075; Vymětal, Jiří/0000-0002-0165-8707; Jakubec, David/0000-0003-4288-0344; vondrasek, jiri/0000-0002-6066-973X	Ministry of Education, Youth and Sports [LM2015047]; Institute of Organic Chemistry and Biochemistry of the CAS [61388963]; National Grid Infrastructure MetaCentrum provided under the programme "Projects of Large Research, Development, and Innovations Infrastructures" [CESNET LM2015042]; ELIXIRCZ project, international ELIXIR infrastructure [LM2015047]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Institute of Organic Chemistry and Biochemistry of the CAS; National Grid Infrastructure MetaCentrum provided under the programme "Projects of Large Research, Development, and Innovations Infrastructures"; ELIXIRCZ project, international ELIXIR infrastructure	This work was supported by The Ministry of Education, Youth and Sports, grant number LM2015047, http://www.msmt.cz/ (J Vo) and Institute of Organic Chemistry and Biochemistry of the CAS (RVO), grant number 61388963, www. uochb.cz/(J Vo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank to M. Oliveberg, M. M. Babu, and T. Majerova for reading the manuscript and for their valuable comments and suggestions. We are also grateful to M. Oliveberg for the concept of Fig 1B. Access to computing and storage facilities owned by parties and projects contributing to the National Grid Infrastructure MetaCentrum provided under the programme "Projects of Large Research, Development, and Innovations Infrastructures" (CESNET LM2015042), is greatly appreciated. Computational resources were provided by the ELIXIRCZ project (LM2015047), part of the international ELIXIR infrastructure.	Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bjorklund AK, 2005, J MOL BIOL, V353, P911, DOI 10.1016/j.jmb.2005.08.067; Bornberg-Bauer E, 2013, CURR OPIN STRUC BIOL, V23, P459, DOI 10.1016/j.sbi.2013.02.012; Eddy SR, 2018, HMMER USERS GUIDE VE; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Lees JG, 2016, CURR OPIN STRUC BIOL, V38, P44, DOI 10.1016/j.sbi.2016.05.016; Liu Y, 2012, MOL BIOL EVOL, V29, P2253, DOI 10.1093/molbev/mss097; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mao WZ, 2015, BIOINFORMATICS, V31, P1929, DOI 10.1093/bioinformatics/btv103; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; Morcos F, 2013, P NATL ACAD SCI USA, V110, P20533, DOI 10.1073/pnas.1315625110; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Neuwald AF, 2016, CURR OPIN STRUC BIOL, V38, P1, DOI 10.1016/j.sbi.2016.04.006; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; PRESS WH, 1992, NUMERICAL RECIPES; Schueler-Furman O, 2016, CURR OPIN STRUC BIOL, V41, P159, DOI 10.1016/j.sbi.2016.06.017; Sutto L, 2015, P NATL ACAD SCI USA, V112, P13567, DOI 10.1073/pnas.1508584112; Uguzzoni G, 2017, P NATL ACAD SCI USA, V114, pE2662, DOI 10.1073/pnas.1615068114; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Yang S, 2011, BIOINFORMATICS, V27, P2972, DOI 10.1093/bioinformatics/btr503; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	34	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203085	10.1371/journal.pone.0203085	http://dx.doi.org/10.1371/journal.pone.0203085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169546	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400020
J	Fleckenstein, J; Kruger, P; Ittner, KP				Fleckenstein, Johannes; Krueger, Peter; Ittner, Karl-Peter			Effects of single-point acupuncture (HT7) in the prevention of test anxiety: Results of a RCT	PLOS ONE			English	Article							TRIER SOCIAL STRESS; RANDOMIZED CONTROLLED-TRIAL; HEALTHY-SUBJECTS; WITHDRAWAL; RESPONSES; SYSTEM; WOMEN; RATS	Background The number of students using neuro enhancement to improve their performance and to prevent test anxiety is increasing. The acupuncture point Heart 7 (HT7) has been described as being prominent in reducing states of anxiety. Methods We conducted a randomized placebo-controlled, two-armed pilot trial to investigate the efficacy of a single-point acupuncture treatment at bilateral HT7 compared to sham laser acupuncture on test anxiety. Test anxiety was induced applying the standardised protocol of the Trier Social Stress Test. Outcome measures included saliva samples analysed for cortisol and amylase, anxiety questionnaires and heart rate variability. Results Twenty-five male subjects (age 28 +/- 5 years) were allocated to either verum acupuncture (n = 12) or sham laser acupuncture (n = 13). Cortisol peaked 20 min after the stress test (2-fold, 18.11 +/- 2 nmo1/1) and amylase 10 min after (2-fold, 259 +/- 49 U/ml) with no difference between groups. There were no differences between groups regarding either anxiety questionnaires or physiological parameters. Compared to reference data (3-fold increase in cortisol), increase in stress hormones and heart rate seemed somewhat reduced. Conclusions Acupuncture may be a possible approach for the treatment of anxiety. Due to the lack of a no control treatment group, we cannot determine the magnitude of possible specific needle effects at HT7 to promote specific effects in the neuroendocrine system. Finally this study only examines the efficacy of a single time treatment.	[Fleckenstein, Johannes] Univ Bern, Inst Complementary Med, Dept TCM Acupuncture, Personalhaus 4 Inselspital, Bern, Switzerland; [Fleckenstein, Johannes; Krueger, Peter; Ittner, Karl-Peter] Univ Hosp Regensburg, Franz Josef Str Allee 11, Regensburg, Germany; [Fleckenstein, Johannes] Goethe Univ Frankfurt, Inst Sports Sci, Dept Sports Med, Frankfurt, Germany	University of Bern; University of Regensburg; Goethe University Frankfurt	Fleckenstein, J (corresponding author), Univ Bern, Inst Complementary Med, Dept TCM Acupuncture, Personalhaus 4 Inselspital, Bern, Switzerland.; Fleckenstein, J (corresponding author), Univ Hosp Regensburg, Franz Josef Str Allee 11, Regensburg, Germany.; Fleckenstein, J (corresponding author), Goethe Univ Frankfurt, Inst Sports Sci, Dept Sports Med, Frankfurt, Germany.	johannes.fleckenstein@ikom.unibe.ch	Fleckenstein, Johannes/AAL-1315-2021	Fleckenstein, Johannes/0000-0003-3442-0380				Akimoto T, 2003, MED SCI SPORT EXER, V35, P1296, DOI 10.1249/01.MSS.0000078934.07213.25; Chan Joseph, 2002, Acupunct Med, V20, P74; de Lorent L, 2016, J ACUPUNCT MERIDIAN, V9, P191, DOI 10.1016/j.jams.2016.03.008; Diekelmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003512; Gaab J, 2005, PSYCHONEUROENDOCRINO, V30, P599, DOI 10.1016/j.psyneuen.2005.02.001; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Gruner F, 2010, THESIS; Haker E, 2000, J AUTONOM NERV SYST, V79, P52, DOI 10.1016/S0165-1838(99)00090-9; Henze GI, 2017, PSYCHONEUROENDOCRINO, V75, P52, DOI 10.1016/j.psyneuen.2016.10.002; Hinz A, 2012, PSYCHOTHER PSYCH MED, V62, P52, DOI 10.1055/s-0031-1297960; Irnich D, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq009; Isoyama D, 2012, ACUPUNCT MED, V30, P85, DOI 10.1136/acupmed-2011-010064; Isserstedt W, 2010, EC SOCIAL CONDITIONS; Kamody RC, 2018, BODY IMAGE, V25, P168, DOI 10.1016/j.bodyim.2018.04.003; Kim DH, 2018, NEUROSCI LETT, V664, P38, DOI 10.1016/j.neulet.2017.11.008; Kim SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081018; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Klausenitz C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168338; Kwong EYL, 2010, J VOICE, V24, P719, DOI 10.1016/j.jvoice.2009.05.005; MacPherson H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093739; MacPherson Hugh, 2002, Acupunct Med, V20, P22; Mandl H., 2006, HDB LERNSTRATEGIEN; Middendorff E., 2012, HOCHSCHUL INF SYST E, P11; Nedeljkovic M, 2012, PSYCHONEUROENDOCRINO, V37, P1171, DOI 10.1016/j.psyneuen.2011.12.007; Park HJ, 2011, CELL MOL NEUROBIOL, V31, P1123, DOI 10.1007/s10571-011-9718-x; Reschke-Hernandez AE, 2017, J NEUROSCI RES, V95, P106, DOI 10.1002/jnr.23851; Rizi MS, 2017, COMPLEMENT THER CLIN, V29, P136, DOI 10.1016/j.ctcp.2017.09.002; Schneider A, 2007, COMPLEMENT THER MED, V15, P255, DOI 10.1016/j.ctim.2006.12.002; Schweden TLK, 2016, J ANXIETY DISORD, V43, P99, DOI 10.1016/j.janxdis.2016.09.005; Shu Shi, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P605; So EWS, 2010, REPROD BIOMED ONLINE, V20, P814, DOI 10.1016/j.rbmo.2010.02.024; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Goyata SLT, 2016, REV BRAS ENFERM, V69, P564, DOI 10.1590/0034-7167.2016690325i; Villas-Boas JD, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/219579; VINCENT C, 1995, J ROY SOC MED, V88, P199; Wichmann S, 2017, PSYCHONEUROENDOCRINO, V77, P9, DOI 10.1016/j.psyneuen.2016.11.030; Zhao RJ, 2006, NEUROSCI LETT, V395, P28, DOI 10.1016/j.neulet.2005.10.043; Zhao ZL, 2015, NEUROSCI LETT, V597, P143, DOI 10.1016/j.neulet.2015.04.045	38	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202659	10.1371/journal.pone.0202659	http://dx.doi.org/10.1371/journal.pone.0202659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161153	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900036
J	LeConte, BA; Szaniszlo, P; Fennewald, SM; Lou, DI; Qiu, SM; Chen, NW; Lee, JH; Resto, VA				LeConte, Bailey A.; Szaniszlo, Peter; Fennewald, Susan M.; Lou, Dianne, I; Qiu, Suimin; Chen, Nai-Wei; Lee, John H.; Resto, Vicente A.			Differences in the viral genome between HPV- positive cervical and oropharyngeal cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; DIVERSIFYING SELECTION; NECK-CANCER; VARIANTS; HEAD; E6; TRENDS; RISK; WORLDWIDE	Human papillomavirus (HPV)-driven oropharyngeal cancer incidence in the United States has steadily increased in the past decades and has now become the most frequently diagnosed HPV-associated cancer type, surpassing cervical cancer. Variations in the HPV genome correlate with tumorigenic risk, and the distribution of genetic variants is extensively studied in cervical cancer, but very little is known about new mutations or the distribution of HPV types and variants in oropharyngeal cancer. Here we present an archival tissue cohort study that compares genomic characteristics of HPV associated with cervical versus oropharyngeal tumors using DNA sequence analysis. We found HPV16 to be more prevalent in oropharyngeal samples than in cervical samples (91.2% versus 52.9%), while HPV18 (1.5% versus 18.2%) and HPV45 (0.7% versus 9.9%) were much less prevalent. Differences between cervix and oropharynx in HPV16 variants distribution were more subtle, but the combined European + Asian (EUR+AS) variant group was more prevalent (90.2% versus 71.4%), while the American Asian 1 + American Asian 2 (AA1+AA2) variant group was much less prevalent (4.4% versus 22.5%) in oropharyngeal cancers. HPV prevalence in oropharyngeal cancers showed an increasing trend from 60% in 2003 to 80% in 2016. We also identified over nine times more nonsynonymous mutations in the HPV E6 gene amplified from oropharyngeal samples, but for E7 the difference in mutation rates between the two anatomical locations was not significant. Overall, we showed that HPV genome in oropharyngeal cancer presents important differences when compared to cervical cancer and this may explain the distinct pathomechanisms and susceptibility to treatment of HPV-associated oropharyngeal cancer.	[LeConte, Bailey A.; Szaniszlo, Peter; Fennewald, Susan M.; Lou, Dianne, I; Resto, Vicente A.] Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; [Qiu, Suimin] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Chen, Nai-Wei] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Lee, John H.] Chan Soon Shiong Inst Mol Med, Dept Adult Med Affairs, Culver City, CA USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Resto, VA (corresponding author), Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA.	varesto@utmb.edu		Szaniszlo, Peter/0000-0002-3565-0957; LeConte, Bailey/0000-0001-8908-2249	National Institutes of Health [K08 CA132988-01 A2]; Department of Otolaryngology at UTMB Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Otolaryngology at UTMB Health	This work was supported by the National Institutes of Health K08 CA132988-01 A2 award and by the Department of Otolaryngology at UTMB Health. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman TA, 2017, CANCER-AM CANCER SOC, V123, P2219, DOI 10.1002/cncr.30588; Boumba LMA, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0010-4; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Centers for Disease Control and Prevention, 2017, HPV ASS CANC STAT; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; DeFilippis VR, 2002, J MOL EVOL, V55, P491, DOI 10.1007/s00239-002-2344-y; Farsi NJ, 2015, CANCER EPIDEMIOL, V39, P1036, DOI 10.1016/j.canep.2015.08.010; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Giannoudis A, 2001, J PATHOL, V193, P295, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH809&gt;3.0.CO;2-C; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Harris SL, 2010, HEAD NECK-J SCI SPEC, V32, P499, DOI 10.1002/hed.21220; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Huertas-Salgado A, 2011, VIROLOGY, V410, P201, DOI 10.1016/j.virol.2010.10.039; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Jackson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101540; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lichtig H, 2006, VIROLOGY, V350, P216, DOI 10.1016/j.virol.2006.01.038; Martinez-Zapien D, 2016, NATURE, V529, P541, DOI 10.1038/nature16481; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Mirabello L, 2017, CELL, V170, P1164, DOI 10.1016/j.cell.2017.08.001; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; O'Sullivan B, 2016, LANCET ONCOL, V17, P440, DOI 10.1016/S1470-2045(15)00560-4; Pytynia KB, 2014, ORAL ONCOL, V50, P380, DOI 10.1016/j.oraloncology.2013.12.019; Saraiya M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv086; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Shah A, 2017, POSTGRAD MED J, V93, P704, DOI 10.1136/postgradmedj-2016-134603; Sherman ME, 2005, CANCER-AM CANCER SOC, V103, P1258, DOI 10.1002/cncr.20877; SNEATH PHA, 1966, J THEOR BIOL, V12, P157, DOI 10.1016/0022-5193(66)90112-3; St Guily JL, 2011, J CLIN VIROL, V51, P100, DOI 10.1016/j.jcv.2011.03.003; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Sun ZR, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-459; Thomas M, 1999, ONCOGENE, V18, P7690, DOI 10.1038/sj.onc.1202953; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Xi LF, 1997, JNCI-J NATL CANCER I, V89, P796, DOI 10.1093/jnci/89.11.796; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Zehbe I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-77; Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706	43	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203403	10.1371/journal.pone.0203403	http://dx.doi.org/10.1371/journal.pone.0203403			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161236	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900120
J	Marino, S; Xu, JC; Zhao, Y; Zhou, NN; Zhou, YW; Dinov, ID				Marino, Simeone; Xu, Jiachen; Zhao, Yi; Zhou, Nina; Zhou, Yiwang; Dinov, Ivo D.			Controlled feature selection and compressive big data analytics: Applications to biomedical and health studies	PLOS ONE			English	Article							ALZHEIMERS-DISEASE	The theoretical foundations of Big Data Science are not fully developed, yet. This study proposes a new scalable framework for Big Data representation, high-throughput analytics (variable selection and noise reduction), and model-free inference. Specifically, we explore the core principles of distribution-free and model-agnostic methods for scientific inference based on Big Data sets. Compressive Big Data analytics (CBDA) iteratively generates random (sub)samples from a big and complex dataset. This subsampling with replacement is conducted on the feature and case levels and results in samples that are not necessarily consistent or congruent across iterations. The approach relies on an ensemble predictor where established model-based or model-free inference techniques are iteratively applied to preprocessed and harmonized samples. Repeating the subsampling and prediction steps many times, yields derived likelihoods, probabilities, or parameter estimates, which can be used to assess the algorithm reliability and accuracy of findings via bootstrapping methods, or to extract important features via controlled variable selection. CBDA provides a scalable algorithm for addressing some of the challenges associated with handling complex, incongruent, incomplete and multi-source data and analytics challenges. Albeit not fully developed yet, a CBDA mathematical framework will enable the study of the ergodic properties and the asymptotics of the specific statistical inference approaches via CBDA. We implemented the high-throughput CBDA method using pure R as well as via the graphical pipeline environment. To validate the technique, we used several simulated datasets as well as a real neuroimaging-genetics of Alzheimer's disease case-study. The CBDA approach may be customized to provide generic representation of complex multimodal datasets and to provide stable scientific inference for large, incomplete, and multisource datasets.	[Marino, Simeone; Xu, Jiachen; Zhao, Yi; Zhou, Nina; Zhou, Yiwang; Dinov, Ivo D.] Univ Michigan, Stat Online Computat Resource, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA; [Marino, Simeone] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Dinov, Ivo D.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Dinov, Ivo D.] Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dinov, ID (corresponding author), Univ Michigan, Stat Online Computat Resource, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA.; Dinov, ID (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.; Dinov, ID (corresponding author), Univ Michigan, Michigan Inst Data Sci, Ann Arbor, MI 48109 USA.	statistics@umich.edu	Zhou, Nina/ABC-4458-2020; Zhou, Yiwang/AAV-9504-2021; PAN, ZEQIANG/X-6341-2018; Marino, Simeone/V-9899-2018	Zhou, Nina/0000-0002-1649-3458; Zhou, Yiwang/0000-0002-8023-205X; Marino, Simeone/0000-0002-0051-8198; ZHAO, YI/0000-0002-1600-5020	NIH [P20 NR015331, P50 NS091856, P30 DK089503, U54 EB020406, P30AG053760, P30 AG010129, K01 AG030514]; NSF [1734853, 1636840, 1416953, 0716055, 1023115]; Elsie Andresen Fiske Research Fund; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS091856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [P20NR015331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG053760, K01AG030514, U01AG024904, P30AG010129] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Elsie Andresen Fiske Research Fund; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All the funds have been given to Ivo Dinov. This study was partially supported by NIH grants P20 NR015331, P50 NS091856, P30 DK089503, U54 EB020406, and P30AG053760, NSF grants 1734853, 1636840, 1416953, 0716055 and 1023115, and the Elsie Andresen Fiske Research Fund. Many colleagues from the Statistics Online Computational Resource (SOCR), Center for Complexity and Self-management of Chronic Disease (CSCD), Big Data Discovery Science (BDDS), and the Michigan Institute for Data Science (MIDAS) provided ideas and feedback. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI (http://www.adni-info.org) is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is Rev March 26, 2012 coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514.	Agarwal R, 2014, INFORM SYST RES, V25, P443, DOI 10.1287/isre.2014.0546; Babu SK, 2017, ADV COMP C IACC 2017; Barber RF, 2015, ANN STAT, V43, P2055, DOI 10.1214/15-AOS1337; Becker RA, 1988, NEW S LANGUAGE PROGR, Vxvii; Boehmke BC, 2016, DATA WRANGLING R; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Dai W, 2009, IEEE T INFORM THEORY, V55, P2230, DOI 10.1109/TIT.2009.2016006; Dinov ID, 2014, FRONT NEUROINFORM, P8; Dinov ID, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0117-6; Familiar B, 2017, ADV ANAL USING MACHI, P351; FOUCART S., 2013, MATH INTRO COMPRESSI; Friedman J., 2016, LASSO ELASTIC NET RE; Hastie TJ., 2017, GEN ADDITIVE MODELS; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hothorn T, 2005, COMPUT STAT DATA AN, V49, P1068, DOI 10.1016/j.csda.2004.06.019; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kapelner A., 2013, ARXIV13122171; Karatzoglou A, 2006, J STAT SOFTW, V15; Korolev IO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138866; Moon SW, 2015, J ALZHEIMERS DIS, V48, P1051, DOI 10.3233/JAD-150335; Moon SW, 2015, J NEUROIMAGING, V25, P728, DOI 10.1111/jon.12252; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Polley E, 2017, PACKAGE SUPERLEARNE; Prestia A, 2013, ALZHEIMERS DEMENT, V9, P677, DOI 10.1016/j.jalz.2012.09.016; Rauhut H, 2010, THEORET FDN NUMER ME, V9, P1, DOI DOI 10.1515/9783110226157.1; Slavakis K, 2014, IEEE SIGNAL PROC MAG, V31, P18, DOI 10.1109/MSP.2014.2327238; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; Wilkinson Mark D, 2016, Sci Data, V3, P160018, DOI 10.1038/sdata.2016.18; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	36	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202674	10.1371/journal.pone.0202674	http://dx.doi.org/10.1371/journal.pone.0202674			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161148	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900038
J	Onishi, H; Udagawa, C; Kubo, M; Nakamura, S; Akashi-Tanaka, S; Kuwayama, T; Watanabe, C; Takamaru, T; Takei, H; Ishikawa, T; Miyahara, K; Matsumoto, H; Hasegawa, Y; Momozawa, Y; Low, SK; Kutomi, G; Shima, H; Satomi, F; Okazaki, M; Zaha, H; Onomura, M; Matsukata, A; Sagara, Y; Baba, S; Yamada, A; Shimada, K; Shimizu, D; Tsugawa, K; Shimo, A; Hartman, M; Chan, CW; Lee, SC; Endo, I; Zembutsu, H				Onishi, Hiroshi; Udagawa, Chihiro; Kubo, Michiaki; Nakamura, Seigo; Akashi-Tanaka, Sadako; Kuwayama, Takashi; Watanabe, Chie; Takamaru, Tomoko; Takei, Hiroyuki; Ishikawa, Takashi; Miyahara, Kana; Matsumoto, Hiroshi; Hasegawa, Yoshie; Momozawa, Yukihide; Low, Siew-Kee; Kutomi, Goro; Shima, Hiroaki; Satomi, Fukino; Okazaki, Minoru; Zaha, Hisamitsu; Onomura, Mai; Matsukata, Ayami; Sagara, Yasuaki; Baba, Shinichi; Yamada, Akimitsu; Shimada, Kazuhiro; Shimizu, Daisuke; Tsugawa, Koichiro; Shimo, Arata; Hartman, Mikael; Chan, Ching-Wan; Lee, Soo Chin; Endo, Itaru; Zembutsu, Hitoshi			A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; KI-67 LABELING INDEX; ADJUVANT TAMOXIFEN; ESTROGEN-RECEPTOR; POSTMENOPAUSAL WOMEN; CLINICAL-OUTCOMES; CYP2D6 POLYMORPHISMS; IN-VITRO; THERAPY; ACTIVATION	Purpose Although association studies of genetic variations with the clinical outcomes of breast cancer patients treated with tamoxifen have been reported, genetic factors which could determine individual response to tamoxifen are not fully clarified. We performed a genome-wide association study (GWAS) to identify novel genetic markers for response to tamoxifen. Experimental design We prospectively collected 347 blood samples from patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative, invasive breast cancer receiving preoperative tamoxifen monotherapy for 14 to 28 days. We used Ki-67 response in breast cancer tissues after preoperative short-term tamoxifen therapy as a surrogate marker for response to tamoxifen. We performed GWAS and genotype imputation using 275 patients, and an independent set of 72 patients was used for replication study. Results The combined result of GWAS and the replication study, and subsequent imputation analysis indicated possible association of three loci with Ki-67 response after tamoxifen therapy (rs17198973 on chromosome 4q34.3, rs4577773 on 6q12, and rs7087428 on 10p13, Pcombined = 5.69 X 10 (-6), 1.64 x 10 -5 , and 9.77 x 10(-6), respectively). When patients were classified into three groups by the scoring system based on the genotypes of the three SNPs, patients with higher scores showed significantly higher after/before ratio of Ki-67 compared to those with lower scores (P = 1.8 x 1 0(-12)), suggesting the cumulative effect of the three SNPs. Conclusion We identified three novel loci, which could be associated with clinical response to tamoxifen. These findings provide new insights into personalized hormonal therapy for the patients with breast cancer.	[Onishi, Hiroshi; Udagawa, Chihiro; Zembutsu, Hitoshi] Natl Canc Ctr, Div Genet, Res Inst, Tokyo, Japan; [Onishi, Hiroshi; Endo, Itaru] Yokohama City Univ, Dept Gastroenterol Surg, Grad Sch Med, Yokohama, Kanagawa, Japan; [Kubo, Michiaki; Momozawa, Yukihide; Low, Siew-Kee] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Nakamura, Seigo; Akashi-Tanaka, Sadako; Kuwayama, Takashi; Watanabe, Chie; Takamaru, Tomoko] Showa Univ, Dept Surg, Div Breast Surg Oncol, Sch Med, Tokyo, Japan; [Takei, Hiroyuki] Nippon Med Sch, Dept Breast Surg, Tokyo, Japan; [Ishikawa, Takashi; Miyahara, Kana] Tokyo Med Univ, Dept Breast Surg, Tokyo, Japan; [Matsumoto, Hiroshi] Saitama Canc Ctr, Dept Breast Surg, Saitama, Japan; [Hasegawa, Yoshie] Hirosaki Municipal Hosp, Dept Breast Surg, Hirosaki, Aomori, Japan; [Kutomi, Goro; Shima, Hiroaki; Satomi, Fukino] Sapporo Med Univ, Dept Surg 1, Sapporo, Hokkaido, Japan; [Okazaki, Minoru] Sapporo Breast Surg Clin, Dept Breast Surg, Sapporo, Hokkaido, Japan; [Zaha, Hisamitsu; Onomura, Mai] Nakagami Hosp, Dept Breast Surg, Okinawa, Okinawa, Japan; [Matsukata, Ayami; Sagara, Yasuaki; Baba, Shinichi] Sagara Hosp, Dept Breast Surg, Kagoshima, Japan; [Yamada, Akimitsu; Shimada, Kazuhiro] Yokohama City Univ, Dept Breast & Thyroid Surg, Med Ctr, Yokohama, Kanagawa, Japan; [Shimizu, Daisuke] Yokohama Minato Red Cross Hosp, Dept Breast Surg, Yokohama, Kanagawa, Japan; [Tsugawa, Koichiro; Shimo, Arata] St Marianna Univ, Dept Breast & Endocrine Surg, Sch Med Hosp, Kawasaki, Kanagawa, Japan; [Hartman, Mikael; Chan, Ching-Wan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore, Singapore; [Hartman, Mikael; Chan, Ching-Wan] Natl Univ Hlth Syst, Singapore, Singapore; [Lee, Soo Chin] Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Hematol Oncol, Singapore, Singapore	National Cancer Center - Japan; Yokohama City University; RIKEN; Showa University; Nippon Medical School; Tokyo Medical University; Sapporo Medical University; Yokohama City University; Saint Marianna University; National University of Singapore; National University of Singapore; National University of Singapore	Zembutsu, H (corresponding author), Natl Canc Ctr, Div Genet, Res Inst, Tokyo, Japan.	hotoshi.zembutsu@jfcr.or.jp	Chan, Ching Wan/C-7606-2011; Sagara, Yasuaki/AAE-3747-2020; Akashi-Tanaka, Sadako/GMX-0687-2022; Hartman, Mikael/B-4324-2011; Lee, Soo Chin/S-9111-2016; Takei, Hiroyuki/AAB-1258-2019	Chan, Ching Wan/0000-0002-9250-1296; Sagara, Yasuaki/0000-0001-5705-1739; Lee, Soo Chin/0000-0002-5835-6419; 	Health Labor Sciences Research Grant; Princess Takamatsu Cancer Research Fund; Japan Research Foundation for Clinical Pharmacology	Health Labor Sciences Research Grant; Princess Takamatsu Cancer Research Fund; Japan Research Foundation for Clinical Pharmacology	This work was supported by a Health Labor Sciences Research Grant (HZ), http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/index.html; Princess Takamatsu Cancer Research Fund (HZ), http://www.ptcrf.or.jp/; Japan Research Foundation for Clinical Pharmacology (HZ), http://www.rinyaku-fdn.or.jp/. The role of the funders was study design, data analysis and preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abraham JE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2629; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; BORGNA JL, 1981, J BIOL CHEM, V256, P859; Clarke M, 1998, LANCET, V351, P1451; Criscitiello C, 2011, ONCOTARGETS THER, V4, P1, DOI 10.2147/OTT.S10155; CUTLER ML, 1992, MOL CELL BIOL, V12, P3750, DOI 10.1128/MCB.12.9.3750; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; DeCensi A, 2011, ANN ONCOL, V22, P582, DOI 10.1093/annonc/mdq427; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Giotopoulou N, 2015, CLIN EXP METASTAS, V32, P255, DOI 10.1007/s10585-015-9701-x; Gjerde J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-313; Gkretsi V, 2017, ONCOTARGET, V8, P27364, DOI 10.18632/oncotarget.16062; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; JANES PW, 1994, ONCOGENE, V9, P3601; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kent Jack W Jr, 2009, BMC Proc, V3 Suppl 7, pS19; Kiyotani K, 2013, J HUM GENET, V58, P327, DOI 10.1038/jhg.2013.39; Kiyotani K, 2012, HUM MOL GENET, V21, P1665, DOI 10.1093/hmg/ddr597; Kiyotani K, 2010, J CLIN ONCOL, V28, P1287, DOI 10.1200/JCO.2009.25.7246; Kuo SH, 2017, ONCOTARGET, V8, P20925, DOI 10.18632/oncotarget.14995; Li JJ, 2016, CHIN CLIN ONCOL, V5, DOI 10.21037/cco.2016.03.24; LIEN EA, 1989, CANCER RES, V49, P2175; Newman WG, 2008, CLIN CANCER RES, V14, P5913, DOI 10.1158/1078-0432.CCR-07-5235; Nicholson RI, 1999, ENDOCR-RELAT CANCER, V6, P373, DOI 10.1677/erc.0.0060373; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; Okishiro M, 2009, CANCER-AM CANCER SOC, V115, P952, DOI 10.1002/cncr.24111; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Cajal TRY, 2010, BREAST CANCER RES TR, V119, P33, DOI 10.1007/s10549-009-0328-y; Regan MM, 2012, JNCI-J NATL CANCER I, V104, P441, DOI 10.1093/jnci/djs125; Rondon-Lagos M, 2016, ENDOCR-RELAT CANCER, V23, P635, DOI 10.1530/ERC-16-0078; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Schroth W, 2009, JAMA-J AM MED ASSOC, V302, P1429, DOI 10.1001/jama.2009.1420; Schuit SCE, 2004, J CLIN ENDOCR METAB, V89, P303, DOI 10.1210/jc.2003-031095; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Wegman P, 2005, BREAST CANCER RES, V7, pR284, DOI 10.1186/bcr993; Wegman P, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1640; Zembutsu H, 2017, CLIN CANCER RES, V23, P2019, DOI 10.1158/1078-0432.CCR-16-1779	44	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201606	10.1371/journal.pone.0201606	http://dx.doi.org/10.1371/journal.pone.0201606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161160	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900012
J	Shentu, XP; Cao, ZY; Xiao, Y; Tang, G; Ochi, K; Yu, XP				Shentu, Xu-Ping; Cao, Zhen-Yan; Xiao, Yin; Tang, Gu; Ochi, Kozo; Yu, Xiao-Ping			Substantial improvement of toyocamycin production in Streptomyces diastatochromogenes by cumulative drug-resistance mutations	PLOS ONE			English	Article							BIOSYNTHETIC GENE CLUSTERS; RIBOSOMAL-PROTEIN S12; ANTIBIOTIC PRODUCTION; COELICOLOR A3(2); RNA-POLYMERASE; ACTIVATION; RPSL; DIFFERENTIATION; STRAINS; GRISEUS	Toyocamycin is a member of the nucleoside antibiotic family and has been recognized as a promising fungicide for the control of plant diseases. However, low productivity of toyocamycin remains an important bottleneck in its industrial production. Therefore, dramatic improvements of strains for overproduction of toyocamycin are of great interest in applied microbiology research. In this study, we sequentially selected for mutations for multiple drug resistance to promote the overproduction of toyocamycin by Streptomyces diastatochromogenes 1628. The triple mutant strain, SD3145 (str str par), was obtained through sequential screenings. This strain showed an enhanced capacity to produce toyocamycin (1500 mg/L), 24-fold higher than the wild type in GYM liquid medium. This dramatic overproduction was attributed at least partially to the acquisition of an rsmG mutation and increased gene expression of toyA, which encodes a LuxR-family transcriptional regulator for toyocamycin biosynthesis. The expression of toyF and toyG, probably directly involved in toyocamycin biosynthesis, was also enhanced, contributing to toyocamycin overproduction. By addition of a small amount of scandium (ScCl3 center dot 6H(2)O), the mutant strain, SD3145, produced more toyocamycin (2664 mg/L) in TPM medium, which was the highest toyocamycin level produced in shake-flask fermentation by a streptomycete so far. We demonstrated that introduction of combined drug resistance mutations into S. diastatochromogenes 1628 resulted in an obvious increase in the toyocamycin production. The triple mutant strain, SD3145, generated in our study could be useful for improvement of industrial production of toyocamycin.	[Shentu, Xu-Ping; Cao, Zhen-Yan; Xiao, Yin; Tang, Gu; Yu, Xiao-Ping] China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Zhejiang, Peoples R China; [Ochi, Kozo] Hiroshima Inst Technol, Dept Life Sci, Hiroshima, Japan	China Jiliang University; Hiroshima Institute of Technology	Yu, XP (corresponding author), China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Zhejiang, Peoples R China.	yxp@cjlu.edu.cn		Shentu, Xuping/0000-0003-4524-0334	National Key Research and Development Program of China [2016YFF0202300]; National Natural Science Foundation of China [31401793, 31640018]; Zhejiang Provincial Programs for Science and Technology Development [2017C32006, 2018C02030]; Zhejiang Provincial Natural Science Foundation [LY12C14012]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Programs for Science and Technology Development; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by National Key Research and Development Program of China (2016YFF0202300), National Natural Science Foundation of China (31401793, 31640018), Zhejiang Provincial Programs for Science and Technology Development (2017C32006, 2018C02030), Zhejiang Provincial Natural Science Foundation (LY12C14012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Baltz RH., 2007, MICROBE, V2, P125; Fukuda K, 2010, J BIOSCI BIOENG, V109, P459, DOI 10.1016/j.jbiosc.2009.10.017; Funane K, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00188-18; Hopwood DA, 2007, STREPTOMYCES NATURE; Hosaka T, 2009, NAT BIOTECHNOL, V27, P462, DOI 10.1038/nbt.1538; Hu HF, 2001, APPL ENVIRON MICROB, V67, P1885, DOI 10.1128/AEM.67.4.1885-1892.2001; Inaoka T, 2004, J BIOL CHEM, V279, P3885, DOI 10.1074/jbc.M309925200; Ma Z, 2014, J BASIC MICROB, V54, P278, DOI 10.1002/jobm.201200489; Ma Z, 2014, CURR MICROBIOL, V68, P180, DOI 10.1007/s00284-013-0461-z; McCarty RM, 2008, CHEM BIOL, V15, P790, DOI 10.1016/j.chembiol.2008.07.012; Ochi K, 2004, ADV APPL MICROBIOL, V56, P155, DOI 10.1016/S0065-2164(04)56005-7; OCHI K, 1987, J BACTERIOL, V169, P3608, DOI 10.1128/jb.169.8.3608-3616.1987; Ochi K, 1997, MOL GEN GENET, V256, P488; Ochi K, 2007, BIOSCI BIOTECH BIOCH, V71, P1373, DOI 10.1271/bbb.70007; Ochi K, 2017, J ANTIBIOT, V70, P25, DOI 10.1038/ja.2016.82; Okamoto-Hosoya Y, 2000, J ANTIBIOT, V53, P1424, DOI 10.7164/antibiotics.53.1424; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shentu XP, 2016, J ANTIBIOT, V69, P406, DOI 10.1038/ja.2015.123; [申屠旭萍 Shentu Xuping], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P105; Shima J, 1996, J BACTERIOL, V178, P7276, DOI 10.1128/jb.178.24.7276-7284.1996; Suzuki T, 2015, BIORESOURCE TECHNOL, V176, P156, DOI 10.1016/j.biortech.2014.10.153; Tanaka Y, 2013, J BACTERIOL, V195, P2959, DOI 10.1128/JB.00147-13; Tanaka Y, 2009, J ANTIBIOT, V62, P669, DOI 10.1038/ja.2009.97; Wang GJ, 2008, APPL ENVIRON MICROB, V74, P2834, DOI 10.1128/AEM.02800-07; Wang G, 2009, ANTIMICROB AGENTS CH, V53, P1019, DOI 10.1128/AAC.00388-08; Wang J, 2018, CURR MICROBIOL, V75, P1345, DOI 10.1007/s00284-018-1529-6; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Xu XH, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-016-2194-1; Yu Bing, 2011, Chinese Journal of Biological Control, V27, P373	31	13	14	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203006	10.1371/journal.pone.0203006	http://dx.doi.org/10.1371/journal.pone.0203006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161195	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900064
J	Yang, SY; Yao, G				Yang, Shengyun; Yao, Gang			Simultaneous removal of concentrated organics, nitrogen and phosphorus nutrients by an oxygen-limited membrane bioreactor	PLOS ONE			English	Article							WASTE-WATER TREATMENT; AMMONIUM-OXIDIZING BACTERIA; ANAEROBIC METHANE OXIDATION; MICROBIAL COMMUNITY STRUCTURE; LONG-TERM OPERATION; NITRIFICATION-DENITRIFICATION; NITRITE ACCUMULATION; ARCHAEAL COMMUNITY; ANAMMOX BACTERIA; MBR	Simultaneous removal of organics, nitrogen and phosphorus was achieved in a bench-scale oxygen-limited membrane bioreactor (OLMBR). Due to the limited dissolved oxygen (similar to 0.2 mg/L equilibrium concentration) and the increased sludge concentration associated with the hollow fiber membrane, the OLMBR was endowed with an excellent performance on the removal of multi-pollutants. The optimized removal efficiencies of COD, nitrogen (N), and total phosphorus (TP) were approximately 95.5%, 90.0% and 82.6%, respectively (COD/N/P = 500:10:1, influent loading = 5.0 kg COD.m(-3).d(-1), 35 degrees C). Mass balance and bacterial community analysis indicated that the removal of organic carbon was mainly achieved by the methane production process (67.6%). Short-cut nitrification-denitrification (SCND) was observed as the primary denitrification process in the OLMBR, in which the concentrated organic compounds served as the electron donors for denitrification. Nitrosomonas was observed to be the predominant ammonium-oxidizing bacteria, while nitrite-oxidizing bacteria were almost absent in the microbial community as revealed by the high-throughput sequencing technique. In addition, Euryarchaeota and Candidatus, which were well associated with the process of denitrifying anaerobic methane oxidation, were also detected. Sludge absorption was the main route for TP removal in the OLMBR, and the production of PH3 gas also accounted for 19.4% of TP removal. This study suggested that the interception effect of hollow fiber membrane provided higher sludge concentration, therefore offering more bacteria for pollutant removal. The OLMBR can be used for simultaneous removal of highly concentrated organics and nutrients in livestock and poultry breeding wastewater.	[Yang, Shengyun; Yao, Gang] Sichuan Univ, Coll Architecture & Environm, Chengdu, Sichuan, Peoples R China	Sichuan University	Yao, G (corresponding author), Sichuan Univ, Coll Architecture & Environm, Chengdu, Sichuan, Peoples R China.	yaogang1962@163.com			science and technology bureau of Zhongshan city; Huoju industrial district of Zhongshan City, Guangdong Province	science and technology bureau of Zhongshan city; Huoju industrial district of Zhongshan City, Guangdong Province	This work was supported by the grants from the science and technology bureau of Zhongshan city and the Huoju industrial district of Zhongshan City, Guangdong Province (team project for the Langqing Membrane Company, http://www.zskj.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Arevalo J, 2013, DESALIN WATER TREAT, V51, P4839, DOI 10.1080/19443994.2013.795214; Ariesyady HD, 2007, WATER RES, V41, P1554, DOI 10.1016/j.watres.2006.12.036; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bannert A, 2012, BIOGEOSCIENCES, V9, P3891, DOI 10.5194/bg-9-3891-2012; Beer M, 2002, FEMS MICROBIOL LETT, V207, P179, DOI 10.1016/S0378-1097(01)00561-4; Bernet N, 2001, J ENVIRON ENG, V127, P266, DOI 10.1061/(ASCE)0733-9372(2001)127:3(266); Blackall LL, 2002, ANTON LEEUW INT J G, V81, P681, DOI 10.1023/A:1020538429009; Brockmann M, 1996, WATER SCI TECHNOL, V34, P205, DOI 10.1016/S0273-1223(96)00806-2; Carvalho G, 2007, WATER RES, V41, P4383, DOI 10.1016/j.watres.2007.06.065; Coats ER, 2011, WATER ENVIRON RES, V83, P461, DOI 10.2175/106143010X12851009156402; de Almeida NM, 2011, BIOCHEM SOC T, V39, P303, DOI 10.1042/BST0390303; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Fuchs W, 2003, WATER RES, V37, P902, DOI 10.1016/S0043-1354(02)00246-4; Gao DW, 2003, J ENVIRON SCI HEAL A, V38, P2933, DOI 10.1081/ESE-120025842; Hu BL, 2010, WATER RES, V44, P5014, DOI 10.1016/j.watres.2010.07.021; Hu JY, 2003, WATER RES, V37, P3463, DOI 10.1016/S0043-1354(03)00205-7; Hu M, 2012, BIORESOURCE TECHNOL, V117, P72, DOI 10.1016/j.biortech.2012.04.061; Hu SH, 2009, ENV MICROBIOL REP, V1, P377, DOI 10.1111/j.1758-2229.2009.00083.x; Hu YA, 2017, ENVIRON INT, V107, P111, DOI 10.1016/j.envint.2017.07.003; Jegatheesan V, 2016, BIORESOURCE TECHNOL, V204, P202, DOI 10.1016/j.biortech.2016.01.006; JENKINS D, 1991, WATER RES, V25, P1471, DOI 10.1016/0043-1354(91)90177-R; Jenkins RO, 2000, SCI TOTAL ENVIRON, V250, P73, DOI 10.1016/S0048-9697(00)00368-5; Kartal B, 2007, SYST APPL MICROBIOL, V30, P39, DOI 10.1016/j.syapm.2006.03.004; Krzeminski P, 2017, J MEMBRANE SCI, V527, P207, DOI 10.1016/j.memsci.2016.12.010; [廖志民 Liao Zhimin], 2010, [中国给水排水, China Water & Wastewater], V26, P51; Liu FH, 2009, J APPL MICROBIOL, V106, P952, DOI 10.1111/j.1365-2672.2008.04064.x; Liu H, 2013, CHINESE J CHEM ENG, V21, P332, DOI 10.1016/S1004-9541(13)60465-6; Liu YJ, 2009, DESALINATION, V249, P445, DOI 10.1016/j.desal.2009.06.059; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Ma WW, 2017, BIORESOURCE TECHNOL, V244, P84, DOI 10.1016/j.biortech.2017.07.083; Ma Z, 2013, BIORESOURCE TECHNOL, V133, P462, DOI 10.1016/j.biortech.2013.01.023; Mutamim NSA, 2013, CHEM ENG J, V225, P109, DOI 10.1016/j.cej.2013.02.131; Neoh CH, 2016, CHEM ENG J, V283, P582, DOI 10.1016/j.cej.2015.07.060; Oehmen A, 2007, WATER RES, V41, P2271, DOI 10.1016/j.watres.2007.02.030; Pancost RD, 2000, APPL ENVIRON MICROB, V66, P1126, DOI 10.1128/AEM.66.3.1126-1132.2000; Pretel R, 2016, J ENVIRON MANAGE, V166, P45, DOI 10.1016/j.jenvman.2015.10.004; Quan ZX, 2008, ENVIRON MICROBIOL, V10, P3130, DOI 10.1111/j.1462-2920.2008.01642.x; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Robles A, 2012, SEP PURIF TECHNOL, V100, P88, DOI 10.1016/j.seppur.2012.09.010; Roels J, 2001, BIORESOURCE TECHNOL, V79, P243, DOI 10.1016/S0960-8524(01)00032-3; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Shi RJ, 2012, WATER SCI TECHNOL, V65, P254, DOI 10.2166/wst.2012.772; Smith AL, 2012, BIORESOURCE TECHNOL, V122, P149, DOI 10.1016/j.biortech.2012.04.055; Smith RV, 1997, J ENVIRON QUAL, V26, P1049, DOI 10.2134/jeq1997.00472425002600040016x; Tocchi C, 2012, WATER RES, V46, P3334, DOI 10.1016/j.watres.2012.03.032; vanLoosdrecht MCM, 1997, WATER SCI TECHNOL, V35, P41, DOI 10.1016/S0273-1223(96)00877-3; Virdis B, 2010, J BIOTECHNOL, V150, pS153, DOI 10.1016/j.jbiotec.2010.08.398; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Wang YY, 2009, BIORESOURCE TECHNOL, V100, P3506, DOI 10.1016/j.biortech.2009.02.026; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Wang Y, 2016, RSC ADV, V6, P80079, DOI 10.1039/c6ra16510a; Wang ZW, 2014, J MEMBRANE SCI, V471, P258, DOI 10.1016/j.memsci.2014.08.024; Woebken D, 2008, ENVIRON MICROBIOL, V10, P3106, DOI 10.1111/j.1462-2920.2008.01640.x; Wyffels S, 2003, J CHEM TECHNOL BIOT, V78, P412, DOI 10.1002/jctb.808; Yao S, 2017, CHEMOSPHERE, V175, P210, DOI 10.1016/j.chemosphere.2017.02.062; You HS, 2007, IEEE T SEMICONDUCT M, V20, P572, DOI 10.1109/TSM.2007.907634; Zhang XH, 2014, IERI PROC, V9, P2, DOI 10.1016/j.ieri.2014.09.032; Zhu GB, 2007, J ENVIRON SCI, V19, P1043, DOI 10.1016/S1001-0742(07)60170-3	60	3	3	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202179	10.1371/journal.pone.0202179	http://dx.doi.org/10.1371/journal.pone.0202179			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161154	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900024
J	Kordyukova, M; Morgunova, V; Olovnikov, I; Komarov, PA; Mironova, A; Olenkina, OM; Kalmykova, A				Kordyukova, Maria; Morgunova, Valeriya; Olovnikov, Ivan; Komarov, Pavel A.; Mironova, Anastasia; Olenkina, Oxana M.; Kalmykova, Alla			Subcellular localization and Egl-mediated transport of telomeric retrotransposon HeT-A ribonucleoprotein particles in the Drosophila germline and early embryogenesis	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; CHROMOSOME ENDS; MULTIPLE ROLES; PIRNA PATHWAY; MELANOGASTER; EGALITARIAN; PROTEIN; TRANSCRIPTION; MACHINERY; MECHANISM	The study of the telomeric complex in oogenesis and early development is important for understanding the mechanisms which maintain genome integrity. Telomeric transcripts are the key components of the telomeric complex and are essential for regulation of telomere function. We study the biogenesis of transcripts generated by the major Drosophila telomere repeat HeT-A in oogenesis and early development with disrupted telomeric repeat silencing. In wild type ovaries, HeT-A expression is downregulated by the Piwi-interacting RNAs (piR-NAs). By repressing piRNA pathway, we show that overexpressed HeT-A transcripts interact with their product, RNA-binding protein Gag-HeT-A, forming ribonucleoprotein particles (RNPs) during oogenesis and early embryonic development. Moreover, during early stages of oogenesis, in the nuclei of dividing cystoblasts, HeT-A RNP form spherical structures, which supposedly represent the retrotransposition complexes participating in telomere elongation. During the later stages of oogenesis, abundant HeT-A RNP are detected in the cytoplasm and nuclei of the nurse cells, as well as in the cytoplasm of the oocyte. Further on, we demonstrate that HeT-A products co-localize with the transporter protein Egalitarian (Egl) both in wild type ovaries and upon piRNA loss. This finding suggests a role of Egl in the transportation of the HeT-A RNP to the oocyte using a dynein motor. Following germline piRNA depletion, abundant maternal HeT-A RNP interacts with Egl resulting in ectopic accumulation of Egl close to the centrosomes during the syncytial stage of embryogenesis. Given the essential role of Egl in the proper localization of numerous patterning mRNAs, we suggest that its abnormal localization likely leads to impaired embryonic axis specification typical for piRNA pathway mutants.	[Kordyukova, Maria; Morgunova, Valeriya; Olovnikov, Ivan; Komarov, Pavel A.; Mironova, Anastasia; Olenkina, Oxana M.; Kalmykova, Alla] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Komarov, Pavel A.] Lomonosov Moscow State Univ, Dept Biochem, Fac Biol, Moscow, Russia; [Mironova, Anastasia] Russian Acad Sci, Far Eastern Branch, Fed Sci Ctr East Asia Terr Biodivers, Vladivostok, Russia	Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Sciences; Federal Scientific Center of the East Asia Terrestrial Biodiversity, Far Eastern Branch of the Russian Academy of Sciences	Kalmykova, A (corresponding author), Russian Acad Sci, Inst Mol Genet, Moscow, Russia.	allakalm@img.ras.ru	Mironova, Anastasia/Y-9552-2018; Kalmykova, Alla/AAG-2381-2021	Mironova, Anastasia/0000-0002-6882-1767; Morgunova, Valeriya/0000-0002-6232-7661; Komarov, Pavel/0000-0001-9482-0349	Russian Science Foundation [16-14-10167]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (16-14-10167) to A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Azzalin CM, 2015, TRENDS CELL BIOL, V25, P29, DOI 10.1016/j.tcb.2014.08.007; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Chu HP, 2017, CELL, V170, P86, DOI 10.1016/j.cell.2017.06.017; Cohen RS, 2005, RNA, V11, P1017, DOI 10.1261/rna.7218905; Danilevskaya ON, 1998, P NATL ACAD SCI USA, V95, P3770, DOI 10.1073/pnas.95.7.3770; Danilevskaya ON, 1997, CELL, V88, P647, DOI 10.1016/S0092-8674(00)81907-8; Danilevskaya ON, 1999, MOL CELL BIOL, V19, P873; Dienstbier M, 2009, GENE DEV, V23, P1546, DOI 10.1101/gad.531009; Dufourt J, 2014, NUCLEIC ACIDS RES, V42, P2512, DOI 10.1093/nar/gkt1184; Gao GJ, 2010, EMBO J, V29, P819, DOI 10.1038/emboj.2009.394; Garavis M, 2013, GENOME BIOL EVOL, V5, P1142, DOI 10.1093/gbe/evt079; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; Kahn T, 2000, MOL CELL BIOL, V20, P7634, DOI 10.1128/MCB.20.20.7634-7642.2000; Khurana JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001246; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Kordyukova M, 2018, CURR OPIN GENET DEV, V49, P56, DOI 10.1016/j.gde.2018.03.002; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lopez-Panades E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128573; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Maxwell PH, 2006, NUCLEIC ACIDS RES, V34, P5498, DOI 10.1093/nar/gkl709; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Morgunova V, 2015, NUCLEIC ACIDS RES, V43, P8762, DOI 10.1093/nar/gkv775; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; Navarro C, 2009, P NATL ACAD SCI USA, V106, P9691, DOI 10.1073/pnas.0903837106; Olovnikov IA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1023, DOI 10.1134/S000629791609011X; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Radion E, 2017, J MOL BIOL, V429, P3280, DOI 10.1016/j.jmb.2016.12.002; Raffa GD, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00112; Rashkova S, 2002, J CELL BIOL, V159, P397, DOI 10.1083/jcb.200205039; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Ryazansky S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006731; Sanghavi P, 2016, GENETICS, V203, P415, DOI 10.1534/genetics.115.184622; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Scheibe M, 2013, GENOME RES, V23, P2149, DOI 10.1101/gr.151878.112; Shpiz S, 2011, NUCLEIC ACIDS RES, V39, P8703, DOI 10.1093/nar/gkr552; Shpiz S, 2009, NUCLEIC ACIDS RES, V37, P268, DOI 10.1093/nar/gkn960; Siriaco GM, 2002, GENETICS, V160, P235; Taylor MS, 2013, CELL, V155, P1034, DOI 10.1016/j.cell.2013.10.021; THEURKAUF WE, 1993, DEVELOPMENT, V118, P1169, DOI 10.1016/0168-9525(93)90134-4; Vagin Vasily V, 2004, RNA Biol, V1, P54; Van De Bor V, 2005, DEV CELL, V9, P51, DOI 10.1016/j.devcel.2005.04.012; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Ye J, 2014, NAT REV GENET, V15, P491, DOI 10.1038/nrg3743; Zhang L, 2014, EMBO J, V33, P1148, DOI 10.1002/embj.201386940; Zhang Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006435	51	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201787	10.1371/journal.pone.0201787	http://dx.doi.org/10.1371/journal.pone.0201787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157274	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400016
J	Pfeffer, PE; Lu, H; Mann, EH; Chen, YH; Ho, TR; Cousins, DJ; Corrigan, C; Kelly, FJ; Mudway, IS; Hawrylowicz, CM				Pfeffer, Paul E.; Lu, Haw; Mann, Elizabeth H.; Chen, Yin-Huai; Ho, Tzer-Ren; Cousins, David J.; Corrigan, Chris; Kelly, Frank J.; Mudway, Ian S.; Hawrylowicz, Catherine M.			Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matter	PLOS ONE			English	Article							AIR-POLLUTION; DIESEL EXHAUST; ASTHMA; PROTECTION; INDUCE; LUNG; SUPPLEMENTATION; INTERLEUKIN-8; ACTIVATION; MECHANISMS	Background Particulate matter (PM) pollutant exposure, which induces oxidative stress and inflammation, and vitamin D insufficiency, which compromises immune regulation, are detrimental in asthma. Objectives Mechanistic cell culture experiments were undertaken to ascertain whether vitamin D abrogates PM-induced inflammatory responses of human bronchial epithelial cells (HBECs) through enhancement of antioxidant pathways. Methods Transcriptome analysis, PCR and ELISA were undertaken to delineate markers of inflammation and oxidative stress; with comparison of expression in primary HBECs from healthy and asthmatic donors cultured with reference urban PM in the presence/absence of vitamin D. Results Transcriptome analysis identified over 500 genes significantly perturbed by PM-stimulation, including multiple pro-inflammatory cytokines. Vitamin D altered expression of a subset of these PM-induced genes, including suppressing IL6. Addition of vitamin D suppressed PM-stimulated IL-6 production, although to significantly greater extent in healthy versus asthmatic donor cultures. Vitamin D also differentially affected PM-stimulated GM-CSF, with suppression in healthy HBECs and enhancement in asthmatic cultures. Vitamin D increased HBEC expression of the antioxidant pathway gene G6PD, increased the ratio of reduced to oxidised glutathione, and in PM-stimulated cultures decreased the formation of 8-isoprostane. Pre-treatment with vitamin D decreased CXCL8 and further decreased IL-6 production in PM-stimulated cultures, an effect abrogated by inhibition of G6PD with DHEA, supporting a role for this pathway in the anti-inflammatory actions of vitamin D. Conclusions In a study using HBECs from 18 donors, vitamin D enhanced HBEC antioxidant responses and modulated the immune response to PM, suggesting that vitamin D may protect the airways from pathological pollution-induced inflammation.	[Pfeffer, Paul E.; Lu, Haw; Mann, Elizabeth H.; Chen, Yin-Huai; Ho, Tzer-Ren; Cousins, David J.; Corrigan, Chris; Hawrylowicz, Catherine M.] Kings Coll London, Guys Hosp, MRC, London, England; [Pfeffer, Paul E.; Lu, Haw; Mann, Elizabeth H.; Chen, Yin-Huai; Ho, Tzer-Ren; Cousins, David J.; Corrigan, Chris; Hawrylowicz, Catherine M.] Kings Coll London, Guys Hosp, Asthma UK Ctr Allerg Mech Asthma, London, England; [Pfeffer, Paul E.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London, England; [Cousins, David J.] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Cousins, David J.] Glenfield Hosp, NIHR Leicester Biomed Res Ctr Resp, Leicester, Leics, England; [Kelly, Frank J.; Mudway, Ian S.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Franklin Wilkins Bldg, London, England; [Kelly, Frank J.; Mudway, Ian S.] Kings Coll London, NIHR HPRU Hlth Impact Environm Hazards, Franklin Wilkins Bldg, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; Queen Mary University London; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of London; King's College London; University of London; King's College London	Hawrylowicz, CM (corresponding author), Kings Coll London, Guys Hosp, MRC, London, England.; Hawrylowicz, CM (corresponding author), Kings Coll London, Guys Hosp, Asthma UK Ctr Allerg Mech Asthma, London, England.	catherine.hawrylowicz@kcl.ac.uk	Kelly, Frank J/C-6125-2009; Chen, Hebe/ABH-4764-2020; Hawrylowicz, Catherine/Q-8483-2017	Kelly, Frank J/0000-0003-2558-8392; Chen, Hebe/0000-0002-8890-691X; Mann, Elizabeth/0000-0001-8339-2094; Hawrylowicz, Catherine/0000-0002-2337-7463; Pfeffer, Paul/0000-0003-0369-2885; Cousins, David/0000-0003-3821-9596	Wellcome Trust [098882/Z/12/Z]; National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London	PEP was a Wellcome Trust Clinical Research Training Fellow and this research was supported by the Wellcome Trust (Grant 098882/Z/12/Z). This research was also supported by the National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust and NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar SD, 2016, ANN EPIDEMIOL, V26, P355, DOI 10.1016/j.annepidem.2016.03.010; Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138; Bao BY, 2008, INT J CANCER, V122, P2699, DOI 10.1002/ijc.23460; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Behndig AF, 2011, THORAX, V66, P12, DOI 10.1136/thx.2010.140053; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bleck B, 2006, J IMMUNOL, V176, P7431, DOI 10.4049/jimmunol.176.12.7431; Bolcas PE, 2019, J ALLERGY CLIN IMMUN, V143, P386, DOI 10.1016/j.jaci.2018.04.042; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Chambers ES, 2011, CURR ALLERGY ASTHM R, V11, P29, DOI 10.1007/s11882-010-0161-8; Chen XY, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0700-0; Codoner-Franch P, 2012, J PEDIATR-US, V161, P848, DOI 10.1016/j.jpeds.2012.04.046; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; ERGER RA, 1995, AM J PHYSIOL-LUNG C, V268, pL117, DOI 10.1152/ajplung.1995.268.1.L117; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Ghio AJ, 2012, J TOXICOL ENV HEAL B, V15, P1, DOI 10.1080/10937404.2012.632359; Gomes EC, 2011, SCAND J MED SCI SPOR, V21, pE452, DOI 10.1111/j.1600-0838.2011.01366.x; Gowers AM, 2012, RESPIROLOGY, V17, P887, DOI 10.1111/j.1440-1843.2012.02195.x; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Herr C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-31; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hosoki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126035; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; ITIN PH, 1994, ENDOCRINOLOGY, V135, P1793, DOI 10.1210/en.135.5.1793; Jacquemin B, 2015, ENVIRON HEALTH PERSP, V123, P613, DOI 10.1289/ehp.1408206; Kelly FJ, 2011, CLIN EXP ALLERGY, V41, P1059, DOI 10.1111/j.1365-2222.2011.03776.x; Kent KD, 2003, IN VITRO CELL DEV-AN, V39, P388; Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC; Kim CK, 2010, RESP MED, V104, P1436, DOI 10.1016/j.rmed.2010.03.023; Lan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111599; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253; Mak Judith C W, 2013, ISRN Allergy, V2013, P561831, DOI 10.1155/2013/561831; Mann EH, 2017, AM J RESP CELL MOL, V57, P355, DOI 10.1165/rcmb.2016-0409OC; Mann EH, 2014, ANN NY ACAD SCI, V1317, P57, DOI 10.1111/nyas.12410; Martineau AR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011511.pub2; MARTINEAU AR, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.I6583; Matthews NC, 2016, AM J RESP CELL MOL, V54, P250, DOI 10.1165/rcmb.2015-0084OC; Miller RL, 2014, J ALLERGY CLIN IMMUN, V134, P1001, DOI 10.1016/j.jaci.2014.07.064; Moore E, 2016, ANN AM THORAC SOC, V13, P1814, DOI 10.1513/AnnalsATS.201601-064OC; Morgan KA, 2017, PHOTOCH PHOTOBIO SCI, V16, P399, DOI 10.1039/c6pp00407e; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; National Institute of Standards & Technology, 2015, STAND REF MAT 1648A; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; Orellano P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174050; Paine R, 2003, AM J PATHOL, V163, P2397, DOI 10.1016/S0002-9440(10)63594-8; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peng XJ, 2010, J CELL BIOCHEM, V110, P1324, DOI 10.1002/jcb.22646; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeffer PE, 2018, CHEST, V153, P1229, DOI 10.1016/j.chest.2017.09.005; Pfeffer PE, 2015, J ALLERGY CLIN IMMUN, V135, P824, DOI 10.1016/j.jaci.2014.09.044; Pfeffer Paul E, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS314, DOI 10.1513/AnnalsATS.201405-204AW; Rivas-Santiago CE, 2015, INFECT IMMUN, V83, P2507, DOI 10.1128/IAI.03018-14; Rohde CM, 1999, J NUTR, V129, P2246, DOI 10.1093/jn/129.12.2246; Rosser F, 2014, AM J RESP CRIT CARE, V190, P1190, DOI 10.1164/rccm.201408-1568LE; Shute JK, 1997, AM J RESP CRIT CARE, V155, P1877, DOI 10.1164/ajrccm.155.6.9196089; Sienra-Monge JJ, 2004, CLIN EXP IMMUNOL, V138, P317, DOI 10.1111/j.1365-2249.2004.02606.x; SOLOPERTO M, 1991, AM J PHYSIOL, V260, pL530, DOI 10.1152/ajplung.1991.260.6.L530; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Stratford K, 2018, ENVIRON SCI TECHNOL, V52, P3054, DOI 10.1021/acs.est.7b04882; Sturrock A, 2012, AM J PHYSIOL-LUNG C, V302, pL343, DOI 10.1152/ajplung.00276.2011; Sun J, 2014, PLACENTA, V35, P143, DOI 10.1016/j.placenta.2013.12.002; Tashakkor AY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-532; Teng Y, 2011, CHEST, V140, P108, DOI 10.1378/chest.10-2816; Vrijheid M, 2014, THORAX, V69, P876, DOI 10.1136/thoraxjnl-2013-204949; Yang X, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6470364; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zhong J, 2017, SCI REP-UK, V7, DOI 10.1038/srep45322; Zuo L, 2013, MOL IMMUNOL, V56, P57, DOI 10.1016/j.molimm.2013.04.002	72	53	54	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0200040	10.1371/journal.pone.0200040	http://dx.doi.org/10.1371/journal.pone.0200040			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157189	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400004
J	Choi, YK; Park, JH; Yun, JA; Cha, JH; Kim, Y; Won, MH; Kim, KW; Hai, KS; Kwon, YG; Kim, YM				Choi, Yoon Kyung; Park, Joon Ha; Yun, Jung-A; Cha, Jong-Ho; Kim, Yonghee; Won, Moo-Ho; Kim, Kyu-Won; Hai, Kwon-Soo; Kwon, Young-Guen; Kim, Young-Myeong			Heme oxygenase metabolites improve astrocytic mitochondrial function via a Ca2+-dependent HIF-1 alpha/ERR alpha circuit	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; ENDOTHELIAL GROWTH-FACTOR; BLOOD-BRAIN-BARRIER; VEGF EXPRESSION; ISCHEMIC-STROKE; HIF-ALPHA; ANGIOGENESIS; BIOGENESIS; ACTIVATION; PROTEIN	Heme oxygenase-1 (HO-1) exerts beneficial effects, including angiogenesis and energy metabolism via the hypoxia-inducible factor-1 alpha (HIF-1 alpha) and peroxisome-proliferator-activating receptor-v coactivator-1 alpha (PGC-1 alpha)/estrogen-related receptor alpha (ERR alpha) pathways, respectively, in astrocytes. However, evidence of cross-talk between both pathways in HO metabolite-mediated mitochondrial biogenesis has not been well elucidated. Here, we found that HIF-1 alpha was upregulated in astrocytes after ischemic brain injury following exposure to the carbon monoxide (CO)-releasing compound CORM-2. Experiments with pharmacological inhibitors and target-specific siRNAs revealed that HIF-1 alpha levels were highly correlated with increased PGC-1 alpha and ERRa levels, which were linked to the HO metabolites CO- and bilirubin-induced activation of apical L-type Ca2+ channel and sequential Ca2+-dependent signal transduction. Moreover, HIF-1 alpha was stabilized in a proline hydroxylase-dependent manner by transient induction of intracellular hypoxia via the PGC-1 alpha/ERR alpha-induced increases in mitochondrial biogenesis and oxygen consumption. HIF-1 alpha knockdown blocked HO-1 system-mediated transcriptional expression of ERR alpha, but not of PGC-1 alpha, suggesting a possible involvement of HIF-1 alpha in ERR alpha-mediated mitochondrial biogenesis. These data suggest that the HO-1-derived metabolites, CO and bilirubin, elevate astrocytic mitochondrial function via a HIF-1 alpha/ERR alpha circuit coupled with L-type Ca2+ channel activation and PGC-1 alpha-mediated oxygen consumption. This circuit may play an important role in repairing neurovascular function after focal ischemic brain injury by stimulating mitochondrial biogenesis.	[Choi, Yoon Kyung; Kim, Yonghee] Konkuk Univ, Dept Integrat Biosci & Biotechnol, Seoul, South Korea; [Park, Joon Ha; Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon, Kangwon Do, South Korea; [Yun, Jung-A; Hai, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon, Kangwon Do, South Korea; [Cha, Jong-Ho; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Cha, Jong-Ho; Kim, Kyu-Won] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea; [Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea	Konkuk University; Kangwon National University; Kangwon National University; Seoul National University (SNU); Seoul National University (SNU); Yonsei University	Choi, YK (corresponding author), Konkuk Univ, Dept Integrat Biosci & Biotechnol, Seoul, South Korea.; Kim, YM (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon, Kangwon Do, South Korea.	ykchoi@konkuk.ac.kr; ymkim@kangwon.ac.kr	Choi, Yoon Kyung/AGX-0481-2022; Kim, Kyu Won/AAJ-7213-2020	Choi, Yoon Kyung/0000-0003-0242-9612; Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2017R1E1A2A01077606, 2017R1A2B3004565, 2015M3A9E6028949]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C2160]	National Research Foundation of Korea (NRF) - Korea Government (MSIP); Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (2017R1E1A2A01077606 to Y.K.C., 2017R1A2B3004565 to Y.M.K., and 2015M3A9E6028949 to Y.M.K.). This research was also supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI17C2160 to Y.K.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (2017R1E1A2A01077606, 2017R1A2B3004565, and 2015M3A9E6028949). This research was also supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI17C2160).	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Choi YK, 2007, J NEUROSCI, V27, P4472, DOI 10.1523/JNEUROSCI.5368-06.2007; Choi YK, 2017, ANTIOXID REDOX SIGN, V27, P21, DOI 10.1089/ars.2016.6684; Choi YK, 2016, BIOCHEM BIOPH RES CO, V479, P297, DOI 10.1016/j.bbrc.2016.09.063; Choi YK, 2010, J BIOL CHEM, V285, P32116, DOI 10.1074/jbc.M110.131284; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Farshbaf MJ, 2016, NEUROMOL MED, V18, P1, DOI 10.1007/s12017-015-8370-x; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Imuta N, 2007, ANTIOXID REDOX SIGN, V9, P543, DOI 10.1089/ars.2006.1519; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Joo HY, 2015, BIOCHEM BIOPH RES CO, V462, P294, DOI 10.1016/j.bbrc.2015.04.119; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Nada SE, 2014, MOL NEUROBIOL, V49, P945, DOI 10.1007/s12035-013-8572-x; Neary MT, 2014, J MOL CELL CARDIOL, V74, P340, DOI 10.1016/j.yjmcc.2014.06.013; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Panahian N, 1999, J NEUROCHEM, V72, P1187; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhu L, 2010, CELL RES, V20, P605, DOI 10.1038/cr.2010.71; Zucker SD, 1999, J BIOL CHEM, V274, P10852, DOI 10.1074/jbc.274.16.10852	47	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202039	10.1371/journal.pone.0202039	http://dx.doi.org/10.1371/journal.pone.0202039			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153269	gold, Green Published, Green Submitted			2022-12-27	WOS:000443001700005
J	Ling, XM; Huang, ZR; Wang, CC; Zhang, F; Wang, P				Ling, Ximan; Huang, Zhiren; Wang, Chengcheng; Zhang, Fan; Wang, Pu			Predicting subway passenger flows under different traffic conditions	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; TRAVEL-TIME PREDICTION; NEURAL-NETWORK MODEL; SERIES; DYNAMICS; VOLUME	Passenger flow prediction is important for the operation, management, efficiency, and reliability of urban rail transit (subway) system. Here, we employ the large-scale subway smart-card data of Shenzhen, a major city of China, to predict dynamical passenger flows in the subway network. Four classical predictive models: historical average model, multilayer perceptron neural network model, support vector regression model, and gradient boosted regression trees model, were analyzed. Ordinary and anomalous traffic conditions were identified for each subway station by using the density-based spatial clustering of applications with noise (DBSCAN) algorithm. The prediction accuracy of each predictive model was analyzed under ordinary and anomalous traffic conditions to explore the high-performance condition (ordinary traffic condition or anomalous traffic condition) of different predictive models. In addition, we studied how long in advance that passenger flows can be accurately predicted by each predictive model. Our finding highlights the importance of selecting proper models to improve the accuracy of passenger flow prediction, and that inherent patterns of passenger flows are more prominently influencing the accuracy of prediction.	[Ling, Ximan; Huang, Zhiren; Wang, Chengcheng; Wang, Pu] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Zhang, Fan] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China	Central South University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Wang, P (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	wangpu@csu.edu.cn	Huang, Zhiren/O-7081-2019	Huang, Zhiren/0000-0002-7868-1630	National Natural Science Foundation of China [61473320]; National Key Research and Development Program of China [2016YFB1200401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) no. 61473320, and by the National Key Research and Development Program of China (http://program.most.gov.cn) no. 2016YFB1200401. These fundings were received by PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhai B, 1999, CALIFORNIA PARTNERS, P219; Ahmed MS, 1979, TRANSPORTATION RES R, V116; Bartholomew D., 1971, J BUSINESS, V22, P199, DOI [DOI 10.1057/JORS.1971.52, DOI 10.1086/295406]; Chrobok R, 2001, 2001 IEEE INTELLIGENT TRANSPORTATION SYSTEMS - PROCEEDINGS, P434, DOI 10.1109/ITSC.2001.948696; Clark S, 2003, J TRANSP ENG, V129, P161, DOI 10.1061/(ASCE)0733-947X(2003)129:2(161); CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DAVIS GA, 1991, J TRANSP ENG-ASCE, V117, P178, DOI 10.1061/(ASCE)0733-947X(1991)117:2(178); Ding C, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8111100; DOUGHERTY M, 1995, TRANSPORT RES C-EMER, V3, P247, DOI 10.1016/0968-090X(95)00009-8; Drucker H, 1997, ADV NEUR IN, V9, P155; Du WB, 2014, CHAOS SOLITON FRACT, V68, P72, DOI 10.1016/j.chaos.2014.07.009; Ester M., 1996, DENSITY BASED ALGORI, V96, P226; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; He GG, 2002, IEEE 5TH INTERNATIONAL CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, PROCEEDINGS, P731, DOI 10.1109/ITSC.2002.1041309; He K, 2016, IEEE T INTELL TRANSP, V17, P2613, DOI 10.1109/TITS.2015.2498186; He K, 2015, PHYSICA A, V431, P1, DOI 10.1016/j.physa.2015.02.087; Huang ZR, 2018, TRANSPORT RES B-METH, V114, P147, DOI 10.1016/j.trb.2018.05.016; Jiang XS, 2014, TRANSPORT RES C-EMER, V44, P110, DOI 10.1016/j.trc.2014.03.016; Jiang XM, 2005, J TRANSP ENG, V131, P771, DOI 10.1061/(ASCE)0733-947X(2005)131:10(771); Li DQ, 2015, P NATL ACAD SCI USA, V112, P669, DOI 10.1073/pnas.1419185112; Li H, 2012, STAT LEARNING METHOD, P137; Li RM, 2016, IEEE-CAA J AUTOMATIC, V3, P141, DOI 10.1109/JAS.2016.7451101; Li Y, 2017, TRANSPORT RES C-EMER, V77, P306, DOI 10.1016/j.trc.2017.02.005; Li ZH, 2014, IEEE INTEL TRANSP SY, V6, P34, DOI 10.1109/MITS.2014.2332591; Lv YS, 2017, IEEE-CAA J AUTOMATIC, V4, P19, DOI 10.1109/JAS.2017.7510316; Ma XL, 2018, COMPUT ENVIRON URBAN, V70, P113, DOI 10.1016/j.compenvurbsys.2018.03.001; McCrea J, 2010, EUR J OPER RES, V207, P676, DOI 10.1016/j.ejor.2010.05.018; OKUTANI I, 1984, TRANSPORT RES B-METH, V18, P1, DOI 10.1016/0191-2615(84)90002-X; Park B, 1998, TRANSPORT RES REC, P39, DOI 10.3141/1651-06; Park D, 1999, J TRANSP ENG, V125, P515, DOI 10.1061/(ASCE)0733-947X(1999)125:6(515); RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schimbinschi F, 2017, EXPERT SYST APPL, V82, P301, DOI 10.1016/j.eswa.2017.04.015; Smith BL, 1997, J TRANSP ENG-ASCE, V123, P261, DOI 10.1061/(ASCE)0733-947X(1997)123:4(261); Stephanedes Y.J., 1981, TRR, P28; Sun YX, 2015, NEUROCOMPUTING, V166, P109, DOI 10.1016/j.neucom.2015.03.085; Tseng FM, 2002, TECHNOL FORECAST SOC, V69, P71, DOI 10.1016/S0040-1625(00)00113-X; van Lint JWC, 2002, TRANSPORT RES REC, P30, DOI 10.3141/1811-04; Vanajakshi L, 2007, 2007 IEEE INTELLIGENT VEHICLES SYMPOSIUM, VOLS 1-3, P7; Vlahogianni EI, 2005, TRANSPORT RES C-EMER, V13, P211, DOI 10.1016/j.trc.2005.04.007; Vythoulkas PC, 1993, 12 INT S TRAFF FLOW, P22; Walker G, 1931, P R SOC LOND A-CONTA, V131, P518, DOI 10.1098/rspa.1931.0069; Wang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080178; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01001; Wang YB, 2008, TRANSPORT RES A-POL, V42, P1340, DOI 10.1016/j.tra.2008.06.001; Wei Y, 2012, TRANSPORT RES C-EMER, V21, P148, DOI 10.1016/j.trc.2011.06.009; Williams BM, 2003, J TRANSP ENG, V129, P664, DOI 10.1061/(ASCE)0733-947X(2003)129:6(664); Wu CH, 2004, IEEE T INTELL TRANSP, V5, P276, DOI 10.1109/TITS.2004.837813; Xue R, 2015, DISCRETE DYN NAT SOC, V2015, DOI 10.1155/2015/682390; Yang X, 2017, IEEE T INTELL TRANSP, V18, P259, DOI 10.1109/TITS.2016.2566801; Yule GU, 1927, PHILOS T R SOC LOND, V226, P267, DOI 10.1098/rsta.1927.0007; Zhang YL, 2008, J INTELL TRANSPORT S, V12, P102, DOI 10.1080/15472450802262281; Zheng XH, 2016, IEEE T INTELL TRANSP, V17, P620, DOI 10.1109/TITS.2015.2480157; Zheng ZH, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0148-6; Zhou Z.H., 2016, MACHING LEARNING, V1, P97	54	13	14	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202707	10.1371/journal.pone.0202707	http://dx.doi.org/10.1371/journal.pone.0202707			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148888	gold, Green Submitted, Green Published			2022-12-27	WOS:000442804200020
J	Garcia-Arroyo, FE; Gonzaga, G; Munoz-Jimenez, I; Blas-Marron, MG; Silverio, O; Tapia, E; Soto, V; Ranganathan, N; Ranganathan, P; Vyas, U; Irvin, A; Ir, D; Robertson, CE; Frank, DN; Johnson, RJ; Sanchez-Lozada, LG				Garcia-Arroyo, Fernando E.; Gonzaga, Guillermo; Munoz-Jimenez, Itzel; Blas-Marron, Monica G.; Silverio, Octaviano; Tapia, Edilia; Soto, Virgilia; Ranganathan, Natarajan; Ranganathan, Pari; Vyas, Usha; Irvin, Anthony; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.; Johnson, Richard J.; Gabriela Sanchez-Lozada, L.			Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM URIC-ACID; CELL-PROLIFERATION; OXIDATIVE STRESS; RAT MODEL; HYPERTENSION; EXPRESSION; INTESTINE; INJURY; ABCG2	Hyperuricemia is highly prevalent and especially common in subjects with metabolic, cardiovascular and renal diseases. In chronic kidney disease, hyperuricemia is extremely common, and uric acid (UA) excretion relies on gut uricolysis by gut microbiota. Current therapy for lowering serum UA includes drugs that may produce undesired secondary effects. Therefore, this pilot study was designed to evaluate the potential of two probiotic supplements to reduce systemic uric acid concentrations. Secondary objectives were to assess whether the hypouricemic effect related to a therapeutic benefit on the hyperuricemia-induced renal damage and hypertension. Analysis of fecal microbiota was also performed. Groups of 6 rats each were followed for 5 weeks and allocated in the following treatment groups: C = Control; HU-ND = Oxonic acid-induced hyperuricemia (HU)+regular diet; HU-P = HU+placebo; HU-F1 = HU+probiotics formula 1 and HU-F2 = HU+probiotics formula 2. We confirmed that oxonic acid-induced hyperuricemia produced hypertension and renal functional and structural changes, along with modest changes in the overall composition of fecal microbiota. Both probiotic-containing diets prevented HU, elevated UA urinary excretion and intrarenal UA accumulation induced by oxonic acid. The hypouricemic effect conferred by probiotic supplementation also prevented the renal changes and hypertension caused by hyperuricemia. However, probiotic treatment did not restore the fecal microbiota. In conclusion, we demonstrated for the first time the ability of probiotics containing uricolytic bacteria to lower serum uric acid in hyperuricemic animals with beneficial consequences on blood pressure and renal disease. As probiotics supplements are innocuous for human health, we recommend clinical studies to test if probiotic supplements could benefit hyperuricemic individuals.	[Garcia-Arroyo, Fernando E.; Gonzaga, Guillermo; Munoz-Jimenez, Itzel; Blas-Marron, Monica G.; Silverio, Octaviano; Tapia, Edilia; Gabriela Sanchez-Lozada, L.] INC Ignacio Chavez, Lab Renal Physiopathol, Mexico City, DF, Mexico; [Soto, Virgilia] INC Ignacio Chavez, Dept Pathol, Mexico City, DF, Mexico; [Ranganathan, Natarajan; Ranganathan, Pari; Vyas, Usha; Irvin, Anthony] Kibow Biotech, Newtown Sq, PA USA; [Ir, Diana; Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Div Infect Dis, Aurora, CO USA; [Johnson, Richard J.] Univ Colorado, Renal Dis & Hypertens, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Sanchez-Lozada, LG (corresponding author), INC Ignacio Chavez, Lab Renal Physiopathol, Mexico City, DF, Mexico.	lgsanchezlozada@gmail.com	Sanchez-Lozada, Laura/AAS-2104-2021	ROBERTSON, CHARLES/0000-0002-4136-4121; Tapia, Edilia/0000-0001-7955-816X; Garcia, Fernando/0000-0003-1545-9765; Vyas, Usha/0000-0002-1860-9872; Sanchez-Lozada, Laura-Gabriela/0000-0003-0348-9617	Kibow Biotech; Kibow Biotech, Inc; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	Kibow Biotech; Kibow Biotech, Inc; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Kibow Biotech. The funder had a role in the study design, provided the experimental diets, participated in the preparation of the manuscript and approved the final version of the manuscript. The funder (Kibow Biotech, Inc) provided support in the form of salaries for authors [NR, PR, UV, AI], manufactured all product formula for testing and completely funded the study for extending the positive in-vitro lab results to the in-vivo rat models, but did have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ARELDUBEAU AM, 2014, OXIDATIVE MED CELLUL, DOI DOI 10.1155/2014/; Bhatnagar V, 2016, CLIN KIDNEY J, V9, P444, DOI 10.1093/ckj/sfw010; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; De Cosmo S, 2015, CLIN J AM SOC NEPHRO, V10, P1921, DOI 10.2215/CJN.03140315; DeBosch BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5642; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ejaz AA, 2013, INT UROL NEPHROL, V45, P449, DOI 10.1007/s11255-012-0192-2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feig DI, 2013, J PEDIATR-US, V162, P896, DOI 10.1016/j.jpeds.2012.12.078; Goicoechea M, 2015, AM J KIDNEY DIS, V65, P543, DOI 10.1053/j.ajkd.2014.11.016; Guo Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep20602; Hobbs DJ, 2010, PEDIATR NEPHROL, V25, P305, DOI 10.1007/s00467-009-1352-1; Hosomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030456; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Jin TR, 2018, AM J PHYSIOL-ENDOC M, V314, pE201, DOI 10.1152/ajpendo.00285.2017; Johnson RJ, 2018, AM J KIDNEY DIS, V71, P851, DOI 10.1053/j.ajkd.2017.12.009; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kanbay M, 2017, ANGIOLOGY, V68, P132, DOI 10.1177/0003319716644395; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Komori H, 2018, BBA-BIOMEMBRANES, V1860, P973, DOI 10.1016/j.bbamem.2018.01.006; Koratala A, 2016, NEPHRON, V134, P231, DOI 10.1159/000448629; Krishnan E, 2013, ARTHRITIS RHEUM-US, V65, P3271, DOI 10.1002/art.38171; Kupferman J, 2016, AM J KIDNEY DIS, V68, P716, DOI 10.1053/j.ajkd.2016.06.012; Lanaspa MA, 2011, SEMIN NEPHROL, V31, P426, DOI 10.1016/j.semnephrol.2011.08.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li ZH, 2016, MOL MED REP, V13, P4343, DOI 10.3892/mmr.2016.5083; Mallat SG, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0684-z; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Mintz M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190997; Nacak H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-91; Nagura M, 2016, NUCLEOS NUCLEOT NUCL, V35, P550, DOI 10.1080/15257770.2016.1163379; Needell JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183786; Nycz BT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191232; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF1238, DOI 10.1152/ajprenal.00164.2006; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Sanchez-Lozada LG, 2005, SEMIN NEPHROL, V25, P19, DOI 10.1016/j.semnephrol.2004.09.004; Sanchez-Lozada LG, 2008, NEPHROLDIALTRANSPLAN; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; SORENSEN LEIF B., 1965, ARTHRITIS RHEUM, V8, P694, DOI 10.1002/art.1780080429; Tapia E, 2016, FREE RADICAL RES, V50, P781, DOI 10.1080/10715762.2016.1174776; Trujillo J, 2013, REDOX BIOL; Vargas-Santos AB, 2017, AM J KIDNEY DIS, V70, P422, DOI 10.1053/j.ajkd.2017.01.055; Wang WQ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006843; Xia X, 2016, METABOLISM, V65, P1326, DOI 10.1016/j.metabol.2016.05.009; Yano H, 2014, CLIN EXP NEPHROL, V18, P50, DOI 10.1007/s10157-013-0806-8; Zuo T, 2016, INT J CARDIOL, V224, P286, DOI 10.1016/j.ijcard.2016.09.033	55	39	45	17	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202901	10.1371/journal.pone.0202901	http://dx.doi.org/10.1371/journal.pone.0202901			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142173	Green Published, gold			2022-12-27	WOS:000442722500047
J	Yang, J; Min, KW; Kim, DH; Son, BK; Moon, KM; Wi, YC; Bang, SS; Oh, YH; Do, SI; Chae, SW; Oh, S; Kim, YH; Kwon, MJ				Yang, Jungho; Min, Kyueng-Whan; Kim, Dong-Hoon; Son, Byoung Kwan; Moon, Kyoung Min; Wi, Young Chan; Bang, Seong Sik; Oh, Young Ha; Do, Sung-Im; Chae, Seoung Wan; Oh, Sukjoong; Kim, Young Hwan; Kwon, Mi Jung			High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE-9 MMP-9; MATRIX METALLOPROTEINASES; EXPRESSION; CARCINOMA; ANGIOGENESIS; PROGRESSION; INVASION; COLLAGEN; CELLS	Background Matrix metalloproteinase-9 (MMP-9) is associated with remodelling of the extracellular matrix and invasion in various cancers. Identifying proteins connected to high MMP-9 expression is important in explaining its mechanisms. Our study aims to shed light on genes associated with high MMP-9 expression and to discuss their clinical impact in breast cancer. Methods We evaluated 173 breast cancer cases from the Kangbuk Samsung Hospital, with 1964 cases from the Molecular Taxonomy of Breast Cancer International Consortium database serving as a validation cohort. We investigated relationships between MMP-9 expression and clinicopathological characteristics. We then used gene set enrichment analyses to detect the association of genes with MMP-9 overexpression, and performed survival analyses to determine the significance of the gene in three independent cohorts. Results High MMP-9 expression correlated with poor prognosis in univariate and multivariate analyses. Using gene set enrichment analysis, we found that tumour necrosis factor receptor superfamily member 12A (TNFRSF12A) was linked to high MMP-9 expression. In the survival analysis of three published data sets (METABRIC, GSE1456, GSE20685), high TNFRSF12A was relevant to a poor survival rate. Conclusions High levels of TNFRSF12A associated with MMP-9 overexpression may be important to explain the progression of breast cancer, and survival could be improved using therapy targeting TNFRSF12A.	[Yang, Jungho; Kim, Dong-Hoon; Do, Sung-Im; Chae, Seoung Wan] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, Seoul, South Korea; [Min, Kyueng-Whan; Oh, Young Ha] Hanyang Univ, Coll Med, Dept Pathol, Guri Hosp, Guri, Gyeonggi Do, South Korea; [Son, Byoung Kwan] Eulji Univ, Eulji Hosp, Dept Internal Med, Sch Med, Seoul, South Korea; [Moon, Kyoung Min] Univ Ulsan, Gangneung Asan Hosp, Dept Internal Med, Coll Med, Kangnung, South Korea; [Wi, Young Chan; Bang, Seong Sik] Hanyang Univ, Dept Pathol, Coll Med, Seoul, South Korea; [Oh, Sukjoong] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Sch Med, Seoul, South Korea; [Kim, Young Hwan] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Nucl Med, Sch Med, Seoul, South Korea; [Kwon, Mi Jung] Hallym Univ, Coll Med, Dept Pathol, Sacred Heart Hosp, Anyang, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Eulji University; University of Ulsan; Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Hallym University	Kim, DH (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Pathol, Sch Med, Seoul, South Korea.; Min, KW (corresponding author), Hanyang Univ, Coll Med, Dept Pathol, Guri Hosp, Guri, Gyeonggi Do, South Korea.	kyueng@gmail.com; idavid.kim@samsung.com			Bumsuk Academic Research Fund in 2017	Bumsuk Academic Research Fund in 2017	This paper was supported by the Bumsuk Academic Research Fund in 2017.	Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Giussani M, 2015, SEMIN CANCER BIOL, V35, P3, DOI 10.1016/j.semcancer.2015.09.012; Jablonska-Trypuc A, 2016, J ENZYM INHIB MED CH, V31, P177, DOI 10.3109/14756366.2016.1161620; Jadhav U, 2004, INT J ONCOL, V25, P1407; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Kodate M, 1997, PATHOL INT, V47, P461, DOI 10.1111/j.1440-1827.1997.tb04525.x; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Nart D, 2010, LIVER TRANSPLANT, V16, P621, DOI 10.1002/lt.22028; PAGE DL, 1983, HISTOPATHOLOGY, V7, P525, DOI 10.1111/j.1365-2559.1983.tb02265.x; Papathoma AS, 2000, ANTICANCER RES, V20, P2009; Parise CA, 2009, BREAST J, V15, P593, DOI 10.1111/j.1524-4741.2009.00822.x; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; Peng YP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-738; Prat A, 2014, J NATL CANC I, V106; Puzovic V, 2014, NEOPLASMA, V61, P439, DOI 10.4149/neo_2014_054; Rahko E, 2004, ANTICANCER RES, V24, P4247; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Scorilas A, 2001, BRIT J CANCER, V84, P1488, DOI 10.1054/bjoc.2001.1810; Shen ZX, 2017, ENVIRON TOXICOL PHAR, V51, P1, DOI 10.1016/j.etap.2017.02.001; Sillanpaa S, 2007, GYNECOL ONCOL, V104, P296, DOI 10.1016/j.ygyno.2006.09.004; Tabouret E, 2016, ONCOTARGET, V7, P18531, DOI 10.18632/oncotarget.7612; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Zeng ZS, 1999, CARCINOGENESIS, V20, P749, DOI 10.1093/carcin/20.5.749	26	15	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202113	10.1371/journal.pone.0202113	http://dx.doi.org/10.1371/journal.pone.0202113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142200	Green Submitted, Green Published, gold			2022-12-27	WOS:000442722500007
J	Hanif, M; Shoaib, MH; Yousuf, RI; Zafar, F				Hanif, Muhammad; Shoaib, Muhammad Harris; Yousuf, Rabia Ismail; Zafar, Farya			Development of in vitro - in vivo correlations for newly optimized Nimesulide formulations	PLOS ONE			English	Article							BIORELEVANT DISSOLUTION; VIVO PERFORMANCE; DRUG PRODUCTS; DOSAGE FORMS; RELEASE; TABLETS; PLASMA; IVIVC; BIOEQUIVALENCE; PROFILE	Use of the human volunteers in bioequivalence studies is being discouraged by the Food and drug administration after the introduction of biowaiver approaches. In-vitro in-vivo correlation (IVIVC) with the level A is accepted for the registration of new molecules. In the present study deconvolution technique with numeric approaches was applied after compressing and in vitro validating the 100mg Nimesulide immediate, intermediate and slow release tablets. Single centered, crossover, randomized study was conducted in four phases with a two-week washout period to obtain the plasma drug concentration data after administrating test and reference products in male healthy volunteers. Kinetica (TM) 4.4.1 (Thermoelectron corp, USA) was used for the calculation of two ways ANOVA with 90% CI from both log transformed and non- transformed data and Phoenix WinNonlin 7 and it's IVIVC toolkit version 7.0 was used for the application of numeric approaches of IVIVC. Results revealed that the individual internal percentage prediction error for AUC(inf )and C-max were found to be < 15% while their average values were < 10% in all medium. Numeric values of % PE at pH 6.8 and pH 7.4 (50 rpm in USP II and 100 rpm in USP I and II apparatus) were found to be (2.5842, 2.9789 and, 7.1732; 7.0944, 2.4721 and 4.350) for AUC(inf) and (2.5842, 0.5736 and 4.6928; 5.6214, 3.0551 and -2.4711) values for C-max respectively. The low values of prediction errors demonstrate that the correlation model is projecting the in vivo response of each formulation. Percentage External error (% PE) was not required because individual values of percentage internal error (%PE) of C-max and AUC(last) were not >15. In order to predict point to point correlation between fraction drug dissolved and drug absorbed, their mean r(2) value was found to be > 0.9112 which showed a linear correlation in slightly alkaline pH.	[Hanif, Muhammad] Bahaudin Zakaria Univ Multan, Fac Pharm, Dept Pharmaceut, Punjab, Pakistan; [Shoaib, Muhammad Harris; Yousuf, Rabia Ismail; Zafar, Farya] Univ Karachi, Fac Pharm & Pharmaceut Sci, Dept Pharmaceut, Karachi, Pakistan	University of Karachi	Hanif, M (corresponding author), Bahaudin Zakaria Univ Multan, Fac Pharm, Dept Pharmaceut, Punjab, Pakistan.	muhammad.hanif@bzu.edu.pk	Shoaib, Muhammad/AAR-8933-2020	Shoaib, Muhammad/0000-0002-3639-0026; Pharmaceutics, Rabia Ismail Yousuf/0000-0003-2341-3011				Ali H, 2016, PAKISTAN J PHARM SCI, V29; Bendas ER, 2009, ARCH PHARM RES, V32, P1317, DOI 10.1007/s12272-009-1918-2; Bernareggi Alberto, 2001, Inflammopharmacology, V9, P81, DOI 10.1163/156856001300248353; CASTOLDI D, 1988, J CHROMATOGR-BIOMED, V425, P413, DOI 10.1016/0378-4347(88)80048-3; Dressman J., 2005, PHARM DISSOLUTION TE; Eddington ND, 1998, PHARMACEUT RES, V15, P466, DOI 10.1023/A:1011988601696; Emami J, 2006, J PHARM PHARM SCI, V9, P169; Galia E, 1998, PHARMACEUT RES, V15, P698, DOI 10.1023/A:1011910801212; Hanif M, 2014, PAKISTAN J PHARM SCI, V27; Hanif M, 2011, J PHARM RES, V4, P2447; Hanif M, 2013, LAT AM J PHARM, V32, P225; Hanif M, 2011, AFR J PHARM PHARMACO, V5, P2342, DOI 10.5897/AJPP11.545; Hiremath PS, 2008, DRUG DELIV, V15, P159, DOI [10.1080/10717540801952498, 10.1080/10717540801952498 ]; Jantratid E, 2006, CLIN PHARMACOKINET, V45, P385, DOI 10.2165/00003088-200645040-00004; Khan A, 2015, LAT AM J PHARM, V34, P269; Klein S, 2010, AAPS J, V12, P397, DOI 10.1208/s12248-010-9203-3; Lue BM, 2008, EUR J PHARM BIOPHARM, V69, P648, DOI 10.1016/j.ejpb.2007.12.013; Macha S, 2009, BIOPHARM DRUG DISPOS, V30, P542, DOI 10.1002/bdd.691; Malinowski H, 1997, VITRO IN VIVO CORREL, P269; Midha KK, 1997, J PHARM SCI-US, V86, P1193, DOI 10.1021/js960516+; Murthy CD, 2007, PHARM PRODUCT DEV IN; Nishimura H, 2007, BIOL PHARM BULL, V30, P2221, DOI 10.1248/bpb.30.2221; Ranjha NM., 2014, INT J PHARM SCI, V6, P410; Sakore S, 2011, J BIOEQUIV AVAILAB S, DOI [DOI 10.4172/JBB.S3, 10.4172/jbb.S3-001, DOI 10.4172/JBB.S3-001]; Sirisuth N, 2002, INT J GENERIC DRUGS, V3, P250; TANDT LAGL, 1995, DRUG DEV IND PHARM, V21, P889, DOI 10.3109/03639049509026655; Uppoor VRS, 2001, J CONTROL RELEASE, V72, P127, DOI 10.1016/S0168-3659(01)00268-1; Vazquez MJ, 1996, EUR J PHARM SCI, V4, P39, DOI 10.1016/0928-0987(95)00030-5; Zhou DL, 2014, J PHARM SCI-US, V103, P1664, DOI 10.1002/jps.23953	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203123	10.1371/journal.pone.0203123	http://dx.doi.org/10.1371/journal.pone.0203123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169547	Green Submitted, Green Published, gold			2022-12-27	WOS:000443374400021
J	Mehta, AS; Lau, DTY; Wang, MJ; Islam, A; Nasir, B; Javaid, A; Poongkunran, M; Block, TM				Mehta, Anand S.; Lau, Daryl T. -Y.; Wang, Mengjun; Islam, Aysha; Nasir, Bilal; Javaid, Asad; Poongkunran, Mugilan; Block, Timothy M.			Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma	PLOS ONE			English	Article							ALPHA-FETOPROTEIN LEVELS; SURVEILLANCE	Background We previously developed a logistic regression algorithm that uses AFP, age, gender, ALK and ALT levels to improve the detection of hepatocellular carcinoma (HCC). In 3,158 patients from 5 independent sites, this algorithm, referred to as the "Doylestown" algorithm, increased the AUROC of AFP 4% to 12% and had equal benefit regardless of tumor size or the etiology of liver disease. Aims Analysis of the Doylestown algorithm using samples from individuals taken before their diagnosis of HCC. Methods Here, the algorithm was tested using samples at multiple time points from (a) patients with established chronic liver disease, without HCC (120 patients) and (b) 116 patients with HCC diagnosis (85 patients with early stage HCC and 31 patients with recurrent HCC), taken at the time of, and up to 12 months prior to cancer diagnosis. Results Among patients who developed HCC, comparing the Doylestown algorithm at a fixed cut-off to AFP at 20 ng/mL, the Doylestown algorithm increased the True Positive Rate (TPR) in identification of HCC from 36 to 50%, at a time point of 12 months prior to the conventional HCC detection. Similar results were obtained in those patients with recurrent HCC, where the Doylestown algorithm increased TPR in detection of HCC from 18% to 59%, at 12 months prior to detection of recurrence. Conclusions This algorithm significantly improves the prediction of HCC by AFP alone and may have value in the early detection of HCC.	[Mehta, Anand S.; Wang, Mengjun] Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC USA; [Lau, Daryl T. -Y.; Islam, Aysha; Nasir, Bilal; Javaid, Asad; Poongkunran, Mugilan] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Liver Res Ctr, Boston, MA USA; [Block, Timothy M.] Baruch Blumberg Inst, Doylestown, PA 18902 USA; [Block, Timothy M.] Hepatitis B Fdn, Doylestown, PA 18902 USA	Medical University of South Carolina; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Block, TM (corresponding author), Baruch Blumberg Inst, Doylestown, PA 18902 USA.; Block, TM (corresponding author), Hepatitis B Fdn, Doylestown, PA 18902 USA.	tim.block@bblumberg.org	lau, daryl/AAH-5057-2020		Hepatitis B Foundation [R01 CA120206, U01 CA168856]; NATIONAL CANCER INSTITUTE [R01CA120206, U01CA168856] Funding Source: NIH RePORTER	Hepatitis B Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01 CA120206 (ASM), U01 CA168856 (ASM) the Hepatitis B Foundation, and an appropriation from The Commonwealth of Pennsylvania.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheema AW, 2004, HEPATO-GASTROENTEROL, V51, P1676; CHEN DS, 1984, GASTROENTEROLOGY, V86, P1404; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DIBISCEGLIE AM, 1989, CANCER, V64, P2117, DOI 10.1002/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7; Ferlay J, 2013, CANC INCIDENCE MORTA, DOI DOI 10.1002/IJC.29210; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Gopal P, 2014, CLIN GASTROENTEROL H, V12, P870, DOI 10.1016/j.cgh.2013.09.053; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; Marrero JA, 2011, HEPATOLOGY, V53, P1060, DOI 10.1002/hep.24033; Martin P, 2015, CLIN GASTROENTEROL H, V13, P2071, DOI 10.1016/j.cgh.2015.07.007; Singal AG, 2013, AM J GASTROENTEROL, V108, P425, DOI 10.1038/ajg.2012.449; Singal AG, 2012, CANCER EPIDEM BIOMAR, V21, P793, DOI 10.1158/1055-9965.EPI-11-1005; Wang M, 2015, CANC PREV RES PHILA	15	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203149	10.1371/journal.pone.0203149	http://dx.doi.org/10.1371/journal.pone.0203149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169533	Green Submitted, gold, Green Published			2022-12-27	WOS:000443374400022
J	Lopes, JSS; Micheletti, JK; Machado, AF; Souto, LR; de Lima, HP; Vanderlei, FM; Netto, J; Pastre, CM				Silva Lopes, Jaqueline Santos; Micheletti, Jessica Kirsch; Machado, Aryane Flauzino; Souto, Larissa Rodrigues; de Lima, Heloisa Paes; Vanderlei, Franciele Marques; Netto Junior, Jayme; Pastre, Carlos Marcelo			Test-retest reliability of knee extensors endurance test with elastic resistance	PLOS ONE			English	Article							STATISTICAL-METHODS; SPORTS-MEDICINE; STRENGTH; TRIAL; METAANALYSIS; PERFORMANCE; VALIDITY; BANDS; POWER	Background Reliable clinical tests capable of measuring resistance are important tools for rehabilitation. One alternative that has recently increased in popularity is the use of elastic tubes, which stand out for being easy to handle, low cost, practical, and feasible. Objective Analyze the test-retest reliability of the knee extensors muscle fatigue resistance test (FRT) with elastic tubes. Methods A total of 116 healthy young males, aged between 18 and 30 years old, participated in the study. Participants performed three pre-test stages: orientation, load presentation, and familiarization with equipment, lasting two weeks. Subsequently, they performed the FRT on two occasions (test and retest), with an interval of seven days. The reliability analyzes were performed using the intraclass correlation coefficient (ICC) with 95% confidence interval and typical measurement error (TME), also expressed as coefficient of variation (CV%). Results The findings regarding the reliability of the test demonstrated satisfactory values (time: ICC = 0.66; 95%CI [0.50; 0.76]; CV(%) = 9.34; repetition: ICC = 0.61; 95% CI[0.46; 0.73], CV(%) = 13.66; rhythm: ICC = 0.52; 95%CI[0.35; 0.67], CV(%) = 10.29. Conclusion From the findings presented, it is concluded that the proposed clinical test with elastic tubes demonstrates evidence of acceptable values.	[Silva Lopes, Jaqueline Santos; Micheletti, Jessica Kirsch; Machado, Aryane Flauzino; Souto, Larissa Rodrigues; de Lima, Heloisa Paes; Vanderlei, Franciele Marques; Netto Junior, Jayme; Pastre, Carlos Marcelo] Sao Paulo State Univ Unesp, Sch Technol & Sci, Dept Phys Therapy, Presidente Prudente, SP, Brazil	Universidade Estadual Paulista	Lopes, JSS (corresponding author), Sao Paulo State Univ Unesp, Sch Technol & Sci, Dept Phys Therapy, Presidente Prudente, SP, Brazil.	jaqueee-santosss@hotmail.com	Souto, Larissa/AAP-3646-2021; Pastre, Carlos M/K-2415-2012; Silva, Jaqueline/J-3066-2018; Micheletti, Jéssica Kirsch/C-5871-2017; Machado, Aryane F/F-3298-2016; Vanderlei, Franciele/GQA-4595-2022; Vanderlei, Franciele M/G-7464-2014	Pastre, Carlos M/0000-0002-0213-6679; Silva, Jaqueline/0000-0003-3883-883X; Micheletti, Jéssica Kirsch/0000-0003-1545-3638; Machado, Aryane F/0000-0003-0419-0473; Vanderlei, Franciele/0000-0001-5792-6072; Rodrigues Souto, Larissa/0000-0003-0968-4835; Paes de Lima, Heloisa/0000-0002-1460-0141	Coordination for the Improvement of Higher Education Personnel (CAPES)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	During the development of the research the main author received financial assistance, in the form of a grant from the Coordination for the Improvement of Higher Education Personnel (CAPES). The money received helped research expenses, which included logistics and purchase of necessary materials, such as elastic tubes. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboodarda SJ, 2016, CLIN BIOMECH, V39, P52, DOI 10.1016/j.clinbiomech.2016.09.008; Almeida AC, 2016, J SCI MED SPORT, V19, P676, DOI 10.1016/j.jsams.2015.10.003; Andersen LL, 2017, SCAND J MED SCI SPOR, V27, P887, DOI 10.1111/sms.12695; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Augustsson J, 2016, INT J SPORTS PHYS TH, V11, P520; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buchheit M, 2009, AM J PHYSIOL-HEART C, V296, pH421, DOI 10.1152/ajpheart.01017.2008; Ramos EMC, 2014, CLIN REHABIL, V28, P1096, DOI 10.1177/0269215514527842; Colado JC, 2012, J STRENGTH COND RES, V26, P3018, DOI 10.1519/JSC.0b013e318245c0c9; Colado JC, 2008, J STRENGTH COND RES, V22, P1441, DOI 10.1519/JSC.0b013e31817ae67a; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; Ferri-Morales A, 2014, ISOKINET EXERC SCI, V22, P17, DOI 10.3233/IES-130522; Ghigiarelli JJ, 2009, J STRENGTH COND RES, V23, P756, DOI 10.1519/JSC.0b013e3181a2b8a2; Guex K, 2015, J SPORT REHABIL, V24, P151, DOI 10.1123/jsr.2013-0131; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2001, SPORTS MED, V31, P211, DOI 10.2165/00007256-200131030-00005; Jakobsen MD, 2014, AM J PHYS MED REHAB, V93, P320, DOI 10.1097/PHM.0000000000000043; Jensen J, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2012-091095; Jeukendrup AE, 2005, MED SCI SPORT EXER, V37, P1820, DOI 10.1249/01.mss.0000175095.56646.4b; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Laursen PB, 2007, MED SCI SPORT EXER, V39, P1374, DOI 10.1249/mss.0b013e31806010f5; Lubans DR, 2011, J SPORT SCI, V29, P685, DOI 10.1080/02640414.2010.551215; Machado AF, 2017, SCAND J MED SCI SPOR, V27, P1356, DOI 10.1111/sms.12734; Manor Brad, 2006, J Geriatr Phys Ther, V29, P18; Martins WR, 2013, ARCH GERONTOL GERIAT, V57, P8, DOI 10.1016/j.archger.2013.03.002; Metgud S, 2015, INT J PHYSIOTHER RES, V3, P1091, DOI [10.16965/ijpr.2015.118, DOI 10.16965/IJPR.2015.118]; Newsam CJ, 2005, J SPORT REHABIL, V14, P35, DOI 10.1123/jsr.14.1.35; Nyberg A., 2016, J NOV PHYS REHABIL, DOI [10.17352/2455-5487.000030, DOI 10.17352/2455-5487.000030]; Pageaux B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163979; Pappas E, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-093796; Sundstrup E, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-67; Wells GD, 2009, PAEDIATR RESPIR REV, V10, P83, DOI 10.1016/j.prrv.2009.04.005	32	8	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203259	10.1371/journal.pone.0203259	http://dx.doi.org/10.1371/journal.pone.0203259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169527	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400029
J	Curran, AM; Scott-Boyer, MP; Kaput, J; Ryan, MF; Drummond, E; Gibney, ER; Gibney, MJ; Roche, HM; Brennan, L				Curran, Aoife M.; Scott-Boyer, Marie Pier; Kaput, Jim; Ryan, Miriam F.; Drummond, Elaine; Gibney, Eileen R.; Gibney, Michael J.; Roche, Helen M.; Brennan, Lorraine			A proteomic signature that reflects pancreatic beta-cell function	PLOS ONE			English	Article							INSULIN; ENDORPHIN; SECRETION; GLUCAGON; HEALTHY; OBESITY; TISSUE	Aim Proteomics has the potential to enhance early identification of beta-cell dysfunction, in conjunction with monitoring the various stages of type 2 diabetes onset. The most routine method of assessing pancreatic beta-cell function is an oral glucose tolerance test, however this method is time consuming and carries a participant burden. The objectives of this research were to identify protein signatures and pathways related to pancreatic beta-cell function in fasting blood samples. Methods Beta-cell function measures were calculated for MECHE study participants who completed an oral glucose tolerance test and had proteomic data (n = 100). Information on 1,129 protein levels was obtained using the SOMAscan assay. Receiver operating characteristic curves were used to assess discriminatory ability of proteins of interest. Subsequent in vitro experiments were performed using the BRIN-BD11 pancreatic beta-cell line. Replication of findings were achieved in a second human cohort where possible. Results Twenty-two proteins measured by aptamer technology were significantly associated with beta-cell function/HOMA-IR while 17 proteins were significantly associated with the disposition index (p <= 0.01). Receiver operator characteristic curves determined the protein panels to have excellent discrimination between low and high beta-cell function. Linear regression analysis determined that beta-endorphin and IL-17F have strong associations with beta-cell function/HOMA-IR, beta = 0.039 (p = 0.005) and beta = -0.027 (p = 0.013) respectively. Calcineurin and CRTAM were strongly associated with the disposition index (beta = 0.005 and beta = 0.005 respectively, p = 0.012). In vitro experiments confirmed that IL-17F modulated insulin secretion in the BRI N-BD1 1 cell line, with the lower concentration of 10 ng/mL significantly increasing glucose stimulated insulin secretion (p = 0.043). Conclusions Early detection of compromised beta-cell function could allow for implementation of nutritional and lifestyle interventions before progression to type 2 diabetes.	[Curran, Aoife M.; Ryan, Miriam F.; Drummond, Elaine; Gibney, Eileen R.; Gibney, Michael J.; Roche, Helen M.; Brennan, Lorraine] Ireland Univ Coll Dublin, Univ Coll Dublin, UCD Sch Agr & Food Sci, Inst Food & Hlth, Dublin, Ireland; [Curran, Aoife M.; Drummond, Elaine; Gibney, Eileen R.; Gibney, Michael J.; Roche, Helen M.; Brennan, Lorraine] Ireland Univ Coll Dublin, Univ Coll Dublin, FHI, Dublin, Ireland; [Scott-Boyer, Marie Pier] Univ Trento, Ctr Computat & Syst Biol COSBI, Microsoft Res, Rovereto, Italy; [Kaput, Jim] Nestle Inst Hlth Sci, Lausanne, Switzerland; [Roche, Helen M.] Univ Coll Dublin, Nutrigen Res Grp, UCD Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Roche, Helen M.] Univ Coll Dublin, UCD Inst Food & Hlth, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [Kaput, Jim] Vydiant Inc, Gold River, CA USA	University College Dublin; University College Dublin; University of Trento; Nestle SA; University College Dublin; University College Dublin	Brennan, L (corresponding author), Ireland Univ Coll Dublin, Univ Coll Dublin, UCD Sch Agr & Food Sci, Inst Food & Hlth, Dublin, Ireland.; Brennan, L (corresponding author), Ireland Univ Coll Dublin, Univ Coll Dublin, FHI, Dublin, Ireland.	lorraine.brennan@ucd.ie	Kaput, Jim/GSD-5978-2022; Kaput, Jim/AAJ-1386-2020; Roche, Helen M/AAF-4164-2019	Roche, Helen M/0000-0002-0628-3318; Brennan, Lorraine/0000-0002-7711-7499	Food for Health Ireland, through Enterprise Ireland [TC20130001]; Nestle Institute of Health Sciences (Lausanne, Switzerland); Department of Agriculture, Fisheries and Food [07FHRIUCD1]; "JINGO-JPI"/"ENPADASI" 2014-2016 [13F407]	Food for Health Ireland, through Enterprise Ireland; Nestle Institute of Health Sciences (Lausanne, Switzerland); Department of Agriculture, Fisheries and Food; "JINGO-JPI"/"ENPADASI" 2014-2016	This research was funded by Food for Health Ireland, through Enterprise Ireland Grant No. TC20130001 and by the Nestle Institute of Health Sciences (Lausanne, Switzerland). This work was in part funded under the Food for Health Research Initiative (NDP 2007-2013; 07FHRIUCD1) by the Department of Agriculture, Fisheries and Food (http://www.agriculture.gov.ie/). This research was also funded in part by grant number 13F407 ("JINGO-JPI"/"ENPADASI" 2014-2016).	Al-Hamodi Z, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-23; Bansal N, 2015, WORLD J DIABETES, V6, P296, DOI 10.4239/wjd.v6.i2.296; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Belongie KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182932; Beristain-Covarrubias N, 2015, IMMUN INFLAMM DIS, V3, P411, DOI 10.1002/iid3.79; Calimlioglu B, 2015, OMICS, V19, P563, DOI 10.1089/omi.2015.0088; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Curran AM, 2017, J PROTEOME RES, V16, P4122, DOI 10.1021/acs.jproteome.7b00501; Curran AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161350; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; El Ouaamari A, 2015, J PROTEOME RES, V14, P3111, DOI 10.1021/acs.jproteome.5b00587; FELDMAN M, 1983, NEW ENGL J MED, V308, P349, DOI 10.1056/NEJM198302173080701; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hathout Y, 2015, EXPERT REV PROTEOMIC, V12, P329, DOI 10.1586/14789450.2015.1064771; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Ip B, 2016, OBESITY, V24, P102, DOI 10.1002/oby.21243; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kennedy J, 2000, J LEUKOCYTE BIOL, V67, P725, DOI 10.1002/jlb.67.5.725; Kiddle SJ, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.78; Kuo TY, 2016, J BIOL CHEM, V291, P9648, DOI 10.1074/jbc.M115.702183; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Makinen VP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004502; Maris M, 2010, J PROTEOME RES, V9, P6274, DOI 10.1021/pr100557w; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Menni C, 2015, J GERONTOL A-BIOL, V70, P809, DOI 10.1093/gerona/glu121; Morris C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072890; Mukherjee P, 2013, BBA-PROTEINS PROTEOM, V1834, P2226, DOI 10.1016/j.bbapap.2013.01.022; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nowak C, 2016, DIABETES, V65, P276, DOI 10.2337/db15-0881; O'Gorman A, 2014, J CHROMATOGR B, V966, P140, DOI [10.1016/j.jchromb.2014.01.032, 10.1016/]; Moreno SO, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201600150; Rao V Srinivasa, 2014, Int J Proteomics, V2014, P147648, DOI 10.1155/2014/147648; REID RL, 1981, J CLIN ENDOCR METAB, V52, P592, DOI 10.1210/jcem-52-3-592; REID RL, 1984, METABOLISM, V33, P197, DOI 10.1016/0026-0495(84)90035-0; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; Riaz S, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/150176; Runau F, 2015, NUTR CLIN PRACT, V30, P363, DOI 10.1177/0884533614567337; Ryan MF, 2013, AM J CLIN NUTR, V97, P261, DOI 10.3945/ajcn.112.047936; Scott Eleanor M, 2005, Diab Vasc Dis Res, V2, P54, DOI 10.3132/dvdr.2005.009; Umeno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130971; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Wallace M, 2014, MOL BIOSYST, V10, P1586, DOI 10.1039/c3mb70529c; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yarmolinsky J, 2016, SCI REP-UK, V6, DOI 10.1038/srep17714; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013; Yildirim C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124347; Zhang JH, 2007, AM J PHYSIOL-ENDOC M, V292, pE1433, DOI 10.1152/ajpendo.00664.2006	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202727	10.1371/journal.pone.0202727	http://dx.doi.org/10.1371/journal.pone.0202727			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161145	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900041
J	Daly, SC; MacNeela, P; Sarma, KM				Daly, Siobhan C.; MacNeela, Padraig; Sarma, Kiran M.			The female spouse: A process of separation when a husband 'comes out' as gay	PLOS ONE			English	Article							MENTAL DISTRESS; THERAPY; CONSEQUENCES; SUPPORT; ISSUES; GENDER	This study investigated the stories of heterosexual women who experienced a husband coming out as gay and a consequential marital separation. Interpretative phenomenological analysis (IPA) was used. Loss, anger, spousal empathy and concerns regarding societal prejudice were reported. Additional stress was experienced when others minimised the experience due to the gay sexual orientation of their husband. Experiencing positive communication with their husband during and after the disclosure aided the resolution of the emotional injury experienced by them. They all eventually let go' of their husband. This involved a process of reconceptualising the self as separated. Findings indicate the importance of supporting women to re-focus on their needs during and following marital dissolution. The importance of non-judgemental support for marital loss, rather than a focus on the gay sexual orientation of the spouse, was highlighted.	[Daly, Siobhan C.; MacNeela, Padraig; Sarma, Kiran M.] Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Daly, SC (corresponding author), Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland.	siobhancdaly@gmail.com						Alase A, 2017, IJELS, V5, P1; Atwood JD, 1997, AM J FAM THER, V25, P55, DOI 10.1080/01926189708251055; Beals KP, 2009, PERS SOC PSYCHOL B, V35, P867, DOI 10.1177/0146167209334783; Bracke PF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-224; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; Buchanan M, 2010, AM J FAM THER, V29, P435; Buxton A. P., 2001, J BISEXUALITY, V2, P155, DOI [10.1300/J159v01n02_06, DOI 10.1300/J159v01n02_06, 10.1300/J159v01n0206]; Buxton AP, 2006, J GLBT FAM STUD, V2, P49, DOI 10.1300/J461v02n03_04; Buxton AP, 2006, SEX ADDICT COMPULS, V13, P317, DOI 10.1080/10720160600897599; Canham S.L., 2014, J DIVORCE REMARRIAGE, V55, P591, DOI [10.1080/10502556.2014.959097, DOI 10.1080/10502556.2014.959097]; Corley MD, 2006, SEX ADDICT COMPULS, V13, P167, DOI 10.1080/10720160600870737; Creswell J, 1998, QUAL INQ; Daly SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145491; Demo DH, 1996, J FAM ISSUES, V17, P388, DOI 10.1177/019251396017003005; Diamond L.M., 2006, SEXUAL ORIENTATION M, P73, DOI [10.1037/11261-004, DOI 10.1037/11261-004]; Gander AM, 1991, J WOMEN AGING, V3, P37; Greenberg L, 2010, J MARITAL FAM THER, V36, P28, DOI 10.1111/j.1752-0606.2009.00185.x; Greenberg LS, 2008, J COUNS PSYCHOL, V55, P185, DOI 10.1037/0022-0167.55.2.185; Grever C, 2012, J GLBT FAM STUD, V8, P67, DOI 10.1080/1550428X.2012.641372; Haldeman DC, 2004, COUNS PSYCHOL, V32, P691, DOI 10.1177/0011000004267560; HAYS D, 1989, J HOMOSEXUAL, V18, P81, DOI 10.1300/J082v18n01_04; Hecker LL, 2015, AUST NZ J FAM THER, V36, P467, DOI 10.1002/anzf.1121; Hennon CB, 1996, VISION 2010 FAMILIES, P23; Herek GM, 2015, AM J ORTHOPSYCHIAT, V85, pS29, DOI 10.1037/ort0000092; Hernandez BC, 2011, J MARITAL FAM THER, V37, P307, DOI 10.1111/j.1752-0606.2010.00202.x; HETHERINGTON EM, 1994, STEPFAMILIES, P55; Idstad M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1662-0; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; Jirek SL, 2017, QUAL SOC WORK, V16, P166, DOI 10.1177/1473325016656046; Karen R, 2001, FORGIVING SELF ROAD; Koopmans GT, 2007, SOC SCI MED, V64, P1216, DOI 10.1016/j.socscimed.2006.11.018; Lambert MJ, 2001, PSYCHOTHERAPY, V38, P357, DOI 10.1037/0033-3204.38.4.357; Lehmiller JJ, 2009, PERS SOC PSYCHOL B, V35, P1452, DOI 10.1177/0146167209342594; Lewis R, 1992, HOMOSEXUALITY PSYCHO, P174; Mark N, 2008, J GAY LESBIAN MENT H, V12, P179, DOI 10.1080/19359700802111189; Marks NF, 1996, J MARRIAGE FAM, V58, P917, DOI 10.2307/353980; Mason B., 1993, HUMAN SYSTEMS J SYST, V4, P189; McCarthy B, 2013, J SEX MARITAL THER, V39, P493, DOI 10.1080/0092623X.2012.665820; McCullough ME, 1998, J PERS SOC PSYCHOL, V75, P1586, DOI 10.1037/0022-3514.75.6.1586; Pietkiewicz IJ, 2016, ARCH SEX BEHAV, V45, P1573, DOI 10.1007/s10508-016-0752-0; Radina M. E., 2008, J DIVORCE REMARRIAGE, V49, P142; Rahav G, 2002, J DIVORCE REMARRIAGE, V37, P41; Reygan F, 2014, CULT RELIG-ABINGDON, V15, P298, DOI 10.1080/14755610.2014.942329; Simon RW, 1999, J HEALTH SOC BEHAV, V40, P111, DOI 10.2307/2676367; Slepian ML, 2012, J EXP PSYCHOL GEN, V141, P619, DOI 10.1037/a0027598; Smith J. A., 2008, DOING SOCIAL PSYCHOL, P229, DOI [10.1002/9780470776278.ch10, DOI 10.1002/9780470776278.CH10, DOI 10.4135/9781848607927.N11]; Smith J.A., 2009, INTERPRETATIVE PHENO, DOI 10.1080/13642537.2011.625197; Smith JA, 2011, HEALTH PSYCHOL REV, V5, P9, DOI 10.1080/17437199.2010.510659; Stack S, 2015, J FAM ISSUES, V36, P695, DOI 10.1177/0192513X13494824; Stryker S, 2000, SOC PSYCHOL QUART, V63, P284, DOI 10.2307/2695840; Tovey Hilary, 2003, SOCIOLOGY IRELAND; Vaillant GE, 2000, AM PSYCHOL, V55, P89, DOI 10.1037/0003-066X.55.1.89; Van Langenhove L., 1995, RETHINKING PSYCHOL, P56; Van Zyl J, 2017, J PSYCHOL AFR, V27, P191, DOI 10.1080/14330237.2017.1303126; Vaughan, 2003, MONOGAMY MYTH PERSON; Waite LJ., 2001, CASE MARRIAGE WHY MA; White M., 2004, HDB NARRATIVE PSYCHO, P15; Wilkinson RT, 2012, FAM J, V20, P140, DOI 10.1177/1066480712442051; Zisook S, 1997, J AFFECT DISORDERS, V45, P85, DOI 10.1016/S0165-0327(97)00062-1	59	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203472	10.1371/journal.pone.0203472	http://dx.doi.org/10.1371/journal.pone.0203472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161234	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900129
J	Gichane, MW; Moracco, KE; Thirumurthy, H; Okitolonda, EW; Behets, F; Yotebieng, M				Gichane, Margaret W.; Moracco, Kathryn E.; Thirumurthy, Harsha; Okitolonda, Emile W.; Behets, Frieda; Yotebieng, Marcel			Intimate partner violence and prevention of mother to child transmission of HIV: Evidence from Kinshasa, Democratic Republic of Congo	PLOS ONE			English	Article							CONDITIONAL CASH TRANSFERS; DOMESTIC VIOLENCE; PREGNANCY; CARE; NONADHERENCE; PREVALENCE; RETENTION; ADHERENCE; BARRIERS; HEALTH	Intimate partner violence (IPV) is a risk factor for non-adherence to HIV treatment for women, however the evidence on the impact of IPV on uptake of the prevention of mother to child transmission of HIV (PMTCT) cascade is inconclusive. We examined data from 433 HIV positive pregnant women in Kinshasa, Democratic Republic of Congo, enrolled between April 2013 and August 2014 and followed-up through 6 weeks postpartum. Participants were asked about their IPV experiences in a face-to-face interview at enrollment. Measures of PMTCT cascade included: uptake of clinical appointments and services, viral suppression, and adherence to antiretrovirals (ARV). Approximately half of the sample (51%) had experienced some form of IPV; 35% had experienced emotional abuse, 29% physical abuse, and 19% sexual abuse. There were no statistically significant associations between experiencing any form of IPV and uptake of clinical appointments and services (Adjusted Prevalence Ratio [aPR] = 1.02; 95% [CI]: 0.89-1.17), viral load suppression (aPR = 1.07, 95% CI:0.96-1.19) and ARV adherence (aPR = 1.01, 95% CI: 0.87-1.18). Findings from this study indicate that, among HIV-infected pregnant women enrolled in PMTCT care, experiencing IPV does not reduce adherence to clinic visits and services, adherence to ARV. The high prevalence of IPV in this population suggests that IPV screening and intervention should be included as part of standard care for PMTCT.	[Gichane, Margaret W.; Moracco, Kathryn E.] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Thirumurthy, Harsha] Univ Penn, Pearlman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Okitolonda, Emile W.] Univ Kinshasa, Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Behets, Frieda] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Behets, Frieda; Yotebieng, Marcel] Univ N Carolina, Dept Social Med, Chapel Hill, NC 27515 USA; [Yotebieng, Marcel] Ohio State Univ, Div Epidemiol, Coll Publ Hlth, Columbus, OH USA	University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Universite de Kinshasa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University	Gichane, MW (corresponding author), Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27515 USA.	warugich@live.unc.edu	Yotebieng, Marcel/L-2083-2013	Yotebieng, Marcel/0000-0003-2110-2631; Thirumurthy, Harsha/0000-0002-3308-7603; Gichane, Margaret/0000-0001-8499-154X	President's Emergency Plan for AIDS Relief (PEPFAR); National Institute of Health and Child Development [NIHCD 1R01HD075171]; National Institute of Health [1U01AI096299-01, 1R01 HD087993]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Health and Child Development; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a grant from the President's Emergency Plan for AIDS Relief (PEPFAR) and the National Institute of Health and Child Development: NIHCD 1R01HD075171. MY is partially supported by the National Institute of Health (1U01AI096299-01 and 1R01 HD087993). The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, writing of the report, or the decision to submit the paper for publication.	Alhusen JL, 2015, J WOMENS HEALTH, V24, P100, DOI 10.1089/jwh.2014.4872; Bernstein M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011999; Centers for Disease Control and Prevention, YOUTH RISK BEH SURV; Coker AL, 2002, J WOMEN HEALTH GEN-B, V11, P465, DOI 10.1089/15246090260137644; Ezeanochie MC, 2011, ACTA OBSTET GYN SCAN, V90, P535, DOI 10.1111/j.1600-0412.2011.01083.x; Garcia-Moreno C, 2013, PREVALENCE HLTH EFFE; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Goo L, 2012, MATERN CHILD HLTH J, V16, P1131, DOI 10.1007/s10995-011-0838-1; Hampanda KM, 2016, SOC SCI MED, V153, P123, DOI 10.1016/j.socscimed.2016.02.011; Hatcher AM, 2016, SOC SCI MED, V168, P130, DOI 10.1016/j.socscimed.2016.09.013; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; Hatcher AM, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19233; Israel B. A., 1987, ADV HLTH ED PROMOTIO, V2, P1; Karamagi CAS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-284; Kiarie JN, 2006, AIDS, V20, P1763, DOI 10.1097/01.aids.0000242823.51754.0c; Kohler PK, 2014, AIDS PATIENT CARE ST, V28, P643, DOI 10.1089/apc.2014.0171; Kosia A, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.32307; Lichtenstein B, 2006, AIDS PATIENT CARE ST, V20, P122, DOI 10.1089/apc.2006.20.122; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; MCFARLANE J, 1992, JAMA-J AM MED ASSOC, V267, P3176, DOI 10.1001/jama.267.23.3176; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Ministere du Plan et Suivi de la Mise en enure de la Revolution de la Modernite (MPSMRM) MdlS International PMaI, 2014, DEM REP CONG DEM HLH; Mohammed BH, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2121-7; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Rahman M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-913; Ramirez-Avila L, 2012, AIDS BEHAV, V16, P2226, DOI 10.1007/s10461-012-0160-y; Rodriguez VJ, 2018, AIDS CARE, V30, P1380, DOI 10.1080/09540121.2018.1458974; Rurangirwa AA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013155; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Tlapek SM, 2015, J INTERPERS VIOLENCE, V30, P2526, DOI 10.1177/0886260514553118; UNAIDS, 2016, FAST TRACK AIDS FREE; UNAIDS, DEM REP CONG 2015 CO; UNAIDS, 2011, COUNTD ZER GLOB PLAN; WHO, 2016, CONS GUID DIAGN TREA; Yotebieng M, 2016, JAIDS-J ACQ IMM DEF, V72, pS124, DOI 10.1097/QAI.0000000000001062; Yotebieng M, 2016, LANCET HIV, V3, pE85, DOI 10.1016/S2352-3018(15)00247-7	37	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203471	10.1371/journal.pone.0203471	http://dx.doi.org/10.1371/journal.pone.0203471			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161260	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900128
J	Gonzalez-Mace, O; Scheu, S				Gonzalez-Mace, Odette; Scheu, Stefan			Response of Collembola and Acari communities to summer flooding in a grassland plant diversity experiment	PLOS ONE			English	Article							ORIBATID MITE; SOIL FAUNA; BIODIVERSITY; HISTORY	Flooding frequency is predicted to increase during the next decades in Europe. Therefore, it is important to understand how short-term disturbance events affect soil biota providing essential ecosystem functions and uncover factors modulating their response such as plant community composition. Here we report on the response of soil microarthropod communities (Collembola and Acari) to a severe summer flood in 2013, which affected major parts of central Europe. Collembola and Acari density and Collembola and Oribatida richness were strongly affected by the flood, but they recovered within three months. Effects of plant community composition on soil microarthropods disappeared after the flood, presumably due to homogenization of the field, but the effects of plant community were in a stage of being reasserted three months after the flood. Widespread, surface living and generalistic microarthropod species recolonized the field quickly. Prostigmata and Oribatida were more resilient or recovered to flooding than Astigmata and Gamasida. Long-term impacts, however, remain unknown and deserve further investigation.	[Gonzalez-Mace, Odette; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Scheu, Stefan] Univ Gottingen, Ctr Biodivers & Sustainable Land Use, Gottingen, Germany	University of Gottingen; University of Gottingen	Gonzalez-Mace, O (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany.	ogonzal@gwdg.de	Scheu, Stefan/H-7049-2015		German Science Foundation (DFG) [FOR 1451]; ETH Zurich	German Science Foundation (DFG)(German Research Foundation (DFG)); ETH Zurich(ETH Zurich)	The Jena Experiment is funded by the German Science Foundation (DFG; FOR 1451) with additional support from ETH Zurich (funds from N. Buchmann research group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, FUNDAMENTALS APPL AC, DOI DOI 10.1007/978-981-10-1594-6; Bardgett RD, 2005, BIOL SOIL COMMUNITY; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Behan-Pelletier VM, 1999, AGR ECOSYST ENVIRON, V74, P411, DOI 10.1016/S0167-8809(99)00046-8; Behan-Pelletier VM, 2003, CAN J SOIL SCI, V83, P279, DOI 10.4141/S01-063; Blankinship JC, 2011, OECOLOGIA, V165, P553, DOI 10.1007/s00442-011-1909-0; Bloschl G, 2013, HYDROL EARTH SYST SC, V17, P5197, DOI 10.5194/hess-17-5197-2013; Bokhorst S, 2017, SOIL BIOL BIOCHEM, V110, P79, DOI 10.1016/j.soilbio.2017.03.009; Chauvat M, 2003, OECOLOGIA, V137, P269, DOI 10.1007/s00442-003-1310-8; Endlweber K, 2007, BIOL FERT SOILS, V43, P741, DOI 10.1007/s00374-006-0157-7; Faraway JJ., 2014, LINEAR MODELS R, V2nd; Filser J, 2002, PEDOBIOLOGIA, V46, P234, DOI 10.1078/0031-4056-00130; Fjellberg A., 1998, COLLEMBOLA FENNOSC 1; FJELLBERG A, 2007, FAUNA ENTOMOL SCAD, V42, P1; Fox J., 2014, R COMPANION APPL REG; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Hertzog LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152777; Hoffmann AA, 2008, P ROY SOC B-BIOL SCI, V275, P2473, DOI 10.1098/rspb.2008.0685; Hopkin SP, 2007, BIOL SPRINGTAILS COL; Kaneko N, 1995, PEDOBIOLOGIA, V39, P538; Kardol P, 2011, APPL SOIL ECOL, V47, P37, DOI 10.1016/j.apsoil.2010.11.001; Karg W, 1993, TIERWELT DEUTSCHLAND, V59; Kaufmann R, 2002, ARCT ANTARCT ALP RES, V34, P242, DOI 10.2307/1552481; Kirtman B., 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Koehler HH, 1999, AGR ECOSYST ENVIRON, V74, P395, DOI 10.1016/S0167-8809(99)00045-6; Krantz GW, 2009, MANUAL ACAROLOGY, P807; Lindberg N, 2005, APPL SOIL ECOL, V28, P163, DOI 10.1016/j.apsoil.2004.07.003; Lindberg N., 2003, SOIL FAUNA GLOBAL CH; Lindberg N, 2006, OIKOS, V114, P494, DOI 10.1111/j.2006.0030-1299.14396.x; Mace OG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166349; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Makkonen M, 2011, SOIL BIOL BIOCHEM, V43, P377, DOI 10.1016/j.soilbio.2010.11.004; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2003, SOIL BIOL BIOCHEM, V35, P1387, DOI 10.1016/S0038-0717(03)00218-9; Maraun M, 2003, EUR J SOIL BIOL, V39, P85, DOI 10.1016/S1164-5563(03)00006-2; Milcu A, 2010, SOIL BIOL BIOCHEM, V42, P2102, DOI 10.1016/j.soilbio.2010.08.005; Norton Roy A., 1994, P99; Ponge JF, 2006, SOIL BIOL BIOCHEM, V38, P1158, DOI 10.1016/j.soilbio.2005.09.004; R Development Core Team, 2009, R LANG ENV STAT COMP; Ravenek JM, 2014, OIKOS, V123, P1528, DOI 10.1111/oik.01502; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Ruf A, 2005, ECOTOX ENVIRON SAFE, V62, P290, DOI 10.1016/j.ecoenv.2005.03.029; Sabais ACW, 2011, ACTA OECOL, V37, P195, DOI 10.1016/j.actao.2011.02.002; Salamon JA, 2004, OIKOS, V106, P51, DOI 10.1111/j.0030-1299.2004.12905.x; Scheu S, 2005, SOIL BIOL, V3, P253; Scheu S, 1996, BIODIVERS CONSERV, V5, P235, DOI 10.1007/BF00055833; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; SIEPEL H, 1994, BIOL FERT SOILS, V18, P263, DOI 10.1007/BF00570628; Socarras A, 2014, PASTOS FORRAJES, V37, P109; Swift M. J., 1979, Decomposition in terrestrial ecosystems.; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Unger IM, 2010, ENVIRON EXP BOT, V69, P113, DOI 10.1016/j.envexpbot.2010.03.005; Visser EJW, 2005, PLANT SOIL, V274, P197, DOI 10.1007/s11104-004-1650-0; Wagner D, 2015, SOIL BIOL BIOCHEM, V89, P135, DOI 10.1016/j.soilbio.2015.07.001; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; WALLWORK J A, 1970, P283; Wallwork JA, 1980, SOIL BIOL RELATED LA, P759; Walter DE, 1999, MITES ECOLOGY EVOLUT; Weigmann G., 2006, HORNMILBEN ORIBATIDA; Williamson WM, 2007, APPL SOIL ECOL, V37, P139, DOI 10.1016/j.apsoil.2007.05.003; Wissuwa J, 2013, EUR J SOIL BIOL, V59, P8, DOI 10.1016/j.ejsobi.2013.08.002; Wright AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7092; Zuur AF, 2007, STAT BIOL HEALTH, P163	64	13	13	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202862	10.1371/journal.pone.0202862	http://dx.doi.org/10.1371/journal.pone.0202862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161191	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900046
J	Kumar, S; Gupte, HA; Isaakidis, P; Mishra, JK; Munjattu, JF				Kumar, Samresh; Gupte, Himanshu A.; Isaakidis, Petros; Mishra, J. K.; Munjattu, Joseph Francis			"They don't like us....": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study	PLOS ONE			English	Article							USERS; CARE	Background Provision of Anti-Retroviral Therapy (ART) and Opioid Substitution Therapy (OST) are important components of the targeted intervention (TI) programme for people who inject drugs (PWID). Homeless HIV positive PWIDs in Delhi is a key population experiencing gaps in uptake of these services, especially the ART uptake which is reportedly far from 90%, UNAIDS' 90-90-90 target to end the AIDS epidemic. Objective To assess the gaps and barriers in accessing the ART and OST services uptake among HIV positive homeless PWID in Delhi and to explore experiences and perspectives of the PWIDs and service providers. Methodology We used a convergent parallel mixed methods design which included a cross-sectional quantitative survey and a qualitative study. Two hundred thirty five homeless HIV positive PWID were interviewed and in-depth interviews were conducted with five PWIDs and nine health providers. Results While only 12% of PWIDs were on ART, 80% were availing OST services. The top individual, health system related and structural barriers for ART service access were insufficient and incorrect knowledge (63%), long waiting time (86%) and lack of family support (44%) respectively. Inconvenient timings, stringent registration requirements and negative attitude of health providers were expressed as major barriers of accessing ART services during the interviews while these were not a concern in OST services. Homelessness, poverty, stigma were common barriers for both services. Integrated, 'single window' service and provision of additional support like nutrition and shelter were suggested as measures to improve access by both health providers and the PWIDs themselves. Conclusion There is an urgent need for structural and health systems changes to improve access to ART and OST services. These include integrated service delivery, flexibility in timing of the centers, accelerated ART initiation, simplification of bureaucratic procedures, nutritional and social support to all homeless HIV positive PWIDs.	[Kumar, Samresh] IHAT, Tech Support Unit, Delhi, India; [Gupte, Himanshu A.] Narotam Sekhsaria Fdn, Bombay, Maharashtra, India; [Isaakidis, Petros] Med Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg; [Mishra, J. K.] DSACS, Delhi, India; [Munjattu, Joseph Francis] IHAT, Tech Support Unit, Bengaluru, India	Doctors Without Borders	Kumar, S (corresponding author), IHAT, Tech Support Unit, Delhi, India.	samreshkumar10@gmail.com		Gupte, Himanshu/0000-0002-6290-2419; Isaakidis, Petros/0000-0002-7881-1554	Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	The training programme and open access publication costs were funded by the Department for International Development (DFID), UK and La Fondation Veuve Emile Metz-Tesch (Luxembourg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2015, QUALITY ASSURANCE IM; [Anonymous], 2015, NHMRC STAT EV WIND H; [Anonymous], 2015, NAT INT BIOL BEH SUR; Chakarpani V, 2015, BARRIERS ANTIRETROVI, V26, P835; Chakrapani MD, 2012, BARRIERS OPPORTUNITI; Chakrapani V, 2012, ACCESS COMPREHENSIVE; Chakrapani V, 2014, AIDS CARE, V26, P835, DOI 10.1080/09540121.2013.861573; Creswell JW, 2013, DBER SPEAK SER, P54; DSACS, DELH STAT AIDS CONTR; International Harm Reduction Development Program (IHRD), OPEN SOC I PUBLIC HE; Joshi V, 2012, DIRECTORATE CENSUS O, P2; Latkin C, RELATIONSHIP DRUG US; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; National AIDS Control Organization, HIV SENT SURV REP; National AIDS Control Organization, OST OV PERF FY 2016; Rao R, 2017, INDIAN J PSYCHIAT, V59, P457; Reid G, 2014, J PUBLIC HEALTH RES, V3, P1, DOI 10.4081/jphr.2014.204; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, 90 90 90 AMB TREATM; UNAIDS, FACT SHEET PEOPL LIV; UNAIDS, 2016, 2016 PREV GAP REP, P6; UNAIDS (Joint United Nations Programme on HIV/AIDS), 2014, FAST TRACK END AIDS, P1; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; World Health Organization, 2016, CONS GUID US ANT DRU	25	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203262	10.1371/journal.pone.0203262	http://dx.doi.org/10.1371/journal.pone.0203262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161255	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900096
J	Seghieri, C; Calovi, M; Ferre, F				Seghieri, Chiara; Calovi, Martina; Ferre, Francesca			Proximity and waiting times in choice models for outpatient cardiological visits in Italy	PLOS ONE			English	Article							HEALTH-CARE; PATIENT CHOICE; ACCESS; EQUITY	We apply mixed logit regression to investigate patients' choice of non-emergency outpatient cardiovascular specialists in Tuscany, Italy. We focused on the effects of travel time and waiting time. Results reveal that patients prefer clinics nearby and with shorter waiting times. Differences in patient choice depend on age and socioeconomic conditions, thus confirming equity concerns in the access of non-acute services. Our results could be used to optimize the allocation of resources, reduce inequities and increase the efficiency and responsiveness of outpatient systems considering patient preferences.	[Seghieri, Chiara; Calovi, Martina; Ferre, Francesca] Scuola Super Sant Anna, Inst Management, Lab Management & Sanita, Pisa, Italy; [Calovi, Martina] Penn State Univ, Dept Geog, Geoinformat & Earth Observat Lab, University Pk, PA 16802 USA; [Calovi, Martina] Penn State Univ, Inst CyberSci, University Pk, PA 16802 USA	Scuola Superiore Sant'Anna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ferre, F (corresponding author), Scuola Super Sant Anna, Inst Management, Lab Management & Sanita, Pisa, Italy.	francesca.ferre@santannapisa.it	ferre, francesca/L-7614-2014	ferre, francesca/0000-0001-5781-517X	regional administration-Direzione Diritti di cittadinanza e coesione sociale-of Tuscany	regional administration-Direzione Diritti di cittadinanza e coesione sociale-of Tuscany	This study was supported by the regional administration-Direzione Diritti di cittadinanza e coesione sociale-of Tuscany. The authors acknowledge Professor Sabina Nuti and all researchers from Laboratorio Management e Sanita, Institute of Management, Sant'Anna School of Advances Studies, for their constant support and useful comments.	Aggarwal A, 2016, MED CARE RES REV; Akinci F., 2004, HLTH MARK Q, V22, P3, DOI DOI 10.1300/J026V22N01_02; [Anonymous], [No title captured]; [Anonymous], SANITA SALUTE TOSCAN; ARS T, 2013, RAPP CRIS EC STAT SA; Balia Silvia, 2014, Dev Health Econ Public Policy, V12, P133; Barsanti S, 2014, INT J HEALTH PLAN M, V29, pE233, DOI 10.1002/hpm.2195; Berkowitz E. N., 1981, J HEALTH CARE MARKET, V1, P25; Bevan GA, HEAL EC POLICY LAW; Boo G, 2015, ISPRS ANN PHOTO REM, VII-3, P263, DOI 10.5194/isprsannals-II-3-W5-263-2015; Boscarino J, 1982, J HLTH CARE MARK, P23; Brekke K., 2014, DEV HLTH EC PUBLIC P, V12; Briggs DJ, 2007, REMOTE SENS ENVIRON, V108, P451, DOI 10.1016/j.rse.2006.11.020; Cooper Z, 2011, ECON J, V121, pF228, DOI 10.1111/j.1468-0297.2011.02449.x; Coulter A., 2010, BMJ, V341; Dixon A, 2010, HEALTH ECON POLICY L, V5, P295, DOI 10.1017/S1744133110000058; Exworthy M, 2006, SOC POLICY ADMIN, V40, P267, DOI 10.1111/j.1467-9515.2006.00489.x; Ferre F, 2014, HEALT SYST TRANSIT, V16, P1; Fotaki M, 2007, PUBLIC ADMIN, V85, P1059, DOI 10.1111/j.1467-9299.2007.00682.x; France G, 2005, J HEALTH POLIT POLIC, V30, P169, DOI 10.1215/03616878-30-1-2-169; Gesler MW, 1989, METHODOLOGICAL ADV H; Glorioso V, 2014, HEALTH SERV RES, V49, P950, DOI 10.1111/1475-6773.12128; Hole AR, 2008, J HEALTH ECON, V27, P1078, DOI 10.1016/j.jhealeco.2007.11.006; Lane PM, 1994, HLTH CARE MARKETING; Magnussen J, 2009, NORDIC HLTH CARE SYS; Masseria C, 2010, EUR J PUBLIC HEALTH, V20, P504, DOI 10.1093/eurpub/ckq029; Ministero della salute, 2012, PIAN NAZ GOV LIST AT; Nuti S., 2016, Medical practice variations, P433; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; RisaHole Arne, 2016, ECONPAPERS; Shah J, 2010, J CLIN UROL, V3, P25, DOI 10.1016/j.bjmsu.2009.10.003; Siciliani L, 2013, OECD HLTH POLICY STU, P1; Sivey P, 2012, HEALTH ECON, V21, P444, DOI 10.1002/hec.1720; WOLINSKY FD, 1984, HOSP HEALTH SERV ADM, V29, P58	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203018	10.1371/journal.pone.0203018	http://dx.doi.org/10.1371/journal.pone.0203018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161181	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900065
J	Stevens, AT; Howe, DK; Hunt, AG				Stevens, Ashley T.; Howe, Daniel K.; Hunt, Arthur G.			Characterization of mRNA polyadenylation in the apicomplexa	PLOS ONE			English	Article							CLEAVAGE FACTOR-I; POLY(A) POLYMERASE; TRYPANOSOMA-BRUCEI; ALTERNATIVE POLYADENYLATION; CHLAMYDOMONAS-REINHARDTII; STRUCTURAL BASIS; FACTOR CPSF-73; SITE CHOICE; ARABIDOPSIS; SUBUNIT	Messenger RNA polyadenylation is a universal aspect of gene expression in eukaryotes. In well-established model organisms, this process is mediated by a conserved complex of 15-20 subunits. To better understand this process in apicomplexans, a group of unicellular parasites that causes serious disease in humans and livestock, a computational and high throughput sequencing study of the polyadenylation complex and poly(A) sites in several species was conducted. BLAST-based searches for orthologs of the human polyadenylation complex yielded clear matches to only two-poly(A) polymerase and CPSF73-of the 19 proteins used as queries in this analysis. As the human subunits that recognize the AAUAAA polyadenylation signal (PAS) were not immediately obvious, a computational analysis of sequences adjacent to experimentally-determined apicomplexan poly(A) sites was conducted. The results of this study showed that there exists in apicomplexans an A-rich region that corresponds in position to the AAUAAA PAS. The set of experimentally-determined sites in one species, Sarcocystis neurona, was further analyzed to evaluate the extent and significance of alternative poly(A) site choice in this organism. The results showed that almost 80% of S. neurona genes possess more than one poly(A) site, and that more than 780 sites showed differential usage in the two developmental stages-extracellular merozoites and intracellular schizonts-studied. These sites affected more than 450 genes, and included a disproportionate number of genes that encode membrane transporters and ribosomal proteins. Taken together, these results reveal that apicomplexan species seem to possess a poly(A) signal analogous to AAUAAA even though genes that may encode obvious counterparts of the AAUAAA-recognizing proteins are absent in these organisms. They also indicate that, as is the case in other eukaryotes, alternative polyadenylation is a widespread phenomenon in S. neurona that has the potential to impact growth and development.	[Stevens, Ashley T.; Hunt, Arthur G.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA; [Howe, Daniel K.] Univ Kentucky, Dept Vet Sci, Lexington, KY USA; [Stevens, Ashley T.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Hunt, AG (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	aghunt00@uky.edu		Hunt, Arthur/0000-0002-0008-4158; Howe, Daniel K./0000-0003-3704-136X; , Ashley Skaggs/0000-0001-6732-1640	Research Experience for Undergraduates award under National Science Foundation [MCB-1243849, IOS-1353354]; USDA National Institute of Food and Agriculture [227792]; Amerman Family Equine Research Fund; Division Of Integrative Organismal Systems [1353354] Funding Source: National Science Foundation	Research Experience for Undergraduates award under National Science Foundation; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Amerman Family Equine Research Fund; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	ATS was supported by a Research Experience for Undergraduates award under the auspices of National Science Foundation (www.nsf.gov) Awards MCB-1243849 and IOS-1353354 made to Dr. Hunt. Other support was from the USDA National Institute of Food and Agriculture (Hatch project accession # 227792; www.nifa.usda.gov) and funds from the Amerman Family Equine Research Fund, both to Dr. Howe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146107; Bercovich N, 2009, BIOCHEM BIOPH RES CO, V380, P850, DOI 10.1016/j.bbrc.2009.01.182; Blazejewski T, 2015, MBIO, V6, DOI 10.1128/mBio.02445-14; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Cann H, 2004, MOL BIOCHEM PARASIT, V137, P239, DOI 10.1016/j.molbiopara.2004.06.005; Chan SL, 2014, GENE DEV, V28, P2370, DOI 10.1101/gad.250993.114; Chikne V, 2017, J MOL BIOL, V429, P3301, DOI 10.1016/j.jmb.2017.04.015; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; de Lorenzo L, 2017, PLANT CELL, V29, P1262, DOI 10.1105/tpc.16.00746; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Elliott BJ, 2003, PLANT MOL BIOL, V51, P373, DOI 10.1023/A:1022035219500; Forbes KP, 2006, J BIOL CHEM, V281, P176, DOI 10.1074/jbc.M510964200; FRANZEN O, 2013, PLOS COMPUT BIOL, V0009; Fuentes V, 2012, EUKARYOT CELL, V11, P725, DOI 10.1128/EC.05322-11; Helming S, 2001, MOL CELL BIOL, V21, P2026, DOI 10.1128/MCB.21.6.2026-2037.2001; Hendriks EF, 2003, J BIOL CHEM, V278, P26870, DOI 10.1074/jbc.M302405200; Howe DK, 2005, INFECT IMMUN, V73, P1023, DOI 10.1128/IAI.73.2.1023-1033.2005; Hunt AG, 2008, CURR TOP MICROBIOL, V326, P151; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Hunt AG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-641; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; Kim H, 2001, BIOCHEM BIOPH RES CO, V289, P513, DOI 10.1006/bbrc.2001.5992; Klimes V, 2014, GENOME BIOL EVOL, V6, P1956, DOI 10.1093/gbe/evu146; Koch H, 2016, RNA BIOL, V13, P221, DOI 10.1080/15476286.2015.1130208; Li XQ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0162-7; Lohman BK, 2016, MOL ECOL RESOUR, V16, P1315, DOI 10.1111/1755-0998.12529; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; Ma LY, 2014, METHODS, V67, P74, DOI 10.1016/j.ymeth.2013.06.037; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672; Oguariri RM, 2006, MOL BIOCHEM PARASIT, V146, P163, DOI 10.1016/j.molbiopara.2005.12.004; Palencia A, 2017, EMBO MOL MED, V9, P385, DOI 10.15252/emmm.201607370; Pati Pratap Kumar, 2015, Methods Mol Biol, V1255, P159, DOI 10.1007/978-1-4939-2175-1_14; PREKER PJ, 1995, CELL, V81, P379, DOI 10.1016/0092-8674(95)90391-7; RUVOLO V, 1993, MOL BIOCHEM PARASIT, V57, P137, DOI 10.1016/0166-6851(93)90251-R; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Schonemann L, 2014, GENE DEV, V28, P2381, DOI 10.1101/gad.250985.114; Shen YJ, 2008, GENETICS, V179, P167, DOI 10.1534/genetics.108.088971; Shi YS, 2015, GENE DEV, V29, P889, DOI 10.1101/gad.261974.115; Siegel TN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-150; Sonoiki E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14574; Sun YD, 2018, P NATL ACAD SCI USA, V115, pE1419, DOI 10.1073/pnas.1718723115; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Thomas PE, 2012, PLANT CELL, V24, P4376, DOI 10.1105/tpc.112.096107; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Wang CX, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4509; Wodniok S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-65; Xing DH, 2011, WIRES RNA, V2, P445, DOI 10.1002/wrna.59; Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107; Yao CG, 2013, RNA, V19, P1781, DOI 10.1261/rna.042317.113; Yao CG, 2012, P NATL ACAD SCI USA, V109, P18773, DOI 10.1073/pnas.1211101109; Zhao ZX, 2014, G3-GENES GENOM GENET, V4, P871, DOI 10.1534/g3.114.010249	57	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203317	10.1371/journal.pone.0203317	http://dx.doi.org/10.1371/journal.pone.0203317			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161237	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900110
J	Tsogbadrakh, B; Ju, KD; Lee, J; Han, M; Koh, J; Yu, Y; Lee, H; Yu, KS; Oh, YK; Kim, HJ; Ahn, C; Oh, KH				Tsogbadrakh, Bodokhsuren; Ju, Kyung Don; Lee, Jinho; Han, Miyeun; Koh, Junga; Yu, Yeonsil; Lee, Hajeong; Yu, Kyung-Sang; Oh, Yun Kyu; Kim, Hyo Jin; Ahn, Curie; Oh, Kook-Hwan			HL156A, a novel pharmacological agent with potent adenosine-monophosphate-activated protein kinase (AMPK) activator activity ameliorates renal fibrosis in a rat unilateral ureteral obstruction model	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR; TGF-BETA; DIABETIC-NEPHROPATHY; METFORMIN; PROLIFERATION; INFLAMMATION; FIBROBLASTS; MECHANISM; STRESS	Background Renal fibrosis is characterized by excessive production and deposition of extracellular matrix (ECM), which leads to progressive renal failure. Adenosine-monophosphate-activated protein kinase (AMPK) is a highly conserved kinase that plays a key role in Smad-3 signaling. Here, we examined the effect of a novel AMPK activator, HL156A, on the inhibition of renal fibrosis in in vivo and in vitro models. Methods Unilateral ureteral obstruction (UUO) was induced in male Wistar rats. Rats with UUO were administered HL156A (20mg/kg/day), and then the kidneys were harvested 10 days after ligation for further analysis. Results In the rat UUO model, HL156A attenuated ECM protein deposition. After HL156A treatment, expressions of TGF-beta 1, p-Smad3, alpha-SMA, fibronectin, and type IV collagen were suppressed, and E-cadherin expression was up-regulated. In the in vitro experiment, NRK52E cells were treated with HL156A before TGF-beta 1 stimulation. The inhibitory effects of HL156A upon the signaling pathways and markers of the epithelial-to-mesenchymal transition (EMT) were analyzed. In TGF-beta 1-treated NRK-52E cells, HL156A co-treatment inhibited the TGF-beta 1-induced Smad3 signaling pathway and EMT markers. Conclusion Taken together, the above findings suggest that HL156A, a novel AMPK activator, ameliorates renal fibrosis in vivo and in vitro.	[Tsogbadrakh, Bodokhsuren; Ju, Kyung Don; Lee, Jinho] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Han, Miyeun; Lee, Hajeong; Oh, Yun Kyu; Ahn, Curie; Oh, Kook-Hwan] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Koh, Junga; Yu, Yeonsil] Seoul Natl Univ Hosp, Dept Internal Med, Renal Div, Seoul, South Korea; [Yu, Kyung-Sang] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med & Hosp, Seoul, South Korea; [Oh, Yun Kyu] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea; [Kim, Hyo Jin] Dongkuk Univ, Dept Internal Med, Kyungju, South Korea; [Ahn, Curie] Seoul Natl Univ Hosp, Transplantat Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Dongguk University; Seoul National University (SNU); Seoul National University Hospital	Oh, KH (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	khoh@snu.ac.kr	Han, Miyeun/AAE-7569-2022; Oh, Yun Kyu/J-5542-2012		Hanall Biophama Co., Korea	Hanall Biophama Co., Korea	This research was funded by Hanall Biophama Co., Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Allouch S, 2017, J CELL PHYSIOL, V232, P3652, DOI 10.1002/jcp.25838; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106554; Chevalier RL, 2009, KIDNEY INT, V76, P475, DOI 10.1038/ki.2009.244; Daskalopoulos EP, 2016, J MOL CELL CARDIOL, V91, P188, DOI 10.1016/j.yjmcc.2016.01.001; Iwano Masayuki, 2010, Front Biosci (Schol Ed), V2, P229; Ju KD, 2016, AM J PHYSIOL-RENAL, V310, pF342, DOI 10.1152/ajprenal.00204.2015; Kim H, 2015, AM J PHYSIOL-RENAL, V308, pF226, DOI 10.1152/ajprenal.00495.2014; Kim IY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00175; Kim SI, 2012, KIDNEY RES CLIN PRAC, V31, P94, DOI 10.1016/j.krcp.2012.04.322; Kim Y, 2016, KIDNEY RES CLIN PRAC, V35, P69, DOI 10.1016/j.krcp.2016.02.004; Klahr S, 2003, KIDNEY INT, V64, pS105, DOI 10.1046/j.1523-1755.64.s87.16.x; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Lan HY, 2012, KIDNEY RES CLIN PRAC, V31, P4, DOI 10.1016/j.krcp.2011.12.001; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Lieberthal W, 2016, AM J PHYSIOL-RENAL, V311, pF731, DOI 10.1152/ajprenal.00541.2015; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Lu JM, 2015, LIFE SCI, V127, P59, DOI 10.1016/j.lfs.2015.01.042; Masaki T, 2003, KIDNEY INT, V63, P1256, DOI 10.1046/j.1523-1755.2003.00874.x; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; Salt IP, 2012, EXPERT OPIN INV DRUG, V21, P1155, DOI 10.1517/13543784.2012.696609; Shihab FS, 2007, CLIN J AM SOC NEPHRO, V2, P876, DOI 10.2215/CJN.02660707; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Thakur S, 2015, AM J PATHOL, V185, P2168, DOI 10.1016/j.ajpath.2015.04.014; Ueno S, 2016, J PHARMACOL SCI, V131, P110, DOI 10.1016/j.jphs.2016.04.021; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhang SW, 2017, EXP THER MED, V14, P383, DOI 10.3892/etm.2017.4475; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201692	10.1371/journal.pone.0201692	http://dx.doi.org/10.1371/journal.pone.0201692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161162	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900013
J	van Loon, A; Bailenson, J; Zaki, J; Bostick, J; Willer, R				van Loon, Austin; Bailenson, Jeremy; Zaki, Jamil; Bostick, Joshua; Willer, Robb			Virtual reality perspective-taking increases cognitive empathy for specific others	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; STIGMATIZED GROUP; SELF; ATTITUDES; RESPONSES; EMOTIONS; MEMBER; MIND	Previous research shows that virtual reality perspective-taking experiences (VRPT) can increase prosocial behavior toward others. We extend this research by exploring whether this effect of VRPT is driven by increased empathy and whether the effect extends to ostensibly real-stakes behavioral games. In a pre-registered laboratory experiment (N = 180), participants interacted with an ostensible partner (a student from the same university as them) on a series of real-stakes economic games after (a) taking the perspective of the partner in a virtual reality, "day-in-the-life" simulation, (b) taking the perspective of a different person in a "day-in-the-life" simulation, or (c) doi ng a neutral activity in a virtual environment. The VRPT experience successfully increased participants' subsequent propensity to take the perspective of their partner (a facet of empathy), but only if the partner was the same person whose perspective participants assumed in the virtual reality simulation. Further, this effect of VRPT on perspective-taking was moderated by participants' reported feeling of immersion in the virtual environment. However, we found no effects of VRPT experience on behavior in the economic games.	[van Loon, Austin; Willer, Robb] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; [Bailenson, Jeremy; Bostick, Joshua] Stanford Univ, Dept Commun, Stanford, CA 94305 USA; [Zaki, Jamil] Stanford Univ, Dept Psychol, Stanford, CA USA	Stanford University; Stanford University; Stanford University	van Loon, A (corresponding author), Stanford Univ, Dept Sociol, Stanford, CA 94305 USA.	avanloon@stanford.edu	van Loon, Austin/GVR-8260-2022	van Loon, Austin/0000-0002-9565-7392	Defense Advanced Research Projects Agency [69783LSDRP]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	Funded by The Defense Advanced Research Projects Agency funding associated with proposal 69783LSDRP, applied to by JB, JZ, and RW. (Website for DARPA: https://www.darpa.mil/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2016, J COMPUT MEDIAT COMM; Ahn SJ, 2013, MEDIA PSYCHOL, V16, P7, DOI 10.1080/15213269.2012.755877; Bailey J. O, 2012, INT SOC PRES RES ANN; Banakou D, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00601; Batson CD, 1997, J PERS SOC PSYCHOL, V73, P495, DOI 10.1037/0022-3514.73.3.495; Batson CD, 2002, PERS SOC PSYCHOL B, V28, P1656, DOI 10.1177/014616702237647; Batson CD, 1997, J PERS SOC PSYCHOL, V73, P517; Batson CD, 1997, J PERS SOC PSYCHOL, V72, P105, DOI 10.1037/0022-3514.72.1.105; Batson CD., 1991, PSYCHOL INQ, V2, P107, DOI [10.1207/s15327965pli0202_1, DOI 10.1207/S15327965PLI0202_1]; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Bunn W, 2009, ACAD PSYCHIATR, V33, P457, DOI 10.1176/appi.ap.33.6.457; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; CLORE GL, 1972, J PERS SOC PSYCHOL, V23, P105, DOI 10.1037/h0032867; Condon P, 2013, PSYCHOL SCI, V24, P2125, DOI 10.1177/0956797613485603; Costa PT., 2008, SAGE HDB PERSONALITY, VLondon, P179, DOI [DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.n9]; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Davis MH, 1996, J PERS SOC PSYCHOL, V70, P713, DOI 10.1037/0022-3514.70.4.713; Davis MH, 1999, J PERS, V67, P469, DOI 10.1111/1467-6494.00062; Eisenberg N, 2012, EMOT REV, V4, P34, DOI 10.1177/1754073911421381; Fox J, 2008, APPL REGRESSION ANAL; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Groom V, 2009, SOC INFLUENCE, V4, P231, DOI 10.1080/15534510802643750; Hasler BS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174965; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hooker CI, 2010, BRAIN RES, V1308, P100, DOI 10.1016/j.brainres.2009.10.006; KAHNEMAN D, 1986, AM ECON REV, V76, P728; KREBS D, 1975, J PERS SOC PSYCHOL, V32, P1134, DOI 10.1037/0022-3514.32.6.1134; Lamm C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0083; Lipps T, 1903, ARCH GESAMTE PSYCHOL, V1, P185; LUNDQVIST LO, 1995, J PSYCHOPHYSIOL, V9, P203; Maister L, 2013, COGNITION, V128, P170, DOI 10.1016/j.cognition.2013.04.002; Meister L, 2015, TRENDS COGN SCI, V19, P6, DOI 10.1016/j.tics.2014.11.001; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Oh SY, 2016, COMPUT HUM BEHAV, V60, P398, DOI 10.1016/j.chb.2016.02.007; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Preston S. D., 2002, BEHAV BRAIN SCI, V25, P20, DOI [10.1017/S0140525X02380014, DOI 10.1017/S0140525X023]; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Schultz PW, 2001, J ENVIRON PSYCHOL, V21, P327; Schutte N.S., 2017, ECOPSYCHOLOGY, V9, P1; Seinfeld S, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Shechtman Z, 2006, PEACE CONFL, V12, P119, DOI 10.1207/s15327949pac1202_2; Sims T, 2015, ANN M GER SOC AM ORL; Slater M, PLOS ONE, V8, DOI [10.1371/journal.pone,0052766, DOI 10.1371/JOURNAL.PONE,0052766]; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Soble JR, 2011, J COUNS PSYCHOL, V58, P151, DOI 10.1037/a0021158; Sturmer S, 2005, J PERS SOC PSYCHOL, V88, P532, DOI 10.1037/0022-3514.88.3.532; Thomas G, 2008, J PERS SOC PSYCHOL, V95, P1165, DOI 10.1037/a0013067; Tibi-Elhanany Y, 2011, ISR J PSYCHIATR REL, V48, P98; Todd AR, 2015, J EXP PSYCHOL GEN, V144, P374, DOI 10.1037/xge0000048; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Waytz A, 2012, J NEUROSCI, V32, P7646, DOI 10.1523/JNEUROSCI.6193-11.2012; Weisz E, OXFORD HDB COMPASSIO; Wellman H. M., 1992, MIND LANG, V7, P145, DOI DOI 10.1111/J.1468-0017.1992.TB00202.X; WRIGHTSMAN LS, 1964, PSYCHOL REP, V14, P743, DOI 10.2466/pr0.1964.14.3.743; Yee N, 2009, MEDIA PSYCHOL, V12, P195, DOI 10.1080/15213260902849943; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zaki J, 2015, CURR DIR PSYCHOL SCI, V24, P471, DOI 10.1177/0963721415599978; Zaki J, 2014, PSYCHOL BULL, V140, P1608, DOI 10.1037/a0037679; Zaki J, 2013, CURR DIR PSYCHOL SCI, V22, P466, DOI 10.1177/0963721413492764; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085; Zakil J, 2017, TRENDS COGN SCI, V21, P59, DOI 10.1016/j.tics.2016.12.004	62	58	58	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202442	10.1371/journal.pone.0202442	http://dx.doi.org/10.1371/journal.pone.0202442			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161144	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900030
J	Felsing, DE; Anastasio, NC; Miszkiel, JM; Gilbertson, SR; Allen, JA; Cunningham, KA				Felsing, Daniel E.; Anastasio, Noelle C.; Miszkiel, Joanna M.; Gilbertson, Scott R.; Allen, John A.; Cunningham, Kathryn A.			Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; RESONANCE ENERGY-TRANSFER; MEDIAL PREFRONTAL CORTEX; MESSENGER-RNAS; BIOLUMINESCENCE-RESONANCE; CELLS; HOMODIMERS; COMPLEXES; AGONISTS; COMPLEMENTATION	The serotonin (5-HT) 5-HT2A receptor (5-HT2AR) and 5-HT2C receptor (5-HT2CR) in the central nervous system are implicated in a range of normal behaviors (e.g., appetite, sleep) and physiological functions (e.g., endocrine secretion) while dysfunctional 5-HT2AR and/or 5-HT2CR are implicated in neuropsychiatric disorders (e.g., addiction, obesity, schizophrenia). Preclinical studies suggest that the 5-HT2AR and 5-HT2CR may act in concert to regulate the neural bases for behavior. Here, we utilize three distinct biophysical and immunocytochemistry-based approaches to identify and study this receptor complex in cultured cells. Employing a split luciferase complementation assay (LCA), we demonstrated that formation of the 5-HT2AR: 5-HT2CR complex exists within 50 nm, increases proportionally to the 5-HT2CR: 5-HT2AR protein expression ratio, and is specific to the receptor interaction and not due to random complementation of the luciferase fragments. Using a proximity ligation assay (PLA), we found that cells stably expressing both the 5-HT2AR and 5-HT2CR exhibit 5-HT2AR: 5-HT2CR heteroreceptor complexes within 40 nm of each other. Lastly, bioluminescence resonance energy transfer (BRET) analyses indicates the formation of a specific and saturable 5-HT2AR: 5-HT2CR interaction, suggesting that the 5-HT2AR and 5-HT2CR form a close interaction within 10 nm of each other in intact live cells. The bioengineered receptors generated for the LCA and the BRET exhibit 5-HT-mediated intracellular calcium signaling as seen for the native receptors. Taken together, this study validates a very close 5-HT2AR: 5-HT2CR interaction in cultured cells.	[Felsing, Daniel E.; Anastasio, Noelle C.; Miszkiel, Joanna M.; Allen, John A.; Cunningham, Kathryn A.] Univ Texas Med Branch, Ctr Addict Res, Galveston, TX 77555 USA; [Anastasio, Noelle C.; Allen, John A.; Cunningham, Kathryn A.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Gilbertson, Scott R.] Univ Houston, Dept Chem, Houston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Houston System; University of Houston	Cunningham, KA (corresponding author), Univ Texas Med Branch, Ctr Addict Res, Galveston, TX 77555 USA.; Cunningham, KA (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	kcunning@utmb.edu	Allen, John A/D-6141-2011; Anastasio, Noelle/GQH-1491-2022	Anastasio, Noelle/0000-0001-5579-4213; Cunningham, Kathryn A./0000-0002-4257-1739	NIDA [P50 DA033935, T32 DA007287, K05 DA020087]; Center for Addiction Research at the University of Texas Medical Branch; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007287, P50DA033935, K05DA020087] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Center for Addiction Research at the University of Texas Medical Branch; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIDA grants, P50 DA033935 (KAC), T32 DA007287 (DEF), K05 DA020087 (KAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIDA grants, P50 DA033935, T32 DA007287, K05 DA020087, and the Center for Addiction Research at the University of Texas Medical Branch. We thank Drs. Kelly A. Berg and William P. Clarke for the gift of cell lines, Dr. David Piwinica-Worms for the gift of plasmids expressing FRB-NLuc and FKBP-CLuc, Dr. Fernanda Laezza for technical guidance, Drs. Latham Fink, Patricia K. Seitz and Thressa D. Smith and Ms. Christina R. Merritt for their technical expertise. We also thank Drs. Claudia Soto and Marcy B. Jordan and Ms. Michelle Land for their helpful discussions. The authors declare no conflicts of interest.	Albizu L, 2011, NEUROPHARMACOLOGY, V61, P770, DOI 10.1016/j.neuropharm.2011.05.023; Anastasio NC, 2015, ACS CHEM NEUROSCI, V6, P1248, DOI 10.1021/acschemneuro.5b00094; Anastasio NC, 2014, NEUROPSYCHOPHARMACOL, V39, P360, DOI 10.1038/npp.2013.199; Anastasio NC, 2013, J NEUROSCI, V33, P1615, DOI 10.1523/JNEUROSCI.2656-12.2013; Aronne L, 2014, POSTGRAD MED, V126, P7, DOI 10.3810/pgm.2014.10.2817; Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Bazovkina DV, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/846589; BERG KA, 1994, MOL PHARMACOL, V45, P826; Berg KA, 1998, ANN NY ACAD SCI, V861, P104, DOI 10.1111/j.1749-6632.1998.tb10180.x; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; Berg KA, 1996, MOL PHARMACOL, V50, P1017; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bigford GE, 2012, J BIOL CHEM, V287, P11049, DOI 10.1074/jbc.M111.277806; Borroto-Escuela DO, 2017, ACS OMEGA, V2, P4779, DOI 10.1021/acsomega.7b00629; Borroto-Escuela DO, 2014, BIOCHEM BIOPH RES CO, V443, P278, DOI 10.1016/j.bbrc.2013.11.104; Burton CL, 2013, BEHAV BRAIN RES, V240, P171, DOI 10.1016/j.bbr.2012.11.030; Carr DB, 2002, J NEUROSCI, V22, P6846; Cunningham KA, 2014, NEUROPHARMACOLOGY, V76, P460, DOI 10.1016/j.neuropharm.2013.06.030; Cunningham KA, 2013, ACS CHEM NEUROSCI, V4, P110, DOI 10.1021/cn300072u; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Herrick-Davis K, 2004, BIOCHEMISTRY-US, V43, P13963, DOI 10.1021/bi048398p; Herrick-Davis K, 2007, EUR J PHARMACOL, V568, P45, DOI 10.1016/j.ejphar.2007.04.030; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Herrick-Davis K, 2015, MOL PHARMACOL, V87, P660, DOI 10.1124/mol.114.096636; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Howell LL, 2015, PHARMACOL REV, V67, P176, DOI 10.1124/pr.114.009514; Iglesias A, 2017, EUR J PHARMACOL, V800, P63, DOI 10.1016/j.ejphar.2017.02.028; Iglesias A, 2016, J BIOMOL SCREEN, V21, P816, DOI 10.1177/1087057116644162; JULIUS D, 1990, P NATL ACAD SCI USA, V87, P928, DOI 10.1073/pnas.87.3.928; Kamal M, 2015, J BIOL CHEM, V290, P11537, DOI 10.1074/jbc.M114.559542; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Luker KE, 2004, METHOD ENZYMOL, V385, P349; Martin-Gronert MS, 2016, DIS MODEL MECH, V9, P401, DOI 10.1242/dmm.023903; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Milligan G, 2004, EUR J PHARM SCI, V21, P397, DOI 10.1016/j.ejps.2003.11.010; Moutkine I, 2017, J BIOL CHEM, V292, P6352, DOI 10.1074/jbc.M117.779041; Navarro G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03522-3; Nocjar C, 2015, NEUROSCIENCE, V297, P22, DOI 10.1016/j.neuroscience.2015.03.050; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Pockros LA, 2012, SYNAPSE, V66, P989, DOI 10.1002/syn.21592; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sahli ZT, 2018, EXPERT OPIN DRUG DIS, V13, P103, DOI 10.1080/17460441.2018.1394838; Schellekens H, 2012, BEHAV PHARMACOL, V23, P634; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seitz PK, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-25; Shavkunov A, 2012, ASSAY DRUG DEV TECHN, V10, P148, DOI 10.1089/adt.2011.413; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; Vinals X, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002194; Vysokanov A, 1998, NEUROSCI LETT, V258, P179, DOI 10.1016/S0304-3940(98)00882-9; Weiner DM, 2001, J PHARMACOL EXP THER, V299, P268; WRIGHT DE, 1995, J COMP NEUROL, V351, P357, DOI 10.1002/cne.903510304	54	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203137	10.1371/journal.pone.0203137	http://dx.doi.org/10.1371/journal.pone.0203137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157263	Green Submitted, gold, Green Published			2022-12-27	WOS:000443071400095
J	Hoff, KE; DeBalsi, KL; Sanchez-Quintero, MJ; Longley, MJ; Hirano, M; Naini, AB; Copeland, WC				Hoff, Kirsten E.; DeBalsi, Karen L.; Sanchez-Quintero, Maria J.; Longley, Matthew J.; Hirano, Michio; Naini, Ali B.; Copeland, William C.			Characterization of the human homozygous R182W POLG2 mutation in mitochondrial DNA depletion syndrome	PLOS ONE			English	Article							POLYMERASE GAMMA-SUBUNITS; ACCESSORY SUBUNIT; DISEASE MUTATIONS; ENERGY-METABOLISM; MTDNA; PROTEIN; RECONSTITUTION; REPLICATION; MAINTENANCE; HOLOENZYME	Mutations in mitochondrial DNA (mtDNA) have been linked to a variety of metabolic, neurological and muscular diseases which can present at any time throughout life. MtDNA is replicated by DNA polymerase gamma (Pol gamma), twinkle helicase and mitochondrial single-stranded binding protein (mtSSB). The Pol gamma holoenzyme is a heterotrimer consisting of the p140 catalytic subunit and a p55 homodimeric accessory subunit encoded by the nuclear genes POLG and POLG2, respectively. The accessory subunits enhance DNA binding and promote processive DNA synthesis of the holoenzyme. Mutations in either POLG or POLG2 are linked to disease and adversely affect maintenance of the mitochondrial genome, resulting in depletion, deletions and/or point mutations in mtDNA. A homozygous mutation located at Chr17: 62492543G> A in POLG2, resulting in R182W substitution in p55, was previously identified to cause mtDNA depletion and fatal hepatic liver failure. Here we characterize this homozygous R182W p55 mutation using in vivo cultured cell models and in vitro biochemical assessments. Compared to control fibroblasts, homozygous R182W p55 primary dermal fibroblasts exhibit a two-fold slower doubling time, reduced mtDNA copy number and reduced levels of POLG and POLG2 transcripts correlating with the reported disease state. Expression of R182W p55 in HEK293 cells impairs oxidative-phosphorylation. Biochemically, R182W p55 displays DNA binding and association with p140 similar to WT p55. R182W p55 mimics the ability of WT p55 to stimulate primer extension, support steady-state nucleotide incorporation, and suppress the exonuclease function of Pol gamma in vitro. However, R182W p55 has severe defects in protein stability as determined by differential scanning fluorimetry and in stimulating function as determined by thermal inactivation. These data demonstrate that the Chr17: 62492543G> A mutation in POLG2, R182W p55, severely impairs stability of the accessory subunit and is the likely cause of the disease phenotype.	[Hoff, Kirsten E.; DeBalsi, Karen L.; Longley, Matthew J.; Copeland, William C.] NIEHS, Genome Integr & Struct Biol Lab, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Sanchez-Quintero, Maria J.; Hirano, Michio; Naini, Ali B.] Columbia Univ, Dept Neurol, Med Ctr, H Houston Merritt Neuromuscular Res Ctr, New York, NY USA; [Naini, Ali B.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Naini, Ali B.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, Div Personalized Genom Med, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Columbia University; Columbia University; Columbia University	Copeland, WC (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019; SANCHEZ-QUINTERO, MARIA J/AAS-6771-2020	Copeland, William/0000-0002-0359-0953; SANCHEZ-QUINTERO, MARIA J/0000-0002-5638-2920	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [ES 065078]; NIH/ NICHD [5P01 HD080642-02]	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/ NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (ES 065078). M.H. and A.B.N. are supported by NIH/ NICHD grant 5P01 HD080642-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Brown TA, 2011, MOL CELL BIOL; Bruni F, 2010, J BIOL CHEM, V285, P3939, DOI 10.1074/jbc.M109.044305; Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Chretien D, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003992; Cohen BH, 1997, POLG RELATED DISORDE; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Craig K, 2012, MITOCHONDRION, V12, P313, DOI 10.1016/j.mito.2011.11.006; DeBalsi KL, 2017, J BIOL CHEM, V292, P4198, DOI 10.1074/jbc.M116.773341; Dott W, 2014, REDOX BIOL, V2, P224, DOI 10.1016/j.redox.2013.12.028; Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506; Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lee SK, 2015, THERIOGENOLOGY, V83, P121, DOI 10.1016/j.theriogenology.2014.08.019; Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Oliveira MT, 2015, GENOME BIOL EVOL, V7, P943, DOI 10.1093/gbe/evv042; Pinz KG, 2006, DNA REPAIR, V5, P121, DOI 10.1016/j.dnarep.2005.08.014; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Ronquist G, 2003, EXP DERMATOL, V12, P572, DOI 10.1034/j.1600-0625.2003.00018.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stumpf JD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011395; Van Maldergem L, 2017, ANN CLIN TRANSL NEUR, V4, P4, DOI 10.1002/acn3.361; Varma H, 2016, EUR J MED GENET, V59, P540, DOI 10.1016/j.ejmg.2016.08.012; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; Wang CK, 2012, BIOINFORMATICS, V28, P439, DOI 10.1093/bioinformatics/btr664; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Young M.J., 2013, MITOCHONDRIAL DISORD, P49; Young MJ, 2015, HUM MOL GENET, V24, P5184, DOI 10.1093/hmg/ddv240; Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203198	10.1371/journal.pone.0203198	http://dx.doi.org/10.1371/journal.pone.0203198			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157269	gold, Green Submitted, Green Published			2022-12-27	WOS:000443071400099
J	Jarque, S; Fetter, E; Veneman, WJ; Spaink, HP; Peravali, R; Strahle, U; Scholz, S				Jarque, Sergio; Fetter, Eva; Veneman, Wouter J.; Spaink, Herman P.; Peravali, Ravindra; Straehle, Uwe; Scholz, Stefan			An automated screening method for detecting compounds with goitrogenic activity using transgenic zebrafish embryos	PLOS ONE			English	Article							THYROID-GLAND; TOXICITY TEST; FISH; EXPRESSION; DISRUPTION; POLLUTANTS; CHEMICALS; EXPOSURE; MODEL; ASSAY	The knowledge on environmentally relevant chemicals that may interfere with thyroid signaling is scarce. Here, we present a method for the screening of goitrogens, compounds that disrupt the thyroid gland function, based on the automatic orientation of zebrafish in a glass capillary and a subsequent imaging of reporter gene fluorescence in the thyroid gland of embryos of the transgenic zebrafish line tg(tg:mCherry). The tg(tg:mCherry) reporter gene indicates a compensatory upregulation of thyroglobulin, the thyroid hormone precursor, in response to inhibition of thyroid hormone synthesis. Fish embryos were exposed to a negative control compound (3,4-dichloroaniline), or a concentration series of known goitrogenic compounds (resorcinol, methimazole, potassium perchlorate, 6-propyl-2-thiouracil, ethylenethiourea, phloroglucinol, pyrazole) with maximum exposure concentration selected based on mortality and/or solubility. Exposure to 3,4-dichloroaniline decreased the fluorescence signal. All goitrogenic compounds exhibited clear concentration-dependent inductions of reporter fluorescence 1.4 to 2.6 fold above control levels. Concentration-response modelling was used to calculate goitrogenic potencies based on EC50 values. The new automated method offers an efficient screening approach for goitrogenic activity.	[Jarque, Sergio] Masaryk Univ, RECETOX, Fac Sci, Brno, Czech Republic; [Fetter, Eva; Scholz, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany; [Veneman, Wouter J.; Spaink, Herman P.] Leiden Univ, Inst Biol, Dept Anim Sci & Hlth, Leiden, Netherlands; [Peravali, Ravindra; Straehle, Uwe] Karlsruhe Inst Technol, Inst Toxicol & Genet, Karlsruhe, Germany	Masaryk University Brno; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leiden University; Leiden University - Excl LUMC; Helmholtz Association; Karlsruhe Institute of Technology	Scholz, S (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany.	stefan.scholz@ufz.de	Spaink, Herman P./S-3586-2017; Straehle, Uwe/K-7054-2013; Scholz, Stefan/B-7776-2014	Spaink, Herman P./0000-0003-4128-9501; Scholz, Stefan/0000-0002-6990-4716; Jarque, Sergio/0000-0002-5528-9054	German Environmental Scholarship foundation; Czech Ministry of Education [LO1214]; Program of "Employment of Newly Graduated Doctors of Science for Scientific Excellence" - European Social Fund [CZ.1.07/2.3.00/30.0009]; State Budget of the Czech Republic; Helmholtz Association	German Environmental Scholarship foundation; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Program of "Employment of Newly Graduated Doctors of Science for Scientific Excellence" - European Social Fund; State Budget of the Czech Republic; Helmholtz Association(Helmholtz Association)	The work of Eva Fetter was supported by a scholarship of the German Environmental Scholarship foundation. Sergio Jarque was supported by the Czech Ministry of Education (LO1214) and the Program of "Employment of Newly Graduated Doctors of Science for Scientific Excellence" (Grant number CZ.1.07/2.3.00/30.0009) co-financed from European Social Fund and the State Budget of the Czech Republic. All other authors did not receive specific fundings for their contribution. We gratefully acknowledge access to the platform CITEPro (Chemicals in the Terrestrial Environment Profiler) funded by the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt B, 2006, DEV DYNAM, V235, P1872, DOI 10.1002/dvdy.20831; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Demeneix B., 2014, LOSING OUR MINDS ENV; Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008; Fetter E, 2015, REPROD TOXICOL, V57, P10, DOI 10.1016/j.reprotox.2015.04.012; Fini JB, 2007, ENVIRON SCI TECHNOL, V41, P5908, DOI 10.1021/es0704129; Freitas J, 2011, TOXICOL IN VITRO, V25, P257, DOI 10.1016/j.tiv.2010.08.013; Freitas JS, 2016, ENVIRON SCI TECHNOL, V50, P13095, DOI 10.1021/acs.est.6b04076; Haber LT, 2018, CRIT REV TOXICOL, V48, P387, DOI 10.1080/10408444.2018.1430121; ISO, 2007, 15088 ISO; Jarque S, 2014, ENVIRON RES, V135, P361, DOI 10.1016/j.envres.2014.09.022; Kah M, 2008, CHEMOSPHERE, V72, P1401, DOI 10.1016/j.chemosphere.2008.04.074; Kluver N, 2016, CHEMOSPHERE, V164, P164, DOI 10.1016/j.chemosphere.2016.08.079; Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q; Lin YH, 2013, ONCOGENE, V32, P4509, DOI 10.1038/onc.2013.309; Liu CS, 2013, CHEMOSPHERE, V93, P2327, DOI 10.1016/j.chemosphere.2013.08.026; Marchesini GR, 2006, ANAL CHEM, V78, P1107, DOI 10.1021/ac051399i; Matthiessen P, 2018, CRIT REV TOXICOL, V48, P195, DOI 10.1080/10408444.2017.1397099; Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247; Mughal BB, 2018, ENDOCR CONNECT, V7, pR160, DOI 10.1530/EC-18-0029; Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38; OECD, 2012, OECD SER TEST ASS, V178; OECD, 2013, OECD 236 GUID TEST C; Opitz R, 2012, DEV BIOL, V372, P203, DOI 10.1016/j.ydbio.2012.09.011; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Paul KB, 2014, CHEM RES TOXICOL, V27, P387, DOI 10.1021/tx400310w; Raldua D, 2009, ENVIRON SCI TECHNOL, V43, P6844, DOI 10.1021/es9012454; Stefan M, 2014, P NATL ACAD SCI USA, V111, P12562, DOI 10.1073/pnas.1408821111; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; Thienpont B, 2011, ENVIRON SCI TECHNOL, V45, P7525, DOI 10.1021/es202248h; Tonyushkina KN, 2014, J CLIN INVEST, V124, P321, DOI 10.1172/JCI70038; Upadhyay G, 2004, HEPATOLOGY, V39, P1120, DOI 10.1002/hep.20085; VAN WEZEL A, 1995, CRIT REV TOXICOL, V25, P255, DOI 10.3109/10408449509089890; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wittbrodt JN, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-36	35	14	15	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203087	10.1371/journal.pone.0203087	http://dx.doi.org/10.1371/journal.pone.0203087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157258	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400088
J	Linhart, P; Salek, M				Linhart, Pavel; Salek, Martin			The assessment of biases in the acoustic discrimination of individuals (vol 12, e0177206, 2017)	PLOS ONE			English	Correction													Salek, Martin/AAE-9233-2019; Linhart, Pavel/AAZ-7474-2021	Linhart, Pavel/0000-0002-6097-5892; Salek, Martin/0000-0003-2639-9745	Czech Science Foundation [GA14-27925S]; Ministry of Agriculture of Czech Republic [MZERO0716]; National Science Centre, Poland - European Union [UMO-2015/19/P/NZ8/02507, 665778]; Academy of Sciences of the Czech Republic [RVO68081766]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Agriculture of Czech Republic(Ministry of Agriculture, Czech Republic); National Science Centre, Poland - European Union; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	PL was supported by the Czech Science Foundation (GA14-27925S), Ministry of Agriculture of Czech Republic (MZERO0716), and by the National Science Centre, Poland (under Polonez fellowship reg. number UMO-2015/19/P/NZ8/02507 funded by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement number 665778); MS I was funded by the Academy of Sciences of the Czech Republic (RVO68081766). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Linhart P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177206	1	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203357	10.1371/journal.pone.0203357	http://dx.doi.org/10.1371/journal.pone.0203357			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157255	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400104
J	Trevillyan, JM; Wong, G; Puls, R; Petoumenos, K; Emery, S; Mellett, NA; Mundra, PA; Meikle, PJ; Hoy, JF				Trevillyan, Janine M.; Wong, Gerard; Puls, Rebekah; Petoumenos, Kathy; Emery, Sean; Mellett, Natalie A.; Mundra, Piyushkumar A.; Meikle, Peter J.; Hoy, Jennifer F.		ALTAIR Study Grp	Changes in plasma lipidome following initiation of antiretroviral therapy	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TREATMENT-NAIVE; CARDIOVASCULAR-DISEASE; FATTY-ACID; HIV; EFAVIRENZ; RISK; ATAZANAVIR/RITONAVIR; INHIBITORS; POPULATION	Introduction HIV and antiretroviral therapy (ART) have been associated with increased cardiovascular disease and important changes in lipid metabolism. Advances in mass-spectrometry technology allow for the detailed assessment of individual lipid species which may illuminate the mechanisms underlying increased cardiovascular risk. We describe the change in plasma lipidome with initiation of antiretroviral therapy and compare these by regimen. Methods Plasma lipid profiling (by electrospray isonisation-tandem mass spectrometry) was performed on ARV-naive HIV positive participants randomised to one of three regimens; tenofovir/emtricitabine with efavirenz, ritonavir-boosted atazanavir (atazanavir/r) or zidovudine/abacavir. Participants (n = 115) who remained on their randomised regimen with complete samples available at baseline, week 12 and 48 were included. 306 lipid species from 22 lipid classes were analysed. Results Initiation of ART led to significant changes in lipidome which were partly dependent on the randomised regimen received. This led to significant differences in 72 lipid species and 7 classes (cholesterol ester, free cholesterol, phosphatidylcholine, GM3 ganglioside, trihexosylceramide, monohexosylceramide, and ceramides) by arm at week 48. Consistently higher lipid concentrations were seen with efavirenz compared with atazanavir/r or zidovudine/abacavir. Twelve of the lipid species and two lipid classes (cholesterol esters and ceramides) that were significantly increased in the efavirenz arm compared with the atazanavir/r or zidovudine/abacavir arms have previously been associated with future cardiovascular events in HIV positive patients. Change in HIV viral load was predictive of change in 3 lipid species. Conclusions Initiation of ART lead to significant changes in the plasma lipidome that were greatest in those receiving efavirenz.	[Trevillyan, Janine M.; Hoy, Jennifer F.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Infect Dis, Melbourne, Vic, Australia; [Wong, Gerard; Mellett, Natalie A.; Mundra, Piyushkumar A.; Meikle, Peter J.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Puls, Rebekah] UNSW Sydney, Fac Med, Sydney, NSW, Australia; [Petoumenos, Kathy; Emery, Sean] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Emery, Sean] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Hoy, Jennifer F.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia	Monash University; Baker Heart and Diabetes Institute; University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; University of Queensland; Florey Institute of Neuroscience & Mental Health	Trevillyan, JM (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Dept Infect Dis, Melbourne, Vic, Australia.	janine.trevillyan@monash.edu	Hoy, Jennifer/AAK-7968-2020; Emery, Sean/O-9122-2019; Trevillyan, Janine/AAD-1631-2019	Emery, Sean/0000-0001-6072-8309; Trevillyan, Janine/0000-0002-8660-5558; Meikle, Peter/0000-0002-2593-4665; Hoy, Jennifer/0000-0002-6948-7086; Mundra, Piyushkumar/0000-0001-7769-2939				Aberg JA, 2012, AIDS RES HUM RETROV, V28, P1184, DOI 10.1089/aid.2011.0327; Belury Martha A, 2017, Pathog Immun, V2, P376, DOI 10.20411/pai.v2i3.218; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blas-Garcia A, 2010, HEPATOLOGY, V52, P115, DOI 10.1002/hep.23647; Carey D, 2010, J ANTIMICROB CHEMOTH, V65, P1878, DOI 10.1093/jac/dkq231; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; den Boer MAM, 2006, ARTERIOSCL THROM VAS, V26, P124, DOI 10.1161/01.ATV.0000194073.87647.10; Desai M, 2015, CLIN INFECT DIS, V61, P445, DOI 10.1093/cid/civ316; El Hadri K, 2004, J BIOL CHEM, V279, P15130, DOI 10.1074/jbc.M312875200; Feeney Eoin R, 2011, Open Cardiovasc Med J, V5, P49, DOI 10.2174/1874192401105010049; Fernandez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071846; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2016, EUR J PREV CARDIOL, V23, P214, DOI 10.1177/2047487315579291; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gotti D, 2012, HIV CLIN TRIALS, V13, P245, DOI 10.1310/hct1305-245; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Kee TH, 2005, CLIN EXP PHARMACOL P, V32, P153, DOI 10.1111/j.1440-1681.2005.04166.x; Lenhard JM, 2000, ARTERIOSCL THROM VAS, V20, P2625, DOI 10.1161/01.ATV.20.12.2625; Li X, 2010, CELL PHYSIOL BIOCHEM, V26, P41, DOI 10.1159/000315104; Martinez E, 2009, JAIDS-J ACQ IMM DEF, V51, P290, DOI 10.1097/QAI.0b013e3181aa12d5; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Oh J, 2007, LANCET INFECT DIS, V7, P787, DOI 10.1016/S1473-3099(07)70287-6; Poss J, 2011, CURR PHARM DESIGN, V17, P861, DOI 10.2174/138161211795428858; Puls RL, 2010, CLIN INFECT DIS, V51, P855, DOI 10.1086/656363; Richmond SR, 2010, BBA-MOL CELL BIOL L, V1801, P559, DOI 10.1016/j.bbalip.2010.01.007; Riddle TM, 2001, J BIOL CHEM, V276, P37514, DOI 10.1074/jbc.M104557200; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; Rotger M, 2013, CLIN INFECT DIS, V57, P112, DOI 10.1093/cid/cit196; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Shafran SD, 2005, HIV MED, V6, P421, DOI 10.1111/j.1468-1293.2005.00328.x; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stegemann C, 2014, CIRCULATION, V129, P1821, DOI 10.1161/CIRCULATIONAHA.113.002500; Tarasov K, 2014, J CLIN ENDOCR METAB, V99, pE45, DOI 10.1210/jc.2013-2559; Tebas P, 2014, CLIN INFECT DIS, V59, P425, DOI 10.1093/cid/ciu234; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Wong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094810; Zhang DX, 2003, AM J PHYSIOL-HEART C, V284, pH605, DOI 10.1152/ajpheart.00697.2002	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202944	10.1371/journal.pone.0202944	http://dx.doi.org/10.1371/journal.pone.0202944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157268	Green Published, gold			2022-12-27	WOS:000443071400076
J	Navia, B; Lopez-Sobaler, AM; Villalobos, T; Aranceta-Bartrina, J; Gil, A; Gonzalez-Gross, M; Serra-Majem, L; Varela-Moreiras, G; Ortega, RM				Navia, Beatriz; Lopez-Sobaler, Ana M.; Villalobos, Tania; Aranceta-Bartrina, Javier; Gil, Angel; Gonzalez-Gross, Marcela; Serra-Majem, Lluis; Varela-Moreiras, Gregorio; Ortega, Rosa M.			Breakfast habits and differences regarding abdominal obesity in a cross-sectional study in Spanish adults: The ANIBES study (vol 12, e0188828, 2017)	PLOS ONE			English	Correction													Gonzalez-Gross, Marcela/W-8000-2018; López-Sobaler, Ana M/I-3589-2016; Ortega, Rosa M/S-5760-2016; Gil, Angel/ABA-7621-2020; Moreno, Emma Ruiz/S-7210-2018	López-Sobaler, Ana M/0000-0002-4133-1450; Ortega, Rosa M/0000-0003-3837-9450; Gil, Angel/0000-0001-7663-0939; Moreno, Emma Ruiz/0000-0003-3662-4440; VARELA-MOREIRAS, GREGORIO/0000-0001-5158-4999				Navia B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188828	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203341	10.1371/journal.pone.0203341	http://dx.doi.org/10.1371/journal.pone.0203341			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153305	Green Submitted, Green Published, gold			2022-12-27	WOS:000443001700050
J	da Silva, HB; de Salles, EM; Lima-Mauro, EF; Sardinha, LR; Alvarez, JM; Lima, MRD				da Silva, Henrique Borges; de Salles, Erika Machado; Lima-Mauro, Eliana Faquim; Sardinha, Luiz Roberto; Alvarez, Jose Maria; D'Imperio Lima, Maria Regina			CD28 deficiency leads to accumulation of germinal-center independent IgM(+) experienced B cells and to production of protective IgM during experimental malaria	PLOS ONE			English	Article							STAGE PLASMODIUM-CHABAUDI; IN-VIVO; T-CELL; ACQUIRED-IMMUNITY; ANTIBODIES; COMPLEMENT; INDUCTION; INFECTION; RESPONSES; IMMUNOGLOBULIN	Protective immunity to blood-stage malaria is attributed to Plasmodium-specific IgG and effector-memory T helper 1 (Th1) cells. However, mice lacking the costimulatory receptor CD28 (CD28KO) maintain chronic parasitemia at low levels and do not succumb to infection, suggesting that other immune responses contribute to parasite control. We report here that CD28KO mice develop long-lasting non-sterile immunity and survive lethal parasite challenge. This protection correlated with a progressive increase of anti-parasite IgM serum levels during chronic infection. Serum IgM from chronically infected CD28KO mice recognize erythrocytes infected with mature parasites, and effectively control Plasmodium infection by promoting parasite lysis and uptake. These antibodies also recognize autoantigens and antigens from other pathogens. Chronically infected CD28KO mice have high numbers of IgM(+) plasmocytes and experienced B cells, exhibiting a germinal-center independent Fas(+)GL7(-)CD38(+)CD73(-) phenotype. These cells are also present in chronically infected C57BL/6 mice although in lower numbers. Finally, IgM(+) experienced B cells from cured C57BL/6 and CD28KO mice proliferate and produce anti-parasite IgM in response to infected erythrocytes. This study demonstrates that CD28 deficiency results in the generation of germinal-center independent IgM(+) experienced B cells and the production of protective IgM during experimental malaria, providing evidence for an additional mechanism by which the immune system controls Plasmodium infection.	[da Silva, Henrique Borges; de Salles, Erika Machado; Alvarez, Jose Maria; D'Imperio Lima, Maria Regina] Univ Sao Paulo, ICB, Dept Imunol, Sao Paulo, Brazil; [Lima-Mauro, Eliana Faquim] Inst Butantan, Lab Imunopatol, Sao Paulo, Brazil; [Sardinha, Luiz Roberto] Inst Israelite Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil; [da Silva, Henrique Borges] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA	Universidade de Sao Paulo; Instituto Butantan; Hospital Israelita Albert Einstein; University of Minnesota System; University of Minnesota Twin Cities	da Silva, HB; Lima, MRD (corresponding author), Univ Sao Paulo, ICB, Dept Imunol, Sao Paulo, Brazil.; da Silva, HB (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA.	hborgesd@umn.edu; relima@usp.br	Salles, Érika Machado/I-6001-2015; D'Império Lima, Maria Regina/I-4747-2012; Alvarez, Jose M/I-6181-2012	D'Império Lima, Maria Regina/0000-0002-4683-7709; Alvarez, Jose M/0000-0002-9711-4914; Borges da Silva, Henrique/0000-0001-9424-3326	Sao Paulo Research Foundation (FAPESP, Brazil) [2010/51150-4, 2013/07140-2, 2015/20432-8]; National Council for Scientific and Technological Development (CNPq, Brazil) [303676/2014-0, 448765/2014-4]; FAPESP [2009/08559-1]	Sao Paulo Research Foundation (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP, Brazil) grants, 2010/51150-4, 2013/07140-2 and 2015/20432-8 (MRDIL), and National Council for Scientific and Technological Development (CNPq, Brazil) grants, 303676/2014-0 and 448765/2014-4 (MRDIL). HBdS received a PhD fellowship from FAPESP (2009/08559-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhouri RR, 2016, CELL REP, V14, P723, DOI 10.1016/j.celrep.2015.12.067; ANDERSSON J, 1972, EUR J IMMUNOL, V2, P349, DOI 10.1002/eji.1830020410; Arama C, 2018, OPEN FORUM INFECT DI, P1; ATKINSON JP, 1974, J CLIN INVEST, V54, P339, DOI 10.1172/JCI107769; Barfod L, 2011, P NATL ACAD SCI USA, P1; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; BRUYN GAW, 1992, CLIN INFECT DIS, V14, P251, DOI 10.1093/clinids/14.1.251; Capolunghi F, 2013, IMMUNOL LETT, V152, P114, DOI 10.1016/j.imlet.2013.04.007; Chan J, 2012, J CLIN INVEST, V122; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Couper KN, 2005, PARASITE IMMUNOL, V27, P171, DOI 10.1111/j.1365-3024.2005.00760.x; D'Imperio Lima M, 1996, SCAND J IMMUNOL; da Silva HB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004598; Elias RM, 2005, J IMMUNOL, V174, P790, DOI 10.4049/jimmunol.174.2.790; Ferguson SE, 1996, J IMMUNOL, V156, P4576; Fossati-Jimack L, 1999, J EXP MED, V190, P1689, DOI 10.1084/jem.190.11.1689; Gomes LR, 2014, LUPUS, V23, P1295, DOI 10.1177/0961203314546021; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; HARTE PG, 1983, NATURE, V302, P256, DOI 10.1038/302256a0; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kubagawa H, 2009, J EXP MED, V206, P2779, DOI 10.1084/jem.20091107; Langhorne J, 1989, Int Immunol, V1, P416, DOI 10.1093/intimm/1.4.416; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; LIMA MRD, 1991, INT IMMUNOL, V3, P1207, DOI 10.1093/intimm/3.12.1207; Lugaajju A, 2017, MALARIA J, P1, DOI [10.1186/s12936-016-1650-6, DOI 10.1186/S12936-016-1650-6]; Marinho CRF, 1999, INFECT IMMUN, V67, P308, DOI 10.1128/IAI.67.1.308-318.1999; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Muxel SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022434; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Pantaleo A, 2008, AUTOIMMUN REV, V7, P457, DOI 10.1016/j.autrev.2008.03.017; Pleass RJ, 2016, TRENDS PARASITOL, V32, P108, DOI 10.1016/j.pt.2015.09.007; PODOBA JE, 1991, INFECT IMMUN, V59, P51, DOI 10.1128/IAI.59.1.51-58.1991; Portugal S, 2015, ELIFE, V4, DOI 10.7554/eLife.07218; Semblat JP, 2006, MOL BIOCHEM PARASIT, V146, P192, DOI 10.1016/j.molbiopara.2005.12.007; Snapper CM, 2012, ANN NY ACAD SCI, V1253, P92, DOI 10.1111/j.1749-6632.2011.06329.x; Stephens R, 2015, TRENDS PARASITOL, V28, P74; Stevenson L, 2015, CELL MICROBIOL, V17, P819, DOI 10.1111/cmi.12403; STEVENSON MM, 1993, CLIN EXP IMMUNOL, V92, P77, DOI 10.1111/j.1365-2249.1993.tb05951.x; Tambourgi DV, 2007, MOL IMMUNOL, V44, P576, DOI 10.1016/j.molimm.2006.02.002; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Wolofsky KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002942	41	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202522	10.1371/journal.pone.0202522	http://dx.doi.org/10.1371/journal.pone.0202522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148845	Green Submitted, gold, Green Published			2022-12-27	WOS:000442804200013
J	Kim, JC; Ha, YJ; Tak, KH; Roh, SA; Kwon, YH; Kim, CW; Yoon, YS; Lee, JL; Park, Y; Kim, SK; Kim, SY; Cho, DH; Kim, YS				Kim, Jin Cheon; Ha, Ye Jin; Tak, Ka Hee; Roh, Seon Ae; Kwon, Yi Hong; Kim, Chan Wook; Yoon, Yong Sik; Lee, Jong Lyul; Park, Yangsoon; Kim, Seon-Kyu; Kim, Seon-Young; Cho, Dong-Hyung; Kim, Yong Sung			Opposite functions of GSN and OAS2 on colorectal cancer metastasis, mediating perineural and lymphovascular invasion, respectively	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; PROGNOSTIC-FACTOR; EXPRESSION; AUTOPHAGY; COLON; GELSOLIN; GROWTH; SYNTHETASE; ACTIVATION; SUPPRESSOR	The present study aimed to identify molecules associated with lymphovascular invasion (LVI) and perineural invasion (PNI) and to examine their biological behavior in colorectal cancer (CRC). LVI- and PNI-associated molecules were identified and verified using sequential processes including (1) identification of 117 recurrence-associated genes differentially expressed on RNA-seq analysis using primary cancer tissues from 130 CRC patients with and without systemic recurrence; (2) analysis of molecules associated with LVI and PNI; (3) assessment of biological properties by measuring proliferation, anoikis, invasion/migration, epithelial-mesenchymal transition and autophagy flux; and (4) verification of disease-free survival using public datasets. Gelsolin (GSN) and 2'-5'-oligoadenylate synthetase 2 (OAS2) were associated with PNI and LVI, respectively. Invasion potential was >2-fold greater in GSN-overexpressing LoVo cells than in control cells (p<0.001-0.005), whereas OAS2-overexpressing RKO cells showed reduced invasion (p<0.001-0.005). GSN downregulated E-cadherin, beta-catenin, claudin-1 and snail, and upregulated N-cadherin and ZEB1, whereas OAS2 overexpression had the opposite effects. Several autophagy-related proteins including ATG5-12, ATG6/BECN1, ATG7 and ATG101 were downregulated in GSN-overexpressing LoVo cells, whereas the opposite pattern was observed in OAS2-overexpressing RKO cells. Patients with low GSN expression had significantly higher 5-year recurrence-free survival (RFS) rates than those with GSN overexpression (73.6% vs. 64.7%, p = 0.038), whereas RFS was longer in patients with OAS2 overexpression than in those with underexpression (73.4% vs. 63.7%, p = 0.01). In conclusion, GSN and OAS2 were positively and negatively associated with recurrence, respectively, suggesting their potential value as predictors of recurrence or therapeutic targets in CRC patients.	[Kim, Jin Cheon; Ha, Ye Jin; Tak, Ka Hee; Roh, Seon Ae; Kwon, Yi Hong; Kim, Chan Wook; Yoon, Yong Sik; Lee, Jong Lyul] Univ Ulsan, Dept Surg, Coll Med, Seoul, South Korea; [Kim, Jin Cheon; Ha, Ye Jin; Tak, Ka Hee; Roh, Seon Ae; Kwon, Yi Hong; Kim, Chan Wook; Yoon, Yong Sik; Lee, Jong Lyul; Park, Yangsoon; Kim, Seon-Kyu; Kim, Seon-Young; Cho, Dong-Hyung; Kim, Yong Sung] Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea; [Park, Yangsoon] Univ Ulsan, Dept Pathol, Coll Med, Seoul, South Korea; [Kim, Seon-Kyu; Kim, Seon-Young; Kim, Yong Sung] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Daejeon, South Korea; [Cho, Dong-Hyung] Kyungpook Natl Univ, Sch Life Sci, Daegu, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University	Kim, JC (corresponding author), Univ Ulsan, Dept Surg, Coll Med, Seoul, South Korea.; Kim, JC; Cho, DH; Kim, YS (corresponding author), Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea.; Kim, YS (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Daejeon, South Korea.; Cho, DH (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Daegu, South Korea.	jckim@amc.seoul.kr; chodong03@gmail.com; yongsung@kribb.re.kr	Lww, Jong Lyul/W-1791-2019	Lww, Jong Lyul/0000-0002-5878-8000; Kim, Seon-Kyu/0000-0002-4176-5187	Korea Research Foundation [2016R1E1A1A02919844, 2017R1A2B1009062]; Ministry of Science, ICT, and Future Planning, Republic of Korea	Korea Research Foundation(National Research Foundation of Korea); Ministry of Science, ICT, and Future Planning, Republic of Korea	This work was supported by grants from the Korea Research Foundation (2016R1E1A1A02919844 to JCK and 2017R1A2B1009062 to SAR), Ministry of Science, ICT, and Future Planning, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng SF, 2002, BIOCHEM J, V366, P807, DOI 10.1042/BJ20020202; Choi UY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.110; Dan MX, 2012, MOL BIOL REP, V39, P7813, DOI 10.1007/s11033-012-1624-x; Dar AA, 2016, IMMUNOLOGY, V147, P251, DOI 10.1111/imm.12560; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Grille SJ, 2003, CANCER RES, V63, P2172; Hibi T, 2009, CLIN CANCER RES, V15, P2864, DOI 10.1158/1078-0432.CCR-08-2946; Justus CR, 2014, JOVE-J VIS EXP, DOI 10.3791/51046; Kim JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155160; Knijn N, 2016, AM J SURG PATHOL, V40, P103, DOI 10.1097/PAS.0000000000000518; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Lacorte LM, 2015, BIOCHEM BIOPH RES CO, V457, P538, DOI 10.1016/j.bbrc.2015.01.019; Li GH, 2012, MED RES REV, V32, P999, DOI 10.1002/med.20231; Ma XJ, 2016, TUMOR BIOL, V37, P7165, DOI 10.1007/s13277-015-4565-x; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Marchesi F, 2010, CYTOKINE GROWTH F R, V21, P77, DOI 10.1016/j.cytogfr.2009.11.001; Marino N, 2013, CANCER RES, V73, P5949, DOI 10.1158/0008-5472.CAN-13-0368; Pan HM, 2016, ONCOTARGET, V7, P21235, DOI 10.18632/oncotarget.6908; Qin WJ, 2015, ONCOTARGET, V6, P39839, DOI 10.18632/oncotarget.5674; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Sebio A, 2014, EXPERT OPIN THER TAR, V18, P611, DOI 10.1517/14728222.2014.906580; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Suren D, 2014, MED SCI MONITOR, V20, P1255, DOI 10.12659/MSM.890598; Takigawa H, 2017, NEOPLASIA, V19, P429, DOI 10.1016/j.neo.2017.02.010; Tochhawng L, 2016, ONCOTARGET, V7, P52832, DOI 10.18632/oncotarget.10451; van Wyk HC, 2017, CRIT REV ONCOL HEMAT, V112, P11, DOI 10.1016/j.critrevonc.2017.02.005; White JD, 2002, CANCER RES, V62, P1669; Xing X, 2013, BRIT J CANCER, V108, P2542, DOI 10.1038/bjc.2013.251; Yang J, 2004, LUNG CANCER-J IASLC, V46, P29, DOI 10.1016/j.lungcan.2004.03.022; Yuan H, 2017, ONCOTARGET, V8, P46565, DOI 10.18632/oncotarget.15425; Yue Z, 2007, AUTOPHAGY, V3, P139, DOI 10.4161/auto.3602; Zhao H, 2017, ONCOTARGET, V8, P59058, DOI 10.18632/oncotarget.19939	36	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202856	10.1371/journal.pone.0202856	http://dx.doi.org/10.1371/journal.pone.0202856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148861	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200028
J	Langfield, T; Pechey, R; Pilling, M; Marteau, TM				Langfield, Tess; Pechey, Rachel; Pilling, Mark; Marteau, Theresa M.			Impact of glass shape on time taken to drink a soft drink: A laboratory-based experiment	PLOS ONE			English	Article							CONSUMPTION; SIZE; PERCEPTION; DISEASE; WEIGHT	Background Glassware design may affect drinking behaviour for alcoholic beverages, with glass shape and size influencing drinking speed and amount consumed. Uncertainty remains both about the extent to which these effects are restricted to alcohol and the underlying mechanisms. The primary aim of the current study was to examine the effect of differently shaped glasses on time taken to drink a soft drink. The secondary aim was to develop hypotheses about mechanisms concerning micro-drinking behaviours and perceptual effects. Method In a single-session experiment, 162 participants were randomised to receive 330ml of carbonated apple juice in a glass that was either inward-sloped, straight-sided, or outward-sloped. The primary outcome measure was total drinking time. Secondary outcome measures included micro-drinking behaviours (sip size, sip duration, interval duration), and perceptual measures (midpoint bias, drink enjoyment). Results Participants drank 21.4% faster from the outward-sloped glass than from the straight-sided glass [95%CI: 0.2%,38.0%] in adjusted models. They were also 18.2% faster from the inward-sloped glass than the straight-sided glass, but this did not reach statistical significance with wide confidence intervals also consistent with slower drinking [95%CI: -3.8%, 35.6%]. Larger sips were associated with faster drinking times (Pearson's r(162) = -.45, p < .001). The direction of effects suggested sips were larger from the outward-sloped and inward-sloped glasses, compared to the straight-sided glass (15.1%, 95%CI: -4.3%,38.0%; 19.4%, 95%CI: -0.5%,43.6%, respectively). There were no significant differences between glasses in mean sip or interval duration. Bias in midpoint estimation was greater for the outward-sloped glass (12.9ml, 95%CI: 6.6ml,19.2ml) than for the straight-sided glass, although the degree of bias was not associated with total drinking time (Pearson's r(162) = 0.01, p= .87). Discussion Individuals drank a soft drink more quickly from an outward-sloped glass, relative to a straight-sided glass. Micro-drinking behaviours, such as sip size, are promising candidates for underlying mechanisms.	[Langfield, Tess; Pechey, Rachel; Pilling, Mark; Marteau, Theresa M.] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England	University of Cambridge	Langfield, T (corresponding author), Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge, England.	tirl2@medschl.cam.ac.uk		Langfield, Tess/0000-0003-0552-1019; Pechey, Rachel/0000-0002-6558-388X	Medical Research Council;  [MR/N013433/1]; MRC [1803821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the Medical Research Council and Sackler Prize awarded to TL [MR/N013433/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043007; Bennett JW, 2009, DYSPHAGIA, V24, P152, DOI 10.1007/s00455-008-9183-y; Bland JM, 1996, BRIT MED J, V312, P1079; Cliceri D, 2018, FOOD QUAL PREFER, V64, P187, DOI 10.1016/j.foodqual.2017.09.008; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Grech A, 2015, OBES REV, V16, P1030, DOI 10.1111/obr.12311; Healthy People 2020, 2010, FDN HLTH MEAS REP HE; Hollands GJ, 2016, HEALTH PSYCHOL REV, V10, P381, DOI 10.1080/17437199.2015.1138093; Hollands GJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1218; Hollands GJ, 2015, COCHRANE DATABASE SY, V14; Kampfer K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186121; Lawless HT, 2003, DYSPHAGIA, V18, P196, DOI 10.1007/s00455-002-0105-0; Maggioni E, 2015, J SENS STUD, V30, P395, DOI 10.1111/joss.12166; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Maynard OM, 2018, ALCOHOL ALCOHOLISM, V53, P12, DOI 10.1093/alcalc/agx066; MCGILL R, 2015, BMC PUBLIC HEALTH, V15; Ohkuma T, 2015, INT J OBESITY, V39, P1589, DOI 10.1038/ijo.2015.96; Olivier J, 2008, ANN ALLERG ASTHMA IM, V100, P333, DOI 10.1016/S1081-1206(10)60595-9; Pechey Rachel, 2017, BMC Res Notes, V10, P287, DOI 10.1186/s13104-017-2610-0; Pechey R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3068-z; Rozin P, 2011, JUDGM DECIS MAK, V6, P323; Shah M, 2011, J HUM NUTR DIET, V24, P612, DOI 10.1111/j.1365-277X.2011.01210.x; Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636; Spence C, 2017, BEVERAGES, V3, DOI 10.3390/beverages3030033; Spence C, 2015, FOOD QUAL PREFER, V39, P131, DOI 10.1016/j.foodqual.2014.07.007; Stafford LD, 2017, J PUBLIC HEALTH-HEID, V25, P147, DOI 10.1007/s10389-016-0770-3; Thaler RH., 2021, NUDGE FINAL EDITION; Troy D, 2017, DOES GLASS SHAPE INF; Troy DM, 2017, EUR J PUBLIC HEALTH, V27, P352, DOI 10.1093/eurpub/ckw142; Van Doorn G, 2017, FOOD QUAL PREFER, V56, P201, DOI 10.1016/j.foodqual.2016.10.013; World Health Organization, 2014, GLOB STAT REP ALC HL, DOI [10.1080/17437199.2015.1138093, DOI 10.1080/17437199.2015.1138093]; Zlatevska N, 2014, J MARKETING, V78, P140, DOI 10.1509/jm.12.0303; Zupan Z, 2017, BMC Psychol, V5, P17, DOI 10.1186/s40359-017-0183-2	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202793	10.1371/journal.pone.0202793	http://dx.doi.org/10.1371/journal.pone.0202793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148889	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200024
J	Minick, SG; May, SB; Amico, KR; Cully, J; Davila, JA; Kallen, MA; Giordano, TP				Minick, Sophie G.; May, Sarah B.; Amico, K. Rivet; Cully, Jeffrey; Davila, Jessica A.; Kallen, Michael A.; Giordano, Thomas P.			Participants' perspectives on improving retention in HIV care after hospitalization: A post-study qualitative investigation of the MAPPS study	PLOS ONE			English	Article							BEHAVIORAL SKILLS MODEL; ANTIRETROVIRAL THERAPY; VIRAL SUPPRESSION; RANDOMIZED-TRIAL; INTERVENTION; ADHERENCE; INFORMATION; MOTIVATION; PROGRAM	Few interventions have been shown to improve retention in HIV care. We recently completed a randomized, controlled trial of a peer mentoring intervention, which failed to increase retention in care or HIV suppression. We sought to gain insight into this negative result and elicit suggestions for future interventions. We conducted semi-structured one-on-one interviews with a sub-sample of participants and all available interventionists after completion of the primary study. Interviews were coded by two researchers and thematically analyzed. Participants in the intervention arm (N = 16) reported good rapport with and benefit from peer mentoring and found the mentors helpful in facilitating the transition from hospital to out-patient clinic. Control arm participants (N = 9) reported similar emotional and social support benefits from the health educators. In both arms, ongoing challenges including completing paperwork, securing transportation, and rescheduling missed appointments were cited, along with internalized stigma and lack of will to seek care, despite the mentors' best efforts. Suggested improvements to the intervention included: more frequent contact with interventionists; additional support for mental health problems; and targeting overall health rather than a more selective focus on HIV. Mentors and health educators agreed with the participant-reported barriers and added that some participants were too sick to meaningfully participate in the intervention, while others appeared unwilling to engage with the interventionists in a meaningful way. Mentoring was highly acceptable and felt to be impactful, however it was not sufficient to overcome structural barriers or stigma and low motivation in some participants. The attention control intervention may have had an unintended positive impact. Future interventions should focus on broad aspects of health and well-being.	[Minick, Sophie G.; May, Sarah B.; Davila, Jessica A.; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Minick, Sophie G.; May, Sarah B.; Cully, Jeffrey; Davila, Jessica A.; Giordano, Thomas P.] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety IQuESt, Houston, TX 77030 USA; [Amico, K. Rivet] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Cully, Jeffrey] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Kallen, Michael A.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA	Baylor College of Medicine; Baylor College of Medicine; University of Michigan System; University of Michigan; Baylor College of Medicine; Northwestern University; Feinberg School of Medicine	Giordano, TP (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.; Giordano, TP (corresponding author), Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety IQuESt, Houston, TX 77030 USA.	tpg@bcm.edu	/AAE-4700-2020	Amico, K Rivet/0000-0002-4458-6934; May, Sarah/0000-0003-1489-8053	National Institutes of Health [R01MH085527]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (grant number R01MH085527; T.P.G.) and the facilities and resources of the Harris Health System and the Michael E. DeBakey VA Medical Center. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health (grant number R01MH085527; T.P.G.) and the facilities and resources of Baylor College of Medicine, Harris Health System and the Michael E. DeBakey VA Medical Center.	Cully JA, 2012, AIDS PATIENT CARE ST, V26, P165, DOI 10.1089/apc.2011.0248; Doshi RK, 2015, CLIN INFECT DIS, V60, P117, DOI 10.1093/cid/ciu722; El-Sadr WM, 2017, JAMA INTERN MED, V177, P1083, DOI 10.1001/jamainternmed.2017.2158; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Fisher Jeffrey D, 2008, Curr HIV/AIDS Rep, V5, P193, DOI 10.1007/s11904-008-0028-y; Gardner LI, 2014, CLIN INFECT DIS, V59, P725, DOI 10.1093/cid/ciu357; Giordano TP, 2016, CLIN INFECT DIS, V63, P678, DOI 10.1093/cid/ciw322; Giordano Thomas P, 2011, Top Antivir Med, V19, P12; Golin CE, 2006, JAIDS-J ACQ IMM DEF, V42, P42, DOI 10.1097/01.qai.0000219771.97303.0a; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Krippendorff K, 1989, CONTENT ANAL; Metsch LR, 2016, JAMA-J AM MED ASSOC, V316, P156, DOI 10.1001/jama.2016.8914; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Smith LR, 2012, AIDS PATIENT CARE ST, V26, P344, DOI 10.1089/apc.2011.0388	14	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202917	10.1371/journal.pone.0202917	http://dx.doi.org/10.1371/journal.pone.0202917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148868	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200032
J	Wallukat, G; Pruss, H; Muller, J; Schimke, I				Wallukat, Gerd; Pruss, Harald; Muller, Johannes; Schimke, Ingolf			Functional autoantibodies in patients with different forms of dementia (vol 13, e0192778, 2018)	PLOS ONE			English	Correction																		Wallukat G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192778	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203253	10.1371/journal.pone.0203253	http://dx.doi.org/10.1371/journal.pone.0203253			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148896	gold, Green Published			2022-12-27	WOS:000442804200053
J	Zanchin, C; Yamaji, K; Rogge, C; Lesche, D; Zanchin, T; Ueki, Y; Windecker, S; Mohacsi, P; Raber, L; Sigurdardottir, V				Zanchin, Christian; Yamaji, Kyohei; Rogge, Carolin; Lesche, Dorothea; Zanchin, Thomas; Ueki, Yasushi; Windecker, Stephan; Mohacsi, Paul; Raber, Lorenz; Sigurdardottir, Vilborg			Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography	PLOS ONE			English	Article							HEART-TRANSPLANT RECIPIENTS; INTRAVASCULAR ULTRASOUND; INTERNATIONAL SOCIETY; CYTOMEGALOVIRUS-INFECTION; ARTERY-DISEASE; ATHEROSCLEROSIS; REGISTRY; TRIAL	Background The purpose of the present study was to assess the short- and long-term progression of cardiac allograft vasculopathy (CAV) using serial 3-vessel quantitative coronary angiography (QCA). Methods CAV progression was assessed using serial 3-vessel QCA analysis at baseline, 1-year and long-term angiographic follow-up (8.5 +/- 3.7 years) after heart transplantation. The change in minimal lumen diameter (MLD) and percent diameter stenosis (%DS) was serially assessed within matched segments. Patients were graded according to the ISHLT-CAV classification and grouped as ISHLT-CAVo and ISHLT-CAV(1-3). The primary endpoint was mean change in MLD and %DS. Results A total of 41 patients and 520 matched segments were available for serial 3-vessel QCA. Overall, MLD decreased non-significantly from baseline to 1-year follow-up and significantly from 1-year to the long-term angiographic follow-up (Delta-0.08mm/year [95%CI -0.11 to -0.05], P<0.001). %DS increased significantly from baseline to 1-year (Delta+0.96%/year [95%CI 0.04 to 1.88], P = 0.041) and from 1-year to long-term angiographic follow-up (Delta+0.61%/year [95%CI 0.33 to 0.88], P<0.001). ISHLT-CAV(1)(-3) at 1 year and at long-term angiographic follow-up was observed in 22% and 61%, respectively. Between baseline and long-term angiographic follow-up, a significant reduction in MLD was observed within both groups without a significant difference in the reduction between the two groups (ISHLT-CAV(0): median -0.49mm [IQR -0.54 to -0.43] vs. ISHLT-CAV(1)(-3): median -0.40mm [IQR -0.44 to -0.35], P = 0.4). Conclusion The current data suggest that QCA can't predict CAV beyond 1 year, but, QCA affirmed that CAV progresses to a similar extent in patients who do not develop visual CAV during long-term follow-up.	[Zanchin, Christian; Yamaji, Kyohei; Rogge, Carolin; Zanchin, Thomas; Ueki, Yasushi; Windecker, Stephan; Mohacsi, Paul; Raber, Lorenz; Sigurdardottir, Vilborg] Bern Univ Hosp, Dept Cardiol, Bern, Switzerland; [Lesche, Dorothea] Bern Univ Hosp, Inst Clin Chem, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Sigurdardottir, V (corresponding author), Bern Univ Hosp, Dept Cardiol, Bern, Switzerland.	vilborgs@gmail.com		Lesche, Dorothea/0000-0002-2862-5681	Swiss National Science Foundation [323530_171146]; Bern University Hospital	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bern University Hospital	TZ is funded by an MD-PhD Grant from the Swiss National Science Foundation (grant no. 323530_171146). The study was supported by research grants from Bern University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2015, AM J TRANSPLANT, V15, P1967, DOI 10.1111/ajt.13214; BILLINGHAM ME, 1992, J HEART LUNG TRANSPL, V11, pS38; Braga JR, 2012, CLIN TRANSPLANT, V26, pE111, DOI 10.1111/j.1399-0012.2011.01565.x; Clerkin KJ, 2017, CURR OPIN CARDIOL, V32, P316, DOI 10.1097/HCO.0000000000000388; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Delgado JF, 2015, J HEART LUNG TRANSPL, V34, P1112, DOI 10.1016/j.healun.2015.03.015; Johansson I, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1321-1; JOHNSON DE, 1989, J HEART TRANSPLANT, V8, P349; Kobashigawa JA, 2005, J AM COLL CARDIOL, V45, P1532, DOI 10.1016/j.jacc.2005.02.035; LIN H, 1994, J HEART LUNG TRANSPL, V13, P824; Lund LH, 2015, J HEART LUNG TRANSPL, V34, P1244, DOI 10.1016/j.healun.2015.08.003; Mancini D, 2003, USE RAPAMYCIN SLOWS, P4, DOI [10.1161/01.CIR, DOI 10.1161/01.CIR]; Pollack A, 2013, JACC-CARDIOVASC IMAG, V6, P613, DOI 10.1016/j.jcmg.2013.03.001; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; Reiber JHC, 2011, CARDIOVASC DIAGN THE, V1, P57, DOI 10.3978/j.issn.2223-3652.2011.09.03; Ruygrok PN, 2003, J HEART LUNG TRANSPL, V22, P1276, DOI 10.1016/S1053-2498(02)01239-1; Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Taniwaki M, 2015, ASS IN STENT NEOATHE, P2167, DOI [10.1093/EURHEARTJ/EHV227, DOI 10.1093/EURHEARTJ/EHV227]; Tsutsui H, 2003, J HEART LUNG TRANSPL, V22, P519, DOI 10.1016/S1053-2498(02)01228-7; Tuzcu EM, 2005, J AM COLL CARDIOL, V45, P1538, DOI 10.1016/j.jacc.2004.12.076; Wong CK, 2001, J HEART LUNG TRANSPL, V20, P385, DOI 10.1016/S1053-2498(00)00230-8; Yeung AC, 1995, J HEART LUNG TRANSPL, V14, pS215	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202950	10.1371/journal.pone.0202950	http://dx.doi.org/10.1371/journal.pone.0202950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148864	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200036
J	Zhou, X; Wang, WP; Wang, T; Li, XB; Jing, T				Zhou, Xin; Wang, Weiping; Wang, Tao; Li, Xiaobo; Jing, Tian			Continuous patrolling in uncertain environment with the UAV swarm	PLOS ONE			English	Article							EFFICIENT	The research about unmanned aerial vehicle (UAV) swarm has developed rapidly in recent years, especially the UAV swarm with sensors which is becoming common means of achieving situational awareness. Due to inadequate researches of the UAV swarm with complex control structure currently, we propose a patrolling task planning algorithm for the UAV swarm with double-layer centralized control structure under the uncertain and dynamic environment. The main objective of the UAV swarm is to collect environment information as much as possible. To summarized, the primary contributions of this paper are as follows. We first define the patrolling problem. After that, the patrolling problem is modeled as the Partially Observable Markov Decision Process (POMDP) problem. Building upon this, we put forward a myopic and scalable online task planning algorithm. The algorithm contains online heuristic function, sequential allocation method, and the mechanism of bottom-up information flow and top-down command flow, reducing the computation complexity effectively. Moreover, as the number of control layers increases, this algorithm guarantees the performance without increasing the computation complexity for the swarm leader. Finally, we empirically evaluate our algorithm in the specific scenarios.	[Zhou, Xin; Wang, Weiping; Wang, Tao; Li, Xiaobo; Jing, Tian] Natl Univ Def Technol, Coll Syst Engn, Changsha 410073, Hunan, Peoples R China	National University of Defense Technology - China	Wang, T (corresponding author), Natl Univ Def Technol, Coll Syst Engn, Changsha 410073, Hunan, Peoples R China.	wangtao1976@nudt.edu.cn	Zhou, Xin/J-7419-2019	Zhou, Xin/0000-0001-7539-2342	National Nature Science Foundation of China [71373282]; National Social Science Foundation of China [14BTQ034]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China	In this paper, the research was supported by National Nature Science Foundation of China (Grant No. 71373282) and National Social Science Foundation of China (Grant No. 14BTQ034).	Albus J., 2002, P SPIE 16 ANN INT S, P303; Altshuler Y, 2017, SWARMS NETWORK INTEL, V729; Bayindir L, 2016, NEUROCOMPUTING, V172, P292, DOI 10.1016/j.neucom.2015.05.116; Brandao AS, 2014, INT CONF UNMAN AIRCR, P1181, DOI 10.1109/ICUAS.2014.6842373; Castanon DA, 2005, IEEE DECIS CONTR P, P4939; Chanel C., 2013, P 27 AAAI C ART INT, P1381; Chen SF, 2016, IEEE T CYBERNETICS, V46, P3364, DOI 10.1109/TCYB.2015.2505737; Chen SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130154; DoD U, 2013, UNM SYST INT ROADM F; Farinelli A., 2008, P AAMAS, P639; Guerrero J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170659; Ji XT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166448; Karimoddini A, 2013, AUTOMATICA, V49, P424, DOI 10.1016/j.automatica.2012.10.008; Keilson J., 1977, STOCHASTIC PROCESSES, V5, P231, DOI [10.1016/0304-4149(77)90033-3, DOI 10.1016/0304-4149(77)90033-3]; Krause A, 2008, J MACH LEARN RES, V9, P235; Kurniawati H., 2008, ROBOTICS SCI SYSTEMS; Laghari S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146760; Le Ny J, 2008, P AMER CONTR CONF, P4220, DOI 10.1109/ACC.2008.4587156; Le QB, 2016, INTRO MULTIAGENT SYS; Liu M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145526; NEMHAUSER GL, 1978, MATH PROGRAM, V14, P265, DOI 10.1007/BF01588971; Otto R.P., 2016, SMALL UNMANNED AIRCR; Ouyang Y, 2012, ANN ALLERTON CONF, P342, DOI 10.1109/Allerton.2012.6483238; Ouyang Y, 2014, IEEE T INFORM THEORY, V60, P681, DOI 10.1109/TIT.2013.2288636; Ponda S.S., HDB UNMANNED AERIAL, V2, P1447, DOI [10.1007/978-90-481-9707-1_16, DOI 10.1007/978-90-481-9707-1_16]; Ramchurn SD, 2016, J ARTIF INTELL RES, V57, P661, DOI 10.1613/jair.5098; Ramirez-Atencia C, 2017, SOFT COMPUT, V21, P4883, DOI 10.1007/s00500-016-2376-7; Sampedro Carlos, 2016, 2016 International Conference on Unmanned Aircraft Systems (ICUAS), P355, DOI 10.1109/ICUAS.2016.7502669; Sandholm WH, 2010, THEOR ECON, V5, P1, DOI 10.3982/TE554; Seeger Matthias, 2004, Int J Neural Syst, V14, P69, DOI 10.1142/S0129065704001899; Shah N. B., 2012, 2012 7th International Conference on System of Systems Engineering (SoSE 2012). Proceedings, P471, DOI 10.1109/SYSoSE.2012.6384205; Silver D., 2010, ADV NEURAL INFORM PR, P2164; Spaan MTJ, 2012, ADAPT LEARN OPTIM, V12, P387; Stranders R, 2013, ARTIF INTELL, V195, P63, DOI 10.1016/j.artint.2012.10.006; Tarapore D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182058; Theraulaz G, 1999, ARTIF LIFE, V5, P97, DOI 10.1162/106454699568700; Verginis Christos K., 2017, 2017 IEEE International Conference on Robotics and Automation (ICRA), P781, DOI 10.1109/ICRA.2017.7989096; Zhang MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182006; Zois DS, 2013, IEEE T SIGNAL PROCES, V61, P1581, DOI 10.1109/TSP.2012.2236320	40	6	6	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202328	10.1371/journal.pone.0202328	http://dx.doi.org/10.1371/journal.pone.0202328			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142198	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500010
J	Morley, C; Unwin, M; Peterson, GM; Stankovich, J; Kinsman, L				Morley, Claire; Unwin, Maria; Peterson, Gregory M.; Stankovich, Jim; Kinsman, Leigh			Emergency department crowding: A systematic review of causes, consequences and solutions	PLOS ONE			English	Review							LENGTH-OF-STAY; ACADEMIC-MEDICAL-CENTER; PATIENT FLOW; GENERAL-PRACTICE; AMBULANCE DIVERSION; CAPACITY PROTOCOL; INPATIENT LENGTH; ABDOMINAL-PAIN; BED MANAGEMENT; WAIT TIMES	Background Emergency department crowding is a major global healthcare issue. There is much debate as to the causes of the phenomenon, leading to difficulties in developing successful, targeted solutions. Aim The aim of this systematic review was to critically analyse and summarise the findings of peer-reviewed research studies investigating the causes and consequences of, and solutions to, emergency department crowding. Method The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. A structured search of four databases (Medline, CINAHL, EMBASE and Web of Science) was undertaken to identify peer-reviewed research publications aimed at investigating the causes or consequences of, or solutions to, emergency department crowding, published between January 2000 and June 2018. Two reviewers used validated critical appraisal tools to independently assess the quality of the studies. The study protocol was registered with the International prospective register of systematic reviews (PROSPERO 2017: CRD42017073439). Results From 4,131 identified studies and 162 full text reviews, 102 studies met the inclusion criteria. The majority were retrospective cohort studies, with the greatest proportion (51%) trialling or modelling potential solutions to emergency department crowding. Fourteen studies examined causes and 40 investigated consequences. Two studies looked at both causes and consequences, and two investigated causes and solutions. Conclusions The negative consequences of ED crowding are well established, including poorer patient outcomes and the inability of staff to adhere to guideline-recommended treatment. This review identified a mismatch between causes and solutions. The majority of identified causes related to the number and type of people attending ED and timely discharge from ED, while reported solutions focused on efficient patient flow within the ED. Solutions aimed at the introduction of whole-of-system initiatives to meet timed patient disposition targets, as well as extended hours of primary care, demonstrated promising outcomes. While the review identified increased presentations by the elderly with complex and chronic conditions as an emerging and widespread driver of crowding, more research is required to isolate the precise local factors leading to ED crowding, with system-wide solutions tailored to address identified causes.	[Morley, Claire; Unwin, Maria; Kinsman, Leigh] Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Hobart, Tas, Australia; [Unwin, Maria; Kinsman, Leigh] Tasmanian Hlth Serv North, Launceston, Tas, Australia; [Peterson, Gregory M.; Stankovich, Jim] Univ Tasmania, Coll Hlth & Med, Sch Med, Hobart, Tas, Australia; [Stankovich, Jim] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia	University of Tasmania; University of Tasmania; Monash University	Morley, C (corresponding author), Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Hobart, Tas, Australia.	Claire.morley@utas.edu.au	Kinsman, Leigh/AAU-7848-2020; Unwin, Maria/AAH-3250-2019; Unwin, Maria/AAB-2478-2020	Kinsman, Leigh/0000-0002-0790-5887; Unwin, Maria/0000-0002-8431-3164; Morley, Claire/0000-0001-9721-9225	Commonwealth Government of Australia via the Tasmanian Health Assistance Package; Australian Government Research Training Program (RTP) Scholarship	Commonwealth Government of Australia via the Tasmanian Health Assistance Package; Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by funding from The Commonwealth Government of Australia via the Tasmanian Health Assistance Package. The primary author is in receipt of an Australian Government Research Training Program (RTP) Scholarship.	Aboagye-Sarfo P, 2015, EMERG MED AUSTRALAS, V27, P202, DOI 10.1111/1742-6723.12396; Allen P, 2015, EMERG MED AUSTRALAS, V27, P113, DOI 10.1111/1742-6723.12366; Anantharaman V, 2008, INT J EMERG MED, V1, P11, DOI 10.1007/s12245-008-0004-8; [Anonymous], 2012, CRITICAL APPRASIAL T; Arain M, 2015, EMERG MED J, V32, P295, DOI 10.1136/emermed-2013-202410; Asha SE, 2014, EMERG MED AUSTRALAS, V26, P158, DOI 10.1111/1742-6723.12201; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Barrett L, 2012, NURS ECON, V30, P82; Begaz T, 2017, ANN EMERG MED, V69, P298, DOI 10.1016/j.annemergmed.2016.06.040; Bond Kenneth, 2007, Healthc Q, V10, P32; Buckley DJ, 2010, MED J AUSTRALIA, V192, P448, DOI 10.5694/j.1326-5377.2010.tb03583.x; Burke JA, 2017, EMERG MED AUSTRALAS, V29, P315, DOI 10.1111/1742-6723.12781; Burley Gwendolyn, 2007, J Healthc Qual, V29, P19; Burstrom L, 2016, UPSALA J MED SCI, V121, P38, DOI 10.3109/03009734.2015.1100223; Cha WC, 2015, YONSEI MED J, V56, P1428, DOI 10.3349/ymj.2015.56.5.1428; Chang AM, 2018, ANN EMERG MED, V71, P497, DOI 10.1016/j.annemergmed.2017.07.022; Chiu IM, 2018, AM J EMERG MED, V36, P56, DOI 10.1016/j.ajem.2017.07.011; Copeland J, 2015, CAN J EMERG MED, V17, P648, DOI 10.1017/cem.2015.41; Cowling Thomas E, 2013, PLoS One, V8, pe66699, DOI 10.1371/journal.pone.0066699; Derlet RW, 2002, SOUTH MED J, V95, P846; Diercks DB, 2007, ANN EMERG MED, V50, P489, DOI 10.1016/j.annemergmed.2007.03.033; Dinh MM, 2015, EMERG MED J, V32, P708, DOI 10.1136/emermed-2014-204174; Dolton P, 2016, J HEALTH ECON, V49, P193, DOI 10.1016/j.jhealeco.2016.05.002; Douma MJ, 2016, ANN EMERG MED, V68, P546, DOI 10.1016/j.annemergmed.2016.06.019; Dunn Robert, 2003, Emerg Med (Fremantle), V15, P232, DOI 10.1046/j.1442-2026.2003.00441.x; Estey Angela, 2003, CJEM, V5, P87; Fatovich DM, 2005, EMERG MED J, V22, P351, DOI 10.1136/emj.2004.018002; Fee C, 2007, ANN EMERG MED, V50, P501, DOI 10.1016/j.annemergmed.2007.08.003; Forster AJ, 2003, ACAD EMERG MED, V10, P127, DOI 10.1111/j.1553-2712.2003.tb00029.x; Fulbrook P, 2017, AUSTRALAS EMERG NURS, V20, P114, DOI 10.1016/j.aenj.2017.05.004; Gaieski DF, 2017, AM J EMERG MED, V35, P953, DOI 10.1016/j.ajem.2017.01.061; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Han JH, 2010, J EMERG MED, V39, P227, DOI 10.1016/j.jemermed.2008.10.006; Holroyd BR, 2007, ACAD EMERG MED, V14, P702, DOI 10.1197/j.aem.2007.04.018; Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014; Howell E, 2008, ANN INTERN MED, V149, P804, DOI 10.7326/0003-4819-149-11-200812020-00006; Hwang U, 2006, J AM GERIATR SOC, V54, P270, DOI 10.1111/j.1532-5415.2005.00587.x; Hwang U, 2011, ACAD EMERG MED, V18, P526, DOI 10.1111/j.1553-2712.2011.01054.x; Hwang U, 2008, ACAD EMERG MED, V15, P1248, DOI 10.1111/j.1553-2712.2008.00267.x; Imperato J, 2012, INTERN EMERG MED, V7, P457, DOI 10.1007/s11739-012-0839-0; Jang JY, 2013, ANN EMERG MED, V61, P145, DOI 10.1016/j.annemergmed.2012.07.021; Jarvis PRE, 2014, BRIT J HOSP MED, V75, P648, DOI 10.12968/hmed.2014.75.11.648; Jo S, 2015, AM J EMERG MED, V33, P1725, DOI 10.1016/j.ajem.2015.08.004; Jones P, 2018, EMERG MED AUSTRALAS, V30, P214, DOI 10.1111/1742-6723.12868; Jones P, 2017, NEW ZEAL MED J, V130, P15; Kawano T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110801; Kawano T, 2014, EMERG MED J, V31, P19, DOI 10.1136/emermed-2012-202050; Kelen GD, 2001, ACAD EMERG MED, V8, P1095, DOI 10.1111/j.1553-2712.2001.tb01122.x; Kim MJ, 2012, INT J MED INFORM, V81, P296, DOI 10.1016/j.ijmedinf.2012.01.001; Knapman M, 2010, INT J NURS PRACT, V16, P310, DOI 10.1111/j.1440-172X.2010.01846.x; Kulstad EB, 2009, INT J EMERG MED, V2, P149, DOI 10.1007/s12245-009-0107-x; Kulstad EB, 2010, AM J EMERG MED, V28, P304, DOI 10.1016/j.ajem.2008.12.014; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; Lauks J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154372; Lee CC, 2012, AM J EMERG MED, V30, P839, DOI 10.1016/j.ajem.2011.05.026; Lee IH, 2017, J CHIN MED ASSOC, V80, P297, DOI 10.1016/j.jcma.2016.11.002; Lee-Lewandrowski E, 2003, ARCH PATHOL LAB MED, V127, P456; Lee-Lewandrowski E, 2009, AM J CLIN PATHOL, V132, P326, DOI 10.1309/AJCP6US3ILGEAREE; Liew D, 2003, MED J AUSTRALIA, V179, P524, DOI 10.5694/j.1326-5377.2003.tb05676.x; Liu SW, 2011, ACAD EMERG MED, V18, P1339, DOI 10.1111/j.1553-2712.2011.01082.x; Lowthian JA, 2012, MED J AUSTRALIA, V196, P128, DOI 10.5694/mja11.10955; Lucas R, 2009, ACAD EMERG MED, V16, P597, DOI 10.1111/j.1553-2712.2009.00397.x; Mason S, 2012, ANN EMERG MED, V59, P341, DOI 10.1016/j.annemergmed.2011.08.017; McCarthy ML, 2009, ANN EMERG MED, V54, P492, DOI 10.1016/j.annemergmed.2009.03.006; McCusker J, 2014, ACAD EMERG MED, V21, P1092, DOI 10.1111/acem.12480; McGrath J, 2015, J EMERG NURS, V41, P503, DOI 10.1016/j.jen.2015.06.002; McHugh M, 2013, J HEALTHC QUAL, V35, P21, DOI 10.1111/j.1945-1474.2011.00163.x; Medley DB, 2012, J EMERG MED, V43, P736, DOI 10.1016/j.jemermed.2011.06.131; Mills AM, 2009, ACAD EMERG MED, V16, P603, DOI 10.1111/j.1553-2712.2009.00441.x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moineddin R, 2011, BMC EMERG MED, V11, DOI 10.1186/1471-227X-11-13; Morley C, 2017, PROSPERO 2017 CRD420, V2017; Morley C, 2018, INT EMERG NURS, V38, P34, DOI 10.1016/j.ienj.2017.09.001; Morris ZS, 2012, EMERG MED J, V29, P460, DOI 10.1136/emj.2010.107078; Mumma BE, 2014, ACAD EMERG MED, V21, P504, DOI 10.1111/acem.12366; Nagree Yusuf, 2004, Aust Health Rev, V28, P285; Nagree Y, 2013, MED J AUSTRALIA, V198, P612, DOI 10.5694/mja12.11754; Ngo H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193902; Nippak PMD, 2014, CAN J RURAL MED, V19, P12; Partovi SN, 2001, ACAD EMERG MED, V8, P990, DOI 10.1111/j.1553-2712.2001.tb01099.x; Patel PB, 2014, ACAD EMERG MED, V21, P266, DOI 10.1111/acem.12327; Perera ML, 2014, EMERG MED AUSTRALAS, V26, P549, DOI 10.1111/1742-6723.12300; Pines JM, 2007, ANN EMERG MED, V50, P510, DOI 10.1016/j.annemergmed.2007.07.021; Pines JM, 2006, ACAD EMERG MED, V13, P873, DOI [10.1197/j.aem.2006.03.568, 10.1111/j.1553-2712.2006.tb01741.x]; Pines JM, 2015, ACAD EMERG MED, V22, P985, DOI 10.1111/acem.12716; Pines JM, 2010, ACAD EMERG MED, V17, P276, DOI 10.1111/j.1553-2712.2009.00676.x; Pines JM, 2009, ACAD EMERG MED, V16, P617, DOI 10.1111/j.1553-2712.2009.00456.x; Plunkett PK, 2006, EUR J EMERG MED, V13, P65, DOI 10.1097/01.mej.0000209056.08752.41; Quinn JV, 2007, AM J EMERG MED, V25, P559, DOI 10.1016/j.ajem.2006.11.034; Reznek MA, 2017, STROKE, V48, P49, DOI 10.1161/STROKEAHA.116.015131; Richardson DB, 2006, MED J AUSTRALIA, V184, P213, DOI 10.5694/j.1326-5377.2006.tb00204.x; Richardson DB, 2002, MED J AUSTRALIA, V177, P492, DOI 10.5694/j.1326-5377.2002.tb04917.x; Richardson D, 2009, EMERG MED AUSTRALAS, V21, P304, DOI 10.1111/j.1742-6723.2009.01201.x; Richardson DB, 2009, MED J AUSTRALIA, V190, P369, DOI 10.5694/j.1326-5377.2009.tb02451.x; Sharma A, 2011, EMERG MED J, V28, P658, DOI 10.1136/emj.2009.086512; Shenoi RP, 2009, ACAD EMERG MED, V16, P116, DOI 10.1111/j.1553-2712.2008.00317.x; Shetty A, 2012, EMERG MED AUSTRALAS, V24, P374, DOI 10.1111/j.1742-6723.2012.01550.x; Shin S, 2018, AM J EMERG MED, V36, P620, DOI 10.1016/j.ajem.2017.09.041; Sikka R, 2010, AM J EMERG MED, V28, P809, DOI 10.1016/j.ajem.2009.06.023; Singer AJ, 2008, ACAD EMERG MED, V15, P324, DOI 10.1111/j.1553-2712.2008.00065.x; Singer AJ, 2011, ACAD EMERG MED, V18, P1324, DOI 10.1111/j.1553-2712.2011.01236.x; Sprivulis PC, 2006, MED J AUSTRALIA, V184, P208, DOI 10.5694/j.1326-5377.2006.tb00203.x; Sprivulis Peter, 2003, Emerg Med (Fremantle), V15, P32, DOI 10.1046/j.1442-2026.2003.00405.x; Sullivan CM, 2014, AUST HEALTH REV, V38, P564, DOI 10.1071/AH14083; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; Takakuwa KM, 2007, J EMERG MED, V32, P337, DOI 10.1016/j.jemermed.2006.07.031; Tekwani KL, 2013, WEST J EMERG MED, V14, P11, DOI 10.5811/westjem.2011.11.11456; Tenbensel T, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2617-1; Tsai MT, 2016, INT J QUAL HEALTH C, V28, P774, DOI 10.1093/intqhc/mzw109; van der Linden C, 2013, J EMERG NURS, V39, P340, DOI 10.1016/j.jen.2011.09.024; Van Der Linden MC, 2017, INT EMERG NURS, V35, P30, DOI 10.1016/j.ienj.2017.06.002; van der Linden MC, 2016, INT EMERG NURS, V29, P27, DOI 10.1016/j.ienj.2016.02.003; Verelst S, 2015, J EMERG MED, V49, P949, DOI 10.1016/j.jemermed.2015.05.034; White BA, 2013, J EMERG MED, V44, P230, DOI 10.1016/j.jemermed.2012.05.007; White BA, 2012, J EMERG MED, V42, P322, DOI 10.1016/j.jemermed.2010.04.022; Whittaker W, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002113; Wickman L, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008457; Willard E, 2017, J EMERG NURS, V43, P413, DOI 10.1016/j.jen.2017.01.007; Zhou JC, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.030	120	366	368	11	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203316	10.1371/journal.pone.0203316	http://dx.doi.org/10.1371/journal.pone.0203316			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161242	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000443388900109
J	Roleska, M; Roman-Urrestarazu, A; Griffiths, S; Ruigrok, ANV; Holt, R; Van Kessel, R; McColl, K; Sherlaw, W; Brayne, C; Czabanowska, K				Roleska, Monika; Roman-Urrestarazu, Andres; Griffiths, Sarah; Ruigrok, Amber N. V.; Holt, Rosemary; Van Kessel, Robin; McColl, Kathleen; Sherlaw, William; Brayne, Carol; Czabanowska, Kasia			Autism and the right to education in the EU: Policy mapping and scoping review of the United Kingdom, France, Poland and Spain	PLOS ONE			English	Review							PATH DEPENDENCE	Introduction Autistic people may have different educational needs that need to be met to allow them to develop their full potential. Education and disability policies remain within the competence of EU Member States, with current educational standards and provisions for autistic people implemented locally. This scoping review aims to map EU and national special education policies with the goal of scoping the level of fulfilment of the right to education of autistic people. Methods Four EU countries (United Kingdom, France, Poland and Spain) were included in this scoping review study. Governmental policies in the field of education, special education needs and disability law were included. Path dependency framework was used for data analysis; a net of inter-dependencies between international, EU and national policies was created. Results and discussion Each country created policies where the right to free education without discrimination is provided. Poland does not have an autism specific strategy, whereas the United Kingdom, France and Spain have policies specifically designed for autistic individuals. Within the United Kingdom, all countries created different autism plans, nevertheless all aim to reach the same goal-inclusive education for autistic children that leads to the development of their full potential. Conclusion Policy-making across Europe in the field of education has been changing through the years in favour of autistic people. Today their rights are noticed and considered, but there is still room for improvement. Results showed that approaches and policies vastly differ between countries, more Member States should be analysed in a similar manner to gain a broader and clearer view with a special focus on disability rights in Central and Eastern Europe.	[Roleska, Monika; Roman-Urrestarazu, Andres; Van Kessel, Robin; Czabanowska, Kasia] Maastricht Univ, Dept Int Hlth, Sch CAPHRI, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Roman-Urrestarazu, Andres; Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Roman-Urrestarazu, Andres; Griffiths, Sarah; Ruigrok, Amber N. V.; Holt, Rosemary] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [McColl, Kathleen; Sherlaw, William] Ecole Hautes Etud Sante Publ, Dept Sci Humaines Sociales & Comportements Sante, Rennes, France; [Czabanowska, Kasia] Jagiellonian Univ, Fac Hlth Sci, Inst Publ Hlth, Krakow, Poland	Maastricht University; Maastricht University Medical Centre (MUMC); University of Cambridge; University of Cambridge; Jagiellonian University; Collegium Medicum Jagiellonian University	Roman-Urrestarazu, A (corresponding author), Maastricht Univ, Dept Int Hlth, Sch CAPHRI, Fac Hlth Med & Life Sci, Maastricht, Netherlands.; Roman-Urrestarazu, A (corresponding author), Univ Cambridge, Inst Publ Hlth, Cambridge, England.; Roman-Urrestarazu, A (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	Aer56@medschl.cam.ac.uk	czbanowska, katarzyna/AAL-4033-2020; van Kessel, Robin/GYD-7902-2022; Roman-Urrestarazu, Andres/U-9224-2018; van Kessel, Robin/GWV-1883-2022; van Kessel, Robin/AAH-9768-2020; Brayne, Carol/AAA-4285-2020	van Kessel, Robin/0000-0001-6309-6343; Roman-Urrestarazu, Andres/0000-0002-2405-9432; van Kessel, Robin/0000-0001-6309-6343; van Kessel, Robin/0000-0001-6309-6343; Brayne, Carol/0000-0001-5307-663X; , Kathy/0000-0001-9920-3112; Griffiths, Sarah Louise/0000-0002-0720-4511	Gillings Fellowship in Global Public Health and Autism Research [YOG054]; Global Public Health Autism Research Trust; EU AIMS [115300]; Innovative Medicines Initiative 2 Joint Undertaking (JU) [777394]; European Union; EFPIA; AUTISM SPEAKS; Autistica; SFARI	Gillings Fellowship in Global Public Health and Autism Research; Global Public Health Autism Research Trust; EU AIMS; Innovative Medicines Initiative 2 Joint Undertaking (JU); European Union(European Commission); EFPIA; AUTISM SPEAKS; Autistica(Autistica); SFARI	Dr Andres Roman-Urrestarazu's work received funding from the Gillings Fellowship in Global Public Health and Autism Research, Grant Award YOG054. This work was also supported by a Global Public Health Autism Research Trust to Dr Rosemary Holt and EU AIMS grant no. 115300: FP7/2007 - 2013) to Dr Amber N. V. Ruigrok and Dr Rosemary Holt. Dr Rosemary Holt and Dr Amber N. V. Ruigrok also received funding from Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 777394. The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and AUTISM SPEAKS, Autistica, SFARI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, 1 AUTISM PLAN; [Anonymous], 2018, POLISH LEGAL SYSTEM; [Anonymous], 1959, DECLARATION RIGHTS C, DOI [10.1017/S0020860400013243, DOI 10.1017/S0020860400013243]; [Anonymous], 2015, SPANISH STRATEGY ASD; [Anonymous], 2005, SPECIAL ED NEEDS DIS; [Anonymous], 2008, 2 AUTISM PLAN; [Anonymous], 2011, 10 YEAR SCOTTISH STR; [Anonymous], 2010, FULFILLING REWARDING, P75; [Anonymous], 2010, STATUTORY GUIDANCE F; [Anonymous], 2014, STAT FRAM EARL YEARS; [Anonymous], 2013, CHARTER PERSONS AUTI; [Anonymous], 2013, 3 AUTISM PLAN; [Anonymous], 2011, WORLD REP DIS; [Anonymous], 2009, ASD STRATEGIC ACTION; Atlantic Strategy, 2020, ATL STRAT 2013 2020; Autism Europe, 2003, AUT ED; Autism-Europe, 1992, CHART PERS AUT; Baron-Cohen S, 2017, J CHILD PSYCHOL PSYC, V58, P744, DOI 10.1111/jcpp.12703; BARONCOHEN S, 1992, BRIT J PSYCHIAT, V161, P839, DOI 10.1192/bjp.161.6.839; Brugha T., 2012, ESTIMATING PREVALENC; Chartered Institute of Legal Executives, 2018, UK LEG SYST; Collier Ruth B., 2002, SHAPING POLITICAL AR; Department for Education, 2015, SPEC ED NEEDS DIS CO; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; European Commission, 2010, EUR DIS STRAT 2010 2; Falleti Tulia, 2006, NEWSLETTER, V17, P9; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; http://About-France.com, 2018, FRENCH LEGAL SYSTEM; Knapp M, 2009, AUTISM, V13, P317, DOI 10.1177/1362361309104246; Lai M-C, 2014, AUTISM SEMIN, V896, P383, DOI [10.1016/S0140-6736(13)61539-1, DOI 10.1016/S0140-6736(13)61539-1]; Mahoney J, 2000, THEOR SOC, V29, P507, DOI 10.1023/A:1007113830879; Newschaffer CJ, 2006, PEDIATRICS, V117, P1436, DOI 10.1542/peds.2005-2834; Pierson P, 2000, AM POLIT SCI REV, V94, P251, DOI 10.2307/2586011; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; The Autistic Spectrum Disorder (ASD), 2009, AUTISTIC SPECTRUM DI; The Charter of Fundamental Rights of the European Union, 2000, CHARTER FUNDAMENTAL, DOI [10.1108/03090550310770974, DOI 10.1108/03090550310770974]; Think Autism: Statutory Guidance, 2015, THINK AUTISM STATUTO; Together for Mental Health, 2012, STRAT MENT HLTH WELL; United Nations, 1975, DECL RIGHTS DIS PERS; United Nations, 1971, DECLARATION RIGHTS M; UNSD, 1999, GEOGR REG; van Heijst BFC, 2015, AUTISM, V19, P158, DOI 10.1177/1362361313517053; WHO, 2016, DEM SOC STAT	43	17	18	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202336	10.1371/journal.pone.0202336	http://dx.doi.org/10.1371/journal.pone.0202336			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161146	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900029
J	Tegegne, TK; Chojenta, C; Loxton, D; Smith, R; Kibret, KT				Tegegne, Teketo Kassaw; Chojenta, Catherine; Loxton, Deborah; Smith, Roger; Kibret, Kelemu Tilahun			The impact of geographic access on institutional delivery care use in low and middle-income countries: Systematic review and meta-analysis	PLOS ONE			English	Review							EMERGENCY OBSTETRIC CARE; DETERMINANTS; BIRTH; ACCESSIBILITY; AVAILABILITY; DISTRICT; POVERTY; WOMEN	Background Geographic access to obstetric care facilities has a significant influence on women's uptake of institutional delivery care. However, this effect was not consistent across studies. Some studies reported that geographic access to obstetric care facilities had no influence on the use of facility delivery. Therefore, this systematic review and meta-analysis synthesized and pooled the influence of geographic access on institutional delivery service uptake in low and middle-income countries. Methods Multiple combinations of search terms were used to search articles from six databases and a hand search of reference lists performed. We included observational studies conducted in low and middle-income countries which reported the influence of geographic access on delivery care use. The pooled effects of geographic access on institutional delivery care use were calculated using a random-effects model with a 95% confidence interval. Findings In this study a total of 31 studies were included. Among these studies, 15 met criteria for inclusion in the meta-analyses, while the remaining 16 were summarized using qualitative synthesis. Studies included in the analysis where women had to walk 60 minutes or less to access a health facility delivery were significantly heterogeneous. Having access to obstetric care facilities within five kilometres was significantly associated with institutional deliveries (pooled OR = 2.27; 95% CI = 1.82, 2.82). Similarly, a travelling time of 60 minutes or less was significantly associated with higher odds of health facility delivery (pooled OR = 3.30; 95% CI = 1.97, 5.53). Every one-hour and one-kilometre increase in travel time and distance, respectively, was negatively associated with institutional delivery care use. Interpretation Geographic access measured in either physical distance and/or travel time was significantly associated with women's use of facility delivery. The greater the distance and/or travel time to obstetric care facilities, the greater the barrier and the lesser the service uptake.	[Tegegne, Teketo Kassaw] Debre Markos Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Markos, Ethiopia; [Tegegne, Teketo Kassaw; Chojenta, Catherine; Loxton, Deborah; Kibret, Kelemu Tilahun] Univ Newcastle, Sch Med & Publ Hlth, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia; [Smith, Roger] Univ Newcastle, Sch Med & Publ Hlth, Mothers & Babies Res Ctr, Newcastle, NSW, Australia; [Kibret, Kelemu Tilahun] Wollega Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia	University of Newcastle; University of Newcastle	Tegegne, TK (corresponding author), Debre Markos Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Markos, Ethiopia.; Tegegne, TK (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia.	kteketo@yahoo.com	Chojenta, Catherine L/B-2521-2008; Kibret, Kelemu T/AAT-4813-2020	Chojenta, Catherine L/0000-0002-2541-4491; Kibret, Kelemu T/0000-0002-4357-4122; TEGEGNE, Teketo/0000-0002-9137-3632; Smith, Roger/0000-0003-4720-0280				Alemayehu M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/436938; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; Anyait A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-132; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Burgert-Brucker CR, 2014, DHS SPATIAL ANAL REP; De Allegri M, 2010, HLTH POLICY, V10, P10, DOI DOI 10.1016/J.HEALTHP0L.2010.10.010; De Allegri M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0764-0; Dussault Gilles, 2006, Hum Resour Health, V4, P12, DOI 10.1186/1478-4491-4-12; Faye A, 2011, ACTA OBSTET GYN SCAN, V90, P1239, DOI 10.1111/j.1600-0412.2011.01163.x; Feyissa TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097194; Fortney JC, 2011, J GEN INTERN MED, V26, pS639, DOI 10.1007/s11606-011-1806-6; Gabrysch S, 2011, INT J GYNECOL OBSTET, V114, P174, DOI 10.1016/j.ijgo.2011.05.007; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gage AL, 2006, POP STUD-J DEMOG, V60, P271, DOI 10.1080/00324720600895934; Habte F, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0716-8; Hailu D, 2014, MIDWIFERY, V30, P1109, DOI 10.1016/j.midw.2014.03.009; Hanson C, 2015, INTERVENTIONS, V1, P2; Hayes E., 1937, JBI CRIT APPR CHECKL, V9, P363; Health Education England, 2014, GROW NUMB LIT REV NU, P1; Holmer H, 2015, BJOG-INT J OBSTET GY, V122, P183, DOI 10.1111/1471-0528.13230; Hounton S, 2008, TROP MED INT HEALTH, V13, P44, DOI 10.1111/j.1365-3156.2008.02086.x; Jain AK, 2015, STUD FAMILY PLANN, V46, P21, DOI 10.1111/j.1728-4465.2015.00013.x; Joanna Briggs Institute, JOANN BRIGGS I REV M; Joharifard S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1049; Joshi D, 2016, PUBLIC HEALTH ACTION, V6, P267, DOI 10.5588/pha.16.0025; Karkee R, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-193; Kawakatsu Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-265; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Kumar S, 2014, APPL ECON, V46, P4091, DOI 10.1080/00036846.2014.950836; Lohela TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052110; Lwelamira J, 2012, ASIAN J MED SCI, V4, P105; Mageda K, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.51.6347; Masters SH, 2013, SOC SCI MED, V93, P147, DOI 10.1016/j.socscimed.2013.06.012; Mayhew M, 2008, AM J PUBLIC HEALTH, V98, P1849, DOI 10.2105/AJPH.2007.123471; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Munn Z, 2015, INT J EVID-BASED HEA, V13, P147, DOI 10.1097/XEB.0000000000000054; Ogolla JO, 2015, ADV PUBLIC HLTH, V2015, P1, DOI DOI 10.1155/2015/493184; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Peltzer K, 2006, Curationis, V29, P54; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Pun-Cheng L. S., 2016, INT ENCY GEOGRAPHY P, P1, DOI [10.1002/9781118786352.wbieg0066, DOI 10.1002/9781118786352.WBIEG0179]; Shimazaki Azusa, 2013, Asia Pac Fam Med, V12, P5, DOI 10.1186/1447-056X-12-5; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; The World Bank, WORLD BANK COUNTR LE; The World Bank and Ministry of Health Ethiopia, 2005, COUNTR STAT REP HLTH; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Wado YD, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-36; Wagle RR, 2004, BMC PREGNANCY CHILDB, V4, P10; Wang W, 2015, DHS ANAL STUDIES, V51; Wang W, 2014, DHS WORKING PAPERS, V114; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wilunda C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0067-y; Worku AG, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-20; Worku Brhanie T, 2016, PRIMARY HLTH CARE OP, V6; World Health Organization, 2003, PRIM HLTH CAR 25 YEA; World Health Organization, 2001, BACKGR PAP TECHN CON; Yanagisawa S, 2006, TROP MED INT HEALTH, V11, P238, DOI 10.1111/j.1365-3156.2005.01547.x; Zegeye K, 2014, PRIM HLTH CARE, V4	62	35	35	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203130	10.1371/journal.pone.0203130	http://dx.doi.org/10.1371/journal.pone.0203130			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161201	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900083
J	Albus, A; Gold, M; Bach, JP; Burg-Roderfeld, M; Jordens, M; Kirchhein, Y; Kronimus, Y; Mengel, D; Zerr, I; Dodel, R				Albus, Alexandra; Gold, Maike; Bach, Jan-Philipp; Burg-Roderfeld, Monika; Joerdens, Marit; Kirchhein, Yvonne; Kronimus, Yannick; Mengel, David; Zerr, Inga; Dodel, Richard			Extending the functional characteristics of naturally occurring autoantibodies against beta-Amyloid, Prion Protein and alpha-Synuclein	PLOS ONE			English	Article							LY-1 B-CELLS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; INTRAVENOUS IMMUNOGLOBULIN; PEPTIDE; PATHOGENESIS; OLIGOMERS; MODELS; NEUROTOXICITY; INFLAMMATION	Background Abnormal aggregation of proteins induces neuronal cell loss in neurodegenerative disorders such as Alzheimer's Disease, Creutzfeldt-Jakob Disease and Parkinson's Disease. Specific stimuli initialize conformational changes in physiological proteins, causing intra- or extracellular protein aggregation. We and other groups have identified naturally occurring autoantibodies (nAbs) as part of the human antibody pool that are able to prevent peptide fibrillation. These nAbs show a rescue effect following exposure of toxic aggregates on neurons, and they support microglial uptake of aggregated peptides. Objective Identification of a putative common epitope among the relevant proteins beta-Amyloid, alpha-Synuclein and Prion Protein for the respective nAbs. Material and methods Binding affinity between the aforementioned proteins and nAbs was tested by Dot Blot, ELISA and SPR-technology. Furthermore, the functionality of the protein-nAbs-complexes was studied in Thioflavin-T assays and microglial uptake experiments to study dependent inhibition of protein aggregation and enhancement of Fc gamma mediated uptake by microglial cells. Results beta-Amyloid and Prion Protein fragment showed considerable binding affinity and functional efficacy for all applied nAbs. Thereby, no significant difference within the different nAbs was detected. In contrast, alpha-Synuclein was bound exclusively by nAbs-alpha-Synuclein, which was reproduced in all binding studies. Surprisingly, functional assays with alpha-Synuclein revealed no significant effect of nAbs in comparison to IVIg treatment. However, all applied nAbs as well as IVIg show a minimal functionality on the microglial uptake of alpha-Synuclein. Conclusion nAbs-A beta, nAbs-PrP possibly display comparable affinity to the same structural epitope within A beta and PrP106-126 A117V whereas the epitope recognized by nAbs-alpha-Syn is only present in alpha-Syn. The structural similarity of A beta and PrP fragment promotes the outline for an efficient antibody for the treatment of several neurodegenerative disorders and extend the functional characteristics of the investigated nAbs.	[Albus, Alexandra; Kronimus, Yannick; Dodel, Richard] Univ Duisburg Essen, Univ Hosp Essen, Chair Geriatr, Essen, Germany; [Albus, Alexandra; Gold, Maike; Bach, Jan-Philipp; Joerdens, Marit; Kirchhein, Yvonne; Kronimus, Yannick; Mengel, David; Dodel, Richard] Philipps Univ, Dept Neurol, Marburg, Germany; [Bach, Jan-Philipp] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Burg-Roderfeld, Monika] Justus Liebig Univ, Dept Hematol & Immunol, Giessen, Germany; [Zerr, Inga] Univ Goettingen, Dept Neurol, Gottingen, Germany	University of Duisburg Essen; Philipps University Marburg; RWTH Aachen University; Justus Liebig University Giessen; University of Gottingen	Dodel, R (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Chair Geriatr, Essen, Germany.; Dodel, R (corresponding author), Philipps Univ, Dept Neurol, Marburg, Germany.	richard.dodel@uk-essen.de		Albus, Alexandra/0000-0002-4897-6972; Burg-Roderfeld, Monika/0000-0003-3455-9171	Novartis; International Parkinson Fonds (Deutschland) GmbH (IPD); German Federal Ministry of Education and Research [01GI1008C]; German Federal Ministry of Education and Research (KNDD - FTLDc); JPND networks SOPHIA, BiomarkAPD and Prefrontals; EU (FAIR-PARK II); foundation of the state Baden-Wurttemberg [D.3830]; BIU (Boehringer Ingelheim University of Ulm Institute) [D.5009]	Novartis(Novartis); International Parkinson Fonds (Deutschland) GmbH (IPD); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (KNDD - FTLDc); JPND networks SOPHIA, BiomarkAPD and Prefrontals; EU (FAIR-PARK II); foundation of the state Baden-Wurttemberg; BIU (Boehringer Ingelheim University of Ulm Institute)	The DEMPARK study was funded by an unrestricted grant from Novartis and a grant from the International Parkinson Fonds (Deutschland) GmbH (IPD). The continuation of the study (LANDSCAPE) is part of the Competence Network Degenerative Dementias (KNDD), which was funded by the German Federal Ministry of Education and Research (project number 01GI1008C). The FTD study was supported by the German Federal Ministry of Education and Research (KNDD - FTLDc), the JPND networks SOPHIA, BiomarkAPD and Prefrontals, the EU (FAIR-PARK II), the foundation of the state Baden-Wurttemberg (D.3830), BIU (Boehringer Ingelheim University of Ulm Institute (D.5009)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Cattepoel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063162; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Gold M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-5; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; HAYAKAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P2494, DOI 10.1073/pnas.81.8.2494; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Holodick NE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00872; Istrin G, 2006, J NEUROSCI RES, V84, P434, DOI 10.1002/jnr.20886; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Koehler NKU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064649; Kronimus Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164953; Laske C, 2014, NEW ENGL J MED, V370, P1459, DOI 10.1056/NEJMc1402193; Magga J, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-90; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Mengel D, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.151; Morales I, 2010, NEUROIMMUNOMODULAT, V17, P202, DOI 10.1159/000258724; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Pasquali JL, 2012, ADV EXP MED BIOL, V750, P145, DOI 10.1007/978-1-4614-3461-0_11; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Roeder AM, 2013, J BIOL CHEM, V288, P27638, DOI 10.1074/jbc.M113.463273; Roettger Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067743; Roettger Y, 2013, NAT REV NEUROL, V9, P98, DOI 10.1038/nrneurol.2012.258; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shoenfeld Yehuda., 2013, AUTOANTIBODIES, V3rd; Simon D, 2014, NEUROPATH APPL NEURO, V40, P311, DOI 10.1111/nan.12066; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wang T, 2016, NEUROPHARMACOLOGY, V105, P561, DOI 10.1016/j.neuropharm.2016.02.015; Wei X, 2012, J BIOL CHEM, V287, P12858, DOI 10.1074/jbc.M111.255836; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3	43	6	6	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202954	10.1371/journal.pone.0202954	http://dx.doi.org/10.1371/journal.pone.0202954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157279	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400077
J	Moriyama, Y; Tamiya, N; Kawamura, A; Mayers, TD; Noguchi, H; Takahashi, H				Moriyama, Yoko; Tamiya, Nanako; Kawamura, Akira; Mayers, Thomas D.; Noguchi, Haruko; Takahashi, Hideto			Effect of short-stay service use on stay-at-home duration for elderly with certified care needs: Analysis of long-term care insurance claims data in Japan	PLOS ONE			English	Article							RESPITE CARE; CAREGIVERS; BURDEN; SYSTEM; HEALTH	Objective Home independence is an important issue for the elderly in many countries and cultures. The aim of this study was to examine the effect of short-stay service use on stay-at-home duration for elderly people by level of care need under the Japanese long-term care insurance system. Methods We analyzed anonymous, Ministry of Health, Labour and Welfare of Japan Long-Term Care Insurance claims data from Ibaraki Prefecture. All participants were certified as eligible for long-term care insurance and had moved into a facility under long-term care insurance after certification between April 2006 and March 2012. Data was analyzed for 2,454 participants aged 65 years or older who entered residential care at least 1 month after initial use of care services. The participants were divided into 2 groups (low- and high-care need), depending on their required level of care. Cox proportional hazard modeling was used to calculate the adjusted hazard ratio (HR) of residential care admission after initial use of care services. Results Use of short-stay services was positively correlated to delay of residential care admission compared to non-use in the low-care need group (HR; 0.834, 95% confidence interval (CI); 0.740 +/- 0.939). In the high-care need group, however, use of short-stay services was somewhat correlated with earlier admission (HR; 1.254, 95% CI; 1.084 +/- 1.451). Conclusions The results of this study show that appropriate timing short-stay service use is necessary for the elderly to stay at home longer.	[Moriyama, Yoko] Natl Inst Publ Hlth, Dept Hlth & Welf Serv, Saitama, Japan; [Moriyama, Yoko; Tamiya, Nanako; Mayers, Thomas D.] Univ Tsukuba, Dept Hlth Serv Res, Fac Med, Ibaraki, Japan; [Tamiya, Nanako] Univ Tsukuba, Hlth Serv Res & Dev Ctr, Ibaraki, Japan; [Kawamura, Akira; Noguchi, Haruko] Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan; [Mayers, Thomas D.] Univ Tsukuba, Med English Commun Ctr, Fac Med, Ibaraki, Japan; [Takahashi, Hideto] Natl Inst Publ Hlth, Saitama, Japan	National Institute of Public Health - Japan; University of Tsukuba; University of Tsukuba; Waseda University; University of Tsukuba; National Institute of Public Health - Japan	Moriyama, Y (corresponding author), Natl Inst Publ Hlth, Dept Hlth & Welf Serv, Saitama, Japan.; Moriyama, Y (corresponding author), Univ Tsukuba, Dept Hlth Serv Res, Fac Med, Ibaraki, Japan.	moriyama.y.aa@niph.go.jp	Kawamura, Akira/AAX-3214-2021; Noguchi, Haruko/ABF-3059-2020	Noguchi, Haruko/0000-0002-4437-8238	Japan Society for the Promotion of Science, JSPS KAKENHI [JP16K21643]; Japan Agency for Medical Research and Development, AMED [JP18dk0110026]; Ministry of Health, Labour and Welfare [H27-seisaku-senryaku-012]	Japan Society for the Promotion of Science, JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by 1. Japan Society for the Promotion of Science, JSPS KAKENHI Grant Number JP16K21643; 2. Japan Agency for Medical Research and Development, AMED under Grant Number JP18dk0110026; 3. Ministry of Health, Labour and Welfare (H27-seisaku-senryaku-012). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DAI 5 KI TSUKUBA SHI; Arai Y, 2004, INT J GERIATR PSYCH, V19, P1205, DOI 10.1002/gps.1153; Cabinet Office in Japan, 2012, KOR KENK KANS CHOUS; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; Goto M., 2003, J HLTH WELF STAT, V50, P17; Ikegami N, 2003, INT J GERIATR PSYCH, V18, P217, DOI 10.1002/gps.818; Ishizuki T, 2010, J SOCIAL WELFARE, V51, P57; Kato Gohei, 2009, BMC Geriatr, V9, P58, DOI 10.1186/1471-2318-9-58; Kim Jung-Nim, 2012, J Rural Med, V7, P6, DOI 10.2185/jrm.7.6; Kono A., 2009, RONEN SHAKAI KAGAKU, V30, P498; Kuchimura A., 2013, KOUREISHA SHOTO STEI; Kuchimura A., 2007, RYUKOKU U J GRADUATE, V15, P35; Kuzuya M, 2011, AM J GERIAT PSYCHIAT, V19, P382, DOI 10.1097/JGP.0b013e3181e9b98d; Matsuda Tomoyuki, 2013, Nihon Koshu Eisei Zasshi, V60, P586; Ministry of Health Labour and Welfare, 2010, KOK SEIK KIS CHOUS G; Neville CC, 2007, INT J MENT HEALTH NU, V16, P81, DOI 10.1111/j.1447-0349.2007.00450.x; Neville CC, 2008, COLLEGIAN, V15, P159, DOI 10.1016/j.colegn.2008.06.003; Ohwa M, 2012, J GERONTOL SOC WORK, V55, P659, DOI 10.1080/01634372.2012.670869; Salminen M, 2017, AGING CLIN EXP RES, V29, P507, DOI 10.1007/s40520-016-0530-9; Schofield HL, 1999, AUST NZ J PUBL HEAL, V23, P585, DOI 10.1111/j.1467-842X.1999.tb01541.x; SCHULZ R, 1990, J GERONTOL, V45, pP181, DOI 10.1093/geronj/45.5.P181; Tamiya N, 2001, ARCH GERONTOL GERIAT, V33, P109, DOI 10.1016/S0167-4943(01)00100-5; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Tatematsu M., 2014, J JAPAN SOC HOME EC, V65, P632; Tatematsu M, 2002, J HOME EC JAPAN, V53, P369; The project of Ministry of Health Labour and Welfare, 2011, INC NONPR ORG SUPP N; Tomita N, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-345; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; Umegaki H, 2014, ARCH GERONTOL GERIAT, V58, P130, DOI 10.1016/j.archger.2013.08.010; van Exel J, 2008, HEALTH POLICY, V88, P73, DOI 10.1016/j.healthpol.2008.03.001; van Exel J, 2006, HEALTH POLICY, V78, P194, DOI 10.1016/j.healthpol.2005.11.002; Vecchio N, 2015, ASS COGNITIVE IMPAIR, DOI [10.1111/HSC.12212, DOI 10.1111/HSC.12212]; Yokozeki M, 2006, JAPANESE J SOCIAL WE, V47, P59; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260	34	10	11	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203112	10.1371/journal.pone.0203112	http://dx.doi.org/10.1371/journal.pone.0203112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157253	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400090
J	Fochmann, M; Sachs, F; Sadrieh, A; Weimann, J				Fochmann, Martin; Sachs, Florian; Sadrieh, Abdolkarim; Weimann, Joachim			The two sides of public debt: Intergenerational altruism and burden shifting	PLOS ONE			English	Article							GOVERNMENT DEBT; SOCIAL-SECURITY; DEFICITS; ECONOMY; POLICY; COMMONS	In controlled laboratory experiments with and without overlapping generations, we study the role of intergenerational altruism in public debt accumulation. Public debt is chosen by popular vote, pays for public goods, and is repaid with general taxes. We use an optimal control model to derive a theoretical benchmark. With a single generation, public debt is accumulated prudently. With multiple and over-lapping generations, the burden of debt and the risk of over-indebtedness are shifted to future generations. We find a weak but significant sign of intergenerational altruism, observing that the revealed debt preferences increase as the number of following generations decreases. However, we find considerably fewer intergenerational fairness concerns than one would expect on the basis of the behavioral and experimental literature. Instead, political debt cycles that vary with voters' age emerge. Debt ceiling mechanisms fail to encourage intergenerational altruism and do not mitigate the problem of burden shifting.	[Fochmann, Martin] Univ Cologne, Fac Management Econ & Social Sci, Cologne, Germany; [Sachs, Florian; Sadrieh, Abdolkarim; Weimann, Joachim] Univ Magdeburg, Fac Econ & Management, Magdeburg, Germany	University of Cologne; Otto von Guericke University	Fochmann, M (corresponding author), Univ Cologne, Fac Management Econ & Social Sci, Cologne, Germany.	fochmann@wisco.uni-koeln.de	Sachs, Florian E./AAV-7613-2020; Fochmann, Martin/ABG-5225-2021; Sadrieh, Abdolkarim/C-7858-2013	Sachs, Florian E./0000-0001-9436-7302; Fochmann, Martin/0000-0002-7747-1105; Sadrieh, Abdolkarim/0000-0002-9322-4729				ALESINA A, 1990, REV ECON STUD, V57, P403, DOI 10.2307/2298021; ALESINA A, 1995, INT MONET FUND S PAP, V42, P1; Alesina A., 1997, POLITICAL CYCLES MAC; Baron J, 2005, STARVING BEAST PSYCH; BARRO RJ, 1979, J POLIT ECON, V87, P940, DOI 10.1086/260807; Beetsma R, 1999, ECON J, V109, P546, DOI 10.1111/1468-0297.00462; BELLMAN R, 1954, B AM MATH SOC, V60, P503, DOI 10.1090/S0002-9904-1954-09848-8; Bertsekas D.P., 2017, DYNAMIC PROGRAMMING, V1; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Cerda R, 2005, J POPUL ECON, V18, P509, DOI 10.1007/s00148-005-0233-6; Chermak JM, 2002, J ENVIRON ECON MANAG, V43, P47, DOI 10.1006/jeem.2000.1173; Cooper D. J., 2016, HAND BOOK EXPT EC, V2, P217; CUKIERMAN A, 1989, AM ECON REV, V79, P713; Fanti L, 2013, ECON MODEL, V33, P843, DOI 10.1016/j.econmod.2013.06.003; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fischer ME, 2004, J ENVIRON ECON MANAG, V48, P811, DOI 10.1016/j.jeem.2003.12.002; Gillet J, 2009, J PUBLIC ECON, V93, P785, DOI 10.1016/j.jpubeco.2009.02.001; GORDON RH, 1988, J PUBLIC ECON, V37, P185, DOI 10.1016/0047-2727(88)90070-9; Greiner B., 2004, DEP EC WORKING PAPER, V10; Herr A, 1997, GAME ECON BEHAV, V19, P77, DOI 10.1006/game.1997.0541; Hock H, 2012, J POPUL ECON, V25, P1019, DOI 10.1007/s00148-011-0372-x; Keuschnigg C, 2011, SWISS J EC STAT, V147, P181; List J. A., 2016, 21875 NAT BUR EC RES; LUCAS RE, 1983, J MONETARY ECON, V12, P55, DOI 10.1016/0304-3932(83)90049-1; MARWELL G, 1981, J PUBLIC ECON, V15, P295, DOI 10.1016/0047-2727(81)90013-X; NORDHAUS WD, 1975, REV ECON STUD, V42, P169, DOI 10.2307/2296528; Ono T, 2003, J POPUL ECON, V16, P363, DOI 10.1007/s001480300148; PERSSON T, 1989, Q J ECON, V104, P325, DOI 10.2307/2937850; Persson Torsten, 2002, HDB PUBLIC EC, V3, P1549, DOI DOI 10.1016/S1573-4420(02)80028-3; Shiller RJ, 1999, CARN ROCH CONF SERIE, V50, P165, DOI 10.1016/S0167-2231(99)00026-3; Song Z, 2012, ECONOMETRICA, V80, P2785, DOI 10.3982/ECTA8910	31	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202963	10.1371/journal.pone.0202963	http://dx.doi.org/10.1371/journal.pone.0202963			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153283	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700033
J	Kurosaki, H; Nakahata, K; Donishi, T; Shiro, M; Ino, K; Terada, M; Kawamata, T; Kaneoke, Y				Kurosaki, Hiromichi; Nakahata, Katsutoshi; Donishi, Tomohiro; Shiro, Michihisa; Ino, Kazuhiko; Terada, Masaki; Kawamata, Tomoyuki; Kaneoke, Yoshiki			Effects of perinatal blood pressure on maternal brain functional connectivity	PLOS ONE			English	Article							WHITE-MATTER LESIONS; DEFAULT-MODE NETWORK; MAGNETIC-RESONANCE; HYPERTENSIVE ENCEPHALOPATHY; PREECLAMPSIA; PREGNANCY; PATHOGENESIS; ECLAMPSIA; SIGNAL; WOMEN	Perinatal hypertensive disorder including pre-eclampsia is a systemic syndrome that occurs in 3-5% of pregnant women. It can result in various degrees of brain damage. A recent study suggested that even gestational hypertension without proteinuria can cause cardiovascular or cognitive impairments later in life. We hypothesized that perinatal hypertension affects the brain functional connectivity (FC) regardless of the clinical manifestation of brain functional impairment. In the present study, we analyzed regional global connectivity (rGC) strength (mean cross-correlation coefficient between a brain region and all other regions) using resting-state functional magnetic resonance imaging to clarify brain FC changes associated with perinatal blood pressure using data from 16 women with a normal pregnancy and 21 pregnant women with pre-eclampsia. The rGC values in the bilateral orbitofrontal gyri were negatively correlated with diastolic blood pressure (dBP), which could not be explained by other pre-eclampsia symptoms. The strength of FC seeding at the left orbitofrontal gyrus was negatively correlated with dBP in the anterior cingulate gyri and right middle frontal gyrus. These results suggest that dBP elevation during pregnancy can affect the brain FC. Since FC is known to be associated with various brain functions and diseases, our findings are important for elucidating the neural correlate of cognitive impairments related to hypertension in pregnancy.	[Kurosaki, Hiromichi; Nakahata, Katsutoshi; Kawamata, Tomoyuki] Wakayama Med Univ, Dept Anesthesiol, Wakayama, Japan; [Donishi, Tomohiro; Kaneoke, Yoshiki] Wakayama Med Univ, Dept Syst Neurophysiol, Grad Sch, Wakayama, Japan; [Shiro, Michihisa; Ino, Kazuhiko] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama, Japan; [Terada, Masaki] Wakayama Minami Radiol Clin, Wakayama, Japan; [Nakahata, Katsutoshi] Kansai Med Univ, Dept Anesthesiol & Intens Care, Osaka, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Kansai Medical University	Kurosaki, H; Nakahata, K (corresponding author), Wakayama Med Univ, Dept Anesthesiol, Wakayama, Japan.; Nakahata, K (corresponding author), Kansai Med Univ, Dept Anesthesiol & Intens Care, Osaka, Japan.	kurosaki@wakayama-med.ac.jp; nakahatak@hirakata.kmu.ac.jp	Kawamata, Tomoyuki/AAY-6918-2020	Shiro, Michihisa/0000-0002-6661-9741	Japan Society for the Promotion of Science [24591303, 25350994]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research C from the Japan Society for the Promotion of Science (24591303 and 25350994) to Y.K. and T.D.; https://kaken.nii.ac.jp/en/search/?kw=24591303, https://kaken.nii.ac.jp/en/search/?kw=25350994.	Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Biswal Bharat B., 2009, V489, P255, DOI 10.1007/978-1-59745-543-5_12; Bohr Iwo Jerzy, 2012, Front Psychiatry, V3, P116, DOI 10.3389/fpsyt.2012.00116; Cipolla MJ, 2007, HYPERTENSION, V50, P14, DOI 10.1161/HYPERTENSIONAHA.106.079442; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Copel J, 2017, OBSTET GYNECOL, V130, pE210, DOI [10.1097/AOG.0000000000002355, 10.1097/AOG.0000000000002237]; de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077; Demirtas Ozgur, 2005, Diagn Interv Radiol, V11, P189; Donishi T, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.890; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fan XJ, 2014, J CLIN INVEST, V124, P4941, DOI 10.1172/JCI76864; Fields JA, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.03.008; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Hannesdottir K, 2009, ACTA NEUROL SCAND, V119, P261, DOI 10.1111/j.1600-0404.2008.01098.x; HAUSER RA, 1988, ARCH NEUROL-CHICAGO, V45, P1078, DOI 10.1001/archneur.1988.00520340032007; Hegarty JP, 2017, BRAIN IMAGING BEHAV, V11, P1278, DOI 10.1007/s11682-016-9604-8; Junewar V, 2014, AM J NEURORADIOL, V35, P1728, DOI 10.3174/ajnr.A3923; Kaneoke Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038131; Li Y, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0489-x; MENTIS MJ, 1994, STROKE, V25, P601, DOI 10.1161/01.STR.25.3.601; Narayanan A, 2010, BRAIN IMAGING BEHAV, V4, P189, DOI 10.1007/s11682-010-9098-8; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ohno Y, 2013, NEUROL MED-CHIR, V53, P513, DOI 10.2176/nmc.53.513; Osmanagaoglu MA, 2005, AUST NZ J OBSTET GYN, V45, P384, DOI 10.1111/j.1479-828X.2005.00453.x; Podymow T, 2010, HYPERTENS PREGNANCY, V29, P294, DOI 10.3109/10641950902777747; Power JD, 2017, NEUROIMAGE, V146, P609, DOI 10.1016/j.neuroimage.2016.09.038; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Rolls ET, 2016, BRAIN COGNITION, V110, P4, DOI 10.1016/j.bandc.2015.07.002; Salomon R, 2011, J NEUROSCI, V31, P12972, DOI 10.1523/JNEUROSCI.2987-11.2011; Scheinost D, 2015, HUM BRAIN MAPP, V36, P1524, DOI 10.1002/hbm.22720; Schwartz RB, 2000, RADIOLOGY, V217, P371, DOI 10.1148/radiology.217.2.r00nv44371; SCHWARTZ RB, 1992, AM J ROENTGENOL, V159, P379, DOI 10.2214/ajr.159.2.1632361; Soma-Pillay P, 2017, PREGNANCY HYPERTENS, V8, P15, DOI 10.1016/j.preghy.2017.02.001; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067778; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016; Vest AR, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-013-0395-8; Waldstein SR, 2005, ANN BEHAV MED, V29, P174, DOI 10.1207/s15324796abm2903_3; WHO Guidelines Approved by the Guidelines Review Committee, 2011, WHO REC PREV TREATM; Wiegman MJ, 2014, OBSTET GYNECOL, V123, P790, DOI 10.1097/AOG.0000000000000162; Williams K, 2003, ULTRASOUND OBST GYN, V21, P507, DOI 10.1002/uog.83; Wong NML, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00108; Yang GJ, 2014, P NATL ACAD SCI USA, V111, P7438, DOI 10.1073/pnas.1405289111; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838; Zhu DC, 2015, J CEREBR BLOOD F MET, V35, P1910, DOI 10.1038/jcbfm.2015.166	56	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203067	10.1371/journal.pone.0203067	http://dx.doi.org/10.1371/journal.pone.0203067			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153298	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700040
J	Gordo, L; Oliver-Roig, A; Martinez-Pampliega, A; Elejalde, LI; Fernandez-Alcantara, M; Richart-Martinez, M				Gordo, Leire; Oliver-Roig, Antonio; Martinez-Pampliega, Ana; Iriarte Elejalde, Leire; Fernandez-Alcantara, Manuel; Richart-Martinez, Miguel			Parental perception of child vulnerability and parental competence: The role of postnatal depression and parental stress in fathers and mothers	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; INFANT VULNERABILITY; MATERNAL DEPRESSION; SELF-EFFICACY; SCALE; TRANSITION; SYMPTOMS; RISK; PSYCHOPATHOLOGY; ADAPTATION	Introduction Parents' perception that their child may be vulnerable to serious life-threatening illnesses can have negative effects on how they exercise their parenting. No studies have yet been carried out on parent's perception of their child's vulnerability, when the child has not suffered a severe illness. This study tries to analyze the relationship between parent's perception of their children's vulnerability and parental competence, and analyzes the mediating role of postnatal depression and parental stress. Method The study was carried out on mothers and fathers of full-term infants who did not have any serious illnesses. A total of 965 people (385 fathers and 580 mothers) participated in the study. Results The results revealed an association between parental perception of their child's vulnerability and parent's perception of parental competence through depression and parental stress. However, this association was different for fathers and mothers. Conclusion The variable of perception of child's vulnerability was a relevant factor to understand parental competence.	[Gordo, Leire; Martinez-Pampliega, Ana; Iriarte Elejalde, Leire] Univ Deusto, Dept Social & Dev Psychol, Bilbao, Spain; [Oliver-Roig, Antonio; Richart-Martinez, Miguel] Univ Alicante, Dept Nursing, Alicante, Spain; [Fernandez-Alcantara, Manuel] Univ Alicante, Dept Hlth Psychol, Alicante, Spain	University of Deusto; Universitat d'Alacant; Universitat d'Alacant	Oliver-Roig, A (corresponding author), Univ Alicante, Dept Nursing, Alicante, Spain.	antonio.oliver@icloud.com	Gordo, Leire/V-3016-2019; Fernández-Alcántara, Manuel/H-1406-2015; PAMPLIEGA, ANA MARTINEZ/L-5282-2014	Gordo, Leire/0000-0001-7702-5028; Fernández-Alcántara, Manuel/0000-0002-3481-8156; PAMPLIEGA, ANA MARTINEZ/0000-0001-9130-9553	General Sub-Directorate for Evaluation and Promotion of Research (Institute of Health Carlos III, ISCIII); European Regional Development Fund (FEDER) "A way to make Europe" [PI14/01549]	General Sub-Directorate for Evaluation and Promotion of Research (Institute of Health Carlos III, ISCIII); European Regional Development Fund (FEDER) "A way to make Europe"	This work was funded by the General Sub-Directorate for Evaluation and Promotion of Research (Institute of Health Carlos III, ISCIII) and co-funded by the European Regional Development Fund (FEDER) "A way to make Europe" (Project reference PI14/01549). The funders had no part in designing the study, collecting, analyzing, interpreting or influencing the writing of the data or the decision to publish.	Allen EC, 2004, PEDIATRICS, V113, P267, DOI 10.1542/peds.113.2.267; Anthony KK, 2011, CHILD HEALTH CARE, V40, P53, DOI 10.1080/02739615.2011.537938; Arbuckle JL, 2014, US GUID, P1, DOI [10.1016/j.enconman.2005.10.016, DOI 10.1016/J.ENCONMAN.2005.10.016]; BELSKY J, 1985, J MARRIAGE FAM, V47, P855, DOI 10.2307/352329; BERRY JO, 1995, J SOC PERS RELAT, V12, P463, DOI 10.1177/0265407595123009; Bloomfield Linda, 2012, Prim Health Care Res Dev, V13, P364, DOI 10.1017/S1463423612000060; Caballero-Pelaez C, 2014, 10 S NAC CAS CLIN TR, P164; Coltrane S, 2000, J MARRIAGE FAM, V62, P1208, DOI 10.1111/j.1741-3737.2000.01208.x; Cousino MK, 2013, J PEDIATR PSYCHOL, V38, P809, DOI 10.1093/jpepsy/jst049; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Doyle M, 2018, BJPSYCH ADV, V21, P5, DOI [10.1192/apt.bp.112.010900, DOI 10.1192/APT.BP.112.010900]; Epifanio MS, 2015, PEDIATRIC REP, V7, P38, DOI 10.4081/pr.2015.5872; Farkas-Klein C, 2008, UNIV PSYCHOL, V7, P457; Field T, 1996, CHILD PSYCHIAT HUM D, V27, P43, DOI 10.1007/BF02353445; Figueiredo B, 2011, ARCH WOMEN MENT HLTH, V14, P247, DOI 10.1007/s00737-011-0217-3; Forsyth BWC, 1996, J PEDIATR PSYCHOL, V21, P89, DOI 10.1093/jpepsy/21.1.89; Garcia-Esteve L, 2003, J AFFECT DISORDERS, V75, P71, DOI 10.1016/S0165-0327(02)00020-4; Goecke TW, 2012, ARCH GYNECOL OBSTET, V286, P309, DOI 10.1007/s00404-012-2286-6; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; GREEN M, 1964, PEDIATRICS, V34, P58; Henninger WR, 2014, CHILD FAM SOC WORK, V19, P467, DOI 10.1111/cfs.12046; Hess CR, 2004, J APPL DEV PSYCHOL, V25, P423, DOI 10.1016/j.appdev.2004.06.002; Horwitz SM, 2015, INFANT MENT HEALTH J, V36, P42, DOI 10.1002/imhj.21484; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson K, 2007, ACTA PAEDIATR, V96, P227, DOI 10.1111/j.1651-2227.2007.00015.x; JOHNSTON C, 1989, J CLIN CHILD PSYCHOL, V18, P167, DOI 10.1207/s15374424jccp1802_8; Jones TL, 2005, CLIN PSYCHOL REV, V25, P341, DOI 10.1016/j.cpr.2004.12.004; Kamalifard Mahin, 2014, J Caring Sci, V3, P57, DOI 10.5681/jcs.2014.007; Karam F, 2016, ARCH WOMEN MENT HLTH, V19, P835, DOI 10.1007/s00737-016-0624-6; Kerruish NJ, 2005, J PAEDIATR CHILD H, V41, P419, DOI 10.1111/j.1440-1754.2005.00658.x; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Moon M, 2008, J GENET PSYCHOL, V169, P261, DOI 10.3200/GNTP.169.3.261-280; Ohan JL, 2000, CAN J BEHAV SCI, V32, P251, DOI 10.1037/h0087122; Oltra P., 2016, THESIS; Oronoz B, 2007, PSICOTHEMA, V19, P687; Perez-Padilla J, 2016, BEHAV PSYCHOL, V24, P51; Perren S, 2005, J PSYCHOSOM OBST GYN, V26, P173, DOI 10.1080/01674820400028407; Righetti-Veltema M, 2003, EUR CHILD ADOLES PSY, V12, P75, DOI 10.1007/s00787-003-0311-9; Saligheh M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00597; Skreden M, 2012, SCAND J PUBLIC HEALT, V40, P596, DOI 10.1177/1403494812460347; Stuart S, 2008, SANTE MENT QUE, V33, P87, DOI 10.7202/019670ar; Teti DM, 2005, J DEV BEHAV PEDIATR, V26, P283, DOI 10.1097/00004703-200508000-00004; THOMASGARD M, 1995, J DEV BEHAV PEDIATR, V16, P47; Tommiska V, 2002, ARCH DIS CHILD-FETAL, V86, P161, DOI 10.1136/fn.86.3.F161; Widarsson M, 2013, SCAND J CARING SCI, V27, P839, DOI 10.1111/j.1471-6712.2012.01088.x; Wilson S, 2010, CLIN PSYCHOL REV, V30, P167, DOI 10.1016/j.cpr.2009.10.007; Yogev S., 1986, WOMEN THER, V5, P313, DOI [10.1300/J015V05N02_29, DOI 10.1300/J015V05N02_29]	47	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202894	10.1371/journal.pone.0202894	http://dx.doi.org/10.1371/journal.pone.0202894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148877	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200030
J	Santos, AP; Correa, RD; Ribeiro-Alves, M; da Silva, ACOS; Mafort, TT; Leung, J; Pereira, GMB; Rodrigues, LS; Rufino, R				Santos, Ana Paula; Correa, Raquel da Silva; Ribeiro-Alves, Marcelo; Oliveira Soares da Silva, Ana Carolina; Mafort, Thiago Thomaz; Leung, Janaina; Batista Pereira, Geraldo Moura; Rodrigues, Luciana Silva; Rufino, Rogerio			Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-gamma, IP-10 and adenosine deaminase	PLOS ONE			English	Article							LINKED IMMUNOSPOT ASSAY; INTERFERON-GAMMA; T-CELLS; RELEASE ASSAY; EFFUSION; METAANALYSIS; CHEMOKINES; INFECTION; CYTOKINES; SITES	Background Pleural tuberculosis (PITB) is the most common extrapulmonary manifestation of this infectious disease which still presents high mortality rates worldwide. Conventional diagnostic tests for PITB register multiple limitations, including the lack of sensitivity of microbiological methods on pleural specimens and the need of invasive procedures such as pleural biopsy performance. In this scenario, the search for biological markers on pleural fluid (PF) has been the target of several studies as a strategy to overcome the limitations of PITB diagnosis. This study aims to evaluate the use either isolated or in combination with adenosine deaminase (ADA), interferon-gamma (IFN-gamma), interferon-gamma inducible protein of 10-kD (IP-10) levels on PF in order to guide an accurate anti-TB treatment in microbiologically non-confirmed cases. Methods and findings Eighty patients presenting pleural effusion under investigation were enrolled in a cross-sectional study conducted at Pedro Ernesto University Hospital, Rio de Janeiro, RJ, Brazil. Peripheral blood (PB) and PF samples collected from all patients were applied to the commercial IFN-gamma release assay, QuantiFERON-TB Gold In-Tube, and samples were analyzed for IFN-gamma and IP-10 by immunoassays. ADA activity was determined on PF by the colorimetric method. Based on microbiological and histological criteria, patients were categorized as follow: confirmed PITB (n = 16), non-confirmed PITB (n = 17) and non-PITB (n = 47). The Mycobacterium tuberculosis antigen-specific production of IFN-gamma and IP-10 on PB or PF did not show significant differences. However, the basal levels of these biomarkers, as well as the ADA activity on PF, were significantly increased in confirmed PITB in comparison to non-PITB group. Receiver operating characteristics curves were performed and the best cut-off points of these three biomarkers were estimated. Their either isolated or combined performances (sensitivity [Se], specificity [Sp], positive predictive value [PPV], negative predictive value [NPV] and accuracy [Acc]) were determined and applied to Venn's diagrams among the groups. Based on the confirmed PITB cases, IFN-gamma showed the best performance of them at a cut-off point of 2.33 IU/mL (Se = 93.8% and Sp = 97.9%) followed by ADA at a cut-off of 25.80 IU/L (Se = 100% and Sp = 84.8%) and IP-10 (Cut-point = 4,361.90 pg/mL, Se = 75% and Sp = 82.6%). IFN-gamma plus ADA((cut-point: 25.80 IU/L)) represent the most accurate biomarker combination (98.4%), showing Se = 93.7%, Sp = 100%, PPV = 100% and NPV = 97.9%. When this analysis was applied in non-confirmed PITB, 15/17 (88.2%) presented at least two positive biomarkers in combination. Conclusion IFN-gamma, IP-10, and ADA in PITB effusions are significantly higher than in non-PITB cases. IFN-gamma is an excellent rule-in and rule-out test compared to IP-10 and ADA. The combination of IFN-gamma and ADA, in a reviewed cut-off point, showed to be particularly useful to clinicians as their positive results combined prompts immediate treatment for TB while both negative results suggest further investigation.	[Santos, Ana Paula; Mafort, Thiago Thomaz; Leung, Janaina; Rufino, Rogerio] State Univ Rio de Janeiro UERJ, Pedro Ernesto Univ Hosp HUPE, Dept Pulm Care, Rio De Janeiro, RJ, Brazil; [Correa, Raquel da Silva; Oliveira Soares da Silva, Ana Carolina; Batista Pereira, Geraldo Moura; Rodrigues, Luciana Silva] State Univ Rio de Janeiro UERJ, Med Sci Fac FCM, Lab Immunopathol, Rio De Janeiro, RJ, Brazil; [Ribeiro-Alves, Marcelo] Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Infectol Evandro Chagas INI, Lab Clin Res STD AIDS, Rio De Janeiro, RJ, Brazil; [Batista Pereira, Geraldo Moura] Oswaldo Cruz Fdn FIOCRUZ, Lab Cellular Microbiol, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Rodrigues, LS (corresponding author), State Univ Rio de Janeiro UERJ, Med Sci Fac FCM, Lab Immunopathol, Rio De Janeiro, RJ, Brazil.	lrodrigues.uerj@gmail.com	da Silva, Ana/GXH-4851-2022	Batista Pereira, Geraldo/0000-0001-6896-5376; Correa, Raquel da Silva/0000-0002-3112-2559	Fundacao Carlos Chagas de Amparo a pesquisa no Estado do Rio de Janeiro [261101792014]	Fundacao Carlos Chagas de Amparo a pesquisa no Estado do Rio de Janeiro	This work was supported by the Fundacao Carlos Chagas de Amparo a pesquisa no Estado do Rio de Janeiro (grant #261101792014).	Abrao FC, 2014, INT J TUBERC LUNG D, V18, P1363, DOI 10.5588/ijtld.14.0257; Aggarwal AN, 2015, J CLIN MICROBIOL, V53, P2451, DOI 10.1128/JCM.00823-15; Ambade Vivek, 2011, Med J Armed Forces India, V67, P338, DOI 10.1016/S0377-1237(11)60080-4; Aoe K, 2003, CHEST, V123, P740, DOI 10.1378/chest.123.3.740; Arnold DT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113047; BAGANHA MF, 1990, CHEST, V97, P605, DOI 10.1378/chest.97.3.605; Bielsa S, 2013, INT J TUBERC LUNG D, V17, P85, DOI 10.5588/ijtld.12.0236; Chen KY, 2016, INT J GEN MED, V9, P183, DOI 10.2147/IJGM.S100237; Choi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165428; Dheda K, 2009, EUR RESPIR J, V34, P1118, DOI 10.1183/09031936.00005309; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; El Fenniri L, 2011, TUBERCULOSIS, V91, P224, DOI 10.1016/j.tube.2010.12.005; Gao Y, 2012, FEMS IMMUNOL MED MIC, V66, P393, DOI 10.1111/1574-695X.12006; Garcia-Zamalloa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038729; GiustiG HV, 1974, METHODS ENZYMATIC AN, P1092, DOI DOI 10.1016/B978-0-12-091302-2.50108-0; Gomes T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-9; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Greco S, 2003, INT J TUBERC LUNG D, V7, P777; Helmy NA, 2012, EGYPT J CHEST DIS TU, V61, P413, DOI 10.1016/j.ejcdt.2012.08.004; Hiraki A, 2003, INT J TUBERC LUNG D, V7, P1172; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; Kabeer BSA, 2012, J INFECTION, V64, P573, DOI 10.1016/j.jinf.2012.02.013; Keng LT, 2013, J INFECTION, V67, P294, DOI 10.1016/j.jinf.2013.05.009; Lee LN, 2009, CLIN MICROBIOL INFEC, V15, P173, DOI 10.1111/j.1469-0691.2008.02655.x; Lee SJ, 2014, AM J MED SCI, V348, P362, DOI 10.1097/MAJ.0000000000000260; Li ZZ, 2015, GENET MOL RES, V14, P11672, DOI 10.4238/2015.September.28.19; Light RW, 2010, RESPIROLOGY, V15, P451, DOI 10.1111/j.1440-1843.2010.01723.x; Liu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084364; Liu Y, 2010, J MATH ARTS, V4, P1, DOI 10.1080/17513470903311644; Liu YY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.80; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Lusiba JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102702; Maynard-Smith L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0709-7; Meldau R, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-58; Nemeth J, 2009, J INTERN MED, V265, P163, DOI 10.1111/j.1365-2796.2008.02012.x; NIWA Y, 1985, CHEST, V87, P351, DOI 10.1378/chest.87.3.351; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Pang CS, 2015, PEERJ, V3, DOI 10.7717/peerj.951; Pokkali S, 2008, CYTOKINE, V41, P307, DOI 10.1016/j.cyto.2007.12.009; Porcel JM, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.07.23; Sehgal IS, 2016, J CLIN MICROBIOL, V54, P1133, DOI 10.1128/JCM.03205-15; SHIMOKATA K, 1991, CHEST, V99, P1103, DOI 10.1378/chest.99.5.1103; Sutherland JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030324; Tay TR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-546; Tiwari RP, 2007, TUBERCULOSIS, V87, P193, DOI 10.1016/j.tube.2006.07.005; Trajman A, 2008, EUR RESPIR J, V31, P1098, DOI 10.1183/09031936.00147507; WHO, 2016, GLOB TUB REP; Wilkinson KA, 2005, CLIN INFECT DIS, V40, P184, DOI 10.1086/426139; Xu HY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008412	49	18	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202481	10.1371/journal.pone.0202481	http://dx.doi.org/10.1371/journal.pone.0202481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148839	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200011
J	Beltran-Alcrudo, D; Kukielka, EA; de Groot, N; Dietze, K; Sokhadze, M; Martinez-Lopez, B				Beltran-Alcrudo, Daniel; Kukielka, Esther A.; de Groot, Nienke; Dietze, Klaas; Sokhadze, Mikheil; Martinez-Lopez, Beatriz			Descriptive and multivariate analysis of the pig sector in Georgia and its implications for disease transmission	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; RISK-FACTORS; MANAGEMENT-PRACTICES; PRODUCTION SYSTEMS; SLAUGHTER PIGS; VIRAL DISEASES; ANIMAL HEALTH; BIOSECURITY; DISTRICTS; OUTBREAKS	Background Georgia is a country in the Caucasus region with a traditional backyard and highly variable pig farming system. The practices of such sectors have seldom been described and analyzed to better understand their implication in the introduction and spread of infectious pig diseases. Moreover, the Georgian pig sector was badly hit by an epidemic of African swine fever in 2007 that quickly spread throughout the region. Materials and methods We interviewed 487 pig farmers and 116 butchers using closed questionnaires on socioeconomic issues related to pig production, husbandry practices, biosecurity, marketing and movements, and disease awareness. Surveys were conducted in four regions of Georgia and descriptive statistics were computed. Factorial analyses of mixed data and hierarchical clustering on principal components were applied to study the relationship among collected variables for both farmers and butchers. Results Results show that pig farming in Georgia is a non-professional sector, highly heterogeneous by region, characterized by smallholdings of few animals, with low inputs, outdated technologies, and poor biosecurity, which all translates into low outputs and productivity. The hierarchical clustering on principal components confirmed that there are five major production and husbandry strategies, which match the four regions where the study was conducted. Conclusions Our results are the first step to quantify biosecurity gaps and risky behaviours, develop risk profiles, and identify critical control points across the market chain where to implement mitigation measures. This study provides the baseline information needed to design realistic and sustainable prevention, surveillance and control strategies.	[Beltran-Alcrudo, Daniel] Food & Agr Org, Reg Off Europe & Cent Asia, Budapest, Hungary; [Kukielka, Esther A.; Martinez-Lopez, Beatriz] Univ Calif Davis, CADMS, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA; [de Groot, Nienke] Univ Utrecht, Utrecht, Netherlands; [Dietze, Klaas] Friedrich Loeffler Inst, Inst Epidemiol, Greifswald, Germany; [Sokhadze, Mikheil] Natl Food Agcy, Tbilisi, Georgia; [Sokhadze, Mikheil] FAO, FAO Representat Georgia, Tbilisi, Georgia	Food & Agriculture Organization of the United Nations (FAO); University of California System; University of California Davis; Utrecht University; Friedrich Loeffler Institute	Beltran-Alcrudo, D (corresponding author), Food & Agr Org, Reg Off Europe & Cent Asia, Budapest, Hungary.	daniel.beltranalcrudo@fao.org	Lopez, Beatriz Martinez/AAE-6692-2021; Beltran-Alcrudo, Daniel/AAL-7358-2021	Beltran-Alcrudo, Daniel/0000-0002-8646-357X; de Groot, Nienke/0000-0001-9006-0071; Kukielka, Esther/0000-0002-8655-3778				Agustina KK, 2017, VET WORLD, V10, P1347, DOI 10.14202/vetworld.2017.1347-1352; Alawneh JI, 2014, PREV VET MED, V114, P73, DOI 10.1016/j.prevetmed.2014.01.020; [Anonymous], 2014, CHAPMAN HALL CRC R S; Beltran-Alcrudo D, 2008, FAO EMPRES WATCH, P1; Beltran-Alcrudo D, 2009, EMPRES WATCH, P1; Boes J, 2005, PREV VET MED, V69, P213, DOI 10.1016/j.prevetmed.2005.02.007; Boinas FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020383; Boklund A, 2004, PREV VET MED, V66, P49, DOI 10.1016/j.prevetmed.2004.08.004; Brioudes A, 2017, TRANSBOUND EMERG DIS, V64, P284, DOI 10.1111/tbed.12370; Brown AA, 2017, TRANSBOUNDARY EMERGI; Casal J, 2007, PREV VET MED, V82, P138, DOI 10.1016/j.prevetmed.2007.05.012; Costard S, 2009, PREV VET MED, V92, P199, DOI 10.1016/j.prevetmed.2009.08.010; DEBOER E, 1991, INT J FOOD MICROBIOL, V12, P375, DOI 10.1016/0168-1605(91)90151-E; Dione MM, 2014, PREV VET MED, V117, P565, DOI 10.1016/j.prevetmed.2014.10.012; EDELSTEN RM, 1995, REV SCI TECH OIE, V14, P655, DOI 10.20506/rst.14.3.865; Edia-Asuke AU, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-45; FAO, 2011, VAL CHAIN APPR AN DI; Farez S, 1997, REV SCI TECH OIE, V16, P65, DOI 10.20506/rst.16.1.992; Fosse J, 2009, ZOONOSES PUBLIC HLTH, V56, P429, DOI 10.1111/j.1863-2378.2008.01185.x; Herrera-Ibata DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182850; Holley RA, 2006, J ENVIRON QUAL, V35, P1170, DOI 10.2134/jeq2005.0449; HURNIK D, 1994, PREV VET MED, V20, P135, DOI 10.1016/0167-5877(94)90112-0; Jori F, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00198; Khomenko S., 2013, EMPRES WATCH, V28, P1, DOI DOI 10.1016/J.MEATSCI.2007.06.018; Khuroo MS, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090253; Kukielka EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178904; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lichoti JK, 2017, PREV VET MED, V140, P87, DOI 10.1016/j.prevetmed.2017.03.005; Monger VR, 2014, PREV VET MED, V117, P222, DOI 10.1016/j.prevetmed.2014.07.005; Nantima N, 2015, TROP ANIM HEALTH PRO, V47, P589, DOI 10.1007/s11250-015-0768-9; OIE, 2008, OIE WORLD AN HLTH IN; OIE, 2007, OIE WORLD AN HLTH IN; OIE, 2007, AFR SWIN FEV ASF CON; Poolkhet C, 2016, ACTA TROP, V159, P44, DOI 10.1016/j.actatropica.2016.03.027; Probst C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170054; Rasamoelina-Andriamanivo H, 2014, ACTA TROP, V135, P10, DOI 10.1016/j.actatropica.2014.03.008; Raymond P, 2017, CAN J VET RES, V81, P162; Relun A, 2015, PREV VET MED, V121, P246, DOI 10.1016/j.prevetmed.2015.07.004; Ribbens S, 2008, PREV VET MED, V83, P228, DOI 10.1016/j.prevetmed.2007.07.009; Ruiz-Fons F, 2008, VET J, V176, P158, DOI 10.1016/j.tvjl.2007.02.017; Thomas LF, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-46; Truong VM, 2014, NEW ZEAL VET J, V62, P199, DOI 10.1080/00480169.2014.888640; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004	43	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202800	10.1371/journal.pone.0202800	http://dx.doi.org/10.1371/journal.pone.0202800			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142224	Green Submitted, Green Published, gold			2022-12-27	WOS:000442722500034
J	Kim, DH				Kim, Du Hyun			Extending Populus seed longevity by controlling seed moisture content and temperature	PLOS ONE			English	Article							STORAGE; GERMINATION; CRYOPRESERVATION; MECHANISMS; VIABILITY; KINETICS; ORCHARD; TRAITS; GROWTH	The poplar species Populus davidiana and P. koreana are widely grown in plantations and as biofuel resources, but little is known about ex-situ seed conservation in poplar. To identify the optimal long-term seed storage conditions for these species, we evaluated the viability of seeds with different seed water contents (SWCs) at various storage temperatures and time periods. P. davidiana seeds with <6% SWC could be stored at room temperature (RT) for 4 weeks, while P. koreana seeds showed no storability at RT. P. davidiana seeds with 3% SWC showed 74% viability after 36 months of storage at 4 degrees C, while those with 9-18% SWC showed >89% viability after 48 months of storage at - 18 degrees C. Long-term storage at -80 degrees C was best for P. davidiana seeds with a wide range of SWCs (3-24%), with 91-98% of normal germination after 48 months of storage. However, the normal germination of P. koreana seeds with 3-24% SWC declined to <20% after 36 months of storage, even at -18 degrees C and -80 degrees C. No significant difference was observed between seeds immersed vs. not immersed in liquid nitrogen for both species. Our findings increase the possibility for longterm seed conservation for both Populus species.	[Kim, Du Hyun] Dong A Univ, Dept Life Resources Ind, Busan, South Korea	Dong A University	Kim, DH (corresponding author), Dong A Univ, Dept Life Resources Ind, Busan, South Korea.	dhimhort@dau.ac.kr			Dong-A University Research Fund	Dong-A University Research Fund	This study was financially supported by the Dong-A University Research Fund.	Annapurna D, 2005, SILVAE GENET, V54, P153, DOI 10.1515/sg-2005-0023; Asakawa S., 1980, P INT S FOR TREE SEE, P136; Ballesteros D, 2017, CRYOLETTERS, V38, P278; Benson M. K., 1972, Genet. Physiol. Note. Institute of Paper Chemistry, P4; Bonner FT, 2008, AGR HDB, P85; Daigle B. I., 2009, Native Plants Journal, V10, P48, DOI 10.2979/NPJ.2009.10.1.48; Dimitriou I, 2017, FOREST ECOL MANAG, V383, P99, DOI 10.1016/j.foreco.2016.08.022; Dreesen D. R., 2003, Native Plants Journal, V4, P118; Dussert S, 2006, CRYOLETTERS, V27, P169; FECHNER GH, 1981, CAN J FOREST RES, V11, P718, DOI 10.1139/x81-100; Gonzalez E, 2010, TREES-STRUCT FUNCT, V24, P151, DOI 10.1007/s00468-009-0388-y; Gordon JC, 2001, FOREST CHRON, V77, P217, DOI 10.5558/tfc77217-2; Gosling P., 2007, FORESTRY COMMISSION; Haggman Hely, 2008, P365, DOI 10.1007/978-0-387-72276-4_14; Hay FR, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot030; Hong T.D., 1996, IPGRI TECHNICAL B, V1; International Organization on Migration, 2009, MOIST CONT DET, p[iv, 1]; Isebrands J, POPLAR CULTURE N AM; Isebrands JG, 2014, POPLARS AND WILLOWS: TREES FOR SOCIETY AND THE ENVIRONMENT, P1, DOI 10.1079/9781780641089.0000; Jin X, 2014, THESIS; Kaputska LA, 1972, THESIS; Koo YB, 2001, KOREAN J BREEDING, V33, P311; Lee WY, 2016, POPLARS SHORT ROTATI; Linington Simon H., 2001, P165; Mamo N, 2006, FOREST ECOL MANAG, V225, P320, DOI 10.1016/j.foreco.2006.01.026; Maroder HL, 2000, ANN BOT-LONDON, V86, P1017, DOI 10.1006/anbo.2000.1265; Moss EH, 1937, BOT GAZ, V99, P529; Noh ER, 1997, RES REP FOR GEN RES, V33, P1; Pence VC, 1996, SEED SCI TECHNOL, V24, P151; Popova E. V., 2012, CryoLetters, V33, P219; Popova EV, 2013, ACTA PHYSIOL PLANT, V35, P3015, DOI 10.1007/s11738-013-1334-6; Pritchard Hugh W, 2007, Methods Mol Biol, V368, P185; Singh O, 2011, ANN FOR RES, V54, P139; Slabaugh PE, 1958, 6302 ASP BIBL, V6302; Stanton Brian J., 1996, P113; Suszka J, 2014, ANN FOREST SCI, V71, P543, DOI 10.1007/s13595-014-0368-2; TAUER CG, 1979, FOREST SCI, V25, P112; Nguyen TP, 2012, PLANT PHYSIOL, V160, P2083, DOI 10.1104/pp.112.206649; Walters C, 2005, INTEGR COMP BIOL, V45, P751, DOI 10.1093/icb/45.5.751; Walters C, 1998, SEED SCI RES, V8, P223, DOI 10.1017/S096025850000413X; Walters CT, 2001, INT SOC SEED SCI BRA, P280; Wang BSP, 1982, P INT S FOR TREE SEE, P142; WARE GH, 1949, ECOLOGY, V30, P478, DOI 10.2307/1932451; Wood CB, 2003, CRYOLETTERS, V24, P17; Wyckoff G. W., 2008, AGR HDB, V727, P856, DOI DOI 10.2979/NPJ.2009.10.3.300; Zasada J. C., 1980, Tree Planters' Notes, V31, P9; ZASADA JC, 1977, SEED SCI TECHNOL, V5, P509	47	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0203080	10.1371/journal.pone.0203080	http://dx.doi.org/10.1371/journal.pone.0203080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142186	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500061
J	Blomqvist, S; Alexanderson, K; Vahtera, J; Westerlund, H; Hanson, LLM				Blomqvist, Sandra; Alexanderson, Kristina; Vahtera, Jussi; Westerlund, Hugo; Hanson, Linda L. Magnusson			Downsizing and purchases of psychotropic drugs: A longitudinal study of stayers, changers and unemployed	PLOS ONE			English	Article							SELF-RATED HEALTH; ORGANIZATIONAL-CHANGE; WHITEHALL-II; JOB INSECURITY; EMPLOYEES; SWEDEN; DEPRESSION; DISORDERS; WOMEN; UNCERTAINTY	Background The evidence is insufficient regarding the association between organizational downsizing and employee mental health. Our aim was to analyze trajectories of prescribed sedatives and anxiolytics with a sufficiently long follow-up time to capture anticipation, implementation and adaption to a downsizing event among stayers, changers and those who become unemployed compared to unexposed employees. Method Swedish residents aged 20-54 years in 2007, with stable employment between 2004 and 2007, were followed between 2005 and 2013 (n = 2,305,795). Employment at a workplace with staff reductions >= 18% between two subsequent years in 2007-2011 (n = 915,461) indicated exposure to, and timing of, downsizing. The unexposed (n = 1,390,334) were randomized into four corresponding sub-cohorts. With generalized estimating equations, we calculated the odds ratios (OR) of purchasing prescribed anxiolytics or sedatives within nine 12-month periods, from four years before to four years after downsizing. In order to investigate whether the groups changed their probability of purchases over time, odds ratios (OR) and their 95% confidence intervals (95% CI) were calculated contrasting the prevalence of purchases during the first and the last 12-month period within four time periods for each exposure group. Results The odds of purchasing anxiolytics increased more for stayers (OR 1.03, 95% CI 1.01-1.06) and unemployed (OR 1.08, 95% CI 1.03-1.14) compared to unexposed before downsizing, and purchases continued to increase after downsizing for stayers. Among those without previous sickness absence, stayers increased their purchases of anxiolytics from the year before the event up to four years after the event. Trajectories for sedatives were similar but less pronounced. Conclusion This study indicates that being exposed to downsizing is associated with increased use of sedatives and anxiolytics, especially before the event, if the employee stays in the organization or becomes unemployed.	[Blomqvist, Sandra; Westerlund, Hugo; Hanson, Linda L. Magnusson] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Alexanderson, Kristina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland	Stockholm University; Karolinska Institutet; University of Turku	Blomqvist, S (corresponding author), Stockholm Univ, Stress Res Inst, Stockholm, Sweden.	sandra.blomqvist@su.se	Hanson, Linda L Magnusson/D-2435-2017; Westerlund, Hugo/A-3049-2012	Hanson, Linda L Magnusson/0000-0002-2908-1903; Westerlund, Hugo/0000-0002-8806-5698; Vahtera, Jussi/0000-0002-6036-061X	Swedish Research Council for Health, Working Life and Welfare [2009-1758]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The study was funded by the Swedish Research Council for Health, Working Life and Welfare recieved by the Stockholm Stress Center [grant number 2009-1758] (http://forte.se/en/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm J, 2013, SCAND J PUBLIC HEALT, V41, P318, DOI 10.1177/1403494812473205; Allen T D, 2000, J Occup Health Psychol, V5, P278, DOI 10.1037/1076-8998.5.2.278; Angst J, 2002, EUR ARCH PSY CLIN N, V252, P201, DOI 10.1007/s00406-002-0381-6; Aslund C, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-22; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bamberger SG, 2012, OCCUP ENVIRON MED, V69, P592, DOI 10.1136/oemed-2011-100381; Bernstrom VH, 2013, SOC SCI MED, V98, P239, DOI 10.1016/j.socscimed.2013.10.001; Bordia P., 2004, EUR J WORK ORGAN PSY, V13, P345, DOI [10.1080/13594320444000128, DOI 10.1080/13594320444000128]; Brenner MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097063; BRENNER SO, 1987, SOC SCI MED, V25, P153, DOI 10.1016/0277-9536(87)90383-2; BROCKNER J, 1985, ORGAN BEHAV HUM DEC, V36, P229, DOI 10.1016/0749-5978(85)90014-7; Brown C, 2003, SOC SCI MED, V57, P1539, DOI 10.1016/S0277-9536(02)00556-7; Cheng GHL, 2008, APPL PSYCHOL-INT REV, V57, P272, DOI 10.1111/j.1464-0597.2007.00312.x; Danielsson U, 2005, SCAND J PRIM HEALTH, V23, P171, DOI 10.1080/02813430510031315; Falkenberg H, 2013, OCCUP ENVIRON MED, V70, P688, DOI 10.1136/oemed-2013-101385; Ferrie JE, 2008, SCAND J WORK ENV HEA, P98; FERRIE JE, 1995, BRIT MED J, V311, P1264, DOI 10.1136/bmj.311.7015.1264; Hanson LLM, 2016, EPIDEMIOLOGY, V27, P257, DOI 10.1097/EDE.0000000000000414; Kivimaki M, 2000, BRIT MED J, V320, P971, DOI 10.1136/bmj.320.7240.971; Kivimaki M, 2003, AM J COMMUN PSYCHOL, V32, P57, DOI 10.1023/A:1025642806557; Kivimaki M, 2001, ANXIETY STRESS COPIN, V14, P59, DOI 10.1080/10615800108248348; Kivimaki M, 2007, J EPIDEMIOL COMMUN H, V61, P154, DOI 10.1136/jech.2006.050955; Laaksonen E, 2007, INT J EPIDEMIOL, V36, P776, DOI 10.1093/ije/dym074; Last JM, 2013, INT J EPIDEMIOL, V42, P1608, DOI 10.1093/ije/dyt113; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Osthus S, 2012, SOC SCI MED, V75, P946, DOI 10.1016/j.socscimed.2012.04.036; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Paulsen N, 2005, HUM RELAT, V58, P463, DOI 10.1177/0018726705055033; Pollard TM, 2001, WORK STRESS, V15, P14, DOI 10.1080/02678370110064609; Quinlan M, 2009, INT J HEALTH SERV, V39, P1, DOI 10.2190/HS.39.1.a; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Smollan RK, 2015, J ORGAN CHANGE MANAG, V28, P301, DOI 10.1108/JOCM-03-2014-0055; Statistics Sweden, 2016, UN STAT STAT SWED; Sundquist K, 2004, BRIT J PSYCHIAT, V184, P293, DOI 10.1192/bjp.184.4.293; Sverke Magnus, 2002, J Occup Health Psychol, V7, P242, DOI 10.1037/1076-8998.7.3.242; Swedish Board of Health and Welfare, PRESCR DRUGS STAT SW; Swedish Work Environment Authority, 2016, WOM MENS WORK COND I; Theorell T, 2014, J EPIDEMIOL COMMUN H, V68, P78, DOI 10.1136/jech-2012-202294; Vahtera J, 1997, LANCET, V350, P1124, DOI 10.1016/S0140-6736(97)03216-9; Wittchen HU, 2000, ACTA PSYCHIAT SCAND, V102, P14, DOI 10.1111/j.0065-1591.2000.acp29[dash]03.x	40	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203433	10.1371/journal.pone.0203433	http://dx.doi.org/10.1371/journal.pone.0203433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161241	Green Submitted, gold, Green Published			2022-12-27	WOS:000443388900125
J	Deniz, B; Altincatal, A; Ambavane, A; Rao, S; Doan, J; Malcolm, B; Michaelson, MD; Yang, S				Deniz, Baris; Altincatal, Arman; Ambavane, Apoorva; Rao, Sumati; Doan, Justin; Malcolm, Bill; Michaelson, M. Dror; Yang, Shuo			Application of dynamic modeling for survival estimation in advanced renal cell carcinoma	PLOS ONE			English	Article							ADVANCED MELANOMA; ECONOMIC-EVALUATION; 1ST-LINE TREATMENT; COMBINED NIVOLUMAB; COST-EFFECTIVENESS; OPEN-LABEL; IPILIMUMAB; CHEMOTHERAPY; MULTICENTER; SUNITINIB	Objective In oncology, extrapolation of clinical outcomes beyond trial duration is traditionally achieved by parametric survival analysis using population-level outcomes. This approach may not fully capture the benefit/risk profile of immunotherapies due to their unique mechanisms of action. We evaluated an alternative approach-dynamic modeling-to predict outcomes in patients with advanced renal cell carcinoma. We compared standard parametric fitting and dynamic modeling for survival estimation of nivolumab and everolimus using data from the phase III CheckMate 025 study. Methods We developed two statistical approaches to predict longer-term outcomes (progression, treatment discontinuation, and survival) for nivolumab and everolimus, then compared these predictions against follow-up clinical trial data to assess their proximity to observed outcomes. For the parametric survival analyses, we selected a probability distribution based on its fit to observed population-level outcomes at 14-month minimum follow-up and used it to predict longer-term outcomes. For dynamic modeling, we used a multivariate Cox regression based on patient-level data, which included risk scores, and probability and duration of response as predictors of longer-term outcomes. Both sets of predictions were compared against trial data with 26- and 38-month minimum follow-up. Results Both statistical approaches led to comparable fits to observed trial data for median progression, discontinuation, and survival. However, beyond the trial duration, mean survival predictions differed substantially between methods for nivolumab (30.8 and 51.5 months), but not everolimus (27.2 and 29.8 months). Longer-term follow-up data from CheckMate 025 and phase I/II studies resembled dynamic model predictions for nivolumab. Conclusions Dynamic modeling can be a good alternative to parametric survival fitting for immunotherapies because it may help better capture the longer-term benefit/risk profile and support health-economic evaluations of immunotherapies.	[Deniz, Baris] Evidera Inc, Bethesda, MD 20814 USA; [Altincatal, Arman] Evidera Inc, Waltham, MA USA; [Ambavane, Apoorva] Evidera Inc, London, England; [Rao, Sumati; Doan, Justin; Malcolm, Bill; Yang, Shuo] Bristol Myers Squibb, Princeton, NJ USA; [Michaelson, M. Dror] Massachusetts Gen Hosp, Boston, MA 02114 USA	Evidera; Evidera; Evidera; Bristol-Myers Squibb; Harvard University; Massachusetts General Hospital	Deniz, B (corresponding author), Evidera Inc, Bethesda, MD 20814 USA.	baris.deniz@evidera.com	Ambavane, Apoorva/AAW-4834-2020	Michaelson, Dror/0000-0001-9249-6338; Deniz, Baris/0000-0002-8423-5629	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Bristol-Myers Squibb provided financial support to Evidera in relation to the conduct of the reported research study. The funder (Bristol-Myers Squibb) provided support in the form of salaries for those authors employed by the funder (S. Yang, S. Rao, J. Doan, and B. Malcolm) and had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Evidera, a commercial company, provided support in the form of salaries and research materials to B. Deniz, A. Altincatal, and A. Ambavane. and had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors received financial support in direct relation to the preparation of this manuscript. Bristol-Myers Squibb provided funding in relation to professional writing/editorial support as outlined in the Acknowledgments section; Medical writing support was provided by Jenny Lloyd, PhD. Professional editorial assistance was provided by Richard Daniel, PhD, and Lawrence Hargett of PPSI (a PAREXEL company), and was funded by Bristol-Myers Squibb.	Benedict A, 2011, BJU INT, V108, P665, DOI 10.1111/j.1464-410X.2010.09957.x; Bohensky M, 2015, VALUE HEALTH, V18, pA699, DOI 10.1016/j.jval.2015.09.2613; Bristol-Myers Squibb, CHECKMATE 025 STUD D; Caro JJ, 2016, PHARMACOECONOMICS, V34, P665, DOI 10.1007/s40273-016-0394-z; Chabot I, 2010, VALUE HEALTH, V13, P837, DOI 10.1111/j.1524-4733.2010.00738.x; Cherny NI, 2015, ANN ONCOL, V26, P1547, DOI 10.1093/annonc/mdv249; Collett, 2003, MODELLING SURVIVAL D; D'Errico G, 2017, CLIN TRANSL MED, V6, DOI 10.1186/s40169-016-0130-5; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Food and Drug Administration, 1989, GANC INJ INTR US HIG; Furlow B., 2016, ASCO 2016 NIVOLUMAB; Hodi FS, 2016, LANCET ONCOL, V17, P1558, DOI 10.1016/S1470-2045(16)30366-7; Hodi FS, 2016, J CLIN ONCOL, V34, P1510, DOI 10.1200/JCO.2015.64.0391; Hoyle MW, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-139; Huang XL, 2016, STAT MED, V35, P2167, DOI 10.1002/sim.6860; Ishak KJ, 2013, PHARMACOECONOMICS, V31, P663, DOI 10.1007/s40273-013-0064-3; Ishak KJ, 2016, ISPOR 19 ANN EUR M O; Kaufman HL, 2016, LANCET ONCOL, V17, P1374, DOI 10.1016/S1470-2045(16)30364-3; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Latimer N., NICE DSU TECHNICAL S; Martin-Liberal J, 2017, CANCER TREAT REV, V54, P74, DOI 10.1016/j.ctrv.2017.01.008; McDermott DF, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.4507; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; National Comprehensive Cancer Network (NCCN), 2011, NCCN CLIN PRACT GUID; National Institute for Health and Care Excellence (NICE), NIV TREAT ADV UNR ME; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Plimack ER, 2016, 15 INT KIDN CANC S N; Remak E, 2008, J CLIN ONCOL, V26, P3995, DOI 10.1200/JCO.2007.13.2662; Ribas A, 2012, CLIN CANCER RES, V18, P336, DOI 10.1158/1078-0432.CCR-11-2323; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Schadendorf D, 2014, J CLIN ONCOL, V56, P2736, DOI DOI 10.1200/JC0.2014.56.2736; Schnipper LE, 2015, J CLIN ONCOL, V33, P2563, DOI 10.1200/JCO.2015.61.6706; Sharma P, 2017, 16 INT KIDN CANC S N; U.S. Food and drug administration, HIGHL PRESCR INF OPD; US Food and Drug Administration, HIGHL PRESCR INF BAV; US Food and Drug Administration, HIGHL PRESCR INF YER; US Food and Drug Administration, HIGHL PRESCR INF KEY; Wan XM, 2017, CANCER-AM CANCER SOC, V123, P2634, DOI 10.1002/cncr.30666; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	42	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203406	10.1371/journal.pone.0203406	http://dx.doi.org/10.1371/journal.pone.0203406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161244	gold, Green Submitted, Green Published			2022-12-27	WOS:000443388900122
J	Jansz, TT; Neradova, A; van Ballegooijen, AJ; Verhaar, MC; Vervloet, MG; Schurgers, LJ; van Jaarsveld, BC				Jansz, Thijs T.; Neradova, Aegida; van Ballegooijen, Adriana J.; Verhaar, Marianne C.; Vervloet, Marc G.; Schurgers, Leon J.; van Jaarsveld, Brigit C.			The role of kidney transplantation and phosphate binder use in vitamin K status	PLOS ONE			English	Article							MATRIX GLA-PROTEIN; VASCULAR CALCIFICATION; HEMODIALYSIS; MORTALITY; SEVELAMER; SURVIVAL; DISEASE; COHORT; IMPACT	Background Cardiovascular disease is the leading cause of death in end-stage renal disease and is strongly associated with vascular calcification. Both kidney transplantation and phosphate binders may lower the risk of vascular calcification. Vascular calcification is actively inhibited by vitamin-K-dependent matrix y-carboxyglutamic acid protein (MGP). Whether kidney transplantation or phosphate binders affect vitamin K status is unknown. Therefore, we studied the influence of kidney transplantation and phosphate binder use on vitamin K status. Methods We measured plasma desphospho-uncarboxylated MGP (dp-ucMGP), a marker reflecting low vitamin K status, in a cross-sectional study of patients on hemodialysis (n = 82), peritoneal dialysis (n = 31) or who recently received a kidney transplantation (n = 36). By medication inventory, we assessed phosphate binder use. With linear regression, we assessed the influence of kidney transplantation and phosphate binder use on natural-log-transformed dp-ucMGP, adjusting for potential confounders. Results Mean age of patients was 52 +/- 13 years; 102 (68%) were male. Dp-ucMGP levels were significantly lower in kidney transplant recipients (median 689 pmol/L) compared to patients on dialysis (median 1537 pmol/L, p<0.001). Eighty-nine patients on dialysis used phosphate binders. Using any phosphate binder was not associated with dp-ucMGP levels (median 1637 pmol/L, p = 0.09) compared to no phosphate binders (median 1142 pmol/L). Twenty-six patients used sevelamer monotherapy, which was associated with higher dp-ucMGP levels (median 1740 pmol/L, p = 0.04) after adjusting for age, sex and vitamin K antagonist use. Conclusions Recent kidney transplantation is associated with lower dp-ucMGP levels suggesting improved vitamin K status after transplantation. Sevelamer monotherapy is associated with higher dp-ucMGP levels suggesting worsening of vitamin K status. Both findings warrant more attention to vitamin K status in patients on dialysis, as vitamin K is necessary for protection against vascular calcification.	[Jansz, Thijs T.; Verhaar, Marianne C.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands; [Neradova, Aegida; van Ballegooijen, Adriana J.; Vervloet, Marc G.; van Jaarsveld, Brigit C.] Vrije Univ Amsterdam, Med Ctr, Dept Nephrol & Cardiovasc Sci, ACS, Amsterdam, Netherlands; [van Ballegooijen, Adriana J.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van Ballegooijen, Adriana J.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Inst, Amsterdam, Netherlands; [Schurgers, Leon J.] Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [van Jaarsveld, Brigit C.] Dianet Dialysis Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Maastricht University	Jansz, TT (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands.	t.t.jansz@umcutrecht.nl	Verhaar, Marianne/AAM-6788-2020; Schurgers, Leon/AAT-7100-2021	Verhaar, Marianne/0000-0002-3276-6428; van Jaarsveld, Brigit/0000-0001-5871-4952; Vervloet, Marc/0000-0003-4607-9415; Schurgers, Leon/0000-0001-7867-6957	Amgen; Baxter; Fresenius Medical Care; Novartis; Roche; Shire Pharmaceuticals; Wellerdieck de Goede Foundation	Amgen(Amgen); Baxter; Fresenius Medical Care; Novartis(Novartis); Roche(Roche Holding); Shire Pharmaceuticals; Wellerdieck de Goede Foundation	This work was supported by unrestricted grants from Amgen, Baxter, Fresenius Medical Care, Novartis, Roche and Shire Pharmaceuticals. T.T. Jansz was supported financially by a grant from the Wellerdieck de Goede Foundation with mediation from Friends of UMC Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Block GA, 2012, J AM SOC NEPHROL, V23, P1407, DOI 10.1681/ASN.2012030223; Boxma PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047991; Cranenburg ECM, 2012, KIDNEY INT, V82, P605, DOI 10.1038/ki.2012.191; Cranenburg ECM, 2010, THROMB HAEMOSTASIS, V104, P811, DOI 10.1160/TH09-11-0786; Dalmeijer GW, 2013, J NUTR BIOCHEM, V24, P624, DOI 10.1016/j.jnutbio.2012.02.012; Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-145; Ewing DT, 1943, J BIOL CHEM, V147, P233; Fusaro M, 2016, ENDOCRINE, V51, P333, DOI 10.1007/s12020-015-0673-z; Kaesler N, 2014, KIDNEY INT, V86, P286, DOI 10.1038/ki.2013.530; Keyzer CA, 2015, AM J KIDNEY DIS, V65, P474, DOI 10.1053/j.ajkd.2014.09.014; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1662, DOI 10.1111/j.1600-6143.2004.00573.x; Neradova A, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0560-3; Palmer SC, 2016, AM J KIDNEY DIS, V68, P691, DOI 10.1053/j.ajkd.2016.05.015; Pierce D, 2011, NEPHROL DIAL TRANSPL, V26, P1615, DOI 10.1093/ndt/gfq598; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Schnuelle P, 1998, J AM SOC NEPHROL, V9, P2135; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Schurgers LJ, 2010, CLIN J AM SOC NEPHRO, V5, P568, DOI 10.2215/CJN.07081009; Shea MK, 2011, J NUTR, V141, P1529, DOI 10.3945/jn.111.139634; Sigrist MK, 2007, CLIN J AM SOC NEPHRO, V2, P1241, DOI 10.2215/CJN.02190507; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P165, DOI 10.1053/j.ajkd.2011.12.001; Takagi K, 2010, CLIN NEPHROL, V73, P30; van Ballegooijen A J, 2017, Curr Nutr Rep, V6, P197, DOI 10.1007/s13668-017-0208-8; Vervloet MC, 2017, NAT REV NEPHROL, V13, P27, DOI 10.1038/nrneph.2016.164; Westenfeld R, 2012, AM J KIDNEY DIS, V59, P186, DOI 10.1053/j.ajkd.2011.10.041; Wolf M, 2016, TRANSPLANTATION, V100, P184, DOI 10.1097/TP.0000000000000823	29	32	35	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203157	10.1371/journal.pone.0203157	http://dx.doi.org/10.1371/journal.pone.0203157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161193	Green Published, gold			2022-12-27	WOS:000443388900085
J	Kwon, JW; Lee, SY; Jee, D; Cho, YK				Kwon, Jin-Woo; Lee, Sun Young; Jee, Donghyun; Cho, Yang Kyung			Prognosis for ocular toxocariasis according to granuloma location	PLOS ONE			English	Article							CLINICAL EXPRESSION; CROSS-REACTIVITY; LARVA MIGRANS; CANIS; DIAGNOSIS; STANDARDIZATION; EPIDEMIOLOGY; PREVENTION; FEATURES; CHILDREN	Purpose To determine the prognosis for ocular toxocariasis (OT) according to the location of the granuloma and to identify factors associated with its recurrence within 1 year. Methods OT patients were classified according to the granuloma lesion. After grouping the patients as posterior or peripheral, we compared sex, age, intraocular pressure, best corrected visual acuity (BCVA), degree of inflammation, immunoglobulin E, eosinophil profiles, recurrence, and complications in each group. We also identified factors associated with recurrence within 1 year. Results A total of 29 (61.70%) patients had granuloma at the periphery, and 18 (38.30%) patients had granuloma around the posterior pole. There were no significant differences in ocular or systemic evaluations except the initial BCVA. The mean decimal BCVA of the posterior pole granuloma group was worse than that of the peripheral granuloma group (p = 0.042). After treatment, the mean BCVA of the posterior pole granuloma group improved significantly (p = 0.019), and the final mean BCVA was not significantly different between the groups (p = 0.673). Multiple logistic regression analyses revealed that recurrence within a year was associated with age at diagnosis (p = 0.007). Conclusions The initial BCVA of OT patients differed according to the location of the granuloma, but the BCVA after treatment was not significantly	[Kwon, Jin-Woo; Lee, Sun Young; Jee, Donghyun; Cho, Yang Kyung] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea	Catholic University of Korea	Jee, D; Cho, YK (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea.	doj087@mail.harvard.edu; yangkyeung@hanmail.net		Kwon, Jin-woo/0000-0003-2093-4284	National Research Foundation of Korea - Korean government (MSIP) [NRF-2016R1D1A1B03932606]	National Research Foundation of Korea - Korean government (MSIP)	The authors wish to acknowledge the financial support of the National Research Foundation of Korea Grant funded by the Korean government (MSIP) (No. NRF-2016R1D1A1B03932606).	Ahn SJ, 2014, ASIA PAC ALLERGY, V4, P134, DOI 10.5415/apallergy.2014.4.3.134; Ahn SJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002938; Akao N, 2007, PARASITOL INT, V56, P87, DOI 10.1016/j.parint.2007.01.009; Alm SJ, 2013, J CATARACT REFR SURG, V39, P830, DOI 10.1016/j.jcrs.2012.12.033; Bae Ki Woong, 2016, Korean J Ophthalmol, V30, P258, DOI 10.3341/kjo.2016.30.4.258; Borecka A, 2015, ANN AGR ENV MED, V22, P28, DOI 10.5604/12321966.1141364; BROWN GC, 1981, ANN OPHTHALMOL, V13, P1385; Choi D, 2012, KOREAN J PARASITOL, V50, P23, DOI 10.3347/kjp.2012.50.1.23; De Visser L, 2008, AM J OPHTHALMOL, V145, P369, DOI 10.1016/j.ajo.2007.09.020; Despommier D, 2003, CLIN MICROBIOL REV, V16, P265, DOI 10.1128/CMR.16.2.265-272.2003; Despreaux R, 2016, AM J OPHTHALMOL, V166, P162, DOI 10.1016/j.ajo.2016.03.050; GLICKMAN LT, 1993, INFECT DIS CLIN N AM, V7, P717; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jee D, 2016, OCUL IMMUNOL INFLAMM, V24, P207, DOI 10.3109/09273948.2014.994783; Jin Y, 2015, J KOREAN MED SCI, V30, P549, DOI 10.3346/jkms.2015.30.5.549; Kempen JH, 2016, AM J OPHTHALMOL, V164, P110, DOI 10.1016/j.ajo.2015.12.034; Kroten A, 2016, PARASITOL RES, V115, P205, DOI 10.1007/s00436-015-4736-0; Lee RM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003116; MARMOR M, 1987, AM J PUBLIC HEALTH, V77, P554, DOI 10.2105/AJPH.77.5.554; NUSSENBLATT RB, 1985, OPHTHALMOLOGY, V92, P467; Ocular toxocariasis-United States, 2009, MMWR MORBIDITY MORTA, V60, P734; Pawlowski Z, 2001, J HELMINTHOL, V75, P299, DOI 10.1017/S0022149X01000464; Perteguer MJ, 2003, ACTA TROP, V89, P85, DOI 10.1016/S0001-706X(03)00201-8; Rubinsky-Elefant G, 2010, ANN TROP MED PARASIT, V104, P3, DOI 10.1179/136485910X12607012373957; SCHANTZ PM, 1979, AM J TROP MED HYG, V28, P24, DOI 10.4269/ajtmh.1979.28.24; SCHANTZ PM, 1980, AM J PUBLIC HEALTH, V70, P1269, DOI 10.2105/AJPH.70.12.1269; SCHANTZ PM, 1994, J AM VET MED ASSOC, V204, P1023; Smith H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/j.pt.2009.01.006; Woodhall D, 2012, OPHTHALMOLOGY, V119, P1211, DOI 10.1016/j.ophtha.2011.12.013; Woodhall DM, 2014, J PEDIATR INFECT DIS, V3, P154, DOI 10.1093/jpids/pit066	30	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202904	10.1371/journal.pone.0202904	http://dx.doi.org/10.1371/journal.pone.0202904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161178	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900049
J	Leutgeb, R; Berger, S; Szecsenyi, J; Laux, G				Leutgeb, Ruediger; Berger, Sarah; Szecsenyi, Joachim; Laux, Gunter			Patients with somatoform disorders: More frequent attendance and higher utilization in primary Out-of-Hours care?	PLOS ONE			English	Article							FUNCTIONAL SOMATIC SYNDROMES; BODILY DISTRESS SYNDROME; LONG-TERM CONDITIONS; AFTER-HOURS CARE; EMERGENCY-DEPARTMENT; HEALTH-CARE; MENTAL-DISORDERS; GENERAL-PRACTICE; DEPRESSION; ATTENDERS	Background One significant health policy challenge in many European countries at present is developing strategies to deal with the increase in patient attendance at Out-of-Hours care (OOHC), whether this is at OOHC-Centres in primary care settings or hospital emergency departments (ED). FAs (FAs) presenting in OOHC are a known challenge and previous studies have shown that FAs present more often with psychological problems and psychiatric comorbidities rather than severe physical complaints. FAs may be also contributing to the rising workload in OOHC-Centres in primary care. The aim of this study was to determine attendance frequencies and health problem presentation patterns for patients with and without somatoform disorders (ICD-10 F45 diagnoses) in OOHC-Centres in primary care. Some of these somatoform disorders may have a psychiatric character. Moreover, we wanted to compare health care utilization patterns (pharmacotherapy and hospitalizations) between these patients groups. Methods Routine OOHC data from a large German statutory health insurance company in the federal state of Baden-Wuerttemberg were evaluated. 3,813,398 health insured persons were included in the data set from 2014. The data were initially made available for our study group in order to evaluate a comprehensive evaluation programme in German primary care, the "Hausarztzentrierte Versorgung" (HZV), loosely translated as "family doctor coordinated care". We used the ICD-10 codes F45.0-F45.9 in regular care to identify patients with somatoform disorders and compared their health care utilization patterns (attendance rates, diagnoses, prescriptions, hospitalization rates) in OOHC to patients without somatoform disorders. Attendance rates were calculated with multivariable regression models in order to adjust for age, gender, comorbidities and for participation in the HZV intervention. Results 350,528 patients (9.2%) of the 3,813,398 insured persons had an F45-diagnosis. In comparison with the whole study-sample, patients with an F45-diagnosis were on average seven years older (51.7 vs. 44.0 years; p<0,0001) and the percentage of women was significantly higher (70.1% vs 53.3%; p<0,0001). In OOHC, as opposed to normal office hours, the adjusted rate of patients with an F45-diagnosis was 60.6% higher (adjusted for age, gender and co-morbidity) than in the general study-sample. Accordingly, in OOHC, prescriptions for antidepressants, hypnotics, anxiolytics but also opioids were significantly higher than in the general study population i.e. those without F45- diagnoses. However, an F45 diagnosis was only made in 3.45% of all F45 patients seen in OOHC in 2014. Conclusions Patients with somatoform disorders were more FAs in both regular office hours and in OOHC in primary care settings. In OOHC, they are normally not identified as such because the somatoform illness is secondary to other acutely presenting symptoms such as pain. While it is acknowledged that it is difficult to make an exact diagnosis in this complex group of somatoform disorders in an OOHC setting, it is still important to develop continuing education programmes for medical staff working in OOHC, to support effective recognition and response to the specific needs of this complex patient group.	[Leutgeb, Ruediger; Berger, Sarah; Szecsenyi, Joachim; Laux, Gunter] Univ Hosp Heidelberg, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Leutgeb, R (corresponding author), Univ Hosp Heidelberg, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	ruediger.leutgeb@med.uni-heidelberg.de	Berger, Sarah/I-8073-2019; Laux, Gunter/AAL-9020-2021					Bair MJ, 2013, CLIN J PAIN, V29, P95, DOI 10.1097/AJP.0b013e3182652ee9; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; Budtz-Lilly A, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0393-8; Buja A, 2015, EUR J PUBLIC HEALTH, V25, P563, DOI 10.1093/eurpub/cku235; Creed F., 2011, MED UNEXPLAINED SYMP; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; De Waal MWM, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-5; de Waal MWM, 2006, NED TIJDSCHR GENEES, V150, P671; den Boer-Wolters D, 2010, FAM PRACT, V27, P129, DOI 10.1093/fampra/cmp103; Dickens C, 2012, J PSYCHOSOM RES, V73, P334, DOI 10.1016/j.jpsychores.2012.08.018; Fink P, 2010, J PSYCHOSOM RES, V68, P415, DOI 10.1016/j.jpsychores.2010.02.004; Flarup L, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-156; Grol R, 2006, HEALTH AFFAIR, V25, P1733, DOI 10.1377/hlthaff.25.6.1733; Hauser W, 2013, SCHMERZ, V27, P380, DOI 10.1007/s00482-013-1340-z; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Henningsen P, 2018, PSYCHOTHER PSYCHOSOM, V87, P12, DOI 10.1159/000484413; Hyphantis T, 2015, J AFFECT DISORDERS, V176, P155, DOI 10.1016/j.jad.2015.01.062; ICD, 1993, MAN INT CLASS DIS IN; Jacob R, 2016, CLIN MED, V16, P325, DOI 10.7861/clinmedicine.16-4-325; Jelinek GA, 2008, MED J AUSTRALIA, V189, P552, DOI 10.5694/j.1326-5377.2008.tb02177.x; Keizer E, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0376-9; Kroenke K, 2007, PSYCHOSOMATICS, V48, P277, DOI 10.1176/appi.psy.48.4.277; Kroenke K, 2014, PAIN MED, V15, P1892, DOI 10.1111/pme.12537; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; Lam TP, 2013, FAM PRACT, V30, P76, DOI 10.1093/fampra/cms037; Laux G, 2013, Z EVIDENZ FORTBILD Q, V107, P372, DOI 10.1016/j.zefq.2013.07.001; Laux G, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-14; Leutgeb R, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0777-7; Leutgeb R, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0609-1; Leutgeb R, 2014, EUR J GEN PRACT, V20, P233, DOI 10.3109/13814788.2014.887069; Majeed A, 2012, ANN INTERN MED, V156, P67, DOI 10.7326/0003-4819-156-1-201201030-00019; Moore L, 2009, EMERG MED J, V26, P263, DOI 10.1136/emj.2008.059428; O'Malley AS, 2012, J GEN INTERN MED, V27, P1406, DOI 10.1007/s11606-012-2087-4; Patel S, 2015, FAM PRACT, V32, P624, DOI 10.1093/fampra/cmv076; Rask MT, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0478-z; Rask MT, 2017, PSYCHOSOM MED, V79, P345, DOI 10.1097/PSY.0000000000000405; Rosendal M, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0592-6; Schaefert R, 2012, DTSCH ARZTEBL INT, V109, P803, DOI 10.3238/arztebl.2012.0803; Schaefert R, 2010, J PSYCHOSOM RES, V69, P267, DOI 10.1016/j.jpsychores.2010.05.003; Smits FTM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-36; Starfield B, 2008, J EPIDEMIOL COMMUN H, V62, P580, DOI 10.1136/jech.2007.071027; Steinbrecher N, 2011, PSYCHOSOMATICS, V52, P263, DOI 10.1016/j.psym.2011.01.007; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Toft T, 2005, PSYCHOL MED, V35, P1175, DOI 10.1017/S0033291705004459; van Bokhoven MA, 2009, ANN FAM MED, V7, P112, DOI 10.1370/afm.958; van Uden CJT, 2006, FAM MED, V38, P565; Wensing M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2000-2; Williams ERL, 2001, J PSYCHOSOM RES, V50, P161, DOI 10.1016/S0022-3999(00)00228-2; Wooden MDG, 2009, EMERG MED AUSTRALAS, V21, P191, DOI 10.1111/j.1742-6723.2009.01181.x; World Health Organization, 1992, SCHED CLIN ASS NEUR; Yon K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014720	51	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202546	10.1371/journal.pone.0202546	http://dx.doi.org/10.1371/journal.pone.0202546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161150	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900033
J	Rothlind, E; Fors, U; Salminen, H; Wandell, P; Ekblad, S				Rothlind, Erica; Fors, Uno; Salminen, Helena; Wandell, Per; Ekblad, Solvig			Circling the undefined-A grounded theory study of intercultural consultations in Swedish primary care	PLOS ONE			English	Article							DOCTOR-PATIENT COMMUNICATION; CULTURAL COMPETENCE; HEALTH-CARE; MEDICAL CONSULTATIONS; FAMILY MEDICINE; INTERPRETERS; OUTCOMES; PERSPECTIVES; UNCERTAINTY; EXPERIENCES	Well-functioning physician-patient communication is central to primary care consultations. An increasing demand on primary care in many countries to manage a culturally diverse population has highlighted the need for improved communication skills in intercultural consultations. In previous studies, intercultural consultations in primary care have often been described as complex for various reasons, but studies exploring physician-patient interactions contributing to the understanding of why they are complex are lacking. Therefore, the aim of this study was to explore intercultural physician-patient communication in primary care consultations, generating a conceptual model of the interpersonal interactions as described by both the patients and the physicians. Using grounded theory methodology, 15 residents in family medicine and 30 foreign-born patients, the latter with Arabic and Somali as native languages, were interviewed. The analysis generated a conceptual model named circling the undefined, where a silent agreement on issues fundamental to the core of the consultation was inadequately presumed and the communicative behaviors used did not contribute to clarity. This could be a possible contributory cause of the perceived complexity of intercultural consultations. Identifying what takes place on an interpersonal level in intercultural consultations might be a first step towards building a common ground for increased mutual understanding, thereby bringing us one step closer to sharing, rather than circling the undefined.	[Rothlind, Erica; Ekblad, Solvig] Karolinska Inst, Dept Learning Informat Management & Eth, Culture Med, Stockholm, Sweden; [Fors, Uno] Stockholm Univ, Dept Comp & Syst Sci, Stockholm, Sweden; [Salminen, Helena; Wandell, Per] Karolinska Inst, Div Family Med & Primary Care, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Ekblad, Solvig] Stockholm Cty Council, Acad Primary Hlth Care Ctr, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Stockholm County Council	Rothlind, E (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth, Culture Med, Stockholm, Sweden.	Erica.Rothlind@ki.se		Wandell, Per/0000-0001-5169-2965; Rothlind, Erica/0000-0002-7302-0286	FORTE Swedish Research Council for Health, Working Life and Welfare [2014-0853]	FORTE Swedish Research Council for Health, Working Life and Welfare	This work was supported by FORTE Swedish Research Council for Health, Working Life and Welfare, 2014-0853, SE, https://forte.se/en/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alizadeh S, 2016, HEALTH SOC CARE COMM, V24, pE117, DOI 10.1111/hsc.12293; Anell Anders, 2012, Health Syst Transit, V14, P1; Anell A, 2015, NEW ENGL J MED, V372, P1, DOI 10.1056/NEJMp1411430; [Anonymous], 2016, SOU201655 SWED GOV; [Anonymous], 2017, HLTH CAR REP 2017; Balint E, 1969, J R Coll Gen Pract, V17, P269; Barbour R, 1999, DEV FOCUS GROUP RES; Beach MC, 2005, MED CARE, V43, P356, DOI 10.1097/01.mlr.0000156861.58905.96; Beck Rainer S, 2002, J Am Board Fam Pract, V15, P25; Bensing JM, 2011, PATIENT EDUC COUNS, V84, P287, DOI 10.1016/j.pec.2011.06.008; Bhise V, 2018, J GEN INTERN MED, V33, P103, DOI 10.1007/s11606-017-4164-1; Bramberg EB, 2013, QUAL HEALTH RES, V23, P241, DOI 10.1177/1049732312467705; Brisset C, 2013, PATIENT EDUC COUNS, V91, P131, DOI 10.1016/j.pec.2012.11.008; Brouwers M, 2017, MED EDUC, V51, P1103, DOI 10.1111/medu.13375; Burstrom B, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0524-z; Burt R.S., 2005, BROKERAGE CLOSURE IN; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; Carroll J, 2007, PATIENT EDUC COUNS, V66, P337, DOI 10.1016/j.pec.2007.01.008; Diaz E, 2018, INT J MED EDUC, V9, DOI 10.5116/ijme.5a7e.bd17; Dogra N., 2003, INT J MED MUSHROOMS, V5, P223; Dogra N, 2016, MED TEACH, V38, P323, DOI 10.3109/0142159X.2015.1105944; Dunn Ardys McNaughton, 2002, J Pediatr Health Care, V16, P105, DOI 10.1067/mph.2002.118245; Evans L, 2009, FAM MED, V41, P319; Foronda C, 2016, J TRANSCULT NURS, V27, P210, DOI 10.1177/1043659615592677; Fox RC., 2000, HDB SOCIAL STUDIES H, P409, DOI DOI 10.4135/9781848608412.N26; Glaser B.G, 1978, THEORETICAL SENSITIV; Haerpfer C., 2018, WORLD VALUES SURVEY, DOI [DOI 10.14281/18241.1, 10.14281/18241.1, 10.14281/18241.13]; HAMPTON JR, 1975, BRIT MED J, V2, P486, DOI 10.1136/bmj.2.5969.486; Horvat L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009405.pub2; Hsieh E, 2007, SOC SCI MED, V64, P924, DOI 10.1016/j.socscimed.2006.10.015; Ingvarsdotter K, 2012, INT J SOC PSYCHIATR, V58, P34, DOI 10.1177/0020764010382693; Jensen NK, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-17; Kai J, 2007, PLOS MED, V4, P1766, DOI 10.1371/journal.pmed.0040323; Karliner LS, 2007, HEALTH SERV RES, V42, P727, DOI 10.1111/j.1475-6773.2006.00629.x; Leanza Y, 2010, SOC SCI MED, V70, P1888, DOI 10.1016/j.socscimed.2010.02.036; Ledford CJW, 2015, FAM MED, V47, P549; Leininger M.M., 1978, TRANSCULTURAL NURSIN; Lewin SA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003267; Mazzi MA, 2016, PATIENT EDUC COUNS, V99, P51, DOI 10.1016/j.pec.2015.08.009; Mead N, 2002, PATIENT EDUC COUNS, V48, P51, DOI 10.1016/S0738-3991(02)00099-X; Muntinga ME, 2016, ADV HEALTH SCI EDUC, V21, P541, DOI 10.1007/s10459-015-9650-9; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; Neuliep J.W., 2018, INTERCULTURAL COMMUN; Official Report of the Swedish Government, 2014, MOR EQ CAR IS POSS A; Papic O, 2012, PATIENT EDUC COUNS, V86, P205, DOI 10.1016/j.pec.2011.05.015; Park ER, 2005, ACAD MED, V80, P874, DOI 10.1097/00001888-200509000-00019; Paternotte E, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0727-9; Paternotte E, 2017, INT J MED EDUC, V8, P170, DOI 10.5116/ijme.591b.19f9; Paternotte E, 2016, PERSPECT MED EDUC, V5, P268, DOI 10.1007/s40037-016-0288-y; Paternotte E, 2015, PATIENT EDUC COUNS, V98, P420, DOI 10.1016/j.pec.2014.11.018; Pieper Hans-Olaf, 2011, Educ Health (Abingdon), V24, P494; Priebe S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-187; Rocque R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139577; Rosenberg E, 2006, PATIENT EDUC COUNS, V61, P236, DOI 10.1016/j.pec.2005.04.002; Rosenberg E, 2007, PATIENT EDUC COUNS, V67, P286, DOI 10.1016/j.pec.2007.03.011; Saha S, 2008, J NATL MED ASSOC, V100, P1275, DOI 10.1016/S0027-9684(15)31505-4; Schouten BC, 2006, PATIENT EDUC COUNS, V64, P21, DOI 10.1016/j.pec.2005.11.014; Schwartz SJ, 2010, AM PSYCHOL, V65, P237, DOI 10.1037/a0019330; Sears KP, 2012, MED EDUC, V46, P545, DOI 10.1111/j.1365-2923.2011.04199.x; Stone L, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0192-7; Strauss, 1967, DISCOVERY GROUNDED T; Tervalon M, 1998, J HEALTH CARE POOR U, V9, P117; The National Board of Health and Welfare, 2015, STAT HLTH CAR PERS O; The National Board of Health and Welfare, 2016, HEALTHC DENT AS NEWL; The Primary Health Care Choice Reform, 2008, PRIM HLTH CAR CHOIC; Van Wieringen JCM, 2002, EUR J PUBLIC HEALTH, V12, P63, DOI 10.1093/eurpub/12.1.63; Wachtler C, 2006, FAM PRACT, V23, P111, DOI 10.1093/fampra/cmi086; Watt K, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0560-6; Weissman JS, 2005, JAMA-J AM MED ASSOC, V294, P1058, DOI 10.1001/jama.294.9.1058; Zendedel R, 2018, PATIENT EDUC COUNS, V101, P1058, DOI 10.1016/j.pec.2018.01.012	70	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203383	10.1371/journal.pone.0203383	http://dx.doi.org/10.1371/journal.pone.0203383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161227	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900117
J	van Rijsbergen, M; van Rietbergen, B; Barthelemy, V; Eltes, P; Lazary, A; Lacroix, D; Noailly, J; Tho, MCHB; Wilson, W; Ito, K				van Rijsbergen, Marc; van Rietbergen, Bert; Barthelemy, Veronique; Eltes, Peter; Lazary, Aron; Lacroix, Damien; Noailly, Jerome; Tho, Marie-Christine Ho Ba; Wilson, Wouter; Ito, Keita			Comparison of patient-specific computational models vs. clinical follow-up, for adjacent segment disc degeneration and bone remodelling after spinal fusion	PLOS ONE			English	Article							FINITE-ELEMENT MODEL; INTERVERTEBRAL DISC; ENGINEERED CARTILAGE; MATRIX COMPOSITION; NUCLEUS PULPOSUS; LUMBAR; DISEASE; STRAIN; BIOSYNTHESIS; RACEMIZATION	Spinal fusion is a standard surgical treatment for patients suffering from low back pain attributed to disc degeneration. However, results are somewhat variable and unpredictable. With fusion the kinematic behaviour of the spine is altered. Fusion and/or stabilizing implants carrying considerable load and prevent rotation of the fused segments. Associated with these changes, a risk for accelerated disc degeneration at the adjacent levels to fusion has been demonstrated. However, there is yet no method to predict the effect of fusion surgery on the adjacent tissue levels, i.e. bone and disc. The aim of this study was to develop a coupled and patient-specific mechanoregulated model to predict disc generation and changes in bone density after spinal fusion and to validate the results relative to patient follow-up data. To do so, a multiscale disc mechanoregulation adaptation framework was developed and coupled with a previously developed bone remodelling algorithm. This made it possible to determine extra cellular matrix changes in the intervertebral disc and bone density changes simultaneously based on changes in loading due to fusion surgery. It was shown that for 10 cases the predicted change in bone density and degeneration grade conforms reasonable well to clinical follow-up data. This approach helps us to understand the effect of surgical intervention on the adjacent tissue remodelling. Thereby, providing the first insight for a spine surgeon as to which patient could potentially be treated successfully by spinal fusion and in which patient has a high risk for adjacent tissue changes.	[van Rijsbergen, Marc; van Rietbergen, Bert; Barthelemy, Veronique; Wilson, Wouter; Ito, Keita] Eindhoven Univ Technol, Dept Biomed Engn, Orthopaed Biomech, Eindhoven, Netherlands; [Eltes, Peter; Lazary, Aron] Buda Hlth Ctr, Natl Ctr Spinal Disorders, Budapest, Hungary; [Lacroix, Damien] Univ Sheffield, INSIGNEO Inst In Silico Med, Dept Mech Engn, Sheffield, S Yorkshire, England; [Noailly, Jerome] Univ Pompeu Fabra, Dept Informat & Commun Technol, BCN MedTech, Barcelona, Spain; [Tho, Marie-Christine Ho Ba] Univ Technol Compiegne, Compiegne, France	Eindhoven University of Technology; University of Sheffield; Pompeu Fabra University; Picardie Universites; Universite de Technologie de Compiegne	van Rietbergen, B (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Orthopaed Biomech, Eindhoven, Netherlands.	b.v.rietbergen@tue.nl	Noailly, Jerome/A-2988-2011; Lacroix, Damien/G-3230-2010; THO, Marie-Christine HO BA/J-1946-2012	Noailly, Jerome/0000-0003-3446-7621; Lacroix, Damien/0000-0002-5482-6006; THO, Marie-Christine HO BA/0000-0003-1192-0075; Eltes, Peter Endre/0000-0002-4377-8635; van Rietbergen, Bert/0000-0002-2278-2934; Lazary, Aron/0000-0002-0157-719X	European Union [FP7-ICT-2009-6, 269909]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7-ICT-2009-6) under grant agreement no 269909, http://cordis.europa.eu/project/rcn/97394_en.html.	ADAMS MA, 1990, J BONE JOINT SURG BR, V72, P266, DOI 10.1302/0301-620X.72B2.2138156; Adams MA, 2006, J BONE MINER RES, V21, P1409, DOI 10.1359/JBMR.060609; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; AOTA Y, 1995, J SPINAL DISORD, V8, P464, DOI 10.1097/00002517-199512000-00008; Barthelemy VMP, 2016, J MECH BEHAV BIOMED, V54, P194, DOI 10.1016/j.jmbbm.2015.09.028; Carreon LY, 2009, SPINE, V34, P725, DOI 10.1097/BRS.0b013e318198cae4; Castro-Mateos I., 2015, RECENT ADV COMPUTATI, P241, DOI [DOI 10.1007/978-3-319-14148-0_22, 10.1007/978-3-319-14148-0_22]; Castro-Mateos I, 2014, PHYS MED BIOL, V59, P7847, DOI 10.1088/0031-9155/59/24/7847; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Colloca M, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026227; Dimicco MA, 2003, TRANSPORT POROUS MED, V50, P57, DOI 10.1023/A:1020677829069; Etebar S, 1999, J NEUROSURG, V90, P163, DOI 10.3171/spi.1999.90.2.0163; Han KS, 2013, MED ENG PHYS, V35, P969, DOI 10.1016/j.medengphy.2012.09.009; HARRIGAN TP, 1988, J BIOMECH, V21, P269, DOI 10.1016/0021-9290(88)90257-6; Harrop JS, 2008, SPINE, V33, P1701, DOI 10.1097/BRS.0b013e31817bb956; Homminga J, 2012, MED ENG PHYS, V34, P453, DOI 10.1016/j.medengphy.2011.08.003; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3; Huiskes R, 1997, J MATER SCI-MATER M, V8, P785, DOI 10.1023/A:1018520914512; HUISKES R, 1989, ORTHOPEDICS, V12, P1255; Isaksson H, 2008, J THEOR BIOL, V252, P230, DOI 10.1016/j.jtbi.2008.01.030; Isaksson H, 2007, J BIOMECH, V40, P2002, DOI 10.1016/j.jbiomech.2006.09.028; Johannessen W, 2005, SPINE, V30, pE724, DOI 10.1097/01.brs.0000192236.92867.15; Kumar MN, 2001, EUR SPINE J, V10, P314, DOI 10.1007/s005860000239; LEE CK, 1988, SPINE, V13, P375, DOI 10.1097/00007632-198803000-00029; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Malandrino A, 2015, FRONT BIOENG BIOTECH, V3, P1, DOI [10.3389/fbioe.2015.00001, DOI 10.3389/FBIOE.2015.00001]; Malandrino A, 2009, J BIOMECH, V42, P2780, DOI 10.1016/j.jbiomech.2009.07.039; McMillan DW, 1996, ANN RHEUM DIS, V55, P880, DOI 10.1136/ard.55.12.880; Narmoneva DA, 1999, J BIOMECH, V32, P401, DOI 10.1016/S0021-9290(98)00184-5; Noailly J, 2009, THESIS; Noailly J, 2007, J BIOMECH, V40, P2414, DOI 10.1016/j.jbiomech.2006.11.021; Noailly J, 2012, EUR SPINE J, V21, pS675, DOI 10.1007/s00586-011-1716-7; PAAJANEN H, 1994, J ORTHOPAED RES, V12, P509, DOI 10.1002/jor.1100120407; Pisu M, 2006, TISSUE ENG, V12, P2311, DOI 10.1089/ten.2006.12.2311; Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6; Pye SR, 2006, ANN RHEUM DIS, V65, P234, DOI 10.1136/ard.2005.038224; Radcliff KE, 2013, SPINE J, V13, P1339, DOI 10.1016/j.spinee.2013.03.020; Rohlmann A, 2000, SPINE, V25, P2981, DOI 10.1097/00007632-200012010-00004; Ruberte LM, 2009, J BIOMECH, V42, P341, DOI 10.1016/j.jbiomech.2008.11.024; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; Ruimerman R, 2005, J BIOMECH, V38, P931, DOI 10.1016/j.jbiomech.2004.03.037; Schmidt H, 2006, CLIN BIOMECH, V21, P337, DOI 10.1016/j.clinbiomech.2005.12.001; Schmidt H, 2010, J BIOMECH, V43, P1849, DOI 10.1016/j.jbiomech.2010.03.035; Sengers BG, 2004, ANN BIOMED ENG, V32, P1718, DOI 10.1007/s10439-004-7824-3; Sivan SS, 2008, J BIOL CHEM, V283, P8796, DOI 10.1074/jbc.M709885200; Sivan SS, 2006, J BIOL CHEM, V281, P13009, DOI 10.1074/jbc.M600296200; van Oers RFM, 2008, BONE, V42, P250, DOI 10.1016/j.bone.2007.10.009; vanLenthe GH, 1997, J BONE JOINT SURG BR, V79B, P117, DOI 10.1302/0301-620X.79B1.6808; vanRijsbergen MM, 2016, BIOMECHANICS MODELIN; Wang Y, 2011, J BONE MINER RES, V26, P2785, DOI 10.1002/jbmr.476; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wilson CG, 2002, ARCH BIOCHEM BIOPHYS, V408, P246, DOI 10.1016/S0003-9861(02)00562-3	55	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0200899	10.1371/journal.pone.0200899	http://dx.doi.org/10.1371/journal.pone.0200899			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161138	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000443388900004
J	Boyce, CJ; Delaney, L; Wood, AM				Boyce, Christopher J.; Delaney, Liam; Wood, Alex M.			The Great Recession and subjective well-being: How did the life satisfaction of people living in the United Kingdom change following the financial crisis?	PLOS ONE			English	Article							EASTERLIN PARADOX; HEALTH BEHAVIORS; LOSS AVERSION; MISSING DATA; INCOME; UNEMPLOYMENT; HAPPINESS; UNDEREMPLOYMENT; PREDICTS; IMPACT	The financial crisis of 2007/08 precipitated a severe global economic downturn, typically referred to as the Great Recession. However, in the United Kingdom this period has been marked by limited change in national indicators of subjective well-being. We assessed the life satisfaction change in response to the Great Recession in a sample of British adults (N = 8,661). We first show that on average the life satisfaction change across the sample was limited. However, average effects may mask substantial amounts of heterogeneity in the data. We therefore explore beyond this average effect to determine whether there were disproportionate changes (losses and gains) in life satisfaction in key sub-groups of the population. We found that individuals experiencing unemployment, who lost income, were sick or disabled, experienced the greatest well-being reductions. Contrastingly the life satisfaction of many individuals did not greatly change following the Great Recession and for some it may have even improved. Our work highlights vulnerable groups that may need additional help during recession periods and also cautions against the over reliance on average measures of well-being.	[Boyce, Christopher J.; Delaney, Liam; Wood, Alex M.] Univ Stirling, Stirling Management Sch, Behav Sci Ctr, Stirling, Scotland; [Delaney, Liam] Univ Coll Dublin, UCD Geary Inst, Dublin, Ireland; [Wood, Alex M.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of Stirling; University College Dublin; University of Manchester	Boyce, CJ (corresponding author), Univ Stirling, Stirling Management Sch, Behav Sci Ctr, Stirling, Scotland.	christopher.boyce@stir.ac.uk	Wood, Alex M/A-2371-2011	Wood, Alex/0000-0002-8010-1455	Economic and Social Research Council [ES/K00588X/1]; ESRC [ES/K00588X/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Economic and Social Research Council provided research support (ES/K00588X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar M, 2013, AM ECON REV, V103, P1664, DOI 10.1257/aer.103.5.1664; Allison P.D., 2009, FIXED EFFECT REGRESS; Allison P. D, 1990, SOCIOL METHODOL, P93; Asgeirsdottir TL, 2014, ECON HUM BIOL, V13, P1, DOI 10.1016/j.ehb.2013.03.005; Barr B, 2015, SOC SCI MED, V147, P324, DOI 10.1016/j.socscimed.2015.11.009; Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Bauer MA, 2012, PSYCHOL SCI, V23, P517, DOI 10.1177/0956797611429579; Bayliss D, 2016, APPL RES QUAL LIFE, P1, DOI 10.1007/s11482-016-9447-x; Beck N, 2001, INT ORGAN, V55, P487, DOI 10.1162/00208180151140658; Binder M, 2011, J ECON BEHAV ORGAN, V79, P275, DOI 10.1016/j.jebo.2011.02.005; Blustein DL, 2013, J VOCAT BEHAV, V82, P256, DOI 10.1016/j.jvb.2013.02.005; Bowling A., 2003, QUAL LIFE RES, V12, P1147; Boyce CJ, 2016, PERS SOC PSYCHOL B, V42, P471, DOI 10.1177/0146167216634060; Boyce CJ, 2015, J APPL PSYCHOL, V100, P991, DOI 10.1037/a0038647; Boyce CJ, 2013, PSYCHOL SCI, V24, P2557, DOI 10.1177/0956797613496436; Boyce CJ, 2013, SOC INDIC RES, V111, P287, DOI 10.1007/s11205-012-0006-z; Boyce CJ, 2011, PSYCHOL SCI, V22, P1397, DOI 10.1177/0956797611421790; Boyce CJ, 2010, PSYCHOL SCI, V21, P471, DOI 10.1177/0956797610362671; Boyce CJ, 2010, J ECON PSYCHOL, V31, P1, DOI 10.1016/j.joep.2009.08.009; Budria S, 2013, J HAPPINESS STUD, V14, P1379, DOI 10.1007/s10902-012-9384-9; Burgard SA, 2015, ANNU REV SOCIOL, V41, P181, DOI 10.1146/annurev-soc-073014-112204; Carolan G, 2012, THE ECONOMY; Cheung F, 2015, PSYCHOL AGING, V30, P120, DOI 10.1037/a0038682; Clark A. E., 2005, ECON J, V115, P118; Clark AE, 2001, ECONOMICA, V68, P221, DOI 10.1111/1468-0335.00243; Clark AE., 2011, LABOUR MARKET WINTER, P128, DOI [10.1093/acprof:osobl/9780199587377.003.0010, DOI 10.1093/ACPROF:OSOBL/9780199587377.003.0010]; Clark A, 2010, LABOUR ECON, V17, P52, DOI 10.1016/j.labeco.2009.05.007; Clark AE, 2008, ECON J, V118, pF222, DOI 10.1111/j.1468-0297.2008.02150.x; Clark AE, 2008, J ECON LIT, V46, P95, DOI 10.1257/jel.46.1.95; Daly M, 2013, SOC SCI MED, V80, P19, DOI 10.1016/j.socscimed.2012.12.008; De Neve J-E, 2015, ID2586417 SOC SCI RE; De Witte H., 1999, EUR J WORK ORGAN PSY, V8, P155, DOI [DOI 10.1080/135943299398302, https://doi.org/10.1080/135943299398302]; Deaton A, 2012, OXFORD ECON PAP, V64, P1, DOI 10.1093/oep/gpr051; DIENER E, 1993, SOC INDIC RES, V28, P195, DOI 10.1007/BF01079018; Diener E, 2009, SOC INDIC RES SER, V37, P11, DOI 10.1007/978-90-481-2350-6_2; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; Dollard M.F., 2002, ADV MENTAL HLTH, V1, P170, DOI [10.5172/jamh.1.3.170, DOI 10.5172/JAMH.1.3.170]; EASTERLIN RA, 1995, J ECON BEHAV ORGAN, V27, P35, DOI 10.1016/0167-2681(95)00003-B; Easterlin RA, 2010, P NATL ACAD SCI USA, V107, P22463, DOI 10.1073/pnas.1015962107; Frey BS, 2002, J ECON LIT, V40, P402, DOI 10.1257/002205102320161320; Gallie D, 2017, IND RELAT J, V48, P174, DOI 10.1111/irj.12174; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Goldberg D, 1991, USERS GUIDE GEN HLTH; Heyes J, 2017, WORK EMPLOY SOC, V31, P71, DOI 10.1177/0950017016666199; Hoynes H, 2012, J ECON PERSPECT, V26, P27, DOI 10.1257/jep.26.3.27; Hurd M. D., 2010, EFFECTS FINANCIAL CR; Kamerade D, 2017, HUM RELAT; Katikireddi SV, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001790; Layard R., 2013, IZA DISCUSSION PAPER; Lucas RE, 1996, J PERS SOC PSYCHOL, V71, P616, DOI 10.1037/0022-3514.71.3.616; Lynn P, 2012, INITIAL LOOK NONRESP, P45; Newgard CD, 2007, ACAD EMERG MED, V14, P669, DOI 10.1197/j.aem.2006.11.038; ODonnell G., 2014, WELLBEING POLICY REP; Office for National Statistics, 2015, NAT WELL BEING MEAS, P5; Oswald AJ, 2010, SCIENCE, V327, P576, DOI 10.1126/science.1180606; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; StatCorp, 2011, STAT STAT SOFTW REL; Stevenson B, 2008, BROOKINGS PAP ECO AC, P1; Stiglitz J., 2009, 200933 OFCE; Stuckler D, 2010, NATURE, V465, P289, DOI 10.1038/465289a; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Weil S. W., 2017, UNEMPLOYED YOUTH SOC; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Xu X, 2013, SOC SCI MED, V77, P126, DOI 10.1016/j.socscimed.2012.11.016	66	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201215	10.1371/journal.pone.0201215	http://dx.doi.org/10.1371/journal.pone.0201215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157180	gold, Green Published, Green Accepted			2022-12-27	WOS:000443071400006
J	Fishbein, AR; Loschner, J; Mallon, JM; Wilkinson, GS				Fishbein, Adam R.; Loeschner, Julia; Mallon, Julie M.; Wilkinson, Gerald S.			Dynamic sex-specific responses to synthetic songs in a duetting suboscine passerine	PLOS ONE			English	Article							ANTBIRD MYRMECIZA-EXSUL; TEMPORAL COORDINATION; BEHAVIOR; MECHANISMS; EVOLUTION; PLAYBACK; BIRDS; DUETS; PATTERNS; DEFENSE	Many bird species produce temporally coordinated duets and choruses, requiring the rapid integration of auditory perception and motor production. While males and females of some species are known to participate in these displays for sex-specific purposes, few studies have identified perceptual features that trigger sex-specific contributions of coordinated song. Especially little is known about perception and production in duetting suboscine passerines, which are thought to have innate songs and largely static, rather than dynamic, vocal behavior. Here, we used synthetic stimuli in a playback experiment on chestnut-backed antbirds (Myrmeciza exsul) to (1) test whether differences in song frequency (Hz) can trigger sex-specific vocal behavior in a suboscine passerine (2) test for the functions of duetting in males and females of this species, and (3) determine whether these suboscines can dynamically adjust the temporal and spectral features of their songs. We found sex-specific responses to synthetic playback manipulated in song frequency (Hz), providing evidence that in this context males sing in duets for general territory defense and females join in for mate guarding purposes. In addition, we found that the birds altered the frequency, duration, and timing of their songs depending on the frequency of the playback songs. Thus, we show that these birds integrate spectral and temporal information about conspecific songs and actively modulate their responses in sex-specific ways.	[Fishbein, Adam R.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Fishbein, Adam R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Loeschner, Julia] Univ Tubingen, Inst Neurobiol, Anim Physiol, Tubingen, Germany; [Mallon, Julie M.; Wilkinson, Gerald S.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Eberhard Karls University of Tubingen; University System of Maryland; University of Maryland College Park	Fishbein, AR (corresponding author), Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA.; Fishbein, AR (corresponding author), Univ Maryland, Dept Psychol, College Pk, MD 20742 USA.	afishbei@terpmail.umd.edu	Mallon, Julie/ABB-7728-2020; Wilkinson, Gerald S./E-4424-2011	Mallon, Julie/0000-0003-3311-3792; Wilkinson, Gerald S./0000-0001-7799-8444; Loschner, Julia/0000-0002-0078-2423; Fishbein, Adam/0000-0001-5918-9256	University of Maryland Graduate School; Institute for Neurobiology at the University of Tubingen; NIDCD [T32 DC000046]; National Science Foundation [1449815]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000046] Funding Source: NIH RePORTER	University of Maryland Graduate School; Institute for Neurobiology at the University of Tubingen; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the University of Maryland Graduate School and the Institute for Neurobiology at the University of Tubingen. A.F is supported by funding from NIDCD T32 DC000046 and the National Science Foundation under Grant No.1449815. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador A, 2008, J NEUROPHYSIOL, V99, P2383, DOI 10.1152/jn.01002.2007; Araya-Ajoy YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008137; Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Dabelsteen T, 1997, ANIM BEHAV, V53, P249, DOI 10.1006/anbe.1996.0369; Dahlin CR, 2014, ETHOLOGY, V120, P1, DOI 10.1111/eth.12182; Diniz P, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01637; Elemans CPH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002581; Elie JE, 2010, ANIM BEHAV, V80, P597, DOI 10.1016/j.anbehav.2010.06.003; Farabaugh S.M., 1982, ACOUSTIC COMMUNICATI, V2, DOI DOI 10.2307/25063377); Fitzsimmons LP, 2008, ANIM BEHAV, V75, P1913, DOI 10.1016/j.anbehav.2007.11.006; Fortune ES, 2011, SCIENCE, V334, P666, DOI 10.1126/science.1209867; Francis CD, 2011, P ROY SOC B-BIOL SCI, V278, P2025, DOI 10.1098/rspb.2010.1847; Hall ML, 2007, CURR BIOL, V17, pR406, DOI 10.1016/j.cub.2007.04.022; Hall ML, 2009, ADV STUD BEHAV, V40, P67, DOI 10.1016/S0065-3454(09)40003-2; Hall ML, 2004, BEHAV ECOL SOCIOBIOL, V55, P415, DOI 10.1007/s00265-003-0741-x; Hall ML, 2000, ANIM BEHAV, V60, P667, DOI 10.1006/anbe.2000.1517; Koloff J, 2013, ETHOLOGY, V119, P462, DOI 10.1111/eth.12084; Koloff J, 2013, J ORNITHOL, V154, P51, DOI 10.1007/s10336-012-0867-6; Koloff J, 2011, ANIM BEHAV, V82, P587, DOI 10.1016/j.anbehav.2011.06.021; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; Logue DM, 2008, ANIM BEHAV, V75, P1803, DOI 10.1016/j.anbehav.2007.10.036; Logue DM, 2007, ANIM BEHAV, V73, P105, DOI 10.1016/j.anbehav.2006.05.011; Logue DM, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00007; Logue DM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0103; LOPEZ PT, 1988, ANIM BEHAV, V36, P1295, DOI 10.1016/S0003-3472(88)80198-2; MacDougall-Shackleton SA, 1999, TRENDS NEUROSCI, V22, P432, DOI 10.1016/S0166-2236(99)01434-4; Maynard DF, 2012, ANIM BEHAV, V84, P563, DOI 10.1016/j.anbehav.2012.06.008; Mennill DJ, 2008, CURR BIOL, V18, P1314, DOI 10.1016/j.cub.2008.07.073; Mennill DJ, 2005, AUK, V122, P175, DOI 10.1642/0004-8038(2005)122[0175:SDISAD]2.0.CO;2; Naguib M, 2010, ANIM BEHAV, V80, pE11, DOI 10.1016/j.anbehav.2010.06.001; Odom KJ, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00014; Odom KJ, 2017, BEHAV ECOL, V28, P1256, DOI 10.1093/beheco/arx087; Odom KJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4379; Raposo Marcos A., 2003, Lundiana, V4, P35; Rios-Chelen AA, 2012, J EVOLUTION BIOL, V25, P2171, DOI 10.1111/j.1420-9101.2012.02597.x; Robinson W. D., 2001, Animal Biodiversity and Conservation, V24, P51; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; Seddon N, 2006, BEHAV ECOL, V17, P73, DOI 10.1093/beheco/ari096; Seddon N, 2005, EVOLUTION, V59, P200; Seddon N, 2008, AM NAT, V171, P620, DOI 10.1086/587071; SIBLEY CG, 1988, AUK, V105, P409, DOI 10.1093/auk/105.3.409; Stanley CQ, 2016, ANIM BEHAV, V112, P255, DOI 10.1016/j.anbehav.2015.12.003; Stutchbury BJM, 2005, ORNITOL NEOTROP, V16, P397; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; Tobias JA, 2011, J EVOLUTION BIOL, V24, P2118, DOI 10.1111/j.1420-9101.2011.02345.x; Tobias JA, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00074; Tobias JA, 2009, CURR BIOL, V19, P577, DOI 10.1016/j.cub.2009.02.036; Topp SM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1107, DOI 10.1007/s00265-007-0538-4; Vehrencamp SL, 2007, BEHAV ECOL, V18, P849, DOI 10.1093/beheco/arm054; WILLIS EO, 1978, ANNU REV ECOL SYST, V9, P243, DOI 10.1146/annurev.es.09.110178.001331; Wilson DR, 2014, BIOACOUSTICS, V23, P99, DOI 10.1080/09524622.2013.827588; Wolfe JD, 2009, WILSON J ORNITHOL, V121, P556, DOI 10.1676/08-111.1; Woltmann S., 2010, THESIS; Woltmann S, 2011, WILSON J ORNITHOL, V123, P15, DOI 10.1676/10-017.1	56	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202353	10.1371/journal.pone.0202353	http://dx.doi.org/10.1371/journal.pone.0202353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157227	gold, Green Published, Green Submitted			2022-12-27	WOS:000443071400056
J	Ryan, K; Wawrzyn, K; Gati, JS; Chronik, BA; Wong, D; Duggal, N; Bartha, R				Ryan, Kayla; Wawrzyn, Krzysztof; Gati, Joseph S.; Chronik, Blaine A.; Wong, Dickson; Duggal, Neil; Bartha, Robert			H-1 MR spectroscopy of the motor cortex immediately following transcranial direct current stimulation at 7 Tesla	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; IN-VIVO; N-ACETYLASPARTATE; RELAXATION-TIMES; HUMAN BRAIN; SHORT-ECHO; AREA SMA; PRE-SMA; TDCS; CREATINE	Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation that may modulate cortical excitability, metabolite concentration, and human behaviour. The supplementary motor area (SMA) has been largely ignored as a potential target for tDCS neurorehabilitation but is an important region in motor compensation after brain injury with strong efferent connections to the primary motor cortex (M1). The objective of this work was to measure tissue metabolite changes in the human motor cortex immediately following tDCS. We hypothesized that bihemispheric tDCS would change levels of metabolites involved in neuromodulation including N-acetylaspartate (NAA), glutamate (Glu), and creatine (tCr). In this single-blind, randomized, cross-over study, fifteen healthy adults aged 21 +/- 60 participated in two 7T MRI sessions, to identify changes in metabolite concentrations by magnetic resonance spectroscopy. Immediately after 20 minutes of tDCS, there were no significant changes in metabolite levels or metabolite ratios comparing tDCS to sham. However there was a trend toward increased NAA/tCr concentration (p = 0.08) in M1 under the stimulating cathode. There was a strong, positive correlation between the change in the absolute concentration of NAA and the change in the absolute concentration of tCr (p<0.001) suggesting an effect of tDCS. Both NAA and creatine are important markers of neurometabolism. Our findings provide novel insight into the modulation of neural metabolites in the motor cortex immediately following application of bihemispheric tDCS.	[Ryan, Kayla; Wong, Dickson; Duggal, Neil; Bartha, Robert] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Ryan, Kayla; Gati, Joseph S.; Wong, Dickson; Duggal, Neil; Bartha, Robert] Univ Western Ontario, Robarts Res Inst, Ctr Funct & Metab Mapping, London, ON, Canada; [Wawrzyn, Krzysztof; Chronik, Blaine A.] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada; [Duggal, Neil] Univ Hosp, London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario)	Bartha, R (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.; Bartha, R (corresponding author), Univ Western Ontario, Robarts Res Inst, Ctr Funct & Metab Mapping, London, ON, Canada.	rbartha@robarts.ca	Bartha, Robert/K-3611-2013; Wong, Dickson/H-4538-2017	Bartha, Robert/0000-0002-7118-9096; Wong, Dickson/0000-0002-4584-7251	Canadian Institute of Health Research [231560]; Brain Canada; Canada First Research Excellence Fund; Schulich School of Medicine and Dentistry, Western University	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Brain Canada; Canada First Research Excellence Fund; Schulich School of Medicine and Dentistry, Western University	Funding was provided by the Canadian Institute of Health Research (231560), Brain Canada, the Canada First Research Excellence Fund, and the Schulich School of Medicine and Dentistry, Western University. ND and RB received all funding. Funding sources had no involvement in the design, data collection, analysis, decision to publish or preparation of the manuscript.	Almeida LS, 2006, SYNAPSE, V60, P118, DOI 10.1002/syn.20280; Andreychenko A, 2013, NMR BIOMED, V26, P1596, DOI 10.1002/nbm.2997; Bachtiar V, 2015, ELIFE, V4, DOI 10.7554/eLife.08789; Bartha R, 1999, NMR BIOMED, V12, P205, DOI 10.1002/(SICI)1099-1492(199906)12:4<205::AID-NBM558>3.0.CO;2-1; Bartha R, 2000, MAGN RESON MED, V44, P641, DOI 10.1002/1522-2594(200010)44:4<641::AID-MRM19>3.0.CO;2-G; Baslow MH, 2007, J MOL NEUROSCI, V32, P235, DOI 10.1007/s12031-007-0049-9; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Beard E, 2010, J NEUROCHEM, V115, P297, DOI 10.1111/j.1471-4159.2010.06935.x; Carey LM, 2005, STROKE, V36, P625, DOI 10.1161/01.STR.0000155720.47711.83; Castellano G, BRAZ J MED BIOL RES, P1031; Clark VP, 2011, NEUROSCI LETT, V500, P67, DOI 10.1016/j.neulet.2011.05.244; DEDEYN PP, 1990, ANN NEUROL, V28, P627, DOI 10.1002/ana.410280505; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; Royes LF, 2008, NEUROCHEM INT, V53, P33, DOI 10.1016/j.neuint.2008.04.008; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Hone-Blanchet A, 2016, BIOL PSYCHIAT, V80, P432, DOI 10.1016/j.biopsych.2015.11.008; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Hupfeld KE, 2017, EXP BRAIN RES, V235, P851, DOI 10.1007/s00221-016-4848-5; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kim S, 2014, NEUROIMAGE, V99, P237, DOI 10.1016/j.neuroimage.2014.05.070; Kreis R, 2005, MAGN RESON MED, V54, P761, DOI 10.1002/mrm.20673; Landim RCG, 2016, MAGN RESON IMAGING, V34, P239, DOI 10.1016/j.mri.2015.10.038; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; Marjanska M, 2012, NMR BIOMED, V25, P332, DOI 10.1002/nbm.1754; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Oz G, 2011, MAGN RESON MED, V65, P901, DOI 10.1002/mrm.22708; Patel T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00039; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Rae CD, 2013, INT J NEUROPSYCHOPH, V16, P1695, DOI 10.1017/S1461145713000084; Rango M, 2008, MAGN RESON MED, V60, P782, DOI 10.1002/mrm.21709; Rango M, 1997, MAGNET RESON MED, V38, P878, DOI 10.1002/mrm.1910380605; Rupsingh R, 2011, NEUROBIOL AGING, V32, P802, DOI 10.1016/j.neurobiolaging.2009.05.002; Ryan K, 2018, J NEUROSURG-SPINE, V28, P379, DOI 10.3171/2017.7.SPINE1768; Schar M, 2004, MAGN RESON MED, V51, P1091, DOI 10.1002/mrm.20123; Stagg CJ, 2011, NEUROPSYCHOLOGIA, V49, P800, DOI 10.1016/j.neuropsychologia.2011.02.009; Stagg CJ, 2009, EUR J NEUROSCI, V30, P1412, DOI 10.1111/j.1460-9568.2009.06937.x; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Stagg Charlotte J, 2011, ROLE GABA HUMAN MOTO, P480; Tremblay S, 2016, RESTOR NEUROL NEUROS, V34, P587, DOI 10.3233/RNN-150569; Vollmann H, 2013, BRAIN STIMUL, V6, P101, DOI 10.1016/j.brs.2012.03.018; Waters S, 2017, J NEUROSCI, V37, P7500, DOI 10.1523/JNEUROSCI.3414-16.2017; Waters-Metenier S, 2014, J NEUROSCI, V34, P1037, DOI 10.1523/JNEUROSCI.2282-13.2014; Wong WW, 2013, BRAIN INJURY, V27, P651, DOI 10.3109/02699052.2013.771796; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xin LJ, 2013, MAGN RESON MED, V69, P931, DOI 10.1002/mrm.24352; Yan HD, 2003, EPILEPSIA, V44, P1153, DOI 10.1046/j.1528-1157.2003.49402.x; Yoon KJ, 2012, BRAIN RES, V1452, P61, DOI 10.1016/j.brainres.2012.02.062	54	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0198053	10.1371/journal.pone.0198053	http://dx.doi.org/10.1371/journal.pone.0198053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157179	Green Submitted, gold, Green Published			2022-12-27	WOS:000443071400001
J	Stiermaier, T; Lange, T; Chiribiri, A; Moller, C; Graf, T; Raaz, U; Villa, A; Kowallick, JT; Lotz, J; Hasenfuss, G; Thiele, H; Schuster, A; Eitel, I				Stiermaier, Thomas; Lange, Torben; Chiribiri, Amedeo; Moeller, Christian; Graf, Tobias; Raaz, Uwe; Villa, Adriana; Kowallick, Johannes T.; Lotz, Joachim; Hasenfuss, Gerd; Thiele, Holger; Schuster, Andreas; Eitel, Ingo			Right ventricular strain assessment by cardiovascular magnetic resonance myocardial feature tracking allows optimized risk stratification in Takotsubo syndrome	PLOS ONE			English	Article							APICAL BALLOONING SYNDROME; STRESS-INDUCED CARDIOMYOPATHY; TAKO-TSUBO; INVOLVEMENT; PREVALENCE; PREDICTORS	Background A substantial number of patients with Takotsubo syndrome (TTS) exhibit right ventricular (RV) dysfunction which has been associated with adverse outcome. The aim of this study was to assess the clinical and prognostic value of RV myocardial strain in TTS using cardiovascular magnetic resonance myocardial feature tracking (CMR-FT). Methods CMR-FT was performed in a core laboratory to determine RV longitudinal strain in 134 TTS patients undergoing CMR in median 2 days after admission to 2 experienced centers. For comparison, RV involvement was evaluated by sole visual assessment concerning RV contraction abnormalities. Both approaches were analyzed regarding their long-term prognostic value. Results The peak global RV longitudinal strain was in median -19%. Segmental analyses located contraction abnormalities primarily in the apical parts of the right ventricle. Sole visual assessment identified 38 patients (28%) with RV involvement. These patients showed a numerically higher long-term mortality without reaching statistical significance (17.1% versus 10.5%; hazard ratio 1.38 [95% confidence interval 0.49-3.88]; p = 0.31). The optimal RV strain cutoff value for risk prediction was -17.24%. Stratification according to this threshold categorized 41% of TTS patients (n = 55) in the high-risk group which demonstrated a significantly increased long-term mortality compared to patients with preserved global RV strain (20.0% versus 7.0%; hazard ratio 2.98 [95% confidence interval 1.02-8.73]; p = 0.03). Conclusions The assessment of RV myocardial strain using CMR-FT enables an accurate evaluation of RV involvement in TTS and represents a promising approach for optimized risk stratification.	[Stiermaier, Thomas; Moeller, Christian; Graf, Tobias; Eitel, Ingo] Univ Hosp Schleswig Holstein, Med Clin 2, Cardiol Angiol Intens Care Med, Univ Heart Ctr Lubeck, Lubeck, Germany; [Stiermaier, Thomas; Moeller, Christian; Graf, Tobias; Eitel, Ingo] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Lubeck, Germany; [Lange, Torben; Raaz, Uwe; Hasenfuss, Gerd; Schuster, Andreas] Georg August Univ, Dept Cardiol & Pneumol, Univ Med Ctr Gottingen, Gottingen, Germany; [Lange, Torben; Raaz, Uwe; Kowallick, Johannes T.; Lotz, Joachim; Hasenfuss, Gerd; Schuster, Andreas] German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, Gottingen, Germany; [Chiribiri, Amedeo; Villa, Adriana] Kings Coll London, Div Imaging Sci & Biomed Engn, London, England; [Kowallick, Johannes T.; Lotz, Joachim] Georg August Univ, Univ Med Ctr Gottingen, Inst Diagnost & Intervent Radiol, Gottingen, Germany; [Thiele, Holger] Heart Ctr Leipzig Univ Hosp, Dept Internal Med Cardiol, Leipzig, Germany; [Schuster, Andreas] Univ Sydney, Kolling Inst, Northern Clin Sch, Royal North Shore Hosp,Dept Cardiol, Sydney, NSW, Australia	University of Kiel; Schleswig Holstein University Hospital; German Centre for Cardiovascular Research; University of Gottingen; German Centre for Cardiovascular Research; University of London; King's College London; University of Gottingen; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Eitel, I (corresponding author), Univ Hosp Schleswig Holstein, Med Clin 2, Cardiol Angiol Intens Care Med, Univ Heart Ctr Lubeck, Lubeck, Germany.; Eitel, I (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Lubeck, Germany.	ingo.eitel@uksh.de	Lotz, Joachim/G-3376-2015; Thiele, Holger/ABE-6792-2020; Chiribiri, Amedeo/T-2771-2019	Lotz, Joachim/0000-0002-1412-2741; Thiele, Holger/0000-0002-0169-998X; Chiribiri, Amedeo/0000-0003-3394-4289; Villa, Adriana/0000-0002-9355-0372; Lange, Torben/0000-0003-0505-2582	German Center for Cardiovascular Research (DZHK)	German Center for Cardiovascular Research (DZHK)	The study was supported by a Research grant from the German Center for Cardiovascular Research (DZHK).	Becher T, 2016, INT J CARDIOL, V220, P371, DOI 10.1016/j.ijcard.2016.06.240; Citro R, 2016, INT J CARDIOL, V219, P455, DOI 10.1016/j.ijcard.2016.06.039; De Gennaro L, 2017, J THROMB THROMBOLYS, V44, P234, DOI 10.1007/s11239-017-1510-4; Eitel I, 2014, INT J CARDIOL, V177, P25, DOI 10.1016/j.ijcard.2014.09.043; Eitel I, 2008, EUR HEART J, V29, P2651, DOI 10.1093/eurheartj/ehn433; Eitel I, 2011, INT J CARDIOL, V151, pE63, DOI 10.1016/j.ijcard.2010.05.017; Eitel I, 2011, JAMA-J AM MED ASSOC, V306, P277, DOI 10.1001/jama.2011.992; Elesber AA, 2006, J AM COLL CARDIOL, V47, P1082, DOI 10.1016/j.jacc.2005.12.004; Finocchiaro G, 2015, J CARD FAIL, V21, P419, DOI 10.1016/j.cardfail.2015.02.001; Fitzgibbons TP, 2009, AM J CARDIOL, V104, P133, DOI 10.1016/j.amjcard.2009.02.049; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Haghi D, 2006, EUR HEART J, V27, P2433, DOI 10.1093/eurheartj/ehl274; Heggemann F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103717; Hor KN, 2010, JACC-CARDIOVASC IMAG, V3, P144, DOI 10.1016/j.jcmg.2009.11.006; Kagiyama N, 2016, EUR HEART J-CARD IMG, V17, P210, DOI 10.1093/ehjci/jev145; Kempny A, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-32; Kwon SW, 2013, INT J CARDIOL, V168, P331, DOI 10.1016/j.ijcard.2012.09.050; Liu K, 2013, AM J CARDIOL, V111, P1232, DOI 10.1016/j.amjcard.2012.12.007; Lyon AR, 2016, EUR J HEART FAIL, V18, P8, DOI 10.1002/ejhf.424; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Santoro F, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006990; Santoro F, 2014, INT J CARDIOL, V177, pE99, DOI 10.1016/j.ijcard.2014.09.088; Schuster A, 2015, CLIN RADIOL, V70, P989, DOI 10.1016/j.crad.2015.05.006; Schuster A, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004077; Schuster A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122858; Schuster A, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-58; Shao Y, 2015, INT J CARDIOL, V197, P349, DOI 10.1016/j.ijcard.2015.06.025; Stahli BE, 2011, EUR HEART J, V32, P1821, DOI 10.1093/eurheartj/ehr079; Stiermaier T, 2016, EUR HEART J-ACUTE CA, V5, P489, DOI 10.1177/2048872615612456; Stiermaier T, 2016, EUR J HEART FAIL, V18, P650, DOI 10.1002/ejhf.494; Stiermaier T, 2015, J AM COLL CARDIOL, V65, P2148, DOI 10.1016/j.jacc.2015.02.062; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761	32	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202146	10.1371/journal.pone.0202146	http://dx.doi.org/10.1371/journal.pone.0202146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157266	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400039
J	Zhang, WW; Liu, T; Cheng, K; Rummy, P				Zhang, Weiwei; Liu, Tao; Cheng, Kun; Rummy, Paul			Declining water depth delayed the breeding time of Fulica atra, not human disturbance	PLOS ONE			English	Article							POPULATION CONSEQUENCES; BIRDS; HABITAT; WETLAND; VEGETATION; PARASITISM; TERRITORY; RESPONSES; SELECTION; BEHAVIOR	Disturbances by tourists have been considered to delay the breeding time of coots. In this study, we investigated the common coot (Fulica atra) from April to June in 2008, 2009 and 2012 around the Anbanghe Nature Reserve and Daqing Longfeng wetland of Heilongjiang Province. We evaluated the correlations of four habitat factors (water depth under coots' nests, distance of nests to banks, distance of nests to human disturbance and nest coverage) to discuss the impacts of those factors on the breeding time of the coots. The water depth under the nest was significantly correlated with the coots' breeding stages in the Anbanghe wetland. In addition, we investigated the breeding dates of 56 pairs of coots and found the dates were significantly negatively correlated with the water levels under the nest for both of the wetlands. However, the breeding time (breeding stages and dates) of coots was not significantly related to the distance of the nest to disturbance, distance to the bank of the lake or the nest coverage. The LME models and GAMs that related breeding time to water level received the greatest support. For the GAM, in the group with a clear breeding date, water level was the most influential variable; in the group for which only breeding stages could be recognized, nest coverage combined with water level had a lower AICc value than water depth itself. In conclusion, we found no clear evidence to indicate that disturbances from tourism delayed the breeding time of the coots; however, the water level had a clear influence on the breeding time. We inferred that reproduction was delayed in order to wait for the improvement of habitat conditions (such as food resource and concealment). Neither water level nor disturbance impacted the reproductive output of the coots as these variables showed no clear relationships with the clutch size.	[Zhang, Weiwei; Liu, Tao] Jiangxi Agr Univ, Ctr Wildlife Resources Conservat Res, Nanchang, Jiangxi, Peoples R China; [Zhang, Weiwei; Cheng, Kun] Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Heilongjiang, Peoples R China; [Rummy, Paul] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China	Jiangxi Agricultural University; Northeast Forestry University - China; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Cheng, K (corresponding author), Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Heilongjiang, Peoples R China.	chengkcn@163.com		Rummy, Paul/0000-0002-8552-9848	National Natural Science Fund of China [31360521]; Science and technology project of Jiangxi Province [20132BAB214013, 2013BBG7004]; Doctoral Scientific Fund Project of Ministry of Education of China [20123603120003]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Science and technology project of Jiangxi Province; Doctoral Scientific Fund Project of Ministry of Education of China	Our research was supported by the National Natural Science Fund of China (No. 31360521), Science and technology project of Jiangxi Province (20132BAB214013, 2013BBG7004) and Doctoral Scientific Fund Project of Ministry of Education of China (20123603120003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; ANDERSON MG, 1978, ECOLOGY, V59, P154, DOI 10.2307/1936642; Arnold TW, 1991, THESIS; [柏祥 BAI Xiang], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P1086; Bancroft GT, 2002, WATERBIRDS, V25, P265, DOI 10.1675/1524-4695(2002)025[0265:DOWBRT]2.0.CO;2; Baschuk MS, 2012, WATERBIRDS, V35, P44, DOI 10.1675/063.035.0105; BRINKHOF MWG, 1993, J ANIM ECOL, V62, P577, DOI 10.2307/5206; Brisbin I. L., 2002, BIRDS N AM; BURGER J, 1995, ENVIRON CONSERV, V22, P56, DOI 10.1017/S0376892900034081; BURGER J, 1991, ENVIRON CONSERV, V18, P158, DOI 10.1017/S0376892900021743; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; CAVE AJ, 1989, ARDEA, V77, P87; Cheng K., 2008, THESIS; Conigliaro M, 2011, REND LINCEI-SCI FIS, V22, P47, DOI 10.1007/s12210-010-0113-1; De Zan LR, 2010, POL J ECOL, V58, P599; Farago S, 2012, HYDROBIOLOGIA, V697, P15, DOI 10.1007/s10750-012-1166-1; Fernandez-Juricic E, 2001, BIODIVERS CONSERV, V10, P2023, DOI 10.1023/A:1013133308987; Fortunati L, 2011, ETHOL ECOL EVOL, V23, P165, DOI 10.1080/03949370.2010.534323; Francl KE, 2002, ENVIRON MONIT ASSESS, V73, P67, DOI 10.1023/A:1012615314061; Frid A, 2002, CONSERV ECOL, V6; Gill JA, 1996, J APPL ECOL, V33, P786, DOI 10.2307/2404948; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Gill JA, 2007, IBIS, V149, P9, DOI 10.1111/j.1474-919X.2007.00642.x; GOODRICH JM, 1994, BIOL CONSERV, V67, P105, DOI 10.1016/0006-3207(94)90354-9; Guan X., 2009, THESIS; Gul O, 2013, EKOLOJI, V22, P29, DOI 10.5053/ekoloji.2013.894; HOCKIN D, 1992, J ENVIRON MANAGE, V36, P253, DOI 10.1016/S0301-4797(08)80002-3; Huxley J. S., 1934, British Birds, V27, P270; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jobin B, 2009, WATERBIRDS, V32, P73, DOI 10.1675/063.032.0108; KNIGHT RL, 1995, WILDLIFE RECREATIONI, P1; Li CL, 1994, WILDLIFE, V1, P15; Liley D, 2007, IBIS, V149, P82, DOI 10.1111/j.1474-919X.2007.00664.x; McNair DB, 2006, WILSON J ORNITHOL, V118, P208, DOI 10.1676/05-020.1; Moskat C, 2000, ECOGRAPHY, V23, P335, DOI 10.1034/j.1600-0587.2000.d01-1642.x; Murison G, 2007, IBIS, V149, P16, DOI 10.1111/j.1474-919X.2007.00660.x; Murkin HR, 2000, PRAIRIE WETLAND ECOLOGY, P249; Murkin HR, 1997, ECOL APPL, V7, P1144; Rek P, 2010, J ORNITHOL, V151, P163, DOI 10.1007/s10336-009-0440-0; Robel R.J., 1961, J WILDL MANAGE, V25, P436, DOI [10.2307/3798837, DOI 10.2307/3798837]; Sauvajot Raymond M., 1999, Urban Ecosystems, V2, P279, DOI 10.1023/A:1009588723665; Seabloom EW, 1998, PLANT ECOL, V138, P203, DOI 10.1023/A:1009711919757; Soderstrom B, 2001, BIODIVERS CONSERV, V10, P1839, DOI 10.1023/A:1013153427422; Uzun A, 2010, EKOLOJI, V19, P160, DOI 10.5053/ekoloji.2010.7419; van der Valk AG, 2000, PRAIRIE WETLAND ECOLOGY, P125; Wang JS, 1990, J ZOOL, V25, P24; Wang Y., 2005, J ANHUI U SCI TECHNO, V25, P27; Wen CY, 2009, J HEBEI AGR SCI, V13, P46; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Xing LL, 1989, J INNERMONGOLIA U, V20, P521; Zacchei D., 2011, Lakes & Reservoirs Research and Management, V16, P281, DOI 10.1111/j.1440-1770.2011.00487.x; Zhang W., 2010, THESIS; Zhang Wei-Wei, 2011, Chinese Journal of Zoology, V46, P19; Zhang Wei-wei, 2011, Shengtaixue Zazhi, V30, P1686; Zhang Wei-wei, 2011, Journal of Forestry Research (Harbin), V22, P289, DOI 10.1007/s11676-011-0164-x; Zhao F, 2005, J NE NORM U, V39, P100	57	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202684	10.1371/journal.pone.0202684	http://dx.doi.org/10.1371/journal.pone.0202684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157235	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400068
J	Chen, GY; Wang, QY; Yang, QW; Li, ZY; Du, ZW; Ren, M; Zhao, HY; Song, Y; Zhang, GZ				Chen, Gaoyang; Wang, Qingyu; Yang, Qiwei; Li, Zhaoyan; Du, Zhenwu; Ren, Ming; Zhao, Haiyue; Song, Yang; Zhang, Guizhen			Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma	PLOS ONE			English	Article							MOLECULAR PATHOGENESIS; CANCER; GENES; CELLS; DIFFERENTIATION; PROLIFERATION; CARCINOMA; INVASION; PLAYS	Background Osteosarcoma (OS) is a primary malignant bone tumor with a high fatality rate. Many circRNAs have been proved to play important roles in the pathogenesis of some diseases. However, the occurrence of circRNAs in OS remains little known. Methods The circular RNA (circRNA) expression file GSE96964 dataset, which included seven osteosarcoma cell lines and one control sample (osteoblast cell line), was downloaded from the Gene Expression Omnibus (GEO) database to explore the potential function of circRNAs in osteosarcoma by competing endogenous RNA (ceRNA) analysis. Three gene expression profiles of OS were downloaded from GEO database and then used for the pathway enrichment analysis, Venn analysis and protein-protein interaction (PPI) network analysis. Realtime qPCR validation and RNA interference were conducted to verify our prediction. Results Differentially expressed circRNAs between OS and control, including 8 up-regulated and 102 down-regulated circRNAs, were generated and ceRNA analysis for 5 most up-regulated or 5 most down-regulated circRNAs in OS were then performed. The pathway enrichment analysis of gene expression profiles indicated differentially expressed genes (DEGs) of three gene profiles significantly enriched in cell cycle pathway, cell adhesion molecules (CAMs) pathway, oxidative phosphorylation pathway, cytokine-cytokine receptor interaction pathway, p53 signaling pathway and proteoglycans in cancer pathway, which were critical important pathways in the pathogenesis of OS. The Venn analysis showed that 2 (one is a pseudogene) up-regulated and 39 down-regulated DEGs were co-expressed in all three gene profiles. Then PPI networks of 41 co-expressed DEGs (up- and down-regulated DEGs) were constructed to predict their functions using the GeneMANIA. The expression levels of these related RNAs also matched our predictions really well. Conclusion Ultimately, we found cell adhesion molecule 1 (CADM1) gene was not only a co-expression mRNA of the three mRNA expression profiles of OS, but also are predicted to be regulated by hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 by functioning as miRNAs `Sponge' in human osteosarcoma. These over-expressed circRNAs may result in the over expression of CADM1 which promote the development of OS. We envision this discovery of these important moleculars, incuding hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 and CADM1 may lead to further development of new concepts, thus allowing for more opportunities in diagnosis and therapy of OS.	[Chen, Gaoyang; Wang, Qingyu; Li, Zhaoyan; Du, Zhenwu; Ren, Ming; Song, Yang; Zhang, Guizhen] Jilin Univ, Hosp 2, Dept Orthoped, Changchun, Jilin, Peoples R China; [Chen, Gaoyang; Wang, Qingyu; Yang, Qiwei; Du, Zhenwu; Zhao, Haiyue; Zhang, Guizhen] Jilin Univ, Hosp 2, Res Ctr, Changchun, Jilin, Peoples R China; [Chen, Gaoyang; Wang, Qingyu; Yang, Qiwei; Li, Zhaoyan; Du, Zhenwu; Ren, Ming; Zhao, Haiyue; Song, Yang; Zhang, Guizhen] Engn Res Ctr Mol Diag & Cell Treatment Metab Bone, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Song, Y; Zhang, GZ (corresponding author), Jilin Univ, Hosp 2, Dept Orthoped, Changchun, Jilin, Peoples R China.; Zhang, GZ (corresponding author), Jilin Univ, Hosp 2, Res Ctr, Changchun, Jilin, Peoples R China.; Song, Y; Zhang, GZ (corresponding author), Engn Res Ctr Mol Diag & Cell Treatment Metab Bone, Changchun, Jilin, Peoples R China.	songyangjlu@foxmail.com; zhangguizhenjlu@163.com		Yang, Qiwei/0000-0003-0681-2184; Wang, Qingyu/0000-0002-6298-5357	National Natural Science Foundation of China [81702195]; project of application demonstration center of precision medicine for molecular diagnosis in Jilin Province (NDRC); Department of Science and Technology of Jilin Province, China [20180520125JH]; Education Department of Jilin Province, China [JJKH20170853KJ]; Bethune Youth Foundation of Jilin University, China [2015409]; Health Management Department of Jilin Province, China [20132003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of application demonstration center of precision medicine for molecular diagnosis in Jilin Province (NDRC); Department of Science and Technology of Jilin Province, China; Education Department of Jilin Province, China; Bethune Youth Foundation of Jilin University, China; Health Management Department of Jilin Province, China	This work was supported by the Project supported by the National Natural Science Foundation of China (Grant No. 81702195), the project of application demonstration center of precision medicine for molecular diagnosis in Jilin Province (2016-2018, NDRC), the Department of Science and Technology of Jilin Province, China (Grant No. 20180520125JH), the Project of Education Department of Jilin Province, China (Grant No. JJKH20170853KJ), the Project of Bethune Youth Foundation of Jilin University, China (Grant No. 2015409), the Project of Health Management Department of Jilin Province, China (Grant No. 20132003).	Abarrategi A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3631764; Bai XP, 2018, J CELL BIOCHEM, V119, P2179, DOI 10.1002/jcb.26379; Barrett SP, 2016, DEVELOPMENT, V143, P1838, DOI 10.1242/dev.128074; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen L, 2017, ONCOGENE, V36, P4551, DOI 10.1038/onc.2017.89; Chen P, 2012, J MOL HISTOL, V43, P63, DOI 10.1007/s10735-011-9370-2; Chiappetta C, 2017, ONCOTARGET, V8, P80416, DOI 10.18632/oncotarget.19010; CLEZARDIN P, 1993, CANCER RES, V53, P4695; Dang HS, 2017, ONCOL RES, V25, P177, DOI 10.3727/096504016X14732772150343; Coelho KMDA, 2017, PATHOL RES PRACT, V213, P1067, DOI 10.1016/j.prp.2017.07.028; Deng NA, 2018, BIOCHEM BIOPH RES CO, V495, P189, DOI 10.1016/j.bbrc.2017.11.028; Deng ZM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/496193; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhondge A, 2012, ENVIRON SCI POLLUT R, V19, P4030, DOI 10.1007/s11356-012-0879-z; Duijvis NW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185097; Evola FR, 2017, FRONT PHARMACOL, V8, P1, DOI [10.3389/fphar.2017.00001, DOI 10.3389/FPHAR.2017.00001]; Guan J, 2016, EXP THER MED, V12, P2815, DOI 10.3892/etm.2016.3713; He JP, 2014, ASIAN PAC J CANCER P, V15, P5967, DOI 10.7314/APJCP.2014.15.15.5967; Helvering LM, 2005, MOL PHARMACOL, V68, P1225, DOI 10.1124/mol.105.011478; Howe JR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177661; Inoue T, 2013, LIFE SCI, V92, P91, DOI 10.1016/j.lfs.2012.10.021; Islam F, 2018, EXP MOL PATHOL, V104, P98, DOI 10.1016/j.yexmp.2018.01.006; Ito A, 2012, ISLETS, V4, DOI 10.4161/isl.18675; Ito T, 2011, GENES CELLS, V16, P791, DOI 10.1111/j.1365-2443.2011.01525.x; Jin X, 2016, ONCOTARGET, V7, P66455, DOI 10.18632/oncotarget.12186; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lin YH, 2017, TRENDS MOL MED, V23, P737, DOI 10.1016/j.molmed.2017.06.004; Lindsey BA, 2017, RHEUMATOL THER, V4, P25, DOI 10.1007/s40744-016-0050-2; Liu PT, 2017, ONCOL LETT, V14, P4779, DOI 10.3892/ol.2017.6747; Liu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep22572; Liu WH, 2017, CELL PHYSIOL BIOCHEM, V43, P969, DOI 10.1159/000481650; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14088-3; Meng G, 2015, TUMOR BIOL, V36, P3009, DOI 10.1007/s13277-014-2935-4; Nikitovic D, 2008, CONNECT TISSUE RES, V49, P235, DOI 10.1080/03008200802147589; Pahl JHW, 2013, CANCER IMMUNOL IMMUN, V62, P1235, DOI 10.1007/s00262-013-1406-x; Palmini G, 2017, MOLECULES, V22, DOI 10.3390/molecules22030417; Palorini R, 2014, J CELL BIOCHEM, V115, P368, DOI 10.1002/jcb.24671; Patop IL, 2018, CURR OPIN GENET DEV, V48, P121, DOI 10.1016/j.gde.2017.11.007; Perbal B, 2008, CLIN CANCER RES, V14, P701, DOI 10.1158/1078-0432.CCR-07-0806; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Selamat W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129634; Song YZ, 2018, BIOCHEM BIOPH RES CO, V495, P2369, DOI 10.1016/j.bbrc.2017.12.050; Sun CH, 2017, ONCOTARGET, V8, P70271, DOI 10.18632/oncotarget.20082; Tang YY, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705745; Yang JX, 2016, ONCOL LETT, V12, P3075, DOI 10.3892/ol.2016.5060; Zhang W, 2016, HEPATOB PANCREAT DIS, V15, P289, DOI 10.1016/S1499-3872(16)60099-1; Zhang ZH, 2017, ENVIRONMENTAL DATA ANALYSIS: METHODS AND APPLICATIONS, P1, DOI 10.1515/9783110424904-002; Zhao MD, 2014, INT J MOL MED, V34, P1565, DOI 10.3892/ijmm.2014.1963; Zhu KP, 2017, ONCOTARGET, V8, P71881, DOI 10.18632/oncotarget.17985	51	33	34	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202896	10.1371/journal.pone.0202896	http://dx.doi.org/10.1371/journal.pone.0202896			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153287	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700030
J	Dadds, MR; Collins, DAJ; Doyle, FL; Tully, LA; Hawes, DJ; Lenroot, RK; Anderson, V; Frick, PJ; Moul, C; Kimonis, ER				Dadds, Mark R.; Collins, Daniel A. J.; Doyle, Frances L.; Tully, Lucy A.; Hawes, David J.; Lenroot, Rhoshel K.; Anderson, Vicki; Frick, Paul J.; Moul, Caroline; Kimonis, Eva R.			A benchmarking study of father involvement in Australian child mental health services	PLOS ONE			English	Article							ENGAGING FATHERS; PARENTING INTERVENTIONS; PROGRAMS; SUPPORT; MOTHERS	Fathers are underrepresented in interventions focussing on child well-being, yet research suggests their involvement may be critical to enhancing intervention effectiveness. This study aimed to provide the first Australian benchmark of rates of father attendance across several child mental health services. Retrospective casefile reviews were conducted to obtain data on father and mother attendance at 10 Australian child mental health services. A total of 2128 casefile records were retrospectively examined to extract family-level data. The main outcome measures were rates of father and mother attendance at sessions involving parents, and rates of father- and mother-instigated referral to services. Across services, fathers attended on average 48.2% (range 39.7% to 72.0%) of total parent sessions, with an average of 68.4% (range 53.1% to 88.1%) of fathers attending at least one session. Mothers attended sessions at significantly higher rates; an average of 92.8% of total parent sessions and 96.9% attendance for at least one session. For self-referred families, on average 12.6% of referrals were from fathers, and 87.4% were from mothers. These results indicate that rates of father attendance at Australian child mental health services vary, but are significantly lower than attendance rates for mothers. This may compromise the quality and outcomes of child mental health services in Australia. Routine monitoring of rates of father attendance is needed, as are strategies to enhance father engagement.	[Dadds, Mark R.; Collins, Daniel A. J.; Doyle, Frances L.; Tully, Lucy A.; Hawes, David J.; Moul, Caroline] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Lenroot, Rhoshel K.] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Frick, Paul J.] Australian Catholic Univ, Learning Sci Inst Australia, Brisbane, Qld, Australia; [Frick, Paul J.] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; [Kimonis, Eva R.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Australian Catholic University; Louisiana State University System; Louisiana State University; University of New South Wales Sydney	Tully, LA (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW, Australia.	lucy.tully@sydney.edu.au	Doyle, Frances L./AAJ-6222-2020; Hawes, David/AAE-6800-2021; Doyle, Frances L/C-8160-2013	Doyle, Frances L./0000-0001-6621-5280; Doyle, Frances L/0000-0001-6621-5280; Collins, Daniel/0000-0003-2195-9037; Dadds, Mark/0000-0002-2900-1715; Frick, Paul/0000-0001-7335-1299; Hawes, David/0000-0003-3260-1225	Movember Foundation Australian Mental Health Initiative	Movember Foundation Australian Mental Health Initiative	This study is an outcome of the Like Father Like Son project, which is funded by a grant received by MD from the Movember Foundation Australian Mental Health Initiative (https://au.movember.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagner DM, 2003, J CLIN CHILD ADOLESC, V32, P599, DOI 10.1207/S15374424JCCP3204_13; Frank TJ, 2015, J CHILD FAM STUD, V24, P937, DOI 10.1007/s10826-014-9904-9; Freeman E, 2011, FATHERING, V9, P291, DOI DOI 10.3149/FTH.0903.291; Glynn L, 2015, AOTEAROA N Z SOC WOR, V27, P59; Gordon DM, 2012, CHILD YOUTH SERV REV, V34, P1399, DOI 10.1016/j.childyouth.2012.03.021; Lundahl BW, 2008, RES SOCIAL WORK PRAC, V18, P97, DOI 10.1177/1049731507309828; Maxwell N, 2012, CHILD FAM SOC WORK, V17, P160, DOI 10.1111/j.1365-2206.2012.00827.x; McBride BA, 2005, FAM RELAT, V54, P360, DOI 10.1111/j.1741-3729.2005.00323.x; Panter-Brick C, 2014, J CHILD PSYCHOL PSYC, V55, P1187, DOI 10.1111/jcpp.12280; Piotrowska PJ, 2017, CLIN CHILD FAM PSYCH, V20, P146, DOI 10.1007/s10567-016-0219-9; Scourfield J, 2014, CHILD YOUTH SERV REV, V43, P40, DOI 10.1016/j.childyouth.2014.04.009; Sicouri G, 2018, AUST NZ J FAM THER, V39, P218, DOI 10.1002/anzf.1307; Tiano JD, 2005, CHILD FAM BEHAV THER, V27, P1, DOI 10.1300/J019v27n04_01; Tully LA, 2018, CHILD PSYCHIAT HUM D, V49, P109, DOI 10.1007/s10578-017-0733-0; Tully LA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4426-1; Wells MB, 2016, SCAND J PUBLIC HEALT, V44, P274, DOI 10.1177/1403494815618841; Zanoni L, 2013, CHILD YOUTH SERV REV, V35, P1055, DOI 10.1016/j.childyouth.2013.04.018	17	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203113	10.1371/journal.pone.0203113	http://dx.doi.org/10.1371/journal.pone.0203113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153291	Green Published, gold			2022-12-27	WOS:000443001700043
J	Ma, DH; Cheng, KW; Ding, P; Li, HY; Wang, P				Ma, Donghua; Cheng, Kangwen; Ding, Ping; Li, Hongyan; Wang, Ping			Self-management of peripherally inserted central catheters after patient discharge via the WeChat smartphone application: A systematic review and meta-analysis	PLOS ONE			English	Review							FOLLOW-UP	WeChat is a smartphone application that may help patients self-manage peripherally inserted central catheters (PICC), although additional data are needed regarding this topic. This systematic review and meta-analysis aimed to determine whether WeChat helped improve PICC-related complications, self-care ability, PICC maintenance dependency in that the behavior of a patient is in compliance with a doctor's order or a will, knowledge mastery, and satisfaction among patients with a PICC. The PubMed, Embase, Cochrane Library, China Biology Medicine, China national Knowledge Infrastructure, Wanfang, Wiper, and Baidu Scholar databases were searched to identify related reports that were published up to April 2018. This search revealed 36 reports that were published during 2014 +/- 2018, including 2,623 controls and 2,662 patients who used the WeChat application. Relative to the traditional follow-up group, the group that received WeChat follow-up had a lower risk of PICC-related complications (odds ratio [OR]: 0.23, 95% confidence interval [CI]: 0.19 +/- 0.27, P < 0.00001), better self-care ability (mean difference: 36.41, 95% CI: 34.68 +/- 38.14, P < 0.00001), higher PICC maintenance dependency (OR: 4.27, 95% CI: 3.35 +/- 5.44, P < 0.00001), and higher patient satisfaction (OR: 6.20, 95% CI: 4.32 +/- 8.90, P < 0.00001). Eight studies reported knowledge mastery, although the different evaluation tools precluded a meta-analysis. Nevertheless, those eight studies revealed that knowledge mastery was significantly higher in the WeChat group than in the traditional follow-up group (P < 0.05). To the best of our knowledge, this is the first meta-analysis to evaluate the effects of WeChat follow-up on self-management among patients who are discharged with a PICC. It appears that WeChat follow-up can help improve the incidence of complications, self-care ability, PICC maintenance dependence, and patient satisfaction. However, the WeChat application itself cannot improve patients' self-management ability. Further studies are needed to produce high-quality evidence to determine whether WeChat is an effective follow-up tool.	[Ma, Donghua] Peoples Hosp Tongling City, Dept Nursing, Tongling, Anhui, Peoples R China; [Cheng, Kangwen] Peoples Hosp Tongling City, Dept Gastrointestinal Surg, Tongling, Anhui, Peoples R China; [Ding, Ping; Wang, Ping] Anhui Med Univ, Affiliated Hosp 1, Dept Nursing, Hefei, Anhui, Peoples R China; [Li, Hongyan] Anhui Med Univ, Dept Urol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Cheng, KW (corresponding author), Peoples Hosp Tongling City, Dept Gastrointestinal Surg, Tongling, Anhui, Peoples R China.	chengkangwen0556@sina.com			Natural Science Foundation of Anhui Province [KJ2016A363]; Natural Science Fund of Anhui Education Department	Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Natural Science Fund of Anhui Education Department	This research is supported by the Natural Science Foundation of Anhui Province (No. KJ2016A363).; Thank you for the great support of the Natural Science Fund of Anhui Education Department. Thanks to Dr. Li Zhang and Dr. Meng Zhang for guidance to statistical methods in this study. Thanks to Editage for making professional modifications to the grammar, spelling, and language of the article.	Bertani Laura, 2016, Acta Biomed, V87, P23; Cao Lihua, 2017, CHINESE MED INNOVATI, V14, P89; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Deng Qin, 2016, CHINESE CONT MED, V23, P189; Fan Hongju, 2016, CLIN RATIONAL USE DR, V9, P139; Fan Zuyan, 2016, NURS RES, V30, P3283; Feng SY, 2017, EUR ARCH OTO-RHINO-L, V274, P1477, DOI 10.1007/s00405-016-4371-0; Fox S, 2007, ONLINE HLTH CARE REV; Gong Xiaolan, 2016, NURSING PRACTICE RES, V13, P146; He Jinye, 2016, PSYCHOLOGIST, V22, P175; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hu Lingli, 2017, TODAY NURSE, P138; Huang Caijuan, 2016, INT MED HLTH GUIDANC, V22, P434; Huang Xiuyan, 2016, NURS RES, V26, P347; Jin Xiaojing, 2017, J NURSING, V24, P64; Li Li, 2017, SW DEFENSE MED, V27, P625; Li XH, 2016, J NURS TRAIN, V31, P1287; Lin Liping, 2017, MED EQUIPMENT, V30, P189; Liu Chunli, 2011, CHIN J NURS ED, V8, P294; Lu Hua, 2015, J NURS EDUC, V30, P1268; Lyu KX, 2016, CHINESE MED J-PEKING, V129, P2816, DOI 10.4103/0366-6999.194635; Ma ZH, 2014, CHIN HLTH MANAG, V2, P238; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meng Caiying, 2017, CHINA MED INNOVATION, V14, P68; Qian Yulan, 2014, NURS RES, P1602; Qu Huiqin, 2017, INTEGRATED CHINESE W, V3, P57; Qu Wen, 2012, PICCS CLIN APPL SAFE, P28; Ruan Shufang, 2017, J ANHUI HLTH VOCATIO, V16, P156; Rui Zhang, 2015, CHINESE J MED LIB IN, V24, P28; Shang Xiuyun, 2016, TODAY NURSE, V4, P67; Shao Min, 2017, B QIUEN MED J, V15, P124; Sun Caixia, 2016, NURSING PRACTICE RES, V13, P91; Tao Jingjing, 2016, CHINESE MED HERALD, V13, P170; Wang Hsiu-Hung, 2000, Kaohsiung Journal of Medical Sciences, V16, P459; Wang Li, 2016, CONT NURSES, V12, P71; Wang Songfeng, 2015, J NURS ADMIN, V15, P215; Wantland DJ, 2004, J MED INTERNET RES, V6, P67; Wei Chongyin, 2016, J FUJIAN MED J, V38, P169; Wei Wang, 2014, NURS RES, V28, P4302; [伍晓莹 Wu Xiaoying], 2016, [中国护理管理, Chinese Nursing Management], V16, P819; Xie Jinlian, 2018, CHINAS HLTH STANDARD, V09, P168; Xu Qiaoli, 2017, J QIQIHAR MED COLL, V38, P2852; Xu Xuefang, 2015, J NURSING, V22, P69; Ye Huirong, 2016, EXAMINATION CLIN MED, V13, P283; Zeng Li, 2015, MODERN CLIN MED, V41, P313; Zhang Fengqing, 2018, ELECT J CLIN NURSING, V3, P140; Zhang Li, 2016, NURSING PRACTICE RES, V13, P117; Zhang Lijie, 2016, CHINESE DIGITAL MED, V11, P20; Zhang Linmei, 2017, CHINESE PRACTICAL ME, V12, P188; Zhang Shuqi, 2015, NURS RES, V29, P2564; Zhao Huanxia, 2017, NURSING PRACTICE RES, V14, P121; Zhao Jie, 2015, CHINESE J MODERN NUR, V21, P1537; [赵林芳 Zhao Linfang], 2013, [中华护理杂志, Chinese Journal of Nursing], V48, P41; Zhao Qinglan, 2015, MODERN J INTEGRATED, V24, P1347; Zhao Yan, 2012, CURRENT SITUATION CO; Zheng Rongrong, 2017, MODERN CLIN MED, V43, P453; Zhu Fenglin, 2017, QILU J NURSING, V23, P63; [邾萍 Zhu Ping], 2015, [中国护理管理, Chinese Nursing Management], V15, P1509	58	15	16	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202326	10.1371/journal.pone.0202326	http://dx.doi.org/10.1371/journal.pone.0202326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153253	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700013
J	Sun, HL; Huang, JB; Liu, K; Wan, MJ; Zhou, Y; Cao, C; Jia, XL; He, L				Sun, Heli; Huang, Jianbin; Liu, Ke; Wan, Mengjie; Zhou, Yu; Cao, Chen; Jia, Xiaolin; He, Liang			Cost-minimizing team hires with participation constraint	PLOS ONE			English	Article							APPROXIMATION ALGORITHM; SET	Team formation, which aims to form a team to complete a given task by covering its required skills, furnishes a natural way to help organizers complete projects effectively. In this work, we propose a new team hiring problem. Given a set of projects P with required skills, and a pool of experts X, each of which has his own skillset, compensation demand and participation constraint (i.e., the maximum number of projects the expert can participate in simultaneously), we seek to hire a team of participation-constrained experts T subset of X to complete all the projects so that the overall compensation is minimized. We refer to this as the participation constrained team hire problem. To the best of our knowledge, this is the first work to investigate the problem. We also study a special case of the problem, where the number of projects is within the participation constraint of each expert and design an exact algorithm for it. Since participation constrained team hire problem is proven to be NP-hard, we design three novel efficient approximate algorithms as its solution, each of which focuses on a particular perspective of the problem. We perform extensive experimental studies, on both synthetic and real datasets, to evaluate the performance of our algorithms. Experimental results show that our exact algorithm far surpasses the brute-force solutions and works well in practice. Besides, the three algorithms behave differently when distinct facets of the problem are involved.	[Sun, Heli; Cao, Chen; Jia, Xiaolin; He, Liang] Xi An Jiao Tong Univ, Dept Comp Sci & Technol, Xian, Shaanxi, Peoples R China; [Huang, Jianbin; Liu, Ke; Wan, Mengjie; Zhou, Yu] Xidian Univ, Sch Software, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xidian University	Huang, JB (corresponding author), Xidian Univ, Sch Software, Xian, Shaanxi, Peoples R China.	jbhuang@xidian.edu.cn	Huang, Jianbin/AAU-6835-2020; Sun, Heli/AAL-7708-2021	, Heli/0000-0002-2765-6582				Agrawal R, 1994, P 20 VLDB C SANT CHI, V1215, P487; Alon N, 2009, SIAM J COMPUT, V39, P361, DOI 10.1137/060661946; An A., 2013, P SIAM INT C DAT MIN, P587, DOI DOI 10.1137/1.9781611972832.65; Anagnostopoulos A., 2012, P 21 INT C WORLD WID, P839, DOI DOI 10.1145/2187836.2187950; BARYEHUDA R, 1981, J ALGORITHM, V2, P198, DOI 10.1016/0196-6774(81)90020-1; Chekuri C, 2012, ACM T ALGORITHMS, V9, DOI 10.1145/2390176.2390185; Cheng-Te Li, 2010, Proceedings of the 2010 IEEE Second International Conference on Social Computing (SocialCom 2010). the Second IEEE International Conference on Privacy, Security, Risk and Trust (PASSAT 2010), P9, DOI 10.1109/SocialCom.2010.12; Chuzhoy J, 2006, SIAM J COMPUT, V36, P498, DOI 10.1137/S0097539703422479; Clarkson KL, 2007, DISCRETE COMPUT GEOM, V37, P43, DOI 10.1007/s00454-006-1273-8; Dorn C, 2010, LECT NOTES COMPUT SC, V6426, P472; DUMAIS ST, 1992, SIGIR 92 : PROCEEDINGS OF THE FIFTEENTH ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P233; Feige U, 1998, J ACM, V45, P634, DOI 10.1145/285055.285059; Feng KY, 2014, SIGMOD'14: PROCEEDINGS OF THE 2014 ACM SIGMOD INTERNATIONAL CONFERENCE ON MANAGEMENT OF DATA, P63, DOI 10.1145/2588555.2612173; Fitzpatrick EL, 2005, COMPUT IND ENG, V48, P593, DOI 10.1016/j.cie.2004.12.014; Gajewar A, 2011, COMPUTER SCI; Gionis A., 2010, P 19 ACM INT C INF K, P599, DOI DOI 10.1145/1871437.1871515; Golshan B, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1196, DOI 10.1145/2623330.2623690; Guo J, 2006, J DISCRET ALGORITHMS, V4, P608, DOI 10.1016/j.jda.2005.07.005; Hua QS, 2009, LECT NOTES COMPUT SC, V5878, P34; Huang JB, 2017, COMPUT J, V60, P1545, DOI 10.1093/comjnl/bxw088; Huang JB, 2017, COMPUT J, V60, P1382, DOI 10.1093/comjnl/bxx009; Huang JB, 2017, COMPUT J, V60, P1078, DOI 10.1093/comjnl/bxw059; Kargar M., 2011, 2011 IEEE International Conference on Data Mining Workshops, P1231, DOI 10.1109/ICDMW.2011.162; Kargar M., 2011, PROC 20 ACM INT C IN, P985, DOI DOI 10.1145/2063576.2063718; Karimzadehgan M, 2008, INT C INFORM KNOWLED, P1113, DOI DOI 10.1145/1458082.1458230; KLEIN P, 1995, J ALGORITHM, V19, P104, DOI 10.1006/jagm.1995.1029; Kou NM, 2015, SIGMOD'15: PROCEEDINGS OF THE 2015 ACM SIGMOD INTERNATIONAL CONFERENCE ON MANAGEMENT OF DATA, P2031, DOI 10.1145/2723372.2723727; Lappas T, 2009, P 15 ACM SIGKDD INT, P938; Li KQ, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1206, DOI 10.1145/2623330.2623724; Liu X., 2012, KDD 2012, P1032; LUND C, 1994, J ACM, V41, P960, DOI 10.1145/185675.306789; Majumder A., 2012, P ACM INT C KNOWL DI, P1005, DOI DOI 10.1145/2339530.2339690; Mimno D, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P500; Nuria RA, 2017, PLOS ONE, V12, P1; Rajagopalan S., 1993, Proceedings. 34th Annual Symposium on Foundations of Computer Science (Cat. No.93CH3368-8), P322, DOI 10.1109/SFCS.1993.366855; Varadarajan K, 2010, ACM S THEORY COMPUT, P641; Vazirani Vijay V., 2001, APPROXIMATION ALGORI; Zhou Y, 2017, INT J DATA WAREHOUS, V13, P25, DOI 10.4018/IJDWM.2017070102; Zhou Y, 2017, J COMPUT SCI TECH-CH, V32, P139, DOI 10.1007/s11390-017-1710-6; Zzkarian A, 2011, IIE T, V31, P85, DOI [10.1080/07408179908969808, DOI 10.1080/07408179908969808]	40	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0201596	10.1371/journal.pone.0201596	http://dx.doi.org/10.1371/journal.pone.0201596			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153254	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700003
J	Du, J; Guo, HB; Li, Q; Forsythe, A; Chen, XH; Yu, XD				Du, Jing; Guo, Hong-Bo; Li, Qi; Forsythe, Adrian; Chen, Xu-Hui; Yu, Xiao-Dan			Genetic diversity of Lepista nuda (Agaricales, Basidiomycota) in Northeast China as indicated by SRAP and ISSR markers	PLOS ONE			English	Article							MOLECULAR MARKER; MUSHROOM EXTRACTS; ANTIOXIDANT; SYSTEMS	Lepista nuda is a popular wild edible mushroom that grows in China. In this study, we used ISSR and SRAP molecular markers to analyze the genetic diversity of 72 samples of L. nuda from eight populations in Northeast China. In total, six ISSR primers and five pairs of SRAP primers that produced clear and polymorphic banding profiles were selected for assessing L. nuda genetic diversity. The results revealed a high level of genetic variation among the 72 samples (94.4% polymorphism) but a low degree of gene flow among the populations. Among L. nuda populations, genetic distance was not correlated significantly with geographic distance. The antioxidant activity of the samples from each population was also tested and the result showed that all the selected samples had more than 60% DPPH scavenging activities. Nonetheless, the antioxidant activity diversity is not coincident with both the genetic diversity and the geographic distribution. The results indicate that ISSR and SRAP molecular markers are useful for studying the genetic diversity of L. nuda. The results also suggest that L. nuda populations in Northeast China require protection.	[Du, Jing; Guo, Hong-Bo; Li, Qi; Chen, Xu-Hui; Yu, Xiao-Dan] Shenyang Agr Univ, Coll Biol Sci & Technol, Shenyang, Liaoning, Peoples R China; [Guo, Hong-Bo] Shenyang Inst Technol, Coll Life Engn, Fushun, Liaoning, Peoples R China; [Forsythe, Adrian] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Shenyang Agricultural University; Shenyang Ligong University; McMaster University	Yu, XD (corresponding author), Shenyang Agr Univ, Coll Biol Sci & Technol, Shenyang, Liaoning, Peoples R China.	yuxd126@126.com	Forsythe, Adrian/P-7105-2019	Forsythe, Adrian/0000-0003-1966-9946; Yu, Xiao-Dan/0000-0001-6297-6592	National Natural Science Foundation of China [31200011, 31770014]; Natural Science Foundation of Liaoning Province Science and Technology Department [201602668]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province Science and Technology Department	This study was supported by the National Natural Science Foundation of China (No. 31200011, 31770014) and the Natural Science Foundation of Liaoning Province Science and Technology Department (201602668). Dr. Yu XD received all the funding.; We are thankful to Prof. Bruce Jaffee for correcting the English. This study was supported by the National Natural Science Foundation of China (No. 31200011, 31770014) and the Natural Science Foundation of Liaoning Province Science and Technology Department (201602668).	Alvarado P, 2015, MYCOLOGIA, V107, P123, DOI 10.3852/13-369; Alves MJ, 2014, PATHOGENS, V3, P667, DOI 10.3390/pathogens3030667; Bao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep18608; Beebee T., 2008, INTRO MOL ECOLOGY, V3; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Chen XH, 2013, PLANT SYST EVOL, V299, P691, DOI 10.1007/s00606-012-0744-z; Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3; Dai YuCheng, 2010, Mycosystema, V29, P1; Debnath SC, 2009, INT J FRUIT SCI, V9, P185, DOI 10.1080/15538360903005061; Geiger R., 1961, UBERARBELTETNEUAUSGA; Geiger R, 1954, LANDOLT BORNSTEIN ZA, P603; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hasan HA, 2018, J FUNGI, V4, DOI 10.3390/jof4020052; Kahle D, 2013, R J, V5, P144; Kaygusuz O, 2017, CYTOTECHNOLOGY, V69, P135, DOI 10.1007/s10616-016-0045-4; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li Y., 2015, ATLAS CHINESE MACROF; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu J, 2015, J BASIC MICROB, V55, P749, DOI 10.1002/jobm.201400774; Ma DL, 2010, AFR J BIOTECHNOL, V9, P6244; Mercan N, 2006, ANN MICROBIOL, V56, P339, DOI 10.1007/BF03175028; MILLER MP, 1997, WINDOWS PROGRAM ANAL; Nylander J. A. A., 2004, MRMODELTEST V2; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Phillips R., 2010, MUSHROOMS OTHER FUNG; RANKER TA, 1992, HEREDITY, V69, P175, DOI 10.1038/hdy.1992.111; Rohlf FJ, 2000, NTSYS PC VERSION 2 1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez C, 2017, SYN SYST BIOTECHNO, V2, P13, DOI 10.1016/j.synbio.2016.12.001; Singer R, 1975, AGARICALES MODERN TA; Sun SJ, 2006, APPL MICROBIOL BIOT, V72, P537, DOI 10.1007/s00253-005-0299-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toledo CV, 2016, MOLECULES, V21, DOI 10.3390/molecules21091201; Wei HL, 2015, NO HORTICULTURE, V39, P132; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu LJ, 2015, INT J MED MUSHROOMS, V17, P1161, DOI 10.1615/IntJMedMushrooms.v17.i12.60; Yao FJ, 2018, MYCOBIOLOGY, V46, P72, DOI 10.1080/12298093.2018.1454004; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yin YG, 2014, CURR MICROBIOL, V68, P397, DOI 10.1007/s00284-013-0489-0; Yu XG, 2011, THESIS; Yu XD, 2014, MYCOSCIENCE, V55, P456, DOI 10.1016/j.myc.2014.01.007; Zeng YF, 2015, MOL ECOL, V24, P5676, DOI 10.1111/mec.13408; Zhang JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187351; Zhang QS, 2012, WORLD J MICROB BIOT, V28, P2237, DOI 10.1007/s11274-012-1031-4; Zhao MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083253; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	47	6	6	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202761	10.1371/journal.pone.0202761	http://dx.doi.org/10.1371/journal.pone.0202761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148893	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200021
J	Karageorgou, D; Imamura, F; Zhang, JY; Shi, PL; Mozaffarian, D; Micha, R				Karageorgou, Dimitra; Imamura, Fumiaki; Zhang, Jianyi; Shi, Peilin; Mozaffarian, Dariush; Micha, Renata			Assessing dietary intakes from household budget surveys: A national analysis in Bangladesh	PLOS ONE			English	Article							EXPENDITURES SURVEYS HCES; CORONARY-HEART-DISEASE; WHOLE GRAIN; RECALL DATA; CONSUMPTION; FOOD; NUTRITION; RISK; CHILDREN; WOMEN	Background Accurate national information on dietary intakes, including heterogeneity among individuals, is critical to inform health implications and policy priorities. In low- and middle-income countries, household expenditure surveys constitute the major source of food data, but with uncertain validity for individual-level intakes. Objective To investigate how individualized dietary consumption estimated from household survey data compared with individual-level 24-hr dietary recalls (24hR); and to assess potential heterogeneity by method for individualizing household intakes, dietary indicator, and individual characteristics (age, sex, education, religion, household income). Methods We evaluated data from the 2011-2012 Bangladesh Household Integrated Survey (BIHS), which included household-level consumption data (5,503 households) and individual-level dietary data based on 24hR from these households (22,173 participants). Household and 24hR estimates were standardized and harmonized for 33 dietary indicators, including 9 food groups, total energy, 8 macronutrients, and 15 micronutrients. Individual consumption was estimated from household data using two approaches, the Adult Male Equivalent (AME) and per capita (PC) approach. For each dietary indicator, differences in household vs. individual mean estimates were evaluated overall and by strata of individual characteristics, using Spearman's correlations and univariate and multivariate linear regression models. Results Individualized household estimates overestimated individual intakes from 24hR for all dietary factors using either estimation method (P<0.001 for each), except for starchy vegetables (AME: P = 0.15; PC: P = 0.85). For foods, overestimation ranged from 4% for seafood to about 240% for fruits, and for nutrients from 11% for carbohydrates and polyunsaturated fats to 55% for vitamin C, with similar overestimation for the AME and the PC method. By strata, overestimation was modestly higher in men vs. women, in children (010y) vs. adolescents (11-19y) and adults (20-44y, >= 45y), among adults of higher (>= 6y) vs. lower (<6y) education, in Muslims vs. other religions (Christians, Hindus), and for the lowest vs. all other income groups. This overestimation was notably higher in young children (0-5y) vs. all other age groups and in the lowest vs. all other income groups. Underestimation was rarely observed, for example for milk intake (-56%) in young children (0-5y). The PC approach did not capture heterogeneity in validity of estimation of different dietary factors by age, mainly in children (0-5y, 6-10y). Spearman's correlations between individualized household estimates and 24hR data were higher for the AME (0.30-0.70) than PC (0.20-0.50) approach. Findings were similar with and without multivariate regression, with proportions of variance (R-2) in 24hR intakes explained by the AME being generally greater than PC estimates, yet still low to modest. Conclusions In this national survey, established methods for estimating individual level intakes from household surveys produce overestimation of intakes of nearly all dietary indicators, with significant variation depending on the dietary factor and modest variation depending on individual characteristics. These findings suggest a need for new methods to estimate individual-level consumption from household survey estimates.	[Karageorgou, Dimitra; Zhang, Jianyi; Shi, Peilin; Mozaffarian, Dariush; Micha, Renata] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Imamura, Fumiaki] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England	Tufts University; University of Cambridge	Micha, R (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	renata.micha@tufts.edu	Imamura, Fumiaki/J-1038-2019; Mozaffarian, Dariush/ABC-2822-2020	Imamura, Fumiaki/0000-0002-6841-8396; Zhang, Jianyi/0000-0002-1501-4822	World Bank; Gates Foundation; MRC [MC_UU_12015/5] Funding Source: UKRI	World Bank(The World Bank India); Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the World Bank and Gates Foundation. The funding agencies did not contribute to design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; Ahmed, 2013, BANGLADESH PARLIAMEN; [Anonymous], 2012, GUID FOOD MATCH VERS; Ansari M. N. A., 2014, International Research Journal of Social Sciences, V3, P22; Aune D, 2013, EUR J EPIDEMIOL, V28, P845, DOI 10.1007/s10654-013-9852-5; Beegle K, 2012, J DEV ECON, V98, P3, DOI 10.1016/j.jdeveco.2011.11.001; Bermudez OI, 2012, FOOD NUTR BULL, V33, pS208, DOI 10.1177/15648265120333S209; Berti PR, 2012, FOOD NUTR BULL, V33, pS163, DOI 10.1177/15648265120333S204; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bognar A., 2002, TABLES WEIGHT YIELD; Charrondiere UR, 2016, FOOD CHEM, V193, P75, DOI 10.1016/j.foodchem.2014.11.055; Christian P, 2010, J NUTR, V140, P437, DOI 10.3945/jn.109.116327; Claro RM, 2010, CAD SAUDE PUBLICA, V26, P2188, DOI 10.1590/S0102-311X2010001100020; Claro RM, 2010, CAD SAUDE PUBLICA, V26, P2168, DOI 10.1590/S0102-311X2010001100018; Coates J, 2017, FOOD POLICY, V72, P27, DOI 10.1016/j.foodpol.2017.08.010; D'Souza A., 2014, EVIDENCE BANGLADESH; Louzada MLD, 2017, FOOD POLICY, V72, P112, DOI 10.1016/j.foodpol.2017.08.017; Dary O, 2012, FOOD NUTR BULL, V33, pS190, DOI 10.1177/15648265120333S207; Del Gobbo LC, 2015, AM J CLIN NUTR, V101, P1038, DOI 10.3945/ajcn.114.087403; EFSA, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4071, 10.2903/j.efsa.2014.3944]; Elshenawy S, 2016, MOL CELL ENDOCRINOL, V435, P2, DOI 10.1016/j.mce.2016.07.002; Engle-Stone R, 2015, FOOD NUTR BULL, V36, P211, DOI 10.1177/0379572115587272; European Food Safety Authority, 2011, FOOD CLASS DESCR SYS; FAO, 2001, REP JOINT FAO WHO UN; FAO, 2014, INTR MIN DIETR DIV W; FAO. Food Balance Sheets, 2001, A HDB; Fiedler JL, 2012, FOOD NUTR BULL, V33, pS170, DOI 10.1177/15648265120333S205; Foster E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169084; Friel S, 2001, PUBLIC HEALTH NUTR, V4, P1143, DOI 10.1079/PHN2001174; Global Nutrition and Policy Consortium, HOM GLOB DIET DAT; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; He YL, 2010, CIRC-CARDIOVASC QUAL, V3, P98, DOI 10.1161/CIRCOUTCOMES.109.875658; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; International Food Policy Research Institute, 2013, STAT FOOD SEC FEED F; International Household Survey Network, 008 INT HOUS SURV NE; Islam R., 2013, CONSUMPTION UNSAFE F; Jacobs K., 2002, REV POTENTIAL WAYS B; Jariseta ZR, 2012, FOOD NUTR BULL, V33, pS199, DOI 10.1177/15648265120333S208; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Kaur J, 2015, J ACAD NUTR DIET, V115, P751, DOI 10.1016/j.jand.2015.01.003; Khatibzadeh S, 2016, B WORLD HEALTH ORGAN, V94, P931, DOI 10.2471/BLT.15.156323; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Kothari M, 2010, NUTR UPDATE 2010; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Low MSY, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009747.pub2; McLean RM, 2014, NUTRIENTS, V6, P4651, DOI 10.3390/nu6114651; Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008; Micha R, 2018, FOOD NUTR BULL, V39, P175, DOI 10.1177/0379572117752986; Micha R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175149; Micha R, 2017, JAMA-J AM MED ASSOC, V317, P912, DOI 10.1001/jama.2017.0947; Micha R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008705; Micha R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2272; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Mozaffarian D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5747; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Murphy S, 2012, FOOD NUTR BULL, V33, pS235, DOI 10.1177/15648265120333S213; Naska A, 2009, BRIT J NUTR, V102, P166, DOI 10.1017/S000711450809466X; Paterakis SE, 2003, PUBLIC HEALTH NUTR, V6, P571, DOI 10.1079/PHN2003469; Pereira TJ, 2015, BIOCHEM CELL BIOL, V93, P438, DOI 10.1139/bcb-2014-0141; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Sekula W, 2005, PUBLIC HEALTH NUTR, V8, P430, DOI 10.1079/PHN2004695; Shaheen N, 2013, FOOD COMPOSITION TAB; Shamah-Levy T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014371; Sichieri R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-89; Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636; Stammers AL, 2015, EUR J CLIN NUTR, V69, P147, DOI 10.1038/ejcn.2014.204; Sununtnasuk C, 2017, FOOD POLICY, V72, P121, DOI 10.1016/j.foodpol.2017.08.018; UN, 2015, MILLENNIUM DEV GOALS; UNICEF World Health Organization World Bank Group, 2017, WORLD BANK GROUP JOI; United Nations General Assembly, 2000, UN MILL DECL; United States Department of Agriculture (USDA), 2007, USDA TABL NUTR RET F, DOI DOI 10.15482/USDA.ADC/1409034; USDA Agricultural Research Service, 1975, AGR HDB, V102; Weisell R, 2012, FOOD NUTR BULL, V33, pS157, DOI 10.1177/15648265120333S203; World Food Programme, 2015, FOOD INS UND URB SLU	81	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202831	10.1371/journal.pone.0202831	http://dx.doi.org/10.1371/journal.pone.0202831			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148863	Green Published, gold			2022-12-27	WOS:000442804200027
J	Kullenberg, C; Rohden, F; Bjorkvall, A; Brouneus, F; Avellan-Hultman, A; Jarlehed, J; Van Meerbergen, S; Nord, A; Nielsen, HL; Rosendal, T; Tomasson, L; Westberg, G				Kullenberg, Christopher; Rohden, Frauke; Bjorkvall, Anders; Brouneus, Fredrik; Avellan-Hultman, Anders; Jarlehed, Johan; Van Meerbergen, Sara; Nord, Andreas; Nielsen, Helle Lykke; Rosendal, Tove; Tomasson, Lotta; Westberg, Gustav			What are analog bulletin boards used for today? Analysing media uses, intermediality and technology affordances in Swedish bulletin board messages using a citizen science approach	PLOS ONE			English	Article								Analog bulletin boards are omnipresent in Swedish urban areas, yet little systematic knowledge about this communication medium exists. In the shadow of the rapid emergence of digital media the analog bulletin board has received less attention than its digital successors, many of them having incorporated similar functionality with novel technical solutions. In this study we used a citizen science method to collect 1167 messages from bulletin boards around Sweden aided by school children and teachers, with the purpose of shedding new light on what is communicated on the boards, by whom, using what types of technologies and in what way the messages refer to other media. Results show that the most common messages are invitations to events, such as concerts, lectures and sports events, followed by buy-and-sell ads for goods and services. The most frequent sender is an association, for example NGOs, sports associations or religious communities. Almost half of the sampled messages were professionally printed, about forty per cent were made by home printers. Only six per cent of the messages were handwritten, almost exclusively by private persons as senders. Moreover, we show how the analog bulletin board has adapted to recent changes in media technology-a media landscape which is saturated with electronicand mobile media. Further, the bulletin board still holds a firm place in a media ecology where local communication is in demand, and exists in parallel with electronic media. Close to forty percent of the messages contained hyperlinks to web pages and we found (and removed for anonymization purposes) more than six hundred phone numbers from the dataset.	[Kullenberg, Christopher; Rohden, Frauke] Univ Gothenburg, Dept Philosophy Linguist & Theory Sci, Gothenburg, Sweden; [Bjorkvall, Anders] Orebro Univ, Sch Humanities Educ & Social Sci, Humanities Div, Orebro, Sweden; [Brouneus, Fredrik; Tomasson, Lotta] VA Publ & Sci, Stockholm, Sweden; [Jarlehed, Johan; Nielsen, Helle Lykke; Rosendal, Tove] Univ Gothenburg, Dept Languages & Literatures, Gothenburg, Sweden; [Van Meerbergen, Sara] Stockholm Univ, Dept Slav & Balt Studies, Finnish Dutch & German, Stockholm, Sweden; [Nord, Andreas] Univ Gothenburg, Dept Swedish, Gothenburg, Sweden; [Nielsen, Helle Lykke] Univ Southern Denmark, Dept Hist, Odense, Denmark; [Westberg, Gustav] Stockholm Univ, Dept Swedish Language & Multilingualism, Stockholm, Sweden	University of Gothenburg; Orebro University; University of Gothenburg; Stockholm University; University of Gothenburg; University of Southern Denmark; Stockholm University	Kullenberg, C (corresponding author), Univ Gothenburg, Dept Philosophy Linguist & Theory Sci, Gothenburg, Sweden.	christopher.kullenberg@gu.se	Järlehed, Johan/AAO-3713-2020; Rosendal, Tove/AAJ-9662-2020; Kullenberg, Christopher/AAF-4577-2019	Kullenberg, Christopher/0000-0002-1577-3570; Nielsen, Helle Lykke/0000-0003-0914-5137; Rohden, Frauke/0000-0002-1532-3940; Bjorkvall, Anders/0000-0002-6396-4240; Jarlehed, Johan/0000-0002-0117-9458; Van Meerbergen, Sara/0000-0002-7375-6808	Marianne and Marcus Wallenberg Foundation [MMW 2013.00.20]; European Union's Horizon 2020 research and innovation programme [722934]	Marianne and Marcus Wallenberg Foundation; European Union's Horizon 2020 research and innovation programme	This research was funded by the Marianne and Marcus Wallenberg Foundation, grant number MMW 2013.00.20 and European Union's Horizon 2020 research and innovation programme, grant number 722934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt F, 2011, LECT NOTES COMPUT SC, V6696, P258, DOI 10.1007/978-3-642-21726-5_17; Baym NK, 2012, J BROADCAST ELECTRON, V56, P320, DOI 10.1080/08838151.2012.705200; Brooks GW, 1923, Patent No. [US1494583A, 1494583A]; Churchill EF, 2003, MULTIMEDIA FLIERS IN, P97, DOI [10.1007/978-94-017-0115-0_6, DOI 10.1007/978-94-017-0115-0_6]; Cooper CB, 2007, ECOL SOC, V12; Gibson J., 1977, TOWARD ECOLOGICAL PS, P62; Gilbertson Scott, 2010, WIRED; Ivkovic D, 2009, INT J MULTILING, V6, P17, DOI 10.1080/14790710802582436; Jaworski A., 2010, SEMIOTIC LANDSCAPES, P1; Jensen K. B., 2012, HDB GLOBAL MEDIA RES, P433, DOI [DOI 10.1002/9781118255278.CH25, 10.1002/9781118255278.ch25]; Jones R. H., 2009, ROUTLEDGE HDB MULTIM; Klemann L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188819; Kullenberg C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147152; Muth S., 2014, INT J SOCIOL LANG, V2014, DOI [10.1515/ijsl-2014-0004, DOI 10.1515/IJSL-2014-0004]; Norman Donald A., 1999, INTERACTION, V6, P38, DOI [DOI 10.1145/301153.301168, 10.1145/301153.301168]; Peck A, 2014, LANG MATTERS, V45, P360, DOI 10.1080/10228195.2014.979859; Peters MA, 2015, J ROY SOC NEW ZEAL, V45, P151, DOI 10.1080/03036758.2015.1051549; Pocock MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172579; Purschke Christoph, 2017, INTROD LINGSCAPE LUX, V85, P181, DOI [10.13092/lo.85.4086, DOI 10.13092/L0.85.4086]; Purschke Christoph, 2017, LINGUISTIC LANDSCAPE, V3, P246, DOI [10.1075/ll.17023.pur., DOI 10.1075/LL.17023.PUR, 10.1075/ll.17023.pur]; Svendsen BA, 2018, J SOCIOLING, V22, P137, DOI 10.1111/josl.12276; Taylor N, 2008, OZCH 2008 WORKSH PUB	22	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202077	10.1371/journal.pone.0202077	http://dx.doi.org/10.1371/journal.pone.0202077			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148848	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200006
J	Onyango, MA; Vian, T; Hirsch, I; Salvi, DD; Laing, R; Rockers, PC; Ashigbie, PG; Wirtz, VJ				Onyango, Monica Adhiambo; Vian, Taryn; Hirsch, Isabel; Salvi, Devashri D.; Laing, Richard; Rockers, Peter C.; Ashigbie, Paul G.; Wirtz, Veronika J.			Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; SOCIAL-RESPONSIBILITY; AVAILABILITY; CARE	In Kenya, noncommunicable diseases (NCDs) account for 27% of all deaths. Adult Kenyans have an 18% chance of dying prematurely from cancers, diabetes, cardiovascular diseases or chronic respiratory diseases. A Novartis Access Initiative is making medicines available to treat cardiovascular diseases, diabetes, chronic respiratory diseases, and breast cancer in 30 countries, including Kenya. Little is known about patients' perceptions of access to medicines for NCDs in Kenya. The study objective was to understand patients' perceptions of access to medicines; as well as barriers and facilitators at the household, community, and healthcare system level. A baseline qualitative study was conducted in eight of 47 counties as part of an evaluation of the Novartis Access Initiative in Kenya. The 84 patients interviewed through a household survey had been diagnosed and treated for an NCD. Although medicines at government facilities were free or cheaper than those sold in private pharmacies, the availability of medicines presented a constant challenge. Patients often resorted to private pharmacies, where NCD medicines cost more than at public facilities. Participants with an NCD took their health seriously and strove to get the medicines, even under difficult circumstances. Buying NCD medicines put a strain on the household budget, especially for the lower-income participants. Some actions to overcome affordability barriers included: borrowing money, selling assets, seeking help from relatives, taking on extra work, buying partial dosages, leaving without the medicines, or resorting to non-medical alternatives. In conclusion, access to NCD medicines is a major challenge for most adults in Kenya. As a result, they engage in complex interactions between public, private facilities and pharmacies to overcome the barriers. The government should ensure well-stocked public sector pharmacies and subsidize prices of medicines for lower-income patients. Integration of industry-led access to medicine programs may help governments to obtain low cost supplies.	[Onyango, Monica Adhiambo; Vian, Taryn; Hirsch, Isabel; Salvi, Devashri D.; Laing, Richard; Rockers, Peter C.; Ashigbie, Paul G.; Wirtz, Veronika J.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02118 USA; [Laing, Richard] Univ Western Cape, Fac Community Hlth Sci, Sch Publ Hlth, Cape Town, South Africa	Boston University; University of the Western Cape	Onyango, MA (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02118 USA.	monyango@bu.edu	Vian, Taryn/H-4609-2019; Wirtz, Veornika/AAG-9712-2019; Salvi, Devashri/CAJ-3216-2022	Wirtz, Veronika J./0000-0002-0863-8768; Onyango, Monica Adhiambo/0000-0003-4998-1682; Salvi, Devashri/0000-0002-7924-1418	Sandoz International GmbH [55205062]; Novartis Access Project [55205062]	Sandoz International GmbH(Novartis); Novartis Access Project	This work received support from Sandoz International GmbH (55205062) and Novartis Access Project, Grant 55205062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Blackburn DF, 2013, PATIENT PREFER ADHER, V7, P183, DOI 10.2147/PPA.S30613; Bloom DE, 2011, GLOBAL EC BURDEN NON; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Droppert H, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0100-5; Hogerzeil HV, 2013, NEW ENGL J MED, V369, P896, DOI 10.1056/NEJMp1303723; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Ministry of Health Government of Kenya, 2014, 2013 KEN HOUS HLTH E; Mwai D., 2016, PUBLIC HLTH RES, V6, P83, DOI [10.5923/j.phr.20160603.02, DOI 10.5923/J.PHR.20160603.02]; Novozymes, 2016, NOV ENZ BIOD HDB, P1; Robertson J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0105-0; Rockers PC, 2017, HEALTH AFFAIR, V36, P706, DOI 10.1377/hlthaff.2016.1213; Rockers PC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013386; Siddharthan T, 2015, HEALTH AFFAIR, V34, P1506, DOI 10.1377/hlthaff.2015.0382; Subramanian S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190113; Vedanthan R, 2015, GLOB HEART, V10, P313, DOI 10.1016/j.gheart.2015.09.003; Vialle-Valentin CE, 2015, HEALTH POLICY PLANN, V30, P1044, DOI 10.1093/heapol/czu107; Vian T, 2018, J HEALTH PSYCHOL, V23, P1895, DOI 10.1177/1359105316672922; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2014, NONC DIS COUNTR PROF	22	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0201917	10.1371/journal.pone.0201917	http://dx.doi.org/10.1371/journal.pone.0201917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142218	Green Submitted, Green Published, gold			2022-12-27	WOS:000442722500006
J	Kim, H; Langohr, IM; Faisal, M; McNulty, M; Thorn, C; Kim, J				Kim, Hana; Langohr, Ingeborg M.; Faisal, Mohammad; McNulty, Margaret; Thorn, Caitlin; Kim, Joomyeong			Ablation of Ezh2 in neural crest cells leads to aberrant enteric nervous system development in mice	PLOS ONE			English	Article							HOX GENES; HIRSCHSPRUNG-DISEASE; STEM-CELLS; HISTONE METHYLTRANSFERASE; MOUSE MODEL; IN-VIVO; SOX10; DIFFERENTIATION; EXPRESSION; INTEGRITY	In the current study, we examined the role of Ezh2 as an epigenetic modifier for the enteric neural crest cell development through H3K27me3. Ezh2 conditional null mice were viable up to birth, but died within the first hour of life. In addition to craniofacial defects, Ezh2 conditional null mice displayed reduced number of ganglion cells in the enteric nervous system. RT-PCR and ChIP assays indicated aberrant up-regulation of Zic1, Pax3, and Sox10 and loss of H3K27me3 marks in the promoter regions of these genes in the myenteric plexus. Overall, these results suggest that Ezh2 is an important epigenetic modifier for the enteric neural crest cell development through repression of Zic1, Pax3, and Sox10.	[Kim, Hana; Faisal, Mohammad; Thorn, Caitlin; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Langohr, Ingeborg M.; McNulty, Margaret] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu	Langohr, Ingeborg M/H-5570-2019	Langohr, Ingeborg M/0000-0001-7366-4391; McNulty, Margaret/0000-0001-6638-253X; Kim, Joomyeong/0000-0001-6577-5526	National Institute of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097074] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health [J.K. R01-GM066225, R01-GM097074].	Amiel J, 2001, J MED GENET, V38, P729, DOI 10.1136/jmg.38.11.729; Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Aubin J, 1999, AM J PHYSL, V277; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bhatt S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008326; Bondurand N, 2013, DEV BIOL, V382, P330, DOI 10.1016/j.ydbio.2013.04.024; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brooks AS, 1999, J MED GENET, V36, P485; Burns AJ, 2000, DEV BIOL, V219, P30, DOI 10.1006/dbio.1999.9592; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chan KK, 2005, DEV DYNAM, V233, P473, DOI 10.1002/dvdy.20347; Debbache J, 2018, GENESIS, V56, DOI 10.1002/dvg.23105; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Fu M, 2003, DEV DYNAM, V228, P1, DOI 10.1002/dvdy.10350; Furness JB, 2004, CELL TISSUE RES, V317, P1, DOI 10.1007/s00441-004-0895-5; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Gershon MD, 1999, HOSP PRACT, V34, P31, DOI 10.3810/hp.1999.07.153; Grundmann D, 2016, SCI REPORT, V5, P9226; Hemming S, 2017, FASEB J, V31, P1011, DOI 10.1096/fj.201600748R; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034; Hong CS, 2007, MOL BIOL CELL, V18, P2192, DOI 10.1091/mbc.E06-11-1047; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Jacques-Fricke BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047794; Kam MKM, 2014, CELL DEATH DIFFER, V21, P278, DOI 10.1038/cdd.2013.142; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kim YJ, 2014, CELL STEM CELL, V15, P497, DOI 10.1016/j.stem.2014.07.013; Lewis AE, 2013, DEV BIOL, V379, P229, DOI 10.1016/j.ydbio.2013.04.026; Maconochie M, 1996, ANNU REV GENET, V30, P529, DOI 10.1146/annurev.genet.30.1.529; Mallo M, 2003, CURR TOP DEV BIOL, V57, P85, DOI 10.1016/S0070-2153(03)57003-X; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Moore SW, 2005, PEDIATR SURG INT, V21, P255, DOI 10.1007/s00383-005-1383-z; Nagashimada M, 2012, J CLIN INVEST, V122, P3145, DOI 10.1172/JCI63401; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Rhodes LSS, 2006, GENE EXPR PATTERNS, V6, P539, DOI 10.1016/j.modgep.2005.10.006; Rothbart SB, 2015, MOL CELL, V59, P502, DOI 10.1016/j.molcel.2015.06.022; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; SERBEDZIJA GN, 1991, DEVELOPMENT, V111, P857; Sham MH, 2001, GUT, V49, P220, DOI 10.1136/gut.49.2.220; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Spazierer D, 2006, MOL CELL BIOL, V26, P559, DOI 10.1128/MCB.26.2.559-568.2006; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; TENNYSON VM, 1993, DEV DYNAM, V198, P28, DOI 10.1002/aja.1001980105; Wu ML, 2008, J CLIN INVEST, V118, P2076, DOI 10.1172/JCI33715; Zakin L, 2004, DEVELOPMENT, V131, P413, DOI 10.1242/dev.00946; Zemke M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0210-9; Zhang JM, 2015, DEV BIOL, V403, P128, DOI 10.1016/j.ydbio.2015.05.010	58	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203391	10.1371/journal.pone.0203391	http://dx.doi.org/10.1371/journal.pone.0203391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169530	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400038
J	Lucke, K; Yan, I; Krohn, S; Volmari, A; Klinge, S; Schmid, J; Schumacher, V; Steinmetz, OM; Rose-John, S; Mittrucker, HW				Luecke, Karsten; Yan, Isabell; Krohn, Sonja; Volmari, Annika; Klinge, Stefanie; Schmid, Joanna; Schumacher, Valea; Steinmetz, Oliver M.; Rose-John, Stefan; Mittruecker, Hans-Willi			Control of Listeria monocytogenes infection requires classical IL-6 signaling in myeloid cells	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; REGULATORY T-CELLS; CYCLIC ADP-RIBOSE; IN-VIVO; INTERLEUKIN-6-DEFICIENT MICE; RECEPTOR; INFECTION; CD38; DIFFERENTIATION; INFLAMMATION	IL-6 is required for the response of mice against Listeria monocytogenes. Control of infection depends on classical IL-6 signaling via membrane IL-6R alpha, but IL-6 target cells and protective mechanisms remain unclear. We used mice with IL-6Ra-deficiency in T cells (Il6ra(fl/fl)xCD4(cre)) or myeloid cells (Il6ra(fl/fl)xLysM(cre)) to define the role of these cells in IL-6-mediated protection. Abrogation of IL-6R alpha in T cells did not interfere with bacteria control and induction of T(H)1 and CD8(+) T-cell responses. IL-6R alpha-deficiency in myeloid cells caused significant defects in listeria control. This defect was not associated with reduced recruitment of granulocytes and inflammatory monocytes, and both cell populations were activated and not impaired in cytokine production. However, IL-6R alpha-deficient inflammatory monocytes displayed diminished expression of IL-4R alpha and of CD38, a protein required for phagocytosis and innate control of listeria. In vitro studies revealed that IL-4 and IL-6 cooperated in induction of CD38. In listeria-infected mice, phagocytic activity of inflammatory monocytes correlated with CD38 expression levels on cells and inflammatory monocytes of Il6ra(fl/fl)xLysM(cre) mice were significantly impaired in phagocytosis. In conclusion, we demonstrate that inhibition of classical IL-6 signaling in myeloid cells causes alterations in differentiation and function of these cells, which subsequently prevent effective control of L. monocytogenes.	[Luecke, Karsten; Yan, Isabell; Klinge, Stefanie; Schmid, Joanna; Schumacher, Valea; Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany; [Krohn, Sonja; Steinmetz, Oliver M.] Univ Med Ctr Hamburg Eppendorf, Med Clin & Polyclin 3, Hamburg, Germany; [Volmari, Annika] Univ Med Ctr Hamburg Eppendorf, Med Clin & Polyclin 1, Hamburg, Germany; [Rose-John, Stefan] Univ Kiel, Inst Biochem, Med Fac, Kiel, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel	Mittrucker, HW (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.	h.mittruecker@uke.de		Mittrucker, Hans-Willi/0000-0001-6166-4191; Yan, Karsten/0000-0002-7343-2205	Deutsche Forschungsgemeinschaft (dfg.de) [SFB841]	Deutsche Forschungsgemeinschaft (dfg.de)	This work was supported by Deutsche Forschungsgemeinschaft (dfg.de), grant no.: SFB841, project A3, to HWM; Deutsche Forschungsgemeinschaft (dfg.de) grant no.: SFB841, project C1, to SRJ; Deutsche Forschungsgemeinschaft (dfg.de), grant: Cluster of Excellence 'Inflammation at Interfaces', to SRJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Bottcher JP, 2014, CELL REP, V8, P1318, DOI 10.1016/j.celrep.2014.07.008; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Carr KD, 2011, EUR J IMMUNOL, V41, P2666, DOI 10.1002/eji.201041363; Cervantes-Sandoval I, 2008, PARASITOL INT, V57, P307, DOI 10.1016/j.parint.2008.01.006; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; DALRYMPLE SA, 1995, INFECT IMMUN, V63, P2262, DOI 10.1128/IAI.63.6.2262-2268.1995; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Estrada-Figueroa LA, 2011, PARASITE IMMUNOL, V33, P661, DOI 10.1111/j.1365-3024.2011.01333.x; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Gally F, 2009, AM J RESP CELL MOL, V40, P433, DOI 10.1165/rcmb.2007-0392OC; Guse AH, 2015, BBA-PROTEINS PROTEOM, V1854, P1132, DOI 10.1016/j.bbapap.2014.12.015; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hoge J, 2013, J IMMUNOL, V190, P703, DOI 10.4049/jimmunol.1201044; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kang J, 2012, J BIOL CHEM, V287, P14502, DOI 10.1074/jbc.M111.329003; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; La Flamme AC, 1999, J IMMUNOL, V162, P5829; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Lauder SN, 2013, EUR J IMMUNOL, V43, P2613, DOI 10.1002/eji.201243018; Lavigne MC, 2002, CELL IMMUNOL, V218, P7, DOI 10.1016/S0008-8749(02)00564-6; Lischke T, 2013, INFECT IMMUN, V81, P4091, DOI 10.1128/IAI.00340-13; Liu FL, 1997, BLOOD, V90, P2583, DOI 10.1182/blood.V90.7.2583.2583_2583_2590; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Luig M, 2015, J AM SOC NEPHROL, P1; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Oberg HH, 2006, INT IMMUNOL, V18, P555, DOI 10.1093/intimm/dxh396; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Partida-Sanchez S, 2003, MICROBES INFECT, V5, P49, DOI 10.1016/S1286-4579(02)00055-2; Postigo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033534; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Rincon M, 2012, TRENDS IMMUNOL, V33, P571, DOI 10.1016/j.it.2012.07.003; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schneider M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134016; SCHOBITZ B, 1995, FASEB J, V9, P659, DOI 10.1096/fasebj.9.8.7768358; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Smith KA, 2014, EUR J IMMUNOL, V44, P150, DOI 10.1002/eji.201343746; Tanaka T, 2001, CYTOKINE, V13, P193, DOI 10.1006/cyto.2000.0828; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Viegas MS, 2011, RHEUMATOLOGY, V50, P1569, DOI 10.1093/rheumatology/ker178; Waetzig GH, 2012, EXPERT OPIN THER TAR, V16, P225, DOI 10.1517/14728222.2012.660307; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Yan I, 2016, J LEUKOCYTE BIOL, V99, P749, DOI 10.1189/jlb.3A0515-207R; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; YOSHIZAKI K, 1989, BLOOD, V74, P1360	61	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203395	10.1371/journal.pone.0203395	http://dx.doi.org/10.1371/journal.pone.0203395			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169526	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400039
J	Grant, C; Nawal, D; Guntur, SM; Kumar, M; Chaudhuri, I; Galavotti, C; Mahapatra, T; Ranjan, K; Kumar, G; Mohanty, S; Alam, MA; Das, A; Jiwani, S				Grant, Carolyn; Nawal, Dipty; Guntur, Sai Mala; Kumar, Manish; Chaudhuri, Indrajit; Galavotti, Christine; Mahapatra, Tanmay; Ranjan, Kunal; Kumar, Gangesh; Mohanty, Sunil; Alam, Mohammed Aftab; Das, Aritra; Jiwani, Safia			'We pledge to improve the health of our entire community': Improving health worker motivation and performance in Bihar, India through teamwork, recognition, and non- financial incentives	PLOS ONE			English	Article								Background Motivation is critical to health worker performance and work quality. In Bihar, India, frontline health workers provide essential health services for the state's poorest citizens. Yet, there is a shortfall of motivated and skilled providers and a lack of coordination between two cadres of frontline health workers and their supervisors. CARE India developed an approach aimed at improving health workers' performance by shifting work culture and strengthening teamwork and motivation. The intervention-qeam-Based Goals and Incentives"-supported health workers to work as teams towards collective goals and rewarded success with public recognition and non-financial incentives. Methods Thirty months after initiating the intervention, 885 health workers and 98 supervisors completed an interviewer-administered questionnaire in 38 intervention and 38 control health sub-centers in one district. The questionnaire included measures of social cohesion, teamwork attitudes, self-efficacy, job satisfaction, teamwork behaviors, equitable service delivery, taking initiative, and supervisory support. We conducted bivariate analyses to examine the impact of the intervention on these psychosocial and behavioral outcomes. Results Results show statistically significant differences across several measures between intervention and control frontline health workers, including improved teamwork (mean = 8.8 vs. 7.3), empowerment (8.5 vs. 7.4), job satisfaction (7.1 vs. 5.99) and equitable service delivery (6.7 vs. 4.99). While fewer significant differences were found for supervisors, they reported improved teamwork (8.4 vs. 5.3), and frontline health workers reported improved fulfillment of supervisory duties by their supervisors (8.9 vs. 7.6). Both frontline health workers and supervisors found public recognition and enhanced teamwork more motivating than the non-financial incentives. Conclusions The Team-Based Goals and Incentives model reinforces intrinsic motivation and supports improvements in the teamwork, motivation, and performance of health workers. It offers an approach to practitioners and governments for improving the work environment in a resource-constrained setting and where there are multiple cadres of health workers.	[Grant, Carolyn; Galavotti, Christine] CARE USA, Sexual & Reprod Hlth & Rights, Atlanta, GA 30303 USA; [Nawal, Dipty; Guntur, Sai Mala; Kumar, Manish; Mahapatra, Tanmay; Ranjan, Kunal; Kumar, Gangesh; Mohanty, Sunil; Alam, Mohammed Aftab; Das, Aritra] CARE India Solut Sustainable Dev, Patna, Bihar, India; [Chaudhuri, Indrajit] Project Concern Int, Jeevika Tech Support Program, Patna, Bihar, India; [Jiwani, Safia] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Grant, C (corresponding author), CARE USA, Sexual & Reprod Hlth & Rights, Atlanta, GA 30303 USA.	cgrant@care.org	; Das, Aritra/C-9076-2014	Chaudhuri, Indrajit/0000-0002-8248-4402; Das, Aritra/0000-0002-7033-1441	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill and Melinda Gates Foundation funded this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TEAMW MOT STAT CONT; Bajpai N, 2011, WORKING PAPER SERIES; Borkum E, 2014, EVALUATION TEAM BASE; Campbell, 2013, UNIVERSAL TRUTH NO H; CARE USA, 2014, HLTH WORK VOIC OP IN; Franco LM, 2004, SOC SCI MED, V58, P343, DOI 10.1016/S0277-9536(03)00203-X; Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6; Gopalan SS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001557; Herzberg F, 1987, HAR BUS REV; Hotchkiss DR, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0083-6; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Kivimaki M, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-170; Kosec K, 2015, GLOBAL HLTH SCI PRAC, V3, P2; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Mbindyo P, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-43; Mbindyo PM, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-40; Ministry of Health and Family Welfare, 2013, GUID COMM PROC ASHA; Ministry of Health and Family Welfare Government of India, 2013, STRAT APPR REPR MAT; Mishra A, 2014, GLOB PUBLIC HEALTH, V9, P960, DOI 10.1080/17441692.2014.934877; Mutale W, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-8; Nandan D, 2007, ASSESSMENT FUNCTIONI; Peters DH, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-27; Rabbani F, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1641-x; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Scott K, 2010, AIDS CARE, V22, P1606, DOI 10.1080/09540121.2010.507751; Sharma R, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25352; Singh D, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0051-1; WHO, 2006, WORK TOG HLTH WORLD; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247	29	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203265	10.1371/journal.pone.0203265	http://dx.doi.org/10.1371/journal.pone.0203265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161213	Green Submitted, gold, Green Published			2022-12-27	WOS:000443388900097
J	Korshed, P; Li, L; Liu, Z; Wang, T				Korshed, Peri; Li, Lin; Liu, Zhu; Wang, Tao			The Molecular Mechanisms of the Antibacterial Effect of Picosecond Laser Generated Silver Nanoparticles and Their Toxicity to Human Cells (vol 11, e0160078, 2016)	PLOS ONE			English	Correction																		Korshed P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160078	1	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203636	10.1371/journal.pone.0203636	http://dx.doi.org/10.1371/journal.pone.0203636			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161224	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900134
J	MacDougall, LK; Broukhanski, G; Simor, A; Johnstone, J; Mubareka, S; McGeer, A; Daneman, N; Garber, G; Brown, KA				MacDougall, Laura K.; Broukhanski, George; Simor, Andrew; Johnstone, Jennie; Mubareka, Samira; McGeer, Allison; Daneman, Nick; Garber, Gary; Brown, Kevin A.			Comparison of qPCR versus culture for the detection and quantification of Clostridium difficile environmental contamination	PLOS ONE			English	Article							QUANTITATIVE PCR; SPORES; SURFACES; INFECTION; METAANALYSIS	Contaminated surfaces serve as an important reservoir for Clostridium difficile transmission. Current strategies to detect environmental contamination of C. difficile rely heavily on culture, and often only indicate presence versus absence of spores. The goal of this study was to compare quantitative PCR (qPCR) to culture for the detection and quantification of C. difficile from inert surfaces. First, we compared the limit of detection (LOD) of a 16S rRNA gene and toxin B gene qPCR assay for detection of C. difficile in solution. Second, we compared the LODs of 16S rRNA gene qPCR versus culture for detection of C. difficile from surfaces. Solution experiments were performed by direct seeding of spores into neutralizing broth, whereas surface experiments involved seeding of spores onto plastic test surfaces, and recovery using sponge swabs. Both experiments were conducted using spores expressing short (NAP1) and long (NAP4) hair lengths. Combining data from both strains, the overall LOD for C. difficile cells in solution was 1.4 cells for 16S rRNA gene and 23.6 cells for toxin B gene qPCR (p<0.001). The overall LOD for C. difficile cells from surfaces was 17.1 cells for 16S rRNA gene qPCR and 54.5 cells for culture (p = 0.05), and was not statistically different between strains for each method (p = 0.52). Overall, the proportion of C. difficile cells recovered from surfaces was good when detected by 16S rRNA gene qPCR and culture (qPCR: 76%, culture: 67%, p = 0.36), but, 16S rRNA gene qPCR was capable of detecting lower levels of surface contamination. Future work attempting to measure the presence of C. difficile on environmental surfaces should consider using qPCR.	[MacDougall, Laura K.; Broukhanski, George; Johnstone, Jennie; Daneman, Nick; Garber, Gary; Brown, Kevin A.] Publ Hlth Ontario, Infect Prevent & Control, Toronto, ON, Canada; [Simor, Andrew; Mubareka, Samira; Daneman, Nick] Sunnybrooke Hlth Sci Ctr, Toronto, ON, Canada; [Simor, Andrew; Johnstone, Jennie; Mubareka, Samira; McGeer, Allison; Daneman, Nick; Garber, Gary] Univ Toronto, Dept Med, Toronto, ON, Canada; [McGeer, Allison] Mt Sinai Healthcare Syst, Toronto, ON, Canada; [Garber, Gary] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Brown, Kevin A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Ottawa; University of Toronto	MacDougall, LK (corresponding author), Publ Hlth Ontario, Infect Prevent & Control, Toronto, ON, Canada.	laurakgreenfield@gmail.com	McGeer, Allison/AAB-6885-2020	McGeer, Allison/0000-0001-5647-6137; Brown, Kevin Antoine/0000-0002-1483-2188; Broukhanski, George/0000-0002-3313-3243	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by a grant from the Canadian Institutes of Health Research (GG, KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2015, J CLIN MICROBIOL, V53, P2570, DOI 10.1128/JCM.00376-15; Barbut F, 2009, INFECT CONT HOSP EP, V30, P507, DOI 10.1086/597232; Best EL, 2014, J HOSP INFECT, V87, P25, DOI 10.1016/j.jhin.2014.02.005; Buttner MP, 2007, APPL ENVIRON MICROB, V73, P3505, DOI 10.1128/AEM.01825-06; Buttner MP, 2001, APPL ENVIRON MICROB, V67, P2564, DOI 10.1128/AEM.67.6.2564-2570.2001; Claro T, 2014, J CLIN MICROBIOL, V52, P3426, DOI 10.1128/JCM.01011-14; Engelhardt NEP, 2017, J HOSP INFECT, V96, P295, DOI 10.1016/j.jhin.2017.03.028; Faires MC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-342; Ganji L, 2017, ARCH PEDIATR INFECT, V5, DOI 10.5812/pedinfect.38888; Goldenberg SD, 2012, J HOSP INFECT, V82, P64, DOI 10.1016/j.jhin.2012.06.004; Johnson Gemma, 2013, Methods Mol Biol, V943, P1, DOI 10.1007/978-1-60327-353-4_1; Joshi LT, 2012, APPL ENVIRON MICROB, V78, P7671, DOI 10.1128/AEM.01862-12; Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Morales L, 2016, AM J INFECT CONTROL, V44, P1517, DOI 10.1016/j.ajic.2016.09.003; Mutters R, 2009, J HOSP INFECT, V71, P43, DOI 10.1016/j.jhin.2008.10.021; Naaber P, 2011, J CLIN MICROBIOL, V49, P3656, DOI 10.1128/JCM.05115-11; Otter JA, 2009, AM J INFECT CONTROL, V37, P517, DOI 10.1016/j.ajic.2009.01.005; Paredes-Sabja D, 2012, J MED MICROBIOL, V61, P1208, DOI 10.1099/jmm.0.043687-0; Phetcharaburanin J, 2014, MOL MICROBIOL, V92, P1025, DOI 10.1111/mmi.12611; Pizarro-Guajardo M, 2016, APPL ENVIRON MICROB, V82, P5892, DOI 10.1128/AEM.01463-16; Public Health Agency of Canada, 2014, NON TRADITIONAL REF; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.20, 10.1128/microbiolspec.EI10-0007-2015]; Vardakas KZ, 2016, INT J ANTIMICROB AG, V48, P1, DOI 10.1016/j.ijantimicag.2016.03.008; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196	27	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201569	10.1371/journal.pone.0201569	http://dx.doi.org/10.1371/journal.pone.0201569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161136	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900010
J	Pertl-Obermeyer, H; Lackner, P; Schulze, WX; Hoepflinger, MC; Hoeftberger, M; Foissner, I; Obermeyer, G				Pertl-Obermeyer, Heidi; Lackner, Peter; Schulze, Waltraud X.; Hoepflinger, Marion C.; Hoeftberger, Margit; Foissner, Ilse; Obermeyer, Gerhard			Dissecting the subcellular membrane proteome reveals enrichment of H+ (co-) transporters and vesicle trafficking proteins in acidic zones of Chara internodal cells	PLOS ONE			English	Article							CYTOSOLIC CALCIUM TRANSIENTS; GREEN PLANT-CELLS; MODEL SYSTEM; PHOTOSYNTHETIC UTILIZATION; CHLORIDE TRANSPORT; PLASMA-MEMBRANES; BANDING-PATTERN; ATPASE ACTIVITY; V-ATPASE; CORALLINA	The Characeae are multicellular green algae with very close relationship to land plants. Their internodal cells have been the subject of numerous (electro-) physiological studies. When exposed to light, internodal cells display alternating bands of low and high pH along their surface in order to facilitate carbon uptake required for photosynthesis. Here we investigated for the first time the subcellular membrane protein composition of acidic and alkaline regions in internodal cells of Chara australis R. Br. using MS-proteomics. The identified peptides were annotated to Chara unigenes using a custom-made Chara database generated from a transcriptome analysis and to orthologous Arabidopsis genes using TAIR (The Arabidopsis Information Resource) database. Apart from providing the first public-available, functionally- annotated sequence database for Chara australis, the proteome study, which is supported by immunodetection, identified several membrane proteins associated with acidic regions that contain a high density of specific plasma membrane (PM) invaginations, the charasomes, which locally increase the membrane area to overcome diffusion limitation in membrane transport. An increased abundance of PM H+ ATPases at charasomes is consistent with their role in the acidification of the environment, but the characean PM H+ ATPase sequence suggests a different regulation compared to higher plant PM H+ ATPases. A higher abundance of H+ co-transporters in the charasome-rich, acidic regions possibly reflects enhanced uptake of ions and nutrients. The increase in mitochondrial proteins confirms earlier findings about the accumulation of cortical mitochondria in the acidic zones. The significant enrichment of clathrin heavy chains and clathrin adaptor proteins as well as other proteins involved in trafficking indicate a higher activity of membrane transport in the charasome-rich than in charasome-poor areas. New and unexpected data, for instance the upregulation and abundance of vacuolar transporters correlating with the charasome-rich, acidic cell regions account for new perspectives in the formation of charasomes.	[Pertl-Obermeyer, Heidi; Obermeyer, Gerhard] Univ Salzburg, Dept Biosci, Mol Plant Biophys & Biochem, Salzburg, Austria; [Lackner, Peter] Univ Salzburg, Dept Biosci, Bioinformat Allergens, Salzburg, Austria; [Schulze, Waltraud X.] Univ Hohenheim, Plant Syst Biol, Stuttgart, Germany; [Hoepflinger, Marion C.; Hoeftberger, Margit; Foissner, Ilse] Univ Salzburg, Dept Biosci, Plant Cell Dynam, Salzburg, Austria	Salzburg University; Salzburg University; University Hohenheim; Salzburg University	Obermeyer, G (corresponding author), Univ Salzburg, Dept Biosci, Mol Plant Biophys & Biochem, Salzburg, Austria.; Foissner, I (corresponding author), Univ Salzburg, Dept Biosci, Plant Cell Dynam, Salzburg, Austria.	ilse.foissner@sbg.ac.at; gerhard.obermeyer@sbg.ac.at	Schulze, Waltraud X/E-9800-2011; Obermeyer, Gerhard/G-4061-2013; Lackner, Peter/L-2900-2015; Pertl-Obermeyer, Heidi/I-5849-2015; Obermeyer, Gerhard/M-5942-2019	Schulze, Waltraud X/0000-0001-9957-7245; Obermeyer, Gerhard/0000-0001-8102-6322; Lackner, Peter/0000-0003-4681-6307; Pertl-Obermeyer, Heidi/0000-0001-9180-5995; Obermeyer, Gerhard/0000-0001-8102-6322; Foissner, Ilse/0000-0002-3060-1064	Austrian Science Fund FWF [P27536, P29626]; Austrian Research Fund (FWF) [P27536, P29626]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Research Fund (FWF)(Austrian Science Fund (FWF))	Austrian Science Fund FWF, https://www.fwf.ac.at/en/, P27536 (IF) and P29626 (GO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; The project was financed by grants of the Austrian Research Fund (FWF) P27536 and P29626 to Ilse Foissner and Gerhard Obermeyer, respectively. We thank Prof. Dr. Masayoshi Maeshima (Nagoya University, Japan) for the generous gift of anti vacuolar H<SUP>+</SUP> PPase antibody, Marketa Absolonova for her help during the rapid collection and freezing of Chara cells and Ana Gimeno for technical assistance. The help of Marie Bolger and Bjorn Usadel (RWTH Aachen, Germany) with Mercator analysis is very much appreciated. We also thank Alexander Bulychev (Moscow University, Russia) for valuable discussion.	Absolonova M, 2018, PROTOPLASMA, V255, P851, DOI 10.1007/s00709-017-1191-z; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; ANDJUS PR, 1992, PLANT SCI, V82, P187, DOI 10.1016/0168-9452(92)90219-C; [Anonymous], 2012, J PROTEOME RES, V11, P5548, DOI [10.1021/pr101065j, DOI 10.1021/PR101065J]; [Anonymous], 2014, PHYSL CHARACEAN CELL; BARTON, 1965, NATURE, V205, P201; Beilby MJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01052; BISSON MA, 1991, AUST J PLANT PHYSIOL, V18, P81, DOI 10.1071/PP9910081; BISSON MA, 1980, J MEMBRANE BIOL, V56, P1, DOI 10.1007/BF01869346; Braun Markus, 2007, V68, P193, DOI 10.1007/978-3-540-36832-8_9; Bulychev A, 2003, PLANTA, V218, P143, DOI 10.1007/s00425-003-1084-6; Bulychev AA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P55, DOI 10.1007/s10541-005-0051-1; Bulychev AA, 2004, J MEMBRANE BIOL, V202, P11, DOI 10.1007/s00232-004-0716-5; Cahoon B, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020080; Casanova MT, 2014, AUST SYST BOT, V27, P23, DOI 10.1071/SB13016; CHAU R, 1994, AUST J PLANT PHYSIOL, V21, P113, DOI 10.1071/PP9940113; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CRAWLEY JCW, 1965, NATURE, V205, P200, DOI 10.1038/205200a0; de Vries J, 2018, P NATL ACAD SCI USA, V115, pE3471, DOI 10.1073/pnas.1719230115; de Vries J, 2018, NEW PHYTOL, V217, P1428, DOI 10.1111/nph.14975; DEBOER AH, 1989, PLANT PHYSIOL, V89, P250, DOI 10.1104/pp.89.1.250; Delwiche CF, 2015, CURR BIOL, V25, pR899, DOI 10.1016/j.cub.2015.08.029; Dettmer J, 2005, PLANT J, V41, P117, DOI 10.1111/j.1365-313X.2004.02282.x; do Amaral MN, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02146; Falhof J, 2016, MOL PLANT, V9, P323, DOI 10.1016/j.molp.2015.11.002; Faraday CD, 1996, J EXP BOT, V47, P589, DOI 10.1093/jxb/47.4.589; Faulkner CR, 2005, PROTEOMICS, V5, P2866, DOI 10.1002/pmic.200401186; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foissner I, 2004, PROTOPLASMA, V224, P145, DOI 10.1007/s00709-004-0075-1; Foissner I, 2012, J MICROSC-OXFORD, V247, P10, DOI 10.1111/j.1365-2818.2011.03572.x; Foissner I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00756; Foissner I, 2014, INT REV CEL MOL BIO, V311, P307, DOI 10.1016/B978-0-12-800179-0.00006-4; FRANCESCHI VR, 1982, PLANTA, V154, P525, DOI 10.1007/BF00402996; FRANCESCHI VR, 1980, PROTOPLASMA, V104, P253, DOI 10.1007/BF01279771; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Gao CJ, 2014, TRENDS PLANT SCI, V19, P508, DOI 10.1016/j.tplants.2014.04.004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hoepflinger MC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00020; Hoepflinger MC, 2013, J EXP BOT, V64, P5553, DOI 10.1093/jxb/ert322; Hofmann, 1993, BIOL CHEM HOPPE SEYL, V374; HOMBLE F, 1990, J PLANT PHYSIOL, V135, P686, DOI 10.1016/S0176-1617(11)80880-1; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Ju CL, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.4, 10.1038/NPLANTS.2014.4]; KEIFER DW, 1982, PLANT PHYSIOL, V70, P1327, DOI 10.1104/pp.70.5.1327; Klima A, 2008, PLANT CELL PHYSIOL, V49, P1508, DOI 10.1093/pcp/pcn122; Krebs M, 2010, P NATL ACAD SCI USA, V107, P3251, DOI 10.1073/pnas.0913035107; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LUCAS WJ, 1986, PROTOPLASMA, V130, P5, DOI 10.1007/BF01283326; LUCAS WJ, 1981, PROTOPLASMA, V107, P255, DOI 10.1007/BF01276829; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; OECKING C, 1991, EUR J BIOCHEM, V199, P685, DOI 10.1111/j.1432-1033.1991.tb16171.x; Oikawa A, 2011, PLANT PHYSIOL, V157, P544, DOI 10.1104/pp.111.183772; Pertl H, 2005, PLANT BIOLOGY, V7, P140, DOI 10.1055/s-2005-837583; Pertl H, 2001, PLANTA, V213, P132, DOI 10.1007/s004250000483; PLIETH C, 1994, PHYSIOL PLANTARUM, V91, P205; Plieth C, 1998, PLANTA, V207, P52, DOI 10.1007/s004250050454; Plieth C, 1998, PLANTA, V207, P42, DOI 10.1007/s004250050453; PRICE GD, 1983, PROTOPLASMA, V116, P65, DOI 10.1007/BF01294232; PRICE GD, 1985, AUST J PLANT PHYSIOL, V12, P241, DOI 10.1071/PP9850241; PRICE GD, 1985, AUST J PLANT PHYSIOL, V12, P257, DOI 10.1071/PP9850257; PRINS HBA, 1989, AQUAT BOT, V34, P59, DOI 10.1016/0304-3770(89)90050-8; Ray S, 2003, AQUAT BOT, V76, P141, DOI 10.1016/S0304-3770(03)00035-4; Rudashevskaya EL, 2012, J BIOL CHEM, V287, P4904, DOI 10.1074/jbc.M111.307264; Sangha Jatinder Singh, 2010, BMC Res Notes, V3, P126, DOI 10.1186/1756-0500-3-126; Schmolzer PM, 2011, PLANT CELL PHYSIOL, V52, P1274, DOI 10.1093/pcp/pcr074; SCHNEIDER AS, 1983, BIOCHEMISTRY-US, V22, P1680, DOI 10.1021/bi00276a025; SPEAR DG, 1969, J GEN PHYSIOL, V54, P397, DOI 10.1085/jgp.54.3.397; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang X, 2017, J EXP BOT, DOI [10.1039/jxb/erx262, DOI 10.1039/JXB/ERX262]; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Wood R.D., 1965, MONOGRAPH CHARACEA 1, P1; Zauber H, 2012, J PROTEOME RES, V11, P5548, DOI 10.1021/pr300413v; Zhang SY, 2016, J PLANT PHYSIOL, V193, P37, DOI 10.1016/j.jplph.2016.02.009	74	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201480	10.1371/journal.pone.0201480	http://dx.doi.org/10.1371/journal.pone.0201480			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157181	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400009
J	Conserve, DF; Muessig, KE; Maboko, LL; Shirima, S; Kilonzo, MN; Maman, S; Kajula, L				Conserve, Donaldson F.; Muessig, Kathryn E.; Maboko, Leonard L.; Shirima, Sylvia; Kilonzo, Mrema N.; Maman, Suzanne; Kajula, Lusajo			Mate Yoko Afya Yako: Formative research to develop the Tanzania HIV self-testing education and promotion (Tanzania STEP) project for men	PLOS ONE			English	Article							DAR-ES-SALAAM; YOUNG MEN; ANTIRETROVIRAL THERAPY; ACCEPTABILITY; INTERVENTION; MASCULINITY; CARE; MICROFINANCE; PREVENTION; LEADERSHIP	The purpose of this formative research, guided by the Integrated Behavioral Model, was to assess men's attitudes and personal agency towards HIV self-testing (HIVST) and confirmatory HIV testing in order to inform the development of the Tanzania STEP (Self-Testing Education and Promotion) Project, a peer-based HIV self-testing intervention for young men in Tanzania. Qualitative in-depth interviews were conducted with 23 men in Dar es Salaam, Tanzania who socialize in networks locally referred to as "camps". Men reported privacy, confidentiality, and saving time as the primary reasons for their self-testing interest. Most participants had high perceived control and self-efficacy to self-test and seek confirmatory HIV testing. Nevertheless, men reported concerns related to their ability to perform the test and the potential lack of post-test counseling. Specific recommendations for the intervention included providing HIVST education and pre-test counseling, and using mobile health (mHealth) strategies for participants to reach a healthcare professional for further assistance. The findings suggest that while HIVST is highly acceptable among men in Tanzania, future interventions will need to address the challenges that men may face with HIVST before promoting it as an alternative or supplement to facility-based HIV testing.	[Conserve, Donaldson F.; Shirima, Sylvia] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Muessig, Kathryn E.; Maman, Suzanne] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA; [Maboko, Leonard L.] Tanzania Commiss AIDS TACAIDS, Dar Es Salaam, Tanzania; [Kilonzo, Mrema N.; Kajula, Lusajo] Muhimbili Univ Hlth & Allied Sci, Dept Psychiat & Mental Hlth, Dar Es Salaam, Tanzania	University of South Carolina System; University of South Carolina Columbia; University of North Carolina; University of North Carolina Chapel Hill; Muhimbili University of Health & Allied Sciences	Conserve, DF (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA.	conserve@mailbox.sc.edu	Muessig, Kate/P-1242-2018	Conserve, Donaldson/0000-0001-8193-817X	University of North Carolina at Chapel Hill Center for AIDS Research [P30AI50410]; National Institute of Mental Health (NIMH) Grant [R01MH098690]; NIMH [K99/R00MH110343]; National Institute of Allergy and Infectious Diseases [T32 AI007001]; National Institute of Health [5R25HL105444-07];  [1UL1TR001111-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH110343, R00MH110343] Funding Source: NIH RePORTER	University of North Carolina at Chapel Hill Center for AIDS Research; National Institute of Mental Health (NIMH) Grant; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the University of North Carolina at Chapel Hill Center for AIDS Research (P30AI50410), National Institute of Mental Health (NIMH) Grant #R01MH098690: PI, Suzanne Maman, NIMH Grant #K99/R00MH110343: PI, Donaldson F. Conserve, a training grant from the National Institute of Allergy and Infectious Diseases #T32 AI007001, and a grant from the National Institute of Health #5R25HL105444-07. We are also grateful for the valuable contributions of Richard S. Youngblood from NC TraCS/CTSA supported by grant #1UL1TR001111-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, GLOB AIDS UPD 2016; Buguzi S., 2018, THE CITIZEN; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Chanda MM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002442; Cherutich P., 2014, Retrovirology: Research and Treatment, V6, P23; Chikovore J, 2016, AIDS CARE, V28, P74, DOI 10.1080/09540121.2016.1178953; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Choko AT, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21610; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Conserve D, 2016, OPEN FORUM INFECT DI; Conserve DF, 2018, AM J MENS HLTH; Conserve DF, 2017, J TELEMED TELECARE, V23, P347, DOI 10.1177/1357633X16639186; Czaicki NL, 2017, AIDS CARE, V29, P876, DOI 10.1080/09540121.2017.1287340; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Frye V, 2015, AIDS PATIENT CARE ST, V29, P617, DOI 10.1089/apc.2015.0100; Guardian T., 2018, GUARDIAN; Hensen B, 2014, AIDS, V28, P2133, DOI 10.1097/QAD.0000000000000395; ILO, 2018, TANZ LAUNCH CAMP HIV; Indravudh PP, 2018, CURR OPIN INFECT DIS, V31, P14, DOI 10.1097/QCO.0000000000000426; Iwelunmor J, 2015, AM J MENS HEALTH, V9, P193, DOI 10.1177/1557988314535235; Jennings L, 2017, ANN GLOB HEALTH, V83, P66; Johnson CC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21594; Joint United Nations Programme on HIV/AIDS, 2014, 90 90 90 AMB TREATM; Kajula L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2774-x; Kelvin EA, 2017, AIDS BEHAV, P1; Kundi GJ, 2014, ONLINE J PUBLIC HLTH, V6; MacPherson P, 2014, JAMA-J AM MED ASSOC, V312, P372, DOI 10.1001/jama.2014.6493; MacQueen K.M., 1998, CAM J, V10, P31, DOI [10.1177/1525822X980100020301, DOI 10.1177/1525822X980100020301, 10.1177/1525822x980100020301]; Makusha T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122783; Maman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174629; Maman S, 2016, GLOB PUBLIC HEALTH, V11, P1202, DOI 10.1080/17441692.2015.1094105; Mamlin J, 2009, AM J PUBLIC HEALTH, V99, P215, DOI 10.2105/AJPH.2008.137174; Masters SH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002166; Mburu G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1061; McCoy SI, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1186-3; Ministry of Health CD, 2017, TANZ HIV IMP SURV 20; Montaner J, 2017, J VIRUS ERAD, V3, P97; Montauo D.E., 2015, HLTH BEHAV; Njau B, 2012, AIDS CARE, V24, P413, DOI 10.1080/09540121.2011.608796; Nkuna Engetani, 2016, Open AIDS J, V10, P78, DOI 10.2174/1874613601610010078; Nyamhanga TM, 2013, TANZANIA GLOBAL HLTH, V6, P21812, DOI DOI 10.3402/GHA.V6I0.21812; Oldenburg CE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014780; Organization WH, 2013, 1 INT S SELF TEST HI; Orr N, 2017, JAIDS-J ACQ IMM DEF, V74, pS69, DOI 10.1097/qai.0000000000001204; Pai NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079772; Perez GIP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151990; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Ratliff EA, 2013, ADV PREVENTIVE MED; Rolfe G, 2006, J ADV NURS, V53, P304, DOI 10.1111/j.1365-2648.2006.03727.x; Siu GE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-33; Siu GE, 2013, SOC SCI MED, V89, P45, DOI 10.1016/j.socscimed.2013.04.025; Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13; Spyrelis A, 2017, AIDS CARE, V29, P339, DOI 10.1080/09540121.2016.1234687; Taggart T, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4387; Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2; van Rooyen H, 2015, J INT AIDS SOC, V18; Wang ZX, 2018, AIDS BEHAV, V22, P190, DOI 10.1007/s10461-017-1887-2; Weiser SD, 2015, AIDS, V29, P1889, DOI 10.1097/QAD.0000000000000781; Welfare MoHaS, 2013, NAT COMPR GUID HIV T; Who, 2015, FACT SHEET WHO CONS; WHO, 2015, CONSOLIDATED GUIDELI; WHO, NUMB COUNTR AD HIV S; World Health Organization, 2016, GUID HIV SELF TEST P, DOI 10665/251655/9789241549868-eng.pdf; Yamanis T, 2017, AIDS BEHAV, V21, P1171, DOI 10.1007/s10461-016-1513-8; Yamanis TJ, 2010, SOC SCI MED, V71, P1601, DOI 10.1016/j.socscimed.2010.07.039; Zanolini A, 2018, AIDS RES HUM RETROV, V34, P254, DOI [10.1089/aid.2017.0156, 10.1089/AID.2017.0156]	66	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202521	10.1371/journal.pone.0202521	http://dx.doi.org/10.1371/journal.pone.0202521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148846	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200012
J	Mesoudi, A; Magid, K; Hussain, D				Mesoudi, Alex; Magid, Kesson; Hussain, Delwar			How Do People Become W.E.I.R.D.? Migration Reveals the Cultural Transmission Mechanisms Underlying Variation in Psychological Processes (vol 11, e0147162, 2016)	PLOS ONE			English	Correction																		Mesoudi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147162	1	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203250	10.1371/journal.pone.0203250	http://dx.doi.org/10.1371/journal.pone.0203250			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148891	Green Submitted, Green Published, gold			2022-12-27	WOS:000442804200051
J	Alam, M; Neal, J; O'Connor, K; Kilian, A; Topp, B				Alam, Mobashwer; Neal, Jodi; O'Connor, Katie; Kilian, Andrzej; Topp, Bruce			Ultra-high-throughput DArTseq-based silicoDArT and SNP markers for genomic studies in macadamia	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; GENETIC DIVERSITY; MOLECULAR MARKERS; POPULATION-STRUCTURE; ASSISTED SELECTION; CROP; SSR; INTEGRIFOLIA; VARIABILITY; RESISTANCE	Macadamia (Macadamia integrifolia, M. tetraphylla and hybrids) is an Australian native nut crop and has a significant economic value in the food industries worldwide. Long juvenility along with traditional breeding strategies impede quick genetic improvement of this crop. The existing cultivars constitute only second to fourth generation of the wild germplasm in the rainforest. The utilisation of molecular markers for genomic selection and genome-wide association studies may accelerate genetic gains. Identification of a robust, reproducible, and cost-effective marker system is instrumental in increasing the efficiency of genomic studies. This study is the first to report the potential of two ultra-high-throughput diversity array technology (DArT) markers (silicoDArT and SNP) in macadamia. Both markers were used to identify the genetic diversity and population structure in 80 macadamia cultivars. Parentage analysis of 25 scions in a rootstock trial was conducted to confirm plant identity where recorded identities did not corroborate with phenotypic field observations. A total of 22,280 silicoDArT and 7,332 SNP markers were reported, of which 11,526 silicoDArT and 3,956 SNP markers were used for analyses after screening with quality control parameters including >95% call rate, >95% reproducibility, and >0.05 one ratio. The average polymorphic information content (PIC) values of silicoDArT and SNP markers were 0.29 and 0.21, respectively. Genetic variance among the cultivars ranged from 0.003 to 0.738 in silicoDArT and 0.004 to 0.412 in SNP markers. Four distinct population groups were identified from SNP data analysis. Most of the accessions used in this study were descended from two or more populations. Cluster analysis clearly separated genotypes of distinct origins, such as the Hawaii Agricultural Experiment Station and Hidden Valley Plantation accessions. Two wild accessions of Macadamia jansenii and M. ternifolia were found to be distantly related to the cultivars. Wild germplasm individuals and their hybrids with cv. '660' formed separate clusters, suggesting that crossing between wild and cultivated genepools can extend genetic diversity. DArTseq-based SNP markers were successfully utilized to confirm the genetic identity of 25 scions in a rootstock trial. Our study suggests that DArT platforms are a robust system for the facilitation of genomic studies with regard to macadamia.	[Alam, Mobashwer; O'Connor, Katie; Topp, Bruce] Univ Queensland, Ctr Hort Sci, Queensland Alliance Agr & Food Innovat, Nambour, Qld, Australia; [Neal, Jodi] Maroochy Res Facil, Dept Agr & Forestry, Nambour, Qld, Australia; [Kilian, Andrzej] Univ Canberra, Divers Arrays Technol Pty Ltd, Monana St, Canberra, ACT, Australia	University of Queensland; Queensland Department of Agriculture & Fisheries; University of Canberra	Alam, M (corresponding author), Univ Queensland, Ctr Hort Sci, Queensland Alliance Agr & Food Innovat, Nambour, Qld, Australia.	m.alam@uq.edu.au	Alam, Mobashwer/F-9833-2010; O'Connor, Katie/T-1385-2019	Alam, Mobashwer/0000-0003-1502-5617; O'Connor, Katie/0000-0003-3052-8300; TOPP, Bruce/0000-0001-5647-3737; Kilian, Andrzej/0000-0002-2730-7462	Hort Innovation Australia; Diversity Arrays Technology Pty Ltd.	Hort Innovation Australia; Diversity Arrays Technology Pty Ltd.	This research has been funded by Hort Innovation Australia, using the Macadamia research and development levy and contributions from the Australian Government. Diversity Arrays Technology Pty Ltd. provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Alam MM, 2014, THEOR APPL GENET, V127, P2253, DOI 10.1007/s00122-014-2377-9; Ambawat S, 2016, EUPHYTICA, V209, P461, DOI 10.1007/s10681-016-1671-9; Aradhya MK, 1998, GENET RESOUR CROP EV, V45, P19, DOI 10.1023/A:1008634103954; Baloch FS, 2016, TURK J AGRIC FOR, V40, P352, DOI 10.3906/tar-1508-27; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, P1; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; Dierig D, 2009, NEW CROPS BREEDING L, P507; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Gan L-p, 2004, J GANSU AGR U, V1; Gitonga LN, 2011, ACTA HORTIC, V918, P877, DOI 10.17660/ActaHortic.2011.918.116; Gitonga L.N., 2009, J PLANT BREED CROP S, V1, P049, DOI [10.5897/jpbcs.9000122, DOI 10.5897/JPBCS.9000122]; Grzebelus D, 2014, MOL BREEDING, V33, P625, DOI 10.1007/s11032-013-9979-9; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hardner C, 2005, ACTA HORTIC, P85, DOI 10.17660/ActaHortic.2005.694.10; Hardner C. M., 2009, Horticultural Reviews, V35, P1; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hudson CJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-240; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; James KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001682; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kilian A., 2003, P INT C WAK DOUBL HE, P443; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Mace ES, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-26; Neto NBM, 2010, CROP BREED APPL BIOT, V10, P266, DOI 10.1590/S1984-70332010000300013; Matthies IE, 2012, MOL BREEDING, V30, P951, DOI 10.1007/s11032-011-9678-3; McHargue L. T., 1996, Progress in new crops: Proceedings of the Third National Symposium, Indianapolis, Indiana, USA, 22-25 October, 1996., P458; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Mohan M, 1997, MOL BREEDING, V3, P87, DOI 10.1023/A:1009651919792; NAGAO MA, 1992, CRIT REV PLANT SCI, V10, P441, DOI 10.1080/07352689209382321; Nock CJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3272-3; Nock CJ, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300089; O'Connor K, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-017-1221-1; O'Connor K, 2015, BIOL CONSERV, V191, P504, DOI 10.1016/j.biocon.2015.08.001; Peace C., 2002, WANATCA Yearbook, V26, P19; Peace C, 2005, GENETIC CHARACTERISA; Peace C. P., 2005, South African Journal of Plant and Soil, V22, P71; Peace Cameron, 2008, V1, P313; Peace CP, 2004, J HORTIC SCI BIOTECH, V79, P965, DOI 10.1080/14620316.2004.11511874; Peace CP, 2003, EUPHYTICA, V134, P17, DOI 10.1023/A:1026190529568; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X, 2003, METHODS DATA ANAL GE, P31; Pritchard JK, 2010, DOCUMENTATION STRUCT; Sanchez-Sevilla JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144960; Sanewski G, 2017, AUSTRALAS PLANT PATH, V46, P499, DOI 10.1007/s13313-017-0512-1; Sansaloni CP, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-16; Schouten HJ, 2012, MOL BREEDING, V29, P645, DOI 10.1007/s11032-011-9579-5; Sharp D, 1997, AUSTR MAC SOC ANN, P20; Shigeura GT, 1984, MACADAMIA NUTS HAWAI; Simko I, 2012, PLANT SCI, V184, P54, DOI 10.1016/j.plantsci.2011.12.009; Steiger DL, 2003, EUPHYTICA, V132, P269, DOI 10.1023/A:1025025522276; Stephenson R., 2005, Chronica Horticulturae, V45, P11; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; Tang J, 2015, PLANTA, V242, P985, DOI 10.1007/s00425-015-2335-z; Topp B, 2016, ACTA HORTIC, V1127, P45, DOI 10.17660/ActaHortic.2016.1127.8; Vishwakarma MK, 2017, COMPEND PL GENOME, P93, DOI 10.1007/978-3-319-63935-2_7; Vithanage V, 1997, INT S BIOT TROP SU 2, P461; Waldron Julie, 2002, Journal of Biomedicine & Biotechnology, V2, P141, DOI 10.1155/S1110724302206026; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z; Yang XP, 2016, PLANT GENET RESOUR-C, V14, P226, DOI 10.1017/S1479262115000659; ZENG ZB, 1994, GENETICS, V136, P1457	68	50	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203465	10.1371/journal.pone.0203465	http://dx.doi.org/10.1371/journal.pone.0203465			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169500	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000443374400042
J	Le Gall, G; Kirchgesner, J; Bejaoui, M; Landman, C; Nion-Larmurier, I; Bourrier, A; Sokol, H; Seksik, P; Beaugerie, L				Le Gall, Guillaume; Kirchgesner, Julien; Bejaoui, Mohamed; Landman, Cecilia; Nion-Larmurier, Isabelle; Bourrier, Anne; Sokol, Harry; Seksik, Philippe; Beaugerie, Laurent			Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR EVENTS; STROKE; METAANALYSIS; MORTALITY	Background and aims In inflammatory bowel disease (IBD), the impact of established cardiovascular risk factors and disease-related factors on the risk of acute arterial events is still unclear. We aimed to identify risk factors of acute arterial events in patients with IBD. Methods All consecutive patients followed at Saint-Antoine Hospital between 1996 and 2015 with subsequent occurrence of acute arterial events (acute coronary syndrome or ischemic stroke) were identified. Traditional cardiovascular risk factors, treatment exposure, systemic inflammation (mean serum CRP level greater than or equal to 5 mg/L) and IBD clinical activity were assessed. A nested case-control study was performed including cases and controls without arterial ischemic event, matched on age, gender, and disease extent. Results A total of 30 patients (median age at acute vascular event occurrence: 42 years (interquartile range: 25-59)) developed acute coronary syndrome (n = 22) or ischemic stroke (n = 8). In univariate analysis, clinical disease activity and the persistence of systemic inflammation, diabetes, dyslipidemia and hypertension were significantly associated with an increased risk of acute arterial events. Neither protective nor aggravating effects associated with treatment exposure were identified. In multivariate analysis, the presence of diabetes (Odds ratio (OR): 14.5, 95% confidence interval (CI): 1.1-184.7) and clinical disease activity (OR: 10.4, 95% CI: 2.1-49.9) remained significantly associated with the risk of acute arterial event. Conclusion Disease activity may have an independent impact on the risk of acute arterial events in patients with IBD. These findings may highlight new potential benefits of optimizing anti-inflammatory treatment in patients with persisting clinical activity.	[Le Gall, Guillaume; Kirchgesner, Julien; Bejaoui, Mohamed; Landman, Cecilia; Nion-Larmurier, Isabelle; Bourrier, Anne; Sokol, Harry; Seksik, Philippe; Beaugerie, Laurent] Hop St Antoine, AP HP, Dept Gastroenterol, Paris, France; [Kirchgesner, Julien] INSERM, UMR S 1136, Paris, France; [Kirchgesner, Julien] UPMC Univ Paris 06, Paris, France; [Sokol, Harry; Seksik, Philippe; Beaugerie, Laurent] Sorbonne Univ, INSERM, ERL INSERM Unite Mixte Rech 1057, Paris, France; [Sokol, Harry; Seksik, Philippe; Beaugerie, Laurent] Sorbonne Univ, Grp Rech Clin 03, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Le Gall, G (corresponding author), Hop St Antoine, AP HP, Dept Gastroenterol, Paris, France.	guillaumelegall1@hotmail.com	Sokol, Harry/E-2290-2019; Kirchgesner, Julien/ABA-1398-2021; sokol, harry/ABA-8991-2020; SEKSIK, Philippe/ABE-2962-2020	Sokol, Harry/0000-0002-2914-1822; sokol, harry/0000-0002-2914-1822; Kirchgesner, Julien/0000-0002-2314-9284; LE GALL, Guillaume/0000-0003-1917-4433; Bejaoui, Mohamed/0000-0002-9977-2304				Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Bergeron V, 2010, AM J GASTROENTEROL, V105, P2405, DOI 10.1038/ajg.2010.248; Chung AR, 2011, J GASTROEN HEPATOL, V26, P60; Cosnes J, 2016, ALIMENT PHARM THER, V44, P1102, DOI 10.1111/apt.13808; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Fumery M, 2014, J CROHNS COLITIS, V8, P469, DOI 10.1016/j.crohns.2013.09.021; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kirchgesner J, 2018, GUT, V67, P1261, DOI 10.1136/gutjnl-2017-314015; Kristensen SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056944; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Pepys MB, 2003, J CLIN INVEST, V112, P299, DOI 10.1172/JCI200318921C; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Shankar A, 2007, AM HEART J, V154, P495, DOI 10.1016/j.ahj.2007.04.060; Singh S, 2014, CLIN GASTROENTEROL H, V12, P382, DOI 10.1016/j.cgh.2013.08.023; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Xiao ZL, 2015, J STROKE CEREBROVASC, V24, P2774, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.008; Zakroysky P, 2015, AM J MED, V128, P303, DOI 10.1016/j.amjmed.2014.10.033; Zanoli L, 2014, ATHEROSCLEROSIS, V234, P346, DOI 10.1016/j.atherosclerosis.2014.03.023	22	23	23	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0201991	10.1371/journal.pone.0201991	http://dx.doi.org/10.1371/journal.pone.0201991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169521	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400006
J	Krishna, A; Peter, SM				Krishna, Anand; Peter, Sebastian M.			Questionable research practices in student final theses - Prevalence, attitudes, and the role of the supervisor's perceived attitudes	PLOS ONE			English	Article							RESEARCH MISCONDUCT; PERCEPTIONS; SCIENCE; REPRODUCIBILITY; REPLICABILITY; PSYCHOLOGY; INTEGRITY; STANDARDS; OPENNESS; FUTURE	Although questionable research practices (QRPs) and p-hacking have received attention in recent years, little research has focused on their prevalence and acceptance in students. Students are the researchers of the future and will represent the field in the future. Therefore, they should not be learning to use and accept QRPs, which would reduce their ability to produce and evaluate meaningful research. 207 psychology students and fresh graduates provided self-report data on the prevalence and predictors of QRPs. Attitudes towards QRPs, belief that significant results constitute better science or lead to better grades, motivation, and stress levels were predictors. Furthermore, we assessed perceived supervisor attitudes towards QRPs as an important predictive factor. The results were in line with estimates of QRP prevalence from academia. The best predictor of QRP use was students' QRP attitudes. Perceived supervisor attitudes exerted both a direct and indirect effect via student attitudes. Motivation to write a good thesis was a protective factor, whereas stress had no effect. Students in this sample did not subscribe to beliefs that significant results were better for science or their grades. Such beliefs further did not impact QRP attitudes or use in this sample. Finally, students engaged in more QRPs pertaining to reporting and analysis than those pertaining to study design. We conclude that supervisors have an important function in shaping students' attitudes towards QRPs and can improve their research practices by motivating them well. Furthermore, this research provides some impetus towards identifying predictors of QRP use in academia.	[Krishna, Anand] Julius Maximilians Univ, Dept Motivat & Emot Psychol, Wurzburg, Germany; [Peter, Sebastian M.] Julius Maximilians Univ, Dept Social Psychol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Krishna, A (corresponding author), Julius Maximilians Univ, Dept Motivat & Emot Psychol, Wurzburg, Germany.	krishna@psychologie.uni-wuerzburg.de	Krishna, Anand/S-3075-2019	Krishna, Anand/0000-0003-3838-9210	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Agnoli F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172792; Alfredo K, 2011, SCI ENG ETHICS, V17, P447, DOI 10.1007/s11948-010-9217-3; Anderson MS, 2007, SCI ENG ETHICS, V13, P387, DOI 10.1007/s11948-007-9047-0; Anderson MS, 2007, J EMPIR RES HUM RES, V2, P3, DOI 10.1525/jer.2007.2.4.3; [Anonymous], CLEAR TRAIN MOD ENH; Antes AL, 2014, ACCOUNT RES, V21, P50, DOI 10.1080/08989621.2013.822269; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Bandura A., 1977, SOCIAL LEARNING THEO, DOI [10.1177/105960117700200317, DOI 10.1177/105960117700200317]; Baumeister RF, 2016, J EXP SOC PSYCHOL, V66, P153, DOI 10.1016/j.jesp.2016.02.003; Bird SJ, 2001, SCI ENG ETHICS, V7, P455, DOI 10.1007/s11948-001-0002-1; Brown ME, 2005, ORGAN BEHAV HUM DEC, V97, P117, DOI 10.1016/j.obhdp.2005.03.002; CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752; Collaborative Replications and Education Project (CREP), 2013, OPEN SCI FRAMEWORK, DOI [10.17605/OSF.IO/WFC6U, DOI 10.17605/OSF.I0/WFC6U]; Conrad CF, 1993, SILENT SUCCESS MASTE, P2715; Davis MS, 2007, SCI ENG ETHICS, V13, P395, DOI 10.1007/s11948-007-9045-2; de Kleijn RAM, 2012, STUD HIGH EDUC, V37, P925, DOI 10.1080/03075079.2011.556717; De Vries R, 2006, J EMPIR RES HUM RES, V1, P43, DOI 10.1525/jer.2006.1.1.43; Demb A., 1999, NACADA J, V19, P18, DOI DOI 10.12930/0271-9517-19.2.18; DuBois JM, 2012, ETHICS BEHAV, V22, P163, DOI 10.1080/10508422.2011.641832; Ebersole CR, 2016, J EXP SOC PSYCHOL, V67, P68, DOI 10.1016/j.jesp.2015.10.012; Eich E, 2014, PSYCHOL SCI, V25, P3, DOI 10.1177/0956797613512465; Fanelli Daniele, 2009, PLoS One, V4, pe5738, DOI 10.1371/journal.pone.0005738; Fanelli D, 2013, P NATL ACAD SCI USA, V110, P15031, DOI 10.1073/pnas.1302997110; Festinger L., 1962, THEORY COGNITIVE DIS; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; Fiedler K, 2016, SOC PSYCHOL PERS SCI, V7, P45, DOI 10.1177/1948550615612150; Franco A, 2016, SOC PSYCHOL PERS SCI, V7, P8, DOI 10.1177/1948550615598377; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Frank MC, 2012, PERSPECT PSYCHOL SCI, V7, P600, DOI 10.1177/1745691612460686; Fuchs HM, 2012, PERSPECT PSYCHOL SCI, V7, P639, DOI 10.1177/1745691612459521; Gilmore RO, 2017, ANN NY ACAD SCI, V1396, P5, DOI 10.1111/nyas.13325; Giner-Sorolla R, 2012, PERSPECT PSYCHOL SCI, V7, P562, DOI 10.1177/1745691612457576; HACKMAN JR, 1975, J APPL PSYCHOL, V60, P159, DOI 10.1037/h0076546; Hayes A.F., 2013, INTRO MEDIATION MODE; Jennions MD., 2013, HDB META ANAL ECOLOG, P207, DOI [10.23943/princeton/9780691137285.003.0014, DOI 10.23943/PRINCETON/9780691137285.003.0014, DOI 10.1515/9781400846184-016]; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kelman H.C., 1958, J CONFLICT RESOLUT, V2, P51, DOI [10.1177/002200275800200106, DOI 10.1177/002200275800200106]; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kornfeld D., 2014, OFFICE RES INTEGRITY, V22, P2; Lakens D, 2014, EUR J SOC PSYCHOL, V44, P701, DOI 10.1002/ejsp.2023; LeBel EP, UNIFIED FRAMEWORK QU, P22; Lebel EP, 2013, PERSPECT PSYCHOL SCI, V8, P424, DOI 10.1177/1745691613491437; List JA, 2001, ECON INQ, V39, P162, DOI 10.1093/ei/39.1.162; Lizzio A, 2002, STUD HIGH EDUC, V27, P27, DOI 10.1080/03075070120099359; LOCK S, 1988, BRIT MED J, V297, P1531, DOI 10.1136/bmj.297.6662.1531; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Mayer DM, 2010, J BUS ETHICS, V95, P7, DOI 10.1007/s10551-011-0794-0; Motyl M, 2017, J PERS SOC PSYCHOL, V113, P34, DOI 10.1037/pspa0000084; Nuijten MB, 2016, BEHAV RES METHODS, V48, P1205, DOI 10.3758/s13428-015-0664-2; Ochroch EA, 2011, ANESTH ANALG, V112, P732, DOI 10.1213/ANE.0b013e318209d4e8; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Rajah-Kanagasabai CJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00535; Resnik D.B., 2000, ACCOUNT RES, V8, P163, DOI [10.1080/08989620008573971, DOI 10.1080/08989620008573971]; Resnik DB, 2017, ACCOUNT RES, V24, P116, DOI 10.1080/08989621.2016.1257387; Richter P, 2000, Z ARB ORGAN, V44, P129, DOI 10.1026//0932-4089.44.3.129; Ripley E, 2012, ACCOUNT RES, V19, P209, DOI 10.1080/08989621.2012.700880; Velasco MS, 2012, J BUS ECON MANAG, V13, P499, DOI 10.3846/16111699.2011.620150; Shamoo A.E., 2003, RESPONSIBLE CONDUCT; Sijtsma K, 2016, PSYCHOMETRIKA, V81, P1, DOI 10.1007/s11336-015-9446-0; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Song F., 2000, HLTH TECHNOLOGY ASSE, V4; Steneck NH, 2006, SCI ENG ETHICS, V12, P53, DOI 10.1007/PL00022268; SWAZEY JP, 1993, AM SCI, V81, P542; Tijdink JK, 2014, J EMPIR RES HUM RES, V9, P64, DOI 10.1177/1556264614552421; Tomlinson M, 2008, BRIT J SOCIOL EDUC, V29, P49, DOI 10.1080/01425690701737457; Versteege N., 2013, SOCIAL COSMOS, V4, P71; Washburn AN, 2018, ADV METH PRACT PSYCH, V1, P166, DOI 10.1177/2515245918757427; Wester KL, 2007, COUNS EDUC SUPERV, V46, P199, DOI 10.1002/j.1556-6978.2007.tb00025.x; Wetzels R, 2012, AM STAT, V66, P104, DOI 10.1080/00031305.2012.695956; Wicherts JM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01832; Wright DE, 2008, SCI ENG ETHICS, V14, P323, DOI 10.1007/s11948-008-9074-5	73	13	13	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203470	10.1371/journal.pone.0203470	http://dx.doi.org/10.1371/journal.pone.0203470			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161249	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900127
J	Whittal, A; Kaviani, M; Graf, R; Humphreys, G; Navabi, A				Whittal, Alexander; Kaviani, Mina; Graf, Robert; Humphreys, Gavin; Navabi, Alireza			Allelic variation of vernalization and photoperiod response genes in a diverse set of North American high latitude winter wheat genotypes	PLOS ONE			English	Article							FLOWERING TIME; SPRING WHEAT; KOLMOGOROV-SMIRNOV; PPD-D1; BARLEY; TRAITS; ADAPTABILITY; ADAPTATION; REGULATOR; NORMALITY	The major physiological determinants of wheat (Triticum aestivum L.) phenology in a given area are a response to vernalization temperature and day length, which are at least in part, regulated by the allelic variation at the vernalization (VRN) and photoperiod (PPD) loci, respectively. Characterization of the existing genetic variation for plant phenology in winter wheat can assist breeding programs improve adaptation to local environments and to optimize wheat phenology for the changing climate. The objectives of this research were to characterize the allelic variation at the major VRNand PPD loci in a diverse panel of high latitude winter wheat genotypes (n = 203) and to associate the allelic variation with phenologic, agronomic and adaptation traits. The panel was genotyped using allele-specific markers at vernalization (VRN-A1, VRN-B1, VRN-D1 and VRN-B3) and photoperiod (PPD-A1, PPDB1, and PPD-D1) loci and phenotyped for agronomically-important traits. Though photoperiod sensitivity was more prevalent, most of the variation in the phenology of the winter wheat panel was explained by allelic variation at PPD-D1, PPD-A1, and the interaction between these loci. While a typical high latitude winter wheat genotype is one that carries winter alleles at all major VRN loci and photoperiod sensitive alleles at the major PPD loci, in lower latitudes where winters are milder, the presence of one or two photoperiod insensitive alleles seems to contribute to higher yield and wider adaptation.	[Whittal, Alexander; Kaviani, Mina; Navabi, Alireza] Univ Guelph, Dept Plant Agr, Guelph, ON, Canada; [Graf, Robert] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Humphreys, Gavin] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada	University of Guelph; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Navabi, A (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON, Canada.	anavabi@uoguelph.ca	Kaviani, Mohammad Javad/T-9205-2019	Kaviani, Mina/0000-0002-5426-7208; Graf, Robert/0000-0003-0922-5049	Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Grain Farmers of Ontario; SeCan National Scientific and Engineering Research Council of Canada (NSERC)	Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Grain Farmers of Ontario; SeCan National Scientific and Engineering Research Council of Canada (NSERC)	Funded by Ontario Ministry of Agriculture, Food, and Rural Affairs (OMAFRA) Grain Farmers of Ontario, SeCan National Scientific and Engineering Research Council of Canada (NSERC).	ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Cane K, 2013, CROP PASTURE SCI, V64, P100, DOI 10.1071/CP13086; Chen H, 2016, EUPHYTICA, V208, P377, DOI 10.1007/s10681-015-1615-9; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; DARLING DA, 1957, ANN MATH STAT, V28, P823, DOI 10.1214/aoms/1177706788; DAVIDSON JL, 1985, AUST J AGR RES, V36, P347, DOI 10.1071/AR9850347; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dyck JA, 2004, CROP SCI, V44, P1976, DOI 10.2135/cropsci2004.1976; Fjellheim S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00431; Foulkes MJ, 2004, EUPHYTICA, V135, P63, DOI 10.1023/B:EUPH.0000009542.06773.13; Fowler DB, 2001, PLANT PHYSIOL, V127, P1676, DOI 10.1104/pp.010483; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Grogan SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152852; Guedira M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154242; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Iqbal M, 2006, CAN J PLANT SCI, V86, P995, DOI 10.4141/P06-002; Iqbal M, 2007, CROP SCI, V47, P1031, DOI 10.2135/cropsci2006.09.0618; Kamran A, 2013, CROP SCI, V53, P84, DOI 10.2135/cropsci2012.05.0313; Karsai I, 2006, PLANT BREEDING, V125, P468, DOI 10.1111/j.1439-0523.2006.01266.x; Kiss T, 2017, CEREAL RES COMMUN; Kiss T, 2014, MOL BREEDING, V34, P297, DOI 10.1007/s11032-014-0034-2; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langer SM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00537; LAW CN, 1978, HEREDITY, V41, P185, DOI 10.1038/hdy.1978.87; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; MCMASTER GS, 1988, AGR FOREST METEOROL, V43, P1, DOI 10.1016/0168-1923(88)90002-0; Milec Z, 2013, EUPHYTICA, V192, P371, DOI 10.1007/s10681-013-0863-9; Miralles DJ, 2000, ANN BOT-LONDON, V85, P655, DOI 10.1006/anbo.2000.1121; Nakamichi N, 2015, PLANT CELL PHYSIOL, V56, P594, DOI 10.1093/pcp/pcu181; Procunier J. D., 1990, Barley Genetics Newsletter, V20, P74; PUGSLEY AT, 1972, EUPHYTICA, V21, P547, DOI 10.1007/BF00039355; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Shcherban AB, 2015, PLANT BREEDING, V134, P49, DOI 10.1111/pbr.12223; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Trevaskis B, 2010, FUNCT PLANT BIOL, V37, P479, DOI 10.1071/FP10056; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Worland AJ, 1996, EUPHYTICA, V89, P49, DOI 10.1007/BF00015718; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yang FP, 2009, EUPHYTICA, V165, P445, DOI 10.1007/s10681-008-9745-y; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang XF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00470	49	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203068	10.1371/journal.pone.0203068	http://dx.doi.org/10.1371/journal.pone.0203068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161188	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900074
J	Young, MF; Nguyen, PH; Casanova, IG; Addo, OY; Tran, LM; Nguyen, S; Martorell, R; Ramakrishnan, U				Young, Melissa F.; Phuong Hong Nguyen; Casanova, Ines Gonzalez; Addo, O. Yaw; Lan Mai Tran; Nguyen, Son; Martorell, Reynaldo; Ramakrishnan, Usha			Role of maternal preconception nutrition on offspring growth and risk of stunting across the first 1000 days in Vietnam: A prospective cohort study	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; CHILD GROWTH; FOLIC-ACID; BIRTH; INCOME; UNDERNUTRITION; UNDERWEIGHT; PREGNANCY; OUTCOMES; INFANT	Growing evidence supports the role of preconception maternal nutritional status (PMNS) on birth outcomes; however, evidence of relationships with child growth are limited. We examined associations between PMNS (height, weight and body mass index- BMI) and offspring growth during the first 1000 days. We used prospective cohort data from a randomized-controlled trial of preconception micronutrient supplementation in Vietnam, PRECONCEPT (n = 1409). Poisson regression models were used to examine associations between PMNS and risk of offspring stunting (<-2 HAZ) at 2 years. We used path analytic models to examine associations with PMNS on fetal growth (ultrasound measurements) and offspring HAZ at birth and 2 years. All models were adjusted for child age, sex, gestational weight gain, education, socioeconomic status and treatment group. A third of women had a preconception height < 150cm or weight < 43 kg. Women with preconception height < 150 cm or a weight < 43 kg were at increased risk of having a stunted child at 2 years (incident risk ratio IRR: 1.85, 95% CI 1.51-2.28; IRR 1.35, 95% CI 1.10-1.65, respectively). While the traditional low BMI cut-off (< 18.5 kg/m 2 ) was not significant, lower BMI cut-offs (< 17.5 kg/m(2) or < 18.0 kg/m(2)) were significantly associated with 1.3 times increased risk of child stunting. In path models, PMNS were positively associated with fetal growth (ultrasound measurements) and offspring HAZ at birth and 2 years. For each 1 standard deviation (SD) increase in maternal height and weight, offspring HAZ at 2 years increased by 0.30 SD and 0.23 SD, respectively. In conclusion, PMNS influences both offspring linear growth and risk of stunting across the first 1000 days. These findings underscore the importance of expanding the scope of current policies and strategies to include the preconception period in order to reduce child stunting.	[Young, Melissa F.; Casanova, Ines Gonzalez; Addo, O. Yaw; Martorell, Reynaldo; Ramakrishnan, Usha] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Phuong Hong Nguyen; Lan Mai Tran; Nguyen, Son] Int Food Policy Res Inst, Washington, DC USA; [Phuong Hong Nguyen] Thai Nguyen Univ Pharm & Med, Thai Nguyen, Vietnam	Emory University; Rollins School Public Health; CGIAR; International Food Policy Research Institute (IFPRI); Thai Nguyen University	Young, MF (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	melissa.young@emory.edu	, Melissa/AAW-2016-2021; Casanova, Ines Gonzalez/AAF-2301-2019; Martorell, Reynaldo/I-2539-2012	Casanova, Ines Gonzalez/0000-0001-5747-8636; Young, Melissa/0000-0002-2768-1673; Nguyen, Phuong H/0000-0003-3418-1674; Addo, O.Yaw/0000-0003-1269-759X	Thrasher Research Fund; Nestle Foundation; Micronutrient Initiative; Mathile Institute for Advancement of Human Nutrition	Thrasher Research Fund; Nestle Foundation(Nestle SA); Micronutrient Initiative; Mathile Institute for Advancement of Human Nutrition	Funding for this research was provided by the Thrasher Research Fund (https://www.thrasherresearch.org/default.aspx), Nestle Foundation (http://www.nestlefoundation.org/e/), Micronutrient Initiative (https://mathileinstitute.org) and the Mathile Institute for Advancement of Human Nutrition (https://mathileinstitute.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo OY, 2015, AM J HUM BIOL, V27, P99, DOI 10.1002/ajhb.22614; Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bruce NG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S8; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; Cogill B, 2003, ANTHROPOMETRIC INDIC; Danaei G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002164; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Dewey KG, 2016, MATERN CHILD NUTR, V12, P27, DOI 10.1111/mcn.12282; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; Gibson R.S., 2005, PRINCIPLES NUTR ASSE, P908; Gonzalez-Casanova I, NUTR HLTH DEV WORLD; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; Hambidge KM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-111; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Institute of Medicine (Subcommittees on Nutritional Status and Weight Gain During Pregnancy and Dietary Intake and Nutrient Supplements During Pregnancy Committee on Nutritional Status During Pregnancy and Lactation Food and Nutrition Board), 1990, NUTR PREGN 1; Johnson W, 2017, AM J CLIN NUTR, V105, P1474, DOI 10.3945/ajcn.116.144196; Khambalia AZ, 2009, AM J CLIN NUTR, V90, P1295, DOI 10.3945/ajcn.2009.28350; Khlangwiset P, 2011, CRIT REV TOXICOL, V41, P740, DOI 10.3109/10408444.2011.575766; King JC, 2016, J NUTR, V146, p1437S, DOI 10.3945/jn.115.223479; Kline R.B., 2011, PRINCIPLES PRACTICE; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Mason JB, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23623; Nguyen PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167416; Nguyen PH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-898; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; Nguyen PH, 2016, PAEDIATR PERINAT EP, V30, P256, DOI 10.1111/ppe.12276; Ramakrishnan U, 2016, J NUTR, V146, p1445S, DOI 10.3945/jn.115.223420; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Smith LE, 2012, ADV NUTR, V3, P526, DOI 10.3945/an.112.002188; StataCorp, 2021, STATA STAT SOFTWARE; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO: World Health Organization, 2010, WHO CHILD GROWTH STA; Wilson RD, 2015, J OBSTET GYNAECOL CA, V37, P534, DOI 10.1016/S1701-2163(15)30230-9; World Health Organization, 2014, COMPR IMPL PLAN MAT; Young MF, 2015, EUR J OBSTET GYN R B, V194, P223, DOI 10.1016/j.ejogrb.2015.09.018; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627	41	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203201	10.1371/journal.pone.0203201	http://dx.doi.org/10.1371/journal.pone.0203201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161206	Green Submitted, gold, Green Published			2022-12-27	WOS:000443388900088
J	Mattern, T; Putz, K; Garcia-Borboroglu, P; Ellenberg, U; Houston, DM; Long, R; Luthi, B; Seddon, PJ				Mattern, Thomas; Puetz, Klemens; Garcia-Borboroglu, Pablo; Ellenberg, Ursula; Houston, David M.; Long, Robin; Luethi, Benno; Seddon, Philip J.			Marathon penguins - Reasons and consequences of long-range dispersal in Fiordland penguins / Tawaki during the premoult period	PLOS ONE			English	Article							NEW-ZEALAND; PRE-MOLT; SUBTROPICAL FRONT; WINTER MIGRATION; SOUTHERN-OCEAN; HABITAT; CONSERVATION; BIRDS; ATTACHMENT; SEABIRDS	Migratory species often roam vast distances bringing them into contact with diverse conditions and threats that could play significant roles in their population dynamics. This is especially true if long-range travels occur within crucial stages of a species' annual life-cycle. Crested penguins, for example, usually disperse over several hundreds of kilometres after completing the energetically demanding breeding season and in preparation for the costly annual moult. A basic understanding of crested penguins' pre-moult dispersal is therefore paramount in order to be able to assess factors affecting individual survival. The Fiordland penguin, or Tawaki, the only crested penguin species breeding on the New Zealand mainland, is currently one of the least studied and rarest penguin species in the world. We successfully satellite tracked the pre-moult dispersal of 17 adult Tawaki from a single colony located in the species' northern breeding distribution. Over the course of 8-10 weeks the penguins travelled up to 2,500 km away from their breeding colony, covering total swimming distances of up to 6,800 km. During outbound travels all penguins headed south-west within a well-defined corridor before branching out towards two general trip destinations. Birds leaving in late November travelled towards the Subtropical Front some 800 km south of Tasmania, whereas penguins that left in December headed further towards the subantarctic front. Using K-select analysis we examined the influence of oceanographic factors on the penguins' dispersal. Water depth, surface current velocity and sea level anomalies had the greatest influence on penguin movements at the subantarctic Front, while sea surface temperature and chlorophyll a concentration were key for birds travelling to the subtropical front. We discuss our findings in the light of anthropogenic activities (or lack thereof) in the regions visited by the penguins as well as the potential consequences of Tawaki pre-moult dispersal for the species' breeding distribution on the New Zealand mainland.	[Mattern, Thomas] Univ Otago, Dept Zool, Dunedin, New Zealand; [Mattern, Thomas; Garcia-Borboroglu, Pablo; Ellenberg, Ursula; Seddon, Philip J.] Global Penguin Soc, Marcos Zar 2716, RA-9120 Puerto Madryn, Chubut, Argentina; [Puetz, Klemens] Antarctic Res Trust, Oste Hamme Kanal 10, Bremervorde, Germany; [Garcia-Borboroglu, Pablo] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Blvd Brown 2825, Puerto Madryn, Chubut, Argentina; [Ellenberg, Ursula] La Trobe Univ, Dept Ecol Environm & Evolut, Melbourne, Vic, Australia; [Houston, David M.] Dept Conservat, Sci & Policy Grp, Auckland, New Zealand; [Long, Robin] West Coast Penguin Trust, Hokitika, New Zealand; [Luethi, Benno] Antarctic Res Trust, Zoo Zurich, Zurichbergstr 221, Zurich, Switzerland	University of Otago; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); La Trobe University	Mattern, T (corresponding author), Univ Otago, Dept Zool, Dunedin, New Zealand.; Mattern, T (corresponding author), Global Penguin Soc, Marcos Zar 2716, RA-9120 Puerto Madryn, Chubut, Argentina.	t.mattern@eudyptes.net	Seddon, Philip/G-8659-2011; Mattern, Thomas/AAJ-6325-2020; Ellenberg, Ursula/AAF-7317-2020	Seddon, Philip/0000-0001-9076-9566; Mattern, Thomas/0000-0003-0745-8180; Ellenberg, Ursula/0000-0002-3100-6742; Puetz, Klemens/0000-0003-1375-2669	Antarctic Research Trust; Global Penguin Society; Ornithological Society New Zealand; JS Watson Trust; Forest Bird Southland	Antarctic Research Trust; Global Penguin Society; Ornithological Society New Zealand; JS Watson Trust; Forest Bird Southland	Devices and data acquisition costs were covered by the Antarctic Research Trust to TM. This study was funded through grants by the Global Penguin Society, Ornithological Society New Zealand (Birds NZ Research grant), the JS Watson Trust and Forest & Bird Southland to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2009, GEN COMP ENDOCR, V163, P142, DOI 10.1016/j.ygcen.2009.03.028; [Anonymous], 2014, R LANG ENV STAT COMP; BANNASCH R, 1994, J EXP BIOL, V194, P83; Berthold P, 2001, J ORNITHOL, V142, P148, DOI 10.1007/BF01651453; Berthold P, 1996, CONTROL BIRD MIGRATI; Beyer HL, 2010, GEOSPATIAL MODELLING; BirdLife International, 2016, EUD PACH IUCN RED LI, V2016, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22697776A93638571.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22697776A93638571.EN]; Bon C, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0057-2; Bostock HC, 2015, PALEOCEANOGRAPHY, V30, P824, DOI 10.1002/2014PA002652; Boyd P, 1999, J GEOPHYS RES-OCEANS, V104, P13395, DOI 10.1029/1999JC900009; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Calenge C, 2005, ECOL MODEL, V186, P143, DOI 10.1016/j.ecolmodel.2004.12.005; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carter L, 2009, DEV EARTH ENV SCI, V8, P85, DOI 10.1016/S1571-9197(08)00004-9; Condie SA, 2006, MAR FRESHWATER RES, V57, P569, DOI 10.1071/MF06009; Crawford R, 2017, ENDANGER SPECIES RES, V34, P373, DOI 10.3354/esr00869; Croxall J. P., 1999, Marine Ornithology, V27, P1; Davis LS., 2003, PENGUINS; Dehnhard N, 2011, POLAR BIOL, V34, P1763, DOI 10.1007/s00300-011-1026-x; Dinica V, 2017, J SUSTAIN TOUR, V25, P1811, DOI 10.1080/09669582.2015.1115512; Ellenberg U, 2015, NEW ZEAL J ECOL, V39, P231; ESRI, 2020, ARCGIS DESKT REL 10; Falla RA, 1954, NOTORNIS, V5, P212; Fayet AL, 2016, BEHAV ECOL, V27, P1061, DOI 10.1093/beheco/arw013; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Borboroglu PG, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P321; Guilford T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021336; Hartin CA, 2014, GEOPHYS RES LETT, V41, P519, DOI 10.1002/2013GL058728; HELBIG AJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P9; Hiscock JA, 2014, NEW ZEAL J ECOL, V38, P124; Holdaway RN, 2001, NEW ZEAL J ZOOL, V28, P119, DOI 10.1080/03014223.2001.9518262; Jaeger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016484; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Kooyman GL, 2000, MAR ECOL PROG SER, V204, P269, DOI 10.3354/meps204269; Kooyman GL, 2004, MAR ECOL PROG SER, V267, P281, DOI 10.3354/meps267281; Le Quere C, 2016, BIOGEOSCIENCES, V13, P4111, DOI 10.5194/bg-13-4111-2016; Long R, 2014, FIORDLAND CRESTED PE; Lowther AD, 2014, ANTARCT SCI, V26, P533, DOI 10.1017/S0954102014000170; Ludynia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050429; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Mattern T, 2017, TAWAKI PROJECT FIELD, DOI [10.13140/RG.2.2.31050.77760, DOI 10.13140/RG.2.2.31050.77760]; Mattern T, 2017, PEERJ, V5, DOI 10.7717/peerj.3272; Mattern T, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P153; Mattern T, 2009, EMU, V109, P204, DOI 10.1071/MU08001; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Meyer S, 2015, MAR BIOL, V162, P1587, DOI 10.1007/s00227-015-2695-8; Morgenthaler A, 2018, POLAR BIOL, V41, P1041, DOI 10.1007/s00300-018-2264-y; Murphy RJ, 2001, NEW ZEAL J MAR FRESH, V35, P343, DOI 10.1080/00288330.2001.9517005; Norris DR, 2007, CONDOR, V109, P535; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Price R, 2016, FUNDING CUT IS NOT C; Putz K, 2007, MAR BIOL, V152, P1227, DOI 10.1007/s00227-007-0770-5; Putz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097164; Putz K, 2006, POLAR BIOL, V29, P735, DOI 10.1007/s00300-006-0110-0; Ramos R, 2017, DIVERS DISTRIB, V23, P794, DOI 10.1111/ddi.12569; Ramos R, 2015, J BIOGEOGR, V42, P1651, DOI 10.1111/jbi.12541; Robertson HA, 2017, NZ THREAT CLASSIF SE, V19; Ropert-Coudert Y, 2007, DEEP-SEA RES PT II, V54, P415, DOI 10.1016/j.dsr2.2006.11.018; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Singh NJ, 2011, J APPL ECOL, V48, P35, DOI 10.1111/j.1365-2664.2010.01905.x; Smith RO, 2013, DEEP-SEA RES PT I, V76, P13, DOI 10.1016/j.dsr.2013.02.007; Thiebot JB, 2014, IBIS, V156, P511, DOI 10.1111/ibi.12151; Trathan PN, 2008, MAR ECOL PROG SER, V370, P285, DOI 10.3354/meps07638; van Heezik Y.M., 1989, Notornis, V36, P151; VANHEEZIK Y, 1990, NEW ZEAL J ZOOL, V17, P543, DOI 10.1080/03014223.1990.10422952; WARHAM J, 1974, IBIS, V116, P1, DOI 10.1111/j.1474-919X.1974.tb00220.x; Whitehead TO, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2794-6; Whitehead TO, 2017, MAR ECOL PROG SER, V565, P227, DOI 10.3354/meps12017; Wienecke B, 2004, POLAR BIOL, V27, P83, DOI 10.1007/s00300-003-0574-0; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067; WILSON RP, 1989, J FIELD ORNITHOL, V60, P104; Wood S.N., 2017, GEN ADDITIVE MODELS; Worthy Trevor H., 1997, New Zealand Natural Sciences, V23, P71	78	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0198688	10.1371/journal.pone.0198688	http://dx.doi.org/10.1371/journal.pone.0198688			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157174	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400002
J	Musa, A; Tripathi, S; Kandhavelu, M; Dehmer, M; Emmert-Streib, F				Musa, Aliyu; Tripathi, Shailesh; Kandhavelu, Meenakshisundaram; Dehmer, Matthias; Emmert-Streib, Frank			Harnessing the biological complexity of Big Data from LINCS gene expression signatures	PLOS ONE			English	Article							CONNECTIVITY MAP; CELL-GROWTH; TARGET; CHALLENGES; RESPONSES	Gene expression profiling using transcriptional drug perturbations are useful for many biomedical discovery studies including drug repurposing and elucidation of drug mechanisms (MoA) and many other pharmacogenomic applications. However, limited data availability across cell types has severely hindered our capacity to progress in these areas. To fill this gap, recently, the LINCS program generated almost 1.3 million profiles for over 40,000 drug and genetic perturbations for over 70 different human cell types, including meta information about the experimental conditions and cell lines. Unfortunately, Big Data like the ones generated from the ongoing LINCS program do not enable easy insights from the data but possess considerable challenges toward their analysis. In this paper, we address some of these challenges. Specifically, first, we study the gene expression signature profiles from all cell lines and their perturbagents in order to obtain insights in the distributional characteristics of available conditions. Second, we investigate the differential expression of genes for all cell lines obtaining an understanding of condition dependent differential expression manifesting the biological complexity of perturbagents. As a result, our analysis helps the experimental design of follow-up studies, e.g., by selecting appropriate cell lines.	[Musa, Aliyu; Tripathi, Shailesh; Emmert-Streib, Frank] Tampere Univ Technol, Dept Signal Proc, Predict Med & Data Analyt Lab, Tampere, Finland; [Musa, Aliyu; Kandhavelu, Meenakshisundaram; Emmert-Streib, Frank] Tampere Univ Technol, Fac Biomed Sci & Engn, Mol Signaling Lab, Tampere, Finland; [Tripathi, Shailesh; Dehmer, Matthias] Univ Appl Sci Upper Austria, Steyr, Austria; [Kandhavelu, Meenakshisundaram] Tampere Univ Technol, BioMediTech Inst, Tampere, Finland; [Dehmer, Matthias] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria	Tampere University; Tampere University; Tampere University	Emmert-Streib, F (corresponding author), Tampere Univ Technol, Dept Signal Proc, Predict Med & Data Analyt Lab, Tampere, Finland.; Emmert-Streib, F (corresponding author), Tampere Univ Technol, Fac Biomed Sci & Engn, Mol Signaling Lab, Tampere, Finland.	frank.emmert-streib@tut.fi	Emmert-Streib, Frank/AAF-2878-2020; Kandhavelu, Meenakshisundaram/AAZ-7503-2021; PAN, ZEQIANG/X-6341-2018; Trpathi, Shailesh/T-2123-2017	Emmert-Streib, Frank/0000-0003-0745-5641; Kandhavelu, Meenakshisundaram/0000-0002-4986-055X; Musa, Aliyu/0000-0003-1217-2638	Austrian Science Funds [P26142]	Austrian Science Funds(Austrian Science Fund (FWF))	Matthias Dehmer thanks the Austrian Science Funds for supporting this work (project P26142).	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Butcher RA, 2005, CURR OPIN CHEM BIOL, V9, P25, DOI 10.1016/j.cbpa.2004.10.009; Cayrefourcq L, 2015, CANCER RES, V75, P892, DOI 10.1158/0008-5472.CAN-14-2613; Duan QN, 2014, NUCLEIC ACIDS RES, V42, pW449, DOI 10.1093/nar/gku476; Dunkel M, 2008, NUCLEIC ACIDS RES, V36, pW55, DOI 10.1093/nar/gkn307; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emmert-Streib F, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00015; Emmert-Streib F, 2013, PEERJ, V1, DOI 10.7717/peerj.10; Fan JQ, 2014, NATL SCI REV, V1, P293, DOI 10.1093/nsr/nwt032; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Finley SD, 2015, DRUG DISCOV TODAY, V20, P187, DOI 10.1016/j.drudis.2014.09.026; Hafner M, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.166; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hinkelmann K, 2008, DESIGN ANAL EXPT INT; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Keenan AB, 2018, CELL SYST, V6, P13, DOI 10.1016/j.cels.2017.11.001; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kibble M, 2015, NAT PROD REP, V32, P1249, DOI 10.1039/c5np00005j; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lewis SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019750; Lim RG, 2017, CELL REP, V19, P1365, DOI 10.1016/j.celrep.2017.04.021; Lincscloud, 2014, LINCS L1000 R TOOLS; Liu CL, 2015, MOL BIOSYST, V11, P714, DOI 10.1039/c4mb00677a; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Miotto R, 2018, BRIEF BIOINFORM, V19, P1236, DOI 10.1093/bib/bbx044; Musa A, 2018, BRIEF BIOINFORM, V19, P506, DOI 10.1093/bib/bbw112; Niepel M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01383-w; Nigsch F, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-2; Ong E, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1981-5; Pan W, 2002, GENOME BIOL, V3; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Simoes RD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-324; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Vidovic D, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00342; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036	41	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201937	10.1371/journal.pone.0201937	http://dx.doi.org/10.1371/journal.pone.0201937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157183	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400020
J	Ali, M; Ali, SI; Kim, D; Hur, T; Bang, J; Lee, S; Kang, BH; Hussain, M				Ali, Maqbool; Ali, Syed Imran; Kim, Dohyeong; Hur, Taeho; Bang, Jaehun; Lee, Sungyoung; Kang, Byeong Ho; Hussain, Maqbool			uEFS: An efficient and comprehensive ensemble-based feature selection methodology to select informative features	PLOS ONE			English	Article							ALGORITHMS; RANKING	Feature selection is considered to be one of the most critical methods for choosing appropriate features from a larger set of items. This task requires two basic steps: ranking and filtering. Of these, the former necessitates the ranking of all features, while the latter involves filtering out all irrelevant features based on some threshold value. In this regard, several feature selection methods with well-documented capabilities and limitations have already been proposed. Similarly, feature ranking is also nontrivial, as it requires the designation of an optimal cutoff value so as to properly select important features from a list of candidate features. However, the availability of a comprehensive feature ranking and a filtering approach, which alleviates the existing limitations and provides an efficient mechanism for achieving optimal results, is a major problem. Keeping in view these facts, we present an efficient and comprehensive univariate ensemble-based feature selection (uEFS) methodology to select informative features from an input dataset. For the uEFS methodology, we first propose a unified features scoring (UFS) algorithm to generate a final ranked list of features following a comprehensive evaluation of a feature set. For defining cutoff points to remove irrelevant features, we subsequently present a threshold value selection (TVS) algorithm to select a subset of features that are deemed important for the classifier construction. The uEFS methodology is evaluated using standard benchmark datasets. The extensive experimental results show that our proposed uEFS methodology provides competitive accuracy and achieved (1) on average around a 7% increase in f-measure, and (2) on average around a 5% increase in predictive accuracy as compared with state-of-the-art methods.	[Ali, Maqbool; Ali, Syed Imran; Kim, Dohyeong; Hur, Taeho; Bang, Jaehun; Lee, Sungyoung] Kyung Hee Univ, Dept Comp Sci & Engn, Yongin, Gyeonggi, South Korea; [Ali, Maqbool; Kang, Byeong Ho] Univ Tasmania, Sch Engn & ICT, Hobart, Tas, Australia; [Hussain, Maqbool] Sejong Univ, Dept Software, Seoul, Gyeonggi, South Korea	Kyung Hee University; University of Tasmania; Sejong University	Lee, S (corresponding author), Kyung Hee Univ, Dept Comp Sci & Engn, Yongin, Gyeonggi, South Korea.	sylee@oslab.khu.ac.kr	Kang, Byeong Ho/J-7907-2014; Lee, Sungyoung/AAK-7257-2020	Kang, Byeong Ho/0000-0003-3476-8838; , Maqbool/0000-0002-4107-7122	MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) [IITP-2017-0-01629]; Institute for Information & Communications Technology Promotion (IITP) - Korean government (MSIT) [2017-0-00655]	MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center); Institute for Information & Communications Technology Promotion (IITP) - Korean government (MSIT)	This research was supported by the MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2017-0-01629) supervised by the IITP (Institute for Information & Communications Technology Promotion). This work was supported by the Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korean government (MSIT) (No. 2017-0-00655).	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Ahmad A, 2005, PATTERN RECOGN LETT, V26, P43, DOI 10.1016/j.patrec.2004.08.015; Ali M, 2017, DOCUMENTATION UFS FE; Ali M, 2017, UFS UNIFIED FEATURES; Ali M, 2018, IEEE ACCESS, V6, P15587, DOI 10.1109/ACCESS.2018.2817022; Ali M, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P382, DOI 10.1109/ICMLA.2013.78; Ali S., 2012, INT J COMPUT APPL, P1, DOI [DOI 10.1109/ICET.2012.6375420, 10.1109/ICET.2012.6375420]; Altidor W, 2011, STABILITY ANAL FEATU; Altidor W, 2011, HANDBOOK OF DATA INTENSIVE COMPUTING, P349, DOI 10.1007/978-1-4614-1415-5_13; Attik M, 2006, LECT NOTES COMPUT SC, V3971, P1359; Belanche L.A., 2011, ARXIV11012320; Bolon-Canedo V, 2014, INFORM SCIENCES, V282, P111, DOI 10.1016/j.ins.2014.05.042; Chen Y, 2006, LECT NOTES COMPUT SC, V4318, P153; Das S., 2001, ICML, P74; Dhote Y, 2015, INT CONF COMPUT INTE, P1375, DOI 10.1109/CICN.2015.267; Doraisamy S., 2008, P ISMIR, P331; Grigorev A, 2014, RULE BASED CLASSIFIE; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Humphrey M., 1998, Intelligent Data Analysis, V2, DOI 10.1016/S1088-467X(98)00029-8; Jong K, 2004, LECT NOTES ARTIF INT, V3202, P267; Joshi R., 2018, ACCURACY PRECISION R; Kalousis A, 2007, KNOWL INF SYST, V12, P95, DOI 10.1007/s10115-006-0040-8; Kenji K, 1992, P 9 INT WORKSH MACH, P249, DOI DOI 10.1016/B978-1-55860-247-2.50037-1; Kononenko I, 1997, APPL INTELL, V7, P39, DOI 10.1023/A:1008280620621; LIU H, 2005, SYSTEMS MAN CYBERN A, V17, P491, DOI DOI 10.1109/TKDE; Liu Z, ED TECHN COMP SCI ET, V1; Lutu PEN, 2010, EXPERT SYST APPL, V37, P602, DOI 10.1016/j.eswa.2009.06.031; Makrehchi M., 2007, FEATURE RANKING TEXT; McLachlan G.J., 2005, ANAL MICROARRAY GENE, V422; Novakovic Jasmina, 2016, YUGOSLAV J OPERATION, V21; Onan A, 2017, J INF SCI, V43, P25, DOI 10.1177/0165551515613226; Osanaiye O, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0623-3; Pratt R., 2012, 2012 IEEE PES Innovative Smart Grid Technologies (ISGT), DOI 10.1109/ISGT.2012.6175820; Rokach L, 2006, STUD COMPUT INTELL, V23, P295; Sadeghi S, 2013, INT J ARTIF INTELL T, V22, DOI 10.1142/S0218213013500103; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Santana LEA, 2007, IEEE IJCNN, P643, DOI 10.1109/IJCNN.2007.4371032; Sarkar C, 2014, APPL ARTIF INTELL, V28, P243, DOI 10.1080/08839514.2014.883903; Seijo-Pardo B, 2017, KNOWL-BASED SYST, V118, P124, DOI 10.1016/j.knosys.2016.11.017; Sharma A., 2012, IJCA SPECIAL ISSUE A, V3, P15; Slavkov I, 2010, JMLR WORKSH CONF PRO, V8, P122; Stoean R, 2013, ANN UNIV CRAIOVA-MAT, V40, P100; Tuv E, 2006, IEEE IJCNN, P2181; Wang GT, 2013, J ARTIF INTELL RES, V47, P1, DOI 10.1613/jair.3831; Whiteson S, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P1225; Williams G., 2010, CROSS VALIDATION DAT; Yousefpour A, 2017, EXPERT SYST APPL, V75, P80, DOI 10.1016/j.eswa.2017.01.009	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202705	10.1371/journal.pone.0202705	http://dx.doi.org/10.1371/journal.pone.0202705			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153294	Green Published, Green Accepted, gold			2022-12-27	WOS:000443001700022
J	Angoua, ELE; Dongo, K; Templeton, MR; Zinsstag, J; Bonfoh, B				Angoua, Eliachie Larissa Emeline; Dongo, Kouassi; Templeton, Michael R.; Zinsstag, Jakob; Bonfoh, Bassirou			Barriers to access improved water and sanitation in poor peri-urban settlements of Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							COUNTRIES; DISEASE; BURDEN	Achieving access to safe water and sanitation still pose major challenges in urban areas of sub-Saharan Africa countries, despite all the progress achieved in the last decade. This study assessed the ability of populations living in poor peri-urban settlements to access improved water and sanitation and identified factors influencing this access, in order to guide sustainable mitigating solutions to address associated health and environmental risks. We conducted a cross-sectional study in six poor peri-urban settlements of Yopougon, the largest municipality of Abidjan. A total of 556 randomly selected households were included. The factors associated with access to improved water and sanitation were identified through explanatory models using multivariate logistic regression. A proportion of 25% of all households assessed did not have access to clean water and 57% lacked improved sanitation. Socioeconomic status and settlement characteristics appear as the main indicators of poor access to reliable water and sanitation in peri-urban settlements. The presence of the household head's wife at home was associated with greater access to clean water (OR = 3.57; 95% CI: 1.74, 7.31), thus highlighting the important role of women in ensuring access to clean water in these specific environments. Household size, education and religion were not significantly associated with the two considered outcomes. Women therefore should be involved at all levels of programming in water promotion in these settlements to improve the population's well-being. While religion does not appear to play an important role in access to water and sanitation, successful interventions should involve religious communities because of their large representation.	[Angoua, Eliachie Larissa Emeline; Dongo, Kouassi; Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Ivoire, Dept Rech & Dev, Abidjan, Cote Ivoire; [Angoua, Eliachie Larissa Emeline; Dongo, Kouassi] Univ Felix Houphouet Boigny, Unite Format & Rech Sci Terre & Ressources Minier, Abidjan, Cote Ivoire; [Angoua, Eliachie Larissa Emeline; Zinsstag, Jakob; Bonfoh, Bassirou] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Angoua, Eliachie Larissa Emeline; Zinsstag, Jakob; Bonfoh, Bassirou] Univ Basel, Basel, Switzerland; [Templeton, Michael R.] Imperial Coll London, Dept Civil & Environm Engn, London, England	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Imperial College London	Angoua, ELE (corresponding author), Ctr Suisse Rech Sci Cote Ivoire, Dept Rech & Dev, Abidjan, Cote Ivoire.; Angoua, ELE (corresponding author), Univ Felix Houphouet Boigny, Unite Format & Rech Sci Terre & Ressources Minier, Abidjan, Cote Ivoire.; Angoua, ELE (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.; Angoua, ELE (corresponding author), Univ Basel, Basel, Switzerland.	lari.angoua@gmail.com		Dongo, Kouassi/0000-0002-2032-290X; Angoua, Eliachie Larissa Emeline/0000-0002-0361-2956	Programme d'Appui Strategique a la Recherche Scientifique, Cote d'Ivoire [PASRES/488-14/SY /TK]	Programme d'Appui Strategique a la Recherche Scientifique, Cote d'Ivoire	This work received support from the Programme d'Appui Strategique a la Recherche Scientifique, Cote d'Ivoire: PASRES/488-14/SY /TK; http://www.csrs.ch/pasres/; Author: ELEA; Role: data collection and analysis.	Arias E, 1996, SOC INDIC RES, V38, P53, DOI 10.1007/BF00293786; Bosch C., 2001, WATER SANITATION POV; Brama K, 2006, VERTIGO REV ELECT SC, DOI [10.4000/vertigo.1828, DOI 10.4000/VERTIGO.1828]; Calvo CM, 1994, CASE STUDY ROLE WOME; CEA UA BAD PNUD., 2014, RAPP OMD 2014 EV PRO; COHRE W SDC and UN-HABITAT, 2008, SAN HUM RIGHTS IMPER; Colcanap M, 1982, ASSAINISSEMENT VILL, P299; Davis J., 2012, P 5 INT C INF COMM T; Dongo K, 2008, VERTIGO REV ELECT SC, V8, P3; Dongo K., 2006, THESIS; El Sanharawi M, 2013, J FR OPHTALMOL, V36, P710, DOI 10.1016/j.jfo.2013.05.008; Graham JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155981; Hawkins P., 2013, POOR INCLUSIVE URBAN; Mahama AM, 2014, J WATER HEALTH, V12, P318, DOI 10.2166/wh.2014.149; Mohamad ZF, 2012, RESOUR CONSERV RECY, V58, P143, DOI 10.1016/j.resconrec.2011.09.020; Obrist B., 2006, EUR J DEV RES, V18, P319, DOI DOI 10.1080/09578810600708387; Pan Y, 2008, EPIDEMIOL INFECT, V136, P421, DOI 10.1017/S095026880700831X; Perez E, 2012, WORKING PAPER, P70944; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; RGPH, 2014, REC GEN POP HAB PRIN; Sorenson SB, 2011, SOC SCI MED, V72, P1522, DOI 10.1016/j.socscimed.2011.03.010; StataCorp, 2015, STAT SOFTW REL 14; StataCorp, 2015, STAT 14 BAS REF MAN; Sweetman C., 2017, Gender and Development, V25, P153, DOI 10.1080/13552074.2017.1349867; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1; Unies N., 2015, OBJECTIFS MILLENAIRE; Vaughan JP, MANUEL EPIDEMIOLOGIE; WHO/UNICEF Joint Monitoring, 2012, PROGR DRINKING WATER; Wisner B., 2002, ENV HLTH EMERGENCIES; World Health Organization, 2015, PROGR SAN DRINK WAT; World Health Organization United Nations Children's Fund., 2017, PROGR DRINKING WATER	31	24	25	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202928	10.1371/journal.pone.0202928	http://dx.doi.org/10.1371/journal.pone.0202928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153297	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000443001700032
J	Eickel, K; Porter, DA; Sohner, A; Maass, M; Ludemann, L; Gunther, M				Eickel, Klaus; Porter, David Andrew; Soehner, Anika; Maass, Marc; Luedemann, Lutz; Guenther, Matthias			Simultaneous multislice acquisition with multi-contrast segmented EPI for separation of signal contributions in dynamic contrast-enhanced imaging	PLOS ONE			English	Article							ARTERIAL INPUT FUNCTION; PERFUSION MRI; DCE-MRI; CANCER; MODEL; T-1	We present a method to efficiently separate signal in magnetic resonance imaging (MRI) into a base signal S0, representing the mainly T1 -weighted component without T2*-relaxation, and its T2*-weighted counterpart by the rapid acquisition of multiple contrasts for advanced pharmacokinetic modelling. This is achieved by incorporating simultaneous multislice (SMS) imaging into a multi-contrast, segmented echo planar imaging (EPI) sequence to allow extended spatial coverage, which covers larger body regions without time penalty. Simultaneous acquisition of four slices was combined with segmented EPI for fast imaging with three gradient echo times in a preclinical perfusion study. Six female domestic pigs, German-landrace or hybrid-form, were scanned for 11 minutes respectively during administration of gadolinium-based contrast agent. Influences of reconstruction methods and training data were investigated. The separation into T1- and T2*-dependent signal contributions was achieved by fitting a standard analytical model to the acquired multi-echo data. The application of SMS yielded sufficient temporal resolution for the detection of the arterial input function in major vessels, while anatomical coverage allowed perfusion analysis of muscle tissue. The separation of the MR signal into T1- and T2*-dependent components allowed the correction of susceptibility related changes. We demonstrate a novel sequence for dynamic contrast-enhanced MRI that meets the requirements of temporal resolution (Delta t< 1.5 s) and image quality. The incorporation of SMS into multi-contrast, segmented EPI can overcome existing limitations of dynamic contrast enhancement and dynamic susceptibility contrast methods, when applied separately. The new approach allows both techniques to be combined in a single acquisition with a large spatial coverage.	[Eickel, Klaus; Guenther, Matthias] Univ Bremen, Bermen, Germany; [Eickel, Klaus; Guenther, Matthias] Fraunhofer MEVIS, Bremen, Germany; [Eickel, Klaus; Guenther, Matthias] mediri GmbH, Heidelberg, Germany; [Porter, David Andrew] Univ Glasgow, Glasgow, Lanark, Scotland; [Soehner, Anika; Luedemann, Lutz] Univ Hosp Essen, Essen, Germany; [Maass, Marc] Evangel Krankenhaus Wesel, Wesel, Germany	University of Bremen; University of Glasgow; University of Duisburg Essen	Eickel, K (corresponding author), Univ Bremen, Bermen, Germany.; Eickel, K (corresponding author), Fraunhofer MEVIS, Bremen, Germany.; Eickel, K (corresponding author), mediri GmbH, Heidelberg, Germany.	klaus.eickel@rub.de	Porter, David A/AAN-8501-2020	Porter, David A/0000-0001-8436-6904; Eickel, Klaus/0000-0002-5700-2029	Deutsche Forschungsgemeinschaft (DFG) [LU 844/8-1]; MRC [MR/N003403/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Lutz Ludemann received Grant No. LU 844/8-1 from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Klaus Eickel and Matthias Gunther were/are employees of mediri GmbH, Heidelberg, Germany, as well as Fraunhofer MEVIS, Bremen, Germany. The funders provided support in the form of salaries for authors [K.E., M.G.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baish JW, 2000, CANCER RES, V60, P3683; Barth M, 2016, MAGN RESON MED, V75, P63, DOI 10.1002/mrm.25897; Breuer F, 2015, CAIPIRINHA REV, P8; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; Breuer FA, 2009, MAGN RESON MED, V62, P739, DOI 10.1002/mrm.22066; Calamante F, 2013, PROG NUCL MAG RES SP, V74, P1, DOI 10.1016/j.pnmrs.2013.04.002; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Castillo M, 2014, RADIOLOGY, V273, pS111, DOI 10.1148/radiol.14140130; Cauley SF, 2014, MAGN RESON MED, V72, P93, DOI 10.1002/mrm.24898; d'Arcy JA, 2002, NMR BIOMED, V15, P174, DOI 10.1002/nbm.755; Deshmane A, 2012, J MAGN RESON IMAGING, V36, P55, DOI 10.1002/jmri.23639; Eichner C, 2014, MAGN RESON MED, V72, P770, DOI 10.1002/mrm.24960; Eickel K, 2016, P INT SOC MAG RESON, V3244; Essig M, 2013, AM J ROENTGENOL, V200, P24, DOI 10.2214/AJR.12.9543; FEINBERG DA, 1994, MAGNET RESON MED, V32, P535, DOI 10.1002/mrm.1910320418; Feinberg DA., 2011, PLOS ONE, DOI [10.1371/annotation/d9496d01-8c5d-4d24-8287-94449ada5064, DOI 10.1371/ANNOTATION/D9496D01-8C5D-4D24-8287-94449ADA5064]; Heid O, 2000, US Patent, Patent No. 6043651A; Heilmann M, 2007, MAGN RESON MATER PHY, V20, P193, DOI 10.1007/s10334-007-0082-2; Hennel F, 1997, CONCEPT MAGNETIC RES, V9, P43, DOI 10.1002/(SICI)1099-0534(1997)9:1<43::AID-CMR4>3.0.CO;2-N; Hindel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170841; Hindel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128060; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Jackson A, 2005, DYNAMIC CONTRAST ENH, DOI [10.1007/b137553, DOI 10.1007/B137553]; Jahng GH, 2014, KOREAN J RADIOL, V15, P554, DOI 10.3348/kjr.2014.15.5.554; Kershaw LE, 2010, MAGN RESON MED, V64, P1772, DOI 10.1002/mrm.22573; Kistler M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2930; Ludemann L, 2009, ANN BIOMED ENG, V37, P749, DOI 10.1007/s10439-009-9645-x; Markwardt CB, 2009, ASTR SOC P, V411, P251; Miyati T, 1997, J MAGN RESON IMAGING, V7, P230, DOI 10.1002/jmri.1880070136; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Mugler JP, 1996, MAGNET RESON MED, V36, P306, DOI 10.1002/mrm.1910360218; Newbould RD, 2007, MAGN RESON MED, V58, P70, DOI 10.1002/mrm.21255; Newton AT, 2016, AM J NEURORADIOL, V37, P1237, DOI 10.3174/ajnr.A4700; Polimeni JR, 2012, P INT SOC MAGN RESON, V20, P2222; Ritter F, 2011, IEEE PULSE, V2, P60, DOI 10.1109/MPUL.2011.942929; Sauerbrey A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/390506; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Sourbron S, 2009, MAGN RESON MED, V62, P672, DOI 10.1002/mrm.22042; Sourbron SP, 2013, NMR BIOMED, V26, P1004, DOI 10.1002/nbm.2940; Vonken EJPA, 2000, MAGNET RESON MED, V43, P820, DOI 10.1002/1522-2594(200006)43:6<820::AID-MRM7>3.0.CO;2-F; YOUNG IR, 1984, BRIT MED BULL, V40, P139, DOI 10.1093/oxfordjournals.bmb.a071960	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202673	10.1371/journal.pone.0202673	http://dx.doi.org/10.1371/journal.pone.0202673			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153275	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000443001700020
J	Popescu, DC; Huang, H; Singhal, NK; Shriver, L; McDonough, J; Clements, RJ; Freeman, EJ				Popescu, Daniela C.; Huang, He; Singhal, Naveen K.; Shriver, Leah; McDonough, Jennifer; Clements, Robert J.; Freeman, Ernest J.			Vitamin K enhances the production of brain sulfatides during remyelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; CUPRIZONE MODEL; DEMYELINATION; METABOLISM; RATS; SKELETAL; MYELIN; MOUSE; MICE	Multiple sclerosis (MS) is a devastating neurological disease, which is characterized by multifocal demyelinating lesions in the central nervous system. The most abundant myelin lipids are galactosylceramides and their sulfated form, sulfatides, which together account for about 27% of the total dry weight of myelin. In this study we investigated the role of vitamin K in remyelination, by using an animal model for MS, the cuprizone model. Demyelination was induced in C57BI6/J mice, by feeding them a special diet containing 0.3% cuprizone (w/w) for 6 weeks. After 6 weeks, cuprizone was removed from the diet and mice were allowed to remyelinate for either 1 or 3 weeks, in the absence or presence of vitamin K(i.p phylloquinone, 2mg, three times per week). Vitamin K enhanced the production of total brain sulfatides, after both 1 week and 3 weeks of remyelination (n = 5, P-values were <0.0001), when compared with the control group. To determine whether or not there is a synergistic effect between vitamins K and D for the production of brain sulfatides, we employed a similar experiment as above. Vitamin K also increased the production of individual brain sulfatides, including d18:1/18:0, d18:1/20:0, d18:1/24:0, and d18:1/24:1 after 3 weeks of remyelination, when compared to the control group. In addition, vitamin D enhanced the production of total brain sulfatides, as well as d18:1/18:0, d18:1/24:0, and d18:1/24:1 sulfatides after 3 weeks of remyelination, but no synergistic effect between vitamins K and D for the production of total brain sulfatides was observed.	[Popescu, Daniela C.] Kent State Univ, Dept Biol Sci, Geauga Campus, Burton, OH 44021 USA; [Huang, He; Shriver, Leah] Univ Akron, Dept Chem & Biol, Akron, OH 44325 USA; [Singhal, Naveen K.; McDonough, Jennifer; Clements, Robert J.; Freeman, Ernest J.] Kent State Univ, Dept Biol Sci, Kent Campus, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Geauga; University System of Ohio; University of Akron; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Popescu, DC (corresponding author), Kent State Univ, Dept Biol Sci, Geauga Campus, Burton, OH 44021 USA.	dpopescu@kent.edu		Singhal, Naveen Kumar/0000-0003-4336-7331; Popescu, Daniela/0000-0002-9603-1084	National Multiple Sclerosis Society Pilot Grant [PP3372]; Kent State University, Geauga campus	National Multiple Sclerosis Society Pilot Grant; Kent State University, Geauga campus	This work was supported by National Multiple Sclerosis Society Pilot Grant PP3372 (D.C. P.) and by Kent State University, Geauga campus (D.C.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhof F, 2003, ARCH NEUROL-CHICAGO, V60, P1073, DOI 10.1001/archneur.60.8.1073; Binder MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017727; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; CONKERTON EJ, 1995, J AM OIL CHEM SOC, V72, P963, DOI 10.1007/BF02542075; Crivello NA, 2010, J NUTR BIOCHEM, V21, P1083, DOI 10.1016/j.jnutbio.2009.09.005; Denisova NA, 2005, NUTR REV, V63, P111, DOI 10.1111/j.1753-4887.2005.tb00129.x; Eckhardt M, 2007, J NEUROSCI, V27, P9009, DOI 10.1523/JNEUROSCI.2329-07.2007; Ferland G, 2012, ADV NUTR, V3, P204, DOI 10.3945/an.111.001784; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Haffa A, 2000, J BONE MINER RES, V15, P872, DOI 10.1359/jbmr.2000.15.5.872; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Iwamoto J, 2003, BONE, V33, P557, DOI 10.1016/S8756-3282(03)00249-7; Kidd PM, 2010, ALTERN MED REV, V15, P199; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Ludwin SK, 2006, J NEUROPATH EXP NEUR, V65, P305, DOI 10.1097/01.jnen.0000225024.12074.80; LUDWIN SK, 1978, LAB INVEST, V39, P597; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Martinez-Gardeazabal J, 2017, BBA-BIOMEMBRANES, V1859, P1548, DOI 10.1016/j.bbamem.2017.02.011; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Mugoni V, 2013, NAT PROTOC, V8, P2337, DOI 10.1038/nprot.2013.139; Nystad AE, 2014, APMIS, V122, P1178, DOI 10.1111/apm.12281; Ropper AH, 2006, NEW ENGL J MED, V354, P965, DOI 10.1056/NEJMe068002; Sachs HH, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551955; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Sundaram KS, 1996, J NUTR, V126, P2746; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Taraboletti A, 2017, BIOCHEMISTRY-US, V56, P1518, DOI 10.1021/acs.biochem.6b01072; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x	28	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203057	10.1371/journal.pone.0203057	http://dx.doi.org/10.1371/journal.pone.0203057			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148869	Green Submitted, gold, Green Published			2022-12-27	WOS:000442804200043
J	Poulsen, ASR; Luise, D; Curtasu, MV; Sugiharto, S; Canibe, N; Trevisi, P; Leuridsen, C				Poulsen, Ann-Sofie Riis; Luise, Diana; Curtasu, Mihai Victor; Sugiharto, Sugiharto; Canibe, Nuria; Trevisi, Paolo; Leuridsen, Charlotte			Effects of alpha-(1,2)-fucosyltransferase genotype variants on plasma metabolome, immune responses and gastrointestinal bacterial enumeration of pigs pre- and post- weaning	PLOS ONE			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; INTESTINAL EPITHELIUM; POSTWEANING DIARRHEA; FUT1 GENE; GUT; PORCINE; MICROBIOTA; EXPRESSION; PIGLETS; SUSCEPTIBILITY	In pigs, the alpha-(1,2) fucosyltransferase (FUT1) gene has been highlighted for its properties in controlling the intestinal expression of enterotoxigenic E. coli (ETEC) F18 receptors; a pathogen causing edema disease and post-weaning diarrhoea. In this study, we hypothesized that pigs with different genotypes (ETEC F18 resistant (FUT1(AA)) versus susceptible (FUT1(AG))) differed in following systemic and enteric responses: growth performance, plasma metabolic profiles, expression of candidate genes for intestinal mucosal homeostasis and immunity, number of selected bacteria and the concentration of short-chain fatty acids (SCFA) in faeces and digesta in piglets pre and post-weaning, and on the ETEC F18 adherence ex vivo. Genotype had the strongest impact on plasma metabolomic profile on day 7 and 28 of age. FUT1(AG) piglets had higher level of N-methyl-2-pyrrolidinone, hippuric acid, oxindole, and 3-oxo-5-beta-chol-7-en-24-oic acid on day 7, and a higher level of guanosine on day 28 than that in the FUT1(AA) piglets. FUT1(AA) piglets had a higher level of betaine on day 7 and 3-methylguanine on day 28. On day 34 of age, the FUT1(AA) pigs had higher levels of S-2-hydroxyglutarate, L-phenylalanine, tauroursodeoxycholic acid and an undetermined PC/LysoPC, while Ile Glu Phe Gly peptide and genistein 5-O-glucuronide, and PC (18:0/0:0) were at higher levels in the FUT1(AG) piglets. FUT1 genotype did not affect the growth performance and expression of candidate genes. FUT1(AG) piglets had a higher number of haemolytic bacteria in faeces and in digesta than that in FUT1(AA) at 34 days of age. The colonic acetic acid concentration was highest in FUT1(AG) piglets. FUT1 genotype may influence not only the expression of E. coli F18 receptors but could potentially impact the gut homeostasis and metabotype of piglets pre and post-weaning. Further investigations on the relation between FUT1 genotype and these aspects including the intestinal commensal microbiota will expand the knowledge on factors affecting the intestinal ecosystem.	[Poulsen, Ann-Sofie Riis; Curtasu, Mihai Victor; Canibe, Nuria; Leuridsen, Charlotte] Aarhus Univ, Fac Sci & Technol, Dept Anim Sci, Tjele, Denmark; [Luise, Diana; Trevisi, Paolo] Univ Bologna, Alma Mater Studiorum, Dept Agr & Food Sci DISTAL, Bologna, Italy; [Sugiharto, Sugiharto] Diponegoro Univ, Fac Anim & Agr Sci, Semarang, Central Java, Indonesia	Aarhus University; University of Bologna; Diponegoro University	Leuridsen, C (corresponding author), Aarhus Univ, Fac Sci & Technol, Dept Anim Sci, Tjele, Denmark.	charlotte.lauridsen@anis.au.dk	Luise, Diana/AAR-6903-2020	Luise, Diana/0000-0001-7864-7822; Canibe, Nuria/0000-0002-5424-9974; Curtasu, Mihai Victor/0000-0001-9823-6692	Graduate School of Science and Technology, Aarhus University, Denmark; COST (European Cooperation in Science and Technology) [FA1401]	Graduate School of Science and Technology, Aarhus University, Denmark; COST (European Cooperation in Science and Technology)(European Cooperation in Science and Technology (COST))	Funding for the experimental work and paper drafting was made possible through a Ph.D.-scholarship obtained from the Graduate School of Science and Technology, Aarhus University, Denmark, for main author Ann-Sofie Riis Poulsen, and a Short Term Scientific Mission grant for main author Diana Luise from the COST Action FA1401 (PiGutNet), supported by COST (European Cooperation in Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is based upon work from COST Action FA1401, supported by COST (European Cooperation in Science and Technology). The authors would like to thank laboratory technicians Trine Poulsen and Karin Durup, technicians Mette Lykkegaard and Karin Johansen and the staff of SB32 at the Department of Animal Science for their skilful technical assistance during the course of the experiment. The authors want to thank Scientist Lone Bruhn Madsen, and research professor Christian Bendixen at Department of Molecular Biology and Genetics for FUT1 genotyping the animals.	ARMSTRONG MD, 1955, P SOC EXP BIOL MED, V90, P675; Bao WB, 2008, J ANIM BREED GENET, V125, P427, DOI 10.1111/j.1439-0388.2008.00722.x; Bao WB, 2012, GENE, V497, P336, DOI 10.1016/j.gene.2012.01.035; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bellaver B, 2015, PURINERG SIGNAL, V11, P571, DOI 10.1007/s11302-015-9475-2; Bian GR, 2016, ENVIRON MICROBIOL, V18, P1566, DOI 10.1111/1462-2920.13272; Broer S, 2017, BIOCHEM J, V474, P1935, DOI 10.1042/BCJ20160822; Canibe N, 2008, LIVEST SCI, V114, P251, DOI 10.1016/j.livsci.2007.05.002; Chen LM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01688; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Ciccarelli R, 1999, GLIA, V25, P93, DOI 10.1002/(SICI)1098-1136(19990101)25:1<93::AID-GLIA9>3.0.CO;2-N; Curtis CD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-9; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; Daly K, 2014, BRIT J NUTR, V111, pS30, DOI 10.1017/S0007114513002274; Domino SE, 2001, MOL CELL BIOL, V21, P8336, DOI 10.1128/MCB.21.24.8336-8345.2001; Francis DH, 2002, J SWINE HEALTH PROD, V10, P171; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Frydendahl K, 2003, VET MICROBIOL, V93, P39, DOI 10.1016/S0378-1135(02)00348-6; Halekoh U, 2014, J STAT SOFTW, V59, P1; HAN K, 1992, BIOTECHNOL BIOENG, V39, P663, DOI 10.1002/bit.260390611; Henry S, 1996, GLYCOCONJUGATE J, V13, P985, DOI 10.1007/BF01053194; Hesselager MO, 2016, GLYCOBIOLOGY, V26, P607, DOI 10.1093/glycob/cww009; Holdeman L. V, 1977, ANAEROBE LAB MANUAL, V4th; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HOU CL, 2015, J ANIM SCI BIOTECHNO, V6, DOI DOI 10.1186/2049-1891-6-1; Hurd EA, 2005, GLYCOBIOLOGY, V15, P1002, DOI 10.1093/glycob/cwi089; Ingerslev AK, 2015, J PROTEOME RES, V14, P3095, DOI 10.1021/acs.jproteome.5b00039; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; Mach N, 2015, ENV MICROBIOL REP, V7, P554, DOI 10.1111/1758-2229.12285; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Meijerink E, 2000, IMMUNOGENETICS, V52, P129, DOI 10.1007/s002510000263; Meijerink E, 1997, MAMM GENOME, V8, P736, DOI 10.1007/s003359900556; MILLER TL, 1974, APPL MICROBIOL, V27, P985, DOI 10.1128/AEM.27.5.985-987.1974; Nanthakumar NN, 2013, GLYCOBIOLOGY, V23, P1131, DOI 10.1093/glycob/cwt050; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Plaza-Diaz J, 2014, WORLD J GASTROENTERO, V20, P15632, DOI 10.3748/wjg.v20.i42.15632; POON K, 1995, DRUG METAB DISPOS, V23, P255; Schopper D, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0002-3; SLIFIERZ MJ, 2015, BMC MICROBIOL, V15, DOI DOI 10.1186/S12866-015-0344-5; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stokes CR, 2004, ANIM RES, V53, P325, DOI 10.1051/animres:2004020; Sugiharto, 2012, J ANIM SCI, V90, P397, DOI [10.2527/jas.53924, 10.2527/jas53924]; Sugiharto S, 2015, BRIT J NUTR, V113, P923, DOI 10.1017/S0007114514003201; Sugiharto S, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-17; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Vogeli P, 1996, ANIM GENET, V27, P321; Wang JJ, 2012, ANTIOXID REDOX SIGN, V17, P282, DOI 10.1089/ars.2011.4381; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams BA, 2005, ANIM RES, V54, P191, DOI 10.1051/animres:2005011; Williams HRT, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-108	55	15	16	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202970	10.1371/journal.pone.0202970	http://dx.doi.org/10.1371/journal.pone.0202970			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148866	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200040
J	Sato, Y; Toida, T; Nakagawa, H; Iwakiri, T; Nishizono, R; Kikuchi, M; Fujimoto, S				Sato, Yuji; Toida, Tatsunori; Nakagawa, Hideto; Iwakiri, Takashi; Nishizono, Ryuzoh; Kikuchi, Masao; Fujimoto, Shouichi			Diminishing dry weight is strongly associated with all-cause mortality among long-term maintenance prevalent dialysis patients	PLOS ONE			English	Article							SURVIVAL	Objectives To investigate the relationship between dry weight (DW) change and survival in long-term maintenance prevalent dialysis patients. Methods We conducted a prospective data collection study with retrospective analysis of the registered data. Patients were followed up for 5 years (1-year observation of DW changes and subsequent 4-year follow-up). The outcome was all-cause mortality. The predictors were 1-year DW change rates. The hazard ratios (HRs) for all-cause mortality were calculated using multivariable Cox regression analysis, fully adjusted for age, sex, basal kidney disease, dialysis vintage, current smoking, past cardiovascular events, serum albumin, DW at enrollment, serum creatinine, mean predialysis systolic blood pressure, and cardiothoracic ratio or 1-year cardiothoracic ratio change rate. Propensity score (PS) analysis was also conducted using the same covariates of Cox regression analysis. Results In total, 899 dialysis patients (mean dialysis vintage: 101.2 months) were followed up, and 180 deaths were recorded, of which 90 were of cardiovascular origin. Each 2% decrement of DW showed adjusted HR, and the 95% confidence interval was 1.24 [1.16-1.33]. According to the 1-year DW change rate, participants were divided into five groups (group A, >=+3%; group B, +1 to +2.9%; group C, -0.9 to +0.9%; group D, -2.9 to -1.0%; and group E, <=-3%). For survival curves based on grouping, group B had the best and group E had the worst survival rate (p<0.01, log-rank test). Therefore, we set group B as a reference; adjusted risks for death of groups D and E were 2.16 [1.23-3.79] and 2.66 [1.54-4.58], respectively. However, this relation was blunted in patients of heavier DW. The PS-matched cohort showed a poorer prognosis in patients with diminishing DW divided by DW change rate at -0.635% (mean value of DW change rate). Conclusion In the long-term maintenance hemodialysis cohort, 1-year DW decrement, especially <=-3.0%, was significantly associated with all-cause mortality, and cardiovascular diseaserelated death was prominent in these patients.	[Sato, Yuji; Nakagawa, Hideto; Iwakiri, Takashi] Univ Miyazaki Hosp, Dialysis Div, Miyazaki, Japan; [Toida, Tatsunori; Fujimoto, Shouichi] Univ Miyazaki, Fac Med, Dept Hemovasc Med & Artificial Organs, Miyazaki, Japan; [Nishizono, Ryuzoh; Kikuchi, Masao] Univ Miyazaki, Fac Med, Dept Internal Med, Div Circulatory & Body Fluid Regulat, Miyazaki, Japan	University of Miyazaki; University of Miyazaki; University of Miyazaki	Sato, Y (corresponding author), Univ Miyazaki Hosp, Dialysis Div, Miyazaki, Japan.	ysato@med.miyazaki-u.ac.jp						Badve SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114897; Bonanni A, 2011, INT J ENV RES PUB HE, V8, P1631, DOI 10.3390/ijerph8051631; Cabezas-Rodriguez I, 2013, CLIN J AM SOC NEPHRO, V8, P1725, DOI 10.2215/CJN.10951012; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Johansen KL, 2004, AM J CLIN NUTR, V80, P324, DOI 10.1093/ajcn/80.2.324; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; London GM, 2000, J AM SOC NEPHROL, V11, P778, DOI 10.1681/ASN.V114778; Nanri A, 2010, INT J OBESITY, V34, P348, DOI 10.1038/ijo.2009.234; Saito I, 2009, J EPIDEMIOL COMMUN H, V63, P447, DOI 10.1136/jech.2008.082065; Sato Y, 2017, THER APHER DIAL, V21, P287, DOI 10.1111/1744-9987.12512; Sato Y, 2016, CLIN J AM SOC NEPHRO, V11, P840, DOI 10.2215/CJN.09830915; Tanaka Y, 2015, BLOOD PURIFICAT, V40, P332, DOI 10.1159/000441582; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Wong JS, 1999, KIDNEY INT, V55, P2515, DOI 10.1046/j.1523-1755.1999.00464.x; Yotsueda R, 2017, AM J KIDNEY DIS, V70, P84, DOI 10.1053/j.ajkd.2016.11.026	15	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203060	10.1371/journal.pone.0203060	http://dx.doi.org/10.1371/journal.pone.0203060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148875	Green Submitted, Green Published, gold			2022-12-27	WOS:000442804200045
J	Chung, SM; Moon, JS; Yoon, JS; Won, KC; Lee, HW				Chung, Seung Min; Moon, Jun Sung; Yoon, Ji Sung; Won, Kyu Chang; Lee, Hyoung Woo			Low urine pH affects the development of metabolic syndrome, associative with the increase of dyslipidemia and dysglycemia: Nationwide cross-sectional study (KNHANES 2013-2015) and a single-center retrospective cohort study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; ACID LEVELS; CARDIOVASCULAR MORTALITY; INSULIN-RESISTANCE; HEALTH; METAANALYSIS; POPULATION; NEPHROLITHIASIS; FEATURES; DISEASE	Introduction Low urine pH (UpH) and high serum uric acid are considered evidence of metabolic disorders. The effect of low UpH on the development of metabolic syndrome (MetS) is less clear than that of high serum uric acid. We investigated the association between low UpH on the development of MetS and its components: central obesity, dyslipidemia, hypertension, and dysglycemia. Methods Two studies were conducted based on 2 datasets. The cross-sectional study included 14,511 subjects aged 19-80 years, based on the Korea National Health and Nutrition Examination Survey in 2013-2015. The retrospective cohort study included 3,453 subjects aged 19-80 years without MetS at the first checkup, who underwent at least 3 health checkups at a single tertiary hospital between 2011 and 2017. UpH was measured using an automatic urine analyzer in the range of 5.0-9.0 at first visit. Results In the cross-sectional study, low UpH (= 5.0) was associated with the prevalence of MetS (odds ratio [OR] = 1.480, 95% confidence interval [CI] 1.334-1.643, p<0.001), particularly central obesity, dyslipidemia, and dysglycemia (OR ranges 1.282-1.422, p<0.001, all). In the retrospective cohort study, compared with the highest UpH subgroup, the lowest UpH subgroup (= 5.0) was associated with higher risk of MetS development (hazard ratio = 1.394, 95% CI 1.096-1.772, p=0.007). The incident risk of MetS increased from the highest to lowest UpH subgroups (p for trend = 0.020), among which dyslipidemia and dysglycemia increased (p for trend <0.01, all). Conclusion Low UpH can be used as a surrogate marker of MetS and affects the development of MetS, associative with the increase of dyslipidemia and dysglycemia in those without MetS. If UpH is <= 5.0, efforts to prevent metabolic disorders are warranted.	[Chung, Seung Min; Moon, Jun Sung; Yoon, Ji Sung; Won, Kyu Chang; Lee, Hyoung Woo] Yeungnam Coll Med, Dept Internal Med, Div Endocrinol & Metab, Daegu, South Korea		Moon, JS; Won, KC (corresponding author), Yeungnam Coll Med, Dept Internal Med, Div Endocrinol & Metab, Daegu, South Korea.	mjs7912@yu.ac.kr; kcwon@med.yu.ac.kr	Chung, Seung Min/AAM-3135-2020	Chung, Seung Min/0000-0003-3336-7557; Moon, Jun Sung/0000-0003-1569-3068; Won, Kyu Chang/0000-0001-5945-3395	Basic Science Research Program though the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2017R1A2B1008877, NRF-2017R1C1B1003429]	Basic Science Research Program though the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by Basic Science Research Program though the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2017R1A2B1008877 and NRF-2017R1C1B1003429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2004, KIDNEY INT, V65, P386, DOI 10.1111/j.1523-1755.2004.00386.x; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823; Billiet Laura, 2014, ISRN Rheumatol, V2014, P852954, DOI 10.1155/2014/852954; Bobulescu IA, 2008, AM J PHYSIOL-RENAL, V294, pF1315, DOI 10.1152/ajprenal.00550.2007; Capolongo G, 2011, UROL RES, V39, P367, DOI 10.1007/s00240-011-0365-y; Cho YH, 2014, J RES MED SCI, V19, P599; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Hara S, 2012, METABOLISM, V61, P281, DOI 10.1016/j.metabol.2011.06.026; Hu G, 2004, ARCH INTERN MED, V164, P1066, DOI 10.1001/archinte.164.10.1066; Jia ZT, 2013, DIABETES RES CLIN PR, V101, P88, DOI 10.1016/j.diabres.2013.03.026; Kanbara A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-39; Kim DW, 2015, PUBLIC HEALTH NUTR, V18, P1369, DOI 10.1017/S1368980014001712; Kraut JA, 2016, AM J KIDNEY DIS, V67, P307, DOI 10.1053/j.ajkd.2015.08.028; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee YJ, 2014, INTERN MED J, V44, P1210, DOI 10.1111/imj.12588; Li M, 2014, ATHEROSCLEROSIS, V232, P265, DOI 10.1016/j.atherosclerosis.2013.11.051; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; Maalouf NM, 2007, CLIN J AM SOC NEPHRO, V2, P883, DOI 10.2215/CJN.00670207; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Odden MC, 2014, AM J KIDNEY DIS, V64, P550, DOI 10.1053/j.ajkd.2014.04.024; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Otsuki M, 2011, ENDOCR J, V58, P363, DOI 10.1507/endocrj.K10E-319; Rendina D, 2014, J NEPHROL, V27, P371, DOI 10.1007/s40620-014-0085-9; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Shimodaira M, 2017, MED PRIN PRACT, V26, P433, DOI 10.1159/000481624; Sun DJY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089696; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105125, 10.1371/journal.pone.0114259]; Welch AA, 2008, BRIT J NUTR, V99, P1335, DOI 10.1017/S0007114507862350; Wiederkehr MR, 2011, CLIN REV BONE MINER, V9, P207, DOI 10.1007/s12018-011-9106-6; Wong YV, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/570674; Yadav D, 2015, ATHEROSCLEROSIS, V241, P271, DOI 10.1016/j.atherosclerosis.2015.04.797; Yamanishi Hachiro, 2014, Rinsho Byori, V62, P692; Yuan HP, 2015, J CLIN ENDOCR METAB, V100, P4198, DOI 10.1210/jc.2015-2527; Yun SH, 2013, J NUTR, V46	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202757	10.1371/journal.pone.0202757	http://dx.doi.org/10.1371/journal.pone.0202757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142166	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500028
J	Cox, F; van der Fits, L; Abbink, P; Larocca, RA; van Huizen, E; Saeland, E; Verhagen, J; Peterson, R; Tolboom, J; Kaufmann, B; Schuitemaker, H; Barouch, DH; Zahn, R				Cox, Freek; van der Fits, Leslie; Abbink, Peter; Larocca, Rafael A.; van Huizen, Ella; Saeland, Eirikur; Verhagen, Janneke; Peterson, Rebecca; Tolboom, Jeroen; Kaufmann, Baerbel; Schuitemaker, Hanneke; Barouch, Dan H.; Zahn, Roland			Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge	PLOS ONE			English	Article							VACCINE PLATFORMS; IMMUNOGENICITY; INFECTION; SAFETY	In 2015, there was a large outbreak of Zika virus (ZIKV) in Brazil. Despite its relatively mild impact on healthy adults, ZIKV infection during pregnancy has been associated with severe birth defects. Currently, there is no ZIKV vaccine available, but several vaccine candidates based on the ZIKV membrane (M) and envelope (Env) structural proteins showed promising results in preclinical and clinical studies. Here, the immunogenicity and protective efficacy of a non-replicating adenoviral vector type 26 (Ad26) that encodes the ZIKV M-Env antigens (Ad26. ZIKV. M-Env) was evaluated in mice and non-human primates (NHP). Ad26. ZIKV. M-Env induced strong and durable cellular and humoral immune responses in preclinical models. Humoral responses were characterized by Env-binding and ZIKV neutralizing antibody responses while cellular responses were characterized by ZIKV reactive CD4(+) and CD8(+) T cells. Importantly, a single immunization with a very low dose of 4x10(7) vp of Ad26. ZIKV. M-Env protected mice from ZIKV challenge. In NHP, a single immunization with a typical human dose of 1x10(11) vp of Ad26. ZIKV. M-Env also induced Env-binding and ZIKV neutralizing antibodies and Env and M specific cellular immune responses that associated with complete protection against viremia from ZIKV challenge as measured in plasma and other body fluids. Together these data provide the rationale to progress the Ad26. ZIKV. M-Env candidate vaccine to clinical testing.	[Cox, Freek; van der Fits, Leslie; van Huizen, Ella; Saeland, Eirikur; Verhagen, Janneke; Tolboom, Jeroen; Kaufmann, Baerbel; Schuitemaker, Hanneke; Zahn, Roland] Janssen Vaccines & Prevent BV, Leiden, Netherlands; [Abbink, Peter; Larocca, Rafael A.; Peterson, Rebecca; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Zahn, R (corresponding author), Janssen Vaccines & Prevent BV, Leiden, Netherlands.	RZahn@its.jnj.com	Zahn, Roland/ABE-8779-2021; Barouch, Dan/Y-3918-2019; Assumpcao Larocca, Rafael/H-1655-2015	Assumpcao Larocca, Rafael/0000-0002-9995-1804; Cox, Freek/0000-0001-9857-7382	Janssen Vaccines & Prevention B.V.	Janssen Vaccines & Prevention B.V.	The authors received no specific funding for this work. Janssen Vaccines & Prevention B.V. provided support in the form of salaries for authors FC, LVDF, EVH, ES, JV, JT, BK, HS AND RZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163; Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Baden LR, 2016, ANN INTERN MED, V164, P313, DOI 10.7326/M15-0880; Baden LR, 2013, J INFECT DIS, V207, P240, DOI 10.1093/infdis/jis670; Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Gaudinski M. R, 2017, LANCET; Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Martinot AJ, 2018, CELL; Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625; Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Modjarrad K, 2017, LANCET; Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617; Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378; Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7; Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2; Song G, 2018, MOL CELL PROTEOMICS, V17, P349, DOI 10.1074/mcp.RA117.000310; Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426; Tebas P, 2017, N ENGL J MED; van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898; Vellinga J, 2014, HUM GENE THER, V25, P318, DOI 10.1089/hum.2014.007; Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x; Waldorf KMA, 2018, NAT MED; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	41	37	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202820	10.1371/journal.pone.0202820	http://dx.doi.org/10.1371/journal.pone.0202820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142207	gold, Green Published, Green Submitted			2022-12-27	WOS:000442722500036
J	Fujihara, M; Yamamizu, K; Comizzoli, P; Wildt, DE; Songsasen, N				Fujihara, Mayako; Yamamizu, Kohei; Comizzoli, Pierre; Wildt, David E.; Songsasen, Nucharin			Retinoic acid promotes in vitro follicle activation in the cat ovary by regulating expression of matrix metalloproteinase 9	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; ASCORBIC-ACID; SURVIVAL; GROWTH; CELLS; DOG	Retinoic acid (RA) facilitates tissue morphogenesis by regulating matrix matalloproteinase (MMPs) expression. Our objective was to examine the influence of RA on in vitro development of follicles enclosed within domestic cat ovarian tissues. Ovarian cortices from 9 prepubertal and 13 adult cats were incubated for 7 d in medium containing 0 (control), 1 or 5 mu M RA and then analyzed for viability. Cortices from additional three animals of each age group were cultured in the same condition and follicle morphology, stage and size were histologically evaluated. In a separate study, cortices from 14 donors (7 prepubertal; 7 adult cats) were incubated in 0 or 5 mu M RA for 7 d and assessed for (1) MMP1, 2, 3, 7, 9 and TIMP1 expression by qPCR and (2) protein expression of MMP9 by immunohistochemistry. Donor age did not influence follicle response to RA. Collective data from both age groups revealed that percentages of primordial follicles in 5 mu M RA treatment were lower (P < 0.05; 40.5 +/- 4.5%) than in fresh cortices (66.7 +/- 5.3%) or controls (60.1 +/- 4.0%) with 1 mu M-RA treatment producing intermediate (56.3 +/- 4.0%) results. Proportion of primary follicles in 5 mu M RA (21.7 +/- 3.3%) was higher than in fresh cortices (4.9 +/- 2.9%) and controls (9.0 +/- 2.8%) with 1 mu M-RA treatment producing an intermediate value (13.8 +/- 2.0%). Furthermore, proportion of secondary follicles increased after 7 d in the presence of 5 mu M RA (9.5 +/- 2.7%) compared to other groups (fresh, 1.9 +/- 0.8%; control, 2.6 +/- 1.1%; 1 mu M RA, 2.5 +/- 0.2%). MMP9 transcript and protein were upregulated, whereas MMP7 mRNA was suppressed by 5 mu M-RA treatment compared to fresh counterparts. RA did not impact MMP1, 2, 3, 13 or TIMP1 expression. In summary, RA activated cat primordial follicle growth likely via a mechanism related to upregulation of MMP9 and down-regulation of MMP7 transcripts.	[Fujihara, Mayako; Comizzoli, Pierre; Wildt, David E.; Songsasen, Nucharin] Smithsonian Conservat Biol Inst, Ctr Species Survival, Natl Zool Pk, Front Royal, VA 22630 USA; [Fujihara, Mayako] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Yamamizu, Kohei] NIA, Lab Genet, NIH, Baltimore, MD 21224 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Fujihara, M (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Natl Zool Pk, Front Royal, VA 22630 USA.; Fujihara, M (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan.	fujihara.mayako.22e@st.kyoto-u.ac.jp	Fujihara, Mayako/N-9965-2019	Fujihara, Mayako/0000-0001-5477-2653	National Institute of Health [R56OD018304]; Smithsonian's Competitive Grant for Sciences; Overseas Research Fellowship from the Japanese Society for the Promotion of Science; RPD Research Fellowship from the Japanese Society for the Promotion of Science [15J40107]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smithsonian's Competitive Grant for Sciences; Overseas Research Fellowship from the Japanese Society for the Promotion of Science; RPD Research Fellowship from the Japanese Society for the Promotion of Science	This study was supported by the National Institute of Health (R56OD018304) and by the Smithsonian's Competitive Grant for Sciences to NS and by an Overseas Research Fellowship and RPD Research Fellowship (15J40107) from the Japanese Society for the Promotion of Science to MF.	Abidin FZ, 2015, ORGANOGENESIS, V11, P122, DOI 10.1080/15476278.2015.1093267; Al-Alem L, 2015, REPRODUCTION, V150, pR55, DOI 10.1530/REP-14-0546; Axel DI, 2001, CARDIOVASC RES, V49, P851, DOI 10.1016/S0008-6363(00)00312-6; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Chaffin CL, 1999, BIOL REPROD, V61, P14, DOI 10.1095/biolreprod61.1.14; Chambaut-Guerin AM, 2000, J NEUROCHEM, V74, P508, DOI 10.1046/j.1471-4159.2000.740508.x; Curry TE, 2003, ENDOCR REV, V24, P428, DOI 10.1210/er.2002-0005; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Fujihara M, 2016, REPROD DOMEST ANIM, V51, P717, DOI 10.1111/rda.12736; Fujihara M, 2012, REPROD DOMEST ANIM, V47, P102, DOI 10.1111/rda.12022; Fujihara M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115089; Gao ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150831; Ii M, 2006, EXP BIOL MED, V231, P20; Ikeda S, 2005, J REPROD DEVELOP, V51, P23, DOI 10.1262/jrd.51.23; Meinel S, 2015, HORM MOL BIOL CLIN I, V24, P91, DOI 10.1515/hmbci-2015-0028; Murray AA, 2001, REPRODUCTION, V121, P89, DOI 10.1530/rep.0.1210089; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pauli SA, 2013, REPROD SCI, V20, P1116, DOI 10.1177/1933719113477487; Rodgers RJ, 2003, REPRODUCTION, V126, P415, DOI 10.1530/rep.0.1260415; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Songsasen N, 2012, REPROD DOMEST ANIM, V47, P13, DOI 10.1111/rda.12067; Tagler D, 2014, BIOTECHNOL BIOENG, V111, P1417, DOI 10.1002/bit.25181; Wildt DE, 2010, FELIDS EX SITU MANAG	23	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202759	10.1371/journal.pone.0202759	http://dx.doi.org/10.1371/journal.pone.0202759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142172	Green Submitted, Green Published, gold			2022-12-27	WOS:000442722500029
J	Oladeinde, A; Cook, K; Orlek, A; Zock, G; Herrington, K; Cox, N; Lawrence, JP; Hall, C				Oladeinde, Adelumola; Cook, Kimberly; Orlek, Alex; Zock, Greg; Herrington, Kyler; Cox, Nelson; Lawrence, Jodie Plumblee; Hall, Carolina			Hotspot mutations and ColE1 plasmids contribute to the fitness of Salmonella Heidelberg in poultry litter	PLOS ONE			English	Article							ENTERICA SEROVAR HEIDELBERG; TOXIN-ANTITOXIN SYSTEMS; ANTIBIOTIC-RESISTANCE; 6'-N-AMINOGLYCOSIDE ACETYLTRANSFERASE; MOLECULAR EVOLUTION; ESCHERICHIA-COLI; CLINICAL ISOLATE; SUPEROXIDE-DISMUTASE; CURATED DATASET; DNA-REPLICATION	Salmonella enterica subsp. enterica serovar Heidelberg (S. Heidelberg) is a clinically-important serovar linked to food-borne illness, and commonly isolated from poultry. Investigations of a large, multistate outbreak in the USA in 2013 identified poultry litter (PL) as an important extra-intestinal environment that may have selected for specific S. Heidelberg strains. Poultry litter is a mixture of bedding materials and chicken excreta that contains chicken gastrointestinal (GI) bacteria, undigested feed, feathers, and other materials of chicken origin. In this study, we performed a series of controlled laboratory experiments which assessed the microevolution of two S. Heidelberg strains (SH-2813 and SH-116) in PL previously used to raise 3 flocks of broiler chickens. The strains are closely related at the chromosome level, differing from the reference genome by 109 and 89 single nucleotide polymorphisms/InDels, respectively. Whole genome sequencing was performed on 86 isolates recovered after 0, 1, 7 and 14 days of microevolution in PL. Only strains carrying an IncX1 (37kb), 2 ColE1 (4 and 6kb) and 1 ColpVC (2kb) plasmids survived more than 7 days in PL. Competition experiments showed that carriage of these plasmids was associated with increased fitness. This increased fitness was associated with an increased copy number of IncX1 and ColE1 plasmids. Further, all Col plasmid-bearing strains had hotspot mutations in 37 loci on the chromosome and in 3 loci on the IncX1 plasmid. Additionally, we observed a decrease in susceptibility to tobramycin, kanamycin, gentamicin, neomycin and fosfomycin for Col plasmid-bearing strains. Our study demonstrates how positive selection from poultry litter can change the evolutionary path of S. Heidelberg.	[Oladeinde, Adelumola; Cook, Kimberly; Zock, Greg; Lawrence, Jodie Plumblee; Hall, Carolina] USDA ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, US Natl Poultry Res Ctr, Athens, GA 30613 USA; [Orlek, Alex] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford, England; [Herrington, Kyler] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Cox, Nelson] USDA ARS, Poultry Microbiol Safety & Proc Res Unit, US Natl Poultry Res Ctr, Athens, GA 30613 USA	United States Department of Agriculture (USDA); University of Oxford; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Oladeinde, A (corresponding author), USDA ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, US Natl Poultry Res Ctr, Athens, GA 30613 USA.	ade.oladeinde@ars.usda.gov	Orlek, Alex/ABB-4720-2020; Oladeinde, Adelumola/AAR-6208-2021	Oladeinde, Adelumola/0000-0002-8659-7068; Cook, Kimberly/0000-0001-7604-0306	USDA-ARS National Program 108 Food Safety (animal and plant products); National Institute for Health Research, Health Protection Research Unit (NI HR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University; Public Health England (PHE) [HPRU-2012-10041]	USDA-ARS National Program 108 Food Safety (animal and plant products); National Institute for Health Research, Health Protection Research Unit (NI HR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University; Public Health England (PHE)	This work was supported by USDA-ARS National Program 108 Food Safety (animal and plant products) and the National Institute for Health Research, Health Protection Research Unit (NI HR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University in partnership with Public Health England (PHE) [grant HPRU-2012-10041]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions expressed in this paper are those of the authors and do not necessarily reflect the official positions and policies of the USDA and any mention of products or trade names does not constitute recommendation for use.	Actis Luis A., 1999, Frontiers in Bioscience, V4, pD43, DOI 10.2741/Actis; [Anonymous], 2009, KIRBY BAUER DISK DIF; Anton AI, 1999, J BACTERIOL, V181, P2703; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bekal S, 2016, J CLIN MICROBIOL, V54, P289, DOI 10.1128/JCM.02200-15; Bobay LM, 2014, P NATL ACAD SCI USA, V111, P12127, DOI 10.1073/pnas.1405336111; Bruger EL, 2016, APPL ENVIRON MICROB, V82, P6498, DOI 10.1128/AEM.01945-16; Burmolle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041259; Bustamante P, 2017, PLASMID, V91, P19, DOI 10.1016/j.plasmid.2017.02.006; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Casey R, 2005, U GEORGIA COOPERATIV, V1267; Castaneda-Garcia A, 2009, J BACTERIOL, V191, P6968, DOI 10.1128/JB.00748-09; Chattopadhyay S, 2012, J BACTERIOL, V194, P5002, DOI 10.1128/JB.00552-12; Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Chattoraj DK, 2000, MOL MICROBIOL, V37, P467, DOI 10.1046/j.1365-2958.2000.01986.x; Chattoraj DK, 1997, PROG NUCLEIC ACID RE, V57, P145, DOI 10.1016/S0079-6603(08)60280-9; Chou SH, 2016, J BACTERIOL, V198, P32, DOI 10.1128/JB.00333-15; Clinical and Laboratory Standards Institute (CLSI), 2009, PERFORMANCE STANDARD; Cressman MD, 2010, APPL ENVIRON MICROB, V76, P6572, DOI 10.1128/AEM.00180-10; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dewey-Mattia D, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6710a1; Dow JM, 2007, CYCLIC DI GMP INTRAC; Dunlop MW, 2016, J ENVIRON MANAGE, V172, P201, DOI 10.1016/j.jenvman.2016.02.036; Dy RL, 2014, NUCLEIC ACIDS RES, V42, P4590, DOI 10.1093/nar/gkt1419; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edirmanasinghe R, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01919-16, 10.1128/AAC.01919-16]; Evans PS, 2014, GENOME ANNOUNC, V2; FDA, 2015, NAT ANT RES MON SYST; Feiner R, 2015, NAT REV MICROBIOL, V13, P641, DOI 10.1038/nrmicro3527; Folster JP, 2012, ANTIMICROB AGENTS CH, V56, P3465, DOI 10.1128/AAC.00201-12; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Gieraltowski L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162369; Giraldo R, 2004, PLASMID, V52, P69, DOI 10.1016/j.plasmid.2004.06.002; Golubeva YA, 2006, J BACTERIOL, V188, P7853, DOI 10.1128/JB.00706-06; Haeusser DP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004217; Hall JPJ, 2017, PLASMID, V91, P90, DOI 10.1016/j.plasmid.2017.04.003; Hansen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029711; Harrison E, 2017, MOL ECOL, V26, P2757, DOI 10.1111/mec.14080; Harrison E, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0361; Harrison E, 2015, CURR BIOL, V25, P2034, DOI 10.1016/j.cub.2015.06.024; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hess JB, 2008, P 2008 NAT POULTR WA; Hoelzer K, 2011, FOODBORNE PATHOG DIS, V8, P1281, DOI 10.1089/fpd.2011.0933; Hoffmann M, 2014, GENOME BIOL EVOL, V6, P1046, DOI 10.1093/gbe/evu079; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; JUKES T H, 1969, P21; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072; Labbe G, 2016, GENOME ANNOUNC, V4; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Leinweber A, 2017, ISME J, V11, P1179, DOI 10.1038/ismej.2016.195; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liakopoulos A, 2016, EMERG INFECT DIS, V22, P1257, DOI 10.3201/eid2207.151377; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftie-Eaton W, 2017, NAT ECOL EVOL, V1, P1354, DOI 10.1038/s41559-017-0243-2; Lopatkin AJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01532-1; Lovanh N, 2007, POULTRY SCI, V86, P1840, DOI 10.1093/ps/86.9.1840; MacDonald JM, 2008, EIB38 USDA EC RES SE; MacLean RC, 2015, CURR BIOL, V25, pR764, DOI 10.1016/j.cub.2015.07.006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng XR, 2016, J VET MED SCI, V78, P1261, DOI 10.1292/jvms.16-0071; Nandi S, 2004, P NATL ACAD SCI USA, V101, P7118, DOI 10.1073/pnas.0306466101; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; NORDSTROM K, 1990, CELL, V63, P1121, DOI 10.1016/0092-8674(90)90405-4; Oladeinde A., 2017, THESIS; OPARA OO, 1992, AVIAN DIS, V36, P664, DOI 10.2307/1591762; Orlek A, 2017, DATA BRIEF, V12, P423, DOI 10.1016/j.dib.2017.04.024; Orlek A, 2017, PLASMID, V91, P42, DOI 10.1016/j.plasmid.2017.03.002; Pacello F, 2008, BBA-GEN SUBJECTS, V1780, P226, DOI 10.1016/j.bbagen.2007.12.001; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Rehman MA, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00410-17, 10.1128/aac.00410-17]; RIGBY CE, 1979, AVIAN DIS, V23, P442, DOI 10.2307/1589575; Roll VFB, 2011, POULTRY SCI, V90, P2257, DOI 10.3382/ps.2011-01583; San Milian A, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0010; San Millan AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6208; San Millan A, 2014, ISME J, V8, P601, DOI 10.1038/ismej.2013.182; Santos-Lopez A, 2017, BIORXIV; Schroder G, 2003, J BACTERIOL, V185, P4371, DOI 10.1128/JB.185.15.4371-4381.2003; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Siryaporn A, 2008, MOL MICROBIOL, V70, P494, DOI 10.1111/j.1365-2958.2008.06426.x; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun S, 2009, GENETICS, V182, P1183, DOI 10.1534/genetics.109.103028; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tada T, 2016, MICROB DRUG RESIST, V22, P103, DOI 10.1089/mdr.2015.0126; Tada T, 2014, ANTIMICROB AGENTS CH, V58, P6324, DOI 10.1128/AAC.03354-14; Tada T, 2013, ANTIMICROB AGENTS CH, V57, P96, DOI 10.1128/AAC.01105-12; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; USDA NASS, POULTRY PRODUCTION A, P1; Varsaki A, 2012, FEBS LETT, V586, P675, DOI 10.1016/j.febslet.2012.01.060; Varsaki A, 2009, J BACTERIOL, V191, P1446, DOI 10.1128/JB.01342-08; Vasse M, 2017, P NATL ACAD SCI USA, V114, P546, DOI 10.1073/pnas.1612522114; Voss-Rech D, 2017, VET MICROBIOL, V203, P308, DOI 10.1016/j.vetmic.2017.03.020; Wang LL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00593; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wasilenko JL, 2012, J FOOD PROTECT, V75, P1939, DOI 10.4315/0362-028X.JFP-12-087; Watve MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009328; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	102	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202286	10.1371/journal.pone.0202286	http://dx.doi.org/10.1371/journal.pone.0202286			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169497	Green Submitted, gold, Green Published			2022-12-27	WOS:000443374400009
J	Afrifa, J; Ogbordjor, WD; Duku-Takyi, R				Afrifa, Justice; Ogbordjor, Wisdom Djange; Duku-Takyi, Ruth			Variation in thyroid hormone levels is associated with elevated blood mercury levels among artisanal small-scale miners in Ghana	PLOS ONE			English	Article							RAT-LIVER; INDIVIDUALS; TOXICITY; EXPOSURE; HEALTH; LEAD; METHYLMERCURY; THYROXINE; POLLUTION; WILDLIFE	Background Mercury can be very toxic to human health even at low dose of exposure. Artisanal small-scale miners (ASGMs) use mercury in gold production, hence are at risk of mercury-induced organ dysfunction. Aim We determined the association between mercury exposure, thyroid function and workrelated factors among artisanal small-scale gold miners in Bibiani- Ghana. Method We conveniently recruited 137 consenting male gold miners at their work site in BibianiGhana, in a comparative cross-sectional study. Occupational activities and socio-demographic data of participants were collected using a questionnaire. Blood sample was analysed for total mercury and thyroid hormones. Results Overall, 58.4% (80/137) of the participants had blood mercury exceeding the occupational exposure threshold (blood mercury >= 5 mu g/L). T3(P<0.0001) and T4(P<0.0001) were significantly reduced among the exposed group compared to the non-exposed. TSH showed no significant variation between the exposed and non-exposed groups. Longer work duration (>= 5years), gold amalgamation, gold smelting and sucking of excess mercury with the mouth were associated with increased odds of mercury exposure. Blood mercury showed negative correlation with T3(r = -0.29, P<0.0001), and T4(r = -0.69, P<0.0001) and positive correlation with work duration (r = 0.88, P<0.001). Even though a positive trend of association between blood mercury and TSH levels was recorded, it was not significant (r = 0.07, P = 0.4121) Conclusion Small scale miners in Bibiani are exposed to mercury above the occupational threshold which may affect thyroid hormone levels.	[Afrifa, Justice; Duku-Takyi, Ruth] Univ Cape Coast, Sch Allied Hlth Sci, Dept Med Lab Sci, Cape Coast, Ghana; [Ogbordjor, Wisdom Djange] Volta River Author, Accra, Ghana	University of Cape Coast	Afrifa, J (corresponding author), Univ Cape Coast, Sch Allied Hlth Sci, Dept Med Lab Sci, Cape Coast, Ghana.	jafrifa@ucc.edu.gh	Afrifa, Justice/GQH-0469-2022; Afrifa, Justice/L-9013-2019	Afrifa, Justice/0000-0003-3399-2969				Abdelouahab N, 2008, ENVIRON RES, V107, P380, DOI 10.1016/j.envres.2008.01.006; Adimado AA, 2002, B ENVIRON CONTAM TOX, V68, P339, DOI [10.1007/s00128-001-0259-8, 10.1007/s001280259]; Afrifa J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4517-z; Akerstrom M, 2017, TOXICOL APPL PHARM, V320, P17, DOI 10.1016/j.taap.2017.02.007; Aryee BNA, 2002, TRENDS SMALL SCALE M; Chen AM, 2013, ENVIRON HEALTH PERSP, V121, P181, DOI 10.1289/ehp.1205239; Chen CY, 2005, CLIN CHEM, V51, P759, DOI 10.1373/clinchem.2004.042093; CHOPRA IJ, 1977, ENDOCRINOLOGY, V101, P453, DOI 10.1210/endo-101-2-453; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; CURRAN PG, 1991, ENDOCR REV, V12, P135, DOI 10.1210/edrv-12-2-135; DepartmentofHealth, 2016, UND MERC EXP LEV; Drake PL, 2001, INT ARCH OCC ENV HEA, V74, P206, DOI 10.1007/s004200000206; Fontaine M, 2001, MERCURY FREE GOLD MI; Iavicoli I, 2009, J TOXICOL ENV HEAL B, V12, P206, DOI 10.1080/10937400902902062; Jonklaas J, 2008, THYROID, V18, P943, DOI 10.1089/thy.2008.0061; Jonklaas J, 2008, JAMA-J AM MED ASSOC, V299, P769, DOI 10.1001/jama.299.7.769; KAWADA J, 1980, J PHARMACOBIO-DYNAM, V3, P149, DOI 10.1248/bpb1978.3.149; LARSEN PR, 1981, ENDOCR REV, V2, P87, DOI 10.1210/edrv-2-1-87; LIN FM, 1975, B ENVIRON CONTAM TOX, V14, P140, DOI 10.1007/BF01701304; MCGREGOR AJ, 1991, HUM EXP TOXICOL, V10, P199, DOI 10.1177/096032719101000309; Mensah EK, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.1.6171; Mensah EK, 2012, EXPOSURE SMALL SCALE; Mol JH, 2001, ENVIRON RES, V86, P183, DOI 10.1006/enrs.2001.4256; Norris DO, 2013, VERTEBRATE ENDOCRINOLOGY, FIFTH EDITION, P1; Obiri S, 2010, ENVIRON TOXICOL PHAR, V29, P209, DOI 10.1016/j.etap.2010.01.001; Osawa T, 2015, INT J HUM CULT STUD, V2015; Ralston NVC, 2010, TOXICOLOGY, V278, P112, DOI 10.1016/j.tox.2010.06.004; Rice Kevin M, 2014, J Prev Med Public Health, V47, P74, DOI 10.3961/jpmph.2014.47.2.74; Risher JF, 2005, MERCURY EXPOSURE, P691; Rolland RM, 2000, J WILDLIFE DIS, V36, P615, DOI 10.7589/0090-3558-36.4.615; Siegel S, 2013, COMMUNITY DEV J, V48, P451, DOI 10.1093/cdj/bst027; SUZUKI TSUGUYOSHI, 1966, INDUST HEALTH, V4, P69; Swain EB, 2007, AMBIO, V36, P45, DOI 10.1579/0044-7447(2007)36[45:SCOMUA]2.0.CO;2; Tan SW, 2009, CRIT REV TOXICOL, V39, P228, DOI 10.1080/10408440802233259; VISSER TJ, 1976, BIOCHEM J, V157, P479, DOI 10.1042/bj1570479; Wada H, 2009, ENVIRON SCI TECHNOL, V43, P6031, DOI 10.1021/es803707f; Wadaan MAM, 2009, J PHARMACOL TOX MET, V4, P126, DOI [10.3923/jpt.2009.126.131, DOI 10.3923/jpt.2009.126.131]; Williams CR, 2011, ENVIRON SCI POLLUT R, V18, P1079, DOI 10.1007/s11356-011-0458-8; YOSHIDA K, 1987, ENVIRON RES, V42, P400, DOI 10.1016/S0013-9351(87)80206-2; Zahir F, 2005, ENVIRON TOXICOL PHAR, V20, P351, DOI 10.1016/j.etap.2005.03.007	42	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203335	10.1371/journal.pone.0203335	http://dx.doi.org/10.1371/journal.pone.0203335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161259	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900114
J	Galvao, EL; Pedras, MJ; Cota, GF; Simoes, TC; Rabello, A				Galvao, Endi Lanza; Pedras, Mariana Junqueira; Cota, Glaucia Fernandes; Simoes, Taynana Cesar; Rabello, Ana			Development and initial validation of a cutaneous leishmaniasis impact questionnaire	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONTENT VALIDITY; INSTRUMENT; HEALTH; INDEX; RELIABILITY; CRITERIA; DISEASES; NUMBER; ALPHA	Background The impact of cutaneous leishmaniasis (CL) on the quality of life of patients has been neglected in research studies worldwide. The few reported studies have used non-specific questionnaires for the disease, which represents a limitation since generic instruments may not address specific aspects of the disease, compromising the evaluation of its real impact. The aim of this paper is to describe the development and the initial validation of an instrument for evaluating the impact of CL, named the Cutaneous Leishmaniasis Impact Questionnaire. Methodology The formulation and validation of the instrument consisted of the following steps: (1) literature review; (2) conceptual framework construction and initial item generation; (3) tool analysis by health professionals (experts); (4) tool evaluation performed by the patients; and (5) a pilot study with 100 patients with localized CL, evaluated at a reference ambulatory facility in Belo Horizonte, in the state of Minas Gerais, Brazil. The structure of the proposed instrument was analyzed using hierarchical cluster analysis (ICLUST). Results Twenty-seven items were initially proposed by the researchers to compose the questionnaire. Content validity (evaluates if the instrument fully assesses the construct of interest) was evaluated by the panel of experts, while face validity (evaluates how potential participants interpret the items) was evaluated by the target population. In this step, some items were excluded, reformulated and/or included. After evaluating a factorial structure of the items in accordance with the cluster analysis, we assembled a questionnaire with 25 items (alpha = 0.86), with high reliability and homogeneity, which address the following: 1) the general impact of the disease (alpha = 0.91, beta = 0.67) and 2) the evaluation of the perception about the treatment and health services (alpha = 0.72, beta = 0.51). Conclusions The Cutaneous Leishmaniasis Impact Questionnaire, developed with contributions from patients and experts, was confirmed, in this first validation, as a useful and reliable instrument.	[Galvao, Endi Lanza; Pedras, Mariana Junqueira; Cota, Glaucia Fernandes; Simoes, Taynana Cesar; Rabello, Ana] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infecto Parasi, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Galvao, EL (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infecto Parasi, Belo Horizonte, MG, Brazil.	endi.lanza@cpqrr.fiocruz.br	Cota, Glaucia/ABC-5378-2020; Junqueira Pedras, Mariana/ABF-1228-2021; Simões, Taynãna César/ABE-8964-2021	Cota, Glaucia/0000-0003-0538-7403; Junqueira Pedras, Mariana/0000-0003-2494-6178; Galvao, Endi Lanza/0000-0002-5648-3932	CNPq (National Counsel of Technological and Scientific Development) [311641/2009-1]; FAPEMIG (Foundation for Research Support of the State of Minas Gerais)	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Foundation for Research Support of the State of Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	AR is currently receiving a grant [311641/2009-1] from CNPq (National Counsel of Technological and Scientific Development). ELG is Ph.D. student and is reciving a scholarship from FAPEMIG (Foundation for Research Support of the State of Minas Gerais). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2014, CHRON MULT ILLN GULF; AUGUSTIN M, 2000, DERMATOL PSYCHOSOM, V1, P12, DOI DOI 10.1159/000017503; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bolarinwa Oladimeji Akeem, 2015, Niger Postgrad Med J, V22, P195, DOI 10.4103/1117-1936.173959; Chahed MK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005090; Chen SC, 2002, ARCH DERMATOL, V138, P803, DOI 10.1001/archderm.138.6.803; Chren MM, 1996, J INVEST DERMATOL, V107, P707, DOI 10.1111/1523-1747.ep12365600; Cooksey RW, 2006, ORGAN RES METHODS, V9, P78, DOI 10.1177/1094428105283939; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Toledo Jr ACD, 2013, T ROY SOC TROP MED H, V107, P335, DOI 10.1093/trstmh/trt021; DeVon HA, 2007, J NURS SCHOLARSHIP, V39, P155, DOI 10.1111/j.1547-5069.2007.00161.x; Fayers PM, 2007, QUALITY LIFE ASSESSM; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; FINLAY AY, 1987, CLIN EXP DERMATOL, V12, P8, DOI 10.1111/j.1365-2230.1987.tb01844.x; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Gurel MS, 2005, INT J DERMATOL, V44, P933, DOI 10.1111/j.1365-4632.2004.02225.x; Halyard MY, 2006, CURR PROB CANCER, V30, P319, DOI 10.1016/j.currproblcancer.2006.08.009; Hareendran A, 2007, WOUND REPAIR REGEN, V15, P465, DOI 10.1111/j.1524-475X.2007.00253.x; Heo M, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0070-6; HORN JL, 1979, MULTIVAR BEHAV RES, V14, P283, DOI 10.1207/s15327906mbr1403_1; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Karimkhani C, 2016, LANCET INFECT DIS, V16, P584, DOI 10.1016/S1473-3099(16)00003-7; Kassi M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000259; KIRSHNER B, 1985, J CHRON DIS, V38, P27, DOI 10.1016/0021-9681(85)90005-0; Litt E, 2012, TRENDS PARASITOL, V28, P195, DOI 10.1016/j.pt.2012.03.001; Luo YH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0246-0; LYNN MR, 1986, NURS RES, V35, P382; Nilforoushzadeh M. A., 2010, SKIN LEISHMANIASIS, V1, P28; Okada K, 2015, RES SYNTH METHODS, V6, P333, DOI 10.1002/jrsm.1155; PAHO, 2013, LEISHM AM REC TRAT C; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Ranawaka R R, 2014, Mymensingh Med J, V23, P345; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reithinger R, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000285; REVELLE W, 1978, BEHAV RES METH INSTR, V10, P739, DOI 10.3758/BF03205389; Revelle W, ICLUST ITEM CLUSTER; Revelle W, 2013, NON TRADITIONAL REF; Revelle W., 2017, INTRO PSYCH PACKAG 2; Revelle W, 1979, BEHAV RES, V14, P57, DOI [10.1207/s15327906mbr1401_4, DOI 10.1207/S15327906MBR1401_4]; Rossiter JR, 2002, INT J RES MARK, V19, P305, DOI 10.1016/S0167-8116(02)00097-6; Ruscio J, 2012, PSYCHOL ASSESSMENT, V24, P282, DOI 10.1037/a0025697; Studerus E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012412; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Vares B, 2013, ARCH IRAN MED, V16, P474, DOI 013168/AIm.008; Warshaw EM, 2007, INT J DERMATOL, V46, P1279, DOI 10.1111/j.1365-4632.2007.03362.x; WHO, 2010, WHO TECHN REP SER; Yanik M, 2004, CLIN EXP DERMATOL, V29, P464, DOI 10.1111/j.1365-2230.2004.01605.x	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203378	10.1371/journal.pone.0203378	http://dx.doi.org/10.1371/journal.pone.0203378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161222	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900116
J	Meester, SB; Wagenmakers, R; van den Akker-Scheek, I; Stevens, M				Meester, Sieger Bertus; Wagenmakers, Robert; van den Akker-Scheek, Inge; Stevens, Martin			Sport advice given by Dutch orthopaedic surgeons to patients after a total hip arthroplasty or total knee arthroplasty	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OLDER-ADULTS; AMERICAN-ASSOCIATION; RETURN; RECOMMENDATIONS; METAANALYSIS; REPLACEMENT; GUIDELINES; SOCIETY; HEALTH	Background The advice given to patients in the Netherlands regarding sport activities after total hip arthroplasty or total knee arthroplasty (THA/TKA) is currently based on the opinion of the individual orthopaedic surgeon. Aim To give an overview of the sport advice given by Dutch orthopaedic surgeons and to examine whether surgeons are familiar with the Dutch health-enhancing physical activity (PA) recommendations (NNGB). Methods 472 surgeons were selected to fill in a questionnaire regarding 40 sport activities for four patient age groups (in years): 1) THA<65, 2) THA>65, 3) TKA<65 4) TKA>65. Surgeons were also asked if they discuss the role of PA postoperatively and about their knowledge and application of the NNGB. Results There was consensus on 29 sport activities for the THA<65 group and 30 activities for the THA>65 group. In the TKA<65 group there was consensus for 33 sports activities and in the TKA>65 group for 32 activities. Amongst orthopaedic surgeons performing THAs and TKAs, respectively 77% and 79% discussed the role of PA postoperatively with their patients, and a total of 34% and 41% were familiar with the NNGB, with 33% and 34% of them giving NNGB-based advice. Conclusion Results can be used to recommend sport activities after THA/TKA. Although the majority of orthopaedic surgeons discuss the role of PA postoperatively with their patients, familiarity with health-enhancing PA recommendations is lacking.	[Meester, Sieger Bertus; van den Akker-Scheek, Inge; Stevens, Martin] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands; [Wagenmakers, Robert] Amphia Hosp Breda, Dept Orthopaed, Breda, Netherlands	University of Groningen; Amphia Hospital	Stevens, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed, Groningen, Netherlands.	m.stevens@umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894; van den Akker-Scheek, Inge/0000-0002-1614-8419				Bates S., 2013, BRIT J SPORT MED, V47, pe3, DOI [10.1136/bjsports-2013-092558.50, DOI 10.1136/BJSPORTS-2013-092558.50]; Bradley BM, 2017, J ARTHROPLASTY, V32, P898, DOI 10.1016/j.arth.2016.09.019; Brandes M, 2011, ARTHRIT CARE RES, V63, P328, DOI 10.1002/acr.20384; Bult P, 1997, SPORT BEWEEG WIJZER; Bult P, 1994, THESIS; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Ethgen O, 2004, HLTH RELATED QUALITY; Fisher NE, 2011, INT ORTHOP, V35, P977, DOI 10.1007/s00264-010-1053-1; Gschwend N, 2000, ACTA ORTHOP SCAND, V71, P243, DOI 10.1080/000164700317411825; Kersten RFMR, 2012, PHYS THER, V92, P1109, DOI 10.2522/ptj.20110273; Klein GR, 2007, J ARTHROPLASTY, V22, P171, DOI 10.1016/j.arth.2006.09.001; Kokkinos Peter, 2012, ISRN Cardiol, V2012, P718789, DOI 10.5402/2012/718789; Laursen Mia K, 2014, Eur J Orthop Surg Traumatol, V24, P1571, DOI 10.1007/s00590-014-1442-z; Motl RW, 2010, PHYS MED REH CLIN N, V21, P299, DOI 10.1016/j.pmr.2009.12.006; Munger P, 2006, ACTA ORTHOP, V77, P567, DOI 10.1080/17453670610012629; Ollivier M, 2012, CLIN ORTHOP RELAT R, V470, P3060, DOI 10.1007/s11999-012-2362-z; Peiris CL, 2013, J PHYSIOTHER, V59, P39, DOI 10.1016/S1836-9553(13)70145-0; Pietschmann MF, 2013, INT ORTHOP, V37, P31, DOI 10.1007/s00264-012-1710-7; Schmalzried TP, 2004, CLIN ORTHOP RELAT R, P94; Schmalzried TP, 2000, CLIN ORTHOP RELAT R, P36; Seyler TM, 2006, SPORTS MED, V36, P571, DOI 10.2165/00007256-200636070-00003; Stevens M, 2012, NIEUWE HEUP KNIE HOE; Stevens M, 2012, CLIN GERIATR MED, V28, P509, DOI 10.1016/j.cger.2012.05.003; Swanson EA, 2009, J ARTHROPLASTY, V24, P120, DOI 10.1016/j.arth.2009.05.014; Trousdale RT, 1999, MAYO CLIN PROC, V74, P978; Vogel LA, 2011, SPORTS HEALTH, V3, P441, DOI 10.1177/1941738111415826; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WIDHALM R, 1990, Z ORTHOP GRENZGEB, V128, P139, DOI 10.1055/s-2008-1039489; Witjes S, 2016, SPORTS MED, V46, P269, DOI 10.1007/s40279-015-0421-9	30	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202494	10.1371/journal.pone.0202494	http://dx.doi.org/10.1371/journal.pone.0202494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161163	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900031
J	Seko, Y; Kato, T; Morita, Y; Yamaji, Y; Haruna, Y; Izumi, T; Miyamoto, S; Nakane, E; Hayashi, H; Haruna, T; Inoko, M				Seko, Yuta; Kato, Takao; Morita, Yusuke; Yamaji, Yuhei; Haruna, Yoshizumi; Izumi, Toshiaki; Miyamoto, Shoichi; Nakane, Eisaku; Hayashi, Hideyuki; Haruna, Tetsuya; Inoko, Moriaki			Impact of left ventricular concentricity on long-term mortality in a hospital-based population in Japan	PLOS ONE			English	Article							EUROPEAN ASSOCIATION; AMERICAN SOCIETY; GEOMETRY; MASS; ECHOCARDIOGRAPHY; RECOMMENDATIONS; DISEASE; UPDATE	Background The prognostic impact of relative wall thickness (RWT), ventricular concentricity, is controversial. Methods We retrospectively analyzed data obtained from 4444 consecutive patients who had undergone both transthoracic echocardiography and electrocardiography at our hospital in 2013. Those who presented with a history of previous episodes of myocardial infarctions and severe or moderate valvular disease were excluded from the analysis. We calculated RWT as follows: (2 x diastolic posterior wall thickness) / (the diastolic LV dimension). We defined high RWT as a ratio > 0.42. A total of 3654 patients were categorized into two groups: 492 with high RWT, and 3162 with normal RWT. Results The mean ages of those in the normal and high RWT groups were 64.6 (+/- standard deviation 16.3) and 71.6 (+/- 12.7) years, respectively (p<0.001). Prevalence of male sex, history of diabetes, hypertension, and chronic kidney disease, and the left atrium volume index was higher for the high RWT group than for the normal RWT group. The median follow-up period was 1274 days (interquartile range, 410-1470). The Kaplan-Meier curves showed a constant increase in all-cause death, with cumulative 3-year incidences of 18.3% and 10.8% for the high RWT and normal RWT groups, respectively (log-rank p<0.001). After adjusting for confounders, the increased mortality risk for those with high RWT relative to normal RWT was significant (hazard ratio, 1.64; 95% confidence interval, 1.27-2.10). This trend was consistent for the composite of deaths and major adverse cardiac events. Conclusion High RWT has a deleterious impact on long-term mortality.	[Seko, Yuta; Morita, Yusuke; Yamaji, Yuhei; Haruna, Yoshizumi; Izumi, Toshiaki; Miyamoto, Shoichi; Nakane, Eisaku; Hayashi, Hideyuki; Haruna, Tetsuya; Inoko, Moriaki] Kitano Hosp, Cardiovasc Ctr, Tazuke Kofukai Med Res Inst, Osaka, Japan; [Kato, Takao] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan	Kitano Hospital; Kyoto University	Kato, T (corresponding author), Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan.	tkato75@kuhp.kyoto-u.ac.jp						CASALE PN, 1986, ANN INTERN MED, V105, P173, DOI 10.7326/0003-4819-105-2-173; Gaasch WH, 2011, J AM COLL CARDIOL, V58, P1733, DOI 10.1016/j.jacc.2011.07.022; Ghali JK, 1998, J AM COLL CARDIOL, V31, P1635, DOI 10.1016/S0735-1097(98)00131-4; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Malatino LS, 2003, HYPERTENSION, V41, P88, DOI 10.1161/01.HYP.0000046919.41112.4B; Milani RV, 2006, AM J CARDIOL, V97, P959, DOI 10.1016/j.amjcard.2005.10.030; Minamino-Muta E, 2017, HEART, V103, P1992, DOI 10.1136/heartjnl-2016-311022; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; NEILL WA, 1979, AM J CARDIOL, V44, P747, DOI 10.1016/0002-9149(79)90297-2; Olsen MH, 2002, AM HEART J, V144, P530, DOI 10.1067/mhj.2002.124863; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Saba PS, 1999, J HYPERTENS, V17, P1007, DOI 10.1097/00004872-199917070-00018; Schafer S, 2002, J HYPERTENS, V20, P1431, DOI 10.1097/00004872-200207000-00031; Seko Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24875-1; Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Zabalgoitia M, 2001, AM J CARDIOL, V88, P646, DOI 10.1016/S0002-9149(01)01807-0	19	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203227	10.1371/journal.pone.0203227	http://dx.doi.org/10.1371/journal.pone.0203227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161243	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900095
J	Yang, TX; Strasburger, H; Poppel, E; Bao, Y				Yang, Taoxi; Strasburger, Hans; Poeppel, Ernst; Bao, Yan			Attentional modulation of speed-change perception in the perifoveal and near- peripheral visual field	PLOS ONE			English	Article							AREA MT; DIRECTION CHANGES; INHIBITION; RETURN; ADAPTATION; CONTRAST; SIZE; DISCRIMINATION; PERFORMANCE; BRIGHTNESS	The ability to perceive changes in motion, such as rapid changes of speed, has important ecological significance. We show that exogenous and endogenous attention have different effects on speed-change perception and operate differently in different regions of the visual field. Using a spatial-cueing paradigm, with either exogenous or endogenous cues followed by drifting Gabor patches of changing speed that appear at the cued or uncued location, we measured participants' thresholds for localizing both acceleration and deceleration of the Gabor patches in different regions (5 degrees and 10 degrees) of the visual field. The results revealed a larger exogenous cueing effect, indexed by a lower threshold for the cued relative to the uncued conditions, at 5 degrees for perceiving acceleration and at 10 degrees for perceiving deceleration. Endogenous attention, in contrast, improved performance equally at both eccentricities. We conclude that exogenous and endogenous spatial orienting constitute two independent attentional systems, with distinct modulation patterns on speed change perception in the visual field. While exogenous attentional modulation is eccentricity-dependent, endogenous attention acts homogeneously in perifoveal and near-peripheral regions of the visual field.	[Yang, Taoxi; Poeppel, Ernst; Bao, Yan] Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China; [Yang, Taoxi; Strasburger, Hans; Poeppel, Ernst; Bao, Yan] Ludwig Maximilians Univ Munchen, Inst Med Psychol, Munich, Germany; [Yang, Taoxi; Strasburger, Hans; Poeppel, Ernst; Bao, Yan] Ludwig Maximilians Univ Munchen, Human Sci Ctr, Munich, Germany; [Strasburger, Hans] Georg August Univ, Dept Med Psychol & Med Sociol, G6ttingen, Germany; [Bao, Yan] Peking Univ, Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China	Peking University; University of Munich; University of Munich; University of Gottingen; Peking University	Bao, Y (corresponding author), Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China.; Bao, Y (corresponding author), Ludwig Maximilians Univ Munchen, Inst Med Psychol, Munich, Germany.; Bao, Y (corresponding author), Ludwig Maximilians Univ Munchen, Human Sci Ctr, Munich, Germany.; Bao, Y (corresponding author), Peking Univ, Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China.	baoyun@pku.edu.cn	Strasburger, Hans/H-2453-2011	Strasburger, Hans/0000-0001-7156-5111	National Natural Science Foundation of China [31771213, 31371018]; German Academic Exchange Service (DAAD); China Scholarship Council [[2014]3026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (Project 31771213 and 31371018), the German Academic Exchange Service (DAAD), and the China Scholarship Council (No. [2014]3026). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson B, 2010, ATTENTION TIME, P407; Anton-Erxleben K, 2013, PSYCHOL SCI, V24, P150, DOI 10.1177/0956797612449178; Anton-Erxleben K, 2007, J VISION, V7, DOI 10.1167/7.11.5; Bao Y, 2013, EXP PSYCHOL, V60, P425, DOI 10.1027/1618-3169/a000215; Bao Y, 2013, NEUROSCI LETT, V534, P7, DOI 10.1016/j.neulet.2012.11.046; Bao Y, 2012, COGN PROCESS, V13, pS93, DOI 10.1007/s10339-012-0469-5; Bao Y, 2011, NEUROSCI LETT, V500, P47, DOI 10.1016/j.neulet.2011.06.003; Bao Yan, 2007, Cogn Process, V8, P37, DOI 10.1007/s10339-006-0151-x; Bosking WH, 2011, J NEUROSCI, V31, P8230, DOI 10.1523/JNEUROSCI.0126-11.2011; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Chica AB, 2013, BEHAV BRAIN RES, V237, P107, DOI 10.1016/j.bbr.2012.09.027; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; ERIKSEN CW, 1970, AM J PSYCHOL, V83, P330, DOI 10.2307/1420410; Galashan FO, 2013, NEURON, V78, P740, DOI 10.1016/j.neuron.2013.03.014; Helmholtz H, 1871, MONATSBERICHTE KONIG, P333; Herrmann K, 2010, NAT NEUROSCI, V13, P1554, DOI 10.1038/nn.2669; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Khayat PS, 2010, J NEUROSCI, V30, P2188, DOI 10.1523/JNEUROSCI.5314-09.2010; Kingdom F, 2009, PALAMEDES MATLAB ROU; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; Klein R, 2009, CAN J EXP PSYCHOL, V63, P240, DOI 10.1037/a0015807; Lei Q, 2012, COGN PROCESS, V13, pS223, DOI 10.1007/s10339-012-0487-3; Lisberger SG, 1999, J NEUROSCI, V19, P2224; Liu TS, 2006, PSYCHON B REV, V13, P1091, DOI 10.3758/BF03213931; Macmillan N. A., 2004, DETECTION THEORY USE; Martinez-Trujillo JC, 2007, CEREB CORTEX, V17, P1733, DOI 10.1093/cercor/bhl084; Mateeff S, 2000, VISION RES, V40, P409, DOI 10.1016/S0042-6989(99)00185-6; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Pazo-Alvarez P, 2004, EUR J NEUROSCI, V19, P1978, DOI 10.1111/j.1460-9568.2004.03273.x; Poppel E, 2012, COGN PROCESS, V13, pS285, DOI 10.1007/s10339-012-0489-1; Poggel DA, 2006, VISION RES, V46, P2998, DOI 10.1016/j.visres.2006.03.018; POPPEL E, 1988, NATURWISSENSCHAFTEN, V75, P463, DOI 10.1007/BF00364030; POPPEL E, 1973, PSYCHOL FORSCH, V36, P145, DOI 10.1007/BF00424967; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Price NSC, 2013, J NEUROSCI, V33, P4359, DOI 10.1523/JNEUROSCI.3165-12.2013; Price NSC, 2005, J NEUROPHYSIOL, V94, P3451, DOI 10.1152/jn.00564.2005; Schlack A, 2008, J VISION, V8, DOI 10.1167/8.8.9; SINGER W, 1977, EXP BRAIN RES, V29, P173; Smith JET, 2011, J NEUROSCI, V31, P13458, DOI 10.1523/JNEUROSCI.1347-11.2011; Strasburger H, 2001, PERCEPT PSYCHOPHYS, V63, P1348, DOI 10.3758/BF03194547; Strasburger H, 2011, J VISION, V11, DOI 10.1167/11.5.13; Traschutz A, 2015, J NEUROPHYSIOL, V113, P890, DOI 10.1152/jn.00335.2014; Traschutz A, 2012, VISION RES, V72, P1, DOI 10.1016/j.visres.2012.08.019; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Turatto M, 2007, VISION RES, V47, P166, DOI 10.1016/j.visres.2006.10.002; Wang ZG, 2010, ATTEN PERCEPT PSYCHO, V72, P76, DOI 10.3758/APP.72.1.76; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wundt W., 1897, GRUNDZUGE PHYSL PSYC, V2; Yang TX, 2015, COGN PROCESS, V16, pS137, DOI 10.1007/s10339-015-0688-7; Yeshurun Y, 2008, VISION RES, V48, P80, DOI 10.1016/j.visres.2007.10.015; Zhou B, 2016, PSYCH J, V5, P145, DOI 10.1002/pchj.141; Zhou B, 2010, NEUROSCI LETT, V483, P101, DOI 10.1016/j.neulet.2010.07.070; ZIHL J, 1980, PSYCHOL RES-PSYCH FO, V41, P297, DOI 10.1007/BF00308875	61	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203024	10.1371/journal.pone.0203024	http://dx.doi.org/10.1371/journal.pone.0203024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161184	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900069
J	Ding, XT; Jiang, YP; Zhao, H; Guo, DD; He, LZ; Liu, FG; Zhou, Q; Nandwani, D; Hui, DF; Yu, JZ				Ding, Xiaotao; Jiang, Yuping; Zhao, Hong; Guo, Doudou; He, Lizhong; Liu, Fuguang; Zhou, Qiang; Nandwani, Dilip; Hui, Dafeng; Yu, Jizhu			Electrical conductivity of nutrient solution influenced photosynthesis, quality, and antioxidant enzyme activity of pakchoi (Brassica campestris L. ssp Chinensis) in a hydroponic system	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; LIGHT-INTENSITY; DIETARY NITRATE; GROWTH; NITROGEN; YIELD; FERTILIZER; CHLOROPHYLL; TOLERANCE; NUTRITION	To find an electrical conductivity (EC) in the nutrient solution used for pakchoi (Brassica campestris L. ssp. Chinensis) cultivation that optimizes the plant's physiology, growth, and quality, we conducted an experiment with eight EC treatments (from EC0 to EC9.6) in a hydroponic production system (i.e. soilless culture) under greenhouse condition in Shanghai, China. Plants biomass production, leaf photosynthesis, vegetable quality variables, tissue nitrate and nitrite contents, and antioxidant enzyme activities were measured. The results showed that very high (EC9.6) or low EC (EC0-0.6) treatments clearly decreased plants fresh weight (FW) and dry weight (DW), leaf size, leaf water content, leaf net photosynthetic rate (P-n), stomatal conductance (G(s)), transpiration rate (T-r), and taste score. Nitrite content, and antioxidant enzyme activities were low in medium EC treatments (EC1.8 and EC2.4), but high in very high or low EC treatments. Leaf relative chlorophyll, ascorbic acid, and nitrate contents increased gradually from low EC to high EC treatments, while crude fiber and soluble sugar contents decreased. Based on growth and quality criteria, the optimal EC treatment would be EC1.8 or EC2.4 for pakchoi in the hydroponic production system. Too high or too low EC would induce nutrient stress, enhance plant antioxidant enzyme activities, and suppress pakchoi growth and quality.	[Ding, Xiaotao; Jiang, Yuping; He, Lizhong; Liu, Fuguang; Zhou, Qiang; Yu, Jizhu] Shanghai Acad Agr Sci, Shanghai Dushi Green Engn Co Ltd, Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China; [Ding, Xiaotao; Zhao, Hong; Guo, Doudou] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Nandwani, Dilip] Tennessee State Univ, Dept Agr & Environm Sci, Nashville, TN 37203 USA; [Hui, Dafeng] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA	Shanghai Academy of Agricultural Sciences; Shanghai Jiao Tong University; Tennessee State University; Tennessee State University	Yu, JZ (corresponding author), Shanghai Acad Agr Sci, Shanghai Dushi Green Engn Co Ltd, Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China.; Hui, DF (corresponding author), Tennessee State Univ, Dept Biol Sci, Nashville, TN 37203 USA.	dhui@tnstate.edu; woloveorange2011@163.com	Guo, Doudou/M-1859-2019	Hui, Dafeng/0000-0002-5284-2897	National High-tech Research and Development Program (863 Program) [2013AA103006]; Shanghai Agriculture Applied Technology Development Program, China [T20170201]; Shanghai Science and Technology Committee Program [16DZ2282100]	National High-tech Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Shanghai Agriculture Applied Technology Development Program, China; Shanghai Science and Technology Committee Program	This work was supported by the National High-tech Research and Development Program (863 Program) (2013AA103006), Shanghai Agriculture Applied Technology Development Program, China (grant no. T20170201) and Shanghai Science and Technology Committee Program (16DZ2282100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S.M., 1999, HDB PLANT CROP STRES, P285, DOI DOI 10.1201/9780824746728.CH12; Albornoz F, 2015, CHIL J AGR RES, V75, P284, DOI 10.4067/S0718-58392015000400003; Albornoz F, 2014, CHIL J AGR RES, V74, P240, DOI 10.4067/S0718-58392014000200017; Almodares A., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V6, P441; Amalfitano C, 2017, HORTIC SCI, V44, P91, DOI [10.17221/172/2015-HORTSCI, 10.17221/172/2015-hortsci]; [Anonymous], OFFICIAL METHODS ANA; Ayub M, 1999, PAKISTAN J BIOL SCI, V2, P2478; Belkhodja R, 1998, PLANT SOIL, V203, P257, DOI 10.1023/A:1004373202458; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Cartea ME, 2011, MOLECULES, V16, P251, DOI 10.3390/molecules16010251; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Conti S, 2015, SCI HORTIC-AMSTERDAM, V183, P136, DOI 10.1016/j.scienta.2014.12.003; Dhingra D, 2012, J FOOD SCI TECH MYS, V49, P255, DOI 10.1007/s13197-011-0365-5; Dietz KJ, 1997, BOOKS SOIL PLANT ENV, P951; Ding XT, 2016, SCI REP-UK, V6, DOI 10.1038/srep35424; Domingues DS, 2012, COMPUT ELECTRON AGR, V84, P53, DOI 10.1016/j.compag.2012.02.006; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fallovo C, 2009, J SCI FOOD AGR, V89, P1682, DOI 10.1002/jsfa.3641; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gorbe E, 2010, ADV BOT RES, V53, P193, DOI 10.1016/S0065-2296(10)53006-4; Grattan SR, 1999, SCI HORTIC-AMSTERDAM, V78, P127, DOI 10.1016/S0304-4238(98)00192-7; Haydon MJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00299; Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131; Hossain M.A., 2012, APPL ENVIRON SOIL SC, DOI [DOI 10.1155/2012/650206, 10.1155/2012/872875]; Islam S, 2001, J HORTIC SCI BIOTECH, V76, P764, DOI 10.1080/14620316.2001.11511443; Jahangir M, 2009, COMPR REV FOOD SCI F, V8, P31, DOI 10.1111/j.1541-4337.2008.00065.x; Karic L., 2005, Acta Agriculturae Slovenica, V85, P219; Kaur R, 2014, PESTIC BIOCHEM PHYS, V115, P39, DOI 10.1016/j.pestbp.2014.08.005; Khalid M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177185; Le Bot J, 1998, SCI HORTIC-AMSTERDAM, V74, P47, DOI 10.1016/S0304-4238(98)00082-X; Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2; Lee YH, 2013, CAN J SOIL SCI, V93, P271, DOI 10.4141/cjss2012-101; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; Lin KH, 2013, SCI HORTIC-AMSTERDAM, V150, P86, DOI 10.1016/j.scienta.2012.10.002; Lisiewska Z, 1996, FOOD CHEM, V57, P267, DOI 10.1016/0308-8146(95)00218-9; LONGSTRETH DJ, 1980, PLANT PHYSIOL, V65, P541, DOI 10.1104/pp.65.3.541; Mensinga Tjeert T., 2003, Toxicological Reviews, V22, P41, DOI 10.2165/00139709-200322010-00005; Morano G., 2017, Advances in Horticultural Science, V31, P25, DOI 10.13128/ahs-20722; MULLER K, 1987, PLANT SOIL, V100, P35, DOI 10.1007/BF02370931; Mullins GL, 1998, SOIL TILL RES, V45, P1, DOI 10.1016/S0167-1987(97)00069-X; Nemali KS, 2004, HORTSCIENCE, V39, P1287, DOI 10.21273/HORTSCI.39.6.1287; NIEMAN RICHARD H., 1962, BOT GAZ, V123, P279, DOI 10.1086/336163; Niinemets U, 2007, PLANT CELL ENVIRON, V30, P1052, DOI 10.1111/j.1365-3040.2007.01683.x; Pannala AS, 2003, FREE RADICAL BIO MED, V34, P576, DOI 10.1016/S0891-5849(02)01353-9; Pinter PJ, 2003, PHOTOGRAMM ENG REM S, V69, P647, DOI 10.14358/PERS.69.6.647; Podsedek A, 2007, LWT-FOOD SCI TECHNOL, V40, P1, DOI 10.1016/j.lwt.2005.07.023; Polesskaya OG, 2004, RUSS J PLANT PHYSL+, V51, P615, DOI 10.1023/B:RUPP.0000040746.66725.77; Romero-Aranda R, 2001, PLANT SCI, V160, P265, DOI 10.1016/S0168-9452(00)00388-5; Samarakoon U. C., 2006, Tropical Agricultural Research, V18, P13; Santamaria P, 2006, J SCI FOOD AGR, V86, P10, DOI 10.1002/jsfa.2351; Savvas D., 2008, EUROP J PLANT SCI BI, V2, P45; Shannon MC, 1999, SCI HORTIC-AMSTERDAM, V78, P5, DOI 10.1016/S0304-4238(98)00189-7; Signore A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00391; Slamic B, 2016, EMIR J FOOD AGR, V28, P398, DOI 10.9755/ejfa.2016-04-340; Smiechowska M, 2006, FOOD CHEM, V94, P366, DOI 10.1016/j.foodchem.2004.11.026; Sonneveld C, 2009, PLANT NUTRITION OF GREENHOUSE CROPS, P1, DOI 10.1007/978-90-481-2532-6; Speijers G. J. A., 1996, FOOD ADDITIVES SERIE, V35, P325; SPIEGELHALDER B, 1976, FOOD COSMET TOXICOL, V14, P545, DOI 10.1016/S0015-6264(76)80005-3; Stefanov M, 2016, PLANT PHYSIOL BIOCH, V101, P54, DOI 10.1016/j.plaphy.2016.01.017; Tewari RK, 2004, PLANT SCI, V166, P687, DOI 10.1016/j.plantsci.2003.11.004; vanIeperen W, 1996, J HORTIC SCI, V71, P99, DOI 10.1080/14620316.1996.11515386; Wu FB, 1998, FIELD CROP RES, V56, P309, DOI 10.1016/S0378-4290(97)00108-1; Wu M, 2008, SCI HORTIC-AMSTERDAM, V116, P122, DOI 10.1016/j.scienta.2007.11.014; Zeng HQ, 2014, PLANT SOIL, V374, P1005, DOI 10.1007/s11104-013-1907-6	65	50	52	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202090	10.1371/journal.pone.0202090	http://dx.doi.org/10.1371/journal.pone.0202090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157185	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400034
J	Hiza, H; Fenner, L; Hella, J; Kuchaka, D; Sasamalo, M; Blauenfeldt, T; Kibiki, G; Kavishe, RA; Mhimbira, F; Ruhwald, M				Hiza, Hellen; Fenner, Lukas; Hella, Jerry; Kuchaka, Davis; Sasamalo, Mohamed; Blauenfeldt, Thomas; Kibiki, Gibson; Kavishe, Reginald A.; Mhimbira, Francis; Ruhwald, Morten			Boosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection	PLOS ONE			English	Article							INTERLEUKIN-7; RESPONSES; BLOOD	Background A quarter of the world's population is estimated to be infected with Myobacterium tuberculosis (Mtb). Infection is detected by immune response to M. tuberculosis antigens using either tuberculin skin test (TST) and interferon gamma release (IGRA's), tests which have low sensitivity in immunocompromised. IL-7 is an important cytokine for T-cell function with potential to augment cytokine release in in-vitro assays. This study aimed to determine whether the addition of IL-7 in interferon-gamma release assays (IGRAs) improves its diagnostic performance of Mtb infection. Methods 44 cases with confirmed TB and 45 household contacts without TB were recruited and 1 ml of blood was stimulated in two separate IGRA's tube set: one set of standard Quantiferon TB gold tubes mitogen, TB antigen and TB Nil; one set of customized Quantiferon TB gold tubes with added IL-7. Following IFN-gamma and IP-10 release was determined using ELISA. Results We found that the addition of IL-7 led to significantly higher release of IFN-gamma in individuals with active TB from 4.2IU/ml (IQR 1.4 +/- 6.9IU/ml) to 5.1IU/ml (IQR 1.5 +/- 8.1IU/ml, p = 0.0057), and we found an indication of a lower release of both IFN-. and IP-10 in participants with negative tests. Conclusions In TB cases addition of IL-7 in IGRA tubes augments IFN-. but not IP-10 release, and seems to lower the response in controls. Whether IL-7 boosted IGRA holds potential over	[Hiza, Hellen; Hella, Jerry; Sasamalo, Mohamed; Mhimbira, Francis] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Fenner, Lukas; Hella, Jerry; Sasamalo, Mohamed] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Fenner, Lukas; Hella, Jerry; Sasamalo, Mohamed] Univ Basel, Basel, Switzerland; [Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Kuchaka, Davis; Kibiki, Gibson; Kavishe, Reginald A.] Kilimanjaro Clin Res Inst, Kilimanjaro, Tanzania; [Blauenfeldt, Thomas; Ruhwald, Morten] Statens Serum Inst, Ctr Vaccine Res, Copenhagen, Denmark; [Kibiki, Gibson] East African Hlth Res Commiss, Bujumbura, Burundi; [Kavishe, Reginald A.] Tumaini Univ, Kilimanjaro Christian Med Univ Coll, Kilimanjaro, Tanzania	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Bern; Statens Serum Institut	Ruhwald, M (corresponding author), Statens Serum Inst, Ctr Vaccine Res, Copenhagen, Denmark.	moru@ssi.dk	Kuchaka, Davis/ABD-5260-2021; Hella, Jerry/I-6738-2017	Kuchaka, Davis/0000-0002-0991-703X; Hella, Jerry/0000-0003-2392-8592; Fenner, Lukas/0000-0003-3309-4835	Rudolf Geigy Foundation (Basel, Switzerland); Statens Serum Institute (Copenhagen, Denmark); European Commission H2020 program [TBVAC2020 643381]; Research Council Norway [GLOBVAC 248042/H10]	Rudolf Geigy Foundation (Basel, Switzerland); Statens Serum Institute (Copenhagen, Denmark); European Commission H2020 program; Research Council Norway(Research Council of Norway)	This work was supported by funding from the Rudolf Geigy Foundation (Basel, Switzerland) and the Statens Serum Institute (Copenhagen, Denmark). Morten Ruhwald received funding from European Commission H2020 program [grant number TBVAC2020 643381] and Research Council Norway [GLOBVAC 248042/H10]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2011, CLIN VACCINE IMMUNOL, V18, P1150, DOI 10.1128/CVI.00051-11; Arlehamn CSL, 2012, J IMMUNOL, V188, P5020, DOI 10.4049/jimmunol.1103556; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; ElKassar N, 2010, J IMMUNOTOXICOL, V7, P1, DOI 10.3109/15476910903453296; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; Feske M, 2008, CLIN VACCINE IMMUNOL, V15, P1616, DOI 10.1128/CVI.00185-08; Feske ML, 2012, METHODS MOL BIOL, V792, P229, DOI 10.1007/978-1-61779-325-7_18; Fletcher HA, 2016, T ROY SOC TROP MED H, V110, P212, DOI 10.1093/trstmh/trw016; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gao JB, 2015, INT J MOL SCI, V16, P10267, DOI 10.3390/ijms160510267; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Liu ZH, 2014, INT J CLIN EXP PATHO, V7, P870; Malherbe ST, 2016, NAT MED, V22, P1094, DOI 10.1038/nm.4177; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mhimbira F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005342; Mikkelsen H, 2012, VET IMMUNOL IMMUNOP, V147, P69, DOI 10.1016/j.vetimm.2012.04.002; Nemes E, 2017, AM J RESP CRIT CARE, V196, P638, DOI 10.1164/rccm.201704-0817OC; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Sester M, 2015, EUR RESPIR J, V46, P1836, DOI 10.1183/13993003.01047-2015; Shmarov VA, 2016, EUR CYTOKINE NETW, V27, P102, DOI 10.1684/ecn.2016.0385; Tagmouti Saloua, 2014, Ann Am Thorac Soc, V11, P1267, DOI 10.1513/AnnalsATS.201405-188OC; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Wang SH, 2012, J CLIN MICROBIOL, V50, P2469, DOI 10.1128/JCM.00674-12; WHO, 2016, GLOB TUB REP	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202525	10.1371/journal.pone.0202525	http://dx.doi.org/10.1371/journal.pone.0202525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157233	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400059
J	Kim, ST; Lee, YJ; Tasaki, T; Hwang, J; Kang, MJ; Yi, EC; Kim, BY; Kwon, YT				Kim, Sung Tae; Lee, Yoon Jee; Tasaki, Takafumi; Hwang, Joonsung; Kang, Min Jueng; Yi, Eugene C.; Kim, Bo Yeon; Kwon, Yong Tae			The N-recognin UBR4 of the N-end rule pathway is required for neurogenesis and homeostasis of cell surface proteins	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; TERMINAL ARGINYLATION; AUTOPHAGIC PROTEOLYSIS; MOLECULAR PRINCIPLES; STATISTICAL-MODEL; E7 ONCOPROTEIN; MICE LACKING; VE-CADHERIN; P600; MOUSE	The N-end rule pathway is a proteolytic system in which single N-terminal amino acids of proteins act as a class of degrons (N-degrons) that determine the half-lives of proteins. We have previously identified a family of mammals N-recognins (termed UBR1, UBR2, UBR4/p600, and UBR5/EDD) whose conserved UBR boxes bind N-degrons to facilitate substrate ubiquitination and proteasomal degradation via the ubiquitin-proteasome system (UPS). Amongst these N-recognins, UBR1 and UBR2 mediate ubiquitination and proteolysis of short-lived regulators and misfolded proteins. Here, we characterized the null phenotypes of UBR4-deficient mice in which the UBR box of UBR4 was deleted. We show that the mutant mice die around embryonic days 9.5-10.5 (E9.5-E10.5) associated with abnormalities in various developmental processes such as neurogenesis and cardiovascular development. These developmental defects are significantly attributed to the inability to maintain cell integrity and adhesion, which significantly correlates to the severity of null phenotypes. UBR4-loss induces the depletion of many, but not all, proteins from the plasma membrane, suggesting that UBR4 is involved in proteome-wide turnover of cell surface proteins. Indeed, UBR4 is associated with and required to generate the multivesicular body (MVB) which transiently store endocytosed cell surface proteins before their targeting to autophagosomes and subsequently lysosomes. Our results suggest that the N-recognin UBR4 plays a role in the homeostasis of cell surface proteins and, thus, cell adhesion and integrity.	[Kim, Sung Tae; Lee, Yoon Jee; Kwon, Yong Tae] Seoul Natl Univ, Prot Metab Med Res Ctr, Seoul, South Korea; [Kim, Sung Tae; Lee, Yoon Jee; Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Sung Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Kim, Sung Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Tasaki, Takafumi] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa, Japan; [Hwang, Joonsung; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, World Class Inst, Anticanc Agents Res Ctr, Ochang, Cheongwon, South Korea; [Kang, Min Jueng; Yi, Eugene C.] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Sch Convergence Sci & Technol, Seoul, South Korea; [Kang, Min Jueng; Yi, Eugene C.] Seoul Natl Univ, Coll Med, Coll Pharm, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kanazawa Medical University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kwon, YT (corresponding author), Seoul Natl Univ, Prot Metab Med Res Ctr, Seoul, South Korea.; Kwon, YT (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Kim, BY (corresponding author), Korea Res Inst Biosci & Biotechnol, World Class Inst, Anticanc Agents Res Ctr, Ochang, Cheongwon, South Korea.; Kwon, YT (corresponding author), Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea.	bykim@kribb.re.kr; yok5@snu.ac.kr			Seoul National University (SNU) Nobel Laureates Invitation Program; National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT) [NRF-2016R1A2B3011 389, NRF-2015M3A9B6073835, NRF-2014M39Ab5073938, NRF-2015-Global]; Brain Korea 21 PLUS; SNU Hospital; Bio and Medical Technology Development Program through the MSIT [2012M3A9B6055305]; R&D Convergence Program of National Research Council of Science & Technology (NST) [CAP-16-03-KRIBB]; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program [NRF-2014M39Ab5073938]; Grant for Promoted Research from Kanazawa Medical University [S2016-13, S2017-6]; JSPS KAKENHI [JP25430119, JP18K06119]	Seoul National University (SNU) Nobel Laureates Invitation Program; National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT); Brain Korea 21 PLUS; SNU Hospital; Bio and Medical Technology Development Program through the MSIT; R&D Convergence Program of National Research Council of Science & Technology (NST); Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program; Grant for Promoted Research from Kanazawa Medical University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Seoul National University (SNU) Nobel Laureates Invitation Program (http://www.snu.ac.kr), the National Research Foundation of Korea (NRF; http://www.nrf.re.kr) funded by the Ministry of Science and ICT (MSIT) (NRF-2016R1A2B3011 389 to Y.T.K., NRF-2015M3A9B6073835 to E.C.Y., NRF-2014M39Ab5073938 to B.Y.K., and NRF-2015-Global PhD Fellowship to Y.J.L.), the Brain Korea 21 PLUS (to SNU; http://bkplus.nrf.re.kr), SNU Hospital (to Y.T.K.; http://www.snuh.org), the Bio and Medical Technology Development Program (project no. 2012M3A9B6055305 to B.Y. K.) through the MSIT (http://www.msit.go.kr), the R&D Convergence Program (CAP-16-03-KRIBB) of National Research Council of Science & Technology (NST; http://www.nst.re.kr/nst), Korea Research Institute of Bioscience and Biotechnology (KRIBB; http://www.kribb.re.kr) Research Initiative Program (NRF-2014M39Ab5073938 to B.Y.K.), and Grant for Promoted Research from Kanazawa Medical University (http://www.kanazawa-med.ac.jp) (S2016-13, S2017-6 to T.T.) and by JSPS KAKENHI (https://www.jsps.go.jp) Grant Number JP25430119 and JP18K06119 (to T.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim IS, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.401; An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Basso M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00127; Belzil C, 2014, BIOL OPEN, V3, P475, DOI 10.1242/bio.20147807; Belzil C, 2013, J BIOL CHEM, V288, P24452, DOI 10.1074/jbc.M113.483107; Bian S., 2013, NEURAL STEM CELLS; Campos EI, 2015, MOL CELL, V60, P697, DOI 10.1016/j.molcel.2015.08.005; Cha-Molstad H, 2018, AUTOPHAGY, V14, P359, DOI 10.1080/15548627.2017.1415190; Cha-Molstad H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00085-7; Cha-Molstad H, 2016, AUTOPHAGY, V12, P426, DOI 10.1080/15548627.2015.1126047; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; DeMasi J, 2005, P NATL ACAD SCI USA, V102, P11486, DOI 10.1073/pnas.0505322102; DeMasi J, 2007, J VIROL, V81, P9419, DOI 10.1128/JVI.00422-07; Enriquez-Barreto L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00076; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Grossier JP, 2014, EMBO J, V33, P35, DOI 10.1002/embj.201385284; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Keerthikumar S, 2015, ONCOTARGET, V6, P15375, DOI 10.18632/oncotarget.3801; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim ST, 2013, AUTOPHAGY, V9, P1100, DOI 10.4161/auto.24643; Kinsella E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157079; Kischel P, 2008, NEOPLASIA, V10, P1014, DOI 10.1593/neo.08570; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Kwon YT, 1999, J BIOL CHEM, V274, P18135, DOI 10.1074/jbc.274.25.18135; Lee MJ, 2008, P NATL ACAD SCI USA, V105, P100, DOI 10.1073/pnas.0708465105; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lescroart F, 2010, DEVELOPMENT, V137, P3269, DOI 10.1242/dev.050674; Lin RT, 2013, MOL CELL, V51, P506, DOI 10.1016/j.molcel.2013.07.002; Luo Y, 2005, J CELL BIOL, V169, P29, DOI 10.1083/jcb.200411127; Munoz-Escobar J, 2017, PROTEIN SCI, V26, P2092, DOI 10.1002/pro.3227; Nakatani Y, 2005, P NATL ACAD SCI USA, V102, P15093, DOI 10.1073/pnas.0507458102; Nakaya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066269; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pavelka N, 2008, MOL CELL PROTEOMICS, V7, P631, DOI 10.1074/mcp.M700240-MCP200; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rybak JN, 2004, PROTEOMICS, V4, P2296, DOI 10.1002/pmic.200300780; Scheurer SB, 2005, PROTEOMICS, V5, P2718, DOI 10.1002/pmic.200401163; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shearer RF, 2018, MOL BIOL CELL, V29, P1542, DOI 10.1091/mbc.E17-04-0248; Shim SY, 2008, J NEUROSCI, V28, P3604, DOI 10.1523/JNEUROSCI.5278-07.2008; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Sriram SM, 2010, NAT STRUCT MOL BIOL, V17, P1164, DOI 10.1038/nsmb1010-1164; TAKEICHI M, 1990, NEUROSCI RES, pS92, DOI 10.1016/0921-8696(90)90036-3; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2013, P NATL ACAD SCI USA, V110, P3800, DOI 10.1073/pnas.1217358110; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; White EA, 2012, P NATL ACAD SCI USA, V109, pE260, DOI 10.1073/pnas.1116776109; Wishart TM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002936; Yau RG, 2017, CELL, V171, P918, DOI 10.1016/j.cell.2017.09.040; Yoo YD, 2018, P NATL ACAD SCI USA, V115, pE2716, DOI 10.1073/pnas.1719110115; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zemskov EA, 2009, J BIOL CHEM, V284, P16693, DOI 10.1074/jbc.M109.010769; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111; Zimmerman SW, 2014, CELL TISSUE RES, V356, P261, DOI 10.1007/s00441-014-1808-x	67	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202260	10.1371/journal.pone.0202260	http://dx.doi.org/10.1371/journal.pone.0202260			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157281	Green Submitted, gold, Green Published			2022-12-27	WOS:000443071400047
J	Mollaioli, D; Di Sante, S; Limoncin, E; Ciocca, G; Gravina, GL; Maseroli, E; Fanni, E; Vignozzi, L; Maggi, M; Lenzi, A; Jannini, EA				Mollaioli, Daniele; Di Sante, Stefania; Limoncin, Erika; Ciocca, Giacomo; Gravina, Giovanni Luca; Maseroli, Elisa; Fanni, Egidia; Vignozzi, Linda; Maggi, Mario; Lenzi, Andrea; Jannini, Emmanuele A.			Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F	PLOS ONE			English	Article							FUNCTION INDEX FSFI; SEXUAL DYSFUNCTION; PREMATURE EJACULATION; VAGINAL ORGASM; WOMEN; QUESTIONNAIRE; INTERNET; STANDARDIZATION; MASTURBATION; SENSITIVITY	The female orgasm represents one of the most complex functions in the field of human sexuality. The conjunction of the anatomical, physiological, psycho-relational and socio-cultural components contributes to make the female orgasm still partly unclear. The female orgasmic experience, its correlates and the relation with sexual desire, arousal and lubrication as predictors are highly debated in scientific community. In this context, little is known about the impact of female sexual dysfunction (SD) on sexual pleasure expressed by subjective orgasmic intensity, and there are no suitable psychometric tools suited to investigate this dimension. Thus, we validate, in female subjects, a Visual Analogue Scale (VAS) that we named Orgasmometer-F, to verify if SD is accompanied by a lower perceived orgasmic intensity. A total of 526 women, recruited through a web-based platform and from sexological outpatient clinic, were enrolled in the study. They were divided into, on the basis of the Female Sexual Function Index (FSFI) score in two groups: 1) 112women suffering from SD, (SD Group); and 2) 414 sexually healthy women (Control Group). The participants were requested to fill out the Orgasmometer-F, recording orgasmic intensity on a Likert scale from 0 (absence of orgasmic intensity) to 10 (maximum orgasmic intensity experienced). Women with SD experienced significantly lower orgasmic intensity than controls, as measured by the Orgasmometer-F (p<0.0001). Interestingly, masturbatory frequency was positively correlated with orgasmic intensity, as were the lubrication, orgasm and sexual satisfaction domains of the FSFI. The Orgasmometer-F was well understood, had a good test-retest reliability (ICC = 0.93) and a high AUC in differentiating between women with and without sexual dysfunction (AUC = 0.9; p<0.0001). The ROC curve analysis showed that a cut-off <5 had 86.5% sensitivity (95% CI 82,8-89,6), 80.4% specificity (95% CI 71.8-87.3), 75.4% positive predictive value (PPV) and 89.5% negative predictive value (NPV). In conclusion, the Orgasmometer-F, a new psychometrically sound tool for measuring orgasmic intensity in female population, demonstrated that SD impair orgasmic intensity.	[Mollaioli, Daniele; Limoncin, Erika; Ciocca, Giacomo; Jannini, Emmanuele A.] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Di Sante, Stefania; Lenzi, Andrea] Sapienza Univ Rome, Dept Expt Med, Div Endocrinol, Rome, Italy; [Gravina, Giovanni Luca] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy; [Maseroli, Elisa; Fanni, Egidia; Vignozzi, Linda; Maggi, Mario] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Jannini, Emmanuele A.] Univ Roma Tor Vergata, Dept Syst Med, Chair Endocrinol & Med Sexol ENDOSEX, Rome, Italy	University of Rome Tor Vergata; Sapienza University Rome; University of L'Aquila; University of Florence; University of Rome Tor Vergata	Jannini, EA (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.; Jannini, EA (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Chair Endocrinol & Med Sexol ENDOSEX, Rome, Italy.	eajannini@gmail.com	Maggi, Mario/AAB-8284-2019; Maseroli, Elisa/AAA-9745-2020; Mollaioli, Daniele/AAR-1039-2020	Maseroli, Elisa/0000-0002-1472-6051; Mollaioli, Daniele/0000-0001-5947-3310; Vignozzi, Linda/0000-0003-0907-0630; MAGGI, Mario/0000-0003-3267-4221				Altman DG., 1999, PRACTICAL STAT MED R; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; APA, 2000, DIAGN STAT MAN MENT; Balercia G, 2007, PSYCHOTHER PSYCHOSOM, V76, P134, DOI 10.1159/000099840; Bancroft J., 2009, HUMAN SEXUALITY ITS, V3rd, P280, DOI [https://doi.org/10.1016/B978-0-443-05161-6.00009-4, DOI 10.1016/B978-0-443-05161-6.00009-4]; Bancroft J, 2011, ARCH SEX BEHAV, V40, P725, DOI 10.1007/s10508-010-9679-z; Bianchi-Demicheli F, 2007, NEUROPSYCHOLOGIA, V45, P2645, DOI 10.1016/j.neuropsychologia.2007.04.016; Brody S, 2008, J SEX MARITAL THER, V34, P343, DOI 10.1080/00926230802096374; Brody S, 2008, J SEX MED, V5, P1167, DOI 10.1111/j.1743-6109.2008.00786.x; Buisson O, 2013, J SEX MED, V10, P2734, DOI 10.1111/jsm.12279; Buisson O, 2010, J SEX MED, V7, P2750, DOI 10.1111/j.1743-6109.2010.01892.x; Burri AV, 2009, J SEX MED, V6, P1930, DOI 10.1111/j.1743-6109.2009.01297.x; Carvalheira A, 2013, J SEX MARITAL THER, V39, P347, DOI 10.1080/0092623X.2011.628440; D'Amati G, 2003, J Endocrinol Invest, V26, P92; D'amati G, 2002, UROLOGY, V60, P191, DOI 10.1016/S0090-4295(02)01663-1; Davidson J K, 1989, Fam Pract Res J, V8, P75; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dove NL, 2000, J SEX MARITAL THER, V26, P67, DOI 10.1080/009262300278650; Dubray S, 2017, J SEX MED, V14, P255, DOI 10.1016/j.jsxm.2016.12.006; Enquist M, 2011, J SEX MED, V8, P140, DOI 10.1111/j.1743-6109.2010.02065.x; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Filocamo MT, 2014, J SEX MED, V11, P447, DOI 10.1111/jsm.12389; Foldes P, 2009, J SEX MED, V6, P1223, DOI 10.1111/j.1743-6109.2009.01231.x; Fugl-Meyer KS, 2006, J SEX MED, V3, P56, DOI 10.1111/j.1743-6109.2005.00170.x; Georgiadis JR, 2011, SEX RELATSH THER, V26, P342, DOI 10.1080/14681994.2011.647904; Giraldi A, 2011, J SEX MED, V8, P2681, DOI 10.1111/j.1743-6109.2011.02395.x; Giuliano F, 2002, J SEX MARITAL THER, V28, P101, DOI 10.1080/00926230252851230; Graham CA, 2010, ARCH SEX BEHAV, V39, P256, DOI 10.1007/s10508-009-9542-2; Gravina GL, 2008, J SEX MED, V5, P610, DOI 10.1111/j.1743-6109.2007.00739.x; Harris JM, 2008, J SEX MED, V5, P1177, DOI 10.1111/j.1743-6109.2008.00800.x; Hatch EE, 2016, EPIDEMIOLOGY, V27, P98, DOI 10.1097/EDE.0000000000000400; Herbenick D, 2010, J SEX MED, V7, P1822, DOI 10.1111/j.1743-6109.2010.01728.x; Jaafar NRN, 2009, ASEAN J PSYCHIATR, V10, P43; Jannini EA, 2014, NAT REV UROL, V11, P531, DOI 10.1038/nrurol.2014.193; Jannini EA, 2012, J SEX MED, V9, P2994, DOI 10.1111/jsm.12018; Jannini EA, 2012, J SEX MED, V9, P956, DOI 10.1111/j.1743-6109.2012.02694.x; Keller A, 2006, J SEX MARITAL THER, V32, P43, DOI 10.1080/00926230500232909; King R, 2011, ARCH SEX BEHAV, V40, P865, DOI 10.1007/s10508-010-9639-7; Kinsey A.C., 1998, SEXUAL BEHAV HUMAN F; Komisaruk BR, 2005, ANN REV SEX RES, V16, P62; Laan E, 2011, SEX RELATSH THER, V26, P329, DOI 10.1080/14681994.2011.649691; Lane TS, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4359; Lavie-Ajayi M, 2009, J HEALTH PSYCHOL, V14, P98, DOI 10.1177/1359105308097950; Limoncin E, 2016, ANDROLOGY-US, V4, P921, DOI 10.1111/andr.12220; Limoncin E, 2014, INT J IMPOT RES, V26, P51, DOI 10.1038/ijir.2013.34; Limoncin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098413; Limoncin E, 2013, J UROLOGY, V189, P1830, DOI 10.1016/j.juro.2012.11.007; Mah K, 2005, J SEX MARITAL THER, V31, P187, DOI 10.1080/00926230590513401; Maseroli E, 2016, ANDROLOGY-US, V4, P911, DOI 10.1111/andr.12224; Maseroli E, 2016, J ENDOCRINOL INVEST, V39, P401, DOI 10.1007/s40618-015-0378-4; Masters WH., 1966, HUMAN SEXUAL RESPONS; McCabe MP, 2016, J SEX MED, V13, P135, DOI 10.1016/j.jsxm.2015.12.019; Meston CM, 2010, J SEX MED, V7, P938, DOI 10.1111/j.1743-6109.2009.01548.x; Meston CM, 2003, J SEX MARITAL THER, V29, P39, DOI 10.1080/713847100; Meston CM, 2004, ANN REV SEX RES, V15, P173; Quirk F, 2005, J SEX MED, V2, P469, DOI 10.1111/j.1743-6109.2005.00076.x; Richters J, 2006, J SEX RES, V43, P217, DOI 10.1080/00224490609552320; Roslan NS, 2017, CURR DRUG TARGETS; Rowland DL, 2016, J SEX MED, V13, P1246, DOI 10.1016/j.jsxm.2016.05.014; Rowland DL, 2018, J SEX MARITAL THER; Rowland DL, 2017, J SEX RES; Salisbury CMA, 2014, J SEX RES, V51, P616, DOI 10.1080/00224499.2013.838934; Sidi H, 2008, ASIA-PAC J PUBLIC HE, V20, P298, DOI 10.1177/1010539508322810; TAYLOR JF, 1994, ARCH SEX BEHAV, V23, P627, DOI 10.1007/BF01541816; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; Yang CC, 2000, J UROLOGY, V164, P2010, DOI 10.1016/S0022-5347(05)66941-8	67	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202076	10.1371/journal.pone.0202076	http://dx.doi.org/10.1371/journal.pone.0202076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157203	Green Published, gold			2022-12-27	WOS:000443071400032
J	Deshpande, R; Kanitkar, M; Kadam, S; Dixit, K; Chhabra, H; Bellare, J; Datar, S; Kale, VP				Deshpande, Rucha; Kanitkar, Meghana; Kadam, Sheetal; Dixit, Kadambari; Chhabra, Hemlata; Bellare, Jayesh; Datar, Savita; Kale, Vaijayanti P.			Matrix-entrapped cellular secretome rescues diabetes-induced EPC dysfunction and accelerates wound healing in diabetic mice	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; NITRIC-OXIDE; IN-VITRO; DIFFERENTIATION; ANGIOGENESIS; REGENERATION; SCAFFOLDS; NANOFIBER; MELLITUS; DISEASE	Cellular secretory products have infinite potential, which is only recently explored for research and therapeutic applications. The present study elaborated on the formation of a unique matrix-entrapped cellular secretome (MCS), a hydrogel-like secretome produced by bone marrow-derived mononuclear cells when cultured on a three-dimensional electrospun nanofiber matrix under specific conditions. These culture conditions support the growth of a mixed population predominantly comprising of endothelial precursor cells (EPCs), along with mesenchymal stromal cells and pericytes. Interestingly, such secretome is not formed in a pure culture of EPCs on the similarly formulated matrix, suggesting that a heterotypic cell-cell interaction is essential for the formation of MCS. In addition, the specific composition of the matrix was found to be a critical necessity for the formation of MCS. Furthermore, the application of the MCS as a substrate promotes the growth of EPCs in culture. It also rescues the diabetes-induced EPC dysfunction as assessed based on the parameters, such as viability, proliferation, colony formation, cellular adhesion, chemotactic migration, and tubule formation. MCS augments the levels of eNOS-specific mRNA (Nos3) and also promotes the restoration of the SDF1/CXCR4 axis in diabetic EPCs. Notably, a topical application of MCS on diabetic wounds leads to an accelerated wound closure. Thus, the current data showed that MCS forms an excellent cell-free biomaterial in the treatment of diabetic wounds and non-healing ulcers.	[Deshpande, Rucha; Kanitkar, Meghana; Kadam, Sheetal; Dixit, Kadambari; Kale, Vaijayanti P.] Natl Ctr Cell Sci, NCCS Complex,Univ Pune Campus, Pune, Maharashtra, India; [Deshpande, Rucha; Datar, Savita] Commerce & Sci Coll, Prof Ramkrishna More Arts, Pune, Maharashtra, India; [Chhabra, Hemlata; Bellare, Jayesh] Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India; [Datar, Savita] SP Coll, Dept Zool, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kale, VP (corresponding author), Natl Ctr Cell Sci, NCCS Complex,Univ Pune Campus, Pune, Maharashtra, India.	vpkale@nccs.res.in	Kale, Vaijayanti/R-9342-2019; Bellare, Jayesh/AAO-8713-2020	Kale, Vaijayanti/0000-0001-7498-7563; Bellare, Jayesh/0000-0002-6792-8327	BRNS [2011/37B/26IBRNS/1251]; National Centre for Cell Science (NCCS)	BRNS(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); National Centre for Cell Science (NCCS)	This work is funded by BRNS, Sanction No. 2011/37B/26IBRNS/1251. The Director of National Centre for Cell Science (NCCS) also provided intramural funding to VPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Callaghan MJ, 2005, ANTIOXID REDOX SIGN, V7, P1476, DOI 10.1089/ars.2005.7.1476; Celestina Mazzotta, 2017, ARTHRITIS RES THER, V19, P27, DOI [10.1186/s13075-017-1233-0, DOI 10.1186/S13075-017-1233-0]; Cheng MF, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/513853; De Falco E, 2009, J CELL MOL MED, V13, P3405, DOI 10.1111/j.1582-4934.2009.00655.x; Dixit K., 2017, BIOMEDICAL RES J, V4, P82; Dubsky M, 2012, J MATER SCI-MATER M, V23, P931, DOI 10.1007/s10856-012-4577-7; Fisher MB, 2012, TISSUE ENG REGEN MED, P251; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Hamed S, 2011, CARDIOVASC RES, V91, P9, DOI 10.1093/cvr/cvq412; Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200; Hynes B, 2013, EUR HEART J, V34, P782, DOI 10.1093/eurheartj/ehr435; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kamoun EA, 2017, J ADV RES, V8, P217, DOI 10.1016/j.jare.2017.01.005; Kanitkar M, 2014, J BIOMED RES, V1, P95; Kanitkar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069960; Kimira Y, 2014, BIOCHEM BIOPH RES CO, V453, P498, DOI 10.1016/j.bbrc.2014.09.121; Kolluru GK, 2012, INT J VASCULAR MED, V918267, P30; Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002; Loomans CJM, 2005, ANTIOXID REDOX SIGN, V7, P1468, DOI 10.1089/ars.2005.7.1468; Maekawa Y, 2011, GERIATR GERONTOL INT, V11, P510, DOI 10.1111/j.1447-0594.2011.00699.x; Makridakis M, 2013, BBA-PROTEINS PROTEOM, V1834, P2380, DOI 10.1016/j.bbapap.2013.01.032; Maltese G, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/757469; Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042; Oh BJ, 2010, BIOCHEM BIOPH RES CO, V398, P627, DOI 10.1016/j.bbrc.2010.06.108; Parekh N, 2017, RSC ADV, V7, P26551, DOI 10.1039/c7ra03288a; Pendharkar N, 2016, J PROTEOMICS, V132, P112, DOI 10.1016/j.jprot.2015.11.024; Rae PC, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-11; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Shimada Toshifumi, ANGIOGENESIS VASCULO; Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126; Sun GM, 2011, P NATL ACAD SCI USA, V108, P20976, DOI 10.1073/pnas.1115973108; Tessari P, 2010, DIABETES, V59, P2152, DOI 10.2337/db09-1772; Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wang X, 2016, ONCOTARGET, V7, P44941, DOI 10.18632/oncotarget.10377; Wu Danli, 2011, J Vis Exp, DOI 10.3791/3357; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Yamashita K, 2014, PRS-GLOB OPEN, V2, DOI 10.1097/GOX.0000000000000045; Yamauchi M, 2016, BIOCHEMBIOPHYS RES C, V13, P845, DOI [10.1016/j.bbrc.2016.03.138, DOI 10.1016/J.BBRC.2016.03.138]; Zheng H, 2007, J CARDIOVASC PHARM, V50, P274, DOI 10.1097/FJC.0b013e318093ec8f; Zullo JA, 2015, STEM CELL TRANSL MED, V4, P852, DOI 10.5966/sctm.2014-0111	47	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202510	10.1371/journal.pone.0202510	http://dx.doi.org/10.1371/journal.pone.0202510			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153276	Green Submitted, gold, Green Published			2022-12-27	WOS:000443001700017
J	Fortuna, ME; Vasilache, V; Ignat, M; Silion, M; Vicol, T; Patras, X; Miron, I; Lobiuc, A				Fortuna, Maria-Emiliana; Vasilache, Viorica; Ignat, Maria; Silion, Mihaela; Vicol, Tudor; Patras, Xenia; Miron, Ionel; Lobiuc, Andrei			Elemental and macromolecular modifications in Triticum aestivum L. plantlets under different cultivation conditions	PLOS ONE			English	Article							ANTIOXIDANT PROPERTIES; WHEATGRASS; MANGANESE; MAGNESIUM; SYSTEMS; GROWTH; SOIL; SUPPLEMENTATION; ACCUMULATION; MECHANISMS	Young wheat plantlets (wheatgrass), represent a significant source of minerals, enzymes, vitamins, while also rich in phenolics and chlorophylls, with considerable bioactivities. As the biosynthesis of such compounds may be influenced by growth conditions, the current research assesses wheatgrass composition in soil based and hydroponic systems, using water with different elemental composition. FTIR spectroscopy did not reveal significant variations between juice and extracts cultivated in different setups. Surface elemental composition indicated higher Na, P, Si concentrations in hydroponic plants, while AAS analyses showed increased Ca and Mn in soil presence. HPLC-MS of extracts showed that soil and spring water increased chlorophyll and hydroxychlorophyll a concentrations. Phenolic contents were higher in hydroponic plants, while maximum values were recorded for spring water. Radical scavenging activity was stimulated by the use of spring water. Results indicate that wheatgrass with improved mineral and macromolecular composition may be obtained using accessible cultivation setups.	[Fortuna, Maria-Emiliana; Ignat, Maria; Silion, Mihaela; Patras, Xenia] Petru Poni Inst Macromol Chem, Iasi, Romania; [Vasilache, Viorica] Alexandru Ioan Cuza Univ, Interdisciplinary Res Dept, Field Sci, Iasi, Romania; [Ignat, Maria] Alexandru Ioan Cuza Univ, Fac Chem, Iasi, Romania; [Vicol, Tudor; Patras, Xenia] Apollonia Univ, Iasi, Romania; [Miron, Ionel] Alexandru Ioan Cuza Univ, Fac Biol, Iasi, Romania; [Lobiuc, Andrei] Alexandru Ioan Cuza Univ, CERNESIM L2, Iasi, Romania; [Lobiuc, Andrei] Stefan cel Mare Univ, Fac Food Engn, Suceava, Romania	Romanian Academy of Sciences; Petru Poni Institute of Macromolecular Chemistry; Alexandru Ioan Cuza University; Alexandru Ioan Cuza University; Apollonia University; Alexandru Ioan Cuza University; Alexandru Ioan Cuza University; Stefan cel Mare University of Suceava	Vasilache, V (corresponding author), Alexandru Ioan Cuza Univ, Interdisciplinary Res Dept, Field Sci, Iasi, Romania.; Lobiuc, A (corresponding author), Alexandru Ioan Cuza Univ, CERNESIM L2, Iasi, Romania.; Lobiuc, A (corresponding author), Stefan cel Mare Univ, Fac Food Engn, Suceava, Romania.	viorica_18v@yahoo.com; andrei.lobiuc@fia.usv.ro	Ignat, Maria/AAA-2511-2022; Ignat, Maria/G-9396-2012; Silion, Mihaela/L-6048-2013; Viorica, Vasilache/A-3614-2019; Lobiuc, Andrei/I-2824-2017	Ignat, Maria/0000-0001-6884-1322; Viorica, Vasilache/0000-0002-8866-3460; 				Abdel-Aal E. M., 2008, The Open Agriculture Journal, V2, P7, DOI 10.2174/1874331500802010007; Ahmad P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00513; Akbas E, 2017, J FUNCT FOODS, V28, P19, DOI 10.1016/j.jff.2016.11.010; Oliveira AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066538; Ding Y, 2006, ANN APPL BIOL, V149, P111, DOI 10.1111/j.1744-7348.2006.00080.x; Durairaj V, 2014, ASIAN PAC J TROP MED, V7, pS398, DOI 10.1016/S1995-7645(14)60265-0; Fageria NK, 2015, HDB PLANT NUTR, P127; Ghumman A, 2017, INT J FOOD SCI TECH, V52, P2191, DOI 10.1111/ijfs.13498; HEENAN DP, 1981, PLANT SOIL, V61, P447, DOI 10.1007/BF02182025; Kashudhan H, 2017, J PHARMACOGNOSY PHYT, V6, P338; Konopka I, 2012, MOLECULES, V17, P12341, DOI 10.3390/molecules171012341; Kulkarni SD, 2007, FOOD CHEM, V103, P681, DOI 10.1016/j.foodchem.2006.07.057; Kulkarni SD, 2006, FOOD CHEM, V95, P699, DOI 10.1016/j.foodchem.2005.04.006; Kulkarni SD, 2006, PHYTOTHER RES, V20, P218, DOI 10.1002/ptr.1838; Kumar Nitya, 2017, Journal of Dietary Supplements, V14, P503, DOI 10.1080/19390211.2016.1267063; Lidon FC, 2004, J PLANT PHYSIOL, V161, P1235, DOI 10.1016/j.jplph.2004.02.003; Lobiuc A, 2017, MOLECULES, V22, DOI 10.3390/molecules22122111; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; Martinez-Ballesta MC, 2010, AGRON SUSTAIN DEV, V30, P295, DOI 10.1051/agro/2009022; Millaleo R, 2010, J SOIL SCI PLANT NUT, V10, P476, DOI 10.4067/S0718-95162010000200008; Miller DD, 2013, FOOD SYSTEM STRATEGI, V13-06, P1; Ogutu F.O., 2017, FOOD SCI QUAL MANAG, V65, P33; Ozkose A, 2016, NOT BOT HORTI AGROBO, V44, P499, DOI 10.15835/nbha44210405; Roca M, 2016, WOODHEAD PUBL FOOD S, V295, P125, DOI 10.1016/B978-0-08-100371-8.00006-3; Salas-Perez L, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8020013; Salcedo, 2011, CHLOROPHYLL STRUCTUR, P177; Santos A. M. P., 2003, Journal of Food Technology, V1, P42; Selma MV, 2012, POSTHARVEST BIOL TEC, V63, P16, DOI 10.1016/j.postharvbio.2011.08.002; Sgherri C, 2010, FOOD CHEM, V123, P416, DOI 10.1016/j.foodchem.2010.04.058; Shenker M, 2004, J PLANT PHYSIOL, V161, P197, DOI 10.1078/0176-1617-00931; Shyam R, 2007, J ALTERN COMPLEM MED, V13, P789, DOI 10.1089/acm.2007.7137; Sinkovic L, 2015, FOOD CHEM, V166, P507, DOI 10.1016/j.foodchem.2014.06.024; Strain J.J., 2009, INTRO HUMAN NUTR, P188; Subbarao GV, 2003, CRIT REV PLANT SCI, V22, P391, DOI 10.1080/07352680390243495; Tavakkoli E, 2010, FUNCT PLANT BIOL, V37, P621, DOI 10.1071/FP09202; Tsai CC, 2013, J BIOL CHEM, V288, P17689, DOI 10.1074/jbc.M112.448381; Urbonaviciute A, 2009, ZEMDIRBYSTE, V96, P119; Verbruggen N, 2013, PLANT SOIL, V368, P87, DOI 10.1007/s11104-013-1589-0	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202441	10.1371/journal.pone.0202441	http://dx.doi.org/10.1371/journal.pone.0202441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153262	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700016
J	Watanabe, H; Ozasa, N; Morimoto, T; Shiomi, H; Bingyuan, B; Suwa, S; Nakagawa, Y; Izumi, C; Kadota, K; Ikeguchi, S; Hibi, K; Furukawa, Y; Kaji, S; Suzuki, T; Akao, M; Inada, T; Hayashi, Y; Nanasato, M; Okutsu, M; Kametani, R; Sone, T; Sugimura, Y; Kawai, K; Abe, M; Kaneko, H; Nakamura, S; Kimura, T				Watanabe, Hiroki; Ozasa, Neiko; Morimoto, Takeshi; Shiomi, Hiroki; Bingyuan, Bao; Suwa, Satoru; Nakagawa, Yoshihisa; Izumi, Chisato; Kadota, Kazushige; Ikeguchi, Shigeru; Hibi, Kiyoshi; Furukawa, Yutaka; Kaji, Shuichiro; Suzuki, Takahiko; Akao, Masaharu; Inada, Tsukasa; Hayashi, Yasuhiko; Nanasato, Mamoru; Okutsu, Masaaki; Kametani, Ryosuke; Sone, Takahito; Sugimura, Yoichi; Kawai, Kazuya; Abe, Mitsunori; Kaneko, Hironori; Nakamura, Sunao; Kimura, Takeshi		CAPITAL-RCT Investigators	Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention	PLOS ONE			English	Article							BETA-BLOCKER THERAPY; LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; CLINICAL-OUTCOMES; MANAGEMENT; DEATH; HOSPITALIZATION; METAANALYSIS; ASSOCIATION; MORTALITY	Background Despite its recommendation by the current guidelines, the role of long-term oral beta-blocker therapy has never been evaluated by randomized trials in uncomplicated ST-segment elevation myocardial infarction (STEMI) patients without heart failure, left ventricular dysfunction or ventricular arrhythmia who underwent primary percutaneous coronary intervention (PCI). Methods and results In a multi-center, open-label, randomized controlled trial, STEMI patients with successful primary PCI within 24 hours from the onset and with left ventricular ejection fraction (LVEF) >= 40% were randomly assigned in a 1-to-1 fashion either to the carvedilol group or to the no beta-blocker group within 7 days after primary PCI. The primary endpoint is a composite of all-cause death, myocardial infarction, hospitalization for heart failure, and hospitalization for acute coronary syndrome. Between August 2010 and May 2014, 801 patients were randomly assigned to the carvedilol group (N = 399) or the no beta-blocker group (N = 402) at 67 centers in Japan. The carvedilol dose was up-titrated from 3.4 +/- 2.1 mg at baseline to 6.3 +/- 4.3 mg at 1-year. During median follow-up of 3.9 years with 96.4% follow-up, the cumulative 3-year incidences of both the primary endpoint and any coronary revascularization were not significantly different between the carvedilol and no beta-blocker groups (6.8% and 7.9%, P = 0.20, and 20.3% and 17.7%, P = 0.65, respectively). There also was no significant difference in LVEF at 1-year between the 2 groups (60.9 +/- 8.4% and 59.6 +/- 8.8%, P = 0.06) Conclusion Long-term carvedilol therapy added on the contemporary evidence-based medications did not seem beneficial in selected STEMI patients treated with primary PCI.	[Watanabe, Hiroki; Ozasa, Neiko; Shiomi, Hiroki; Bingyuan, Bao; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan; [Suwa, Satoru] Juntendo Univ, Div Cardiol, Shizuoka Hosp, Izunokuni, Japan; [Nakagawa, Yoshihisa; Izumi, Chisato] Tenri Hosp, Div Cardiol, Nara, Japan; [Kadota, Kazushige] Kurashiki Cent Hosp, Div Cardiol, Kurashiki, Okayama, Japan; [Ikeguchi, Shigeru] Shiga Gen Hosp, Div cardiol, Moriyama, Japan; [Hibi, Kiyoshi] Yokohama City Univ, Div Cardiol, Med Ctr, Yokohama, Kanagawa, Japan; [Furukawa, Yutaka; Kaji, Shuichiro] Kobe City Med Ctr Gen Hosp, Div Cardiol, Kobe, Hyogo, Japan; [Suzuki, Takahiko] Toyohashi Heart Ctr, Div Cardiol, Toyohashi, Aichi, Japan; [Akao, Masaharu] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Inada, Tsukasa] Osaka Red Cross Hosp, Cardiovasc Ctr, Osaka, Japan; [Hayashi, Yasuhiko] Tsuchiya Gen Hosp, Div Cardiol, Hiroshima, Japan; [Nanasato, Mamoru] Nagoya Daini Red Cross Hosp, Cardiovasc Ctr, Nagoya, Aichi, Japan; [Okutsu, Masaaki] Nozaki Tokushukai Hosp, Div Cardiol, Osaka, Japan; [Kametani, Ryosuke] Nagoya Tokushukai Gen Hosp, Div Cardiol, Kasugai, Aichi, Japan; [Sone, Takahito] Ogaki Municipal Hosp, Div Cardiol, Ogaki, Japan; [Sugimura, Yoichi] Kawakita Gen Hosp, Div Cardiol, Tokyo, Japan; [Kawai, Kazuya] Chikamori Hosp, Div Cardiol, Kochi, Japan; [Abe, Mitsunori] Yotsuba Circulat Clin, Div Cardiol, Matsuyama, Ehime, Japan; [Kaneko, Hironori] Hoshi Gen Hosp, Div Cardiol, Koriyama, Fukushima, Japan; [Nakamura, Sunao] New Tokyo Hosp, Div Cardiol, Chiba, Japan	Kyoto University; Hyogo College of Medicine; Juntendo University; Tenri Hospital; Kurashiki Central Hospital; Yokohama City University; Kobe City Medical Center General Hospital; Toyohashi Heart Center; Osaka Red Cross Hospital; Japanese Red Cross Nagoya Daini Hospital; Ogaki Municipal Hospital	Kimura, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	taketaka@kuhp.kyoto-u.ac.jp	Shiomi, Hiroki/ADJ-9510-2022	Shiomi, Hiroki/0000-0001-7234-023X	Research Institute for Production Development (Kyoto, Japan)	Research Institute for Production Development (Kyoto, Japan)	The study was supported by an educational grant from the Research Institute for Production Development (Kyoto, Japan).	Bangalore S, 2014, CIRC-CARDIOVASC QUAL, V7, P872, DOI 10.1161/CIRCOUTCOMES.114.001073; Bangalore S, 2012, JAMA-J AM MED ASSOC, V308, P1340, DOI 10.1001/jama.2012.12559; Bao BY, 2013, CARDIOVASC INTERV TH, V28, P139, DOI 10.1007/s12928-012-0137-9; BRAUNWALD E, 1993, NEW ENGL J MED, V329, P1650, DOI 10.1056/NEJM199311253292211; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Donataccio MP, 2015, INT J CARDIOL, V201, P265, DOI 10.1016/j.ijcard.2015.08.065; Dondo TB, 2017, J AM COLL CARDIOL, V69, P2710, DOI 10.1016/j.jacc.2017.03.578; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Goldberger JJ, 2015, J AM COLL CARDIOL, V66, P1431, DOI 10.1016/j.jacc.2015.07.047; HJALMARSON A, 1985, EUR HEART J, V6, P199; Hori M, 2004, AM HEART J, V147, P324, DOI 10.1016/j.ahj.2003.07.023; Horiuchi Y, 2016, INT J CARDIOL, V221, P765, DOI 10.1016/j.ijcard.2016.07.123; Huang BT, 2015, AM J CARDIOL, V115, P1529, DOI 10.1016/j.amjcard.2015.02.057; McAlister FA, 2009, ANN INTERN MED, V150, P784, DOI 10.7326/0003-4819-150-11-200906020-00006; Misumida N, 2016, J CARDIOVASC PHARM T, V21, P280, DOI 10.1177/1074248415608011; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Ozasa N, 2010, AM J CARDIOL, V106, P1225, DOI 10.1016/j.amjcard.2010.06.048; Pedersen F, 2014, J AM COLL CARDIOL, V64, P2101, DOI 10.1016/j.jacc.2014.08.037; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; Puymirat E, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4801; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Simon T, 2003, EUR HEART J, V24, P554, DOI 10.1016/S0195-668X(02)00743-1; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Taniguchi T, 2017, AM J CARDIOL, V119, P1729, DOI 10.1016/j.amjcard.2017.03.013; TEO KK, 1993, JAMA-J AM MED ASSOC, V270, P1589, DOI 10.1001/jama.270.13.1589; Yamashita Y, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.002790; Yang JH, 2014, JACC-CARDIOVASC INTE, V7, P592, DOI 10.1016/j.jcin.2013.12.206	29	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0199347	10.1371/journal.pone.0199347	http://dx.doi.org/10.1371/journal.pone.0199347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153268	gold, Green Published, Green Submitted			2022-12-27	WOS:000443001700002
J	Yue, CY; Lu, LKY; Li, M; Zhang, QL; Ying, CM				Yue, Chao-Yan; Lu, Lou-kai-yi; Li, Meng; Zhang, Qian-Lan; Ying, Chun-Mei			Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women	PLOS ONE			English	Article							INSULIN-RESISTANCE; FOLLICULAR ARREST; MLLERIAN HORMONE; HYPERANDROGENISM; EXPRESSION; RESERVE; MARKERS; EXCESS; LEVEL; PCOS	Objective We intended to establish the threshold for anti-Mullerian hormone (AMH) in the diagnosis of polycystic ovary syndrome (PCOS) in China. Methods A total of 771 women (653 with PCOS and 118 healthy controls) were enrolled. The serum AMH, follicle-stimulating hormone (FSH), luteinizing hormone (LH), FSH/LH, prolactin, estradiol, testosterone (T), dehydroepiandrosterone sulfate (DHEA-S), sex hormone-binding globulin (SHBG), 17 alpha-OH progesterone (17 alpha-OHP), fasting insulin (INS), fasting glucose, free androgen index (FAI%) and homeostasis model assessment for insulin resistance (HOMA-IR) index were analyzed, and the diagnostic utility of AMH, LH/FSH, T and INS was established using receiver operator characteristic (ROC) curves. With AMH, LH/FSH, T and INS as independent variables, a logistic regression model was established, and the ROC curve for combined detection was fitted with the probability value of the model. Results The serum level of FSH, LH, LH/FSH, AMH, FAI%, 17 alpha-OHP, fasting INS, T, SHBG, DHEAS and HOMA-IR were altered in the PCOS patients. The best compromise between sensitivity and specificity was found at an AMH cut-off level of 8.16 ng/ml and 5.89 ng/ml for the age groups 20-29 and 30-39 years, with the corresponding area under the curve being 0.846 and 0.865 respectively. The area under the ROC curve for combined detection was 0.951, which was significantly greater than that of each index. Finally, the concentration of AMH was associated with FSH, LH, LH/FSH, T, and ovarian volume in PCOS patients. Conclusion The optimal AMH diagnostic threshold for PCOS was 8.16 ng/ml (20-29 years) and 5.89 ng/ml (30-39 years) in the Chinese population of this study. Moreover, serum AMH, LH/FSH, T and INS could be used in combination to improve the diagnostic specificity and sensitivity for the detection of PCOS.	[Yue, Chao-Yan; Lu, Lou-kai-yi; Zhang, Qian-Lan; Ying, Chun-Mei] Fudan Univ, Dept Lab Med, Obstet & Gynecol Hosp, Shanghai, Peoples R China; [Li, Meng] Fudan Univ, Dept Ultrasound, Obstet & Gynecol Hosp, Shanghai, Peoples R China	Fudan University; Fudan University	Ying, CM (corresponding author), Fudan Univ, Dept Lab Med, Obstet & Gynecol Hosp, Shanghai, Peoples R China.	ycmzh2012@163.com		Yue, Chao-yan/0000-0003-4030-0166	Shanghai Municipal Commission of Health and Family Planning [20154Y0029]	Shanghai Municipal Commission of Health and Family Planning	This work was supported by Shanghai Municipal Commission of Health and Family Planning (No. 20154Y0029).	Bako AU, 2005, REV GYNECOL PRACT, V5, P115; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; CARTER GD, 1983, ANN CLIN BIOCHEM, V20, P262, DOI 10.1177/000456328302000502; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Dewailly D, 2010, J CLIN ENDOCR METAB, V95, P4399, DOI 10.1210/jc.2010-0334; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Fraissinet A, 2017, HUM REPROD, V32, P1716, DOI 10.1093/humrep/dex239; Genuth S, 2003, DIABETES CARE, V26, P3160; Jonard S, 2004, HUM REPROD UPDATE, V10, P107, DOI 10.1093/humupd/dmh010; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Nardo LG, 2009, HUM REPROD, V24, P2917, DOI 10.1093/humrep/dep225; ORSINI LF, 1985, FERTIL STERIL, V43, P709; Pellatt L, 2007, J CLIN ENDOCR METAB, V92, P240, DOI 10.1210/jc.2006-1582; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pierre A, 2013, HUM REPROD, V28, P762, DOI 10.1093/humrep/des460; Pigny P, 2003, J CLIN ENDOCR METAB, V88, P5957, DOI 10.1210/jc.2003-030727; Pigny P, 2016, FERTIL STERIL, V105, P1063, DOI 10.1016/j.fertnstert.2015.12.023; Piouka A, 2009, AM J PHYSIOL-ENDOC M, V296, pE238, DOI 10.1152/ajpendo.90684.2008; Romualdi D, 2016, REPROD SCI, V23, P655, DOI 10.1177/1933719115611751; Skalba P, 2011, EUR J OBSTET GYN R B, V158, P254, DOI 10.1016/j.ejogrb.2011.06.006; Speroff L., 2005, LIPPINCOTT WILLIAMS, V12, P485; Stepto NK, 2013, HUM REPROD, V28, P777, DOI 10.1093/humrep/des463; Streuli I, 2008, FERTIL STERIL, V90, P395, DOI 10.1016/j.fertnstert.2007.06.023; Stubbs SA, 2005, J CLIN ENDOCR METAB, V90, P5536, DOI 10.1210/jc.2005-0907; Weerakiet S, 2007, GYNECOL ENDOCRINOL, V23, P455, DOI 10.1080/09513590701485212; Wiweko B, 2014, J ASSIST REPROD GEN, V31, P1311, DOI 10.1007/s10815-014-0300-6; Xu J, 2018, BIOL REPROD, V98, P197, DOI 10.1093/biolre/iox181	28	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203129	10.1371/journal.pone.0203129	http://dx.doi.org/10.1371/journal.pone.0203129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153296	Green Submitted, Green Published, gold			2022-12-27	WOS:000443001700046
J	Adachi, M; Takahashi, M; Takayanagi, N; Yoshida, S; Yasuda, S; Tanaka, M; Osato-Kaneda, A; Saito, M; Kuribayashi, M; Kato, S; Nakamura, K				Adachi, Masaki; Takahashi, Michio; Takayanagi, Nobuya; Yoshida, Satomi; Yasuda, Sayura; Tanaka, Masanori; Osato-Kaneda, Ayako; Saito, Manabu; Kuribayashi, Michito; Kato, Sumi; Nakamura, Kazuhiko			Adaptation of the Autism Spectrum Screening Questionnaire (ASSQ) to preschool children (vol 13, e0199590, 2018)	PLOS ONE			English	Correction									Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan	Hirosaki University				Takahashi, Michio/0000-0002-7151-1364				Adachi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199590	1	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203254	10.1371/journal.pone.0203254	http://dx.doi.org/10.1371/journal.pone.0203254			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148898	gold, Green Published			2022-12-27	WOS:000442804200054
J	Araujo, ARD; Melo, T; Maciel, EA; Pereira, C; Morais, CM; Santinha, DR; Tavares, JF; Oliveira, H; Jurado, AS; Costa, V; Domingues, P; Domingues, MRM; Santos, MAS				Araujo, Ana Rita D.; Melo, Tania; Maciel, Elisabete A.; Pereira, Clara; Morais, Catarina M.; Santinha, Deolinda R.; Tavares, Joana F.; Oliveira, Helena; Jurado, Amalia S.; Costa, Vitor; Domingues, Pedro; Domingues, Maria Rosario M.; Santos, Manuel A. S.			Errors in protein synthesis increase the level of saturated fatty acids and affect the overall lipid profiles of yeast	PLOS ONE			English	Article							GENETIC-CODE ALTERATION; TRANSFER-RNA SYNTHETASE; MACULAR DYSTROPHY; BARTH-SYNDROME; SUPERCOMPLEX FORMATION; MYOCLONIC EPILEPSY; MITOCHONDRIAL-DNA; RESPIRATORY-CHAIN; CYTOCHROME BC(1); OXIDATIVE STRESS	The occurrence of protein synthesis errors (mistranslation) above the typical mean mistranslation level of 10(-4) is mostly deleterious to yeast, zebrafish and mammal cells. Previous yeast studies have shown that mistranslation affects fitness and deregulates genes related to lipid metabolism, but there is no experimental proof that such errors alter yeast lipid profiles. We engineered yeast strains to misincorporate serine at alanine and glycine sites on a global scale and evaluated the putative effects on the lipidome. Lipids from whole cells were extracted and analysed by thin layer chromatography (TLC), liquid chromatography-mass spectrometry(LC-MS) and gas chromatography (GC). Oxidative damage, fatty acid desaturation and membrane fluidity changes were screened to identify putative alterations in lipid profiles in both logarithmic (fermentative) and post-diauxic shift (respiratory) phases. There were alterations in several lipid classes, namely lyso-phosphatidylcholine, phosphatidic acid, phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, and triglyceride, and in the fatty acid profiles, namely C16:1, C16:0, C18:1 and C18:0. Overall, the relative content of lipid species with saturated FA increased in detriment of those with unsaturated fatty acids. The expression of the OLE1 mRNA was deregulated, but phospholipid fluidity changes were not observed. These data expand current knowledge of mistranslation biology and highlight its putative roles in human diseases.	[Araujo, Ana Rita D.; Tavares, Joana F.; Santos, Manuel A. S.] Univ Aveiro, Dept Med Sci, Aveiro, Portugal; [Araujo, Ana Rita D.; Tavares, Joana F.; Santos, Manuel A. S.] Univ Aveiro, Inst Biomed iBiMED, Aveiro, Portugal; [Araujo, Ana Rita D.; Melo, Tania; Maciel, Elisabete A.; Santinha, Deolinda R.; Domingues, Pedro; Domingues, Maria Rosario M.] Univ Aveiro, Mass Spectrometry Ctr, Dept Chem, QOPNA, Aveiro, Portugal; [Maciel, Elisabete A.] Univ Aveiro, Dept Biol, CESAM, Aveiro, Portugal; [Pereira, Clara; Costa, Vitor] Univ Porto, i3S, Porto, Portugal; [Pereira, Clara; Costa, Vitor] Univ Porto, IBMC, Porto, Portugal; [Pereira, Clara; Costa, Vitor] Univ Porto, Inst Ciencias Biomed Abel Salazar, Dept Biol Mol, Porto, Portugal; [Morais, Catarina M.; Jurado, Amalia S.] Univ Coimbra, Ctr Neurosci & Cell Biol, CNC, Coimbra, Portugal; [Oliveira, Helena] Univ Aveiro, Dept Biol, Lab Biotechnol & Cyt, CESAM, Aveiro, Portugal; [Jurado, Amalia S.] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Aveiro; Universidade de Coimbra	Santos, MAS (corresponding author), Univ Aveiro, Dept Med Sci, Aveiro, Portugal.; Santos, MAS (corresponding author), Univ Aveiro, Inst Biomed iBiMED, Aveiro, Portugal.; Domingues, MRM (corresponding author), Univ Aveiro, Mass Spectrometry Ctr, Dept Chem, QOPNA, Aveiro, Portugal.	mrd@ua.pt; msantos@ua.pt	Melo, Tânia/Q-6709-2018; Jurado, Amália S./AAJ-9498-2020; Oliveira, Helena/M-5068-2013; Morais, Catarina M./I-2093-2017; Domingues, Pedro/E-5202-2010; Costa, Vítor/A-2647-2008; Pereira, Clara/D-4963-2013; Domingues, Maria Rosario/K-7444-2014; Maciel, Elisabete/I-8868-2017	Melo, Tânia/0000-0002-0508-4034; Oliveira, Helena/0000-0002-4673-0696; Morais, Catarina M./0000-0002-4762-0798; Domingues, Pedro/0000-0002-8060-7675; Costa, Vítor/0000-0002-7868-4663; Pereira, Clara/0000-0002-8167-6912; Tavares, Joana/0000-0001-7083-6266; S. Jurado, Amalia/0000-0001-7095-5337; Santos, Manuel/0000-0002-0437-1146; Domingues, Maria Rosario/0000-0001-5357-3601; D. Araujo, Ana Rita/0000-0003-3729-747X; Santinha, Deolinda/0000-0001-8948-5232; Maciel, Elisabete/0000-0003-3637-6854	FCT (Fundacao para a Ciencia e a Tecnologia); European Union; QREN; POPH; FEDER; COMPETE through the iBiMED [FCT-ANR/IMI-MIC/0041/2012, PTDC/IMI-MIC/5350/2014, PTDC/BEX-BCM/2121/2014, UID/BIM/04501/2013]; COMPETE through the QOPNA research units [PTDC/QUI-BIQ/104968/2008, UID QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296]; COMPETE through the RNEM [LISBOA-01-0145-FEDER-402-022125, REDE/1504/REM/2005]; European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme [CENTRO-01-0145-FEDER-000008]; European Regional Development Fund (ERDF), through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation; FCT - Fundacao para a Ciencia e a Tecnologia [POCI-01-0145-FEDER-016390, POCI-01-0145-FEDER-007440]; FCT [SFRH/BD/78835/2011, SFRH/BD/79077/2011, SFRH/BPD/104165/2014, SFRH/BPD/111736/2015, BPD/UI51/5388/2017]; Fundo Social Europeu and Programa Operacional Potencial Humano through FCT investigator grant [IF/00889/2015]; Fundação para a Ciência e a Tecnologia [PTDC/QUI-BIQ/104968/2008, UID/BIM/04501/2013, FCT-ANR/IMI-MIC/0041/2012] Funding Source: FCT	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); European Union(European Commission); QREN; POPH; FEDER(European Commission); COMPETE through the iBiMED; COMPETE through the QOPNA research units; COMPETE through the RNEM; European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme; European Regional Development Fund (ERDF), through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation; FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Social Europeu and Programa Operacional Potencial Humano through FCT investigator grant; Fundação para a Ciência e a Tecnologia	This work was supported by FCT (Fundacao para a Ciencia e a Tecnologia), the European Union, QREN, POPH, FEDER and COMPETE [FCT-ANR/IMI-MIC/0041/2012; PTDC/IMI-MIC/5350/2014; PTDC/BEX-BCM/2121/2014] through the iBiMED (UID/BIM/04501/2013) and QOPNA research units [PTDC/QUI-BIQ/104968/2008; UID QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296], and RNEM [LISBOA-01-0145-FEDER-402-022125 that concerns the Portuguese Mass Spectrometry Network), REDE/1504/REM/2005]. This work was also financed by the European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme under project CENTRO-01-0145-FEDER-000008: BrainHealth 2020, and through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation and Portuguese national funds via FCT - Fundacao para a Ciencia e a Tecnologia, I.P., under projects POCI-01-0145-FEDER-016390:CANCEL STEM and POCI-01-0145-FEDER-007440. Ana R. D. Araujo [SFRH/BD/78835/2011], Catarina Morais [SFRH/BD/79077/2011], Elisabete Maciel [SFRH/BPD/104165/2014], Helena Oliveira [SFRH/BPD/111736/2015], and Tania Melo [BPD/UI51/5388/2017] were supported by FCT grants. Clara Pereira was supported by Fundo Social Europeu and Programa Operacional Potencial Humano through FCT investigator grant IF/00889/2015.	Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Ambasudhan R, 2004, GENOMICS, V83, P615, DOI 10.1016/j.ygeno.2003.10.004; Arnarez C, 2013, J AM CHEM SOC, V135, P3112, DOI 10.1021/ja310577u; Aued-Pimentel S, 2004, J CHROMATOGR A, V1054, P235, DOI 10.1016/j.chroma.2004.07.090; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Ballesteros M, 2001, EMBO J, V20, P5280, DOI 10.1093/emboj/20.18.5280; Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; Baud F, 1999, P NATL ACAD SCI USA, V96, P12494, DOI 10.1073/pnas.96.22.12494; Bezerra AR, 2013, P NATL ACAD SCI USA, V110, P11079, DOI 10.1073/pnas.1302094110; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Costa TLVM, 2012, CELLULAR RESPONSES G; Daum G, 1999, YEAST, V15, P601, DOI 10.1002/(SICI)1097-0061(199905)15:7<601::AID-YEA390>3.0.CO;2-N; De Smet CH, 2012, MOL BIOL CELL, V23, P1146, DOI 10.1091/mbc.E11-07-0624; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Epand RM, 2017, J MEMBRANE BIOL, V250, P353, DOI 10.1007/s00232-016-9909-y; Fan YQ, 2015, NUCLEIC ACIDS RES, V43, P1740, DOI 10.1093/nar/gku1404; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; Gasch AP, 2007, YEAST STRESS RESPONS, P11; Geslain R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1083; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gomes ACEO, 2012, THESIS; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gong J, 1996, BIOCHEMISTRY-US, V35, P14109, DOI 10.1021/bi961296h; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Grayson C, 2005, J BIOL CHEM, V280, P32521, DOI 10.1074/jbc.M503411200; Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028; Haiens TH, 2002, FEBS LETT, V528, P35, DOI 10.1016/S0014-5793(02)03292-1; Higdon A, 2012, BIOCHEM J, V442, P453, DOI 10.1042/BJ20111752; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kajiwara S, 2000, APPL MICROBIOL BIOT, V53, P568, DOI 10.1007/s002530051658; Karan G, 2005, MOL VIS, V11, P657; Kim HS, 2011, BIOTECHNOL LETT, V33, P509, DOI 10.1007/s10529-010-0465-8; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010; Lamari F, 2013, J INHERIT METAB DIS, V36, P411, DOI 10.1007/s10545-012-9509-7; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li JX, 1998, J BIOL CHEM, V273, P6796, DOI 10.1074/jbc.273.12.6796; Loo TW, 2015, J BIOL CHEM, V290, P29389, DOI 10.1074/jbc.M115.695171; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Mateus DD, 2011, MOL RECONSTRUCTION G; Mateus DD, 2013, RNA BIOL, V10, P969, DOI 10.4161/rna.24683; Miranda I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000996; Pan T, 2013, ANNU REV GENET, V47, P121, DOI 10.1146/annurev-genet-111212-133522; Paredes JA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-55; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Reverendo M, 2014, RNA BIOL, V11, P1199, DOI 10.4161/rna.32199; de Pouplana LR, 2014, TRENDS BIOCHEM SCI, V39, P355, DOI 10.1016/j.tibs.2014.06.002; Santos MAS, 1996, EMBO J, V15, P5060, DOI 10.1002/j.1460-2075.1996.tb00886.x; Santos MAS, 1999, MOL MICROBIOL, V31, P937, DOI 10.1046/j.1365-2958.1999.01233.x; Schink KO, 2013, BIOESSAYS, V35, P900, DOI 10.1002/bies.201300064; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; SHEN HG, 1994, J BIOL CHEM, V269, P9424; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Shulga YV, 2012, J BIOL CHEM, V287, P35953, DOI 10.1074/jbc.M112.370155; Silva RM, 2007, EMBO J, V26, P4555, DOI 10.1038/sj.emboj.7601876; SILVESTRI G, 1992, AM J HUM GENET, V51, P1213; Simoes JMS, 2013, PHENOTYPIC CONSEQUEN; Simoes J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00401; Singh A, 2011, CELL MICROBIOL, V13, P177, DOI 10.1111/j.1462-5822.2010.01550.x; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	93	2	2	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202402	10.1371/journal.pone.0202402	http://dx.doi.org/10.1371/journal.pone.0202402			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148852	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200009
J	Ohur, I; Velamuri, M				Ohur, Ilke; Velamuri, Malathi			The gap between self-reported and objective measures of disease status in India	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LYMPHOEPITHELIOMA-LIKE CARCINOMA; EPSTEIN-BARR-VIRUS; BLOOD-PRESSURE; HEALTH; HYPERTENSION; POPULATION; MORTALITY; ADDRESS; RISK	Researchers interested in the effect of health on various life outcomes (such as employment, earnings and life satisfaction) often use self-reported health and disease status as an indicator of true, underlying health status. Self-reports appear to be reasonable measures of overall health. For example, self-assessed overall health has been found to be a reliable predictor of mortality. However, the validity of self-reports is questionable when investigating specific diseases such as diabetes and hypertension. A small and nascent body of research comparing self-reported status on certain diseases with the true status based on clinical diagnoses has found significant gaps. These validation exercises predominantly use data from high-income countries. In this paper, we use survey data from India to compare self-reports of disease prevalence to diagnostic tests conducted on the same individuals. We focus on hypertension and lung disease, two of the primary causes of death in India. We find that self-reported measures substantially understate the true disease burden for both conditions. The attenuation bias from using self-reports is over 80 percent for both diseases, and bigger than estimates from high-income countries. We test and reject the hypothesis that self-reports of the disease status are identical to the true disease status in expectation. We identify characteristics associated with false negative reporting (reporting not having the disease but testing positive for it) for both diseases. The large awareness gap between self-reports and true disease burden indicates multiple deficiencies in India's public health policy. The survey data depicts limited access to medical facilities, high levels of health illiteracy, low rates of health insurance, and other barriers related to poverty and lack of equity in the delivery of health services. These factors prevent timely intervention for managing health and controlling disease, invariably leading to morbidity and often to premature death.	[Ohur, Ilke] Univ South Australia, Sch Commerce, Adelaide, SA, Australia; [Velamuri, Malathi] Chennai Math Inst, Madras, Tamil Nadu, India	University of South Australia; Chennai Mathematical Institute	Ohur, I (corresponding author), Univ South Australia, Sch Commerce, Adelaide, SA, Australia.	ilke.onur@unisa.edu.au	PAN, ZEQIANG/X-6341-2018; Onur, Ilke/F-3868-2013	Onur, Ilke/0000-0001-5082-6298				Baker M, 2004, J HUM RESOUR, V39, P1067, DOI 10.2307/3559039; Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004; Beniwal Sunil, 2011, J Assoc Physicians India, V59, P360; Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Bloom D., 2014, LONGITUDINAL AGING S; BOUND J, 1994, J LABOR ECON, V12, P345, DOI 10.1086/298348; Castro CY, 2001, HUM PATHOL, V32, P863, DOI 10.1053/hupa.2001.26457; Cramm JM, 2015, J POPUL AGEING, V8, P245, DOI 10.1007/s12062-015-9122-2; Cutler DM, 2008, 14333 NAT BUR EC RES; Cutler DM., 2006, ED HLTH EVALUATING T; Das Shyamal Kumar, 2005, Int J Med Sci, V2, P70; Gupta R., 2017, RUHS J HLTH SCI, V2, P40; Irwin A, 2006, PLOS MED, V3, P749, DOI 10.1371/journal.pmed.0030106; Johnston DW, 2009, J HEALTH ECON, V28, P540, DOI 10.1016/j.jhealeco.2009.02.010; Johri M, 2015, J EPIDEMIOL COMMUN H, V69, P849, DOI 10.1136/jech-2014-205436; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kikuya M, 2000, HYPERTENSION, V36, P901, DOI 10.1161/01.HYP.36.5.901; KPMG, 2016, POST BUDG SECT POINT; KPMG, 2015, HEALTHC IND CURR STA, V2015; Lahariya Chandrakant, 2015, Indian J Public Health, V59, P172, DOI 10.4103/0019-557X.164653; Lakoski SG, 2005, J AM COLL CARDIOL, V46, P1869, DOI 10.1016/j.jacc.2005.07.050; Lee J., 2012, LONGITUDINAL AGING S; McDade TW, 2004, CLIN CHEM, V50, P652, DOI 10.1373/clinchem.2003.029488; Mohan S, 2013, INDIAN J MED RES, V137, P627; Ngan RKC, 2002, CLIN CANCER RES, V8, P986; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Onur I, 2016, J HUM CAPITAL, V10, P520, DOI 10.1086/688898; Powdthavee N, 2010, J HUM CAPITAL, V4, P173, DOI 10.1086/657020; Rama Baru, 2010, Economic and Political Weekly, V45, P49; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Singh N, 2008, HEALTH AFFAIR, V27, P991, DOI 10.1377/hlthaff.27.4.991; Suziedelyte A, 2013, ECON LETT, V121, P163, DOI 10.1016/j.econlet.2013.07.027; VANDEVEN WPMM, 1981, J ECONOMETRICS, V17, P229, DOI 10.1016/0304-4076(81)90028-2; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; WHO, 2014, IND AIR QUAL GUID HO; World Health Organization, 2015, GLOB TUB REP 2015; Wu SQ, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-320, 10.1186/1471-2458-13-636]; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	39	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202786	10.1371/journal.pone.0202786	http://dx.doi.org/10.1371/journal.pone.0202786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148894	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000442804200023
J	Yang, SH; Lee, TY; Ho, CA; Yang, CY; Huang, WY; Lin, YC; Nieh, S; Lin, YS; Chen, SF; Lin, FH				Yang, Shih-Hsien; Lee, Tsai-Yu; Ho, Chun An; Yang, Chin-Yuh; Huang, Wen-Yen; Lin, Yu-Chun; Nieh, Shin; Lin, Yaoh-Shiang; Chen, Su-Feng; Lin, Fu-Huang			Exposure to nicotine-derived nitrosamine ketone and arecoline synergistically facilitates tumor aggressiveness via overexpression of epidermal growth factor receptor and its downstream signaling in head and neck squamous cell carcinoma	PLOS ONE			English	Article							ALPHA-7-NICOTINIC ACETYLCHOLINE-RECEPTOR; ALDEHYDE DEHYDROGENASE 1; ORAL EPITHELIAL-CELLS; STEM-CELLS; MESENCHYMAL TRANSDIFFERENTIATION; CANCER; APOPTOSIS; ALKALOIDS; ARECA; EMT	Long-term nicotine-derived nitrosamine ketone (NNK) and arecoline exposure promotes carcinogenesis and head and neck squamous cell carcinoma (HNSCC) progression, although most associated data on the two were analyzed individually. The molecular mechanisms underlying tumor progression associated with the synergistic effects of NNK and arecoline remain unclear. We treated SCC-25 and FaDu cells with NNK and arecoline (separately or in combination) for 3 months. Comparative analysis was performed to investigate the mechanism underlying the acquisition of properties related to tumor promotion, including stemness, anti-apoptosis, and resistance to HNSCC therapeutics. Long-term exposure to NNK and arecoline resulted in an increase in cancer stem cell properties, anti-apoptosis, and the resistance to cisplatin in HNSCC. We detected abundant epidermal growth factor receptor (EGFR) expression in HNSCC cells after combined treatment with NNK and arecoline. EGFR was pivotal in inducing tumor promotion and anti-apoptosis in cancer cells by inducing pAKT and NF kappa B. Combined treatment with NNK and arecoline synergistically facilitated tumor aggressiveness via EGFR-AKT signaling. Targeting EGFR-AKT signaling may be a feasible strategy for treating HNSCC.	[Yang, Shih-Hsien] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Yang, Shih-Hsien] Natl Def Med Ctr, Dept Med Adm Off, Taipei, Taiwan; [Yang, Shih-Hsien] Triserv Gen Hosp, Beitou Branch, Taipei, Taiwan; [Lee, Tsai-Yu] Triserv Gen Hosp, Songshan Branch, Natl Def Med Ctr, Div Colon & Rectum Surg,Dept Surg, Taipei, Taiwan; [Ho, Chun An; Lin, Yu-Chun; Nieh, Shin] Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Ho, Chun An; Lin, Yu-Chun; Nieh, Shin] Triserv Gen Hosp, Taipei, Taiwan; [Yang, Chin-Yuh] Cheng Hsin Hosp, Dept Dent, Taipei, Taiwan; [Huang, Wen-Yen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Huang, Wen-Yen] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lin, Yaoh-Shiang] Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Chen, Su-Feng] China Med Univ, Dept Dent Hyg & Sch Dent, Taichung, Taiwan; [Lin, Fu-Huang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Cheng Hsin General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; China Medical University Taiwan; National Defense Medical Center	Lin, YS (corresponding author), Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan.; Chen, SF (corresponding author), China Med Univ, Dept Dent Hyg & Sch Dent, Taichung, Taiwan.; Lin, FH (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	yaohshiang@gmail.com; su374065@gmail.com; nolding@ms10.hinet.net	huang, wen/GXW-0661-2022		Tri-Service General Hospital [TSGH-C106-040, TSGH-C106-038]; National Science Council, Republic of China [NSC105-2320-B-039-028-MY2, NSC105-2314-B-016-028-MY2]	Tri-Service General Hospital; National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This study was partly supported by the Tri-Service General Hospital (Grant Numbers TSGH-C106-040 and TSGH-C106-038) and the National Science Council, Republic of China (Grant Numbers NSC105-2320-B-039-028-MY2 and NSC105-2314-B-016-028-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by the Tri-Service General Hospital (Grant Numbers TSGH-C106-040 and TSGH-C106-038) and the National Science Council, Republic of China (Grant Numbers NSC105-2320-B-039-028-MY2 and NSC105-2314-B-016-028-MY2). We thank Chun An Ho for her assistance in performing some experiments in this study.	Akcakanat A, 2008, CANCER-AM CANCER SOC, V112, P2352, DOI 10.1002/cncr.23456; Bai Y, 2017, EXP BIOL MED, V242, P527, DOI 10.1177/1535370216685433; Brunzell DH, 2014, ANN NY ACAD SCI, V1327, P27, DOI 10.1111/nyas.12421; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Chen X, 2017, ONCOL REP, V38, P2141, DOI 10.3892/or.2017.5874; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chinn SB, 2015, HEAD NECK-J SCI SPEC, V37, P317, DOI 10.1002/hed.23600; Chinn Steven B, 2012, Front Endocrinol (Lausanne), V3, P90, DOI 10.3389/fendo.2012.00090; Chojnacka K, 2013, BIOORG MED CHEM LETT, V23, P4145, DOI 10.1016/j.bmcl.2013.05.039; Chou MY, 2015, ORAL ONCOL, V51, P31, DOI 10.1016/j.oraloncology.2014.10.002; Chu NS, 2002, ADDICT BIOL, V7, P111, DOI 10.1080/13556210120091473; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Grando Sergei A, 2012, Handb Exp Pharmacol, P429, DOI 10.1007/978-3-642-23274-9_18; Havelek R, 2014, PHYTOMEDICINE, V21, P479, DOI 10.1016/j.phymed.2013.09.005; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Huang LW, 2012, TOXICOL APPL PHARM, V258, P199, DOI 10.1016/j.taap.2011.11.001; Huang RY, 2011, ONCOGENE, V30, P106, DOI 10.1038/onc.2010.390; Huang S, 2016, ONCOTARGET, V7, P38718, DOI 10.18632/oncotarget.9586; Janmaat ML, 2003, CLIN CANCER RES, V9, P2316; Javed F, 2010, SCAND J PUBLIC HEALT, V38, P838, DOI 10.1177/1403494810379291; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kao SY, 2015, CHIN J DENT RES, V18, P7, DOI 10.3290/j.cjdr.a33965,PubMed:25815378; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lord GA, 2002, ADDICT BIOL, V7, P99, DOI 10.1080/13556210120091455; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Nair JJ, 2016, CURR MED CHEM, V23, P161, DOI 10.2174/0929867323666151118121124; Nair JJ, 2012, BIOORG MED CHEM LETT, V22, P6195, DOI 10.1016/j.bmcl.2012.08.005; Nieh S, 2015, HEAD NECK-J SCI SPEC, V37, P1712, DOI 10.1002/hed.23820; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Song H, 2015, ASIA-PAC J PUBLIC HE, V27, pNP47, DOI 10.1177/1010539513486921; Spindel Eliot R, 2012, Handb Exp Pharmacol, P451, DOI 10.1007/978-3-642-23274-9_19; Sun X, 2017, MAR DRUGS, V15, DOI 10.3390/md15070215; Tang J, 2013, SEMIN CANCER BIOL, V23, P533, DOI 10.1016/j.semcancer.2013.08.009; te Raa GD, 2016, BEST PRACT RES CL HA, V29, P90, DOI 10.1016/j.beha.2016.08.002; Thill M, 2011, MOL VIS, V17, P85; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Tsai LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087207; Uche FI, 2016, PHYTOTHER RES, V30, P1533, DOI 10.1002/ptr.5660; Wang TY, 2016, ONCOTARGET, V7, P84072, DOI 10.18632/oncotarget.11432; Wang W, 2012, ANN SURG ONCOL, V19, pS580, DOI 10.1245/s10434-011-2064-x; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; Wong HPS, 2007, TOXICOL APPL PHARM, V221, P261, DOI 10.1016/j.taap.2007.04.002; Yu CC, 2013, TOXICOL APPL PHARM, V266, P459, DOI 10.1016/j.taap.2012.11.023; Zhang D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-146	52	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0201267	10.1371/journal.pone.0201267	http://dx.doi.org/10.1371/journal.pone.0201267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148841	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200002
J	Yu, MY; Kim, DK; Park, JH; Shin, SJ; Lee, SH; Choi, BS; Lim, CS; Chin, HJ				Yu, Mi-Yeon; Kim, Dong Ki; Park, Jung Hwan; Shin, Sung Joon; Lee, Sang Ho; Choi, Bum Soon; Lim, Chun Soo; Chin, Ho Jun			Albuminuria during treatment with angiotensin type II receptor blocker is a predictor for GFR decline among non-diabetic hypertensive CKD patients	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; URINARY PROTEIN EXCRETION; CHRONIC KIDNEY-DISEASE; POST-HOC ANALYSIS; RENAL-DISEASE; RESIDUAL PROTEINURIA; CONTROLLED-TRIAL; IGA NEPHROPATHY; DIET; PROGRESSION	Background Albuminuria is a predictor of disease progression in patients with chronic kidney disease (CKD). However, the ability of proteinuria parameters measured at various time periods to predict renal outcomes is unclear. Method This observational cohort study included 165 non-diabetic hypertensive CKD patients who took olmesartan medoxomil. We measured the albuminuria at five different time points (0, 2, 4, 26, and 38 months) and the mean levels. The mean albuminuria levels were calculated during 0-4 months, 0-26 months, and 0-38 months. The renal outcome was defined as a decline in eGFR >= 40% during the entire study period. Result The albuminuria at five different time points and the mean albuminuria levels were independent risk factors for a worse renal outcome after adjusting for age, sex, and estimated glomerular filtration rate (eGFR) at enrollment and were able to predict the renal outcome, although the performance of the estimation tended to be more effective using the mean albuminuria level at the 38-month follow-up time point. The risk of a decline in eGFR >= 40% was increased by 1.690-folds [95% CI 1.110-2.572, P= 0.014] per 500 mg/day increase in the mean albuminuria at 38 months. With a cut-off value of 897 mg/day for mean albuminuria at 38 months after treatment, a decline in eGFR >= 40% was predicted with a sensitivity of 88.9% and specificity of 81.3%. The ability of albuminuria to predict a renal event at different measurement points does not differ in CKD patients. Conclusion The time-averaged albuminuria cut-off of 900 mg/day during the 3-year follow-up period showed high sensitivity and specificity for predicting a decline in eGFR >= 40% in CKD patients, although the albuminuria at different measurement points did not predict a worse renal outcome.	[Yu, Mi-Yeon] Hanyang Univ, Dept Internal Med, Guri Hosp, Guri, South Korea; [Kim, Dong Ki] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Dong Ki; Lim, Chun Soo; Chin, Ho Jun] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Park, Jung Hwan] Konkuk Univ, Dept Internal Med, Sch Med, Seoul, South Korea; [Shin, Sung Joon] Dongguk Univ, Dept Internal Med, Ilsan Hosp, Goyang, South Korea; [Lee, Sang Ho] Kyung Hee Univ, Dept Internal Med, Med Ctr, Seoul, South Korea; [Choi, Bum Soon] Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea; [Lim, Chun Soo] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea; [Chin, Ho Jun] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Chin, Ho Jun] Res Inst Salt & Hlth, Seoul, South Korea	Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Konkuk University; Konkuk University Medical Center; Dongguk University; NHIS Ilsan Hospital; Kyung Hee University; Seoul St. Mary's Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Chin, HJ (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.; Chin, HJ (corresponding author), Res Inst Salt & Hlth, Seoul, South Korea.	mednep@snubh.org	/W-5371-2019; Yu, Mi-Yeon/ABB-7937-2021; Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852; Park, Jung Hwan/0000-0002-8737-0084	Daiichi Sankyo Korea Co. Ltd.; Seoul National University Bundang Hospital [02-2017-043]	Daiichi Sankyo Korea Co. Ltd.(Daiichi Sankyo Company Limited); Seoul National University Bundang Hospital	This study was funded by Daiichi Sankyo Korea Co. Ltd. and Seoul National University Bundang Hospital (grant number: 02-2017-043). Daiichi Sankyo Korea Co. Ltd. supplied the drug during trial phase. The funder had no role in study design, data collection, interpretation of data and analysis, decision to publish, or preparation of the manuscript.	Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; Berhane AM, 2011, CLIN J AM SOC NEPHRO, V6, P2444, DOI 10.2215/CJN.00580111; Chin HJ, 2015, NUTRITION, V31, P1333, DOI 10.1016/j.nut.2015.05.004; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Heerspink HJL, 2016, DIABETES OBES METAB, V18, P169, DOI 10.1111/dom.12600; Hwang JH, 2014, CLIN J AM SOC NEPHRO, V9, P2059, DOI 10.2215/CJN.01310214; Imai E, 2013, NEPHROL DIAL TRANSPL, V28, P2526, DOI 10.1093/ndt/gft249; Johnson DW, 2012, MED J AUSTRALIA, V197, P224, DOI 10.5694/mja11.11468; Lambers Heerspink HJ, 2010, J AM SOC NEPHROL, V21, P1355, DOI 10.1681/ASN.2010010063; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Oh YJ, 2016, KOREAN J INTERN MED, V31, P344, DOI 10.3904/kjim.2015.227; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 2003, KIDNEY INT, V63, P2254, DOI 10.1046/j.1523-1755.2003.00033.x; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Sarcina C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158584; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Thompson A, 2012, NAT REV NEPHROL, V8, P306, DOI 10.1038/nrneph.2012.43; Xie D, 2011, J CLIN PHARMACOL, V51, P1025, DOI 10.1177/0091270010377502	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202676	10.1371/journal.pone.0202676	http://dx.doi.org/10.1371/journal.pone.0202676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148871	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200018
J	Yan, Y; Xiao, SY; Liu, HH; Chue, P				Yan, Yuan; Xiao, Shuiyuan; Liu, Haihong; Chue, Pierre			Self-reported sexual orientation among undergraduates of 10 universities in Guangzhou, China	PLOS ONE			English	Article							MENTAL-HEALTH; US CITIES; WOMEN; GAY; DISPARITIES; DEPRESSION; BEHAVIOR; ISSUES; URBAN	Few studies have investigated the distribution of sexual orientation among Chinese university students and identified the socio-demographic factors associated with sexual orientation. For the present study, we administered a paper-based, 5-point, self-report, sexual orientation scale to a stratified, random sample of 9071 undergraduates across all 10 universities in Guangzhou Higher Education Mega Center, Guangzhou, China. Multivariable ordinal regression analysis was used to explore the relationship between demographic factors and sexual orientation. A total of 8320 respondents completed the survey. Of 8182 valid respondents, 80.6% self-reported as exclusively heterosexual, 12.6% self-reported as mostly heterosexual, 5.4% self-reported as bisexual, 0.7% self-reported as mostly homosexual, and 0.8% self-reported as exclusively homosexual. About one fifth of male students and one fourth of female students reported some degree of divergence from exclusive heterosexuality. This indicates that in China there are a large number of university students who are potentially involved in same-sex sexual attraction.	[Yan, Yuan; Xiao, Shuiyuan; Liu, Haihong] Cent S Univ, Xiangya Hosp, Mental Hlth Ctr, Changsha, Hunan, Peoples R China; [Yan, Yuan] Guangdong Univ Technol, Psychoeduc & Counseling Ctr, Guangzhou, Guangdong, Peoples R China; [Xiao, Shuiyuan] Cent S Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China; [Chue, Pierre] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada	Central South University; Guangdong University of Technology; Central South University; University of Alberta	Xiao, SY; Liu, HH (corresponding author), Cent S Univ, Xiangya Hosp, Mental Hlth Ctr, Changsha, Hunan, Peoples R China.; Xiao, SY (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China.	xiaosy@csu.edu.cn; liuhaihong9@csu.edu.cn			"CMB-CSU" Collaborative Program for Mental Health Policy Development (II) [14-188]; National Natural Science Foundation of China [81000587]	"CMB-CSU" Collaborative Program for Mental Health Policy Development (II); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by "CMB-CSU" Collaborative Program for Mental Health Policy Development (II)(Grant Number 14-188) and National Natural Science Foundation of China (Grant Number 81000587). Shuiyuan Xiao and Haihong Liu received the findings respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogaert AF, 2018, J SEX RES, V55, P951, DOI 10.1080/00224499.2017.1287844; Cong L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-250; Eliason MJ, 2004, SUBST USE MISUSE, V39, P625, DOI 10.1081/JA-120030063; Feng YL, 2012, J ADOLESCENT HEALTH, V50, pS52, DOI 10.1016/j.jadohealth.2011.12.008; Fernando D, 2017, PREV MED, V105, P368, DOI 10.1016/j.ypmed.2017.06.013; Friedman MR, 2017, ARCH SEX BEHAV, V46, P903, DOI 10.1007/s10508-016-0863-7; Guo C, 2016, SEX HEALTH, V13, P497, DOI 10.1071/SH16041; Joseph HA, 2018, ARCH SEX BEHAV, V47, P183, DOI 10.1007/s10508-017-1052-z; Lambert EG, 2006, J HOMOSEXUAL, V50, P1, DOI 10.1300/J082v50n04_01; Lhomond B, 2014, ARCH SEX BEHAV, V43, P607, DOI 10.1007/s10508-013-0124-y; Lippa RA, 2010, ARCH SEX BEHAV, V39, P619, DOI 10.1007/s10508-008-9380-7; Lourie MA, 2017, J YOUTH ADOLESCENCE, V46, P943, DOI 10.1007/s10964-016-0553-8; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Moser C, 2016, ARCH SEX BEHAV, V45, P505, DOI 10.1007/s10508-015-0625-y; Raymond HF, 2017, J ACQUIR IMMUNE DEFI; Rutter TM, 2016, J AFFECT DISORDERS, V206, P87, DOI 10.1016/j.jad.2016.07.003; Saewyc EM, 2011, J RES ADOLESCENCE, V21, P256, DOI 10.1111/j.1532-7795.2010.00727.x; Savin-Williams RC, 2016, PSYCHOL SCI PUBL INT, V17, P37, DOI 10.1177/1529100616637618; Shadaker S, 2017, JAIDS-J ACQ IMM DEF, V75, pS281, DOI [10.1097/QAI.0000000000001403, 10.1097/qai.0000000000001403]; Svallfors S, 2005, EUR SOC, V7, P255, DOI 10.1080/14616690500083493; Talley AE, 2017, ASSESSMENT, V24, P632, DOI 10.1177/1073191115617016; Talley AE, 2012, J STUD ALCOHOL DRUGS, V73, P290, DOI 10.15288/jsad.2012.73.290; VanKim NA, 2010, AM J PUBLIC HEALTH, V100, P2392, DOI 10.2105/AJPH.2009.186270; Ward Brian W, 2014, Natl Health Stat Report, P1; Zheng LJ, 2011, ARCH SEX BEHAV, V40, P533, DOI 10.1007/s10508-010-9700-6	25	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0201817	10.1371/journal.pone.0201817	http://dx.doi.org/10.1371/journal.pone.0201817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142217	Green Submitted, gold, Green Published			2022-12-27	WOS:000442722500005
J	Amssoms, K; Born, PA; Beugeling, M; De Clerck, B; Van Gulck, E; Hinrichs, WLJ; Frijlink, HW; Grasmeijer, N; Kraus, G; Sutmuller, R; Simmen, K; Baert, L				Amssoms, Katie; Born, Philip A.; Beugeling, Max; De Clerck, Ben; Van Gulck, Ellen; Hinrichs, Wouter L. J.; Frijlink, Henderik W.; Grasmeijer, Niels; Kraus, Guenter; Sutmuller, Roger; Simmen, Kenny; Baert, Lieven			Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice	PLOS ONE			English	Article							IN-VITRO; VACCINE; FORMULATION; DEGRADATION; MECHANISMS; POWDER	A single-injection vaccine formulation that provides for both a prime and a boost immunization would have various advantages over a multiple-injection regime. For such a vaccine formulation, it is essential that the booster dose is released after a certain, preferably adjustable, lag time. In this study we investigated whether a core-shell based implant, containing ovalbumin as core material and poly(DL-lactic-co-glycolic acid) of various monomer ratios as shell material can be used to obtain such a booster release. An in vitro release study showed that the lag time after which the ovalbumin was released from the core-shell implant increased with increasing lactic to glycolic acid ratio of the polymer and ranged from 3-6 weeks. Fluorescence spectroscopy showed minimal differences between native ovalbumin and ovalbumin from core-shell implants that were incubated until just before the observed in vitro release. In addition, mice immunized with a subcutaneous inserted core-shell implant containing ovalbumin showed an ovalbumin-specific IgG1 antibody response after a lag time of 4 or 6-8 weeks. Moreover, delayed release of ovalbumin caused higher IgG1 antibody titers than conventional subcutaneous vaccination with ovalbumin dissolved in PBS. Collectively, these findings could contribute to the further development of a single-injection vaccine, making multiple injections of the vaccine superfluous.	[Amssoms, Katie; De Clerck, Ben] Janssen Res & Dev, Discovery Sci, Beerse, Belgium; [Born, Philip A.; Beugeling, Max; Hinrichs, Wouter L. J.; Frijlink, Henderik W.; Grasmeijer, Niels] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Van Gulck, Ellen; Kraus, Guenter; Sutmuller, Roger] Janssen Res & Dev, Infect Dis & Vaccines Therapeut Area, Beerse, Belgium; [Simmen, Kenny] Johnson & Johnson Innovat Ctr, London, England; [Baert, Lieven] Jalima Pharma Bvba, Brugge, Belgium	Johnson & Johnson; Janssen Pharmaceuticals; University of Groningen; Johnson & Johnson; Janssen Pharmaceuticals	Hinrichs, WLJ (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	w.l.j.hinrichs@rug.nl	Hinrichs, Wouter/J-3893-2019; Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198; Hinrichs, Wouter/0000-0002-1481-2769; Beugeling, Max/0000-0002-5018-347X	Janssen Sciences Ireland UC, an affiliate of Johnson Johnson	Janssen Sciences Ireland UC, an affiliate of Johnson Johnson	Please note that Janssen Sciences Ireland UC, an affiliate of Johnson & Johnson, funded the underlying project. The co-authors employed by this commercial company were actively involved in experimental analysis and drafting of the manuscript. The specific roles of each author are articulated in the 'author contributions' section.	Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004; Cleland JL, 1999, TRENDS BIOTECHNOL, V17, P25, DOI 10.1016/S0167-7799(98)01272-4; Grasmeijer N, 2013, BBA-PROTEINS PROTEOM, V1834, P763, DOI 10.1016/j.bbapap.2013.01.020; Guse C, 2006, INT J PHARMACEUT, V314, P161, DOI 10.1016/j.ijpharm.2005.12.051; Hansson M, 2000, BIOTECHNOL APPL BIOC, V32, P95, DOI 10.1042/BA20000034; Igartua M, 1998, J CONTROL RELEASE, V56, P63, DOI 10.1016/S0168-3659(98)00077-7; Kardani K, 2016, VACCINE, V34, P413, DOI 10.1016/j.vaccine.2015.11.062; Lechevalier V, 2003, J AGR FOOD CHEM, V51, P6354, DOI 10.1021/jf034184n; Lee S, 2015, IMMUNE NETW, V15, P51, DOI 10.4110/in.2015.15.2.51; Leo O, 2011, PERSPECT VACCINOL, V1, P25, DOI DOI 10.1016/J.PERVAC.2011.05.002; Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8; Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F; Mahler HC, 2012, ANAL AGGREGATES PART, DOI [10.1002/9781118150573, DOI 10.1002/9781118150573]; Maurer JM, 2016, INT J PHARMACEUT, V505, P175, DOI 10.1016/j.ijpharm.2016.03.027; McHugh KJ, 2017, SCIENCE, V357, P1138, DOI 10.1126/science.aaf7447; McHugh KJ, 2015, J CONTROL RELEASE, V219, P596, DOI 10.1016/j.jconrel.2015.07.029; Siegrist C-A, 2013, VACCINES, P12; Tonnis WF, 2014, EUR J PHARM SCI, V55, P36, DOI 10.1016/j.ejps.2014.01.005; Tzeng SY, 2018, P NATL ACAD SCI USA, V115, pE5269, DOI 10.1073/pnas.1720970115; Wahjudi M, 2013, EUR J PHARM SCI, V48, P637, DOI 10.1016/j.ejps.2012.12.015; WHO, 2018, IMM COV; Zijlstra GS, 2009, PHARM DEV TECHNOL, V14, P358, DOI 10.1080/10837450802662820	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202961	10.1371/journal.pone.0202961	http://dx.doi.org/10.1371/journal.pone.0202961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161264	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900054
J	Mangine, GT; Redd, MJ; Gonzalez, AM; Townsend, JR; Wells, AJ; Jajtner, AR; Beyer, KS; Boone, CH; La Monica, MB; Stout, JR; Fukuda, DH; Ratamess, NA; Hoffman, JR				Mangine, Gerald T.; Redd, Michael J.; Gonzalez, Adam M.; Townsend, Jeremy R.; Wells, Adam J.; Jajtner, Adam R.; Beyer, Kyle S.; Boone, Carleigh H.; La Monica, Michael B.; Stout, Jeffrey R.; Fukuda, David H.; Ratamess, Nicholas A.; Hoffman, Jay R.			Resistance training does not induce uniform adaptations to quadriceps	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; SKELETAL-MUSCLE; ARCHITECTURAL CHANGES; MUSCULAR ADAPTATIONS; NEURAL ACTIVATION; FASCICLE LENGTH; HIGH-INTENSITY; STRENGTH; HYPERTROPHY; EXERCISE	Resistance training may differentially affect morphological adaptations along the length of uni-articular and bi-articular muscles. The purpose of this study was to compare changes in muscle morphology along the length of the rectus femoris (RF) and vastus lateralis (VL) in response to resistance training. Following a 2-wk preparatory phase, 15 resistance-trained men (24.0 +/- 3.0 y, 90.0 +/- 13.8 kg, 174.9 +/- 20.7 cm) completed pre-training (PRE) assessments of muscle thickness (MT), pennation angle (PA), cross-sectional area (CSA), and echo-intensity in the RF and VL at 30, 50, and 70% of each muscle's length; fascicle length (FL) was estimated from respective measurements of MT and PA within each muscle and region. Participants then began a high intensity, low volume (4 x 3-5 repetitions, 3min rest) lower-body resistance training program, and repeated all PRE-assessments after 8 weeks (2 d . wk(-1)) of training (POST). Although three-way (muscle [RF, VL] x region [30, 50, 70%] x time [PRE, POST]) repeated measures analysis of variance did not reveal significant interactions for any assessment of morphology, significant simple (muscle x time) effects were observed for CSA (p = 0.002) and FL (p = 0.016). Specifically, average CSA changes favored the VL (2.96 +/- 0.69 cm(2), p < 0.001) over the RF (0.59 +/- 0.20 cm(2), p = 0.011), while significant decreases in average FL were noted for the RF (-1.03 +/- 0.30 cm, p = 0.004) but not the VL (-0.05 +/- 0.36 cm, p = 0.901). No other significant differences were observed. The findings of this study demonstrate the occurrence of non-homogenous adaptations in RF and VL muscle size and architecture following 8 weeks of high-intensity resistance training in resistance-trained men. However, training does not appear to influence region-specific adaptations in either muscle.	[Mangine, Gerald T.] Kennesaw State Univ, Exercise Sci & Sport Management, Kennesaw, GA 30144 USA; [Redd, Michael J.; Wells, Adam J.; Beyer, Kyle S.; Boone, Carleigh H.; La Monica, Michael B.; Stout, Jeffrey R.; Fukuda, David H.; Hoffman, Jay R.] Univ Cent Florida, Inst Exercise Physiol & Wellness, Orlando, FL 32816 USA; [Gonzalez, Adam M.] Hofstra Univ, Dept Hlth Profess, Hempstead, NY 11550 USA; [Townsend, Jeremy R.] Lipscomb Univ, Exercise & Nutr Sci, Nashville, TN USA; [Jajtner, Adam R.] Kent State Univ, Exercise Sci Physiol, Kent, OH 44242 USA; [Ratamess, Nicholas A.] Coll New Jersey, Hlth & Exercise Sci, Ewing, NJ USA	University System of Georgia; Kennesaw State University; State University System of Florida; University of Central Florida; Hofstra University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; College of New Jersey	Mangine, GT (corresponding author), Kennesaw State Univ, Exercise Sci & Sport Management, Kennesaw, GA 30144 USA.	gmangine@kennesaw.edu	Wells, Adam John/C-7212-2017; Fukuda, David/F-4507-2014; Hoffman, Jay/AAF-2005-2019; Stout, Jeffrey R/F-5805-2014	Wells, Adam John/0000-0003-0243-3574; Fukuda, David/0000-0002-4299-7764; Hoffman, Jay/0000-0002-0073-6603; Stout, Jeffrey R/0000-0001-6114-1649; Townsend, Jeremy/0000-0002-4938-1532; Mangine, Gerald/0000-0003-2718-2564	Institute of Exercise Physiology and Wellness at the University of Central Florida	Institute of Exercise Physiology and Wellness at the University of Central Florida	The authors received no specific funding for this work. All costs pertaining to this study were covered by the Institute of Exercise Physiology and Wellness at the University of Central Florida.	Abe T, 1998, MED SCI SPORT EXER, V30, P1066, DOI 10.1097/00005768-199807000-00007; Alegre LM, 2006, J SPORT SCI, V24, P501, DOI 10.1080/02640410500189322; ANDERSON T, 1982, RES Q EXERCISE SPORT, V53, P1; Bemben MG, 2002, J STRENGTH COND RES, V16, P103, DOI 10.1519/00124278-200202000-00016; BERG HE, 1993, ACTA PHYSIOL SCAND, V148, P379, DOI 10.1111/j.1748-1716.1993.tb09573.x; Boudreau SN, 2009, J SPORT REHABIL, V18, P91, DOI 10.1123/jsr.18.1.91; Brzycki M., 1993, J PHYS ED REC DANCE, V64, P88, DOI [10.1080/07303084.1993.10606684, DOI 10.1080/07303084.1993.10606684]; Butterfield TA, 2006, PFLUG ARCH EUR J PHY, V451, P688, DOI 10.1007/s00424-005-1503-6; Cadore EL, 2012, EXP GERONTOL, V47, P473, DOI 10.1016/j.exger.2012.04.002; Carosio S, 2011, AGEING RES REV, V10, P35, DOI 10.1016/j.arr.2009.08.001; Caterisano A, 2002, J STRENGTH COND RES, V16, P428; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Ema R, 2016, EUR J APPL PHYSIOL, V116, P1031, DOI 10.1007/s00421-016-3363-5; Ema R, 2013, EUR J APPL PHYSIOL, V113, P2691, DOI 10.1007/s00421-013-2700-1; Escamilla RF, 2001, MED SCI SPORT EXER, V33, P1552, DOI 10.1097/00005768-200109000-00020; Evans WJ, 2002, CLIN ORTHOP RELAT R, pS211, DOI 10.1097/01.blo.0000031991.92980.b4; Floyd RT, 2014, MANUAL STRUCTURAL KI; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; French D, 2015, ESSENTIALS STRENGTH; Gentil P, 2013, APPL PHYSIOL NUTR ME, V38, P341, DOI 10.1139/apnm-2012-0176; Goto K, 2004, J STRENGTH COND RES, V18, P730, DOI 10.1519/00124278-200411000-00008; Haff GG, 2015, ESSENTIALS STRENGTH, V4th; Hakkinen K, 2001, J APPL PHYSIOL, V91, P569, DOI 10.1152/jappl.2001.91.2.569; Ikegawa S, 2008, J STRENGTH COND RES, V22, P128, DOI 10.1519/JSC.0b013e31815f2fd3; Kawakami Y, 1995, EUR J APPL PHYSIOL O, V72, P37, DOI 10.1007/BF00964112; KAWAKAMI Y, 1993, J APPL PHYSIOL, V74, P2740, DOI 10.1152/jappl.1993.74.6.2740; Kumagai K, 2000, J APPL PHYSIOL, V88, P811, DOI 10.1152/jappl.2000.88.3.811; Luera MJ, 2014, J STRENGTH COND RES, V28, P328, DOI 10.1519/JSC.0b013e3182a1f434; Lynn R, 1998, J APPL PHYSIOL, V85, P98, DOI 10.1152/jappl.1998.85.1.98; LYNN R, 1994, J APPL PHYSIOL, V77, P1439, DOI 10.1152/jappl.1994.77.3.1439; Mangine GT, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12472; McCaw ST, 1999, MED SCI SPORT EXER, V31, P428, DOI 10.1097/00005768-199903000-00012; MORITANI T, 1993, J BIOMECH, V26, P95, DOI 10.1016/0021-9290(93)90082-P; Narici MV, 1996, ACTA PHYSIOL SCAND, V157, P175, DOI 10.1046/j.1365-201X.1996.483230000.x; Purkayastha S, 2006, J ATHL TRAINING, V41, P314; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Schoenfeld BJ, 2016, J STRENGTH COND RES, V30, P1805, DOI 10.1519/JSC.0000000000001272; Schoenfeld BJ, 2014, J STRENGTH COND RES, V28, P2909, DOI 10.1519/JSC.0000000000000480; Seynnes OR, 2007, J APPL PHYSIOL, V102, P368, DOI 10.1152/japplphysiol.00789.2006; Stensdotter AK, 2003, MED SCI SPORT EXER, V35, P2043, DOI 10.1249/01.MSS.0000099107.03704.AE; Toigo M, 2006, EUR J APPL PHYSIOL, V97, P643, DOI 10.1007/s00421-006-0238-1; Watanabe K, 2014, J BIOMECH, V47, P3502, DOI 10.1016/j.jbiomech.2014.09.001; Watanabe K, 2012, J ELECTROMYOGR KINES, V22, P251, DOI 10.1016/j.jelekin.2011.11.004; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wells AJ, 2014, MUSCLE NERVE	45	28	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0198304	10.1371/journal.pone.0198304	http://dx.doi.org/10.1371/journal.pone.0198304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161137	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900002
J	Muthukrishna, M; Henrich, J; Toyokawa, W; Hamamura, T; Kameda, T; Heine, SJ				Muthukrishna, Michael; Henrich, Joseph; Toyokawa, Wataru; Hamamura, Takeshi; Kameda, Tatsuya; Heine, Steven J.			Overconfidence is universal? Elicitation of Genuine Overconfidence (EGO) procedure reveals systematic differences across domain, task knowledge, and incentives in four populations	PLOS ONE			English	Article							PROBABILITY JUDGMENT ACCURACY; CROSS-NATIONAL DIFFERENCES; SELF-ENHANCEMENT; GENDER-DIFFERENCES; GENERAL KNOWLEDGE; CONFIDENCE JUDGMENTS; CULTURAL-DIFFERENCES; CEO OVERCONFIDENCE; ABOVE-AVERAGE; UNITED-STATES	Overconfidence is sometimes assumed to be a human universal, but there remains a dearth of data systematically measuring overconfidence across populations and contexts. Moreover, cross-cultural experiments often fail to distinguish between placement and precision and worse still, often compare population-mean placement estimates rather than individual performance subtracted from placement. Here we introduce a procedure for concurrently capturing both placement and precision at an individual level based on individual performance: The Elicitation of Genuine Overconfidence (EGO) procedure. We conducted experiments using the EGO procedure, manipulating domain, task knowledge, and incentives across four populations-Japanese, Hong Kong Chinese, Euro Canadians, and East Asian Canadians. We find that previous measures of population-level overconfidence may have been misleading; rather than universal, overconfidence is highly context dependent. Our results reveal cross-cultural differences in sensitivity to incentives and differences in overconfidence strategies, with underconfidence, accuracy, and overconfidence. Comparing sexes, we find inconsistent results for overplacement, but that males are consistently more confident in their placement. These findings have implications for our understanding of the adaptive value of overconfidence and its role in explaining population-level and individuallevel differences in economic and psychological behavior.	[Muthukrishna, Michael] London Sch Econ & Polit Sci, Dept Psychol & Behav Sci, London, England; [Henrich, Joseph] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Henrich, Joseph] Canadian Inst Adv Res, Toronto, ON, Canada; [Toyokawa, Wataru] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Hamamura, Takeshi] Curtin Univ, Sch Psychol & Speech Pathol, Perth, WA, Australia; [Kameda, Tatsuya] Univ Tokyo, Dept Social Psychol, Tokyo, Japan; [Heine, Steven J.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of London; London School Economics & Political Science; Harvard University; Canadian Institute for Advanced Research (CIFAR); University of St Andrews; Curtin University; University of Tokyo; University of British Columbia	Muthukrishna, M (corresponding author), London Sch Econ & Polit Sci, Dept Psychol & Behav Sci, London, England.	m.muthukrishna@lse.ac.uk	Hamamura, Takeshi/D-2069-2011; Muthukrishna, Michael/Z-1655-2019; Henrich, Joseph/A-2403-2009	Hamamura, Takeshi/0000-0003-2122-6300; Muthukrishna, Michael/0000-0002-7079-5166; Toyokawa, Wataru/0000-0001-8558-8568				ADAMS JK, 1961, PSYCHOL REV, V68, P33, DOI 10.1037/h0040274; Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Barber BM, 2001, Q J ECON, V116, P261, DOI 10.1162/003355301556400; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Benabou R, 2002, Q J ECON, V117, P871, DOI 10.1162/003355302760193913; Benoit JP, 2011, ECONOMETRICA, V79, P1591, DOI 10.3982/ECTA8583; Beyer S, 1997, PERS SOC PSYCHOL B, V23, P157, DOI 10.1177/0146167297232005; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Camerer C, 1999, AM EC REV, P306; CAMPBELL JD, 1986, J PERS SOC PSYCHOL, V50, P281, DOI 10.1037/0022-3514.50.2.281; Cheng JT, 2010, EVOL HUM BEHAV, V31, P334, DOI 10.1016/j.evolhumbehav.2010.02.004; Chuang W-I, 2013, FINANC MANAGE, V43, P113; Chudek M, 2015, HDB EVOLUTIONARY PSY, V2; DUNNING D, 1989, J PERS SOC PSYCHOL, V57, P1082, DOI 10.1037/0022-3514.57.6.1082; DUNNING D, 1995, PERS SOC PSYCHOL B, V21, P1297, DOI 10.1177/01461672952112007; Falk CF, 2015, PERS SOC PSYCHOL REV, V19, P177, DOI 10.1177/1088868314544693; Freund PA, 2012, PSYCHOL BULL, V138, P296, DOI 10.1037/a0026556; GIGERENZER G, 1991, PSYCHOL REV, V98, P506, DOI 10.1037/0033-295X.98.4.506; Gneezy U, 2009, ECONOMETRICA, V77, P1637, DOI 10.3982/ECTA6690; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; GREENWALD AG, 1980, AM PSYCHOL, V35, P603, DOI 10.1037//0003-066X.35.7.603; Hamamura T, 2007, MOTIV EMOTION, V31, P247, DOI 10.1007/s11031-007-9072-y; Haran U, 2010, JUDGM DECIS MAK, V5, P467; Heine SJ, 2005, J PERS SOC PSYCHOL, V89, P531, DOI 10.1037/0022-3514.89.4.531; Heine SJ, 2000, PERS SOC PSYCHOL B, V26, P71, DOI 10.1177/0146167200261007; Heine SJ, 1999, PSYCHOL REV, V106, P766, DOI 10.1037/0033-295X.106.4.766; Heine SJ, 2007, PERS SOC PSYCHOL REV, V11, P4, DOI 10.1177/1088868306294587; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Hsee CK, 1999, J BEHAV DECIS MAKING, V12, P165, DOI 10.1002/(SICI)1099-0771(199906)12:2<165::AID-BDM316>3.0.CO;2-N; John O.P., 2008, HDB PERSONALITY THEO, V3, P114; John OP., 1991, BIG 5 INVENTORY VERS; Johnson DDP, 2011, NATURE, V477, P317, DOI 10.1038/nature10384; Johnson DominicD.P., 2009, OVERCONFIDENCE WAR; Kim YH, 2010, J PERS SOC PSYCHOL, V98, P904, DOI 10.1037/a0017936; Kitayama S, 1997, J PERS SOC PSYCHOL, V72, P1245, DOI 10.1037/0022-3514.72.6.1245; Klar Y, 1997, J PERS SOC PSYCHOL, V73, P885, DOI 10.1037/0022-3514.73.5.885; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; LENNEY E, 1977, PSYCHOL BULL, V84, P1; LICHTENSTEIN S, 1977, ORGAN BEHAV HUM PERF, V20, P159, DOI 10.1016/0030-5073(77)90001-0; LUNDEBERG MA, 1994, J EDUC PSYCHOL, V86, P114, DOI 10.1037/0022-0663.86.1.114; Malmendier U, 2005, J FINANC, V60, P2661, DOI 10.1111/j.1540-6261.2005.00813.x; Malmendier U, 2008, J FINANC ECON, V89, P20, DOI 10.1016/j.jfineco.2007.07.002; MILLER DT, 1975, PSYCHOL BULL, V82, P213, DOI 10.1037/h0076486; Moore DA, 2018, OVERCONFIDENCE CULTU, DOI [10.31234/osf.io/rhnxc, DOI 10.31234/OSF.IO/RHNXC]; Moore DA, 2008, PSYCHOL REV, V115, P502, DOI 10.1037/0033-295X.115.2.502; Moore DA, 2015, ORGAN BEHAV HUM DEC, V131, P110, DOI 10.1016/j.obhdp.2015.09.003; Muthukrishna M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0192; Odean T, 1998, J FINANC, V53, P1887, DOI 10.1111/0022-1082.00078; Ortoleva P, 2015, AM ECON REV, V105, P504, DOI 10.1257/aer.20130921; Prims JP, 2017, JUDGM DECIS MAK, V12, P29; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI DOI 10.1515/9781400876136; Ryder AG, 2000, J PERS SOC PSYCHOL, V79, P49, DOI 10.1037//0022-3514.79.1.49; Sedikides C, 1997, ADV EXP SOC PSYCHOL, V29, P209, DOI 10.1016/S0065-2601(08)60018-0; SHANE S, 1995, J MANAGE, V21, P931, DOI 10.1016/0149-2063(95)90048-9; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Steinborn MB, 2018, PSYCHOL ASSESSMENT, V30, P339, DOI 10.1037/pas0000482; SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6; Talhelm T, 2014, SCIENCE, V344, P603, DOI 10.1126/science.1246850; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Taylor SE, 2000, AM PSYCHOL, V55, P99, DOI 10.1037//0003-066X.55.1.99; WHITCOMB KM, 1995, J BEHAV DECIS MAKING, V8, P51, DOI 10.1002/bdm.3960080105; Williams EF, 2008, J EXP SOC PSYCHOL, V44, P1121, DOI 10.1016/j.jesp.2008.01.002; WRIGHT GN, 1978, J CROSS CULT PSYCHOL, V9, P285, DOI 10.1177/002202217893002; Yamagishi T, 2012, ASIAN J SOC PSYCHOL, V15, P60, DOI 10.1111/j.1467-839X.2011.01362.x; YATES JF, 1989, ORGAN BEHAV HUM DEC, V43, P145, DOI 10.1016/0749-5978(89)90048-4; Yates JF, 1998, ORGAN BEHAV HUM DEC, V74, P89, DOI 10.1006/obhd.1998.2771; Yates JF, 1997, ORGAN BEHAV HUM DEC, V70, P87, DOI 10.1006/obhd.1997.2696	70	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202288	10.1371/journal.pone.0202288	http://dx.doi.org/10.1371/journal.pone.0202288			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161140	Green Published, Green Accepted, gold			2022-12-27	WOS:000443388900028
J	Wen, ZJ; Chen, JY; Bian, LZ; Xie, AL; Peng, MQ; Li, M; Wei, L				Wen, Zunjia; Chen, Junyu; Bian, Lanzheng; Xie, Ailing; Peng, Mingqi; Li, Mei; Wei, Li			The nasal oxygen practice in intensive care units in China: A multi-centered survey	PLOS ONE			English	Article							MECHANICAL VENTILATION; THERAPY; ANESTHESIA; EMERGENCY; OPINION	Background Nurses frequently administer nasal oxygen therapy for patients in intensive care units (ICUs). However, little is known about the current status, nurses' management and perception on the nasal oxygen therapy in China. Therefore, we aimed to investigate the nasal oxygen practice of ICUs in China to provide insights into future direction. Methods A cross-sectional survey on 10 hospitals was conducted. A self-designed questionnaire was administered to ICU nurses. Descriptive statistics, univariate, and multiple stepwise regression analyses were performed to analyze the respondents' questionnaires. Results A total of 580 respondents with a response rate of 96.67% were included in this study. The average correct answer rate was 58.28%. The current status of nasal oxygen administration in ICUs in Chinese hospitals lagged behind the recommendations of related guidelines. Nurses in China were eager to learn about the updated knowledge on oxygen therapy. The gender, age, clinical experience, degree, job title, and classification of working hospitals were not related to the oxygen therapy-related knowledge scores (all P>0.05). Conclusion Many deficiencies are observed regarding the nasal oxygen practice in ICUs of Chinese hospitals. Increased efforts by authorities and medical staff are required to narrow the gap between the current status of oxygen practice and the recommendations from related guidelines.	[Wen, Zunjia; Chen, Junyu; Wei, Li] Nanjing Med Univ, SICU, Childrens Hosp, Nanjing, Jiangsu, Peoples R China; [Wen, Zunjia; Chen, Junyu; Bian, Lanzheng; Xie, Ailing; Peng, Mingqi; Li, Mei] Nanjing Med Univ, Nursing Dept, Childrens Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wei, L (corresponding author), Nanjing Med Univ, SICU, Childrens Hosp, Nanjing, Jiangsu, Peoples R China.	13815889954@163.com						Asfar P, 2015, INTENS CARE MED, V41, P1118, DOI 10.1007/s00134-015-3670-z; Camporota L, 2015, MINERVA ANESTESIOL, V81, P1170; [楚姝 Chu Shu], 2016, [中国护理管理, Chinese Nursing Management], V16, P88; Eastwood GM, 2011, ANAESTH INTENS CARE, V39, P122, DOI 10.1177/0310057X1103900120; Eastwood GM, 2014, AUST CRIT CARE, V27, P120, DOI 10.1016/j.aucc.2013.11.004; Fang Yu-xia, 2013, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V31, P753; Franchini ML, 2016, CHEST, V150, P407, DOI 10.1016/j.chest.2016.03.035; Galiatsatos P, 2017, NEW ENGL J MED, V376, P286, DOI 10.1056/NEJMc1615074; Gao, 2016, CHINESE J CRITICAL C, V2, P63; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Hafner S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0084-6; Hickey Steven, 2007, Br J Nurs, V16, P1132; Kallstrom Thomas J, 2002, Respir Care, V47, P717; Kill C, 2013, ANASTH INTENSIV NOTF, V48, P84, DOI 10.1055/s-0032-1333087; La Fauci V, 2017, J Prev Med Hyg, V58, pE161; Liu Yangyun, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P890; Mao C, 1999, CRIT CARE MED, V27, P2806, DOI 10.1097/00003246-199912000-00033; Martin Daniel, 2017, J Intensive Care Soc, V18, P279, DOI 10.1177/1751143717712162; Meyhoff CS, 2012, CURR OPIN ANESTHESIO, V25, P363, DOI 10.1097/ACO.0b013e328352b402; Niu YM, 2012, HUM EXP TOXICOL, V31, P126, DOI 10.1177/0960327111412806; O'Driscoll BR, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2016-000170; Pannu SR, 2016, AM J RESP CRIT CARE, V193, P4, DOI 10.1164/rccm.201509-1810ED; Raman S, 2016, CRIT CARE RES PRACT, V2016, DOI 10.1155/2016/6312970; Renda T, 2018, BRIT J ANAESTH, V120, P18, DOI 10.1016/j.bja.2017.11.010; Ricard JD, 2009, INTENS CARE MED, V35, P963, DOI 10.1007/s00134-009-1457-9; Rush B, 2016, CHEST, V6, P23, DOI DOI 10.1016/J.CHEST.2016.06.023; Sun X, 2016, CHINESE J EVIDENCE B, V4, P1097; Templeton L, 1997, BRIT J GEN PRACT, V47, P91; Wen ZJ, 2017, J ADV NURS, V73, P2522, DOI 10.1111/jan.13323; Xiao A, 2011, CHINESE J MODERN NUR, V17, P3461; You L, 2017, INTERNAL MED NURSING; 张静, 2017, [中华医学杂志, National Medical Journal of China], V97, P1540; 남애리나, 2013, [Journal of Korean Academy of Nursing Administration, 간호행정학회지], V19, P87, DOI 10.11111/jkana.2013.19.1.87	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203332	10.1371/journal.pone.0203332	http://dx.doi.org/10.1371/journal.pone.0203332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161225	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900112
J	Yamamoto, J; Espindola, JM; Zamora-Camacho, A; Castellanos, G				Yamamoto, Jaime; Espindola, Juan M.; Zamora-Camacho, A.; Castellanos, Guillermo			The origin of the recent (2012-2016) seismic activity in the Guadalajara, Jalisco, Mexico, area: A block boundary interaction?	PLOS ONE			English	Article							RIVERA PLATE; EARTHQUAKE SEQUENCE; SUBDUCTION ZONE; WESTERN MEXICO; TECTONICS; GRABEN	The central part of Jalisco, Mexico, has experienced low-magnitude earthquake sequences and swarms. Although the effects of these earthquakes have been limited to relatively small areas, the earthquakes have caused general alarm among the population and, in some cases, have been catastrophic. These earthquake swarms are significant because they affect the most populous area of the state, including the capital city of Guadalajara. An extraordinary example is an earthquake swarm that started on 8 May 1912 and lasted until September of that year. The region remained seismically quiescent until May 2012, when seismic activity resumed, lasting to the present. We analyze the recent seismic activity, starting with the earthquake of 18 May 2012 (03:07 UT) at the western edge of Lake Chapala and ending with the magnitude 4.2 earthquake on 3 November 2016. Our analysis includes eight earthquakes with magnitudes between 3.5 and 4.8, the revision of hypocenter locations, and the determination of focal mechanism solutions using the inversion of the moment tensor method. When possible, inversion solutions are compared with solutions obtained with the first arrival polarity method. We compare our results for the recent seismicity with the distribution of reported damage associated with historical earthquakes. Our work indicates a N-S trending seismic source zone and an orientation of nodal planes that suggests reactivation of preexisting local faults induced by the interaction of the western border of the Trans-Mexican Volcanic Belt with the eastern border of the Jalisco Block.	[Yamamoto, Jaime] Univ Nacl Autonoma Mexico, Inst Geofis, Dept Seismol, Mexico City, DF, Mexico; [Espindola, Juan M.] Univ Nacl Autonoma Mexico, Inst Geofis, Dept Vulcanol, Mexico City, DF, Mexico; [Zamora-Camacho, A.] Univ Guadalajara, Ctr Univ Costa, Dept Exact Sci, Guadalajara, Jalisco, Mexico; [Castellanos, Guillermo] Univ Guadalajara, Ctr Univ Ciencias Exactas & Ingn, Dept Project Engn, Guadalajara, Jalisco, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad de Guadalajara; Universidad de Guadalajara	Yamamoto, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Geofis, Dept Seismol, Mexico City, DF, Mexico.	yamas@igeofisica.unam.mx			PRODEP through CUCOSTA, U. de G;  [CONACyT 428427-P]	PRODEP through CUCOSTA, U. de G; 	Field operation of a portable seismic station, data collection, and the preparation of the first manuscript draft were partially supported by the Academic Exchange Program of the Universidad Nacional Autonoma de Mexico (UNAM) and the University of Guadalajara. Data for this research were obtained with instruments obtained through grant CONACyT 428427-P. Support for publication of this article was provided by PRODEP through CUCOSTA, U. de G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DREGER DS, 1990, B SEISMOL SOC AM, V80, P1162; DREGER DS, 1993, J GEOPHYS RES-SOL EA, V98, P8107, DOI 10.1029/93JB00023; EISSLER HK, 1984, J GEOPHYS RES, V89, P4520, DOI 10.1029/JB089iB06p04520; Ferrari L, 2012, TECTONOPHYSICS, V522, P122, DOI 10.1016/j.tecto.2011.09.018; Garcia V, 1996, SISMOS HIST MEXICO, VI, P1; Havskov J., 1999, SEISMOL RES LETT, V705, P532, DOI [DOI 10.1785/GSSRL.70.5.532, 10.1785/gssrl.70.5.532]; Johnson C.A, 1987, THESIS; Singh SK, 2017, GEOFIS INT, V56, P173; LUHR JF, 1985, GEOLOGY, V13, P54, DOI 10.1130/0091-7613(1985)13<54:ARISMM>2.0.CO;2; MOLNAR P, 1969, GEOL SOC AM BULL, V80, P1639, DOI 10.1130/0016-7606(1969)80[1639:TOTCAM]2.0.CO;2; Mooser F, 1972, SOC GEOL MEX 2 CONV, P186; Nunez-Cornu FJ, 2002, PHYS EARTH PLANET IN, V132, P141, DOI 10.1016/S0031-9201(02)00049-3; Ordonez E., 1912, B SEISMOL SOC AM, V2, P134; Pacheco JF, 1999, J S AM EARTH SCI, V12, P557, DOI 10.1016/S0895-9811(99)00039-5; Pacheco JF, 1999, J S AM EARTH SCI, V12, P567, DOI 10.1016/S0895-9811(99)00040-1; PARDO M, 1993, GEOPHYS RES LETT, V20, P2391, DOI 10.1029/93GL02794; Rosas-Elguera J, 1998, INT GEOL REV, V40, P350; Selvans MM, 2011, PURE APPL GEOPHYS, V168, P1435, DOI 10.1007/s00024-010-0201-2; Servicio Sismologico Nacional, 2015, SISM DIC 2015 REG JA; SINGH SK, 1985, B SEISMOL SOC AM, V75, P1301; SINGH SK, 1981, B SEISMOL SOC AM, V71, P827; SUAREZ G, 1994, TECTONOPHYSICS, V234, P117, DOI 10.1016/0040-1951(94)90207-0; Waitz P., 1919, BOLETIN, V19; Yamamoto J, 2016, AGU FALL M	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0200991	10.1371/journal.pone.0200991	http://dx.doi.org/10.1371/journal.pone.0200991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161126	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900006
J	Krieger, B; Piskur, B; Schulze, C; Jakobs, U; Beurskens, A; Moser, A				Krieger, Beate; Piskur, Barbara; Schulze, Christina; Jakobs, Uta; Beurskens, Anna; Moser, Albine			Supporting and hindering environments for participation of adolescents diagnosed with autism spectrum disorder: A scoping review	PLOS ONE			English	Review							HIGH-FUNCTIONING AUTISM; PHYSICAL-ACTIVITY PARTICIPATION; MAINSTREAM SECONDARY-SCHOOLS; QUALITY-OF-LIFE; SOCIAL-PARTICIPATION; ASPERGER-SYNDROME; YOUNG-ADULTS; INTERNATIONAL CLASSIFICATION; SENSORY EXPERIENCES; RETT-SYNDROME	The influence of a person's environment and its modifying potential on participation is well recognized for most childhood disabilities, but scarcely studied for adolescents with autism spectrum disorder (ASD). A scoping review was conducted, the aim of which was to map the existing literature about supporting and hindering environments for the participation of adolescents with ASD. Sources of scientific evidence were searched for in four data-bases. Inclusion criteria were the perspectives of adolescents between 12 and 21, families, peers, or significant others; ecologic validity; and a clear connection between environment and participation. The publication dates ranged from 2001 to 2014 and partly up to 2018. The International Classification of Functioning, Disability and Health (ICF) served as the guiding framework for inclusion/exclusion during the selection process. Thematic analysis was performed by five independent reviewers. Results were additionally validated by stake-holders. This scoping review identified 5528 articles, and finally included 31 studies. Two main themes were found: "providing security" indicates how the environment, and specifically the parental, physical, and informational environments, have a securing or intimidating effect. The second theme, "helping to connect", indicates which environments support or hinder social relationships or social activities, and hence participation. An additional third main theme, "tension in participation", relates to ambiguities that seem essential to understand participation or isolation of adolescents with ASD. Results show that participation is a value-laden concept. This research widens the field of dealing with adolescents with ASD, as it directs attention towards the responsibility of the environment regarding participation.	[Krieger, Beate; Schulze, Christina; Jakobs, Uta] Zurich Univ Appl Sci, Sch Hlth Profess, Inst Occupat Therapy, Winterthur, Switzerland; [Krieger, Beate; Beurskens, Anna; Moser, Albine] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands; [Piskur, Barbara; Beurskens, Anna; Moser, Albine] Zuyd Univ Appl Sci, Res Ctr Auton & Participat People Chron Illness, Heerlen, Netherlands	Zurich University of Applied Sciences; Maastricht University	Krieger, B (corresponding author), Zurich Univ Appl Sci, Sch Hlth Profess, Inst Occupat Therapy, Winterthur, Switzerland.; Krieger, B (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands.	beate.krieger@zhaw.ch	Piskur, Barbara/X-3484-2018	Schulze, Christina/0000-0002-5662-5347				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Anaby D, 2014, ARCH PHYS MED REHAB, V95, P908, DOI 10.1016/j.apmr.2014.01.005; Anaby D, 2013, DISABIL REHABIL, V35, P1589, DOI 10.3109/09638288.2012.748840; Andrews J, 2014, DISABIL REHABIL, V36, P894, DOI 10.3109/09638288.2013.813083; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Arnell S, 2018, J AUTISM DEV DISORD, V48, P1792, DOI 10.1007/s10803-017-3436-2; Ashburner J, 2013, AUST OCCUP THER J, V60, P171, DOI 10.1111/1440-1630.12025; Ashby C, 2010, DISABIL SOC, V25, P345, DOI 10.1080/09687591003701249; Assouline SG, 2012, J AUTISM DEV DISORD, V42, P1781, DOI 10.1007/s10803-011-1403-x; Badley EM, 2008, SOC SCI MED, V66, P2335, DOI 10.1016/j.socscimed.2008.01.026; Baines AD, 2012, DISABIL SOC, V27, P547, DOI 10.1080/09687599.2012.662825; Ben-Sasson A, 2009, J AUTISM DEV DISORD, V39, P1, DOI 10.1007/s10803-008-0593-3; Bentley JKC, 2008, INT J INCLUSIVE EDUC, V12, P543, DOI 10.1080/13603110802377599; Billstedt E, 2011, AUTISM, V15, P7, DOI 10.1177/1362361309346066; Bishop DVM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015112; Bolte S, 2018, AUTISM, P1; Brewster S, 2011, BRIT J LEARN DISABIL, V39, P284, DOI 10.1111/j.1468-3156.2010.00665.x; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Castro S, 2013, DISABIL REHABIL, V35, P125, DOI 10.3109/09638288.2012.690494; Chen YW, 2016, J AUTISM DEV DISORD, V46, P1403, DOI 10.1007/s10803-015-2682-4; Chiang HM, 2012, J AUTISM DEV DISORD, V42, P685, DOI 10.1007/s10803-011-1297-7; Cox NB, 2012, J AUTISM DEV DISORD, V42, P2257, DOI 10.1007/s10803-012-1470-7; Cronin A., 2015, HUMAN DEV PERFORMANC; Csikszemtmihalyi M, 1984, BEING ADOLESCENT CON; Daudt HML, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-48; de Schipper E, 2015, AUTISM RES, V8, P782, DOI 10.1002/aur.1485; de Schipper E, 2016, AUTISM RES, V9, P959, DOI 10.1002/aur.1592; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Dixon RM, 2013, AUSTRALAS J SPEC EDU, V37, P28, DOI 10.1017/jse.2013.5; Eaves LC, 2008, J AUTISM DEV DISORD, V38, P739, DOI 10.1007/s10803-007-0441-x; Edgington L, 2016, RES DEV DISABIL, V59, P221, DOI 10.1016/j.ridd.2016.09.004; Egilson ST, 2017, SCAND J OCCUP THER, V24, P187, DOI 10.1080/11038128.2016.1198419; Egilson ST, 2017, AUTISM, V21, P133, DOI 10.1177/1362361316630881; Evans IM, 2001, DISABIL REHABIL, V23, P167; Falkmer Marita, 2012, Autism Res Treat, V2012, P656981, DOI 10.1155/2012/656981; Farley MA, 2009, AUTISM RES, V2, P109, DOI 10.1002/aur.69; Forsyth R, 2007, DEV MED CHILD NEUROL, V49, P345, DOI 10.1111/j.1469-8749.2007.00345.x; Frankel FD, 2011, J CHILD PSYCHOL PSYC, V52, P571, DOI 10.1111/j.1469-7610.2010.02318.x; Giarelli E, 2013, J PEDIATR NURS, V28, P563, DOI 10.1016/j.pedn.2012.12.010; Giarelli E, 2013, DISABIL HEALTH J, V6, P227, DOI 10.1016/j.dhjo.2013.01.010; Goeke-Morey MC, 2013, SCHOOL PSYCHOL INT, V34, P243, DOI 10.1177/0143034311435162; Granlund M, 2012, AM J PHYS MED REHAB, V91, pS84, DOI 10.1097/PHM.0b013e31823d5376; Gregor S, 2018, RES AUTISM SPECT DIS, V48, P53, DOI 10.1016/j.rasd.2018.01.007; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hare DJ, 2004, AUTISM, V8, P425, DOI 10.1177/1362361304047225; Hart R, 1992, FLORENCE UNICEF INNO; Henninger NA, 2013, AUTISM, V17, P103, DOI 10.1177/1362361312441266; Howe FEJ, 2016, J AUTISM DEV DISORD, V46, P1656, DOI 10.1007/s10803-015-2693-1; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Hull L, 2017, J AUTISM DEV DISORD, V47, P2519, DOI 10.1007/s10803-017-3166-5; Humphrey N., 2010, EUR J SPEC NEEDS EDU, V25, P77, DOI [DOI 10.1080/08856250903450855, 10.1080/08856250903450855]; Humphrey N, 2008, AUTISM, V12, P23, DOI 10.1177/1362361307085267; Humphrey N, 2011, AUTISM, V15, P397, DOI 10.1177/1362361310387804; Hwang AW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126693; Imms C, 2017, DEV MED CHILD NEUROL, V59, P16, DOI 10.1111/dmcn.13237; Imms C, 2016, DEV MED CHILD NEUROL, V58, P29, DOI 10.1111/dmcn.12932; Jing W, 2014, BRIEF REPORT CHILDRE, P1478, DOI [10.1007/s10803-013-1994-5, DOI 10.1007/S10803-013-1994-5]; Joffe H, 2004, RES METHODS CLIN HLT, P56, DOI DOI 10.4135/9781849209793; Kaplan R., 2005, URBAN PLACE RECONNEC, P271; Kaplan S., 2008, URBAN ECOL INT PERSP, P557, DOI [DOI 10.1007/978-0-387-73412-5_36, 10.1007/978-0-387-73412-5_36]; Kaplan S, 2009, J ENVIRON PSYCHOL, V29, P329, DOI 10.1016/j.jenvp.2008.10.005; Kasari C, 2013, AUTISM, V17, P254, DOI 10.1177/1362361312470496; King G, 2013, DISABIL REHABIL, V35, P1578, DOI 10.3109/09638288.2012.748836; Knapp M, 2009, AUTISM, V13, P317, DOI 10.1177/1362361309104246; Kuo MH, 2014, AUTISM, V18, P914, DOI 10.1177/1362361313497832; Kuo MH, 2013, AUTISM, V17, P481, DOI 10.1177/1362361311416380; Kuusikko S, 2008, J AUTISM DEV DISORD, V38, P1697, DOI 10.1007/s10803-008-0555-9; Lai MC, 2017, AUTISM, V21, P690, DOI 10.1177/1362361316671012; Lawrence DH, 2010, ARCH PSYCHIAT NURS, V24, P227, DOI 10.1016/j.apnu.2009.07.004; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Liptak GS, 2011, J DEV BEHAV PEDIATR, V32, P277, DOI 10.1097/DBP.0b013e31820b49fc; Locke J, 2010, J RES SPEC EDUC NEED, V10, P74, DOI 10.1111/j.1471-3802.2010.01148.x; Mallinson T, 2010, ARCH PHYS MED REHAB, V91, pS29, DOI 10.1016/j.apmr.2010.04.027; Matson JL, 2011, RES AUTISM SPECT DIS, V5, P418, DOI 10.1016/j.rasd.2010.06.004; Matsuoka H, 2009, LANDSCAPE URBAN PLAN, V84, P7; McAllister K, 2012, BRIT J SPEC EDUC, V39, P201, DOI 10.1111/1467-8578.12006; Meek SE, 2012, RES AUTISM SPECT DIS, V6, P815, DOI 10.1016/j.rasd.2011.11.001; Muskat B, 2015, AUTISM, V19, P482, DOI 10.1177/1362361314531341; Myers E, 2015, J AUTISM DEV DISORD, V45, P2373, DOI 10.1007/s10803-015-2403-z; Nagib W, 2017, HOUSING STUD, V32, P140, DOI 10.1080/02673037.2016.1181719; Nesbitt S., 2000, WHY WHY NOT FACTORS, P357; O'Halloran M., 2013, LEARNING DISABILITY, V16, P14, DOI [10.7748/ldp2013.04.16.3.14.e679, DOI 10.7748/LDP2013.04.16.3.14.E679]; Orsmond GI, 2006, AM J MENT RETARD, V111, P121, DOI 10.1352/0895-8017(2006)111[121:MRQAAA]2.0.CO;2; Orsmond GI, 2004, J AUTISM DEV DISORD, V34, P245, DOI 10.1023/B:JADD.0000029547.96610.df; Ouellette P, 2005, J ENVIRON PSYCHOL, V25, P175, DOI 10.1016/j.jenvp.2005.06.001; Petalas MA, 2015, J CHILD FAM STUD, V24, P38, DOI 10.1007/s10826-013-9811-5; Pham MT, 2014, RES SYNTH METHODS, V5, P371, DOI 10.1002/jrsm.1123; Piskur B, 2014, CLIN REHABIL, V28, P211, DOI 10.1177/0269215513499029; Pisula E, 2011, PERCEPTION SOCIAL RE, DOI [10.1177/0143034311415784, DOI 10.1177/0143034311415784]; Rao PA, 2008, J AUTISM DEV DISORD, V38, P353, DOI 10.1007/s10803-007-0402-4; Reichow B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008511.pub2; Rossetti ZS, 2011, THATS WE DO IT FRIEN, P23; Rumrill PD, 2010, WORK, V35, P399, DOI 10.3233/WOR-2010-0998; Ryan S, 2010, HEALTH PLACE, V16, P868, DOI 10.1016/j.healthplace.2010.04.012; Saggers B, 2011, AUSTRALAS J SPEC EDU, V35, P173, DOI 10.1375/ajse.35.2.173; Schneidert M, 2003, DISABIL REHABIL, V25, P588, DOI 10.1080/0963828031000137090; Seltzer M. M., 2010, AUTISM, V13, DOI [10.1177/1362361308097119.Siblings, DOI 10.1177/1362361308097119.SIBLINGS]; Shattuck PT, 2011, PARTICIPATION SOCIAL, V6, DOI [10.1371/journal.pone.0027176, DOI 10.1371/JOURNAL.PONE.0027176]; Sood D, 2014, OPEN J OCCUPATIONAL, DOI [10.15453/2168-6408.1082, DOI 10.15453/2168-6408.1082]; Sreckovic MA, 2014, RES AUTISM SPECT DIS, V8, P1155, DOI 10.1016/j.rasd.2014.06.004; Symes W, 2010, SCHOOL PSYCHOL INT, V31, P478, DOI 10.1177/0143034310382496; Tanner K, 2015, AM J OCCUP THER, V69, DOI 10.5014/ajot.2015.017806; Taylor EL, 2008, ATTACH HUM DEV, V10, P143, DOI 10.1080/14616730802113687; Taylor JL, 2017, AUTISM RES, V10, P663, DOI 10.1002/aur.1709; Tobin MC, 2014, RES AUTISM SPECT DIS, V8, P214, DOI 10.1016/j.rasd.2013.12.002; Turcotte PL, 2015, OCCUP THER MENT HEAL, V31, P234, DOI 10.1080/0164212X.2015.1051641; Vandell DL, 2005, ADV CHILD DEV BEHAV, V33, P43, DOI 10.1016/S0065-2407(05)80004-7; Wainscot J. J., 2008, INT J PSYCHOL PSYCHO, V8, P25; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; WHO, 2012, ICD 10 CLASS MENT BE; WHO, 2001, WHO INT CLASS FUNCT; Wigston C, 2015, DEV NEUROREHABIL, V8423, P1, DOI [10.3109/17518423.2015.1046091109, DOI 10.3109/17518423.2015.1046091109]; Willis C, 2017, DISABIL REHABIL, V39, P1771, DOI 10.1080/09638288.2016.1207716	115	37	37	8	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202071	10.1371/journal.pone.0202071	http://dx.doi.org/10.1371/journal.pone.0202071			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157207	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400031
J	Reijntjes, DOJ; Schubert, NMA; Pietrus-Rajman, A; van Dijk, P; Pyott, SJ				Reijntjes, Daniel O. J.; Schubert, Nick M. A.; Pietrus-Rajman, Alexander; van Dijk, Pim; Pyott, Sonja J.			Changes in spontaneous movement in response to silent gaps are not robust enough to indicate the perception of tinnitus in mice	PLOS ONE			English	Article							EXPOSURE; HEARING; RATS	Approaches to identify the perception of tinnitus in various animal models have been difficult to apply to mouse. As a result, mice have been underutilized to investigate the cellular, molecular, and genetic mechanisms underlying tinnitus. A recent study in guinea pigs identified a novel spontaneous behavior (unconditioned response), changes in movement during silent gaps, that identified a subgroup of animals presumably with tinnitus. Guinea pigs identified with tinnitus failed to ''freeze'' in response to silent gaps in sound. In the hope of developing a rapid and reliable assay for mice, we used a similar approach. C57BL/6J mice underwent three trials in which spontaneous movement was video recorded in the presence of white noise interrupted with six silent gaps. Movement metrics included velocity and body movement. Before the third trial, mice underwent either sham or noise exposure to induce hearing loss and tinnitus. Auditory brainstem responses before and after noise trauma confirmed normal hearing in sham-treated animals and hearing loss in the noise-exposed cohort. No differences in the various movement metrics were detected during the silent gaps either before or after sham/noise exposure. Variability in spontaneous movement both before and after sham/noise exposure was substantially greater in mice compared to guinea pigs. Thus, this assay is not sufficiently statistically powerful to identify changes in movement that might indicate tinnitus perception in mice. Previous observations also reported increased movement overall in guinea pigs identified as suffering tinnitus. In contrast, mice showed no statistically significant differences in movement between the three trials. Despite our results, other unconditioned (as well as conditioned) behaviors should be examined in mice to test their utility to detect changes that indicate the perception of tinnitus. Such assays are essential to accelerate the use of mouse models in tinnitus research.	[Reijntjes, Daniel O. J.; Schubert, Nick M. A.; Pietrus-Rajman, Alexander; van Dijk, Pim; Pyott, Sonja J.] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol & Head Neck Surg, Groningen, Netherlands	University of Groningen	Pyott, SJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol & Head Neck Surg, Groningen, Netherlands.	s.pyott@umcg.nl	Pyott, Sonja/AAW-8789-2020; Reijntjes, Daniël/AAH-1877-2020; Van Dijk, Pim/E-8019-2010; Schubert, Nick/D-7744-2017	Reijntjes, Daniël/0000-0002-6485-588X; Van Dijk, Pim/0000-0002-8023-7571; Schubert, Nick/0000-0003-3611-2939; Pyott, Sonja/0000-0001-7750-2437	Heinsius Houbolt Foundation; Stichting Gehoorgestoorde Kind; University of Groningen Rosalind Franklin Fellowship	Heinsius Houbolt Foundation; Stichting Gehoorgestoorde Kind; University of Groningen Rosalind Franklin Fellowship	This study was supported by the Heinsius Houbolt Foundation, the Stichting Gehoorgestoorde Kind, the University of Groningen Rosalind Franklin Fellowship to S. J. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyen K, 2015, EAR HEARING, V36, pe138, DOI 10.1097/AUD.0000000000000156; Burkard R, 2006, BRAIN RES, V1091, P27, DOI 10.1016/j.brainres.2006.02.132; Campolo J, 2013, NOISE HEALTH, V15, P398, DOI 10.4103/1463-1741.121232; Galazyuk A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00088; Hayes SH, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00179; Heeringa AN, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00207; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Ingham Neil J, 2011, Curr Protoc Mouse Biol, V1, P279, DOI 10.1002/9780470942390.mo110059; JASTREBOFF PJ, 1988, LARYNGOSCOPE, V98, P280; Longenecker RJ, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-542; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Maes IHL, 2013, EAR HEARING, V34, P508, DOI 10.1097/AUD.0b013e31827d113a; McCormack A, 2016, HEARING RES, V337, P70, DOI 10.1016/j.heares.2016.05.009; Mwilambwe-Tshilobo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137749; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Swain SK, 2016, J FORMOS MED ASSOC, V115, P139, DOI 10.1016/j.jfma.2015.11.011; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; von der Behrens W, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/741452; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yu H, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00158; Zeman F, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-7; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	23	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202882	10.1371/journal.pone.0202882	http://dx.doi.org/10.1371/journal.pone.0202882			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157212	Green Published, gold			2022-12-27	WOS:000443071400074
J	Sylvestre, TF; Cavalcante, RD; da Silva, JD; Paniago, AMM; Weber, SS; Pauletti, BA; de Carvalho, LR; dos Santos, LD; Mendes, RP				Sylvestre, Tatiane Fernanda; Cavalcante, Ricardo de Souza; da Silva, Julhiany de Fatima; Miranda Paniago, Anamaria Mello; Weber, Simone Schneider; Pauletti, Bianca Alves; de Carvalho, Lidia Raquel; dos Santos, Lucilene Delazari; Mendes, Rinaldo Poncio			Serological proteomic biomarkers to identify Paracoccidioides species and risk of relapse	PLOS ONE			English	Article							HUMAN PLASMA PROTEOME; BRASILIENSIS; IRON	The sensitivity of the double agar gel immunodiffusion test is about 90% in patients with untreated paracoccidioidomycosis (PCM), but it is much lower in cases of relapse. In addition, serum from patients with PCM caused by Paracoccidioides lutzii, frequent in the Midwest region of Brazil, do not react with the classical antigen obtained from Pb B-339. These findings showed the need for alternative diagnostic methods, such as biological markers through proteomics. The aim of this study was to identify biomarkers for the safe identification of PCM relapse and specific proteins that could distinguish infections caused by Paracoccidioides brasiliensis from those produced by Paracoccidioides lutzii. Proteomic analysis was performed in serum from 9 patients with PCM caused by P. brasiliensis, with and without relapse, from 4 patients with PCM produced by P. lutzii, and from 3 healthy controls. The comparative evaluation of the 29 identified plasma proteins suggested that the presence of the immunoglobulin (Ig) alpha-2 chain C region and the absence of Ig heavy chain V-III TIL indicate infection by P. lutzii. In addition, the absence of complement factor B protein might be a predictor of relapse. The evaluation of these proteins in a higher number of patients should be carried out in order to validate these findings.	[Sylvestre, Tatiane Fernanda; Cavalcante, Ricardo de Souza; da Silva, Julhiany de Fatima; Mendes, Rinaldo Poncio] Univ Estadual Paulista, UNESP, Fac Med Botucatu, Botucatu, SP, Brazil; [Miranda Paniago, Anamaria Mello; Weber, Simone Schneider] Univ Fed Mato Grosso do Sul UFMS, Fac Med, Campo Grande, Brazil; [Weber, Simone Schneider] Univ Fed Amazonas UFAM, Inst Ciencias Exatas & Tecnol, Itacoatiara, Brazil; [Pauletti, Bianca Alves] CNPEM, Lab Nacl Biociencias, Campinas, SP, Brazil; [de Carvalho, Lidia Raquel] Univ Estadual Paulista, UNESP, Inst Biociencia Botucatu, Botucatu, SP, Brazil; [dos Santos, Lucilene Delazari] UNESP, CEVAP, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Amazonas; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista	Sylvestre, TF (corresponding author), Univ Estadual Paulista, UNESP, Fac Med Botucatu, Botucatu, SP, Brazil.	thaty_sylvestre@hotmail.com	de Fátima da Silva, Julhiany F/F-8706-2012; Paniago, Anamaria M M/B-7747-2012; dos Santos, Lucilene Delazari/AAY-5226-2020; de Souza Cavalcante, Ricardo/D-2058-2013; Paniago, Anamaria/AGS-6094-2022; Sylvestre, Tatiane/AAV-4449-2021; Carvalho, Lidia Raquel de/C-2973-2013	de Fátima da Silva, Julhiany F/0000-0002-9675-088X; Paniago, Anamaria M M/0000-0002-8925-7712; dos Santos, Lucilene Delazari/0000-0001-5832-1825; de Souza Cavalcante, Ricardo/0000-0001-6382-2675; Paniago, Anamaria/0000-0002-8925-7712; Weber, Simone/0000-0002-4181-142X; Carvalho, Lidia Raquel de/0000-0003-0575-2263; Sylvestre, Tatiane Fernanda/0000-0002-0023-964X				Almeida SR, 1998, MED MYCOL, V36, P405, DOI 10.1080/02681219880000641; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Andres MT, 2010, ANTIMICROB AGENTS CH, V54, P4335, DOI 10.1128/AAC.01620-09; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; ARANGO R, 1988, J MED VET MYCOL, V26, P113; Batista J, 2010, MYCOSES, V53, P176, DOI 10.1111/j.1439-0507.2008.01687.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo ZP, 2003, MED MYCOL, V41, P539, DOI 10.1080/13693780310001615358; Casaletti L, 2017, YEAST, V34, P179, DOI 10.1002/yea.3225; Castilho DG, 2014, J PROTEOME RES, V13, P4259, DOI 10.1021/pr5002274; Del Chierico F, 2016, EXP PARASITOL, V170, P82, DOI 10.1016/j.exppara.2016.09.007; Dias-Melicio LA, 2006, MICROBIOL IMMUNOL, V50, P307, DOI 10.1111/j.1348-0421.2006.tb03798.x; Gegembauer G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002986; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Kalsheker NA, 1996, INT J BIOCHEM CELL B, V28, P961, DOI 10.1016/1357-2725(96)00032-5; Kerr MA, 1990, BIOCHEM J, V271, P185; Mailhac A, 2017, J PROTEOMICS, V152, P150, DOI 10.1016/j.jprot.2016.10.017; Marques S A, 1983, Rev Inst Med Trop Sao Paulo, V25, P87; Vidal MSM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003174; Mendes Rinaldo Poncio, 2017, Open Microbiol J, V11, P224, DOI 10.2174/1874285801711010224; Mendes RP, 1994, PARACOCCIDIOIDOMYCOS, V2, P233, DOI DOI 10.1201/9781351075329-16; Otto A, 2014, INT J MED MICROBIOL, V304, P110, DOI 10.1016/j.ijmm.2013.11.007; Parente AFA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022810; Pieper R, 2003, PROTEOMICS, V3, P422, DOI 10.1002/pmic.200390057; Pitarch A, 2004, PROTEOMICS, V4, P3084, DOI 10.1002/pmic.200400903; Putnam FR, 1984, PLASMA PROTEINS STRU, V2, P45; RESTREPO A, 1985, SABOURAUDIA, V23, P323; Rezende TCV, 2011, J PROTEOMICS, V75, P572, DOI 10.1016/j.jprot.2011.08.020; Ribeiro DM, 2008, GENET MOL RES, V7, P1045, DOI 10.4238/vol7-4gmr472; Brandao RMSD, 2014, FUTURE MICROBIOL, V9, P871, DOI [10.2217/fmb.14.49, 10.2217/FMB.14.49]; Shikanai-Yasuda MA, 1997, MYCOPATHOLOGIA, V138, P65, DOI 10.1023/A:1006806615226; Singh P, 2015, WORLD J MICROB BIOT, V31, P1923, DOI 10.1007/s11274-015-1936-9; Martins LMS, 2013, FUTURE MICROBIOL, V8, P549, DOI [10.2217/FMB.13.22, 10.2217/fmb.13.22]; Sylvestre TF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002834; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Virginio ED, 2014, INT J MOL SCI, V15, P14505, DOI 10.3390/ijms150814505; WANG AC, 1977, J BIOL CHEM, V252, P7192; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12	39	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202804	10.1371/journal.pone.0202804	http://dx.doi.org/10.1371/journal.pone.0202804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157221	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400070
J	van de Rijt, A				van de Rijt, Arnout			All-sense-all networks are suboptimal for sensorimotor synchronization	PLOS ONE			English	Article							AUDITORY SEQUENCES; PHASE ATTRACTION; DYNAMICS	In human groups that seek to synchronize to a common steady beat, every member can typically perceive every other member. We question whether this naturally occurring all-senseall condition is optimal for temporal coordination. We consider alternative configurations represented by directed graphs, in which individuals can only hear or see a subset of others. We identify a trade-off in the topology of such networks: While denser graphs provide stronger coupling, improving synchrony, density increases sensitivity to early taps, which produces rushing. Results from an experimental study with music conservatory students show that networks that combine short path length with low density match all-sense-all networks in synchrony while yielding a steadier beat. These findings suggest that professional teams in arts, sports, industry, and the military may improve temporal coordination by employing technology that strategically configures who can track whom.	[van de Rijt, Arnout] Univ Utrecht, Dept Sociol, Utrecht, Netherlands	Utrecht University	van de Rijt, A (corresponding author), Univ Utrecht, Dept Sociol, Utrecht, Netherlands.	a.vanderijt@uu.nl		van de Rijt, Arnout/0000-0002-4208-3452	NSF Division of Social and Economic Sciences [1340122]; NSF [1340122]	NSF Division of Social and Economic Sciences; NSF(National Science Foundation (NSF))	This research was supported by NSF Division of Social and Economic Sciences grant #1340122 to the author (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1340122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author thanks the editor and two reviewers for very helpful comments. This research was supported by NSF grant #1340122 to the author.	[Anonymous], 2004, PHYS TODAY; [Anonymous], 2010, NETWORKS INTRO NETWO, DOI DOI 10.1093/ACPROF:OSO/9780199206650.001.0001; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Bruggeman J, ARXIV13126809V31; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chafe C, 2010, PERCEPTION, V39, P982, DOI 10.1068/p6465; Colson JF, 2012, TEMPO ENSEMBLE PRECI; Cuijpers LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133527; Eckhardt B, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021110; Glass L, 1988, CLOCKS CHAOS RHYTHMS; Hattori Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01566; Hennig H, 2014, P NATL ACAD SCI USA, V111, P12974, DOI 10.1073/pnas.1324142111; Hong H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.067105; JONES MDR, 1964, NATURE, V203, P322, DOI 10.1038/203322a0; Keller PE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0394; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; MATES J, 1994, BIOL CYBERN, V70, P463, DOI 10.1007/BF00203239; Miyake I., 1902, STUD YALE PSYCHOL LA, V10, P1; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Nowicki L., 2013, PSYCHOMUSICOLOGY, V23, P6, DOI [10.1037/a0032039, DOI 10.1037/A0032039]; Okano M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43987; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2004, HUM MOVEMENT SCI, V23, P389, DOI 10.1016/j.humov.2004.08.014; Repp BH, 2003, J EXP PSYCHOL HUMAN, V29, P290, DOI 10.1037/0096-1523.29.2.290; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; SISMONDO E, 1990, SCIENCE, V249, P55, DOI 10.1126/science.249.4964.55; Thomson M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18539-9; van der Steen MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00253; Vorberg D, 2002, J MATH PSYCHOL, V46, P56, DOI 10.1006/jmps.2001.1375; WALKER TJ, 1969, SCIENCE, V166, P891, DOI 10.1126/science.166.3907.891; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winfree AT., 1980, GEOMETRY BIOL TIME; Wing AM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1125	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202056	10.1371/journal.pone.0202056	http://dx.doi.org/10.1371/journal.pone.0202056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157192	Green Published, gold			2022-12-27	WOS:000443071400029
J	Yourkavitch, J; Burgert-Brucker, C; Assaf, S; Delgado, S				Yourkavitch, Jennifer; Burgert-Brucker, Clara; Assaf, Shireen; Delgado, Stephen			Using geographical analysis to identify child health inequality in sub-Saharan Africa	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITY; DEVELOPING-COUNTRIES; DEVELOPMENT GOALS; EQUITY; MORTALITY; COVERAGE; IMPACT; CARE; INTERVENTIONS; CONSEQUENCES	One challenge to achieving Millennium Development Goals was inequitable access to quality health services. In order to achieve the Sustainable Development Goals, interventions need to reach underserved populations. Analyzing health indicators in small geographic units aids the identification of hotspots where coverage lags behind neighboring areas. The purpose of these analyses is to identify areas of low coverage or high need in order to inform effective resource allocation to reduce child health inequity between and within countries. Using data from The Demographic and Health Survey Program surveys conducted in 27 selected African countries between 2010 and 2014, we computed estimates for six child health indicators for subnational regions. We calculated Global Moran's I statistics and used Local Indicator of Spatial Association analysis to produce a spatial layer showing spatial associations. We created maps to visualize sub-national autocorrelation and spatial clusters. The Global Moran's I statistic was positive for each indicator (range: 0.41 to 0.68), and statistically significant (p < 0.05), suggesting spatial autocorrelation across national borders, and highlighting the need to examine health indicators both across countries and within them. Patterns of substantial differences among contiguous subareas were apparent; the average intra-country difference for each indicator exceeded 20 percentage points. Clusters of cross-border associations were also apparent, facilitating the identification of hotspots and informing the allocation of resources to reduce child health inequity between and within countries. This study exposes differences in health indicators in contiguous geographic areas, indicating that specific regional and subnational, in addition to national, strategies to improve health and reduce health inequalities are warranted.	[Yourkavitch, Jennifer; Burgert-Brucker, Clara; Assaf, Shireen] ICF, DHS Program, Rockville, MD 20850 USA; [Delgado, Stephen] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA	Columbia University	Yourkavitch, J (corresponding author), ICF, DHS Program, Rockville, MD 20850 USA.	jennifer.yourkavitch@icf.com	Burgert, Clara/X-4071-2018	Burgert, Clara/0000-0002-6001-4960; Assaf, Shireen/0000-0002-0024-9717	USAID; ICF [AID-OAA-C-13-00095]; ICF	USAID(United States Agency for International Development (USAID)); ICF; ICF	The study was funded by USAID through a contract with ICF (Contract: #AID-OAA-C-13-00095). ICF provided support in the form of salaries for authors JY, CBB, and SA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amin S, 2002, DEMOGRAPHY, V39, P251, DOI 10.2307/3088338; [Anonymous], 2014, MIDWIFERY, V30; [Anonymous], 2015, MDG REP 2015 ASS PRO; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Balk D., 2004, Population, Space and Place, V10, P175, DOI 10.1002/psp.328; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bennett A, 2015, DHS WORKING PAPERS; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Blanford JI, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-24; Bruce N, 2014, AM J PUBLIC HEALTH, V104, P647, DOI 10.2105/AJPH.2013.301658; Burgert CR., 2014, DHS SPATIAL ANAL REP; Burgert-Brucker CR, 2015, DHS SPATIAL ANAL REP; Cai XD, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-12; Callaghan WM, 2014, AM J OBSTET GYNECOL, V211, P278, DOI 10.1016/j.ajog.2014.06.043; Carrera C, 2012, LANCET, V380, P1341, DOI 10.1016/S0140-6736(12)61378-6; Chin B, 2011, HEALTH PLACE, V17, P929, DOI 10.1016/j.healthplace.2011.04.006; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; CUTTS FT, 1991, B WORLD HEALTH ORGAN, V69, P407; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S29; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Ebener S, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0012-x; Feikin DR, 2009, TROP MED INT HEALTH, V14, P54, DOI 10.1111/j.1365-3156.2008.02193.x; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Gwatkin D. R., 2002, WHO WOULD GAIN MOST; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; HABICHT JP, 1974, LANCET, V1, P611; Houweling TAJ, 2006, TROP MED INT HEALTH, V11, P1218, DOI 10.1111/j.1365-3156.2006.01676.x; ICF, 2018, METHODOLOGY; ICF, DEM HLTH SURV PROGR; ICF International, 2008, SPAT DAT REP; Johnson FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120556; Kadobera D, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19099; Kandala NB, 2006, SOC SCI MED, V62, P1138, DOI 10.1016/j.socscimed.2005.07.028; Kandala NB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-266; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Kassile T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-348; Lakew Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2078-6; Lee J.H., 2011, IMPROVING EQUITY HLT; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Machingaidze S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001405; Metcalf CJE, 2015, EPIDEMIOL INFECT, V143, P1457, DOI 10.1017/S0950268814001988; MICHALOPOULOS Stelios, 2011, 17620 NAT BUR EC RES; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nykiforuk CIJ, 2011, HEALTH PROMOT PRACT, V12, P63, DOI 10.1177/1524839909334624; O'Hare BAM, 2007, J ROY SOC MED, V100, P564, DOI 10.1258/jrsm.100.12.564; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P4; Pullan RL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001626; Raj A, 2010, ARCH DIS CHILD, V95, P931, DOI 10.1136/adc.2009.178707; Rasanathan K, 2014, J GLOB HEALTH, V4, P48, DOI 10.7189/jogh.04.020401; Root G P, 1999, Int J Popul Geogr, V5, P117, DOI 10.1002/(SICI)1099-1220(199903/04)5:2<117::AID-IJPG127>3.0.CO;2-I; Rosero-Bixby L, 2004, SOC SCI MED, V58, P1271, DOI 10.1016/S0277-9536(03)00322-8; Salami A, 2011, ADB AFRICA EC BRIEF, V2, P2; Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386; Tangcharoensathien V, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0342-3; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tugwell P., 2007, MAPPING GLOBAL HLTH; UNICEF, 2015, PROGR CHILDR AV LEAR; United Nations, 2018, SUST DEV KNOWL PLATF; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Wamani H, 2007, BMC PEDIATR, V7, DOI [10.1016/S0140-6736(07)61690-0, DOI 10.1016/S0140-6736(07)61690-0]; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; WHO, 2015, STAT IN REPR MAT NEW; WHO/UNICEF, 2012, JOINT STAT INT COMM; WHO (World Health Organization), 2011, EXCLUSIVE BREASTFEED; Wirth ME, 2006, B WORLD HEALTH ORGAN, V84, P519, DOI 10.2471/BLT.04.019984; Woldemicael G, 2010, MATERN CHILD HLTH J, V14, P988, DOI 10.1007/s10995-009-0535-5; World Health Organization, 2014, WORLD HLTH ASS GLOB; World Health Organization, 2015, MEASL FACT SHEET	73	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201870	10.1371/journal.pone.0201870	http://dx.doi.org/10.1371/journal.pone.0201870			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157198	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400018
J	Diplock, N; Johnston, K; Mellon, A; Mitchell, L; Moore, M; Schneider, D; Taylor, A; Whitney, J; Zegar, K; Kioko, J; Kiffner, C				Diplock, Nathan; Johnston, Kate; Mellon, Antoine; Mitchell, Laura; Moore, Madison; Schneider, Daniel; Taylor, Alyssa; Whitney, Jess; Zegar, Kera; Kioko, John; Kiffner, Christian			Large mammal declines and the incipient loss of mammal-bird mutualisms in an African savanna ecosystem	PLOS ONE			English	Article							OXPECKER BUPHAGUS-ERYTHRORHYNCHUS; PRESENT ECOLOGICAL DISTRIBUTION; SEX-BIASED PARASITISM; RED-BILLED OXPECKERS; NATIONAL-PARK; BODY-SIZE; TICK PARASITISM; HOST PREFERENCE; WILDLIFE; HABITAT	Over the past half-century, large mammal populations have declined substantially throughout East Africa, mainly due to habitat loss and unsustainable direct exploitation. While it has been acknowledged that the loss of large mammals can have direct and cascading effects on community composition and ecosystem characteristics, limited quantitative work has been done on how declines of large herbivore populations impacts the abundance of mutualistic symbionts. Using a space-for-time observational approach, we quantified the large mammal community alongside the densities, host preferences and behaviors of mutualistic red-billed oxpeckers (Buphagus erythrorhynchus), and yellow-billed oxpeckers (Buphagus africanus) in northern Tanzania. At the landscape scale, mammal community composition was substantially less diverse in highly human-dominated areas when compared with more protected areas, with an observed complete loss of large wild mammal species in two study areas. Mirroring this trend, oxpecker densities were lowest in the least protected areas, and highest in fully protected areas. Using resource selection functions implemented via generalized linear models at different scales, we found that oxpeckers (1) were predominantly (67% of red-billed oxpeckers; 70% of yellow-billed oxpeckers) feeding on larger (between 500kg and 1500kg) ungulate host species within the mammal community, (2) usually preferred feeding on larger individuals (adults and males) within a specific host species population, and (3) preferred hosts that were more tolerant of their presence. In particular, cattle were especially intolerant of oxpecker presence and were relatively effective in displacing oxpeckers. We found little evidence that oxpecker feeding was parasitic across all host species; wound feeding was only observed on giraffe, comprising 6% and 4% of feeding behavior in red-billed and yellow-billed oxpeckers respectively. Thus, a loss of large-bodied and oxpecker tolerant host species is a likely explanation for declines of oxpecker populations in human dominated landscapes, which may have further cascading effects.	[Diplock, Nathan; Kioko, John; Kiffner, Christian] Sch Field Studies, Ctr Wildlife Management Studies, Karatu, Tanzania; [Johnston, Kate] Augsburg Univ, Dept Biol, Minneapolis, MN USA; [Mellon, Antoine] Southern Methodist Univ, Dept Biol Sci, Dallas, TX USA; [Mitchell, Laura] Univ Vermont, Dept Biol, Burlington, VT USA; [Moore, Madison] Franklin & Marshall Coll, Dept Biol Fdn Behav, Lancaster, PA 17604 USA; [Schneider, Daniel] Muhlenberg Coll, Dept Environm Sci, Allentown, PA 18104 USA; [Taylor, Alyssa] Elizabethtown Coll, Dept Biol, Elizabethtown, PA 17022 USA; [Whitney, Jess] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Zegar, Kera] Univ Washington, Coll Environm, Seattle, WA 98195 USA	Augsburg University; Southern Methodist University; University of Vermont; Franklin & Marshall College; University of Massachusetts System; University of Massachusetts Amherst; University of Washington; University of Washington Seattle	Kiffner, C (corresponding author), Sch Field Studies, Ctr Wildlife Management Studies, Karatu, Tanzania.	ckiffne@gwdg.de	Kiffner, Christian/F-4088-2012	Kiffner, Christian/0000-0002-7475-9023; Diplock, Nathan/0000-0002-4208-0892	SFS	SFS	SFS supported this project through its directed research program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, INT J COMPLEX SYSTEM; Attweil R. I. G., 1966, Puku, VNo. 4, P17; Barton K., 2012, MUMIN MULTIMODEL INF; Beaune D, 2013, FOREST ECOL MANAG, V295, P109, DOI 10.1016/j.foreco.2012.12.041; Bencin H, 2016, J NAT CONSERV, V34, P82, DOI 10.1016/j.jnc.2016.09.004; BEZUIDENHOUT JD, 1980, ONDERSTEPOORT J VET, V47, P51; Bourgarel M, 2002, AFR J ECOL, V40, P186, DOI 10.1046/j.1365-2028.2002.00377.x; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Brashares JS, 2017, SCIENCE, V356, P136, DOI 10.1126/science.aan0499; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Buckley RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044134; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chritz KL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32807; Cochrane EP, 2003, J TROP ECOL, V19, P579, DOI 10.1017/S0266467403003638; COHEN AS, 1993, PALEOBIOLOGY, V19, P433; Colwell RK, 2012, ANNU REV ECOL EVOL S, V43, P183, DOI 10.1146/annurev-ecolsys-110411-160304; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Crawley M.J., 2007, R BOOK; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; Decker JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004254; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Esser HJ, 2016, INT J PARASITOL-PAR, V5, P295, DOI 10.1016/j.ijppaw.2016.10.001; Essl F, 2015, DIVERS DISTRIB, V21, P534, DOI 10.1111/ddi.12312; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Galetti M, 2018, BIOL REV, V93, P845, DOI 10.1111/brv.12374; Gallivan GJ, 1997, S AFR J WILDL RES, V27, P63; Greenway JP, 1969, VEGETATION LAKE MANY, V57, P127; Grobler J.H., 1980, Koedoe, V23, P89; GROBLER JH, 1978, S AFR J WILDL RES, V8, P169; Grzeda E, 2017, PARASITOL RES, V116, P3163, DOI 10.1007/s00436-017-5633-5; Hanya G, 2013, ECOL RES, V28, P183, DOI 10.1007/s11284-012-1012-y; HUSTLER K, 1987, AFR J ECOL, V25, P241, DOI 10.1111/j.1365-2028.1987.tb01115.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kalle R, 2017, ECOL EVOL, V7, P1974, DOI 10.1002/ece3.2787; Kashoma I. P. B., 2011, Livestock Research for Rural Development, V23, P94; Keesing F, 2014, BIOSCIENCE, V64, P487, DOI 10.1093/biosci/biu059; Keesing F, 2013, ECOL APPL, V23, P1410, DOI 10.1890/12-1607.1; Kiffner C, 2016, J NAT CONSERV, V31, P29, DOI 10.1016/j.jnc.2016.02.006; Kiffner C, 2014, ANIM CONSERV, V17, P603, DOI 10.1111/acv.12131; Kiffner C, 2011, MED VET ENTOMOL, V25, P39, DOI 10.1111/j.1365-2915.2010.00929.x; Kiffner C, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2027; Kiffner C, 2015, TROP CONSERV SCI, V8, P318, DOI 10.1177/194008291500800204; Kiffner C, 2015, AFR J ECOL, V53, P156, DOI 10.1111/aje.12160; Kiffner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113446; Kiffner C, 2013, OECOLOGIA, V173, P1009, DOI 10.1007/s00442-013-2664-1; Kiffner C, 2011, PARASITOL RES, V108, P323, DOI 10.1007/s00436-010-2065-x; Kingdon J, 2012, KINGDON FIELD GUIDE; Kioko J, 2015, VET WORLD, V8, P755, DOI 10.14202/vetworld.2015.755-762; Koenig WD, 1997, EVOL ECOL, V11, P91, DOI 10.1023/A:1018439614008; Krasnov BR, 2005, OECOLOGIA, V146, P209, DOI 10.1007/s00442-005-0189-y; LIGHTFOOT CJ, 1981, S AFR J WILDL RES, V11, P41; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Manly B.F.J., 2002, RESOURCE SELECTION A; Mikula P, 2018, PEERJ, V6, DOI 10.7717/peerj.4520; Montoya JM, 2018, TRENDS ECOL EVOL, V33, P71, DOI 10.1016/j.tree.2017.10.004; Mooring MS, 2000, ANIM BEHAV, V60, P35, DOI 10.1006/anbe.2000.1461; Mooring MS, 1996, AFR J ECOL, V34, P54, DOI 10.1111/j.1365-2028.1996.tb00594.x; Morrison TA, 2016, BIOL CONSERV, V197, P53, DOI 10.1016/j.biocon.2016.02.034; Mwakitwange G, 2004, DONKEYS PEOPLE DEV, P113; MWALYOSI RBB, 1992, J APPL ECOL, V29, P581, DOI 10.2307/2404465; Ndlovu M, 2015, KOEDOE, V57, DOI 10.4102/koedoe.v57i1.1316; Nunn CL, 2011, EVOLUTION, V65, P1297, DOI 10.1111/j.1558-5646.2010.01212.x; Plantan T., 2012, AFRICAN J ECOLOGY, V51, P325, DOI DOI 10.1111/AJE.12042); Plantan T. B., 2009, THESIS; Poulin R, 2007, INT J PARASITOL, V37, P359, DOI 10.1016/j.ijpara.2006.11.009; PRINS HHT, 1988, J BIOGEOGR, V15, P451, DOI 10.2307/2845275; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; R Core Team, 2018, R LANG ENV STAT COMP; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Ripple WJ, 2017, P NATL ACAD SCI USA, V114, P10678, DOI 10.1073/pnas.1702078114; Ripple WJ, 2017, BIOSCIENCE, V67, P197; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Robertson A, 2000, BIOL CONSERV, V92, P241, DOI 10.1016/S0006-3207(99)00069-5; Steadman DW, 2003, EARTH-SCI REV, V61, P133, DOI 10.1016/S0012-8252(02)00116-2; STUTTERHEIM CJ, 1981, S AFR J ZOOL, V16, P44; STUTTERHEIM CJ, 1982, S AFR J ZOOL, V17, P190; STUTTERHEIM IM, 1988, ONDERSTEPOORT J VET, V55, P173; Tyrberg Tommy, 2008, Oryctos, V7, P249; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; Warwick BT, 2016, INT J ACAROL, V42, P12, DOI 10.1080/01647954.2015.1109708; Weeks P, 1999, ANIM BEHAV, V58, P1253, DOI 10.1006/anbe.1999.1265; Weeks P, 2000, BEHAV ECOL, V11, P154, DOI 10.1093/beheco/11.2.154; Wilson TR, 2003, LIVESTOCK PRODUCTION, V15; Wilson TR, 2015, TANZANIA SO HIGHLAND; Zimmerman DA, 1999, BIRDS KENYA NO TANZA	86	7	7	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202536	10.1371/journal.pone.0202536	http://dx.doi.org/10.1371/journal.pone.0202536			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153277	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700018
J	Ma, RS; Qin, ZL; Yu, XM; Liu, S; Qu, WY; Hu, HH; Luo, D; Lu, ZB; Jiang, H				Ma, Ruisong; Qin, Zhiliang; Yu, Xiaomei; Liu, Shan; Qu, Weiyi; Hu, Huihui; Luo, Da; Lu, Zhibing; Jiang, Hong			Selective ablation of the ligament of Marshall reduces ischemia and reperfusion-induced ventricular arrhythmias	PLOS ONE			English	Article							CARDIAC SYMPATHETIC DENERVATION; AUTONOMIC INNERVATION; MANAGEMENT	Cardiac sympathetic tone overdrive is a key mechanism of arrhythmia. Cardiac sympathetic nerves denervation, such as LSG ablation or renal sympathetic denervation, suppressed both the prevalence of VAs and the incidence of SCD. Accumulating evidence demonstrates the ligament of Marshall (LOM) is a key component of the sympathetic conduit between the left stellate ganglion (LSG) and the ventricles. The present study aimed to investigate the roles of the distal segment of LOM (LOMLSPV) denervation in ischemia and reperfusion (IR)induced VAs, and compared that LSG denervation. Thirty-three canines were randomly divided into group 1 (IR group, n = 11), group 2 (LOMLspv Denervation + IR, n = 9), and group 3 (LSG Denervation + IR, n = 13). Hematoxylin-Eosin (HE) and Immunohistochemistry staining revealed that LOMLSPV contained bundles of sympathetic but not parasympathetic nerves. IR increased the cardiac sympathetic tone [serum concentrations of noradrenaline (NE) and epinephrine (E)] and induced the prevalence of VAs [ventricular premature beat (VPB), salvo of VPB, ventricular tachycardia (VT), VT duration (VTD) and ventricular fibrillation (VF)]. Both LOMLSPV denervation and LSG denervation could reduce the cardiac sympathetic tone in Baseline (BS) [heart rate variability (HRV)]. Compared with group 1, LOMLSPV denervation and LSG denervation similarly reduced sympathetic tone [NE (1.39 +/- 0.068 ng/ml in group 2, 1.29 +/- 0.081 ng/ml in group 3 vs 2.32 +/- 0.17 ng/ml in group 1, P<0.05) and E (114.64 +/- 9.22 pg/ml in group 2, 112.60 +/- 9.69 pg/ml in group 3 vs 166.18 +/- 15.78 pg/ml in group 1, P<0.05),] and VAs [VT (0 +/- 3.00 in group 2, 0 +/- 1.75 in group 3 vs 8.00 +/- 11.00 in group 1, P<0.05) and VTD (0 +/- 4 s in group 2, 0 +/- 0.88s in group 3 vs 10.0 +/- 22.00s in group 1, P<0.05)] after 2h reperfusion. These findings indicated LOMLSPV denervation reduced the prevalence of VT by suppressing SNS activity. These effects are comparable to those of LSG denervation. In myocardial IR, the anti-arrhythmic effects of LOMLSPV Denervation may be related to the inhibition of the expression of NE and E.	[Ma, Ruisong; Qin, Zhiliang; Yu, Xiaomei; Liu, Shan; Qu, Weiyi; Hu, Huihui; Luo, Da; Lu, Zhibing; Jiang, Hong] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Ma, Ruisong; Qin, Zhiliang; Yu, Xiaomei; Liu, Shan; Qu, Weiyi; Hu, Huihui; Luo, Da; Lu, Zhibing; Jiang, Hong] Wuhan Univ, Cardiovasc Res Inst, Wuhan, Hubei, Peoples R China; [Ma, Ruisong; Qin, Zhiliang; Yu, Xiaomei; Liu, Shan; Qu, Weiyi; Hu, Huihui; Luo, Da; Lu, Zhibing; Jiang, Hong] Hubei Key Lab Cardiol, Wuhan, Hubei, Peoples R China; [Lu, Zhibing] Cent Hosp Enshi Tujia & Miao Autonomous Prefectur, Dept Cardiol, Enshi City, Hubei, Peoples R China	Wuhan University; Wuhan University	Jiang, H (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan, Hubei, Peoples R China.; Jiang, H (corresponding author), Wuhan Univ, Cardiovasc Res Inst, Wuhan, Hubei, Peoples R China.; Jiang, H (corresponding author), Hubei Key Lab Cardiol, Wuhan, Hubei, Peoples R China.	414542231@qq.com			Beijing Lisheng Cardiovascular Health Foundation [LHJJ20155430]; National Natural Science Foundation of China [81270250, 81370281, 81300181]	Beijing Lisheng Cardiovascular Health Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work received support from the Beijing Lisheng Cardiovascular Health Foundation (Grant number: LHJJ20155430): buying canines; The National Natural Science Foundation of China (Grants numbers: 81270250, 81370281, 81300181): buying antibody, commercial kit, consumable material, et al.	Camm AJ, 1996, EUR HEART J, V17, P354; Doshi RN, 1999, CIRCULATION, V100, P876, DOI 10.1161/01.CIR.100.8.876; Garcia-Moran E, 2013, REV ESP CARDIOL, V66, P595, DOI 10.1016/j.rec.2013.01.015; Hayase J, 2013, J CARDIOVASC ELECTR, V24, P926, DOI 10.1111/jce.12138; Huang B, 2015, EUROINTERVENTION, V11, P598, DOI 10.4244/EIJV11I5A119; Kim DT, 2000, J AM COLL CARDIOL, V36, P1324, DOI 10.1016/S0735-1097(00)00819-6; Makino M, 2006, J CARDIOVASC ELECTR, V17, P594, DOI 10.1111/j.1540-8167.2006.00375.x; Nordkamp LRAO, 2014, NETH HEART J, V22, P160, DOI 10.1007/s12471-014-0523-2; Schneider HE, 2013, CLIN RES CARDIOL, V102, P33, DOI 10.1007/s00392-012-0492-7; Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; VANSTEE EW, 1978, ENVIRON HEALTH PERSP, V26, P151, DOI 10.1289/ehp.7826151; Wang Songyun, 2016, JACC Clin Electrophysiol, V2, P97, DOI 10.1016/j.jacep.2015.09.014; Wang SY, 2015, HEART RHYTHM, V12, P1628, DOI 10.1016/j.hrthm.2015.03.023; Zhao Y, 2016, HEART RHYTHM, V13, P2083, DOI 10.1016/j.hrthm.2016.07.014; Zhou S, 2008, HEART RHYTHM, V5, P131, DOI 10.1016/j.hrthm.2007.09.007	16	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203083	10.1371/journal.pone.0203083	http://dx.doi.org/10.1371/journal.pone.0203083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153281	Green Submitted, gold, Green Published			2022-12-27	WOS:000443001700042
J	Tornero, I; Boix, D; Bagella, S; Pinto-Cruz, C; Caria, MC; Belo, A; Lumbreras, A; Sala, J; Compte, J; Gascon, S				Tornero, Irene; Boix, Dani; Bagella, Simonetta; Pinto-Cruz, Carla; Caria, Maria Carmela; Belo, Anabela; Lumbreras, Ana; Sala, Jordi; Compte, Jordi; Gascon, Stephanie			Dispersal mode and spatial extent influence distance-decay patterns in pond metacommunities	PLOS ONE			English	Article							MEDITERRANEAN TEMPORARY PONDS; BETA DIVERSITY; ENVIRONMENTAL HETEROGENEITY; FLORISTIC VARIATION; COMMUNITY STRUCTURE; SIMILARITY; BIODIVERSITY; LIMITATION; DYNAMICS; PLANT	Assuming that dispersal modes or abilities can explain the different responses of organisms to geographic or environmental distances, the distance-decay relationship is a useful tool to evaluate the relative role of local environmental structuring versus regional control in community composition. Based on continuing the current theoretical framework on metacommunity dynamics and based on the predictive effect of distance on community similarity, we proposed a new framework that includes the effect of spatial extent. In addition, we tested the validity of our proposal by studying the community similarity among three biotic groups with different dispersal modes (macrofaunal active and passive dispersers and plants) from two pond networks, where one network had a small spatial extent, and the other network had an extent that was 4 times larger. Both pond networks have similar environmental variability. Overall, we found that environmental distance had larger effects than geographical distances in both pond networks. Moreover, our results suggested that species sorting is the main type of metacommunity dynamics shaping all biotic groups when the spatial extent is larger. In contrast, when the spatial extent is smaller, the observed distance-decay patterns suggested that different biotic groups were mainly governed by different metacommunity dynamics. While the distance-decay patterns of active dispersers better fit the trend that was expected when mass effects govern a metacommunity, passive dispersers showed a pattern that was expected when species sorting prevails. Finally, in the case of plants, it is difficult to associate their distance-decay patterns with one type of metacommunity dynamics.	[Tornero, Irene; Boix, Dani; Sala, Jordi; Compte, Jordi; Gascon, Stephanie] Univ Girona, Inst Aquat Ecol, GRECO, Girona, Spain; [Bagella, Simonetta; Caria, Maria Carmela] Univ Sassari, Dept Chem & Pharm, Sassari, Italy; [Pinto-Cruz, Carla; Belo, Anabela] Univ Evora, ICAAM, Dept Biol, Escola Ciencias & Tecnol, Evora, Portugal; [Lumbreras, Ana] Univ Evora, ICAAM, Evora, Portugal	Universitat de Girona; University of Sassari; University of Evora; University of Evora	Tornero, I (corresponding author), Univ Girona, Inst Aquat Ecol, GRECO, Girona, Spain.	irene.tornero1987@gmail.com	Pinto-Cruz, Carla/AAG-3826-2021; Boix, Dani/L-5190-2014; Caria, Maria Carmela/ABD-9019-2020; Compte, Jordi/L-9231-2014; Gascón, Stéphanie/L-7471-2014; Bagella, Simonetta/Y-8876-2019; Sala, Jordi/L-8234-2014; Tornero, Irene/AAA-4176-2021; Pinto-Cruz, Carla/H-7017-2019; Belo, Anabela Dias Ferreira/AAG-6651-2021	Pinto-Cruz, Carla/0000-0002-2818-5700; Boix, Dani/0000-0001-5468-2236; Compte, Jordi/0000-0002-2715-5518; Gascón, Stéphanie/0000-0003-1951-9083; Sala, Jordi/0000-0002-1227-8566; Tornero, Irene/0000-0001-7337-4263; Pinto-Cruz, Carla/0000-0002-2818-5700; Belo, Anabela Dias Ferreira/0000-0002-4699-3824	Ministerio de Economia y Competitividad of the Spanish Government [CGL2011-23907, CGL2016-76024-R]; Agency for Management of University and Research Grants (AGAUR) of the Generalitat de Catalunya [2017 SGR 548]; Autonomous Region of Sardinia, Italy [CRP-24943]	Ministerio de Economia y Competitividad of the Spanish Government(Spanish Government); Agency for Management of University and Research Grants (AGAUR) of the Generalitat de Catalunya; Autonomous Region of Sardinia, Italy(Regione Sardegna)	This work was supported by two scientific research grants (CGL2011-23907 and CGL2016-76024-R) from the Ministerio de Economia y Competitividad of the Spanish Government (http://www.idi.mineco.gob.es/portal/site/MICINN/), the Agency for Management of University and Research Grants (AGAUR) of the Generalitat de Catalunya (2017 SGR 548) (http://agaur.gencat.cat/) and by a scientific research grant (CRP-24943) from the Autonomous Region of Sardinia, Italy (https://www.regione.sardegna.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfinito S, 2013, ANN BOT-ITALY, V3, P51, DOI 10.4462/annbotrm-10242; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Ballon C, 2016, LIMNETICA, V35, P73; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Beja P, 2003, BIOL CONSERV, V114, P317, DOI 10.1016/S0006-3207(03)00051-X; Bohonak AJ, 1999, LIMNOL OCEANOGR, V44, P487, DOI 10.4319/lo.1999.44.3.0487; Briers RA, 2005, AQUAT CONSERV, V15, P549, DOI 10.1002/aqc.742; BUSH MB, 1991, J BIOGEOGR, V18, P341, DOI 10.2307/2845404; Canha P, 2010, PLANO GESTAO CHARCOS; Caramujo MJ, 2010, J LIMNOL, V69, P64, DOI 10.4081/jlimnol.2010.64; Castillo-Escriva A, 2017, FRESHWATER BIOL, V62, P1004, DOI 10.1111/fwb.12920; Chaves ML, 1999, THESIS; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Cogoni A, 2009, PLANT BIOSYST, V143, pS97, DOI 10.1080/11263500903220190; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2004, ECOLOGY, V85, P114, DOI 10.1890/03-3004; Daftologic, 2015, GOOGL MAPS AR CALC T; Damschen EI, 2008, P NATL ACAD SCI USA, V105, P19078, DOI 10.1073/pnas.0802037105; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Martins MJF, 2010, J LIMNOL, V69, P160, DOI 10.3274/JL10-69-1-15; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Gan D., 2007, ANN ENV SCI, V1, P11; Girdler EB, 2008, PLANT ECOL, V198, P211, DOI 10.1007/s11258-008-9396-z; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Harte J, 2003, NATURE, V424, P1006, DOI 10.1038/4241006a; Hautala K, 2000, WATER RES, V34, P246, DOI 10.1016/S0043-1354(99)00137-2; Heino J, 2015, ECOL EVOL, V5, P1525, DOI 10.1002/ece3.1460; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Heino J, 2015, FRESHWATER BIOL, V60, P223, DOI 10.1111/fwb.12502; Heino J, 2013, OECOLOGIA, V171, P971, DOI 10.1007/s00442-012-2451-4; Heino J, 2013, BIOL REV, V88, P166, DOI 10.1111/j.1469-185X.2012.00244.x; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Hill MJ, 2017, OIKOS, V126, P1575, DOI 10.1111/oik.04266; Hoopes MF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P35; Horvath Z, 2016, ECOGRAPHY, V39, P726, DOI 10.1111/ecog.01685; Borthagaray AI, 2014, ECOGRAPHY, V37, P564, DOI 10.1111/j.1600-0587.2013.00366.x; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; Jurasinski G, 2015, PACKAGE SIMBA; Kneitel JM, 2016, ECOLOGY, V97, P961, DOI 10.1890/15-1584.1; Konig C, 2017, GLOBAL ECOL BIOGEOGR, V26, P228, DOI 10.1111/geb.12536; Koroleff F., 1983, METHODS SEAWATER ANA, P125; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2004, LIMNOL OCEANOGR, V49, P1278, DOI 10.4319/lo.2004.49.4_part_2.1278; Leo P., 2011, CONSERVAZIONE HABITA, V5, P243; Logan M., 2010, BIOSTATISTICAL DESIG; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Machado M, 1999, CRUSTACEANA, V72, P591, DOI 10.1163/156854099503636; MASCAGNI A., 2011, CONSERVAZIONE HABITA, V5, P389; Moritz C, 2013, OIKOS, V122, P1401, DOI 10.1111/j.1600-0706.2013.00377.x; Morlon H, 2008, ECOL LETT, V11, P904, DOI 10.1111/j.1461-0248.2008.01202.x; MURA G, 1986, HYDROBIOLOGIA, V134, P273, DOI 10.1007/BF00008496; Mura G, 1999, HYDROBIOLOGIA, V405, P57, DOI 10.1023/A:1003701004970; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nekola JC, 2014, ECOGRAPHY, V37, P309, DOI 10.1111/j.1600-0587.2013.00407.x; O'Malley MA, 2007, NAT REV MICROBIOL, V5, P647, DOI 10.1038/nrmicro1711; Poulin R, 2003, J BIOGEOGR, V30, P1609, DOI 10.1046/j.1365-2699.2003.00949.x; Ptacnik R, 2010, ECOSYSTEMS, V13, P1201, DOI 10.1007/s10021-010-9380-z; Qian H, 2012, GLOBAL ECOL BIOGEOGR, V21, P341, DOI 10.1111/j.1466-8238.2011.00672.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; Rocchi S., 2011, CONSERVAZIONE HABITA, V5, P287; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Soininen J, 2007, ECOSCIENCE, V14, P146, DOI 10.2980/1195-6860(2007)14[146:NNADOP]2.0.CO;2; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Steinbauer MJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1203, DOI 10.1111/j.1466-8238.2012.00772.x; Steinitz O, 2006, J BIOGEOGR, V33, P1044, DOI 10.1111/j.1365-2699.2006.01473.x; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Tonkin JD, 2016, FRESHWATER BIOL, V61, P607, DOI 10.1111/fwb.12728; Tornero I, 2016, LIMNETICA, V35, P337; Tornero Irene, 2014, Boletin de la SEA, P326; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tuomisto H, 2012, ECOGRAPHY, V35, P961, DOI 10.1111/j.1600-0587.2012.07339.x; Van De Meutter F, 2007, ECOLOGY, V88, P1687, DOI 10.1890/06-0333.1; Vanschoenwinkel B, 2008, FRESHWATER BIOL, V53, P2264, DOI 10.1111/j.1365-2427.2008.02071.x; Verleyen E, 2009, OIKOS, V118, P1239, DOI 10.1111/j.1600-0706.2009.17575.x; Warfe DM, 2013, FRESHWATER BIOL, V58, P292, DOI 10.1111/fwb.12058; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	83	14	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203119	10.1371/journal.pone.0203119	http://dx.doi.org/10.1371/journal.pone.0203119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153308	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700045
J	Waberski, D; Schafer, J; Bolling, A; Scheld, M; Henning, H; Hambruch, N; Schuberth, HJ; Pfarrer, C; Wrenzycki, C; Hunter, RHF				Waberski, Dagmar; Schaefer, Jana; Boelling, Alexandra; Scheld, Manon; Henning, Heiko; Hambruch, Nina; Schuberth, Hans-Joachim; Pfarrer, Christiane; Wrenzycki, Christine; Hunter, Ronald H. F.			Seminal plasma modulates the immune-cytokine network in the porcine uterine tissue and pre-ovulatory follicles	PLOS ONE			English	Article							IN-VITRO; LEUKOCYTE RECRUITMENT; ENZYME-IMMUNOASSAY; EMBRYO DEVELOPMENT; OOCYTE MATURATION; GENE-EXPRESSION; CUMULUS CELLS; OVULATION; GILTS; INSEMINATION	Evidence is emerging that the interaction between male seminal fluid and female tissues promotes fertility, pregnancy, and health of offspring. This includes the acceleration of ovulation in a species known as a spontaneous ovulator, the domestic pig. Earlier studies revealed that seminal plasma acts by a local mechanism in the female pig. The aim of the present study was to examine local short-term and mid-term effects of seminal plasma (SP) on mRNA expression of immunoregulatory genes and transcripts associated with follicle- and oocyte maturation. In the porcine animal model, effects on mRNA expression in the female tract and preovulatory follicles were examined. SP suppressed mRNA expression of Prostaglandin-Endoperoxide Synthase 2 (PTGS2) ipsilateral to the infused uterine horn which was associated with a lower presence of immune cells in the uterine epithelium and lower PTGS2 immunoreaction. Depending on the sampling time (2 h vs. 17 h) and hormonal status, SP altered significant correlative relations of mRNA expression between PTGS2 and the transcripts Tumor Necrosis Factor Alpha, Tumor Necrosis Factor Alpha-Induced Protein 6 and Pentraxin 3 in uterus, granulosa and cumulus cells. A modulatory effect of SP on the oocyte gene network comprising eight oocyte transcripts was observed: uterine exposure to SP induced positive correlations (r >0.08, p<0.05) of maturation promoting factors among each other and with cumulus cells on the side of the treated horn. In conclusion, SP orchestrates the gene network regulating the bidirectional communication between oocytes and surrounding somatic cells. The modulation of the immune-cytokine network of the female reproductive system could contribute to the previously reported SP-induced acceleration of ovulation in the porcine species.	[Waberski, Dagmar; Schaefer, Jana; Boelling, Alexandra; Henning, Heiko; Hunter, Ronald H. F.] Univ Vet Med Hannover, Unit Reprod Med Clin, Clin Pigs & Small Ruminants, Hannover, Germany; [Scheld, Manon; Hambruch, Nina; Pfarrer, Christiane] Univ Vet Med Hannover, Inst Anat, Hannover, Germany; [Schuberth, Hans-Joachim] Univ Vet Med Hannover, Immunol Unit, Hannover, Germany; [Wrenzycki, Christine] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany; [Henning, Heiko] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Wrenzycki, Christine] Justus Liebig Univ Giessen, Fac Vet Med, Clin Obstet Gynecol & Androl Large & Small Anim, Chair Mol Reprod Med, Giessen, Giessen, Germany; [Hunter, Ronald H. F.] Ladfield, Jedburgh, Roxburghshire, Scotland	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Utrecht University; Justus Liebig University Giessen	Waberski, D (corresponding author), Univ Vet Med Hannover, Unit Reprod Med Clin, Clin Pigs & Small Ruminants, Hannover, Germany.	dagmar.waberski@tiho-hannover.de	Schuberth, Hans-Joachim/AAE-4845-2020	Hambruch, Nina/0000-0002-6592-834X; Pfarrer, Christiane/0000-0001-5282-8406	German Research Foundation (DFG) [INST 193/49-1 AOJB:567417]; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover	German Research Foundation (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover	This study was funded by the German Research Foundation (DFG; grant number: INST 193/49-1 AOJB:567417) and its publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISCHOF RJ, 1994, J REPROD IMMUNOL, V26, P131, DOI 10.1016/0165-0378(94)90036-1; BRANNSTROM M, 1995, REPROD FERT DEVELOP, V7, P67, DOI 10.1071/RD9950067; Cahill JF, 2016, RAPID COMMUN MASS SP, V30, P611, DOI 10.1002/rcm.7477; Diaz FJ, 2007, J CELL SCI, V120, P1330, DOI 10.1242/jcs.000968; Einer-Jensen N, 2005, REPRODUCTION, V129, P9, DOI 10.1530/rep.1.00278; Field SL, 2014, MOL REPROD DEV, V81, P284, DOI 10.1002/mrd.22285; Fink Ludger, 2005, Methods Mol Biol, V293, P167; Hou J, 2016, BRIEF FUNCT GENOMICS, V15, P95, DOI 10.1093/bfgp/elv040; Jiwakanon J, 2011, ANIM REPROD SCI, V123, P210, DOI 10.1016/j.anireprosci.2010.11.016; JOCHLE W, 1975, J REPROD FERTIL, P165; Kaczmarek MM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103564; Kawashima I, 2008, REPRODUCTION, V136, P9, DOI 10.1530/REP-08-0074; LOVELL JE, 1968, AM J VET RES, V29, P609; MEYER HHD, 1990, J STEROID BIOCHEM, V35, P263, DOI 10.1016/0022-4731(90)90283-X; Mikuni M, 1998, BIOL REPROD, V59, P1077, DOI 10.1095/biolreprod59.5.1077; O'Leary S, 2006, REPRODUCTION, V132, P147, DOI 10.1530/rep.1.01119; O'Leary S, 2004, REPRODUCTION, V128, P237, DOI 10.1530/rep.1.00160; Persani L, 2014, HUM REPROD UPDATE, V20, P869, DOI 10.1093/humupd/dmu036; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRAKASH BS, 1987, J STEROID BIOCHEM, V28, P623, DOI 10.1016/0022-4731(87)90389-X; Price JC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110965; Richards JS, 2008, TRENDS ENDOCRIN MET, V19, P191, DOI 10.1016/j.tem.2008.03.001; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Robertson SA, 2016, FERTIL STERIL, V106, P511, DOI 10.1016/j.fertnstert.2016.07.1101; Rozeboom KJ, 1998, J REPROD FERTIL, V114, P195, DOI 10.1530/jrf.0.1140195; Rozeboom KJ, 1999, J ANIM SCI, V77, P2201; Schjenken JE, 2014, REPROD DOMEST ANIM, V49, P27, DOI 10.1111/rda.12383; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuberth HJ, 2008, THERIOGENOLOGY, V70, P1174, DOI 10.1016/j.theriogenology.2008.07.020; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Soede NM, 1998, ANIM REPROD SCI, V54, P23, DOI 10.1016/S0378-4320(98)00140-7; Stinshoff H, 2014, REPROD FERT DEVELOP, V26, P502, DOI 10.1071/RD12372; Taylor U, 2009, REPROD DOMEST ANIM, V44, P180, DOI 10.1111/j.1439-0531.2007.01015.x; Waberski D, 1999, J VET MED A, V46, P431, DOI 10.1046/j.1439-0442.1999.00230.x; Waberski D, 1995, J REPROD FERTIL, V105, P247, DOI 10.1530/jrf.0.1050247; Waberski D, 1997, J REPROD FERTIL, V109, P29, DOI 10.1530/jrf.0.1090029; Waberski D, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-13; WEITZE KF, 1990, REPROD DOMEST ANIM, V25, P61, DOI 10.1111/j.1439-0531.1990.tb00682.x; Zhang DX, 2009, MOL REPROD DEV, V76, P881, DOI 10.1002/mrd.21056; Zhang XQ, 2005, FERTIL STERIL, V83, P1169, DOI 10.1016/j.fertnstert.2004.11.030	41	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202654	10.1371/journal.pone.0202654	http://dx.doi.org/10.1371/journal.pone.0202654			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153288	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700019
J	Jabbari, K; Bobbili, DR; Lal, D; Reinthaler, EM; Schubert, J; Wolking, S; Sinha, V; Motameny, S; Thiele, H; Kawalia, A; Altmuller, J; Toliat, MR; Kraaij, R; van Rooij, J; Uitterlinden, AG; Ikram, MA; Zara, F; Lehesjoki, AE; Krause, R; Zimprich, F; Sander, T; Neubauer, BA; May, P; Lerche, H; Nurnberg, P				Jabbari, Kamel; Bobbili, Dheeraj R.; Lal, Dennis; Reinthaler, Eva M.; Schubert, Julian; Wolking, Stefan; Sinha, Vishal; Motameny, Susanne; Thiele, Holger; Kawalia, Amit; Altmueller, Janine; Toliat, Mohammad Reza; Kraaij, Robert; van Rooij, Jeroen; Uitterlinden, Andre G.; Ikram, M. Arfan; Zara, Federico; Lehesjoki, Anna-Elina; Krause, Roland; Zimprich, Fritz; Sander, Thomas; Neubauer, Bernd A.; May, Patrick; Lerche, Holger; Nuernberg, Peter		EuroEPINOMICS CoGIE Consortium	Rare gene deletions in genetic generalized and Rolandic epilepsies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AUTISM CANDIDATE GENES; COPY NUMBER VARIATION; DE-NOVO MUTATIONS; STRUCTURAL VARIATION; DEVELOPMENTAL DELAY; PARKINSONS-DISEASE; RISK LOCI; VARIANTS; DISORDERS	Genetic Generalized Epilepsy (GGE) and benign epilepsy with centro-temporal spikes or Rolandic Epilepsy (RE) are common forms of genetic epilepsies. Rare copy number variants have been recognized as important risk factors in brain disorders. We performed a systematic survey of rare deletions affecting protein-coding genes derived from exome data of patients with common forms of genetic epilepsies. We analysed exomes from 390 European patients (196 GGE and 194 RE) and 572 population controls to identify low-frequency genic deletions. We found that 75 (32 GGE and 43 RE) patients out of 390, i.e. similar to 19%, carried rare genic deletions. In particular, large deletions (>400 kb) represent a higher burden in both GGE and RE syndromes as compared to controls. The detected low-frequency deletions (1) share genes with brain-expressed exons that are under negative selection, (2) overlap with known autism and epilepsy-associated candidate genes, (3) are enriched for CNV intolerant genes recorded by the Exome Aggregation Consortium (ExAC) and (4) coincide with likely disruptive de novo mutations from the NPdenovo database. Employing several knowledge databases, we discuss the most prominent epilepsy candidate genes and their protein-protein networks for GGE and RE.	[Jabbari, Kamel; Lal, Dennis; Motameny, Susanne; Thiele, Holger; Kawalia, Amit; Altmueller, Janine; Toliat, Mohammad Reza; Sander, Thomas; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Jabbari, Kamel] Univ Cologne, Cologne Bioctr, Inst Genet, Cologne, Germany; [Bobbili, Dheeraj R.; Krause, Roland; May, Patrick] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Lal, Dennis] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Lal, Dennis] Harvard Med Sch, Boston, MA USA; [Lal, Dennis] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lal, Dennis] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Reinthaler, Eva M.; Zimprich, Fritz] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Schubert, Julian; Wolking, Stefan; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Sinha, Vishal] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Altmueller, Janine] Univ Cologne, Inst Human Genet, Cologne, Germany; [Kraaij, Robert; van Rooij, Jeroen; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Zara, Federico] Inst G Gaslini, Lab Neurogenet & Neurosci, Genoa, Italy; [Lehesjoki, Anna-Elina] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Neurosci Ctr, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Neubauer, Bernd A.] Univ Giessen, Dept Neuropediat, Med Fac, Giessen, Germany; [Nuernberg, Peter] Univ Cologne, CMMC, Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	University of Cologne; University of Cologne; University of Luxembourg; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Helsinki; University of Cologne; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Genoa; IRCCS Istituto Giannina Gaslini; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Justus Liebig University Giessen; University of Cologne; University of Cologne	Nurnberg, P (corresponding author), Univ Cologne, Cologne Ctr Genom, Cologne, Germany.; Nurnberg, P (corresponding author), Univ Cologne, CMMC, Cologne, Germany.; Nurnberg, P (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.	nuernberg@uni-koeln.de	May, Patrick/B-1238-2010; Neubauer, Bernd/AAZ-9391-2020; Zimprich, Fritz/O-1406-2019; Thiele, Holger/ABE-6792-2020; Ikram, M. Arfan/AAM-5225-2021; May, Patrick/N-1019-2019; Zara, Federico/U-3477-2017	May, Patrick/0000-0001-8698-3770; Zimprich, Fritz/0000-0002-6998-5480; Thiele, Holger/0000-0002-0169-998X; May, Patrick/0000-0001-8698-3770; Zara, Federico/0000-0001-9744-5222; Wolking, Stefan/0000-0002-1460-6623; Altmuller, Janine/0000-0003-4372-1521	EuroEPINOMICS programme (DFG grant) [LE1030/11-1, NU50/8-1, SA434/5-1]; EuroEPINOMICS programme (FWF grant) [I643-B09]; JPND Courage-PD research grant; NCER FNR grant; German Research Foundation (DFG) [FOR2715, LE1030/16-1, NU50/11-1, SA434/6-1]; Foundation Nationale de Recherche in Luxembourg (FNR grant) [INTER/DFG/17/11583046]; Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NOW Investments [175.010.2005.011, 911-03-012]; Netherlands Genomics Initiative (NGI)/NOW project [050-060-810]	EuroEPINOMICS programme (DFG grant); EuroEPINOMICS programme (FWF grant); JPND Courage-PD research grant; NCER FNR grant; German Research Foundation (DFG)(German Research Foundation (DFG)); Foundation Nationale de Recherche in Luxembourg (FNR grant); Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NOW Investments; Netherlands Genomics Initiative (NGI)/NOW project	H.L., P.N., T.S., F.Z. received grants by the EuroEPINOMICS programme (DFG grant numbers: HL: LE1030/11-1, PN: NU50/8-1, TS: SA434/5-1, FWF grant number: FZ: I643-B09) within the EUROCORES framework of the European Science Foundation (ESF). D.R.B. and P.M. were supported by the JPND Courage-PD research grant, P.M. also from the NCER FNR grant. H.L., P.N., T.S., and R.K. received further support from the Research Unit FOR2715 funded by the German Research Foundation (DFG grant numbers: HL: LE1030/16-1, PN: NU50/11-1, TS: SA434/6-1) and the Foundation Nationale de Recherche in Luxembourg (FNR grant number: RK: INTER/DFG/17/11583046). The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of genomics data for the Rotterdam Study are supported by the Netherlands Organisation of Scientific Research NOW Investments (nr. 175.010.2005.011, 911-03-012) and the Netherlands Genomics Initiative (NGI)/NOW project nr. 050-060-810 (Netherlands Consortium for Healthy Ageing; NCHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis L, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000056; Afawi Z, 2016, NEUROLOGY, V86, P713, DOI 10.1212/WNL.0000000000002404; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; BERGLUND EO, 1994, GENOMICS, V21, P571, DOI 10.1006/geno.1994.1316; Bizzoca A, 2003, DEVELOPMENT, V130, P29, DOI 10.1242/dev.00183; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Buckley AW, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022749; Campbell IM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003797; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cooper EC, 2011, SEMIN CELL DEV BIOL, V22, P185, DOI 10.1016/j.semcdb.2010.10.001; Damiano JA, 2015, EPILEPSY RES, V117, P70, DOI 10.1016/j.eplepsyres.2015.09.007; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dimassi S, 2014, EPILEPSIA, V55, P370, DOI 10.1111/epi.12502; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Foa L, 2009, J NEUROCHEM, V108, P1, DOI 10.1111/j.1471-4159.2008.05726.x; Forman OP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064627; Gau SSF, 2012, AM J MED GENET B, V159B, P710, DOI 10.1002/ajmg.b.32074; Gerber S, 2016, AM J HUM GENET, V98, P971, DOI 10.1016/j.ajhg.2016.03.004; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Helbig KL, 2016, GENET MED, V18, P898, DOI 10.1038/gim.2015.186; Hertle DN, 2007, NEUROSCIENCE, V150, P625, DOI 10.1016/j.neuroscience.2007.09.058; Hesdorffer DC, 2011, NEUROLOGY, V76, P23, DOI 10.1212/WNL.0b013e318204a36a; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Huttenlocher J, 2015, HUM MOL GENET, V24, P5637, DOI 10.1093/hmg/ddv277; Iwaki A, 2008, J MED GENET, V45, P32, DOI 10.1136/jmg.2007.053942; Jabbari K, 2016, GENOMICS, V108, P31, DOI 10.1016/j.ygeno.2016.01.001; Jahn JA, 2014, EPILEPSY RES, V108, P109, DOI 10.1016/j.eplepsyres.2013.10.001; Ji TY, 2010, J HUM GENET, V55, P486, DOI 10.1038/jhg.2010.51; Joshi N. A., 2011, SICKLE SLIDING WINDO; Kawalia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126321; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kremer PHC, 2015, J NEUROL NEUROSUR PS, V86, P524, DOI 10.1136/jnnp-2013-307276; Lal D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005226; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Leu C, 2016, CURR OPIN NEUROL, V29, P158, DOI 10.1097/WCO.0000000000000296; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JC, 2016, MOL PSYCHIATR, V21, P290, DOI 10.1038/mp.2015.40; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Lupski JR, 2016, HUM GENET, V135, P591, DOI 10.1007/s00439-016-1682-6; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Mahfouz A, 2015, J MOL NEUROSCI, V57, P580, DOI 10.1007/s12031-015-0641-3; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mayer M, 2010, GENE EXPR PATTERNS, V10, P351, DOI 10.1016/j.gep.2010.08.002; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Miyatake S, 2015, J HUM GENET, V60, P175, DOI 10.1038/jhg.2014.124; Mulley JC, 2011, EPILEPSIA, V52, P423, DOI 10.1111/j.1528-1167.2010.02932.x; Muona M, 2015, NAT GENET, V47, P39, DOI 10.1038/ng.3144; Nicita F, 2015, ANN HUM GENET, V79, P209, DOI 10.1111/ahg.12106; Pescosolido MF, 2013, J AM ACAD CHILD PSY, V52, P414, DOI 10.1016/j.jaac.2013.01.003; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran X, 2015, NUCLEIC ACIDS RES, V43, pD893, DOI 10.1093/nar/gku943; Rasmussen MB, 2014, J MED GENET, V51, P605, DOI 10.1136/jmedgenet-2014-102535; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Reinthaler EM, 2015, ANN NEUROL, V77, P972, DOI 10.1002/ana.24395; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Saitsu H, 2010, AM J HUM GENET, V86, P881, DOI 10.1016/j.ajhg.2010.04.013; Scheffer IE, 2014, NAT REV NEUROL, V10, P490, DOI 10.1038/nrneurol.2014.146; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stogmann E, 2013, BRAIN, V136, P1155, DOI 10.1093/brain/awt068; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Szafranski P, 2015, EUR J HUM GENET, V23, P173, DOI 10.1038/ejhg.2014.75; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Uddin M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28663; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang P, 2013, NEUROTOXICOLOGY, V37, P51, DOI 10.1016/j.neuro.2013.03.007; Wang YB, 2016, CELL REP, V16, P79, DOI 10.1016/j.celrep.2016.05.044; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Zhang P, 2014, GENOME, V57, P253, DOI 10.1139/gen-2014-0032; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	82	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202022	10.1371/journal.pone.0202022	http://dx.doi.org/10.1371/journal.pone.0202022			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148849	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200005
J	Seroussi, E; Blum, SE; Krifucks, O; Lavon, Y; Leitner, G				Seroussi, Eyal; Blum, Shlomo E.; Krifucks, Oleg; Lavon, Yaniv; Leitner, Gabriel			Application of pancreatic phospholipase A2 for treatment of bovine mastitis	PLOS ONE			English	Article							ESCHERICHIA-COLI MASTITIS; STAPHYLOCOCCUS-AUREUS; MAMMARY-GLAND; A(2); STRATEGIES; CELLS; COWS	Recent findings have indicated that secreted phospholipases A2 (sPLA2s) have anti-inflammatory functions, including relief of symptoms in a mouse model of mastitis. This prompted us to investigate the therapeutic application of sPLA2, PLA2G1B, for bovine mastitis. Initial testing of PLA2G1B's effect on bovine mammary epithelial cell (bMEC) line PS revealed no changes in cell viability or cytokine-secretion pattern. However, when cells were first treated with lipopolysaccharide endotoxin (LPS) or live bacteria (Escherichia coli or Staphylococcus aureus), incubation with PLA2G1B significantly improved cell viability, suggesting involvement of sPLA2s in protecting membranes from lipid-peroxidation damage, rather than a bactericidal action. When PLA2G1B was applied simultaneously with LPS, a significant short-term reduction in interleukin-8 secretion was observed compared with bMECs treated only with LPS, supporting previous reports that PLA2G1B affects interleukin-8 signaling in similar cells. Following the favorable outcome of the in vitro experiments, we tested PLA2G1B in vivo by mammary infusion into infected glands. In one of a small sample (n = 4) of lactating cows chronically infected with Streptococcus dysgalactiae, a single PLA2G1B treatment completely cleared inflammation and bacteria, demonstrating its potential to cure subclinical mastitis. PLA2G1B treatment did not affect coagulase-negative staphylococci infection. These types of mastitis may involve formation of a resistant biofilm, and its elimination may relate to sPLA2s' characteristic ability to aggregate with cellular debris, facilitating their internalization by macrophages. In a bovine model of clinical mastitis based on introduction of E. colivia the streak canal, a single mammary infusion of PLA2G1B led to faster recovery to pre-infection milk-yield levels and decrease of somatic cell counts. In this case, all of sPLA2s' modes of resolving inflammation may apply, including competitive binding of the sPLA2s' receptor, the inactivation of which confers resistance to endotoxic shock. Hence, this study strongly supports further research into PLA2G1B as a cure for bovine mastitis.	[Seroussi, Eyal] ARO, Inst Anim Sci, Rishon Letsiyon, Israel; [Blum, Shlomo E.; Krifucks, Oleg; Leitner, Gabriel] Kimron Vet Inst, Natl Mastitis Reference Ctr, Dept Bacteriol, Bet Dagan, Israel; [Lavon, Yaniv] Israel Cattle Breeders Assoc, Caesarea, Israel	Kimron Veterinary Institute	Seroussi, E (corresponding author), ARO, Inst Anim Sci, Rishon Letsiyon, Israel.	seroussi@agri.huji.ac.il	Lavon, Yaniv/ABZ-1072-2022		Chief Scientist of the Israeli Ministry of Agriculture [20-11-0009]	Chief Scientist of the Israeli Ministry of Agriculture	This work was supported by a grant #20-11-0009 from The Chief Scientist of the Israeli Ministry of Agriculture.	Bar-Gal GK, 2015, VET MICROBIOL, V176, P143, DOI 10.1016/j.vetmic.2015.01.007; Birts CN, 2010, TRENDS BIOCHEM SCI, V35, P28, DOI 10.1016/j.tibs.2009.08.003; Blum S E, 2015, PLOS ONE, V10; Blum SE, 2014, VET J, V201, P72, DOI 10.1016/j.tvjl.2014.04.008; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Gomes F, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw006; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Herry V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03724-7; Kempf F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147954; Kruzel ML, 2010, INNATE IMMUN-LONDON, V16, P67, DOI 10.1177/1753425909105317; Kurz JP, 2018, THESIS, P6910; Leitner G, 2003, VET IMMUNOL IMMUNOP, V93, P159, DOI 10.1016/S0165-2427(03)00069-2; Leitner G, 2003, J VET MED B, V50, P45, DOI 10.1046/j.1439-0450.2003.00602.x; Litwinczuk Z, 2015, ANN ANIM SCI, V15, P819, DOI 10.1515/aoas-2015-0035; Mavangira V, 2018, RES VET SCI; McDougall S, 2009, VET MICROBIOL, V134, P177, DOI 10.1016/j.vetmic.2008.09.026; Murakami M, 2017, P JPN ACAD B-PHYS, V93, P677, DOI 10.2183/pjab.93.043; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Okano W, 2015, ACTA SCI VET, V43; Owens, 2004, MICROBIOLOGICAL PROC, V4th ed.; Paulrud CO, 2005, VET RES COMMUN, V29, P215, DOI 10.1023/B:VERC.0000047496.47571.41; Pyorala S, 2002, REPROD DOMEST ANIM, V37, P211, DOI 10.1046/j.1439-0531.2002.00378.x; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; SANDHOLM M, 1990, J VET PHARMACOL THER, V13, P248, DOI 10.1111/j.1365-2885.1990.tb00774.x; Seroussi E, 2013, IMMUNOGENETICS, V65, P861, DOI 10.1007/s00251-013-0738-1; Tan TL, 2017, PLOS ONE, V12; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; van den Borne BHP, 2010, J DAIRY SCI, V93, P218, DOI 10.3168/jds.2009-2567; VANKUIJK FJGM, 1987, TRENDS BIOCHEM SCI, V12, P31, DOI 10.1016/0968-0004(87)90014-4; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Zadoks R., 2009, IR VET J S4, V62, pS59; Zheng LH, 2016, FREE RADICAL BIO MED, V96, P166, DOI 10.1016/j.freeradbiomed.2016.04.022	36	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203132	10.1371/journal.pone.0203132	http://dx.doi.org/10.1371/journal.pone.0203132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148880	Green Submitted, Green Published, gold			2022-12-27	WOS:000442804200048
J	Bae, SH; Choi, DG				Bae, Seok Hyun; Choi, Dong Gyu			Changes of corneal topographic measurements and higher-order aberrations after surgery for exotropia	PLOS ONE			English	Article							EXTRAOCULAR-MUSCLE SURGERY; LATERAL RECTUS RECESSION; STRABISMUS SURGERY; REFRACTIVE SURGERY; ASTIGMATISM; THICKNESS; CHILDREN; SYSTEM; EYE	Purpose To analyze changes in corneal topographic measurements and higher-order aberrations (HOAs) after horizontal muscle surgery for exotropia. Design Retrospective, observational study. Methods A total of 131 eyes of 121 patients who had undergone surgery for exotropia were included. The eyes with unilateral lateral rectus (ULR) or bilateral lateral rectus (BLR) recession(s) were assigned to group A, and those with unilateral lateral rectus recession & medial rectus resection (R&R) to group B. Corneal topographic measurements and HOAs were compared between the preoperative and postoperative periods using a Placido-dual Scheimpflug analyzer (Galilei 2 (TM), Ziemer, Port., Switzerland) for each group. Results In group A, simulated keratometery (sim K) was significantly changed until 3 months postoperatively relative to the preoperative value (postoperative 1 week, p = 0.017; 1 month, p = 0.037; and 3 months, p = 0.023, respectively). All steep K (steep sim K, steep-Kpost, and TCP-steep K) parameters also were significantly changed at postoperative 1 month (p<0.001, p = 0.015, p<0.001, respectively), but not at 3 months. Among the higher-order aberrations, spherical aberration (Z(4)(0)) and secondary horizontal astigmatism (Z(4)(2)) at postoperative 1 week had significantly changed from the preoperative values, as had horizontal quadrafoil (Z(4)(4)) at 1 month. However, in group B, only vertical quadrafoil (Z(4)(-4)) showed statistically significant changes, at postoperative 1 and 3 months. None of the other postoperative parameters was significantly different from the corresponding preoperative value. Conclusion Lateral rectus recession induced changes in both corneal topographic measurements and HOAs, whereas R&R did so only in HOAs. These changes might explain some patients' complaints about poor quality of vision.	[Bae, Seok Hyun] Cent Phys Examinat Off, Dept Ophthalmol, Daegu, South Korea; [Choi, Dong Gyu] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea	Hallym University	Choi, DG (corresponding author), Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea.	eyechoi@hallym.or.kr						Al-Zeraid FM, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0205-5; Applegate RA, 1997, J REFRACT SURG, V13, P295; Brum GS, 2011, ARQ BRAS OFTALMOL, V74, P24, DOI 10.1590/S0004-27492011000100006; Campbell CE, 2004, J REFRACT SURG, V20, pS495; Charman WN, 2005, OPHTHAL PHYSL OPT, V25, P285, DOI 10.1111/j.1475-1313.2005.00297.x; Chen D, 2007, J CATARACT REFR SURG, V33, P448, DOI 10.1016/j.jcrs.2006.11.008; de Paiva CS, 2003, OPHTHALMOLOGY, V110, P1102; DENIS D, 1995, OPHTHALMOLOGICA, V209, P136, DOI 10.1159/000310599; DOTTAN SA, 1988, OPHTHALMIC SURG LAS, V19, P128; Fix A, 1985, AM ORTHOPT J, V35, P59; Hainsworth DP, 1999, J AAPOS, V3, P80, DOI 10.1016/S1091-8531(99)70074-1; Jahadi Hosseini Seyed Hamid Reza, 2016, J Ophthalmic Vis Res, V11, P350; Killer HE, 1999, OPHTHALMOLOGICA, V213, P209, DOI 10.1159/000027422; KWITKO S, 1991, ARCH OPHTHALMOL-CHIC, V109, P873, DOI 10.1001/archopht.1991.01080060137042; KWITKO S, 1992, CORNEA, V11, P36, DOI 10.1097/00003226-199201000-00005; Lawless MA, 2005, CLIN EXP OPHTHALMOL, V33, P199, DOI 10.1111/j.1442-9071.2005.00994.x; Liu ZG, 1999, BRIT J OPHTHALMOL, V83, P774, DOI 10.1136/bjo.83.7.774; Marshall D, 1936, ARCH OPHTHALMOL-CHIC, V15, P1020; Menassa N, 2008, J CATARACT REFR SURG, V34, P1742, DOI 10.1016/j.jcrs.2008.06.024; Nardi M, 1997, J PEDIAT OPHTH STRAB, V34, P244; PRESLAN MW, 1992, J PEDIATR OPHTHALMOL, V29, P300; Rajavi Zhale, 2008, International Ophthalmology, V28, P83, DOI 10.1007/s10792-007-9116-z; REYNOLDS RD, 1991, AM J OPHTHALMOL, V111, P371, DOI 10.1016/S0002-9394(14)72327-X; Seo KY, 2011, YONSEI MED J, V52, P527, DOI 10.3349/ymj.2011.52.3.527; THOMPSON WE, 1980, J PEDIAT OPHTH STRAB, V17, P372; Wang XG, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/140628	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202864	10.1371/journal.pone.0202864	http://dx.doi.org/10.1371/journal.pone.0202864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142210	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500043
J	Morioka, N; Tomio, J; Seto, T; Yumoto, Y; Ogata, Y; Kobayashi, Y				Morioka, Noriko; Tomio, Jun; Seto, Toshikazu; Yumoto, Yoshie; Ogata, Yasuko; Kobayashi, Yasuki			Association between local-level resources for home care and home deaths: A nationwide spatial analysis in Japan	PLOS ONE			English	Article							UNIVERSAL HEALTH-CARE; PLACE; MORTALITY; SITE	Aim Little is known about whether and how local-level resources regarding home care are associated with the prevalence of home deaths. We aimed to investigate whether geographic patterns of the resources for home care were associated with the prevalence of home deaths, taking spatial variation into consideration. Methods We conducted an ecological cross-sectional study in Japan using nationwide data in 2014. The areal unit was the municipality, the smallest administrative unit in Japan. We investigated the association between the percentage of home deaths and the resources of home care support clinics with available 24-hour-a-day functions, considering the geographic effect of neighboring municipalities by applying a geographically weighted regression model. Results The mean and standard deviation of the percentages of home deaths were 11.4% (5.0%), and those of the number of home care support clinics per 10,000 elderly population were 3.4 (3.7). The percentages of home deaths in neighboring municipalities tended to be significantly correlated (Moran's I 0.34, p<0.001). Adjusting for the number of hospital beds, total population, and the socio-economic status of municipality, the results of an ordinary least squares regression model showed a positive correlation between the percentage of home deaths and the local resources for home care support clinics per 10,000 elderly population (regression coefficient 0.15, 95% confidence interval 0.07, 0.22), while the existence of spatial autocorrelation of the residual was suggested (Moran's I of the residual 0.227, p<0.001). The geographically weighted regression model showed local regression coefficients varying across municipalities with a better model fit over the analogous ordinary least squares model (adjusted R-2 0.414 vs. 0.131). Conclusion Home deaths were more prevalent in municipalities with greater home care resources. This association was geographically varied and further strengthened in some areas.	[Morioka, Noriko; Yumoto, Yoshie; Ogata, Yasuko] Tokyo Med & Dent Univ, Dept Gerontol Nursing & Care Syst Dev, Tokyo, Japan; [Morioka, Noriko; Tomio, Jun; Kobayashi, Yasuki] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Seto, Toshikazu] Univ Tokyo, Ctr Spatial Informat Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo	Morioka, N (corresponding author), Tokyo Med & Dent Univ, Dept Gerontol Nursing & Care Syst Dev, Tokyo, Japan.; Morioka, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan.	morioka.gh@tmd.ac.jp	Seto, Toshikazu/AAE-9741-2019	Seto, Toshikazu/0000-0003-0281-1790; Morioka, Noriko/0000-0001-9355-4173	JSPS KAKENHI [18K17633]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 18K17633.	Akiyama Akiko, 2007, Nihon Ronen Igakkai Zasshi, V44, P740, DOI 10.3143/geriatrics.44.740; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Chen DR, 2010, HEALTH PLACE, V16, P1248, DOI 10.1016/j.healthplace.2010.08.013; Clark CR, 2016, JAMA-J AM MED ASSOC, V316, P2363, DOI 10.1001/jama.2016.12818; Costa V, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0077-8; Dasch B, 2015, DTSCH ARZTEBL INT, V112, P496, DOI 10.3238/arztebl.2015.0496; De Roo ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093762; Ford MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146085; Fotheringham A. S., 2003, GEOGRAPHICALLY WEIGH; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Grande GE, 1998, SOC SCI MED, V47, P565, DOI 10.1016/S0277-9536(98)00115-4; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006954; Hanaoka C, 2008, SOC SCI MED, V67, P1002, DOI 10.1016/j.socscimed.2008.05.006; Hayashi T, 2011, ARCH GERONTOL GERIAT, V53, P242, DOI 10.1016/j.archger.2010.12.005; Igarashi M, 2014, PALLIATIVE CARE RES, V9, P114; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Kaiser Family Foundation, 2017, 4 COUNTR SURV AG END; Kamata K, 2009, J POPULATION STUDIES, V45, P1; Kinjo K, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1961-x; Ministry of Health, VIT STAT; Ministry of Health, 2015, VIT STAT; Ministry of Health, LAB WELF; Ministry of Health Labour and Welfare, 2016, ANN HLTH LAB WELF RE; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nakaya T., 2013, GEOGRAPHICALLY WEIGH; Odoi A, 2014, SPAT SPATIO-TEMPORAL, V11, P109, DOI 10.1016/j.sste.2014.10.001; Office for National Statistics, 2015, NATL SURV BER PEOPL; Ohta Hideki, 2015, Japan Med Assoc J, V58, P6; Sauvaget C, 1996, TOHOKU J EXP MED, V180, P87, DOI 10.1620/tjem.180.87; Shepperd S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009231.pub2; Shoff C, 2012, GEOJOURNAL, V77, P331, DOI 10.1007/s10708-010-9405-3; Statistics Bureau Ministry of Internal Affairs and Communications, 2014, STAT OBS SHI KU MACH; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Tsutsui Takako, 2014, Int J Integr Care, V14, pe002; United Nations, 2015, WORLD POP AG, V2015; World Health Organization (WHO), 2015, WORLD REPORT ON AGEI; Yang Limin, 2006, BMC Palliat Care, V5, P2, DOI 10.1186/1472-684X-5-2	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0201649	10.1371/journal.pone.0201649	http://dx.doi.org/10.1371/journal.pone.0201649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142197	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500004
J	Pallikkuth, S; Martin, C; Farzam, F; Edwards, JS; Lakin, MR; Lidke, DS; Lidke, KA				Pallikkuth, Sandeep; Martin, Cheyenne; Farzam, Farzin; Edwards, Jeremy S.; Lakin, Matthew R.; Lidke, Diane S.; Lidke, Keith A.			Sequential super-resolution imaging using DNA strand displacement	PLOS ONE			English	Article							DESIGN; LOCALIZATION; EXCHANGE; STORM	Sequential labeling and imaging in fluorescence microscopy allows the imaging of multiple structures in the same cell using a single fluorophore species. In super-resolution applications, the optimal dye suited to the method can be chosen, the optical setup can be simpler and there are no chromatic aberrations between images of different structures. We describe a method based on DNA strand displacement that can be used to quickly and easily perform the labeling and removal of the fluorophores during each sequence. Site-specific tags are conjugated with unique and orthogonal single stranded DNA. Labeling for a particular structure is achieved by hybridization of antibody-bound DNA with a complimentary dye-labeled strand. After imaging, the dye is removed using toehold-mediated strand displacement, in which an invader strand competes off the dye-labeled strand than can be subsequently washed away. Labeling and removal of each DNA-species requires only a few minutes. We demonstrate the concept using sequential dSTORM super-resolution for multiplex imaging of subcellular structures.	[Pallikkuth, Sandeep; Farzam, Farzin; Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Martin, Cheyenne; Lidke, Diane S.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Martin, Cheyenne; Edwards, Jeremy S.; Lidke, Diane S.; Lidke, Keith A.] Univ New Mexico, Comprehens Canc Ctr, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Edwards, Jeremy S.] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA; [Lakin, Matthew R.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Lakin, Matthew R.] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico; University of New Mexico	Lidke, KA (corresponding author), Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA.; Lidke, KA (corresponding author), Univ New Mexico, Comprehens Canc Ctr, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	klidke@unm.edu			NIH [1R21EB019589, P30CA118100]; New Mexico Spatiotemporal Modeling Center (NIH) [P50GM085273]; National Science Foundation [1525553, 1518861, 1318833]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB019589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Mexico Spatiotemporal Modeling Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH 1R21EB019589, the New Mexico Spatiotemporal Modeling Center (NIH P50GM085273). MRL was additionally supported by the National Science Foundation grants 1525553, 1518861, and 1318833. We thank Shayna Lucero for assistance with cell culture. We gratefully acknowledge use of the University of New Mexico Comprehensive Cancer Center fluorescence microscopy core, as well as the NIH P30CA118100 support for these cores.	[Anonymous], 1999, FAC APPL SCI DELFT U; Chen YJ, 2013, NAT NANOTECHNOL, V8, P755, DOI 10.1038/nnano.2013.189; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; Groves B, 2016, NAT NANOTECHNOL, V11, P287, DOI [10.1038/NNANO.2015.278, 10.1038/nnano.2015.278]; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Lin DY, 2018, BIOPHYS J, V114, P1980, DOI 10.1016/j.bpj.2018.03.023; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schueder F, 2017, ANGEW CHEM INT EDIT, V56, P4052, DOI 10.1002/anie.201611729; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Tam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101772; Valley CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123941; Wolfe BR, 2017, J AM CHEM SOC, V139, P3134, DOI 10.1021/jacs.6b12693; Wolfe BR, 2015, ACS SYNTH BIOL, V4, P1086, DOI 10.1021/sb5002196; Yi J, 2016, MOL BIOL CELL, V27, P3591, DOI 10.1091/mbc.E16-05-0330; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957	20	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203291	10.1371/journal.pone.0203291	http://dx.doi.org/10.1371/journal.pone.0203291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169528	gold, Green Published, Green Submitted			2022-12-27	WOS:000443374400034
J	Valencia-Mendez, O; Rodriguez-Zaragoza, FA; Calderon-Aguilera, LE; Dominguez-Dominguez, O; Lopez-Perez, A				Valencia-Mendez, Omar; Alejandro Rodriguez-Zaragoza, Fabian; Eduardo Calderon-Aguilera, Luis; Dominguez-Dominguez, Omar; Lopez-Perez, Andres			Gamma-diversity partitioning of gobiid fishes (Teleostei: Gobiidae) ensemble along of Eastern Tropical Pacific: Biological inventory, latitudinal variation and species turnover	PLOS ONE			English	Article							DWELLING FISHES; BETA-DIVERSITY; REEF; SPECIATION; SPECIALIZATION; REDESCRIPTION; GOBIOSOMATINI; BIOGEOGRAPHY; PERCIFORMES; DIVERGENCE	Gobies are the most diverse marine fish family. Here, we analysed the gamma-diversity (gamma-diversity) partitioning of gobiid fishes to evaluate the additive and multiplicative components of alpha and beta-diversity, species replacement and species loss and gain, at four spatial scales: sample units, ecoregions, provinces and realms. The richness of gobies from the realm Eastern Tropical Pacific (ETP) is represented by 87 species. Along latitudinal and longitudinal gradients, we found that the gamma-diversity is explained by the beta-diversity at both spatial scales, ecoregions and provinces. At the ecoregion scale, species are diverse in the north (Cortezian ecoregion) and south (Panama Bight ecoregion) and between insular and coastal ecoregions. At the province scale, we found that the species turnover between the warm temperate Northeast Pacific (WTNP), Tropical East Pacific (TEaP) and the Galapagos Islands (Gala) was high, and the species nestedness was low. At the ecoregion scale, historical factors, and phylogenetic factors have influenced the hotspots of gobiid fish biodiversity, particularly in the Cortezian, Panama Bight and Cocos Island ecoregions, where species turnover is high across both latitudinal and longitudinal gradients. At the provincial level, we found that the contributions of the beta-diversity from north to south, in the WTNP, TEaP and Gala were high, as result of the high number of unique species. Species turnover was also high at this scale, with a low contribution from species nestedness that was probably due to the low species/gene flow within the provinces. These results highlight the importance and successful inclusion of a cryptobenthic fish component in ecological and biogeographical studies.	[Valencia-Mendez, Omar] Univ Autonoma Metropolitana Iztapalapa, Ciencias Biol & Salud, Ciudad De Mexico, Mexico; [Alejandro Rodriguez-Zaragoza, Fabian] Univ Guadalajara, CUCBA, Dept Ecol, Guadalajara, Jalisco, Mexico; [Eduardo Calderon-Aguilera, Luis] CICESE, Dept Ecol Marina, Ensenada, Baja California, Mexico; [Dominguez-Dominguez, Omar] Univ Michoacana, Fac Biol, Morelia, Michoacan, Mexico; [Lopez-Perez, Andres] Univ Autonoma Metropolitana Iztapalapa, Dept Hidrobiol, Ciudad De Mexico, Mexico; [Eduardo Calderon-Aguilera, Luis] Univ Southampton, Southampton, Hants, England	Universidad Autonoma Metropolitana - Mexico; Universidad de Guadalajara; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Universidad Michoacana de San Nicolas de Hidalgo; Universidad Autonoma Metropolitana - Mexico; University of Southampton	Lopez-Perez, A (corresponding author), Univ Autonoma Metropolitana Iztapalapa, Dept Hidrobiol, Ciudad De Mexico, Mexico.	alopez@xanum.uam.mx	Calderon-Aguilera, Luis Eduardo E/E-1522-2015; Zaragoza, Fabian Alejandro Rodriguez/B-3477-2015; Lopez-Perez, Andres/U-1151-2017; MENDEZ, OMAR VALENCIA/AAJ-6099-2020; Lopez-Perez, Andres/GPJ-9537-2022	Calderon-Aguilera, Luis Eduardo E/0000-0001-5427-6043; Zaragoza, Fabian Alejandro Rodriguez/0000-0002-0066-4275; Lopez-Perez, Andres/0000-0003-1246-7401; MENDEZ, OMAR VALENCIA/0000-0002-8623-5446; Lopez-Perez, Andres/0000-0003-1246-7401	Consejo Nacional de Ciencia y Tecnologia [401738]; Consejo Nacional de Ciencia y Tecnologoia [240875, 236654, 257987]; Universidad Michoacana de San NicolaAs de Hidalgo [CIC-2013-2017]; CONACyT (Consejo Nacional de Ciencia y TecnologoAa, Mexico) [401738]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologoia; Universidad Michoacana de San NicolaAs de Hidalgo; CONACyT (Consejo Nacional de Ciencia y TecnologoAa, Mexico)	This work was supported by the Consejo Nacional de Ciencia y Tecnologia, PhD scholarship 401738, MC Omar Valencia-Mendez; Consejo Nacional de Ciencia y Tecnologia, 257987, Dr. FabiaAn Alejandro RodroAguez-Zaragoza; Consejo Nacional de Ciencia y Tecnologoia, 240875, Dr. Omar DomoAnguez-DomoAnguez; Universidad Michoacana de San NicolaAs de Hidalgo, CIC-2013-2017, Dr. Omar DomoAnguez-DomoAnguez; Consejo Nacional de Ciencia y Tecnologia, 236654, Dr. AndreAs LoApez-PeArez and Omar Valencia-Mendez received a Ph.D. scholarship from CONACyT (Consejo Nacional de Ciencia y TecnologoAa, Mexico), fellowship no. 401738. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gonzalez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065665; Ahmadia GN, 2018, CORAL REEFS, V37, P279, DOI 10.1007/s00338-018-1657-2; Amador JA, 2006, PROG OCEANOGR, V69, P101, DOI 10.1016/j.pocean.2006.03.007; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2015, ARCMAP VERS 10 4 1 S; [Anonymous], NOM062ZOO1999; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bermingham Eldredge, 1997, P113, DOI 10.1016/B978-012417540-2/50009-9; Bograd SJ, 2015, DEEP-SEA RES PT II, V112, P42, DOI 10.1016/j.dsr2.2014.04.009; Boschi Enrique E., 2000, Revista de Investigacion y Desarrollo Pesquero, V13, P7; Brandl SJ, 2018, BIOL REV, V93, P1846, DOI 10.1111/brv.12423; Briggs J. C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; BUSSING WA, 1990, REV BIOL TROP, V38, P99; Chao A, 2012, ECOLOGY, V93, P2037, DOI 10.1890/11-1817.1; Chapman ASA, 2018, DIVERS DISTRIB, V24, P568, DOI 10.1111/ddi.12712; Clarke KR, 2006, PRIMER V 6 USER MANU; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Coker DJ, 2018, CORAL REEFS, V37, P193, DOI 10.1007/s00338-017-1647-9; Colwell RK, 2013, ESTIMATES STAT ESTIM; Costello MJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01121-2; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Erisman BE, 2011, ZOOTAXA, P26; Eschmeyer W. N., CATALOG FISHES; Fiedler PC, 2017, CORAL REEFS WORLD, V8, P59, DOI 10.1007/978-94-017-7499-4_3; Fourriere M, 2016, ZOOTAXA, V4150, P436, DOI 10.11646/zootaxa.4150.4.4; Francisco-Ramos V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078761; Galland GR, 2017, MAR ECOL PROG SER, V584, P175, DOI 10.3354/meps12364; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gilbert C., 1882, P US NATL MUS, V14, P539; Gilbert C. H., 1890, P US NATL MUS, V13, P49, DOI DOI 10.5479/SI.00963801.13-797.49; Gill AC, 2012, ZOOTAXA, P41; Ginsburg I., 1939, Journal of the Washington Academy of Sciences, V29, P51; Ginsburg I, 1938, A HANCOCK PACIFIC EX, V2, P109; GINSBURG ISAAC, 1932, BULL BINGHAM OCEANOGR COLL, V4, P1; GINSBURG ISAAC, 1933, BULL BINGHAM OCEANOGR COLL, V4, P1; Glynn PW, 2017, CORAL REEFS WORLD, V8, P107, DOI 10.1007/978-94-017-7499-4_5; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Goatley CHR, 2016, MAR ECOL PROG SER, V544, P271, DOI 10.3354/meps11614; Greve M, 2006, ECOGRAPHY, V29, P347, DOI 10.1111/j.2006.0906-7590.04493.x; Gunther A., 1864, Proceedings of the Zoological Society, P23; Gunther A., 1861, CATALOGUE ACANTHOPTE, V3, P1; Hastings PA, 2000, ZOOL J LINN SOC-LOND, V128, P319, DOI 10.1006/zjls.1998.0196; Herler J, 2007, MAR ECOL-EVOL PERSP, V28, P82, DOI 10.1111/j.1439-0485.2007.00165.x; Herler J, 2012, BIOLOGY OF GOBIES, P493; HOESE DF, 1985, COPEIA, P333, DOI 10.2307/1444842; HOESE DF, 1976, COPEIA, P295; Hoese DF, 2001, REV BIOL TROP, V49, P157; Hoese DF, 2001, REV BIOL TROP, V49, P169; Jenkins O. P., 1889, P US NATL MUS, V11, P137, DOI DOI 10.5479/SI.00963801.11-698.137; Jordan D.S., 1882, B US FISH COMM, V1, P306; Jordan DS, 1882, P US NATL MUS, V4, P338, DOI DOI 10.5479/SI; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Kohda M, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3060-2; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Kulbicki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081847; Lasso-Alcala A OM, 2008, MEMORIA FDN SALLE CI, V67, P117; Leitao RP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0084; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Lessios HA, 2017, CORAL REEFS WORLD, V8, P477, DOI 10.1007/978-94-017-7499-4_16; Lopez-Perez A, 2016, MAR ECOL-EVOL PERSP, V37, P679, DOI 10.1111/maec.12337; Meek S, 1923, ZOOL SER, V15, P1; Miller PJ, 2001, REV BIOL TROP, V49, P141; Mora C, 2005, J BIOGEOGR, V32, P277, DOI 10.1111/j.1365-2699.2004.01155.x; Mora C, 2005, ECOLOGY, V86, P1771, DOI 10.1890/04-0883; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Munday PL, 2004, ECOLOGY, V85, P623, DOI 10.1890/03-3100; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Nelson J. S., 2016, FISHES WORLD, DOI [10.1002/9781119174844, DOI 10.1002/9781119174844]; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P659, DOI 10.1111/geb.12020; R Development Core Team, 2016, R LANG ENV STAT COMP; Robertson D. R., 2015, SHOREFISHES TROPICAL; Robertson DR, 2009, MAR ECOL PROG SER, V380, P1, DOI 10.3354/meps07925; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; Rocha LA, 2000, ENVIRON BIOL FISH, V59, P453, DOI 10.1023/A:1026584708092; Rodriguez-Zaragoza FA, 2011, BIODIVERS CONSERV, V20, P1655, DOI 10.1007/s10531-011-0053-9; Romero-Torres M, 2017, ICES J MAR SCI, V74, P613, DOI 10.1093/icesjms/fsw218; Ruber L, 2003, EVOLUTION, V57, P1584; RUBINOFF RW, 1971, EVOLUTION, V25, P88, DOI 10.1111/j.1558-5646.1971.tb01861.x; Smith DG, 1999, P BIOL SOC WASH, V112, P433; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Taylor MS, 2005, EVOLUTION, V59, P374; Thacker C, 2012, BIOLOGY OF GOBIES, P129; Tornabene L, 2016, MOL ECOL, V25, P3662, DOI 10.1111/mec.13704; Tornabene L, 2015, MOL PHYLOGENET EVOL, V82, P200, DOI 10.1016/j.ympev.2014.09.012; Tornabene L, 2014, J NAT HIST, V48, P1413, DOI 10.1080/00222933.2013.840938; Tornabene L, 2013, MOL PHYLOGENET EVOL, V66, P391, DOI 10.1016/j.ympev.2012.10.014; Van Der Laan R, 2014, ZOOTAXA, V3882, P1, DOI 10.11646/zootaxa.3882.1.1; Van Tassell JL, 2012, Biology of Gobies, P139; Van Tassell JL, 2004, ZOOTAXA, P1; Van Tassell JL, 2012, GOBIIDAE; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA, 2009, PARTITION SOFTWARE H; Violle C, 2017, TRENDS ECOL EVOL, V32, P356, DOI 10.1016/j.tree.2017.02.002; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; WoRMS Editorial Board, 2016, WORLD REGISTER MARIN	98	3	3	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202863	10.1371/journal.pone.0202863	http://dx.doi.org/10.1371/journal.pone.0202863			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169538	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000443374400014
J	Alkhouri, N; Johnson, C; Adams, L; Kitajima, S; Tsuruno, C; Colpitts, TL; Hatcho, K; Lawitz, E; Lopez, R; Feldstein, A				Alkhouri, Naim; Johnson, Casey; Adams, Leon; Kitajima, Sachiko; Tsuruno, Chikayuki; Colpitts, Tracey L.; Hatcho, Kazuki; Lawitz, Eric; Lopez, Rocio; Feldstein, Ariel			Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis	PLOS ONE			English	Article							MAC-2 BINDING-PROTEIN; NATURAL-HISTORY; FIBROSIS STAGE; SPECTRUM; DISEASE	Objective The race for finding effective treatments for nonalcoholic fatty liver disease (NAFLD) has been slowed down by the high screen-failure rate for including patients in trials due to the lack of a noninvasive biomarker that can identify patients with significant disease. Recently, Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA(+)-M2BP) has shown promise in predicting liver fibrosis. The aims of this study were to evaluate the utility of WFA -M2BP as a biomarker to sub-classify patients with NAFLD according to their disease severity and to assess its correlation with histologic features of NAFLD. Methods Patients undergoing biopsy for clinical suspicion of NAFLD and healthy controls were included. Patients with NAFLD were classified into: NAFL, early NASH (F0-F1), fibrotic NASH (F2-F3), and NASH cirrhosis (F4). Levels of WFA(+)-M2BP in sera was measured by a HISCL (TM) M2BPGi (TM) assay kit using an automated immunoanalyzer (HISCL (TM)-800; Sysmex, Kobe, Japan). Analysis of covariance was used to assess difference in WFA(+)-M2BP between the groups and Spearman's correlation coefficients were used to assess correlation with histological features. Results Our cohort consisted of 20 healthy controls and 198 patients with biopsy-proven NAFLD divided as follows: 52 with NAFL, 62 with early NASH, 52 with fibrotic NASH, and 32 with NASH cirrhosis. WFA(+)-M2BP level was found to be significantly increased in the fibrotic NASH and NASH cirrhosis groups compared to healthy controls and those with early NAFLD after adjusting for age, gender and BMI. Furthermore, patients with NASH cirrhosis had significantly higher WFA(+)-M2BP levels (2.4[1.5, 4.2] C.0.1 (Cut-off Index)) than those with fibrotic NASH (1.2[0.79, 1.9]), p < 0.001. WFA(+) -M2BP level had moderate correlation with inflammation, ballooning and NAFLD activity score and strong correlation with fibrosis stage. Additionally, ROC curve analysis demonstrated that WFA(+) -M2BP accurately differentiated F2-4 from F0-F1. Conclusion In a large cohort of patients with the full spectrum of NAFLD, WFA(+)-M2BP levels predicted the presence of advanced disease and correlated strongly with fibrosis stage.	[Alkhouri, Naim; Lawitz, Eric] Univ Texas UT Hlth Sci Ctr, Texas Liver Inst, San Antonio, TX 78229 USA; [Johnson, Casey; Feldstein, Ariel] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Adams, Leon] Univ Western Australia, Crawley, Australia; [Colpitts, Tracey L.; Hatcho, Kazuki] Sysmex Corp R&D Ctr Amer, Lincolnshire, IL USA; [Lopez, Rocio] Cleveland Clin, Digest Dis & Surg Inst, Cleveland, OH 44106 USA	University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; University of Western Australia; Cleveland Clinic Foundation	Alkhouri, N (corresponding author), Univ Texas UT Hlth Sci Ctr, Texas Liver Inst, San Antonio, TX 78229 USA.	Alkhouri@txliver.com		Lopez, Ana Rocio/0000-0002-4319-420X	Sysmex	Sysmex	The study was supported by an unrestrictive grant from Sysmex. Sysmex provided HISCLTM M2BPGiTM assay kit and an automated immunoanalyzer HISCLTM-800. The funder provided support in the form of salaries for authors SK, CT, TLC, and KH; but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Alkhouri Naim, 2012, Gastroenterol Hepatol (N Y), V8, P661; Angulo P, 2015, GASTROENTEROLOGY; Caldwell SH, 2004, J HEPATOL, V40, P578, DOI 10.1016/j.jhep.2004.02.013; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Doycheva I, 2017, J CLIN GASTROENTEROL; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Goh GBB, 2016, DIGEST DIS SCI, V61, P1226, DOI 10.1007/s10620-016-4095-4; Ito K, 2017, J GASTROEN HEPATOL, V32, P1922, DOI 10.1111/jgh.13802; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lai LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174982; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Nishikawa H, 2016, J VIRAL HEPATITIS, V23, P977, DOI 10.1111/jvh.12575; Nishikawa H, 2016, HEPATOL RES, V46, P1194, DOI 10.1111/hepr.12662; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; White DL, 2017, GASTROENTEROLOGY, V152, P812, DOI 10.1053/j.gastro.2016.11.020; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305	21	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202226	10.1371/journal.pone.0202226	http://dx.doi.org/10.1371/journal.pone.0202226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161179	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900026
J	Hartstein, LE; LeBourgeois, MK; Berthier, NE				Hartstein, Lauren E.; LeBourgeois, Monique K.; Berthier, Neil E.			Light correlated color temperature and task switching performance in preschool-age children: Preliminary insights	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; RETINAL GANGLION-CELLS; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; WAKING ELECTROENCEPHALOGRAM; MELATONIN SUPPRESSION; WORKING-MEMORY; MELANOPSIN; INHIBITION; SCHOOL	Data from a growing number of experimental studies show that exposure to higher correlated color temperature (CCT) ambient light, containing more blue light, can positively impact alertness and cognitive performance in older children and adults. To date, few if any studies have examined whether light exposure influences cognitive task performance in preschool-age children, who are in the midst of rapid developmental changes in attention and executive function skills. In this study, healthy children aged 4.5-5.5 years (n = 20; 11 females) completed measures of sustained attention and task switching twice while being exposed to LED light set to either 3500K (a lower CCT) or 5000K (a higher CCT). A control group (n = 18; 10 females) completed the tasks twice under only the 3500K lighting condition. Although the lighting condition did not impact performance on the sustained attention task, exposure to the higher CCT light lead to greater improvement in preschool-age children's task switching performance (F(1,36) = 4.41, p = 0.04). Children in the control group showed a 6.5% increase in task switching accuracy between time points, whereas those in the experimental group improved by 15.2%. Our primary finding-that exposure to light at a higher correlated color temperature leads to greater improvement in task switching performance-indicates that the relationship between the spectral power distribution of light and executive function abilities is present early in cognitive development. These data have implications for designing learning environments and suggest that light may be an important contextual factor in the lives of young children in both the home and the classroom.	[Hartstein, Lauren E.; Berthier, Neil E.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA; [Hartstein, Lauren E.] Rensselaer Polytech Inst, Lighting Enabled Syst & Applicat Engn Res Ctr, Troy, NY 12180 USA; [Hartstein, Lauren E.; LeBourgeois, Monique K.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Massachusetts System; University of Massachusetts Amherst; Rensselaer Polytechnic Institute; University of Colorado System; University of Colorado Boulder	Hartstein, LE (corresponding author), Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA.; Hartstein, LE (corresponding author), Rensselaer Polytech Inst, Lighting Enabled Syst & Applicat Engn Res Ctr, Troy, NY 12180 USA.; Hartstein, LE (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	Lauren.Hartstein@colorado.edu		Hartstein, Lauren/0000-0002-3643-8894	Engineering Research Centers Program of the National Science Foundation under NSF [EEC-0812056]	Engineering Research Centers Program of the National Science Foundation under NSF	This work was supported in part by the Engineering Research Centers Program of the National Science Foundation under NSF Cooperative Agreement No. EEC-0812056. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akacem LD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13617; al Enezi J, 2011, J BIOL RHYTHM, V26, P314, DOI 10.1177/0748730411409719; Amundadottir ML, 2017, LIGHTING RES TECHNOL, V49, P673, DOI 10.1177/1477153516655844; [Anonymous], 2011, S017E2011 CIE; Barkmann C, 2012, PHYSIOL BEHAV, V105, P621, DOI 10.1016/j.physbeh.2011.09.020; Barrett P, 2015, BUILD ENVIRON, V89, P118, DOI 10.1016/j.buildenv.2015.02.013; Berman SM, 2006, LIGHTING RES TECHNOL, V38, P41, DOI 10.1191/13657828061i155oa; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Best JR, 2011, LEARN INDIVID DIFFER, V21, P327, DOI 10.1016/j.lindif.2011.01.007; Brainard GC, 2005, J BIOL RHYTHM, V20, P314, DOI 10.1177/0748730405278951; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Burdette HL, 2004, ARCH PEDIAT ADOL MED, V158, P353, DOI 10.1001/archpedi.158.4.353; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Chang AM, 2013, SLEEP, V36, P1239, DOI 10.5665/sleep.2894; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Cristia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128338; Crowley SJ, 2015, J CLIN ENDOCR METAB, V100, P4067, DOI 10.1210/jc.2015-2775; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI [10.1093/acprof:oso/9780195134971.003.0029, DOI 10.1093/ACPROF:OSO/9780195134971.003.0029, /10.1093/acprof:oso/9780195134971.003.0029]; Ferlazzo F, 2014, J ENVIRON PSYCHOL, V39, P92, DOI 10.1016/j.jenvp.2014.03.005; Gaggioni G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00126; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hartstein LE, 2017, LIGHTING RES TECHNOL, P1; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Higuchi S, 2016, CHRONOBIOL INT, V33, P448, DOI 10.3109/07420528.2016.1152978; Higuchi S, 2014, J CLIN ENDOCR METAB, V99, P3298, DOI 10.1210/jc.2014-1629; Huiberts LM, 2015, BEHAV BRAIN RES, V294, P234, DOI 10.1016/j.bbr.2015.07.045; Kabali HK, 2015, PEDIATRICS, V136, P1044, DOI 10.1542/peds.2015-2151; Keis O, 2014, TRENDS NEUROSCI EDUC, V3, P86, DOI 10.1016/j.tine.2014.09.001; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Lamm C, 2012, BRAIN COGNITION, V79, P181, DOI 10.1016/j.bandc.2012.02.013; Lee S, 2016, J SLEEP RES, V25, P144; LEVY F, 1980, J CHILD PSYCHOL PSYC, V21, P77, DOI 10.1111/j.1469-7610.1980.tb00018.x; Lockley SW, 2006, SLEEP, V29, P161; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mott MS, 2012, SAGE OPEN, V2, DOI 10.1177/2158244012445585; Nayfeld I, 2013, LEARN INDIVID DIFFER, V26, P81, DOI 10.1016/j.lindif.2013.04.011; ROBINSON J, 1990, ARCH DIS CHILD-FETAL, V65, P35, DOI 10.1136/adc.65.1_Spec_No.35; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sleegers P. J. C., 2012, LIGHTING RES TECHNOL, P1; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Steinmayr R, 2010, LEARN INDIVID DIFFER, V20, P14, DOI 10.1016/j.lindif.2009.10.009; Tandon PS, 2013, AM J PREV MED, V44, P85, DOI 10.1016/j.amepre.2012.09.052; Tanner CK, 2009, J EDUC ADMIN, V47, P381, DOI 10.1108/09578230910955809; Tarttelin EE, 2003, EXP EYE RES, V76, P393, DOI 10.1016/S0014-4835(02)00300-7; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Vandewalle G., 2013, J COGNITIVE NEUROSCI, P1; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; WEALE RA, 1988, J PHYSIOL-LONDON, V395, P577, DOI 10.1113/jphysiol.1988.sp016935; Werner H, 2008, ARCH PEDIAT ADOL MED, V162, P350, DOI 10.1001/archpedi.162.4.350	55	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202973	10.1371/journal.pone.0202973	http://dx.doi.org/10.1371/journal.pone.0202973			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161180	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900056
J	Ishoso, DK; Tshefu, AK; Coppieters, Y				Ishoso, Daniel Katuashi; Tshefu, Antoinette Kitoto; Coppieters, Yves			Analysis of induced abortion-related complications in women admitted to referral health facilities in Kinshasa, Democratic Republic of the Congo	PLOS ONE			English	Article							UNSAFE ABORTION; MATERNAL MORTALITY; POSTABORTION CARE; RISK-FACTORS; AGE	Background Due to a lack of relevant data on induced abortions in the Democratic Republic of the Congo (DRC), as well as the persistence of maternal deaths in the country, this study aims to analyze the extent and characteristics of induced abortion-related complications in women who were admitted to referral health facilities in Kinshasa, including the duration of hospitalization, the mortality rate due to induced abortion complications and their characteristics, and the deaths that occurred after two days of hospitalization. Methods This is a cross-sectional study on 843 obstetric and gynecological patients who were admitted as emergency cases to five referral health facilities in Kinshasa during 2014. These facilities were selected as being representative of five types of districts in Kinshasa, according to their cultural, socioeconomic, and infrastructural characteristics. Patient data were collected from patient records and analyzed. Results From the 843 patients admitted to receive obstetric and gynecological emergency care services in 2014 at the health facilities surveyed, 14.7% (95% CI: 12.4-17.3%) had complications due to induced abortion. These complications were significantly diagnosed in adolescents (p = 0.003) and in single, separated, divorced, or widowed women (p = 0.03). The median duration of hospitalization was nine days, and this period of time was significantly longer for the patients who underwent surgery for pelvic peritonitis due to uterine perforation compared with the patients who underwent Caesarean section/hysterectomy. Furthermore, it was significantly longer for the patients who were treated for other induced-abortion related complications compared with patients treated for spontaneous abortion. The mortality rate related to induced abortions was 5.6% (95% CI: 2.3-11.3%), with an increase in risk of death in the presence of a postabortive pelvic peritonitis-type complication; 42.9% of deaths occurred after two days of hospitalization. Conclusion The complications of induced abortions are a major public health problem due to their frequency among patients admitted to Kinshasa's referral health facilities, their mortality, and their poor medical management. Therefore, there is a need to understand the reason for its poor medical management in order to provide an adequate intervention program.	[Ishoso, Daniel Katuashi; Tshefu, Antoinette Kitoto] Univ Kinshasa, Kinshasa Sch Publ Hlth, Community Hlth Dept, Kinshasa1, Kinshasa, DEM REP CONGO; [Coppieters, Yves] ULB, Res Ctr Policies & Hlth Syst Int Hlth, Sch Publ Hlth, Brussels, Belgium	Universite de Kinshasa; Universite Libre de Bruxelles	Ishoso, DK (corresponding author), Univ Kinshasa, Kinshasa Sch Publ Hlth, Community Hlth Dept, Kinshasa1, Kinshasa, DEM REP CONGO.	dishosok@gmail.com		Ishoso Katuashi, Daniel/0000-0001-9392-1316	DRC government	DRC government	This research was funded by our salaries received from the DRC government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun O M, 2013, Afr J Med Med Sci, V42, P111; Adinma E, 2011, West Afr J Med, V30, P245; Ahman E, 2011, INT J GYNECOL OBSTET, V115, P121, DOI 10.1016/j.ijgo.2011.05.027; [Anonymous], 2014, ENQ DEM SANT REP DEM; Basinga P, 2012, STUD FAMILY PLANN, V43, P11, DOI 10.1111/j.1728-4465.2012.00298.x; Bernabe-Ortiz A, 2009, CAN MED ASSOC J, V180, P541, DOI 10.1503/cmaj.090188; Bernabe-Ortiz A, 2009, CAN MED ASSOC J, V180, P298, DOI 10.1503/cmaj.071399; Biddlecom Ann, 2008, Issues Brief (Alan Guttmacher Inst), P1; Boltanski L., 2004, CONDITION FOETALE SO; Chae S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184389; DeTourris H., 1994, ABREGE GYNECOLOGIE O, P671; Dragoman M, 2014, BJOG-INT J OBSTET GY, V121, P25, DOI 10.1111/1471-0528.12689; Ekanem E I, 2009, Niger J Med, V18, P370; Erfani A, 2011, INT PERSPECT SEX R H, V37, P134, DOI 10.1363/3713411; Faundes A, 2012, INT J GYNECOL OBSTET, V119, pS68, DOI 10.1016/j.ijgo.2012.03.021; Fawcus SR, 2008, BEST PRACT RES CL OB, V22, P533, DOI 10.1016/j.bpobgyn.2007.10.006; Ganatra B, 2017, LANCET; Gebreselassie H, 2010, INT PERSPECT SEX R H, V36, P6, DOI 10.1363/ipsrh.36.006.10; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Henshaw SK, 2008, INT FAM PLAN PERSPEC, V34, P40, DOI 10.1363/ifpp.34.140.08; Ibrahim IA, 2012, W INDIAN MED J, V61, P163; Igberase GO, 2008, TROP DOCT, V38, P146, DOI 10.1258/td.2007.070096; Irene T, 2006, ANN HIST SCI SOC, V2, P483; Jain V, 2004, J OBSTET GYNAECOL RE, V30, P197, DOI 10.1111/j.1447-0756.2004.00183.x; Johnson-Hanks J, 2002, SOC SCI MED, V55, P1337, DOI 10.1016/S0277-9536(01)00276-3; Juarez F, 2008, INT FAM PLAN PERSPEC, V34, P158, DOI [10.1363/3415808, 10.1363/ifpp.34.158.08]; Kigbu J H, 2009, Niger J Med, V18, P103; Kinoti S N, 2004, East Afr Med J, V81, P63; Lelo NF, 2004, PAUVRETE URBAINE KIN, P41; Levandowski Brooke A, 2012, Afr J Reprod Health, V16, P253; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Mitsunaga TM, 2005, J WOMENS HEALTH, V14, P515, DOI 10.1089/jwh.2005.14.515; Moreau C, 2005, BJOG-INT J OBSTET GY, V112, P430, DOI 10.1111/j.1471-0528.2004.00478.x; Okonofua F, 2006, J OBSTET GYNAECOL CA, V28, P974, DOI 10.1016/S1701-2163(16)32307-6; Rasch V, 2011, ACTA OBSTET GYN SCAN, V90, P692, DOI 10.1111/j.1600-0412.2011.01165.x; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sedgh Gilda, 2010, Issues Brief (Alan Guttmacher Inst), P1; Shah IH, 2012, REPROD HEALTH MATTER, V20, P169, DOI 10.1016/S0968-8080(12)39598-0; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Shah N, 2011, J PAK MED ASSOC, V61, P582; Singh S, 2016, BJOG-INT J OBSTET GY, V123, P1489, DOI 10.1111/1471-0528.13552; Singh S, 2006, LANCET, V368, P1887, DOI 10.1016/S0140-6736(06)69778-X; Sudhinaraset May, 2008, Issues Brief (Alan Guttmacher Inst), P1; Thorp JM, 2003, OBSTET GYNECOL SURV, V58, P67, DOI 10.1097/00006254-200301000-00023	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203186	10.1371/journal.pone.0203186	http://dx.doi.org/10.1371/journal.pone.0203186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161265	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900086
J	Tasse, J; Trouillet-Assant, S; Josse, J; Martins-Simoes, P; Valour, F; Langlois-Jacques, C; Badel-Berchoux, S; Provot, C; Bernardi, T; Ferry, T; Laurent, F				Tasse, Jason; Trouillet-Assant, Sophie; Josse, Jerome; Martins-Simoes, Patricia; Valour, Florent; Langlois-Jacques, Carole; Badel-Berchoux, Stephanie; Provot, Christian; Bernardi, Thierry; Ferry, Tristan; Laurent, Frederic			Association between biofilm formation phenotype and clonal lineage in Staphylococcus aureus strains from bone and joint infections	PLOS ONE			English	Article							BOVINE MASTITIS; OSTEOMYELITIS; EPIDEMIOLOGY; EPIDERMIDIS; ENZYMES; DEVICE	Biofilm formation is a critical virulence factor responsible for treatment failure and chronicity in orthopaedic device-related infections (ODIs) caused by Staphylococcus aureus. Clonal lineages differ in terms of their biofilm forming capacities. The aim of this study was to investigate the correlation between the clonal complex (CC) affiliation and biofilm phenotype of 30 clinical S. aureus isolates responsible of ODI based on i) early biofilm formation using BioFilm Ring Test (R) and mature biofilm formation using crystal violet assays, ii) biofilm composition using DNase and proteinase K activity, and iii) prevention of biofilm formation by cloxacillin, teicoplanin and vancomycin using Antibiofilmogram (R) (biofilm minimal inhibitory concentration-bMIC). In terms of early biofilm formation, the CC30 strains were significantly slower than the CC5, CC15 and CC45 strains. CC45 strains produced significantly more mature biofilm than other group of strains did. The formation of biofilms was highly dependent on the presence of extracellular DNA in the CC5, CC15 and CC30 strains whereas it was mostly dependent on the presence of proteins in CC45. Finally, the CC30 group highlighted higher proportion of susceptible (bMIC < breakpoints of EUCAST guidelines) for cloxacillin, teicoplanin and vancomycin compared to the other CCs. These results demonstrate that the biofilm phenotype of clinical S. aureus isolates from ODIs is strongly related to their respective CC affiliation.	[Tasse, Jason; Trouillet-Assant, Sophie; Josse, Jerome; Martins-Simoes, Patricia; Valour, Florent; Ferry, Tristan; Laurent, Frederic] Ctr Int Rech Infectiol, Pathogenie Staphylocoques, INSERM U1111, Lyon, France; [Tasse, Jason; Trouillet-Assant, Sophie; Josse, Jerome; Martins-Simoes, Patricia; Valour, Florent; Langlois-Jacques, Carole; Ferry, Tristan; Laurent, Frederic] Univ Claude Bernard Lyon 1, Lyon, France; [Tasse, Jason; Trouillet-Assant, Sophie; Josse, Jerome; Martins-Simoes, Patricia; Laurent, Frederic] Hosp Civils Lyon, Inst Agents Infect, Lyon, France; [Tasse, Jason; Badel-Berchoux, Stephanie; Provot, Christian; Bernardi, Thierry] BioFilm Control, St Beauzire, France; [Valour, Florent; Ferry, Tristan] Hosp Civils Lyon, Serv Malad Infect & Trop, Lyon, France; [Langlois-Jacques, Carole] Hosp Civils Lyon, Serv Biostat & Bioinformat, Lyon, France; [Langlois-Jacques, Carole] CNRS, UMR, Lab Biometrie & Biol Evolut, Equipe Biostat Sante, Villeurbanne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Tasse, J (corresponding author), Ctr Int Rech Infectiol, Pathogenie Staphylocoques, INSERM U1111, Lyon, France.; Tasse, J (corresponding author), Univ Claude Bernard Lyon 1, Lyon, France.; Tasse, J (corresponding author), Hosp Civils Lyon, Inst Agents Infect, Lyon, France.; Tasse, J (corresponding author), BioFilm Control, St Beauzire, France.	jason.tasse@chu-lyon.fr	trouillet-assant, sophie/L-9400-2014; LAURENT, Frederic/AGM-0706-2022; Ferry, Tristan/M-5108-2014	laurent, frederic/0000-0003-0609-9091; M Simoes, Patricia/0000-0001-5130-6016; JOSSE, Jerome/0000-0001-6780-9646; Badel-Berchoux, stephanie/0000-0002-7212-8199; Valour, Florent/0000-0002-1467-6162; Tasse, Jason/0000-0002-7496-7594; ferry, tristan/0000-0003-3082-7001	Fonds Unique Interministeriel 15th; Association Nationale de la Recherche et de la Technologie (ANRT); Biofilm Control through a CIFRE fellowship; 15th Fonds Unique Interministeriel (FUI) call for projects	Fonds Unique Interministeriel 15th; Association Nationale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR)); Biofilm Control through a CIFRE fellowship; 15th Fonds Unique Interministeriel (FUI) call for projects	This work was supported by Fonds Unique Interministeriel 15th and by Association Nationale de la Recherche et de la Technologie (ANRT) and Biofilm Control through a CIFRE fellowship to JT. Biofilm Control provided support in the form of salaries for authors JT, SBB, CP, TB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was partly supported by a grant from the 15th Fonds Unique Interministeriel (FUI) call for projects.	Badel S, 2011, ENZYME MICROB TECH, V48, P248, DOI 10.1016/j.enzmictec.2010.11.003; Bardiau M, 2016, VET MICROBIOL, V185, P1, DOI 10.1016/j.vetmic.2016.01.003; Bardiau M, 2014, VET MICROBIOL, V169, P74, DOI 10.1016/j.vetmic.2013.12.010; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Cafiso V, 2007, FEMS IMMUNOL MED MIC, V51, P220, DOI 10.1111/j.1574-695X.2007.00298.x; Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Cortes MF, 2015, INT J MED MICROBIOL, V305, P140, DOI 10.1016/j.ijmm.2014.11.011; Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9; Croes S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-229; Darley ESR, 2004, J ANTIMICROB CHEMOTH, V53, P928, DOI 10.1093/jac/dkh191; Elchinger PH, 2014, LETT APPL MICROBIOL, V59, P507, DOI 10.1111/lam.12305; Gbejuade HO, 2015, ACTA ORTHOP, V86, P147, DOI 10.3109/17453674.2014.966290; Grammatico-Guillon L, 2012, J HOSP INFECT, V82, P40, DOI 10.1016/j.jhin.2012.04.025; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Iyamba JML, 2011, BIOFOULING, V27, P811, DOI 10.1080/08927014.2011.604776; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kaplan JB, 2009, INT J ARTIF ORGANS, V32, P545, DOI 10.1177/039139880903200903; Laurent F, 2001, J ANTIMICROB CHEMOTH, V47, P277, DOI 10.1093/jac/47.3.277; Lipsky BA, 2007, INFECT CONT HOSP EP, V28, P1290, DOI 10.1086/520743; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Naicker PR, 2016, MICROB PATHOGENESIS, V90, P41, DOI 10.1016/j.micpath.2015.10.023; Rao NL, 2011, PLAST RECONSTR SURG, V127, p177S, DOI 10.1097/PRS.0b013e3182001f0f; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Tasse J, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw057; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Zapotoczna M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005671	29	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0200064	10.1371/journal.pone.0200064	http://dx.doi.org/10.1371/journal.pone.0200064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161132	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900003
J	Chakraborty, A; Kichikawa, Y; Iino, T; Iyetomi, H; Inoue, H; Fujiwara, Y; Aoyama, H				Chakraborty, Abhijit; Kichikawa, Yuichi; Iino, Takashi; Iyetomi, Hiroshi; Inoue, Hiroyasu; Fujiwara, Yoshi; Aoyama, Hideaki			Hierarchical communities in the walnut structure of the Japanese production network	PLOS ONE			English	Article								This paper studies the structure of the Japanese production network, which includes one million firms and five million supplier-customer links. This study finds that this network forms a tightly-knit structure with a core giant strongly connected component (GSCC) surrounded by IN and OUT components constituting two half-shells of the GSCC, which we call awalnut structure because of its shape. The hierarchical structure of the communities is studied by the Infomap method, and most of the irreducible communities are found to be at the second level. The composition of some of the major communities, including overexpressions regarding their industrial or regional nature, and the connections that exist between the communities are studied in detail. The findings obtained here cause us to question the validity and accuracy of using the conventional input-output analysis, which is expected to be useful when firms in the same sectors are highly connected to each other.	[Chakraborty, Abhijit; Inoue, Hiroyasu; Fujiwara, Yoshi] Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo, Japan; [Kichikawa, Yuichi; Iino, Takashi; Iyetomi, Hiroshi] Niigata Univ, Fac Sci, Niigata, Japan; [Aoyama, Hideaki] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	University of Hyogo; Niigata University; Kyoto University	Chakraborty, A (corresponding author), Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo, Japan.	abhiphyiitg@gmail.com	Chakraborty, Abhijit/AAJ-4443-2021; Chakraborty, Abhijit/GLN-5371-2022	Chakraborty, Abhijit/0000-0001-5866-1985	Project "Large-scale Simulation and Analysis of Economic Network for Macro Prudential Policy" undertaken at Research Institute of Economy, Trade and Industry (RIETI); MEXT; JSPS [25400393, 17H02041]; Kyoto University Supporting Program for Interaction-based Initiative Team Studies: SPIRITS, as part of the Program for Promoting the Enhancement of Research Universities, MEXT, JAPAN	Project "Large-scale Simulation and Analysis of Economic Network for Macro Prudential Policy" undertaken at Research Institute of Economy, Trade and Industry (RIETI); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto University Supporting Program for Interaction-based Initiative Team Studies: SPIRITS, as part of the Program for Promoting the Enhancement of Research Universities, MEXT, JAPAN	This study was supported in part by the Project "Large-scale Simulation and Analysis of Economic Network for Macro Prudential Policy" undertaken at Research Institute of Economy, Trade and Industry (RIETI), MEXT as Exploratory Challenges on Post-K computer (Studies of Multi-level Spatiotemporal Simulation of Socioeconomic Phenomena), Grant-in-Aid for Scientific Research (KAKENHI) by JSPS Grant Numbers 25400393, 17H02041 and the Kyoto University Supporting Program for Interaction-based Initiative Team Studies: SPIRITS, as part of the Program for Promoting the Enhancement of Research Universities, MEXT, JAPAN.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2013, ECONOPHYSICS AGENT B; [Anonymous], [No title captured]; [Anonymous], 2017, MACRO ECONOPHYSICS N; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Caiani A., 2016, EC HETEROGENEOUS INT; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Currarini S, 2009, ECONOMETRICA, V77, P1003, DOI 10.3982/ECTA7528; Draghici S., 2003, DATA ANAL TOOLS DNA; Echenique F, 2007, Q J ECON, V122, P441, DOI 10.1162/qjec.122.2.441; Esquivel AV, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021025; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Fujiwara Y, 2010, EUR PHYS J B, V77, P565, DOI 10.1140/epjb/e2010-00275-2; Fujiwara Y, 2012, PROG THEOR PHYS SUPP, P158; Iino T, 2015, ADV JPN BUS ECON, V4, P39, DOI 10.1007/978-4-431-55390-8_3; Kawamoto T, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012809; Krichene H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186467; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Leontief WW, 1936, REV ECON STATISTICS, V18, P105, DOI 10.2307/1927837; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Miller RG., 1981, SIMULTANEOUS STAT IN, P37; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Onnela JP, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056110; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; Tesfatsion L., 2006, HDB COMPUTATIONAL EC, V2; Tumminello M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01019	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202739	10.1371/journal.pone.0202739	http://dx.doi.org/10.1371/journal.pone.0202739			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157210	gold, Green Published, Green Submitted			2022-12-27	WOS:000443071400069
J	Abu Asab, N; Cuestas, JC; Montagnoli, A				Abu Asab, Nora; Carlos Cuestas, Juan; Montagnoli, Alberto			Inflation targeting or exchange rate targeting: Which framework supports the goal of price stability in emerging market economies?	PLOS ONE			English	Article							OUTPUT GROWTH; CONDITIONAL HETEROSKEDASTICITY; EMPIRICAL-EVIDENCE; MONETARY-POLICY; UNITED-KINGDOM; LONG MEMORY; UNCERTAINTY; MODEL; LINK; HETEROSCEDASTICITY	The paper investigates and compares the relationship between inflation and inflation uncertainty under inflation targeting and, alternatively, a conventional fixed exchange rate system, for a group of emerging countries. To do so we estimate GARCH in mean models and we find that there is a bi-directional relationship between inflation and inflation uncertainty under the two monetary regimes. It is also found that the fixed exchange rate regime has no impact on average inflation and inflation inertia, while inflation targeting has been successful at lowering both average inflation and inflation persistence.	[Abu Asab, Nora; Montagnoli, Alberto] Univ Sheffield, Dept Econ, Sheffield, S Yorkshire, England; [Carlos Cuestas, Juan] Jaume I Univ, Dept Econ & IEI, Castellon de La Plana, Spain; [Carlos Cuestas, Juan] Tallinn Univ Technol, Dept Econ & Finance, Tallinn, Estonia; [Carlos Cuestas, Juan] Eesti Pank, Res Unit, Tallinn, Estonia	University of Sheffield; Universitat Jaume I; Tallinn University of Technology; Bank of Estonia (Eesti Pank)	Cuestas, JC (corresponding author), Jaume I Univ, Dept Econ & IEI, Castellon de La Plana, Spain.; Cuestas, JC (corresponding author), Tallinn Univ Technol, Dept Econ & Finance, Tallinn, Estonia.; Cuestas, JC (corresponding author), Eesti Pank, Res Unit, Tallinn, Estonia.	cuestasjuancarlos@gmail.com	Cuestas, Juan Carlos/K-4270-2014; Abu Asab, Noura/W-7263-2018	Cuestas, Juan Carlos/0000-0002-7313-2157; Abu Asab, Noura/0000-0002-8114-617X	'Agencia Estatal de Investigacion' (AEI) [ECO2017-83255-C3-3-P, ECO2017-85503-R]; 'Fondo Europeo de Desarrollo Regional' (FEDER)	'Agencia Estatal de Investigacion' (AEI); 'Fondo Europeo de Desarrollo Regional' (FEDER)	JCC acknowledges the financial support from the following: the ECO2017-83255-C3-3-P and ECO2017-85503-R projects from 'Agencia Estatal de Investigacion' (AEI) and 'Fondo Europeo de Desarrollo Regional' (FEDER).	ACKLEY G, 1978, AM ECON REV, V68, P149; Baillie RT, 1996, J APPL ECONOM, V11, P23, DOI 10.1002/(SICI)1099-1255(199601)11:1<23::AID-JAE374>3.0.CO;2-M; BALL L, 1990, BROOKINGS PAP ECO AC, P215; BALL L, 1992, J MONETARY ECON, V29, P371, DOI 10.1016/0304-3932(92)90032-W; BARRO RJ, 1983, J MONETARY ECON, V12, P101, DOI 10.1016/0304-3932(83)90051-X; Batini N., 2007, MONETARY POLICY INFL, V11, P467; Bernanke BS, 1997, INFLATION TARGETING, P5893; Bernholz P., 2015, MONETARY REGIMES INF; Bhar R, 2012, ECON ANAL POLICY, V42, P305, DOI 10.1016/S0313-5926(12)50031-7; Bhar R, 2013, EMPIR ECON, V45, P1333, DOI 10.1007/s00181-012-0650-9; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Box GeorgeE.P., 1970, J AM STAT ASSOC, V1st; Capistran C, 2010, J MONEY CREDIT BANK, V42, P113, DOI 10.1111/j.1538-4616.2009.00280.x; Caporale GM, 2012, EMPIR ECON, V43, P597, DOI 10.1007/s00181-011-0489-5; Caporale GM, 2009, J INT MONEY FINANC, V28, P954, DOI 10.1016/j.jimonfin.2008.09.004; CARLSON JA, 1977, ANN ECON SOC MEAS, V6, P27; Castillo P, 2012, J APPL ECON, V15, P71, DOI 10.1016/S1514-0326(12)60004-X; Chang KL, 2010, MANCH SCH, V78, P126, DOI 10.1111/j.1467-9957.2009.02162.x; Conrad C, 2005, JPN WORLD ECON, V17, P327, DOI 10.1016/j.japwor.2004.03.002; Cuestas JC, 2016, SCOT J POLIT ECON, V63, P519, DOI 10.1111/sjpe.12114; CUKIERMAN A, 1982, AM ECON REV, V72, P508; CUKIERMAN A, 1986, ECONOMETRICA, V54, P1099, DOI 10.2307/1912324; Daal E, 2005, ECON LETT, V89, P180, DOI 10.1016/j.econlet.2005.05.024; Engle, 1993, PERMANENT TRANSITORY; ENGLE RF, 1987, ECONOMETRICA, V55, P391, DOI 10.2307/1913242; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; EVANS M, 1991, J MONEY CREDIT BANK, V23, P169, DOI 10.2307/1992775; Fischer S, 1989, SHOULD NATIONS LEARN, P2815; Fountas S, 2004, MANCH SCH, V72, P221, DOI 10.1111/j.1467-9957.2004.00390.x; Fountas S, 2001, ECON LETT, V74, P77, DOI 10.1016/S0165-1765(01)00522-5; Fountas S, 2010, ECON MODEL, V27, P896, DOI 10.1016/j.econmod.2010.06.001; FRIEDMAN M, 1977, J POLIT ECON, V85, P451, DOI 10.1086/260579; GLEZAKOS C, 1984, WORLD DEV, V12, P755, DOI 10.1016/0305-750X(84)90086-X; Golob J.E., 1994, ECON REV, V79, P27; Grier KB, 2004, J APPL ECONOMET, V19, P551, DOI 10.1002/jae.763; Grier KB, 1998, J INT MONEY FINANC, V17, P671, DOI 10.1016/S0261-5606(98)00023-0; Harvey AC, 2013, DYNAMIC MODELS VOLAT; HOLLAND AS, 1995, J MONEY CREDIT BANK, V27, P827, DOI 10.2307/2077753; Hu Y, 2003, IIE WORKING PAPERS S, P03; Jiranyakul K, 2010, J ASIAN ECON, V21, P105, DOI 10.1016/j.asieco.2009.09.007; Wilson BK, 2006, J MACROECON, V28, P609, DOI 10.1016/j.jmacro.2004.11.004; Khan M, 2013, WORKING PAPERS HALSH, V00804556; KIM CJ, 1993, J BUS ECON STAT, V11, P341, DOI 10.2307/1391959; Kontonikas A, 2004, ECON MODEL, V21, P525, DOI 10.1016/j.econmod.2003.08.001; Mallik G, 2011, J ECON STUD, V38, P620, DOI 10.1108/01443581111177358; Nazar Dahmardeh, 2010, American Journal of Applied Sciences, V7, P535, DOI 10.3844/ajassp.2010.535.539; Neanidis KC, 2011, ECON LETT, V112, P26, DOI 10.1016/j.econlet.2011.03.025; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; Neumann MJ, 2002, DOES INFLATION TARGE, P9577; OKUN AM, 1971, BROOKINGS PAP ECO AC, P485; PAGAN AR, 1983, REV ECON STUD, V50, P585, DOI 10.2307/2297762; POURGERAMI A, 1987, WORLD DEV, V15, P287, DOI 10.1016/0305-750X(87)90083-0; Rizvi SKA, 2009, 26 INT S MON BANK FI; Samimi AJ, 2012, UNIVERSAL J MANAGEME, V2, P57; SIDRAUSKI M, 1967, J POLIT ECON, V75, P796, DOI 10.1086/259360; STOCKMAN AC, 1981, J MONETARY ECON, V8, P387, DOI 10.1016/0304-3932(81)90018-0; Tas BKO, 2013, AUST ECON REV, V46, DOI 10.1111/1467-8462.12036; TOBIN J, 1972, AM ECON REV, V62, P1; TOBIN J, 1965, ECONOMETRICA, V33, P671, DOI 10.2307/1910352; UNGAR M, 1993, J MONEY CREDIT BANK, V25, P709, DOI 10.2307/2077800; Wachtel P, 1977, ANAL INFLATION 1965, P361; Walsh CE, 2009, INT FINANC, V12, P195, DOI 10.1111/j.1468-2362.2009.01236.x; Wright JH, 2011, AM ECON REV, V101, P1514, DOI 10.1257/aer.101.4.1514; Yeh CC, 2011, APPL ECON, V43, P2593, DOI 10.1080/00036840903299763; ZAKOIAN JM, 1994, J ECON DYN CONTROL, V18, P931, DOI 10.1016/0165-1889(94)90039-6	65	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0201798	10.1371/journal.pone.0201798	http://dx.doi.org/10.1371/journal.pone.0201798			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153258	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000443001700004
J	Jager, F; Libensek, S; Gersak, K				Jager, Franc; Libensek, Sonja; Gersak, Ksenija			Characterization and automatic classification of preterm and term uterine records	PLOS ONE			English	Article							ELECTRICAL-ACTIVITY; APPROXIMATE ENTROPY; ELECTROMYOGRAPHY; SIGNAL; PREGNANCY; DELIVERY; UTERUS; IDENTIFICATION; CONTRACTIONS; MUSCLE	Predicting preterm birth is uncertain, and numerous scientists are searching for noninvasive methods to improve its predictability. Current researches are based on the analysis of ElectroHysteroGram (EHG) records, which contain information about the electrophysiological properties of the uterine muscle and uterine contractions. Since pregnancy is a long process, we decided to also characterize, for the first time, non-contraction intervals (dummy intervals) of the uterine records, i.e., EHG signals accompanied by a simultaneously recorded external tocogram measuring mechanical uterine activity (TOCO signal). For this purpose, we developed a new set of uterine records, TPEHGT DS, containing preterm and term uterine records of pregnant women, and uterine records of non-pregnant women. We quantitatively characterized contraction intervals (contractions) and dummy intervals of the uterine records of the TPEHGT DS in terms of the normalized power spectra of the EHG and TOCO signals, and developed a new method for predicting preterm birth. The results on the characterization revealed that the peak amplitudes of the normalized power spectra of the EHG and TOCO signals of the contraction and dummy intervals in the frequency band 1.0-2.2 Hz, describing the electrical and mechanical activity of the uterus due to the maternal heart (maternal heart rate), are high only during term pregnancies, when the delivery is still far away; and they are low when the delivery is close. However, these peak amplitudes are also low during preterm pregnancies, when the delivery is still supposed to be far away (thus suggesting the danger of preterm birth); and they are also low or barely present for non-pregnant women. We propose the values of the peak amplitudes of the normalized power spectra due to the influence of the maternal heart, in an electro-mechanical sense, in the frequency band 1.0-2.2 Hz as a new biophysical marker for the preliminary, or early, assessment of the danger of preterm birth. The classification of preterm and term, contraction and dummy intervals of the TPEHGT DS, for the task of the automatic prediction of preterm birth, using sample entropy, the median frequency of the power spectra, and the peak amplitude of the normalized power spectra, revealed that the dummy intervals provide quite comparable and slightly higher classification performances than these features obtained from the contraction intervals. This result suggests a novel and simple clinical technique, not necessarily to seek contraction intervals but using the dummy intervals, for the early assessment of the danger of preterm birth. Using the publicly available TPEHG DB database to predict preterm birth in terms of classifying between preterm and term EHG records, the proposed method outperformed all currently existing methods. The achieved classification accuracy was 100% for early records, recorded around the 23rd week of pregnancy; and 96.33%, the area under the curve of 99.44%, for all records of the database. Since the proposed method is capable of using the dummy intervals with high classification accuracy, it is also suitable for clinical use very early during pregnancy, around the 23rd week of pregnancy, when contractions may or may not be present.	[Jager, Franc; Libensek, Sonja] Univ Ljubljana, Fac Comp & Informat Sci, Dept Software, Ljubljana, Slovenia; [Gersak, Ksenija] Univ Ljubljana, Fac Med, Dept Obstet & Gynecol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Jager, F (corresponding author), Univ Ljubljana, Fac Comp & Informat Sci, Dept Software, Ljubljana, Slovenia.	franc.jager@fri.uni.lj.si		Gersak, Ksenija/0000-0001-9088-2382	Slovenian Research Agency (ARRS) [P3-0124]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work was financed by the Slovenian Research Agency (ARRS) (https://www.arrs.gov.si/) under the research project P3-0124 Metabolic and inborn factors of reproductive health, birth II (FJ, KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2017, COMPUT BIOL MED, V85, P33, DOI 10.1016/j.compbiomed.2017.04.013; Ahmed MU, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19010002; Alamedine D, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/485684; Alexandersson A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.17; Baker PN, 2011, OBSTET 10 TEACHERS, P436; Batista AG, 2016, COMPUT BIOL MED, V76, P178, DOI 10.1016/j.compbiomed.2016.07.003; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; BLUMAN AG, 2009, ELEMENTARY STAT STEP; Borowska M, 2018, COMPUT METH PROG BIO, V153, P227, DOI 10.1016/j.cmpb.2017.10.018; Buhimschi C, 1997, OBSTET GYNECOL, V90, P102, DOI 10.1016/S0029-7844(97)83837-9; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen LL, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/7949507; Choi E, 2003, PATTERN RECOGN, V36, P1703, DOI 10.1016/S0031-3203(03)00035-9; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; de Lau H, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-192; DEVEDEUX D, 1993, AM J OBSTET GYNECOL, V169, P1636, DOI 10.1016/0002-9378(93)90456-S; Diab A, 2014, P VIRT PHYS HUM C; Diab A, 2014, MED ENG PHYS, V36, P761, DOI 10.1016/j.medengphy.2014.01.009; Diab M.O., 2007, INT J COMPUT COGNIT, V5, P8; Dunne K., 2002, J MACH LEARN RES, V1, P1; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fele-Zorz G, 2008, MED BIOL ENG COMPUT, V46, P911, DOI 10.1007/s11517-008-0350-y; Fergus P, 2016, NEUROCOMPUTING, V188, P42, DOI 10.1016/j.neucom.2015.01.107; Fergus P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077154; Garfield RE, 2005, BJOG-INT J OBSTET GY, V112, P103, DOI 10.1111/j.1471-0528.2005.00596.x; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hanley GE, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0857-4; Hassan M, 2011, MED ENG PHYS, V33, P980, DOI 10.1016/j.medengphy.2011.03.010; Hassan M, 2013, IEEE T BIO-MED ENG, V60, P1160, DOI 10.1109/TBME.2012.2229279; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; Horoba K, 2016, BIOCYBERN BIOMED ENG, V36, P610, DOI 10.1016/j.bbe.2016.08.005; Horoba K, 2016, BIOCYBERN BIOMED ENG, V36, P574, DOI 10.1016/j.bbe.2016.06.004; Howson C, 2012, BORN TOO SOON GLOBAL; Hussain AJ, 2015, NEUROCOMPUTING, V151, P963, DOI 10.1016/j.neucom.2014.03.087; Iams JD, 2003, OBSTET GYNECOL, V101, P402, DOI 10.1016/S0029-7844(02)02505-X; Idowu IO, 2015, CIT/IUCC/DASC/PICOM 2015 IEEE INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION TECHNOLOGY - UBIQUITOUS COMPUTING AND COMMUNICATIONS - DEPENDABLE, AUTONOMIC AND SECURE COMPUTING - PERVASIVE INTELLIGENCE AND COMPUTING, P215, DOI 10.1109/CIT/IUCC/DASC/PICOM.2015.31; Jezewski J, 2005, PHYSIOL MEAS, V26, P753, DOI 10.1088/0967-3334/26/5/014; Jyothi R, 2016, 2016 INT C SIGN PROC, P1; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lammers WJEP, 2013, REPROD SCI, V20, P182, DOI 10.1177/1933719112446082; Leman H, 1999, IEEE T BIO-MED ENG, V46, P1222, DOI 10.1109/10.790499; Libensek S, 2014, THESIS; Lucovnik M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.024; Lucovnik M, 2011, ACTA OBSTET GYN SCAN, V90, P150, DOI 10.1111/j.1600-0412.2010.01031.x; Maner WL, 2007, ANN BIOMED ENG, V35, P465, DOI 10.1007/s10439-006-9248-8; Maner WL, 2003, OBSTET GYNECOL, V101, P1254, DOI 10.1016/S0029-7844(03)00341-7; MARQUE C, 1986, IEEE T BIO-MED ENG, V33, P1182, DOI 10.1109/TBME.1986.325698; Marque Catherine K, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS5, DOI 10.1186/1471-2393-7-S1-S5; Moslem B, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-167; Moslem B, 2010, J MED BIOL ENG, V30, P361, DOI 10.5405/jmbe.768; Newman J., 2008, PHYS LIFE SCI, DOI DOI 10.1007/978-0-387-77259-2; OLAH KS, 1994, EUR J OBSTET GYN R B, V57, P157, DOI 10.1016/0028-2243(94)90292-5; Rabotti C, 2015, ACTA PHYSIOL, V213, P406, DOI 10.1111/apha.12424; Ren P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132116; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Sikora J., 2011, ARCH PERINAT MED, V17, P97; Smrdel A, 2015, PHYSIOL MEAS, V36, P341, DOI 10.1088/0967-3334/36/2/341; Terrien J, 2010, COMPUT BIOL MED, V40, P223, DOI 10.1016/j.compbiomed.2009.11.019; Verdenik I, 2001, EUR J OBSTET GYN R B, V95, P149, DOI 10.1016/S0301-2115(00)00418-8; WHITNEY AW, 1971, IEEE T COMPUT, VC 20, P1100, DOI 10.1109/T-C.1971.223410; Zhou P, 2014, PHYSIOL MEAS, V35, P45, DOI 10.1088/0967-3334/35/1/45	62	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202125	10.1371/journal.pone.0202125	http://dx.doi.org/10.1371/journal.pone.0202125			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153264	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700006
J	Chen, WL; Wang, CC; Chiang, ST; Wang, YC; Sun, YS; Wu, WT; Liou, SH				Chen, Wei-Liang; Wang, Chung-Ching; Chiang, Sheng-Ta; Wang, Ying-Chuan; Sun, Yu-Shan; Wu, Wei-Te; Liou, Saou-Hsing			The impact of occupational psychological hazards and metabolic syndrome on the 8-year risk of cardiovascular diseases-A longitudinal study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LONG WORKING HOURS; JOB STRAIN; PHYSICAL-ACTIVITY; METAANALYSIS; OBESITY; HEALTH; RECOGNITION; ASSOCIATION; OVERWEIGHT	There was little information concerning the combined effect of occupational psychosocial hazards such as long working hours, high job stress, and high fatigue on the risk of cardiovascular and cerebrovascular diseases (CVD). The aim of this study was to investigate the interaction among occupational psychosocial hazards and the impact of metabolic syndrome (MetS) on the risk of CVD among bus drivers. The Taiwan Bus Driver Cohort Study involving 1014 professional drivers was established in 2005 and comprehensively studied. The interactions among occupational psychosocial hazards and the impact of MetS on the risk of CVD were measured. A working pattern questionnaire, job stress questionnaires, the Swedish occupational fatigue inventory, the stress satisfaction offset score, biochemical measurements, and physical examinations were used to assess psychosocial hazards and the presence of metabolic syndrome. There were 707 eligible bus drivers with a mean age of 43.5years old. During the 8-years of follow-up, 77 drivers were diagnosed with CVD. Long working hours, high job stress, and high fatigue were associated with an increased risk of cardiovascular disease incidence in the multivariate analysis. There were synergistic effects among long working hours, high job stress, and high fatigue only in drivers with MetS. A combination of long working hours, high job stress, and high fatigue increased the risk of developing CVD in bus drivers with MetS.	[Chen, Wei-Liang; Wang, Chung-Ching; Chiang, Sheng-Ta; Wang, Ying-Chuan; Sun, Yu-Shan; Liou, Saou-Hsing] Triserv Gen Hosp, Natl Def Med Ctr, Dept Family & Community Med, Div Fanily Med,Div Occupat Med, Taipei, Taiwan; [Wu, Wei-Te; Liou, Saou-Hsing] Natl Inst Environm Hlth Sci, Natl Hlth Res Inst, Miaoli, Taiwan; [Liou, Saou-Hsing] Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan; National Defense Medical Center	Liou, SH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Family & Community Med, Div Fanily Med,Div Occupat Med, Taipei, Taiwan.; Wu, WT; Liou, SH (corresponding author), Natl Inst Environm Hlth Sci, Natl Hlth Res Inst, Miaoli, Taiwan.; Liou, SH (corresponding author), Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan.	ader.una@gmail.com; shliou@nhri.org.tw	Wu, Wei-Te/S-8189-2019	Liou, Saou-Hsing/0000-0002-6602-4414	National Health Research Institutes of Taiwan [98-EO-PP01, 99-EO-PP01, 00-EO-PP01, EO-101-PP-01, EO-102-PP-01, EO-103-PP-01]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	Funded by National Health Research Institutes of Taiwan (98-EO-PP01, 99-EO-PP01, 00-EO-PP01, EO-101-PP-01, EO-102-PP-01 and EO-103-PP-01) to Dr. Saou-Hsing Liou National Institute of Occupational Safety and Health, Japan (IOSH96-M102 and IOSH97-M102) to Dr. Saou-Hsing Liou.	Ahsberg E, 1997, INT J IND ERGONOM, V20, P121, DOI 10.1016/S0169-8141(96)00044-3; [Anonymous], 1999, OHS CANADA, V15, P10; [Anonymous], 2017, DEF MET SYNDR AD HLT; APPELS A, 1987, INT J CARDIOL, V17, P15, DOI 10.1016/0167-5273(87)90029-5; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Basu N, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0662-y; Brown DL, 2009, AM J EPIDEMIOL, V169, P1370, DOI 10.1093/aje/kwp056; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chien TW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-478; Cohen R, 2017, AM J CARDIOL, V119, P1211, DOI 10.1016/j.amjcard.2017.01.009; Collins S, 2010, INT J OCCUP MED ENV, V23, P267, DOI 10.2478/v10001-010-0023-6; HAYANO J, 1990, CIRCULATION, V81, P1217, DOI 10.1161/01.CIR.81.4.1217; Hellerstedt WL, 1997, INT J EPIDEMIOL, V26, P575, DOI 10.1093/ije/26.3.575; Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95; Hidaka T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153368; Jarczok MN, 2013, NEUROSCI BIOBEHAV R, V37, P1810, DOI 10.1016/j.neubiorev.2013.07.004; KARASEK R, 1981, AM J PUBLIC HEALTH, V71, P694, DOI 10.2105/AJPH.71.7.694; Karasek R., 1990, HLTH WORK STRESS PRO; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2015, INT J OBESITY, V39, P1597, DOI 10.1038/ijo.2015.103; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; Kouvonen A, 2005, PREV MED, V41, P532, DOI 10.1016/j.ypmed.2005.01.004; Liaw FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22750; Lin RT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00198-5; Lin YC, 2003, PREV MED, V37, P233, DOI 10.1016/S0091-7435(03)00119-1; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Moe B, 2013, OCCUP ENVIRON MED, V70, P86, DOI 10.1136/oemed-2012-100734; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Park J, 2012, IND HEALTH, V50, P17, DOI 10.2486/indhealth.MS1317; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Virtanen M, 2012, AM J EPIDEMIOL, V176, P586, DOI 10.1093/aje/kws139; Wu WJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8010006	34	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202977	10.1371/journal.pone.0202977	http://dx.doi.org/10.1371/journal.pone.0202977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148874	Green Submitted, Green Published, gold			2022-12-27	WOS:000442804200041
J	Fors, A; Blanck, E; Ali, L; Ekberg-Jansson, A; Fu, M; Kjellberg, IL; Makitalo, A; Swedberg, K; Taft, C; Ekman, I				Fors, Andreas; Blanck, Elin; Ali, Lilas; Ekberg-Jansson, Ann; Fu, Michael; Kjellberg, Irma Lindstrom; Makitalo, Asa; Swedberg, Karl; Taft, Charles; Ekman, Inger			Effects of a person-centred telephone-support in patients with chronic obstructive pulmonary disease and/or chronic heart failure - A randomized controlled trial	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; SELF-EFFICACY; COST-EFFECTIVENESS; PRIMARY-CARE; INTERVENTIONS; MANAGEMENT; MORBIDITIES; EDUCATION; SYMPTOMS; OUTCOMES	Purpose To evaluate the effects of person-centred support via telephone in two chronically ill patient groups, chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF). Method 221 patients >= 50 years with COPD and/or CHF were randomized to usual care vs. usual care plus a person-centred telephone-support intervention and followed for six months. Patients in the intervention group were telephoned by a registered nurse initially to co-create a person-centred health plan with the patient and subsequently to discuss and evaluate the plan. The primary outcome measure was a composite score comprising General Self-Efficacy (GSE), re-hospitalization and death. Patients were classified as deteriorated if GSE had decreased by >= 5 points, or if they had been re-admitted to hospital for unscheduled reasons related to COPD and/or CHF or if they had died. Results At six-month follow-up no difference in the composite score was found between the two study groups (57.6%, n = 68 vs. 46.6%, n = 48; OR = 1.6, 95% CI: 0.9-2.7; P = 0.102) in the intention-to-treat analysis (n = 221); however, significantly more patients in the control group showed a clinically important decrease in GSE (>= 5 units) (22.9%, n = 27 vs. 9.7%, n = 10; OR = 2.8, 95% CI: 1.3-6.0; P = 0.011). There were 49 clinical events (14 deaths, 35 readmissions) in the control group and 41 in the intervention group (9 deaths, 32 re-admissions). Per-protocol analysis (n = 202) of the composite score showed that more patients deteriorated in the control group than in the intervention group (57.6%, n = 68 vs. 42.9%, n = 36; OR = 1.8, 95% CI 1.0-3.2; P = 0.039). Conclusion Person-centred support via telephone mitigates worsening self-efficacy without increasing the risk of clinical events in chronically ill patients with CHF and/or COPD. This indicates that a patient-healthcare professional partnership may be established without the need for face-to-face consultations, even in vulnerable patient groups.	[Fors, Andreas; Blanck, Elin; Ali, Lilas; Kjellberg, Irma Lindstrom; Taft, Charles; Ekman, Inger] Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, Gothenburg, Sweden; [Fors, Andreas; Blanck, Elin; Ali, Lilas; Kjellberg, Irma Lindstrom; Swedberg, Karl; Taft, Charles; Ekman, Inger] Univ Gothenburg, Ctr Person Ctr Care GPCC, Gothenburg, Sweden; [Fors, Andreas] Narhalsan Res & Dev Primary Hlth Care, Gothenburg, Sweden; [Ekberg-Jansson, Ann] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Resp Med & Allergol, Gothenburg, Sweden; [Ekberg-Jansson, Ann] Res & Dev Dept, Halmstad, Sweden; [Fu, Michael; Swedberg, Karl] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Makitalo, Asa] Univ Gothenburg, Dept Educ Commun & Learning, Gothenburg, Sweden; [Swedberg, Karl] Imperial Coll, Natl Heart & Lung Inst, London, England	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Imperial College London	Fors, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, Gothenburg, Sweden.; Fors, A (corresponding author), Univ Gothenburg, Ctr Person Ctr Care GPCC, Gothenburg, Sweden.; Fors, A (corresponding author), Narhalsan Res & Dev Primary Hlth Care, Gothenburg, Sweden.	andreas.fors@gu.se	Swedberg, Karl/B-2475-2008	Makitalo, Asa/0000-0003-3711-3781; Fors, Andreas/0000-0001-8980-0538	Centre for Person-Centred Care at the University of Gothenburg (GPCC), Sweden; Swedish Government's grant for Strategic Research Areas, Care Sciences [2009-1088]; University of Gothenburg, Sweden; Swedish Research Council [521-2013-2723]; Swedish agreement between the government and the county councils concerning economic support for providing an infrastructure for research and education of doctors [ALFGBG-444681]; Research and Development Unit, Primary Health Care, Region Vastra Gotaland	Centre for Person-Centred Care at the University of Gothenburg (GPCC), Sweden; Swedish Government's grant for Strategic Research Areas, Care Sciences; University of Gothenburg, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish agreement between the government and the county councils concerning economic support for providing an infrastructure for research and education of doctors; Research and Development Unit, Primary Health Care, Region Vastra Gotaland	This work was supported by the Centre for Person-Centred Care at the University of Gothenburg (GPCC), Sweden. GPCC is funded by the Swedish Government's grant for Strategic Research Areas, Care Sciences (Application to Swedish Research Council no. 2009-1088) (IE) and co-funded by the University of Gothenburg, Sweden. The Swedish Research Council (DNr 521-2013-2723) (IE), the Swedish agreement between the government and the county councils concerning economic support for providing an infrastructure for research and education of doctors (ALFGBG-444681) (IE), and Research and Development Unit, Primary Health Care, Region Vastra Gotaland also contributed to the funding of the study (AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N., 2014, PERSON CTR CARE IDEA; Ali L, 2018, J CLIN NURS, V27, pE1089, DOI 10.1111/jocn.14170; Baker E, 2017, INT J NURS STUD, V71, P125, DOI 10.1016/j.ijnurstu.2017.03.010; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bohm M, 2015, AM J CARDIOL, V116, P1890, DOI 10.1016/j.amjcard.2015.09.029; Brannstrom M, 2014, EUR J HEART FAIL, V16, P1142, DOI 10.1002/ejhf.151; Dudas K, 2013, EUR J CARDIOVASC NUR, V12, P521, DOI 10.1177/1474515112472270; Ekman I, 2012, EUR HEART J, V33, P1112, DOI 10.1093/eurheartj/ehr306; Ekman I, 2011, EUR J CARDIOVASC NUR, V10, P248, DOI 10.1016/j.ejcnurse.2011.06.008; Fors A, 2017, INT J CARDIOL, V249, P42, DOI 10.1016/j.ijcard.2017.08.069; Fors A, 2016, INT J CARDIOL, V221, P957, DOI 10.1016/j.ijcard.2016.07.060; Fors A, 2016, EUR J CARDIOVASC NUR, V15, P186, DOI 10.1177/1474515115623437; Fors A, 2015, INT J CARDIOL, V187, P693, DOI 10.1016/j.ijcard.2015.03.336; Hanlon Peter, 2017, J Med Internet Res, V19, pe172, DOI 10.2196/jmir.6688; Hansson E, 2016, EUR J CARDIOVASC NUR, V15, P276, DOI 10.1177/1474515114567035; Holland R, 2005, HEART, V91, P899, DOI 10.1136/hrt.2004.048389; Jackson L, 2005, HEART, V91, P10, DOI 10.1136/hrt.2004.045559; Joekes K, 2007, J HEALTH PSYCHOL, V12, P4, DOI 10.1177/1359105306069096; Kenealy TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116188; Lau-Walker M, 2009, PATIENT EDUC COUNS, V75, P290, DOI 10.1016/j.pec.2009.02.001; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Love J, 2012, QUAL LIFE RES, V21, P1249, DOI 10.1007/s11136-011-0030-5; Markgren R, 2019, BMJ SUPPORT PALLIAT, V9, DOI 10.1136/bmjspcare-2015-000894; Marks R, 2005, HEALTH PROMOT PRACT, V6, P148, DOI 10.1177/1524839904266792; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Packer M, 2001, J CARD FAIL, V7, P176, DOI 10.1054/jcaf.2001.25652; Rabe KF, 2017, LANCET, V389, P1931, DOI 10.1016/S0140-6736(17)31222-9; Sahlen KG, 2016, PALLIATIVE MED, V30, P296, DOI 10.1177/0269216315618544; Sanchez MM, 2006, STAT MED, V25, P1169, DOI 10.1002/sim.2244; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Simpson Edwina, 2013, Br J Nurs, V22, P1105; Sol BGM, 2011, EUR J CARDIOVASC NUR, V10, P180, DOI 10.1016/j.ejcnurse.2010.06.005; Strang S, 2014, PALLIAT SUPPORT CARE, V12, P465, DOI 10.1017/S1478951513000369; Theander K, 2014, INT J CHRONIC OBSTR, V9, P785, DOI 10.2147/COPD.S62563; Ulin K, 2016, EUR J CARDIOVASC NUR, V15, pE19, DOI 10.1177/1474515115569945; van Deursen VM, 2014, EUR J HEART FAIL, V16, P103, DOI 10.1002/ejhf.30; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wildevuur SE, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3687; Wolf A, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4890; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yehle KS, 2010, J CARDIOVASC NURS, V25, P175, DOI 10.1097/JCN.0b013e3181c71e8e	41	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203031	10.1371/journal.pone.0203031	http://dx.doi.org/10.1371/journal.pone.0203031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2JK	30169539	Green Submitted, Green Published, gold			2022-12-27	WOS:000443374400017
J	Baldwin, T; Islamovic, E; Klos, K; Schwartz, P; Gillespie, J; Hunter, S; Bregitzer, P				Baldwin, Thomas; Islamovic, Emir; Klos, Kathy; Schwartz, Paul; Gillespie, James; Hunter, Samuel; Bregitzer, Phil			Silencing efficiency of dsRNA fragments targeting Fusarium graminearum TRI6 and patterns of small interfering RNA associated with reduced virulence and mycotoxin production	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DICER-LIKE PROTEINS; HEAD BLIGHT; GC PREFERENCE; GENE; DEOXYNIVALENOL; RESISTANCE; WHEAT; MECHANISMS; MICRORNAS	Deoxynivalenol (DON) contamination of cereal grains caused by Fusarium head blight may be addressed by future RNA interference (RNAi)-based gene silencing approaches. However, utilizing these approaches will require a greater understanding of the principles that govern RNAi effectiveness in the pathogen Fusarium graminearum. RNAi in higher eukaryotes, including fungi, involves processing double stranded RNA (dsRNA) into small interfering RNA (siRNA) that silence gene expression based on base pair complementarity. This study examined virulence, DON production, and the small RNA (sRNA) populations in response to RNAi-based silencing of TRI6, a transcription factor that positively regulates DON synthesis via control of TRI5 expression. Silencing was accomplished via the expression of transgenes encoding inverted repeats targeting various regions of TRI6 (RNAi vectors). Transgene expression was associated with novel, TR/6-specific siRNAs. For RNAi vectors targeting the majority of TRI6 sequence (similar to 600 bp), a discontinuous, repeatable pattern was observed in which most siRNAs mapped to specific regions of TRI6. Targeting shorter regions (250-350 bp) did not alter the siRNA populations corresponding to that region of TRI6. No phased processing was observed. The 5' base of similar to 83% of siRNAs was uracil, consistent with DICER processing and ARGONAUTE binding preferences for siRNA. Mutant lines showed TRI6siRNA-associated reductions of TRI5expression on toxin inducing media and DON in infected wheat and barley spikes. Shorter RNAi vectors resulted in variable levels of silencing that were less than for the similar to 600 bp RNAi vector, with a 343 bp RNAi vector targeting the 5' end of TRI6 having the best silencing efficiency. This work identifies efficient shorter region for silencing of TRI6 and describes the patterns of siRNA corresponding to those regions.	[Baldwin, Thomas; Klos, Kathy; Bregitzer, Phil] USDA ARS, Natl Small Grains Germplasm Res Facil, Aberdeen, ID 83210 USA; [Islamovic, Emir] BASF, Res Triangle Pk, NC USA; [Schwartz, Paul; Gillespie, James] North Dakota State Univ, Dept Plant Sci, Fargo, ND USA; [Hunter, Samuel] Univ Idaho, iBEST, Moscow, ID USA	United States Department of Agriculture (USDA); BASF; North Dakota State University Fargo; Idaho; University of Idaho	Bregitzer, P (corresponding author), USDA ARS, Natl Small Grains Germplasm Res Facil, Aberdeen, ID 83210 USA.	phil.bregitzer@ars.usda.gov			USDA-ARS [2050-21000-031-00D]; U.S. Wheat and Barley Scab Initiative [FY16-BR-013, FY16-BA-005]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); U.S. Wheat and Barley Scab Initiative(United States Department of Agriculture (USDA))	This project was funded by USDA-ARS project 2050-21000-031-00D and by the U.S. Wheat and Barley Scab Initiative projects FY16-BR-013 and FY16-BA-005. The USDA-ARS is an equal opportunity employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BASF had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript, and did not provide salaries to any authors during conduction of the experiments.	Ah-Fong AMV, 2008, FUNGAL GENET BIOL, V45, P1197, DOI 10.1016/j.fgb.2008.05.009; Alexander NJ, 2011, FUNGAL GENET BIOL, V48, P485, DOI 10.1016/j.fgb.2011.01.003; Alexander NJ, 1998, APPL ENVIRON MICROB, V64, P221; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Baldwin TT, 2018, FUNGAL GENET BIOL, V115, P90, DOI 10.1016/j.fgb.2018.01.002; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12500; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; Dahlmann TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125989; Desjardins AE, 1997, MOL PLANT MICROBE IN, V10, P147, DOI 10.1094/MPMI.1997.10.2.147; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fang X, 2016, PLANT CELL; Garcia-Pedrajas MD, 2008, FUNGAL GENET BIOL, V45, P379, DOI 10.1016/j.fgb.2007.11.001; Gardiner DM, 2009, MICROBIOL-SGM, V155, P3149, DOI 10.1099/mic.0.029546-0; Ghag SB, 2014, PLANT BIOTECHNOL J, V12, P541, DOI 10.1111/pbi.12158; Goldoni M, 2004, FUNGAL GENET BIOL, V41, P1016, DOI 10.1016/j.fgb.2004.08.002; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Hallen-Adams HE, 2011, METHODS MOL BIOL, V722, P79, DOI 10.1007/978-1-61779-040-9_6; He KY, 2012, TOXICOL SCI, V127, P382, DOI 10.1093/toxsci/kfs134; Ho T, 2008, BIOCHEM BIOPH RES CO, V368, P433, DOI 10.1016/j.bbrc.2008.01.110; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; Iki T, 2017, J PLANT RES, V130, P7, DOI 10.1007/s10265-016-0876-2; Jeong D. H, 2011, PLANT CELL; Kazan K, 2012, MOL PLANT PATHOL, V13, P399, DOI 10.1111/j.1364-3703.2011.00762.x; King R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1756-1; Kobayashi H, 2016, BBA-GENE REGUL MECH, V1859, P71, DOI 10.1016/j.bbagrm.2015.08.007; Koch A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005901; Koch A, 2013, P NATL ACAD SCI USA, V110, P19324, DOI 10.1073/pnas.1306373110; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Li MX, 2008, TOXICOL SCI, V105, P67, DOI 10.1093/toxsci/kfn111; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; McDonald T, 2005, MOL PLANT MICROBE IN, V18, P539, DOI 10.1094/MPMI-18-0539; McMullen M, 2012, PLANT DIS, V96, P1712, DOI 10.1094/PDIS-03-12-0291-FE; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mochizuki K, 2013, BIOCHEM BIOPH RES CO, V436, P497, DOI 10.1016/j.bbrc.2013.05.133; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Quoc NB, 2015, FUNG BIOL-US, P107, DOI 10.1007/978-3-319-10503-1_8; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Pan X, 2014, TOXICOL SCI, V138, P217, DOI 10.1093/toxsci/kft270; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Roberts AF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00958; Scherm B, 2011, MOL PLANT PATHOL, V12, P759, DOI 10.1111/J.1364-3703.2011.00709.X; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwab R, 2010, P NATL ACAD SCI USA; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Son H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006595; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tacke BK, 1996, J AOAC INT, V79, P472; Tinoco MLP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-27; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Weiberg A, 2015, CURR OPIN BIOTECH, V32, P207, DOI 10.1016/j.copbio.2014.12.025; Yang YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069463; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111	66	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202798	10.1371/journal.pone.0202798	http://dx.doi.org/10.1371/journal.pone.0202798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161200	Green Published, gold			2022-12-27	WOS:000443388900044
J	Hoorntje, ET; Posafalvi, A; Syrris, P; van der Velde, KJ; Bolling, MC; Protonotarios, A; Boven, LG; Amat-Codina, N; Groeneweg, JA; Wilde, AA; Sobreira, N; Calkins, H; Hauer, RNW; Jonkman, MF; McKenna, WJ; Elliott, PM; Sinke, RJ; van den Berg, MP; Chelko, SP; James, CA; van Tintelen, JP; Judge, DP; Jongbloed, JDH				Hoorntje, Edgar T.; Posafalvi, Anna; Syrris, Petros; van der Velde, K. Joeri; Bolling, Marieke C.; Protonotarios, Alexandros; Boven, Ludolf G.; Amat-Codina, Nuria; Groeneweg, Judith A.; Wilde, Arthur A.; Sobreira, Nara; Calkins, Hugh; Hauer, Richard N. W.; Jonkman, Marcel F.; McKenna, William J.; Elliott, Perry M.; Sinke, Richard J.; van den Berg, Maarten P.; Chelko, Stephen P.; James, Cynthia A.; van Tintelen, J. Peter; Judge, Daniel P.; Jongbloed, Jan D. H.			No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy	PLOS ONE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; MUSCULAR-DYSTROPHY; GENETIC-VARIANTS; ASSOCIATION; MUTATIONS; INTEGRITY; DIAGNOSIS; PATHOLOGY; ISOFORMS; REVEALS	Aims Likely pathogenic/pathogenic variants in genes encoding desmosomal proteins play an important role in the pathophysiology of arrhythmogenic right ventricular cardiomyopathy (ARVC). However, for a substantial proportion of ARVC patients, the genetic substrate remains unknown. We hypothesized that plectin, a cytolinker protein encoded by the PLEC gene, could play a role in ARVC because it has been proposed to link the desmosomal protein desmoplakin to the cytoskeleton and therefore has a potential function in the desmosomal structure. Methods We screened PLEC in 359 ARVC patients and compared the frequency of rare coding PLEC variants (minor allele frequency [MAF] <0.001) between patients and controls. To assess the frequency of rare variants in the control population, we evaluated the rare coding variants (MAF <0.001) found in the European cohort of the Exome Aggregation Database. We further evaluated plectin localization by immunofluorescence in a subset of patients with and without a PLEC variant. Results Forty ARVC patients carried one or more rare PLEC variants (11%, 40/359). However, rare variants also seem to occur frequently in the control population (18%, 4754/26197 individuals). Nor did we find a difference in the prevalence of rare PLEC variants in ARVC patients with or without a desmosomal likely pathogenic/pathogenic variant (14% versus 8%, respectively). However, immunofluorescence analysis did show decreased plectin junctional localization in myocardial tissue from 5 ARVC patients with PLEC variants. Conclusions Although PLEC has been hypothesized as a promising candidate gene for ARVC, our current study did not show an enrichment of rare PLEC variants in ARVC patients compared to controls and therefore does not support a major role for PLEC in this disorder. Although rare PLEC variants were associated with abnormal localization in cardiac tissue, the confluence of data does not support a role for plectin abnormalities in ARVC development.	[Hoorntje, Edgar T.; Posafalvi, Anna; van der Velde, K. Joeri; Boven, Ludolf G.; Sinke, Richard J.; van Tintelen, J. Peter; Jongbloed, Jan D. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Hoorntje, Edgar T.; van Tintelen, J. Peter] Netherlands Heart Inst, Durrer Cardiovasc Res Ctr, Utrecht, Netherlands; [Syrris, Petros; Protonotarios, Alexandros; McKenna, William J.; Elliott, Perry M.] UCL, Ctr Heart Muscle Dis, Inst Cardiovasc Sci, London, England; [Bolling, Marieke C.; Jonkman, Marcel F.] Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Groningen, Netherlands; [Amat-Codina, Nuria; Calkins, Hugh; Chelko, Stephen P.; James, Cynthia A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Groeneweg, Judith A.; Hauer, Richard N. W.; Judge, Daniel P.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Wilde, Arthur A.] Univ Amsterdam, Amsterdam Univ Med Ctr, Cardiovasc Sci, Heart Ctr,Dept Clin & Expt Cardiol, Amsterdam, Netherlands; [Wilde, Arthur A.] Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Sobreira, Nara] Johns Hopkins Univ, Sch Med, Dept Genet, Baltimore, MD USA; [van den Berg, Maarten P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van Tintelen, J. Peter] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Clin Genet, Cardiovasc Sci, Amsterdam, Netherlands; [Judge, Daniel P.] Med Univ South Carolina, Charleston, SC 29425 USA	University of Groningen; University of London; University College London; University of Groningen; Johns Hopkins University; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Johns Hopkins University; University of Groningen; University of Amsterdam; Medical University of South Carolina	Jongbloed, JDH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	j.d.h.jongbloed@umcg.nl	Elliott, Perry/AAR-3430-2020; van Tintelen, J. Peter/AAJ-9962-2021; SYRRIS, PETROS/C-1703-2008; McKenna, William J/C-3243-2008; Protonotarios, Alexandros/G-1046-2018	Elliott, Perry/0000-0003-3383-3984; SYRRIS, PETROS/0000-0002-2363-8758; McKenna, William J/0000-0001-7994-2460; Protonotarios, Alexandros/0000-0001-8595-7212; Hoorntje, Edgar/0000-0002-8326-7717; van den Berg, Maarten/0000-0002-1493-2998; Chelko, Stephen/0000-0003-1675-5945; Judge, Daniel/0000-0002-3407-0248; James, Cynthia/0000-0001-8040-4600	Netherlands Cardiovascular Research Initiative of the Dutch Heart Foundation [CVON2012-10 PREDICT, CVON 2014-40 DOSIS]; Baylor-Hopkins Center for Mendelian Genomics - NHGRI/NHLBI [2UM1HG006542]; Netherlands Organisation for Scientific Research (NWO); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER	Netherlands Cardiovascular Research Initiative of the Dutch Heart Foundation; Baylor-Hopkins Center for Mendelian Genomics - NHGRI/NHLBI; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was financially supported by the Netherlands Cardiovascular Research Initiative of the Dutch Heart Foundation (CVON2012-10 PREDICT and CVON 2014-40 DOSIS projects), the Baylor-Hopkins Center for Mendelian Genomics, which is funded by a grant from the NHGRI/NHLBI (2UM1HG006542), the Netherlands Organisation for Scientific Research (NWO, visitor's travel grant	Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Basso C, 2009, LANCET, V373, P1289, DOI 10.1016/S0140-6736(09)60256-7; Bhonsale A, 2015, EUR HEART J, V36, P847, DOI 10.1093/eurheartj/ehu509; Bolling MC, 2010, J INVEST DERMATOL, V130, P1178, DOI 10.1038/jid.2009.390; Bolling MC, 2014, J INVEST DERMATOL, V134, P273, DOI 10.1038/jid.2013.277; Castanon MJ, 2013, HISTOCHEM CELL BIOL, V140, P33, DOI 10.1007/s00418-013-1102-0; Chelko SP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85923; Eger A, 1997, J CELL SCI, V110, P1307; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; Gostynska KB, 2015, HUM MOL GENET, V24, P3155, DOI 10.1093/hmg/ddv066; Groeneweg JA, 2015, CIRC-CARDIOVASC GENE, V8, P437, DOI 10.1161/CIRCGENETICS.114.001003; Hoorntje ET, 2017, CARDIOVASC RES, V113, P1521, DOI 10.1093/cvr/cvx150; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Koss-Harnes D, 2002, J INVEST DERMATOL, V118, P87, DOI 10.1046/j.0022-202x.2001.01591.x; Lazzarini E, 2015, HUM MUTAT, V36, P403, DOI 10.1002/humu.22765; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Marcus FI, 2013, J AM COLL CARDIOL, V62, P1911, DOI 10.1016/j.jacc.2013.07.064; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McMilian JR, 1998, J INVEST DERMATOL, V110, P132, DOI 10.1046/j.1523-1747.1998.00102.x; Ortega E, 2016, J BIOL CHEM, V291, P18643, DOI 10.1074/jbc.M116.732909; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schroder R, 2002, J NEUROPATH EXP NEUR, V61, P520, DOI 10.1093/jnen/61.6.520; Sen-Chowdhry S, 2007, CIRCULATION, V115, P1710, DOI 10.1161/CIRCULATIONAHA.106.660241; Sen-Chowdhry S, 2010, ANNU REV MED, V61, P233, DOI 10.1146/annurev.med.052208.130419; te Rijdt WP, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.124; Teekakirikul P, 2013, J MOL DIAGN, V15, P158, DOI 10.1016/j.jmoldx.2012.09.002; Thorolfsdottir RB, 2017, J AM COLL CARDIOL, V70, P2157, DOI 10.1016/j.jacc.2017.09.005; Villa CR, 2015, NEUROMUSCULAR DISORD, V25, P165, DOI 10.1016/j.nmd.2014.09.011; Walko G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002396; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; WICHE G, 1984, EXP CELL RES, V155, P43, DOI 10.1016/0014-4827(84)90766-3; Winter L, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0314-7; Ye JJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-11	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203078	10.1371/journal.pone.0203078	http://dx.doi.org/10.1371/journal.pone.0203078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161220	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900078
J	Bigford, GE; Darr, AJ; Bracchi-Ricard, VC; Gao, H; Nash, MS; Bethea, JR				Bigford, Gregory E.; Darr, Andrew J.; Bracchi-Ricard, Valerie C.; Gao, Han; Nash, Mark S.; Bethea, John R.			Effects of ursolic acid on sub-lesional muscle pathology in a contusion model of spinal cord injury	PLOS ONE			English	Article							FUNCTIONAL ELECTRICAL-STIMULATION; MESSENGER-RNA EXPRESSION; BONE-MINERAL DENSITY; SYNTHASE KINASE 3; SKELETAL-MUSCLE; CARDIOVASCULAR-DISEASE; PARAPLEGIC PATIENTS; SIGNALING PATHWAYS; UBIQUITIN LIGASES; QUADRICEPS MUSCLE	Spinal Cord Injury (SCI) results in severe sub-lesional muscle atrophy and fiber type transformation from slow oxidative to fast glycolytic, both contributing to functional deficits and maladaptive metabolic profiles. Therapeutic countermeasures have had limited success and muscle-related pathology remains a clinical priority. mTOR signaling is known to play a critical role in skeletal muscle growth and metabolism, and signal integration of anabolic and catabolic pathways. Recent studies show that the natural compound ursolic acid (UA) enhances mTOR signaling intermediates, independently inhibiting atrophy and inducing hypertrophy. Here, we examine the effects of UA treatment on sub-lesional muscle mTOR signaling, catabolic genes, and functional deficits following severe SCI in mice. We observe that UA treatment significantly attenuates SCI induced decreases in activated forms of mTOR, and signaling intermediates PI3K, AKT, and S6K, and the upregulation of catabolic genes including FOXO1, MAFbx, MURF-1, and PSMD11. In addition, UA treatment improves SCI induced deficits in body and sub-lesional muscle mass, as well as functional outcomes related to muscle function, motor coordination, and strength. These findings provide evidence that UA treatment may be a potential therapeutic strategy to improve muscle-specific pathological consequences of SCI.	[Bigford, Gregory E.; Gao, Han; Nash, Mark S.] Miami Project Cure Paralysis, Miami, FL 33136 USA; [Bigford, Gregory E.; Gao, Han; Nash, Mark S.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Darr, Andrew J.] Univ Illinois, Coll Med Peoria, Dept Hlth Sci Educ, Peoria, IL USA; [Bracchi-Ricard, Valerie C.; Bethea, John R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Nash, Mark S.] Univ Miami, Miller Sch Med, Dept Rehabil Med, Miami, FL 33136 USA	University of Miami; University of Illinois System; University of Illinois Peoria; Drexel University; University of Miami	Bigford, GE (corresponding author), Miami Project Cure Paralysis, Miami, FL 33136 USA.; Bigford, GE (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA.	gbigford@med.miami.edu	Bigford, Gregory/GMW-4031-2022	Bigford, Gregory/0000-0001-8990-3465	Miami Project to Cure Paralysis	Miami Project to Cure Paralysis	This work was supported by the Miami Project to Cure Paralysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JL, 1996, PFLUG ARCH EUR J PHY, V431, P513, DOI 10.1007/BF02191897; Baldi JC, 1998, SPINAL CORD, V36, P463, DOI 10.1038/sj.sc.3100679; Bang HS, 2014, KOREAN J PHYSIOL PHA, V18, P441, DOI 10.4196/kjpp.2014.18.5.441; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Battaglino RA, 2012, CURR OSTEOPOROS REP, V10, P278, DOI 10.1007/s11914-012-0117-0; Bauman W A, 2001, J Spinal Cord Med, V24, P266; Bauman W A, 2000, Phys Med Rehabil Clin N Am, V11, P109; BAUMAN WA, 1992, PARAPLEGIA, V30, P697, DOI 10.1038/sc.1992.136; Bauman WA, 1999, ASSIST TECHNOL, V11, P88, DOI 10.1080/10400435.1999.10131993; Bauman WA, 1999, SPINAL CORD, V37, P601, DOI 10.1038/sj.sc.3100911; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BRENES G, 1986, ARCH PHYS MED REHAB, V67, P445; Burnham R, 1997, SPINAL CORD, V35, P86, DOI 10.1038/sj.sc.3100364; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Castro MJ, 1999, J APPL PHYSIOL, V86, P350, DOI 10.1152/jappl.1999.86.1.350; Castro MJ, 1999, EUR J APPL PHYSIOL, V80, P373, DOI 10.1007/s004210050606; Chelh I, 2011, ANIMAL, V5, P278, DOI 10.1017/S1751731110001862; Chelh I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-196; Chen Y, 2006, SPINAL CORD, V44, P82, DOI 10.1038/sj.sc.3101818; Chu X, 2015, MOL NUTR FOOD RES, V59, P1491, DOI 10.1002/mnfr.201400670; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Csibi A, 2009, J BIOL CHEM, V284, P4413, DOI 10.1074/jbc.M807641200; DEARWATER SR, 1986, MED SCI SPORT EXER, V18, P541; DEVOL DL, 1990, AM J PHYSIOL, V259, pE89, DOI 10.1152/ajpendo.1990.259.1.E89; Donaldson N, 2000, SPINAL CORD, V38, P680, DOI 10.1038/sj.sc.3101072; Dudley-Javoroski S, 2008, J REHABIL RES DEV, V45, P283, DOI 10.1682/JRRD.2007.02.0031; Dupont-Versteegden EE, 2000, AM J PHYSIOL-CELL PH, V279, pC1677, DOI 10.1152/ajpcell.2000.279.6.C1677; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Elkina Y, 2011, J CACHEXIA SARCOPENI, V2, P143, DOI 10.1007/s13539-011-0035-5; Frey-Rindova P, 2000, SPINAL CORD, V38, P26, DOI 10.1038/sj.sc.3100905; Gael JB, 2005, PEPTIDES, V26, P1528, DOI 10.1016/j.peptides.2005.03.011; Garikipati DK, 2012, AM J PHYSIOL-REG I, V302, pR1059, DOI 10.1152/ajpregu.00523.2011; GARLAND DE, 1992, J ORTHOPAED RES, V10, P371, DOI 10.1002/jor.1100100309; Garshick E, 2005, SPINAL CORD, V43, P408, DOI 10.1038/sj.sc.3101729; Gerrits HL, 1999, MUSCLE NERVE, V22, P1249, DOI 10.1002/(SICI)1097-4598(199909)22:9<1249::AID-MUS13>3.3.CO;2-E; Giangregorio L, 2006, J SPINAL CORD MED, V29, P489, DOI 10.1080/10790268.2006.11753898; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; GORDON T, 1994, PHYS THER, V74, P50, DOI 10.1093/ptj/74.1.50; Gorgey AS, 2007, SPINAL CORD, V45, P304, DOI 10.1038/sj.sc.3101968; Gorgey AS, 2011, PM&R, V3, P440, DOI 10.1016/j.pmrj.2011.01.011; GRANAT MH, 1993, PARAPLEGIA, V31, P207, DOI 10.1038/sc.1993.39; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; GRIMBY G, 1976, SCAND J REHABIL MED, V8, P37; Groah SL, 2011, J CARDIOPULM REHABIL, V31, P73, DOI 10.1097/HCR.0b013e3181f68aba; Groah SL, 2009, J SPINAL CORD MED, V32, P25, DOI 10.1080/10790268.2009.11760749; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Huang ZQ, 2011, CELL SIGNAL, V23, P1441, DOI 10.1016/j.cellsig.2011.05.003; Jia Y, 2015, MOL NUTR FOOD RES, V59, P344, DOI 10.1002/mnfr.201400399; Jung SH, 2007, BIOCHEM J, V403, P243, DOI 10.1042/BJ20061123; KARLSSON AK, 1995, METABOLISM, V44, P52, DOI 10.1016/0026-0495(95)90289-9; Kemp Bryan J, 2005, Phys Med Rehabil Clin N Am, V16, P1, DOI 10.1016/j.pmr.2004.06.009; Koopman R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00032; Kostovski E, 2008, SPINAL CORD, V46, P559, DOI 10.1038/sc.2008.3; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JY, 2011, BIOCHEM BIOPH RES CO, V415, P632, DOI 10.1016/j.bbrc.2011.10.124; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Leger B, 2009, MUSCLE NERVE, V40, P69, DOI 10.1002/mus.21293; LEVY M, 1990, J BIOMED ENG, V12, P150, DOI 10.1016/0141-5425(90)90136-B; Liang H, 2007, ARCH PHYS MED REHAB, V88, P1198, DOI 10.1016/j.apmr.2007.05.023; LIEBER RL, 1986, DEV MED CHILD NEUROL, V28, P533; Lin CY, 2018, J NEUROTRAUM, V35, P1737, DOI 10.1089/neu.2017.5444; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; LOTTA S, 1991, PARAPLEGIA, V29, P247, DOI 10.1038/sc.1991.35; Maimoun L, 2006, SPINAL CORD, V44, P203, DOI 10.1038/sj.sc.3101832; MAKI KC, 1995, PARAPLEGIA, V33, P102, DOI 10.1038/sc.1995.24; McGlinchey-Berroth R, 1995, J Spinal Cord Med, V18, P183; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Minetti GC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002038; Modlesky CM, 2004, J APPL PHYSIOL, V96, P561, DOI 10.1152/japplphysiol.00207.2003; Moore CD, 2015, J MUSCULOSKEL NEURON, V15, P32; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Myers J, 2007, AM J PHYS MED REHAB, V86, P142, DOI 10.1097/PHM.0b013e31802f0247; Nash Mark S, 2005, J Neurol Phys Ther, V29, P87; Nash MS, 2016, ARCH PHYS MED REHAB, V97, P1696, DOI 10.1016/j.apmr.2016.07.002; NASH MS, 1995, PARAPLEGIA, V33, P80, DOI 10.1038/sc.1995.20; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Novotny L, 2001, NEOPLASMA, V48, P241; Ogasawara R, 2013, AM J PHYSIOL-ENDOC M, V305, pE760, DOI 10.1152/ajpendo.00302.2013; Ohnishi Y, 2012, NEUROREPORT, V23, P157, DOI 10.1097/WNR.0b013e32834f4048; Qin WP, 2010, ANN NY ACAD SCI, V1211, P66, DOI 10.1111/j.1749-6632.2010.05806.x; RABISCHONG E, 1992, PARAPLEGIA, V30, P467, DOI 10.1038/sc.1992.100; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; ROCHESTER L, 1995, PARAPLEGIA, V33, P437, DOI 10.1038/sc.1995.97; Rodriguez DJ, 1997, SPINAL CORD, V35, P599, DOI 10.1038/sj.sc.3100439; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; ROUND JM, 1993, J NEUROL SCI, V116, P207, DOI 10.1016/0022-510X(93)90327-U; Roy RL, 2000, MUSCLE NERVE, V23, P735, DOI 10.1002/(SICI)1097-4598(200005)23:5<735::AID-MUS11>3.0.CO;2-T; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; SaKM G, 2010, TOP SPINAL CORD INJ, V15, P1; Sanchez AMJ, 2013, INT J BIOCHEM CELL B, V45, P2158, DOI 10.1016/j.biocel.2013.06.001; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCELSI R, 1982, ACTA NEUROPATHOL, V57, P243, DOI 10.1007/BF00692178; Seiliez I, 2013, GEN COMP ENDOCR, V186, P9, DOI 10.1016/j.ygcen.2013.02.008; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shields RK, 1997, J APPL PHYSIOL, V82, P1499, DOI 10.1152/jappl.1997.82.5.1499; SHIELDS RK, 1995, J NEUROPHYSIOL, V73, P2195, DOI 10.1152/jn.1995.73.6.2195; Spungen AM, 2003, J APPL PHYSIOL, V95, P2398, DOI 10.1152/japplphysiol.00729.2002; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Talmadge RJ, 2002, J APPL PHYSIOL, V93, P1487, DOI 10.1152/japplphysiol.00053.2002; Thomas CK, 1997, EXP NEUROL, V148, P414, DOI 10.1006/exnr.1997.6690; TSITOURAS PD, 1995, HORM METAB RES, V27, P287, DOI 10.1055/s-2007-979961; Urso ML, 2007, J PHYSIOL-LONDON, V579, P877, DOI 10.1113/jphysiol.2006.118042; Urso ML, 2009, MED SCI SPORT EXER, V41, P1860, DOI 10.1249/MSS.0b013e3181a6458a; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Wahman K, 2011, J REHABIL MED, V43, P237, DOI 10.2340/16501977-0658; Wang Zhihui, 2009, MEAS CONTROL, V19, P11, DOI DOI 10.1016/j.ejphar.2009.11.019; Wei ZJ, 2016, MOL MED REP, V14, P165, DOI 10.3892/mmr.2016.5272; Yang Y, 2014, J MOL CELL CARDIOL, V67, P103, DOI 10.1016/j.yjmcc.2013.12.018; Zehnder Y, 2004, OSTEOPOROSIS INT, V15, P180, DOI 10.1007/s00198-003-1529-6; Zeman RJ, 2009, PFLUG ARCH EUR J PHY, V458, P525, DOI 10.1007/s00424-009-0643-5; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zlotolow S P, 1992, J Am Paraplegia Soc, V15, P158	123	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203042	10.1371/journal.pone.0203042	http://dx.doi.org/10.1371/journal.pone.0203042			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157245	Green Submitted, gold, Green Published			2022-12-27	WOS:000443071400084
J	Fogues, RL; Such, JM; Espinosa, A; Garcia-Fornes, A				Fogues, Ricard L.; Such, Jose M.; Espinosa, Agustin; Garcia-Fornes, Ana			Tie and tag: A study of tie strength and tags for photo sharing	PLOS ONE			English	Article							PRIVACY	Tie strength and tags have been separately suggested as possible attributes for photo access controls in Social Network Services. However, an evaluation is missing about the benefits/drawbacks of adding one or both of these attributes to the ones already used in access controls for Social Network Services (groups and individuals). In this paper, we describe an experiment with 48 participants using access controls that include tie strength and tags (separately and simultaneously) together with attributes for groups and individuals. We analyze the results using several quantitative and qualitative metrics. We find that users consider these two new attributes useful in defining their sharing policies, and they prefer to employ access controls that consider tags and tie strength jointly. Specifically, users believe that tie strength improves policy understandability and that tags help them define sharing policies faster. However, we also observe that when users employ these two attributes they tend to make more mistakes in terms of the resulting sharing policy. We hypothesize that this could be caused by the lack of experience using tie strength and tags in access controls.	[Fogues, Ricard L.; Espinosa, Agustin; Garcia-Fornes, Ana] Univ Politecn Valencia, Dept Sistemas Informat & Computac, Valencia, Spain; [Such, Jose M.] Kings Coll London, Dept Informat, London, England	Universitat Politecnica de Valencia; University of London; King's College London	Fogues, RL (corresponding author), Univ Politecn Valencia, Dept Sistemas Informat & Computac, Valencia, Spain.	rilopez@dsic.upv.es	Garcia-Fornes, Ana/C-8260-2014; Such, Jose/AAH-5257-2020; Espinosa, Agustín/L-5630-2014; Espinosa, Agustín/ABG-2376-2020	Garcia-Fornes, Ana/0000-0003-4482-8793; Such, Jose/0000-0002-6041-178X; Espinosa, Agustín/0000-0001-8070-3344; Espinosa, Agustín/0000-0001-8070-3344	Ministerio de Economia y Competitividad [TIN2014-55206-R, TIN2017-89156-R]	Ministerio de Economia y Competitividad(Spanish Government)	This research was supported by the Ministerio de Economia y Competitividad (http://www.mineco.gob.es/), grant number: TIN2014-55206-R and TIN2017-89156-R to A.G.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amershi S, 2012, P ACM C HUM FACT COM; [Anonymous], P 19 INT C WORLD WID; Bejugam R., 2011, 2011 IEEE International Conference on Data Mining Workshops, P620, DOI 10.1109/ICDMW.2011.74; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Bruns G., 2012, P CODASPY, P117, DOI DOI 10.1145/2133601.2133616; Carminati B, 2009, ACM T INFORM SYST SE, V13, DOI 10.1145/1609956.1609962; Cheek GP, 2012, P 17 ACM S ACC CONTR, P23; Dunbar RIM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150292; Fang, 2010, P 19 INT C WORLD WID, P351, DOI DOI 10.1145/1772690.1772727; Fiesler C, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P567, DOI 10.1145/2998181.2998223; Fogues RL, 2014, INFORM SYST FRONT, V16, P225, DOI 10.1007/s10796-013-9453-6; Fong P.W., 2011, P 1 ACM C DATA APPL, P191, DOI DOI 10.1145/1943513.1943539; Frank E, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P1269, DOI 10.1007/978-0-387-09823-4_66; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hart Michael, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P401, DOI 10.1109/CSE.2009.425; Javed Y, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P544, DOI 10.1109/SocialCom.2013.82; Jones S., 2010, P S US PRIV SEC; Klemperer P., 2012, P SIGCHI C HUMAN FAC, P377; Kokciyan N, 2016, IEEE T KNOWL DATA EN, V28, P2724, DOI 10.1109/TKDE.2016.2583425; Kucuktunc O, 2008, TAG SUGGESTR AUTOMAT, P61; Lipford H.R., 2008, UPSEC, P1; Lipford HR, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1111; Litt E, 2016, SOC MEDIA SOC, V2, DOI 10.1177/2056305116633482; Madejski M., 2012, 2012 IEEE International Conference on Pervasive Computing and Communications Workshops (PerCom Workshops), P340, DOI 10.1109/PerComW.2012.6197507; Nissenbaum H, 2004, WASH LAW REV, V79, P119; Papacharissi Z., 2012, INT J COMMUNICATION, V6; Quinlan JR, 1993, MORGAN KAUFMANN SERI, DOI 10.1016/C2009-0-27846-9; Robinson G.K., 1991, STAT SCI, P15, DOI DOI 10.1214/SS/1177011926; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Semaan B, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P1158, DOI 10.1145/2675133.2675187; Sleeper M., 2013, P 2013 C COMPUTER SU, P793, DOI DOI 10.1145/2441776.2441865; Squicciarini A., 2011, P 22 ACM C HYP HYP, P261, DOI DOI 10.1145/1995966.1996000; Thomas K, 2010, LECT NOTES COMPUT SC, V6205, P236, DOI 10.1007/978-3-642-14527-8_14; Vitak J, 2015, INT J COMMUNICATION, V9; Wiese J, 2011, UBICOMP'11: PROCEEDINGS OF THE 2011 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P197; Wisniewski P., 2012, P 30 ACM ANN C HUMAN, P609, DOI DOI 10.1145/2207676.2207761; Yeung CA, 2009, P AAAI SPRING S SOC, V2	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202540	10.1371/journal.pone.0202540	http://dx.doi.org/10.1371/journal.pone.0202540			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157223	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400060
J	Gonzalez-Crespo, C; Serrano, E; Cahill, S; Castillo-Contreras, R; Cabaneros, L; Lopez-Martin, JM; Roldan, J; Lavin, S; Lopez-Olvera, JR				Gonzalez-Crespo, Carlos; Serrano, Emmanuel; Cahill, Sean; Castillo-Contreras, Raquel; Cabaneros, Lluis; Maria Lopez-Martin, Jose; Roldan, Joan; Lavin, Santiago; Ramon Lopez-Olvera, Jorge			Stochastic assessment of management strategies for a Mediterranean peri-urban wild boar population	PLOS ONE			English	Article							SUS-SCROFA; IBERIAN PENINSULA; RISK-ASSESSMENT; LIFE-HISTORY; ELASTICITY; ABUNDANCE; ECOSYSTEM; FOOD; MORTALITY; PRESSURE	Wild boar (Sus scrofa) population spread into urban and periurban areas has exacerbated conflicts with humans. There is a need for planned wild boar management strategies, and Population viability analysis (PVA) combined with perturbation analyses allow the assessment of the management effort of control methods. Our study aims to develop stochastic predictive models of the increasing wild boar population of the 80 km(2) peri-urban Mediterranean area of Collserola Natural Park (CNP), located near Barcelona, Spain, as well as assessing specific management measures (including reduced food availability, selective harvest, and reduction in fertility). Population parameters were estimated from previously published census and hunting data provided by the CNP and the local hunting administration. The results revealed that under the current conditions the CNP wild boar population will continue to increase. The most efficient strategy to reduce wild boar abundance was a combination of reducing supplementary anthropogenic food resources and selective removal of juvenile (<1 year) and yearling (1-2 years) wild boar. These strategies will probably be also the most efficient ones in other oversupplemented increasing wild boar populations in similar situations, although specific studies will be needed to fine-tune the best management option for each context. PVA allows the prediction of future population trends and the assessment of the efficacy and efficiency of potential management strategies before implementing management measures.	[Gonzalez-Crespo, Carlos; Serrano, Emmanuel; Castillo-Contreras, Raquel; Lavin, Santiago; Ramon Lopez-Olvera, Jorge] Univ Autonoma Barcelona UAB, Wildlife Ecol & Hlth Grp, Barcelona, Spain; [Gonzalez-Crespo, Carlos; Serrano, Emmanuel; Castillo-Contreras, Raquel; Lavin, Santiago; Ramon Lopez-Olvera, Jorge] Univ Autonoma Barcelona UAB, Serv Ecopatol Fauna Salvatge SEFaS, Dept Med & CirurgiaAnim, Fac Vet, Barcelona, Spain; [Serrano, Emmanuel] Univ Aveiro UA, Dept Biol, Aveiro, Portugal; [Serrano, Emmanuel] Univ Aveiro UA, Cesam, Aveiro, Portugal; [Cahill, Sean; Cabaneros, Lluis] Consorci Parc Nat Serra Collserola, Barcelona, Spain; [Maria Lopez-Martin, Jose] Generalitat Catalunya, Serv Terr Barcelona, Dept Agr Ramaderia Pesca & Alimentacio, Barcelona, Spain; [Roldan, Joan] Generalitat Catalunya, Forestal Catalana SA, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Universidade de Aveiro; Universidade de Aveiro	Lopez-Olvera, JR (corresponding author), Univ Autonoma Barcelona UAB, Wildlife Ecol & Hlth Grp, Barcelona, Spain.; Lopez-Olvera, JR (corresponding author), Univ Autonoma Barcelona UAB, Serv Ecopatol Fauna Salvatge SEFaS, Dept Med & CirurgiaAnim, Fac Vet, Barcelona, Spain.	Jordi.Lopez.Olvera@uab.cat	Gonzalez-Crespo, Carlos/GYV-0388-2022; Lavín, Santiago/L-5975-2014; Castillo-Contreras, Raquel/AAI-1831-2019; Contreras, Raquel Castillo/AAG-6050-2020; Martin, Josep Maria Lopez/H-8392-2015; SERRANO-FERRON, Emmanuel/J-4489-2013; Lopez Olvera, Jorge Ramon/H-8382-2015	Gonzalez-Crespo, Carlos/0000-0003-4312-0398; Lavín, Santiago/0000-0001-5655-588X; Contreras, Raquel Castillo/0000-0002-5770-7264; Martin, Josep Maria Lopez/0000-0001-8162-3960; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Lopez Olvera, Jorge Ramon/0000-0002-2999-3451	Fundacao para a Ciencia e a Tecnologia (Portugal) [SFRH/B+PD/96637/2013]; University of Aveiro (Department of Biology); FCT/MEC [CESAM RU UID/AMB/50017]; FEDER within the PT2020 Partnership Agreement; Universitat Auto noma de Barcelona [13/051, 15/0174]; Municipality of Barcelona [13/051, 15/0174]; Generalitat de Catalunya (Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement) [2016FI_B 00425]; European Social Fund (ESF)	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); University of Aveiro (Department of Biology); FCT/MEC; FEDER within the PT2020 Partnership Agreement; Universitat Auto noma de Barcelona; Municipality of Barcelona; Generalitat de Catalunya (Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement); European Social Fund (ESF)(European Social Fund (ESF))	E. Serrano was supported by the Fundacao para a Ciencia e a Tecnologia (Portugal), through the postdoctoral program (SFRH/B+PD/96637/2013), and the University of Aveiro (Department of Biology) and FCT/MEC (CESAM RU UID/AMB/50017), co-financed by the FEDER within the PT2020 Partnership Agreement. This research was funded by the contracts 13/051 and 15/0174 to Jorge Ramon Lopez-Olvera between the Universitat Auto noma de Barcelona and the Municipality of Barcelona. Raquel Castillo-Contreras benefitted from a PhD grant (2016FI_B 00425) co-financed by Generalitat de Catalunya (Secretaria d'Universitats i Recerca, Departament d'Economia i Coneixement) and the European Social Fund (ESF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; Acevedo P, 2014, ECOL INDIC, V36, P594, DOI 10.1016/j.ecolind.2013.09.019; Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; Akû║akaya H.R., 1999, APPL POPULATION ECOL; Andersen MC, 2008, WILDLIFE RES, V35, P242, DOI 10.1071/WR07107; Andersen MC, 2005, HUM ECOL RISK ASSESS, V11, P1083, DOI 10.1080/10807030500278610; Benton TG, 1999, TRENDS ECOL EVOL, V14, P467, DOI 10.1016/S0169-5347(99)01724-3; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Boitani L, 1985, J MOUNTAIN ECOLOGY, V3, p197 ; Bosch J, 2012, FOLIA ZOOL, V61, P138, DOI 10.25225/fozo.v61.i2.a7.2012; Braga C, 2010, EUR J WILDLIFE RES, V56, P465, DOI 10.1007/s10344-010-0373-1; Cahill S, 2012, ANIM BIODIV CONSERV, V35, P221; Cahill SL, 2012, 30 IUGB C 5 9 SEPT B; Cahill Sean, 2004, Galemys, V16, P37; Castillo-Contreras R, 2018, SCI TOTAL ENVIRON, V615, P282, DOI 10.1016/j.scitotenv.2017.09.277; Choquenot D, 2003, J ANIM ECOL, V72, P14, DOI 10.1046/j.1365-2656.2003.00676.x; Duca C, 2009, BIOL CONSERV, V142, P563, DOI 10.1016/j.biocon.2008.11.010; Fernandez-Llario P, 2000, ETHOL ECOL EVOL, V12, P335; Fernandez-Llario P, 2005, FOLIA ZOOL, V54, P240; Fernandez-Martinez M, 2012, ACTA OECOL, V43, P51, DOI 10.1016/j.actao.2012.05.006; Focardi S, 1996, FOREST ECOL MANAG, V88, P7, DOI 10.1016/S0378-1127(96)03804-2; Focardi S, 2008, J MAMMAL, V89, P1113, DOI 10.1644/07-MAMM-A-164.1; Fonseca C., 2004, GALEMYS, V16, P53; Geisser H, 2005, J ZOOL, V267, P89, DOI 10.1017/S095283690500734X; Geisser H, 2004, J WILDLIFE MANAGE, V68, P939, DOI 10.2193/0022-541X(2004)068[0939:EOHFAF]2.0.CO;2; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; Herrero J, 2008, ACTA THERIOL, V53, P355, DOI 10.1007/BF03195196; Hone J., 2012, APPL POPULATION COMM; Keuling O, 2017, ECOLOGY CONSERVATION, p202 ; Keuling O, 2013, EUR J WILDLIFE RES, V59, P805, DOI 10.1007/s10344-013-0733-8; Koenig WD, 2015, ECOLOGY, V96, P184, DOI 10.1890/14-0819.1; Lacy R., 2005, VORTEX10 STOCHASTIC; Lacy RC, 2015, VORTEX 10 1 MANUAL; Licoppe A, 2013, INT SURV REP INTR WO, P1; Llimona F., 2007, GALEMYS, V19, P215; Massei G, 1996, ACTA THERIOL, V41, P307, DOI 10.4098/AT.arch.96-29; Massei G, 1997, J ZOOL, V242, P394; Massei Giovanna, 2004, Galemys, V16, P135; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Massei Giovanna, 2011, Human-Wildlife Interactions, V5, P79; Mills L. S., 2013, CONSERVATION WILDLIF; Pepin KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183441; RodriguezEstevez V, 2007, ARCH ZOOTEC, V56, P25; Rosell C., 1998, BIOLOGIAIECOLOGIA SE; Rosell C., 2001, GALEMYS, V13, P1; Santos P, 2006, EUR J WILDLIFE RES, V52, P207, DOI 10.1007/s10344-005-0025-z; Serrano E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01307; Servanty S, 2011, J APPL ECOL, V48, P835, DOI 10.1111/j.1365-2664.2011.02017.x; Servanty S, 2009, J ANIM ECOL, V78, P1278, DOI 10.1111/j.1365-2656.2009.01579.x; Tenes Anna, 2007, Galemys, V19, P169; Toigo C, 2008, J WILDLIFE MANAGE, V72, P1532, DOI 10.2193/2007-378; Vetter SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132178	54	29	30	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202289	10.1371/journal.pone.0202289	http://dx.doi.org/10.1371/journal.pone.0202289			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157225	gold, Green Published, Green Submitted			2022-12-27	WOS:000443071400049
J	Hernando, C; Hernando, C; Collado, EJ; Panizo, N; Martinez-Navarro, I; Hernando, B				Hernando, Carlos; Hernando, Carla; Joaquin Collado, Eladio; Panizo, Nayara; Martinez-Navarro, Ignacio; Hernando, Barbara			Establishing cut-points for physical activity classification using triaxial accelerometer in middle-aged recreational marathoners	PLOS ONE			English	Article							GENEA ACCELEROMETER; ENERGY-EXPENDITURE; OXYGEN-UPTAKE; RUNNERS; PARTICIPATION; INTENSITY; ATHLETE; CONTEXT; YOUTH	The purpose of this study was to establish GENEA (Gravity Estimator of Normal Everyday Activity) cut-points for discriminating between six relative-intensity activity levels in middle-aged recreational marathoners. Nighty-eight (83 males and 15 females) recreational marathoners, aged 30-45 years, completed a cardiopulmonary exercise test running on a treadmill while wearing a GENEA accelerometer on their non-dominant wrist. The breath-by-breath- <(V)over dot>O-2 data was also collected for criterion measure of physical activity categories (sedentary, light, moderate, vigorous, very vigorous and extremely vigorous). GENEA cut-points for physical activity classification was performed via Receiver Operating Characteristic (ROC) analysis. Spearman's correlation test was applied to determine the relationship between estimated and measured intensity classifications. Statistical analysis were done for all individuals, and separating samples by sex. The GENEA cut-points established were able to distinguish between all six-relative intensity levels with an excellent classification accuracy (area under the ROC curve (AUC) values between 0.886 and 0.973) for all samples. When samples were separated by sex, AUC values were 0.881-0.973 and 0.924-0.968 for males and females, respectively. The total variance in energy expenditure explained by GENEA accelerometer data was 78.50% for all samples, 78.14% for males, and 83.17% for females. In conclusion, the wrist-worn GENEA accelerometer presents a high capacity of classifying the intensity of physical activity in middle-aged recreational marathoners when examining all samples together, as well as when sample set was separated by sex. This study suggests that the triaxial GENEA accelerometers (worn on the non-dominant wrist) can be used to predict energy expenditure for running activities.	[Hernando, Carlos] Jaume I Univ, Sport Serv, Castellon de La Plana, Spain; [Hernando, Carlos] Jaume I Univ, Dept Educ, Castellon de La Plana, Spain; [Hernando, Carla] Carlos III Univ Madrid, Dept Math, Madrid, Spain; [Joaquin Collado, Eladio; Panizo, Nayara] Jaume I Univ, Fac Hlth Sci, Castellon de La Plana, Spain; [Martinez-Navarro, Ignacio] Univ Valencia, Dept Phys Educ & Sport, Valencia, Spain; [Hernando, Barbara] Jaume I Univ, Dept Med, Castellon de La Plana, Spain	Universitat Jaume I; Universitat Jaume I; Universitat Jaume I; University of Valencia; Universitat Jaume I	Hernando, C (corresponding author), Jaume I Univ, Sport Serv, Castellon de La Plana, Spain.; Hernando, C (corresponding author), Jaume I Univ, Dept Educ, Castellon de La Plana, Spain.	hernando@uji.es	Hernando, Carlos/N-2601-2019; Collado-Boira, Eladio/AAB-6001-2019; Hernando, Barbara/AAZ-7357-2021; Hernando, Barbara/AAW-9979-2021	Hernando, Carlos/0000-0001-7182-4785; Collado-Boira, Eladio/0000-0001-8062-4152; Hernando, Barbara/0000-0003-4019-2732; MARTINEZ-NAVARRO, IGNACIO/0000-0002-2942-1293	Fundacion Trinidad Alfonso; Vithas-Nisa Hospitals group	Fundacion Trinidad Alfonso; Vithas-Nisa Hospitals group	Current research was funded by Fundacion Trinidad Alfonso (https://fundaciontrinidadalfonso.org) and Vithas-Nisa Hospitals group (https://www.hospitales.nisa.es). The study funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cordero MJA, 2014, NUTR HOSP, V29, P1250, DOI 10.3305/nh.2014.29.6.7410; Ahmadyar B, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1254-6; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Angus SD, 2014, J SPORT SCI, V32, P31, DOI 10.1080/02640414.2013.803592; Bassett DR, 2015, MED SCI SPORT EXER, V47, P833, DOI 10.1249/MSS.0000000000000468; Boone J, 2012, SPORTS MED, V42, P511, DOI 10.2165/11599690-000000000-00000; Burrows M, 2000, SPORTS MED, V30, P281, DOI 10.2165/00007256-200030040-00004; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Dijkstra HP, 2014, BRIT J SPORT MED, V48, P523, DOI 10.1136/bjsports-2013-093222; El Helou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037407; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Esteve-Lanao J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00298; Fudge BW, 2007, MED SCI SPORT EXER, V39, P192, DOI 10.1249/01.mss.0000235884.71487.21; Gabbett TJ, 2017, BRIT J SPORT MED, V51, P1451, DOI 10.1136/bjsports-2016-097298; Hamlyn-Williams CC, 2014, BMC SPORTS SCI MED R, V6, P35, DOI [10.1186/2052-1847-6-35, DOI 10.1186/2052-1847-6-35]; Hoffman MD, 2018, SPORTS MED, V48, P243, DOI 10.1007/s40279-017-0782-3; Hoffman MD, 2015, INT J SPORT PHYSIOL, V10, P93, DOI 10.1123/ijspp.2013-0534; Hoffman MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083867; Hoffman MD, 2010, INT J HIST SPORT, V27, P1877, DOI 10.1080/09523367.2010.494385; Knechtle B, 2017, CHIN J PHYSL, V60; Mansour SG, 2017, AM J KIDNEY DIS, V70, P252, DOI 10.1053/j.ajkd.2017.01.045; Montoye AHK, 2015, MED SCI SPORT EXER, V47, P1735, DOI 10.1249/MSS.0000000000000597; MONTOYE HJ, 1983, MED SCI SPORT EXER, V15, P403; Morgan KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094532; Myers J, 2000, SPORTS MED, V30, P23, DOI 10.2165/00007256-200030010-00003; Nightingale TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126086; Pentecost C, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0881-0; Phillips LRS, 2013, J SCI MED SPORT, V16, P124, DOI 10.1016/j.jsams.2012.05.013; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Schaefer CA, 2014, MED SCI SPORT EXER, V46, P826, DOI 10.1249/MSS.0000000000000150; Shephard RJ, 2001, MED SCI SPORT EXER, V33, pS400, DOI 10.1097/00005768-200106001-00008; Strath SJ, 2013, CIRCULATION, DOI [10.1161/01.cir, DOI 10.1161/01.CIR]; Szabo A, 2013, J BEHAV ADDICT, V2, P249, DOI 10.1556/JBA.2.2013.4.9; Trappe S, 2007, SPORTS MED, V37, P302, DOI 10.2165/00007256-200737040-00008; Vickers AJ, 2016, BMC SPORTS SCI MED R, V8, DOI 10.1186/s13102-016-0052-y; Welch WA, 2014, MED SCI SPORT EXER, V46, P1825, DOI 10.1249/MSS.0000000000000283; Welch WA, 2013, MED SCI SPORT EXER, V45, P2012, DOI 10.1249/MSS.0b013e3182965249; Wijndaele K, 2015, MED SCI SPORT EXER, V47, P2129, DOI 10.1249/MSS.0000000000000661; Zavorsky GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172121; Zhang SY, 2012, MED SCI SPORT EXER, V44, P2228, DOI 10.1249/MSS.0b013e31825e19fd; Zhang SY, 2012, MED SCI SPORT EXER, V44, P742, DOI 10.1249/MSS.0b013e31823bf95c	44	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202815	10.1371/journal.pone.0202815	http://dx.doi.org/10.1371/journal.pone.0202815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157271	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400071
J	Blackburn, NE; Mc Veigh, JG; Mc Caughan, EM; Kennedy, RD; McIntosh, SA; Wilson, IM				Blackburn, Nicole E.; Mc Veigh, Joseph G.; Mc Caughan, Eilis M.; Kennedy, Richard D.; McIntosh, Stuart A.; Wilson, Iseult M.			The musculoskeletal consequences of latissmus dorsi breast reconstruction in women following mastectomy for breast cancer	PLOS ONE			English	Article							BRIEF PAIN INVENTORY; ADJUVANT TREATMENT; OUTCOME MEASURES; UPPER EXTREMITY; FLAP; MORBIDITY; PERSPECTIVES; SURVIVORS; IMPACT	Introduction Current evidence suggests that patients who have latissimus dorsi (LD) breast reconstruction following mastectomy for breast cancer can experience long-term shoulder dysfunction. However, as there is no standardised assessment or follow-up period within the literature, findings are conflicting. This research aimed to investigate the impact on daily living of immediate and delayed LD breast reconstruction in women following mastectomy for breast cancer. Methods Both qualitative and quantitative methods of enquiry were used. A focus group study explored the musculoskeletal consequences of surgery as perceived by the women (n = 15) and their healthcare professionals (n =11). A questionnaire survey was administered (n = 159), including a range of outcome measures to quantify both the physical and psychosocial impact of LD breast reconstruction. Dyad interviews were also conducted in order to determine the impact of surgery on function and activities of daily living (ADL) from the woman's perspective and that of her significant other (n = 8). Results The qualitative studies highlighted a lack of preparedness and unrealistic expectations regarding functional recovery among women and their significant others'. Post-surgery it was apparent that women weighed up reduced shoulder function against survival, demonstrating resilience in their approach to coping with this adaptive way of living. The survey identified low to moderate effect on the outcomes assessed (n = 159), however, node removal significantly impacted certain aspects of quality of life (p<0.05) and disability (p = 0.04). Conclusions Breast reconstruction using the LD had an impact on shoulder function and some ADL, which impacted not only on the women but also family and significant others. Despite the functional implications associated with surgery, findings would suggest that shoulder dysfunction is not their main concern. This work identified that women and their significant other require further information to clarify expectation regarding recovery, highlighting the changing priorities of women throughout their journey from diagnosis into long-term recovery.	[Blackburn, Nicole E.] Queens Univ Belfast, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Blackburn, Nicole E.] UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Mc Veigh, Joseph G.] Univ Coll Cork, Coll Med & Hlth, Sch Clin Therapies, Cork, Ireland; [Mc Caughan, Eilis M.] Ulster Univ, Inst Nursing & Hlth Res, Coleraine, Londonderry, North Ireland; [Kennedy, Richard D.; McIntosh, Stuart A.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Wilson, Iseult M.] Ulster Univ, Ctr Hlth & Rehabil Technol, Inst Nursing & Hlth Res, Jordanstown, North Ireland	Queens University Belfast; University College Cork; Ulster University; Queens University Belfast; Ulster University	Blackburn, NE (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.; Blackburn, NE (corresponding author), UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland.	N.Blackburn@qub.ac.uk	McIntosh, Stuart/J-9512-2012; McVeigh, Joseph/A-5050-2018	McIntosh, Stuart/0000-0002-4123-9611; McVeigh, Joseph/0000-0003-0789-1419; Blackburn, Nicole/0000-0003-4379-6312; Wilson, Iseult M/0000-0002-5107-2843	Department of Employment and Learning, Northern Ireland; Cancer Focus Northern Ireland; Department of Employment and Learning	Department of Employment and Learning, Northern Ireland; Cancer Focus Northern Ireland; Department of Employment and Learning	We gratefully acknowledge the Department of Employment and Learning, Northern Ireland for funding the researcher's (NEB) studentship and Cancer Focus Northern Ireland for kindly funding the focus group and survey component of this research (to IMW).; This research would not have been possible without the participation of the women, their significant others and the healthcare professionals. We thank the PIs at each of the involved Trust sites and the breast care nurses and physiotherapists for their involvement in the focus groups and assistance with the recruitment for the study. We would also like to acknowledge the staff at the Northern Ireland Cancer Trials Network for their help in facilitating this research. A special thanks to the clinical research nurses at each site for their helpful contribution to the survey component of our study and to the staff from the charities and special interest groups involved in the dyad interviews. We gratefully acknowledge the Department of Employment and Learning for funding the researcher's studentship and Cancer Focus Northern Ireland for kindly funding the focus group and survey component of this research.	Adams Eike, 2010, Community Pract, V83, P18; Bodai Balazs I, 2015, Perm J, V19, P48, DOI 10.7812/TPP/14-241; Brackley PTH, 2010, J PLAST RECONSTR AES, V63, P1495, DOI 10.1016/j.bjps.2009.07.040; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Button J, 2010, J PLAST RECONSTR AES, V63, P1505, DOI 10.1016/j.bjps.2009.08.017; Castel LD, 2007, J PAIN SYMPTOM MANAG, V34, P380, DOI 10.1016/j.jpainsymman.2006.12.007; Cheville AL, 2007, J SURG ONCOL, V95, P409, DOI 10.1002/jso.20782; Chow TL, 2008, SURG PRACT, V12, P35, DOI 10.1111/j.1744-1633.2008.00394.x; Chung EJ, 2013, J EXERC REHABIL, V9, P532, DOI 10.12965/jer.130079; Ciesla S., 2012, EFFECT BREAST RECONS; Collins KK, 2011, BREAST CANCER RES TR, V126, P167, DOI 10.1007/s10549-010-1077-7; De Gournay E, 2010, EJSO-EUR J SURG ONC, V36, P520, DOI 10.1016/j.ejso.2010.04.008; De Oliveira GS, 2014, BREAST J, V20, P9, DOI 10.1111/tbj.12207; Finlay L, 2006, QUALITATIVE RES ALLL; Fodor L, 2011, CHIRURGIA-BUCHAREST, V106, P485; Forthomme B, 2010, CLIN PHYSIOL FUNCT I, V30, P406, DOI 10.1111/j.1475-097X.2010.00956.x; Fraser SM, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-16; FRAULIN FOG, 1995, ANN PLAS SURG, V35, P349, DOI 10.1097/00000637-199510000-00003; Giordano S, 2011, SCAND J SURG, V100, P202, DOI 10.1177/145749691110000312; Glassey N, 2008, PLAST RECONSTR SURG, V122, P1334, DOI 10.1097/PRS.0b013e3181881ffe; Gorman JR, 2011, CANCER NURS, V34, P32, DOI 10.1097/NCC.0b013e3181e4528d; Harrington S, 2014, ARCH PHYS MED REHAB, V95, P153, DOI 10.1016/j.apmr.2013.07.022; Hunsaker FG, 2002, J BONE JOINT SURG AM, V84A, P208, DOI 10.2106/00004623-200202000-00007; Inrig T, 2012, J OCCUP REHABIL, V22, P59, DOI 10.1007/s10926-011-9323-3; Javid SH, 2017, BREAST J, V23, P127, DOI 10.1111/tbj.12707; Kelly BJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-65; Kim SH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0399-x; Kim Z, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-259; Krueger RA., 2009, FOCUS GROUPS PRACTIC; Krueger RA, 2009, FOCUS GROUPS PRACTIC; Kumar SP, 2011, INDIAN J PALLIAT CAR, V17, P108, DOI 10.4103/0973-1075.84531; Lateef Fatimah, 2011, J Emerg Trauma Shock, V4, P163, DOI 10.4103/0974-2700.82199; Losken A, 2010, ANN PLAS SURG, V65, P17, DOI 10.1097/SAP.0b013e3181bda349; Lutringer J, 2012, ANN CHIR PLAST ESTH, V57, P567, DOI 10.1016/j.anplas.2012.04.006; Mintken PE, 2010, ARCH PHYS MED REHAB, V91, P1128, DOI 10.1016/j.apmr.2010.04.009; Molina Y, 2014, CLIN J ONCOL NURS, V18, P93, DOI 10.1188/14.CJON.93-101; Nelson JA, 2018, PRS-GLOB OPEN, V6, DOI 10.1097/GOX.0000000000001640; Pallant J.F, 2016, SPSS SURVIVAL MANUAL, V6; Parahoo K., 2014, NURSING RES PRINCIPL; Pathak A., 2012, MALAYS J ELT RES, V8, P1; Perdikis G., 2011, EPLASTY, V11, P411; Purushotham AD, 2005, J CLIN ONCOL, V23, P4312, DOI 10.1200/JCO.2005.03.228; Pusic AL, 2012, EXPERT REV PHARM OUT, V12, P149, DOI [10.1586/ERP.11.105, 10.1586/erp.11.105]; Reefy S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-171; Saint-Cyr M, 2009, PLAST RECONSTR SURG, V123, P13, DOI 10.1097/PRS.0b013e3181934838; Sajid MS, 2011, CLIN BREAST CANCER, V11, P357, DOI 10.1016/j.clbc.2011.04.006; Scully OJ, 2012, CANCER GENOM PROTEOM, V9, P311; Senkus E., 2013, ANN ONCOLOGY, V24; Sledge GW, 2014, J CLIN ONCOL, V32, P1979, DOI 10.1200/JCO.2014.55.4139; Smith Susan L, 2014, J Adv Pract Oncol, V5, P181; Spagnola Sarah, 2003, Breast J, V9, P463, DOI 10.1046/j.1524-4741.2003.09603.x; Stout NL, 2012, CANCER-AM CANCER SOC, V118, P2191, DOI 10.1002/cncr.27476; Szychta P, 2013, BREAST, V22, P667, DOI 10.1016/j.breast.2013.01.001; Tarantino I, 2006, PLAST RECONSTR SURG, V117, P1387, DOI 10.1097/01.prs.0000207396.22527.68; Teymouri Hr, 2006, Hippokratia, V10, P153; Thiruchelvam P. T. R., 2013, BRIT MED J, V347; Tomita K., 2013, EPLASTY, V13, P206; van Huizum MA, 2016, J PLAST SURG HAND SU, V50, P202, DOI 10.3109/2000656X.2016.1151436; Winters ZE, 2016, BRIT J SURG, V103, P524, DOI 10.1002/bjs.10102; Winters ZE, 2013, BRIT J SURG, V100, P240, DOI 10.1002/bjs.8959	60	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202859	10.1371/journal.pone.0202859	http://dx.doi.org/10.1371/journal.pone.0202859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153282	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700027
J	Cerutti, F; Modesto, P; Rizzo, F; Cravero, A; Jurman, I; Costal, S; Giammarino, M; Mandola, ML; Goria, M; Radovic, S; Cattonaro, F; Acutis, PL; Peletto, S				Cerutti, Francesco; Modesto, Paola; Rizzo, Francesca; Cravero, Alessandra; Jurman, Irena; Costal, Stefano; Giammarino, Mauro; Mandola, Maria Lucia; Goria, Mariella; Radovic, Slobodanka; Cattonaro, Federica; Acutis, Pier Luigi; Peletto, Simone			The microbiota of hematophagous ectoparasites collected from migratory birds	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; TICK IXODES-RICINUS; RICKETTSIA-BELLII; MIDICHLORIA-MITOCHONDRII; INTRACELLULAR BACTERIUM; GLOBAL DISTRIBUTION; MOLECULAR-DETECTION; IXODIDAE; DNA; IDENTIFICATION	Arthropod vectors are responsible for the transmission of human pathogens worldwide. Several arthropod species are bird ectoparasites, however, no study to date has characterized their microbiota as a whole. We sampled hematophagous ectoparasites that feed on migratory birds and performed 16S rRNA gene metabarcoding to characterize their microbial community. A total of 194 ectoparasites were collected from 115 avian hosts and classified into three groups: a) Hippoboscidae diptera; b) ticks; c) other arthropods. Metabarcoding showed that endosymbionts were the most abundant genera of the microbial community, including Wolbachia for Hippoboscidae diptera, Candidatus Midichloria for ticks, Wolbachia and Arsenophonus for the other arthropod group. Genera including pathogenic species were: Rickettsia, Borrelia, Coxiella, Francisella, Bartonella, Anaplasma. Co-infection with Borrelia-Rickettsia and Anaplasma-Rickettsia was also observed. A global overview of the microbiota of ectoparasites sampled from migratory birds was obtained with the use of 16S rRNA gene metabarcoding. A novel finding is the first identification of Rickettsia in the common swift louse fly, Crataerina pallida. Given their possible interaction with pathogenic viruses and bacteria, the presence of endosymbionts in arthropods merits attention. Finally, molecular characterization of genera, including both pathogenic and symbiont species, plays a pivotal role in the design of targeted molecular diagnostics.	[Cerutti, Francesco; Acutis, Pier Luigi; Peletto, Simone] Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Genet & Immunobiochim, Turin, Italy; [Modesto, Paola] Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Sez Genova, Genoa, Italy; [Rizzo, Francesca; Mandola, Maria Lucia] Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Lab Specialist Diagnost Mol Virol & Ovocoltura, Turin, Italy; [Cravero, Alessandra; Goria, Mariella] Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Microbiol Mol & Anal Genom, Turin, Italy; [Jurman, Irena; Radovic, Slobodanka; Cattonaro, Federica] IGA Technol Serv, Udine, Italy; [Costal, Stefano] Lab Chim Camera Commercio Torino, Turin, Italy; [Giammarino, Mauro] ASL CN 1, Dept Prevent, Racconigi, CN, Italy	IZS Piemonte Liguria e Valle D'aosta; IZS Piemonte Liguria e Valle D'aosta; IZS Piemonte Liguria e Valle D'aosta; IZS Piemonte Liguria e Valle D'aosta	Peletto, S (corresponding author), Ist Zooprofilatt Sperimentale Piemonte Liguria &, SS Genet & Immunobiochim, Turin, Italy.	simone.peletto@izsto.it	Cerutti, Francesco/J-5920-2016; Rizzo, Francesca/O-7333-2019; Modesto, Paola/AAW-3642-2020; Rizzo, Francesca/GNP-1521-2022; Peletto, Simone/K-2005-2016	Cerutti, Francesco/0000-0003-0480-8296; Rizzo, Francesca/0000-0001-7659-1773; Rizzo, Francesca/0000-0001-7659-1773; Goria, Maria/0000-0001-8908-4447; Peletto, Simone/0000-0002-8684-898X	Italian Ministry of Health [IZS PLV 16/12 RC]	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health [Ricerca Corrente 2012 IZS PLV 16/12 RC]. Irena Jurman, Slobodanka Radovic and Federica Cattonaro are employed by IGA technology services. IGA technology services provided support in the form of salaries for authors IJ, SR and FC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Amore G, 2007, J MED ENTOMOL, V44, P303, DOI 10.1603/0022-2585(2007)44[303:BLIIIR]2.0.CO;2; Barbieri ARM, 2012, PATHOG GLOB HEALTH, V106, P188, DOI 10.1179/2047773212Y.0000000022; Bazzocchi C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-350; Berri M, 2000, VET MICROBIOL, V72, P285, DOI 10.1016/S0378-1135(99)00178-9; Blanco CM, 2017, TICKS TICK-BORNE DIS, V8, P90, DOI 10.1016/j.ttbdis.2016.10.003; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cossio MLT, 2015, MANUAL DIAGNOSTIC TE, P1, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Dietrich M, 2014, EMERG INFECT DIS, V20, P838, DOI 10.3201/eid2005.131088; Duron O, 2016, MICROB ECOL, V71, P761, DOI 10.1007/s00248-015-0702-8; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Duron O, 2014, TICKS TICK-BORNE DIS, V5, P557, DOI 10.1016/j.ttbdis.2014.04.003; Elsa Jourdain, 2015, Infection Ecology & Epidemiology, V5, P29230, DOI 10.3402/iee.v5.29230; Epis S, 2008, PARASITOLOGY, V135, P485, DOI 10.1017/S0031182007004052; European Centre for Disease Prevention and Control (ECDC), 2014, IX RIC FACTSH EXP; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Finney CAM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004646; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Gerhart JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep33670; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gofton AW, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0958-3; Hayashi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155794; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hecht JA, 2016, J MED ENTOMOL, V53, P1492, DOI 10.1093/jme/tjw111; HOOGSTRAAL H, 1963, B WORLD HEALTH ORGAN, V28, P235; Hornok S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-128; IBNSALEM J, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Jameson LJ, 2012, TICKS TICK-BORNE DIS, V3, P95, DOI 10.1016/j.ttbdis.2011.12.002; Lindeborg M, 2012, EMERG INFECT DIS, V18, P2095, DOI 10.3201/eid1812.120718; Machado-Ferreira E, 2016, PARASITOL RES, V115, P4691, DOI 10.1007/s00436-016-5230-z; Mariconti M, 2012, PATHOG GLOB HEALTH, V106, P391, DOI 10.1179/2047773212Y.0000000050; Martello E, 2013, TICKS TICK-BORNE DIS, V4, P518, DOI 10.1016/j.ttbdis.2013.07.002; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miranda J, 2014, TICKS TICK-BORNE DIS, V5, P208, DOI 10.1016/j.ttbdis.2013.10.008; Mohanty I, 2016, J VECTOR DIS, V53, P199; Moutailler S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004539; Narasimhan S, 2015, TRENDS PARASITOL, V31, P315, DOI 10.1016/j.pt.2015.03.010; Novakova E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00526; Ogrzewalska M, 2012, TICKS TICK-BORNE DIS, V3, P254, DOI 10.1016/j.ttbdis.2012.05.003; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Pintore MD, 2015, ZOONOSES PUBLIC HLTH, V62, P365, DOI 10.1111/zph.12156; Poupon MA, 2006, APPL ENVIRON MICROB, V72, P976, DOI 10.1128/AEM.72.1.976-979.2006; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2009, R LANG ENV STAT COMP; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Saldana MA, 2017, MEM I OSWALDO CRUZ, V112, P81, DOI 10.1590/0074-02760160373; Sassera D, 2006, INT J SYST EVOL MICR, V56, P2535, DOI 10.1099/ijs.0.64386-0; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Skotarczak B, 2002, ANN AGR ENV MED, V9, P25; Sprong H, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-41; Stuen S, 2003, ANN NY ACAD SCI, V990, P433, DOI 10.1111/j.1749-6632.2003.tb07407.x; Sumrandee C, 2014, TICKS TICK-BORNE DIS, V5, P632, DOI 10.1016/j.ttbdis.2014.04.013; Tomassone L, 2010, EXP APPL ACAROL, V52, P93, DOI 10.1007/s10493-010-9339-y; Troyo A, 2016, TICKS TICK-BORNE DIS, V7, P1128, DOI 10.1016/j.ttbdis.2016.08.009; Varela-Stokes AS, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00179; Vilcins IME, 2009, EXP APPL ACAROL, V49, P229, DOI 10.1007/s10493-009-9260-4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119	60	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202270	10.1371/journal.pone.0202270	http://dx.doi.org/10.1371/journal.pone.0202270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148833	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200008
J	Hein, Z; Borchert, B; Abualrous, ET; Springer, S				Hein, Zeynep; Borchert, Britta; Abualrous, Esam Tolba; Springer, Sebastian			Distinct mechanisms survey the structural integrity of HLA-B*27:05 intracellularly and at the surface (vol 13, e0200811, 2018)	PLOS ONE			English	Correction													Springer, Sebastian/AAJ-7036-2021	Springer, Sebastian/0000-0002-5527-6149; Abualrous, Esam/0000-0001-9582-9089				Hein Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200811	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203092	10.1371/journal.pone.0203092	http://dx.doi.org/10.1371/journal.pone.0203092			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148856	gold, Green Submitted, Green Published			2022-12-27	WOS:000442804200046
J	Kim, S; Mitterer, H; Cho, T				Kim, Sahyang; Mitterer, Holger; Cho, Taehong			A time course of prosodic modulation in phonological inferencing: The case of Korean post-obstruent tensing	PLOS ONE			English	Article							SPEECH-PERCEPTION; ASSIMILATION; RECOGNITION; WORDS; BOUNDARIES; PROMINENCE; TRACKING; STOPS	Application of a phonological rule is often conditioned by prosodic structure, which may create a potential perceptual ambiguity, calling for phonological inferencing. Three eye-tracking experiments were conducted to examine how spoken word recognition may be modulated by the interaction between the prosodically-conditioned rule application and phonological inferencing. The rule examined was post-obstruent tensing (POT) in Korean, which changes a lax consonant into a tense after an obstruent only within a prosodic domain of Accentual Phrase (AP). Results of Experiments 1 and 2 revealed that, upon hearing a derived tense form, listeners indeed recovered its underlying (lax) form. The phonological inferencing effect, however, was observed only in the absence of its tense competitor which was acoustically matched with the auditory input. In Experiment 3, a prosodic cue to an AP boundary (which blocks POT) was created before the target using an F0 cue alone (i.e., without any temporal cues), and the phonological inferencing effect disappeared. This supports the view that phonological inferencing is modulated by listeners' online computation of prosodic structure (rather than through a low-level temporal normalization). Further analyses of the time course of eye movement suggested that the prosodic modulation effect occurred relatively later in the lexical processing. This implies that speech processing involves segmental processing in conjunction with prosodic structural analysis, and calls for further research on how prosodic information is processed along with segmental information in language-specific vs. universally applicable ways.	[Kim, Sahyang] Hongik Univ, Dept English Educ, Seoul, South Korea; [Mitterer, Holger] Univ Malta, Dept Cognit Sci, Msida, Malta; [Cho, Taehong] Hanyang Univ, Hanyang Inst Phonet & Cognit Sci Language, Dept English Language & Literature, Seoul, South Korea	Hongik University; University of Malta; Hanyang University	Cho, T (corresponding author), Hanyang Univ, Hanyang Inst Phonet & Cognit Sci Language, Dept English Language & Literature, Seoul, South Korea.	tcho@hanyang.ac.kr	Mitterer, Holger/D-1908-2010	Mitterer, Holger/0000-0003-4318-0032; Cho, Taehong/0000-0002-8148-745X	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2016S1A5A2A01027109]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2016S1A5A2A01027109) awarded to SK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2016S1A5A2A01027109).	Abramson AS, 2017, J PHONETICS, V63, P75, DOI 10.1016/j.wocn.2017.05.002; Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Beckman ME, 1996, LANG COGNITIVE PROC, V11, P17, DOI 10.1080/016909696387213; Cho T., 2011, CONTINUUM COMPANION, P343; Cho TH, 2007, J PHONETICS, V35, P210, DOI 10.1016/j.wocn.2006.03.003; Cho T, 2009, J PHONETICS, V37, P466, DOI 10.1016/j.wocn.2009.08.001; Cho TH, 2005, J PHONETICS, V33, P121, DOI 10.1016/j.wocn.2005.01.001; Cho TH, 2002, J PHONETICS, V30, P193, DOI 10.1006/jpho.2001.0153; Cho TH, 2001, J PHONETICS, V29, P155, DOI 10.1006/jpho.2001.0131; Christophe A, 2004, J MEM LANG, V51, P523, DOI 10.1016/j.jml.2004.07.001; Cutler A., 1987, Computer Speech and Language, V2, P133, DOI 10.1016/0885-2308(87)90004-0; Davidson L, 2016, J PHONETICS, V54, P35, DOI 10.1016/j.wocn.2015.09.003; de Jong K, 1998, J PHONETICS, V26, P283, DOI 10.1006/jpho.1998.0077; Gaskell MG, 2008, J EXP PSYCHOL HUMAN, V34, P1632, DOI 10.1037/a0011977; Gaskell MG, 1996, J EXP PSYCHOL HUMAN, V22, P144, DOI 10.1037/0096-1523.22.1.144; Gow D. W., 2007, PAPERS LAB PHONOLOGY, V9, P173; Gow DW, 2004, J MEM LANG, V51, P279, DOI 10.1016/j.jml.2004.05.004; Gow DW, 2002, J EXP PSYCHOL HUMAN, V28, P163, DOI 10.1037//0096-1523.28.1.163; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Jun S.-A., 1998, PHONOLOGY, V15, P189, DOI DOI 10.1017/S0952675798003571; Jun S.-A., 2005, PROSODIC TYPOLOGY PH, P201, DOI DOI 10.1093/ACPROF:OSO/9780199249633.003.0008; Jun SA, 2000, TEXT SPEECH LANG TEC, V15, P209; Katsika A, 2016, J PHONETICS, V55, P149, DOI 10.1016/j.wocn.2015.12.003; Kim S, 2003, JAPANESE/KOREAN LINGUSITICS, VOL 11, P263; Kim S, 2017, J ACOUST SOC AM, V142, pEL362, DOI 10.1121/1.5005132; Kim S, 2013, J ACOUST SOC AM, V134, pEL19, DOI 10.1121/1.4807431; Kim S, 2012, STUD SECOND LANG ACQ, V34, P415, DOI 10.1017/S0272263112000137; Klatt D., 1975, J PHONETICS, V3, P129, DOI DOI 10.1016/S0095-4470(19)31360-9; Kuzla C., 2010, LAB PHONOLOGY, V10, P731; Kuzla C, 2007, J PHONETICS, V35, P301, DOI 10.1016/j.wocn.2006.11.001; LAHIRI A, 1991, COGNITION, V38, P245, DOI 10.1016/0010-0277(91)90008-R; McQueen JM, 2007, Q J EXP PSYCHOL, V60, P661, DOI 10.1080/17470210601183890; McQueen JM, 1995, PHONOLOGY PHONETIC E, V4, P61; Mitterer H, 2006, COGNITIVE SCI, V30, P451, DOI 10.1207/s15516709cog0000_57; Mitterer H, 2016, J PHONETICS, V54, P68, DOI 10.1016/j.wocn.2015.09.002; Mitterer H, 2013, J MEM LANG, V69, P59, DOI 10.1016/j.jml.2013.02.001; Mitterer H, 2009, J EXP PSYCHOL HUMAN, V35, P244, DOI 10.1037/a0012730; Nespor M, 1986, PROSODIC PHONOLOGY S; Ohala JJ., 1995, PHONOLOGY PHONETIC E, P41, DOI [DOI 10.1159/000262167, DOI 10.1017/CB09780511554315.004]; Pierrehumbert J., 1992, PAPERS LAB PHONOLOGY, P90, DOI DOI 10.1017/CBO9780511519918.005; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Salverda AP, 2003, COGNITION, V90, P51, DOI 10.1016/S0010-0277(03)00139-2; ShattuckHufnagel S, 1996, J PSYCHOLINGUIST RES, V25, P193, DOI 10.1007/BF01708572; SUMMERFIELD Q, 1981, J EXP PSYCHOL HUMAN, V7, P1074, DOI 10.1037/0096-1523.7.5.1074; Tanner J, 2017, LAB PHONOL, V8, DOI 10.5334/labphon.96; Tyler MD, 2009, J ACOUST SOC AM, V126, P367, DOI 10.1121/1.3129127; WIGHTMAN CW, 1992, J ACOUST SOC AM, V91, P1707, DOI 10.1121/1.402450	48	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202912	10.1371/journal.pone.0202912	http://dx.doi.org/10.1371/journal.pone.0202912			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148859	gold, Green Published			2022-12-27	WOS:000442804200031
J	Schad, F; Thronicke, A; Steele, ML; Merkle, A; Matthes, B; Grah, C; Matthes, H				Schad, Friedemann; Thronicke, Anja; Steele, Megan L.; Merkle, Antje; Matthes, Burkhard; Grah, Christian; Matthes, Harald			Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis	PLOS ONE			English	Article							STANDARDIZED MISTLETOE EXTRACT; QUALITY-OF-LIFE; COMPLEMENTARY TREATMENT; GENDER-DIFFERENCES; SUPPORTIVE CARE; IN-VITRO; THERAPY; SAFETY; HISTOLOGY; EPIDEMIOLOGY	Background Stage IV non-small cell lung cancer (NSCLC) is associated with a five-year survival rate of around 1%. Treatment with Viscum album L. (VA) extracts has been shown to reduce chemotherapy (CTx)-related adverse events, decrease CTx dose reductions and improve quality of life in a number of cancers. Recent data suggest a beneficial effect of add-on treatment with Viscum album L. (VA, European mistletoe) on survival in cancer patients. The objective of this study was to evaluate the effect of VA in addition to chemotherapy on survival in stage IV NSCLC patients. Methods The observational study was conducted using data from the Network Oncology clinical registry which is an accredited conjoint clinical registry of German oncological hospitals, practitioners and out-patient centers.Patients were included if they had stage IV NSCLC at diagnosis, lived at least for four weeks post-diagnosis and received chemotherapeutic treatment. Patients with EGFR mutations as well as patients receiving tyrosine kinase inhibitors or immune checkpoint inhibitors were not included. Overall survival and impact on hazard in patients with chemotherapy (CTx) to patients receiving CTx plus VA were compared. To identify factors associated with survival and to address potential sources of bias a multivariate analyses using Cox proportional hazard model was performed. Results The median age of the population was 64.1 years with 55.7% male patients. The highest proportion of patients had adenocarcinoma (72.2%) and most of the patients were current or past smokers (70.9%). Of 158 stage IV NSCLC patients, 108 received CTx only and 50 additional VA. Median survival was 17.0 months in the CTx plus VA group (95%CI : 11.040.0) and was 8.0 months (95%CI: 7.0-11.0) in the CTx only group (chi(2) = 7.2, p = .007). Overall survival was significantly prolonged in the VA group (HR 0.44, 95%CI: 0.26-0.74, p = .002). One-year and three-year overall survival rates were greater with CTx plus VA compared to CTX alone (1y: 60.2% vs. 35.5%; 3y: 25.7% vs. 14.2%). Conclusion Our findings suggest that concomitant VA is positively associated with survival in stage IV NSCLC patients treated with standard CTx. These findings complement pre-existing knowldedge of add-on VA's clinical impact, however, results should be interpreted with caution in light of the study's observational character.	[Schad, Friedemann; Thronicke, Anja; Merkle, Antje; Matthes, Burkhard; Grah, Christian; Matthes, Harald] Hosp Havelhohe, Res Inst Havelhohe, Berlin, Germany; [Schad, Friedemann; Merkle, Antje; Matthes, Burkhard] Hosp Havelhohe, Interdisciplinary Oncol & Palliat Care, Berlin, Germany; [Steele, Megan L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Grah, Christian] Hosp Havelhohe, Lung Canc Ctr, Berlin, Germany; [Grah, Christian] Hosp Havelhohe, Dept Pneumol, Berlin, Germany; [Matthes, Harald] Charite Univ Med Berlin, Med Clin Gastroenterol Infectiol & Rheumatol CBF, Berlin, Germany; [Matthes, Harald] Charite Univ Med Berlin, Inst Social Med Epidemiol & Hlth Econ CCM, Berlin, Germany	Queensland University of Technology (QUT); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schad, F (corresponding author), Hosp Havelhohe, Res Inst Havelhohe, Berlin, Germany.; Schad, F (corresponding author), Hosp Havelhohe, Interdisciplinary Oncol & Palliat Care, Berlin, Germany.	fschad@havelhoehe.de	Thronicke, Anja/AAR-2482-2021; Matthes, Harald/AAR-2256-2021; Thronicke, Anja/AAZ-3508-2020; Steele, Megan/D-8647-2013	Matthes, Harald/0000-0002-4053-4379; Thronicke, Anja/0000-0002-6421-8290; Steele, Megan/0000-0001-5728-8365	Iscador AG Arlesheim, Switzerland; ABNOBA GmbH Pforzheim, Germany; Helixor GmbH Rosenfeld, Germany	Iscador AG Arlesheim, Switzerland; ABNOBA GmbH Pforzheim, Germany; Helixor GmbH Rosenfeld, Germany	The Network Oncology was funded by unrestricted research grants from Iscador AG Arlesheim, Switzerland; ABNOBA GmbH Pforzheim, Germany; and Helixor GmbH Rosenfeld, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. By contract, researchers were independent from the funder.	Administration USFD, 2016, PEMBR KEYTRUDA CHECK; Administration USFD, 2015, FDA EXP APPR US OPD; Axtner J, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2594-5; Bar-Sela G, 2013, EUR J CANCER, V49, P1058, DOI 10.1016/j.ejca.2012.11.007; Bennouna J, 2011, LUNG CANCER, V74, P30, DOI 10.1016/j.lungcan.2011.02.004; Berg PA, 1996, GRUNDLAGEN MISTELTHE; Bock Paul R., 2014, Inflammation & Allergy Drug Targets, V13, P105; Bock PR, 2004, ARZNEIMITTELFORSCH, V54, P456; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Bussing A, 2009, EUR J MED RES, V14, P223; Bussing A, 2012, EVID-BASED COMPL ALT, V2012, DOI [10.1155/2012/165410, 10.1155/2012/219402]; Cetin Karynsa, 2011, Clin Epidemiol, V3, P139, DOI 10.2147/CLEP.S17191; Champiat S, 2016, ANN ONCOL, V27, P559, DOI 10.1093/annonc/mdv623; Chen G, 2013, ANN ONCOL, V24, P1615, DOI 10.1093/annonc/mdt012; David EA, 2017, J THORAC ONCOL, V12, P1636, DOI 10.1016/j.jtho.2017.08.008; Delebinski CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133892; Eisenbraun J, 2011, PHYTOMEDICINE, V18, P151, DOI 10.1016/j.phymed.2010.06.013; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Emmons KM, 1999, CHEST, V116, p490S, DOI 10.1378/chest.116.suppl_3.490S; Fonnebo V, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-7; Garattini S, 2016, EUR J INTERN MED, V32, P13, DOI 10.1016/j.ejim.2016.03.020; Gardin NE, 2009, PHYTOTHER RES, V23, P407, DOI 10.1002/ptr.2643; Girard N, 2017, CLIN LUNG CANCER, V18, pE89, DOI 10.1016/j.cllc.2016.10.004; Greenlee H, 2017, CA-CANCER J CLIN, V67, P195, DOI 10.3322/caac.21397; Greenlee Heather, 2014, Journal of the National Cancer Institute Monographs, P346, DOI 10.1093/jncimonographs/lgu041; Grossarth-Maticek R, 2001, ALTERN THER HEALTH M, V7, P57; Hajto T, 1998, NAT IMMUN, V16, P34, DOI 10.1159/000069428; Heinzerling L, 2006, J CLIN IMMUNOL, V26, P347, DOI 10.1007/s10875-006-9023-5; Horneber MA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003297.pub2; Hostanska K, 1995, NAT IMMUN, V14, P295; Jackman DM, 2017, J ONCOL PRACT, V13, pE346, DOI 10.1200/JOP.2017.021741; Khozin S, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx187; Kienle GS, 2007, EUR J MED RES, V12, P103; Kienle GS, 2003, EUR J MED RES, V8, P109; Kienle GS, 2003, MISTEL ONKOLOGIE FAK; Kienle GS, 2017, UBERSICHT MERKURSTAB, V70, p176 ; Kienle GS, 2017, MERKURSTAB, V3, P176; Kienle GS, 2010, INTEGR CANCER THER, V9, P142, DOI 10.1177/1534735410369673; Kim S, 2017, PHYTOMEDICINE, V36, P183, DOI 10.1016/j.phymed.2017.09.017; Kobold S, 2015, DTSCH ARZTEBL INT, V112, P809, DOI 10.3238/arztebl.2015.0809; Lange-Lindberg Anna-Maria, 2006, GMS Health Technol Assess, V2, pDoc18; Lee SJ, 2007, J CLIN IMMUNOL, V27, P477, DOI 10.1007/s10875-007-9098-7; Lynch TJ, 2014, J THORAC ONCOL, V9, P1332, DOI 10.1097/JTO.0000000000000257; Matthes H, 2010, CURR MOL MED, V10, P430, DOI 10.2174/156652410791317057; Mistletoe Bussing A., THE GENUS VISCUM2000; Mol M, 2016, J THORAC ONCOL, V11, pS138; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Morgensztern D, 2009, J THORAC ONCOL, V4, P1524, DOI 10.1097/JTO.0b013e3181ba3634; Mulsow K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153825; Naidoo J, 2015, ANN ONCOL, V26, P2375, DOI 10.1093/annonc/mdv383; Nishijima TF, 2017, ONCOLOGIST, V22, P470, DOI 10.1634/theoncologist.2016-0419; Ostermann T, 2012, EXPLORE-NY, V8, P277, DOI 10.1016/j.explore.2012.06.005; Ostermann T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-451; Putora PM, 2015, CLIN EXP METASTAS, V32, P143, DOI 10.1007/s10585-015-9699-0; R Core Team, 2015, R LANGUAGE ENV STAT; Raez LE, 2013, CANCER CHEMOTH PHARM, V72, P1103, DOI 10.1007/s00280-013-2301-z; Rasco DW, 2010, J THORAC ONCOL, V5, P1529, DOI 10.1097/JTO.0b013e3181e9a00f; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Rizvi NA, 2016, J CLIN ONCOL, V34, P2969, DOI 10.1200/JCO.2016.66.9861; Sakurai H, 2010, J THORAC ONCOL, V5, P1594, DOI 10.1097/JTO.0b013e3181f1923b; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schad F, 2018, INTEGR CANCER THER, V17, P41, DOI 10.1177/1534735416681641; Schad F, 2014, INTEGR CANCER THER, V13, P332, DOI 10.1177/1534735413513637; Schad F, 2013, FORSCH KOMPLEMENTMED, V20, P353, DOI 10.1159/000356204; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Schuette W, 2016, PNEUMOLOGIE, V70, P579, DOI 10.1055/s-0042-109760; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh BN, 2016, RSC ADV, V6, P23837, DOI 10.1039/c5ra27381a; Sobin L, 2009, TNM CLASSIFICATION M; Spahn G, 2013, INTEGRATIVE APPROACH; Steele M, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/724258; Steele ML, 2015, INTEGR CANCER THER, V14, P140, DOI 10.1177/1534735414563977; Steele ML, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/236310; Thies A, 2005, TOXICOLOGY, V207, P105, DOI 10.1016/j.tox.2004.09.009; Trani L, 2010, LUNG CANCER, V70, P200, DOI 10.1016/j.lungcan.2010.02.003; Troger W, 2013, EUR J CANCER, V49, P3788, DOI 10.1016/j.ejca.2013.06.043; Visbal AL, 2004, ANN THORAC SURG, V78, P209, DOI 10.1016/j.athoracsur.2003.11.021; Warren GW, 2013, J THORAC ONCOL, V8, P543, DOI 10.1097/JTO.0b013e318288dc96; Weber JS, 2017, J CLIN ONCOL, V35, P785, DOI 10.1200/JCO.2015.66.1389; Weissenstein U, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1246-2; World Health Organization, 2017, GLOB HLTH OBS; Yan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135829; Yang JY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005599; Yoshida Y, 2016, THORAC CARDIOV SURG, V64, P507, DOI 10.1055/s-0035-1558995	85	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203058	10.1371/journal.pone.0203058	http://dx.doi.org/10.1371/journal.pone.0203058			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148853	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200044
J	Szuroczki, D; Richardson, JML				Szuroczki, Dorina; Richardson, Jean M. L.			The Behavioral Response of Larval Amphibians (Ranidae) to Threats from Predators and Parasites (vol 7, e49592, 2012)	PLOS ONE			English	Correction													Richardson, Jean/D-2702-2014					Szuroczki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049592	1	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203252	10.1371/journal.pone.0203252	http://dx.doi.org/10.1371/journal.pone.0203252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148890	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200052
J	Haske, D; Beckers, SK; Hofmann, M; Lefering, R; Preiser, C; Gliwitzky, B; Grutzner, PA; Stockle, U; Munzberg, M				Haeske, David; Beckers, Stefan K.; Hofmann, Marzellus; Lefering, Rolf; Preiser, Christine; Gliwitzky, Bernhard; Gruetzner, Paul Alfred; Stoeckle, Ulrich; Muenzberg, Matthias			Performance Assessment of Emergency Teams and Communication in Trauma Care (PERFECT checklist)-Explorative analysis, development and validation of the PERFECT checklist: Part of the prospective longitudinal mixed-methods EPPTC trial	PLOS ONE			English	Article							STRUCTURED CLINICAL EXAMINATION; GERMAN NATIONAL GUIDELINE; TEAMWORK; RELIABILITY; COMPETENCE; EDUCATION; LEVEL	Background Trainings in emergency medicine are well structured, but examinations are rarely validated. We are evaluating the impact of pre-hospital emergency trainings on participants and patient care and developed and validated a checklist to assess emergency trainings. Methods We used videos recorded at the time points directly before (t0), directly after (t1), and one year after (t2) training to develop the PERFECT checklist (Performance Assessment of Emergency Teams and Communication in Trauma Care). The videos were assessed using semi-qualitative/linguistic analysis as well as expert panel appraisal and recommendations using the Delphi method. The checklist was tested for validity and reliability. Results The inter-rater reliability (ICC = 0.99) and internal consistency (a = 0.99) were high. Concurrent validity was moderate to high (r = 0.65-r = 0.93 (p<0.001)). We included scales for procedures, non-technical skills, technical skills and global performance. The procedures were done faster in the mean over the timeline (t0: 2:29, 95% CI 1:54-3:03 min., t1: 1:11, 95%C 0:53-1:30 min, t2: 1:14, 95% CI 0:56 - 1:31 min.). All experts rated the recorded scenarios at t0 with the lowest sum score (mean 31 +/- 8), with a significantly better performance of the teams at t1 (mean 69 +/- 7). The performance at t2 (mean 66 +/- 13) was slightly lower than at t1, but still better than at t0. At t1 and t2, linguistic analysis showed a change in the team leaders communication behaviour, which can be interpreted as a surrogate parameter for reduced stress. Conclusion The PERFECT checklist has a good validity and high reliability for assessing trauma procedures and teamwork.	[Haeske, David] Eberhard Karls Univ Tubingen, Fac Med, Tubingen, Germany; [Haeske, David] DRK Rettungsdienst Reutlingen, Reutlingen, Germany; [Beckers, Stefan K.] Univ Hosp RWTH, Fac Med, Dept Anaesthesiol, Aachen, Aachen, Germany; [Beckers, Stefan K.] Fire Dept, Emergency Med Serv, Aachen, Aachen, Germany; [Hofmann, Marzellus] Univ Witten Herdecke, Fac Hlth, Witten, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med, Cologne, Germany; [Preiser, Christine] Univ Hosp Tubingen, Coordinat Ctr Hlth Serv Res, Tubingen, Germany; [Preiser, Christine] Univ Hosp Tubingen, Inst Occupat & Social Med & Hlth Serv Res, Tubingen, Germany; [Gliwitzky, Bernhard] Megamed Emergency Management GbR, Maikammer, Germany; [Gruetzner, Paul Alfred; Muenzberg, Matthias] BG Hosp Ludwigshafen, Dept Trauma & Orthopaed Surg, Ludwigshafen, Germany; [Stoeckle, Ulrich] BG Hosp Tubingen, Dept Traumatol & Reconstruct Surg, Tubingen, Germany; [Muenzberg, Matthias] BG Hosp Ludwigshafen, Ctr Interdisciplinary Rescue & Emergency Med, Ludwigshafen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Witten Herdecke University; Witten Herdecke University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Munzberg, M (corresponding author), BG Hosp Ludwigshafen, Dept Trauma & Orthopaed Surg, Ludwigshafen, Germany.; Munzberg, M (corresponding author), BG Hosp Ludwigshafen, Ctr Interdisciplinary Rescue & Emergency Med, Ludwigshafen, Germany.	Matthias.Muenzberg@bgu-ludwigshafen.de	Häske, David/B-6250-2017; Häske, David/O-6358-2019; Beckers, Stefan K./O-2943-2019	Häske, David/0000-0001-5190-3937; Häske, David/0000-0001-5190-3937; Beckers, Stefan K./0000-0002-2896-7948; stockle, ulrich/0000-0002-6419-2203	German Association of Emergency Medical Technicians (Deutscher Berufsverband Rettungsdienst e.V. DBRD) [2013-Hae_01]	German Association of Emergency Medical Technicians (Deutscher Berufsverband Rettungsdienst e.V. DBRD)	The German Association of Emergency Medical Technicians (Deutscher Berufsverband Rettungsdienst e.V. DBRD) funded the study in form of research materials (www.dbrd.de) (Funding-Account: 2013-Hae_01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bortz J., 2009, FORSCHUNGSMETHODEN E; Carter EA, 2013, RESUSCITATION, V84, P66, DOI 10.1016/j.resuscitation.2011.10.032; Cooper S, 2010, RESUSCITATION, V81, P446, DOI 10.1016/j.resuscitation.2009.11.027; Crossley J, 2002, MED EDUC, V36, P800, DOI 10.1046/j.1365-2923.2002.01294.x; Dankbaar MEW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114663; Debus F, 2015, DTSCH ARZTEBL INT, V112, P823, DOI 10.3238/arztebl.2015.0823; DeMoor S, 2017, J TRAUMA ACUTE CARE, V83, P159, DOI 10.1097/TA.0000000000001526; Doepfer AK, 2017, OPHTHALMOLOGE, V114, P890, DOI 10.1007/s00347-017-0522-y; Francis ME, 1993, TECHNICAL REPORT; Greif R, 2015, NOTFALL RETTUNGSMED, V18, P1016, DOI 10.1007/s10049-015-0092-y; Haske D, 2013, NOTFALL RETTUNGSMED, V16, P611, DOI 10.1007/s10049-013-1793-8; Haske D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170004; Haske D, 2016, J TRAUMA ACUTE CARE, V81, P388, DOI 10.1097/TA.0000000000001125; Haske D, 2013, Z EVIDENZ FORTBILD Q, V107, P484, DOI 10.1016/j.zefq.2013.06.007; Haske D, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-32; Haske D, IMPACT PHTLS COURSES; Haske D, 2017, SCAND J TRAUMA RESUS, V25, P1, DOI [10.1186/s13049-016-0342-0, DOI 10.1186/S13049-016-0342-0]; Hodges B, 1998, ACAD MED, V73, P910, DOI 10.1097/00001888-199808000-00019; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Johansson J, 2012, RESUSCITATION, V83, P1259, DOI 10.1016/j.resuscitation.2012.02.018; Krage R, 2017, EMERG MED J, V34, P728, DOI 10.1136/emermed-2016-205754; LUNENFELD E, 1991, MED EDUC, V25, P38, DOI 10.1111/j.1365-2923.1991.tb00024.x; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Muller S, 2018, GESUNDHEITSWESEN, V80, P1099, DOI 10.1055/s-0042-116435; Munzberg M, 2015, WORLD J SURG, V39, P2061, DOI 10.1007/s00268-015-3063-z; NAEMT, 2012, PRAKL TRAUM PREH TRA; Newble D, 2004, MED EDUC, V38, P199, DOI 10.1111/j.1365-2923.2004.01755.x; Nikendei C, 2006, GMS Z MED AUSBILD, V23, P47; Pape-Koehler C, 2013, SURG ENDOSC, V27, P1737, DOI 10.1007/s00464-012-2672-y; Parker-Raley J, 2012, J COMMUN HEALTHC, V5, P102, DOI DOI 10.1179/1753807612Y.0000000007; Passauer-Baierl S, 2013, GESUNDHEITSWESEN, DOI [10.1016/j.zefq.2013.05.007, DOI 10.1016/J.ZEFQ.2013.05.007]; Patterson MD, 2013, BMJ QUAL SAF, V22, P468, DOI 10.1136/bmjqs-2012-000942; Polytrauma Guideline Update Group, 2018, Eur J Trauma Emerg Surg, V44, P3, DOI 10.1007/s00068-018-0922-y; Rall M, 2009, MILLERS ANESTHESIA, P93; Ringsted C, 2007, RESUSCITATION, V75, P153, DOI 10.1016/j.resuscitation.2007.03.003; Ruesseler M, 2010, ADV HEALTH SCI EDUC, V15, P81, DOI 10.1007/s10459-009-9173-3; Sexton J B, 2000, Hum Perf Extrem Environ, V5, P63; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Steinemann S, 2012, AM J SURG, V203, P69, DOI 10.1016/j.amjsurg.2011.08.004; Vetter B, 2015, ANAESTHESIST, V64, P298, DOI 10.1007/s00101-015-2423-2; Wallin CJ, 2007, MED EDUC, V41, P173, DOI 10.1111/j.1365-2929.2006.02670.x; Wolf M, 2008, DIAGNOSTICA, V54, P85, DOI 10.1026/0012-1924.54.2.85	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202795	10.1371/journal.pone.0202795	http://dx.doi.org/10.1371/journal.pone.0202795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142204	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500033
J	Kim, GE; Choi, HY; Kim, EJ				Kim, Ga Eun; Choi, Hee-Yeon; Kim, Eui-Jung			Impact of economic problems on depression in single mothers: A comparative study with married women	PLOS ONE			English	Article							SOCIAL SUPPORT; HEALTH; UNEMPLOYMENT; STRESS	Objective The purpose of this study was to investigate the risk factors that influence depression among single mothers. Methods Participants were 195 single mothers and 357 married mothers living in an urban community in South Korea. All subjects completed self-report questionnaires that included the following self-rating scales: the Global Assessment of Recent Stress, the Center for Epidemiologic Studies-Depression scale, and the Korean version of the Alcohol Use Disorder Identification Test. Multiple logistic regression analysis was performed to examine independent factors affecting single mothers' depression. Results The prevalence of depression differed notably between the single mothers and the control group, at 33% and 8%, respectively. In the single mothers, young age, low income, residential instability, high stress, and high alcohol-related problems were determined to be associated with depression. Furthermore, after adjusting for covariates, living in rental housing (OR = 11.46, 95% CI 1.72 +/- 76.46) was found to be an independent risk factor of depression in the single mothers, while stress (OR = 1.16, 95% CI 1.09 +/- 1.24) was found to have this effect on the married mothers. Conclusions Practical services concerning economic stability and parenting support should be provided for single mothers to reduce depression among this demographic.	[Kim, Ga Eun; Kim, Eui-Jung] Ewha Womans Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Hee-Yeon] Deadong Hosp, Daegu, South Korea	Ewha Womans University	Kim, EJ (corresponding author), Ewha Womans Univ, Coll Med, Dept Psychiat, Seoul, South Korea.	christie@ewha.ac.kr						[Anonymous], 2015, STUD STAT SINGL PAR; Bambra C, 2010, J EPIDEMIOL COMMUN H, V64, P213, DOI 10.1136/jech.2009.090621; BARTLEY M, 1994, J EPIDEMIOL COMMUN H, V48, P333, DOI 10.1136/jech.48.4.333; Benzeval M, 1998, SOC SCI MED, V46, P1337, DOI 10.1016/S0277-9536(97)10083-1; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Byun WS, 2001, STUDY LIVING CONDITI; Cairney J, 2003, SOC PSYCH PSYCH EPID, V38, P442, DOI 10.1007/s00127-003-0661-0; Cho M, 1993, J KOREAN NEUROPSYCHI, V32, P381, DOI DOI 10.1590/S0080-62342012000400002; Crosier T, 2007, SOC PSYCH PSYCH EPID, V42, P6, DOI 10.1007/s00127-006-0125-4; Dixit AR, 2000, AM J PSYCHIAT, V157, P751, DOI 10.1176/appi.ajp.157.5.751; HELZER JE, 1988, J STUD ALCOHOL, V49, P219, DOI 10.15288/jsa.1988.49.219; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hwang ES, 2007, J KOR SINGLE PARENT, V6, P1; Kim DS, 2010, INT J PUBLIC HEALTH, V55, P551, DOI 10.1007/s00038-010-0169-9; Kim HR, 2003, J KOREAN ALCOHOL SCI, V4, P105; Kim JE, 2014, COMMUN SCI DISORD-CS, V19, P60, DOI 10.12963/csd.14118; Kim MS, 2006, THE WOMEN, V71, P75; Koh K.-B., 2000, KOREAN J PSYCHOSOM M, V8, P201; Lee BO, 2000, J KOREAN ACAD ADDICT, V4, P83; 임선영, 2005, Korean Journal of Clinical Psychology, V24, P869; LINN MW, 1985, INT J PSYCHIAT MED, V15, P47, DOI 10.2190/XP8N-RP1W-YE2B-9Q7V; Ok Sun-Wha, 2004, [J. of Korean Home Management Association, 한국가정관리학회지], V22, P181; Park SK, 2005, STRUCTURAL DIVERSITY, V103, P73; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Targosz S, 2003, PSYCHOL MED, V33, P715, DOI 10.1017/S0033291703007347; Wang JL, 2004, SOC PSYCH PSYCH EPID, V39, P26, DOI 10.1007/s00127-004-0699-7	27	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0203004	10.1371/journal.pone.0203004	http://dx.doi.org/10.1371/journal.pone.0203004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142180	gold, Green Published, Green Submitted			2022-12-27	WOS:000442722500058
J	Weintrob, N; Eyal, O; Slakman, M; Becker, AS; Ish-Shalom, M; Israeli, G; Kalter-Leibovici, O; Ben-Shachar, S				Weintrob, Naomi; Eyal, Ori; Slakman, Meital; Becker, Anat Segev; Ish-Shalom, Maya; Israeli, Galit; Kalter-Leibovici, Ofra; Ben-Shachar, Shay			The effect of CAG repeats length on differences in hirsutism among healthy Israeli women of different ethnicities (vol 13, e0195046, 2018)	PLOS ONE			English	Correction									[Ish-Shalom, Maya] Tel Aviv Univ, Sackler Fac Med 2, Tel Aviv, Israel; [Ish-Shalom, Maya] Tel Aviv Sourasky Med Ctr, Inst Endocrinol Metab & Hypertens, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center								Weintrob N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195046	1	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0203181	10.1371/journal.pone.0203181	http://dx.doi.org/10.1371/journal.pone.0203181			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142179	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500063
J	Lee, HH; Chiu, CC; Lee, KT; Wang, JJ; Lin, JJ; Chao, CM; Shi, HY				Lee, Hao-Hsien; Chiu, Chong-Chi; Lee, King-Teh; Wang, Jhi-Joung; Lin, Jin-Jia; Chao, Chien-Ming; Shi, Hon-Yi			Do preoperative depressive symptoms predict quality of life after laparoscopic cholecystectomy: A longitudinal prospective study	PLOS ONE			English	Article							GASTROESOPHAGEAL REFLUX DISEASE; ANTIREFLUX SURGERY; ANXIETY DISORDERS; CANCER	Objective The impact of preoperative depressive symptoms on quality of life (QOL) after laparoscopic cholecystectomy (LC) remains unclear. The purpose of this study was to develop a bench-mark for capturing the burden of depressive symptoms on QOL after LC and for supporting evidence-based clinical interventions for remediating these effects. Methods Patients diagnosed with depressive symptoms (Beck Depression Inventory score > 13) after LC (n = 336) were classified into a depressive symptoms group. Propensity score matching was then used to match them with 336 patients in a non-depressive symptoms group for all potential confounding factors. All patients completed the 36-item Short Form Health Survey (SF-36) and the Gastrointestinal Quality of Life Index (GIQLI) at baseline and at 2 years postoperatively. The 95% confidence intervals (CIs) for differences in responsiveness estimates were derived by bootstrap estimation. Results The GIQLI results revealed that the non-depressive symptoms group had relatively stronger responses for emotional impairment (4.10, 95% CI 2.81 to 5.39) and social impairment (4.06, 95% CI 2.65 to 5.46) in comparison with the depressive symptoms group. In the SF-36, the non-depressive symptoms group also had stronger responses for role emotional (12.63, 95% CI 10.73 to 14.54), social functioning (11.25, 95% CI 9.85 to 12.65), vitality (3.81, 95% CI 2.82 to 4.81), mental health (11.97, 95% CI 10.36 to 13.56) and general health (3.84, 95% CI 2.95 to 4.75). Conclusions Depressive symptoms complicate the management of LC patients and are associated with poorer outcomes. Because depressive symptoms are very common, further studies are needed to evaluate integrated and comprehensive approaches for assessing and treating these symptoms.	[Lee, Hao-Hsien; Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Gen Surg, Liouying, Taiwan; [Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Gen Surg, Yongkang, Taiwan; [Chiu, Chong-Chi] Southern Taiwan Univ Sci & Technol, Dept Elect Engn, Tainan, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Dept Surg, Div Hepatobiliary Surg, Kaohsiung, Taiwan; [Lee, King-Teh; Shi, Hon-Yi] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lin, Jin-Jia] Chi Mei Med Ctr, Dept Psychiat, Tainan, Taiwan; [Lin, Jin-Jia] Chi Mei Hosp, Dept Psychiat, Tainan, Taiwan; [Lin, Jin-Jia] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan; [Chao, Chien-Ming] Chi Mei Med Ctr, Dept Intens Care Med, Liouying, Taiwan; [Shi, Hon-Yi] Natl Sun Yat Sen Univ, Dept Business Management, Kaohsiung, Taiwan; [Shi, Hon-Yi] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chi Mei Hospital; Chi Mei Hospital; Taipei Medical University; Chi Mei Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Shi, HY (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.; Shi, HY (corresponding author), Natl Sun Yat Sen Univ, Dept Business Management, Kaohsiung, Taiwan.; Shi, HY (corresponding author), Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.	hshi@kmu.edu.tw			Chi Mei Medical Center, Liouying [CLFHR10606]; Chi-Mei Medical Center; Kaohsiung Medical University Research Foundation [104CM-KMU-04, 105CM-KMU-02, 106CM-KMU-09]	Chi Mei Medical Center, Liouying; Chi-Mei Medical Center; Kaohsiung Medical University Research Foundation	This study was supported by grants from Chi Mei Medical Center, Liouying (CLFHR10606) and from the Chi-Mei Medical Center and the Kaohsiung Medical University Research Foundation (104CM-KMU-04, 105CM-KMU-02 & 106CM-KMU-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspinen S, 2017, QUAL LIFE RES, V26, P665, DOI 10.1007/s11136-016-1485-1; BAKER LH, 1995, AM J GASTROENTEROL, V90, P1797; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beutel ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116440; Biertho Laurent, 2007, Ann Surg Innov Res, V1, P2, DOI 10.1186/1750-1164-1-2; Brookes S T, 2001, Health Technol Assess, V5, P1; Che HH, 2002, TAIWAN J PSYCHIAT, V16, P301, DOI DOI 10.1016/J.YEBEH.2015.01.019; Cheung FM, 2008, PSYCHOL ASSESSMENT, V20, P103, DOI 10.1037/1040-3590.20.2.103; Dressler JA, 2016, SURG ENDOSC, V30, P1592, DOI 10.1007/s00464-015-4384-6; Eom JM, 2015, SURG ENDOSC, V29, P1850, DOI 10.1007/s00464-014-3875-1; Foster C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155434; Fuh JL, 2000, QUAL LIFE RES, V9, P675, DOI 10.1023/A:1008993821633; Ghoneim MM, 2016, BMC SURG, V16, DOI 10.1186/s12893-016-0120-y; Gurusamy K, 2008, BRIT J SURG, V95, P161, DOI 10.1002/bjs.6105; Gurusamy KS, 2014, COCHRANE DB SYST REV, V2; Johansson M, 2006, BRIT J SURG, V93, P40, DOI 10.1002/bjs.5241; Kamolz T, 2003, SURG ENDOSC, V17, P55, DOI 10.1007/s00464-002-8504-8; Kamolz T, 2001, DIGEST LIVER DIS, V33, P659, DOI 10.1016/S1590-8658(01)80041-4; Li LL, 2011, AM J EPIDEMIOL, V174, P345, DOI 10.1093/aje/kwr096; Mack I, 2016, OBES SURG, V26, P2967, DOI 10.1007/s11695-016-2219-8; Mystakidou K, 2005, QUAL LIFE RES, V14, P1825, DOI 10.1007/s11136-005-4324-3; Nigatu YT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148871; Nilsson E, 2004, INT J QUAL HEALTH C, V16, P473, DOI 10.1093/intqhc/mzh077; Rapaport MH, 2005, AM J PSYCHIAT, V162, P1171, DOI 10.1176/appi.ajp.162.6.1171; Rippel SW, 2012, GASTROENTEROLOGY, V142, P754, DOI 10.1053/j.gastro.2011.12.043; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Shi HY, 2011, QUAL LIFE RES, V20, P335, DOI 10.1007/s11136-010-9760-z; Shim EJ, 2006, BREAST CANCER RES TR, V99, P341, DOI 10.1007/s10549-006-9216-x; Wright B, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007969; Zhu YL, 2007, RISK ANAL, V27, P447, DOI 10.1111/j.1539-6924.2007.00897.x	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202266	10.1371/journal.pone.0202266	http://dx.doi.org/10.1371/journal.pone.0202266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161169	gold, Green Submitted, Green Published			2022-12-27	WOS:000443388900027
J	Liou, YS; Yang, FY; Chen, HY; Jong, GP				Liou, Yi-Sheng; Yang, Fu-Yu; Chen, Hung-Yi; Jong, Gwo-Ping			Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; OXIDATIVE STRESS; RISK; THIAZOLIDINEDIONES; METFORMIN; ROSIGLITAZONE; PIOGLITAZONE; ASSOCIATION; PREVALENCE; MORTALITY	Currently, the potential risk of atrial fibrillation associated with antihyperglycemic drug use has been a topic of considerable interest. However, it remains uncertain whether different classes of antihyperglycemic drug therapy are associated with the risk of atrial fibrillation risk. Here, we investigated the association between different classes of antihyperglycemic drugs and new-onset atrial fibrillation (NAF). A case-matched study was performed based on the National Health Insurance Program in Taiwan. Patients who had NAF were considered the NAF group and were matched in a 1:4 ratio with patients without NAF, who were assigned to the non-NAF group. Patients were matched according to sex, age, diabetes mellitus duration, index date, and Charlson Comorbidity Index score. We used multivariate logistic regression controlling for potential confounders to examine the association between different classes of antihyperglycemic drug use and the risk of NAF. Overall, we identified 2,882 cases and 11,528 matched controls for the study. After adjusting for sex, age, comorbidities, and concurrent medications, users of biguanides or thiazolidinediones were at a lower risk of developing NAF when compared with non-users (odds ratio [OR] 0.81, 95% confidence interval [CI] 0.71-0.95 and OR 0.72, 95% CI 0.63-0.83, respectively). In contrast, users of insulin were at a higher risk of developing NAF than were non-users (OR 1.19, 95% CI 1.06-1.35). Sulfonylureas, glinides, a-glucosidase inhibitors, and dipeptidyl peptidase-4 inhibitors were not associated with developing the risk of NAF. In conclusion, the use of biguanides or thiazolidinediones may be associated with a low risk of NAF, whereas insulin may be associated with a significant increase in the risk of NAF in patients with type 2 diabetes mellitus during long-term follow-up. Further prospective randomized studies should investigate which specific class of antihyperglycemic drug treatment for diabetes mellitus can prevent or postpone NAF.	[Liou, Yi-Sheng] Taichung Vet Gen Hosp, Dept Family Med & Geriatr, Taipei, Taiwan; [Liou, Yi-Sheng] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Yang, Fu-Yu; Chen, Hung-Yi] China Med Univ, Inst Pharm, Taichung, Taiwan; [Chen, Hung-Yi] China Med Univ, Dept Pharm, Beigang Hosp, Touliu, Yunlin, Taiwan; [Jong, Gwo-Ping] Chung Shan Med Univ Hosp, Div Internal Cardiol, Taichung, Taiwan; [Jong, Gwo-Ping] Chung Shan Med Univ, Taichung, Taiwan	Taichung Veterans General Hospital; National Defense Medical Center; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Jong, GP (corresponding author), Chung Shan Med Univ Hosp, Div Internal Cardiol, Taichung, Taiwan.; Jong, GP (corresponding author), Chung Shan Med Univ, Taichung, Taiwan.	cgp8009@yahoo.com.tw		Jong, Gwo-Ping/0000-0002-7786-5497				Alves-Cabratosa L, 2016, ANN MED, V48, P119, DOI 10.3109/07853890.2016.1144930; Anglade MW, 2007, CURR MED RES OPIN, V23, P2849, DOI 10.1185/030079907X242494; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bloomgarden Z, 2016, J AM COLL CARDIOL, V67, P248, DOI 10.1016/j.jacc.2015.11.035; Calixto MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076786; Chang SH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0123-x; Chao TF, 2012, INT J CARDIOL, V156, P199, DOI 10.1016/j.ijcard.2011.08.081; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Davis TME, 1999, ARCH INTERN MED, V159, P1097, DOI 10.1001/archinte.159.10.1097; de Bock MI, 2015, DIABETES CARE, V38, pE186, DOI 10.2337/dc15-1047; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dublin S, 2010, J GEN INTERN MED, V25, P853, DOI 10.1007/s11606-010-1340-y; Fidan E, 2011, ACTA DIABETOL, V48, P297, DOI 10.1007/s00592-011-0276-y; Giannini S, 2004, J ENDOCRINOL INVEST, V27, P982, DOI 10.1007/BF03347546; Gu J, 2011, EUROPACE, V13, P1256, DOI 10.1093/europace/eur131; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hussain H, 2015, J GEN INTERN MED, V30, P833, DOI 10.1007/s11606-015-3262-1; Huxley RR, 2012, HEART, V98, P133, DOI 10.1136/heartjnl-2011-300503; Huxley RR, 2011, AM J CARDIOL, V108, P56, DOI 10.1016/j.amjcard.2011.03.004; Kume O, 2011, HEART RHYTHM, V8, P278, DOI 10.1016/j.hrthm.2010.10.029; Lachin JM, 2011, CLIN J AM SOC NEPHRO, V6, P1032, DOI 10.2215/CJN.09291010; Liu T, 2008, INT J CARDIOL, V128, P129, DOI 10.1016/j.ijcard.2007.05.051; Liu T, 2014, CARDIOVASC THER, V32, P178, DOI 10.1111/1755-5922.12079; Lown M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013535; Marfella R, 2009, HEART, V95, P1020, DOI 10.1136/hrt.2009.165969; NHIR, DATABASE; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Pallisgaard JL, 2017, EUR HEART J-CARD PHA, V3, P140, DOI 10.1093/ehjcvp/pvw036; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Salman ZK, 2013, EUR J PHARMACOL, V714, P448, DOI 10.1016/j.ejphar.2013.07.002; Schoen T, 2012, J AM COLL CARDIOL, V60, P1421, DOI 10.1016/j.jacc.2012.06.030; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Vijayakumar P, 2017, DIABETES CARE, V40, P16, DOI 10.2337/dc16-1358; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yan RH, 2017, J AM HEART ASSOC, V6, DOI [10.1161/JAHA.116.004445, 10.1161/jaha.116.004445]; Yeh YH, 2011, CARDIOVASC RES, V91, P62, DOI 10.1093/cvr/cvr041; Zhang ZW, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0531-4	38	35	36	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0197245	10.1371/journal.pone.0197245	http://dx.doi.org/10.1371/journal.pone.0197245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161122	Green Submitted, gold, Green Published			2022-12-27	WOS:000443388900001
J	Pombejra, SN; Jamklang, M; Uhrig, JP; Vu, K; Gelli, A				Pombejra, Sarisa Na; Jamklang, Mantana; Uhrig, John P.; Vu, Kiem; Gelli, Angie			The structure-function analysis of the Mpr1 metalloprotease determinants of activity during migration of fungal cells across the blood-brain barrier	PLOS ONE			English	Article							PROTEOLYTIC CLEAVAGE SITES; CENTRAL-NERVOUS-SYSTEM; CRYPTOCOCCUS-NEOFORMANS; ASPERGILLUS-FUMIGATUS; MICROSPORUM-CANIS; PROTEASES; PROTEIN; FAMILY; DISSEMINATION; PATHOGENICITY	Cryptococcal meningoencephalitis, the most common form of cryptococcosis, is caused by the opportunistic fungal pathogen, Cryptococcus neoformans. Molecular strategies used by C. neoformans to invade the central nervous system (CNS) have been the focus of several studies. Recently, the role of a novel secreted metalloprotease (Mpr1) in the pathogenicity of C. neoformans was confirmed by studies demonstrating that Mpr1 mediated the migration of fungal cells into the CNS. Given this central function, the aim here was to identify the molecular determinants of Mpr1 activity and resolve their role in the migration of cryptococci across the blood-brain barrier (BBB). The Mpr1 protein belongs to an understudied group of metalloproteases of the M36 class of fungalysins unique to fungi. They are generally synthesized as propeptides with fairly long prodomains and highly conserved regions within their catalytic core. Through structure-function analysis of Mpr1, our study identified the prodomain cleavage sites of Mpr1 and demonstrated that when mutated, the prodomain appears to remain attached to the catalytic C-terminus of Mpr1 rendering a nonfunctional Mpr1 protein and an inability for cryptococci to cross the BBB. We found that proteolytic activity of Mpr1 was dependent on the coordination of zinc with two histidine residues in the active site of Mpr1, since amino acid substitutions in the HExxH motif abolished Mpr1 proteolytic activity and prevented the migration of cryptococci across the BBB. A phylogenetic analysis of Mpr1 revealed a distinct pattern likely reflecting the neurotropic nature of C. neoformans and the specific function of Mpr1 in breaching the BBB. This study contributes to a deeper understanding of the molecular regulation of Mpr1 activity and may lead to the development of specific inhibitors that could be used to restrict fungal penetration of the CNS and thus prevent cryptococcal meningoencephalitis-related deaths.	[Pombejra, Sarisa Na; Jamklang, Mantana; Uhrig, John P.; Vu, Kiem; Gelli, Angie] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA; [Pombejra, Sarisa Na] Chulalongkorn Univ, Dept Microbiol, Bangkok, Thailand; [Jamklang, Mantana] Suranaree Univ Technol, Sch Preclin, Inst Sci, Nakhon Ratchasima, Thailand; [Uhrig, John P.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of California System; University of California Davis; Chulalongkorn University; Suranaree University of Technology; University of Massachusetts System; University of Massachusetts Amherst	Gelli, A (corresponding author), Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA.	acgelli@ucdavis.edu	Gelli, Angie/F-1764-2018; Vu, Kiem/GQZ-3955-2022	Na Pombejra, Sarisa/0000-0002-5472-0674; Gelli, Angie/0000-0003-3351-0683	National Institute of Allergy and Infectious Diseases [AI22329]; Hartwell Foundation Individual Biomedical Research Award	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Hartwell Foundation Individual Biomedical Research Award	This work was supported by National Institute of Allergy and Infectious Diseases - AI22329 Awarded to AG; https://www.niaid.nih.gov/, and the Hartwell Foundation Individual Biomedical Research Award Awarded to AG; http://thehartwellfoundation.org/2012/2012_Investigators.shtml.	Aaron PA, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12811; Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Berzigotti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036400; Brouta F, 2002, INFECT IMMUN, V70, P5676, DOI 10.1128/IAI.70.10.5676-5683.2002; Brouta F, 2001, MED MYCOL, V39, P269, DOI 10.1080/mmy.39.3.269.275; Buchanan KL, 1998, EMERG INFECT DIS, V4, P71, DOI 10.3201/eid0401.980109; Casadevall A, 2010, J CLIN INVEST, V120, P1389, DOI 10.1172/JCI42949; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Chisholm ST, 2005, P NATL ACAD SCI USA, V102, P2087, DOI 10.1073/pnas.0409468102; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; De Baets S, 2001, Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet, V66, P283; Eigenheer RA, 2007, FEMS YEAST RES, V7, P499, DOI 10.1111/j.1567-1364.2006.00198.x; Fernandez D, 2013, ACTA CRYSTALLOGR D, V69, P1946, DOI 10.1107/S0907444913017642; Ferraris DM, 2011, J BIOL CHEM, V286, P32475, DOI 10.1074/jbc.M111.271809; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; Gebbie L, 2014, METHODS MOL BIOL, V1099, P159, DOI 10.1007/978-1-62703-715-0_14; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Heslop OD, 2011, J CLIN MICROBIOL, V49, P4405, DOI 10.1128/JCM.05028-11; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; Lennon FE, 2014, J BIOL CHEM, V289, P24043, DOI 10.1074/jbc.M114.554766; Lilly WW, 2008, MYCOL RES, V112, P389, DOI 10.1016/j.mycres.2007.11.013; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Liu TB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003247; MARKARYAN A, 1994, INFECT IMMUN, V62, P2149, DOI 10.1128/IAI.62.6.2149-2157.1994; Markaryan A, 1996, J BACTERIOL, V178, P2211, DOI 10.1128/jb.178.8.2211-2215.1996; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Nagase H, 2001, CURRENT PROTOCOLS PR; Naumann TA, 2011, J BIOL CHEM, V286, P35358, DOI 10.1074/jbc.M111.279646; Nickerson NN, 2008, MOL MICROBIOL, V69, P1530, DOI 10.1111/j.1365-2958.2008.06384.x; Noverr MC, 2004, INFECT IMMUN, V72, P1693, DOI 10.1128/IAI.72.3.1693-1699.2004; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Polaina J, 2007, IND ENZYMES STRUCTUR, P221; Pombejra SN, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00296; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/S1473-3099(17)30243-8, 10.1016/s1473-3099(17)30243-8]; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P325, DOI 10.1016/B978-0-12-382219-2.00077-6; Santiago-Tirado FH, 2017, MBIO, V8, DOI 10.1128/mBio.02183-16; Shepherd CT, 2009, METHODS MOL BIOL, V526, P129, DOI 10.1007/978-1-59745-494-0_11; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; STARK R, 1993, J VIROL, V67, P7088, DOI 10.1128/JVI.67.12.7088-7095.1993; Tang B, 2003, BIOCHEM BIOPH RES CO, V301, P1093, DOI 10.1016/S0006-291X(03)00084-6; Ugalde AP, 2010, METHODS MOL BIOL, V622, P3, DOI 10.1007/978-1-60327-299-5_1; Vu K, 2014, MBIO, V5, DOI 10.1128/mBio.01101-14; Vu K, 2009, EUKARYOT CELL, V8, P1803, DOI 10.1128/EC.00240-09; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yeats C, 2004, TRENDS BIOCHEM SCI, V29, P169, DOI 10.1016/j.tibs.2004.02.004; Zhang XK, 2014, MED MYCOL, V52, P36, DOI 10.3109/13693786.2013.811552	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203020	10.1371/journal.pone.0203020	http://dx.doi.org/10.1371/journal.pone.0203020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161190	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900067
J	Rmoutilova, R; Guyomarc'h, P; Veleminsky, P; Sefcakova, A; Samsel, M; Santos, F; Maureille, B; Bruzek, J				Rmoutilova, Rebeka; Guyomarc'h, Pierre; Veleminsky, Petr; Sefcakova, Alena; Samsel, Mathilde; Santos, Frederic; Maureille, Bruno; Bruzek, Jaroslav			Virtual reconstruction of the Upper Palaeolithic skull from Zlaty Kun, Czech Republic: Sex assessment and morphological affinity	PLOS ONE			English	Article							LATE-GLACIAL RECOLONIZATION; LATE PLEISTOCENE; CENTRAL-EUROPE; HUMAN FOSSILS; RELIABILITY; CALIBRATION; DIMORPHISM; EVOLUTION; SOUTHWESTERN; INFORMATION	The incomplete cranium discovered at the Zlaty kun site in the Bohemian Karst is a rare piece of skeletal evidence of human presence in Central Europe during the Late Glacial period. The relative position of cranial fragments was restored and missing parts of the cranium were virtually reconstructed using mirroring and the Thin-plate splines algorithm. The reconstruction allowed us to collect principal cranial measurements, revise a previous unfounded sex assignment and explore the specimen's morphological affinity. Visual assessment could not reliably provide a sexual diagnosis, as such methods have been developed on modern populations. Using a population-specific approach developed on cranial measurements collected from the literature on reliably sexed European Upper Palaeolithic specimens, linear discriminant analysis confirmed previous assignment to the female sex. However, caution is necessary with regard to the fact that it was assessed from the skull. The Zlaty kun specimen clearly falls within the range of Upper Palaeolithic craniometric variation. Despite the shift in cranial variation that accompanied the Last Glacial Maximum (LGM), the ZlatY kun skull exhibits a morphological affinity with the pre-LGM population. Several interpretations are proposed with regard to the complex population processes that occurred after the LGM in Europe.	[Rmoutilova, Rebeka; Bruzek, Jaroslav] Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague, Czech Republic; [Rmoutilova, Rebeka; Guyomarc'h, Pierre; Samsel, Mathilde; Santos, Frederic; Maureille, Bruno] Univ Bordeaux, CNRS, MCC, UMR PACEA 5199, Pessac, France; [Veleminsky, Petr] Natl Museum, Dept Anthropol, Prague, Czech Republic; [Sefcakova, Alena] Nat Hist Museum, Slovak Natl Museum, Dept Anthropol, Bratislava, Slovakia	Charles University Prague; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; National Museum	Rmoutilova, R (corresponding author), Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague, Czech Republic.; Rmoutilova, R (corresponding author), Univ Bordeaux, CNRS, MCC, UMR PACEA 5199, Pessac, France.	vejnaror@natur.cuni.cz	Santos, Frédéric/I-3565-2019; Šefčáková, Alena/ABB-6414-2021; Rmoutilova, Rebeka/S-3185-2017	Santos, Frédéric/0000-0003-1445-3871; Šefčáková, Alena/0000-0002-4957-9944; Guyomarc'h, Pierre/0000-0002-9419-9270; Rmoutilova, Rebeka/0000-0003-2426-4521; Veleminsky, Petr/0000-0003-3691-7817; Maureille, Bruno/0000-0002-7616-0073	Charles University Grant Agency [1088217]; Ministry of Culture of the Czech Republic [00023272, DKRVO 2018/17]	Charles University Grant Agency; Ministry of Culture of the Czech Republic	RR was supported by the Charles University Grant Agency, research grant GAUK No. 1088217. National Museum (00023272) obtained funding from the Ministry of Culture of the Czech Republic (DKRVO 2018/17) (PV).	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Amano H, 2014, DYNAMICS LEARNING NE, V2, P161, DOI [10.1007/978-4-431-54553-8_18, DOI 10.1007/978-4-431-54553-8_18]; Amano H, 2015, AM J PHYS ANTHROPOL, V158, P185, DOI 10.1002/ajpa.22777; [Anonymous], 1980, J HUM EVOL, V9, P517; [Anonymous], 2009, ENTHESOPATHIES ACTIV; [Anonymous], 1971, CATALOGUE FOSSIL H 2; Arbour JH, 2014, METHODS ECOL EVOL, V5, P16, DOI 10.1111/2041-210X.12128; Auerbach BM, HOWELLS CRANIOMETRIC; Benazzi S, 2009, ANAT REC, V292, P1088, DOI 10.1002/ar.20933; Berg GE, 2017, FORENSIC ANTHR COMPR, P143; Blockley SPE, 2006, J QUATERNARY SCI, V21, P575, DOI 10.1002/jqs.1041; Blockley SPE, 2009, RADIOCARBON, V51, P287, DOI 10.1017/S0033822200033828; Blockley SPE, 2000, ANTIQUITY, V74, P112, DOI 10.1017/S0003598X00066199; Brauer G, 2007, VERTEBR PALEOBIOL PA, P269; Brauer G., 1988, HDB VERGLEICHENDEN B, V1, P160; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brewster C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5094; Bronk Ramsey Christopher, 2002, ARCHAEOMETRY, V44, P1, DOI DOI 10.1111/J.1475-4754.2002.TB01101.X; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Bruzek J, 2006, EARLY MODERN HUMAN E, P46; Bruzek J, 2017, AM J PHYS ANTHROPOL, V164, P440, DOI 10.1002/ajpa.23282; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Churchill SE, 1999, HUNTERS GOLDEN AGE M, P31; Cieri RL, 2014, CURR ANTHROPOL, V55, P419, DOI 10.1086/677209; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Claude J, 2013, HYSTRIX, V24, P94, DOI 10.4404/hystrix-24.1-6316; Conard NJ, 2004, NATURE, V430, P198, DOI 10.1038/nature02690; Couqueugniot H, 2000, INT J OSTEOARCHAEOL, V10, P426; D'Amore G, 2009, J HUM EVOL, V56, P537, DOI 10.1016/j.jhevol.2009.02.002; Dutailly B, 2016, THESIS; Dutailly B, TIVMI; Dutailly B, 2009, IEEE IMAGE PROC, P2505, DOI 10.1109/ICIP.2009.5413911; FRAYER DW, 1980, J HUM EVOL, V9, P399, DOI 10.1016/0047-2484(80)90050-0; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Gabor H, 2010, HUM BIOL, V82, P29, DOI 10.3378/027.082.0103; Garcia-Vazquez A, 2018, QUATERN INT, V481, P42, DOI 10.1016/j.quaint.2017.08.063; Garvin HM, 2018, J FORENSIC SCI, V63, P1243, DOI 10.1111/1556-4029.13688; Godinho RM, 2017, HUMAN REMAINS ANOTHE, P135, DOI [10.1016/B978-0-12-804602-9.00011-4, DOI 10.1016/B978-0-12-804602-9.00011-4]; Grine FE, 2007, SCIENCE, V315, P226, DOI 10.1126/science.1136294; Gunther T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003703; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Hansen J, 2017, DANISH J ARCHAEOLOGY, V6, P50, DOI [10.1080/21662282.2017.1381418, DOI 10.1080/21662282.2017.1381418]; Holt BM, 2008, YEARB PHYS ANTHROPOL, V51, P70, DOI 10.1002/ajpa.20950; Hor?ek I., 2015, FORGOTTEN TIMES SPAC, P363; Housley R.A., 1997, P PREHIST SOC, V63, P25, DOI DOI 10.1017/S0079497X0000236X; Howells W. W., 1973, PAPERS PEABODY MUSEU; Howells W. W., 1989, SKULL SHAPES MAP CRA; Irish JD, 2008, J HUM EVOL, V55, P736, DOI 10.1016/j.jhevol.2008.03.007; Jelinek J, 1999, HOMINID REMAINS CZEC; Josse J, 2016, J STAT SOFTW, V70; Josse J, 2012, J SFDS, V153, P79; Katina S, 2011, ACTA MUSEI NATL PRAG, V67, P3; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Kozlowski SK, 2012, QUATERN INT, V272, P288, DOI 10.1016/j.quaint.2012.02.052; Kranioti EK, 2017, FORENSIC SCI INT, V271, DOI 10.1016/j.forsciint.2016.11.018; Kukla J., 1952, CESKOSLOVENSKY KRAS, V5, P49; Kuzelka V, 1997, ANTHROPOLOGIE, VXXXV, P247; Langley NR, 2018, J FORENSIC SCI, V63, P31, DOI 10.1111/1556-4029.13534; Laznickova-Gonysevova M, 2002, ANTHROPOLOGIE, V106, P525; Lestrel PE, 2013, HOMO, V64, P247, DOI 10.1016/j.jchb.2013.05.001; Lewis CJ, 2016, J FORENSIC SCI, V61, P743, DOI 10.1111/1556-4029.13013; Loth SR, 1996, AM J PHYS ANTHROPOL, V99, P473, DOI 10.1002/(SICI)1096-8644(199603)99:3<473::AID-AJPA8>3.0.CO;2-X; Maier A, 2015, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-94-017-7206-8; Martin Rudolf, 1928, LEHRBUCH ANTHR SYSTE; Meiklejohn C, 2015, MESOLITHIC MISCELLAN, V23, P12; Morel P, 1993, ARCHEOLOGIE SUISSE, V16, P110; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Musil R., 2010, QUARTAR, V57, P95; Nerudova Z., 2015, FORGOTTEN TIMES SPAC, P378, DOI [10.5817/CZ.MUNI.M210-7781-2015-28, DOI 10.5817/CZ.MUNI.M210-7781-2015-28]; Orschiedt J., 2002, PAL O, V14, P241, DOI [10.4000/paleo.1504, DOI 10.4000/PALEO.1504]; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pietrusewsky M, 2012, ENCY GLOBAL ARCHAEOL, P244; Pilloud M.A., 2016, BIOL DISTANCE ANAL F; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Prosek F, 1952, CESKOSLOVENSKY KRAS, V1-2, P161; Relethford JH, 2016, BIOLOGICAL DISTANCE ANALYSIS: FORENSIC AND BIOARCHAEOLOGICAL PERSPECTIVES, P23, DOI 10.1016/B978-0-12-801966-5.00002-0; Relethford JH, 2013, ORIGINS OF MODERN HUMANS: BIOLOGY RECONSIDERED, 2ND EDITION, P321; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; Ross AH, 2011, FORENSIC SCI INT, V206, DOI 10.1016/j.forsciint.2011.01.003; RUFF C, 1987, J HUM EVOL, V16, P391, DOI 10.1016/0047-2484(87)90069-8; Samsel M, 2018, MICROEVOLUTION BIOAR; Samsel M, 2017, AM J PHYS ANTHROPOL, V162, P343; Santos F, 2014, FORENSIC SCI INT, V245, DOI 10.1016/j.forsciint.2014.10.010; Schlager S., 2016, MORPHO CALCULATIONS; Schwartz J. H., 2002, HUMAN FOSSIL RECORD, V1; Side P, 2007, ARCHEOLOGIE STREDNIC, V11, P9; Skrdla P, 2015, FORGOTTEN TIMES SPAC, P395, DOI [10.5817/CZ.MUNI.M210-7781-2015-29, DOI 10.5817/CZ.MUNI.M210-7781-2015-29]; Sladek V, 2002, J HUM EVOL, V43, P787, DOI 10.1006/jhev.2002.0606; Smith FH, 1999, P NATL ACAD SCI USA, V96, P12281, DOI 10.1073/pnas.96.22.12281; SMITH FH, 1980, AM J PHYS ANTHROPOL, V53, P589, DOI 10.1002/ajpa.1330530414; SMITH FH, 1982, CURR ANTHROPOL, V23, P667, DOI 10.1086/202920; Straus Lawrence Guy, 1995, Evolutionary Anthropology, V4, P4, DOI 10.1002/evan.1360040103; Street M, 1999, ANTIQUITY, V73, P259, DOI 10.1017/S0003598X00088232; Street M, 2006, J HUM EVOL, V51, P551, DOI 10.1016/j.jhevol.2006.04.014; Street Martin, 2002, Bonner Zoologische Beitraege, V50, P269; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Svoboda J, 2000, J HUM EVOL, V38, P523, DOI 10.1006/jhev.1999.0361; SVOBODA J, 2004, DSD, V42, P161; Svoboda J. A., 2004, ARCHAOL KORRESPONDEN, V34, P463; Svoboda JA, 2002, ANTIQUITY, V76, P957, DOI 10.1017/S0003598X00091754; Svoboda JA, 2003, VE SLUZBACH ARCHEOLO, V4, P278; Terberger T, 2002, ANTIQUITY, V76, P691, DOI 10.1017/S0003598X00091134; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; TRINKAUS E, 1982, AM J PHYS ANTHROPOL, V57, P27, DOI 10.1002/ajpa.1330570106; Ubelaker DH, 2017, FORENSIC SCI INT, V278, DOI 10.1016/j.forsciint.2017.06.012; VENABLES WN, 2002, MODERN APPL STAT S F; Vencl S, 1976, ARCHEOL ROZHL, V28, P424; Verpoorte A, 2004, ANTIQUITY, V78, P257, DOI 10.1017/S0003598X0011292X; Verpoorte A, 2009, QUATERN INT, V201, P77, DOI 10.1016/j.quaint.2008.05.021; Villotte S, 2007, PAL SOC M PHIL; Villotte S, 2010, J HUM EVOL, V59, P35, DOI 10.1016/j.jhevol.2010.02.001; VLCEK E, 1991, ANTHROPOLOGIE, V95, P409; Vlcek E, 1956, ANTHROPOZOIKUM, V6, P283; Vlcek E, 1957, ARCHEOL ROZHL, VIX, P305; Vlcek E, 1952, CESKOSLOVENSKY KRAS, VV, P180; Vlcek E, 1951, CASOPIS CESKYCH LEKA, V49, P1457; von Cramon-Taubadel N, 2016, BIOLOGICAL DISTANCE ANALYSIS: FORENSIC AND BIOARCHAEOLOGICAL PERSPECTIVES, P425, DOI 10.1016/B978-0-12-801966-5.00023-8; Walker PL, 2008, AM J PHYS ANTHROPOL, V136, P39, DOI 10.1002/ajpa.20776; Walrath DE, 2004, AM J PHYS ANTHROPOL, V125, P132, DOI 10.1002/ajpa.10373; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Wisniewski A, 2017, GEOCHRONOMETRIA, V44, P16, DOI 10.1515/geochr-2015-0052; Wolpoff MH, 2006, EARLY MODERN HUMANS AT THE MORAVIAN GATE: THE MLADEC CAVES AND THEIR REMAINS, P273, DOI 10.1007/978-3-211-49294-9_10; Wygal BT, 2014, J WORLD PREHIST, V27, P111, DOI 10.1007/s10963-014-9075-z; Zazvorka V, 1951, CESKOSLOVENSKY KRAS, V4, P60	125	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201431	10.1371/journal.pone.0201431	http://dx.doi.org/10.1371/journal.pone.0201431			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161127	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900008
J	Vancampfort, D; Smith, L; Stubbs, B; Swinnen, N; Firth, J; Schuch, FB; Koyanagi, A				Vancampfort, Davy; Smith, Lee; Stubbs, Brendon; Swinnen, Nathalie; Firth, Joseph; Schuch, Felipe B.; Koyanagi, Ai			Associations between active travel and physical multi-morbidity in six low- and middle-income countries among community-dwelling older adults: A cross-sectional study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MAJOR DEPRESSIVE DISORDER; SKELETAL-MUSCLE MASS; SEDENTARY BEHAVIOR; NONCOMMUNICABLE DISEASES; GENERAL-POPULATION; MULTIMORBIDITY; HEALTH; PEOPLE; METAANALYSIS	Background There is little evidence on the potential health benefits of active travel in low- and middle-income countries (LMICs). The aim of this study was to assess the association between levels of active travel and physical multi-morbidity (i.e., two or more chronic physical conditions) and individual physical conditions among community-dwelling adults aged 65 or older in six LMICs. Methods Data were analyzed from the World Health Organization's Study on Global Ageing and Adult Health (China, Ghana, India, Mexico, Russia, South Africa). Active travel (minutes/week) was assessed with questions of the Global Physical Activity Questionnaire (GPAQ) and presented in tertiles. Eleven chronic conditions (angina, arthritis, asthma, chronic back pain, chronic lung disease, diabetes, edentulism, hearing problems, hypertension, stroke, visual impairment) were assessed by self-report of diagnosis, symptoms, or blood pressure measurement. Multivariable logistic regression analysis was conducted to assess the association between levels of active travel, physical conditions and physical multi-morbidity. Results The final sample consisted of 14,585 individuals aged >= 65 years (mean age = 72.6 +/- 0.1 years; 54.9% female). In the fully adjusted model, compared to the highest tertile, those in the lowest tertile of active travel had a 1.28 (95%CI = 1.06-1.54) times higher odds for physical multi-morbidity. The association between active travel and physical multi-morbidity was significantly mediated by affect (14.4%) and cognition (9.7%). With regard to individual conditions, hearing problems, hypertension, stroke, and visual impairment were particularly strongly associated with less active travel. Conclusion The current data suggest that lower levels of active travel are associated with the presence of physical health conditions and physical multi-morbidity. This multi-national study offers potentially valuable insight for a number of hypotheses which may influence this relationship, although testing with longitudinal studies is needed.	[Vancampfort, Davy; Swinnen, Nathalie] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Vancampfort, Davy; Swinnen, Nathalie] Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium; [Smith, Lee] Anglia Ruskin Univ, Cambridge Ctr Sport & Exercise Sci, Dept Life Sci, Cambridge, England; [Stubbs, Brendon] South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, Denmark Hill, London, England; [Stubbs, Brendon] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, London, England; [Stubbs, Brendon] Anglia Ruskin Univ, Fac Hlth Social Care & Educ, Chelmsford, Essex, England; [Firth, Joseph] Univ Western Sydney, Sch Sci & Hlth, NICM Hlth Res Unit, Sydney, NSW, Australia; [Firth, Joseph] Univ Manchester, Fac Biol Med & Hlth, Div Psychol & Mental Hlth, Manchester, Lancs, England; [Schuch, Felipe B.] Univ La Salle Unilasalle, Canoas, Brazil; [Schuch, Felipe B.] Escola Educ Fis Fisioterapia & Danca, Porto Alegre, RS, Brazil; [Schuch, Felipe B.] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Koyanagi, Ai] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, CIBERSAM, Madrid, Spain; [Koyanagi, Ai] Univ Barcelona, Res & Dev Unit, Fundacio St Joan Deu, Barcelona, Spain	KU Leuven; KU Leuven; Anglia Ruskin University; University of London; King's College London; Anglia Ruskin University; Western Sydney University; University of Manchester; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of Barcelona	Vancampfort, D (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium.; Vancampfort, D (corresponding author), Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium.	davy.vancampfort@kuleuven.be	Koyanagi, Ai/D-3833-2018; Firth, Joseph/ABE-6809-2020; Vancampfort, Davy/AAD-1987-2019; Stubbs, Brendon/X-1904-2018; Vancampfort, Davy/ABF-2439-2020; Schuch, Felipe/AAH-2586-2019; Schuch, Felipe/AAF-5028-2019	Koyanagi, Ai/0000-0002-9565-5004; Firth, Joseph/0000-0002-0618-2752; Stubbs, Brendon/0000-0001-7387-3791; Vancampfort, Davy/0000-0002-4592-8625; Schuch, Felipe/0000-0002-5190-4515; Schuch, Felipe/0000-0002-5190-4515; Swinnen, Nathalie/0000-0003-0087-8967	ISCIII General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER); National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care Funding scheme;  [CP13/00150];  [PI15/00862]	ISCIII General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER)(European Commission); National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care Funding scheme; ; 	Ai Koyanagi's work is supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII General Branch Evaluation and Promotion of Health Research - and the European Regional Development Fund (ERDF-FEDER). Brendon Stubbs receives funding from the National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care Funding scheme. The funders had no role in: design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; An KO, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.07.005; Arokiasamy P, 2017, AM J EPIDEMIOL, V185, P414, DOI 10.1093/aje/kww125; Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Bertheussen GF, 2011, MED SCI SPORT EXER, V43, P1220, DOI 10.1249/MSS.0b013e318206c66e; Breen R, 2013, SOCIOL METHOD RES, V42, P164, DOI 10.1177/0049124113494572; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de Souto Barreto P, 2017, J GERONTOL A-BIOL; Foong YC, 2016, J CACHEXIA SARCOPENI, V7, P275, DOI 10.1002/jcsm.12065; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063315; Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128; Gispen FE, 2014, J AM GERIATR SOC, V62, P1427, DOI 10.1111/jgs.12938; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Helbig AK, 2017, SLEEP MED, V33, P151, DOI 10.1016/j.sleep.2017.01.016; Hupin D, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094306; Kubesch NJ, 2015, OCCUP ENVIRON MED, V72, P284, DOI 10.1136/oemed-2014-102106; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Kivimaki M, 2017, LANCET PUBLIC HEALTH, V2, pE277, DOI 10.1016/S2468-2667(17)30074-9; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Koyanagi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114742; Lara E, 2016, INT J GERIATR PSYCH, V31, P858, DOI 10.1002/gps.4398; Laverty AA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0223-3; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Loprinzi PD, 2018, PHYSICIAN SPORTSMED, V46, P123, DOI 10.1080/00913847.2018.1407619; Marmeleira J, 2014, ADAPT PHYS ACT Q, V31, P283, DOI 10.1123/apaq.2013-0039; Mijinarends DM, 2016, AGE AGEING, V45, P614, DOI 10.1093/ageing/afw090; Millett C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001459; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Nuevo R, 2013, ACTA PSYCHIAT SCAND, V127, P482, DOI 10.1111/acps.12010; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Pengpid S, 2015, INT J PUBLIC HEALTH, V60, P539, DOI 10.1007/s00038-015-0680-0; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Qin L, 2012, AM J PREV MED, V43, P1, DOI 10.1016/j.amepre.2012.03.022; Read JR, 2017, J AFFECT DISORDERS, V221, P36, DOI 10.1016/j.jad.2017.06.009; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Saunders LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069912; Schuch FB, 2018, AM J PSYCHIAT; Schuch F, 2017, J AFFECT DISORDERS, V210, P139, DOI 10.1016/j.jad.2016.10.050; Smit W, 2016, HEALTH PLACE, V39, P196, DOI 10.1016/j.healthplace.2016.04.006; Smith L, 2016, BMJ OPEN OPHTHALMOL, V1, DOI 10.1136/bmjophth-2016-000046; Stubbs B, 2017, PSYCHOL MED, V47, P2107, DOI 10.1017/S0033291717000551; Stubbs B, 2018, J AFFECT DISORDERS, V229, P231, DOI 10.1016/j.jad.2017.12.104; Stubbs B, 2018, MATURITAS, V107, P84, DOI 10.1016/j.maturitas.2017.10.007; Tyrovolas S, 2016, J CACHEXIA SARCOPENI, V7, P312, DOI 10.1002/jcsm.12076; Urie Y, 2016, TRAFFIC INJ PREV, V17, P686, DOI 10.1080/15389588.2016.1146823; Vancampfort D, 2017, MILD COGNITIVE UNPUB; Vancampfort D, 2017, EXP GERONTOL, V100, P100, DOI 10.1016/j.exger.2017.10.028; Vancampfort D, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0602-z; Vancampfort D, 2017, WORLD PSYCHIATRY, V16, P308, DOI 10.1002/wps.20458; Vancampfort D, 2017, GEN HOSP PSYCHIAT, V45, P1, DOI 10.1016/j.genhosppsych.2016.11.002; Vancampfort D, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0463-5; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2018, WORLD REP AG HLTH	59	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203277	10.1371/journal.pone.0203277	http://dx.doi.org/10.1371/journal.pone.0203277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161211	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000443388900100
J	Yan, SJ; Gan, Y; Song, XY; Chen, YQ; Liao, N; Chen, S; Lv, CZ				Yan, Shijiao; Gan, Yong; Song, Xingyue; Chen, Yunqiang; Liao, Na; Chen, Song; Lv, Chuanzhu			Association between refrigerator use and the risk of gastric cancer: A systematic review and meta-analysis of observational studies	PLOS ONE			English	Review							STOMACH-CANCER; EPIDEMIOLOGY; SALT; DIET	There were many observational studies that examined the association between refrigerator use and stomach cancer. However, the results remain to be a contradiction. This study aimed to evaluate the association between refrigerator use and the risk of gastric cancer. We systematically searched the PubMed, Embase, Web of Science databases (up to 31 May 2017), and manually reviewed the references lists of retrieved articles, to identify studies that evaluated the association between refrigerator use and the risk of gastric cancer. Observational studies reporting odds ratio (OR) with 95% confidence intervals (Cis) for the relationship between refrigerator use and the risk of gastric cancer were included. Two authors independently reviewed and selected eligible studies and conducted the study quality evaluation. We included a total of twelve studies enrolling 14,361 individuals. The summarized OR the association between refrigerator use and the risk of gastric cancer was 0.70 (95% CI, 0.56-0.88; P<0.001). Subgroup analysis showed that a significantly inverse association between refrigerator use and gastric cancer risk was observed in in some Asian countries (OR = 0.68, 95% CI, 0.50-0.93; P = 0.002), but not in some Western countries, such as Germany, etc. Refrigerator use is significantly associated with a decreased risk of gastric cancer. Further studies are warranted to confirm whether refrigerator use could reduce the risk of gastric cancer among some Asian countries.	[Yan, Shijiao] Hainan Med Univ, Sch Int Educ, Haikou, Hainan, Peoples R China; [Gan, Yong; Song, Xingyue] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan, Hubei, Peoples R China; [Chen, Yunqiang; Lv, Chuanzhu] Hainan Med Univ, Emergency & Trauma Coll, Haikou, Hainan, Peoples R China; [Liao, Na] Hainan Med Univ, Affiliated Hosp 2, Dept Nursing, Haikou, Hainan, Peoples R China; [Chen, Song] Hainan Med Univ, Affiliated Hosp 1, Dept Emergency, Haikou, Hainan, Peoples R China	Hainan Medical University; Huazhong University of Science & Technology; Hainan Medical University; Hainan Medical University; Hainan Medical University	Lv, CZ (corresponding author), Hainan Med Univ, Emergency & Trauma Coll, Haikou, Hainan, Peoples R China.	lvchuanzhu677@126.com			Science and Technology Department of Hainan Province "Exploration of the New Mode of Trauma Care in Hainan Province with Fast-track surgery" [ZDXM 2017123]; China Postdoctoral Science Foundation [2018M630870]	Science and Technology Department of Hainan Province "Exploration of the New Mode of Trauma Care in Hainan Province with Fast-track surgery"; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was funded by Science and Technology Department of Hainan Province "Exploration of the New Mode of Trauma Care in Hainan Province with Fast-track surgery" (ZDXM 2017123), and the China Postdoctoral Science Foundation funded project (2018M630870). The funders of the study had no role in study design, data collection, data analysis, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Binici DN, 2009, DIGEST DIS SCI, V54, P2629, DOI 10.1007/s10620-008-0647-6; BOEING H, 1991, INT J CANCER, V47, P858, DOI 10.1002/ijc.2910470612; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Cai L, 2003, WORLD J GASTROENTERO, V9, P214, DOI 10.3748/wjg.v9.i2.214; Cai M, 2017, CANCER MED-US, V6, P708, DOI 10.1002/cam4.1038; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fei Su Juan, 2006, Chin J Dig Dis, V7, P83, DOI 10.1111/j.1443-9573.2006.00252.x; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; HANSSON LE, 1993, INT J CANCER, V55, P181, DOI 10.1002/ijc.2910550203; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoang BV, 2016, WORLD J GASTROENTERO, V22, P6257, DOI 10.3748/wjg.v22.i27.6257; HOWSON CP, 1986, EPIDEMIOL REV, V8, P1; Jagerstad M, 2005, MUTAT RES-FUND MOL M, V574, P156, DOI 10.1016/j.mrfmmm.2005.01.030; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; LAVECCHIA C, 1990, BRIT J CANCER, V62, P136, DOI 10.1038/bjc.1990.245; LAVECCHIA C, 1995, INT J CANCER, V60, P748, DOI 10.1002/ijc.2910600603; Mathew A, 2000, EUR J CANCER PREV, V9, P89, DOI 10.1097/00008469-200004000-00004; Munoz N, 2001, INT J CANCER, V93, P417, DOI 10.1002/ijc.1333; Pakseresht M, 2011, CANCER CAUSE CONTROL, V22, P725, DOI 10.1007/s10552-011-9744-5; Park JY, 2018, TOXINS, V10, DOI 10.3390/toxins10040163; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peleteiro B, 2011, BRIT J CANCER, V104, P198, DOI 10.1038/sj.bjc.6605993; Song P, 2015, NUTRIENTS, V7, P9872, DOI 10.3390/nu7125505; SORBYE H, 1994, CARCINOGENESIS, V15, P673, DOI 10.1093/carcin/15.4.673; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tsugane S, 2005, CANCER SCI, V96, P1, DOI 10.1111/j.1349-7006.2005.00006.x; van den Brandt PA, 2003, CANCER CAUSE CONTROL, V14, P427, DOI 10.1023/A:1024979314124; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; WALTERS CI, 1992, FOOD ADDIT CONTAM, V9, P441, DOI 10.1080/02652039209374096; Wells G., NEWCASTLE OTTAWA SCA; XIAO SD, 1986, CHINESE MED J-PEKING, V99, P903	33	8	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203120	10.1371/journal.pone.0203120	http://dx.doi.org/10.1371/journal.pone.0203120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161245	Green Submitted, gold, Green Published			2022-12-27	WOS:000443388900081
J	Grases, F; Costa-Bauza, A; Roig, J; Rodriguez, A				Grases, Felix; Costa-Bauza, Antonia; Roig, Joan; Rodriguez, Adrian			Xanthine urolithiasis: Inhibitors of xanthine crystallization	PLOS ONE			English	Article							HEREDITARY XANTHINURIA; CLASSICAL XANTHINURIA; MUTATION; IDENTIFICATION; GENE	Objective To identify in vitro inhibitors of xanthine crystallization that have potential for inhibiting the formation of xanthine crystals in urine and preventing the development of the renal calculi in patients with xanthinuria. Methods The formation of xanthine crystals in synthetic urine and the effects of 10 potential crystallization inhibitors were assessed using a kinetic turbidimetric system with a photometer. The maximum concentration tested for each compound was: 20 mg/L for 3-methylxanthine (3MX); 40 mg/L for 7-methylxanthine (7-MX), 1-methylxanthine (1-MX), theobromine (TB), theophylline, paraxanthine, and caffeine; 45 mg/L for 1-methyluric acid; 80 mg/L for 1,3-dimethyluric acid; and 200 mg/L for hypoxanthine. Scanning electron microscopy was used to examine the morphology of the crystals formed when inhibitory effects were observed. Results Only 7-MX, 3-MX, and 1-MX significantly inhibited xanthine crystallization at the tested concentrations. Mixtures of inhibitors had an additive effect rather than a synergistic effect on crystallization. Conclusion Two of the inhibitors identified here D 7-MX and 3-MX D are major metabolites of TB. In particular, after TB consumption, 20% is excreted in the urine as TB, 21.5% as 3-MX, and 36% as 7-MX. Thus, consumption of theobromine could protect patients with xanthinuria from the development of renal xanthine calculi. Clinical trials are necessary to demonstrate these effects in vivo.	[Grases, Felix; Costa-Bauza, Antonia; Roig, Joan; Rodriguez, Adrian] Univ Balearic Isl, Fac Sci, Univ Inst Hlth Sci Res IUNICS IdISBa, Lab Renal Lithiasis Res, Palma De Mallorca, Spain	Universitat de les Illes Balears	Grases, F (corresponding author), Univ Balearic Isl, Fac Sci, Univ Inst Hlth Sci Res IUNICS IdISBa, Lab Renal Lithiasis Res, Palma De Mallorca, Spain.	fgrases@uib.es	RODRIGUEZ, ADRIAN/D-6606-2019	RODRIGUEZ, ADRIAN/0000-0002-6521-4558; Grases, Felix/0000-0001-5636-9139				Arnaud Maurice J, 2011, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-642-13443-2_3; CARPENTER TO, 1986, J PEDIATR-US, V109, P307, DOI 10.1016/S0022-3476(86)80391-2; CRAIG WJ, 1984, J FOOD SCI, V49, P302, DOI 10.1111/j.1365-2621.1984.tb13737.x; Grases F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111184; HISATOME I, 1993, NEPHRON, V65, P578, DOI 10.1159/000187567; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; Ichida K, 2012, INT J MOL SCI, V13, P15475, DOI 10.3390/ijms131115475; MATEOS FA, 1987, J CLIN INVEST, V79, P847, DOI 10.1172/JCI112893; Mraz M, 2015, UROLITHIASIS, V43, P61, DOI 10.1007/s00240-014-0734-4; Nicoletta JA, 2006, PEDIATR CLIN N AM, V53, P479, DOI 10.1016/j.pcl.2006.03.001; Peretz H, 2007, MOL GENET METAB, V91, P23, DOI 10.1016/j.ymgme.2007.02.005; Yamamoto T, 2003, METABOLISM, V52, P1501, DOI 10.1016/S0026-0495(03)00272-5	12	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0198881	10.1371/journal.pone.0198881	http://dx.doi.org/10.1371/journal.pone.0198881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157195	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400003
J	Hobbs, SJ; Nauwelaerts, S; Sinclair, J; Clayton, HM; Back, W				Hobbs, Sarah Jane; Nauwelaerts, Sandra; Sinclair, Jonathan; Clayton, Hilary M.; Back, Willem			Sagittal plane fore hoof unevenness is associated with fore and hindlimb asymmetrical force vectors in the sagittal and frontal planes	PLOS ONE			English	Article							GROUND REACTION FORCE; HORSES; LATERALITY; LAMENESS; MOTOR; KINEMATICS; BACK; LOAD; BODY; FEET	Asymmetry in forelimb dorsal hoof wall angles, termed unevenness, is associated with forelimb gait asymmetries, but compensatory mechanisms and out of plane ground reaction forces (GRFs) due to unevenness have yet to be documented. The aim of this study was therefore to investigate the effects of fore hoof unevenness on contralateral fore and hind limb force vectors patterns, in both sagittal and frontal planes. A group of n=34 riding horses were classified into four groups: hoof angle difference of more than 1.5 degrees (UNEVEN; n=27), including higher left fore (HIGH-LF; n=12), higher right fore (HIGH-RF; n=15), and hoof angle difference of less than 1.5 degrees (EVEN; n=7). Three dimensional ground reaction forces GRFs were collected during trotting. GRF summary vectors representing the magnitude (VecMag) and angular direction (VecAng) of the entire stance phase in the sagittal and the frontal plane were calculated. The effects of unevenness on GRF production were explored using linear regression, repeated measures ANOVA and statistical parametric mapping (SPM) with significance at (P<0.05). In all uneven groups, increasing unevenness affected sagittal VecAng values in the forelimbs, with more propulsive GRF in the high hoof. In the HIGH-RF group, medial GRFs were also found in the high RF hoof compared to lateral GRFs in the low LF hoof (RF VecAng: 0.97 +/- 1.64 (deg); LF VecAng: -0.64 +/- 1.19 (deg); P<0.05). In both HIGH groups, compensatory associations to increasing unevenness were only found in the RH, but also a significantly greater lateral VecAng was found in the LH (P<0.05) compared to the RH limb. No significant differences (P>0.05) were found between hindlimb pairs in the EVEN group. Unbalanced sagittal and increased frontal plane GRFs in uneven horses suggest that they have greater locomotory challenges, as the equine musculoskeletal system is not constructed to withstand movement and loading in the frontal plane as effectively as it is in the sagittal plane.	[Hobbs, Sarah Jane; Sinclair, Jonathan] Univ Cent Lancashire, Ctr Appl Sport & Exercise Sci, Preston, Lancs, England; [Nauwelaerts, Sandra] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Nauwelaerts, Sandra] Antwerp Zoo Ctr Res & Conservat, Antwerp, Belgium; [Clayton, Hilary M.] Sport Horse Sci, Mason, MI USA; [Back, Willem] Univ Utrecht, Dept Equine Sci, Fac Vet Med, Utrecht, Netherlands; [Back, Willem] Univ Ghent, Fac Vet Med, Dept Surg & Anaesthesia Domest Anim, Ghent, Belgium	University of Central Lancashire; University of Antwerp; Utrecht University; Ghent University	Hobbs, SJ (corresponding author), Univ Cent Lancashire, Ctr Appl Sport & Exercise Sci, Preston, Lancs, England.	sjhobbs1@uclan.ac.uk		Sinclair, Jonathan/0000-0002-2231-3732; Clayton, Hilary/0000-0002-8759-0925; Hobbs, Sarah Jane/0000-0002-1552-8647	Qualisys grant; FWO-Flanders grant; IOF grant (IOF SBO) [34424]	Qualisys grant; FWO-Flanders grant; IOF grant (IOF SBO)	This work was supported by a Qualisys grant to Sarah Jane Hobbs, an FWO-Flanders grant to Sandra Nauwelaerts and an IOF grant (IOF SBO ID 34424) to Sandra Nauwelaerts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CBG, 2008, EQUINE VET J, V40, P153, DOI 10.2746/042516408X250292; Alvarez CBG, 2007, EQUINE VET J, V39, P197, DOI 10.2746/042516407X173668; American Association of Equine Practitioners, 2017, LAM EX EV LAM HORS; Berki V, 2015, J BIOMECH, V48, P2214, DOI 10.1016/j.jbiomech.2015.03.025; Brindle RA, 2014, GAIT POSTURE, V39, P124, DOI 10.1016/j.gaitpost.2013.06.010; Clayton HM, 2017, PEERJ, V5, DOI 10.7717/peerj.3866; Colborne GR, 2016, NEW ZEAL VET J, V64, P76, DOI 10.1080/00480169.2015.1068138; Colborne GR, 2011, AM J VET RES, V72, P336, DOI 10.2460/ajvr.72.3.336; Crevier-Denoix N, 2010, EQUINE VET J, V42, P544, DOI 10.1111/j.2042-3306.2010.00202.x; Curtis SJ, 2012, C MED CHIR EQ GEN GE; DALIN G, 1985, EQUINE VET J, V17, P292, DOI 10.1111/j.2042-3306.1985.tb02501.x; Ducro B, 2009, EQUINE VET J, V49, P1439; Ducro BJ, 2009, EQUINE VET J, V41, P144, DOI 10.2746/042516408X363800; Hobbs SJ, 2018, PEERJ, V6, DOI 10.7717/peerj.4399; Hobbs SJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2190; Hopkins S., 2014, EQUINE VET J S46, V46, P42, DOI [10.1111/evj.12267_127, DOI 10.1111/EVJ.12267_127]; Ishihara A, 2005, AM J VET RES, V66, P1805, DOI 10.2460/ajvr.2005.66.1805; Kambhampati SBS, 2007, J BIOMECH, V40, P3748, DOI 10.1016/j.jbiomech.2007.06.012; KHODADADEH S, 1986, CLIN BIOMECH, V1, P77, DOI 10.1016/0268-0033(86)90079-3; Kienapfel K, 2018, J ANIM PHYSIOL AN N, V102, pE818, DOI 10.1111/jpn.12840; Lucidi P, 2013, PHYSIOL BEHAV, V109, P8, DOI 10.1016/j.physbeh.2012.11.006; McGreevy PD, 2005, APPL ANIM BEHAV SCI, V92, P337, DOI 10.1016/j.applanim.2004.11.012; Meardon SA, 2014, J BIOMECH, V47, P2738, DOI 10.1016/j.jbiomech.2014.04.047; Morley JB, 2010, J APPL BIOMECH, V26, P205, DOI 10.1123/jab.26.2.205; Nauwelaerts S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167477; Pataky T., 2016, SPM1D; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Pearce GP, 2005, AUST VET J, V83, P367, DOI 10.1111/j.1751-0813.2005.tb15636.x; PEDOTTI A, 1977, IEEE T BIO-MED ENG, V24, P456, DOI 10.1109/TBME.1977.326186; Peham C, 2004, EQUINE VET J, V36, P703, DOI 10.2746/0425164044848091; Penny W., 2007, STAT PARAMETR MAPP A, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Polk JD, 2017, GAIT POSTURE, V52, P140, DOI 10.1016/j.gaitpost.2016.11.028; TING LH, 1994, J EXP BIOL, V197, P251; van Heel MCV, 2006, EQUINE VET J, V38, P646, DOI 10.2746/042516406X159070; van Heel MCV, 2010, EQUINE VET J, V42, P444, DOI 10.1111/j.2042-3306.2010.00064.x; Wakeling J. M., 2007, Equine and Comparative Exercise Physiology, V4, P95, DOI 10.1017/S1478061507812126; Watson KM, 2003, EQUINE VET J, V35, P712, DOI 10.2746/042516403775696348; Weishaupt MA, 2006, VET J, V171, P135, DOI 10.1016/j.tvjl.2004.09.004; Weishaupt MA, 2008, VET CLIN N AM-EQUINE, V24, P79, DOI 10.1016/j.cveq.2007.11.010; Wiggers N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114836; Williams DE, 2007, ANIM BEHAV, V74, P941, DOI 10.1016/j.anbehav.2007.01.014; Wilson GH, 2009, EQUINE VET J, V41, P238, DOI 10.2746/042516409X395561	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203134	10.1371/journal.pone.0203134	http://dx.doi.org/10.1371/journal.pone.0203134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157249	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000443071400093
J	Jimeaez-Silva, CL; Carreno, MF; Ortiz-Baez, AS; Rey, LA; Villabona-Arenas, CJ; Ocazionez, RE				Jimeaez-Silva, Cinthy L.; Fernanda Carreno, Maria; Susana Ortiz-Baez, Ayda; Aida Rey, Luz; Villabona-Arenas, Christian Julian; Ocazionez, Raquel E.			Evolutionary history and spatio-temporal dynamics of dengue virus serotypes in an endemic region of Colombia	PLOS ONE			English	Article							ZIKA VIRUS; MULTIPLE INTRODUCTIONS; AMERICA; EPIDEMIOLOGY; PHYLOGENETICS; SINGAPORE; AREA	Dengue is a prevalent disease in Colombia and all dengue virus serotypes (DENV-1 to -4) co-circulate in the country since 2001. However, the relative impact of gene flow and local diversification on epidemic dynamics is unknown due to heterogeneous sampling and lack of sufficient genetic data. The region of Santander is one of the areas with the highest incidence of dengue in Colombia. To provide a better understanding of the epidemiology of dengue, we inferred DENV population dynamics using samples collected between 1998 and 2015. We used Bayesian phylogenetic analysis and included 143 new envelope gene sequences from Colombia, mainly from the region of Santander, and 235 published sequences from representative countries in the Americas. We documented one single genotype for each serotype but multiple introductions. Whereas the majority of DENV-1, DENV-2, and DENV-4 strains fell into one single lineage, DENV-3 strains fell into two distinct lineages that co-circulated. The inferred times to the most recent common ancestors for the most recent clades of DENV-1, DENV-2, and DENV-4 fell between 1977 and 1987, and for DENV-3 was around 1995. Demographic reconstructions suggested a gradual increase in viral diversity over time. A phylogeographical analysis underscored that Colombia mainly receives viral lineages and a significant diffusion route between Colombia and Venezuela. Our findings contribute to a better understanding of the viral diversity and dengue epidemiology in Colombia.	[Jimeaez-Silva, Cinthy L.; Fernanda Carreno, Maria; Susana Ortiz-Baez, Ayda; Ocazionez, Raquel E.] Univ Ind Santander, Lab Arbovirus, Ctr Invest Enfermedades Trop CINTROP, Bucaramanga, Colombia; [Aida Rey, Luz] Univ Ind Santander, Unidad Epidemiol Clin, Escuela Med, Bucaramanga, Colombia; [Villabona-Arenas, Christian Julian] Univ Montpellier, IRD, Lab TransVIHMI, Montpellier, France; [Villabona-Arenas, Christian Julian] Univ Montpellier, IBC, LIRMM, Montpellier, France	Universidad Industrial de Santander; Universidad Industrial de Santander; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier	Villabona-Arenas, CJ (corresponding author), Univ Montpellier, IRD, Lab TransVIHMI, Montpellier, France.; Villabona-Arenas, CJ (corresponding author), Univ Montpellier, IBC, LIRMM, Montpellier, France.	christian-julian.villabona-arenas@ird.fr		Carreno, Maria Fernanda/0000-0003-4294-1848; Villabona Arenas, Christian Julian/0000-0001-9928-3968; Ortiz Baez, Ayda Susana/0000-0003-0080-0633	Colombian Government: Science, Technology and Innovation Fund of Sistema General de Regalias, Santander, Casanare, Valle del Cauca [BPIN 2013000100011]	Colombian Government: Science, Technology and Innovation Fund of Sistema General de Regalias, Santander, Casanare, Valle del Cauca	This study was supported by the Colombian Government: Science, Technology and Innovation Fund of Sistema General de Regalias, Santander, Casanare, Valle del Cauca (BPIN 2013000100011).	Afreen N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004511; Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Alvarez DP, 2012, DENGUE COLOMBIA EPID, P142; Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Baele G, 2013, BIOINFORMATICS, V29, P1970, DOI 10.1093/bioinformatics/btt340; Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285; Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Campos RD, 2013, J CLIN VIROL, V56, P86, DOI 10.1016/j.jcv.2012.10.006; Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866; (DANE) DAN de E, EST DEM POBL; Departamento Nacional de Planeacion (DANE), AN MOV INT VIAJ COL; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; Gomez Rangel S. Y., 2008, Dengue Bulletin, V32, P126; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Instituto Nacional de Salud, INSTR INT ACC VIG PR; Villabona-Arenas CJ, 2009, TROP MED INT HEALTH, V14, P1241, DOI 10.1111/j.1365-3156.2009.02339.x; Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538; Kotaki T, 2016, INFECT GENET EVOL, V37, P88, DOI 10.1016/j.meegid.2015.11.002; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Manakkadan A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-37; Mendez JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-64; Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226; Mir D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098519; Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769; Ocazionez RE, 2006, MEM I OSWALDO CRUZ, V101, P725, DOI 10.1590/S0074-02762006000700004; Ocazionez-Jimenez RE, 2013, BIOMEDICA, V33, P22, DOI 10.7705/biomedica.v33i0.717; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Ospina MC, 2010, AM J TROP MED HYG, V83, P672, DOI 10.4269/ajtmh.2010.09-0766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez G, 2014, COLECCION EC REGIONA; Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161; R Core team, 2015, R LANG ENV STAT COMP, V55, P275; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Ramirez Clemencia, 2013, PERFIL MIGRATORIO CO; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; RODRIGUEZROCHE R, 2013, BIO MED RES INT, V2013, P20, DOI DOI 10.1155/2013/690835; Santiago GA, 2012, J INFECT DIS, V206, P893, DOI 10.1093/infdis/jis426; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sharp Tyler M, 2017, Curr Epidemiol Rep, V4, P11, DOI 10.1007/s40471-017-0095-y; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Teoh BT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-213; Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]; Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694; Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007; Villabona-arenas CJ, 2016, PLOS NEGLECT TROP D, P5; Villamor E, 2017, EPIDEMIOL INFECT, V145, P2961, DOI [10.1017/S0950268817002059, 10.1017/s0950268817002059]; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Xia XH, 2017, J HERED, V108, P431, DOI 10.1093/jhered/esx033; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005	63	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203090	10.1371/journal.pone.0203090	http://dx.doi.org/10.1371/journal.pone.0203090			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157270	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400089
J	de la Lama, RL; De la Puente, S; Riveros, JC				Lopez de la Lama, Rocio; De la Puente, Santiago; Carlos Riveros, Juan			Attitudes and misconceptions towards sharks and shark meat consumption along the Peruvian coast	PLOS ONE			English	Article							WORD-ASSOCIATION; CONSERVATION; SEAFOOD; BEHAVIOR	Misconceptions, lack of knowledge, and negative attitudes towards sharks act as barriers preventing actions required to tackle threats to shark populations, limiting the success of global shark conservation initiatives. Peru, a major player for the international trade of shark products, recently approved the 'National Action Plan for the Conservation and Management of Sharks, Rays and Chimaeras' (PAN-Tib); a guiding document for conservation initiatives aimed at these fishes. Within PAN-Tib, the assessment of Peruvians' current knowledge and attitudes towards sharks is listed as a research priority. Between June and October 2016, 2004 Peruvians were surveyed along the coast to characterize their (i) shark meat consumption patterns, and (ii) knowledge and attitudes towards sharks. Results suggest that shark meat consumption is extended, but not necessarily frequent, and higher in the northern regions of the country. However, 77.5% of shark meat consumers were unaware that they had eaten sharks. Although 57.6% of the participants recognized that sharks are present in Peruvian waters, only 19.4% of the surveyed population was capable of naming at least one local shark species. Moreover, Peruvians have very negative attitudes towards sharks. They fear them and view them as man-eaters, despite this, no shark attacks have ever been reported in the country. These results highlight the need to: (i) encourage sustainable shark meat consumption, and (ii) promote communication campaigns aimed at increasing knowledge about sharks, and their importance as a source of employment and food for coastal communities, as for the national economy.	[Lopez de la Lama, Rocio] Univ British Columbia, IRES, Vancouver, BC, Canada; [Lopez de la Lama, Rocio] Univ Peruana Cayetano Heredia, LEB, Lima, Peru; [De la Puente, Santiago] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Carlos Riveros, Juan] OCEANA Peru, Lima, Peru	University of British Columbia; Universidad Peruana Cayetano Heredia; University of British Columbia	de la Lama, RL (corresponding author), Univ British Columbia, IRES, Vancouver, BC, Canada.; de la Lama, RL (corresponding author), Univ Peruana Cayetano Heredia, LEB, Lima, Peru.; De la Puente, S (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada.	rocio.lopez@upch.pe; s.delapuente@oceans.ubc.ca		De la Puente, Santiago/0000-0002-6189-9596; Lopez de la Lama, Rocio/0000-0001-6696-5401; Riveros, Juan Carlos/0000-0003-4051-181X	Pew Charitable Trusts; Oceana Peru	Pew Charitable Trusts; Oceana Peru	This study was funded by The Pew Charitable Trusts and Oceana Peru. The funding was mainly used for field work and data collection along the Peruvian coast.	Aipanjiguly S, 2003, CONSERV BIOL, V17, P1098, DOI 10.1046/j.1523-1739.2003.01452.x; [Anonymous], 2006, CUADERNOS INVESTIGAC; [Anonymous], 590 FAO; [Anonymous], 2010, TELEGRAPH; APEGA, 2013, BOOM GAST PERUANO 20; Cardenas-Alayza S., 2017, CONSULTORIA ELABORAD; Carlucci D, 2015, APPETITE, V84, P212, DOI 10.1016/j.appet.2014.10.008; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Chirichigno N., 2001, CATA LOGO COMENTADO; Christensen V, 2014, MAR POLICY, V44, P302, DOI 10.1016/j.marpol.2013.09.022; Clemente L. E., 2010, LIBERTAD SALAVERRY; Cornejo Rodolfo, 2015, Check List, V11, P1809; Crona BI, 2016, FISH FISH, V17, P1175, DOI 10.1111/faf.12109; de Andrade JC, 2016, MEAT SCI, V117, P68, DOI 10.1016/j.meatsci.2016.02.039; De la Puente S., 2017, CHARACTERIZING KNOWL; Donoghue S., 2000, J CONSUM SCI, V28, P47, DOI 10.4314/jfecs.v28i1.52784; Friedrich LA, 2014, MAR POLICY, V47, P1, DOI 10.1016/j.marpol.2014.02.003; Garla RC, 2015, MAR POLICY, V60, P128, DOI 10.1016/j.marpol.2015.06.012; Gonzalez-Pestana A., 2016, F1000RESEARCH, V3, P164, DOI DOI 10.12688/F1000RESEARCH.4412.2; Gonzalez-Pestana A, 2017, FISH B-NOAA, V115, P451, DOI 10.7755/FB.115.4.2; IMARPE, 2015, SER DIV CIENT I MAR, V1, P1; INEI, 2018, PER IND EMPL INGR DE; INEI, 2012, CONSUMO CPITA PRINCI; Jacques PJ, 2010, PROG OCEANOGR, V86, P192, DOI 10.1016/j.pocean.2010.04.001; Jacquet JL, 2008, MAR POLICY, V32, P309, DOI 10.1016/j.marpol.2007.06.007; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Lavallee D, 2011, CHUNGARA, V43, P333, DOI 10.4067/S0717-73562011000300002; Lopez de la Lama R., 2018, ORYX; Lowell B., 2015, ONE NAME ONE FISH WH, P1; Mascia MB, 2003, CONSERV BIOL, V17, P649, DOI 10.1046/j.1523-1739.2003.01738.x; Mendo J., 2014, 201421 U BRIT COL FI, P23; MINAM, 2014, DIR GEN DIV BIOL; Muter BA, 2013, CONSERV BIOL, V27, P187, DOI 10.1111/j.1523-1739.2012.01952.x; Neff C, 2015, AUST J POLIT SCI, V50, P114, DOI 10.1080/10361146.2014.989385; Pepin-Neff C., 2018, CONSERV LETT, V11, P1, DOI DOI 10.1111/C0NL.12407; Prieto G, 2015, THESIS; PRODUCE, 2014, PROGR NAC COM PESC U; PRODUCE, 2016, AN EST PESQ AC 2015; PRODUCE, 2014, 0022014PRODUCE; Roininen K, 2006, FOOD QUAL PREFER, V17, P20, DOI 10.1016/j.foodqual.2005.04.012; Rose S, 2015, MANAGEMENT RESEARCH: APPLYING THE PRINCIPLES, P1; Schultz PW, 2011, CONSERV BIOL, V25, P1080, DOI 10.1111/j.1523-1739.2011.01766.x; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Simpfendorfer CA, 2017, CURR BIOL, V27, pR97, DOI 10.1016/j.cub.2016.12.017; Steel BS, 2005, OCEAN COAST MANAGE, V48, P97, DOI 10.1016/j.ocecoaman.2005.01.002; Thompson TL, 2002, INT J SCI EDUC, V24, P645, DOI 10.1080/09500690110110115; Velez-Zuazo X, 2015, FISH RES, V161, P34, DOI 10.1016/j.fishres.2014.06.005; Zelezny L. C., 1999, J ENVIRON EDUC, V31, P5, DOI DOI 10.1080/00958969909598627	48	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202971	10.1371/journal.pone.0202971	http://dx.doi.org/10.1371/journal.pone.0202971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157282	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400079
J	Ogawa, T; Yamaki, T; Sato, T				Ogawa, Tatsuhiko; Yamaki, Tetsuya; Sato, Tatsuhiko			Analysis of scintillation light intensity by microscopic radiation transport calculation and Forster quenching model	PLOS ONE			English	Article							PLASTIC SCINTILLATORS; ORGANIC SCINTILLATORS; HEAVY-IONS; PROTONS; ELECTRONS; NE-228	The scintillation light yield of plastic scintillator considering the quenching effect is reproduced by a calculation model based on a track-structure simulation code and the Forster effect. Energy deposition and its nm-scale spatial arrangement in the irradiation by electrons, protons, and heavy ions (He-4 to Br-81) in an NE-102A scintillator were simulated by a track-structure simulation code. The spatial arrangements of the excited molecules emitting scintillation light and those dissipating the excitation energy were then obtained to calculate the strength of the quenching effect. Light emission from the excited molecules was integrated to finally obtain the observable light yield. The calculated light yields are in good agreement with the earlier measurement data. Moreover, in the case of low-LET particle incidence, a statistical micro-dosimetric model can substitute the track-structure simulation code for reproducing the light yield.	[Ogawa, Tatsuhiko; Sato, Tatsuhiko] Japan Atom Energy Agcy, Res Grp Radiat Transport Anal, Div Environm & Radiat Sci, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan; [Yamaki, Tetsuya] Natl Inst Quantum & Radiol Sci & Technol, Takasaki Adv Radiat Res, Takasaki, Gunma 3701292, Japan	Japan Atomic Energy Agency; National Institutes for Quantum Science & Technology	Ogawa, T (corresponding author), Japan Atom Energy Agcy, Res Grp Radiat Transport Anal, Div Environm & Radiat Sci, Nucl Sci & Engn Ctr, Tokai, Ibaraki 3191195, Japan.	ogawa.tatsuhiko@jaea.go.jp	Ogawa, Tatsuhiko/T-1279-2019; Yamaki, Tetsuya/ABA-6261-2020	Sato, Tatsuhiko/0000-0001-9902-7083				BECCHETTI FD, 1976, NUCL INSTRUM METHODS, V138, P93, DOI 10.1016/0029-554X(76)90154-3; BIRKS JB, 1951, P PHYS SOC LOND A, V64, P874, DOI 10.1088/0370-1298/64/10/303; CHOU CN, 1952, PHYS REV, V87, P904, DOI 10.1103/PhysRev.87.904; CRAUN RL, 1970, NUCL INSTRUM METHODS, V80, P239, DOI 10.1016/0029-554X(70)90768-8; CZIRR JB, 1963, NUCL INSTRUM METHODS, V25, P106; DEXTER DL, 1953, J CHEM PHYS, V21, P836, DOI 10.1063/1.1699044; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GOODING TJ, 1960, NUCL INSTRUM METHODS, V7, P189, DOI 10.1016/0029-554X(60)90126-9; HORROCKS DL, 1974, APPL LIQUID SCINTILL, P12; KASHA M, 1950, DISCUSS FARADAY SOC, P14, DOI 10.1039/df9500900014; MADEY R, 1978, NUCL INSTRUM METHODS, V151, P445, DOI 10.1016/0029-554X(78)90154-4; MADEY R, 1972, NUCL INSTRUM METHODS, V104, P253, DOI 10.1016/0029-554X(72)90538-1; Matsufuji N, 1999, NUCL INSTRUM METH A, V437, P346, DOI 10.1016/S0168-9002(99)00755-X; Plante I, 2011, MONTE CARLO SIMULATI; Plante Ianik, COMMUNICATION; PORTER FT, 1966, NUCL INSTRUM METHODS, V39, P35, DOI 10.1016/0029-554X(66)90041-3; Sato T, 2006, RADIAT PROT DOSIM, V122, P41, DOI 10.1093/rpd/ncl407; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; SMITH DL, 1968, NUCL INSTRUM METHODS, V64, P157, DOI 10.1016/0029-554X(68)90189-4; Technology E, PLAST SCINT PROD	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202011	10.1371/journal.pone.0202011	http://dx.doi.org/10.1371/journal.pone.0202011			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157187	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400026
J	Choukem, SP; Efie, DT; Djiogue, S; Kaze, FF; Mboue-Djieka, Y; Boudjeko, T; Dongo, E; Gautier, JF; Kengne, AP				Choukem, Simeon-Pierre; Efie, Derrick Tembi; Djiogue, Sefirin; Kaze, Francois F.; Mboue-Djieka, Yannick; Boudjeko, Thad; Dongo, Etienne; Gautier, Jean-Francois; Kengne, Andre-Pascal			Effects of hydroquinone-containing creams on capillary glycemia before and after serial hand washings in Africans	PLOS ONE			English	Article							BLOOD-GLUCOSE	Background Hydroquinone-containing creams cause false increases in capillary glycemia. However, the magnitude of this false increase, and the means to reverse it have not been investigated. Objective To evaluate the technical and clinical impact of hydroquinone-containing creams on capillary glycemia and investigate the efficacy of hand washing and other common practices, in reversing cream effects. Methods We included 91 participants in a quasi-experimental study in Buea, Cameroon. After determining the hydroquinone content of a cream, Caro Light, we used two glucometers with different enzymatic systems (Accu-Chek Active and OneTouch Ultra 2) to measure fasting glycemia after: initial hand washing (reference), application of 1 ml of hydroquinone-containing cream, finger swabbing with wet gauze, sanitizer application and a series of three hand washings following cream application. Reference glycemia was compared to those obtained after various interventions. Statistical significance was assessed by paired sample t-test, clinical significance by total error allowable (TEa), and clinical impact by Parke's error grid analysis. Results The mean differences in capillary glycemia (Intervention-reference) measured by Accu-Chek Active in mg/dl were 28, 27, 38, 16, 4, and -2 after cream application, finger swabbing, sanitizer application, one, two, and three hand washings respectively. Corresponding values for OneTouch Ultra2 were 41, 44, 64, 22, 5 and -5. These differences, except after two and three hand washings were both statistically (p < 0.0001) and clinically significant (TEa). After cream application, Accu-Check had 9.9% of values in Parke's Zones C-E, while OneTouch had 18.7%. Conclusion Hydroquinone-containing creams cause significant false increase in capillary glycemia irrespective of the enzymatic system of the glucometer used, and can lead to potentially wrong clinical decisions. A minimum of two hand washings is required prior to capillary glucose measurement.	[Choukem, Simeon-Pierre; Efie, Derrick Tembi] Univ Buea, Fac Hlth Sci, Dept Internal Med & Paediat, Buea, Cameroon; [Choukem, Simeon-Pierre; Efie, Derrick Tembi; Mboue-Djieka, Yannick] Hlth & Human Dev 2HD Res Network, Douala, Cameroon; [Choukem, Simeon-Pierre] Douala Gen Hosp, Dept Internal Med, Douala, Cameroon; [Djiogue, Sefirin] Univ Yaounde I, Fac Sci, Dept Anim Biol & Physiol, Yaounde, Cameroon; [Kaze, Francois F.] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Subspecialties, Yaounde, Cameroon; [Boudjeko, Thad] Univ Yaounde I, Fac Sci, Dept Biochem, Yaounde, Cameroon; [Dongo, Etienne] Univ Yaounde I, Fac Sci, Dept Organ Chem, Yaounde, Cameroon; [Gautier, Jean-Francois] Univ Paris Diderot, Paris 7, Lariboisiere Hosp, AP HP,Dept Diabet Endocrinol & Nutr, Paris, France; [Kengne, Andre-Pascal] South African Med Res Council, Cape Town, South Africa; [Kengne, Andre-Pascal] Univ Cape Town, Cape Town, South Africa	University of Yaounde I; University of Yaounde I; University of Yaounde I; University of Yaounde I; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; South African Medical Research Council; University of Cape Town	Choukem, SP (corresponding author), Univ Buea, Fac Hlth Sci, Dept Internal Med & Paediat, Buea, Cameroon.; Choukem, SP (corresponding author), Hlth & Human Dev 2HD Res Network, Douala, Cameroon.; Choukem, SP (corresponding author), Douala Gen Hosp, Dept Internal Med, Douala, Cameroon.	schoukem@gmail.com	Kengne, Andre Pascal/ABB-3696-2020	DJIOGUE, Sefirin/0000-0002-3525-7047; Tembi Efie, Derrick/0000-0003-3609-809X; Choukem, Simeon Pierre/0000-0003-1399-5513; Kengne, Andre Pascal/0000-0002-5183-131X	Tseu Medical Institute, Harris Manchester College, University of Oxford, UK	Tseu Medical Institute, Harris Manchester College, University of Oxford, UK	The Health and Human Development (2HD) Research Network is supported by a Cruddas Link Fellowship (SPC), Tseu Medical Institute, Harris Manchester College, University of Oxford, UK. The authors are grateful to all participants, and to the collaborators of the Department of Organic Chemistry, Faculty of Sciences, University of Yaounde I.	Bihan H, 2011, ANN INTERN MED, V155, P649, DOI 10.7326/0003-4819-155-9-201111010-00023; Bouche CH, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3879; García Pedro López, 2007, Rev. Bras. Cienc. Farm., V43, P397, DOI 10.1590/S1516-93322007000300008; Ginsberg Barry H, 2009, J Diabetes Sci Technol, V3, P903; Harr KE, 2013, VET CLIN PATH, V42, P424, DOI 10.1111/vcp.12101; Hortensius J, 2012, DIABETES EDUCATOR, V38, P101, DOI 10.1177/0145721711427787; Hortensius J, 2011, DIABETES CARE, V34, P556, DOI 10.2337/dc10-1694; ISO, ISO STAND BLOOD GLUC; Mahoney John J, 2011, J Diabetes Sci Technol, V5, P1444; Olumide YM, 2008, INT J DERMATOL, V47, P344, DOI 10.1111/j.1365-4632.2008.02719.x; Parkes JL, 2000, DIABETES CARE, V23, P1143, DOI 10.2337/diacare.23.8.1143; Rajaratnam H, 2012, SRI LANKA J DIABETES, V1, P22; Rosindale S, 2004, J DIABETES NURS, V8, P272; Sobngwi E, 2013, DIABETES METAB, V39, pA2; Westgard, DES BIOL VAR DAT SPE	15	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202271	10.1371/journal.pone.0202271	http://dx.doi.org/10.1371/journal.pone.0202271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153255	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700010
J	Mochizuki, M; Miyagi, K; Kishigami, S				Mochizuki, Masato; Miyagi, Kodai; Kishigami, Satoshi			Optimizing treatment of tauroursodeoxycholic acid to improve embryonic development after in vitro maturation of cumulus-free oocytes in mice	PLOS ONE			English	Article							APOPTOSIS	Cumulus-free in vitro maturation (IVM) provides a powerful tool to manipulate immature oocytes, but IVM oocytes lead to poor development after fertilization. Supplementation of the culture medium with tauroursodeoxycholic acid (TUDCA), a bile acid, has been reported to improve the development of embryos derived from in vivo fertilized (IVF) embryos after in vitro culture (IVC) by attenuating endoplasmic reticulum stress. However, it remains unclear if TUDCA can improve development of IVM-IVF embryos. Here, we examined whether TUDCA treatment could improve embryonic development during or after IVM. Immature GV oocytes collected from ovaries of ICR female mice that were free from cumulus cells were subjected to IVM in alpha MEM containing 5% FBS for 16 h. TUDCA was added to the media at varying concentrations (0-1000 mu M) during IVM and IVC. TUDCA treatment during IVM reduced both MII and pronuclear (PN) rates but did not affect blastocyst rates of fertilized embryos. In contrast, TUDCA treatment during IVC significantly increased blastocyst formation rates in a concentration dependent manner. Finally, embryo transfer after TUDCA treatment revealed a significant improvement in the rates of offspring production (15% with 1000 mu M TUDCA vs. 6.0% control). These results show that treatment with 1000 mu M of TUDCA significantly can improve poor embryonic development of cumulus-free IVM-IVF embryos.	[Mochizuki, Masato; Miyagi, Kodai; Kishigami, Satoshi] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi, Japan; [Kishigami, Satoshi] Univ Yamanashi, Adv Biotechnol Ctr, Kofu, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Kishigami, S (corresponding author), Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi, Japan.; Kishigami, S (corresponding author), Univ Yamanashi, Adv Biotechnol Ctr, Kofu, Yamanashi, Japan.	skishigami@yamanashi.ac.jp		Kishigami, Satoshi/0000-0001-9447-5100	JSPS KAKENHI [17K08134, 16H02593]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant (Numbers 17K08134 to SK, 16H02593 to TW and SK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JD, 2009, J LIPID RES, V50, P1721, DOI 10.1194/jlr.R900011-JLR200; [Anonymous], 2011, BIOL REPROD, V85, P70, DOI 10.1095/biolreprod.110.089342; Child TJ, 2002, OBSTET GYNECOL, V100, P665, DOI 10.1016/S0029-7844(02)02193-2; Dicks N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187717; Eppig JJ, 2009, HUM REPROD, V24, P922, DOI 10.1093/humrep/den466; Fonseca I, 2017, MOL NEUROBIOL, V54, P6107, DOI 10.1007/s12035-016-0145-3; Gilchrist RB, 2007, THERIOGENOLOGY, V67, P6, DOI 10.1016/j.theriogenology.2006.09.027; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Jia ZW, 2018, TOXICOL LETT, V294, P20, DOI 10.1016/j.toxlet.2018.05.007; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Lin T, 2015, REPROD BIOL, V15, P101, DOI 10.1016/j.repbio.2015.01.004; Miki H, 2006, J REPROD DEVELOP, V52, P239, DOI 10.1262/jrd.17078; Ogura A, 1998, P NATL ACAD SCI USA, V95, P5611, DOI 10.1073/pnas.95.10.5611; OOGA M, 2013, BIOL REPROD, V89, DOI DOI 10.1095/BI0LREPR0D.113.113258; Park HJ, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12458; Ramalho RM, 2004, J NEUROCHEM, V90, P567, DOI 10.1111/j.1471-4159.2004.02517.x; Wang DQH, 2014, WORLD J GASTROENTERO, V20, P9952, DOI 10.3748/wjg.v20.i29.9952; Yamazaki Y, 2001, ZYGOTE, V9, P277, DOI 10.1017/S0967199401001307; Zhang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040433	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202962	10.1371/journal.pone.0202962	http://dx.doi.org/10.1371/journal.pone.0202962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148855	Green Submitted, Green Published, gold			2022-12-27	WOS:000442804200038
J	Hsu, JC; Lin, JY; Hsu, MY; Lin, PC				Hsu, Jason C.; Lin, Jia-Yu; Hsu, May-Ying; Lin, Peng-Chan			Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan	PLOS ONE			English	Article							CELL LUNG-CANCER; STAGE-III MELANOMA; UNTREATED MELANOMA; OPEN-LABEL; CHOICE CHEMOTHERAPY; COMBINED NIVOLUMAB; IPILIMUMAB; PEMBROLIZUMAB; TRIAL; SURVIVAL	Background Since 2012, several immune checkpoint inhibitors have been approved by the Taiwan FDA for various types of cancer treatment. However, none of them are covered by Taiwan National Health Insurance due to the fact that they are expensive, and there is a lack of clinical evidence as to their effectiveness. Objectives This study was aimed toward an exploration of clinical experiences with use of immune checkpoint inhibitors, including indications, prescription types, drug effectiveness, adverse drug event types, and incidence, all of which shall serve as references for future clinical drug use. Methods This is a retrospective study focusing on three immune checkpoint inhibitors (ipilimumab, nivolumab, and pembrolizumab), which are available for cancer treatment in Taiwan. We collected data from medical records for the period from January 1st, 2015 to January 12th, 2017 at National Cheng Kung University Hospital (NCKUH), a medical center in southern Taiwan, and recorded these cases until May 31st, 2017. Overall survival (OS) and progression-free survival (PFS) were estimated using the Kaplan-Meier method, and adverse drug reaction odds ratios were analyzed using a chi-square analysis. Results The 50 patients under consideration in this study had used any one of the immune checkpoint inhibitors in NCKUH. Non-small cell lung cancer (n = 24, 48%) accounted for the highest percentage, followed by hepatocellular carcinoma (n = 4, 8%). The median OS was not reached, and the PFS for all immunotherapies was 4.9 months. The median OS period and PFS for non-small cell lung cancer (NSCLC) patients were 13 and 4.9 months, respectively, which were similar to those in many clinical trials. For NSCLC patients, the OS and PFS were only 0.63 and 1.37 months for squamous cell type NSCLC, and for patients who were PD-L1 negative, the OS and PFS were only 11.53 and 2.6 months, respectively. The most common adverse events in this study included fatigue (42%), rashes (22%), nausea (20%), and fever (20%), while one patient developed severe deep venous thrombosis and tissue inflammation, which was not confirmed in previous clinical trials. Conclusions The histological subtype, the intensity of the PD-L1 expression, and the timing of treatment affected the NSCLC therapeutic results. It is recommended that clinical tests be conducted in order to enhance therapeutic effectiveness. It is expected that more testing, observation-based studies, and research results will validate their efficacy and the tolerance levels of patients.	[Hsu, Jason C.] Natl Cheng Kung Univ, Coll Med, Sch Pharm, Tainan, Taiwan; [Hsu, Jason C.] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan; [Lin, Jia-Yu; Hsu, May-Ying] Natl Cheng Kung Univ Hosp, Dept Pharm, Tainan, Taiwan; [Lin, Peng-Chan] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Hsu, JC (corresponding author), Natl Cheng Kung Univ, Coll Med, Sch Pharm, Tainan, Taiwan.; Hsu, JC (corresponding author), Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan.	jasonhsu@mail.ncku.edu.tw			Taiwan Ministry of Science and Technology [MOST 104-2320-B-006-005, MOST 106-2320-B-006-039]	Taiwan Ministry of Science and Technology	Dr. Hsu was supported by Taiwan Ministry of Science and Technology grants (Grant ID: MOST 104-2320-B-006-005, MOST 106-2320-B-006-039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Calpe-Armero P, 2017, CHEMOTHERAPY, V62, P374, DOI 10.1159/000475803; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; D'Angelo SP, 2017, J CLIN ONCOL, V35, P226, DOI 10.1200/JCO.2016.67.9258; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gauvain C, 2018, LUNG CANCER, V116, P62, DOI 10.1016/j.lungcan.2017.12.008; Gettinger SN, 2015, J CLIN ONCOL, V33, P2004, DOI 10.1200/JCO.2014.58.3708; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hui R, 2017, ANN ONCOL, V28, P874, DOI 10.1093/annonc/mdx008; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; National Institutes of Health National Cancer Institute, 2010, COMMON TERMINOLOGY C; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Vokes EE, 2018, ANN ONCOL, V29, P959, DOI 10.1093/annonc/mdy041; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Xia B, 2016, IMMUNOTHERAPY-UK, V8, P279, DOI 10.2217/imt.15.123	26	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202725	10.1371/journal.pone.0202725	http://dx.doi.org/10.1371/journal.pone.0202725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142174	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500027
J	Damgaard, D; Bawadekar, M; Senolt, L; Stensballe, A; Shelef, MA; Nielsen, CH				Damgaard, Dres; Bawadekar, Mandar; Senolt, Ladislav; Stensballe, Allan; Shelef, Miriam A.; Nielsen, Claus H.			Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; PROTEIN/PEPTIDE ANTIBODIES; DISEASE-ACTIVITY; ASSOCIATION; PEPTIDES; CCP; NEUTROPHILS; EPITOPES; AUTOANTIBODIES	Objective Peptidylarginine deiminase 2 (PAD2) and PAD4 are expressed in the synovium of rheumatoid arthritis (RA) patients and catalyze citrullination of arginine residues in proteins targeted by anti-citrullinated protein antibodies (ACPAs). Little is known about the relative importance of PAD2 and PAD4 in generating citrullinated self-antigens. Here we investigate the ability of PAD2 and PAD4 to generate citrullinated targets for ACPAs in four human proteins. Methods Synovial fluid (SF) and plasma were collected from 42 RA patients. Human fibrinogen, human alpha-enolase (ENO1), human histone H3, and human serum albumin (HSA) were citrullinated in vitro by PAD2 or PAD4. The total degree of citrullination was determined using the anti-modified citrulline approach. Antibody binding to native and citrullinated proteins was measured by ELISA. Results ACPAs within pooled SF from multiple RA patients reacted equally well with, and cross-reacted with, PAD2- and PAD4-citrullinated fibrinogen. ACPAs from most individual patient SF and plasma samples bound equally well to PAD2- and PAD4-citrullinated fibrinogen or ENO1. When histone H3 was used as target, PAD4 was generally superior in generating epitopes recognized by ACPAs. No binding to citrullinated HSA was observed. Conclusion In most patients, PAD2 and PAD4 are equally efficient in generating citrullinated target sites for ACPAs in fibrinogen and ENO1. The binding of autoantibodies to histone H3 was generally higher after citrullination with PAD4 than with PAD2. Citrullinated HSA is not a target for ACPAs.	[Damgaard, Dres; Nielsen, Claus H.] Copenhagen Univ Hosp, Rigshosp, Ctr Rheumatol & Spine Dis, Inst Inflammat Res, Copenhagen, Denmark; [Damgaard, Dres; Nielsen, Claus H.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Periodontol Microbiol & Community Dent, Copenhagen, Denmark; [Bawadekar, Mandar; Shelef, Miriam A.] Univ Wisconsin, Dept Med, Madison, WI USA; [Senolt, Ladislav] Charles Univ Prague, Fac Med 1, Inst Rheumatol, Prague, Czech Republic; [Senolt, Ladislav] Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic; [Stensballe, Allan] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Shelef, Miriam A.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Wisconsin System; University of Wisconsin Madison; Charles University Prague; Institute of Rheumatology; Charles University Prague; Aalborg University; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Damgaard, D (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Rheumatol & Spine Dis, Inst Inflammat Res, Copenhagen, Denmark.; Damgaard, D (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Periodontol Microbiol & Community Dent, Copenhagen, Denmark.	dres.damgaard@regionh.dk	Stensballe, Allan/K-6756-2019	Stensballe, Allan/0000-0002-9888-1955; Nielsen, Claus Henrik/0000-0001-7543-9016	project of the MHCR [023728]; National Institute of Health (NIH) [K08 AR065500]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR065500] Funding Source: NIH RePORTER	project of the MHCR; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	LS was supported by a project of the MHCR for conceptual research development No. 023728. This work was also supported by the National Institute of Health (NIH) K08 AR065500 to MAS.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Asaga H, 2001, J LEUKOCYTE BIOL, V70, P46; Assohou-Luty C, 2014, BBA-PROTEINS PROTEOM, V1844, P829, DOI 10.1016/j.bbapap.2014.02.019; Bawadekar M, 2017, J AUTOIMMUN, V80, P39, DOI 10.1016/j.jaut.2017.01.006; Blachere NE, 2017, ARTHRITIS RHEUMATOL, V69, P986, DOI 10.1002/art.40035; Burkhardt H, 2005, EUR J IMMUNOL, V35, P1643, DOI 10.1002/eji.200526000; Damgaard D, 2017, J ENZYM INHIB MED CH, V32, P1203, DOI 10.1080/14756366.2017.1368505; Damgaard D, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1000-7; Damgaard D, 2016, RHEUMATOLOGY, V55, P918, DOI 10.1093/rheumatology/kev440; Damgaard D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0498-9; Del Val Del Amno N, 2006, CLIN EXP RHEUMATOL, V24, P281; Feitsma AL, 2010, ARTHRITIS RHEUM-US, V62, P117, DOI 10.1002/art.25059; Fernandes-Cerqueira C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0666-6; Forslind K, 2004, ANN RHEUM DIS, V63, P1090, DOI 10.1136/ard.2003.014233; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Kinloch A, 2008, ARTHRITIS RHEUM, V58, P2287, DOI 10.1002/art.23618; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Konig MF, 2016, ANN RHEUM DIS, V75, P2022, DOI 10.1136/annrheumdis-2015-208529; Lee DM, 2003, ANN RHEUM DIS, V62, P870, DOI 10.1136/ard.62.9.870; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403; Makrygiannakis D, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3702; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Meng XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165501; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Nakayama-Hamada M, 2005, BIOCHEM BIOPH RES CO, V327, P192, DOI 10.1016/j.bbrc.2004.11.152; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Sebbag M, 2006, EUR J IMMUNOL, V36, P2250, DOI 10.1002/eji.200535790; Snir O, 2009, ANN RHEUM DIS, V68, P736, DOI 10.1136/ard.2008.091355; Sokolove J, 2011, ARTHRITIS RHEUM-US, V63, P53, DOI 10.1002/art.30081; Spengler J, 2015, ARTHRITIS RHEUMATOL, V67, P3135, DOI 10.1002/art.39313; Takizawa Y, 2006, ANN RHEUM DIS, V65, P1013, DOI 10.1136/ard.2005.044743; Tutturen AEV, 2014, J PROTEOME RES, V13, P2867, DOI 10.1021/pr500030x; van Beers JJBC, 2013, ARTHRITIS RHEUM-US, V65, P69, DOI 10.1002/art.37720; van Beers JJBC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3205; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wang F, 2016, CLIN RHEUMATOL; Zhou YB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01200	45	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203214	10.1371/journal.pone.0203214	http://dx.doi.org/10.1371/journal.pone.0203214			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161253	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900091
J	Frinhani, RDD; de Carvalho, MAM; Soma, NY				Dias Frinhani, Rafael de Magalhaes; Moreira de Carvalho, Marco Antonio; Soma, Nei Yoshihiro			A PageRank-based heuristic for the minimization of open stacks problem	PLOS ONE			English	Article							SEQUENCING CUTTING PATTERNS; MAXIMUM NUMBER; WEB	The minimization of open stacks problem (MOSP) aims to determine the ideal production sequence to optimize the occupation of physical space in manufacturing settings. Most of current methods for solving the MOSP were not designed to work with large instances, precluding their use in specific cases of similar modeling problems. We therefore propose a PageRank-based heuristic to solve large instances modeled in graphs. In computational experiments, both data from the literature and new datasets up to 25 times fold larger in input size than current datasets, totaling 1330 instances, were analyzed to compare the proposed heuristic with state-of-the-art methods. The results showed the competitiveness of the proposed heuristic in terms of quality, as it found optimal solutions in several cases, and in terms of shorter run times compared with the fastest available method. Furthermore, based on specific graph densities, we found that the difference in the value of solutions between methods was small, thus justifying the use of the fastest method. The proposed heuristic is scalable and is more affected by graph density than by size.	[Dias Frinhani, Rafael de Magalhaes] Univ Fed Itajuba, Math & Comp Sci Inst, BR-37500903 Itajuba, MG, Brazil; [Moreira de Carvalho, Marco Antonio] Univ Fed Ouro Preto, Comp Sci Dept, BR-35400000 Ouro Preto, MG, Brazil; [Soma, Nei Yoshihiro] Technol Inst Aeronaut, Comp Sci Div, BR-12228900 Sao Jose Dos Campos, SP, Brazil	Universidade Federal de Itajuba; Universidade Federal de Ouro Preto; Comando-Geral de Tecnologia Aeroespacial (CTA); Instituto Tecnologico de Aeronautica (ITA)	Frinhani, RDD (corresponding author), Univ Fed Itajuba, Math & Comp Sci Inst, BR-37500903 Itajuba, MG, Brazil.	frinhani@unifei.edu.br	Carvalho, M. A. M./B-8465-2009	Carvalho, M. A. M./0000-0001-7484-1548; Soma, Nei Yoshihiro/0000-0003-3069-9644	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [441565/2014, 303328/2016-9]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/01860-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was partially financed by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grants numbers 441565/2014 and 303328/2016-9; and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 2016/01860-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACM de Oliveira, 2002, BRAZ S ART INT, P313; [Anonymous], 2017, IGRAPH PYTHON COLLEC; Ashikaga Fernando Masanori, 2009, Pesqui. Oper., V29, P439, DOI 10.1590/S0101-74382009000200010; Avrachenkov K, 2015, INT WORKSH ALG MOD W, P151; Becceneri JC, 2004, COMPUT OPER RES, V31, P2315, DOI 10.1016/S0305-0548(03)00189-8; Beggs CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178458; Berkhin P, 2005, INTERNET MATH, V2, P73, DOI 10.1080/15427951.2005.10129098; Cambazard H, 2007, SOLVING MINIMUM NUMB, P14; Chu G, 2009, LECT NOTES COMPUT SC, V5732, P242, DOI 10.1007/978-3-642-04244-7_21; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Costa RD, 2017, 18 ONPCE OF ANC PROB; de la Banda MG, 2007, INFORMS J COMPUT, V19, P607, DOI 10.1287/ijoc.1060.0205; Faggioli E, 1998, EUR J OPER RES, V110, P564, DOI 10.1016/S0377-2217(97)00268-3; Freeman L.C., 1979, SOC NETWORKS, V2, P119, DOI [10.1016/0378-8733(79)90002-9, DOI 10.1016/0378-8733(79)90002-9]; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gent I., 2005, IJCAI 2005 5 WORKSH, P1; Gleich DF, 2015, SIAM REV, V57, P321, DOI 10.1137/140976649; Goncalves JF, 2016, INT T OPER RES, V23, P25, DOI 10.1111/itor.12109; Grando F, 2016, IEEE GLOB COMM CONF, DOI 10.1109/GLOCOM.2016.7841580; Grolmusz V., 2012, ARXIV12051960; Held S., 2011, COMBINATORIAL OPTIMI, P33; Hernandez J. M., 2011, CLASSIFICATION GRAPH, P1; Ivan G, 2011, BIOINFORMATICS, V27, P405, DOI 10.1093/bioinformatics/btq680; Lages J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190812; Langville A. N., 2011, GOOGLES PAGERANK; Langville AN, 2005, SIAM REV, V47, P135, DOI 10.1137/S0036144503424786; Linhares A, 2002, COMPUT OPER RES, V29, P1759, DOI 10.1016/S0305-0548(01)00054-5; Mihalcea R., 2004, P ACL 2004 INT POST, P20; de Carvalho MAM, 2015, J OPER RES SOC, V66, P936, DOI 10.1057/jors.2014.60; National Research Council Committee on Network Science for Future Army Applications, 2005, NETWORK SCI; Nomikos G., 2014, P 26 INT TEL C ITC, P1; Page L., 1999, 199966 STANF INFOLAB, P1999; Yanasse H. H., 2004, International Transactions in Operational Research, V11, P277, DOI 10.1111/j.1475-3995.2004.00458.x; Yanasse H.H., 1997, PESQUISA OPERACIONAL, V17, P57; Yanasse HH, 1997, EUR J OPER RES, V100, P454, DOI 10.1016/S0377-2217(97)84107-0; Yanasse HH, 2003, 35 SBPO S BRAS PESQ, P1516; Yanasse HH, 2007, EUR J OPER RES, V183, P1353, DOI 10.1016/j.ejor.2005.09.054; Yanasse HH, 2010, EUR J OPER RES, V203, P559, DOI 10.1016/j.ejor.2009.09.017; Yang Z, 2016, NATURAL COMPUTING, P1; YUEN BJ, 1995, EUR J OPER RES, V87, P57, DOI 10.1016/0377-2217(94)00068-N; YUEN BJ, 1991, EUR J OPER RES, V55, P183, DOI 10.1016/0377-2217(91)90222-H	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203076	10.1371/journal.pone.0203076	http://dx.doi.org/10.1371/journal.pone.0203076			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161217	Green Submitted, gold, Green Published			2022-12-27	WOS:000443388900077
J	Raizada, N; Khaparde, SD; Rao, R; Kalra, A; Sarin, S; Salhotra, VS; Swaminathan, S; Khanna, A; Chopra, KK; Hanif, M; Singh, V; Umadevi, KR; Nair, SA; Huddart, S; Tripathi, R; Prakash, CHS; Saha, BK; Denkinger, CM; Boehme, C				Raizada, Neeraj; Khaparde, Sunil D.; Rao, Raghuram; Kalra, Aakshi; Sarin, Sanjay; Salhotra, Virender Singh; Swaminathan, Soumya; Khanna, Ashwani; Chopra, Kamal Kishore; Hanif, M.; Singh, Varinder; Umadevi, K. R.; Nair, Sreenivas Achuthan; Huddart, Sophie; Tripathi, Rajneesh; Prakash, C. H. Surya; Saha, B. K.; Denkinger, Claudia M.; Boehme, Catharina			Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; DIAGNOSTIC-ACCURACY; RIFAMPIN RESISTANCE; TREATMENT OUTCOMES; CHILDREN; ASSAY; METAANALYSIS	Background Diagnosis of tuberculosis (TB) in infants is challenging due to non-specific clinical presentations of the disease in this age-group and low sensitivity of widely available TB diagnostic tools, which in turn delays prompt access to TB treatment. Upfront access to Xpert/MTB RIF (Xpert) testing, a highly sensitive and specific rapid diagnostic tool, could potentially address some of these challenges. Under the current project, we assessed the utility and feasibility of applying upfront Xpert for diagnosis of tuberculosis in infants, including for testing of nonsputum specimens. Methods A high throughput lab was established in each of the four project cities, and linked to various health care providers across the city, through rapid specimen transportation and electronic reporting linkages. Free Xpert testing was offered to all infant (<2 years of age) presumptive TB cases (both pulmonary and extra-pulmonary) seeking care at public and private health facilities. Results A total of 7,994 presumptive infant TB cases were enrolled in the project from April 2014 to October 2016, detecting 465 (5.8%, CI: 5.3-6.4) TB cases. The majority (93.9%; CI: 93.4-94.4) of patient specimens were non-sputum and TB positivity was higher amongst non- sputum specimens. Further, a high proportion (5.6% CI 3.8-8.1) of infant TB cases were found to be rifampicin resistant. Covering large cities with a single lab per city over more than two years, the project demonstrated the feasibility of same-day diagnosis with upfront Xpert testing. This in turn led to prompt treatment initiation, with a two-day median turnaround time to treatment initiation. Case mortality observed in the project cohort of diagnosed TB cases was 11.0% (CI 8.4-14.1), the majority of which was pre- or early treatment mortality, in spite of prompt access to treatment for most diagnosed cases. Conclusion The current project demonstrated the feasibility of applying rapid and upfront Xpert testing for presumptive infant TB cases. Rapid TB diagnosis in turn facilitates prompt and appropriate treatment initiation. Further, levels of rifampicin resistance observed in infants TB cases highlight the additional benefit of upfront resistance testing. However, high rates of early case mortality, in spite of prompt diagnosis and treatment initiation, highlight the need for further research in infant patient pathways for overall improvement in TB care for infant populations.	[Raizada, Neeraj; Kalra, Aakshi; Sarin, Sanjay; Tripathi, Rajneesh] Fdn Innovat New Diagnost, New Delhi, India; [Khaparde, Sunil D.; Rao, Raghuram; Salhotra, Virender Singh] Govt India, Cent TB Div, New Delhi, India; [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India; [Khanna, Ashwani] Govt NCT, State TB Off, New Delhi, India; [Chopra, Kamal Kishore; Hanif, M.] New Delhi TB Ctr, New Delhi, India; [Singh, Varinder] Kalawati Saran Childrens Hosp, Lady Hardinge Med Coll & Assoc, New Delhi, India; [Umadevi, K. R.] Natl Inst Res TB, Madras, Tamil Nadu, India; [Nair, Sreenivas Achuthan] WHO, Country Off India, New Delhi, India; [Huddart, Sophie] McGill Univ, Montreal, PQ, Canada; [Prakash, C. H. Surya] Intermediate Reference Lab, Hyderabad, India; [Saha, B. K.] Intermediate Reference Lab, Kolkata, India; [Denkinger, Claudia M.; Boehme, Catharina] Fdn Innovat New Diagnost, Geneva, Switzerland	Foundation For Innovative New Diagnostics; Indian Council of Medical Research (ICMR); Lady Hardinge Medical College & Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization; McGill University; Foundation For Innovative New Diagnostics	Denkinger, CM (corresponding author), Fdn Innovat New Diagnost, Geneva, Switzerland.	cdenki@gmail.com	Huddart, Sophie/AAF-8844-2020	Huddart, Sophie/0000-0001-6425-3371; Nair, Sreenivas/0000-0002-2586-6797; Raizada, Neeraj/0000-0003-2116-332X	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The project was funded by United States Agency for International Development (USAID) under Challenge TB project to SS. FIND was responsible for implementation, training, coordination, monitoring, data analysis and writing of the report in close coordination with Central TB Division, Ministry of Health and Family Welfare, Government of India.	Adejumo OA, 2016, J TROP PEDIATRICS, V62, P131, DOI 10.1093/tropej/fmv089; Aketi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153914; Al-Ateah SM, 2012, SAUDI MED J, V33, P1100; Alvarez-Uria Gerardo, 2012, Tuberc Res Treat, V2012, P932862, DOI 10.1155/2012/932862; Bates M, 2013, LANCET INFECT DIS, V13, P36, DOI 10.1016/S1473-3099(12)70245-1; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Central TB Division Ministry of Health and Family Welfare New Delhi India, 2012, NAT GUID DIAGN TREAT; Connell TG, 2011, J INFECT DIS, V204, pS1151, DOI 10.1093/infdis/jir413; Cuevas LE, 2012, J INFECT DIS, V205, pS209, DOI 10.1093/infdis/jir879; Detjen AK, 2015, LANCET RESP MED, V3, P451, DOI 10.1016/S2213-2600(15)00095-8; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Driessche KV, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/781320; Friedrich SO, 2011, J CLIN MICROBIOL, V49, P4341, DOI 10.1128/JCM.05454-11; Gomez-Pastrana D, 1999, PEDIATR PULM, V28, P344; Government of India, 2018, REP 1 NAT ANT TUB DR; Harries AD, 2002, INT J TUBERC LUNG D, V6, P424; Hatherill M, 2010, B WORLD HEALTH ORGAN, V88, P312, DOI 10.2471/BLT.09.062893; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Kalra A, 2017, INT J TUBERC LUNG D, V21, P645, DOI 10.5588/ijtld.16.0563; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Maynard-Smith L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0709-7; Miller MB, 2011, J CLIN MICROBIOL, V49, P3458, DOI 10.1128/JCM.05212-11; Mpofu N, 2014, PEDIATR INFECT DIS J, V33, P1226, DOI 10.1097/INF.0000000000000523; Munoz-Sellart M, 2009, SCAND J INFECT DIS, V41, P450, DOI 10.1080/00365540902865736; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6; Pai Madhukar, 2014, Indian J Chest Dis Allied Sci, V56, P71; Palme IB, 2004, ACTA PAEDIATR, V93, P311, DOI 10.1080/08035250410023566; Pang Y, 2014, PEDIATR INFECT DIS J, V33, P1047, DOI 10.1097/INF.0000000000000403; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Rabie H, 2015, J INT AIDS SOC, V18, P35, DOI 10.7448/IAS.18.7.20236; Raizada N, PLOS ONE; Raizada N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140375; Raizada N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089301; Raj A, 2012, IOSR J PHARM, V2, P83; Revised National Tuberculosis Control Program, 2014, STANDARD OPERATING P; Scott LE, 2014, J CLIN MICROBIOL, V52, P1818, DOI 10.1128/JCM.03553-13; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; VALLEJO JG, 1994, PEDIATRICS, V94, P1; WHO, 2017, GLOB TUB REP 2017; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11	47	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202085	10.1371/journal.pone.0202085	http://dx.doi.org/10.1371/journal.pone.0202085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161142	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000443388900020
J	Reichhardt, C; Cegelski, L				Reichhardt, Courtney; Cegelski, Lynette			The Congo red derivative FSB binds to curli amyloid fibers and specifically stains curliated E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; EXTRACELLULAR-MATRIX; BIOFILMS; CELLS; PURIFICATION; ARCHITECTURE; INFECTIONS; ATTACHMENT; SECRETION; CELLULOSE	The Congo red derivative (E,E)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy) styrylbenzene (FSB) specifically stains the functional amyloid curli in Escherichia coli biofilms. FSB binds to curli with similar affinity as Congo red, yet exhibits much greater fluorescence upon binding to curli as compared to Congo red and does not exhibit undesired binding to the cellulosic component of the biofilm. Thus, FSB presents a powerful tool to identify and visualize curli in E. coli biofilms and also enables new biophysical investigations of curli.	[Reichhardt, Courtney; Cegelski, Lynette] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Reichhardt, Courtney] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Stanford University; University of Washington; University of Washington Seattle	Reichhardt, C; Cegelski, L (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Reichhardt, C (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	crreich@uw.edu; cegelski@stanford.edu		Reichhardt, Courtney/0000-0002-1022-5110	National Science Foundation Division of Molecular and Cellular Biosciences CAREER Award [1453247]; Althouse Family Stanford Graduate Fellowship	National Science Foundation Division of Molecular and Cellular Biosciences CAREER Award; Althouse Family Stanford Graduate Fellowship	LC acknowledges support from the National Science Foundation Division of Molecular and Cellular Biosciences CAREER Award 1453247. CR acknowledges support from the Althouse Family Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri CJ, 2007, P NATL ACAD SCI USA, V104, P5145, DOI 10.1073/pnas.0602304104; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Gophna U, 2001, INFECT IMMUN, V69, P2659, DOI 10.1128/IAI.69.4.2659-2665.2001; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Inouye H, 2000, AMYLOID, V7, P179, DOI 10.3109/13506120009146832; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Kudinha T, 2013, PEDIATR INFECT DIS J, V32, P543, DOI 10.1097/INF.0b013e31828ba3f1; Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Lim JY, 2014, BIOCHEM BIOPH RES CO, V443, P345, DOI 10.1016/j.bbrc.2013.11.026; McCrate OA, 2013, J MOL BIOL, V425, P4286, DOI 10.1016/j.jmb.2013.06.022; McCrate OA, 2013, CHEM COMMUN, V49, P4193, DOI 10.1039/c2cc37792f; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Pawar DM, 2005, J APPL MICROBIOL, V99, P418, DOI 10.1111/j.1365-2672.2005.02499.x; Prade E, 2014, NEW DEV NMR, V3, P533; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Reichhardt C, 2016, ANAL BIOANAL CHEM, V408, P7709, DOI 10.1007/s00216-016-9868-2; Reichhardt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140388; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Ryu JH, 2004, LETT APPL MICROBIOL, V39, P359, DOI 10.1111/j.1472-765X.2004.01591.x; Sato K, 2004, EUR J MED CHEM, V39, P573, DOI 10.1016/j.ejmech.2004.02.013; Schutz AK, 2011, ANGEW CHEM INT EDIT, V50, P5956, DOI 10.1002/anie.201008276; Serra DO, 2014, ENVIRON MICROBIOL, V16, P1455, DOI 10.1111/1462-2920.12483; Serra DO, 2013, MBIO, V4, DOI 10.1128/mBio.00103-13; Thongsomboon W, 2018, SCIENCE, V359, P334, DOI 10.1126/science.aao4096; Westermark GT, 1999, METHOD ENZYMOL, V309, P3	34	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203226	10.1371/journal.pone.0203226	http://dx.doi.org/10.1371/journal.pone.0203226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161215	Green Submitted, gold, Green Published			2022-12-27	WOS:000443388900094
J	Roper, L; Tran, DT; Einarsdottir, K; Preen, DB; Havard, A				Roper, Lucinda; Duong Thuy Tran; Einarsdottir, Kristjana; Preen, David B.; Havard, Alys			Algorithm for resolving discrepancies between claims for smoking cessation pharmacotherapies during pregnancy and smoking status in delivery records: The impact on estimates of utilisation	PLOS ONE			English	Article							NICOTINE REPLACEMENT THERAPY; BIRTH CERTIFICATES; PRIMARY-CARE; WOMEN; QUESTIONNAIRES; VARENICLINE; PREVALENCE; ADHERENCE; ACCURACY; EXPOSURE	Background The linkage of routine data collections are valuable for population-based evaluation of smoking cessation pharmacotherapy in pregnancy where little is known about the utilisation or safety of these pharmacotherapies antenatally. The use of routine data collections to study smoking cessation pharmacotherapy is limited by disparities among data sources. This study developed an algorithm to resolve disparity between the evidence of pharmacotherapy utilisation for smoking cessation and the recording of smoking in pregnancy, examined its face validity and assessed the implications on estimates of smoking cessation pharmacotherapy utilisation. Methods Perinatal records (n = 1,098,203) of women who gave birth in the Australian States of Western Australia and New South Wales (2004-2012) were linked to hospital admissions and pharmaceutical dispensing data. An algorithm, based on dispensing information about the type of smoking therapy, timing and quantity of supply reclassified certain groups of women as smoking during pregnancy. Face validity of the algorithm was tested by examining the distribution of factors associated with inaccurate recording of smoking status among women that the algorithm classified as misreporting smoking in pregnancy. Rate of utilisation among smokers, according to original and reclassified smoking status, was measured, to demonstrate the utility of the algorithm. Results Smoking cessation pharmacotherapy were dispensed to 2184 women during pregnancy, of those 1013 women were originally recorded as non-smoking as per perinatal and hospital data. Application of the algorithm reclassified 730 women as smoking during pregnancy. The algorithm satisfied the test of face validity-the expected demographic factors of marriage, private hospital delivery and higher socioeconomic status, were more common in women whom the algorithm identified as misreporting their smoking status. Application of the algorithm resulted in smoking cessation pharmacotherapy utilisation estimates ranging from 2.3-3.6% of all pregnancies. Conclusion Researchers can use the algorithm presented herein to improve the identification of smoking among women who use cessation pharmacotherapies during pregnancy. Improved identification can improve the validity of safety analyses of smoking cessation pharmacotherapy-providing clinicians with valuable evidence to use when counselling women on the role of pharmacotherapy for smoking cessation during pregnancy.	[Roper, Lucinda; Duong Thuy Tran; Havard, Alys] UNSW, CBDRH, Sydney, NSW, Australia; [Einarsdottir, Kristjana] Univ Iceland, Ctr Publ Hlth Sci, Sch Hlth Sci, Reykjavik, Iceland; [Einarsdottir, Kristjana] Univ Iceland, Unit Nutr Res, Sch Hlth Sci, Reykjavik, Iceland; [Preen, David B.] Univ Western Australia, Ctr Hlth Serv Res, Perth, WA, Australia	University of New South Wales Sydney; University of Iceland; University of Iceland; University of Western Australia	Roper, L (corresponding author), UNSW, CBDRH, Sydney, NSW, Australia.	roper.lucinda@gmail.com	; Einarsdottir, Kristjana/E-8337-2011; Preen, David/H-5663-2014	Havard, Alys/0000-0001-6563-8804; Tran, Duong Thuy/0000-0002-1454-9462; Einarsdottir, Kristjana/0000-0003-4931-7650; Preen, David/0000-0002-2982-2169; Roper, Lucinda/0000-0002-8756-5295	Australian National Health and Medical Research Council [1028543]; National Heart Foundation Future Leader Fellowship [100411]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation Future Leader Fellowship(National Heart Foundation of Australia)	The Smoking MUMS study is supported by an Australian National Health and Medical Research Council Project Grant (#1028543), and AH is supported by a National Heart Foundation Future Leader Fellowship (#100411). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2008, PUBLIC HEALTH REP, V123, P586, DOI 10.1177/003335490812300508; Ampt Amanda J, 2013, N S W Public Health Bull, V24, P65, DOI 10.1071/NB12116; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Australian Bureau of Statistics, 2011, CENS POP HOUS SOC IN; Berard A, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.06.059; Bruin JE, 2010, TOXICOL SCI, V116, P364, DOI 10.1093/toxsci/kfq103; Carrozzi Laura, 2008, Ther Adv Respir Dis, V2, P301, DOI 10.1177/1753465808096136; Catz SL, 2011, NICOTINE TOB RES, V13, P361, DOI 10.1093/ntr/ntr003; CHeReL, 2009, QUAL ASS REC LINK; Chun-Fai-Chan B, 2005, AM J OBSTET GYNECOL, V192, P932, DOI 10.1016/j.ajog.2004.09.027; Claydon K, 2014, NATL DRUG STRATEGY H; Coleman T, 2012, PHARM INTERVENTIONS; Coleman T, 2011, ADDICTION, V106, P52, DOI 10.1111/j.1360-0443.2010.03179.x; Dhalwani NN, 2014, BRIT J GEN PRACT, V64, pE554, DOI 10.3399/bjgp14X681361; Dietz PM, 1998, AM J EPIDEMIOL, V148, P1048; Downey F, 2007, VALIDATION STUDY W A, DOI [10.1071/NB12116, DOI 10.1071/NB12116]; Tran DT, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0385-6; Tran DT, 2014, AUST NZ J PUBL HEAL, V38, P258, DOI 10.1111/1753-6405.12213; Eitelhuber T, 2016, DATA LINKAGE MAKING; Eldridge D, 2015, AUSTR MOTHERS BABIES; England LJ, 2007, NICOTINE TOB RES, V9, P1005, DOI 10.1080/14622200701491255; Gaither KH, 2009, MATERN CHILD HLTH J, V13, P497, DOI 10.1007/s10995-008-0361-1; Harrison-Woolrych M, 2013, PHARMACOEPIDEM DR S, V22, P1086, DOI 10.1002/pds.3489; Havard A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003692; Hays L, 2010, NICOTINE TOBACCO RES; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Irvine L, 2010, DRUG SAFETY, V33, P593, DOI 10.2165/11532330-000000000-00000; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Land TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034853; Lassen TH, 2010, PAEDIATR PERINAT EP, V24, P272, DOI 10.1111/j.1365-3016.2010.01104.x; Lumley J, 2009, INTERVENTIONS PROMOT; MedicineWise N, 2011, NIC PATCH NIC P NIC; Morales-Suarez-Varela MM, 2006, OBSTET GYNECOL, V107, P51, DOI 10.1097/01.AOG.0000194079.66834.d5; NCCH, INT STAT CLASS DIS R; Pollak KI, 2007, AM J PREV MED, V33, P297, DOI 10.1016/j.amepre.2007.05.006; Pollak KI, 2006, NICOTINE TOB RES, V8, P547, DOI 10.1080/14622200600789882; Price JH, 2006, J COMMUN HEALTH, V31, P160, DOI 10.1007/s10900-005-9009-x; Rao J, 2009, Kathmandu Univ Med J (KUMJ), V7, P162; Richardson JL, 2017, REPROD TOXICOL, V67, P26, DOI [10.1016/j.reProtox.2016.11.010, 10.1016/j.reprotox.2016.11.010]; Rigotti NA, 2008, OBSTET GYNECOL, V111, P348, DOI 10.1097/01.AOG.0000297305.54455.2e; Russell TV, 2004, NICOTINE TOB RES, V6, pS141, DOI 10.1080/14622200410001669141; Schneider S, 2010, DRUG ALCOHOL REV, V29, P81, DOI 10.1111/j.1465-3362.2009.00098.x; Shipton D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4347; Spencer K, 2013, PRENATAL DIAG, V33, P245, DOI 10.1002/pd.4053; Strandberg-Larsen K, 2008, BJOG-INT J OBSTET GY, V115, P1405, DOI 10.1111/j.1471-0528.2008.01867.x; Taylor L., 2000, NEW S WALES PUBLIC H, V11, P97, DOI [DOI 10.1071/NB00S11, 10.1071/NB00045, DOI 10.1071/NB00045]; Tong VT, 2015, ACTA OBSTET GYN SCAN, V94, P106, DOI 10.1111/aogs.12532; Tong VT, 2008, AM J PREV MED, V35, P327, DOI 10.1016/j.amepre.2008.06.033; van Gool K., 2015, MEDICARE AUSTR DATA; Vaz L, 2016, NICOTINE TOB RES; Vinikoor LC, 2010, PAEDIATR PERINAT EP, V24, P102, DOI 10.1111/j.1365-3016.2009.01087.x; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987; WHO Collaborating Centre for Drug Statistics Methodology, GUID ATC CLASS DDD A; Zhu AZX, 2012, CLIN PHARMACOL THER, V92, P771, DOI 10.1038/clpt.2012.186; Zwar NA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7535	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202999	10.1371/journal.pone.0202999	http://dx.doi.org/10.1371/journal.pone.0202999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161203	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900063
J	Ruiz, N; Piskernik, B; Witting, A; Fuiko, R; Ahnert, L				Ruiz, Nina; Piskernik, Bernhard; Witting, Andrea; Fuiko, Renate; Ahnert, Lieselotte			Parent-child attachment in children born preterm and at term: A multigroup analysis	PLOS ONE			English	Article							MATERNAL SENSITIVITY; INFANT INTERACTION; MOTHER; BIRTH; FATHER; GENDER; QUALITY; EXPECTATIONS; METAANALYSIS; SECURITY	Objective While ample research exists about mother-child attachment, so far little focus has been on specifics of father-child attachment. Even less research is available on the nature of the father-child relationship for children born preterm. The objective of this study was to determine whether children born preterm (23 to 37 weeks gestation) differ in their attachment to their fathers and mothers from their term peers (> 37 weeks gestation), and whether specific child characteristics, such as gender, twin status, and developmental status, have an influence on the parent-child relationship. Methods The sample consisted of 290 children (n = 140 girls, 48.28%), 190 born before term (including 45 twin pairs) between 12 and 36 months of age (M=19.5, SD = 5.7) and 100 term children of the same age (M= 18.8, SD= 6.1) with their 245 fathers and mothers. Attachment of the children with their mothers and fathers was assessed using the Attachment Q-sort during two home visits. Children's developmental status was measured with the Bayley Scales of Infant and Toddler Development. Results Within a multigroup analysis of parents with children born preterm and at term more secure attachment was found for both parents in the term sample than in the preterm group. Correlates of attachment specific to fathers of children born preterm accumulated to an explained variance of R-2 = .82. For those fathers, less education as well as lower development scores and male gender of the child were associated with lower attachment scores. In the three other parent-child constellations the explained variance did not exceed 20%. Child development proved to be a significant predictor for father-child attachment regardless of the child's birth status. Male gender was associated with lower attachment scores for children born preterm with either parent. Conclusion The findings highlight the importance of including fathers in research and clinical practice and informing them about preterm birth, possible problems, and developmental consequences as well. Health professionals should be advised to create interventions focusing on both parents to enhance the quality of attachment in parent-child dyads in children born preterm.	[Ruiz, Nina; Piskernik, Bernhard; Witting, Andrea; Ahnert, Lieselotte] Univ Vienna, Fac Psychol, Dept Appl Psychol Hlth Dev Enhancement & Interven, Vienna, Austria; [Fuiko, Renate] Univ Childrens Hosp Vienna, Vienna, Austria	University of Vienna; University Hospital Vienna	Piskernik, B (corresponding author), Univ Vienna, Fac Psychol, Dept Appl Psychol Hlth Dev Enhancement & Interven, Vienna, Austria.	bernhard.piskernik@univie.ac.at		Piskernik, Bernhard/0000-0001-7296-2645	Jacobs Foundation [AZ: 2013-1049]; University of Vienna	Jacobs Foundation; University of Vienna	This work was supported by the Jacobs Foundation (AZ: 2013-1049) and all phases of the study were carried out as part of CENOF (the Central European Network on Fatherhood with headquarters at the University of Vienna) (Recipient: L.A.). Open access funding was provided by the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Ainsworth M., 1978, PATTERNS ATTACHMENT; [Anonymous], ATTACHMENT COMPLEX S; Arpi E, 2013, DEV MED CHILD NEUROL, V55, P788, DOI 10.1111/dmcn.12142; BARBEE AP, 1993, J SOC ISSUES, V49, P175, DOI 10.1111/j.1540-4560.1993.tb01175.x; Barre N, 2011, J PEDIATR-US, V158, P766, DOI 10.1016/j.jpeds.2010.10.032; Bayley N, 1993, BAYLEY SCALES INFANT; Beer C, 2013, EARLY HUM DEV, V89, P555, DOI 10.1016/j.earlhumdev.2013.02.006; Bilgin A, 2015, PEDIATRICS, V136, pE177, DOI 10.1542/peds.2014-3570; Breeman LD, 2015, PEDIATRICS, V136, P415, DOI 10.1542/peds.2015-0608; Cassidy J, 2016, HANDBOOK OF ATTACHMENT, 3 EDITION, P3; Chapieski ML, 1997, SEMIN PERINATOL, V21, P221, DOI 10.1016/S0146-0005(97)80065-1; Clark CAC, 2008, CHILD DEV, V79, P1444, DOI 10.1111/j.1467-8624.2008.01198.x; DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107; EASTERBROOKS MA, 1989, CHILD DEV, V60, P825, DOI 10.2307/1131023; Eryigit-Madzwamuse S, 2015, ARCH DIS CHILD-FETAL, V100, pF524, DOI 10.1136/archdischild-2014-308007; Hall RAS, 2015, PARENT-SCI PRACT, V15, P247, DOI 10.1080/15295192.2015.1053333; Hall RAS, 2015, J CHILD FAM STUD, V24, P1715, DOI 10.1007/s10826-014-9975-7; Harrison MJ, 1996, RES NURS HEALTH, V19, P451, DOI 10.1002/(SICI)1098-240X(199612)19:6<451::AID-NUR1>3.0.CO;2-N; Jaekel J, 2015, J CHILD PSYCHOL PSYC, V56, P693, DOI 10.1111/jcpp.12331; Jaekel J, 2012, DEV MED CHILD NEUROL, V54, P716, DOI 10.1111/j.1469-8749.2012.04323.x; Karabekiroglu K, 2015, NOROPSIKIYATRI ARS, V52, P157, DOI 10.5152/npa.2015.7343; Korja R, 2012, ACTA OBSTET GYN SCAN, V91, P164, DOI 10.1111/j.1600-0412.2011.01304.x; Lamb M.E., 2010, ROLE FATHER CHILD DE; Loehr T., 2000, ARCH WOMEN MENT HLTH, V3, P41, DOI DOI 10.1007/S007370070004; Loureiro A., 2004, P KDNET S KNOWL BAS; Lovas GS, 2005, INFANT MENT HEALTH J, V26, P327, DOI 10.1002/imhj.20056; Lundy BL, 2002, INFANT BEHAV DEV, V25, P221, DOI 10.1016/S0163-6383(02)00123-6; LYTTON H, 1991, PSYCHOL BULL, V109, P267, DOI 10.1037/0033-2909.109.2.267; Mangelsdorf SC, 1996, DEV PSYCHOL, V32, P914, DOI 10.1037/0012-1649.32.5.914; Marks JL, 2009, SEX ROLES, V61, P221, DOI 10.1007/s11199-009-9619-3; McBride BA, 2002, J MARRIAGE FAM, V64, P998, DOI 10.1111/j.1741-3737.2002.00998.x; Muller-Nix C, 2004, EARLY HUM DEV, V79, P145, DOI 10.1016/j.earlhumdev.2004.05.002; Muthen L. K., 2017, MPLUS USERS GUIDE ST, V8th, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Neri E, 2017, INFANT BEHAV DEV, V49, P97, DOI 10.1016/j.infbeh.2017.08.001; Osborne JW., 2004, PRACTICAL ASSESSMENT, V9, P6, DOI [10.7275/QF69-7K43, DOI 10.7275/QF69-7K43]; Paquette D, 2004, HUM DEV, V47, P193, DOI 10.1159/000078723; Paquette D., 2013, CHILD DEV RES, V13, P1, DOI [DOI 10.1155/2013/102860, 10.1155/2013/102860]; Peacock JL, 2012, PEDIATR RES, V71, P305, DOI 10.1038/pr.2011.50; Plant EA, 2000, PSYCHOL WOMEN QUART, V24, P81, DOI 10.1111/j.1471-6402.2000.tb01024.x; Sandnabba NK, 1999, SEX ROLES, V40, P249, DOI 10.1023/A:1018851005631; Schappin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054992; Simpson JA., 2008, HDB ATTACHMENT THEOR, P131; Slade A, 2005, ATTACH HUM DEV, V7, P283, DOI 10.1080/14616730500245880; Stevenson DK, 2000, ARCH DIS CHILD-FETAL, V83, pF182, DOI 10.1136/fn.83.3.F182; Tallandini MA, 2015, J PEDIATR PSYCHOL, V40, P545, DOI 10.1093/jpepsy/jsv010; Telford EJ, 2016, J CHILD PSYCHOL PSYC, V57, P861, DOI 10.1111/jcpp.12546; TOMASELLO M, 1990, J CHILD LANG, V17, P115, DOI 10.1017/S0305000900013131; TRIVERS RL, 1974, AM ZOOL, V14, P249; van Ijzendoorn MH, 2004, CHILD DEV, V75, P1188, DOI 10.1111/j.1467-8624.2004.00733.x; VAN IJZENDOORN MH, 1995, SOC DEV, V4, P115; VANBEEK Y, 1994, BEHAVIOUR, V129, P35, DOI 10.1163/156853994X00343; Waters E, 1995, MONOGR SOC RES CHILD, V60, P234, DOI 10.2307/1166181; Witting A., 2016, INT J DEV SCI, V10, P89, DOI [10.3233/DEZ.16194, DOI 10.3233/DEZ.16194]; Wolke D, 2014, ARCH DIS CHILD-FETAL, V99, pF70, DOI 10.1136/archdischild-2013-303788; Zelkowitz P, 2007, INFANT MENT HEALTH J, V28, P296, DOI 10.1002/imhj.20137	56	12	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202972	10.1371/journal.pone.0202972	http://dx.doi.org/10.1371/journal.pone.0202972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161170	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900055
J	Sacchi, A; Tumino, N; Grassi, G; Casetti, R; Cimini, E; Sordoni, V; Ammassari, A; Antinori, A; Agrati, C				Sacchi, Alessandra; Tumino, Nicola; Grassi, Germana; Casetti, Rita; Cimini, Eleonora; Sordoni, Veronica; Ammassari, Adriana; Antinori, Andrea; Agrati, Chiara			A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry	PLOS ONE			English	Article							CANCER-PATIENTS; INFECTION; BLOOD; FREQUENCY	Myeloid derived suppressor cells (MDSC) is a heterogeneous subset of immature and mature cells of the myeloid lineage, undergoing expansion during pathologic conditions, and able to perform strong immune suppressive functions. It has been shown that cryopreservation selectively impacts the polimorphonuclear (PMN) MDSC viability and recovery, and alters the correct analysis of MDSC subsets. In laboratory practice, cryopreservation is often inevitable, in particular in multicenter studies where samples have to be shipped to a centralized laboratory. Aim of the present work was to set out a new protocol to evaluate the frequency of PMN-MDSC in thawed cells by flow-cytometry. PBMC were isolated from HIV+ patients and healthy donors, and were cryopreserved for at least ten days. After thawing, two different protocols were used: 1. standard protocol (SP) consisting of staining with the antibodies mix and then fixing with formalin 1%; 2. thawed protocol (TP) in which fixation foregoes the staining with the antibodies mix. Results showed that PMN-MDSC frequency in ex vivo PBMC evaluated by means TP was comparable to that analysed by SP, indicating that the protocol did not alter PMN-MDSC quantification in ex vivo cells. We then demonstrated that PMN-MDSC frequency in thawed PBMC tested by TP was almost identical to the frequency obtained in ex vivo cells evaluated by using SP. However, we observed that after three hours of culture post-thawing, PMN-MDSC were not assessable anymore with both SP and TP. In conclusion, we herein demonstrated that fixing PBMC soon after thawing and before antibody staining allows preservation of PMN-MDSC integrity and a reliable cells quantification. Thus, it is possible to phenotipically identify PMN-MDSC in cryopreserved PBMC, consenting adequate test precision and accuracy as well as making multicentre research more feasible.	[Sacchi, Alessandra; Tumino, Nicola; Grassi, Germana; Casetti, Rita; Cimini, Eleonora; Sordoni, Veronica; Agrati, Chiara] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol & Pharmacol Lab, Rome, Italy; [Ammassari, Adriana; Antinori, Andrea] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Sacchi, A (corresponding author), IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol & Pharmacol Lab, Rome, Italy.	alessandra.sacchi@inmi.it	Antinori, Andrea/K-7125-2016; Tumino, Nicola/Y-4761-2019; Cimini, Eleonora/K-8878-2016; Sacchi, Alessandra/K-7782-2016; Agrati, Chiara/K-8806-2016	Antinori, Andrea/0000-0003-2121-4684; Tumino, Nicola/0000-0003-3773-8829; Grassi, Germana/0000-0001-8168-8721; Cimini, Eleonora/0000-0002-2659-0868; Sacchi, Alessandra/0000-0003-4964-386X; Agrati, Chiara/0000-0002-5252-0927; Ammassari, Adriana/0000-0002-0284-0340	Italian Ministry of Health ("Ricerca Corrente")	Italian Ministry of Health ("Ricerca Corrente")(Ministry of Health, Italy)	The study was supported by grants from the Italian Ministry of Health ("Ricerca Corrente").	Boros P, 2016, HUM IMMUNOL, V77, P631, DOI 10.1016/j.humimm.2016.05.024; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Damuzzo V, 2015, CYTOM PART B-CLIN CY, V88, P77, DOI [10.1002/cyto.b.21206, 10.1002/cytob.21206]; De Veirman K, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00349; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; du Plessis N, 2013, AM J RESP CRIT CARE, V188, P724, DOI 10.1164/rccm.201302-0249OC; Duffy A, 2013, CANCER IMMUNOL IMMUN, V62, P299, DOI 10.1007/s00262-012-1332-3; Dumitru, 2013, CANCER IMMUNOL IMMUN, V61, P1155; Elkord E, 2009, J IMMUNOL METHODS, V347, P87, DOI 10.1016/j.jim.2009.06.001; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Goh C, 2013, IMMUNOL REV, V255, P210, DOI 10.1111/imr.12084; Grutzner E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0755-y; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Kotsakis A, 2012, J IMMUNOL METHODS, V381, P14, DOI 10.1016/j.jim.2012.04.004; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Qin AP, 2013, J VIROL, V87, P1477, DOI 10.1128/JVI.01759-12; Schmielau J, 2001, CANCER RES, V61, P4756; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Tacke RS, 2012, HEPATOLOGY, V55, P343, DOI 10.1002/hep.24700; Tobin RP, 2017, J LEUKOCYTE BIOL, V102, P381, DOI 10.1189/jlb.5VMR1016-449R; Tumino N, 2017, JAIDS-J ACQ IMM DEF, V74, P575, DOI 10.1097/QAI.0000000000001283; Tumino N, 2015, AIDS, V29, P2397, DOI 10.1097/QAD.0000000000000871; Vollbrecht T, 2012, AIDS, V26, pF31, DOI 10.1097/QAD.0b013e328354b43f	26	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202920	10.1371/journal.pone.0202920	http://dx.doi.org/10.1371/journal.pone.0202920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161175	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900051
J	Stafuzza, NB; Silva, RMD; Peripolli, E; Bezerra, LAF; Lobo, RB; Magnabosco, CD; Di Croce, FA; Osterstock, JB; Munari, DP; Lourenco, DAL; Baldi, F				Stafuzza, Nedenia Bonvino; de Oliveira Silva, Rafael Medeiros; Peripolli, Elisa; Framartino Bezerra, Luiz Antonio; Lobo, Raysildo Barbosa; Magnabosco, Claudio de Ulhoa; Di Croce, Fernando A.; Osterstock, Jason B.; Munari, Danisio Prado; Lino Lourenco, Daniela A.; Baldi, Fernando			Genome-wide association study provides insights into genes related with horn development in Nelore beef cattle	PLOS ONE			English	Article							EXCHANGE FACTOR TIAM1; BONE HOMEOSTASIS; HOLSTEIN CATTLE; DAIRY-CATTLE; SCURS LOCUS; INHERITANCE; STRATIFICATION; HOMOZYGOSITY; INTERFERON; POLLEDNESS	The causal mutation for polledness in Nelore (Bos taurus indicus) breed seems to have appeared first in Brazil in 1957. The expression of the polled trait is known to be ruled by a few groups of alleles in taurine breeds; however, the genetic basis of this trait in indicine cattle is still unclear. The aim of this study was to identify genomic regions associated with the hornless trait in a commercial Nelore population. A total of 107,294 animals had phenotypes recorded and 2,238 were genotyped/imputed for 777k SNP. The weighted single-step approach for genome-wide association study (WssGWAS) was used to estimate the SNP effects and variances accounted for by 1 Mb sliding SNP windows. A centromeric region of chromosome 1 with 3.11 Mb size (BTA1: 878,631-3,987,104 bp) was found to be associated with hornless in the studied population. A total of 28 protein-coding genes are mapped in this region, including the taurine Polled locus and the IFNAR1, IFNAR2, IFNGR2, KRTAP11-1, MIS18A, OLIG1, OLIG2, and SOD1 genes, which expression can be related to the horn formation as described in literature. The functional enrichment analysis by DAVID tool revealed cytokine-cytokine receptor interaction, JAK-STAT signaling, natural killer cell mediated cytotoxicity, and osteoclast differentiation pathways as significant (P < 0.05). In addition, a runs of homozygosity (ROH) analysis identified a ROH island in polled animals with 2.47 Mb inside the region identified by WssGWAS. Polledness in Nelore cattle is associated with one region in the genome with 3.1 Mb size in chromosome 1. Several genes are harbored in this region, and they may act together in the determination of the polled/horned phenotype. Fine mapping the locus responsible for polled trait in Nelore breed and the identification of the molecular mechanisms regulating the horn growth deserve further investigation.	[Stafuzza, Nedenia Bonvino; Munari, Danisio Prado] Univ Estadual Paulista, UNESP, FCAV, Dept Ciencias Exatas, Jaboticabal, SP, Brazil; [Stafuzza, Nedenia Bonvino; de Oliveira Silva, Rafael Medeiros; Lino Lourenco, Daniela A.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [de Oliveira Silva, Rafael Medeiros] ARS, USDA, NCCCWA, Leetown, WV USA; [Peripolli, Elisa; Baldi, Fernando] Univ Estadual Paulista, UNESP, FCAV, Dept Zootecnia, Jaboticabal, SP, Brazil; [Framartino Bezerra, Luiz Antonio] Univ Sao Paulo, FMRP, Dept Genet, Ribeirao Preto, SP, Brazil; [Lobo, Raysildo Barbosa] ANCP, Ribeirao Preto, SP, Brazil; [Magnabosco, Claudio de Ulhoa] Empresa Brasileira Pesquisa Agr EMBRAPA, Planaltina, DF, Brazil; [Di Croce, Fernando A.; Osterstock, Jason B.] Zoetis, Kalamazoo, MI USA	Universidade Estadual Paulista; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Universidade Estadual Paulista; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Zoetis	Stafuzza, NB (corresponding author), Univ Estadual Paulista, UNESP, FCAV, Dept Ciencias Exatas, Jaboticabal, SP, Brazil.; Stafuzza, NB (corresponding author), Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA.	nedeniabs@gmail.com	Magnabosco, Cláudio Ulhoa/ABC-4494-2021; Stafuzza, Nedenia B./C-4419-2013; Munari, Danisio P/C-6384-2012; Baldi, Fernando/E-5492-2012; Stafuzza, Nedenia Bonvino/M-9224-2019	Magnabosco, Cláudio Ulhoa/0000-0002-7274-0134; Stafuzza, Nedenia B./0000-0001-6432-2330; Munari, Danisio P/0000-0001-6915-038X; Baldi, Fernando/0000-0003-4094-2011; Stafuzza, Nedenia Bonvino/0000-0001-6432-2330; Lourenco, Daniela/0000-0003-3140-1002; Peripolli, Elisa/0000-0002-0962-6603	Zoetis; Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD); Sao Paulo Research Foundation (FAPESP) [16/24084-7]; productivity research fellowship from National Counsel of Technological and Scientific Development (CNPq)	Zoetis; Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); productivity research fellowship from National Counsel of Technological and Scientific Development (CNPq)	The Zoetis provided support in the form of salaries for authors FADC and JBO but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. NBS was supported by a postdoctoral fellowship from Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD). EP received a fellowship from Sao Paulo Research Foundation (FAPESP 16/24084-7). DPM and FB were supported by productivity research fellowship from National Counsel of Technological and Scientific Development (CNPq).	Allais-Bonnet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063512; Asai M, 2004, ANIM GENET, V35, P34, DOI 10.1111/j.1365-2052.2003.01079.x; Bateson W, 1902, REPORTS EVOLUTIONARY; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Boissier P, 2014, CELL SIGNAL, V26, P483, DOI 10.1016/j.cellsig.2013.11.034; Brem G., 1982, Bayerisches Landwirtschaftliches Jahrbuch, V59, P688; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Capitan A, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-33; Cargill Edward J, 2008, BMC Res Notes, V1, P128, DOI 10.1186/1756-0500-1-128; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Dove WF, 1935, J EXP ZOOL, V69, P347, DOI 10.1002/jez.1400690302; FRISCH JE, 1980, ANIM PROD, V31, P119, DOI 10.1017/S000335610002434X; Fujimoto S, 2014, J DERMATOL SCI, V74, P39, DOI 10.1016/j.jdermsci.2013.12.006; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Glatzer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067992; Gong H, 2016, GENES-BASEL, V7, DOI 10.3390/genes7060024; Gurgul A, 2016, J APPL GENET, V57, P527, DOI 10.1007/s13353-016-0337-6; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; *IBGE, 2015, PROD PEC MUN; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li Jiliang, 2013, JAKSTAT, V2, pe23930, DOI 10.4161/jkst.23930; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; Lutter AH, 2010, J CELL BIOCHEM, V109, P1025, DOI 10.1002/jcb.22485; Magnabosco CU, 1997, DOCUMENTOS EMBRAPA C; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Mastrangelo S, 2016, ANIMAL, V10, P746, DOI 10.1017/S1751731115002943; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Meijer DH, 2012, NAT REV NEUROSCI, V13, P819, DOI 10.1038/nrn3386; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Oliveira JHF, 2002, DOCUMENTOS EMBRAPA C; Park KC, 2017, J INVEST DERMATOL, V137, P414, DOI 10.1016/j.jid.2016.09.012; Prayaga KC, 2007, AUST J AGR RES, V58, P1, DOI 10.1071/AR06044; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; Rothammer S, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-44; Santiago AA, 1987, GADO NELORE 100 ANOS; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Smith ADB, 1927, J GENET, V18, P365, DOI 10.1007/BF02983113; Stachowicz K, 2011, J DAIRY SCI, V94, P5160, DOI 10.3168/jds.2010-3308; Ferraz JBS, 2010, MEAT SCI, V84, P238, DOI 10.1016/j.meatsci.2009.06.006; Takayanagi H, 2005, IMMUNOL REV, V208, P181, DOI 10.1111/j.0105-2896.2005.00337.x; Takayanagi H, 2005, J CELL BIOCHEM, V94, P232, DOI 10.1002/jcb.20316; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tetens J, 2015, ANIM GENET, V46, P224, DOI 10.1111/age.12237; Tsuruta S., 2006, P 8 WORLD C GEN APPL; Utsunomiya ATH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3049-8; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vozzi PA, 2007, GENET MOL RES, V6, P1044; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00134; Wang L, 2015, CELL DEATH DIFFER, V22, P1654, DOI 10.1038/cdd.2015.14; WARWICK EJ, 1979, BREEDING IMPROVEMENT; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500; Wiedemar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093435; Wiener DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127691; Wohlke A, 2010, ANIM GENET, V41, P335, DOI 10.1111/j.1365-2052.2009.02009.x; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	68	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202978	10.1371/journal.pone.0202978	http://dx.doi.org/10.1371/journal.pone.0202978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161212	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900058
J	Kong, M; Yoon, J; Ham, DI				Kong, Mingui; Yoon, Jaemoon; Ham, Don-Il			Electrophysiological function in eyes with reticular pseudodrusen according to fundus distribution	PLOS ONE			English	Article							SUBRETINAL DRUSENOID DEPOSITS; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; PREVALENCE; ELECTRORETINOGRAPHY; RISK	Reticular pseudodrusen (RPD) could be present not only in the posterior pole but extramacular area also as a confluent morphological pattern. Thus RPD can be classified by the fundus distribution for the assessment of visual prognosis. The electrophysiological function in eyes with reticular pseudodrusen (RPD), showing various fundus distribution were evaluated using full-field electroretinogram (ERG). Retinal distribution of RPD was divided into three types (localized, intermediate, and diffuse) according to the extent of involvement of retinal areas by fundus photograph montages. RPD were present with the diffuse type in 21 eyes (25.6%), with the intermediate type in 30 eyes (36.6%), and with the localized type in 31 eyes (37.8%). The average age was 74.76 +/- 4.52 (range, 65 +/- 81) years in the diffuse type, 72.47 +/- 9.13 (range, 55 +/- 91) years in the intermediate type, and 70.26 +/- 7.77 (range, 61 +/- 89) years in the localized type. The mean amplitudes of the scotopic rod response, scotopic maximal combined response, oscillatory potentials (OP), photopic cone response, and 30Hz cone flicker response were more decreased in the diffuse, intermediate, and localized types in order, except for the photopic cone a-wave response. The diffuse type showed reduced amplitudes of ERG responses than the normal control group under all testing conditions except for the photopic a-wave response, and differences were statistically significant with the age restriction and adjustment methods (Bonferroni-corrected P < 0.05). The mean implicit times of ERG responses were significantly delayed in the diffuse type in the photopic b-wave. (Bonferroni-corrected P < 0.05). Extensive retinal involvement of RPD correlates with severely reduced electrophysiological retinal function. This acquired form of decreased electrophysiological function should be regarded as different from those of hereditary retinal degeneration.	[Kong, Mingui] Hangil Eye Hosp, Incheon, South Korea; [Kong, Mingui] Catholic Kwandong Univ, Dept Ophthalmol, Coll Med, Incheon, South Korea; [Yoon, Jaemoon] Seobusan Eye Clin, Busan, South Korea; [Ham, Don-Il] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Catholic Kwandong University; Sungkyunkwan University (SKKU); Samsung Medical Center	Ham, DI (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	oculus@naver.com						Alten F, 2014, GRAEF ARCH CLIN EXP, V252, P715, DOI 10.1007/s00417-013-2525-y; Alten F, 2014, INVEST OPHTH VIS SCI, V55, P6073, DOI 10.1167/iovs.13-13804; Alten F, 2012, INVEST OPHTH VIS SCI, V53, P6263, DOI 10.1167/iovs.12-10094; ARNOLD JJ, 1995, RETINA-J RET VIT DIS, V15, P183, DOI 10.1097/00006982-199515030-00001; BIRCH DG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1571, DOI 10.1001/archopht.1992.01080230071024; Cohen SY, 2007, BRIT J OPHTHALMOL, V91, P354, DOI 10.1136/bjo.2006.101022; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Flamendorf J, 2015, OPHTHALMOLOGY, V122, P2053, DOI 10.1016/j.ophtha.2015.06.023; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Lee MY, 2012, BRIT J OPHTHALMOL, V96, P1222, DOI 10.1136/bjophthalmol-2011-301207; Lois N, 2002, AM J OPHTHALMOL, V133, P341, DOI 10.1016/S0002-9394(01)01404-0; MARCUS M, 1983, ANN OPHTHALMOL, V15, P235; MIMOUN G, 1990, J FR OPHTALMOL, V13, P511; Schmitz-Valckenberg S, 2010, OPHTHALMOLOGY, V117, P1169, DOI 10.1016/j.ophtha.2009.10.044; Smith RT, 2009, AM J OPHTHALMOL, V148, P733, DOI 10.1016/j.ajo.2009.06.028; Spaide RF, 2013, RETINA-J RET VIT DIS, V33, P1800, DOI 10.1097/IAE.0b013e31829c3765; Spaide RF, 2010, RETINA-J RET VIT DIS, V30, P1441, DOI 10.1097/IAE.0b013e3181ee5ce8; Steinberg JS, 2015, JAMA OPHTHALMOL, V133, P690, DOI 10.1001/jamaophthalmol.2015.0477; Walter P, 1999, GRAEF ARCH CLIN EXP, V237, P962, DOI 10.1007/s004170050331; WELEBER RG, 1981, INVEST OPHTH VIS SCI, V20, P392; WRIGHT CE, 1985, DOC OPHTHALMOL, V59, P365, DOI 10.1007/BF00159171; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P1775, DOI 10.1016/j.ophtha.2010.01.027; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	24	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203146	10.1371/journal.pone.0203146	http://dx.doi.org/10.1371/journal.pone.0203146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157256	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400096
J	Martinez-Jauregui, M; Serra-Varela, MJ; Diaz, M; Sollino, M				Martinez-Jauregui, Maria; Jesus Serra-Varela, Maria; Diaz, Mario; Sollino, Mario			Mitigation strategies for conserving bird diversity under climate change scenarios in Europe: The role of forest naturalization	PLOS ONE			English	Article							PLANTATION FORESTS; PINE PLANTATIONS; SPECIES RICHNESS; BIODIVERSITY; MANAGEMENT; LANDSCAPE; CONSERVATION; COMMUNITIES; ASSEMBLAGES; FUTURE	There are many possible strategies to promote naturalization in anthropogenic landscapes to mitigate global change effects. We combined large-scale databases available for continental Spain on: (1) distribution of breeding birds, (2) forest inventory stands, (3) land-use cover, (4) 18 global climate models recently developed at local scales, and (5) historical and genetically-based information on the distribution of natural versus planted pine forests, to analyze whether back to nature strategies may help to mitigate biodiversity loss due to climate change. We performed the analysis along environmental and ecological gradients of pine forests in Southern Europe. Models suggested that, naturalization strategies, in this case defined by the replacement of planted pine forests and eucalyptus forests by natural pine forests, could help to mitigate the expected loss of bird diversity due to climate change, but that mitigation efficiency will vary along environmental and ecological gradients. Maximum levels of diversity mitigation were predicted at intermediate levels of naturalization, with lower bird richness in areas where all pine forests were either planted or naturalized. Efficiency also varied spatially, given that both cold-and hot-spots of climate-driven bird diversity loss were identified. Transforming planted forest into natural forest is not a mitigation panacea, and additional regionally-adapted strategies may be identified to mitigate the expected biodiversity loss in forest ecosystems.	[Martinez-Jauregui, Maria; Jesus Serra-Varela, Maria; Sollino, Mario] Natl Inst Agr & Food Res & Technol INIA, Forest Res Ctr CIFOR, Madrid, Spain; [Martinez-Jauregui, Maria; Jesus Serra-Varela, Maria; Sollino, Mario] Univ Valladolid, Sustainable Forest Management Res Inst, Palencia, Spain; [Martinez-Jauregui, Maria; Jesus Serra-Varela, Maria; Sollino, Mario] INIA, Palencia, Spain; [Diaz, Mario] Museo Nacl Ciencias Nat BGC MNCN CSIC, Dept Biogeog & Global Change, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Martinez-Jauregui, M (corresponding author), Natl Inst Agr & Food Res & Technol INIA, Forest Res Ctr CIFOR, Madrid, Spain.; Martinez-Jauregui, M (corresponding author), Univ Valladolid, Sustainable Forest Management Res Inst, Palencia, Spain.; Martinez-Jauregui, M (corresponding author), INIA, Palencia, Spain.	martinezmari@gmail.com	Martinez-Jauregui, Maria/AGA-8083-2022; MARTINEZ-JAUREGUI, MARIA/B-3339-2011; Soliño, Mario/A-5648-2012; Martinez-Jauregui, Maria/M-6005-2019; Diaz, Mario/C-3052-2017	Martinez-Jauregui, Maria/0000-0002-7590-822X; MARTINEZ-JAUREGUI, MARIA/0000-0002-7590-822X; Martinez-Jauregui, Maria/0000-0002-7590-822X; Diaz, Mario/0000-0002-6384-6674	Spanish Ministry of Economy and Competitiveness [RTA2013-00048-C03-01]; REMEDINAL3-CM [S2013/MAE-2719]; Spanish Ministry of Agriculture, Food and Environment	Spanish Ministry of Economy and Competitiveness(Spanish Government); REMEDINAL3-CM; Spanish Ministry of Agriculture, Food and Environment(Spanish Government)	This study is framed within the project INIA ref. RTA2013-00048-C03-01 funded by the Spanish Ministry of Economy and Competitiveness, and is a contribution to the thematic network REMEDINAL3-CM (S2013/MAE-2719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to David Sanchez de Ron, Iciar Alberdi and Javier Portoles for their collaboration during previous research stages, and to the staff of SEO/BirdLife for their work in the management of the bird atlas data. We acknowledge the Spanish Meteorological Agency (AEMET) and the Climate Research Foundation (FIC) for producing and making available the bioclimatic data. We also thank the "Scientific research for the adaptation of Pinus pinaster Ait. and Pinus halepensis Mill. to climate change" project, funded by the Spanish Ministry of Agriculture, Food and Environment. This study is framed within the project INIA ref. RTA2013-00048-C03-01 funded by the Spanish Ministry of Economy and Competitiveness, and is a contribution to the thematic network REMEDINAL3-CM (S2013/MAE-2719).	Alberdi I, 2010, ENVIRON MONIT ASSESS, V164, P649, DOI 10.1007/s10661-009-0919-4; Alia R, 2009, REGIONES PROCEDENCIA; Araujo M, 2011, IMPACTOS VULNERABILI, V2, P640; Assessment ME, 2005, EC HUM WELL BEING BI; Bedia J, 2013, GLOBAL PLANET CHANGE, V107, P1, DOI 10.1016/j.gloplacha.2013.04.005; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Calladine J, 2017, ECOLOGY CONSERVATION; Calvino-Cancela M, 2013, FOREST ECOL MANAG, V310, P692, DOI 10.1016/j.foreco.2013.09.014; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carnus JM, 2006, J FOREST, V104, P65; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Diaz M, 1998, J APPL ECOL, V35, P562, DOI 10.1046/j.1365-2664.1998.3540562.x; Diaz M., 2016, CURRENT LANDSCAPE EC, V1, P168, DOI [10.1007/s40823-016-0017-6, DOI 10.1007/S40823-016-0017-6]; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Gamborg C, 2003, FOREST ECOL MANAG, V179, P559, DOI 10.1016/S0378-1127(02)00553-4; Gil-Tena A, 2007, FOREST ECOL MANAG, V242, P470, DOI 10.1016/j.foreco.2007.01.080; Gjerde I, 1997, BIOL CONSERV, V79, P241, DOI 10.1016/S0006-3207(96)00093-6; Greenwood O, 2016, J APPL ECOL, V53, P885, DOI 10.1111/1365-2664.12602; Guiot J, 2016, SCIENCE, V354, P465, DOI 10.1126/science.aah5015; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huntley B., 2007, CLIMATIC ATLAS EUROP; Serra-Varela MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171549; Lemes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054323; Luck GW, 2008, FOREST ECOL MANAG, V255, P2688, DOI 10.1016/j.foreco.2008.01.029; Martinez-Jauregui M, 2016, DIVERS DISTRIB, V22, P1255, DOI 10.1111/ddi.12488; Martinez-Jauregui M, 2016, FOREST ECOL MANAG, V376, P183, DOI 10.1016/j.foreco.2016.06.021; Martui R., 2003, ATLAS AVES REPRODUCT; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Montoya D, 2008, SCIENCE, V320, P1502, DOI 10.1126/science.1158404; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naudts K, 2016, SCIENCE, V351, P597, DOI 10.1126/science.aad7270; Navarro L., 2015, REWILDING EUROPEAN L, P3, DOI DOI 10.1007/978-3-319-12039-3_1; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Pawson SM, 2013, BIODIVERS CONSERV, V22, P1203, DOI 10.1007/s10531-013-0458-8; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Santana J, 2012, J APPL ECOL, V49, P632, DOI 10.1111/j.1365-2664.2012.02141.x; Stephens SS, 2007, J FOREST, V105, P307; Stocker T.F., 2013, CLIMATE CHANGE 2013, P33; Sweeney OFM, 2010, BIRD STUDY, V57, P301, DOI 10.1080/00063651003801713; Team RC., 2013, R LANG ENV STAT COMP; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Urban MC, 2016, SCIENCE, V353, P1113, DOI 10.1126/science.aad8466; Varela E, 2018, SCI TOTAL ENVIRON, V619, P1319, DOI 10.1016/j.scitotenv.2017.11.190; Wilson MW, 2006, BIRD STUDY, V53, P225, DOI 10.1080/00063650609461437	49	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202009	10.1371/journal.pone.0202009	http://dx.doi.org/10.1371/journal.pone.0202009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157226	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400025
J	Redford, L; Alhilal, G; Needham, S; O'Brien, O; Coaker, J; Tyson, J; Amorim, LM; Middleton, I; Izuogu, O; Arends, M; Oniscu, A; Alonso, AM; Laguna, SM; Gallon, R; Sheth, H; Santibanez-Koref, M; Jackson, MS; Burn, J				Redford, Lisa; Alhilal, Ghanim; Needham, Stephanie; O'Brien, Ottie; Coaker, Julie; Tyson, John; Amorim, Leonardo Maldaner; Middleton, Iona; Izuogu, Osagi; Arends, Mark; Oniscu, Anca; Alonso, Angel Miguel; Laguna, Sira Moreno; Gallon, Richard; Sheth, Harsh; Santibanez-Koref, Mauro; Jackson, Michael S.; Burn, John			A novel panel of short mononucleotide repeats linked to informative polymorphisms enabling effective high volume low cost discrimination between mismatch repair deficient and proficient tumours	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY DETECTION; REVISED BETHESDA GUIDELINES; COLORECTAL-CANCER PATIENTS; LYNCH-SYNDROME; RISK; IMMUNOHISTOCHEMISTRY; STRATEGIES; MUTATIONS; FRAMEWORK; ALIGNMENT	Somatic mutations in mononucleotide repeats are commonly used to assess the mismatch repair status of tumours. Current tests focus on repeats with a length above 15bp, which tend to be somatically more unstable than shorter ones. These longer repeats also have a substantially higher PCR error rate, and tests that use capillary electrophoresis for fragment size analysis often require expert interpretation. In this communication, we present a panel of 17 short repeats (length 7 - 12bp) for sequence-based microsatellite instability (MSI) testing. Using a simple scoring procedure that incorporates the allelic distribution of the mutant repeats, and analysis of two cohort of tumours totalling 209 samples, we show that this panel is able to discriminate between MMR proficient and deficient tumours, even when constitutional DNA is not available. In the training cohort, the method achieved 100% concordance with fragment analysis, while in the testing cohort, 4 discordant samples were observed (corresponding to 97% concordance). Of these, 2 showed discrepancies between fragment analysis and immunohistochemistry and one was reclassified after re-testing using fragment analysis. These results indicate that our approach offers the option of a reliable, scalable routine test for MSI.	[Redford, Lisa; Alhilal, Ghanim; Middleton, Iona; Izuogu, Osagi; Gallon, Richard; Sheth, Harsh; Santibanez-Koref, Mauro; Jackson, Michael S.; Burn, John] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Needham, Stephanie; O'Brien, Ottie] NHS Fdn Trust, Newcastle Hosp, Dept Pathol, Newcastle Upon Tyne, Tyne & Wear, England; [Needham, Stephanie; O'Brien, Ottie] NHS Fdn Trust, Newcastle Hosp, Northern Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England; [Coaker, Julie; Tyson, John] QuantuMDx Grp ltd, Lugano Bldg, Newcastle Upon Tyne, Tyne & Wear, England; [Amorim, Leonardo Maldaner] Univ Fed Parana, Dept Genet, Lab Genet Mol Humana, Curitiba, Parana, Brazil; [Arends, Mark; Oniscu, Anca] Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Alonso, Angel Miguel; Laguna, Sira Moreno] Hosp Virgen Camino, Complejo Hosp Navarra, Serv Genet Med, C Irunlarrea 4, Pamplona, Spain	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Universidade Federal do Parana; University of Edinburgh; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea	Sheth, H; Santibanez-Koref, M; Jackson, MS (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England.	sheth2@newcastle.ac.uk; mauro.santibanez-koref@newcastle.ac.uk; michael.jackson@leeds.ac.uk	ALONSO, ANGEL/P-1145-2019	ALONSO, ANGEL/0000-0001-5111-310X; Jackson, Michael/0000-0001-7179-1354; Maldaner Amorim, Leonardo/0000-0001-6418-3772; Burn, John/0000-0002-9823-2322; tyson, John/0000-0002-1108-7602; Sheth, Harsh/0000-0001-9626-0971; Izuogu, Osagie/0000-0003-3116-2558	QuantuMDx Ltd.; Barbour Foundation	QuantuMDx Ltd.; Barbour Foundation	LR and HS acknowledge the funding support received from QuantuMDx Ltd. The funder provided support in the form of salaries for authors LR and HS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors received grant from the Barbour Foundation as a support for the Cancer Genetics Research Programme at the Institute of Genetic Medicine, Newcastle University. The funder had no role in the study design, sample collection and data analysis, decision to publish, or preparation of the manuscript.	Ahadova A, 2018, INT J CANCER, V143, P139, DOI 10.1002/ijc.31300; Alhopuro P, 2008, P NATL ACAD SCI USA, V105, P5513, DOI 10.1073/pnas.0801213105; Ananda G, 2013, GENOME BIOL EVOL, V5, P606, DOI 10.1093/gbe/evs116; Berg KD, 2000, J MOL DIAGN, V2, P20, DOI 10.1016/S1525-1578(10)60611-3; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bonneville R, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00073; Boyle TA, 2014, ARCH PATHOL LAB MED, V138, P363, DOI 10.5858/arpa.2013-0159-CP; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Canard G, 2012, ANN SURG ONCOL, V19, P809, DOI 10.1245/s10434-011-2014-7; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Engel C, 2012, J CLIN ONCOL, V30, P4409, DOI 10.1200/JCO.2012.43.2278; Gelman A, 2014, BAYESIAN DATA ANAL, Vxiv; Guindalini RSC, 2015, GASTROENTEROLOGY, V149, P1446, DOI 10.1053/j.gastro.2015.07.052; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Haraldsdottir S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00189; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Julie C, 2008, AM J GASTROENTEROL, V103, P2825, DOI 10.1111/j.1572-0241.2008.02084.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Laiho P, 2002, CANCER RES, V62, P1166; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063056; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Middha S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00084; Mills AM, 2014, AM J SURG PATHOL, V38, P1501, DOI 10.1097/PAS.0000000000000321; Moller P, 2017, GUT, V66, P464, DOI 10.1136/gutjnl-2015-309675; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NICE, 2017, MOL TEST STRAT LYNCH; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Palomaki GE, 2009, GENET MED, V11, P42, DOI 10.1097/GIM.0b013e31818fa2db; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Rogers MF, 2018, BIOINFORMATICS, V34, P511, DOI 10.1093/bioinformatics/btx536; Rozen S, 2000, Methods Mol Biol, V132, P365; Salipante SJ, 2014, CLIN CHEM, V60, P1192, DOI 10.1373/clinchem.2014.223677; Sammalkorpi H, 2007, CANCER RES, V67, P5691, DOI 10.1158/0008-5472.CAN-06-4314; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shia J, 2008, J MOL DIAGN, V10, P293, DOI 10.2353/jmoldx.2008.080031; Shibata Darryl, 2006, Cancer Biomarkers, V2, P29; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Snowsill T, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI [10.3310/hta19020, 10.3310/hta18580]; Susanti S, 2018, J CLIN PATHOL, V71, P713, DOI 10.1136/jclinpath-2018-205013; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2013, GUT, V62, P812, DOI 10.1136/gutjnl-2012-304356; Zhang LY, 2008, J MOL DIAGN, V10, P301, DOI 10.2353/jmoldx.2008.080062; Zhu LZ, 2018, J MOL DIAGN, V20, P225, DOI 10.1016/j.jmoldx.2017.11.007	49	9	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203052	10.1371/journal.pone.0203052	http://dx.doi.org/10.1371/journal.pone.0203052			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157243	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400085
J	Skarp, S; Kamarainen, OP; Wei, GH; Jakkula, E; Kiviranta, I; Kroger, H; Auvinen, J; Lehenkari, P; Ala-Kokko, L; Mannikko, M				Skarp, Sini; Kamarainen, Olli-Pekka; Wei, Gong-Hong; Jakkula, Eveliina; Kiviranta, Ilkka; Kroger, Heikki; Auvinen, Juha; Lehenkari, Petri; Ala-Kokko, Leena; Mannikko, Minna			Whole exome sequencing in Finnish families identifies new candidate genes for osteoarthritis	PLOS ONE			English	Article							ONSET GENERALIZED OSTEOARTHRITIS; KNEE OSTEOARTHRITIS; HIP OSTEOARTHRITIS; EXPRESSION; LINKAGE; DISEASE; RISK; ARTHRITIS; ALLELES; HEALTH	Introduction Osteoarthritis (OA) is the most common degenerative joint disease and one of the major causes of disability worldwide. It is a multifactorial disorder with a significant genetic component. The heritability of OA has been estimated to be 60% for hip OA and 39% for knee OA. Genetic factors behind OA are still largely unknown. Studying families with strong history of OA, facilitates examining the co-segregation of genetic variation and OA. The aim of this study was to identify new, rare genetic factors and novel candidate genes for OA. Methods Eight patients from three Finnish families with hip and knee OA were studied using whole exome sequencing. We focused on rare exonic variants with predicted pathogenicity and variants located in active promoter or strong enhancer regions. Expression of identified candidate genes were studied in bone and cartilage tissues and the observed variants were investigated using bioinformatic analyses. Results Two rare variants co-segregated with OA in two families. In Family 8 a missense variant (c.628C>G, p.Arg210Gly) was observed in the OLIG3 gene that encodes a transcription factor known to be associated with rheumatoid arthritis and inflammatory polyarthritis. The Arg210Gly variant was estimated to be pathogenic by Polyphen-2 and Mutation taster and the locus is conserved among mammals. In Family 12 the observed variant (c.-127G>T) was located in the transcription start site of the FIP1L1 gene. FIP1L1 participates in the regulation of polyadenylation. The c.-127G>T is located in the transcription start site and may alter the DNA-binding of transcription factors. Both, OLIG3 and FIP1L1 were observed in human bone and cartilage. Conclusion The identified variants revealed novel candidate genes for OA. OLIG3 and FIP1L1 have specific roles in transcription and may effect expression of other genes. Identified variants in these genes may thus have a role in the regulatory events leading to OA.	[Skarp, Sini; Auvinen, Juha; Mannikko, Minna] Univ Oulu, Fac Med, Ctr Life Course Hlth Res, Oulu, Finland; [Skarp, Sini; Kamarainen, Olli-Pekka; Wei, Gong-Hong; Jakkula, Eveliina; Mannikko, Minna] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Kiviranta, Ilkka] Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland; [Kiviranta, Ilkka] Helsinki Univ Hosp, Helsinki, Finland; [Kiviranta, Ilkka] Jyvaskyla Cent Hosp, Dept Orthopaed & Traumatol, Jyvaskyla, Finland; [Kroger, Heikki] Kuopio Univ Hosp, Dept Orthopaed & Traumatol, Kuopio, Finland; [Kroger, Heikki] Univ Eastern Finland, Kuopio Musculoskeletal Res Unit, Kuopio, Finland; [Lehenkari, Petri] Univ Oulu, Med Res Ctr, Dept Anat & Cell Biol, Oulu, Finland; [Lehenkari, Petri] Univ Oulu, Med Res Ctr, Surg Clin, Oulu, Finland; [Lehenkari, Petri] Oulu Univ Hosp, Oulu, Finland; [Ala-Kokko, Leena] Connect Tissue Gene Tests, Allentown, PA USA; [Mannikko, Minna] Univ Oulu, Northern Finland Birth Cohort, Fac Med, Oulu, Finland	University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Skarp, S (corresponding author), Univ Oulu, Fac Med, Ctr Life Course Hlth Res, Oulu, Finland.; Skarp, S (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	sini.skarp@oulu.fi	Skarp, Sini/AAH-2995-2021; Lehenkari, Petri/O-3009-2016	Skarp, Sini/0000-0003-2336-4221; Lehenkari, Petri/0000-0002-0055-5183; Wei, Gong-Hong/0000-0001-6546-9334	University of Oulu; Connective Tissue Gene Tests (Allentown)	University of Oulu; Connective Tissue Gene Tests (Allentown)	This study was funded by the University of Oulu (university researcher recruitment funding, MM); The Connective Tissue Gene Tests (Allentown) provided support in the form of salaries for author [LAK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of authors are articulated in the 'author contributions' section.	Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chheda H, 2017, EUR J HUM GENET, V25, P477, DOI 10.1038/ejhg.2016.205; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Gonzalez A, 2013, OSTEOARTHR CARTILAGE, V21, P1443, DOI 10.1016/j.joca.2013.07.001; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Iwasaki J, 2014, ANN HEMATOL, V93, P1473, DOI 10.1007/s00277-014-2085-1; Jakkula E, 2005, OSTEOARTHR CARTILAGE, V13, P497, DOI 10.1016/j.joca.2005.02.005; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kraatari M, 2017, SPINE, V42, P1201, DOI 10.1097/BRS.0000000000002049; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lou H, 1998, J ENDOCRINOL, V156, P401, DOI 10.1677/joe.0.1560401; Luyten FP, 2009, BONE, V44, P522, DOI 10.1016/j.bone.2008.12.006; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P2410, DOI 10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meulenbelt I, 2006, EUR J HUM GENET, V14, P1280, DOI 10.1038/sj.ejhg.5201704; Min JL, 2007, EUR J HUM GENET, V15, P791, DOI 10.1038/sj.ejhg.5201829; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Neame RL, 2004, ANN RHEUM DIS, V63, P1022, DOI 10.1136/ard.2003.014498; NEVANLINNA H R, 1980, Haematologia, V13, P65; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Plant D, 2012, PHARMACOGENOMICS J, V12, P128, DOI 10.1038/tpj.2010.80; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Ramos YFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103056; Reynard LN, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.4; Salem S, 2014, J CELL MOL MED, V18, P1588, DOI 10.1111/jcmm.12327; Shepherd C, 2018, ARTHRITIS RHEUMATOL; Soul J, 2018, ANN RHEUM DIS, V77; Spector TD, 1996, BRIT MED J, V312, P940; Styrkarsdottir U, 2017, NAT GENET, V49, P801, DOI 10.1038/ng.3816; Styrkarsdottir U, 2014, NAT GENET, V46, P498, DOI 10.1038/ng.2957; Syddall CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003557; Taipale M, 2016, OSTEOARTHR CARTILAGE, V24, P655, DOI 10.1016/j.joca.2015.10.019; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Thomas E, 2014, RHEUMATOLOGY, V53, P338, DOI 10.1093/rheumatology/ket346; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; VIKKULA M, 1993, ARTHRITIS RHEUM, V36, P401, DOI 10.1002/art.1780360317; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu Y, 2012, OSTEOARTHR CARTILAGE, V20, P1029, DOI 10.1016/j.joca.2012.05.006; Zechner D, 2007, DEV BIOL, V303, P181, DOI 10.1016/j.ydbio.2006.10.045	47	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203313	10.1371/journal.pone.0203313	http://dx.doi.org/10.1371/journal.pone.0203313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157244	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400102
J	Savo, APH; Zheng, YX; Zheng, YT; Lewbart, GA				Savo, Alison P. H.; Zheng, Yaxin; Zheng, Yuting; Lewbart, Gregory A.			Health status assessment of traumatic injury freshwater turtles	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; BIOCHEMICAL REFERENCE INTERVALS; TERRAPENE-CAROLINA-CAROLINA; BOX TURTLES; LEPIDOCHELYS-KEMPII; RESPIRATORY STATUS; CARETTA-CARETTA; NORTH-CAROLINA; HEMATOLOGY; USA	A group of injured yellow-bellied sliders (Trachemys scripta) and river cooters (Pseudemys concinna) were evaluated for a variety of health values at presentation to the NC State Turtle Rescue Team and prior to release. An i-STAT Portable Clinical Analyzer and CG8+ cartridges were used to determine venous blood gas and biochemical values, the packed cell volume (PCV) and total protein were evaluated using hematocrit tubes and high speed centrifugation, and a differential WBC percentage was determined manually with Diff-Quick stained blood smear slides. Forty-six turtles were sampled on presentation and twenty-three of those were sampled again prior to release. Blood values were analyzed for significant differences between samples collected at presentation and prior to release, as well as differences between surviving and non-surviving turtles. Five variables were identified as significantly different between presenting and recuperated samples: pH, pCO2, Glu, % heterophils, and % eosinophils. When comparing samples between turtles that survived versus those that did not, two variables were identified as being significant prognostic indicators; lactate and PCV. Identification of these significant variables can aid in determining patient prognosis and triage therapy for injured aquatic turtles.	[Savo, Alison P. H.; Lewbart, Gregory A.] North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Zheng, Yaxin; Zheng, Yuting] North Carolina State Univ, Dept Stat, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Lewbart, GA (corresponding author), North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.	greg_lewbart@ncsu.edu		Lewbart, Gregory/0000-0003-0716-1387	George H. Hitchings New Investigator award	George H. Hitchings New Investigator award	This work was supported in part by a George H. Hitchings New Investigator award to Alison Harrelson Savo.	Adamovicz L, 2015, J ZOO WILDLIFE MED, V46, P39, DOI 10.1638/2014-0066R.1; Anderson ET, 2011, J ZOO WILDLIFE MED, V42, P247, DOI 10.1638/2010-0217.1; Budischak SA, 2006, SOUTHEAST NAT, V5, P191, DOI 10.1656/1528-7092(2006)5[191:NHOTCB]2.0.CO;2; Camacho M, 2013, JAVMA-J AM VET MED A, V242, P396, DOI 10.2460/javma.242.3.396; Casal AB, 2009, VET REC, V164, P663, DOI 10.1136/vr.164.21.663; Chittick EJ, 2002, J AM VET MED ASSOC, V221, P1019, DOI 10.2460/javma.2002.221.1019; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Gillespie I, 2017, VET CLIN N AM-SMALL, V47, P325, DOI 10.1016/j.cvsm.2016.10.011; Harvey J.H., 2001, ATLAS VET HEMATOLOGY, P3; Heatley JJ, 2010, J EXOT PET MED, V19, P160, DOI 10.1053/j.jepm.2010.06.002; Hidalgo-Vila J, 2007, J WILDLIFE DIS, V43, P798, DOI 10.7589/0090-3558-43.4.798; Hidalgo-Vila J, 2011, J WILDLIFE DIS, V47, P201, DOI 10.7589/0090-3558-47.1.201; Hunt K. E., 2016, CONSERV PHYSIOL, V4, P1; Innis CJ, 2007, J ZOO WILDLIFE MED, V38, P425, DOI 10.1638/1042-7260(2007)38[425:HAPBAO]2.0.CO;2; Innis CJ, 2007, J COMP PHYSIOL B, V177, P623, DOI 10.1007/s00360-007-0160-9; Innis CJ, 2009, JAVMA-J AM VET MED A, V235, P426, DOI 10.2460/javma.235.4.426; Keller Krista A., 2012, Journal of Herpetological Medicine and Surgery, V22, P99, DOI 10.5818/1529-9651-22.3.99; Keller KA, 2012, JAVMA-J AM VET MED A, V240, P317, DOI 10.2460/javma.240.3.317; Kimble SJA, 2012, J WILDLIFE DIS, V48, P799, DOI 10.7589/0090-3558-48.3.799; Li TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120796; MONTALI RJ, 1988, J COMP PATHOL, V99, P1, DOI 10.1016/0021-9975(88)90101-6; Roberts Brian K, 2016, Vet Clin North Am Exot Anim Pract, V19, P347, DOI 10.1016/j.cvex.2016.01.010; Snoddy JE, 2009, J WILDLIFE MANAGE, V73, P1394, DOI 10.2193/2008-472; Stacy NI, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot003; Steen DA, 2017, CONSERV BIOL, V31, P1333, DOI 10.1111/cobi.12926; Ultsch GR, 2006, BIOL REV, V81, P339, DOI 10.1017/S1464793106007032; Warren DE, 2008, J COMP PHYSIOL B, V178, P133, DOI 10.1007/s00360-007-0212-1; Willoughby JR, 2013, HERPETOLOGICA, V69, P186, DOI 10.1655/HERPETOLOGICA-D-12-00033R2; Wolf KN, 2008, JAVMA-J AM VET MED A, V233, P470, DOI 10.2460/javma.233.3.470	29	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202194	10.1371/journal.pone.0202194	http://dx.doi.org/10.1371/journal.pone.0202194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153271	Green Submitted, gold, Green Published			2022-12-27	WOS:000443001700009
J	Trevis, T; Gosse, M; Santarossa, N; Tabrizi, S; Russell, D; McBride, WJ				Trevis, Thomas; Gosse, Marianne; Santarossa, Nicola; Tabrizi, Sepehr; Russell, Darren; McBride, William John			Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance	PLOS ONE			English	Article							REAL-TIME PCR; MACROLIDE RESISTANCE; NONGONOCOCCAL URETHRITIS; CHLAMYDIA-TRACHOMATIS; SEXUAL-BEHAVIOR; TRICHOMONAS-VAGINALIS; RISK BEHAVIOR; MEN; TRAVELERS; INFECTION	Background Mycoplasma genitalium is a sexually transmitted infection (STI), and a common cause of non-gonococcal urethritis (NGU). There is concern regarding the rise in prevalence of M. genitalium and rates of resistance to macrolide antibiotics. International backpackers represent a unique population that may be at an increased risk of STIs. The purpose of this study was to determine the prevalence of M. genitalium and antibiotic resistance in international backpackers. Methods First void urine samples were obtained utilising opportunistic sampling from 294 non-treatment-seeking international backpackers at a variety of hostels in Cairns, Queensland Australia. Participants also answered a fixed-answer survey regarding sociodemographic characteristics and sexual risk behaviours. Samples were tested for M. genitalium, Chlamydia trachomatis and Neisseria gonorrhoeae using polymerase chain reaction (PCR). Samples positive for M. genitalium were investigated for macrolide resistance-associated mutations in the 23S rRNA genome at positions A2058G, A2058C, A2058T, A2059G and A2059C (Escherichia coli numbering). Results Of the 294 samples, 23 failed the internal control. The prevalence of M. genitalium was 1.8% (5/271, 95% confidence interval [CI] +/- 1.58), C. trachomatis was 4.1% (11/271, 95% CI +/- 2.36) and N. gonorrhoeae was not detected. Macrolide resistance-associated mutations were identified in 40% (2/5) of M. genitalium-positive samples. M. genitalium infection was associated with reporting symptoms (odds ratio [OR] 14.36, 95% CI 2.17-94.94, p < 0.05). Conclusions M. genitalium and C. trachomatis are relatively common amongst non-treatment seeking international backpackers, but may not differ from Australian population prevalence. This article provides evidence to further support the increased utilisation of M. genitalium PCR in the diagnosis of NGU, and for macrolide resistance testing for all identified M. genitalium infections.	[Trevis, Thomas; Santarossa, Nicola; McBride, William John] James Cook Univ, Cairns Hosp, Clin Sch, Cairns, Qld, Australia; [Gosse, Marianne] Norwegian Univ Sci & Technol, Fac Med, Trondheim, Norway; [Tabrizi, Sepehr] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Russell, Darren] Cairns Sexual Hlth Serv, Cairns North, Qld, Australia	James Cook University; Norwegian University of Science & Technology (NTNU); University of Melbourne	Trevis, T (corresponding author), James Cook Univ, Cairns Hosp, Clin Sch, Cairns, Qld, Australia.	thomastrevis@gmail.com	McBride, William/GQY-9084-2022	McBride, William/0000-0001-8894-533X	Cairns Sexual Health Services; James Cook University School of Medicine and Dentistry	Cairns Sexual Health Services; James Cook University School of Medicine and Dentistry	The Cairns Sexual Health Services was a major source of support for this work, providing the necessary funding and equipment required to complete the project. Further funding was sourced through the James Cook University School of Medicine and Dentistry.	Ansart S, 2009, J TRAVEL MED, V16, P79, DOI 10.1111/j.1708-8305.2008.00279.x; Australasian Society for HIV, 2018, AUSTR STI MAN GUID U; Bavastrelli M, 1998, J Travel Med, V5, P57, DOI 10.1111/j.1708-8305.1998.tb00464.x; Bissessor M, 2015, CLIN INFECT DIS, V60, P1228, DOI 10.1093/cid/ciu1162; Bradshaw CS, 2009, SEX TRANSM INFECT, V85, P432, DOI 10.1136/sti.2008.035535; Bradshaw CS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003618; Bradshaw CS, 2006, EMERG INFECT DIS, V12, P1149, DOI 10.3201/eid1207.051558; Buhrer-Skinner M, 2009, SEX HEALTH, V6, P51, DOI 10.1071/SH08019; Cabada MM, 2011, TRAVEL MED INFECT DI, V9, P75, DOI 10.1016/j.tmaid.2011.02.002; Cabada MM, 2003, J TRAVEL MED, V10, P214, DOI 10.2310/7060.2003.40508; Cabada MM, 2002, SEX TRANSM DIS, V29, P510, DOI 10.1097/00007435-200209000-00003; Cornall AM, 2013, INT J CANCER, V133, P2253, DOI 10.1002/ijc.28228; Couldwell DL, 2013, INT J STD AIDS, V24, P822, DOI 10.1177/0956462413502008; Couldwell DL, 2015, INFECT DRUG RESISTAN, V8; Daley GM, 2014, INT J STD AIDS, V25, P475, DOI 10.1177/0956462413515196; Daley GM, 2014, SEX HEALTH, V11, P587, DOI 10.1071/SH14147; Davies SC, 2011, INT J STD AIDS, V22, P160, DOI 10.1258/ijsa.2010.010354; Davies SC, 2013, SEX HEALTH, V10, P185, DOI 10.1071/SH12136; Fischer JA, 2015, ASIA-PAC J PUBLIC HE, V27; Gesink D, 2016, CANADIAN FAMILY PHYS, V62; Gesink DC, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18203; HAWKES S, 1994, AIDS, V8, P247, DOI 10.1097/00002030-199402000-00013; HAWKES S, 1995, GENITOURIN MED, V71, P351; Henning D, 2014, INT J STD AIDS, V25, P299, DOI 10.1177/0956462413502317; Horner P, 2016, INT J STD AIDS, V27, P85, DOI 10.1177/0956462415586675; Horner P, 2014, CURR OPIN INFECT DIS, V27, P68, DOI 10.1097/QCO.0000000000000030; Horner PJ, 2011, SEX TRANSM INFECT, V87, P38, DOI 10.1136/sti.2010.044487; Horner PJ, 2002, INT J STD AIDS, V13, P667, DOI 10.1258/095646202760326408; Hughes K, 2009, SEX TRANSM INFECT, V85, P477, DOI 10.1136/sti.2009.036921; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Leung A, 2006, INT J STD AIDS, V17, P285, DOI 10.1258/095646206776790231; Lillis RA, 2011, J CLIN MICROBIOL, V49, P1990, DOI 10.1128/JCM.00129-11; Lis R, 2015, CLIN INFECT DIS, V61, P418, DOI 10.1093/cid/civ312; Lusk MJ, 2016, SEX TRANSM INFECT, V92, P175, DOI 10.1136/sextrans-2015-052332; Manhart LE, 2013, INFECT DIS CLIN N AM, V27, P779, DOI 10.1016/j.idc.2013.08.003; Manhart LE, 2011, CLIN INFECT DIS, V53, pS129, DOI 10.1093/cid/cir702; McNulty AM, 2010, SEX TRANSM INFECT, V86, P247, DOI 10.1136/sti.2009.038737; Ona Samsiya, 2016, Infect Dis Obstet Gynecol, V2016, P4513089, DOI 10.1155/2016/4513089; Rane VS, 2014, J CLIN MICROBIOL, V52, P2971, DOI 10.1128/JCM.00899-14; RESNICK RM, 1990, JNCI-J NATL CANCER I, V82, P1477, DOI 10.1093/jnci/82.18.1477; Salado-Rasmussen K, 2014, CLIN INFECT DIS, V59, P24, DOI 10.1093/cid/ciu217; Sena AC, 2012, J INFECT DIS, V206, P357, DOI 10.1093/infdis/jis356; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Tabrizi SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156740; Tabrizi SN, 2005, SEX TRANSM DIS, V32, P199, DOI 10.1097/01.olq.0000154495.24519.bf; Tagg KA, 2013, J CLIN MICROBIOL, V51, P2245, DOI 10.1128/JCM.00495-13; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Therapeutic Guidelines Limited, 2015, ETG COMPL MARCH; Tourism Australia, 2011, BACKP UNC WHAT TRAV; Trembizki E, 2017, J MED MICROBIOL, V66, P1451, DOI 10.1099/jmm.0.000584; Twin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035593; Vajdic Claire M, 2005, Sex Health, V2, P169, DOI 10.1071/SH05018; van der Veer C, 2016, SEX TRANSM INFECT, V92, P83, DOI 10.1136/sextrans-2015-052118; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; Walker J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-35; Wand H, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000004; Wetmore CM, 2011, SEX TRANSM DIS, V38, P180, DOI 10.1097/OLQ.0b013e3182040de9; Whiley DM, 2004, EUR J CLIN MICROBIOL, V23, P705, DOI 10.1007/s10096-004-1170-0; Wroblewski JKH, 2006, J CLIN MICROBIOL, V44, P3306, DOI 10.1128/JCM.00553-06; Zheng HP, 2015, SEX TRANSM DIS, V42, P115, DOI 10.1097/OLQ.0000000000000241	60	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202428	10.1371/journal.pone.0202428	http://dx.doi.org/10.1371/journal.pone.0202428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153259	Green Published, Green Accepted, gold			2022-12-27	WOS:000443001700015
J	Sakai, D; Nakai, T; Hiraishi, S; Nakamura, Y; Ando, K; Naiki, M; Watanabe, M				Sakai, Daisuke; Nakai, Tomoko; Hiraishi, Shunsuke; Nakamura, Yoshihiko; Ando, Kiyoshi; Naiki, Mitsuru; Watanabe, Masahiko			Upregulation of glycosaminoglycan synthesis by Neurotropin in nucleus pulposus cells via stimulation of chondroitin sulfate N-acetylgalactosaminyltransferase 1: A new approach to attenuation of intervertebral disc degeneration	PLOS ONE			English	Article							LOW-BACK-PAIN; MESENCHYMAL STEM-CELLS; IN-VITRO; GROWTH-FACTOR; AGGRECAN; DIFFERENTIATION; EXPRESSION; PHENOTYPE; EFFICACY; PATHWAY	It is suggested that most cases of low back pain are related to degeneration of intervertebral discs. Disc degeneration is a chronic and progressive disease and the search for effective medical treatments continues. Neurotropin is widely used in Japan and China to treat low back pain and neck-shoulder-arm syndrome. The present study aimed to investigate the effect of Neurotropin on glycosaminoglycan synthesis in nucleus pulposus cells. Cultured human nucleus pulposus cells were treated with Neurotropin every second day for two weeks. Production of glycosaminoglycan was assessed using a dimethyl-methylene blue assay and PicoGreen was used to measure DNA content. Microarray analysis, real-time PCR, and western blotting were performed to assess the biological processes related to Neurotropin-stimulated glycosaminoglycan synthesis. The results showed that the level of glycosaminoglycan normalized to DNA content was significantly upregulated by the addition of Neurotropin. Gene expression profiling showed over two-fold upregulation of 697 genes in response to Neurotropin treatment. Among these genes, ontological analysis suggested significant implication of phosphatidylinositol 3-kinase signaling, and analysis focused on this pathway demonstrated marked upregulation of angiopoietin 1 and insulin-like growth factor 1. Activation of phosphorylation of the signal transducer protein AKT was detected by western blotting. Of the genes related to sulfated glycosaminoglycan synthesis, the greatest increase in mRNA levels was observed for chondroitin sulfate N-acetylgalactosaminyltransferase 1, an enzyme initiating synthesis of chondroitin sulfate side chains attached to a core protein of aggrecan, which is a predominant disc matrix component. These findings suggest that Neurotropin may activate the phosphatidylinositol 3-kinase-AKT pathway and stimulate glycosaminoglycan synthesis through upregulation of expression of mRNA for chondroitin sulfate N-acetylgalactosaminyltransferase 1. Because there was no cytotoxic cellular growth inhibition, Neurotropin treatment might offer an accessible therapeutic strategy for intervertebral disc degeneration.	[Sakai, Daisuke; Nakai, Tomoko; Hiraishi, Shunsuke; Watanabe, Masahiko] Tokai Univ, Sch Med, Dept Orthopaed Surg Surg Sci, Isehara, Kanagawa, Japan; [Sakai, Daisuke; Nakamura, Yoshihiko; Ando, Kiyoshi] Tokai Univ, Sch Med, Res Ctr Regenerat Med & Canc Stem Cell, Isehara, Kanagawa, Japan; [Naiki, Mitsuru] Nippon Zoki Pharmaceut Co Ltd, Inst Bioact Sci, Kato, Hyogo, Japan	Tokai University; Tokai University	Sakai, D (corresponding author), Tokai Univ, Sch Med, Dept Orthopaed Surg Surg Sci, Isehara, Kanagawa, Japan.; Sakai, D (corresponding author), Tokai Univ, Sch Med, Res Ctr Regenerat Med & Canc Stem Cell, Isehara, Kanagawa, Japan.	daisakai1@gmail.com	Sakai, Daisuke/X-9164-2019	Sakai, Daisuke/0000-0003-4189-9270; Nakai, Tomoko/0000-0003-2800-8568	Nippon Zoki Pharmaceutical Company Ltd.	Nippon Zoki Pharmaceutical Company Ltd.	The authors received a research grant from Nippon Zoki Pharmaceutical Company Ltd. (http://www.nippon-zoki.co.jp/). The funder provided support in the form of a salary for an author TN and contributed to decision to publish this work. The specific role of the author is articulated in the author contributions section.	Ambs S, 1999, CANCER RES, V59, P5773; Anderson DG, 2005, SPINE, V30, pS14, DOI 10.1097/01.brs.0000175174.50235.ba; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Chothe PP, 2013, SPINE J, V13, P549, DOI 10.1016/j.spinee.2013.01.022; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2017, ANN INTERN MED, V166, P480, DOI 10.7326/M16-2458; DEREUCK J, 1994, ACTA NEUROCHIR, P332; Fujita N, 2008, BIOCHEM BIOPH RES CO, V372, P367, DOI 10.1016/j.bbrc.2008.05.044; Greene MA, 2015, OSTEOARTHR CARTILAGE, V23, P949, DOI 10.1016/j.joca.2015.01.014; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jimbo K, 2005, J NEUROSURG-SPINE, V2, P589, DOI 10.3171/spi.2005.2.5.0589; Johnson WEB, 2005, SPINE, V30, P1139, DOI 10.1097/01.brs.0000162624.95262.73; Johnson WEB, 2002, ARTHRITIS RHEUM-US, V46, P2658, DOI 10.1002/art.10585; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kivitz AJ, 2013, PAIN, V154, P1009, DOI 10.1016/j.pain.2013.03.006; Krock E, 2016, J BIOL CHEM, V291, P3541, DOI 10.1074/jbc.M115.675900; Liu XB, 2008, ACTA PHARMACOL SIN, V29, P815, DOI 10.1111/j.1745-7254.2008.00811.x; Loeser RF, 2014, ARTHRITIS RHEUMATOL, V66, P2201, DOI 10.1002/art.38641; Masuguchi K, 2014, LIFE SCI, V98, P49, DOI 10.1016/j.lfs.2013.12.229; Nakai T, 2016, J ORTHOP RES, V34, P1361, DOI 10.1002/jor.23326; Nishiyama Tomoki, 2006, J Anesth, V20, P240, DOI 10.1007/s00540-006-0399-4; O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608; OHSHIMA H, 1995, J ORTHOPAED RES, V13, P22, DOI 10.1002/jor.1100130106; Ohtori S, 2015, SPINE J, V15, P1347, DOI 10.1016/j.spinee.2013.07.490; Okada M, 2002, INTERNAL MED, V41, P498, DOI 10.2169/internalmedicine.41.498; Okada T, 1997, ACTA PAEDIATR JAPON, V39, P690; Okazaki R, 2008, ANESTH ANALG, V107, P1064, DOI 10.1213/ane.0b013e31817e7a59; Okuda S, 2001, SPINE, V26, P2421, DOI 10.1097/00007632-200111150-00005; Risbud MV, 2015, J ORTHOP RES, V33, P283, DOI 10.1002/jor.22789; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; SCHWARTZ ER, 1977, J CLIN INVEST, V60, P96, DOI 10.1172/JCI108774; Sivan SS, 2014, BBA-GEN SUBJECTS, V1840, P3181, DOI 10.1016/j.bbagen.2014.07.013; Sun Y, 2015, OSTEOARTHR CARTILAGE, V23, P1194, DOI 10.1016/j.joca.2015.02.166; Tang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052020; Tao YQ, 2015, GROWTH FACTORS, V33, P326, DOI 10.3109/08977194.2015.1088532; Toda K, 2008, PAIN MED, V9, P460, DOI 10.1111/j.1526-4637.2007.00279.x; Walsh AJL, 2004, SPINE, V29, P156, DOI 10.1097/01.BRS.0000107231.67854.9F; Yamazaki Y, 2011, J HEADACHE PAIN, V12, P661, DOI 10.1007/s10194-011-0382-9; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838; Yoshida T, 2008, J NEUROSURG-SPINE, V9, P411, DOI 10.3171/SPI.2008.9.11.411; Yoshikawa T, 2011, SPINE J M ABSTRACTS; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114071; Zhang RX, 2012, INT J COLORECTAL DIS, V27, P1645, DOI 10.1007/s00384-012-1509-4; Zhu Mengye, 2017, J Pain Res, V10, P1391, DOI 10.2147/JPR.S135037	45	10	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202640	10.1371/journal.pone.0202640	http://dx.doi.org/10.1371/journal.pone.0202640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148873	Green Submitted, Green Published, gold			2022-12-27	WOS:000442804200017
J	Chen, X; Yang, YZ; Katz, SI				Chen, Xiao; Yang, Yizeng; Katz, Sharyn, I			Dexamethasone pretreatment impairs the thymidylate synthase inhibition mediated flare in thymidine salvage pathway activity in non-small cell lung cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HUMAN TUMOR-CELLS; IN-VIVO; PET; 5-FLUOROURACIL; VALIDATION; METABOLISM; EXPRESSION; TRANSPORT	Introduction Successful inhibition of thymidylate synthase (TS) by pemetrexed, a TS inhibitor, results in a reproducible transient burst or "flare" in thymidine salvage pathway activity at 2 hrs. of therapy which can be measurable with FLT-PET ([18F]fluorothymidine-positron emission tomography) in non-small cell lung cancer (NSCLC). Routine administration of dexamethasone with pemetrexed-based therapy could potentially confound this imaging approach since dexamethasone is known to inhibit expression of thymidine kinase 1, a key enzyme in the thymidine salvage pathway. Here we examine the potential impact of dexamethasone on the TS inhibition-mediated thymidine salvage pathway "flare" in NSCLC. Materials and methods In order to determine NSCLC cell line sensitivity to dexamethasone and pemetrexed, IC50 studies were performed on NSCLC cell lines H23, H1975, H460, H1299. TS inhibition-mediated "flare" in thymidine salvage pathway activity was then measured at 2hrs. of exposure to pemetrexed and cisplatin in NSCLC cells lines following using H-3-thymidine incorporation assays under the following conditions: control (no chemotherapy or dexamethasone), or treated with pemetrexed and cisplatin without dexamethasone, with 24 hrs. pre-treatment of dexamethasone or with dexamethasone administered together with chemotherapy. These conditions were chosen to model the delivery of pemetrexed-based therapy in the clinic. Results The IC50 of H23, H1975, H460, H1299 for dexamethasone and pemetrexed were 40, 5.9, 718, 362 mu M and 0.22, 0.73, 0.14 and 0.66 mu M respectively. Significant blunting of the thymidine salvage pathway "flare" is observed at 2hrs. of pemetrexed-based therapy when dexamethasone sensitive cell lines H23 and H1975 were pretreated with dexamethasone but not when dexamethasone was given together with pemetrexed therapy or in the setting of dexamethasone resistance (H460 and H1299). Conclusion 24 hr. pretreatment with dexamethasone, but not same day co-administration of dexamethasone with therapy, impairs the TS inhibition-mediated "flare" in thymidine salvage pathway activity in NSCLC.	[Chen, Xiao; Katz, Sharyn, I] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chen, Xiao] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing, Peoples R China; [Yang, Yizeng] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Army Medical University; University of Pennsylvania; Pennsylvania Medicine	Katz, SI (corresponding author), Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	Sharyn.Katz@uphs.upenn.edu	Katz, Sharyn/AAK-1408-2020	Katz, Sharyn/0000-0001-9816-2291	Department of Defense, Lung Cancer Research Program, Career Development Award [W81XWH-14-1-0197]; Department of Radiology, University of Pennsylvania Perelman School of Medicine	Department of Defense, Lung Cancer Research Program, Career Development Award; Department of Radiology, University of Pennsylvania Perelman School of Medicine	This project was supported by the Department of Defense, Lung Cancer Research Program, Career Development Award, (W81XWH-14-1-0197 to S.K.), http://cdmrp.army.mil/lcrp/default; and through the Department of Radiology, University of Pennsylvania Perelman School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buxant F, 2015, MOL MED REP, V12, P4051, DOI 10.3892/mmr.2015.3920; Chen X, 2017, ONCOTARGET, V8, P82705, DOI 10.18632/oncotarget.19751; Chen X, 2017, ONCOTARGET, V8, P24213, DOI 10.18632/oncotarget.12085; Chouhan Jyoti D, 2011, J Oncol Pharm Pract, V17, P155, DOI 10.1177/1078155210367950; Elsoueidi R, 2016, J ONCOL PHARM PRACT, V22, P271, DOI 10.1177/1078155215583523; Frings V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063705; FROST GH, 1993, J BIOL CHEM, V268, P6748; Greenberg AK, 2002, AM J RESP CELL MOL, V27, P320, DOI 10.1165/rcmb.4710; Grierson JR, 2004, NUCL MED BIOL, V31, P829, DOI 10.1016/j.nucmedbio.2004.06.004; Hong YS, 2013, J NUCL MED, V54, P1209, DOI 10.2967/jnumed.112.117010; Lee SJ, 2010, BIOCHEM PHARMACOL, V80, P1528, DOI 10.1016/j.bcp.2010.08.004; McHugh C, 2018, J NUCL MED, DOI [10.2967/jnumed.117, DOI 10.2967/JNUMED.117]; McHugh CI, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0092-2; Muzi M, 2005, J NUCL MED, V46, P274; Patki M, 2014, J THORAC ONCOL, V9, P519, DOI 10.1097/JTO.0000000000000111; Perumal M, 2006, CANCER RES, V66, P8558, DOI 10.1158/0008-5472.CAN-06-0898; Plotnik DA, 2012, NUCL MED BIOL, V39, P970, DOI 10.1016/j.nucmedbio.2012.03.009; Plotnik DA, 2010, J NUCL MED, V51, P1464, DOI 10.2967/jnumed.110.076794; PRESSACCO J, 1995, CANCER RES, V55, P1505; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Wells P, 2003, JNCI-J NATL CANCER I, V95, P675, DOI 10.1093/jnci/95.9.675	22	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202384	10.1371/journal.pone.0202384	http://dx.doi.org/10.1371/journal.pone.0202384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142195	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500013
J	Fowler, DN; Webb, EB; Baldwin, FB; Vrtiska, MP; Hobson, KA				Fowler, Drew N.; Webb, Elisabeth B.; Baldwin, Frank B.; Vrtiska, Mark P.; Hobson, Keith A.			A multi-isotope (delta C-13, delta N-15, delta S-34, delta H-2) approach to establishing migratory connectivity in lesser snow geese: Tracking an overabundant species	PLOS ONE			English	Article							STABLE-ISOTOPES; HYDROGEN; WINTER; NUTRITION; ORIGINS; GROUNDS; SULFUR; BIRDS; DIETS; C-13	Expanding populations of North American midcontinent lesser snow geese (Anser caerulescens caerulescens) have potential to alter ecosystems throughout the Arctic and subarctic where they breed. Efforts to understand origins of harvested lesser snow geese to better inform management decisions have traditionally required mark-recapture approaches, while aerial photographic surveys have typically been used to identify breeding distributions. As a potential alternative, isotopic patterns that are metabolically fixed within newly grown flight feathers following summer molting could provide inferences regarding geographic breeding origin of individuals, without the need for prior capture. Our objective was to assess potential to use four stable isotopes (delta C-13, delta N-15, delta S-34, delta H-2) from feather material to determine breeding origins. We obtained newly grown flight feathers from individuals during summer banding at three Arctic and two subarctic breeding colonies in 2014 (n = 56) and 2016 (n = 45). We used linear discriminant analyses to predict breeding origins from models using combinations of stable isotopes as predictors and evaluated model accuracy when predicting colony, subregion, or subpopulation levels. We found a strong inverse relationship between delta H-2 values and increasing latitude (R-2 = 0.83), resulting in differences (F-4,F- 51 = 90.41, P < 0.0001) among sampled colonies. No differences in delta C-13 or delta N-15 were detected among colonies, although delta S-34 in Akimiski Island, Baffin Island, and Karrak Lake were more enriched (F4, 51 = 11.25, P < 0.0001). Using delta H-2 values as a predictor, discriminant analyses improved accuracy in classification level as precision decreased [model accuracy = 67% (colony), 88% (subregion), 94% (subpopulation)]. Application of the isotopic methods we describe could be used to provide an alternative monitoring method of population metrics, such as overall breeding population distribution, region-specific productivity and migratory connectivity that are informative to management decision makers and provide insight into cross-seasonal effects that may influence migratory behavior.	[Fowler, Drew N.] Univ Missouri, Sch Nat Resources, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO 65211 USA; [Webb, Elisabeth B.] Univ Missouri, Sch Nat Resources, US Geol Survey, Missouri Cooperat Fisheries & Wildlife Res Unit, Columbia, MO USA; [Baldwin, Frank B.] Dept Sustainable Dev, Winnipeg, MB, Canada; [Vrtiska, Mark P.] Nebraska Game & Pk Commiss, Lincoln, NE USA; [Hobson, Keith A.] Western Univ, Dept Biol, London, ON, Canada	University of Missouri System; University of Missouri Columbia; United States Department of the Interior; United States Geological Survey; University of Missouri System; University of Missouri Columbia; Western University (University of Western Ontario)	Fowler, DN (corresponding author), Univ Missouri, Sch Nat Resources, Missouri Cooperat Fish & Wildlife Res Unit, Columbia, MO 65211 USA.	dnftgb@mail.missouri.edu	Hobson, Keith/Q-9306-2019	Webb, Lisa/0000-0003-3851-6056	U.S. Fish and Wildlife Service's Sportfish and Wildlife Restoration Program through the Nebraska Game and Parks Commission; Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research; Missouri Department of Conservation; University of Missouri; U.S. Fish and Wildlife Service; U.S. Geological Survey; Wildlife Management Institute	U.S. Fish and Wildlife Service's Sportfish and Wildlife Restoration Program through the Nebraska Game and Parks Commission; Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research; Missouri Department of Conservation; University of Missouri; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey(United States Geological Survey); Wildlife Management Institute	Funding for this project was provided by the U.S. Fish and Wildlife Service's Sportfish and Wildlife Restoration Program through the Nebraska Game and Parks Commission and by Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by the U.S. Fish and Wildlife Service's Sportfish and Wildlife Restoration Program through the Nebraska Game and Parks Commission and by Ducks Unlimited Canada's Institute for Wetland and Waterfowl Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank R. Alisauskas, R. Brook, D. Kellett, J. Leafloor, R. Rockwell and others who collected feathers on breeding colonies for this project. Chantel Gryba prepared samples for isotope analysis and Geoff Koehler performed CNS isotope analyses at the Environment Canada Stable Isotope Laboratory in Saskatoon, SK. The Missouri Cooperative Fish and Wildlife Research Unit is jointly sponsored by the Missouri Department of Conservation, the University of Missouri, the U.S. Fish and Wildlife Service, the U.S. Geological Survey, and the Wildlife Management Institute. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	ABRAHAM K F, 1980, Wildfowl, V31, P89; Abraham K. F., 2012, ARCTIC GOOSE JOINT V; Abraham KF, 2005, GLOBAL CHANGE BIOL, V11, P841, DOI 10.1111/j.1365-2486.2005.00943.x; Alisauskas RT, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.5; Alisauskas RT, 2009, ENVIRON ECOL STAT SE, V3, P463, DOI 10.1007/978-0-387-78151-8_20; ALISAUSKAS RT, 1993, J WILDLIFE MANAGE, V57, P49, DOI 10.2307/3808999; Alisauskas RT, 2002, J WILDLIFE MANAGE, V66, P181, DOI 10.2307/3802884; Batt B., 1997, ARCTIC ECOSYSTEMS PE; Calvert AM, 2017, J WILDLIFE MANAGE, V81, P1009, DOI 10.1002/jwmg.21277; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Central Flyway Council, 2013, MAN GUID CENTR FLYW; Drake NA, 2004, EARTH SURF PROC LAND, V29, P1459, DOI 10.1002/esp.1133; Fox AD, 2009, J AVIAN BIOL, V40, P108, DOI 10.1111/j.1600-048X.2009.04720.x; Hache S, 2012, CAN J ZOOL, V90, P722, DOI 10.1139/Z2012-039; Henaux V, 2012, AVIAN CONSERV ECOL, V7, DOI 10.5751/ACE-00515-070105; Hill RJ, 2003, INFLUENCE BODY SIZE, V67, P530; HOBAUGH WC, 1985, J WILDLIFE MANAGE, V49, P1028, DOI 10.2307/3801390; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hobson KA, PLOS ONE; Hobson KA, 2008, TERRESTIAL ECOLOGY S, V2; Hobson KA, 2015, ECOL EVOL, V5, P799, DOI 10.1002/ece3.1383; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hobson KA, 2009, J APPL ECOL, V46, P572, DOI 10.1111/j.1365-2664.2009.01651.x; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jonsson JE, 2015, SOUTHEAST NAT, V14, P293, DOI 10.1656/058.014.0212; Kerbes RH, 2006, TECHNICAL REPORT SER, V447; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; Leafloor J. O., 2012, ARCTIC GOOSE JOINT V; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Morrissette M, 2010, OIKOS, V119, P1181, DOI 10.1111/j.1600-0706.2009.18079.x; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Paxton KL, 2015, J AVIAN BIOL, V46, P495, DOI 10.1111/jav.00614; Ross MV, 2017, ECOLOGY, V98, P1869, DOI 10.1002/ecy.1856; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Slattery SM, 2007, J WILDLIFE MANAGE, V71, P2230, DOI 10.2193/2005-502; Smith AD, 2005, CONDOR, V107, P547, DOI 10.1650/0010-5422(2005)107[0547:VITSIC]2.0.CO;2; Szymanski ML, 2007, J WILDLIFE MANAGE, V71, P1317, DOI 10.2193/2006-188; Van Wilgenburg Steven L., 2012, Endangered Species Research, V16, P17, DOI 10.3354/esr00383; Vander Zanden HB, 2014, METHODS ECOL EVOL, V5, P891, DOI 10.1111/2041-210X.12229; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Webster Michael S., 2005, P199; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Zazzo A, 2011, RAPID COMMUN MASS SP, V25, P2371, DOI 10.1002/rcm.5131	46	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0203077	10.1371/journal.pone.0203077	http://dx.doi.org/10.1371/journal.pone.0203077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142189	Green Published, gold			2022-12-27	WOS:000442722500060
J	Goldammer, J; Mantziaris, C; Buschges, A; Schmidt, J				Goldammer, Jens; Mantziaris, Charalampos; Bueschges, Ansgar; Schmidt, Joachim			Calcium imaging of CPG-evoked activity in efferent neurons of the stick insect	PLOS ONE			English	Article							UNPAIRED MEDIAN NEURONS; CARAUSIUS-MOROSUS; ELECTRICAL-PROPERTIES; PATTERN GENERATION; MANDUCA-SEXTA; NEUROMODULATORY NEURONS; MOTONEURONAL ACTIVITY; SEARCHING MOVEMENTS; INTRACELLULAR CA2+; PLATEAU POTENTIALS	The stick insect is a well-established experimental animal to study the neural basis of walking. Here, we introduce a preparation that allows combining calcium imaging in efferent neurons with electrophysiological recordings of motor neuron activity in the stick insect thoracic nerve cord. The intracellular free calcium concentration in middle leg retractor coxae motor neurons and modulatory octopaminergic DUM neurons was monitored after backfilling lateral nerve nl5 that contains the axons of these neurons with the calcium indicator Oregon Green BAPTA-1. Rhythmic spike activity in retractor and protractor motor neurons was evoked by pharmacological activation of central pattern generating neuronal networks and recorded extracellularly from lateral nerves. A primary goal of this study was to investigate whether changes in the intracellular free calcium concentration observed in motor neurons during oscillatory activity depend on action potentials. We show that rhythmic spike activity in leg motor neurons induced either pharmacologically or by tactile stimulation of the animal is accompanied by a synchronous modulation in the intracellular free calcium concentration. Calcium oscillations in motor neurons do not appear to depend on calcium influx through voltage-sensitive calcium channels that are gated by action potentials because Calcium oscillations persist after pharmacologically blocking action potentials in the motor neurons. Calcium oscillations were also apparent in the modulatory DUM neurons innervating the same leg muscle. However, the timing of calcium oscillations varied not only between DUM neurons and motor neurons, but also among different DUM neurons. Therefore, we conclude that the motor neurons and the different DUM neurons receive independent central drive.	[Goldammer, Jens; Mantziaris, Charalampos; Bueschges, Ansgar; Schmidt, Joachim] Univ Cologne, Bioctr Cologne, Inst Zool, Anim Physiol, Cologne, Germany; [Goldammer, Jens] Univ Cologne, Bioctr Cologne, Inst Zool, Expt Morphol, Cologne, Germany	University of Cologne; University of Cologne	Schmidt, J (corresponding author), Univ Cologne, Bioctr Cologne, Inst Zool, Anim Physiol, Cologne, Germany.	jachim.schmidt@uni-koeln.de		Buschges, Ansgar/0000-0003-2123-1900; Mantziaris, Charalampos/0000-0003-2280-1733; Goldammer, Jens/0000-0002-5623-8339	DFG [SCHM 1084/3-1]; BMBF/NFS [CRCNS 01GQ1412]; Fellowships of the GSfBS	DFG(German Research Foundation (DFG)); BMBF/NFS; Fellowships of the GSfBS	This research was supported by DFG grant SCHM 1084/3-1 to JS, http://www.dfg.de/en/index.jsp; the BMBF/NFS (CRCNS 01GQ1412) grant to AB, https://www.bmbf.de/en/index.html; and the Fellowships of the GSfBS to JG and CM, http://www.gs-biosciences.uni-koeln.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden T, 2009, EUR J NEUROSCI, V29, P1357, DOI 10.1111/j.1460-9568.2009.06694.x; BASSLER U, 1986, PHYSIOL ENTOMOL, V11, P359, DOI 10.1111/j.1365-3032.1986.tb00426.x; BASSLER U, 1983, J EXP BIOL, V105, P127; Bassler U, 1998, BRAIN RES REV, V27, P65, DOI 10.1016/S0165-0173(98)00006-X; Baudoux S, 1998, J NEUROPHYSIOL, V79, P361, DOI 10.1152/jn.1998.79.1.361; BENNETT DL, 1995, CURR BIOL, V5, P1225, DOI 10.1016/S0960-9822(95)00243-0; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bidaye SS, 2018, J NEUROPHYSIOL, V119, P459, DOI 10.1152/jn.00658.2017; Blivis D, 2012, JOVE-J VIS EXP, DOI 10.3791/4008; Bonnot AS, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0001.2002; Braunig P, 2001, ADV INSECT PHYSIOL, V28, P185, DOI 10.1016/S0065-2806(01)28011-4; Buschges A, 2008, BRAIN RES REV, V57, P162, DOI 10.1016/j.brainresrev.2007.06.028; BUSCHGES A, 1995, J EXP BIOL, V198, P435; BUSCHGES A, 1989, J EXP BIOL, V144, P81; Buschges A, 2004, EUR J NEUROSCI, V19, P1856, DOI 10.1111/j.1460-9568.2004.03312.x; Buschges A, 1998, BRAIN RES, V783, P262, DOI 10.1016/S0006-8993(97)01370-X; Buschges A., 2015, E NEUROFORUM, V6, P105, DOI [10.1007/s13295-015-0017-8, DOI 10.1007/S13295-015-0017-8]; Cherniak M, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00143; CHRACHRI A, 1987, NEUROSCI LETT, V77, P49, DOI 10.1016/0304-3940(87)90605-7; De Sinety R., 1901, B SOC ENTOMOL FRANCE, P255; Duch C, 2002, J NEUROPHYSIOL, V87, P1415, DOI 10.1152/jn.00524.2001; Edwards DH, 2017, NEUROBIOLOGY MOTOR C, P263; EVANS PD, 1977, NATURE, V270, P257, DOI 10.1038/270257a0; EVANS PD, 1982, J PHYSIOL-LONDON, V324, P93, DOI 10.1113/jphysiol.1982.sp014102; Fischer H, 2001, J NEUROPHYSIOL, V85, P341, DOI 10.1152/jn.2001.85.1.341; Fuchs E, 2011, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00125; Fushiki A, 2016, ELIFE, V5, DOI 10.7554/eLife.13253; Gobel W, 2007, PHYSIOLOGY, V22, P358, DOI 10.1152/physiol.00032.2007; Goldammer J, 2012, J COMP NEUROL, V520, P230, DOI 10.1002/cne.22676; GOODMAN CS, 1979, J EXP BIOL, V83, P95; GRAHAM D, 1985, ADV INSECT PHYSIOL, V18, P31; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Grillner S, 2015, CURR OPIN NEUROBIOL, V31, P244, DOI 10.1016/j.conb.2015.01.003; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; HALE JP, 1985, J EXP BIOL, V117, P401; Harris-Warrwick RM, 2017, NEUROBIOLOGY MOTOR C, P225; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Hinckley CA, 2015, NEURON, V87, P1008, DOI 10.1016/j.neuron.2015.08.005; Hinckley CA, 2013, ANN NY ACAD SCI, V1279, P71, DOI 10.1111/nyas.12092; HOUNSGAARD J, 1993, J PHYSIOL-LONDON, V468, P245, DOI 10.1113/jphysiol.1993.sp019769; HOYLE G, 1975, J EXP ZOOL, V193, P425, DOI 10.1002/jez.1401930321; HOYLE G, 1978, J NEUROBIOL, V9, P43, DOI 10.1002/neu.480090105; Hultborn H, 1999, PROG BRAIN RES, V123, P39, DOI 10.1016/S0079-6123(08)62842-3; Hultborn H, 2013, CURR PHARM DESIGN, V19, P4357, DOI 10.2174/1381612811319240004; Ivanov AI, 2000, J NEUROSCI, V20, P4930; Johnston RM, 1996, J NEUROPHYSIOL, V76, P3178, DOI 10.1152/jn.1996.76.5.3178; Johnston RM, 1999, J EXP BIOL, V202, P103; Kadas D, 2017, J NEUROSCI, V37, P10971, DOI 10.1523/JNEUROSCI.1064-17.2017; KIEHN O, 1991, TRENDS NEUROSCI, V14, P68, DOI 10.1016/0166-2236(91)90023-N; Knopfel T, 2012, NAT REV NEUROSCI, V13, P687, DOI 10.1038/nrn3293; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Ludwar BC, 2005, J NEUROPHYSIOL, V94, P2772, DOI 10.1152/jn.00493.2005; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; McLean DL, 2011, CURR OPIN NEUROBIOL, V21, P110, DOI 10.1016/j.conb.2010.09.011; Mentel T, 2008, J INSECT PHYSIOL, V54, P51, DOI 10.1016/j.jinsphys.2007.08.010; Messutat S, 2001, CELL CALCIUM, V30, P199, DOI 10.1054/ceca.2001.0227; Mills JD, 1997, J NEUROPHYSIOL, V78, P2455, DOI 10.1152/jn.1997.78.5.2455; Oliveira EE, 2010, J NEUROPHYSIOL, V103, P2770, DOI 10.1152/jn.00963.2009; Orlovsky G, 1999, NEURAL CONTROL LOCOM; Pfluger HJ, 2005, ARTHROPOD STRUCT DEV, V34, P379, DOI 10.1016/j.asd.2005.04.004; PITMAN RM, 1988, J EXP BIOL, V135, P95; PITMAN RM, 1975, J PHYSIOL-LONDON, V247, P511, DOI 10.1113/jphysiol.1975.sp010944; Portugues R, 2013, CURR OPIN NEUROBIOL, V23, P119, DOI 10.1016/j.conb.2012.11.001; Pulver SR, 2015, J NEUROPHYSIOL, V114, P2564, DOI 10.1152/jn.00731.2015; RYCKEBUSCH S, 1993, J NEUROPHYSIOL, V69, P1583, DOI 10.1152/jn.1993.69.5.1583; Ryglewski S, 2007, PLOS BIOL, V5, P818, DOI 10.1371/journal.pbio.0050066; Ryglewski S, 2012, J PHYSIOL-LONDON, V590, P809, DOI 10.1113/jphysiol.2011.222836; Schmidt J, 2001, J NEUROPHYSIOL, V85, P354, DOI 10.1152/jn.2001.85.1.354; SCHMITZ J, 1988, COMP BIOCHEM PHYS A, V91, P769, DOI 10.1016/0300-9629(88)90963-2; Simpson JH, 2018, GENETICS, V208, P1291, DOI 10.1534/genetics.117.300228; Streit AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148461; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; Sun XNR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3170; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; TSIEN RY, 1990, CELL CALCIUM, V11, P93, DOI 10.1016/0143-4160(90)90063-Z; Tuschick S., 1994, THESIS; WALZ B, 1995, J GEN PHYSIOL, V105, P537, DOI 10.1085/jgp.105.4.537; WEIDLER DJ, 1969, Z VERGL PHYSIOL, V64, P372, DOI 10.1007/BF00340433; Westmark S, 2009, J NEUROPHYSIOL, V102, P1049, DOI 10.1152/jn.91360.2008; Zwart MF, 2016, NEURON, V91, P615, DOI 10.1016/j.neuron.2016.06.031	81	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202822	10.1371/journal.pone.0202822	http://dx.doi.org/10.1371/journal.pone.0202822			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142206	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500037
J	Chatterjee, R; Davenport, CA; Raffield, LM; Maruthur, N; Lange, L; Selvin, E; Butler, K; Yeh, HC; Wilson, JG; Correa, A; Edelman, D; Hauser, E				Chatterjee, Ranee; Davenport, Clemontina A.; Raffield, Laura M.; Maruthur, Nisa; Lange, Leslie; Selvin, Elizabeth; Butler, Kenneth; Yeh, Hsin-Chieh; Wilson, James G.; Correa, Adolfo; Edelman, David; Hauser, Elizabeth			KCNJ11 variants and their effect on the association between serum potassium and diabetes risk in the Atherosclerosis Risk in Communities (ARIC) Study and Jackson Heart Study (JHS) cohorts	PLOS ONE			English	Article							K-ATP CHANNELS; GLUCOSE-INTOLERANCE; THIAZIDE DIURETICS; TYPE-2; POLYMORPHISM; POPULATION; PREVENTION; VARIANTS; MELLITUS; DISEASE	Background In the Atherosclerosis Risk in Communities (ARIC) Study and Jackson Heart Study (JHS) cohorts, serum potassium (K) is an independent predictor of diabetes risk, particularly among African-American participants. Experimental studies show that serum K levels affects insulin secretion. The KCNJ11 gene encodes for a K channel that regulates insulin secretion and whose function is affected by serum K levels. Variants in KCNJ11 are associated with increased diabetes risk. We hypothesized that there could be a gene-by-environment interaction between KCNJ11 variation and serum K on diabetes risk. Methods Evaluating a combined cohort of ARIC and JHS participants, we sought to determine if KCNJ11 variants are risk factors for diabetes; and if KCNJ11 variants modify the association between serum K and diabetes risk. Among participants without diabetes at baseline, we performed multivariable logistic regression to determine the effect of serum K, KCNJ11 variants, and their interactions on the odds of incident diabetes mellitus over 8-9 years in the entire cohort and by race. Results Of 11,812 participants, 3220 (27%) participants developed diabetes. 48% and 47% had 1 or 2 diabetes risk alleles of rs5215 and rs5219, respectively. Caucasians had higher proportions of these risk alleles compared to African Americans (60% vs 17% for rs5215 and 60% vs 13% for rs5219, p<0.01). Serum K was a significant independent predictor of incident diabetes. Neither rs5215 nor rs5219 was associated with incident diabetes. In multivariable models, we found no statistically significant interactions between race and either rs5215 or rs5219 (P-values 0.493 and 0.496, respectively); nor between serum K and either rs5215 or rs5219 on odds of incident diabetes (P-values 0.534 and 0.687, respectively). Conclusion In this cohort, rs5215 and rs5219 of KCNJ11 were not significant predictors of incident diabetes nor effect modifiers of the association between serum K and incident diabetes.	[Chatterjee, Ranee; Davenport, Clemontina A.; Edelman, David; Hauser, Elizabeth] Duke Univ, Durham, NC 27708 USA; [Raffield, Laura M.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Maruthur, Nisa; Selvin, Elizabeth; Yeh, Hsin-Chieh] Johns Hopkins Univ, Baltimore, MD USA; [Lange, Leslie] Univ Colorado, Denver, CO 80202 USA; [Butler, Kenneth; Wilson, James G.; Correa, Adolfo] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of Colorado System; University of Colorado Denver; University of Mississippi; University of Mississippi Medical Center	Chatterjee, R (corresponding author), Duke Univ, Durham, NC 27708 USA.	ranee.chatterjee@duke.edu	Butler, Kenneth Ray/S-3328-2019; Correa, Adolfo/E-7883-2011	Correa, Adolfo/0000-0002-9501-600X; Hauser, Elizabeth/0000-0003-0367-9189; Raffield, Laura/0000-0002-7892-193X; Edelman, David/0000-0001-7112-6151	NIH/Duke Clinical and Translational Science Awards [KL2TR001115-02]; National Center for Advancing Translational Sciences (NCATS) [UL1TR001117]; Johns Hopkins-University of Maryland Diabetes Research Center [P30DK079637]; National Institute of General Medical Sciences [U54GM115428]; NIH [T32 HL129982]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001115] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL129982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, P30DK096493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115428] Funding Source: NIH RePORTER	NIH/Duke Clinical and Translational Science Awards; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Johns Hopkins-University of Maryland Diabetes Research Center; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Chatterjee was supported by a NIH/Duke Clinical and Translational Science Awards KL2TR001115-02. Dr. Davenport was partially supported by UL1TR001117 from the National Center for Advancing Translational Sciences (NCATS). Dr. Yeh was supported by the Johns Hopkins-University of Maryland Diabetes Research Center grant (P30DK079637). Dr. James Wilson is supported by U54GM115428 from the National Institute of General Medical Sciences. Dr. Laura Raffield was funded by NIH (T32 HL129982) as she assisted with additional requested analyses in the Jackson Heart Study.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2016, CLIN J AM SOC NEPHRO, V11, P1384, DOI 10.2215/CJN.13111215; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Babenko AP, 1998, CIRC RES, V83, P1132, DOI 10.1161/01.RES.83.11.1132; Barzilay JI, 2006, ARCH INTERN MED, V166, P2191, DOI 10.1001/archinte.166.20.2191; Bressler J, 2017, AM J MED GENET B, V174, P269, DOI 10.1002/ajmg.b.32509; Brunetti A, 2014, WORLD J DIABETES, V5, P128, DOI 10.4239/wjd.v5.i2.128; Burke TA, 2007, PHARMACOEPIDEM DR S, V16, P979, DOI 10.1002/pds.1444; Carpenter MA, 2004, AM J MED SCI, V328, P131, DOI 10.1097/00000441-200409000-00001; Chatterjee R, 2017, AM J CLIN NUTR, V105, P442, DOI 10.3945/ajcn.116.143255; Chatterjee R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157252; Chatterjee R, 2014, J GEN INTERN MED, V29, P290, DOI 10.1007/s11606-013-2569-z; Chatterjee R, 2011, AM J CLIN NUTR, V93, P1087, DOI 10.3945/ajcn.110.007286; Chatterjee R, 2010, ARCH INTERN MED, V170, P1745, DOI 10.1001/archinternmed.2010.362; Doenyas-Barak K, 2014, DIABETES VASC DIS RE, V11, P103, DOI 10.1177/1479164114521227; Florez JC, 2007, DIABETES, V56, P531, DOI 10.2337/db06-0966; Fuqua SR, 2005, ETHNIC DIS, V15, pS18; Gong B, 2012, DNA CELL BIOL, V31, P801, DOI 10.1089/dna.2011.1445; GORDEN P, 1973, DIABETES, V22, P544, DOI 10.2337/diab.22.7.544; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Heianza Y, 2011, DIABETOLOGIA, V54, P762, DOI 10.1007/s00125-010-2029-9; HELDERMAN JH, 1983, DIABETES, V32, P106, DOI 10.2337/diabetes.32.2.106; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Meisinger C, 2013, DIABETOLOGIA, V56, P484, DOI 10.1007/s00125-012-2786-8; Ng MCY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004517; Qiu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093961; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Schwanstecher C, 2002, DIABETES, V51, pS363, DOI 10.2337/diabetes.51.2007.S363; Shafi T, 2008, HYPERTENSION, V52, P1022, DOI 10.1161/HYPERTENSIONAHA.108.119438; Taylor EN, 2006, DIABETES CARE, V29, P1065, DOI 10.2337/dc05-2366; van Dam RM, 2005, DIABETIC MED, V22, P590, DOI 10.1111/j.1464-5491.2005.01465.x; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zillich AJ, 2006, HYPERTENSION, V48, P219, DOI 10.1161/01.HYP.0000231552.10054.aa	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203213	10.1371/journal.pone.0203213	http://dx.doi.org/10.1371/journal.pone.0203213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169531	Green Submitted, gold, Green Published			2022-12-27	WOS:000443374400025
J	Sharrock, A; Ruthe, A; Andrews, ESV; Arcus, VA; Hicks, JL				Sharrock, Abigail; Ruthe, Alaine; Andrews, Emma S. V.; Arcus, Vickery A.; Hicks, Joanna L.			VapC proteins from Mycobacterium tuberculosis share ribonuclease sequence specificity but differ in regulation and toxicity	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; CRYSTAL-STRUCTURE; RNA-BINDING; TRANSLATION; REVEALS; INHIBITION; PEPTIDES; DOMAINS; COMPLEX; OPERON	The chromosome of Mycobacterium tuberculosis (Mtb) contains a large number of Type II toxin-antitoxin (TA) systems. The majority of these belong to the VapBC TA family, characterised by the VapC protein consisting of a PIN domain with four conserved acidic residues, and proposed ribonuclease activity. Characterisation of five VapC (VapC1, 19, 27, 29 and 39) proteins from various regions of the Mtb chromosome using a combination of pentaprobe RNA sequences and mass spectrometry revealed a shared ribonuclease sequence-specificity with a preference for UAGG sequences. The TA complex VapBC29 is auto-regulatory and interacts with inverted repeat sequences in the vapBC29 promoter, whereas complexes VapBC1 and VapBC27 display no auto-regulatory properties. The difference in regulation could be due to the different properties of the VapB proteins, all of which belong to different VapB protein families. Regulation of the vapBC29 operon is specific, no cross-talk among Type II TA systems was observed. VapC29 is bacteriostatic when expressed in Mycobacterium smegmatis, whereas VapC1 and VapC27 displayed no toxicity upon expression in M. smegmatis. The shared sequence specificity of the five VapC proteins characterised is intriguing, we propose that the differences observed in regulation and toxicity is the key to understanding the role of these TA systems in the growth and persistence of Mtb.	[Sharrock, Abigail; Ruthe, Alaine; Andrews, Emma S. V.; Arcus, Vickery A.; Hicks, Joanna L.] Univ Waikato, Sch Sci, Hamilton, New Zealand	University of Waikato	Hicks, JL (corresponding author), Univ Waikato, Sch Sci, Hamilton, New Zealand.	joanna.hicks@waikato.ac.nz	Sharrock, Abigail/GWC-8967-2022; Andrews, Emma/P-9877-2016	Sharrock, Abigail/0000-0003-2837-9481; Andrews, Emma/0000-0003-2153-4346; Hicks, Joanna/0000-0002-0307-0923	New Zealand Royal Society, Te Aparangi, Marsden Fund [10-UOW-091]	New Zealand Royal Society, Te Aparangi, Marsden Fund	VAA received funding from the New Zealand Royal Society, Te Aparangi, Marsden Fund, grant number: 10-UOW-091, https://www.royalsociety.org.nz/what-we-do/funds-and-opportunities/marsden/marsden-fund-standard/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Albrethsen J, 2013, MOL CELL PROTEOMICS, V12, P1180, DOI 10.1074/mcp.M112.018846; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Bashiri G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015803; Bashyam MD, 1996, J BACTERIOL, V178, P4847, DOI 10.1128/jb.178.16.4847-4853.1996; Beste DJV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005349; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Chiang CY, 2013, RESPIROLOGY, V18, P596, DOI 10.1111/resp.12067; Das U, 2014, J STRUCT BIOL, V188, P249, DOI 10.1016/j.jsb.2014.10.002; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Gupta A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06003-7; Hayes F, 2014, TOXINS, V6, P337, DOI 10.3390/toxins6010337; Kang SM, 2017, NUCLEIC ACIDS RES, V45, P8564, DOI 10.1093/nar/gkx489; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; Kwan AHY, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng124; Lee IG, 2015, NUCLEIC ACIDS RES, V43, P7624, DOI 10.1093/nar/gkv689; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; McKenzie JL, 2012, J BACTERIOL, V194, P2189, DOI 10.1128/JB.06790-11; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Min AB, 2012, PROTEIN SCI, V21, P1754, DOI 10.1002/pro.2161; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Rustad TR, 2013, NUCLEIC ACIDS RES, V41, P509, DOI 10.1093/nar/gks1019; Sharp JD, 2012, J BIOL CHEM, V287, P12835, DOI 10.1074/jbc.M112.340109; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Winther K, 2016, NUCLEIC ACIDS RES, V44, P9860, DOI 10.1093/nar/gkw781; Winther KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3796; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhu L, 2010, J BIOL CHEM, V285, P39732, DOI 10.1074/jbc.M110.163105	39	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203412	10.1371/journal.pone.0203412	http://dx.doi.org/10.1371/journal.pone.0203412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169502	Green Published, Green Submitted, gold			2022-12-27	WOS:000443374400040
J	Unakafov, AM; Moller, S; Kagan, I; Gail, A; Treue, S; Wolf, F				Unakafov, Anton M.; Moeller, Sebastian; Kagan, Igor; Gail, Alexander; Treue, Stefan; Wolf, Fred			Using imaging photoplethysmography for heart rate estimation in non-human primates	PLOS ONE			English	Article							NEUROSCIENCE RESEARCH; CYNOMOLGUS MONKEYS; RHESUS-MONKEYS; SKIN; NONCONTACT; SYSTEM; LIGHT; RESTRAINT; VALUES; GREEN	For humans and for non-human primates heart rate is a reliable indicator of an individual's current physiological state, with applications ranging from health checks to experimental studies of cognitive and emotional state. In humans, changes in the optical properties of the skin tissue correlated with cardiac cycles (imaging photoplethysmogram, iPPG) allow non-contact estimation of heart rate by its proxy, pulse rate. Yet, there is no established simple and non-invasive technique for pulse rate measurements in awake and behaving animals. Using iPPG, we here demonstrate that pulse rate in rhesus monkeys can be accurately estimated from facial videos. We computed iPPGs from eight color facial videos of four awake head-stabilized rhesus monkeys. Pulse rate estimated from iPPGs was in good agreement with reference data from a contact pulse-oximeter: the error of pulse rate estimation was below 5% of the individual average pulse rate in 83% of the epochs; the error was below 10% for 98% of the epochs. We conclude that iPPG allows non-invasive and non-contact estimation of pulse rate in non-human primates, which is useful for physiological studies and can be used toward welfare-assessment of non-human primates in research.	[Unakafov, Anton M.; Moeller, Sebastian; Gail, Alexander; Treue, Stefan] Univ Goettingen, Georg Elias Muller Inst Psychol, Gottingen, Germany; [Unakafov, Anton M.; Wolf, Fred] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Unakafov, Anton M.; Moeller, Sebastian; Kagan, Igor; Gail, Alexander; Treue, Stefan; Wolf, Fred] Leibniz ScienceCampus Primate Cognit, Gottingen, Germany; [Moeller, Sebastian; Kagan, Igor; Gail, Alexander; Treue, Stefan] Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany; [Gail, Alexander; Treue, Stefan; Wolf, Fred] Bernstein Ctr Computat Neurosci, Gottingen, Germany	University of Gottingen; Max Planck Society; Deutsches Primatenzentrum (DPZ)	Unakafov, AM (corresponding author), Univ Goettingen, Georg Elias Muller Inst Psychol, Gottingen, Germany.; Unakafov, AM (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.; Unakafov, AM (corresponding author), Leibniz ScienceCampus Primate Cognit, Gottingen, Germany.	anton@nld.ds.mpg.de	; Kagan, Igor/C-6182-2009	Unakafov, Anton/0000-0001-6782-5099; Wolf, Fred/0000-0002-7068-3762; Kagan, Igor/0000-0002-1814-4200	Hermann and Lilly Schilling Foundation (Germany); Ministry for Science and Education of Lower Saxony; Volkswagen Foundation through the program "NiedersaEchsisches Vorab"; DFG research unit [2591, 321137804]; Leibniz Association through Leibniz ScienceCampus Primate Cognition; Max Planck Society	Hermann and Lilly Schilling Foundation (Germany); Ministry for Science and Education of Lower Saxony; Volkswagen Foundation through the program "NiedersaEchsisches Vorab"; DFG research unit(German Research Foundation (DFG)); Leibniz Association through Leibniz ScienceCampus Primate Cognition; Max Planck Society(Max Planck Society)	We acknowledge funding from Hermann and Lilly Schilling Foundation (Germany), https:// www.deutsches-stiftungszentrum.de/stiftungen/hermann-und-lilly-schilling-stiftung-f%C3%BCr-medizinische-forschung (received by IK). We acknowledge funding from the Ministry for Science and Education of Lower Saxony and the Volkswagen Foundation through the program "NiedersaEchsisches Vorab," https://www.volkswagenstiftung.de/unsere-foerderung/unser-foerderangebot-im-ueberblick/vorab.html. We acknowledge funding from the DFG research unit 2591 "Severity assessment in animal based research," http://gepris.dfg.de/gepris/projekt/ 321137804 (received by AG, ST). We acknowledge additional support by the Leibniz Association through funding for the Leibniz ScienceCampus Primate Cognition and the Max Planck Society, https://www.leibniz-gemeinschaft.de/en/home/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison PS, 2016, IEEE ENG MED BIO, P4747, DOI 10.1109/EMBC.2016.7591788; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; [Anonymous], 2016, CHAMELEON3 USB 3 0 D; Bamji CS, 2015, IEEE J SOLID-ST CIRC, V50, P303, DOI 10.1109/JSSC.2014.2364270; Bashkatov AN, 2005, J PHYS D APPL PHYS, V38, P2543, DOI 10.1088/0022-3727/38/15/004; Berger M, 2018, J NEUROPHYSIOL, V119, P796, DOI 10.1152/jn.00614.2017; Blackford EB, 2016, PROC SPIE, V9715, DOI 10.1117/12.2208130; Blanik N., 2014, P 15 INT C BIOM ENG, P92, DOI DOI 10.1007/978-3-319-02913-9_; Blazek V, 1996, QUANTITATIVE PHOTOPL; Bousefsaf F, 2016, BIO-MED MATER ENG, V27, P527, DOI 10.3233/BME-161606; Bousefsaf F, 2017, J MED BIOL ENG, V37, P374, DOI 10.1007/s40846-017-0229-1; Bousefsaf F, 2013, BIOMED SIGNAL PROCES, V8, P568, DOI 10.1016/j.bspc.2013.05.010; Calapai A, 2017, BEHAV RES METHODS, V49, P35, DOI 10.3758/s13428-016-0707-3; Challoner A., 1979, NONINVASIVE PHYSL ME, V1, P125; Chui RW, 2012, J PHARMACOL TOX MET, V66, P84, DOI 10.1016/j.vascn.2012.05.002; CLARKE AS, 1994, AM J PRIMATOL, V33, P133, DOI 10.1002/ajp.1350330207; Damianou D, 1995, WAVELENGTH DEPENDENC; Derakhchan K, 2014, BRIT J PHARMACOL, V171, P509, DOI 10.1111/bph.12484; Dominguez-Vargas AU, 2017, J NEUROSCI, V37, P2234, DOI 10.1523/JNEUROSCI.1984-16.2016; Downs ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125911; Elgendi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076585; Feng LT, 2015, IEEE T CIRC SYST VID, V25, P879, DOI 10.1109/TCSVT.2014.2364415; Gacsi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058475; Grandi LC, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00050; Hassimoto M, 2004, J MED PRIMATOL, V33, P175, DOI 10.1111/j.1600-0684.2004.00069.x; Hassimoto M, 2002, INT J BIOELECTROMAGN, V4; Higham JP, 2010, BEHAV ECOL, V21, P739, DOI 10.1093/beheco/arq047; Hoffmann P, 2014, TOXICOL PATHOL, V42, P684, DOI 10.1177/0192623313516828; Holton BD, 2013, PHYSIOL MEAS, V34, P1499, DOI 10.1088/0967-3334/34/11/1499; Hulsbusch M, 2002, PROC SPIE, V4683, P110, DOI 10.1117/12.463573; Hulsbusch M, 2008, IMAGE BASED FUNCTION; Huss MK, 2015, J AM ASSOC LAB ANIM, V54, P25; KAMAL AAR, 1989, COMPUT METH PROG BIO, V28, P257, DOI 10.1016/0169-2607(89)90159-4; Kamshilin AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10494; Kremer JJ, 2011, J PHARM TOXICOL METH, V1, pe47, DOI [10.1016/j.vascn.2011.03.164, DOI 10.1016/J.VASCN.2011.03.164]; Kumar M, 2015, BIOMED OPT EXPRESS, V6, P1565, DOI 10.1364/BOE.6.001565; Kviesis-Kipge E, 2010, INT SOC OPTICS PHOTO; Lee J, 2013, IEEE ENG MED BIO, P1724, DOI 10.1109/EMBC.2013.6609852; Lewandowska M., 2011, 2011 Federated Conference on Computer Science and Information Systems (FedCSIS), P405; Lewis S, 2012, IEEE IMTC P, P996; LINDBERG LG, 1991, MED BIOL ENG COMPUT, V29, P48, DOI 10.1007/BF02446295; Lindqvist A, 2016, REMOTE HEART RATE EX; Maeda Y, 2008, IEEE ENG MED BIO, P2270, DOI 10.1109/IEMBS.2008.4649649; McDuff DJ, 2015, IEEE ENG MED BIO, P6398, DOI 10.1109/EMBC.2015.7319857; Moco AV, 2016, BIOMED OPT EXPRESS, V7, P1737, DOI 10.1364/BOE.7.001737; MONTAGNA W, 1964, AM J PHYS ANTHROPOL, V22, P307, DOI 10.1002/ajpa.1330220317; Morel P, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016002; Niehoff M, 2014, J PHARMACOL TOX MET, V70, P338, DOI 10.1016/j.vascn.2014.03.102; Pagliari D, 2015, SENSORS-BASEL, V15, P27569, DOI 10.3390/s151127569; Pfefferle D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190190; Poh MZ, 2011, IEEE T BIO-MED ENG, V58, P7, DOI 10.1109/TBME.2010.2086456; Prescott Mark J., 2003, Journal of Applied Animal Welfare Science, V6, P157, DOI 10.1207/S15327604JAWS0603_01; Roelfsema PR, 2014, NEURON, V82, P1200, DOI 10.1016/j.neuron.2014.06.003; Schafer A, 2013, INT J CARDIOL, V166, P15, DOI 10.1016/j.ijcard.2012.03.119; Schwedhelm P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18153-9; Shin HS, 2009, COMPUT BIOL MED, V39, P1145, DOI 10.1016/j.compbiomed.2009.10.006; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Spigulis J, 2007, APPL OPTICS, V46, P1754, DOI 10.1364/AO.46.001754; Stricker R, 2014, IEEE ROMAN, P1056, DOI 10.1109/ROMAN.2014.6926392; Sun XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071876; Sun Y, 2016, IEEE T BIO-MED ENG, V63, P463, DOI 10.1109/TBME.2015.2476337; Tamura T, 2014, ELECTRONICS-SWITZ, V3, P282, DOI 10.3390/electronics3020282; TATSUMI T, 1990, EXP ANIM TOKYO, V39, P361, DOI 10.1538/expanim1978.39.3_361; Unakafov AM, 2017, ARXIV171008369; van Gastel M, 2015, IEEE T BIO-MED ENG, V62, P1425, DOI 10.1109/TBME.2015.2390261; van Hoof RHM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179024; Vezhnevets V, 2003, P GRAPH; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Vizbara V, 2013, BIOMEDICAL ENG, V17; Wang WJ, 2017, IEEE T BIO-MED ENG, V64, P1479, DOI 10.1109/TBME.2016.2609282; Wang WJ, 2016, IEEE T BIO-MED ENG, V63, P1974, DOI 10.1109/TBME.2015.2508602; Witham CL, 2018, J NEUROSCI METH, V300, P157, DOI 10.1016/j.jneumeth.2017.07.020; Wu T, 2000, PROC SPIE, V4163, P62, DOI 10.1117/12.407646; Yamaoka A, 2013, J AM ASSOC LAB ANIM, V52, P491; Zarit B. D., 1999, Proceedings International Workshop on Recognition, Analysis, and Tracking of Faces and Gestures in Real-Time Systems. In Conjunction with ICCV'99 (Cat. No.PR00378), P58, DOI 10.1109/RATFG.1999.799224; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071384	79	14	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202581	10.1371/journal.pone.0202581	http://dx.doi.org/10.1371/journal.pone.0202581			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169537	gold, Green Submitted, Green Published			2022-12-27	WOS:000443374400012
J	El-Say, KM; Hosny, KM				El-Say, Khalid Mohamed; Hosny, Khaled Mohamed			Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits	PLOS ONE			English	Article							IN-VITRO; SILDENAFIL CITRATE; TOPICAL DELIVERY; DRUG-DELIVERY; FORMULATION; SLN; CARRIERS; TABLETS; SURFACE; DESIGN	Solid lipid nanoparticles (SLNs) are prospective carriers for oral delivery of poorly soluble drugs with low bioavailability. Therefore, the study aimed at developing carvedilol (CVD) in SLNs to control its release and enhance its bioavailability in the management of hypertension, and cardiac diseases. Box-Behnken design (BBD) was applied to optimize the variables affecting the quality of CVD-SLNs which prepared by homogenization-ultrasonication technique. The concentrations of Percirol (X-1), Gelucire (X-2), and stearylamine (X-3) were chosen as the crucial independent variables. The dependent variables were estimated and analyzed by Statgraphics software to achieve the optimum characteristics of the developed SLNs. The optimized SLNs was evaluated in vitro and in vivo for pharmacokinetic parameters on male New Zealand white rabbits. The results of this study revealed that the CVD-SLNs have a colloidal size of 31.3 nm with zeta potential of 24.25 mV indicating good stability and 91.43% entrapment efficiency. The in vitro release of CVD from the SLNs was best fitted to Hixon-Crowell model that describes the release from the particles with uniform size. The in vivo pharmacokinetics results indicated the prolongation in the mean residence time of CVD to 23 h when delivered in SLNs and its oral bioavailability enhanced by more than 2-folds.	[El-Say, Khalid Mohamed; Hosny, Khaled Mohamed] King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut, Jeddah, Saudi Arabia; [Hosny, Khaled Mohamed] Beni Suef Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Bani Suwayf, Egypt	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Beni Suef University	El-Say, KM (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Pharmaceut, Jeddah, Saudi Arabia.	kelsay1@kau.edu.sa	El-Say, Khalid/I-7339-2012; Hosny, Khaled M/H-9793-2012; Hosny, Khaled/GWC-2586-2022	El-Say, Khalid/0000-0002-5539-3193; 	King Abdulaziz University, Jeddah [D-169-166-1437]; DSR	King Abdulaziz University, Jeddah; DSR	This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. D-169-166-1437. The authors, therefore, gratefully acknowledge the DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (D-169-166-1437). The authors, therefore, gratefully acknowledge the DSR technical and financial support.	Ahmed TA, 2016, DRUG DES DEV THER, V10, P405, DOI 10.2147/DDDT.S98078; Al-Subaie MM, 2015, INT J NANOMED, V10, P3973, DOI 10.2147/IJN.S83962; Aljimaee YHM, 2015, DRUG DES DEV THER, V9, P1379, DOI 10.2147/DDDT.S80294; Becker K, 2015, PHARM RES-DORDR, V32, P1519, DOI 10.1007/s11095-015-1661-y; Cavalli R, 2002, INT J PHARM, V238, P241, DOI 10.1016/S0378-5173(02)00080-7; Chakraborty S., 2009, Current Drug Delivery, V6, P291; El-Housiny S, 2018, DRUG DELIV, V25, P78, DOI 10.1080/10717544.2017.1413444; El-Say KM, 2016, J LIPOSOME RES, V26, P57, DOI 10.3109/08982104.2015.1029495; El-Say KM, 2015, PHARM DEV TECHNOL, V20, P738, DOI 10.3109/10837450.2014.920353; Elshafeey AH, 2009, AAPS PHARMSCITECH, V10, P361, DOI 10.1208/s12249-009-9213-6; Harbi I, 2016, AAPS PHARMSCITECH, V17, P1404, DOI 10.1208/s12249-016-0481-7; Harde H, 2011, EXPERT OPIN DRUG DEL, V8, P1407, DOI 10.1517/17425247.2011.604311; Hixson AW, 1931, IND ENG CHEM, V23, P1160, DOI 10.1021/ie50262a025; Hosny KM, 2018, J DRUG DELIV SCI TEC, V45, P168, DOI 10.1016/j.jddst.2018.03.010; Hosny KM, 2014, EXPERT OPIN DRUG DEL, V11, P1015, DOI 10.1517/17425247.2014.912212; Jeon HS, 2013, INT J PHARMACEUT, V452, P311, DOI 10.1016/j.ijpharm.2013.05.023; Kassem MA, 2017, J PHARM SCI-US, V106, P111, DOI 10.1016/j.xphs.2016.07.007; Khalil RM, 2014, BRIT J PHARM RES, V4, P490, DOI 10.9734/BJPR/2014/7055; Kim S-H., 2010, AM J ANAL CHEM, V01, P135, DOI [10.4236/AJAC.2010.13017, DOI 10.4236/AJAC.2010.13017]; KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9; Lingayat VJ., 2017, J NANOSCI NANOTECHNO, V2, P67, DOI DOI 10.12691/NNR-4-2-5; Mukherjee S, 2009, INDIAN J PHARM SCI, V71, P349, DOI 10.4103/0250-474X.57282; Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4; Naseri N, 2015, ADV PHARM BULL, V5, P305, DOI 10.15171/apb.2015.043; Nimbalkar UA, 2011, INT J PHARM SCI RES, V2, P2974, DOI 10.13040/IJPSR.0975-8232.2(11).2974-82; Padhye SG, 2013, INDIAN J PHARM SCI, V75, P591; Pandita D, 2009, PHARMAZIE, V64, P301, DOI 10.1691/ph.2009.8338; PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110; Ponchel G, 1997, EUR J PHARM BIOPHARM, V44, P25, DOI 10.1016/S0939-6411(97)00098-2; Potluri RHK, 2011, ARCH PHARM RES, V34, P51, DOI 10.1007/s12272-011-0106-3; Runge S., 1996, European Journal of Pharmaceutical Sciences, V4, pS132, DOI 10.1016/S0928-0987(97)86381-6; Sarangi M.K., 2016, J CRIT REV, V3, P5, DOI DOI 10.5958/0975-4377.2016.00030.6; Shidhaye S. S., 2008, Current Drug Delivery, V5, P324, DOI 10.2174/156720108785915087; Stancampiano A.H.S., 2008, OPEN DRUG DELIV, V2, P26; Tanwar Yuveraj Singh, 2007, Acta Pharmaceutica (Zagreb), V57, P151, DOI 10.2478/v10007-007-0012-x; Ubaidulla U, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0801002; Uner M, 2007, INT J NANOMED, V2, P289; Venishetty VK, 2012, COLLOID SURFACE B, V95, P1, DOI 10.1016/j.colsurfb.2012.01.001; Verma S, 2016, J CHEM RES, V8, P102, DOI DOI 10.20959/WJPPS20164-6495; Wissing SA, 2004, ADV DRUG DELIVER REV, V56, P1257, DOI 10.1016/j.addr.2003.12.002; Xie SY, 2011, INT J NANOMED, V6, P547, DOI 10.2147/IJN.S17083; Zirak MB., 2015, INT J CURR MICROBIOL, V4, P924, DOI 10.20964/2016.10.30	42	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203405	10.1371/journal.pone.0203405	http://dx.doi.org/10.1371/journal.pone.0203405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161251	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900121
J	Fitzgerald, A; Mac Giollabhui, N; Dolphin, L; Whelan, R; Dooley, B				Fitzgerald, Amanda; Mac Giollabhui, Naoise; Dolphin, Louise; Whelan, Robert; Dooley, Barbara			Dissociable psychosocial profiles of adolescent substance users	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; PROTECTIVE FACTORS; ALCOHOL-USE; TOBACCO USE; DRUG-USE; EARLY ADULTHOOD; CANADIAN YOUTH; UNITED-STATES; MARIJUANA USE; DEPENDENCE	Objective Alcohol, tobacco and cannabis use in adolescence is associated with adverse outcomes. Characterizing adolescent substance misusers, however, is difficult due to the wide range of risk and protective factors linked to substance use. The aim of the present study was to examine the role of the Individual, Family, School, Peer, and Social Environment on alcohol (lifetime and risky), tobacco (risky only), and cannabis use (lifetime and riskiness). Method Data were analyzed from a national sample of 5,680 adolescents, capturing substance use behavior alongside risk and protective factors across Individual, Family, School, Peer and Social domains. We applied a sophisticated machine learning classifier to develop models of alcohol, tobacco and cannabis initiation and misuse. Results We found highly accurate (area under curve of receiver-operator-characteristic for out-ofsample performance was > .88) and replicable (over multiple iterations and in comparison with permuted outcomes) dissociable psychosocial profiles of alcohol, tobacco and cannabis use. Alongside common predictors (peer relations and externalizing behavior), dissociable risk and resilience factors were observed. Adolescent profiles of alcohol use were distinguished by the contribution of multiple domains. In contrast, tobacco use was characterized by a small number of individual variables, including female gender and poor perceived academic position. Cannabis use was differentiated by the distinct contribution of Individual risk factors, in particular male gender and feelings of anger. Differential associations were also evident, with the strength and direction of association differing substantially across substances. Conclusion This study indicates that the relationship between the environment and substance use is more complex than previously thought.	[Fitzgerald, Amanda; Dolphin, Louise; Dooley, Barbara] Univ Coll Dublin, Sch Psychol, Newman Bldg, Dublin, Ireland; [Mac Giollabhui, Naoise] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Whelan, Robert] Trinity Coll Dublin, Sch Psychol, Trinity Inst Neurosci TCIN, Dublin, Ireland	University College Dublin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Trinity College Dublin	Dooley, B (corresponding author), Univ Coll Dublin, Sch Psychol, Newman Bldg, Dublin, Ireland.	barbara.dooley@ucd.ie	Dooley, Barbara/A-3037-2013; Mac Giollabhui, Naoise/J-4768-2019	Dooley, Barbara/0000-0002-2139-8316; Mac Giollabhui, Naoise/0000-0003-4226-5704; Whelan, Robert/0000-0002-2790-7281	One Foundation; University College Dublin College of Social Sciences and Law Research Fund; One Foundation Dublin, Ireland	One Foundation; University College Dublin College of Social Sciences and Law Research Fund; One Foundation Dublin, Ireland	Funding for the My World Survey was granted by The One Foundation. Publication funding was granted by University College Dublin College of Social Sciences and Law Research Fund.; The authors would like to thank all the young people, school principals and staff who gave their time to participate in this research. The authors would also like to acknowledge funding for this research from the One Foundation Dublin, Ireland and support of the University College Dublin College of Social Sciences and Law Research Fund.	Armstrong TD, 2002, J CONSULT CLIN PSYCH, V70, P1224, DOI 10.1037/0022-006X.70.6.1224; Bailey JA, 2014, DRUG ALCOHOL DEPEN, V138, P161, DOI 10.1016/j.drugalcdep.2014.02.023; Baker JH, 2012, BEHAV GENET, V42, P345, DOI 10.1007/s10519-011-9516-8; Barrett AE, 2006, ADDICTION, V101, P109, DOI 10.1111/j.1360-0443.2005.01296.x; Beyers JM, 2004, J ADOLESCENT HEALTH, V35, P3, DOI 10.1016/j.jadohealth.2003.08.015; Blum RW, 2001, VULNERABILITY RISK P; Burt SA, 2009, PSYCHOL BULL, V135, P608, DOI 10.1037/a0015702; Cleveland MJ, 2008, J ADOLESCENT HEALTH, V43, P157, DOI 10.1016/j.jadohealth.2008.01.015; Cruz JE, 2012, DEV PSYCHOL, V48, P1390, DOI 10.1037/a0027515; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Donath C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-84; Dooley B.A., 2012, MY WORLD SURVEY NATL; Fothergill KE, 2006, DRUG ALCOHOL DEPEN, V82, P61, DOI 10.1016/j.drugalcdep.2005.08.009; Gardner DG, 1998, EDUC PSYCHOL MEAS, V58, P898, DOI 10.1177/0013164498058006003; Graves KN, 2005, J YOUTH ADOLESCENCE, V34, P379, DOI 10.1007/s10964-005-5766-1; Hamdan S, 2013, J CLIN PSYCHIAT, V74, P828, DOI 10.4088/JCP.13m08391; Hemphill SA, 2011, J ADOLESCENT HEALTH, V49, P312, DOI 10.1016/j.jadohealth.2010.12.017; Hermens DF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002229; Hicks BM, 2013, DEV PSYCHOPATHOL, V25, P119, DOI 10.1017/S0954579412000946; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; JAMES P, 2013, ADOLESCENTS SUBSTANC; Kaai SC, 2013, PREV MED, V57, P113, DOI 10.1016/j.ypmed.2013.04.022; Kendler KS, 2007, ARCH GEN PSYCHIAT, V64, P1313, DOI 10.1001/archpsyc.64.11.1313; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Leatherdale ST, 2012, ADDICT BEHAV, V37, P318, DOI 10.1016/j.addbeh.2011.10.007; Leatherdale ST, 2010, J PRIM PREV, V31, P99, DOI 10.1007/s10935-010-0211-y; Leatherdale ST, 2008, CANCER CAUSE CONTROL, V19, P361, DOI 10.1007/s10552-007-9095-4; Low NCP, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-116; McConnell MM, 2014, ADDICT BEHAV, V39, P1394, DOI 10.1016/j.addbeh.2014.05.018; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Moss HB, 2014, DRUG ALCOHOL DEPEN, V136, P51, DOI 10.1016/j.drugalcdep.2013.12.011; Nargiso JE, 2013, J EARLY ADOLESCENCE, V33, P973, DOI 10.1177/0272431613477238; Palamar JJ, 2014, AM J DRUG ALCOHOL AB, V40, P438, DOI 10.3109/00952990.2014.943371; Palmer RHC, 2012, DRUG ALCOHOL DEPEN, V123, pS24, DOI 10.1016/j.drugalcdep.2011.12.015; Patton GC, 2011, PEDIATRICS, V127, P308, DOI 10.1542/peds.2010-0748; Richardson CG, 2013, CAN J PUBLIC HEALTH, V104, pE60, DOI 10.1007/BF03405656; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Santis R, 2009, DRUG ALCOHOL DEPEN, V103, P155, DOI 10.1016/j.drugalcdep.2009.01.017; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scherrer JF, 2012, ADDICT BEHAV, V37, P240, DOI 10.1016/j.addbeh.2011.10.005; Simantov E, 2000, ARCH PEDIAT ADOL MED, V154, P1025, DOI 10.1001/archpedi.154.10.1025; ter Bogt TFM, 2014, ADDICTION, V109, P273, DOI 10.1111/add.12373; Tharp-Taylor S, 2009, ADDICT BEHAV, V34, P561, DOI 10.1016/j.addbeh.2009.03.012; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tucker JS, 2013, DRUG ALCOHOL DEPEN, V128, P83, DOI 10.1016/j.drugalcdep.2012.08.006; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; Whelan R, 2014, NATURE, V512, P185, DOI 10.1038/nature13402; White J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1585-9; Wong CF, 2013, DRUG ALCOHOL DEPEN, V132, P165, DOI 10.1016/j.drugalcdep.2013.01.024; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zullig KJ, 2001, J ADOLESCENT HEALTH, V29, P279, DOI 10.1016/S1054-139X(01)00269-5	52	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202498	10.1371/journal.pone.0202498	http://dx.doi.org/10.1371/journal.pone.0202498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161166	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900032
J	Huizinga, P; Schrauwen, E; Garcia-Cobos, S; Willemsen, I; Verhulst, C; Friedrich, AW; Savelkoul, PHM; Rossen, JW; Kluytmans, J				Huizinga, Pepijn; Schrauwen, Eefje; Garcia-Cobos, Silvia; Willemsen, Ina; Verhulst, Carlo; Friedrich, Alexander W.; Savelkoul, Paul H. M.; Rossen, John W.; Kluytmans, Jan			Extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) isolated from bean sprouts in the Netherlands	PLOS ONE			English	Article							AMPC-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; CHICKEN MEAT; RISK-FACTORS; PREVALENCE; CARRIAGE; COLONIZATION; COMMUNITY; PLASMIDS; HUMANS	Community-acquired carriage and infections due to extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) are increasing worldwide, resulting in increased morbidity, mortality and healthcare costs. The origins of community-acquired ESBL-E-carriage and infections remain unclear. Bean sprouts are a potential source of Enterobacteriaceae for the community, as illustrated by outbreaks of pathogenic Enterobacteriaceae in the past. The current study focuses on contamination of retail bean sprouts with ESBL-E in the Netherlands. Of 131 bean sprout samples purchased between 2013 and 2016, 25 (19%) were contaminated with ESBL-E. The detected isolates were almost exclusively Klebsiella spp. and co-resistance to other antibiotics was observed frequently. Over time there was substantial genetic diversity between isolates. On the other hand, isolates from samples closely matched in time were frequently clonally related, indicative of batch contamination. Remarkably, no Escherichia colt was found. In conclusion, bean sprouts frequently harbor ESBL-E, which is a potential source for consumers.	[Huizinga, Pepijn; Willemsen, Ina; Verhulst, Carlo; Kluytmans, Jan] Amphia Hosp, Dept Infect Control, Breda, Netherlands; [Huizinga, Pepijn] Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Schrauwen, Eefje; Willemsen, Ina] Avans Univ Appl Sci, Acad Technol & Environm Hlth, Breda, Netherlands; [Garcia-Cobos, Silvia; Friedrich, Alexander W.; Rossen, John W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Savelkoul, Paul H. M.] Maastricht Univ, Med Ctr, Caphri Sch Publ Hlth & Primary Care, Dept Med Microbiol, Maastricht, Netherlands; [Savelkoul, Paul H. M.] Univ Amsterdam, Med Ctr, Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Kluytmans, Jan] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); University of Groningen; Maastricht University; University of Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Huizinga, P (corresponding author), Amphia Hosp, Dept Infect Control, Breda, Netherlands.; Huizinga, P (corresponding author), Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands.	pepijnhuizinga@gmail.com	Rossen, John W/G-7564-2011; Friedrich, Alex/ABG-9823-2020; GARCIA-COBOS, SILVIA/A-7087-2017	Rossen, John W/0000-0002-7167-8623; GARCIA-COBOS, SILVIA/0000-0002-1417-5691	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank the team of curators of the Institut Pasteur MLST and whole genome MLST databases for curating the data and making them publicly available at http://bigsdb.pasteur.fr. This publication also made use of the PubMLST website (https://pubmlst.org/) developed by Keith Jolley (Jolley & Maiden 2010, BMC Bioinformatics, 11: 595) and sited at the University of Oxford. The development of that website was funded by the Wellcome Trust.	Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Blaak H, 2014, INT J FOOD MICROBIOL, V168, P8, DOI 10.1016/j.ijfoodmicro.2013.10.006; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; De Boeck H, 2012, EMERG INFECT DIS, V18, P1019, DOI 10.3201/eid1806.111214; Egervarn M, 2017, SCI TOTAL ENVIRON, V587, P466, DOI 10.1016/j.scitotenv.2017.02.157; EUCAST T, 2017, BREAKPOINT TABLES IN; European Centre for Disease Prevention and Control, 2015, ANN REPORT EUROPEAN, DOI [10.2900/23549, DOI 10.2900/23549]; European Committee on Antimicrobial Susceptibility Testing, 2013, EUCAST GUID DET RES; Evers EG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169589; German institut for risk Assesment (BfR), 2011, EHEC OUTBR BFR CONF; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Karanika S, 2016, CLIN INFECT DIS, V63, P195, DOI 10.1093/cid/ciw240; Kim HS, 2015, INT J FOOD MICROBIOL, V207, P83, DOI 10.1016/j.ijfoodmicro.2015.04.049; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Kluytmans-van den Bergh MFQ, 2016, J CLIN MICROBIOL, V54, P2919, DOI 10.1128/JCM.01648-16; Larsen MV, 2014, J CLIN MICROBIOL, V52, P1529, DOI 10.1128/JCM.02981-13; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Martinez-Romero E, 2018, SALUD PUBLICA MEXICO, V60, P56, DOI 10.21149/8149; Meyer E, 2012, INFECTION, V40, P685, DOI 10.1007/s15010-012-0324-8; Miranda IB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav024; Netherlands Society for Medical Microbiology, 2012, NVMM GUID LAB DET HI; Overdevest ITMA, 2011, J CLIN MICROBIOL, V49, P519, DOI 10.1128/JCM.01953-10; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; P Huizinga, 2016, CLIN INFECT DIS, V702; Reuland EA, 2016, J ANTIMICROB CHEMOTH, V71, P1076, DOI 10.1093/jac/dkv441; Reuland EA, 2014, EUR J CLIN MICROBIOL, V33, P1843, DOI 10.1007/s10096-014-2142-7; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shitrit P, 2013, J HOSP INFECT, V85, P230, DOI 10.1016/j.jhin.2013.07.014; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stuart JC, 2010, J ANTIMICROB CHEMOTH, V65, P1377, DOI 10.1093/jac/dkq146; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomsen MCF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157718; Tumbarello M, 2010, ANTIMICROB AGENTS CH, V54, P4085, DOI 10.1128/AAC.00143-10; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; van der Bij AK, 2011, ANTIMICROB AGENTS CH, V55, P3576, DOI 10.1128/AAC.00074-11; van Hoek AHAM, 2015, INT J FOOD MICROBIOL, V204, P1, DOI 10.1016/j.ijfoodmicro.2015.03.014; Voets GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052102; Willemsen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141765; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203338	10.1371/journal.pone.0203338	http://dx.doi.org/10.1371/journal.pone.0203338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161223	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900115
J	Okabe, T; Yakushiji, T; Shimazu, S; Saito, J; Kimura, T; Oyama, Y; Igawa, W; Ono, M; Kido, T; Ebara, S; Yamashita, K; Yamamoto, MH; Amemiya, K; Isomura, N; Ochiai, M				Okabe, Toshitaka; Yakushiji, Tadayuki; Shimazu, Suguru; Saito, Jumpei; Kimura, Taro; Oyama, Yuji; Igawa, Wataru; Ono, Morio; Kido, Takehiko; Ebara, Seitaro; Yamashita, Kennosuke; Yamamoto, Myong Hwa; Amemiya, Kisaki; Isomura, Naoei; Ochiai, Masahiko			Serum zinc concentration in patients with acute myocardial infarction in percutaneous coronary intervention era	PLOS ONE			English	Article							WORSENING RENAL-FUNCTION; CELL-DEATH; HEART-FAILURE; INFLAMMATION; METABOLISM; ACTIVATION; APOPTOSIS; MORTALITY	Introduction There were few studies that investigated the association between serum zinc concentration and acute myocardial infarction (AMI) in percutaneous coronary intervention era. Objective We assessed the relationships between serum zinc concentration, complications, and prognosis in AMI patients after primary percutaneous coronary intervention. Methods We conducted a single-center, prospective, observational study including 50 patients with AMI. We divided patients into two groups (High-zinc group and Low-zinc group) by median serum zinc concentration and compared two groups about clinical outcomes up to 1 year follow up. Results The mean age of patients was 66.2 +/- 11.8 years old. Patients in the Low-zinc group had STsegment elevation more frequently than those in the High-zinc group (96.0% vs. 72.0%, P = 0.02). All-cause mortality at 1 year was similar in both groups (P (log-rank) = 0.33). However, the lengths of hospital stay and in coronary care unit were longer in patients in the Low-zinc group than in those in the High-zinc group (15.6 +/- 9.2 days vs. 11.9 +/- 2.9 days, P = 0.06; 3.9 +/- 2.8 days vs. 2.3 +/- 0.8 days, P = 0.01). Multivariate regression analysis showed that low serum zinc concentration was associated with the use of cardiac or respiratory assist devices (adjusted odds ratio, 17.79; 95% CI 1.123 to 1216.5; P = 0.04). Conclusions Although there was no significance difference in mortality in Low-zinc and High-zinc groups, low serum zinc concentration was associated with longer stay in the coronary care unit, and was one of the independent predictors for the use of cardiac or respiratory assist devices.	[Okabe, Toshitaka] Showa Univ, Div Cardiol, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan; Cardiac Catheterizat Labs, Yokohama, Kanagawa, Japan	Showa University	Okabe, T (corresponding author), Showa Univ, Div Cardiol, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan.	alone_with_music@hotmail.com	Okabe, Toshitaka/AAI-8887-2020	Amemiya, kisaki/0000-0001-7912-7423; Okabe, Toshitaka/0000-0001-9687-9256				Abdallah NH, 2018, J CELL PHYSIOL, V233, P8677, DOI 10.1002/jcp.26747; Bao B, 2010, AM J CLIN NUTR, V91, P1634, DOI 10.3945/ajcn.2009.28836; Besecker BY, 2011, AM J CLIN NUTR, V93, P1356, DOI 10.3945/ajcn.110.008417; Bolignano D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178699; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Filippatos G, 2007, J CARD FAIL, V13, P360, DOI 10.1016/j.cardfail.2007.02.005; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Hofstra L, 2000, LANCET, V356, P209, DOI 10.1016/S0140-6736(00)02482-X; Lang C, 2007, AM J PHYSIOL-LUNG C, V292, pL577, DOI 10.1152/ajplung.00280.2006; LINDEMAN RD, 1973, J LAB CLIN MED, V81, P194; LOW WI, 1976, BRIT HEART J, V38, P1339, DOI 10.1136/hrt.38.12.1339; Okabe T, 2017, INT J CARDIOL, V230, P47, DOI 10.1016/j.ijcard.2016.12.101; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P2005, DOI 10.1006/jmcc.1996.0193; Pannitteri G, 1997, AM J CARDIOL, V80, P622, DOI 10.1016/S0002-9149(97)00434-7; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Saraste A, 1997, CIRCULATION, V95, P320; Soinio M, 2007, DIABETES CARE, V30, P523, DOI 10.2337/dc06-1682; Szuster-Ciesielska A, 2000, TOXICOLOGY, V145, P159, DOI 10.1016/S0300-483X(00)00144-X; Truong-Tran AQ, 2001, BIOMETALS, V14, P315, DOI 10.1023/A:1012993017026; WACKER WEC, 1956, NEW ENGL J MED, V255, P449, DOI 10.1056/NEJM195609062551001; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520	22	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203074	10.1371/journal.pone.0203074	http://dx.doi.org/10.1371/journal.pone.0203074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161233	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900076
J	Wu, CW; Chiu, WT; Hsieh, TH; Hsieh, CH; Chen, JJJ				Wu, Chun-Wei; Chiu, Wen-Tai; Hsieh, Tsung-Hsun; Hsieh, Cho-Han; Chen, Jia-Jin Jason			Modulation of motor excitability by cortical optogenetic theta burst stimulation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ELECTRICAL-STIMULATION; NEURAL CIRCUITRY; IN-VIVO; PLASTICITY; CORTEX; INTERROGATION; TECHNOLOGY; RATS	Intermittent theta burst stimulation (iTBS) and continuous theta burst stimulation (cTBS) are protocols used in repetitive transcranial magnetic stimulation (rTMS) or cortical electrical stimulation (CES) to facilitate or suppress corticospinal excitability. However, rTMS and CES excite all types of neuron in the target cortex probed by the coil or electrode, making it difficult to differentiate the effect of TBS on specific neural circuits involved in motor plasticity. In this study, TBS protocols were converted into an optogenetic model to achieve focalized and cell-type-specific cortical modulation. Light-sensitive channelrhodopsin-2 (ChR2) was expressed in the glutamatergic neuron in the primary motor cortex (M1) driven by the CaMKI la promoter. A custom-made optrode comprising an optical fiber and a metal cannula electrode was fabricated to achieve optogenetic stimulation and simultaneous local field potential (LFP) recording. Single-pulse CES was delivered into M1 to elicit motor-evoked potential (MEP), which served as an indicator of motor excitability, before and after TBS intervention. Results show that both CES-iTBS and optogenetic iTBS (Opto-iTBS) can potentiate MEP activity. However, CES-cTBS suppressed MEP activity whereas Opto-cTBS enhanced it. This discrepancy may have resulted from the different neural networks targeted by the two TBS modalities, with CES-cTBS exciting all types of neuron and Opto-cTBS targeting excitatory neuron specifically. The results support the idea that intra-cortical networks determine the variation of TBS-induced neuroplasticity. This study shows that focalized and cell-type-specific brain stimulation using the optogenetic approach is viable and can be extended for further exploration of neuroplasticity.	[Wu, Chun-Wei; Chiu, Wen-Tai; Hsieh, Cho-Han; Chen, Jia-Jin Jason] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Sch Phys Therapy, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan	National Cheng Kung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chen, JJJ (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.	chenjj@mail.ncku.edu.tw	Hsieh, Tung-Hsun/AAZ-5010-2020	Hsieh, Tung-Hsun/0000-0002-1794-7941	National Health Research Institutes of Taiwan [NHRI-EX103-10139EI]; Ministry of Science and Technology of Taiwan [MOST104-2314-B-006-007-MY3]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Health Research Institutes of Taiwan (http://www.nhri.org.tw/) (NHRI-EX103-10139EI) and the Ministry of Science and Technology of Taiwan (www.most.gov.tw) (MOST104-2314-B-006-007-MY3) for financially supporting this study to J-JJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardenas-Morales L, 2010, BRAIN TOPOGR, V22, P294, DOI 10.1007/s10548-009-0084-7; Di Lazzaro V, 2014, J PHYSIOL-LONDON, V592, P4115, DOI 10.1113/jphysiol.2014.274316; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Hess G, 1996, ACTA NEUROBIOL EXP, V56, P397; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hsieh T-H, 2014, CEREBRAL CORTEX; Hsieh TH, 2015, J MED BIOL ENG, V35, P62, DOI 10.1007/s40846-015-0006-y; Huang X, 2017, MOL PSYCHIATR, V22, P1274, DOI 10.1038/mp.2017.143; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Larson J, 2015, BRAIN RES, V1621, P38, DOI 10.1016/j.brainres.2014.10.034; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Seeger-Armbruster S, 2015, J NEUROSCI, V35, P1211, DOI 10.1523/JNEUROSCI.3277-14.2015; Suppa A, 2016, BRAIN STIMUL, V9, P323, DOI 10.1016/j.brs.2016.01.006; Wischnewski M, 2015, BRAIN STIMUL, V8, P685, DOI 10.1016/j.brs.2015.03.004; Xie YF, 2013, ACTA PHARMACOL SIN, V34, P1381, DOI 10.1038/aps.2013.150; Xiong WH, 2012, J NEUROSCI METH, V210, P119, DOI 10.1016/j.jneumeth.2012.07.019; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	24	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203333	10.1371/journal.pone.0203333	http://dx.doi.org/10.1371/journal.pone.0203333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161250	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900113
J	Hupman, K; Stockin, KA; Pollock, K; Pawley, MDM; Dwyer, SL; Lea, C; Tezanos-Pinto, G				Hupman, Krista; Stockin, Karen A.; Pollock, Kenneth; Pawley, Matthew D. M.; Dwyer, Sarah L.; Lea, Catherine; Tezanos-Pinto, Gabriela			Challenges of implementing Mark-recapture studies on poorly marked gregarious delphinids (vol 13, e0198167, 2018)	PLOS ONE			English	Correction									[Hupman, Krista; Stockin, Karen A.; Pawley, Matthew D. M.; Dwyer, Sarah L.; Lea, Catherine; Tezanos-Pinto, Gabriela] Massey Univ, Inst Nat & Math Sci, Coastal Marine Res Grp, Auckland, New Zealand; [Hupman, Krista] Natl Inst Water & Atmospher Res, 301 Evans Bay Parade, Wellington 6021, New Zealand; [Pollock, Kenneth] North Carolina State Univ, Dept Appl Ecol, Raleigh, NC USA	Massey University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of North Carolina; North Carolina State University	Hupman, K (corresponding author), Massey Univ, Inst Nat & Math Sci, Coastal Marine Res Grp, Auckland, New Zealand.; Hupman, K (corresponding author), Natl Inst Water & Atmospher Res, 301 Evans Bay Parade, Wellington 6021, New Zealand.		Stockin, Karen A/B-4452-2010	Stockin, Karen/0000-0002-2981-3983				Hupman K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198167	1	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203356	10.1371/journal.pone.0203356	http://dx.doi.org/10.1371/journal.pone.0203356			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153303	gold, Green Published, Green Submitted			2022-12-27	WOS:000443001700052
J	Yano, Y; Kurebe, H; Edahiro, R; Hosono, Y; Nakatsubo, S; Nishida, K; Sawa, N; Ishijima, M; Uenami, T; Kanazu, M; Akazawa, Y; Yamaguchi, T; Mori, M				Yano, Yukihiro; Kurebe, Hiroyuki; Edahiro, Ryuya; Hosono, Yuki; Nakatsubo, Saeko; Nishida, Kohei; Sawa, Nobuyuki; Ishijima, Mikako; Uenami, Takeshi; Kanazu, Masaki; Akazawa, Yuki; Yamaguchi, Toshihiko; Mori, Masahide			Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study	PLOS ONE			English	Article							RESPONSE RATES; CHEMOTHERAPY; PEMBROLIZUMAB; INHIBITORS; DOCETAXEL	Objectives The effectiveness of treatment after cessation of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) has not been well investigated. The aim of the present study was to clarify the clinical benefit of post-nivolumab treatment in such patients. Materials and methods A retrospective review was conducted on patients who received treatment after cessation of nivolumab due to disease progression or adverse events at the Toneyama National Hospital between January 2016 and April 2017. Results Among 64 patients treated with nivolumab, 26 patients received treatment after cessation of nivolumab due to disease progression (n = 21) or adverse events (n = 5). The median age of the patients was 68 years and 19 patients were male. Nineteen patients had performance status (PS) 1 or less at initiation of post-nivolumab treatment. Four, 20, and 2 patients were treated with platinum doublets, a single agent, and molecular targeting agents, respectively. Response rate, disease control rate, and median progression-free survival of first-line post-nivolumab treatment were 34.6% (9 patients), 73.1% (19 patients), and 2.8 months (95% confidence interval [CI]: 1.7-5.2), respectively. Adverse events (>= grade 3) and treatment cessation were observed in 57.7% (15 patients) and 19.2% (5 patients), respectively. There were no statistically significant differences for the majority of patient characteristics between the groups with (n = 26) and without post-nivolumab treatment. However, PS at cessation of nivolumab and post-progression survival (PPS) after cessation of nivolumab (median PPS: 12.6 vs. 1.4 months, 95% CI: 3.8-14.7 vs. 0.4-2.2) were significantly different between the groups. A multivariate Cox regression analysis showed significant correlation of PS at cessation of nivolumab (hazard ratio [HR]: 0.34, 95% CI: 0.13-0.87) and post-nivolumab treatment (HR: 0.19, 95% CI: 0.08-0.43) with prolonged PPS after nivolumab. Conclusion Median post-progression survival in patients with advanced NSCLC who received post-nivolumab treatment was approximately 1 year.	[Yano, Yukihiro; Kurebe, Hiroyuki; Edahiro, Ryuya; Hosono, Yuki; Nakatsubo, Saeko; Nishida, Kohei; Sawa, Nobuyuki; Ishijima, Mikako; Uenami, Takeshi; Kanazu, Masaki; Akazawa, Yuki; Yamaguchi, Toshihiko; Mori, Masahide] Natl Hosp Org, Toneyama Natl Hosp, Dept Thorac Oncol, Toyonaka, Osaka, Japan		Yano, Y (corresponding author), Natl Hosp Org, Toneyama Natl Hosp, Dept Thorac Oncol, Toyonaka, Osaka, Japan.	yanoy@toneyama.go.jp						Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Grigg C, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9082; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Kogure Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135393; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Leger PD, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9084; Lesterhuis WJ, 2011, J CLIN INVEST, V121, P3100, DOI 10.1172/JCI43656; Li JY, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/286170; Park SE, 2018, J THORAC ONCOL, V13, P106, DOI 10.1016/j.jtho.2017.10.011; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rizvi NA, 2016, J CLIN ONCOL, V34, P2969, DOI 10.1200/JCO.2016.66.9861; Roselli M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27025; Schvartsman G, 2017, LUNG CANCER, V112, P90, DOI 10.1016/j.lungcan.2017.07.034; Yoshioka H, 2017, ANN ONCOL, V28, P285, DOI 10.1093/annonc/mdw621	17	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203070	10.1371/journal.pone.0203070	http://dx.doi.org/10.1371/journal.pone.0203070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153300	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700041
J	Wei, LH; Arastoo, M; Georgiou, I; Manning, DR; Riobo-Del Galdo, NA				Wei, Lan Ho; Arastoo, Mohammad; Georgiou, Ioanna; Manning, David R.; Riobo-Del Galdo, Natalia A.			Activation of the G(i) protein-RHOA axis by non-canonical Hedgehog signaling is independent of primary cilia	PLOS ONE			English	Article							MOUSE; RECEPTOR; SUBUNIT; GTPASES; LACKING; CANCER	Primary cilia are solitary organelles that emanate from the plasma membrane during growth arrest in almost all mammalian cells. The canonical Hedgehog (HH) pathway requires trafficking of the G protein-coupled receptor SMOOTHENED (SMO) and the GLI transcription factors to the primary cilium upon binding of a HH ligand to PATCHED1. However, it is unknown if activation of the small GTPase RHOA by SMO coupling to heterotrimeric G(i) proteins, a form of non-canonical HH signaling, requires localization of SMO in the primary cilium. In this study, we compared RHOA and G i protein stimulation by activation of SMO or sphingosine 1-phosphate receptor (SIP) receptors in WT and KIF3A-deficient mouse embryonic fibroblasts that lack primary cilia. We found that activation of SMO in response to Sonic HH (SHH) or purmorphamine (PUR), a small molecule agonist of SMO, stimulates G i proteins and RHOA independently of the presence of primary cilia, similar to the effects of SIP. However, while S1 P induced a fast activation of AKT that is sensitive to the G i inhibitor pertussis toxin, HH pathway activators did not significantly activate AKT, suggesting that RHOA activation is not downstream of AKT. Our findings demonstrate that early events in some forms of non-canonical HH signaling occur in extraciliary membranes, which might be particularly relevant for actively-cycling cells, for some cancers characterized by loss of primary cilia, and in ciliopathies.	[Wei, Lan Ho] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Arastoo, Mohammad; Georgiou, Ioanna; Riobo-Del Galdo, Natalia A.] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Manning, David R.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Riobo-Del Galdo, Natalia A.] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Arastoo, Mohammad] Univ Aberdeen, Scottish Biol Facil, Aberdeen, Scotland	Jefferson University; University of Leeds; University of Pennsylvania; Pennsylvania Medicine; University of Leeds; University of Aberdeen	Riobo-Del Galdo, NA (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England.; Riobo-Del Galdo, NA (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.	n.a.riobo-delgaldo@leeds.ac.uk	Galdo, Natalia Riobo-Del/AAP-2938-2020	Galdo, Natalia Riobo-Del/0000-0002-8942-7873; Arastoo, Mohammad/0000-0002-0805-4949	National Institute of General Medical Sciences [2 R01 GM080396-05A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080396] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the National Institute of General Medical Sciences (2 R01 GM080396-05A1 to DRM and NARDG; https://www.nigms.nih.gov/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijlsma MF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002798; Brennan D, 2012, VITAM HORM, V88, P55, DOI 10.1016/B978-0-12-394622-5.00003-1; Carbe CJ, 2014, AM J PHYSIOL-HEART C, V307, pH66, DOI 10.1152/ajpheart.00166.2014; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Haga Raquel B, 2016, Small GTPases, V7, P207; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Kono M, 2014, J CLIN INVEST, V124, P2076, DOI 10.1172/JCI71194; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Martinez-Chinchilla P, 2008, METHOD ENZYMOL, V446, P189, DOI 10.1016/S0076-6879(08)01611-X; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Plotnikova OV, 2008, CANCER RES, V68, P2058, DOI 10.1158/0008-5472.CAN-07-5838; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Teperino R, 2014, SEMIN CELL DEV BIOL, V33, P81, DOI 10.1016/j.semcdb.2014.05.007; Uschner FE, 2015, SCI REP-UK, V5, DOI 10.1038/srep14573; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828; Wu FJ, 2017, CELL CHEM BIOL, V24, P252, DOI 10.1016/j.chembiol.2017.02.010; Yuan X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11024	29	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203170	10.1371/journal.pone.0203170	http://dx.doi.org/10.1371/journal.pone.0203170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148884	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200050
J	Ge, WZ; Jiao, Y; Chang, LZ				Ge, Wenzhang; Jiao, Yang; Chang, Lianzhen			The association between MTHFR gene polymorphisms (C677T, A1298C) and oral squamous cell carcinoma: A systematic review and meta-analysis	PLOS ONE			English	Review							ABERRANT DNA METHYLATION; METHYLENETETRAHYDROFOLATE REDUCTASE C677T; CANCER RISK; FOLATE INTAKE; HMLH1 GENES; MGMT; COMBINATION; P16; GENOTYPE; IMPACT	A consensus has not been reached regarding the association of MTHFR gene polymorphism and susceptibility to oral squamous cell carcinoma (OSCC). We performed a metaanalysis to better evaluate the association between MTHFR C677T, A1298C polymorphism and OSCC risk. The studies regarding the association of MTHFR C677T, A1298C polymorphisms and OSCC were identified in PubMed and EMBASE and Google Scholar. The pooled odd rates (ORs) with 95% CIs were estimated using a fixed-effect or random-effect model. The associations between MTHFR polymorphisms and OSCC risk were assessed under the dominant, recessive and additive models. A collective total of 1539 OSCC patients and 2131 normal controls were included across 13 studies. The minor T allele of MTHFR C677T was significantly associated with the increased risk of OSCC development (OR = 1.35, 95% CI 1.04 +/- 1.76). Individuals carrying the `` T allele (TT+ CT) had a nearly 43% increased risk for OSCC development when compared with CC (OR = 1.43, 95% CI 1.02 +/- 1.99). Under additive model, the results also showed that individuals with CT or TT genotype were more susceptible to OSCC than CC (OR = 1.45, 95% CI 1.02 +/- 2.08; OR = 1.79, 95% CI 1.28 +/- 2.50; respectively). The subgroup analysis by ethnicity revealed that significant difference in C677T allele distribution could be observed in European (OR = 1.33, 95% CI 1.02 +/- 1.75) rather than Asian (OR = 1.59, 95% CI 0.91 +/- 2.78). No significant association of MTHFR A1298C polymorphism and OSCC risk could be observed. The present study revealed that T allele and TT genotype of MTHFR C677T polymorphism were significantly associated with the increased risk of OSCC development.	[Ge, Wenzhang] Jinan Stomatol Hosp, Dept Special Clin, Jinan, Shandong, Peoples R China; [Jiao, Yang] Jinan Stomatol Hosp, Dept Med & Educ, Jinan, Shandong, Peoples R China; [Chang, Lianzhen] Jinan Stomatol Hosp, Dept Periodont & Oral Med, Jinan, Shandong, Peoples R China		Chang, LZ (corresponding author), Jinan Stomatol Hosp, Dept Periodont & Oral Med, Jinan, Shandong, Peoples R China.	changlzoral@163.com						Addala L, 2013, AM J CANC RES CLIN O, DOI [10.7726/ajcrco.2013.1001, DOI 10.7726/AJCRCO.2013.1001]; [Anonymous], 2014, MEDITERRANEAN ONCOLO, V4, P34; Barbosa A, 2016, BRAZ J OTORHINOLAR, V82, P558, DOI 10.1016/j.bjorl.2015.10.012; Bezerra AM, 2014, MOL BIOL REP, V41, P7737, DOI 10.1007/s11033-014-3494-x; Botezatu A, 2013, J CELL MOL MED, V17, P543, DOI 10.1111/jcmm.12032; Chen J, 2012, ASIAN PAC J CANCER P, V13, P5303, DOI 10.7314/APJCP.2012.13.10.5303; Christensen KE, 2015, AM J CLIN NUTR, V101, P646, DOI 10.3945/ajcn.114.086603; Ferlazzo N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040724; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gonzalez-Moles MA, 2012, ORAL DIS, V18, P40, DOI 10.1111/j.1601-0825.2011.01845.x; He LL, 2017, ONCOTARGETS THER, V10, P227, DOI 10.2147/OTT.S121472; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia J, 2014, TUMOR BIOL, V35, P4943, DOI 10.1007/s13277-014-1650-5; Jiang S, 2017, ONCOTARGETS THER, V10, P303, DOI 10.2147/OTT.S124690; Jung AY, 2014, CANCER CAUSE CONTROL, V25, P1119, DOI 10.1007/s10552-014-0412-4; Kessler P, 2007, STRAHLENTHER ONKOL, V183, P184, DOI 10.1007/s00066-007-1469-8; Kingsley K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-87; Liu N, 2013, GENET MOL RES, V12, P5160, DOI 10.4238/2013.October.29.10; Ma E, 2009, NUTR CANCER, V61, P447, DOI 10.1080/01635580802610123; Miri-Moghaddam E, 2016, J ORAL PATHOL MED, V45, P96, DOI 10.1111/jop.12343; Naqvi H, 2017, CLIN ORAL INVEST, V21, P1929, DOI 10.1007/s00784-016-1976-z; Pelucchi C, 2003, ANN ONCOL, V14, P1677, DOI 10.1093/annonc/mdg448; Qin BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079580; Qin BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063401; Sailasree R, 2011, J ORAL PATHOL MED, V40, P61, DOI 10.1111/j.1600-0714.2010.00943.x; Singh PK, 2014, TUMOR BIOL, V35, P12275, DOI 10.1007/s13277-014-2538-0; Solomon PR, 2008, ORAL DIS, V14, P633, DOI 10.1111/j.1601-0825.2007.01437.x; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Supic G, 2011, J DENT RES, V90, P65, DOI 10.1177/0022034510385243; Tang C, 2018, J CANCER, V9, P1057, DOI 10.7150/jca.23391; Tang M, 2014, MOL BIOL REP, V41, P4659, DOI 10.1007/s11033-014-3337-9; Trimmer EE, 2013, CURR PHARM DESIGN, V19, P2574; Tsang BL, 2015, AM J CLIN NUTR, V101, P1286, DOI 10.3945/ajcn.114.099994; Vairaktaris E, 2006, J CANCER RES CLIN, V132, P219, DOI 10.1007/s00432-005-0065-5; Vylliotis A, 2013, ANTICANCER RES, V33, P4033; Wang JM, 2008, CANCER EPIDEM BIOMAR, V17, P118, DOI 10.1158/1055-9965.EPI-07-0733; Weinstein SJ, 2002, J NUTR, V132, P762, DOI 10.1093/jn/132.4.762; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Xiong HL, 2013, ASIAN PAC J CANCER P, V14, P3139, DOI 10.7314/APJCP.2013.14.5.3139; Xu LY, 2017, BIOSCIENCE REP, V37, DOI [10.1042/BSR20170917, 10.1042/bsr20170917]	42	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202959	10.1371/journal.pone.0202959	http://dx.doi.org/10.1371/journal.pone.0202959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142181	gold, Green Submitted, Green Published			2022-12-27	WOS:000442722500053
J	Last, BS; Lawson, GM; Breiner, K; Steinberg, L; Farah, MJ				Last, Briana S.; Lawson, Gwen M.; Breiner, Kaitlyn; Steinberg, Laurence; Farah, Martha J.			Childhood socioeconomic status and executive function in childhood and beyond	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ACADEMIC-ACHIEVEMENT; DIVERSITY; SYSTEMS; WEALTH; HEALTH; UNITY; TASK; GAP; AGE	Socioeconomic status (SES) predicts health, wellbeing, and cognitive ability, including executive function (EF). A body of recent work has shown that childhood SES is positively related to EF, but it is not known whether this disparity grows, diminishes or holds steady over development, from childhood through adulthood. We examined the association between childhood SES and EF in a sample ranging from 9 +/- 25 years of age, with six canonical EF tasks. Analyzing all of the tasks together and in functionally defined groups, we found positive relations between SES and EF, and the relations did not vary by age. Analyzing the tasks separately, SES was positively associated with performance in some but not all EF measures, depending on the covariates used, again without varying by age. These results add to a growing body of evidence that childhood SES is associated with EF abilities, and contribute novel evidence concerning the persistence of this association into early adulthood.	[Last, Briana S.; Lawson, Gwen M.; Farah, Martha J.] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA; [Breiner, Kaitlyn] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Steinberg, Laurence] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Breiner, Kaitlyn] Calif State Univ Dominguez Hills, Dept Child Dev, Carson, CA 90747 USA	University of Pennsylvania; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; California State University System; California State University Dominguez Hills	Last, BS (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	brishiri@sas.upenn.edu	Steinberg, Laurence/Y-2488-2019; Last, Briana/GYD-5057-2022	Last, Briana/0000-0002-5473-1357; Lawson, Gwendolyn/0000-0003-4363-3169	John D. and Catherine T. MacArthur Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH109433] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research is supported by a grant from the John D. and Catherine T. MacArthur Foundation. Its contents reflect the views of the authors, and do not necessarily represent the official views of either the John D. and Catherine T. MacArthur Foundation or the MacArthur Foundation Research Network on Law and Neuroscience (www.lawneuro.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Alys Ferragamo for her assistance in coding the Hollingshead occupation data. This research is supported by a grant from the John D. and Catherine T. MacArthur Foundation. Its contents reflect the views of the authors, and do not necessarily represent the official views of either the John D. and Catherine T. MacArthur Foundation or the MacArthur Foundation Research Network on Law and Neuroscience.	Barsky R, 2002, J AM STAT ASSOC, V97, P663, DOI 10.1198/016214502388618401; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bornstein MH, 2013, CHILD DEV, V84, P154, DOI 10.1111/j.1467-8624.2012.01849.x; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Chein JM, 2010, PSYCHON B REV, V17, P193, DOI 10.3758/PBR.17.2.193; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohen AO, 2016, PSYCHOL SCI, V27, P549, DOI 10.1177/0956797615627625; Cohen S, 2010, ANN NY ACAD SCI, V1186, P37, DOI 10.1111/j.1749-6632.2009.05334.x; Farah MJ, 2017, NEURON, V96, P56, DOI 10.1016/j.neuron.2017.08.034; French A., 2008, MULTIVARIATE ANAL VA; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Hackman DA, 2015, DEVELOPMENTAL SCI, V18, P686, DOI 10.1111/desc.12246; Hackman DA, 2014, CHILD DEV, V85, P1433, DOI 10.1111/cdev.12242; Hall PA, 2014, PREV MED, V68, P44, DOI 10.1016/j.ypmed.2014.07.008; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Hughes C, 2011, J EXP CHILD PSYCHOL, V108, P663, DOI 10.1016/j.jecp.2010.06.005; Johnson S. B., 2016, PEDIATRICS, V137, P2015; Lawson GM, 2017, DEVELOPMENTAL SCI, DOI [10.1111/j.1467-8624.2007.01019.x, DOI 10.1111/J.1467-8624.2007.01019.X]; Lawson GM, 2017, INT J BEHAV DEV, V41, P94, DOI 10.1177/0165025415603489; Levy DJ, 2016, AM PSYCHOL, V71, P455, DOI 10.1037/a0040322; Meyers L. S., 2006, APPL MULTIVARIATE RE; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Patterson J., 2011, ENCY CLIN NEUROPSYCH, P2603, DOI [10.1007/978-0- 387- 79948- 3_1423, DOI 10.1007/978-0-387-79948-3_1423, 10.1007/978-0-387-79948-3_1423]; Reardon SF, 2013, EDUC LEADERSHIP, V70, P10; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; STERNBERG S, 1969, AM SCI, V57, P421; Wechsler D., 2016, WECHSLER INTELLIGENC	29	38	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202964	10.1371/journal.pone.0202964	http://dx.doi.org/10.1371/journal.pone.0202964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142188	gold, Green Published, Green Submitted			2022-12-27	WOS:000442722500054
J	Schwedhelm, C; Knuppel, S; Schwingshackl, L; Boeing, H; Iqbal, K				Schwedhelm, Carolina; Knueppel, Sven; Schwingshackl, Lukas; Boeing, Heiner; Iqbal, Khalid			Meal and habitual dietary networks identified through Semiparametric Gaussian Copula Graphical Models in a German adult population	PLOS ONE			English	Article							NUTRIENT INTAKE; PATTERNS; BEHAVIOR; QUALITY; HEALTH	Gaussian graphical models (GGMs) are exploratory methods that can be applied to construct networks of food intake. Such networks were constructed for meal-structured data, elucidating how foods are consumed in relation to each other at meal level. Meal-specific networks were compared with habitual dietary networks using data from an EPIC-Potsdam sub-cohort study. Three 24-hour dietary recalls were collected cross-sectionally from 815 adults in 2010 +/- 2012. Food intake was averaged to obtain the habitual intake. GGMs were applied to four main meals and habitual intakes of 39 food groups to generate meal-specific and habitual dietary networks, respectively. Communities and centrality were detected in the dietary networks to facilitate interpretation. The breakfast network revealed five communities of food groups with other vegetables, sauces, bread, margarine, and sugar & confectionery as central food groups. The lunch and afternoon snacks networks showed higher variability in food consumption and six communities were detected in each of these meal networks. Among the central food groups detected in both of these meal networks were potatoes, red meat, other vegetables, and bread. Two dinner networks were identified with five communities and other vegetables as a central food group. Partial correlations at meals were stronger than on the habitual level. The meal-specific dietary networks were only partly reflected in the habitual dietary network with a decreasing percentage: 64.3% for dinner, 50.0% for breakfast, 36.2% for lunch, and 33.3% for afternoon snack. The method of GGM yielded dietary networks that describe combinations of foods at the respective meals. Analysing food consumption on the habitual level did not exactly reflect meal level intake. Therefore, interpretation of habitual networks should be done carefully. Meal networks can help understand dietary habits, however, GGMs warrant validation in other populations.	[Schwedhelm, Carolina; Knueppel, Sven; Schwingshackl, Lukas; Boeing, Heiner; Iqbal, Khalid] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Epidemiol, Nuthetal, Germany; [Schwedhelm, Carolina; Schwingshackl, Lukas; Boeing, Heiner; Iqbal, Khalid] NutriAct Competence Cluster Nutr Res Berlin Potsd, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Schwedhelm, C (corresponding author), German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Epidemiol, Nuthetal, Germany.; Schwedhelm, C (corresponding author), NutriAct Competence Cluster Nutr Res Berlin Potsd, Nuthetal, Germany.	carolina.schwedhelm@dife.de	Schwingshackl, Lukas/AAC-4119-2019; Schwedhelm, Carolina/AAE-6756-2022; Knüppel, Sven/AAI-7195-2020; Iqbal, Khalid/AAD-7112-2022	Schwingshackl, Lukas/0000-0003-3407-7594; Knüppel, Sven/0000-0001-9006-9906; Iqbal, Khalid/0000-0002-3312-4259	German Federal Ministry of Education and Research, Germany (BMBF) [01ER0808, 01EA1408A]; Open Access Fund of the Leibniz Association	German Federal Ministry of Education and Research, Germany (BMBF); Open Access Fund of the Leibniz Association	This study was funded by the German Federal Ministry of Education and Research, Germany, https://www.bmbf.de/ (BMBF, 01ER0808 and 01EA1408A). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Human Study Centre (HSC) of the German Institute of Human Nutrition Potsdam-Rehbruecke for the collection, the data hub for the processing, the participants for the provision of the data. We would also like to thank Manuela Bergman, head of the HSC, for the contribution to the study design and data generation, and Ellen Kohlsdorf for data handling and technical assistance. The publication of this article was funded by the Open Access Fund of the Leibniz Association.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; [Anonymous], 2012, INTRO GRAPHICAL MODE; Ares G, 2007, APPETITE, V49, P148, DOI 10.1016/j.appet.2007.01.006; Arndt S, 1999, J PSYCHIAT RES, V33, P97, DOI 10.1016/S0022-3956(98)90046-2; Bishara AJ, 2012, PSYCHOL METHODS, V17, P399, DOI 10.1037/a0028087; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Camntech, 2017, ACT US MAN VERS 4 0; DeGregory KW, 2018, OBES REV, V19, P668, DOI 10.1111/obr.12667; Floegel A, 2014, INT J OBESITY, V38, P1388, DOI 10.1038/ijo.2014.39; Forbes MK, 2017, J ABNORM PSYCHOL, V126, P969, DOI 10.1037/abn0000276; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Haardorfer R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2764-z; Haubrock J, 2011, J NUTR, V141, P914, DOI 10.3945/jn.109.120394; Hearty AP, 2007, APPETITE, V48, P1, DOI 10.1016/j.appet.2006.03.329; Hearty AP, 2008, AM J CLIN NUTR, V88, P1632, DOI 10.3945/ajcn.2008.26619; Honorio J, 2012, VARIABLE SELECTION G, P538; Iqbal K, 2017, EUR J CLIN NUTR, V71, P1312, DOI 10.1038/ejcn.2017.116; Iqbal K, 2018, EUROPEAN J NUTR; Iqbal K, 2016, J NUTR, V146, P646, DOI 10.3945/jn.115.221135; Kalinka AT, 2014, GENERATION VISUALIZA, P1; Keller K, 2014, APPETITE, V83, P63, DOI 10.1016/j.appet.2014.08.012; Kramer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-384; Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262; Liu H., 2012, ARXIV12066488; Liu H, 2012, ANN STAT, V40, P2293, DOI 10.1214/12-AOS1037; Liu H, 2009, J MACH LEARN RES, V10, P2295; Milliron BJ, 2014, J ACAD NUTR DIET, V114, P932, DOI 10.1016/j.jand.2013.08.015; Neamat-Allah J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091586; Ocke MC, 2013, P NUTR SOC, V72, P191, DOI 10.1017/S0029665113000013; POSNER BM, 1992, EPIDEMIOLOGY, V3, P171, DOI 10.1097/00001648-199203000-00016; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schulz M, 2008, BRIT J NUTR, V100, P942, DOI 10.1017/S0007114508966149; Schwedhelm C, 2018, AM J CLIN NUTR; Shimamura T, 2007, GENOME INFORM SER, V19, P142; Siega-Riz AM, 2014, AM J CLIN NUTR, V99, P1487, DOI 10.3945/ajcn.113.082685; Staedler N, 2015, PACKAGE NETHET; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Vainik U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144134; Voss S, 1998, Z ERNAHRUNGSWISS, V37, P227, DOI 10.1007/s003940050021; Woolhead C, 2015, AM J CLIN NUTR, V102, P316, DOI 10.3945/ajcn.114.106112; Yates L, 2015, APPETITE, V84, P299, DOI 10.1016/j.appet.2014.10.017; Zhao, 2015, PACKAGE HUGE	43	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202936	10.1371/journal.pone.0202936	http://dx.doi.org/10.1371/journal.pone.0202936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142191	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500051
J	Ranasinghe, SL; Boyle, GM; Fischer, K; Potriquet, J; Mulvenna, JP; McManus, DP				Ranasinghe, Shiwanthi L.; Boyle, Glen M.; Fischer, Katja; Potriquet, Jeremy; Mulvenna, Jason P.; McManus, Donald P.			Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer	PLOS ONE			English	Article							CELL; NEUTROPHILS; PEGYLATION; MIGRATION; PROTEINS; DRUGS; ASSAY	EgKI-1, a member of the Kunitz type protease inhibitor family, is highly expressed by the oncosphere of the canine tapeworm Echinococcus granulosus, the stage that is infectious to humans and ungulates, giving rise to a hydatid cyst localized to the liver and other organs. Larval protoscoleces, which develop within the hydatid cyst, have been shown to possess anti-cancer properties, although the precise molecules involved have not been identified. We show that recombinant EgKI-1 inhibits the growth and migration of a range of human cancers including breast, melanoma and cervical cancer cell lines in a dose-dependent manner in vitro without affecting normal cell growth. Furthermore, EgKI-1 treatment arrested the cancer cell growth by disrupting the cell cycle and induced apoptosis of cancer cells in vitro. An in vivo model of triple negative breast cancer (MDA-MB-231) in BALB/c nude mice showed significant tumor growth reduction in EgKI-1-treated mice compared with controls. These findings indicate that EgKI-1 shows promise for future development as an anti-cancer therapeutic.	[Ranasinghe, Shiwanthi L.; McManus, Donald P.] QIMR Berghofer Med Res Inst, Immunol Dept, Mol Parasitol Lab, Brisbane, Qld, Australia; [Boyle, Glen M.] QIMR Berghofer Med Res Inst, Cell & Mol Biol Dept, Canc Drug Mech Grp, Brisbane, Qld, Australia; [Fischer, Katja] QIMR Berghofer Med Res Inst, Cell & Mol Biol Dept, Scabies Grp, Brisbane, Qld, Australia; [Potriquet, Jeremy] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Australia; [Mulvenna, Jason P.] QIMR Berghofer Med Res Inst, Biomarkers & Biol Infect Related Cancers Lab, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; James Cook University; QIMR Berghofer Medical Research Institute	Ranasinghe, SL (corresponding author), QIMR Berghofer Med Res Inst, Immunol Dept, Mol Parasitol Lab, Brisbane, Qld, Australia.	shiwanthi.ranasinghe@qimrberghofer.edu.au	Boyle, Glen/G-1347-2013; Fischer, Katja/H-4989-2014; McManus, Don/AAC-5394-2020	Boyle, Glen/0000-0002-1385-529X; Fischer, Katja/0000-0003-3408-3337; McManus, Don/0000-0001-6443-1449	Australian National Health and Medical Research Council (NHMRC) [APP1037304]; Senior Scientist at QIMR Berghofer	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Senior Scientist at QIMR Berghofer	This project was funded by program (APP1037304 to DPM) from the Australian National Health and Medical Research Council (NHMRC). DPM is a NHMRC Senior Principal Research Fellow and Senior Scientist at QIMR Berghofer.	Atayde VD, 2008, MELANOMA RES, V18, P172, DOI 10.1097/CMR.0b013e3282feeaab; Baig S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.275; Bergstrom FC, 2009, J IMMUNOL, V182, P7809, DOI 10.4049/jimmunol.0804205; Boyle GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108887; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Comsa S, 2015, ANTICANCER RES, V35, P3147; Craig PS, 2003, PARASITOLOGY, V127, pS5, DOI 10.1017/S0031182003004384; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Tong HV, 2017, EBIOMEDICINE, V15, P12, DOI 10.1016/j.ebiom.2016.11.034; Ivankovic M, 2007, BIOGERONTOLOGY, V8, P163, DOI 10.1007/s10522-006-9043-9; Kintzing JR, 2016, TRENDS PHARMACOL SCI, V37, P993, DOI 10.1016/j.tips.2016.10.005; Kruger N J, 1994, Methods Mol Biol, V32, P9; Li LT, 2015, MOL MED REP, V11, P1566, DOI 10.3892/mmr.2014.2914; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mattheolabakis G, 2014, J PHARMACOL EXP THER, V351, P61, DOI 10.1124/jpet.114.217208; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Mishra P, 2016, ASIAN J PHARM SCI, V11, P337, DOI 10.1016/j.ajps.2015.08.011; Paul CD, 2017, NAT REV CANCER, V17, P131, DOI 10.1038/nrc.2016.123; Pellegrini M, 2013, CASPASES BCL 2 FAMIL; Ponce D, 2016, TOXINS, V8, DOI 10.3390/toxins8040102; Potriquet J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175967; Qi WJ, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-3; RANASINGHE S, 2016, TREATMENT INFLAMMATI; Ranasinghe SL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004268; Rayburn Elizabeth R, 2009, Mol Cell Pharmacol, V1, P29; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Schubert OT, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.015; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shirzad H, 2012, TOXOPLASMA GONDII NO; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; So E. Y., 2013, J CANC BIOL RES, V1, P1; Srikanth S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00470; Toomey P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068561; Uribe-Querol E, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/983698; Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030; Wei BJ, 2016, ONCOTARGETS THER, V9, P5567, DOI 10.2147/OTT.S108419; Wittrup KD, 2012, METHOD ENZYMOL, V503, P255, DOI 10.1016/B978-0-12-396962-0.00010-0; Young RE, 2007, BRIT J PHARMACOL, V151, P628, DOI 10.1038/sj.bjp.0707267; Yousofi Darani Hossein, 2012, J Parasitol Res, V2012, P304183, DOI 10.1155/2012/304183	47	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0200433	10.1371/journal.pone.0200433	http://dx.doi.org/10.1371/journal.pone.0200433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169534	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000443374400003
J	Rule, AM; Apau, O; Ahrenholz, SH; Brueck, SE; Lindsley, WG; de Perio, MA; Noti, JD; Shaffer, RE; Rothman, R; Grigorovitch, A; Noorbakhsh, B; Beezhold, DH; Yorio, PL; Perl, TM; Fisher, EM				Rule, Ana M.; Apau, Otis; Ahrenholz, Steven H.; Brueck, Scott E.; Lindsley, William G.; de Perio, Marie A.; Noti, John D.; Shaffer, Ronald E.; Rothman, Richard; Grigorovitch, Alina; Noorbakhsh, Bahar; Beezhold, Donald H.; Yorio, Patrick L.; Perl, Trish M.; Fisher, Edward M.			Healthcare personnel exposure in an emergency department during influenza season	PLOS ONE			English	Article							FILTERING FACEPIECE RESPIRATORS; VIRUS; STATES	Introduction Healthcare personnel are at high risk for exposure to influenza by direct and indirect contact, droplets and aerosols, and by aerosol generating procedures. Information on air and surface influenza contamination is needed to assist in developing guidance for proper prevention and control strategies. To understand the vulnerabilities of healthcare personnel, we measured influenza in the breathing zone of healthcare personnel, in air and on surfaces within a healthcare setting, and on filtering facepiece respirators worn by healthcare personnel when conducting patient care. Methods Thirty participants were recruited from an adult emergency department during the 2015 influenza season. Participants wore personal bioaerosol samplers for six hours of their work shift, submitted used filtering facepiece respirators and medical masks and completed questionnaires to assess frequency and types of interactions with potentially infected patients. Room air samples were collected using bioaerosol samplers, and surface swabs were collected from high-contact surfaces within the adult emergency department. Personal and room bioaerosol samples, surface swabs, and filtering facepiece respirators were analyzed for influenza A by polymerase chain reaction. Results Influenza was identified in 42% (53/125) of personal bioaerosol samples, 43% (28/96) of room bioaerosol samples, 76% (23/30) of pooled surface samples, and 25% (3/12) of the filtering facepiece respirators analyzed. Influenza copy numbers were greater in personal bioaerosol samples (17 to 631 copies) compared to room bioaerosol samples (16 to 323 copies). Regression analysis suggested that the amount of influenza in personal samples was approximately 2.3 times the amount in room samples (Wald chi 2 = 16.21, p<0.001). Conclusions Healthcare personnel may encounter increased concentrations of influenza virus when in close proximity to patients. Occupations that require contact with patients are at an increased risk for influenza exposure, which may occur throughout the influenza season. Filtering facepiece respirators may become contaminated with influenza when used during patient care.	[Rule, Ana M.; Apau, Otis; Grigorovitch, Alina] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA; [Ahrenholz, Steven H.; Brueck, Scott E.; de Perio, Marie A.] NIOSH, DSHEFS, Cincinnati, OH 45226 USA; [Lindsley, William G.; Noti, John D.; Noorbakhsh, Bahar; Beezhold, Donald H.] NIOSH, HELD, Morgantown, WV USA; [Shaffer, Ronald E.; Yorio, Patrick L.; Fisher, Edward M.] NIOSH, NPPTL, Pittsburgh, PA 15222 USA; [Rothman, Richard] Johns Hopkins Univ Hosp, Adult Emergency Dept, Baltimore, MD 21287 USA; [Perl, Trish M.] UT Southwestern Med Ctr, Div Infect Dis, Dallas, TX USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Fisher, EM (corresponding author), NIOSH, NPPTL, Pittsburgh, PA 15222 USA.	fxw7@cdc.gov	Shaffer, Ronald/ABI-6508-2020	Shaffer, Ronald/0000-0001-6352-7967; Lindsley, William/0000-0003-0720-5829	Centers for Disease Control and Prevention; NIH [HHSN272201400007C];  [BARDA 1 IDSEP130014-01-00]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This research was funded by the Centers for Disease Control and Prevention and in part by BARDA 1 IDSEP130014-01-00 and NIH HHSN272201400007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrenholz SH, 2018, J OCCUP ENV HYG; Aizenberg V, 2000, AM IND HYG ASSOC J, V61, P398, DOI 10.1080/15298660008984550; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P281; [Anonymous], 2021, HIV US GLANC; Appiah GD, 2015, MMWR-MORBID MORTAL W, V64, P583; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Blachere FM, 2011, J VIROL METHODS, V176, P120, DOI 10.1016/j.jviromet.2011.05.030; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brady TM, 2017, J OCCUP ENVIRON HYG, V14, P898, DOI 10.1080/15459624.2017.1346799; *CDCP, 2009, FLUVIEW 2008 2009 IN; Centers for Disease Control and P, 2008, 2007 2008 INFL FLU S; Centers for Disease Control and Prevention, INT GUID US MASKS CO; Centers for Disease Control and Prevention, 2014, RECOMMENDED GUIDANCE; Centers for Disease Control and Prevention, 2014, EST INFL ILLN HOSP A; Cummings KJ, 2014, J INFECT DIS; Fisher EM, 2014, J OCCUP ENVIRON HYG, V11, pD115, DOI 10.1080/15459624.2014.902954; Glaser CA, 2002, EMERG INFECT DIS, V8, P569, DOI 10.3201/eid0806.010370; Heimbuch BK, 2016, J OCCUP ENVIRON HYG, V13, pD11, DOI 10.1080/15459624.2015.1091966; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Killingley B, 2011, J INFECT DIS; Killingley B, 2016, J INFECT PUBLIC HEAL, V9, P278, DOI 10.1016/j.jiph.2015.10.009; Kuster SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026239; Leung NHL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148669; Li J, 2017, OPEN FORUM INFECT DI, V4, pS34; Lietz J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162061; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Luksamijarulkul Pipat, 2014, Oman Med J, V29, P346, DOI 10.5001/omj.2014.92; Mubareka S, 2015, J CLIN VIROL, V73, P105, DOI 10.1016/j.jcv.2015.11.002; Nikitin N, 2014, ADV VIROL, V2014, DOI 10.1155/2014/859090; Occupational Safety Health Administration (OSHA), 2007, PAND INFL PREP RESP PAND INFL PREP RESP; Peterson K, 2015, AM J INFECT CONTROL, V43, P63, DOI 10.1016/j.ajic.2014.10.008; Santos CD, 2010, DISASTER MED PUBLIC, V4, P47, DOI 10.1017/S193578930000241X; Tang JW, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020238; Tang JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107338; Thompson KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056278; Wise ME, 2011, CLIN INFECT DIS, V52, pS198, DOI 10.1093/cid/ciq038	36	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203223	10.1371/journal.pone.0203223	http://dx.doi.org/10.1371/journal.pone.0203223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169507	gold, Green Published, Green Submitted			2022-12-27	WOS:000443374400026
J	Fuseya, Y; Muro, S; Sato, S; Tanabe, N; Sato, A; Tanimura, K; Hasegawa, K; Uemasu, K; Kubo, T; Kido, A; Fujimoto, K; Fushimi, Y; Kusahara, H; Sakashita, N; Ohno, Y; Togashi, K; Mishima, M; Hirai, T				Fuseya, Yoshinori; Muro, Shigeo; Sato, Susumu; Tanabe, Naoya; Sato, Atsuyasu; Tanimura, Kazuya; Hasegawa, Koichi; Uemasu, Kiyoshi; Kubo, Takeshi; Kido, Aki; Fujimoto, Koji; Fushimi, Yasutaka; Kusahara, Hiroshi; Sakashita, Naotaka; Ohno, Yoshiharu; Togashi, Kaori; Mishima, Michiaki; Hirai, Toyohiro			Complementary regional heterogeneity information from COPD patients obtained using oxygen-enhanced MRI and chest CT	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LOW ATTENUATION AREAS; LUNG-FUNCTION; COMPUTED-TOMOGRAPHY; DIFFUSING-CAPACITY; EMPHYSEMA; HYPOXEMIA; THERAPY; PROGRESSION; MORTALITY	Background The heterogeneous distribution of emphysema is a key feature of chronic obstructive pulmonary disease (COPD) patients that typically is evaluated using high-resolution chest computed tomography (HRCT). Oxygen-enhanced pulmonary magnetic resonance imaging (OEMRI) is a new method to obtain information regarding regional ventilation, diffusion, and perfusion in the lung without radiation exposure. We aimed to compare OEMRI with HRCT for the assessment of heterogeneity in COPD patients. Methods Forty patients with stable COPD underwent quantitative HRCT, OEMRI, and pulmonary function tests, including arterial blood gas analysis. OEMRI was also performed on nine healthy control subjects. We measured the severity of emphysema (percent low attenuation volume; LAV%) in whole lungs and the standard deviations (SDs) of the LAV% values of 10 isovolumetric partitions (SD-LAV) as an index of cranial-caudal heterogeneity. Similarly, relative enhancement ratios of oxygen (RERs) in whole lungs from OEMRI and SD-RER were analyzed. Results COPD patients showed a lower mean RER than control subjects (12.6% vs 22.0%, p<0.01). The regional heterogeneity of the RERs was not always consistent with the LAV distribution. Both the HRCT (LAV% and SD-LAV) and the OEMRI (RER and SD-RER) indices were significantly associated with the diffusion capacity (DLCO) and partial pressure of oxygen in arterial blood (PaO2). The PaO2 was associated only with the heterogeneity index of HRCT (SD-LAV) (R-2 = 0.39); however, the PaO2 was associated with both the mean RER and heterogeneity (SD-RER) in the multivariate analysis (R-2 = 0.38). Conclusions OEMRI-derived parameters were directly associated with oxygen uptake in COPD patients. Although the OEMRI-derived parameters were not identical to the HRCT-derived parameters, the cranial-caudal heterogeneity in HRCT or OEMRI was complementary to that in evaluations of oxygen uptake in the lungs. Functional imaging seems to provide new insights into COPD pathophysiology without radiation exposure.	[Fuseya, Yoshinori; Muro, Shigeo; Sato, Susumu; Tanabe, Naoya; Sato, Atsuyasu; Tanimura, Kazuya; Hasegawa, Koichi; Uemasu, Kiyoshi; Mishima, Michiaki; Hirai, Toyohiro] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Kubo, Takeshi; Kido, Aki; Fujimoto, Koji; Fushimi, Yasutaka; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Kusahara, Hiroshi; Sakashita, Naotaka] Toshiba Med Syst Corp, Otawara, Tochigi, Japan; [Ohno, Yoshiharu] Kobe Univ, Grad Sch Med, Dept Radiol, Div Funct & Diagnost Imaging Res, Kobe, Hyogo, Japan; [Ohno, Yoshiharu] Kobe Univ, Adv Biomed Imaging Res Ctr, Grad Sch Med, Kobe, Hyogo, Japan	Kyoto University; Kyoto University; Toshiba Corporation; Kobe University; Kobe University	Muro, S; Sato, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	smuro@kuhp.kyoto-u.ac.jp; ssato@kuhp.kyoto-u.ac.jp	Fushimi, Yasutaka/L-8922-2017; Sato, Atsuyasu/H-9690-2016; Sato, Susumu/R-8976-2019; Ohno, Yoshiharu/AAE-2970-2020	Fushimi, Yasutaka/0000-0002-1982-3168; Sato, Atsuyasu/0000-0001-8068-9984; Sato, Susumu/0000-0002-9626-1090; Tanimura, Kazuya/0000-0002-3406-9394; Uemasu, Kiyoshi/0000-0002-5818-3028; Kido, Aki/0000-0001-5131-2870	Ministry of Education, Culture, Sports, Science and Technology, Japan [25461156]; Toshiba Medical Systems Incorporated, Japan [150100700014]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toshiba Medical Systems Incorporated, Japan	This study is supported by a Grant-in-Aid for Scientific Research (25461156) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a sponsored research program "Research for improvement of MR visualization" (No.150100700014) provided to Professor Kaori Togashi by Toshiba Medical Systems Incorporated, Japan. The funder provided support in the form of salaries for authors [N.S. and H.K.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cardus J, 1997, AM J RESP CRIT CARE, V156, P648, DOI 10.1164/ajrccm.156.2.9606016; Coxson HO, 2014, AM J RESP CRIT CARE, V190, P135, DOI 10.1164/rccm.201402-0256PP; de Torres JP, 2011, CHEST, V139, P36, DOI 10.1378/chest.10-0984; Gietema HA, 2010, RESP MED, V104, P76, DOI 10.1016/j.rmed.2009.08.004; GOULD GA, 1991, EUR RESPIR J, V4, P141; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Ito I, 2005, AM J RESP CRIT CARE, V172, P1378, DOI 10.1164/rccm.200506-953OC; Kent BD, 2011, INT J CHRONIC OBSTR, V6, P199, DOI 10.2147/COPD.S10611; Kim DK, 2011, RESP MED, V105, P1211, DOI 10.1016/j.rmed.2011.02.015; Kim Victor, 2008, Proc Am Thorac Soc, V5, P513, DOI 10.1513/pats.200708-124ET; Laszlo G, 2006, THORAX, V61, P744, DOI 10.1136/thx.2006.061648; Madani A, 2008, RADIOLOGY, V248, P1036, DOI 10.1148/radiol.2483071434; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Muller CJ, 2002, RADIOLOGY, V222, P499, DOI 10.1148/radiol.2222000869; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nakano Y, 1999, THORAX, V54, P384, DOI 10.1136/thx.54.5.384; Ogawa E, 2009, THORAX, V64, P20, DOI 10.1136/thx.2008.097543; Ohno Y, 2005, RADIOLOGY, V236, P704, DOI 10.1148/radiol.2361040005; Ohno Y, 2001, EUR J RADIOL, V37, P164, DOI 10.1016/S0720-048X(00)00299-0; Ohno Y, 2008, AM J RESP CRIT CARE, V177, P1095, DOI 10.1164/rccm.200709-1322OC; Ohno Y, 2007, EUR J RADIOL, V64, P320, DOI 10.1016/j.ejrad.2007.08.006; Okubadejo AA, 1996, THORAX, V51, P44, DOI 10.1136/thx.51.1.44; Petersson J, 2014, EUR RESPIR J, V44, P1023, DOI 10.1183/09031936.00037014; SAKAI N, 1994, CHEST, V106, P1319, DOI 10.1378/chest.106.5.1319; Stadler A, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/23624; Stavngaard T, 2006, ACTA RADIOL, V47, P914, DOI 10.1080/02841850600917170; Stolk J, 2007, EUR RESPIR J, V29, P1138, DOI 10.1183/09031936.00056206; Stoller JK, 2010, CHEST, V138, P179, DOI 10.1378/chest.09-2555; Tanabe N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044993; Tanabe N, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-31; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; WAKAYAMA K, 1993, EUR RESPIR J, V6, P1362	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203273	10.1371/journal.pone.0203273	http://dx.doi.org/10.1371/journal.pone.0203273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161221	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900099
J	Fuss, J; Uhlig, G; Bohme, M				Fuss, Jochen; Uhlig, Gregor; Boehme, Madeleine			Earliest evidence of caries lesion in hominids reveal sugar-rich diet fora Middle Miocene dryopithecine from Europe	PLOS ONE			English	Article							URIC-ACID LEVELS; DENTAL-CARIES; ENAMEL THICKNESS; CENTRAL PARATETHYS; FAT ACCUMULATION; PATHOLOGIES; PRIMATES; FRUCTOSE; HUMANS; MICROSTRUCTURE	The formation of dental caries is mainly caused by dietary habits and therefore, may contain information for dietary reconstructions of fossil hominids. This study investigates the caries lesion in the 12.5 Ma old type specimen of Dryopithecus carinthiacus Mottl 1957 (Primates, Hominidae) from St. Stefan (Austria). Potential food sources are identified on associated palynological data, which allow conclusions about food quality, sugar availability and the hominid metabolism during the Middle Miocene. Using micro computed tomography (pCT) and scanning electron microscopy (SEM) we provide a detailed analysis and characterization of the individuals' caries type. Its lesion is compared with a dataset of 311 wild chimpanzees, indicating morphological and etiological differences in caries formation between both species. The affected molar of D. carinthiacus reveals features known from severe dental caries in humans: (1) Cavitation with steep walls and smooth surface; (2) Reparative dentine at the roof of the pulp chamber; (3) Sclerotic dentine below the cavitation; (4) Association with dental calculus and (5) Unilateral usage of the healthy right tooth row. Its advanced primary caries, initiating on the intact enamel surface, indicates a frequent intake of highly cariogenic sugar-rich fruits, which likely exceeds the frugivory of extant chimpanzees. This finding corresponds with the associated palynological record, which infers a habitat with nearly yearround supply (9-10 months/year) of high quality foods (>carbohydrates; < fibers). Our conclusions challenge the model of a step-wise increase in dietary quality during hominid evolution and support the uricase hypothesis, which discusses the hominid autapomorphy of a fructose-based fat accumulation for periods of starvation. This model receives further validation by the identification of soft-tissue preservation, interpreted as fossilized white adipose cells, in the articulated hominid skeleton of Oreopithecus bamboli from Italy.	[Fuss, Jochen; Boehme, Madeleine] Eberhard Karls Univ Tubingen, Dept Geosci, Tubingen, Germany; [Fuss, Jochen; Boehme, Madeleine] Senckenberg Ctr Human Evolut & Palaeoenvironm HEP, Tubingen, Germany; [Uhlig, Gregor] Tech Univ Dresden, Dept Chem & Food Chem, Dresden, Germany	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Technische Universitat Dresden	Fuss, J (corresponding author), Eberhard Karls Univ Tubingen, Dept Geosci, Tubingen, Germany.; Fuss, J (corresponding author), Senckenberg Ctr Human Evolut & Palaeoenvironm HEP, Tubingen, Germany.	jochen.fuss@uni-tuebingen.de						Abraham A, 2014, J NEUROL, V261, P1133, DOI 10.1007/s00415-014-7331-x; Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Aiglstorfer M, 2014, PALAEOBIO PALAEOENV, V94, P83, DOI 10.1007/s12549-013-0141-9; Alba DM, 2010, P ROY SOC B-BIOL SCI, V277, P2237, DOI 10.1098/rspb.2010.0218; Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ANDREWS P, 1991, PHILOS T R SOC B, V334, P199, DOI 10.1098/rstb.1991.0109; Andrews P., 1996, P168; Arens U, 1998, REPORT BRIT NUTR FDN; Ayaz F. A., 2000, Journal of Food Composition and Analysis, V13, P171, DOI 10.1006/jfca.1999.0868; Bairlein F, 2002, NATURWISSENSCHAFTEN, V89, P1, DOI 10.1007/s00114-001-0279-6; Bartol M, 2014, PALAEOGEOGR PALAEOCL, V394, P144, DOI 10.1016/j.palaeo.2013.12.009; Bassier H, 1964, KOHLEFLOZE LAVANTTAL; BATES B C, 1970, Primates, V11, P271, DOI 10.1007/BF01793893; Bechtel A, 2007, INT J COAL GEOL, V70, P325, DOI 10.1016/j.coal.2006.07.002; Beck-Mannagetta P, 1952, JB GEOL B A; Begun David R., 1994, Yearbook of Physical Anthropology, V37, P11; Begun DR, 2002, CAM S BIO EVOL ANTHR, V33, P339; Begun DR, 1998, AM J PHYS ANTHROPOL, V105, P279, DOI 10.1002/(SICI)1096-8644(199803)105:3<279::AID-AJPA2>3.0.CO;2-N; BERGER WALTER, 1955, NEUES JAHRB GEOL U PALAONTOL ABHANDL, V100, P402; Bohme M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177347; Bohme M, 2011, J HUM EVOL, V61, P332, DOI 10.1016/j.jhevol.2011.04.012; Bohme M, 2008, EARTH PLANET SC LETT, V275, P393, DOI 10.1016/j.epsl.2008.09.011; Brothwell D.R., 1963, DENT ANTHR, P271; Burgos Nohemi Sala, 2007, Coloquios de Paleontologia, V57, P7; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Conklin-Brittain Nancy Lou, 2002, P61; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; CROVELLA S, 1994, PRIMATES, V35, P225, DOI 10.1007/BF02382058; DeMiguel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097442; Fleagle JG, 2013, PRIMATE ADAPTION EVO; Fuss J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177127; Galbany J., 2004, ANTHROPOLOGIE, V42, P13; Gierlinaki GD, 2017, P GEOLOGISTS ASS; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Grimsson F, 2016, GRANA, V55, P101, DOI 10.1080/00173134.2015.1096566; Grimsson F, 2015, GRANA, V54, P85, DOI 10.1080/00173134.2015.1007081; Grimsson F, 2011, GRANA, V50, P262, DOI 10.1080/00173134.2011.641450; Grimsson F, 2011, GRANA, V50, P102, DOI 10.1080/00173134.2011.585804; GRINE FE, 1990, ARCH ORAL BIOL, V35, P381, DOI 10.1016/0003-9969(90)90185-D; Han Kang-xin, 2002, Acta Anthropologica Sinica, V21, P191; Hanya G, 2013, PRIMATES, V54, P101, DOI 10.1007/s10329-012-0341-3; Harzhauser M., 2004, STRATIGRAPHY, V1, P65; Harzhauser M, 2007, PALAEOGEOGR PALAEOCL, V253, P8, DOI 10.1016/j.palaeo.2007.03.031; Heizmann EPJ, 2001, J HUM EVOL, V41, P463, DOI 10.1006/jhev.2001.0495; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Hershkovitz I, 1997, J HUM EVOL, V33, P507, DOI 10.1006/jhev.1997.0149; Hillson S., 2008, TECHNIQUE APPL DENT, P111, DOI [10.1017/CBO9780511542442.006, DOI 10.1017/CBO9780511542442.006]; Hillson S, 1996, DENT ANTHR, P254; Humphrey LT, 2013, PNAS, V111, P954; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Johnson RJ, 2010, EVOL ANTHROPOL, V19, P250, DOI 10.1002/evan.20266; Johnson Richard J, 2010, Trans Am Clin Climatol Assoc, V121, P295; KAY RF, 1977, NATURE, V268, P628, DOI 10.1038/268628a0; Kear BP, 2001, ALCHERINGA, V25, P387, DOI 10.1080/03115510108619228; Keizman D, 2009, J NEUROL SCI, V285, P95, DOI 10.1016/j.jns.2009.06.002; Kelley J, 2002, J HUM EVOL, V42, P39, DOI 10.1006/jhev.2001.0504; Kemp Anne, 2013, P499; KILGORE L, 1989, AM J PHYS ANTHROPOL, V80, P219, DOI 10.1002/ajpa.1330800210; Klaus W., 1984, BEITRAGE PALAONTOLOG, V11, P289; Kratzer JT, 2014, P NATL ACAD SCI USA, V111, P3763, DOI 10.1073/pnas.1320393111; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Lacy SA, 2014, INT J PALEOPATHOL, V7, P57, DOI 10.1016/j.ijpp.2014.06.005; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Lanaspa MA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047948, 10.1371/journal.pone.0048801]; Lanfranco L.P., 2012, CONT APPROACH DENT C, DOI DOI 10.1111/j.1601-0825.2009.01624.x; LEAKEY RE, 1986, NATURE, V324, P143, DOI 10.1038/324143a0; Lingstrom P, 2000, CRIT REV ORAL BIOL M, V11, P366, DOI 10.1177/10454411000110030601; Lukacs JR, 2006, AM J HUM BIOL, V18, P540, DOI 10.1002/ajhb.20530; Lukacs JR, 2011, CLIN ORAL INVEST, V15, P649, DOI 10.1007/s00784-010-0445-3; Mahapatra A., 2012, ADV J FOOD SCI TECHN, V4, P15; MAIER W, 1981, Zeitschrift fuer Morphologie und Anthropologie, V72, P127; MAIER W, 1982, J HUM EVOL, V11, P693, DOI 10.1016/S0047-2484(82)80057-2; Margvelashvili A, 2016, AM J PHYS ANTHROPOL, V160, P229, DOI 10.1002/ajpa.22966; Marlowe FW, 2014, J HUM EVOL, V71, P119, DOI 10.1016/j.jhevol.2014.03.006; Marsh P., 2016, UNDERSTANDING DENT C; Martin LB, 2003, J HUM EVOL, V45, P351, DOI 10.1016/j.jhevol.2003.08.005; Martin SL, 2008, DIABETES VASC DIS RE, V5, P76, DOI 10.3132/dvdr.2008.013; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Miles AEW, 1990, COLYERS VARIATIONS D; Milton K, 2003, COMP BIOCHEM PHYS A, V136, P47, DOI 10.1016/S1095-6433(03)00084-9; MILTON K, 1993, SCI AM, V269, P86, DOI 10.1038/scientificamerican0893-86; Mottl M., 1957, Carinthia II, V67, P39; Mottl M, 1958, MITTEILUNGEN MUSEUMS, V19, P3; Mottl M, 1964, CARINTHIA 2, V74, P22; Mottl M, 1958, CARINTHIA 2, V68, P46; Moynihan P, 2007, PUBLIC HEALTH NUTR, V7; NAGATOSHI K, 1990, INT J PRIMATOL, V11, P283, DOI 10.1007/BF02193001; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Oxilia G, 2017, AM J PHYS ANTHROPOL, V163, P446, DOI 10.1002/ajpa.23216; Oxilia G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12150; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Palcu DV, 2015, GLOBAL PLANET CHANGE, V133, P346, DOI 10.1016/j.gloplacha.2015.08.014; Papp A, 1952, WIEN JB GEOL B A, P5; PILBEAM D, 1982, NATURE, V295, P232, DOI 10.1038/295232a0; Piller WE, 2005, TERRA NOVA, V17, P450, DOI 10.1111/j.1365-3121.2005.00632.x; Pinilla B., 2009, PALEORIENT, V35, P69, DOI [10.3406/paleo.2009.5278, DOI 10.3406/PALEO.2009.5278]; Pitts NB, 2017, NAT REV DIS PRIMERS, V3, P1, DOI 10.1038/nrdp.2017.30; Powell M.L., 1985, ANAL PREHISTORIC DIE, P307; R/gl F., 1998, ANN NATURHIST MUS A, V99A, P279, DOI DOI 10.2307/41702129; Reichenbacher B, 2013, SWISS J GEOSCI, V106, P309, DOI 10.1007/s00015-013-0142-8; Reischenbacher D, 2013, INT J EARTH SCI, V102, P517, DOI 10.1007/s00531-012-0807-y; Rink WJ, 2008, QUATERNARY RES, V69, P377, DOI 10.1016/j.yqres.2008.02.008; Roncal-Jimenez CA, 2011, METABOLISM, V60, P1259, DOI 10.1016/j.metabol.2011.01.008; Smith TM, 2003, J HUM EVOL, V44, P283, DOI 10.1016/S0047-2484(03)00006-X; SOFAER JA, 1981, J MED GENET, V18, P410, DOI 10.1136/jmg.18.6.410; Souci S., 2016, FOOD COMPOSITION NUT; STONER KE, 1995, AM J PHYS ANTHROPOL, V98, P307, DOI 10.1002/ajpa.1330980305; Sutin AR, 2014, BIOL PSYCHIAT, V75, P31, DOI 10.1016/j.biopsych.2013.02.024; Teichmuller M, 1962, GEOL JB, V80, P69; TILLIER AM, 1995, J HUM EVOL, V29, P189, DOI 10.1006/jhev.1995.1055; Trinkaus E, 2000, J ARCHAEOL SCI, V27, P1017, DOI 10.1006/jasc.1999.0512; UNGAR PS, 1995, P NATL ACAD SCI USA, V92, P5479, DOI 10.1073/pnas.92.12.5479; Ungar PS, 1996, J HUM EVOL, V31, P335, DOI 10.1006/jhev.1996.0065; Van Schaik C. P., 2005, SEASONALITY PRIMATES; Vogel ER, 2012, BIOL LETTERS, V8, P333, DOI 10.1098/rsbl.2011.1040; Wang XM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17657-8; Yamasaki Y, 2012, ARCH ORAL BIOL, V57, P1183, DOI 10.1016/j.archoralbio.2012.02.015; Youlatos D, 2017, INT ENCY PRIMATOLOGY, P1	121	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203307	10.1371/journal.pone.0203307	http://dx.doi.org/10.1371/journal.pone.0203307			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161214	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900106
J	Gray, CL; Messer, LC; Rappazzo, KM; Jagai, JS; Grabich, SC; Lobdell, DT				Gray, Christine L.; Messer, Lynne C.; Rappazzo, Kristen M.; Jagai, Jyotsna S.; Grabich, Shannon C.; Lobdell, Danelle T.			The association between physical inactivity and obesity is modified by five domains of environmental quality in US adults: A cross-sectional study	PLOS ONE			English	Article							BODY-MASS INDEX; UNITED-STATES; BUILT ENVIRONMENT; ISCHEMIC-STROKE; RISK; OVERWEIGHT; NEIGHBORHOOD; PREVENTION; HEALTH; TIME	Physical inactivity is a primary contributor to the obesity epidemic, but may be promoted or hindered by environmental factors. To examine how cumulative environmental quality may modify the inactivity-obesity relationship, we conducted a cross-sectional study by linking county-level Behavioral Risk Factor Surveillance System data with the Environmental Quality Index (EQI), a composite measure of five environmental domains (air, water, land, built, sociodemographic) across all U.S. counties. We estimated the county-level association (N = 3,137 counties) between 2009 age-adjusted leisure-time physical inactivity (LTPIA) and 2010 age-adjusted obesity from BRFSS across EQI tertiles using multi-level linear regression, with a random intercept for state, adjusted for percent minority and rural-urban status. We modelled overall and sex-specific estimates, reporting prevalence differences (PD) and 95% confidence intervals (CI). In the overall population, the PD increased from best (PD = 0.341 (95% CI: 0.287, 0.396)) to worst (PD = 0.645 (95% CI: 0.599, 0.690)) EQI tertile. We observed similar trends in males from best (PD = 0.244 (95% CI: 0.194, 0.294)) to worst (PD = 0.601 (95% CI: 0.556, 0.647)) quality environments, and in females from best (PD = 0.446 (95% CI: 0.385, 0.507)) to worst (PD = 0.655 (95% CI: 0.607, 0.703)). We found that poor environmental quality exacerbates the LTPIA-obesity relationship. Efforts to improve obesity through LTPIA may benefit from considering this relationship.	[Gray, Christine L.] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Gray, Christine L.; Grabich, Shannon C.] US EPA, Oak Ridge Inst Sci & Educ, Human Studies Facil, Chapel Hill, NC USA; [Messer, Lynne C.] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA; [Rappazzo, Kristen M.; Lobdell, Danelle T.] US EPA, Natl Hlth & Environm Effects Res Lab, Human Studies Facil, Chapel Hill, NC 27514 USA; [Jagai, Jyotsna S.] Univ Illinois, Sch Publ Hlth, Div Environm & Occupat Hlth Sci, Chicago, IL USA; [Grabich, Shannon C.] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; Oregon Health & Science University; Portland State University; United States Environmental Protection Agency; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lobdell, DT (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Human Studies Facil, Chapel Hill, NC 27514 USA.	lobdell.danelle@epa.gov		Rappazzo, Kristen/0000-0002-9939-0883; Gray, Christine/0000-0002-0751-1626	Office of Research and Development at the U.S. Environmental Protection Agency [EP12D000264, EP09D000003, EP17D000079, EP17D000063]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949] Funding Source: NIH RePORTER	Office of Research and Development at the U.S. Environmental Protection Agency; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Office of Research and Development at the U.S. Environmental Protection Agency (contracts EP12D000264, EP09D000003 and EP17D000079 to LCM, contract EP17D000063 to JSJ, and appointment of CLG to the Research Participation Program, administered through the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Environmental Protection Agency; epa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Borrell LN, 2014, AM J PUBLIC HEALTH, V104, P512, DOI 10.2105/AJPH.2013.301597; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Centers for Disease Control and Prevention (CDC), 2009, BEH RISK FACT SURV S; Cummins S, 2006, INT J EPIDEMIOL, V35, P100, DOI 10.1093/ije/dyi276; Donaldson EA, 2015, PREV MED, V74, P117, DOI 10.1016/j.ypmed.2015.02.013; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Eyler AA, 2016, J PHYS ACT HEALTH, V13, P207, DOI 10.1123/jpah.2015-0010; Flowers EP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3050-9; Gaalema DE, 2014, J CARDIOPULM REHABIL, V34, P248, DOI 10.1097/HCR.0000000000000059; Ghosh-Dastidar B, 2014, AM J PREV MED, V47, P587, DOI 10.1016/j.amepre.2014.07.005; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hawkes C, 2009, NUTR REV, V67, P333, DOI 10.1111/j.1753-4887.2009.00206.x; Heo M, 2010, OBESITY, V18, P2030, DOI 10.1038/oby.2009.400; Hines F, 1970, 272 USDA EC RES SERV; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Jebb SA, 1999, MED SCI SPORT EXER, V31, pS534, DOI 10.1097/00005768-199911001-00008; Jian Y, 2017, ENVIRON HEALTH PERSP, V125, P355, DOI 10.1289/EHP119; Jiao L, 2010, CANCER CAUSE CONTROL, V21, P1305, DOI 10.1007/s10552-010-9558-x; Jones SA, 2015, PREV MED, V78, P17, DOI 10.1016/j.ypmed.2015.05.028; Kaczynski AT, 2007, LEISURE SCI, V29, P315, DOI 10.1080/01490400701394865; Kelishadi R, 2013, J OBES, V2013, DOI 10.1155/2013/208392; Keum N, 2015, JNCI-J NATL CANCER I, V107, DOI [10.1093/jnci/dju428, 10.1093/jnci/djv088]; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Ladabaum U, 2014, AM J MED, V127, P717, DOI 10.1016/j.amjmed.2014.02.026; Langlois PH, 2010, J RURAL HEALTH, V26, P164, DOI 10.1111/j.1748-0361.2010.00278.x; Lee RE, 2015, AM J HEALTH PROMOT, V29, P210, DOI 10.4278/ajhp.130403-QUAN-148; Leskinen T, 2009, INT J OBESITY, V33, P1211, DOI 10.1038/ijo.2009.170; Li WY, 2016, OBESITY, V24, P2593, DOI 10.1002/oby.21630; Lobdell D. T, 2014, EPA600R14304; Lobdell DT, 2011, AM J PUBLIC HEALTH, V101, pS277, DOI 10.2105/AJPH.2011.300184; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Luben TJ, 2009, HEALTH PLACE, V15, P863, DOI 10.1016/j.healthplace.2009.02.006; Messer LC, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-39; Messer LC, 2010, ANN EPIDEMIOL, V20, P32, DOI 10.1016/j.annepidem.2009.09.006; Mitchell NS, 2011, PSYCHIAT CLIN N AM, V34, P717, DOI 10.1016/j.psc.2011.08.005; Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335; Nguyen NT, 2011, OBES SURG, V21, P351, DOI 10.1007/s11695-010-0335-4; Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pierannunzi C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-49; Popkin BM, 2011, EMBO REP, V12, P11, DOI 10.1038/embor.2010.200; Richardson AS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3959-z; Roberts JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090143; SAS Institute Inc, 2013, SAS STAT SOFTW VERS; Schulz A, 2013, J URBAN HEALTH, V90, P872, DOI 10.1007/s11524-013-9793-z; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; U.S. Centers for Disease Control and Prevention, 2016, AD OB CAUS CONS; USDA, 2003, RUR URB CONT COD; van der Sande MAB, 2001, B WORLD HEALTH ORGAN, V79, P321; Van Dyck D, 2015, HEALTH PLACE, V36, P65, DOI 10.1016/j.healthplace.2015.09.007; von Hippel P, 2014, AM J PUBLIC HEALTH, V104, P1287, DOI 10.2105/AJPH.2013.301838; Wanahita N, 2008, AM HEART J, V155, P310, DOI 10.1016/j.ahj.2007.10.004; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wen M, 2012, HEALTH PLACE, V18, P1314, DOI 10.1016/j.healthplace.2012.09.002; Wiklund P, 2016, J SPORT HEALTH SCI, V5, P151, DOI 10.1016/j.jshs.2016.04.001; World Health Organization, 2018, OB OV FACT SHEET 311; Xu YQ, 2015, HEALTH PLACE, V34, P19, DOI 10.1016/j.healthplace.2015.03.010; Yang QH, 2015, AM J PREV MED, V48, P58, DOI 10.1016/j.amepre.2014.09.014; Yatsuya H, 2010, J EPIDEMIOL, V20, P347, DOI 10.2188/jea.JE20090186; Yatsuya H, 2010, STROKE, V41, P417, DOI 10.1161/STROKEAHA.109.566299	66	27	27	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203301	10.1371/journal.pone.0203301	http://dx.doi.org/10.1371/journal.pone.0203301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161196	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900105
J	Lung, FW; Chen, PF; Shu, BC				Lung, For-Wey; Chen, Po-Fei; Shu, Bih-Ching			Performance of Wisconsin Card Sorting Test in five-year-old children in Taiwan: Relationship to intelligence and cognitive development	PLOS ONE			English	Article							EXECUTIVE FUNCTION; TASK; FLEXIBILITY; ABILITY; NORMS; AGE	Objective (1) To develop the norm of Wisconsin Card Sorting Test (WCST), (2) to investigate the pathway of the indices for WCST performances and (3) the association between WCST, intelligence quotient (10), and parent-report measures of children's development in typically developing five-year-olds in the community. Method Fifty-three children were recruited from community health centers. The WCST, Wechsler Preschool and Primary Scale of Intelligence-Revised (WPPSI-R), and Taiwan Birth Cohort Study- Developmental Instrument (TBCS-DI) was used to measure children's executive function, IQ and parent report of children's development respectively. Results Mean categories achieved (CA) was 2.02 (standard deviation [SD] = 1.41), and percent conceptual level response (PCLR) was 29.85(SD = 18.36) in five year-olds. The WCST indices showed a pathway relationship of PCLR being negatively associated with perseverative error (PE), and PE and non- perseverative error being negatively associated with CA. Association among the PCLR index of the WCST, cognitive domain of the TBCS-DI, and performance IQ and verbal IQ of the WPPSI-R was found. Conclusion Regular improvement with age was found compared to the norm of six-year-olds in a previous study of children from the same region. The number sorting criteria was more difficult thus they continued to perform persistent errors of color or form when sorting. Association was found among the professional administered 10, computerized WCST, and a parent report developmental instrument. Showing parent report is an accurate reflection of children's cognitive development at this age.	[Lung, For-Wey; Chen, Po-Fei] Calo Psychiat Ctr, Xinpi Township, Pingtung County, Taiwan; [Lung, For-Wey] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Shu, Bih-Ching] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Tainan, Taiwan; [Shu, Bih-Ching] Natl Cheng Kung Univ, Dept Nursing, Tainan, Taiwan	National Defense Medical Center; National Cheng Kung University; National Cheng Kung University	Shu, BC (corresponding author), Natl Cheng Kung Univ, Inst Allied Hlth Sci, Tainan, Taiwan.; Shu, BC (corresponding author), Natl Cheng Kung Univ, Dept Nursing, Tainan, Taiwan.	forweylung@gmail.com			Bureau of Health Promotion [BHP-PHRC-92-4]	Bureau of Health Promotion	This work was supported by the Bureau of Health Promotion [number BHP-PHRC-92-4]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Ardila A, 1998, NEUROPSYCHOL REV, V8, P171, DOI 10.1023/A:1021618218943; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Arffa S, 1998, ARCH CLIN NEUROPSYCH, V13, P713; Avila R, 2009, INT PSYCHOGERIATR, V21, P560, DOI 10.1017/S1041610209008928; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; BROWNE MW, 1989, MULTIVAR BEHAV RES, V24, P445, DOI 10.1207/s15327906mbr2404_4; Bujoreanu IS, 2008, DEV NEUROPSYCHOL, V33, P584, DOI 10.1080/87565640802254364; Chen J. H., 2000, MANUAL WECHSLER PRES; Glascoe FP, 2007, PEDIAT DEV BEHAV; Goldstein FC, 1995, CLIN NEUROPSYCHOLOGI; Heaton R.K., 1993, WISCONSIN CARD SORTI; Huizinga M, 2007, DEV NEUROPSYCHOL, V31, P193, DOI 10.1080/87565640701190817; Lung FW, 2008, ACTA PAEDIATR, V97, P1093, DOI 10.1111/j.1651-2227.2008.00832.x; Lung FW, 2011, RES DEV DISABIL, V32, P100, DOI 10.1016/j.ridd.2010.09.004; Lung FW, 2009, PEDIATR INT, V51, P666, DOI 10.1111/j.1442-200X.2009.02844.x; Ni TL, 2011, EARLY HUM DEV, V87, P137, DOI 10.1016/j.earlhumdev.2010.11.013; Pennington B.F., 1996, ATTENTION MEMORY EXE, P327, DOI [10.1097/00004703-199608000-00014, DOI 10.1097/00004703-199608000-00014]; RICCIO CA, 1994, DEV NEUROPSYCHOL, V10, P215, DOI 10.1080/87565649409540580; Romine CB, 2004, ARCH CLIN NEUROPSYCH, V19, P1027, DOI 10.1016/j.acn.2003.12.009; ROSSELLI M, 1993, CLIN NEUROPSYCHOL, V7, P145, DOI 10.1080/13854049308401516; Shu BC, 2000, CLIN NEUROPSYCHOL, V14, P275, DOI 10.1076/1385-4046(200008)14:3;1-P;FT275; Smidts DP, 2004, DEV NEUROPSYCHOL, V26, P385, DOI 10.1207/s15326942dn2601_2; Somsen RJM, 2007, DEVELOPMENTAL SCI, V10, P664, DOI 10.1111/j.1467-7687.2007.00613.x; Tanabe MK, 2014, APPL NEUROPSYCH-CHIL, V3, P275, DOI 10.1080/21622965.2012.757700; Tien Allen Y., 1996, Kaohsiung Journal of Medical Sciences, V12, P479; van der Sluis S, 2007, INTELLIGENCE, V35, P427, DOI 10.1016/j.intell.2006.09.001; Wechsler D., 1989, MANUAL WECHSLER PRES; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Zhu Sheng, 2012, Shanghai Arch Psychiatry, V24, P217, DOI 10.3969/j.issn.1002-0829.2012.04.002	29	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202099	10.1371/journal.pone.0202099	http://dx.doi.org/10.1371/journal.pone.0202099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161263	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900021
J	Wettmann, L; Bonny, M; Kruse, K				Wettmann, Lukas; Bonny, Mike; Kruse, Karsten			Effects of geometry and topography on Min-protein dynamics	PLOS ONE			English	Article							DIVISION SITE SELECTION; TO-POLE OSCILLATIONS; ESCHERICHIA-COLI; CELL-DIVISION; SELF-ORGANIZATION; PATTERN-FORMATION; RAPID POLE; IN-VITRO; MEMBRANE; BINDING	In the rod-shaped bacterium Escherichia coli, the center is selected by the Min-proteins as the site of cell division. To this end, the proteins periodically translocate between the two cell poles, where they suppress assembly of the cell division machinery. Ample evidence notably obtained from in vitro reconstitution experiments suggests that the oscillatory pattern results from self-organization of the proteins MinD and MinE in presence of a membrane. A mechanism built on cooperative membrane attachment of MinD and persistent MinD removal from the membrane induced by MinE has been shown to be able to reproduce the observed Min-protein patterns in rod-shaped E. coliand on flat supported lipid bilayers. Here, we report our results of a numerical investigation of patterns generated by this mechanism in various geoemtries. Notably, we consider the dynamics on membrane patches of different forms, on topographically structured lipid bilayers, and in closed geometries of various shapes. We find that all previously described patterns can be reproduced by the mechanism. However, it requires different parameter sets for reproducing the patterns in closed and in open geometries.	[Wettmann, Lukas; Bonny, Mike; Kruse, Karsten] Univ Saarland, Theoret Phys, Saarbrucken, Germany; [Kruse, Karsten] Univ Geneva, Dept Biochem, NCCR Chem Biol, Geneva, Switzerland; [Kruse, Karsten] Univ Geneva, Dept Theoret Phys, NCCR Chem Biol, Geneva, Switzerland	Saarland University; University of Geneva; University of Geneva	Kruse, K (corresponding author), Univ Saarland, Theoret Phys, Saarbrucken, Germany.; Kruse, K (corresponding author), Univ Geneva, Dept Biochem, NCCR Chem Biol, Geneva, Switzerland.; Kruse, K (corresponding author), Univ Geneva, Dept Theoret Phys, NCCR Chem Biol, Geneva, Switzerland.	Karsten.Kruse@unige.ch	Kruse, Karsten/GOG-8298-2022	Kruse, Karsten/0000-0001-8665-2349	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 1027]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 1027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiranashvili A, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/9/093049; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Bonny M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003347; Caspi Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19271; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Fischer-Friedrich E, 2007, PHYS BIOL, V4, P38, DOI 10.1088/1478-3975/4/1/005; Fischer-Friedrich E, 2010, P NATL ACAD SCI USA, V107, P6134, DOI 10.1073/pnas.0911708107; Halatek J, 2014, P NATL ACAD SCI USA, V111, pE1817, DOI 10.1073/pnas.1220971111; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kruse K, 2002, BIOPHYS J, V82, P618, DOI 10.1016/S0006-3495(02)75426-X; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma LY, 2004, MOL MICROBIOL, V54, P99, DOI 10.1111/j.1365-2958.2004.04265.x; Ma LY, 2003, J BACTERIOL, V185, P4948, DOI 10.1128/JB.185.16.4948-4955.2003; Mannik J, 2012, P NATL ACAD SCI USA, V109, P6957, DOI 10.1073/pnas.1120854109; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Park KT, 2017, P NATL ACAD SCI USA, V114, P7497, DOI 10.1073/pnas.1707385114; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Petrasek Z, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/4/043023; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Renner LD, 2012, J BIOL CHEM, V287, P38835, DOI 10.1074/jbc.M112.407817; Schweizer J, 2012, P NATL ACAD SCI USA, V109, P15283, DOI 10.1073/pnas.1206953109; Sengupta S, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/056003; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Varma A, 2008, J BACTERIOL, V190, P2106, DOI 10.1128/JB.00720-07; Vecchiarelli AG, 2016, P NATL ACAD SCI USA, V113, pE1479, DOI 10.1073/pnas.1600644113; Walsh JC, 2016, AIMS BIOPHYS, V3, P119, DOI 10.3934/biophy.2016.1.119; Walsh JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128148; Wettmann L, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0039; Wettmann L, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0111; Wu FB, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156724; Wu FB, 2015, NAT NANOTECHNOL, V10, P719, DOI [10.1038/NNANO.2015.126, 10.1038/nnano.2015.126]; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Zieske K, 2014, ELIFE, V3, DOI 10.7554/eLife.03949; Zieske K, 2014, FEBS LETT, V588, P2545, DOI 10.1016/j.febslet.2014.06.026; Zieske K, 2013, ANGEW CHEM INT EDIT, V52, P459, DOI 10.1002/anie.201207078	54	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203050	10.1371/journal.pone.0203050	http://dx.doi.org/10.1371/journal.pone.0203050			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161173	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900073
J	Yang, HW; Kim, HJ; Park, JH; Shin, JM; Lee, HM				Yang, Hyun-Woo; Kim, Hwee-Jin; Park, Joo-Hoo; Shin, Jae-Min; Lee, Heung-Man			Apigenin alleviates TGF-beta 1-induced nasal mucosa remodeling by inhibiting MAPK/NF-kappa B signaling pathways in chronic rhinosinusitis	PLOS ONE			English	Article							INFLAMMATION; FLAVONOIDS; FIBROBLAST; POLYPOSIS; GROWTH; ASTHMA; BETA	Background Chronic rhinosinusitis is involved in tissue remodeling of nasal mucosa such as nasal myofibroblast differentiation and extracellular matrix production. Apigenin (4',5,7-trihydroxyflavone) is a bioflavonoid compound and has anti-tissue remodeling characteristics. The aims of this study were to evaluate the effect of apigenin on TGF-beta 1-induced myofibroblast differentiation and extracellular matrix accumulation and to determine the underlying mechanism. Methods Nasal fibroblasts and ex vivo nasal inferior turbinate tissues were stimulated with TGF-beta 1 with or without apigenin. The expression levels of a-SMA, fibronectin and collagen type I were determined by real-time PCR, western blot and immunocytochemical staining. Mitogen-activated protein kinase (MAPK) phosphorylation induced by TGF-beta 1 were determined by western blot analysis. The transcriptional activity of NF-kappa B was measured by luciferase assay. Migration effects of fibroblasts were evaluated by wound scratch and transwell migration assay. Contractile activity was determined by collagen gel contraction assay. Results The expression levels of alpha-SMA, fibronectin, and collagen type I significantly increased in TGF-beta 1-stimulated nasal fibroblasts. In TGF-beta 1-stimulated nasal fibroblasts, apigenin inhibited the expressions of alpha-SMA, fibronectin, and collagen type I. Inhibitors of MAPK (p-38, JNK) and NF-kappa B blocked the expression of alpha-SMA, fibronectin and collagen type I. Apigenin suppressed the activation of MAPK (p-38, JNK) and NF-kappa B induced by TGF-beta 1 treatment. Apigenin also inhibited the functional activity of fibroblasts by reducing the migration and collagen contractile activities. Conclusions These results suggests the possible use of apigenin as a chronic rhinosinusitis therapeutic agent which can suppress tissue remodeling in nasal mucosa.	[Yang, Hyun-Woo; Kim, Hwee-Jin; Park, Joo-Hoo; Lee, Heung-Man] Korea Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Shin, Jae-Min; Lee, Heung-Man] Korea Univ, Guro Hosp, Coll Med, IVD Support Ctr, Seoul, South Korea; [Shin, Jae-Min; Lee, Heung-Man] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, HM (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Lee, HM (corresponding author), Korea Univ, Guro Hosp, Coll Med, IVD Support Ctr, Seoul, South Korea.; Lee, HM (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	lhman146@gmail.com		park, joo hoo/0000-0002-3221-640X	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C1512]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C1512).	Bachert C, 2000, AM J RHINOL, V14, P279, DOI 10.2500/105065800781329573; Chen L, 2016, EXP THER MED, V11, P230, DOI 10.3892/etm.2015.2885; Cho JS, 2012, CLIN EXP ALLERGY, V42, P872, DOI 10.1111/j.1365-2222.2011.03931.x; Gonzalez ACD, 2016, AN BRAS DERMATOL, V91, P614, DOI 10.1590/abd1806-4841.20164741; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Jun JB, 2010, RHEUMATOL INT, V30, P1695, DOI 10.1007/s00296-009-1285-9; Kim DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139945; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li L., 2016, INFORM DOCUMENTATION, V2, P63; Li RR, 2010, IMMUNOPHARM IMMUNOT, V32, P364, DOI 10.3109/08923970903420566; Lim HN, 2007, SYNTHESIS-STUTTGART, P3376, DOI 10.1055/s-2007-990809; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082373; Nabavi SM, 2015, ANTI-CANCER AGENT ME, V15, P728, DOI 10.2174/1871520615666150304120643; Ricupero DA, 2001, FEBS LETT, V506, P15, DOI 10.1016/S0014-5793(01)02737-5; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Shukla S, 2014, CARCINOGENESIS, V35, P452, DOI 10.1093/carcin/bgt316; Sim GS, 2007, ARCH PHARM RES, V30, P290, DOI 10.1007/BF02977608; Tos M, 2010, NASAL POLYPOSIS: PATHOGENESIS, MEDICAL AND SURGICAL TREATMENT, P53, DOI 10.1007/978-3-642-11412-0_7; Van Bruaene N, 2011, CURR OPIN ALLERGY CL, V11, P8, DOI 10.1097/ACI.0b013e32834233ef; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Wang J, 2014, INFLAMMATION, V37, P2085, DOI 10.1007/s10753-014-9942-x; Wojcik KA, 2013, PHARMACOL REP, V65, P164, DOI 10.1016/S1734-1140(13)70974-5; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	28	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201595	10.1371/journal.pone.0201595	http://dx.doi.org/10.1371/journal.pone.0201595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161164	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900011
J	Yu, DS; He, J; Zhang, EM; Wang, P; Liu, DP; Hou, YD; Zhang, HM; Wei, KF; Gou, FX; Zhan, HJ; Li, W; Wei, JC				Yu, Deshan; He, Jian; Zhang, Enmin; Wang, Peng; Liu, Dongpeng; Hou, Yadong; Zhang, Huimin; Wei, Kongfu; Gou, Faxiang; Zhan, Huijuan; Li, Wei; Wei, Jianchun			Investigation and source-tracing of an anthrax outbreak in Gansu Province, China	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; EPIDEMIOLOGY	Anthrax is an endemic disease in China. Cases are reported every year, especially in the northwestern areas. In August 2016, an outbreak of 21 cutaneous anthrax cases was reported in Min County, Gansu Province, China. In this study, the general characteristics of the anthrax outbreak are described. Two molecular typing methods, canonical single-nucleotide polymorphism (canSNP) and multiple-locus variable-number tandem repeat analysis with 15 markers (MLVA15), were used to investigate the possible source of transmission and to identify the genetic relationship among the strains/samples isolated in this outbreak as well as previous isolates. In this outbreak, all patients were infected through contact with diseased livestock or contaminated animal products. Livestock had been introduced into the local area shortly before the outbreak from Gannan Prefecture (in Gansu Province), Sichuan and Qinghai Provinces. In the molecular typing analysis, there were two canSNP subgroups found in Gansu, A.Br.001/002 and A.Br.Ames, and five MLVA15 genotypes were observed. The strains collected from the anthrax outbreak in Min County in 2016 belonged to the A. Br.001/002 canSNP subgroup and the MLVA15-28 and MLVA15-30 genotype. Strains previously isolated from Sichuan, Inner Mongolia and Maqu County (in Gannan Prefecture, Gansu Province) were clustered with these outbreak-related strains/samples according to the MLVA15-30 genotype. The MLVA15-28 genotype was found in strains isolated from Gansu and Xinjiang in previous studies. Combining the epidemiological investigation and molecular typing results, we conclude that the patients in this outbreak were infected by a local pathogen present in the adjoining area of Gansu, Sichuan and Qinghai Provinces.	[Yu, Deshan; He, Jian; Wang, Peng; Liu, Dongpeng; Zhang, Huimin; Wei, Kongfu; Gou, Faxiang] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Gansu, Peoples R China; [Zhang, Enmin; Zhan, Huijuan; Li, Wei; Wei, Jianchun] China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Enmin; Zhan, Huijuan; Li, Wei; Wei, Jianchun] State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhang, Enmin; Zhan, Huijuan; Li, Wei; Wei, Jianchun] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Hou, Yadong] Min Cty Ctr Dis Control & Prevent, Minxian, Gansu, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Wei, JC (corresponding author), China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.; Wei, JC (corresponding author), State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Wei, JC (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	weijianchun@icdc.cn			National Science and Technology Mega-Projects of China [2012ZX1004208, 2012ZX10004215]; National Priority Development Project on Key Science Instrument [2012YQ09019706]	National Science and Technology Mega-Projects of China; National Priority Development Project on Key Science Instrument	This work was supported by National Science and Technology Mega-Projects of China (2012ZX1004208 and 2012ZX10004215, www.most.gov.cn) and National Priority Development Project on Key Science Instrument (2012YQ09019706, www.caiq.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P677; Chen WJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004637; Dauphin LA, 2012, J CLIN MICROBIOL, V50, P3960, DOI 10.1128/JCM.02076-12; Girault G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-288; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1111, DOI 10.3201/eid0810.020394; Jung KH, 2012, J VET SCI, V13, P385, DOI 10.4142/jvs.2012.13.4.385; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Li S, 2015, EUR J CLIN MICROBIOL, V34, P89, DOI 10.1007/s10096-014-2195-7; Li Y, 2017, EMERG INFECT DIS, V23, P14, DOI 10.3201/eid2301.150947; Mao LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157496; Quinn CP, 2002, EMERG INFECT DIS, V8, P1103, DOI 10.3201/eid0810.020380; Simonson TS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-71; Tan ZM, 2014, AM J TROP MED HYG, V91, P574, DOI 10.4269/ajtmh.13-0633; Thierry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095131; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; WHO, 2008, ANTHRAX HUMANS ANIMA; [姚光海 Yao Guanghai], 2014, [中国人兽共患病学报, Chinese Journal of Zoonoses], V30, P871; Zhou W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135777	19	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203267	10.1371/journal.pone.0203267	http://dx.doi.org/10.1371/journal.pone.0203267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161194	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900098
J	Favero, V; Sakuma, S; Alccayhuaman, KAA; Benedetto, GA; Bengazi, F; Botticelli, D				Favero, Vittorio; Sakuma, Shigeru; Alccayhuaman, Karol Ali Apaza; Alejandro Benedetto, Guillermo; Bengazi, Franco; Botticelli, Daniele			Healing at sites prepared using different drilling protocols. An experimental study in the tibiae of sheep	PLOS ONE			English	Article							HYDROPHOBIC IMPLANT SURFACES; SINUS FLOOR ELEVATION; HEAT-GENERATION; IN-VITRO; BONE-FORMATION; TITANIUM IMPLANTS; DENTAL IMPLANTS; SINGLE-DRILL; IRRIGATION; SPEED	The aim of the experiment was to study the healing at implants installed in site prepared in bone type 1 using different rotation speeds and cooling strategies. The tibiae of twelve sheep were used as experimental sites. Two implant sites were prepared in each tibia using drills either at a high or a mixed speed under irrigation. At the mixed-speed sites, 60 rpm without irrigation were applied for the last drill, the countersink and during implant installation. Biopsies representing the healing after 1, 2, and 6 weeks were obtained and ground sections were prepared. At the histological analyses, after 1 week of healing, no new bone was found at both high- and mixed-speed sites. After 2 weeks of healing, small amounts of newly formed bone were observed in the cortical layer, reaching percentages of 3.6 +/- 3.0% at the mixed-speed sites, and of 2.2 +/- 1.5% at the high-speed sites. An irrelevant quantity of new bone was seen in the marrow compartments of a few specimens. After 6 weeks of healing, new bone was found in higher quantity, reaching in the cortical compartment 66.9 +/- 6.8% and 67.3 +/- 17.7% at the mixed- and high-speed sites, respectively. The respective percentages in the marrow compartment were 23.2 +/- 13.0% and 30.6 +/- 29.2%. No statistically significant differences between high- and mixed-speed groups were found. It was concluded that the use of the last drill and the installation of the implant with or without irrigation yielded similar bone healing and osseointegration.	[Favero, Vittorio] Univ Verona, Unit Maxillofacial Surg & Dent, Verona, Italy; [Sakuma, Shigeru; Alccayhuaman, Karol Ali Apaza; Bengazi, Franco; Botticelli, Daniele] Ariminum Odontol, ARDEC Acad, Rimini, Italy; [Alejandro Benedetto, Guillermo] Univ Buenos Aires, Fac Odontol, Buenos Aires, DF, Argentina; [Bengazi, Franco; Botticelli, Daniele] Univ Med Sci, Fac Dent, Havana, Cuba	University of Verona; University of Buenos Aires	Alccayhuaman, KAA (corresponding author), Ariminum Odontol, ARDEC Acad, Rimini, Italy.	caroline7_k@hotmail.com	Botticelli, Daniele/ABF-6494-2020; Apaza Alccayhuaman, Karol Ali/AAD-3583-2022	Botticelli, Daniele/0000-0003-2804-1632; Apaza Alccayhuaman, Karol Ali/0000-0003-4565-5222	BTI Biotechnology Institute, Vitoria-Gasteiz (AAlava), Spain; ARDEC Academy, Ariminum Odontologica s.r.l., Rimini, Italy	BTI Biotechnology Institute, Vitoria-Gasteiz (AAlava), Spain; ARDEC Academy, Ariminum Odontologica s.r.l., Rimini, Italy	BTI Biotechnology Institute, Vitoria-Gasteiz (AAlava), Spain, provided funds to Ariminum Odontologica s.r.l., Rimini, Italy to cover part of the costs. The remaining costs were covered by ARDEC Academy, Ariminum Odontologica s.r.l., Rimini, Italy.	Abboud M, 2015, CLIN IMPLANT DENT R, V17, pE472, DOI 10.1111/cid.12273; Barrak I, 2017, IMPLANT DENT, V26, P541, DOI 10.1097/ID.0000000000000607; Bogovic V, 2016, P I MECH ENG H, V230, P907, DOI 10.1177/0954411916660737; Bosshardt DD, 2011, CLIN ORAL IMPLAN RES, V22, P357, DOI 10.1111/j.1600-0501.2010.02107.x; Botticelli D, 2003, CLIN ORAL IMPLAN RES, V14, P35, DOI 10.1034/j.1600-0501.2003.140105.x; Botticelli D, 2003, CLIN ORAL IMPLAN RES, V14, P1, DOI 10.1034/j.1600-0501.2003.140101.x; Botticelli D, 2017, CLIN ORAL IMPLAN RES, V28, P742, DOI 10.1111/clr.12872; Bulloch SE, 2012, INT J ORAL MAX IMPL, V27, P1456; Caneva M, 2015, CLIN ORAL IMPLAN RES, V26, P293, DOI 10.1111/clr.12475; Caroprese M, 2017, CLIN ORAL IMPLAN RES, V28, P1030, DOI 10.1111/clr.12913; Cordioli G, 1997, INT J ORAL MAX IMPL, V12, P186; De Santis E, 2017, CLIN ORAL IMPLAN RES, V28, P503, DOI 10.1111/clr.12825; Delgado-Ruiz RA, 2018, CLIN ORAL INVEST, V22, P349, DOI 10.1007/s00784-017-2119-x; Ercoli C, 2004, INT J ORAL MAX IMPL, V19, P335; Favero R, 2016, CLIN IMPLANT DENT R, V18, P369, DOI 10.1111/cid.12311; Favero R, 2016, CLIN ORAL IMPLAN RES, V27, P203, DOI 10.1111/clr.12591; Flanagan D, 2014, J ORAL IMPLANTOL, V40, P174, DOI 10.1563/AAID-JOI-D-13-00261; Gaspar J, 2013, ACTA MEDICA PORT, V26, P231; Gehrke SA, 2018, CLIN ORAL IMPLAN RES, V29, P772, DOI 10.1111/clr.12827; Guazzi P, 2015, EUR J ORAL IMPLANTOL, V8, P283; Iyer S, 1997, INT J PROSTHODONT, V10, P536; Iyer S, 1997, INT J PROSTHODONT, V10, P411; Koo KT, 2015, J ORAL IMPLANTOL, V41, pE19, DOI 10.1563/AAID-JOI-D-13-00151; Lang NP, 2011, CLIN ORAL IMPLAN RES, V22, P349, DOI 10.1111/j.1600-0501.2011.02172.x; Lucchiari N, 2016, CLIN IMPLANT DENT R, V18, P182, DOI 10.1111/cid.12246; MATTHEWS LS, 1972, J BONE JOINT SURG AM, VA 54, P297, DOI 10.2106/00004623-197254020-00008; Morelli F, 2015, CLIN ORAL IMPLAN RES, V26, P300, DOI 10.1111/clr.12487; Oh HJ, 2017, INT J ORAL MAX IMPL, V32, P483, DOI 10.11607/jomi.4819; Pellicer-Chover H, 2017, MED ORAL PATOL ORAL, V22, pE730, DOI 10.4317/medoral.21694; Rossi F, 2014, CLIN ORAL IMPLAN RES, V25, P124, DOI 10.1111/clr.12097; Russell WMS, 1959, PRINCIPLES HUMAN EXP; Sannino G, 2015, INT J ORAL MAX IMPL, V30, P351, DOI 10.11607/jomi.3747; Scala A, 2012, CLIN ORAL IMPLAN RES, V23, P175, DOI 10.1111/j.1600-0501.2011.02227.x; Scarano A, 2011, CLIN IMPLANT DENT R, V13, P319, DOI 10.1111/j.1708-8208.2009.00209.x; Schweikert MT, 2016, CLIN IMPLANT DENT R, V18, P439, DOI 10.1111/cid.12330; Sener BC, 2009, CLIN ORAL IMPLAN RES, V20, P294, DOI 10.1111/j.1600-0501.2008.01643.x; Sindel A, 2017, MED ORAL PATOL ORAL, V22, pE506, DOI 10.4317/medoral.21880; Stelzle F, 2014, CLIN ORAL IMPLAN RES, V25, pE140, DOI 10.1111/clr.12077; Strbac GD, 2014, CLIN ORAL IMPLAN RES, V25, P665, DOI 10.1111/clr.12032; T A, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X; Tehemar SH, 1999, INT J ORAL MAX IMPL, V14, P127; Trisi P, 2014, CLIN ORAL IMPLAN RES, V25, P696, DOI 10.1111/clr.12127; Yacker M J, 1996, Int J Oral Maxillofac Implants, V11, P634; Yeniyol S, 2013, OR SURG OR MED OR PA, V116, P550, DOI 10.1016/j.oooo.2013.07.001	44	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202957	10.1371/journal.pone.0202957	http://dx.doi.org/10.1371/journal.pone.0202957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157237	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400078
J	Komatsu, Y; Kasahara, K; Inoue, T; Lee, ST; Muratani, T; Yano, H; Kirita, T; Mikasa, K				Komatsu, Yuko; Kasahara, Kei; Inoue, Takashi; Lee, Sang-Tae; Muratani, Tetsuro; Yano, Hisakazu; Kirita, Tadaaki; Mikasa, Keiichi			Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; RISK-FACTORS; RESISTANT ENTEROBACTERIACEAE; PREVALENCE	Objectives To identify risk factors and clinical outcomes in patients with bacteremia due to extended-spectrum beta-lactamase (ESBL) or carbapenemase-producing Escherichia coli, as well as to determine the prevalence and genetic background of such isolates. Methods Case control study was performed with patients with E. coli bacteremia between January 2008 and May 2013 (n = 115) at a tertiary university hospital in Japan. Cases had ESBL-producing E. coli (ESBL-EC) whereas controls had non-ESBL-producing E. coli (non-ESBL-EC) isolates. A retrospective chart review was performed to identify risk factors and clinical outcomes. Isolates were characterized by antimicrobial susceptibility testing, polymerase chain reaction analysis for beta-lactamase genes, and multi-locus sequence typing. Results Of 115 unique cases of E. coli bacteremia, 30 (26.1%) were due to ESBL-EC and three (2.6%) were due to carbapenemase-producing E. coli. All three carbapenemase-producing E. coli isolates were IMP-6 and concurrently produced ESBL (ESBL/IMP-6-EC). ESBL-EC isolates showed multidrug resistance. Of the ESBL-EC isolates, CTX-M-27 was the most prevalent (33.3%), followed by CTX-M-14 (30%). Multi-locus sequence typing revealed that 19 (63.3%) isolates were ST131. The multivariate analysis identified nursing home-associated infections and antibiotic administration in the preceding 30 days as risk factors for ESBL-EC bacteremia. The 14-day mortality non-ESBL-EC, ESBL-EC, and ESBL/IMP-6-EC was 4.7% (4/85), 20% (6/30), and 66.7% (2/3), respectively. Conclusions CTX-M-27, CTX-M-14, and ST131 were the most prevalent ESBL-EC isolates from bacteremic patients in a Japanese hospital. Further studies with larger sample sizes are warranted to investigate the clinical significance of ESBL-EC and ESBL/IMP-6-EC.	[Komatsu, Yuko; Kasahara, Kei; Lee, Sang-Tae; Mikasa, Keiichi] Nara Med Univ, Ctr Infect Dis, Nara, Japan; [Komatsu, Yuko; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Nara, Japan; [Inoue, Takashi] Nara Med Univ, Inst Clin & Translat Sci, Nara, Japan; [Muratani, Tetsuro] Hibiki AMR Lab, Fukuoka, Japan; [Muratani, Tetsuro] Kyurin Corp, Dept Clin Lab, Fukuoka, Fukuoka, Japan; [Yano, Hisakazu] Nara Med Univ, Dept Microbiol & Infect Dis, Nara, Japan	Nara Medical University; Nara Medical University; Nara Medical University; Nara Medical University	Kasahara, K (corresponding author), Nara Med Univ, Ctr Infect Dis, Nara, Japan.	kassan@naramed-u.ac.jp		Lee, Sang-Tae/0000-0003-1265-5509				CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Denis B, 2015, INT J INFECT DIS, V39, P1, DOI 10.1016/j.ijid.2015.07.010; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Gudiol C, 2010, J ANTIMICROB CHEMOTH, V65, P333, DOI 10.1093/jac/dkp411; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Institute CaLS, 2009, 19 INF SM, V29, P76; Ishii Y, 2017, J INFECT CHEMOTHER, V23, P583, DOI 10.1016/j.jiac.2017.06.009; Matsumura Y, 2013, CLIN MICROBIOL INFEC, V19, P161, DOI 10.1111/j.1469-0691.2012.03762.x; Matsumura Y, 2016, EMERG INFECT DIS, V22, P1900, DOI 10.3201/eid2211.160519; McKinnell JA, 2016, INFECT CONT HOSP EP, V37, P1485, DOI 10.1017/ice.2016.215; Nakamura A, 2016, J INFECT CHEMOTHER, V22, P102, DOI 10.1016/j.jiac.2015.11.001; Namikawa H, 2017, INTERNAL MED, V56, P1807, DOI 10.2169/internalmedicine.56.7702; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; Ohno Y, 2017, J INFECT CHEMOTHER, V23, P224, DOI 10.1016/j.jiac.2016.12.013; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P180, DOI 10.1111/j.1469-0691.2007.01884.x; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Shigemoto N, 2012, DIAGN MICR INFEC DIS, V72, P109, DOI 10.1016/j.diagmicrobio.2011.09.019; Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427; Willemsen I, 2015, INFECT CONT HOSP EP, V36, P394, DOI 10.1017/ice.2014.76; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Yamamoto N, 2017, J HOSP INFECT, V97, P212, DOI 10.1016/j.jhin.2017.07.015; Yano H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064359; Yano H, 2012, ANTIMICROB AGENTS CH, V56, P4554, DOI 10.1128/AAC.00617-12	27	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202276	10.1371/journal.pone.0202276	http://dx.doi.org/10.1371/journal.pone.0202276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157275	Green Submitted, gold, Green Published			2022-12-27	WOS:000443071400048
J	Leonska-Duniec, A; Cieszczyk, P; Jastrzebski, Z; Jazdzewska, A; Lulinska-Kuklik, E; Moska, W; Ficek, K; Niewczas, M; Maciejewska-Skrendo, A				Leonska-Duniec, Agata; Cieszczyk, Pawel; Jastrzebski, Zbigniew; Jazdzewska, Aleksandra; Lulinska-Kuklik, Ewelina; Moska, Waldemar; Ficek, Krzysztof; Niewczas, Marta; Maciejewska-Skrendo, Agnieszka			The polymorphisms of the PPARD gene modify post-training body mass and biochemical parameter changes in women	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-DELTA; MESSENGER-RNA EXPRESSION; CORONARY-ARTERY-DISEASE; PEROXISOME-PROLIFERATOR; SKELETAL-MUSCLE; RISK-FACTORS; ENDURANCE; PPARGC1A; DELTA+294T/C; ASSOCIATION	In this study we examined the genotype distribution of the PPARD rs2267668, rs2016520, and rs1053049 alleles in a group of women, before and after the completion of a 12-week training program. There were two significant genotype x training interactions resulting in decreases of total cholesterol (Chol) through training in rs2267668 G allele carriers and significant increases of triglyceride (TGL) levels in rs2267668 AA homozygotes. Carriers of rs2016520 PPARD C allele exhibited a significant decrease in Chol through training with an accompanying decrease in TGL. There was also overrepresentation of PPARD rs1053049 TT homozygotes in the group with higher post-training TGL levels. Moreover (rs2267668/rs2016520/rs1053049) G/C/T haplotype displayed smaller post-training body mass decrease, suggesting that harboring this specific G/C/T haplotype is unfavorable for achieving the desired training-induced body mass changes. On the other hand, the G/C/C haplotype was significantly associated with post-training increase in fat free mass (FFM) and with lower levels of Chol as well as TGL as observed in the blood of the participants in response to applied training. This observation constitutes the second important finding of the study, implying that when specific training-induced biochemical changes are taken into account, some individuals may benefit from carrying the G/C/C haplotype.	[Leonska-Duniec, Agata] Szczecin Univ, Fac Phys Culture & Hlth Promot, Szczecin, Poland; [Leonska-Duniec, Agata; Cieszczyk, Pawel] Gdansk Univ Phys Educ & Sport, Fac Phys Educ, Gdansk, Poland; [Jastrzebski, Zbigniew; Jazdzewska, Aleksandra; Lulinska-Kuklik, Ewelina; Moska, Waldemar; Maciejewska-Skrendo, Agnieszka] Gdansk Univ Phys Educ & Sport, Fac Tourism & Recreat, Gdansk, Poland; [Ficek, Krzysztof] Jerzy Kukuczka Acad Phys Educ Katowice, Fac Physiotherapy, Katowice, Poland; [Niewczas, Marta] Univ Rzeszow, Fac Phys Educ, Rzeszow, Poland	University of Szczecin; Gdansk University of Physical Education & Sport; Gdansk University of Physical Education & Sport; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach; University of Rzeszow	Cieszczyk, P (corresponding author), Gdansk Univ Phys Educ & Sport, Fac Phys Educ, Gdansk, Poland.	cieszczyk@poczta.onet.pl	Cieszczyk, Pawel/AFK-4645-2022; Krzysztof, Ficek/X-3529-2018; Cieszczyk, Pawel/AAG-3328-2022; Moska, Waldemar/S-9944-2017	Cieszczyk, Pawel/0000-0002-7735-7580; Krzysztof, Ficek/0000-0002-3027-9984; Cieszczyk, Pawel/0000-0002-7735-7580; Moska, Waldemar Piotr/0000-0002-7177-8376; Niewczas, Marta/0000-0002-2687-3243; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; Jastrzebski, Zbigniew/0000-0003-2006-125X; Leonska-Duniec, Agata/0000-0001-6787-3760; Jazdzewska, Aleksandra/0000-0002-7518-855X; Lulinska, Ewelina/0000-0002-1021-8885; Moska, Waldemar/0000-0003-4323-0765	National Science Centre of Poland [2012/07/B/NZ7/01155]	National Science Centre of Poland(National Science Centre, Poland)	The study was supported by National Science Centre of Poland (No. 2012/07/B/NZ7/01155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Aberle J, 2006, INT J OBESITY, V30, P1709, DOI 10.1038/sj.ijo.0803345; Aberle Jens, 2006, Int J Med Sci, V3, P108; Akhmetov I I, 2007, Ross Fiziol Zh Im I M Sechenova, V93, P837; Burch LR, 2010, J CLIN ENDOCR METAB, V95, P1830, DOI 10.1210/jc.2009-1201; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Eynon N, 2009, EXP PHYSIOL, V94, P1147, DOI 10.1113/expphysiol.2009.049668; Gouni-Berthold L, 2005, ATHEROSCLEROSIS, V183, P336, DOI 10.1016/j.atheroscelerosis.2005.03.016; Grarup N, 2007, DIABETOLOGIA, V50, P1201, DOI 10.1007/s00125-007-0668-2; Hautala AJ, 2007, AM J PHYSIOL-HEART C, V292, pH2498, DOI 10.1152/ajpheart.01092.2006; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; Jguirim-Souissi I, 2010, GENET MOL RES, V9, P1326, DOI 10.4238/vol9-3gmr831; Karpe F, 2009, CURR OPIN LIPIDOL, V20, P333, DOI 10.1097/MOL.0b013e32832dd4b1; Leibowitz MD, 2000, FEBS LETT, V473, P333, DOI 10.1016/S0014-5793(00)01554-4; Leonska-Duniec A, 2016, BIOL SPORT, V33, P207, DOI 10.5604/20831862.1201052; Leonska-Duniec A, 2018, J SPORT HEALTH SCI, V7, P459, DOI 10.1016/j.jshs.2016.08.013; Lundell K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-70; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Maciejewska-Karlowska A, 2014, SCAND J MED SCI SPOR, V24, pE148, DOI 10.1111/sms.12126; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Miao L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-145; Nikitin AG, 2010, HEART VESSELS, V25, P229, DOI 10.1007/s00380-009-1159-9; Nilsson E, 2007, J PHYSIOL-LONDON, V584, P1011, DOI 10.1113/jphysiol.2007.140673; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Pilegaard H, 2008, J APPL PHYSIOL, V104, P1264, DOI 10.1152/japplphysiol.90346.2008; Polimanti R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160654; Robitaille J, 2007, INT J OBESITY, V31, P411, DOI 10.1038/sj.ijo.0803450; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Shin HD, 2004, DIABETES, V53, P847, DOI 10.2337/diabetes.53.3.847; Skogsberg J, 2003, J INTERN MED, V254, P597, DOI 10.1111/j.1365-2796.2003.01236.x; Skogsberg J, 2000, INT J MOL MED, V6, P73; Stefan N, 2007, J CLIN ENDOCR METAB, V92, P1827, DOI 10.1210/jc.2006-1785; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Thamer C, 2008, J CLIN ENDOCR METAB, V93, P1497, DOI 10.1210/jc.2007-1209; Vanttinen M, 2005, DIABETES, V54, P3587, DOI 10.2337/diabetes.54.12.3587; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; ZHU YJ, 1993, J BIOL CHEM, V268, P26817	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202557	10.1371/journal.pone.0202557	http://dx.doi.org/10.1371/journal.pone.0202557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157214	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400061
J	Li, XY; Cui, L; Li, YB; Zhu, LJ; Wang, CL; Liu, J; Fang, SK				Li, Xinyuan; Cui, Li; Li, Yunbo; Zhu, Lijun; Wang, Chenglin; Liu, Jing; Fang, Shaokuan			Prevalence and geographical variation of Factor V Leiden in patients with cerebral venous thrombosis: A meta-analysis	PLOS ONE			English	Article							GENETIC RISK-FACTORS; MUTATION; THROMBOPHILIA; G20210A	Background Previous results regarding the prevalence of Factor V Leiden (FVL) in patients with cerebral venous thrombosis (CVT) varied remarkably. Therefore, we performed a meta-analysis to evaluate the potential association between FVL and CVT. Methods The PubMed, Embase, Cochrane Central Register of Controlled Trials, and Web of Science were searched for relevant case-control studies. The data were pooled for analysis of the association between FVL and CVT with a random-effects model. Subgroup and sensitivity analyses were performed to evaluate the robustness of the results. Publication bias was assessed by funnel plot and the Egger's test. Results A total of 39 case-control studies including 1807 cases of CVT and 7699 control cases were included. FVL was more common in patients with CVT (195/1822) than in controls(369/7795), [odds ratio(OR) = 2.70, 95% confidence interval(CI) 2.16 +/- 3.38, P < 0.00001]. Results of subgroup analyses indicated that the association between FVL and CVT varied according to geographic regions. The associations between FVL and CVT were significant in studies from Germany (OR = 2.42, 95% CI 1.70 +/- 3.45, P < 0.00001), Brazil (OR = 2.82, 95% CI 1.24 +/- 6.42, P = 0.01), France (OR = 5.44, 95% CI 1.35 +/- 21.92, P = 0.02), Iran (OR = 6.61, 95% CI 1.83 +/- 23.93, P = 0.004), and Tunisia (OR = 6.54, 95% CI 2.89 +/- 14.82, P < 0.00001), but not in those from Italy (OR = 1.49, 95% CI 0.59 +/- 3.78, P = 0.40) or the US (OR = 2.37, 95% CI 0.59 +/- 9.42, P = 0.22). Conclusion FVL may be more common in patients with CVT. However, the association between FVL and CVT varied depending on the geographic origin of the studies.	[Li, Xinyuan; Cui, Li; Wang, Chenglin; Liu, Jing; Fang, Shaokuan] Jilin Univ, Teaching Hosp 1, Neurosci Ctr, Dept Neurol, Changchun, Jilin, Peoples R China; [Li, Yunbo] Jilin Univ, Teaching Hosp 1, Dept Neurosurg, Changchun, Jilin, Peoples R China; [Zhu, Lijun] Jilin Univ, China Japan Union Hosp, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Fang, SK (corresponding author), Jilin Univ, Teaching Hosp 1, Neurosci Ctr, Dept Neurol, Changchun, Jilin, Peoples R China.	fang20063536@sina.com			National Natural Science Foundation of China [81271294]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by The National Natural Science Foundation of China (81271294). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; Cantu C, 2004, STROKE, V35, P1790, DOI 10.1161/01.STR.0000132570.24618.78; Cinier G, 2016, INT HEART J, V57, P654, DOI 10.1536/ihj.16-004; Crous-Bou M, 2016, SEMIN THROMB HEMOST, V42, P808, DOI 10.1055/s-0036-1592333; Dindagur N, 2007, THROMB RES, V119, P497, DOI 10.1016/j.thromres.2006.04.008; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekim M, 2015, HIPPOKRATIA, V19, P309; Gonzalez JV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151607; Hotoleanu C, 2017, ADV EXP MED BIOL, V906, P253, DOI 10.1007/5584_2016_120; Lauw MN, 2013, SEMIN THROMB HEMOST, V39, P913, DOI 10.1055/s-0033-1357504; Le Cam-Duchez V, 2005, BLOOD COAGUL FIBRIN, V16, P495, DOI 10.1097/01.mbc.0000184738.27723.b2; Lichy C, 2007, J NEUROL, V254, P1124, DOI 10.1007/s00415-006-0417-3; Marjot T, 2011, STROKE, V42, P913, DOI 10.1161/STROKEAHA.110.602672; Martinelli I, 1996, THROMB HAEMOSTASIS, V75, P393; Martinelli I, 2010, EUR J NEUROL, V17, P1482, DOI 10.1111/j.1468-1331.2010.03068.x; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; Martinelli I, 2010, CIRCULATION, V121, P2740, DOI 10.1161/CIRCULATIONAHA.109.927046; Meng Qiang, 2002, Zhonghua Yi Xue Za Zhi, V82, P47; Mistry EA, 2017, STROKE, V48, P2450, DOI 10.1161/STROKEAHA.117.017320; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Pomero F, 2014, THROMB RES, V134, P84, DOI 10.1016/j.thromres.2014.04.012; Sabino AD, 2007, J THROMB THROMBOLYS, V24, P261, DOI 10.1007/s11239-007-0024-x; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tufano A, 2005, THROMB RES, V115, P439, DOI 10.1016/j.thromres.2004.11.002; White RH, 2009, THROMB RES, V123, pS11, DOI 10.1016/S0049-3848(09)70136-7; Zakai NA, 2011, J THROMB HAEMOST, V9, P1877, DOI 10.1111/j.1538-7836.2011.04443.x; Zhu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176068	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203309	10.1371/journal.pone.0203309	http://dx.doi.org/10.1371/journal.pone.0203309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157246	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400101
J	Shoji, M; Sato, K; Yukitake, H; Kondo, Y; Narita, Y; Kadowaki, T; Naito, M; Nakayama, K				Shoji, Mikio; Sato, Keiko; Yukitake, Hideharu; Kondo, Yoshio; Narita, Yuka; Kadowaki, Tomoko; Naito, Mariko; Nakayama, Koji			Por Secretion System-Dependent Secretion and Glycosylation of Porphyromonas gingivalis Hemin-Binding Protein 35 (vol 6, e21372, 2011)	PLOS ONE			English	Correction													Shoji, Mikio/J-8283-2018	Shoji, Mikio/0000-0002-7605-4721				Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372	1	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203154	10.1371/journal.pone.0203154	http://dx.doi.org/10.1371/journal.pone.0203154			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157252	Green Submitted, gold, Green Published			2022-12-27	WOS:000443071400097
J	Gonzalez-Perez, M; Susi, R; Barrio, A; Antona, B				Gonzalez-Perez, Mariano; Susi, Rosario; Barrio, Ana; Antona, Beatriz			Five levels of performance and two subscales identified in the computer-vision symptom scale (CVSS17) by Rasch, factor, and discriminant analysis	PLOS ONE			English	Article							PATIENT-REPORTED OUTCOMES; PROS USE SERIES; CLINICAL-PRACTICE; MONTREAL ACCORD; QUESTIONNAIRES; ASTHENOPIA; STRESS; EYE	Purpose To quantify the levels of performance (symptom severity) of the computer-vision symptom scale (CVSS17), confirm its bifactorial structure as detected in an exploratory factor analysis, and validate its factors as subscales. Methods By partial credit model (PCM), we estimated CVSS17 measures and the standard error for every possible raw score, and used these data to determine the number of different performance levels in the CVSS17. In addition, through discriminant analysis, we checked that the scale's two main factors could classify subjects according to these determined levels of performance. Finally, a separate Rasch analysis was performed for each CVSS17 factor to assess their measurement properties when used as isolated scales. Results We identified 5.8 different levels of performance. Discriminant functions obtained from sample data indicated that the scale's main factors correctly classified 98.4% of the cases. The main factors: Internal symptom factor (ISF) and external symptom factor (ESF) showed good measurement properties and can be considered as subscales. Conclusion CVSS17 scores defined five different levels of performance. In addition, two main factors (ESF and ISF) were identified and these confirmed by discriminant analysis. These subscales served to assess either the visual or the ocular symptoms attributable to computer use.	[Gonzalez-Perez, Mariano; Barrio, Ana; Antona, Beatriz] Univ Complutense Madrid, Fac Opt & Optometry, Madrid, Spain; [Susi, Rosario] Univ Complutense Madrid, Fac Stat Studies, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Gonzalez-Perez, M (corresponding author), Univ Complutense Madrid, Fac Opt & Optometry, Madrid, Spain.	mgonper@hotmail.com	Susi, Rosario/L-4897-2014; Gonzalez, Mariano/ABA-5085-2020; ANTONA, BEATRIZ/I-8883-2016	Susi, Rosario/0000-0002-0664-7062; Gonzalez, Mariano/0000-0001-5967-5000; ANTONA, BEATRIZ/0000-0001-5219-8643				Ahmed S, 2017, J CLIN EPIDEMIOL, V89, P160, DOI 10.1016/j.jclinepi.2017.04.011; Bingham CO, 2017, J CLIN EPIDEMIOL, V89, P136, DOI 10.1016/j.jclinepi.2017.04.014; Castellanos Perez M. A., 2015, THESIS; Conlon EG, 1999, VIS COGN, V6, P637, DOI 10.1080/135062899394885; Daum Kent M, 2004, Optometry, V75, P33, DOI 10.1016/S1529-1839(04)70009-3; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Segui MD, 2015, J CLIN EPIDEMIOL, V68, P662, DOI 10.1016/j.jclinepi.2015.01.015; Dougherty BE, 2011, INVEST OPHTH VIS SCI, V52, P8630, DOI 10.1167/iovs.11-8027; Fenwick EK, 2016, QUAL LIFE RES, V25, P871, DOI 10.1007/s11136-015-1141-1; Gonzalez-Perez M, 2014, INVEST OPHTH VIS SCI, V55, P4504, DOI 10.1167/iovs.13-13818; Gowrisankaran S, 2015, WORK, V52, P303, DOI 10.3233/WOR-152162; Gowrisankaran S, 2012, OPTOMETRY VISION SCI, V89, P97, DOI 10.1097/OPX.0b013e318236dd88; Hayes JR, 2007, OPTOMETRY VISION SCI, V84, P738, DOI 10.1097/OPX.0b013e31812f7546; Instituto Nacional de Seguridad e Higiene en el Trabajo, 2012, GUIA TECN EV PREV RI; Khadka J, 2013, OPTOMETRY VISION SCI, V90, P720, DOI 10.1097/OPX.0000000000000001; Kroenke K, 2015, J CLIN EPIDEMIOL, V68, P1085, DOI 10.1016/j.jclinepi.2015.03.023; LACHENBRUCH PA, 1979, BIOMETRICS, V35, P69, DOI 10.2307/2529937; Lamoureux EL, 2006, INVEST OPHTH VIS SCI, V47, P4732, DOI 10.1167/iovs.06-0220; Marais Ida, 2008, J Appl Meas, V9, P200; McAlinden C, 2017, OCUL SURF, V15, P202, DOI 10.1016/j.jtos.2017.01.005; Nahar NK, 2007, OPTOMETRY VISION SCI, V84, P620, DOI 10.1097/OPX.0b013e3180dc99a8; Nahar NK, 2011, OPTOMETRY, V82, P689, DOI 10.1016/j.optm.2011.07.003; Portello JK, 2012, OPHTHAL PHYSL OPT, V32, P375, DOI 10.1111/j.1475-1313.2012.00925.x; Rosenfield M, 2012, OPHTHAL PHYSL OPT, V32, P142, DOI 10.1111/j.1475-1313.2011.00887.x; Rosenfield M, 2011, OPHTHAL PHYSL OPT, V31, P502, DOI 10.1111/j.1475-1313.2011.00834.x; Sharma S, 1995, APPL MULTIVARIATE TE; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Snyder CF, 2012, QUAL LIFE RES, V21, P1305, DOI 10.1007/s11136-011-0054-x; Vilela M.A., 2015, INT J ADV MED SCI, V3, P51, DOI [10.12783/ams.2015.0302.03, DOI 10.12783/AMS.2015.0302.03]; Wright BD, 2001, RASCH MEASUREMENT T, V14, P786; Wu M., 2007, APPL RASCH MODEL PSY	31	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202173	10.1371/journal.pone.0202173	http://dx.doi.org/10.1371/journal.pone.0202173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153272	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000443001700007
J	Gmel, AI; Druml, T; Portele, K; von Niederhausern, R; Neuditschko, M				Gmel, Annik Imogen; Druml, Thomas; Portele, Katrin; von Niederhausern, Rudolf; Neuditschko, Markus			Repeatability, reproducibility and consistency of horse shape data and its association with linearly described conformation traits in Franches-Montagnes stallions	PLOS ONE			English	Article							GENETIC-PARAMETERS; GEOMETRIC MORPHOMETRICS; EQUINE CONFORMATION; POPULATION	Linear description (LD) of conformation traits was introduced in horse breeding to minimise subjectivity in scoring. However, recent studies have shown that LD traits show essentially the same problems as traditionally scored traits, such as data converging around the mean value with very small standard deviations. To improve the assessment of conformation traits of horses, we investigated the application of the recently described horse shape space model based upon 403 digitised photographs of 243 Franches-Montagnes (FM) stallions and extracted joint angles based on specific landmark triplets. Repeatability, reproducibility and consistency of the resulting shape data and joint angles were assessed with Procrustes ANOVA (Rep) and intra-class correlation coefficients (ICC). Furthermore, we developed a subjective score to classify the posture of the horses on each photograph. We derived relative warp scores (PCs) based upon the digitised photos conducting a principal component analysis (PCA). The PCs of the shapes and joint angles were compared to the posture scores and to the linear description data using linear mixed effect models including significant posture scores as random factors. The digitisation process was highly repeatable and reproducible for the shape (Rep = 0.72-0.99, ICC = 0.99). The consistency of the shape was limited by the age and posture (p < 0.05). The angle measurements were highly repeatable within one digitiser. Between digitisers, we found a higher variability of ICC values (ICC = 0.054-0.92), indicating digitising error in specific landmarks (e.g. shoulder point). The posture scores were highly repeatable (Fleiss' kappa = 0.713-0.857). We identified significant associations (p(x(2)) < 0.05) with traits describing the withers height, shoulder length and incline, overall leg conformation, walk and trot step length. The horse shape data and angles provide additional information to explore the morphology of horses and therefore can be applied to improve the knowledge of the genetic architecture of LD traits.	[Gmel, Annik Imogen; Portele, Katrin; von Niederhausern, Rudolf; Neuditschko, Markus] Agroscope Swiss Natl Stud Farm, Avenches, Switzerland; [Gmel, Annik Imogen] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Druml, Thomas; Neuditschko, Markus] Vet Univ Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Portele, Katrin] Vet Univ Vienna, Equine Sci Fac, Vienna, Austria; [Portele, Katrin] Vet Univ Vienna, Messerli Res Inst, Vienna, Austria	Swiss Federal Research Station Agroscope; University of Bern; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Gmel, AI (corresponding author), Agroscope Swiss Natl Stud Farm, Avenches, Switzerland.; Gmel, AI (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	annik.gmel@agroscope.admin.ch	Gmel, Annik Imogen/AAO-3076-2020	Gmel, Annik Imogen/0000-0002-6259-2377; Druml, Thomas/0000-0002-2777-4669; Portele, Katrin/0000-0001-6963-3568	Swiss Federal Office for Agriculture (FOAG) [625000469]	Swiss Federal Office for Agriculture (FOAG)	This study was funded by the Swiss Federal Office for Agriculture (FOAG) under the contract number 625000469. The funding payed the salary of Annik Gmel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2014, GEOMORPH R PACKAGE S; Anderson TM, 2004, EQUINE VET J, V36, P563, DOI 10.2746/0425164044864507; Bignon O, 2005, J ARCHAEOL SCI, V32, P375, DOI 10.1016/j.jas.2004.02.016; Bromiley PA, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0061-1; Burren A, 2015, ZUCHTERISCHE AUSWERT; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Druml T, 2015, ANIMAL, P1, DOI [10.1017/S1751731114002602, DOI 10.1017/S1751731114002602]; Druml T, 2016, ARCH ANIM BREED, V59, P309, DOI 10.5194/aab-59-309-2016; Duensing J, 2014, J EQUINE VET SCI, V34, P360, DOI 10.1016/j.jevs.2013.09.002; Fruciano C, 2016, DEV GENES EVOL, V226, P139, DOI 10.1007/s00427-016-0537-4; Gamer M, 2012, IRR R PACKAGE VARIOU; Institut franc E ais du cheval et de l'e A quitation IFCE Les Haras du Pin, 2018, APPR MOD ALL CHEV QU; KOENEN EPC, 1995, LIVEST PROD SCI, V43, P85, DOI 10.1016/0301-6226(95)00010-I; Kristjansson T, 2013, LIVEST SCI, V158, P12, DOI 10.1016/j.livsci.2013.09.019; Kropatsch WG, 2015, PHANOTYPISIERUNG SCH, P93; Kuznetsova A, 2016, LMERTEST R PACKAGE T; Lefcheck JS, 2016, PIECEWISESEM R PACKA; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Olsson EG, 2000, LIVEST PROD SCI, V65, P81, DOI 10.1016/S0301-6226(99)00176-1; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Pfammatter M., 2017, SYSTEME DESCRIPTION; Plyusnin I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001742; R Core Team, 2017, R LANGUAGE ENV STAT; Rohlf F.J., 2016, TPSDIG2 DIGITIZE LAN; Rohlf FJ, 2016, TPS UTILITY PROGRAM; Samore AB, 1997, LIVEST PROD SCI, V52, P105, DOI 10.1016/S0301-6226(97)00143-7; Sanchez MJ, 2017, EQUINE VET J, V49, P196, DOI 10.1111/evj.12569; Schroderus E, 2010, J ANIM BREED GENET, V127, P395, DOI 10.1111/j.1439-0388.2010.00856.x; Seetah K, 2014, J ARCHAEOL SCI, V41, P904, DOI 10.1016/j.jas.2013.10.022; Smythe R.H., 1957, WHAT MAKES GOOD HORS; THOMPSON JR, 1981, J DAIRY SCI, V64, P1610, DOI 10.3168/jds.S0022-0302(81)82733-6; Viklund A, 2008, ANIMAL, V2, P1832, DOI 10.1017/S1751731108003030; Viklund A, 2018, J ANIM BREED GENET, V135, P62, DOI 10.1111/jbg.12311; Weller R, 2006, EQUINE VET J, V38, P616, DOI 10.2746/042516406X150394; Weller R, 2006, EQUINE VET J, V38, P610, DOI 10.2746/042516406X150367; Wolak ME, 2015, ICC R PACKAGE FACILI; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	38	9	9	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202931	10.1371/journal.pone.0202931	http://dx.doi.org/10.1371/journal.pone.0202931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148872	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200034
J	Panagiotopoulou, E; Filippetti, ML; Gentsch, A; Fotopoulou, A				Panagiotopoulou, Elena; Filippetti, Maria Laura; Gentsch, Antje; Fotopoulou, Aikaterini			Dissociable sources of erogeneity in social touch: Imagining and perceiving C-Tactile optimal touch in erogenous zones	PLOS ONE			English	Article							PLEASANT TOUCH; UNMYELINATED AFFERENTS; HAIRY SKIN; CORTEX; INTEROCEPTION; INTENSITY; RESPONSES	Previous research points to two major hypotheses regarding the mechanisms by which touch can be experienced as erotogenic. The first concerns the body part to which touch is applied (erogenous zones) and the second the modality of touch (sensual touch optimal in activating C Tactile afferents). In this study, we explored for the first time the relation between those two mechanisms in actual and imagined social touch. In a first experiment, we randomly assigned "Giver" and "Receiver" roles within 19 romantic couples (20 females, 18 males, age 32.34 +/- 8.71SD years) and asked the Giver" to apply CT-optimal (3 cm/s) vs. CT-suboptimal (18 cm/s) touch on an erogenous (neck) vs. non-erogenous zone (forehead) of their partner. We then obtained ratings of pleasantness and sexual arousal from both "Receivers" and Givers". In a second experiment, 32 healthy females (age 25.16 +/- 5.91SD years) were asked to imagine CT-optimal vs. CT-suboptimal stimulation (stroking vs. patting) and velocity (3 cm/s vs. 18 cm/s) on different erogenous vs. non-erogenous zones and rate pleasantness. While both erogenous body part and CT-optimal, sensual touch were found to increase pleasant and erotic sensations, the results showed a lack of an interaction. Furthermore, pleasantness was induced by mere imagination of touch without any tactile stimulation, and touch that was sexually arousing for the receiver was rated as more sexually arousing for the giver as well, pointing to top-down, learned expectations of sensory pleasure and erogeneity. Taken together, these studies provide the first direct evidence that while both the body location to which touch is applied and the mode of touch contribute to pleasant and erotic sensations, these two factors appear to mediate subjective pleasantness and erogeneity by, at least partly, independent mechanisms.	[Panagiotopoulou, Elena; Filippetti, Maria Laura; Fotopoulou, Aikaterini] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Filippetti, Maria Laura] Univ Essex, Ctr Brain Sci, Dept Psychol, Colchester, Essex, England; [Gentsch, Antje] Ludwig Maximillians Univ, Dept Psychol, Munich, Germany	University of London; University College London; University of Essex; University of Munich	Panagiotopoulou, E (corresponding author), UCL, Res Dept Clin Educ & Hlth Psychol, London, England.	e.panagiotopoulou@ucl.ac.uk	Filippetti, Maria Laura/ABG-7461-2021	Filippetti, Maria Laura/0000-0002-1824-9774; Panagiotopoulou, Elena/0000-0001-8410-4920	European Research Council (ERC) [ERC-2012-STG GA313755]; Economic and Social Research Council (ESRC); Neuropsychoanalysis Fund (NPSA)	European Research Council (ERC)(European Research Council (ERC)European Commission); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Neuropsychoanalysis Fund (NPSA)	The work was funded by the European Research Council (ERC) Starting Grant ERC-2012-STG GA313755 (https://erc.europa.eu/funding/starting-grants) to AF and a PhD studentship to E. P., co-funded by Economic and Social Research Council (ESRC) and Neuropsychoanalysis Fund (NPSA): (http://www.esrc.ac.uk/skills-and-careers/studentships/https://npsa-association.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; Bendas J, 2017, J SEX MED, V17, P30366; Bjornsdotter M, 2010, EXP BRAIN RES, V207, P149, DOI 10.1007/s00221-010-2408-y; Bjornsdotter M, 2009, J NEUROSCI, V29, P9314, DOI 10.1523/JNEUROSCI.0400-09.2009; Blakeslee, 1998, PHANTOMS BRAIN HUMAN; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Case LK, 2017, NEUROSCI LETT, V653, P84, DOI 10.1016/j.neulet.2017.05.006; Case LK, 2016, J NEUROSCI, V36, P5850, DOI 10.1523/JNEUROSCI.1130-15.2016; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Croy I, 2017, PLOS ONE, V9; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; Field T., 2001, TOUCH; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Gallace A, 2014, TOUCH FUTURE SENSE C; Gazzola V, 2012, P NATL ACAD SCI USA, V109, pE1657, DOI 10.1073/pnas.1113211109; Gentsch A, 2015, CURR BIOL, V25, P2392, DOI 10.1016/j.cub.2015.07.049; Goldstein P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03627-7; Gordon I, 2013, HUM BRAIN MAPP, V34, P914, DOI 10.1002/hbm.21480; Hertenstein MJ, 2006, EMOTION, V6, P528, DOI 10.1037/1528-3542.6.3.528; Jonsson EH, 2015, J SEX MED, V12, P1338, DOI 10.1111/jsm.12905; Kandel E. R., 2013, PRINCIPLES NEURAL SC; LEITENBERG H, 1995, PSYCHOL BULL, V117, P469, DOI 10.1037/0033-2909.117.3.469; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; Lucas MV, 2014, CEREB CORTEX, V9, P470; McGlone F, 2012, EUR J NEUROSCI, V35, P1782, DOI 10.1111/j.1460-9568.2012.08092.x; Mitchell WB, 1998, ARCH SEX BEHAV, V27, P197, DOI 10.1023/A:1018686631428; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson H, 2008, EXP BRAIN RES, V184, P135, DOI 10.1007/s00221-007-1175-x; Peterson ZD, 2007, ARCH SEX BEHAV, V36, P793, DOI 10.1007/s10508-006-9145-0; Turnbull OH, 2014, CORTEX, V53, P146, DOI 10.1016/j.cortex.2013.07.010; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; von Mohr M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13355-7	36	6	6	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0203039	10.1371/journal.pone.0203039	http://dx.doi.org/10.1371/journal.pone.0203039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142185	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000442722500059
J	Sumrell, RM; Nightingale, TE; McCauley, LS; Gorgey, AS				Sumrell, Ryan M.; Nightingale, Thomas E.; McCauley, Liron S.; Gorgey, Ashraf S.			Anthropometric cutoffs and associations with visceral adiposity and metabolic biomarkers after spinal cord injury	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; CORONARY-HEART-DISEASE; BODY-COMPOSITION; WAIST CIRCUMFERENCE; PHYSICAL-ACTIVITY; LIPID-METABOLISM; TISSUE; INDIVIDUALS; OBESITY; INSULIN	Background/Objectives To examine associations of different anthropometric measurements of central adiposity to visceral adipose tissue (measured via multi-axial magnetic resonance imaging; MRI) and cardiometabolic disease risk factors in men with spinal cord injury (SCI). Additionally, to determine population-specific seated/supine waist and abdominal circumference cutoffs, which may identify men at increased risk of cardiometabolic disease. Participants/Methods Twenty-two men with chronic SCI underwent MRI scans, anthropometric measurements along with assessments of various cardiometabolic risk biomarkers. Pearson/part (accounting for age as a covariate) correlation coefficients were calculated to determine the associations between study variables. Abdominal and waist circumference cutoffs were extrapolated using the slope of linear regression equations. Results Seated/supine abdominal and waist circumferences were (P < 0.01) associated with MRI visceral fat cross-sectional area (VAT(CSA)), VAT volume and CSA:Total(CSA). Low density lipoprotein, non-high-density lipoprotein and total cholesterol were positively associated with seated/supine abdominal and waist circumferences after controlling for age; r = 0.500.61, r = 0.46-0.58, r = 0.52-0.58, P < 0.05, respectively. Tumor necrosis factor alpha was associated with seated/supine abdominal and waist circumferences after accounting for age; r = 0.49-0.51 and r = 0.48-0.56, P < 0.05 respectively. The population-specific cutoffs were 86.5cm and 88.3cm for supine waist and abdominal circumferences, respectively, as well as 89cm and 101cm for seated waist and abdominal circumferences, respectively. After dichotomizing VAT(CSA) (< or >= 100cm(2)), peak oxygen uptake, triglycerides, insulin sensitivity and glycated hemoglobin were different (P < 0.05) between groups. After dichotomizing (< or >= 86.5cm) supine waist circumference, VAT(CSA), triglycerides and insulin sensitivity were different (P < 0.05) between groups. Conclusions Seated/supine circumferences are associated with both central adiposity and biomarkers of cardiometabolic disease risk in persons with SCI. Population-specific cutoffs are proposed herein to identify central adiposity and potential cardiometabolic disease risk after SCI.	[Sumrell, Ryan M.; Nightingale, Thomas E.; McCauley, Liron S.; Gorgey, Ashraf S.] Hunter Holmes McGuire VA Med Ctr, Spinal Cord Injury Serv & Disorders, Richmond, VA 23249 USA; [Nightingale, Thomas E.; Gorgey, Ashraf S.] Virginia Commonwealth Univ, Phys Med & Rehabil, Richmond, VA 23284 USA	Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Gorgey, AS (corresponding author), Hunter Holmes McGuire VA Med Ctr, Spinal Cord Injury Serv & Disorders, Richmond, VA 23249 USA.; Gorgey, AS (corresponding author), Virginia Commonwealth Univ, Phys Med & Rehabil, Richmond, VA 23284 USA.	ashraf.gorgey@va.gov	Nightingale, Tom E/Q-8525-2019; Gorgey, Ashraf S/I-5455-2019	Nightingale, Tom E/0000-0003-2947-4931; Gorgey, Ashraf S/0000-0002-9157-6034	Veteran Affairs, Veteran Health Administration, Rehabilitation Research and Development Service [VA-RRD CDA2: B7867-W]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002649] Funding Source: NIH RePORTER	Veteran Affairs, Veteran Health Administration, Rehabilitation Research and Development Service; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by Ashraf S. Gorgey received a VA-RRD CDA2: B7867-W grant Veteran Affairs, Veteran Health Administration, Rehabilitation Research and Development Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Laura O'Brien and Chase Wade in the Spinal Cord Injury and Disorders Service for their assistance with basal metabolic rate, anthropometric measurements and image analysis. We are also indebted to our research coordinator, Refka Khalil for her help with participant recruitment. We are thankful to the Hunter Holmes McGuire Research Institute and Virginia Commonwealth University (VCU) Clinical Research Service for providing appropriate environments to conduct clinical human research trials. This work was supported by the Veteran Affairs, Veteran Health Administration, Rehabilitation Research and Development Service (VA-RRD CDA2: B7867-W). We are also grateful to the study participants for their time and effort.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Bauman WA, 2008, SPINAL CORD, V46, P466, DOI 10.1038/sj.sc.3102161; Bauman W A, 2001, J Spinal Cord Med, V24, P266; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; Buchholz AC, 2005, SPINAL CORD, V43, P513, DOI 10.1038/sj.sc.3101744; CAMPBELL PJ, 1988, METABOLISM, V37, P15, DOI 10.1016/0026-0495(88)90023-6; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; DUCKWORTH WC, 1980, DIABETES, V29, P906, DOI 10.2337/diabetes.29.11.906; Edwards LA, 2008, AM J CLIN NUTR, V87, P600, DOI 10.1093/ajcn/87.3.600; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Feasel S, 2009, TOP SPINAL CORD INJ, V14, P58; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Gater David R Jr, 2007, Phys Med Rehabil Clin N Am, V18, P333, DOI 10.1016/j.pmr.2007.03.004; Gilbert O, 2014, ATHEROSCLEROSIS, V232, P305, DOI 10.1016/j.atherosclerosis.2013.11.028; Gorgey AS, 2017, PM R; Gorgey AS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014125; Gorgey AS, 2016, J SPINAL CORD MED, V39, P699, DOI 10.1080/10790268.2016.1157970; Gorgey AS, 2016, PM&R, V8, P225, DOI 10.1016/j.pmrj.2015.10.006; Gorgey AS, 2015, ARCH PHYS MED REHAB, V96, P1646, DOI 10.1016/j.apmr.2015.05.013; Gorgey AS, 2014, J SPINAL CORD MED, V37, P693, DOI 10.1179/2045772314Y.0000000245; Gorgey AS, 2012, MED SCI SPORT EXER, V44, P165, DOI 10.1249/MSS.0b013e31822672aa; Gorgey AS, 2011, METABOLISM, V60, P843, DOI 10.1016/j.metabol.2010.08.002; Gorgey AS, 2011, J SPINAL CORD MED, V34, P99, DOI 10.1179/107902610X12911165975106; Gorgey AS, 2010, J SPINAL CORD MED, V33, P6, DOI 10.1080/10790268.2010.11689669; Groah SL, 2009, J SPINAL CORD MED, V32, P25, DOI 10.1080/10790268.2009.11760749; Hirata K, 2000, BIOCHEM BIOPH RES CO, V272, P90, DOI 10.1006/bbrc.2000.2747; Inayama T, 2014, SPINAL CORD, V52, P836, DOI 10.1038/sc.2014.162; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; LaVela SL, 2006, J SPINAL CORD MED, V29, P387, DOI 10.1080/10790268.2006.11753887; LEMIEUX S, 1994, DIABETOLOGIA, V37, P757, DOI 10.1007/BF00404332; LEMIEUX S, 1995, ATHEROSCLEROSIS, V118, P155, DOI 10.1016/0021-9150(95)05603-T; Liou TH, 2005, NUTR REV, V63, P321, DOI [10.1111/j.1753-4887.2005.tb00110.x, 10.1301/nr.2005.oct.321.331]; MAKI KC, 1995, PARAPLEGIA, V33, P102, DOI 10.1038/sc.1995.24; Maruyama Y, 2008, SPINAL CORD, V46, P494, DOI 10.1038/sj.sc.3102171; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nightingale TE, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0590-z; Nightingale TE, 2019, J SPINAL CORD MED, V42, P328, DOI 10.1080/10790268.2017.1368203; Paradis ME, 2006, J LIPID RES, V47, P2808, DOI 10.1194/jlr.P600002-JLR200; Radziuk J, 2014, DIABETES, V63, P1850, DOI 10.2337/db14-0116; Rankin KC, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1364818; Ravensbergen HJC, 2014, J NEUROTRAUM, V31, P292, DOI 10.1089/neu.2013.3042; Rimmer JH, 2012, EXERC SPORT SCI REV, V40, P22, DOI 10.1097/JES.0b013e31823b8b82; Silveira SL, 2017, SPINAL CORD, V55, P812, DOI 10.1038/sc.2017.79; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011	48	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203049	10.1371/journal.pone.0203049	http://dx.doi.org/10.1371/journal.pone.0203049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169541	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400018
J	Leung, Y; Dean, RT				Leung, Yvonne; Dean, Roger Thornton			Learning unfamiliar pitch intervals: A novel paradigm for demonstrating the learning of statistical associations between musical pitches	PLOS ONE			English	Article							LEXICAL DECISION TASK; EXPECTANCY; PERCEPTION; SEQUENCES; ENCULTURATION; EXPECTATIONS; CHILDREN; INFANTS; MELODY	While mastering a musical instrument takes years, becoming familiar with a new music system requires less time and skills. In this study, we examine whether musically untrained Western listeners can incidentally learn an unfamiliar, microtonal musical scale from simply engaging in a timbre discrimination task. The experiment is comprised of an Exposure and a Test phase. During Exposure, 21 non-musicians were instructed to detect a timbre shift (TS) within short microtonal melodies, and we hypothesised that they would incidentally learn about the pitch interval structure of the microtonal scale from attending to the melodies during the task. In a follow-up Test phase, the tone before the TS was either a member (congruent) or a non-member (incongruent) of the scale. Based on our statistical manipulation of the stimuli, incongruent tones would be a better predictor of an incoming TS than the congruent tones. We therefore expect a faster response time to the shift after the participants have heard an incongruent tone. Specifically, a faster response time observed after an incongruent tone would imply participants' ability to differentiate tones from the microtonal and the diatonic scale, and reflect their learning of the microtonal pitch intervals. Results are consistent with our predictions. In investigating the learning of a microtonal scale, our study can offer directions for future research on the perception of computer music and new musical genres.	[Leung, Yvonne; Dean, Roger Thornton] Western Sydney Univ, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia	Western Sydney University	Leung, Y (corresponding author), Western Sydney Univ, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia.	yvonne.leung@unsw.edu.au	Leung, Yvonne/M-5086-2017	Leung, Yvonne/0000-0001-9110-7054; Dean, Roger Thornton/0000-0002-8859-8902	MARCS Postgraduate Scholarship; MARCS Institute for Brain, Behaviour and Development, Western Sydney University	MARCS Postgraduate Scholarship; MARCS Institute for Brain, Behaviour and Development, Western Sydney University	This work is funded by the MARCS Postgraduate Scholarship, that was granted to YL for her PhD Candidature. The funder is the MARCS Institute for Brain, Behaviour and Development, Western Sydney University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluri V, 2012, MUSIC PERCEPT, V29, P297, DOI 10.1525/MP.2012.29.3.297; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; BHARUCHA JJ, 1986, J EXP PSYCHOL HUMAN, V12, P403, DOI 10.1037/0096-1523.12.4.403; BHARUCHA JJ, 1987, MUSIC PERCEPT, V5, P1; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; CAREY N, 1989, MUSIC THEOR SPECTRUM, V11, P187, DOI 10.1525/mts.1989.11.2.02a00030; Corrigall KA, 2014, DEVELOPMENTAL SCI, V17, P142, DOI 10.1111/desc.12100; Creel SC, 2004, J EXP PSYCHOL LEARN, V30, P1119, DOI 10.1037/0278-7393.30.5.1119; CUDDY LL, 1992, PSYCHOL RES-PSYCH FO, V54, P51, DOI 10.1007/BF00937133; Cui AX, 2016, PEERJ, V4, DOI 10.7717/peerj.2399; Dean RT, 2009, LEONARDO, V42, P94, DOI 10.1162/leon.2009.42.1.94; Eerola T, 2009, MUSIC SCI, V13, P231, DOI 10.1177/102986490901300203; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Hannon EE, 2011, DEVELOPMENTAL SCI, V14, P865, DOI 10.1111/j.1467-7687.2011.01036.x; Huron D.B., 2006, SWEET ANTICIPATION M; Kinoshita S, 2003, J EXP PSYCHOL LEARN, V29, P405, DOI 10.1037/0278-7393.29.3.405; Krumhansl CL, 2010, SPRINGER HANDB AUDIT, V36, P51, DOI 10.1007/978-1-4419-6114-3_3; KRUMHANSL CL, 1992, J EXP PSYCHOL HUMAN, V18, P739, DOI 10.1037/0096-1523.18.3.739; Krumhansl CL, 1999, MUSIC PERCEPT, V17, P151; KRUMHANSL CL, 1991, ANNU REV PSYCHOL, V42, P277; KRUMHANSL CL, 1982, MEM COGNITION, V10, P243, DOI 10.3758/BF03197636; Kuhn G, 2005, J EXP PSYCHOL LEARN, V31, P1417, DOI 10.1037/0278-7393.31.6.1417; Kuhn G, 2006, Q J EXP PSYCHOL, V59, P1725, DOI 10.1080/17470210500438361; Leman M, 2000, MUSIC PERCEPT, V17, P481; Leung Y, 2018, J NEW MUSIC RES, V47, P206, DOI 10.1080/09298215.2018.1432060; Loui P, 2010, MUSIC PERCEPT, V27, P377, DOI 10.1525/mp.2010.27.5.377; LYNCH MP, 1992, PERCEPT PSYCHOPHYS, V52, P599, DOI 10.3758/BF03211696; Marmel F, 2010, J EXP PSYCHOL HUMAN, V36, P1016, DOI 10.1037/a0018735; Milne Andrew J., 2011, Mathematics and Computation in Music. Proceedings of the Third International Conference, MCM 2011, P180, DOI 10.1007/978-3-642-21590-2_14; Mullensiefen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101091; NARMOUR E, 1990, ANAL COGNITION BASIC; NEELY JH, 1989, J EXP PSYCHOL LEARN, V15, P1003, DOI 10.1037/0278-7393.15.6.1003; Ollen J. E., 2006, THESIS; PALMER C, 1990, J EXP PSYCHOL HUMAN, V16, P728, DOI 10.1037/0096-1523.16.4.728; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Posner M., 1975, INFORM PROCESSING CO; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Rohrmeier M., 2012, INT C MUSIC PERCEPTI, P857, DOI [10.1111/cogs.12404, DOI 10.1111/COGS.12404]; Rohrmeier M, 2011, CONSCIOUS COGN, V20, P214, DOI 10.1016/j.concog.2010.07.004; Rohrmeier MA, 2012, INT J PSYCHOPHYSIOL, V83, P164, DOI 10.1016/j.ijpsycho.2011.12.010; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Schellenberg EG, 2002, J EXP PSYCHOL GEN, V131, P511, DOI 10.1037//0096-3445.131.4.511; Thompson WF, 2015, MUSIC THOUGHT FEELIN; Tillmann B, 2006, EUR J COGN PSYCHOL, V18, P343, DOI 10.1080/09541440500269548; Tillmann B, 2004, J EXP PSYCHOL LEARN, V30, P1131, DOI 10.1037/0278-7393.30.5.1131; Tillmann B, 2006, PSYCHOL RES-PSYCH FO, V70, P345, DOI 10.1007/s00426-005-0222-0; Tillmann B, 2010, Q J EXP PSYCHOL, V63, P1646, DOI 10.1080/17470210903511228; Topolinski S, 2010, CURR DIR PSYCHOL SCI, V19, P402, DOI 10.1177/0963721410388803; Trainor LJ, 2012, SPRINGER HANDB AUDIT, V42, P223, DOI 10.1007/978-1-4614-1421-6_8; Unyk AM, 1987, PSYCHOMUSICOLOGY, V7, P3, DOI [DOI 10.1037/H0094189, 10.1037/h0094189]; Wentura D, 2000, J EXP PSYCHOL LEARN, V26, P456, DOI 10.1037/0278-7393.26.2.456	51	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203026	10.1371/journal.pone.0203026	http://dx.doi.org/10.1371/journal.pone.0203026			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161174	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900070
J	Raberahona, M; Razafinambinintsoa, T; Andriananja, V; Ravololomanana, N; Tongavelona, J; Rakotomalala, R; Andriamamonjisoa, J; Andrianasolo, RL; Rakotoarivele, RA; Randria, MJD				Raberahona, Mihaja; Razafinambinintsoa, Tiana; Andriananja, Volatiana; Ravololomanana, Njaratiana; Tongavelona, Juliana; Rakotomalala, Rado; Andriamamonjisoa, Johary; Andrianasolo, Radonirina Lazasoa; Rakotoarivele, Rivonirina Andry; Randria, Mamy Jean de Dieu			Hospitalization of HIV positive patients in a referral tertiary care hospital in Antananarivo Madagascar, 2010-2016: Trends, causes and outcome	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; COHORT; RATES; METAANALYSIS; MORTALITY; WORLDWIDE; MARKERS; COST; ERA	Background During the last few years, significant efforts have been made to improve access to antiretroviral therapy which led to dramatic reduction in AIDS-related events and mortality in HIV positive patients at the global level. However, current data in Africa suggested modest impact of widespread antiretroviral therapy scale-up especially regarding HIV-related hospitalization. In this study, we aimed to describe causes of hospitalization and factors associated with AIDS-defining events and inpatient mortality. Materials and methods A retrospective study was performed on medical records of HIV positive patients admitted for at least 24 hours in the Infectious Diseases Unit of the University Hospital Joseph Raseta Befelatanana Antananarivo. Cause of hospitalization was considered as the main diagnosis related to the symptoms at admission. Diagnostic criteria were based on criteria described in WHO guidelines. AIDS-defining events were defined as diseases corresponding to WHO stage 4 or category C of CDC classification. Results From 2010 to 2016, 236 hospital admissions were included. AIDS-defining events were the most frequent cause of hospitalization (61.9%) with an increasing trend during the study period. Tuberculosis (28.4%), pneumocystis pneumonia (11.4%), cerebral toxoplasmosis (7.2%) and cryptococcosis (5.5%) were the most frequent AIDS-defining events. Tuberculosis was also the most frequent cause of overall hospitalization. In multivariate analysis, recent HIV diagnosis (aOR = 2.0, 95% CI: 1.0-3.9), CD4<200 cells/mu l (aOR = 4.0, 95% CI: 1.9-8.1), persistent fever (aOR = 4.4, 95%Cl: 2.1-9.0), duration of symptoms >= 6 weeks (aOR = 2.6, 95%Cl: 1.2-5.4) were associated with AIDS-defining events. Overall inpatient mortality was 19.5%. Age >= 55 years (aOR = 4.9, 95%Cl: 1.5-16.6), neurological signs (aOR = 3.2, 95%Cl: 1.5-6.9) and AIDS-defining events (aOR = 2.9, 95%Cl: 1.2-7.2) were associated with inpatient mortality. Conclusions AIDS-defining events were the most frequent cause of hospitalization during the study period. Factors associated with AIDS-defining events mostly reflected delay in HIV diagnosis. Factors associated with mortality were advanced age, neurological signs and AIDS-defining events.	[Raberahona, Mihaja; Andriananja, Volatiana; Randria, Mamy Jean de Dieu] Univ Hosp Antananar, Univ Hosp Joseph Raseta Befelatanana, Infect Dis Unit, Antananarivo, Madagascar; [Razafinambinintsoa, Tiana; Ravololomanana, Njaratiana; Tongavelona, Juliana; Rakotomalala, Rado; Andriamamonjisoa, Johary; Andrianasolo, Radonirina Lazasoa; Randria, Mamy Jean de Dieu] Univ Antananar, Fac Med, Antananarivo, Madagascar; [Tongavelona, Juliana; Rakotoarivele, Rivonirina Andry] Univ Hosp Tambohobe, Infect Dis Unit, Fianarantsoa, Madagascar; [Rakotoarivele, Rivonirina Andry] Univ Fianarantsoa, Fianarantsoa, Madagascar		Raberahona, M (corresponding author), Univ Hosp Antananar, Univ Hosp Joseph Raseta Befelatanana, Infect Dis Unit, Antananarivo, Madagascar.	raberahona@gamil.com		Rakotoarivelo, Rivonirina Andry/0000-0003-3438-8624				Agbor AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115211; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Assen A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3263-y; Buchacz K, 2008, AIDS, V22, P1345, DOI 10.1097/QAD.0b013e328304b38b; Buve A, 1997, TROP MED INT HEALTH, V2, P136, DOI 10.1046/j.1365-3156.1997.d01-235.x; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Coelho LE, 2017, BRAZ J INFECT DIS, V21, P190, DOI 10.1016/j.bjid.2016.10.007; Druyts EF, 2009, HIV MED, V10, P88, DOI 10.1111/j.1468-1293.2008.00656.x; Falster K, 2010, AIDS, V24, P1329, DOI 10.1097/QAD.0b013e328339e245; Fielden SJ, 2008, AIDS CARE, V20, P297, DOI 10.1080/09540120701561296; Ford N, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20714; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lewden C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18797; Luo B, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003802; Mahlab-Guri K, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006812, 10.1097/md.0000000000006812]; Meintjes G, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002269; Mocroft A, 2004, HIV MED, V5, P437, DOI 10.1111/j.1468-1293.2004.00250.x; Paul S, 2002, AIDS RES HUM RETROV, V18, P501, DOI 10.1089/088922202317406646; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; UNAIDS, AMB TREATM TARG HELP; UNAIDS, 2018, COUNTR FACTSH MAD; UNAIDS, 2016, GLOB AIDS UPD; van der Kop ML, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1500-8; WHO (World Health Organization), 2017, TREAT ALL POL AD IMP; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2016, TUB PROF MAD	30	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203437	10.1371/journal.pone.0203437	http://dx.doi.org/10.1371/journal.pone.0203437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161228	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900126
J	Akombi, BJ; Ghimire, PR; Agho, KE; Renzaho, AM				Akombi, Blessing Jaka; Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore; Renzaho, Andre Masumbuko			Stillbirth in the African Great Lakes region: A pooled analysis of Demographic and Health Surveys	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; MATERNAL SMOKING; PREGNANCY; DETERMINANTS; SURVIVAL; INDIA; COST; RISK; CARE	Background The aim of this study was to estimate the rate and predisposing factors associated with stillbirth in the African Great Lakes region (Burundi, Congo Democratic Republic, Kenya, Rwanda, Tanzania and Uganda). Methods and findings Cross-sectional data from the most recent Demographic and Health Surveys (DHS) of countries in the African Great Lakes region were used in this study. DHS from Congo Democratic Republic was not included in the analyses because data was not collected for stillbirth in the country survey. A pooled sample of 57046 pregnancies of 7+ months' duration and 1002 stillbirths were included in the final analysis. The analyses were restricted to stillbirths reported in the 5 years preceding the surveys. Stillbirth was defined as foetal death in the third trimester (>= 28 weeks' gestation). Multilevel logistic regression analyses that adjusted for cluster and survey weights were used to determine the factors associated with stillbirth in the Africa Great Lakes region. Health service variables and maternal medical condition variables were not included in the analysis because DHS do not collect data on these variables for pregnancies that did not result in a live birth. Burundi had the highest stillbirth rate per 1000 births [23% (95% CI: 20, 25)] within the region. Factors associated with stillbirth across the region were: no schooling [1.85 (95% Cl: 1.44, 2.38)] and primary education [1.64 (1.32, 2.05)], advanced maternal age [2.39 (95% CI: 1.59, 3.59)], smoking [1.99 (95% CI: 1.19, 3.32)] and drinking water from unimproved sources [1.18 (95% CI: 1.01, 1.37)]. Conclusion To achieve Every Newborn Action Plan (ENAP) stillbirth target of 12 per 1000 births or less by 2030, policy interventions to prevent stillbirth should focus on promoting community-based socio-educational programmes which encourages a healthy lifestyle especially among uneducated women in the advanced age spectrum.	[Akombi, Blessing Jaka; Ghimire, Pramesh Raj; Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Renzaho, Andre Masumbuko] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia	Western Sydney University; Western Sydney University	Akombi, BJ (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	B.Akombi@westernsydney.edu.au	Agho, Kingsley/AAW-5622-2021; Agho, Kingsley/AAE-9971-2020; Akombi-Inyang, Blessing/AAT-6507-2020; Renzaho, Andre M.N./AAH-7679-2021	Agho, Kingsley/0000-0003-4111-3207; Akombi-Inyang, Blessing/0000-0002-6410-4154; Ghimire, Pramesh/0000-0002-7902-7294; RENZAHO, ANDRE/0000-0002-6844-0833; Ghimire, Pramesh Raj/0000-0003-2816-0463				Abir T, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1410048; Afulani PA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0925-9; Badimsuguru AB, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.1.6168; Bernis L, 2016, LANCET, V387, P703, DOI [10.1016/S0140-6736(15)00954-X, DOI 10.1016/S0140-6736(15)00954-X]; Bhutta ZA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002364; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Bjornholt SM, 2016, ACTA OBSTET GYN SCAN, V95, P1305, DOI 10.1111/aogs.13011; BRADLEY S. E. K., 2015, DHS METHODOLOGICAL R, V17; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chahande M. S., 2002, INDIAN J COMMUNITY M, V27, P106; Chakraborty N, 2003, HLTH PROMOTION INT, V18; Christou A, 2017, TROP MED INT HEALTH, V22, P294, DOI 10.1111/tmi.12828; Di Mario S, 2007, SEX TRANSM DIS, V34, pS11, DOI 10.1097/01.olq.0000258130.07476.e3; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Froen JF, 2016, LANCET, V387, P574, DOI 10.1016/S0140-6736(15)00818-1; Ghimire PR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181332; Ghosh Banerjee S, TRACKING ACCESS NONS; Giri A, 2012, NEPAL MED COLL J NMC, V15, P87; Goldenberg RL, 2007, ACTA OBSTET GYN SCAN, V86, P1303, DOI 10.1080/00016340701644876; Grossman D.S., 2017, W VIRGINIA U COLL BU, P17; Hogberg L, 2007, BJOG-INT J OBSTET GY, V114, P699, DOI 10.1111/j.1471-0528.2007.01340.x; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute, 2015, KEN DEM HLTH SURV 20; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Lean SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186287; Marufu TC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1552-5; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) Ministry of Health (MoH) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and ICF, 2016, TANZ DEM HLTH SURV M; Ministry to the Presidency in charge of Good Governance and Planning [Burundi] (MPBGP) Ministry of Health Public Health and the Fight against AIDS [Burundi] (MSPLS) Institute of Statistics and Economic Studies of Burundi (ISTEEBU) and ICF, 2017, 3 DEM HLTH SURV; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Mukhopadhyay P, 2010, J HEALTH POPUL NUTR, V28, P494; National Institute of Statistics of Rwanda (NISR) [Rwanda]; Ministry of Health (MOH) [Rwanda]; and ICF International, 2015, RWAND DEM HLTH SURV; Olusanya BO, 2009, ACTA OBSTET GYN SCAN, V88, P1243, DOI 10.3109/00016340903287474; Onadeko M O, 1996, Afr J Med Med Sci, V25, P81; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Philips M, 2004, BRIT J GEN PRACT, V54, P634; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Sharma A K, 2001, Indian Pediatr, V38, P1405; Stringer EM, 2011, OBSTET GYNECOL, V117, P1151, DOI 10.1097/AOG.0b013e3182167627; Tshibumbu DD, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i1.1054; UBOS ICF, 2018, UGANDA DEMOGRAPHIC H; United Nations, 2016, GREAT LAK REG STRAT; USAID, GLOBAL HLTH; Varner MW, 2014, OBSTET GYNECOL, V123, P113, DOI 10.1097/AOG.0000000000000052; WHO/UNICEF, 2014, PROGR DRINK WAT SAN; World Health Organization, 2015, MAT NEWB CHILD AD HL; World Health Organization UNICEF, 2003, ANT CAR DEV COUNTR P	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202603	10.1371/journal.pone.0202603	http://dx.doi.org/10.1371/journal.pone.0202603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157230	Green Submitted, gold, Green Published			2022-12-27	WOS:000443071400065
J	Lutz, ND; Lemes, E; Krubitzer, L; Collin, SP; Haverkamp, S; Peichl, L				Lutz, Nicolas D.; Lemes, Emina; Krubitzer, Leah; Collin, Shaun P.; Haverkamp, Silke; Peichl, Leo			The rod signaling pathway in marsupial retinae	PLOS ONE			English	Article							AII-AMACRINE CELLS; MACAQUE MONKEY RETINA; BIPOLAR CELLS; RABBIT RETINA; MAMMALIAN RETINA; MOUSE RETINA; IMMUNOCYTOCHEMICAL ANALYSIS; PHOTORECEPTOR TYPES; AMERICAN OPOSSUM; MACROPUS-EUGENII	The retinal rod pathway, featuring dedicated rod bipolar cells (RBCs) and AII amacrine cells, has been intensely studied in placental mammals. Here, we analyzed the rod pathway in a nocturnal marsupial, the South American opossum Monodelphis domestica to elucidate whether marsupials have a similar rod pathway. The retina was dominated by rods with densities of 338,000-413,000/mm. Immunohistochemistry for the RBC-specific marker protein kinase C alpha (PKC alpha) and the AII cell marker calretinin revealed the presence of both cell types with their typical morphology. This is the first demonstration of RBCs in a marsupial and of the integration of RBCs and AII cells in the rod signaling pathway. Electron microscopy showed invaginating synaptic contacts of the PKC alpha-immunoreactive bipolar cells with rods; light microscopic co-immunolabeling for the synaptic ribbon marker CtBP2 confirmed dominant rod contacts. The RBC axon terminals were mostly located in the innermost stratum S5 of the inner plexiform layer (IPL), but had additional side branches and synaptic varicosities in strata S3 and S4, with S3-S5 belonging to the presumed functional ON sublayer of the IPL, as shown by immunolabeling for the ON bipolar cell marker G.13. Triple-immunolabeling for PKC alpha, calretinin and CtBP2 demonstrated RBC synapses onto AII cells. These features conform to the pattern seen in placental mammals, indicating a basically similar rod pathway in M. domestica. The density range of RBCs was 9,900-16,600/mm(2), that of AII cells was 1,500-3,260/mm(2). The numerical convergence (density ratio) of 146-156 rods to 4.7-6.0 RBCs to 1 AII cell is within the broad range found among placental mammals. For comparison, we collected data for the Australian nocturnal dunnart Sminthopsis crassicaudata, and found it to be similar to M. domestica, with rod-contacting PKCa-immunoreactive bipolar cells that had axon terminals also stratifying in IPL strata S3-S5.	[Lutz, Nicolas D.; Haverkamp, Silke; Peichl, Leo] Max Planck Inst Brain Res, Frankfurt, Germany; [Lutz, Nicolas D.] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Lutz, Nicolas D.] Univ Tubingen, IMPRS Cognit & Syst Neurosci, Grad Training Ctr Neurosci, Tubingen, Germany; [Lemes, Emina; Haverkamp, Silke; Peichl, Leo] Goethe Univ Frankfurt, Dr Senckenbergische Anat, Inst Cellular & Mol Anat, Frankfurt, Germany; [Krubitzer, Leah] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Collin, Shaun P.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Collin, Shaun P.] Univ Western Australia, Oceans Grad Sch, Crawley, WA, Australia; [Haverkamp, Silke] Ctr Adv European Studies & Res, Dept Computat Neuroethol, Bonn, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Goethe University Frankfurt; University of California System; University of California Davis; University of Western Australia; University of Western Australia; Center of Advanced European Studies & Research (CAESAR)	Peichl, L (corresponding author), Max Planck Inst Brain Res, Frankfurt, Germany.; Peichl, L (corresponding author), Goethe Univ Frankfurt, Dr Senckenbergische Anat, Inst Cellular & Mol Anat, Frankfurt, Germany.	peichl.retina@gmail.com		Lutz, Nicolas D./0000-0002-8451-2630; Lemes, Emina/0000-0002-4342-0940; Peichl, Leo/0000-0002-8141-0911	NATIONAL EYE INSTITUTE [R01EY022987] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY022987] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHNELT PK, 1995, VISUAL NEUROSCI, V12, P793, DOI 10.1017/S0952523800009366; AMMERMULLER J, 1995, J COMP NEUROL, V358, P1, DOI 10.1002/cne.903580102; Arrese CA, 2006, CURR BIOL, V16, pR193, DOI 10.1016/j.cub.2006.02.036; Arrese CA, 2003, VISUAL NEUROSCI, V20, P307, DOI 10.1017/S0952523803203096; Behrens C, 2016, ELIFE, V5, DOI 10.7554/eLife.20041; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Davies WIL, 2012, MOL ECOL, V21, P3121, DOI 10.1111/j.1365-294X.2012.05617.x; Deeb SS, 2010, MARSUPIAL GENETICS AND GENOMICS, P403, DOI 10.1007/978-90-481-9023-2_19; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Ebeling W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086531; Ebeling W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014231; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; GRUNERT U, 1994, J COMP NEUROL, V348, P607, DOI 10.1002/cne.903480410; GRUNERT U, 1991, J NEUROSCI, V11, P2742; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; Huang LQ, 2003, J COMP NEUROL, V455, P1, DOI 10.1002/cne.10396; Hunt DM, 2009, GENE, V433, P50, DOI 10.1016/j.gene.2008.12.006; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jeon YK, 2007, NEUROREPORT, V18, P1095, DOI 10.1097/WNR.0b013e3281e72afe; KARSCHIN A, 1990, J NEUROPHYSIOL, V63, P860, DOI 10.1152/jn.1990.63.4.860; KOLB H, 1985, VISION RES, V25, P1207, DOI 10.1016/0042-6989(85)90035-5; Kuhrt H, 2017, BRAIN BEHAV EVOLUT, V89, P84, DOI 10.1159/000464097; Li YN, 2012, J COMP NEUROL, V520, P3786, DOI 10.1002/cne.23168; Massey SC, 1999, J COMP NEUROL, V411, P3; MILLS SL, 1991, J COMP NEUROL, V304, P491, DOI 10.1002/cne.903040312; Mills SL, 1999, J COMP NEUROL, V411, P19; Muller B, 2013, J NEUROSCI, V33, P1014, DOI 10.1523/JNEUROSCI.2072-12.2013; Muller LPD, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00039; Neumann S, 2013, J COMP NEUROL, V521, P709, DOI 10.1002/cne.23201; Palacios AG, 2010, J COMP NEUROL, V518, P1589, DOI 10.1002/cne.22292; Pang JJ, 2018, J COMP NEUROL, V526, P1896, DOI 10.1002/cne.24456; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2004, EUR J NEUROSCI, V19, P1545, DOI 10.1111/j.1460-9568.2004.03263.x; Peichl L, 2000, VISUAL NEUROSCI, V17, P937, DOI 10.1017/S0952523800176138; Sakaguchi DS, 2008, BRAIN RES, V1195, P28, DOI 10.1016/j.brainres.2007.12.018; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; STERLING P, 1988, J NEUROSCI, V8, P623; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; VandeBerg John L., 1997, ILAR J, V38, P4; VANEY DI, 1991, J COMP NEUROL, V310, P154, DOI 10.1002/cne.903100203; VANEY DI, 1985, PROC R SOC SER B-BIO, V224, P475, DOI 10.1098/rspb.1985.0045; Vlahos LM, 2014, J COMP NEUROL, V522, P3423, DOI 10.1002/cne.23610; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WASSLE H, 1991, VISUAL NEUROSCI, V7, P99, DOI 10.1017/S095252380001097X; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1995, J COMP NEUROL, V361, P537, DOI 10.1002/cne.903610315; WASSLE H, 1993, J COMP NEUROL, V332, P407; WONG ROL, 1986, EXP BRAIN RES, V63, P102; YOUNG HM, 1991, J COMP NEUROL, V310, P139, DOI 10.1002/cne.903100202; YOUNG HM, 1990, VISUAL NEUROSCI, V5, P61, DOI 10.1017/S0952523800000079; 정세진, 2014, [Journal of Korean Ophthalmic Optics Society, 한국안광학회지], V19, P271	57	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202089	10.1371/journal.pone.0202089	http://dx.doi.org/10.1371/journal.pone.0202089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157204	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400033
J	O'Harte, FPM; Parthsarathy, V; Hogg, C; Flatt, PR				O'Harte, Finbarr P. M.; Parthsarathy, Vadivel; Hogg, Christopher; Flatt, Peter R.			Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice	PLOS ONE			English	Article							BETA-CELL FUNCTION; CARDIOVASCULAR-DISEASE; BODY-COMPOSITION; ADIPOSE-TISSUE; RECEPTOR; INSULIN; GLUCOSE; OBESITY; APJ; LIRAGLUTIDE	Previous studies have shown that modified apelin analogues exhibited enzyme resistance in plasma and improved circulating half-life compared to apelin-13. This study investigated the antidiabetic effects of chronic administration of stable long acting fatty acid modified apelin analogues, namely, (Lys(8)GluPAL) apelin-13 amide and pGlu(Lys(8)GluPAL) apelin-13 amide, in high-fat fed obese-diabetic mice. Male NIH Swiss mice (groups n = 8) were maintained either on a high-fat diet (45% fat) from 8 to 28 weeks old, or control mice were fed a normal diet (10% fat). When diet induced obesity-diabetes was established after high-fat feeding, mice were injected i.p. once daily with apelin analogues, liraglutide (25 nmol/kg) or saline (controls). Administration of (Lys(8)GluPAL) apelin-13 amide and pGlu(Lys(8)GluPAL) apelin-13 amide for 28 days significantly reduced food intake and decreased body weight. Non-fasting glucose was reduced (p<0.01 to p<0.001) and plasma insulin concentrations increased (p<0.01 to p<0.001). This was accompanied by enhanced insulin responses (p<0.01 to p<0.001) and significant reductions in glucose excursion after oral (p<0.01) or i.p. (p<0.01) glucose challenges and feeding. Apelin analogues also significantly improved HbA1c (p<0.01), enhanced insulin sensitivity (p<0.01), reduced triglycerides (p<0.001), increased HDL-cholesterol (p<0.01) and decreased LDL-cholesterol (p<0.01), compared to high-fat fed saline treated control mice. Cholesterol levels were decreased (p<0.01) by pGlu (Lys(8)GluPAL) apelin-13 amide and both apelin treated groups showed improved bone mineral content, reduced fat deposits and increased plasma GLP-1. Daily treatment with liraglutide mirrored many of these changes (not on bone or adipose tissue), but unlike apelin analogues increased plasma amylase. Consumption of O-2, production of CO2, respiratory exchange ratio and energy expenditure were improved by apelin analogues. These results indicate that long-term treatment with acylated analogues (Lys(8)GluPAL) apelin-13 amide and particularly pGlu(Lys(8)GluPAL) apelin-13 amide resulted in similar or enhanced therapeutic responses to liraglutide in high-fat fed mice. Fatty acid derived apelin analogues represent a new and exciting development in the treatment of obesity-diabetes.	[O'Harte, Finbarr P. M.; Parthsarathy, Vadivel; Hogg, Christopher; Flatt, Peter R.] Ulster Univ, Sch Biomed Sci, SAAD Ctr Pharm & Diabet, Coleraine, Londonderry, North Ireland; [Parthsarathy, Vadivel] Univ Derby, Coll Life & Nat Sci, Kedleston Rd, Derby, England	Ulster University; University of Derby	O'Harte, FPM (corresponding author), Ulster Univ, Sch Biomed Sci, SAAD Ctr Pharm & Diabet, Coleraine, Londonderry, North Ireland.	fpm.oharte@ulster.ac.uk		Parthsarathy, Vadivel/0000-0002-2037-7804; O'Harte, Finbarr/0000-0002-7199-4239	Department for the Economy, Northern Ireland; Invest-NI Proof of Concept [PoC518]	Department for the Economy, Northern Ireland; Invest-NI Proof of Concept	The Department for the Economy, Northern Ireland (https://www.nidirect.gov.uk/articles/department-economy-studentships, formerly DEL-NI) provided a PhD studentship to CH and FOH to perform this work. Invest-NI Proof of Concept funding (https://www.investni.com/support-for-business/proof-of-concept.html, PoC518) was secured by FOH and PRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alfarano C, 2015, INT J OBESITY, V39, P312, DOI 10.1038/ijo.2014.122; [Anonymous], 2018, DIABETES CARE, V41, pS1, DOI [10.2337/dc18-Sint01, 10.2337/dc18-SINT01]; Aring AM, 2005, AM FAM PHYSICIAN, V71, P2123; Bailey CJ, 2015, CLIN PHARMACOL THER, V98, P1532; Balistreri CR, 2010, MEDIAT INFLAMM, V80, P207, DOI [10.3389/fphys.2015.00115, DOI 10.3389/FPHYS.2015.00115]; Bertrand C, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00115; Black BL, 1998, METABOLISM, V47, P1354, DOI 10.1016/S0026-0495(98)90304-3; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Castan-Laurell I, 2008, EUR J ENDOCRINOL, V158, P905, DOI 10.1530/EJE-08-0039; Cho NH, 2018, IDF DIABETES ATLAS G; DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.19; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; FLATT PR, 1981, DIABETOLOGIA, V20, P573; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Fournel A, 2017, GUT, V66, P258, DOI 10.1136/gutjnl-2015-310230; Gerbier R, 2017, FASEB J, V31, P687, DOI 10.1096/fj.201600784R; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Hasib A, 2017, DIABETOLOGIA, V60, P541, DOI 10.1007/s00125-016-4186-y; Hayes L, 2002, J PUBLIC HEALTH MED, V24, P170, DOI 10.1093/pubmed/24.3.170; Higuchi K, 2007, ENDOCRINOLOGY, V148, P2690, DOI 10.1210/en.2006-1270; Holst JJ, 2011, DIABETES CARE, V34, pS251, DOI 10.2337/dc11-s227; Hu HL, 2016, MOL GENET METAB, V119, P20, DOI 10.1016/j.ymgme.2016.07.012; Iepsen EW, 2015, EXPERT REV CARDIOVAS, V13, P753, DOI 10.1586/14779072.2015.1054810; Irwin N, 2015, WORLD J DIABETES, V6, P1285, DOI 10.4239/wjd.v6.i15.1285; Jeon SM, 2013, J MED FOOD, V16, P133, DOI 10.1089/jmf.2012.2249; Ji QH, 2017, CLIN THER, V39, P1244, DOI 10.1016/j.clinthera.2017.03.013; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Millar P, 2017, J ENDOCRINOL, V234, P255, DOI 10.1530/JOE-17-0263; Mughal A, 2018, PHARM THER; Nauck MA, 2011, DIABETES, V60, P1561, DOI 10.2337/db10-0474; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; O'Harte FPM, 2018, PEPTIDES, V100, P219, DOI 10.1016/j.peptides.2017.12.004; O'Harte FPM, 2014, DIABETES OBES METAB, V16, P1214, DOI 10.1111/dom.12360; O'Harte FPM, 2017, BIOCHEM PHARMACOL, V146, P165, DOI 10.1016/j.bcp.2017.10.002; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Parthsarathy V, 2018, DIABETES OBES METAB, V20, P319, DOI 10.1111/dom.13068; Savini I, 2013, INT J MOL SCI, V14, P10497, DOI 10.3390/ijms140510497; Schinzari F, 2017, HYPERTENSION, V69, P942, DOI 10.1161/HYPERTENSIONAHA.116.08916; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Thomas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032619; Valle A, 2008, J NEUROENDOCRINOL, V20, P79, DOI 10.1111/j.1365-2826.2007.01617.x; WEST DB, 1995, AM J PHYSIOL-REG I, V268, pR658, DOI 10.1152/ajpregu.1995.268.3.R658; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zhu SM, 2011, MOL CELL BIOCHEM, V353, P305, DOI 10.1007/s11010-011-0799-0	52	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202350	10.1371/journal.pone.0202350	http://dx.doi.org/10.1371/journal.pone.0202350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157220	gold, Green Published, Green Submitted			2022-12-27	WOS:000443071400055
J	Szekely, P; Eguiguren, JS; Szekely, D; Ordonez-Delgado, L; Armijos-Ojeda, D; Riofrio-Guaman, ML; Cogalniceanu, D				Szekely, Paul; Sebastian Eguiguren, Juan; Szekely, Diana; Ordonez-Delgado, Leonardo; Armijos-Ojeda, Diego; Lorena Riofrio-Guaman, Maria; Cogalniceanu, Dan			A new minute Pristimantis (Amphibia: Anura: Strabomantidae) from the Andes of southern Ecuador	PLOS ONE			English	Article							FROG	We describe a new rainfrog species (Pristimantis), from the wetland complex Ona, Nabon, Saraguro and Yacuambi, in the Andes of southern Ecuador, at altitudes ranging between 3000-3400 ma.s.l. Pristimantis tiktik sp. nov. is a small frog, displaying sexual dimorphism (the males with dorsum of various shades of gray, brown, orange or green and a whitish or pinkish yellow venter; females with brownish gray or gray dorsum and a reticulated white and black venter), with SVL ranging between 19.7-20.4 mm in females (n = 3) and 16.1-18.4 mm in males (n = 6). The skin on dorsum is tuberculated, that on venter is coarsely areolate, dorsolateral folds are absent, tympanic membrane is absent but the tympanic annulus is evident, cranial crests are absent, discs on fingers just slightly expanded, heel is lacking enlarged tubercles, inner edge of tarsus is bearing a long fold, Toe V is slightly longer than Toe III and the iris coloration is bronze with fine black reticulations. The males have a large subgular vocal sac that extends onto the chest and vocal slits but lack nuptial pads. The unique advertisement call consists of long duration series of periodically repeated clicks: "tik". Molecular analyses place the new species in the recently resurrected P. orestes group, as the sister species of the assemblage that contains P. bambu, P. mazar, P. simonbolivari and an undescribed species.	[Szekely, Paul; Sebastian Eguiguren, Juan; Ordonez-Delgado, Leonardo; Armijos-Ojeda, Diego; Lorena Riofrio-Guaman, Maria] Univ Tecn Particular Loja, Dept Ciencias Biol, EcoSs Lab, Calle Marcelino Champagnat S-N, San Cayetano Alto, Loja, Ecuador; [Szekely, Paul] Assoc Chelonia Romania, Bucharest, Romania; [Szekely, Diana; Cogalniceanu, Dan] Ovidius Univ Constanta, Fac Nat & Agr Sci, Constanta, Romania; [Szekely, Diana] Univ Liege, Lab Fish & Amphibian Ethol, Behav Biol Grp, Freshwater & OCean Sci Unit ReS FOCUS, Liege, Belgium	Universidad Tecnica Particular de Loja; Ovidius University; University of Liege	Szekely, D (corresponding author), Ovidius Univ Constanta, Fac Nat & Agr Sci, Constanta, Romania.; Szekely, D (corresponding author), Univ Liege, Lab Fish & Amphibian Ethol, Behav Biol Grp, Freshwater & OCean Sci Unit ReS FOCUS, Liege, Belgium.	diana@butanescu.com	Cogalniceanu, Dan/B-7065-2011; Ordóñez-Delgado, Leonardo/AAE-3098-2019; Székely, Paul/V-8239-2017; Szekely, Diana/O-6147-2017	Cogalniceanu, Dan/0000-0003-2959-014X; Ordóñez-Delgado, Leonardo/0000-0002-4593-1728; Székely, Paul/0000-0002-9252-1596; Szekely, Diana/0000-0002-3786-3729; Armijos Ojeda, Diego/0000-0003-3685-7631; Riofrio Guaman, Maria Lorena/0000-0003-2706-4701; Eguiguren, Juan Sebastian/0000-0002-8866-4316	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion, Republic of Ecuador (SENESCYT) through the Prometeo Project; SYNTHESYS [SE-TAF-4807, GBTAF-4710]; European Community-Research Infrastructure Action under the FP7 "Capacities" Specific Programme; Municipalidad de Saraguro trough the project "Inventario de areas protegidas de canton Saraguro e implementacion de un plan de conservacion de areas de interes ecologico y reforestacion con especies nativas" (PY2029)	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion, Republic of Ecuador (SENESCYT) through the Prometeo Project; SYNTHESYS; European Community-Research Infrastructure Action under the FP7 "Capacities" Specific Programme; Municipalidad de Saraguro trough the project "Inventario de areas protegidas de canton Saraguro e implementacion de un plan de conservacion de areas de interes ecologico y reforestacion con especies nativas" (PY2029)	PS and DC received funding from Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion, Republic of Ecuador (SENESCYT) through the Prometeo Project. Research was supported by SYNTHESYS grants: SE-TAF-4807 to PS and GBTAF-4710 to DC. The SYNTHESYS Project is financed by the European Community-Research Infrastructure Action under the FP7 "Capacities" Specific Programme. Field work was partially financed by the Municipalidad de Saraguro trough the project "Inventario de areas protegidas de canton Saraguro e implementacion de un plan de conservacion de areas de interes ecologico y reforestacion con especies nativas" (PY2029) granted to LOD.	[Anonymous], 2009, TERRESTRIAL BREEDING; [Anonymous], ANFIBIOS DEL ECUADOR; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; De Oliveira EA, 2017, ZOOKEYS, P101, DOI 10.3897/zookeys.687.13221; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fine PVA, 2015, ANNU REV ECOL EVOL S, V46, P369, DOI 10.1146/annurev-ecolsys-112414-054102; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2013, ZOOTAXA, V3750, P569, DOI 10.11646/zootaxa.3750.5.8; Frost D. R., 2018, AMPHIBIAN SPECIES WO; Guayasamin JM, 2013, ZOOTAXA, V3616, P345, DOI 10.11646/zootaxa.3616.4.3; Hawkins BA, 2001, TRENDS ECOL EVOL, V16, P470, DOI 10.1016/S0169-5347(01)02197-8; Hedges SB, 2008, ZOOTAXA, P1; Heinicke MP, 2018, MOL PHYLOGENET EVOL, V118, P145, DOI 10.1016/j.ympev.2017.09.021; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jorge Brito M., 2017, Papeis Avulsos de Zoologia (Sao Paulo), V57, P177, DOI 10.11606/0031-1049.2017.57.15; Katoh K, 2017, BRIEF BIOINFORM, DOI [DOI 10.1093/BIB/BBX108, 10.1093/bib/bbx108]; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Kohler G., 2012, COLOR CATALOGUE FIEL; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lehr E, 2007, COPEIA, P140, DOI 10.1643/0045-8511(2007)7[140:TNSOEA]2.0.CO;2; Lehr E, 2008, HERPETOLOGICA, V64, P354, DOI 10.1655/07-089.1; LYNCH J D, 1979, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Lynch JD, 1997, SPECIAL PUBLICATION, V23, P1, DOI [10.5962/bhl.title.7951, DOI 10.5962/BHL.TITLE.7951]; Padial JM, 2014, ZOOTAXA, V3825, P1, DOI 10.11646/zootaxa.3825.1.1; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; Rodrigues ASL, 2010, BIOSCIENCE, V60, P798, DOI 10.1525/bio.2010.60.10.6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teran-Valdez A, 2010, ZOOTAXA, P53; Toledo LF, 2015, ACTA ETHOL, V18, P87, DOI 10.1007/s10211-014-0194-4; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Zwickl DJ., 2006, GENETIC ALGORITHM AP	35	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202332	10.1371/journal.pone.0202332	http://dx.doi.org/10.1371/journal.pone.0202332			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157209	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400052
J	Tack, ILMM; Nimmegeers, P; Akkermans, S; Logist, F; Van Impe, JFM				Tack, Ignace L. M. M.; Nimmegeers, Philippe; Akkermans, Simen; Logist, Filip; Van Impe, Jan F. M.			A low-complexity metabolic network model for the respiratory and fermentative metabolism of Escherichia coli	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE; LISTERIA-MONOCYTOGENES; ANAEROBIC FERMENTATION; GENOME SEQUENCE; MICROBIAL LAG; GROWTH-RATE; PH; TEMPERATURE; ACID; MAINTENANCE	Over the last decades, predictive microbiology has made significant advances in the mathematical description of microbial spoiler and pathogen dynamics in or on food products. Recently, the focus of predictive microbiology has shifted from a (semi-) empirical population-level approach towards mechanistic models including information about the intracellular metabolism in order to increase model accuracy and genericness. However, incorporation of this subpopulation-level information increases model complexity and, consequently, the required run time to simulate microbial cell and population dynamics. In this paper, results of metabolic flux balance analyses (FBA) with a genome-scale model are used to calibrate a low-complexity linear model describing the microbial growth and metabolite secretion rates of Escherichia coli as a function of the nutrient and oxygen uptake rate. Hence, the required information about the cellular metabolism (i.e., biomass growth and secretion of cell products) is selected and included in the linear model without incorporating the complete intracellular reaction network. However, the applied FBAs are only representative for microbial dynamics under specific extracellular conditions, viz., a neutral medium without weak acids at a temperature of 37 degrees C. Deviations from these reference conditions lead to metabolic shifts and adjustments of the cellular nutrient uptake or maintenance requirements. This metabolic dependency on extracellular conditions has been taken into account in our low-complex metabolic model. In this way, a novel approach is developed to take the synergistic effects of temperature, pH, and undissociated acids on the cell metabolism into account. Consequently, the developed model is deployable as a tool to describe, predict and control E. coli dynamics in and on food products under various combinations of environmental conditions. To emphasize this point, three specific scenarios are elaborated: (i) aerobic respiration without production of weak acid extracellular metabolites, (ii) anaerobic fermentation with secretion of mixed acid fermentation products into the food environment, and (iii) respiro-fermentative metabolic regimes in between the behaviors at aerobic and anaerobic	[Tack, Ignace L. M. M.; Nimmegeers, Philippe; Akkermans, Simen; Logist, Filip; Van Impe, Jan F. M.] Katholieke Univ Leuven, BioTeC, Dept Chem Engn, Ghent, Belgium	KU Leuven	Van Impe, JFM (corresponding author), Katholieke Univ Leuven, BioTeC, Dept Chem Engn, Ghent, Belgium.	jan.vanimpe@kuleuven.be	Nimmegeers, Philippe/ABD-4568-2020; Logist, Filip/AAG-4210-2020; Nimmegeers, Philippe/AAG-1512-2020; Akkermans, Simen/F-7549-2018	Nimmegeers, Philippe/0000-0002-2086-7694; Logist, Filip/0000-0001-8621-7531; Akkermans, Simen/0000-0003-2904-0439; Van Impe, Jan/0000-0002-5904-1638	Agency for Innovation by Science and Technology (IWT) [IWT SB-111565]; Research Foundation Flanders (FWO) [FWO-G.0930.13, FWO KAN2013,1.5.189.13]; KU Leuven Research Fund [PFV/10/002]; Knowledge Platform (SCORES4CHEM) of the KU Leuven Industrial Research Fund [KP/09/005]; Belgian Program on Interuniversity Poles of Attraction; Belgian Federal Science Policy Office (IAP Phase VII - 19 DYSCO)	Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); KU Leuven Research Fund(KU Leuven); Knowledge Platform (SCORES4CHEM) of the KU Leuven Industrial Research Fund; Belgian Program on Interuniversity Poles of Attraction(Belgian Federal Science Policy Office); Belgian Federal Science Policy Office (IAP Phase VII - 19 DYSCO)(Belgian Federal Science Policy Office)	The research of I.L.M.M. Tack is funded by PhD grant IWT SB-111565 of the Agency for Innovation by Science and Technology (IWT, https://www.vlaio.be/nl). In addition, this work is supported by projects FWO-G.0930.13 and FWO KAN2013,1.5.189.13 of the Research Foundation Flanders (FWO, https://www.vlaio.be/nl), project PFV/10/002 (Center of Excellence OPTEC - Optimization in Engineering) of the KU Leuven Research Fund (https://www.kuleuven.be/english/research/support/if), Knowledge Platform KP/09/005 (SCORES4CHEM) of the KU Leuven Industrial Research Fund (https://www.kuleuven.be/english/research/iof), and the Belgian Program on Interuniversity Poles of Attraction, initiated by the Belgian Federal Science Policy Office (IAP Phase VII - 19 DYSCO, https://www.belspo.be).	ALAM KY, 1989, J BACTERIOL, V171, P6213, DOI 10.1128/jb.171.11.6213-6217.1989; [Anonymous], 1994, ILJ, V23, DOI DOI 10.1016/0168-1605(94)90157-0; Baka M, 2013, FOOD CONTROL, V29, P328, DOI 10.1016/j.foodcont.2012.04.022; Banerjee C, 2016, BIOTECHNOL J, V11, P303, DOI 10.1002/biot.201500284; Baweja M, 2016, FRONTIER DISCOVERIES, P207, DOI DOI 10.1007/978-81-322-2610-9_13; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bernaerts K, 2002, INT J FOOD MICROBIOL, V73, P145, DOI 10.1016/S0168-1605(01)00645-6; Biryukova IV, 2010, RUSS J GENET+, V46, P308, DOI 10.1134/S1022795410030075; BLACKWOOD AC, 1956, J BACTERIOL, V72, P497, DOI 10.1128/JB.72.4.497-499.1956; Buchanan RL, 1998, J FOOD PROTECT, V61, P1531, DOI 10.4315/0362-028X-61.11.1531; Bunch PK, 1997, MICROBIOL-UK, V143, P187, DOI 10.1099/00221287-143-1-187; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x; Clomburg JM, 2011, BIOTECHNOL BIOENG, V108, P867, DOI 10.1002/bit.22993; COLE MB, 1990, J APPL BACTERIOL, V69, P63, DOI 10.1111/j.1365-2672.1990.tb02912.x; Coroller L, 2005, INT J FOOD MICROBIOL, V100, P167, DOI 10.1016/j.ijfoodmicro.2004.10.014; Dens EJ, 2005, INT J FOOD MICROBIOL, V101, P319, DOI 10.1016/j.ijfoodmicro.2004.11.017; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; DiezGonzalez F, 1997, MICROBIOL-UK, V143, P1175, DOI 10.1099/00221287-143-4-1175; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Eklund T, 1989, MECH ACTION FOOD PRE, P160; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Ferrier R, 2013, APPL ENVIRON MICROB, V79, P5870, DOI 10.1128/AEM.01311-13; Ginovart M, 2002, J THEOR BIOL, V214, P305, DOI 10.1006/jtbi.2001.2466; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HEIJNEN JJ, 1981, BIOTECHNOL BIOENG, V23, P739, DOI 10.1002/bit.260230407; Higgins TE, 1970, J BACTERIOL, V101, P885, DOI 10.1128/JB.101.3.885-891.1970; Hinshelwood, 1946, CHEM KINETICS BACTER; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ihssen J, 2007, MICROBIOL-SGM, V153, P2052, DOI 10.1099/mic.0.2006/002006-0; Ingraham J. L., 1996, ESCHERICHIA COLI SAL, V2, P1570; Jiang GRJ, 2001, MICROBIOL-SGM, V147, P2437, DOI 10.1099/00221287-147-9-2437; Jin Qi, 2002, Nucleic Acids Research, V30, P4432, DOI 10.1093/nar/gkf566; KAREL SF, 1989, BIOTECHNOL BIOENG, V34, P337, DOI 10.1002/bit.260340308; Le Marc Y, 2002, INT J FOOD MICROBIOL, V73, P219, DOI 10.1016/S0168-1605(01)00640-7; Leistner L, 2000, INT J FOOD MICROBIOL, V55, P181, DOI 10.1016/S0168-1605(00)00161-6; MATJAN F, 1989, J BACTERIOL, V171, P342, DOI 10.1128/jb.171.1.342-348.1989; Monod J., 1942, ACTUALITES SCI IND; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Pharkya P, 2003, BIOTECHNOL BIOENG, V84, P887, DOI 10.1002/bit.10857; PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069; Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10; Prats C, 2006, J THEOR BIOL, V241, P939, DOI 10.1016/j.jtbi.2006.01.029; Presser KA, 1997, APPL ENVIRON MICROB, V63, P2355, DOI 10.1128/AEM.63.6.2355-2360.1997; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; Sanchez AM, 2005, METAB ENG, V7, P229, DOI 10.1016/j.ymben.2005.03.001; Scheibe TD, 2009, MICROB BIOTECHNOL, V2, P274, DOI 10.1111/j.1751-7915.2009.00087.x; SCHULZE KL, 1964, ARCH MIKROBIOL, V48, P1, DOI 10.1007/BF00406595; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043; Standaert A. R., 2004, 9 IFAC S COMP APPL B, V9, P183; Stephanopoulos G. N., 1998, METAB ENG, P115, DOI [10.1016/b978-012666260-3/50005-4, DOI 10.1016/B978-012666260-3/50005-4]; Stling O C, 1993, J APPL BACTERIOL, V75, P18, DOI [10.1111/j.1365-2672.1993.tb03402.x, DOI 10.1111/J.1365-2672.1993.TB03402.X]; STOKES JL, 1949, J BACTERIOL, V57, P147, DOI 10.1128/JB.57.2.147-158.1949; Swinnen IAM, 2005, INT J FOOD MICROBIOL, V100, P85, DOI 10.1016/j.ijfoodmicro.2004.10.022; Tack ILMM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02509; TARMY EM, 1968, J BIOL CHEM, V243, P2587; terSteeg PF, 1995, FOOD MICROBIOL, V12, P471, DOI 10.1016/S0740-0020(95)80132-4; Trinh CT, 2009, APPL ENVIRON MICROB, V75, P6696, DOI 10.1128/AEM.00670-09; Valero A, 2006, EUR FOOD RES TECHNOL, V224, P91, DOI 10.1007/s00217-006-0293-1; van Bodegom P, 2007, MICROB ECOL, V53, P513, DOI 10.1007/s00248-006-9049-5; Van Derlinden E, 2009, QUANTIFYING MICROBIA; VARMA A, 1993, APPL ENVIRON MICROB, V59, P2465, DOI 10.1128/AEM.59.8.2465-2473.1993; Varma A, 1993, J THEOR BIOL, V1993, P4; Verhulst AJ, 2011, FOOD MICROBIOL, V28, P656, DOI 10.1016/j.fm.2010.07.014; WALLACE RJ, 1986, FEMS MICROBIOL LETT, V37, P317, DOI 10.1016/0378-1097(86)90427-1; Yazdani SS, 2008, METAB ENG, V10, P340, DOI 10.1016/j.ymben.2008.08.005; Zaldivar J, 1999, BIOTECHNOL BIOENG, V66, P203, DOI [10.1002/(SICI)1097-0290(1999)66:4<203::AID-BIT1>3.0.CO;2-#, 10.1002/(SICI)1097-0290(1999)66:4&lt;203::AID-BIT1&gt;3.0.CO;2-#]; ZWIETERING MH, 1992, J FOOD PROTECT, V55, P973, DOI 10.4315/0362-028X-55.12.973	73	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202565	10.1371/journal.pone.0202565	http://dx.doi.org/10.1371/journal.pone.0202565			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157229	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400062
J	Li, HZ; Hai, Y; Lim, SY; Toledo, N; Crecente-Campo, J; Schalk, D; Li, L; Omange, RW; Dacoba, TG; Liu, LR; Abul Kashem, M; Wan, YM; Liang, BH; Li, QS; Rakasz, E; Schultz-Darken, N; Alonso, MJ; Plummer, FA; Whitney, JB; Luo, M				Li, Hongzhao; Hai, Yan; Lim, So-Yon; Toledo, Nikki; Crecente-Campo, Jose; Schalk, Dane; Li, Lin; Omange, Robert W.; Dacoba, Tamara G.; Liu, Lewis R.; Abul Kashem, Mohammad; Wan, Yanmin; Liang, Binhua; Li, Qingsheng; Rakasz, Eva; Schultz-Darken, Nancy; Alonso, Maria J.; Plummer, Francis A.; Whitney, James B.; Luo, Ma			Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; SIMIAN IMMUNODEFICIENCY; HIV-1 INFECTION; VIRAL PROTEASE; ISOTYPE DIVERSIFICATION; IMMUNE-RESPONSES; PROCESSING SITES; IGG ANTIBODIES; NANOPARTICLES	HIV mutates rapidly and infects CD4(+) T cells, especially when they are activated. A vaccine targeting conserved, essential viral elements while limiting CD4(+) T cell activation could be effective. Learning from natural immunity observed in a group of highly HIV-1 exposed seronegative Kenyan female sex workers, we are testing a novel candidate HIV vaccine targeting the 12 viral protease cleavage sites (PCSs) (the PCS vaccine), in comparison with a vaccine targeting full-length Gag and Env (the Gag/Env vaccine) in a Mauritian cynomolgus macaque/SIV model. In this study we evaluated these vaccines for induction of mucosal antibodies to SIV immunogens at the female genital tract. Bio-Plex and Western blot analyses of cervicovaginal lavage samples showed that both the PCS and Gag/Env vaccines can elicit mucosal IgG antibody responses to SIV immunogens. Significantly higher increase of anti-PCS antibodies was induced by the PCS vaccine than by the Gag/Env vaccine (p<0.0001). The effect of the mucosal antibody responses in protection from repeated low dose pathogenic SIVmac251 challenges is being evaluated.	[Li, Hongzhao; Hai, Yan; Toledo, Nikki; Omange, Robert W.; Liu, Lewis R.; Abul Kashem, Mohammad; Plummer, Francis A.; Luo, Ma] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Lim, So-Yon; Whitney, James B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Crecente-Campo, Jose; Dacoba, Tamara G.; Alonso, Maria J.] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Campus Vida, Santiago De Compostela, Spain; [Schalk, Dane; Schultz-Darken, Nancy] Wisconsin Natl Primate Res Ctr, Sci Protocol Implementat Unit, Madison, WI USA; [Li, Lin; Liang, Binhua; Plummer, Francis A.; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Wan, Yanmin; Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE USA; [Liang, Binhua] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Rakasz, Eva] Wisconsin Natl Primate Res Ctr, Immunol Serv Unit, Madison, WI USA; [Whitney, James B.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA	University of Manitoba; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidade de Santiago de Compostela; Public Health Agency of Canada; University of Nebraska System; University of Nebraska Lincoln; University of Manitoba; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Luo, M (corresponding author), Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.; Luo, M (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Ma.Luo@phac-aspc.gc.ca	, yanmin/GQH-2789-2022; Alonso, Maria Jose/K-3893-2014; Rakasz, Eva G/H-9197-2019; Campo, Crecente/AAA-2646-2019; Liang, Binhua/ABN-9806-2022; Omange, Were/F-1454-2016	, yanmin/0000-0001-5027-9423; Campo, Crecente/0000-0002-8630-5010; Kashem, Mohammad/0000-0002-6472-3676; Omange, Were/0000-0002-0421-110X; Dacoba, Tamara/0000-0003-0770-6340; liang, binhua/0000-0002-1108-6407	National Institute of Allergy and Infectious Diseases [R01AI111805]; Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative; National Microbiology Laboratory of Canada; Office of the Director, National Institutes of Health [P51OD011106]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NIH [R01AI111805]; CIHR/CHVI; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015459, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111805] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative(Canadian Institutes of Health Research (CIHR)); National Microbiology Laboratory of Canada; Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR/CHVI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the following funding awarded to ML: a National Institute of Allergy and Infectious Diseases grant, with grant number: R01AI111805 and URL: https://www.niaid.nih.gov/; a Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative Bridging grant (no grant number available), with URL: http://www.cihr-irsc.gc.ca/e/42458.html; and funding from National Microbiology Laboratory of Canada (no grant number available), with URL: https://www.nml-lnm.gc.ca/index-eng.htm. Research reported in this publication was supported in part by the Office of the Director, National Institutes of Health under Award Number P51OD011106 to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank staff at Wisconsin National Primate Research Center Scientific Protocol Implementation Unit and Immunology Services Unit for important technical support. We recognize Dr. Stuart Shapiro, NIH Vaccine Research Program, and Dr. Matthew Gilmour, National Microbiology Laboratory of Canada, for important support and discussion. This work was supported by a NIH grant (R01AI111805), a CIHR/CHVI bridging grant and funding from National Microbiology Laboratory of Canada.	Adamson CS, 2009, EXPERT OPIN THER TAR, V13, P895, DOI 10.1517/14728220903039714; Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; [Anonymous], 2003, AIDS Alert, V18, P43; [Anonymous], 2007, Nature, V449, P390; [Anonymous], 2003, AIDS ALERT, V18, P3; Antony JM, 2015, VACCINE, V33, P3073, DOI 10.1016/j.vaccine.2014.12.004; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; Calvo P, 1997, PHARMACEUT RES, V14, P1431, DOI 10.1023/A:1012128907225; Carias AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005885; Chen YX, 2014, VACCINES, V2, P138, DOI 10.3390/vaccines2010138; Correia-Pinto JF, 2013, INT J PHARMACEUT, V440, P27, DOI 10.1016/j.ijpharm.2012.04.047; Craig L, 1998, J MOL BIOL, V281, P183, DOI 10.1006/jmbi.1998.1907; de Oliveira T, 2003, J VIROL, V77, P9422, DOI 10.1128/JVI.77.17.9422-9430.2003; French MA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00780; French MA, 2013, VACCINES, V1, P328, DOI 10.3390/vaccines1030328; French MA, 2013, AIDS, V27, P519, DOI 10.1097/QAD.0b013e32835cb720; French MA, 2010, AIDS, V24, P1983, DOI 10.1097/QAD.0b013e32833c1ce0; He T, 2016, J IMMUNOL, V197, P4535, DOI 10.4049/jimmunol.1601539; Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6; Hope TJ, 2018, NAT MED, V24, P384, DOI 10.1038/nm.4534; Joag VR, 2016, MUCOSAL IMMUNOL, V9, P1, DOI 10.1038/mi.2015.28; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; Lema D, 2014, SCAND J IMMUNOL, V80, P1, DOI 10.1111/sji.12184; Li HZ, 2018, BIOINFORMATION, V14, P48, DOI 10.6026/97320630014048; Li HZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186079; Li HZ, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0174-7; Li HZ, 2017, J MED PRIMATOL, V46, P137, DOI 10.1111/jmp.12300; Lin SW, 2007, VACCINE, V25, P2187, DOI 10.1016/j.vaccine.2006.11.044; Lu S, 1996, J VIROL, V70, P3978, DOI 10.1128/JVI.70.6.3978-3991.1996; Lu S, 1997, VACCINE, V15, P920, DOI 10.1016/S0264-410X(96)00282-4; Lu S, 2010, CURR HIV RES, V8, P622, DOI 10.2174/157016210794088290; Luo M, 2013, VACCINE, V31, P3000, DOI 10.1016/j.vaccine.2013.04.057; Luo M, 2012, J VIROL, V86, P1166, DOI 10.1128/JVI.05721-11; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; McCarthy M, 2003, LANCET, V361, P755, DOI 10.1016/S0140-6736(03)12669-4; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Nguyen M, 2006, JAIDS-J ACQ IMM DEF, V42, P412, DOI 10.1097/01.qai.0000222289.97825.35; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Pandrea I, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005384; Paolicelli P, 2010, NANOMEDICINE-UK, V5, P843, DOI [10.2217/nnm.10.69, 10.2217/NNM.10.69]; Pavot V, 2014, AIDS, V28, P1701, DOI 10.1097/QAD.0000000000000308; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Pettit SC, 2002, J VIROL, V76, P10226, DOI 10.1128/JVI.76.20.10226-10233.2002; Plotkin SA, 2010, HUM VACCINES, V6, P159; Policicchio BB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005879; Policicchio BB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190908; Prego C, 2005, J CONTROL RELEASE, V101, P151, DOI 10.1016/j.jconrel.2004.07.030; Prego C, 2010, VACCINE, V28, P2607, DOI 10.1016/j.vaccine.2010.01.011; Racine T, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0179-2; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Routy JP, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0164-9; Ruprecht RM, 2017, CURR OPIN HIV AIDS, V12, P222, DOI 10.1097/COH.0000000000000369; Schell JB, 2015, VIROLOGY, V476, P405, DOI 10.1016/j.virol.2014.12.027; Sheng ZZ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004940; Stieh DJ, 2016, CELL HOST MICROBE, V19, P529, DOI 10.1016/j.chom.2016.03.005; Stieh DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004440; Sunshine JE, 2015, J VIROL, V89, P10303, DOI 10.1128/JVI.01876-15; Tatsis N, 2007, VIROLOGY, V367, P156, DOI 10.1016/j.virol.2007.05.028; Tebit DM, 2012, CURR HIV RES, V10, P3, DOI 10.2174/157016212799304689; Tjiam MC, 2016, AIDS, V30, P2757, DOI 10.1097/QAD.0000000000001242; Tjiam MC, 2015, J IMMUNOL, V194, P5320, DOI 10.4049/jimmunol.1402918; Tobio M, 1998, PHARMACEUT RES, V15, P270, DOI 10.1023/A:1011922819926; Tomaras GD, 2017, IMMUNOL REV, V275, P245, DOI 10.1111/imr.12514; Vaccari M, 2010, EXPERT REV VACCINES, V9, P997, DOI [10.1586/erv.10.104, 10.1586/ERV.10.104]; Vicente S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062500; Vila A, 2004, J AEROSOL MED, V17, P174, DOI 10.1089/0894268041457183; Vila A, 2004, EUR J PHARM BIOPHARM, V57, P123, DOI 10.1016/j.ejpb.2003.09.006; Whitney JB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-96; Whitney JB, 2002, J VIROL, V76, P8958, DOI 10.1128/JVI.76.17.8958-8962.2002; Willyard C, 2010, NATURE, V466, pS8, DOI 10.1038/nature09238	77	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202997	10.1371/journal.pone.0202997	http://dx.doi.org/10.1371/journal.pone.0202997			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153293	Green Published, gold			2022-12-27	WOS:000443001700037
J	Ojansivu, M; Mishra, A; Vanhatupa, S; Juntunen, M; Larionova, A; Massera, J; Miettinen, S				Ojansivu, Miina; Mishra, Ayush; Vanhatupa, Sari; Juntunen, Miia; Larionova, Antonina; Massera, Jonathan; Miettinen, Susanna			The effect of S53P4-based borosilicate glasses and glass dissolution products on the osteogenic commitment of human adipose stem cells	PLOS ONE			English	Article							BIOACTIVE GLASS; IN-VITRO; CONTROLLABLE DEGRADATION; BONE REGENERATION; GROWTH-FACTORS; 3D CULTURE; TISSUE; DIFFERENTIATION; SCAFFOLDS; BORATE	Despite the good performance of silicate bioactive glasses in bone regeneration, there is considerable potential to enhance their properties by chemical modifications. In this study, S53P4-based borosilicate glasses were synthesized and their dissolution profile was studied in simulated body fluid by assessing pH change, ion release and conversion to hydroxyapatite. The viability, proliferation, attachment, osteogenesis and endothelial marker expression of human adipose stem cells (hASCs) was evaluated upon direct culture on glass discs and in the extract medium. This is the first study evaluating cell behavior in response to borosilicate glasses based on S53P4 (commercially available as BonAlive (R)). Replacing silicate with borate in S53P4 increased the glass reactivity. Despite the good viability of hASCs under all conditions, direct culture of cells on borosilicate discs and in undiluted extract medium reduced cell proliferation. This was accompanied with changes in cell morphology. Regarding osteogenic commitment, alkaline phosphatase activity was significantly reduced by the borosilicate glass discs and extracts, whereas the expression of osteogenic markers RUNX2a, OSTERIX, DLX5 and OSTEOPONTIN was upregulated. There was also a borosilicate glass-induced increase in osteocalcin protein production. Moreover, osteogenic supplements containing borosilicate extracts significantly increased the mineral production in comparison to the osteogenic medium control. Interestingly, borosilicate glasses stimulated the expression of endothelial markers vWF and PECAM-1. To conclude, our results reveal that despite reducing hASC proliferation, S53P4-based borosilicate glasses and their dissolution products stimulate osteogenic commitment and upregulate endothelial markers, thus supporting their further evaluation for regenerative medicine.	[Ojansivu, Miina; Vanhatupa, Sari; Juntunen, Miia; Larionova, Antonina; Miettinen, Susanna] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Ojansivu, Miina; Vanhatupa, Sari; Juntunen, Miia; Larionova, Antonina; Miettinen, Susanna] Univ Tampere, BioMediTech Inst, Tampere, Finland; [Ojansivu, Miina; Vanhatupa, Sari; Juntunen, Miia; Larionova, Antonina; Miettinen, Susanna] Tampere Univ Hosp, Sci Ctr, Tampere, Finland; [Mishra, Ayush; Massera, Jonathan] Tampere Univ Technol, Fac Biomed Sci & Engn, Tampere, Finland; [Mishra, Ayush; Massera, Jonathan] Tampere Univ Technol, BioMediTech Inst, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University	Ojansivu, M (corresponding author), Univ Tampere, Fac Med & Life Sci, Tampere, Finland.; Ojansivu, M (corresponding author), Univ Tampere, BioMediTech Inst, Tampere, Finland.; Ojansivu, M (corresponding author), Tampere Univ Hosp, Sci Ctr, Tampere, Finland.	miinaojansivu@hotmail.com		Massera, Jonathan/0000-0002-1099-8420; Ojansivu, Miina/0000-0002-5493-3530; Miettinen, Susanna/0000-0002-0647-9556	TEKES, the Finnish Funding Agency for Innovation; Academy of Finland [275427]; Jane and Aatos Erkko Foundation; Tampere University Hospital; Doctoral Programme in Biomedicine and Biotechnology	TEKES, the Finnish Funding Agency for Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Academy of Finland(Academy of Finland); Jane and Aatos Erkko Foundation; Tampere University Hospital; Doctoral Programme in Biomedicine and Biotechnology	This study was supported by TEKES, the Finnish Funding Agency for Innovation (https://www.businessfinland.fi/en/), Academy of Finland (grant number #275427; http://www.aka.fi/en), Jane and Aatos Erkko Foundation (https://jaes.fi/en/), the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (http://www.pshp.fi/en-US/Hospital_District), and the Doctoral Programme in Biomedicine and Biotechnology (http://www.uta.fi/med/en/MED_doctoral_programme.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SF, 2012, J MATER SCI-MATER M, V23, P789, DOI 10.1007/s10856-011-4531-0; Balasubramanian P, 2018, J EUR CERAM SOC, V38, P855, DOI 10.1016/j.jeurceramsoc.2017.11.001; Benderdour M, 1998, J TRACE ELEM MED BIO, V12, P2, DOI 10.1016/S0946-672X(98)80014-X; Bi LX, 2012, J BIOMED MATER RES A, V100A, P3267, DOI 10.1002/jbm.a.34272; Blair HC, 2017, TISSUE ENG PART B-RE, V23, P268, DOI [10.1089/ten.TEB.2016.0454, 10.1089/ten.teb.2016.0454]; Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008; Brown RF, 2009, J BIOMED MATER RES A, V88A, P392, DOI 10.1002/jbm.a.31679; Day RM, 2005, J BIOMED MATER RES A, V75A, P778, DOI 10.1002/jbm.a.30433; Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768; Durand LAH, 2014, J MATER CHEM B, V2, P7620, DOI 10.1039/c4tb01043d; Fu HL, 2009, MAT SCI ENG C-MATER, V29, P2275, DOI 10.1016/j.msec.2009.05.013; Fu QA, 2010, J BIOMED MATER RES A, V95A, P164, DOI 10.1002/jbm.a.32824; Fu QA, 2010, J BIOMED MATER RES A, V95A, P172, DOI 10.1002/jbm.a.32823; Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032; Gu YF, 2014, MAT SCI ENG C-MATER, V36, P294, DOI 10.1016/j.msec.2013.12.023; Gu YF, 2013, ACTA BIOMATER, V9, P9126, DOI 10.1016/j.actbio.2013.06.039; Hakki SS, 2010, J TRACE ELEM MED BIO, V24, P243, DOI 10.1016/j.jtemb.2010.03.003; Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z; Hench LL, 1971, J BIOMED MATER RES S, V5, P117, DOI [10.1002/jbm.820050611, DOI 10.1002/JBM.820050611]; Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004; Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z; Jones Julian R, 2015, Acta Biomater, V23 Suppl, pS53, DOI 10.1016/j.actbio.2015.07.019; Kargozar S, 2018, TRENDS BIOTECHNOL, V36, P430, DOI 10.1016/j.tibtech.2017.12.003; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Lakhkar NJ, 2013, ADV DRUG DELIVER REV, V65, P405, DOI 10.1016/j.addr.2012.05.015; Ledieu A, 2004, J NON-CRYST SOLIDS, V343, P3, DOI 10.1016/j.jnoncrysol.2004.06.006; Leu A, 2008, PHARM RES-DORDR, V25, P1222, DOI 10.1007/s11095-007-9508-9; Li X, 2016, J BIOMED MATER RES B, V104, P323, DOI 10.1002/jbm.b.33391; Lian J B, 1995, Iowa Orthop J, V15, P118; Lindfors NC, 2010, J BIOMED MATER RES B, V94B, P157, DOI 10.1002/jbm.b.31636; Lindroos B, 2009, CYTOTHERAPY, V11, P958, DOI 10.3109/14653240903233081; Lynch MP, 1998, J CELL BIOCHEM, V68, P31; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Marion NW, 2005, MECH ADV MATER STRUC, V12, P239, DOI 10.1080/15376490590928615; Marklein RA, 2016, STEM CELLS, V34, P935, DOI 10.1002/stem.2322; Massera J, 2011, J NON-CRYST SOLIDS, V357, P3623, DOI 10.1016/j.jnoncrysol.2011.06.037; Massera J, 2014, J MATER SCI-MATER M, V25, P657, DOI 10.1007/s10856-013-5120-1; Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082; McCullen SD, 2010, TISSUE ENG PT A, V16, P1971, DOI [10.1089/ten.tea.2009.0691, 10.1089/ten.TEA.2009.0691]; Modglin VC, 2013, J MATER SCI-MATER M, V24, P1191, DOI 10.1007/s10856-013-4875-8; Monfoulet LE, 2014, TISSUE ENG PT A, V20, P1827, DOI [10.1089/ten.tea.2013.0500, 10.1089/ten.TEA.2013.0500]; Ojansivu M, 2018, EUR CELLS MATER, V35, P54, DOI 10.22203/eCM.v035a05; Ojansivu M, 2015, ACTA BIOMATER, V21, P190, DOI 10.1016/j.actbio.2015.04.017; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabiee SM, 2015, CERAM INT, V41, P7241, DOI 10.1016/j.ceramint.2015.02.140; Sandor GK, 2014, STEM CELL TRANSL MED, V3, P530, DOI 10.5966/sctm.2013-0173; Takagishi Y, 2006, TISSUE ENG, V12, P927, DOI 10.1089/ten.2006.12.927; Tirkkonen L, 2013, EUR CELLS MATER, V25, P144, DOI 10.22203/eCM.v025a10; Waselau M, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412467789; Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503; Ying XZ, 2011, BIOL TRACE ELEM RES, V144, P306, DOI 10.1007/s12011-011-9094-x; Zhang J, 2015, BIOMED MATER, V10; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	53	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202740	10.1371/journal.pone.0202740	http://dx.doi.org/10.1371/journal.pone.0202740			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153295	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700024
J	Brabazon, F; Bermudez, S; Shaughness, M; Khayrullina, G; Byrnes, KR				Brabazon, Fiona; Bermudez, Sara; Shaughness, Michael; Khayrullina, Guzal; Byrnes, Kimberly R.			The effects of insulin on the inflammatory activity of BV2 microglia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE DEMENTIA; MILD COGNITIVE IMPAIRMENT; NITRIC-OXIDE SYNTHASE; NADPH OXIDASE; BRAIN-INJURY; CELL-DEATH; IN-VITRO; ACTIVATION; NEUROTOXICITY; EXPRESSION	Microglia are the macrophages of the central nervous system (CNS), which function to monitor and maintain homeostasis. Microglial activation occurs after CNS injury, infection or disease. Prolonged microglial activation is detrimental to the CNS as they produce nitric oxide (NO), reactive oxygen species (ROS) and pro-inflammatory cytokines, resulting in neuronal cell dysfunction and death. Microglial activation is implicated in the neurological deficits following traumatic brain injury (TBI) and Alzheimer's disease. Intranasal insulin administration is a promising treatment of Alzheimer's disease and TBI. However, the exact effect of insulin on microglia is currently unclear. The goal of this study was therefore to examine the effect of insulin administration on activated microglia. The microglial cell line BV2 were exposed to a pro-inflammatory stimulus, lipopolysaccharide (LPS), followed by insulin administration. Outcome measures were conducted at 24 hours after treatment. In vitro assays quantified NO and ROS production. Western blot, immunocytochemistry and phagocytosis assay further examined the effect of insulin on microglial activity. Insulin treatment significantly reduced NO, ROS and TNF alpha production and increased phagocytic activity. Insulin treatment also significantly reduced iNOS expression, but had no significant effect on any other M1 or M2 macrophage polarization marker examined. These data suggest that insulin has very specific effects to reduce pro-inflammatory or chemoattractant properties of microglia, and this may be one mechanism by which insulin has beneficial effects in CNS injury or neurodegenerative conditions.	[Brabazon, Fiona; Shaughness, Michael; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA; [Bermudez, Sara; Khayrullina, Guzal; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA.; Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.; Byrnes, KR (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	kimberly.byrnes@usuhs.edu		Byrnes, Kimberly/0000-0002-7501-7734; Brabazon, Fiona/0000-0003-1642-808X	Uniformed Services University of the Health Sciences Student Grant [T0-70-3278]; NIH/NINDS grant [1R01NS073667-01A1]	Uniformed Services University of the Health Sciences Student Grant; NIH/NINDS grant	This study was funded by the Uniformed Services University of the Health Sciences Student Grant T0-70-3278 to FB and NIH/NINDS grant number 1R01NS073667-01A1 to KRB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adzovic L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0282-z; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Brabazon F, 2017, J CEREBR BLOOD F MET, V37, P3203, DOI 10.1177/0271678X16685106; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Cooney SJ, 2014, FREE RADICAL RES, V48, P929, DOI 10.3109/10715762.2014.927578; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Dandona P, 2010, DIABETES CARE, V33, P2416, DOI 10.2337/dc10-0929; Engelhardt JF, 2001, ANTIOXID REDOX SIGN, V3, P341, DOI 10.1089/15230860152408997; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Kim WK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072108; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Krupa A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/124762; Kumar A, 2014, FREE RADICAL BIO MED, V73, P51, DOI 10.1016/j.freeradbiomed.2014.04.014; Licinio J, 1999, MOL MED TODAY, V5, P225, DOI 10.1016/S1357-4310(99)01453-7; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maimaiti S, 2016, J GERONTOL A-BIOL, V71, P30, DOI 10.1093/gerona/glu314; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Morris JK, 2012, CURR NEUROL NEUROSCI, V12, P520, DOI 10.1007/s11910-012-0297-0; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Neniskyte U, 2014, FEBS LETT, V588, P2952, DOI 10.1016/j.febslet.2014.05.046; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Orihuela R, 2015, BR J PHARM, DOI 10.1111/bph.13139; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spielman LJ, 2015, CURR ALZHEIMER RES, V12, P684, DOI 10.2174/1567205012666150710104428; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stevens RB, 1997, J IMMUNOL, V159, P5329; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068	43	22	25	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0201878	10.1371/journal.pone.0201878	http://dx.doi.org/10.1371/journal.pone.0201878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148836	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200003
J	Pena-Peniche, A; Ruvalcaba-Ortega, I; Rojas-Soto, O				Pena-Peniche, Alexander; Ruvalcaba-Ortega, Irene; Rojas-Soto, Octavio			Climate complexity in the migratory cycle of Ammodramus bairdii	PLOS ONE			English	Article							SPECIES DISTRIBUTION; GRASSLAND BIRDS; HABITAT USE; VEGETATION STRUCTURE; POPULATION-DYNAMICS; DISTRIBUTION MODEL; ECOLOGICAL NICHES; ENVELOPE MODELS; DISTRIBUTIONS; EVOLUTION	One way to understand the ecology of bird migration is to analyze how birds use their ecological niche during their annual cycle. Ammodramus bairdii is a grassland specialist sparrow that breeds in southern Canada and the northern U.S.A. and winters in the Chihuahuan Desert. A continuous and alarming decrease of its populations has been observed over the last 50 years, and studying its seasonal distribution and associated climatic niches could help improve strategies for its conservation. We analyzed the temporal use of its Grinnellian niche (GN)-set of environmental conditions under which a species can establish and persist; in this case the climatic attributes-. We modeled the GN for the reproductive and winter seasons and projected them onto each other (inter-prediction), and also onto transient migratory periods. To measure niche breadth and their overlap, minimum convex polygons (MCP) were calculated for the climatic space. The niches of each of the two seasons were tested for similarity using the PCA axes of climatic variables. The geographic areas with optimal, suboptimal and marginal conditions were identified, based on the distance to the centroid of the GN. The models for each season revealed no geographic inter-prediction among them, with the exception of winter to migratory seasons. The niche breadth of the winter was greater than that of the reproductive season, with an overlap of 22.47% and 45.18%, respectively. The similarity analyses showed a value of zero between seasons. The climate conditions for the records during the migratory months corresponded with suboptimal and marginal conditions of the sparrow's winter niche. These results suggest that A. bairdii uses different climate conditions within ecological niches of each season during its migratory cycle.	[Pena-Peniche, Alexander; Rojas-Soto, Octavio] Inst Ecol AC, Lab Bioclimatol, Red Biol Evolut, Xalapa, Veracruz, Mexico; [Ruvalcaba-Ortega, Irene] UANL, Fac Ciencias Biol, Lab Biol Conservac & Desarrollo Sustentable, Ciudad Univ, San Nicolas De Los Garza, Nuevo Leon, Mexico	Instituto de Ecologia - Mexico; Universidad Autonoma de Nuevo Leon	Rojas-Soto, O (corresponding author), Inst Ecol AC, Lab Bioclimatol, Red Biol Evolut, Xalapa, Veracruz, Mexico.	octavio.rojas@inecol.mx		Rojas-Soto, Octavio/0000-0002-0201-1454; Pena-Peniche, Alexander/0000-0002-8518-5002; Ruvalcaba-Ortega, Irene/0000-0001-8309-7618	Consejo Nacional de Ciencia y Tecnologia [371044/250334]; Consejo Nacional de Ciencia y Tecnologia Project [CB-2013-01-222920]; Universidad Autonoma de Nuevo Leon [PAICYT CN375-15]; Mexico's National Science and Technology Council (CONACYT, Consejo Nacional de Ciencia y Tecnologia) [371044/250334]; CONACYT [CB-2013-01-222920]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia Project; Universidad Autonoma de Nuevo Leon; Mexico's National Science and Technology Council (CONACYT, Consejo Nacional de Ciencia y Tecnologia); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This reasearch was supported by the Consejo Nacional de Ciencia y Tecnologia, the award of a scholarship (No. 371044/250334); to APP; the Consejo Nacional de Ciencia y Tecnologia Project No. CB-2013-01-222920; to IRC; and the Universidad Autonoma de Nuevo Leon (PAICYT CN375-15); to IRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Instituto de Ecologia A. C. for logistical support and to Mexico's National Science and Technology Council (CONACYT, Consejo Nacional de Ciencia y Tecnologia) for the award of a scholarship to APP (No. 371044/250334). Funding for this project was provided by CONACYT (Project No. CB-2013-01-222920) and the Universidad Autonoma de Nuevo Leon (PAICYT CN375-15). Juan Cervantes-Pasqualli advised us on the use of scripts in R. The Conservation Biology and Sustainable Development Lab (Laboratorio de Biologia de Conservacion y Desarrollo Sustentable) at the Universidad Autonoma de Nuevo Leon and the Integrated Monitoring for Bird Conservation Regions (Monitoreo Integrado en Regiones para la Conservacion de Aves provided record localities. We are especially grateful to two anonymous reviewers. For valuable feedback that improved this manuscript.	Ahlering MA, 2009, AUK, V126, P799, DOI 10.1525/auk.2009.08154; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Bairlein F, 2003, BIRD STUDY, V50, P243, DOI 10.1080/00063650309461317; Barve N, 2008, TOOL PARTIAL ROC VER; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Cardador L, 2014, DIVERS DISTRIB, V20, P515, DOI 10.1111/ddi.12156; Carroll C, 1999, CONSERV BIOL, V13, P1344, DOI 10.1046/j.1523-1739.1999.98364.x; Cartwright B. W., 1937, Transactions of the Canadian Institute, V21, P153; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2012, COSEWIC ASS STAT REP; Culp LA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1565; Davis SK, 1998, WILSON BULL, V110, P262; Davis SK, 1999, WILSON BULL, V111, P389; DECHANT J. A., 2002, EFFECTS MANAGEMENT P, V125, P1; Deppe JL, 2008, ECOL MONOGR, V78, P461, DOI 10.1890/07-0163.1; Di Cola V, 2017, ECOGRAPHY, V40, P774, DOI 10.1111/ecog.02671; Dinerstein E, 2001, NATURE, V376; EDELSBRUNNER H, 1983, IEEE T INFORM THEORY, V29, P551, DOI 10.1109/TIT.1983.1056714; Engler JO, 2017, J AVIAN BIOL, V48, P1483, DOI 10.1111/jav.01248; Engler JO, 2014, J ORNITHOL, V155, P657, DOI 10.1007/s10336-014-1049-5; ESRI (Environmental Systems Research Institute), 1999, ARCVIEW GIS V 3 2; Eyres A, 2017, J AVIAN BIOL, V48, P1517, DOI 10.1111/jav.01308; Fletcher RJ, 2006, J WILDLIFE MANAGE, V70, P145, DOI 10.2193/0022-541X(2006)70[145:CDPFDS]2.0.CO;2; Frans VF, 2018, METHODS ECOL EVOL, V9, P98, DOI 10.1111/2041-210X.12847; GAUTHREAUX SA, 1991, AM ZOOL, V31, P187; Gomez C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2458; Green M.T., 2002, BIRDS N AM, DOI [10.2173/bna.638, DOI 10.2173/BNA.638]; Grinnell J., 1917, Auk Cambridge Mass, V34; Gschweng M, 2012, J APPL ECOL, V49, P803, DOI 10.1111/j.1365-2664.2012.02170.x; Guisande C, 2006, TRATAMIENDO DE DATOS; Hahn S, 2013, OECOLOGIA, V173, P1217, DOI 10.1007/s00442-013-2726-4; Heglund PJ, 2005, CONDOR, V107, P193, DOI 10.1650/7806; Heikkinen RK, 2006, DIVERS DISTRIB, V12, P502, DOI 10.1111/j.1366-9516.2006.00284.x; Herkert J. R., 1996, MANAGEMENT MIDWESTER, P89; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hostetler JA, 2015, AUK, V132, P433, DOI 10.1642/AUK-14-211.1; Hoyt A.C., 2002, ENDANGER SPECIES B, V27, P16; Hufkens K, 2016, NAT CLIM CHANGE, V6, P710, DOI [10.1038/NCLIMATE2942, 10.1038/nclimate2942]; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Hutto R.L., 1985, P455; Hutto RL, 2000, STUD AVIAN BIOL-SER, P109; Igl LD, 1999, CONDOR, V101, P771, DOI 10.2307/1370064; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Joseph L, 2003, J BIOGEOGR, V30, P925, DOI 10.1046/j.1365-2699.2003.00841.x; Joseph L, 2000, P ACAD NAT SCI PHILA, V150, P293; Joseph L., 1996, ECOTROPICA, V2, P185; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Laube I, 2015, J BIOGEOGR, V42, P1896, DOI 10.1111/jbi.12565; Lemoine N, 2003, CONSERV BIOL, V17, P577, DOI 10.1046/j.1523-1739.2003.01389.x; Liminana R, 2015, ORYX, V49, P329, DOI 10.1017/S0030605313001075; Lira-Noriega A, 2014, EVOLUTION, V68, P1082, DOI 10.1111/evo.12343; Lloyd P, 1998, AUK, V115, P404; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Luce R, 2003, SPECIES ASSESSMENT B; Macias-Duarte A, 2011, WINTERING GRASSLAND, P164; Macias-Duarte A, 2009, AUK, V126, P896, DOI 10.1525/auk.2009.08251; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; Manel S, 1999, J APPL ECOL, V36, P734, DOI 10.1046/j.1365-2664.1999.00440.x; Manthey JD, 2015, ENDANGER SPECIES RES, V26, P201, DOI 10.3354/esr00646; Marini MA, 2013, J ORNITHOL, V154, P393, DOI 10.1007/s10336-012-0903-6; Marini MA, 2010, BIOL CONSERV, V143, P102, DOI 10.1016/j.biocon.2009.09.009; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Martinez-Guerrero JH, 2011, AGROCIENCIA-MEXICO, V45, P441; Martinez-Meyer E, 2004, P ROY SOC B-BIOL SCI, V271, P1151, DOI 10.1098/rspb.2003.2564; Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Monahan WB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007921; Monroe AP, 2014, AM MIDL NAT, V171, P97, DOI 10.1674/0003-0031-171.1.97; Moore F. R, 2000, STUD AVIAN BIOL, V20, P133; Nakazawa Y, 2004, AUK, V121, P610, DOI 10.1642/0004-8038(2004)121[0610:SNONMB]2.0.CO;2; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; Norris DR, 2007, CONDOR, V109, P535; Pateiro-Lopez B, 2010, J STAT SOFTW, V34, P1; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perez-Moreno H, 2016, ECOL EVOL, V6, P2022, DOI 10.1002/ece3.1973; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 1999, ECOL MODEL, V117, P159, DOI 10.1016/S0304-3800(99)00023-X; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 1998, IBIS, V140, P288, DOI 10.1111/j.1474-919X.1998.tb04391.x; Peterson AT, 2002, IBIS, V144, pE27, DOI 10.1046/j.0019-1019.2001.00031.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Petit DR, 2000, STUD AVIAN BIOL-SER, P15; Pool DB, 2012, 1RGJV1101 RMBO; Pool DB, 2014, BIOL CONSERV, V170, P274, DOI 10.1016/j.biocon.2013.12.019; Quintero I, 2013, GLOBAL ECOL BIOGEOGR, V22, P422, DOI 10.1111/geb.12001; RAPPOLE JH, 1994, AUK, V111, P652; Rappole JH., 1995, ECOLOGY MIGRANT BIRD; Rising J, 2014, HDB BIRDS WORLD ALIV; Rising J.D., 2010, GUIDE IDENTIFICATION; Ruiz-Sanchez A, 2015, J AVIAN BIOL, V46, P516, DOI 10.1111/jav.00531; Rushing CS, 2016, ECOLOGY, V97, P1218, DOI 10.1890/15-1259.1; Ruth JM, 2014, SOUTHWEST NAT, V59, P199, DOI 10.1894/F07-GDS-13.1; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; Sauer JR, 2017, N AM BREEDING BIRD S, DOI [10.1111/jav.00319, DOI 10.1111/JAV.00319]; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Soberon J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175138; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Somveille M, 2015, GLOBAL ECOL BIOGEOGR, V24, P664, DOI 10.1111/geb.12298; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; STOCKWELL DRB, 1992, MATH COMPUT SIMULAT, V33, P385, DOI 10.1016/0378-4754(92)90126-2; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Sutter B, 2005, J FIELD ORNITHOL, V76, P345, DOI 10.1648/0273-8570-76.4.345; Sutter GC, 1995, ECOSCIENCE, V2, P344, DOI 10.1080/11956860.1995.11682302; Swanson DL, 2009, J FIELD ORNITHOL, V80, P351, DOI 10.1111/j.1557-9263.2009.00241.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tobon-Sampedro A, 2015, BIRD CONSERV INT, V25, P489, DOI 10.1017/S0959270914000501; Tottrup AP, 2008, BIOL LETTERS, V4, P685, DOI 10.1098/rsbl.2008.0290; Travers SE, 2015, WILSON J ORNITHOL, V127, P43, DOI 10.1676/14-033.1; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Urena-Aranda CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131452; Vickery PD, 2001, AUK, V118, P11, DOI 10.1642/0004-8038(2001)118[0011:RAIGBR]2.0.CO;2; Voelker G, 2004, CONDOR, V106, P910, DOI 10.1650/7500; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; White R., 2000, PILOT ANAL GLOBAL EC, DOI 10.1021/es0032881; Wiggings DA, 2006, BAIRDS SPARROW AMMOD; Williams HM, 2017, J AVIAN BIOL, V48, P1624, DOI 10.1111/jav.01476; Wilson S, 2011, ECOLOGY, V92, P1789, DOI 10.1890/10-1757.1; Yanez-Arenas C, 2012, OIKOS, V121, P2081, DOI 10.1111/j.1600-0706.2012.20350.x; Zink RM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603133	138	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202678	10.1371/journal.pone.0202678	http://dx.doi.org/10.1371/journal.pone.0202678			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148886	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000442804200019
J	Raghu, D; Christodoulides, JA; Christophersen, M; Liu, JL; Anderson, GP; Robitaille, M; Byers, JM; Raphael, MP				Raghu, Deepa; Christodoulides, Joseph A.; Christophersen, Marc; Liu, Jinny L.; Anderson, George P.; Robitaille, Michael; Byers, Jeff M.; Raphael, Marc P.			Nanoplasmonic pillars engineered for single exosome detection	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; EXTRACELLULAR VESICLES; CANCER; BIOMARKERS; RESOLUTION; BIOSENSOR; CELLS	Exosomes are secreted nanovesicles which incorporate proteins and nucleic acids, thereby enabling multifunctional pathways for intercellular communication. There is an increasing appreciation of the critical role they play in fundamental processes such as development, wound healing and disease progression, yet because of their heterogeneous molecular content and low concentrations in vivo, their detection and characterization remains a challenge. In this work we combine nano- and microfabrication techniques for the creation of nanosensing arrays tailored toward single exosome detection. Elliptically-shaped nanoplasmonic sensors are fabricated to accommodate at most one exosome and individually imaged in real time, enabling the label-free recording of digital responses in a highly multiplexed geometry. This approach results in a three orders of magnitude sensitivity improvement over previously reported real-time, multiplexed platforms. Each nanosensor is elevated atop a quartz nanopillar, minimizing unwanted nonspecific substrate binding contributions. The approach is validated with the detection of exosomes secreted by MCF7 breast adenocarcinoma cells. We demonstrate the increasingly digital and stochastic nature of the response as the number of subsampled nanosensors is reduced from four hundred to one.	[Raghu, Deepa; Christodoulides, Joseph A.; Robitaille, Michael; Byers, Jeff M.; Raphael, Marc P.] Naval Res Lab, Mat Sci & Technol Div, Washington, DC 20375 USA; [Christophersen, Marc] Naval Res Lab, Space Sci Div, Washington, DC 20375 USA; [Liu, Jinny L.; Anderson, George P.] Naval Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA; [Raghu, Deepa] Sigma Aldrich Corp, BioReliance, Rockville, MD USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory; Merck KGaA; MilliporeSigma	Raphael, MP (corresponding author), Naval Res Lab, Mat Sci & Technol Div, Washington, DC 20375 USA.	marc.raphael@nrl.navy.mil		Robitaille, Michael/0000-0002-8445-7205	Naval Research Laboratory's Institute for Nanoscience; Office of the Assistant Secretary of Defense for Research & Engineering (Vannevar Bush Award); National Research Council Research Postdoc Associateship Award	Naval Research Laboratory's Institute for Nanoscience(United States Department of Defense); Office of the Assistant Secretary of Defense for Research & Engineering (Vannevar Bush Award); National Research Council Research Postdoc Associateship Award	This work was supported by the Naval Research Laboratory's Institute for Nanoscience, the Office of the Assistant Secretary of Defense for Research & Engineering (Vannevar Bush Award), and a National Research Council Research Postdoc Associateship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Daaboul GG, 2016, SCI REP-UK, V6, DOI 10.1038/srep37246; Dahlin AB, 2006, ANAL CHEM, V78, P4416, DOI 10.1021/ac0601967; Di Noto G, 2016, BIOSENS BIOELECTRON, V77, P518, DOI 10.1016/j.bios.2015.09.061; Di Noto G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00517; Henderson MC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00038; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Im H, 2009, ANAL CHEM, V81, P2854, DOI 10.1021/ac802276x; Kalra H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020170; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Li JT, 2009, BIOMED CIRC SYST C, P9, DOI 10.1109/BIOCAS.2009.5372096; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Paolini L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23550; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Raphael MP, 2015, PLASMONICS, V10, P1649, DOI 10.1007/s11468-015-9969-3; Raphael MP, 2013, BIOPHYS J, V105, P602, DOI 10.1016/j.bpj.2013.06.022; Raphael MP, 2013, BIOPHYS J, V104, P30, DOI 10.1016/j.bpj.2012.11.3821; Raphael MP, 2012, ANAL CHEM, V84, P1367, DOI 10.1021/ac2023266; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smith ZJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28533; Su J, 2015, ACS PHOTONICS, V2, P1241, DOI 10.1021/acsphotonics.5b00142; Thakur A, 2017, BIOSENS BIOELECTRON, V94, P400, DOI 10.1016/j.bios.2017.03.036; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Witwer KW, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1396823; Yoshioka Y, 2014, NAT COMMUN, P5, DOI [10.1038/ncomms4591WOS:000335220400009, DOI 10.1038/NCOMMS459125230337]	32	43	43	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202773	10.1371/journal.pone.0202773	http://dx.doi.org/10.1371/journal.pone.0202773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142169	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500031
J	Deng, JY; Jhandey, A; Zhu, X; Yang, ZB; Yik, KFP; Zuo, Z; Lam, TN				Deng, Jianyuan; Jhandey, Anika; Zhu, Xiao; Yang, Zhibo; Yik, Kin Fu Patrick; Zuo, Zhong; Lam, Tai Ning			In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption	PLOS ONE			English	Article							TRANSPORT; METABOLISM; PHARMACOKINETICS; BIOAVAILABILITY; BIOEQUIVALENCE; DISPOSITION; SIMULATION; MIDAZOLAM; DEVICE	Background An agent-based modeling approach has been suggested as an alternative to traditional, equation-based modeling methods for describing oral drug absorption. It enables researchers to gain a better understanding of the pharmacokinetic (PK) mechanisms of a drug. This project demonstrates that a biomimetic agent-based model can adequately describe the absorption and disposition kinetics both of midazolam and clonazepam. Methods An agent-based biomimetic model, in silico drug absorption tract (ISDAT), was built to mimic oral drug absorption in humans. The model consisted of distinct spaces, membranes, and metabolic enzymes, and it was altogether representative of human physiology relating to oral drug absorption. Simulated experiments were run with the model, and the results were compared to the referent data from clinical equivalence trials. Acceptable similarity was verified by pre-specified criteria, which included 1) qualitative visual matching between the clinical and simulated concentration-time profiles, 2) quantitative similarity indices, namely, weighted root mean squared error (RMSE), and weighted mean absolute percentage error (MAPE) and 3) descriptive similarity which requires less than 25% difference between key PK parameters calculated by the clinical and the simulated concentration-time profiles. The model and its parameters were iteratively refined until all similarity criteria were met. Furthermore, simulated PK experiments were conducted to predict bioavailability (F). For better visualization, a graphical user interface for the model was developed and a video is available in Supporting Information. Results Simulation results satisfied all three levels of similarity criteria for both drugs. The weighted RMSE was 0.51 and 0.92, and the weighted MAPE was 5.99% and 8.43% for midazolam and clonazepam, respectively. Calculated PK parameter values, including area under the curve (AUC), peak plasma drug concentration (C-max), time to reach C-max (T-max), terminal elimination rate constant (Kel), terminal elimination half life (T-1/2), apparent oral clearance (CL/F), and apparent volume of distribution (V/F), were reasonable compared to the referent values. The predicted absolute oral bioavailability (F) was 44% for midazolam (literature reported value, 31-72%) and 93% (literature reported value, >= 90%) for clonazepam. Conclusion The ISDAT met all the pre-specified similarity criteria for both midazolam and clonazepam, and demonstrated its ability to describe absorption kinetics of both drugs. Therefore, the validated ISDAT can be a promising platform for further research into the use of similar in silico models for drug absorption kinetics.	[Deng, Jianyuan; Jhandey, Anika; Zhu, Xiao; Yik, Kin Fu Patrick; Zuo, Zhong; Lam, Tai Ning] Chinese Univ Hong Kong, Sch Pharm, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Jhandey, Anika] Univ Nottingham, Sch Pharm, Nottingham, England; [Yang, Zhibo] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Lam, Tai Ning] Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of Nottingham; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese University of Hong Kong	Lam, TN (corresponding author), Chinese Univ Hong Kong, Sch Pharm, Fac Med, Hong Kong, Hong Kong, Peoples R China.; Lam, TN (corresponding author), Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China.	teddylam@cuhk.edu.hk	Deng, Jianyuan/ABE-5454-2021; Deng, Jianyuan/ABE-5456-2021; Lam, Teddy/C-6180-2016; Zuo, Zhong/B-6884-2008	Deng, Jianyuan/0000-0003-0647-1287; Lam, Tai Ning/0000-0002-7259-4050; Zhu, Xiao/0000-0003-3295-619X; Zuo, Zhong/0000-0002-6976-6157	Hong Kong University Grants Committee Research Grants Council Early Career Scheme [CUHK489813]	Hong Kong University Grants Committee Research Grants Council Early Career Scheme	This project is partially supported by research grants from the Hong Kong University Grants Committee Research Grants Council Early Career Scheme (https://www.ugc.edu.hk/eng/rgc/funding_opport/early_career.html), Grant number CUHK489813 (TNL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2007, J CRIT CARE, V22, P169, DOI 10.1016/j.jcrc.2006.12.011; An G, 2009, WIRES SYST BIOL MED, V1, P159, DOI 10.1002/wsbm.45; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; Cavedal LE, 2007, J MASS SPECTROM, V42, P81, DOI 10.1002/jms.1141; Chen ML, 2001, CLIN PHARMACOKINET, V40, P701, DOI 10.2165/00003088-200140100-00001; Cosgrove J, 2015, CPT-PHARMACOMET SYST, V4, P615, DOI 10.1002/psp4.12018; Crevoisier C, 2003, EUR NEUROL, V49, P173, DOI 10.1159/000069089; El-Kattan A, 2012, TOPICS ON DRUG METABOLISM, P1; Engelberg JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002030; Garmire LX, 2007, PHARM RES-DORDR, V24, P2171, DOI 10.1007/s11095-007-9391-4; HEIZMANN P, 1983, BRIT J CLIN PHARMACO, V16, pS43, DOI 10.1111/j.1365-2125.1983.tb02270.x; Hunt CA, 2013, WIRES SYST BIOL MED, V5, P461, DOI 10.1002/wsbm.1222; Hunt CA, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-35; Hunt CA, 2009, PHARM RES-DORDR, V26, P2369, DOI 10.1007/s11095-009-9958-3; Jaki T, 2011, PHARM STAT, V10, P284, DOI 10.1002/pst.449; Kadono K, 2010, DRUG METAB DISPOS, V38, P1230, DOI 10.1124/dmd.109.029322; Kim SHJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-122; Lalonde RL, 2007, CLIN PHARMACOL THER, V82, P21, DOI 10.1038/sj.clpt.6100235; Lam TN, 2010, J PHARMACOL EXP THER, V332, P398, DOI 10.1124/jpet.109.160739; Lam TN, 2008, IEEE ENG MED BIO, P5462, DOI 10.1109/IEMBS.2008.4650450; Lam TN, 2009, DRUG METAB DISPOS, V37, P237, DOI 10.1124/dmd.108.023820; Landersdorfer CB, 2008, CLIN PHARMACOKINET, V47, P417, DOI 10.2165/00003088-200847070-00001; Liu Y, 2006, PHARM RES-DORDR, V23, P493, DOI 10.1007/s11095-006-9505-4; Liu Y, 2005, BIOSYSTEMS, V82, P154, DOI 10.1016/j.biosystems.2005.06.008; Luke S, 2005, SIMUL-T SOC MOD SIM, V81, P517, DOI 10.1177/0037549705058073; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Park S, 2010, J PHARMACOL EXP THER, V334, P124, DOI 10.1124/jpet.110.168526; Sakuda S, 2006, XENOBIOTICA, V36, P331, DOI 10.1080/00498250600571749; Seal JB, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-33; Sheiner LB, 2000, ANNU REV PHARMACOL, V40, P67, DOI 10.1146/annurev.pharmtox.40.1.67; Spector P, 2008, USE R, P1; Tang J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000681; Wang ZH, 2015, J PHARMACOKINET PHAR, V42, P179, DOI 10.1007/s10928-015-9403-7; Wang ZH, 2012, MATH MED BIOL, V29, P95, DOI 10.1093/imammb/dqq023; Wening K, 2011, INT J PHARMACEUT, V404, P1, DOI 10.1016/j.ijpharm.2010.11.001; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yan L, 2008, PHARM RES, V25, P1023, DOI 10.1007/s11095-007-9494-y; Zhou HH, 2003, J CLIN PHARMACOL, V43, P211, DOI 10.1177/0091270002250613; Zhu X, 2016, AAPS J, V18, P1475, DOI 10.1208/s12248-016-9955-5	39	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203361	10.1371/journal.pone.0203361	http://dx.doi.org/10.1371/journal.pone.0203361			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169515	Green Published, Green Submitted, gold			2022-12-27	WOS:000443374400037
J	Jimenez-Lopez, D; Munoz-Belman, F; Gonzalez-Prieto, JM; Aguilar-Hernandez, V; Guzman, P				Jimenez-Lopez, Domingo; Munoz-Belman, Francisco; Manuel Gonzalez-Prieto, Juan; Aguilar-Hernandez, Victor; Guzman, Plinio			Repertoire of plant RING E3 ubiquitin ligases revisited: New groups counting gene families and single genes	PLOS ONE			English	Article							CONFERS DROUGHT TOLERANCE; ARABIDOPSIS-THALIANA; FINGER PROTEIN; EXPRESSION ANALYSIS; NEGATIVE REGULATOR; SEED-GERMINATION; ROOT DEVELOPMENT; DNA METHYLATION; ATL FAMILY; STRESS	E3 ubiquitin ligases of the ubiquitin proteasome system (UPS) mediate recognition of substrates and later transfer the ubiquitin (Ub). They are the most expanded components of the system. The Really Interesting New Gene (RING) domain contains 40-60 residues that are highly represented among E3 ubiquitin ligases. The Arabidopsis thaliana E3 ubiquitin ligases with a RING finger primarily contain RING-HC or RING-H2 type domains or less frequently RING-v, RING-C2, RING-D, RING-S/T and RING-G type domains. Our previous work on three E3 ubiquitin ligase families with a RING-H2 type domain, ATL, BTL, and CTL, suggested that a phylogenetic distribution based on the RING domain allowed for the creation a catalog of known domains or unknown conserved motifs. This work provided a useful and comprehensive view of particular families of RING E3 ubiquitin ligases. We updated the annotation of A. thaliana RING proteins and surveyed RING proteins from 30 species across eukaryotes. Based on domain architecture profile of the A. thaliana proteins, we catalogued 4711 RING finger proteins into 107 groups, including 66 previously described gene families or single genes and 36 novel families or undescribed genes. Forty-four groups were specific to a plant lineage while 41 groups consisted of proteins found in all eukaryotic species. Our present study updates the current classification of plant RING finger proteins and reiterates the importance of these proteins in plant growth and adaptation.	[Jimenez-Lopez, Domingo; Munoz-Belman, Francisco; Guzman, Plinio] IPN, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Unidad Irapuato, Irapuato, Gto, Mexico; [Jimenez-Lopez, Domingo; Manuel Gonzalez-Prieto, Juan] Inst Politecn Nacl, Biotecnol Vegetal, Ctr Biotecnol Genom, Reynosa, Tamaulipas, Mexico; [Aguilar-Hernandez, Victor] CONACYT, Unidad Bioquim & Biol Mol Plantas, Ctr Invest Cient Yucatan, Merida, Yucatan, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Centro de Investigacion Cientifica de Yucatan	Guzman, P (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Unidad Irapuato, Irapuato, Gto, Mexico.; Aguilar-Hernandez, V (corresponding author), CONACYT, Unidad Bioquim & Biol Mol Plantas, Ctr Invest Cient Yucatan, Merida, Yucatan, Mexico.	victor.aguilar@cicy.mx; plinio.guzman@cinvestav.mx	Aguilar-Hernández, Victor/Q-9860-2019	Aguilar-Hernández, Victor/0000-0001-7308-4047; Guzman, Plinio/0000-0001-7905-5693	Fronteras de la Ciencia 20 from Consejo Nacional de Ciencia y Tecnologia de Mexico	Fronteras de la Ciencia 20 from Consejo Nacional de Ciencia y Tecnologia de Mexico	This work was funded by grant Fronteras de la Ciencia 20 from Consejo Nacional de Ciencia y Tecnologia de Mexico. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Aguilar-Henonin L, 2006, CURR GENET, V50, P257, DOI 10.1007/s00294-006-0093-y; Aguilar-Hernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072729; Aguilar-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023934; Alam I, 2017, SCI REP-UK, V7, DOI 10.1038/srep40690; Ariani P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38260; Azevedo J, 2008, P NATL ACAD SCI USA, V105, P9123, DOI 10.1073/pnas.0800909105; Bao Y, 2014, NEW PHYTOL, V202, P174, DOI 10.1111/nph.12644; Baylis T, 2013, NEW PHYTOL, V197, P737, DOI 10.1111/nph.12084; Belda-Palazon B, 2016, PLANT CELL, V28, P2291, DOI 10.1105/tpc.16.00178; Berrocal-Lobo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014426; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Bourbousse C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002825; Burkhart SE, 2014, PLANT PHYSIOL, V166, P1329, DOI 10.1104/pp.114.247148; Chen IP, 2008, PLANT PHYSIOL, V146, P1786, DOI 10.1104/pp.108.116806; Chen MJ, 2006, PLANT J, V46, P823, DOI 10.1111/j.1365-313X.2006.02740.x; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; Dong CH, 2006, P NATL ACAD SCI USA, V103, P8281, DOI 10.1073/pnas.0602874103; Dong H, 2017, GENE DEV, V31, P197, DOI 10.1101/gad.292235.116; Duong S, 2017, J EXP BOT, V68, P1555, DOI 10.1093/jxb/erx046; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Figueroa P, 2005, PLANT CELL, V17, P1180, DOI 10.1105/tpc.105.031989; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gao Y, 2016, MAR GENOM, V26, P51, DOI 10.1016/j.margen.2015.12.008; Greve K, 2003, BIOCHEM J, V371, P97, DOI 10.1042/BJ20021123; Guerra DD, 2013, FEBS LETT, V587, P3400, DOI 10.1016/j.febslet.2013.08.045; Guo L, 2016, PLANT J, V86, P161, DOI 10.1111/tpj.13158; Guzman P, 2014, PLANT SCI, V215, P69, DOI 10.1016/j.plantsci.2013.10.017; Guzman P, 2012, PLANT SIGNAL BEHAV, V7, P1014, DOI 10.4161/psb.20851; Hershko A, 1998, ANN REV; Hindt MN, 2017, METALLOMICS, V9, P876, DOI 10.1039/c7mt00152e; Hsia MM, 2010, J BIOL CHEM, V285, P37070, DOI 10.1074/jbc.M110.168021; Huang YD, 2010, PLANT PHYSIOL, V152, P1889, DOI 10.1104/pp.109.150573; Jimenez-Lopez D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190969; Katoh S, 2005, J BIOL CHEM, V280, P41015, DOI 10.1074/jbc.M411127200; Kawasaki T, 2005, PLANT J, V44, P258, DOI 10.1111/j.1365-313X.2005.02525.x; Kim SJ, 2013, FEBS LETT, V587, P2584, DOI 10.1016/j.febslet.2013.06.038; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Koiwai H, 2007, PLANT J, V51, P92, DOI 10.1111/j.1365-313X.2007.03120.x; Kosarev P, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-4-research0016; Kraft E, 2008, PLANT J, V56, P704, DOI 10.1111/j.1365-313X.2008.03631.x; Lazaro A, 2015, PLANT CELL, V27, P2437, DOI 10.1105/tpc.15.00529; Lee HK, 2009, PLANT CELL, V21, P622, DOI 10.1105/tpc.108.061994; Li HM, 2011, PLANT PHYSIOL, V156, P550, DOI 10.1104/pp.111.176214; Li J, 2015, PLANT CELL, V27, P908, DOI 10.1105/tpc.114.135095; Li JQ, 2017, INT J PARASITOL-PAR, V6, P8, DOI 10.1016/j.ijppaw.2016.12.003; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Li XW, 2017, PLANT BIOTECHNOL-NAR, V34, P71, DOI 10.5511/plantbiotechnology.17.0306a; Li YZ, 2011, MOL GENET GENOMICS, V286, P81, DOI 10.1007/s00438-011-0625-0; Lim SD, 2014, PLANT CELL ENVIRON, V37, P1097, DOI 10.1111/pce.12219; Lim SD, 2013, J EXP BOT, V64, P2899, DOI 10.1093/jxb/ert143; Lim SD, 2010, PLANT MOL BIOL, V72, P369, DOI 10.1007/s11103-009-9576-9; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Liu HX, 2010, PLANT CELL, V22, P2630, DOI 10.1105/tpc.110.076075; Liu H, 2016, MOL PLANT, V9, P1634, DOI 10.1016/j.molp.2016.10.010; Liu JJ, 2008, PLANT CELL, V20, P1538, DOI 10.1105/tpc.108.059741; Luo G, 2012, J INTEGR PLANT BIOL, V54, P814, DOI 10.1111/j.1744-7909.2012.01152.x; Luo HL, 2010, PLANT PHYSIOL, V154, P1766, DOI 10.1104/pp.110.163915; Lyzenga WJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00502; Lyzenga WJ, 2012, PLANT J, V71, P23, DOI 10.1111/j.1365-313X.2012.04965.x; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; MartinezGarcia M, 1996, MOL GEN GENET, V252, P587, DOI 10.1007/s004380050266; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Mladek C, 2003, PLANT PHYSIOL, V131, P27, DOI 10.1104/pp.012781; Molnar G, 2002, PLANTA, V215, P127, DOI 10.1007/s00425-001-0723-z; Moschou PN, 2016, DEV CELL, V37, P350, DOI 10.1016/j.devcel.2016.04.015; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Nodzon LA, 2004, PLANT J, V40, P996, DOI 10.1111/j.1365-313X.2004.02266.x; Occhialini A, INT J MOL SCI; Oh TR, 2017, PLANT PHYSIOL, V174, P2515, DOI 10.1104/pp.17.00467; Pan RH, 2016, P NATL ACAD SCI USA, V113, pE7307, DOI 10.1073/pnas.1613530113; Patharkar OR, 2006, PLANTA, V225, P57, DOI 10.1007/s00425-006-0330-0; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Ranjan A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-178; Roig-Villanova I, 2006, PLANT PHYSIOL, V141, P85, DOI 10.1104/pp.105.076331; Ruzicka K, 2017, NEW PHYTOL, V215, P157, DOI 10.1111/nph.14586; Sakai T, 2012, PLANT J, V70, P303, DOI 10.1111/j.1365-313X.2011.04870.x; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Serrano M, 2004, GENETICS, V167, P919, DOI 10.1534/genetics.104.028043; Shin LJ, 2013, PLANT CELL, V25, P3039, DOI 10.1105/tpc.113.115212; Son O, 2009, PLANT CELL REP, V28, P561, DOI 10.1007/s00299-009-0680-8; Sonoda Y, 2007, PLANT J, V50, P586, DOI 10.1111/j.1365-313X.2007.03062.x; Sparkes IA, 2005, PLANT PHYSIOL, V139, P690, DOI 10.1104/pp.105.065094; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Su W, 2011, P NATL ACAD SCI USA, V108, P870, DOI 10.1073/pnas.1013251108; Tan XY, 2017, BIOCHEM BIOPH RES CO, V491, P794, DOI 10.1016/j.bbrc.2017.07.059; Trapp O, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00019; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Voiniciuc C, 2013, PLANT CELL, V25, P944, DOI 10.1105/tpc.112.107888; Vonarx EJ, 2006, PLANT J, V46, P512, DOI 10.1111/j.1365-313X.2006.02705.x; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wu Q, 2016, PLANT CELL, V28, P2178, DOI 10.1105/tpc.16.00364; Wywial E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-157; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Xu DQ, 2014, PLANT CELL, V26, P1981, DOI 10.1105/tpc.114.124024; Yaeno T, 2008, PLANT PHYSIOL, V148, P1032, DOI 10.1104/pp.108.124529; Yang L, 2016, J INTEGR PLANT BIOL, V58, P67, DOI 10.1111/jipb.12364; Yasuda S, 2014, J BIOL CHEM, V289, P15179, DOI 10.1074/jbc.M113.533133; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zang DD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01272; Zhang HW, 2015, PLANT CELL, V27, P214, DOI 10.1105/tpc.114.134163; Zhang J., 2016, IEEE T IND ELECTRON, V1-1, P1, DOI DOI 10.1007/S00253-016-7741-Z; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhao HY, 2014, PLANT PHYSIOL, V165, P1255, DOI 10.1104/pp.114.239699; Zhao YS, 2014, PLANT CELL, V26, P2660, DOI 10.1105/tpc.114.126730; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	116	14	14	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203442	10.1371/journal.pone.0203442	http://dx.doi.org/10.1371/journal.pone.0203442			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169501	Green Published, Green Submitted, gold			2022-12-27	WOS:000443374400041
J	Jose, V; Fumagalli, D; Rothe, F; Majjaj, S; Loi, S; Michiels, S; Sotiriou, C				Jose, Vinu; Fumagalli, Debora; Rothe, Francoise; Majjaj, Samira; Loi, Sherene; Michiels, Stefan; Sotiriou, Christos			Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays	PLOS ONE			English	Article							BREAST-CANCER; NORMALIZATION; MICROARRAYS; BIOLOGY	The reliability of differential gene expression analysis on formalin-fixed, paraffin-embedded (FFPE) expression profiles generated using Affymetrix arrays is questionable, due to the high range of percent-present values reported in studies which profiled FFPE samples using this technology. Moreover, the validity of gene-modules derived from external datasets in FFPE microarray expression profiles is unknown. By generating matched gene expression profiles using RNAs derived from fresh-frozen (FF) and FFPE preserved breast tumors with Affymetrix arrays and FF/FFPE RNA specific amplification-and-labeling kits, the reliability of differential expression analysis and the validity of gene modules derived from external datasets were investigated. Specifically, the reliability of differential expression analysis was investigated by developing de-novo ER/HER2 pathway gene-modules from the matched datasets and validating them on external FF/FFPE gene expression datasets using ROC analysis. Spearman's rank correlation coefficient of module scores between matched FFPE/frozen datasets was used to measure the reliability of gene-modules derived from external datasets in FFPE expression profiles. Independent of the array/amplification-kit/sample preservation method used, de-novo ER/HER2 gene-modules derived from all matched datasets showed similar prediction performance in the independent validation (AUC range in FFPE dataset; ER: 0.93-0.95, HER2: 0.85-0.91), except for the de-novo ER/HER2 gene-module derived from the FFPE dataset using the 3'IVT kit (AUC range in FFPE dataset; ER: 0.79-0.81, HER2: 0.78). Among the external gene modules considered, roughly similar to 50% gene modules showed high concordance between expression profiles derived from matching FF and FFPE RNA. The remaining discordant gene modules between FF and FFPE expression profiles showed high concordance within matching FF datasets and within matching FFPE datasets independently, implying that microarrays still require improved amplification-and-sample-preparation protocols for deriving 100% concordant expression profiles from matching FF and FFPE RNA.	[Jose, Vinu; Rothe, Francoise; Majjaj, Samira; Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium; [Fumagalli, Debora] Univ Libre Bruxelles, Inst Jules Bordet, Breast Int Grp, Brussels, Belgium; [Loi, Sherene] Univ Melbourne, Div Res & Canc Med, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Michiels, Stefan] Univ Paris Saclay, Univ Paris Sud, Fac Med, Serv Biostat & Epidemiol,Gustave Roussy,CESP,U101, Villejuif, France; [Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med, Med Oncol Clin, Brussels, Belgium	Institut Jules Bordet; Universite Libre de Bruxelles; Breast International Group; Institut Jules Bordet; Universite Libre de Bruxelles; Peter Maccallum Cancer Center; University of Melbourne; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut Jules Bordet; Universite Libre de Bruxelles	Sotiriou, C (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium.; Sotiriou, C (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Dept Med, Med Oncol Clin, Brussels, Belgium.	christos.sotiriou@bordet.be	Loi, Sherene/H-1979-2016; Michiels, Stefan/L-1516-2013	Loi, Sherene/0000-0001-6137-9171; Michiels, Stefan/0000-0002-6963-2968; Jose, Vinu/0000-0002-0562-8337	F.R.S-FNRS "Fonds de la Recherche Scientifique" - Televie (Belgium)	F.R.S-FNRS "Fonds de la Recherche Scientifique" - Televie (Belgium)(Fonds de la Recherche Scientifique - FNRS)	VJ received funding from a grant F.R.S-FNRS "Fonds de la Recherche Scientifique" - Televie (Belgium), for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF INC, 2002, GENECHIP EXPR AN DAT; [Anonymous], 2021, LANG ENV STAT COMP; Auguie B., 2015, GRIDEXTRA MISCELLANE; Azim HA, 2014, ENDOCR-RELAT CANCER, V21, P545, DOI 10.1530/ERC-14-0111; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Budczies J, 2011, J HISTOCHEM CYTOCHEM, V59, P146, DOI 10.1369/jhc.2010.956607; Callari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086511; Chen YA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-101; Clement-Ziza M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-246; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Hollander M., 1973, NONPARAMETRIC STAT M; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobson TAS, 2011, INT J ONCOL, V38, P1075, DOI 10.3892/ijo.2011.936; Kucho KI, 2004, GENES GENET SYST, V79, P189, DOI 10.1266/ggs.79.189; Lassmann S, 2009, J MOL MED, V87, P211, DOI 10.1007/s00109-008-0419-y; Li J, 2018, JCO PRECIS ONCOL, DOI [10.1200/PO.17.00091, DOI 10.1200/PO.17.00091]; Linton KM, 2009, BIOTECHNIQUES, V47, P587, DOI 10.2144/000113169; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lu J, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr241; NanoString Technologies Inc, 2011, NCOUNTER EXPR CODESE; Neuwirth E, RCOLORBREWER PROVIDE; Roberts L, 2009, GENOMICS, V94, P341, DOI 10.1016/j.ygeno.2009.07.007; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sachs MC, 2016, PLOTROC GENERATE USE; Sanchez G., 2013, COLORTOOLS R PACKAGE; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Thomas Marlene, 2013, J Clin Bioinforma, V3, P10, DOI 10.1186/2043-9113-3-10; Tukey J. W., 1977, EXPLORATORY DATA ANA; Viale Agnes, 2007, J Biomol Tech, V18, P150; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Williams PM, 2010, J MOL DIAGN, V12, P680, DOI 10.2353/jmoldx.2010.090164; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203346	10.1371/journal.pone.0203346	http://dx.doi.org/10.1371/journal.pone.0203346			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169535	Green Published, gold			2022-12-27	WOS:000443374400035
J	Pan, GD; Munukutla, S; Kar, A; Gardinier, J; Thandavarayan, RA; Palaniyandi, SS				Pan, Guodong; Munukutla, Srikar; Kar, Ananya; Gardinier, Joseph; Thandavarayan, Rajarajan A.; Palaniyandi, Suresh Selvaraj			Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography (vol 13, e0195796, 2018)	PLOS ONE			English	Correction															NHLBI NIH HHS [R01 HL139877, R56 HL131891] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL131891] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Pan GD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195796	1	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203581	10.1371/journal.pone.0203581	http://dx.doi.org/10.1371/journal.pone.0203581			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161229	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900132
J	Kim, JJ; Kim, T; Lee, H; Byun, SS; Lee, SE; Choe, G; Hong, SK				Kim, Jung Jun; Kim, Taejin; Lee, Hakjong; Byun, Seok-Soo; Lee, Sang Eun; Choe, Gheeyoung; Hong, Sung Kyu			Prediction of unilateral prostate cancer by the combination of transrectal ultrasonography-guided prostate biopsy and multi-parametric magnetic resonance imaging: A real-life experience	PLOS ONE			English	Article							ULTRASOUND FUSION BIOPSY; FOCAL THERAPY; CLINICAL-SIGNIFICANCE; MRI; LATERALITY; CONSENSUS; ACCURACY	Hemi-ablation of prostate cancer (PCa) requires an accurate prediction of laterality. Recently, multi-parametric magnetic resonance imaging (mpMRI) has recently been increasingly used to enhance clinical staging and characterization of tumor foci. Thus, we tried to investigate the real-life accuracy of combinatory approach of using both transrectal ultrasound (TRUS)-guided prostatic biopsy and mpMRI in predicting the laterality of PCa. We reviewed the records of 335 men who were suspected of having unilateral PCa on multi (>= 12)-core TRUS-guided biopsy and preoperative mpMRI and subsequently had undergone radical prostatectomy (RP) at our institution. Based on the analysis of pathologic outcomes from RP, the performance of the combinatory approach in predicting the pathological laterality of PCa was evaluated. Pathology was classified to be unfavorable when showing a Gleason pattern of 4/5 or pT3/N1 features. Significant cancer was defined as non-organconfined disease, having a Gleason pattern of 4/5, or showing a cancer volume of >= 0.5 mL. Among the 335 unilateral lobes not suspected to harbor tumor from either the TRUS biopsy or mpMRI, the actual absence rate of malignancy was only 13.7% from a pathologic analysis of RP specimens. Even among the 115 D'Amico low-risk group, the absence rate of malignancy was only 26.1% in unilateral lobes not suspected to harbor tumor. Among the 335 lobes, unfavorable pathology and significant cancer were not observed in 36.1% and 30.7%, respectively. The absence rates of unfavorable pathology and significant cancer among the D'Amico low risk group were 56.5% and 47.8%, respectively. Meanwhile, the absence rate of dominant Gleason pattern 4 or 5 was 74.9% among the 335 total subjects. Our real-life clinical experience showed that the combination of multi-core TRUS-guided biopsy and mpMRI did not provide reliable accuracy in the prediction of true unilaterality of PCa.	[Kim, Jung Jun; Kim, Taejin; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu] Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea; [Lee, Hakjong] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Byun, Seok-Soo; Hong, Sung Kyu] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea; [Choe, Gheeyoung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea.; Hong, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea.	skhong@snubh.org		Hong, Sung Kyu/0000-0002-8344-6774				Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Ahmed HU, 2012, LANCET ONCOL, V13, P622, DOI 10.1016/S1470-2045(12)70121-3; Baco E, 2015, EUR UROL, V67, P787, DOI 10.1016/j.eururo.2014.08.077; Bahn D, 2012, EUR UROL, V62, P55, DOI 10.1016/j.eururo.2012.03.006; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Berkowitz BA, 2016, INVEST OPHTH VIS SCI, V57, P577, DOI 10.1167/iovs.15-18972; Branger N, 2017, BJU INT, V119, P449, DOI 10.1111/bju.13657; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Cordeiro ER, 2012, BJU INT, V110, P1228, DOI 10.1111/j.1464-410X.2012.11262.x; de Rooij M, 2014, AM J ROENTGENOL, V202, P343, DOI 10.2214/AJR.13.11046; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Feijoo ERC, 2016, EUR UROL, V69, P214, DOI 10.1016/j.eururo.2015.06.018; Filson CP, 2016, CANCER-AM CANCER SOC, V122, P884, DOI 10.1002/cncr.29874; Jeldres C, 2008, EUR UROL, V54, P1306, DOI 10.1016/j.eururo.2007.11.057; Jeong CW, 2012, UROLOGY, V79, P1322, DOI 10.1016/j.urology.2012.01.080; Kawakami Satoru, 2006, Int J Clin Oncol, V11, P127, DOI 10.1007/s10147-005-0547-0; Le JD, 2015, EUR UROL, V67, P569, DOI 10.1016/j.eururo.2014.08.079; Matsuoka Y, 2016, BJU INT, V117, P94, DOI 10.1111/bju.12901; Meiers I, 2007, UROLOGY, V70, P3, DOI 10.1016/j.urology.2007.06.1129; Tran M, 2016, BJU INT, V117, P48, DOI 10.1111/bju.13090; Mouraviev V, 2007, CANCER, V110, P906, DOI 10.1002/cncr.22858; Numao N, 2012, BJU INT, V109, P665, DOI 10.1111/j.1464-410X.2011.10427.x; Polascik TJ, 2009, CANCER, V115, P2104, DOI 10.1002/cncr.24258; Radtke JP, 2016, EUR UROL, V70, P846, DOI 10.1016/j.eururo.2015.12.052; Rosenkrantz AB, 2012, J UROLOGY, V187, P2032, DOI 10.1016/j.juro.2012.01.074; STAMEY TA, 1993, CANCER, V71, P933, DOI 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L; Thompson JE, 2014, J UROLOGY, V192, P67, DOI 10.1016/j.juro.2014.01.014; Valerio M, 2014, EUR UROL, V66, P732, DOI 10.1016/j.eururo.2013.05.048; van den Bos W, 2014, EUR UROL, V65, P1078, DOI 10.1016/j.eururo.2014.01.001; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052; Zhang K, 2017, ASIAN J UROL, V4, P86, DOI 10.1016/j.ajur.2016.08.010	32	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202872	10.1371/journal.pone.0202872	http://dx.doi.org/10.1371/journal.pone.0202872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157232	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400072
J	Lequeux, BD; Ahumada-Sempoal, MA; Lopez-Perez, A; Reyes-Hernandez, C				Lequeux, Bertrand D.; Ahumada-Sempoal, Miguel-Angel; Lopez-Perez, Andres; Reyes-Hernandez, Cristobal			Coral connectivity between equatorial eastern Pacific marine protected areas: A biophysical modeling approach	PLOS ONE			English	Article							POPULATION CONNECTIVITY; TROPICAL PACIFIC; LARVAL DISPERSAL; REEF RECOVERY; CO2 SYSTEM; OCEAN; DYNAMICS; GULF; TEHUANTEPEC; ARCHIPELAGO	There are many marine protected areas (MPAs) containing coral reef aggregations in the eastern Pacific region. However, the connectivity of corals between MPAs is still poorly known, especially in the Marine Conservation Corridor of the Eastern Tropical Pacific (MCCETP). Here, we assess the potential connectivity of corals across equatorial eastern Pacific MPAs through a Lagrangian particle-tracking algorithm coupled offline with an ocean-circulation numerical model. Connectivity metrics and graph theory were used to analyze the networks and highlight those MPAs that are critical for maintaining the connectivity of corals across the region. Our results show that the equatorial eastern Pacific MPAs form a relatively well-connected network, at least 40% of coral larvae released per year end up within the boundaries of an MPA. MPAs like Malpelo and Gorgona islands included in the MCCETP were found to be critical for connectivity of corals because of their high between-ness centrality and potential role as stepping-stones between coastal MPAs and offshore MPAs such as the Galapagos Islands. Two pelagic larval duration (PLD) scenarios (40 and 130 days) indicate a quasi-unidirectional larval flow from coastal MPAs toward oceanic MPAs, where the only resilient MPAs (Coiba and Malpelo islands) depend mostly on subsidiary recruitment from MPAs located along the coast of Costa Rica, Panama and Colombia. In the two PLD scenarios, Cocos Island maintains a very low resilience potential. Our results indicate the imperative need to include coastal MPAs in the MCCETP network initiative, since connectivity and resilience of coral reefs in the equatorial eastern Pacific region rely heavily on coastal MPAs.	[Lequeux, Bertrand D.] Univ Mar, Program Marine Biol, Ciudad Univ S-N, San Pedro Pochutla, Oaxaca, Mexico; [Ahumada-Sempoal, Miguel-Angel; Reyes-Hernandez, Cristobal] Univ Mar, Ciudad Univ S-N, San Pedro Pochutla, Oaxaca, Mexico; [Lopez-Perez, Andres] Univ Autonoma Metropolitana, Unidad Iztapalapa, Mexico City, DF, Mexico	Universidad Autonoma Metropolitana - Mexico	Ahumada-Sempoal, MA (corresponding author), Univ Mar, Ciudad Univ S-N, San Pedro Pochutla, Oaxaca, Mexico.	ahumada@angel.umar.mx	Lopez-Perez, Andres/U-1151-2017; Lopez-Perez, Andres/GPJ-9537-2022; Reyes-Hernandez, Cristobal/GPP-4329-2022	Lopez-Perez, Andres/0000-0003-1246-7401; Lopez-Perez, Andres/0000-0003-1246-7401; Reyes-Hernandez, Cristobal/0000-0002-9064-7136; Ahumada-Sempoal, Miguel-Angel/0000-0003-3465-3643; Lequeux, Bertrand Didier/0000-0002-3617-3806				Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Andrello M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068564; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; Baums IB, 2012, MOL ECOL, V21, P5418, DOI 10.1111/j.1365-294X.2012.05733.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyer T, 2005, INT J CLIMATOL, V25, P931, DOI 10.1002/joc.1173; Chapa-Balcorta C, 2015, J GEOPHYS RES-OCEANS, V120, P7752, DOI 10.1002/2015JC011249; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crowder LB, 2000, B MAR SCI, V66, P799; da Silva AM., 1994, ATLAS SURFACE MARINE; Debreu L, 2012, OCEAN MODEL, V49-50, P1, DOI 10.1016/j.ocemod.2012.03.003; Fiedler PC, 2017, CORAL REEFS WORLD, V8, P59, DOI 10.1007/978-94-017-7499-4_3; Glynn PW, 2015, CORAL REEFS, V34, P421, DOI 10.1007/s00338-015-1280-4; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Glynn PW, 2003, LATIN AMERICAN CORAL REEFS, P449, DOI 10.1016/B978-044451388-5/50020-5; Glynn PW, 2017, CORAL REEF WORLD COR; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Guzman HM, 2008, ENVIRON CONSERV, V35, P46, DOI 10.1017/S0376892908004542; Guzman HM, 2007, MAR BIOL, V151, P401, DOI 10.1007/s00227-006-0495-x; Guzman HM, 2001, B MAR SCI, V69, P133; Alvarado JJ, 2017, CORAL REEFS WORLD, V8, P565, DOI 10.1007/978-94-017-7499-4_21; Karstensen J, 2009, PERU CHILE CURRENT S, P85; Lessios HA, 2017, CORAL REEFS WORLD, V8, P477, DOI 10.1007/978-94-017-7499-4_16; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Lopez-Perez A, 2016, MAR ECOL-EVOL PERSP, V37, P679, DOI 10.1111/maec.12337; Lopez-Perez RA, 2012, MAR ECOL-EVOL PERSP, V33, P407, DOI 10.1111/j.1439-0485.2011.00505.x; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Manzello DP, 2017, CORAL REEFS WORLD, V8, P517, DOI 10.1007/978-94-017-7499-4_18; Manzello DP, 2010, LIMNOL OCEANOGR, V55, P239, DOI 10.4319/lo.2010.55.1.0239; Marchesiello P, 2001, OCEAN MODEL, V3, P1, DOI 10.1016/s1463-5003(00)00013-5; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Peven P, 2007, ENVIRON MODELL SOFTW, V23, P660; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Risien CM, 2008, J PHYS OCEANOGR, V38, P2379, DOI 10.1175/2008JPO3881.1; Roberts C.M., 2001, CONSERV PRACT, V2, P10, DOI [DOI 10.1111/J.1526-4629.2001.TB00012.X, 10.1111/j.1526-4629.2001.tb00012.x]; Romero-Torres M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27644-2; Sale PF, 2010, PRESERVING REEF CONN; Santiago-Garcia MW, 2014, PROG OCEANOGR, V123, P64, DOI 10.1016/j.pocean.2014.02.002; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Tay YC, 2012, AQUAT BIOL, V15, P283, DOI 10.3354/ab00433; TRASVINA A, 1995, J GEOPHYS RES-OCEANS, V100, P20649, DOI 10.1029/95JC01283; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Treml EA, 2012, CONSERV LETT, V5, P441, DOI 10.1111/j.1755-263X.2012.00260.x; Veron J, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2014.00081; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wood S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12571; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101	51	17	17	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202995	10.1371/journal.pone.0202995	http://dx.doi.org/10.1371/journal.pone.0202995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157276	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400080
J	Lee, TM; Chang, NC; Lin, SZ				Lee, Tsung-Ming; Chang, Nen-Chung; Lin, Shinn-Zong			Effect of proton pump inhibitors on sympathetic hyperinnervation in infarcted rats: Role of magnesium	PLOS ONE			English	Article							POTASSIUM CHANNEL AGONISTS; NERVE GROWTH-FACTOR; MYOCARDIAL-INFARCTION; HYPOMAGNESEMIA; PROTEIN; MG2+; ATP; PEROXYNITRITE; SUPEROXIDE; ACTIVATION	The long-term use of proton pump inhibitors (PPIs) has been shown to increase the risk of cardiovascular mortality, however the molecular mechanisms are unknown. Superoxide has been implicated in the regulation of nerve growth factor (NGF), a mediator of sympathetic innervation. The purpose of this study was to determine whether PPIs increase ventricular arrhythmias through magnesium-mediated superoxide production in infarcted rats. Male Wistar rats were randomly assigned to receive vehicle, omeprazole, omeprazole + magnesium sulfate, or famotidine treatment for 4 weeks starting 24 hours after the induction of myocardial infarction by ligating the coronary artery. Increased myocardial superoxide and nitrotyrosine levels were noted post-infarction, in addition to a significant upregulation of NGF expression on mRNA and protein levels. Sympathetic hyperinnervation after infarction was confirmed by measuring myocardial norepinephrine and immunofluorescent analysis. Compared with the vehicle, omeprazole-treated infarcted rats had significantly reduced myocardial magnesium content, increased oxidant production, and increased sympathetic innervation, which in turn increased ventricular arrhythmias. These effects were prevented by the coadministration of magnesium sulfate. In an in vivo study, an omeprazole-induced increase in NGF was associated with a superoxide pathway, which was further confirmed by an ex vivo study showing the attenuation of NGF levels after coadministration of the superoxide scavenger Tiron. Magnesium sulfate did not further attenuate NGF levels compared with omeprazole + Tiron. Our results indicate that the long-term administration of PPIs was associated with reduced tissue magnesium content and increased myocardial superoxide production, which exacerbated ventricular arrhythmias after infarction. Magnesium may be a potential target for PPI-related arrhythmias after infarction.	[Lee, Tsung-Ming] China Med Univ, An Nan Hosp, Cardiovasc Inst, Tainan, Taiwan; [Lee, Tsung-Ming] China Med Univ, Dept Med, Taichung, Taiwan; [Lee, Tsung-Ming; Chang, Nen-Chung] Taipei Med Univ, Sch Med, Dept Internal Med, Taipei, Taiwan; [Chang, Nen-Chung] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Lin, Shinn-Zong] Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Dept Neurosurg, Hualien, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Lin, SZ (corresponding author), Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Dept Neurosurg, Hualien, Taiwan.	shinnzong@yahoo.com.tw	Lin, Shinn-Zong/AAX-2379-2020		An-Nan Hospital [ANHRF106-07]; Ministry of Science and Technology, Taiwan [MOST-106-2314-B-039-049]	An-Nan Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grants of An-Nan Hospital (ANHRF106-07, TML) and Ministry of Science and Technology (MOST-106-2314-B-039-049, TML), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; BENGHEDALIA D, 1975, BRIT J NUTR, V33, P87, DOI 10.1079/BJN19750011; Broeren MAC, 2009, ANN INTERN MED, V151, P755, DOI 10.7326/0003-4819-151-10-200911170-00016; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Cernak I, 2000, MAGNESIUM RES, V13, P29; Colangelo AM, 1998, P NATL ACAD SCI USA, V95, P10920, DOI 10.1073/pnas.95.18.10920; DAHLSTRO.A, 1965, J ANAT, V99, P677; Eshraghi T, 2015, MAGNESIUM RES, V28, P32, DOI 10.1684/mrh.2015.0380; Ferdinandy P, 2006, BRIT J PHARMACOL, V148, P1, DOI 10.1038/sj.bjp.0706693; Food and Drug Administration, 2011, FDA SAF COMM LOW MAG; HAIGNEY MCP, 1995, CIRCULATION, V92, P2190, DOI 10.1161/01.CIR.92.8.2190; HERRE JM, 1988, J AM COLL CARDIOL, V11, P414, DOI 10.1016/0735-1097(88)90110-6; Howden CW, 2000, J CLIN GASTROENTEROL, V30, P29, DOI 10.1097/00004836-200001000-00006; Kang CS, 2009, AM J PHYSIOL-HEART C, V296, pH1949, DOI 10.1152/ajpheart.00903.2008; Kim S, 2015, AM J THER, V22, P14, DOI 10.1097/MJT.0b013e31829c4c71; Kuzniar A, 2003, BIOMETALS, V16, P349, DOI 10.1023/A:1020632505289; Landi SN, 2018, GASTROENTEROLOGY; Lee TM, 2004, CARDIOVASC RES, V63, P109, DOI 10.1016/j.cardiores.2004.03.009; Lee TM, 2008, J AM COLL CARDIOL, V51, P1309, DOI 10.1016/j.jacc.2007.11.067; Lee TM, 2014, FREE RADICAL BIO MED, V77, P71, DOI 10.1016/j.freeradbiomed.2014.08.022; Lee TM, 2011, FREE RADICAL BIO MED, V50, P1461, DOI 10.1016/j.freeradbiomed.2011.01.031; Lee TM, 2010, CARDIOVASC RES, V85, P137, DOI 10.1093/cvr/cvp286; Li Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02101-8; MASUMOTO N, 1992, BIOCHEM BIOPH RES CO, V182, P906, DOI 10.1016/0006-291X(92)91818-B; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; Park SH, 2015, KIDNEY RES CLIN PRAC, V34, P98, DOI 10.1016/j.krcp.2015.03.001; Pehar M, 2006, FREE RADICAL BIO MED, V41, P1632, DOI 10.1016/j.freeradbiomed.2006.08.010; Perazella MA, 2013, KIDNEY INT, V83, P553, DOI 10.1038/ki.2012.462; Perez-de-Arce K, 2005, BIOCHEM BIOPH RES CO, V338, P1103, DOI 10.1016/j.bbrc.2005.10.053; REINHART RA, 1988, ARCH INTERN MED, V148, P2415, DOI 10.1001/archinte.148.11.2415; REINHART RA, 1991, J AM COLL CARDIOL, V17, P651, DOI 10.1016/S0735-1097(10)80179-2; SEGAWA K, 1987, Gastroenterologia Japonica, V22, P413; Sener-Muratoglu G, 2001, DIGEST DIS SCI, V46, P318, DOI 10.1023/A:1005652815921; Shah NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124653; Siwik DA, 1999, CIRC RES, V85, P147, DOI 10.1161/01.RES.85.2.147; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SPARROW MP, 1964, BIOCHIM BIOPHYS ACTA, V90, P425, DOI 10.1016/0304-4165(64)90215-6; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Tamura M, 2001, BBA-BIOMEMBRANES, V1510, P270, DOI 10.1016/S0005-2736(00)00358-8; Thongon N, 2016, PFLUG ARCH EUR J PHY, V468, P1809, DOI 10.1007/s00424-016-1905-7; VRACKO R, 1990, LAB INVEST, V63, P490; WEGLICKI WB, 1994, CIRC RES, V74, P1009, DOI 10.1161/01.RES.74.5.1009; Westermaier Thomas, 2013, Exp Transl Stroke Med, V5, P6, DOI 10.1186/2040-7378-5-6; Xia QG, 2001, CARDIOVASC RES, V49, P110, DOI 10.1016/S0008-6363(00)00227-3; Yepuri G, 2016, CIRC RES, V118, pE36, DOI 10.1161/CIRCRESAHA.116.308807	45	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202979	10.1371/journal.pone.0202979	http://dx.doi.org/10.1371/journal.pone.0202979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153299	Green Submitted, Green Published, gold			2022-12-27	WOS:000443001700034
J	Sousa-Santos, AR; Afonso, C; Santos, A; Borges, N; Moreira, P; Padrao, P; Fonseca, I; Amaral, TF				Sousa-Santos, Ana Rita; Afonso, Claudia; Santos, Alejandro; Borges, Nuno; Moreira, Pedro; Padrao, Patricia; Fonseca, Isabel; Amaral, Teresa F.			The association between 25(OH)D levels, frailty status and obesity indices in older adults	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; PARATHYROID-HORMONE LEVELS; BODY-MASS INDEX; 25-HYDROXYVITAMIN D; PHYSICAL-ACTIVITY; MUSCLE STRENGTH; WEIGHT-LOSS; METAANALYSIS; WOMEN; HEALTH	Background Vitamin D deficiency is common in older adults and has been linked with frailty and obesity, but it remains to be studied whether frail obese older adults are at higher risk of vitamin D deficiency. Therefore, the aim of this study is to explore the association between frailty, obesity indices and serum 25(OH)D concentrations. Methods 1447 individuals with 65 years or older, participating in a cross-sectional study (Nutrition UP 65) were included. Frailty, according to Fried etal., body mass index (BMI), waist circumference (WC), body roundness index (BRI) and body shape index (ABSI) were evaluated. A stepwise multinomial logistic regression was carried out to quantify the association between 25(OH)D quartiles and independent variables. Results Median 25(OH)D levels were lower in individuals presenting both frailty and obesity (p<0.001). In the multivariate analysis, pre-frailty (OR: 2.65; 95% CI: 1.63-4.33) and frailty (OR: 3.77; 95% CI: 2.08-6.83) were associated with increased odds of lower 25(OH)D serum levels (first quartile). Regarding obesity indices, the highest categories of BMI (OR: 1.74; 95% CI: 1.06-2.86), WC (OR: 3.46; 95% CI: 1.95-6.15), BRI (OR: 4.35; 95% CI: 2.60-7.29) and ABSI (OR: 3.17 95% CI: 1.86-5.38) were directly associated with lower 25 (OH)D serum levels (first quartile). Conclusions A positive association between frailty or obesity and lower vitamin D levels was found. Moreover, besides BMI and WC, other indicators of body adiposity, such as BRI and ABSI, were associated with lower 25(OH)D serum concentrations.	[Sousa-Santos, Ana Rita; Afonso, Claudia; Santos, Alejandro; Borges, Nuno; Moreira, Pedro; Padrao, Patricia; Amaral, Teresa F.] FCNAUP, Porto, Portugal; [Santos, Alejandro] Univ Porto, I3S, Porto, Portugal; [Borges, Nuno] CINTESIS Ctr Invest Tecnol & Serv Saude, Porto, Portugal; [Moreira, Pedro; Padrao, Patricia; Fonseca, Isabel] Univ Porto, EPIUnit, Inst Saude Publ, Porto, Portugal; [Moreira, Pedro] Univ Porto, CIAFEL Ctr Invest Atividade Fis Saude & Lazer, Porto, Portugal; [Fonseca, Isabel] Ctr Hosp Porto, Porto, Portugal; [Amaral, Teresa F.] Univ Porto, UISPA, LAETA INEGI Fac Engn, Porto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Sousa-Santos, AR (corresponding author), FCNAUP, Porto, Portugal.	anaritadesousasantos@gmail.com	Moreira, Pedro/U-3034-2019; Afonso, Cláudia/C-1453-2018; Santos, Alejandro/L-2658-2013; Padrão, Patrícia/K-8230-2012; Moreira, Pedro/U-2581-2019; Moreira, Pedro/K-5456-2012; Fonseca, Isabel/K-6339-2013	Moreira, Pedro/0000-0002-7035-7799; Santos, Alejandro/0000-0003-0706-5301; Padrão, Patrícia/0000-0001-6310-4956; Moreira, Pedro/0000-0002-7035-7799; Fonseca, Isabel/0000-0001-8984-1751; F Amaral, Teresa/0000-0002-3998-6730; Sousa Santos, Ana Rita/0000-0001-6440-4870; Borges, Nuno/0000-0001-6357-0615	European Economic Area (EEA); Faculdade de Ciencias da Nutricao e Alimentacao, Universidade do Porto; European Economic Area Grants	European Economic Area (EEA); Faculdade de Ciencias da Nutricao e Alimentacao, Universidade do Porto; European Economic Area Grants	Nutrition UP 65 is funded by Iceland, Liechtenstein, and Norway through European Economic Area (EEA) Grants in 85% and by Faculdade de Ciencias da Nutricao e Alimentacao, Universidade do Porto in 15%. Iceland, Liechtenstein, and Norway sponsor initiatives and projects in various program areas, primarily focusing on reducing economic and social disparities. The European Economic Area Grants are managed by Administracao Central do Sistema de Saude through the Programa Iniciativas em Saude Publica.	Amaral Teresa F, 2016, JMIR Res Protoc, V5, pe184, DOI 10.2196/resprot.6037; Atef SH, 2018, J STEROID BIOCHEM, V175, P136, DOI 10.1016/j.jsbmb.2017.02.011; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023/A:1017535728844; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2012, REV ENDOCR METAB DIS, V13, P71, DOI 10.1007/s11154-011-9200-6; Blaum CS, 2005, J AM GERIATR SOC, V53, P927, DOI 10.1111/j.1532-5415.2005.53300.x; Bouillon R, 2001, ENDOCRINOLOGY, P1009; Bouillon R, 2006, J STEROID BIOCHEM, V102, P156, DOI 10.1016/j.jsbmb.2006.09.014; Cardoso S, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0644-8; Cederholm T, 2015, CLIN NUTR, V34, P335, DOI 10.1016/j.clnu.2015.03.001; CHUMLEA WC, 1988, J AM DIET ASSOC, V88, P564; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dirks-Naylor AJ, 2011, J STEROID BIOCHEM, V125, P159, DOI 10.1016/j.jsbmb.2011.03.003; Drincic A, 2013, J CLIN ENDOCR METAB, V98, P4845, DOI 10.1210/jc.2012-4103; Drincic AT, 2012, OBESITY, V20, P1444, DOI 10.1038/oby.2011.404; Fess EE, 1992, CLIN ASSESSMENT RECO, V2nd; Fitzpatrick T. B., 1975, J MED ESTHETIQUE, V2, P33, DOI DOI 10.1159/000251345; Fraser WD, 2013, CALCIFIED TISSUE INT, V92, P118, DOI 10.1007/s00223-012-9693-3; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gerdhem P, 2005, OSTEOPOROSIS INT, V16, P1425, DOI 10.1007/s00198-005-1860-1; Guerreiro M, 2010, REV PORT MED GERAL F, V26; Hilger J, 2014, BRIT J NUTR, V111, P23, DOI 10.1017/S0007114513001840; Holick MF, 2005, J NUTR, V135, p2726S, DOI 10.1093/jn/135.11.2726S; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; KAMEI Y, 1993, BIOCHEM BIOPH RES CO, V193, P948, DOI 10.1006/bbrc.1993.1717; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kull M, 2009, INTERN MED J, V39, P256, DOI 10.1111/j.1445-5994.2009.01900.x; Li J, 2008, J STEROID BIOCHEM, V112, P122, DOI 10.1016/j.jsbmb.2008.09.006; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Mason C, 2011, AM J CLIN NUTR, V94, P95, DOI 10.3945/ajcn.111.015552; McGill AT, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-4; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Pereira-Santos M, 2015, OBES REV, V16, P341, DOI 10.1111/obr.12239; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rejnmark L, 2011, THER ADV CHRONIC DIS, V2, P25, DOI 10.1177/2040622310381934; Rock CL, 2012, OBESITY, V20, P2296, DOI 10.1038/oby.2012.57; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1; Samper-Ternent R, 2012, REV CLIN GERONTOL, V22, P10, DOI 10.1017/S0959259811000190; Saneei P, 2013, OBES REV, V14, P393, DOI 10.1111/obr.12016; Santos A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016123; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Sousa-Santos AR, 2018, ARCH GERONTOL GERIAT, V74, P162, DOI 10.1016/j.archger.2017.10.018; Stewart A., 2011, INT STANDARDS ANTHRO, V137; Thomas DM, 2013, OBESITY, V21, P2264, DOI 10.1002/oby.20408; TSAI KS, 1984, J CLIN INVEST, V73, P1668, DOI 10.1172/JCI111373; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Wamberg L, 2013, INT J OBESITY, V37, P651, DOI 10.1038/ijo.2012.112; Wang YJ, 2011, ENDOCRINOLOGY, V152, P354, DOI 10.1210/en.2010-1109; World Health Organization, 2000, WHO TECHNICAL REPORT; World Health Organization, 2018, WORLD REP AG HLTH; World Health Organization (WHO), 2011, WAIST CIRCUMFERENCE; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yao YS, 2015, INT J CLIN EXP MED, V8, P14977; Zhou JH, 2016, MATURITAS, V94, P70, DOI 10.1016/j.maturitas.2016.09.003	59	21	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0198650	10.1371/journal.pone.0198650	http://dx.doi.org/10.1371/journal.pone.0198650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153256	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700001
J	Linde, K; Atmann, O; Meissner, K; Schneider, A; Meister, R; Kriston, L; Werner, C				Linde, Klaus; Atmann, Oxana; Meissner, Karin; Schneider, Antonius; Meister, Ramona; Kriston, Levente; Werner, Christoph			How often do general practitioners use placebos and non-specific interventions? Systematic review and meta-analysis of surveys	PLOS ONE			English	Review							PRIMARY-CARE PHYSICIANS; CLINICAL-PRACTICE; QUESTIONNAIRE SURVEY; FAMILY PHYSICIANS; IMPURE PLACEBO; PERSPECTIVES; ATTITUDES; GERMANY; BELIEVE; GPS	Background In a systematic review and meta-analysis we summarize the available evidence on how frequently general practitioners/family physicians (GPs) use pure placebos (e.g., placebo pills) and non-specific therapies (sometimes referred to as impure placebos; e.g., antibiotics for common cold). Methods We searched Medline, PubMed and SCOPUS up to July 2018 to identify cross-sectional quantitative surveys among GPs. Outcomes of primary interest were the percentages of GPs having used any placebo, pure placebos or non-specific therapies at least once in their career, at least once in the last year, at least monthly or at least weekly. Outcomes were described as proportions and pooled with random-effects meta-analysis. Results Of 674 publications, 16 studies from 13 countries with a total of 2.981 participating GPs (range 27 to 783) met the inclusion criteria. The percentage of GPs having used any form of placebo at least once in their career ranged from 29% to 97%, in the last year at least once from 46% to 95%, at least monthly from 15% to 89%, and at least weekly from 1% to 75%. The use of non-specific therapies by far outnumbered the use of pure placebo. For example, the proportion of GPs using pure placebos at least monthly varied between 2% and 15% compared to 53% and 89% for non-specific therapies; use at least weekly varied between 1% and 3% for pure placebos and between 16% and 75% for non-specific therapies. Besides eliciting placebos effects, many other reasons related to patient expectations, demands and medical problems were reported as reasons for applying placebo interventions. Conclusion High prevalence estimates of placebo use among GPs are mainly driven by the frequent use of non-specific therapies; pure placebos are used rarely. The interpretation of our quantitative findings is complicated by the diversity of definitions and survey methods.	[Linde, Klaus; Atmann, Oxana; Schneider, Antonius; Werner, Christoph] Tech Univ Munich, TUM Sch Med, Inst Gen Practice, Munich, Germany; [Meissner, Karin] Univ Appl Sci Coburg, Div Hlth Promot, Coburg, Germany; [Meissner, Karin] Ludwig Maximilians Univ Munchen, Fac Med, Inst Med Psychol, Munich, Germany; [Meister, Ramona; Kriston, Levente] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	Technical University of Munich; Hochschule Coburg; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Linde, K (corresponding author), Tech Univ Munich, TUM Sch Med, Inst Gen Practice, Munich, Germany.	klaus.linde@mri.tum.de	MEISSNER, Karin/AAS-2483-2021; Kriston, Levente/D-1713-2013	Kriston, Levente/0000-0003-0748-264X; Linde, Klaus/0000-0002-2902-970X				Babel P, 2013, MED PRIN PRACT, V22, P484, DOI 10.1159/000351563; Babel P, 2012, EVAL HEALTH PROF, V35, P447, DOI 10.1177/0163278711420285; Bishop FL, 2014, FAM PRACT, V31, P357, DOI 10.1093/fampra/cmu016; Bostick NA, 2008, J CLIN ETHIC, V19, P58; Braga-Simoes J, 2017, EUR J GEN PRACT, V23, P98, DOI 10.1080/13814788.2017.1291625; Charlesworth James E G, 2017, J Evid Based Med, V10, P97, DOI 10.1111/jebm.12251; Colloca L, 2011, PHILOS T R SOC B, V366, P1922, DOI 10.1098/rstb.2010.0399; COMAROFF J, 1976, SOCIOL REV, V24, P79, DOI 10.1111/j.1467-954X.1976.tb00574.x; Fassler M, 2011, BRIT J GEN PRACT, V61, P101, DOI 10.3399/bjgp11X556209; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fassler M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-144; Fent R, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-11; Ferentzi E, 2010, CLIN EXPT MED J, V5, P21, DOI DOI 10.1556/CEMED.4.2010.2.5; Ferentzi E, 2011, CLIN EXP MED J, V5, P73, DOI DOI 10.1556/CEMED.5.2011.2.2; Guimet P., 2011, USAGE PLACEBOS MED G; Harris C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140876; Harris Gardiner, 2008, NY TIMES; Henriksen K, 2004, SOC SCI MED, V59, P47, DOI 10.1016/j.socscimed.2003.10.004; Holt S, 2009, NZ MED J, V122, P1298; Howick J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058247; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Hrobjartsson A, 2008, J CLIN ETHIC, V19, P66; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kermen R, 2010, FAM MED, V42, P636; Khan SAF, 2015, INDOAMERICAN J PHARM, V5; Koch K, 2011, DTSCH ARZTEBL INT, V108, P255, DOI 10.3238/arztebl.2011.0255; Kumar A, 2015, RES J PHARM BIOL CHE, V6, P1036; Linde K, 2015, Z ALLGMED, V91, P254; Lindea K, 2015, FAM PRACT, V32, P62, DOI 10.1093/fampra/cmu071; Linde K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092938; Linde K, 2013, FORSCH KOMPLEMENTMED, V20, P361, DOI 10.1159/000356230; Linde K, 2011, PHILOS T R SOC B, V366, P1905, DOI 10.1098/rstb.2010.0383; Louhiala P, 2015, THEOR MED BIOETH, V36, P279, DOI 10.1007/s11017-015-9336-6; Meissner K, 2012, FAM PRACT, V29, P79, DOI 10.1093/fampra/cmr045; Miller FG, 2009, AM J BIOETHICS, V9, P39, DOI 10.1080/15265160903316263; Nitzan U, 2004, BMJ-BRIT MED J, V329, P944, DOI 10.1136/bmj.38236.646678.55; Raz A, 2011, CAN J PSYCHIAT, V56, P198, DOI 10.1177/070674371105600403; Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324; Schoen C, 2009, HEALTH AFFAIR, V28, pW1171, DOI 10.1377/hlthaff.28.6.w1171; SCHWARTZ RK, 1989, SOC SCI MED, V28, P577, DOI 10.1016/0277-9536(89)90252-9; Shah Kartik N, 2009, Indian J Med Sci, V63, P472, DOI 10.4103/0019-5359.57640; Shermon R, 2008, J GEN INTERN MED, V23, P7, DOI 10.1007/s11606-007-0332-z; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Tonkin-Crine S, 2011, J ANTIMICROB CHEMOTH, V66, P2215, DOI 10.1093/jac/dkr279; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Weiss MC, 1997, PHARM J, V259, P339; Wells G., NEWCASTLE OTTAWA SCA	47	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202211	10.1371/journal.pone.0202211	http://dx.doi.org/10.1371/journal.pone.0202211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142199	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500008
J	Moreno-Padilla, M; Fernandez-Serrano, MJ; del Paso, GAR				Moreno-Padilla, Maria; Jose Fernandez-Serrano, Maria; Reyes del Paso, Gustavo A.			Risky decision-making after exposure to a food-choice task in excess weight adolescents: Relationships with reward-related impulsivity and hunger	PLOS ONE			English	Article							BODY-MASS INDEX; SENSATION SEEKING; TAKING PROPENSITY; BEHAVIOR; BRAIN; OBESITY; DISINHIBITION; OVERWEIGHT; INCREASES; ADULTHOOD	Objective To assess the effects of exposure to a food-choice task (appetizing versus healthy food) on risky decision-making by excess versus normal weight adolescents. We also analyzed the influence of food visualization on hunger levels, as well as group differences in food choices and impulsivity. Methods Fifty-six adolescents (aged 13 +/- 18 years) classified as excess (n = 27) or normal (n = 29) weight participated in the study. Risky-decision-making was assessed through the Balloon Analogue Risk Task, which was administered before and after a food-choice task. We also evaluated impulsivity traits through the UPPS-P Scale, and subjective hunger levels with a visual analogue scale. Results Adolescents with excess weight showed enhanced risky decision-making after the foodchoice task compared to normal weight adolescents, as well as increased hunger levels. Furthermore, excess weight adolescents made more appetizing choices, and showed greater scores for Positive Urgency and Sensation Seeking. Reward-related impulsivity measures were positively associated with the number of appetizing choices in the foodchoice task. Several associations were found between impulsivity measures, hunger levels and risk-taking variables. Conclusions Excess weight adolescents increased their risky-decision-making after food exposure and this augmentation was associated with the increase in hunger levels. Increased hunger levels and risk-taking after food exposure could lead to overeating. Alterations in decision-making caused by food signals may be a long-term risk factor for the development of obesity in adulthood. In modern societies, with the high availability and continuous exposure to food cues, decision-making may be a crucial factor in maintain healthy eating habits in adolescents.	[Moreno-Padilla, Maria; Jose Fernandez-Serrano, Maria; Reyes del Paso, Gustavo A.] Univ Jaen, Dept Psychol, Jaen, Spain	Universidad de Jaen	Moreno-Padilla, M (corresponding author), Univ Jaen, Dept Psychol, Jaen, Spain.	maria.moreno@uiaen.es	Reyes del Paso, Gustavo A./G-4179-2011; PADILLA, MARÍA M/Z-1050-2018; Fernandez-Serrano, Maria Jose/AGA-6711-2022; Serrano, M Josefa Fernández/V-3124-2019	Reyes del Paso, Gustavo A./0000-0002-2188-8673; Serrano, M Josefa Fernández/0000-0002-6158-237X; MORENO PADILLA, MARIA/0000-0002-4751-8283				[Anonymous], [No title captured]; ARNETT J, 1992, DEV REV, V12, P339, DOI 10.1016/0273-2297(92)90013-R; BALL SA, 1994, J CONSULT CLIN PSYCH, V62, P1053, DOI 10.1037/0022-006X.62.5.1053; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Brogan A, 2011, J PSYCHOSOM RES, V70, P89, DOI [10.1016/j.jbtep.2013.09.009, DOI 10.1016/J.JBTEP.2013.09.009]; Candido A., 2012, TRASTORNOS ADICTIVOS, V14, P73, DOI DOI 10.1016/S1575-0973(12)70048-X; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cooper ML, 2000, J PERS, V68, P1059, DOI 10.1111/1467-6494.00126; Cosenza M, 2017, J GAMBL STUD, V33, P383, DOI 10.1007/s10899-016-9623-9; Davis C, 2007, ASTRON GEOPHYS, V48, P12, DOI 10.1016/j.appet.2006.05.016; Del Boca FK, 2004, J CONSULT CLIN PSYCH, V72, P155, DOI 10.1037/0022-006X.72.2.155; Delgado-Rico E, 2012, OBESITY, V20, P1604, DOI 10.1038/oby.2012.47; Doolan KJ, 2015, P NUTR SOC, V74, P37, DOI 10.1017/S002966511400144X; Epstein LH, 2006, APPETITE, V46, P22, DOI 10.1016/j.appet.2005.04.006; Ernst M, 2009, NEUROSCI BIOBEHAV R, V33, P367, DOI 10.1016/j.neubiorev.2008.10.009; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; GRAY JA, 1987, THE PSYCHOLOGY OF FE; Hanson KL, 2014, J PSYCHOPHARMACOL, V28, P1080, DOI 10.1177/0269881114550352; Jones JD, 2016, J CLIN EXP NEUROPSYC, V38, P709, DOI 10.1080/13803395.2016.1156652; Fernandez-Serrano MJ, 2011, PSYCHOPHARMACOLOGY, V217, P331, DOI 10.1007/s00213-011-2288-2; Koritzky G, 2012, APPETITE, V59, P289, DOI 10.1016/j.appet.2012.05.020; Lane SD, 2000, DRUG ALCOHOL DEPEN, V60, P179, DOI 10.1016/S0376-8716(99)00155-6; Lee H, 2011, J ADOLESCENT HEALTH, V49, P601, DOI 10.1016/j.jadohealth.2011.04.019; Lejuez C, 2003, J ADOLESCENCE, V26, P475, DOI 10.1016/S0140-1971(03)00036-8; Lejuez CW, 2005, NICOTINE TOB RES, V7, P71, DOI 10.1080/14622200412331328484; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Loeber S, 2013, APPETITE, V71, P32, DOI 10.1016/j.appet.2013.07.008; Macchi R, 2017, APPETITE, V116, P442, DOI 10.1016/j.appet.2017.05.031; MacPherson L, 2010, ALCOHOL CLIN EXP RES, V34, P1400, DOI 10.1111/j.1530-0277.2010.01223.x; Millar L, 2014, OBESITY, V22, pE96, DOI 10.1002/oby.20665; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185; Nazarbol N, 2015, BIOMED PHARM J, V8, P729, DOI DOI 10.13005/BPJ/776; Nederkoorn C, 2010, HEALTH PSYCHOL, V29, P389, DOI 10.1037/a0019921; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Robbins RN, 2004, J ADOLESCENT RES, V19, P428, DOI 10.1177/0743558403258860; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rothman KJ, 2014, J GEN INTERN MED, V29, P1060, DOI 10.1007/s11606-013-2755-z; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Velazquez-Sanchez C, 2014, NEUROPSYCHOPHARMACOL, V39, P2463, DOI 10.1038/npp.2014.98; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Volkow ND, 2015, TRENDS NEUROSCI, V38, P345, DOI 10.1016/j.tins.2015.04.002; Werthmann J, 2015, P NUTR SOC, V74, P99, DOI 10.1017/S0029665114001451; Werthmann J, 2014, J BEHAV THER EXP PSY, V45, P136, DOI 10.1016/j.jbtep.2013.09.009; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; Yeomans MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137626; Yuen KSL, 2003, J AFFECT DISORDERS, V75, P11, DOI 10.1016/S0165-0327(02)00022-8; Zheng H, 2009, INT J OBESITY, V33, pS8, DOI 10.1038/ijo.2009.65; Zuckerman M, 1986, NIDA Res Monogr, V74, P59	56	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202994	10.1371/journal.pone.0202994	http://dx.doi.org/10.1371/journal.pone.0202994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142187	Green Submitted, gold, Green Published			2022-12-27	WOS:000442722500057
J	Angell, B; Laba, T; Lukaszyk, C; Coombes, J; Eades, S; Keay, L; Ivers, R; Jan, S				Angell, Blake; Laba, Tracey; Lukaszyk, Caroline; Coombes, Julieann; Eades, Sandra; Keay, Lisa; Ivers, Rebecca; Jan, Stephen			Participant preferences for an Aboriginal-specific fall prevention program: Measuring the value of culturally-appropriate care	PLOS ONE			English	Article								Background Culturally-specific services are central to efforts to improve the health of Aboriginal Australians. Few empirical studies have demonstrated the value of such services relative to mainstream alternatives. Objective To assess the preferences and willingness to pay (WTP) of participants for attending a class and the relative importance of transport, cost and cultural-appropriateness in the choices made by participants. Design A discrete choice experiment (DCE) was conducted alongside a study of a culturally-specific fall-prevention service. Attributes that were assessed were out-of-pocket costs, whether transport was provided and whether the class was Aboriginal-specific. Choices of participants were modelled using panel-mixed logit methods. Results 60 patients completed the DCE. Attending a service was strongly preferred over no service (selected 99% of the time). Assuming equivalent efficacy of fall-prevention programs, participants indicated a preference for services that were culturally-specific (OR 1.25 95% CI: 1.00-1.55) and incurred lower out-of-pocket participant costs (OR 1.19 95% CI 1.11-1.27). The provision of transport did not have a statistically significant influence on service choice (p = 0.57). Discussion and conclusions This represents the first published DCE in the health field examining preferences amongst an Aboriginal population. The results empirically demonstrate the value of the culturally-specific element of a program has to this cohort and the potential that stated-preference methods can have in incorporating the preferences of Aboriginal Australians and valuing cultural components of health services. Note on terminology As the majority of the NSW Aboriginal and Torres Strait Islander population is Aboriginal (97.2%), this population will be referred to as 'Aboriginal' in this manuscript.	[Angell, Blake; Laba, Tracey; Lukaszyk, Caroline; Coombes, Julieann; Keay, Lisa; Ivers, Rebecca; Jan, Stephen] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Angell, Blake] Univ Sydney, Sydney Med Sch, Poche Ctr Indigenous Hlth, Sydney, NSW, Australia; [Laba, Tracey] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Menzies Ctr Hlth Policy, Sydney, NSW, Australia; [Eades, Sandra] Baker IDI, Melbourne, Vic, Australia; [Ivers, Rebecca] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; Baker Heart and Diabetes Institute; University of New South Wales Sydney	Angell, B (corresponding author), Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia.; Angell, B (corresponding author), Univ Sydney, Sydney Med Sch, Poche Ctr Indigenous Hlth, Sydney, NSW, Australia.	bangell@georgeinstitute.org.au	Jan, Stephen/AAG-3333-2021; Eades, Sandra/C-1286-2014; Laba, Tracey-Lea/H-8908-2013	Ivers, Rebecca/0000-0003-3448-662X; Eades, Sandra/0000-0001-8629-3390; Angell, Blake/0000-0002-7188-7740; Laba, Tracey-Lea/0000-0002-5182-9092; Keay, Lisa/0000-0003-2215-0678; Jan, Stephen/0000-0003-2839-1405	NSW Ministry of Health	NSW Ministry of Health	The Ironbark study was funded by the NSW Ministry of Health. No specific funds were received for this particular work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageing WHO Unit LC., 2008, WHO GLOB REP FALLP; Alford KA, 2015, MED J AUSTRALIA, V203, P403, DOI 10.5694/mja15.00349; Angell BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111249; Australian Institute of Health and Welfare, 2011, OLD AB TORR STRAIT I; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Haener MK, 2001, AM J AGR ECON, V83, P1334, DOI 10.1111/0002-9092.00287; Hayman NE, 2009, MED J AUSTRALIA, V190, P604, DOI 10.5694/j.1326-5377.2009.tb02581.x; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Jan S, 1998, SOC SCI MED, V47, P1565, DOI 10.1016/S0277-9536(98)00228-7; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Liaw ST, 2011, AUST NZ J PUBL HEAL, V35, P238, DOI 10.1111/j.1753-6405.2011.00701.x; Lukaszyk C, HLTH PROMOTION J AUS; Lukaszyk C, 2016, AUSTR NZ J PUBLIC HL; Lukaszyk C, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4628-6; Lukaszyk C, 2016, PUBLIC HEALTH RES PR, V26, DOI 10.17061/phrp2651659; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; Mooney G., 2009, CHALLENGING HLTH EC; Zander KK, 2010, ECOL ECON, V69, P2417, DOI 10.1016/j.ecolecon.2010.07.010	19	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203264	10.1371/journal.pone.0203264	http://dx.doi.org/10.1371/journal.pone.0203264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2JK	30169525	gold, Green Published, Green Accepted			2022-12-27	WOS:000443374400030
J	Nijssen, SRR; Schaap, G; Verheijen, GP				Nijssen, Sari R. R.; Schaap, Gabi; Verheijen, Geert P.			Has your smartphone replaced your brain? Construction and validation of the Extended Mind Questionnaire (XMQ)	PLOS ONE			English	Article							CELL PHONE USE; DIGITAL NATIVES; ACADEMIC-PERFORMANCE; INTERNET; PARADIGM; MEMORY	As digital devices, such as smartphones, are becoming ever more absorbed in the daily lives of adolescents, a major assumption is that they start taking over basic functions of the human mind. A main focus of current debate and research is therefore on investigating adolescents' use of digital technologies. However, the lack of an instrument measuring the degree to which adolescents offload cognitive and social functions to technology hinders debate and research. This paper tests the reliability and validity of the Extended Mind Questionnaire (XMQ) which measures the degree to which digital technology is used to offload cognitive and social functions. In a first study on young adults (n = 63), we constructed a 12-tem scale, which proved to be highly reliable. A large-scale study on teenagers (n = 947) demonstrated the high structural validity, reliability, and construct and criterion validity of the XMQ. In sum, these studies provide evidence that the XMQ is psychometrically sound and valid, and can be useful in future research on the consequences of digital technology in the daily lives of adolescents.	[Nijssen, Sari R. R.; Schaap, Gabi; Verheijen, Geert P.] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands	Radboud University Nijmegen	Nijssen, SRR (corresponding author), Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands.	s.nijssen@psych.ru.nl		Schaap, Gabi/0000-0002-4661-701X; Nijssen, Sari/0000-0002-0340-8509; Verheijen, Geert/0000-0003-1254-4067	Behavioural Science Institute	Behavioural Science Institute	The Behavioural Science Institute funded this research with a seedcorn grant to GS and SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcayir M, 2016, COMPUT HUM BEHAV, V60, P435, DOI 10.1016/j.chb.2016.02.089; Barr N, 2015, COMPUT HUM BEHAV, V48, P473, DOI 10.1016/j.chb.2015.02.029; Bennett S, 2008, BRIT J EDUC TECHNOL, V39, P775, DOI 10.1111/j.1467-8535.2007.00793.x; Carr NG, 2009, SHALLOWS WHAT INTERN; CHURCHILL GA, 1979, J MARKETING RES, V16, P64, DOI 10.2307/3150876; Clark A, 1998, ANALYSIS, V58, P7, DOI 10.1111/1467-8284.00096; Clark A, 2008, SUPERSIZING MIND EMB; Clayton RB, 2015, J COMPUT-MEDIAT COMM, V20, P119, DOI 10.1111/jcc4.12109; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dror IE, 2008, COGNITION DISTRIBUTE; Etchells P, 2017, GUARDIAN, V102; GERBING DW, 1988, J MARKETING RES, V25, P186, DOI 10.2307/3172650; Giedd JN, 2012, J ADOLESCENT HEALTH, V51, P101, DOI 10.1016/j.jadohealth.2012.06.002; Glassman M, 2012, NEW IDEAS PSYCHOL, V30, P308, DOI 10.1016/j.newideapsych.2012.05.002; Glassman M, 2012, COMPUT HUM BEHAV, V28, P673, DOI 10.1016/j.chb.2011.11.014; Harari YN., 2016, HOMO DEUS BRIEF HIST; Hartanto A, 2016, COMPUT HUM BEHAV, V64, P329, DOI 10.1016/j.chb.2016.07.002; Helsper EJ, 2010, BRIT EDUC RES J, V36, P503, DOI 10.1080/01411920902989227; Hofferth SL, 2010, CHILD DEV, V81, P1598, DOI 10.1111/j.1467-8624.2010.01494.x; Jacobsen WC, 2011, CYBERPSYCH BEH SOC N, V14, P275, DOI 10.1089/cyber.2010.0135; Jones C., 2011, NET GENERATION DIGIT; Kuhn S, 2015, ADDICT BIOL, V20, P415, DOI 10.1111/adb.12128; Lenhart A., 2015, SMARTPHONES FACILITA; Lepp A, 2014, COMPUT HUM BEHAV, V31, P343, DOI 10.1016/j.chb.2013.10.049; Li J, 2015, COMPUT HUM BEHAV, V52, P450, DOI 10.1016/j.chb.2015.06.021; Loh KK, 2016, NEUROSCIENTIST, V22, P506, DOI 10.1177/1073858415595005; Margaryan A, 2011, COMPUT EDUC, V56, P429, DOI 10.1016/j.compedu.2010.09.004; McDaniel BT, 2015, TECHNOFERENCE EVERYD; Meerkerk GJ, 2009, CYBERPSYCHOL BEHAV, V12, P1, DOI 10.1089/cpb.2008.0181; Nestojko JF, 2013, PSYCHOL INQ, V24, P321, DOI 10.1080/1047840X.2013.844056; Oblinger D., 2005, ED NET GENERATION; Oliveira A, 2017, DIGITAL MIND SCI IS; Oulasvirta A, 2012, PERS UBIQUIT COMPUT, V16, P105, DOI 10.1007/s00779-011-0412-2; Prensky M., 2001, HORIZON, V9, P1, DOI [10.1108/10748120110424816, DOI 10.1108/10748120110424816]; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sapacz M, 2016, COMPUT HUM BEHAV, V57, P153, DOI 10.1016/j.chb.2015.12.004; Small G., 2008, SCI AM MIND, V19, P42, DOI [DOI 10.1038/SCIENTIFICAMERICANMIND1008-42, 10.1038/scientificamericanmind1008-42]; Small GW, 2009, AM J GERIAT PSYCHIAT, V17, P116, DOI 10.1097/JGP.0b013e3181953a02; Sparrow B, 2011, SCIENCE, V333, P776, DOI 10.1126/science.1207745; Spitzer Manfred, 2012, DIGITALE DEMENZ; Stoltz S, 2016, AGGRESSIVE BEHAV, V42, P29, DOI 10.1002/ab.21603; Teo T, 2013, COMPUT EDUC, V67, P51, DOI 10.1016/j.compedu.2013.02.012; Van Dorsselaer S, 2016, JEUGD RISKANT GEDRAG; Ward AF, 2013, PSYCHOL INQ, V24, P341, DOI 10.1080/1047840X.2013.850148; Wegner D. M., 1987, THEORIES GROUP BEHAV, V185, P208; Wegner D. M., 1995, SOC COGNITION, V13, P1; WEGNER DM, 1991, J PERS SOC PSYCHOL, V61, P923, DOI 10.1037/0022-3514.61.6.923	48	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202188	10.1371/journal.pone.0202188	http://dx.doi.org/10.1371/journal.pone.0202188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2JK	30169499	gold, Green Published, Green Submitted			2022-12-27	WOS:000443374400008
J	Steele, AJ; Denaxas, SC; Shah, AD; Hemingway, H; Luscombe, NM				Steele, Andrew J.; Denaxas, Spiros C.; Shah, Anoop D.; Hemingway, Harry; Luscombe, Nicholas M.			Machine learning models in electronic health records can outperform conventional survival models for predicting patient mortality in coronary artery disease	PLOS ONE			English	Article							PROGNOSTIC MODELS; RISK PREDICTION; RANDOM FORESTS; OPPORTUNITIES; CHALLENGES; FUTURE	Prognostic modelling is important in clinical practice and epidemiology for patient management and research. Electronic health records (EHR) provide large quantities of data for such models, but conventional epidemiological approaches require significant researcher time to implement. Expert selection of variables, fine-tuning of variable transformations and interactions, and imputing missing values are time-consuming and could bias subsequent analysis, particularly given that missingness in EHR is both high, and may carry meaning. Using a cohort of 80,000 patients from the CALIBER programme, we compared traditional modelling and machine-learning approaches in EHR. First, we used Cox models and random survival forests with and without imputation on 27 expert-selected, preprocessed variables to predict all-cause mortality. We then used Cox models, random forests and elastic net regression on an extended dataset with 586 variables to build prognostic models and identify novel prognostic factors without prior expert input. We observed that data-driven models used on an extended dataset can outperform conventional models for prognosis, without data preprocessing or imputing missing values. An elastic net Cox regression based with 586 unimputed variables with continuous values discretised achieved a C-index of 0.801 (bootstrapped 95% CI 0.799 to 0.802), compared to 0.793 (0.791 to 0.794) for a traditional Cox model comprising 27 expert-selected variables with imputation for missing values. We also found that data-driven models allow identification of novel prognostic variables; that the absence of values for particular variables carries meaning, and can have significant implications for prognosis; and that variables often have a nonlinear association with mortality, which discretised Cox models and random forests can elucidate. This demonstrates that machine-learning approaches applied to raw EHR data can be used to build models for use in research and clinical practice, and identify novel predictive variables and their effects to inform future research.	[Steele, Andrew J.; Luscombe, Nicholas M.] Francis Crick Inst, London, England; [Denaxas, Spiros C.; Shah, Anoop D.; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, Inst Hlth Informat, London, England; [Shah, Anoop D.] Univ Coll London Hosp NHS Fdn Trust, London, England; [Luscombe, Nicholas M.] UCL, UCL Genet Inst, Dept Genet Evolut & Environm, London, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol Grad Univ, Onna, Okinawa, Japan	Francis Crick Institute; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Okinawa Institute of Science & Technology Graduate University	Steele, AJ (corresponding author), Francis Crick Inst, London, England.	statto+plosone@andrewsteele.co.uk	Luscombe, Nicholas/G-6011-2015; Shah, Anoop Dinesh/D-4396-2014; Hemingway, Harry/C-1219-2009	Luscombe, Nicholas/0000-0001-5293-4778; Steele, Andrew/0000-0002-6836-5925; Shah, Anoop Dinesh/0000-0002-8907-5724; Denaxas, Spiros/0000-0001-9612-7791; Hemingway, Harry/0000-0003-2279-0624	Cancer Research UK [FC001110]; UK Medical Research Council [FC001110]; Wellcome Trust [FC001110, WT 086091/Z/08/Z]; Medical Research Council Medical Bioinformatics Award eMedLab [MR/L016311/1]; National Institute for Health Research [RP-PG-0407-10314]; Medical Research Prognosis Research Strategy Partnership [G0902393/99558]; Farr Institute of Health Informatics Research; Medical Research Council [K006584/1]; MRC [MR/L016311/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council Medical Bioinformatics Award eMedLab(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Prognosis Research Strategy Partnership; Farr Institute of Health Informatics Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001110), the UK Medical Research Council (FC001110), and the Wellcome Trust (FC001110). NML and HH were supported by the Medical Research Council Medical Bioinformatics Award eMedLab (grant number MR/L016311/1). The CALIBER programme was supported by the National Institute for Health Research (RP-PG-0407-10314, PI HH); Wellcome Trust (WT 086091/Z/08/Z, PI HH); the Medical Research Prognosis Research Strategy Partnership (G0902393/99558, PI HH) and the Farr Institute of Health Informatics Research, funded by the Medical Research Council (K006584/1, PI HH), in partnership with Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates) and the Wellcome Trust.	Bhaskaran K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003389; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE; Brisimi TS, 2018, INT J MED INFORM, DOI [10.1016/j.ijmedinf.2018.01.007PMID:29500022, DOI 10.1016/J.IJMEDINF.2018.01.007PMID:29500022]; Casey JA, 2016, ANNU REV PUBL HEALTH, V37, P61, DOI 10.1146/annurev-publhealth-032315-021353; Chen HC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-102; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Denaxas S, 2017, IJPDS, V1, DOI [10.23889/ijpds.v1i1.84, DOI 10.23889/IJPDS.V1I1.84]; Denaxas Spiros C, 2012, Int J Epidemiol, V41, P1625, DOI 10.1093/ije/dys188; Denaxas SC, 2015, EUR HEART J-QUAL CAR, V1, P9, DOI 10.1093/ehjqcco/qcv005; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Diaz-Uriarte R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-328; Fan J, 2010, HIGH DIMENSIONAL VAR; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Friedman J ., ELEMENTS STAT LEARNI; Goldstein BA, 2017, J AM MED INFORM ASSN, V24, P198, DOI 10.1093/jamia/ocw042; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hawthorne V, 2002, HEART, V88, P222; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Hersh WR, 2013, MED CARE, V51, pS30, DOI 10.1097/MLR.0b013e31829b1dbd; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Ishwaran H., 2007, R NEWS, V7, P25; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Jones MP, 1996, J AM STAT ASSOC, V91, P222, DOI 10.2307/2291399; Kattan MW, 1998, COMPUT BIOMED RES, V31, P363, DOI 10.1006/cbmr.1998.1488; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001; Lisboa PJG, 2003, ARTIF INTELL MED, V28, P1, DOI 10.1016/S0933-3657(03)00033-2; Loh WY, 1997, STAT SINICA, V7, P815; Miao F, 2015, IFMBE PROC, V45, P740, DOI 10.1007/978-3-319-11128-5_184; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Perperoglou A, 2014, STAT MED, V33, P170, DOI 10.1002/sim.5921; Poppe KK, 2017, HEART, V103, P917, DOI 10.1136/heartjnl-2016-310668; Quinlan J. R., 2014, C4 5 PROGRAMS MACHIN; Rapsomaniki E, 2014, EUR HEART J, V35, P844, DOI 10.1093/eurheartj/eht533; Riley RD, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3140; Ross EG, 2016, J VASC SURG, V64, P1515, DOI 10.1016/j.jvs.2016.04.026; Rubin, 2002, STAT ANAL MISSING DA; Schmid M, 2016, EXPERT SYST APPL, V63, P450, DOI 10.1016/j.eswa.2016.07.018; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wainer J, 2016, COMP 14 DIFFERENT FA; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944; Wiens J, 2017, CLIN INFECT DIS; Wright MN, 2016, RANDOM FORESTS SURVI; Wu JL, 2010, MED CARE, V48, pS106, DOI 10.1097/MLR.0b013e3181de9e17; Zhang GY, 2012, J APPL STAT, V39, P151, DOI 10.1080/02664763.2011.578621	49	85	89	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202344	10.1371/journal.pone.0202344	http://dx.doi.org/10.1371/journal.pone.0202344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2JK	30169498	Green Published, Green Submitted, gold			2022-12-27	WOS:000443374400010
J	Brandt, SC; Ellinger, B; van Nguyen, T; Thi, QD; Van Nguyen, G; Baschien, C; Yurkov, A; Hahnke, RL; Schafer, W; Gand, M				Brandt, Sophie C.; Ellinger, Bernhard; van Nguyen, Thuat; Quyen Dinh Thi; Giang Van Nguyen; Baschien, Christiane; Yurkov, Andrey; Hahnke, Richard L.; Schaefer, Wilhelm; Gand, Martin			A unique fungal strain collection from Vietnam characterized for high performance degraders of bioecological important biopolymers and lipids	PLOS ONE			English	Article							PENICILLIUM-CITRINUM; ASPERGILLUS-FUMIGATUS; XYLANASE PRODUCTION; FUSARIUM-OXYSPORUM; PURIFICATION; TRICHODERMA; LIPASE; IDENTIFICATION; ENDO-1,4-BETA-XYLANASE; BIODIVERSITY	Fungal strains are abundantly used throughout all areas of biotechnology and many of them are adapted to degrade complex biopolymers like chitin or lignocellulose. We therefore assembled a collection of 295 fungi from nine different habitats in Vietnam, known for its rich biodiversity, and investigated their cellulase, chitinase, xylanase and lipase activity. The collection consists of 70 isolates from wood, 55 from soil, 44 from rice straw, 3 found on fruits, 24 from oil environments (butchery), 12 from hot springs, 47 from insects as well as 27 from shrimp shells and 13 strains from crab shells. These strains were cultivated and selected by growth differences to enrich phenotypes, resulting in 211 visually different fungi. DNA isolation of 183 isolates and phylogenetic analysis was performed and 164 species were identified. All were subjected to enzyme activity assays, yielding high activities for every investigated enzyme set. In general, enzyme activity corresponded with the environment of which the strain was isolated from. Therefore, highest cellulase activity strains were isolated from wood substrates, rice straw and soil and similar substrate effects were observed for chitinase and lipase activity. Xylanase activity was similarly distributed as cellulase activity, but substantial activity was also found from fungi isolated from insects and shrimp shells. Seven strains displayed significant activities against three of the four tested substrates, while three degraded all four investigated carbon sources. The collection will be an important source for further studies. Therefore representative strains were made available to the scientific community and deposited in the public collection of the Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig.	[Brandt, Sophie C.; van Nguyen, Thuat; Schaefer, Wilhelm; Gand, Martin] Univ Hamburg, Dept Mol Phytopathol, Hamburg, Germany; [Ellinger, Bernhard] Fraunhofer Inst Mol Biol & Appl Ecol IME, Dept ScreeningPort, Hamburg, Germany; [Quyen Dinh Thi] Vietnam Acad Sci & Technol, Inst Biotechnol, Hanoi, Vietnam; [Giang Van Nguyen] Vietnam Natl Univ Agr, Fac Biotechnol, Hanoi, Vietnam; [Baschien, Christiane; Yurkov, Andrey; Hahnke, Richard L.] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany; [Gand, Martin] Justus Liebig Univ Giessen, Inst Food Chem & Food Biotechnol, Giessen, Germany	University of Hamburg; Fraunhofer Gesellschaft; Vietnam Academy of Science & Technology (VAST); Vietnam National University of Agriculture (VNUA); Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Justus Liebig University Giessen	Gand, M (corresponding author), Univ Hamburg, Dept Mol Phytopathol, Hamburg, Germany.; Gand, M (corresponding author), Justus Liebig Univ Giessen, Inst Food Chem & Food Biotechnol, Giessen, Germany.	martin.gand@lcb.chemie.uni-giesssen.de	Yurkov, Andrey M./E-7854-2011; Gand, Martin/ABE-4962-2020	Yurkov, Andrey M./0000-0002-1072-5166; Gand, Martin/0000-0001-8211-691X; Ellinger, Bernhard/0000-0001-5703-3901	German federal ministry BMBF [03A0150B]	German federal ministry BMBF(Federal Ministry of Education & Research (BMBF))	This work was funded by the German federal ministry BMBF under contract No. 03A0150B within the framework of Bioeconomy International 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fatah OM, 2012, BRAZ J MICROBIOL, V43, P1, DOI 10.1590/S1517-83822012000100001; Aleku GA, 2017, NAT CHEM, V9, P961, DOI [10.1038/nchem.2782, 10.1038/NCHEM.2782]; [Anonymous], 2004, HOTSPOTS REVISITED E; [Anonymous], 2010, COLD SPRING HARB PRO; Archer DB, 2008, ADV BIOCHEM ENG BIOT, V111, P99, DOI 10.1007/10_2007_094; Bagewadi Z.K., 2016, BIOTECH, V3, P6, DOI [10.1007/s13205-016-0489-4, DOI 10.1007/S13205-016-0489-4]; Baker RA, 1996, TRENDS FOOD SCI TECH, V7, P279, DOI 10.1016/0924-2244(96)10030-3; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Barbi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116264; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; BEDFORD MR, 1991, POULTRY SCI, V70, P1571, DOI 10.3382/ps.0701571; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bennett JW, 1998, J BIOTECHNOL, V66, P101, DOI 10.1016/S0168-1656(98)00133-3; Berdy J, 2012, J ANTIBIOT, V65, P385, DOI [10.1038/ja.2012.27, 10.1038/ja.2012.54]; BIELY P, 1985, TRENDS BIOTECHNOL, V3, P286, DOI 10.1016/0167-7799(85)90004-6; Bischof RH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0507-6; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bommarius AS, 2005, BIOCATALYSIS, P159; Bormann J, 2014, GESUNDE PFLANZ, V66, P23, DOI 10.1007/s10343-013-0312-7; Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599; Breuil C, 1984, ENZYME MICROB TECHNO, V7; Butt MS, 2008, FOOD TECHNOL BIOTECH, V46, P22; Cantrell SA, 2011, MYCOLOGIA, V103, P1161, DOI 10.3852/11-108; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chambergo FS, 2016, APPL MICROBIOL BIOT, V100, P2567, DOI 10.1007/s00253-016-7305-2; Cherif S, 2011, LIPIDS HLTH DIS, V10; Collen B, 2014, GLOBAL ECOL BIOGEOGR, V23, P40, DOI 10.1111/geb.12096; da Silva LRC, 2011, BRAZ J MICROBIOL, V42, P49, DOI 10.1590/S1517-83822011000100007; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Danso D, 2018, APPL ENV MICROBIOL; DAR RA, 2013, ADV ENZYME RES, V1, P91, DOI DOI 10.4236/AER.2013.14010; de Alencar Guimaraes NC, 2013, SPRINGERPLUS, V2, P380, DOI DOI 10.1186/2193-1801-2-380; de Maria PD, 2005, J MOL CATAL B-ENZYM, V37, P36, DOI 10.1016/j.molcatb.2005.09.001; De Queiroz JS, 2013, VIETNAM TROPICAL FOR; Dhiman TR, 2002, ANIM FEED SCI TECH, V101, P115, DOI 10.1016/S0377-8401(02)00177-3; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Druzhinina IS, 2012, FEMS MICROBIOL LETT, V337, P1, DOI 10.1111/j.1574-6968.2012.02665.x; Druzhinina IS, 2005, FUNGAL GENET BIOL, V42, P813, DOI 10.1016/j.fgb.2005.06.007; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Ferguson BA, 2003, CAN J FOREST RES, V33, P612, DOI 10.1139/x03-065; Ferrari AR, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-37; Garvey M, 2013, TRENDS BIOTECHNOL, V31, P581, DOI 10.1016/j.tibtech.2013.06.006; Ghoshal G, 2014, CHEM BIOCHEM ENG Q, V28, P399, DOI 10.15255/CABEQ.2013.1885; Ghoshal G, 2012, CHEM BIOCHEM ENG Q, V26, P61; Goker M, 2011, STAND GENOMIC SCI, V4, P63, DOI 10.4056/sigs.1533840; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Hwang HT, 2014, BIOTECHNOL BIOENG, V111, P639, DOI 10.1002/bit.25162; Jaafaru M.I., 2013, ISRN MICROBIOL, V2013, P2013, DOI DOI 10.1155/2013/283423; Jaklitsch WM, 2015, STUD MYCOL, P1, DOI 10.1016/j.simyco.2014.11.001; Jung WJ, 2006, PROTEIN EXPRES PURIF, V45, P125, DOI 10.1016/j.pep.2005.06.016; Karthik N, 2014, INDIAN J EXP BIOL, V52, P1025; Kelly SA, 2018, CHEM REV, V118, P349, DOI 10.1021/acs.chemrev.7b00437; Kim SK, 2010, SOURCES PRODUCTION C; Kwon Hyuk Woo, 2007, Mycobiology, V35, P162, DOI 10.4489/MYCO.2007.35.3.162; LEACH J, 1982, J GEN MICROBIOL, V128, P1719; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Lombard L, 2015, STUD MYCOL, P189, DOI 10.1016/j.simyco.2014.12.002; Lu Y, 2009, GLYCOCONJUGATE J, V26, P525, DOI 10.1007/s10719-008-9203-z; Mai C, 2004, APPL MICROBIOL BIOT, V63, P477, DOI 10.1007/s00253-003-1411-7; MASE T, 1995, BIOSCI BIOTECH BIOCH, V59, P1771, DOI 10.1271/bbb.59.1771; Matny ON, 2015, ADV PLANTS AGR RES, V2, P1; Mayordomo I, 2000, J AGR FOOD CHEM, V48, P105, DOI 10.1021/jf9903354; Mirzaakhmedov SY, 2007, CHEM NAT COMPD+, V43, P594, DOI 10.1007/s10600-007-0199-6; Mohsenzadeh A, 2017, CHEMBIOENG REV, V4, P75, DOI 10.1002/cben.201600025; Morita T, 2011, BIOSCI BIOTECH BIOCH, V75, P1597, DOI 10.1271/bbb.110036; MUELLER GM, 2004, BIODIVERSITY FUNGI I, P1; Omumasaba CA, 2001, J GEN APPL MICROBIOL, V47, P53, DOI 10.2323/jgam.47.53; PING S, 1948, IND ENG CHEM, V40, P1202; Pscheidt B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-25; Quintanilla D, 2015, ADV BIOCHEM ENG BIOT, V149, P29, DOI 10.1007/10_2015_309; REYES F, 1989, FEMS MICROBIOL LETT, V65, P83, DOI 10.1016/0378-1097(89)90370-4; Ribeiro LFC, 2014, BRIT BIOTECHNOLOGY J, V4, P30, DOI DOI 10.9734/BBJ/2014/6066; Richards E, 2001, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0203s27; Robert V, 2013, IMA FUNGUS, V4, P371, DOI 10.5598/imafungus.2013.04.02.16; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; Ruijter GJG, 2002, MYCOTA, V10, P213; Rush CL, 2010, CHEM BIOL, V17, P1275, DOI 10.1016/j.chembiol.2010.07.018; Samson RA, 2014, STUD MYCOL, P141, DOI 10.1016/j.simyco.2014.07.004; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; SHEPPARD PO, 1994, GENE, V150, P163, DOI 10.1016/0378-1119(94)90878-8; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Sreenath HK, 1996, J FERMENT BIOENG, V81, P18, DOI 10.1016/0922-338X(96)83113-8; Steinecke F, 1983, EXPT BIOL; Su GD, 2010, APPL MICROBIOL BIOT, V86, P1493, DOI 10.1007/s00253-009-2382-0; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Tanaka H, 2005, J BIOSCI BIOENG, V100, P623, DOI 10.1263/jbb.100.623; Visagie CM, 2014, STUD MYCOL, P343, DOI 10.1016/j.simyco.2014.09.001; VONTIGERSTROM RG, 1989, CAN J MICROBIOL, V35, P511, DOI 10.1139/m89-079; Wakiyama M, 2008, J BIOSCI BIOENG, V105, P367, DOI 10.1263/jbb.105.367; Walia A, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-016-0584-6; Ward OP, 2012, BIOTECHNOL ADV, V30, P1119, DOI 10.1016/j.biotechadv.2011.09.012; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; WONG KKY, 1992, CRIT REV BIOTECHNOL, V12, P413, DOI 10.3109/07388559209114234; Zhao ZP, 2013, APPL MICROBIOL BIOT, V97, P10003, DOI 10.1007/s00253-013-4767-3; Zheng YB, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-50	99	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202695	10.1371/journal.pone.0202695	http://dx.doi.org/10.1371/journal.pone.0202695			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161149	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900039
J	Brogan, AJ; Davis, AE; Goodwin, B				Brogan, Anita J.; Davis, Ashley E.; Goodwin, Bridgett			Short-term cost analysis of raltegravir versus atazanavir plus ritonavir or darunavir plus ritonavir for treatment-naive adults with HIV-1 infection in the United States	PLOS ONE			English	Article							DARUNAVIR/RITONAVIR; INHIBITORS; EFFICACY; HEALTH; ERA	Objective The head-to-head AIDS Clinical Trial Group (ACTG) 5257 clinical trial found raltegravir (RAL) to be superior to atazanavir + ritonavir (ATV/r) and darunavir + ritonavir (DRV/r), when used in combination with emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) by treatment-naive adults with HIV-1 infection, in a 96-week composite endpoint combining virologic efficacy and tolerability. The objective of this study was to estimate the total HIV treatment costs associated with these three regimens in the United States. Methods Ninety-six-week costs for antiretroviral drugs, adverse event management, and HIV care for individuals initiating RAL, ATV/r, or DRV/r as first-line therapy for HIV-1 infection were estimated using an economic model. Efficacy and safety data (mean CD4 cell count changes, discontinuation rates, grade 3/4 adverse event incidence) for each regimen through 96 weeks of treatment were taken from the ACTG 5257 clinical trial. Antiretroviral drug costs for each initial regimen and for each substitution regimen, as used by individuals who discontinued their initial regimen, were based on wholesale acquisition costs. Adverse event management costs and HIV care costs, stratified by CD4 cell count range, were taken from published sources and inflated to 2016 dollars. Scenario and sensitivity analyses were conducted to assess the robustness of the results. Cost outcomes were discounted at an annual rate of 3.0%. Results Total 96-week costs were $81,231 for RAL, $88,064 for ATV/r, and $87,680 for DRV/r, where differences were primarily due to lower antiretroviral drug costs for RAL than for ATV/ r or DRV/r. These results were found to be robust in scenario and sensitivity analyses. Conclusions Relative to the DRV/r and ATV/r regimens, the RAL regimen had the lowest cost for treatment-naive adults with HIV-1 infection in the United States.	[Brogan, Anita J.; Davis, Ashley E.] RTI Hlth Solut, Res Triangle Pk, NC 27703 USA; [Goodwin, Bridgett] Merck & Co Inc, Kenilworth, NJ USA	Research Triangle Institute; Merck & Company	Brogan, AJ (corresponding author), RTI Hlth Solut, Res Triangle Pk, NC 27703 USA.	abrogan@rti.org		Davis, Ashley/0000-0002-7500-6533; Brogan, Anita/0000-0002-9003-994X	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA	Funding for this study was provided to RTI Health Solutions by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. The funder also provided support in the form of salary for author B.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'Author Contributions' section of the online submission form.	[Anonymous], PAN ANT GUID AD AD G; Brogan AJ, 2010, HIV CLIN TRIALS, V11, P133, DOI 10.1310/hct1103-133; Centers for Disease Control and Prevention, 2016, HIV US GLANC; Chaudhary MA, 2011, EXPERT REV PHARM OUT, V11, P627, DOI [10.1586/erp.11.79, 10.1586/ERP.11.79]; Davis AE, 2017, HIV CLIN TRIALS, V18, P214, DOI 10.1080/15284336.2017.1402144; Dekoven Mitch, 2016, J Int Assoc Provid AIDS Care, V15, P66, DOI 10.1177/2325957415594883; Eaton EF, 2016, AIDS, V30, P2215, DOI 10.1097/QAD.0000000000001120; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Latour A, 2015, VALUE HEALTH, V18, pA581, DOI 10.1016/j.jval.2015.09.1939; Lennox JL, 2014, ANN INTERN MED, V161, P461, DOI 10.7326/M14-1084; Red Book Online, MICR 2 0; Ribaudo H, 2013, PHASE 3 COMP STUDY 3; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Simpson KN, 2014, HIV MED, V15, P488, DOI 10.1111/hiv.12145; United States Department of Labor, MED CAR COMP CONS PR	15	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203293	10.1371/journal.pone.0203293	http://dx.doi.org/10.1371/journal.pone.0203293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161205	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900103
J	Espin-Perez, A; Portier, C; Chadeau-Hyam, M; van Veldhoven, K; Kleinjans, JCS; de Kok, TMCM				Espin-Perez, Almudena; Portier, Chris; Chadeau-Hyam, Marc; van Veldhoven, Karin; Kleinjans, Jos C. S.; de Kok, Theo M. C. M.			Comparison of statistical methods and the use of quality control samples for batch effect correction in human transcriptome data	PLOS ONE			English	Article							MICROARRAY	Batch effects are technical sources of variation introduced by the necessity of conducting gene expression analyses on different dates due to the large number of biological samples in population-based studies. The aim of this study is to evaluate the performances of linear mixed models (LMM) and Combat in batch effect removal. We also assessed the utility of adding quality control samples in the study design as technical replicates. In order to do so, we simulated gene expression data by adding "treatment" and batch effects to a real gene expression dataset. The performances of LMM and Combat, with and without quality control samples, are assessed in terms of sensitivity and specificity while correcting for the batch effect using a wide range of effect sizes, statistical noise, sample sizes and level of balanced/unbalanced designs. The simulations showed small differences among LMM and Combat. LMM identifies stronger relationships between big effect sizes and gene expression than Combat, while Combat identifies in general more true and false positives than LMM. However, these small differences can still be relevant depending on the research goal. When any of these methods are applied, quality control samples did not reduce the batch effect, showing no added value for including them in the study design.	[Espin-Perez, Almudena; Portier, Chris; Kleinjans, Jos C. S.; de Kok, Theo M. C. M.] Maastricht Univ, Dept Toxicogen, Maastricht, Netherlands; [Chadeau-Hyam, Marc; van Veldhoven, Karin] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England	Maastricht University; Imperial College London	Espin-Perez, A (corresponding author), Maastricht Univ, Dept Toxicogen, Maastricht, Netherlands.	a.espin@maastrichtuniversity.nl	Chadeau, Marc/AAN-7586-2021; Portier, Christopher/A-3160-2010	Chadeau, Marc/0000-0001-8341-5436; van Veldhoven, Karin/0000-0001-5298-6148; Portier, Christopher/0000-0002-0954-0279	EXPOsOMICS - grant FP7 of the European Commission 'Enhanced exposure assessment and omic profiling for high priority environmental exposures in Europe' [308610]	EXPOsOMICS - grant FP7 of the European Commission 'Enhanced exposure assessment and omic profiling for high priority environmental exposures in Europe'	This work was supported by EXPOsOMICS, a project supported by the grant FP7 of the European Commission 'Enhanced exposure assessment and omic profiling for high priority environmental exposures in Europe' (no. 308610), http://www.exposomicsproject.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; Chadeau-Hyam M, 2014, ANN ONCOL, V25, P1065, DOI 10.1093/annonc/mdu056; Harrison A, 2013, NUCLEIC ACIDS RES, V41, P2779, DOI 10.1093/nar/gks1358; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Heidecker B, 2007, HEART FAIL REV, V12, P1, DOI 10.1007/s10741-007-9004-7; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Huang HW, 2012, BIOINFORMATICS, V28, P1182, DOI 10.1093/bioinformatics/bts096; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Jaksik R, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0077-2; Janssen BG, 2017, INT J EPIDEMIOL, V46, P1386, DOI [10.1093/ije/dyw269, 10.1093/ije/dyx033]; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kussmann M, 2006, J BIOTECHNOL, V124, P758, DOI 10.1016/j.jbiotec.2006.02.014; Lauss M, 2013, CANCER INFORM, V12, P193, DOI 10.4137/CIN.S12862; Leek JT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku864; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Liu Q., 2016, INFECT DIS TRANSL ME, V2, P3, DOI DOI 10.11979/IDTM.201601002; Luo J, 2010, PHARMACOGENOMICS J, V10, P278, DOI 10.1038/tpj.2010.57; McHale CM, 2011, ENVIRON HEALTH PERSP, V119, P628, DOI 10.1289/ehp.1002546; Muller C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156594; Nygaard V, 2016, BIOSTATISTICS, V17, P29, DOI 10.1093/biostatistics/kxv027; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Sims AH, 2008, BMC MED GENOMICS, V1; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299	23	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202947	10.1371/journal.pone.0202947	http://dx.doi.org/10.1371/journal.pone.0202947			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161168	Green Published, gold			2022-12-27	WOS:000443388900053
J	Namwongsa, S; Puntumetakul, R; Neubert, MS; Chaiklieng, S; Boucaut, R				Namwongsa, Suwalee; Puntumetakul, Rungthip; Neubert, Manida Swangnetr; Chaiklieng, Sunisa; Boucaut, Rose			Ergonomic risk assessment of smartphone users using the Rapid Upper Limb Assessment (RULA) tool	PLOS ONE			English	Article							MUSCLE-ACTIVITY; NECK-SHOULDER; WORK; PAIN; POSTURE; DISCOMFORT; SYMPTOMS; CHILDREN; SCHOOL	The number of smartphone users globally is rapidly increasing. This study aimed to assess the level of ergonomic risk to smartphone users, and to evaluate the correlation between any selfreported musculoskeletal disorders and the level of ergonomic risk. Thirty participants completed a questionnaire, tailored specifically for smartphone users, to determine any musculoskeletal disorders. Participants were given a seated smartphone texting task and their postures were video recorded during the task. The video scenarios were evaluated by three independent researchers to determine the level of ergonomic risk using the Rapid Upper Limb Assessment (RULA) tool. RULA is an observation-based screening tool which has been widely used to assess the postural risk of IT device users. However, it has not yet been specifically utilized with smartphone users. The RULA tool scores identified ergonomics risks from using smartphones to text. Most smartphone users had a total RULA Grand Score of 6 for both sides (left side: 80.00%, right side: 90.00%), indicating the need for further investigation and changes (Action Level 3). Notably, no participants had acceptable RULA Grand Scores of 1 or 2. The correlation between musculoskeletal disorders and the ergonomic risk among smartphone users was determined using the Chi-Square test and Fisher's exact test; p<0.05 was considered statistically significant. There was a significant correlation between right RULA Grand Score and neck musculoskeletal disorder (chi(2) = 9.424 at p value = 0.009) and right RULA Grand Score and upper back musculoskeletal disorder (chi(2) = 31.717 at p value <0.001). RULA Score B (combination of neck, trunk and leg postures) and RULA Score D (combination of Score B, muscle use and force scores for group B) were also significantly correlated with neck musculoskeletal disorders (chi(2) = 19.286 at pvalue<0.001 and chi(2) = 9.310 at p value = 0.002 respectively). The RULA results identified the high ergonomics risk of smartphone users, this resulted from two key risk factors: posture and muscle use. The neck, trunk and leg postures had a combined effect on neck musculoskeletal disorders. Future investigations should consider these factors when designing ergonomic interventions for smartphone users.	[Namwongsa, Suwalee; Puntumetakul, Rungthip; Neubert, Manida Swangnetr; Chaiklieng, Sunisa] Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand; [Namwongsa, Suwalee; Puntumetakul, Rungthip] Khon Kaen Univ, Fac Associated Med Sci, Sch Phys Therapy, Khon Kaen, Thailand; [Neubert, Manida Swangnetr] Khon Kaen Univ, Fac Technol, Program Prod Technol, Khon Kaen, Thailand; [Chaiklieng, Sunisa] Khon Kaen Univ, Fac Publ Hlth, Dept Environm Hlth Sci, Khon Kaen, Thailand; [Boucaut, Rose] Univ South Australia, iCAHE Int Ctr Allied Hlth Evidence, Sch Hlth Sci Physiotherapy, Adelaide, SA, Australia	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; University of South Australia	Puntumetakul, R (corresponding author), Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand.; Puntumetakul, R (corresponding author), Khon Kaen Univ, Fac Associated Med Sci, Sch Phys Therapy, Khon Kaen, Thailand.	rungthiprt@gmail.com	Chaiklieng, Sunisa/AAO-9644-2020	Chaiklieng, Sunisa/0000-0003-4190-4930; Boucaut, Rose/0000-0002-1832-077X	Research Center in Back, Neck, Other Joint Pain and Human Performance (BNOJPH), Khon Kaen University, Khon Kaen, Thailand	Research Center in Back, Neck, Other Joint Pain and Human Performance (BNOJPH), Khon Kaen University, Khon Kaen, Thailand	The work was supported by Research Center in Back, Neck, Other Joint Pain and Human Performance (BNOJPH), Khon Kaen University, Khon Kaen, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JH, 2003, OCCUP ENVIRON MED, V60, P649, DOI 10.1136/oem.60.9.649; Ariens GAM, 2002, SCAND J WORK ENV HEA, V28, P222, DOI 10.5271/sjweh.669; Breen R, 2007, ERGONOMICS, V50, P1582, DOI 10.1080/00140130701584944; Briggs A, 2004, ERGONOMICS, V47, P790, DOI 10.1080/00140130410001663569; Chaiklieng S, 2016, SRINAGARIND MED J, V31, P202; Chen JD, 2014, APPL ERGON, V45, P398, DOI 10.1016/j.apergo.2013.05.004; da Costa BR, 2010, AM J IND MED, V53, P285, DOI 10.1002/ajim.20750; Danuta RL, 2017, RISK FACTORS MUSCULO; David GC, 2005, OCCUP MED-OXFORD, V55, P190, DOI 10.1093/occmed/kqi082; Dennerlein JT, 2015, WORK, V52, P269, DOI 10.3233/WOR-152159; 엄수현, 2013, [Journal of Korea Safety Management & Science, 대한안전경영과학회지], V15, P113, DOI 10.12812/ksms.2013.15.2.113; eMarketer, 2014, 2 BILL CONS WORLDW G; Ericsson, 2015, ER MOB REP NOV 2015; Feveile H, 2002, INT ARCH OCC ENV HEA, V75, P243, DOI 10.1007/s00420-001-0298-9; Gustafsson E, 2010, J ELECTROMYOGR KINES, V20, P127, DOI 10.1016/j.jelekin.2008.11.010; Han Yi, 2012, Journal of Shanghai Jiaotong University (Science), V17, P39, DOI 10.1007/s12204-012-1227-7; Harrison DD, 1999, J MANIP PHYSIOL THER, V22, P594, DOI 10.1016/S0161-4754(99)70020-5; Hulley SB, 2015, DELINEANDO PESQUISA, V4; Johnston V, 2008, APPL ERGON, V39, P171, DOI 10.1016/j.apergo.2007.05.011; Kang JH, 2012, ANN REHABIL MED-ARM, V36, P98, DOI 10.5535/arm.2012.36.1.98; Karukunchit U, 2015, THESIS; Kelly G, 2009, WORK, V32, P321, DOI 10.3233/WOR-2009-0830; Kim GY, 2012, J PHYS THER SCI, V24, P1255, DOI 10.1589/jpts.24.1255; Kim HJ, 2015, J PHYS THER SCI, V27, P575, DOI 10.1589/jpts.27.575; Kim MS, 2015, J PHYS THER SCI, V27, P15, DOI 10.1589/jpts.27.15; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Laeser K. L., 1998, Journal of Research on Computing in Education, V31, P173; Lee J, 2014, J PHYS THER SCI, V26, P595, DOI 10.1589/jpts.26.595; Lee S, 2015, ERGONOMICS, V58, P220, DOI 10.1080/00140139.2014.967311; Maslen B, 2009, WORK, V32, P311, DOI 10.3233/WOR-2009-0829; MCATAMNEY L, 1993, APPL ERGON, V24, P91, DOI 10.1016/0003-6870(93)90080-S; Namwongsa S, 2015, DARE DESIRE; Namwongsa S, 2017, DARE DESIRE; Namwongsa S, 2018, WORK, V61, P367, DOI 10.3233/WOR-182819; Oates S., 1998, Computers in the Schools, V14, P55, DOI 10.1300/J025v14n03_06; Occupational Health and Safety Council of Ontario (OHSCO), 2007, RES MAN MSD PREV G 2; OSHA U.D.L, 2000, ERGONOMICS STUDY WOR; Rodjanapanurat N, 2014, THESIS; Saetan O, 2007, THESIS; Smedley J, 2003, OCCUP ENVIRON MED, V60, P864, DOI 10.1136/oem.60.11.864; Straker Leon, 2002, Work, V18, P239; Straker LM, 1997, APPL ERGON, V28, P263, DOI 10.1016/S0003-6870(96)00073-7; Toh SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181220; Viikari-Juntura E, 2001, OCCUP ENVIRON MED, V58, P345, DOI 10.1136/oem.58.5.345; Xie YF, 2016, ERGONOMICS, V59, P61, DOI 10.1080/00140139.2015.1056237; 김양곤, 2013, [Physical Therapy Korea, 한국전문물리치료학회지], V20, P10, DOI 10.12674/ptk.2013.20.1.010	46	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203394	10.1371/journal.pone.0203394	http://dx.doi.org/10.1371/journal.pone.0203394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161266	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000443388900118
J	Kamel, NA; El-tayeb, WN; El-Ansary, MR; Mansour, MT; Aboshanab, KM				Kamel, Noha A.; El-tayeb, Wafaa N.; El-Ansary, Mona R.; Mansour, Mohamed T.; Aboshanab, Khaled M.			Phenotypic screening and molecular characterization of carbapenemase-producing Gram-negative bacilli recovered from febrile neutropenic pediatric cancer patients in Egypt	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; BLUE-CARBA TEST; ACUTE-LEUKEMIA; MULTIPLEX PCR; ENTEROBACTERIACEAE; SPREAD; OXA-48; ASSAY	Aim Infections with carbapenem-resistant Gram-negative bacteria (GNB) are among the most frequent complications in the immunocompromised cancer patients because of their considerable morbidity and mortality. Therefore, the aim of the current study was to characterize the prevalence of carbapenemase-producing GNB recovered from febrile neutropenic pediatric cancer patients in Egypt. Methods Standard methods were used for identification, sensitivity testing (Kirby-Bauer and broth microdilution method according to CLSI guidelines). Standard methods were applied for both phenotypic and genotypic detection of the carbapenemase-producing GNB. Results A total of 185 GNB were recovered from different clinical specimens, Escherichia (E.) coli (86; 46.48%), followed by Klebsiella spp. (71; 38.37%), Acinetobacter (A.) baumannii (7; 3.78%) and others including Pseudomonas spp., Enterobacter (Ent.) cloacae and Proteus spp. (21; 11.35%). It is a matter of concern that 116 out of 171 enterobacterial isolates (94.15%) showed resistance to three or more antimicrobial classes and were considered multidrug resistant. Additionally, the rate of carbapenem-resistance displayed a worrisome trend as 113 out of 171 enterobacterial isolates (66.08%) and 12 out of 14 non fermenting bacilli (85.71%) showed resistance pattern to at least one of the tested carbapenems. After performing a series of phenotypic tests for initial screening of potential carbapenemase producers, molecular characterization to the 29 extracted plasmids were subjected to PCR using 5 common carbapenemase primers). The results revealed that bla(OXA-48) was the most prevalent 17 (58.62%), followed by bla(NDM) 8(27.58%), then bla(VIM) 3 (10.3%) and bla(KPC) 2 (6.89%). Conclusion These results are an alarming threat to public health that calls for urgent application of antimicrobial stewardship programs along with routine surveillance for controlling outbreaks.	[Kamel, Noha A.; El-tayeb, Wafaa N.] Misr Int Univ, Fac Pharm, Dept Microbiol, Cairo, Egypt; [El-Ansary, Mona R.] Modern Univ Technol & Informat, Dept Biochem, Cairo, Egypt; [Mansour, Mohamed T.] Cairo Univ, Childrens Canc Hosp 57357, Dept Virol & Immunol, Cairo, Egypt; [Aboshanab, Khaled M.] Ain Shams Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Misr International University; Children's Cancer Hospital 57357; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Ain Shams University	Aboshanab, KM (corresponding author), Ain Shams Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt.	aboshanab2012@pharma.asu.edu.eg	Aboshanab, Khaled/L-9848-2019	Eltayeb, Wafaa N/0000-0002-5309-1917; Aboshanab, Khaled/0000-0002-7608-850X; El-Ansary, Mona/0000-0002-7904-7914; Ahmed Kamel, Noha/0000-0001-7703-6579				AlTamimi M, 2017, SAUDI J BIOL SCI, V24, P155, DOI 10.1016/j.sjbs.2016.07.004; [Anonymous], SDF, DOI DOI 10.1128/CMR.00117-13; [Anonymous], 2011, MANUAL CLIN MICROBIO; [Anonymous], 2017, EGYPTIAN J MED MICRO; [Anonymous], 2018, INFECT DIS; [Anonymous], 2013, J CLIN MICROBIOL, DOI DOI 10.1128/JCM.01634-13; Averbuch D, 2017, INFECTION, V45, P327, DOI 10.1007/s15010-017-0988-1; Bakthavatchalam YD, 2016, J GLOB INFECT DIS, V8, P41, DOI 10.4103/0974-777X.176149; Bochennek K, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2015.110; Boutal H, 2018, J ANTIMICROB CHEMOTH, V73, P909, DOI 10.1093/jac/dkx521; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Cattaneo C, 2018, ANN HEMATOL, P1, DOI [10.1007/s00277-017-3149-9, DOI 10.1007/S00277-017-3149-9]; Chavda KD, 2016, ANTIMICROB AGENTS CH, V60, P6957, DOI 10.1128/AAC.01458-16; CLSI, 2017, PERFORMANCE STANDARD, V26; Dortet L, 2017, EUROSURVEILLANCE, V22, P10, DOI [10.2807/1560-7917.ES.2017.22.6.30461, 10.2807/1560-7917.es.2017.22.6.30461]; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Gauthier L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170769; Holt J., 1994, BERGEYS MANUAL DETER; Islas-Munoz B, 2018, INT J INFECT DIS, V71, P59, DOI 10.1016/j.ijid.2018.03.022; Koroska F, 2017, J CLIN MICROBIOL, V55, P877, DOI 10.1128/JCM.01929-16; Kuo FC, 2017, J MICROBIOL IMMUNOL, V50, P507, DOI 10.1016/j.jmii.2015.08.013; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Nastro M, 2017, J CHEMOTHERAPY, V29, P150, DOI 10.1080/1120009X.2016.1201272; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Pasteran F, 2015, J CLIN MICROBIOL, V53, P1996, DOI 10.1128/JCM.03026-14; Patel J.B., 2015, PERFORMANCE STANDARD; Pires J, 2013, J CLIN MICROBIOL, V51, P4281, DOI 10.1128/JCM.01634-13; Poirel L, 2013, INT J ANTIMICROB AG, V41, P90, DOI 10.1016/j.ijantimicag.2012.08.015; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; Pournaras S, 2013, J CLIN MICROBIOL, V51, P2986, DOI 10.1128/JCM.00901-13; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Ramana K V, 2013, J Nat Sci Biol Med, V4, P346, DOI 10.4103/0976-9668.117009; Safdar A, 2011, CLIN INFECT DIS, V53, P798, DOI 10.1093/cid/cir492; Sambrook J., 2001, MOL CLONING LAB MANU; Sherry N, 2018, EXPERT REV ANTI-INFE, V21, P1; Shibl A, 2013, INT J INFECT DIS, V17, pE1130, DOI 10.1016/j.ijid.2013.06.016; Yao JF, 2017, CHINESE MED J-PEKING, V130, P2076, DOI 10.4103/0366-6999.213411	39	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202119	10.1371/journal.pone.0202119	http://dx.doi.org/10.1371/journal.pone.0202119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157188	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400037
J	Morgan, AC; Way, SF; Clauset, A				Morgan, Allison C.; Way, Samuel F.; Clauset, Aaron			Automatically assembling a full census of an academic field	PLOS ONE			English	Article							PRODUCTIVITY; PLACEMENT; DISCIPLINES; NETWORKS; SCIENCE; WORK	The composition of the scientific workforce shapes the direction of scientific research, directly through the selection of questions to investigate, and indirectly through its influence on the training of future scientists. In most fields, however, complete census information is difficult to obtain, complicating efforts to study workforce dynamics and the effects of policy. This is particularly true in computer science, which lacks a single, all-encompassing directory or professional organization. A full census of computer science would serve many purposes, not the least of which is a better understanding of the trends and causes of unequal representation in computing. Previous academic census efforts have relied on narrow or biased samples, or on professional society membership rolls. A full census can be constructed directly from online departmental faculty directories, but doing so by hand is expensive and time-consuming. Here, we introduce a topical web crawler for automating the collection of faculty information from web-based department rosters, and demonstrate the resulting system on the 205 PhD-granting computer science departments in the U.S. and Canada. This method can quickly construct a complete census of the field, and achieve over 99% precision and recall. We conclude by comparing the resulting 2017 census to a hand-curated 2011 census to quantify turnover and retention in computer science, in general and for female faculty in particular, demonstrating the types of analysis made possible by automated census construction.	[Morgan, Allison C.; Way, Samuel F.; Clauset, Aaron] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Clauset, Aaron] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Clauset, Aaron] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; The Santa Fe Institute	Morgan, AC (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.	allison.morgan@colorado.edu		CLAUSET, AARON/0000-0002-3529-8746; Morgan, Allison/0000-0003-2926-2162	NSF [SMA 1633791]	NSF(National Science Foundation (NSF))	All authors were supported by NSF award SMA 1633791. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON PD, 1990, AM SOCIOL REV, V55, P469, DOI 10.2307/2095801; Amir R, 2008, REV ECON STAT, V90, P185, DOI 10.1162/rest.90.1.185; ARACHNID Menczer F., 1997, P 14 INT C MACH LEAR, P227; Butt AS, 2015, P 8 INT C KNOWL CAPT, P9; Chakrabarti S, 1999, COMPUT NETW, V31, P1623, DOI 10.1016/S1389-1286(99)00052-3; Cho J, 1998, COMPUT NETWORKS ISDN, V30, P161, DOI 10.1016/S0169-7552(98)00108-1; Clauset A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400005; COLE S, 1979, AM J SOCIOL, V84, P958, DOI 10.1086/226868; Fowler JH, 2007, PS-POLIT SCI POLIT, V40, P729, DOI 10.1017/S104909650707117X; Groves RM, 2011, SURVEY METHODOLOGY, V561; Hanneman RA., 2001, CONNECTIONS, V24, P68; Hill C., 2010, WOMEN SCI TECHNOLOGY, DOI [10.1002/sce.21007, DOI 10.1002/SCE.21007]; Imai K, 2011, AM POLIT SCI REV, V105, P765, DOI 10.1017/S0003055411000414; Jadidi M, 2017, GENDER DISPARITIES S; Katz DM, 2011, J LEGAL EDUC, V61, P76; Kulis S, 2002, RES HIGH EDUC, V43, P657, DOI 10.1023/A:1020988531713; LONG JS, 1995, ANNU REV SOCIOL, V21, P45, DOI 10.1146/annurev.so.21.080195.000401; McCallum AK, 2000, INFORM RETRIEVAL, V3, P127, DOI 10.1023/A:1009953814988; McLeod PL, 1996, SMALL GR RES, V27, P248, DOI 10.1177/1046496496272003; Menczer F., 2001, SIGIR Forum, P241; Menczer F., 2004, ACM T INTERNET TECHN, V4, P378, DOI [10.1145/1031114.1031117, DOI 10.1145/1031114.1031117]; Milem JF., 2003, COMPELLING INTEREST, P126, DOI [10.1515/9780804764537-009, DOI 10.1515/9780804764537-009]; Mitchell T, 2015, AAAI CONF ARTIF INTE, P2302; Myers SA, 2011, CHAOS, V21, DOI 10.1063/1.3668043; Page SE, 2008, DIFFERENCE POWER DIV; Pant G, 2004, WEB DYNAMICS: ADAPTING TO CHANGE IN CONTENT, SIZE TOPOLOG AND USE, P153; Pell AN, 1996, J ANIM SCI, V74, P2843; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Schlagberger E, 2016, SCIENTOMETRICS, V109, P723, DOI 10.1007/s11192-016-2059-2; Schmidt BM, 2007, PS-POLIT SCI POLIT, V40, P523, DOI 10.1017/S1049096507070771; VanDyne L, 1996, BRIT J SOC PSYCHOL, V35, P151; Way SF, 2017, P NATL ACAD SCI USA, V114, pE9216, DOI 10.1073/pnas.1702121114; Way SF, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P1169; Weisberg H. F., 2009, TOTAL SURVEY ERROR A; Xie Y, 1998, AM SOCIOL REV, V63, P847, DOI 10.2307/2657505; Xu YJ, 2008, RES HIGH EDUC, V49, P607, DOI 10.1007/s11162-008-9097-4; Zuckerman H., 1977, SCI ELITE NOBEL LAUR	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202223	10.1371/journal.pone.0202223	http://dx.doi.org/10.1371/journal.pone.0202223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157278	gold, Green Published, Green Submitted			2022-12-27	WOS:000443071400045
J	Nomura, K; Fujiwara, A; Iwasaki, Y; Nishiki, I; Matsuura, A; Ozaki, A; Sudo, R; Tanaka, H				Nomura, Kazuharu; Fujiwara, Atushi; Iwasaki, Yuki; Nishiki, Issei; Matsuura, Aiko; Ozaki, Akiyuki; Sudo, Ryusuke; Tanaka, Hideki			Genetic parameters and quantitative trait loci analysis associated with body size and timing at metamorphosis into glass eels in captive-bred Japanese eels (Anguilla japonica)	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; FRESH-WATER EELS; NORTHERN KYUSHU; EVOLUTION; LARVAE; MAPS; LEPTOCEPHALI; AQUACULTURE; DISPERSAL; MIGRATION	The Japanese eel (Anguilla japonica) is among the most important aquaculture fish species in Eastern Asia. The present study aimed to identify the genetic parameters underlying body size and the timing at metamorphosis from leptocephali to glass eels in captive-bred Japanese eels, with the intent to foster sustainable development. Larvae from a partly factorial cross (14 sires x 11 dams) were reared until the point of metamorphosis into glass eels. In these organisms, we observed moderate heritability and mild genetic correlations among traits related to body size (h(2) = 0.16 +/- 0.33) and timing at metamorphosis (h(2) = 0.36 +/- 0.41). In an F1 full-sib family, quantitative trait loci (QTL) mapping for these traits identified one significant (genome-wide P < 0.05) and five suggestive QTLs (chromosome-wide P < 0.05). These results suggest that in the Japanese eel, metamorphic traits exhibit a polygenic genetic structure comprising many QTLs with small effects. In addition, we updated the genetic linkage map for the Japanese eel and integrated it with our newly constructed de novo genome assembly. The information and tools generated from this study will contribute to the development of freshwater eel genetics and genomics.	[Nomura, Kazuharu; Ozaki, Akiyuki; Sudo, Ryusuke; Tanaka, Hideki] Japan Fisheries Res & Educ Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan; [Fujiwara, Atushi; Iwasaki, Yuki; Nishiki, Issei; Matsuura, Aiko] Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Iwasaki, Yuki] Natl Inst Genet, Mishima, Shizuoka, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Nomura, K (corresponding author), Japan Fisheries Res & Educ Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan.	nomurak@affrc.go.jp		nomura, kazuharu/0000-0002-0459-9992	Ministry of Agriculture, Forestry, and Fisheries (MAFF), Government of Japan; Bio-oriented Technology Research Advancement Institution (NARO)	Ministry of Agriculture, Forestry, and Fisheries (MAFF), Government of Japan; Bio-oriented Technology Research Advancement Institution (NARO)	This work was supported in part by a Grant-in-Aid for "Development of Sustainable Aquaculture Technology Independent of Wild Fishery Resources" from the Ministry of Agriculture, Forestry, and Fisheries (MAFF), Government of Japan and "The special scheme project on advanced research and development for next-generation technology" from the Project of the Bio-oriented Technology Research Advancement Institution (NARO).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashton DT, 2017, MOL ECOL, V26, P1465, DOI 10.1111/mec.13965; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Cheng PW, 1996, MAR ECOL PROG SER, V131, P87, DOI 10.3354/meps131087; Fierst JL, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00220; Gilmoura R, 2015, ASREML USER GUIDE, P2005; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Iwasaki Y, 2016, GENE, V576, P644, DOI 10.1016/j.gene.2015.10.015; Jansen HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07650-6; Kagawa H, 2005, FISH PHYSIOL BIOCHEM, V31, P193, DOI 10.1007/s10695-006-0024-3; Kai W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-233; Kawakami Y, 1998, FISHERIES SCI, V64, P235, DOI 10.2331/fishsci.64.235; Kawakami Y, 1999, B MAR SCI, V64, P315; Koh ICC, 2017, AQUACULTURE, V473, P487, DOI 10.1016/j.aquaculture.2017.03.011; Kuroki M, 2014, CAN J ZOOL, V92, P749, DOI 10.1139/cjz-2013-0303; Laugen AT, 2005, GENET RES, V86, P161, DOI 10.1017/S0016672305007810; Leander NJ, 2013, ANGUILLA JAPONICA A, V52, P1, DOI [10.1186/1810-522X-52-30, DOI 10.1186/1810-522X-52-30]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Masuda Y, 2011, NIPPON SUISAN GAKK, V77, P416, DOI 10.2331/suisan.77.416; Miller MJ, 2017, CAN J FISH AQUAT SCI, V74, P958, DOI 10.1139/cjfas-2016-0281; Nomura K, 2006, AQUACULTURE, V257, P53, DOI 10.1016/j.aquaculture.2006.03.011; Nomura K, 2004, FISHERIES SCI, V70, P247, DOI 10.1111/j.1444-2906.2003.00798.x; Nomura K, 2011, AQUACULTURE, V310, P329, DOI 10.1016/j.aquaculture.2010.11.006; Ohta H, 2017, AQUACULTURE, V479, P150, DOI 10.1016/j.aquaculture.2017.05.044; Okamura A, 2014, ECOL FRESHW FISH, V23, P95, DOI 10.1111/eff.12086; Page RB, 2013, GENOME BIOL EVOL, V5, P1716, DOI 10.1093/gbe/evt123; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pavey SA, 2017, MOL ECOL RESOUR, V17, P806, DOI 10.1111/1755-0998.12608; Sekino M, 2012, CONSERV GENET RESOUR, V4, P275, DOI 10.1007/s12686-011-9523-3; Shiraishi H, 2015, MARKET DYNAMICS ANAL; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; TABETA O, 1987, NIPPON SUISAN GAKK, V53, P1727; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tanaka H, 2001, PRODUCTION LEPTOCEPH, P51; Tanaka H, 2015, FISHERIES SCI, V81, P11, DOI 10.1007/s12562-014-0821-z; Tang HB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0573-1; Tsukamoto K, 2002, CAN J FISH AQUAT SCI, V59, P1989, DOI 10.1139/F02-165; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Voss SR, 2012, HEREDITY, V109, P293, DOI 10.1038/hdy.2012.41; Wang CH, 2000, FISH RES, V46, P191, DOI 10.1016/S0165-7836(00)00146-6; YAMAMOTO K, 1974, NATURE, V251, P220, DOI 10.1038/251220a0	46	6	6	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201784	10.1371/journal.pone.0201784	http://dx.doi.org/10.1371/journal.pone.0201784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157280	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400015
J	Sansom, A; Wilson, LJ; Caldow, RWG; Bolton, M				Sansom, Alex; Wilson, Linda J.; Caldow, Richard W. G.; Bolton, Mark			Comparing marine distribution maps for seabirds during the breeding season derived from different survey and analysis methods	PLOS ONE			English	Article							FORAGING HOTSPOTS; PELAGIC SEABIRDS; TRACKING; MODELS; CONSERVATION; TECHNOLOGY; SPACE; AREAS	Understanding how seabirds use the marine environment is key for marine spatial planning, and maps of their marine distributions derived from transect-based surveys and from tracking of individual bird's movements are increasingly available for the same geographic areas. Although the value of integrating these different datasets is well recognised, few studies have undertaken quantitative comparisons of the resulting distributions. Here we take advantage of four existing distribution maps and conduct a quantitative comparison for four seabird species (black-legged kittiwake Rissa tridactyla; European shag Phalacrocorax aristotelis; common guillemot Uria aalge; and razorbill Alca torda). We quantify the amount of overlap and agreement in the location of high use areas identified from either tracking or transect samples and use Bhattacharyya's Affinity to quantify levels of similarity in the general distribution patterns. Despite multiple differences in the properties of the datasets, there was a far greater degree of overlap than would be expected by chance, except when adopting the most constrained definition of high use. Distance to the nearest conspecific colony appeared to be an important driver of the degree of similarity. Agreed areas of highest use tended to occur close to colonies and, with increasing distance from colonies, similarity between datasets declined and/or there was similarity in respect of their being relatively low usage. Interpreting reasons for agreement between data sources in some areas and not others was limited by an inability to control for the multiple potential sources of differences from both the sampling and modelling processes of the underlying datasets. Nevertheless, our quantitative comparative approach provides a valuable tool to quantify the degree to which an area's importance is corroborated across multiple datasets, and therefore confidence that an important area has been correctly identified. This can help prioritise where the implementation of conservation measures should be targeted and identify where greatest scrutiny is required of the potential adverse environmental effects of any planned anthropogenic activities.	[Sansom, Alex] Scottish Headquarters, Royal Soc Protect Birds, Ctr Conservat Sci, Edinburgh, Midlothian, Scotland; [Wilson, Linda J.] Royal Soc Protect Birds, Ctr Conservat Sci, Inverness, Scotland; [Caldow, Richard W. G.] Nat England, Blandford Forum, Sheffield, Dorset, England; [Bolton, Mark] Royal Soc Protect Birds, Ctr Conservat Sci, Sandy, Beds, England	Royal Society for Protection of Birds; Royal Society for Protection of Birds; Royal Society for Protection of Birds	Wilson, LJ (corresponding author), Royal Soc Protect Birds, Ctr Conservat Sci, Inverness, Scotland.	Linda.Wilson@rspb.org.uk		Bolton, Mark/0000-0001-5605-687X	Natural England; Royal Society for the Protection of Birds under the Action for Birds in England partnership	Natural England; Royal Society for the Protection of Birds under the Action for Birds in England partnership	This work was funded jointly by Natural England and the Royal Society for the Protection of Birds under the Action for Birds in England partnership. These funders conceived and managed the project and employed the authors.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; [Anonymous], 2004, STANDARDISED SEABIRD; [Anonymous], 431 JNCC; Barrett R, 2006, ICES J MARINE SCI; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; BirdLife International, 2011, MAR IMP BIRD AR TOOL; Bradbury G, 2017, RISK ASSESSMENT SEA; Bradbury G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106366; Buckland ST, 2012, J APPL ECOL, V49, P960, DOI 10.1111/j.1365-2664.2012.02150.x; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; Camphuysen KCJ, 2004, ATLANTIC SEABIRDS, V6, P1; Camphuysen K, 2012, BIOL CONSERV, V156, P22, DOI 10.1016/j.biocon.2011.12.024; Carroll MJ, 2017, AIDS CARE, P1; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellis JR, 2010, MB5301 FOOD RUR AFF; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Frederiksen M, 2013, GLOBAL CHANGE BIOL, V19, P364, DOI 10.1111/gcb.12072; Furness R.W., 2015, NATURAL ENGLAND COMM; Goodship Nicola, 2015, British Birds, V108, P506; Hijmans R. J., 2016, R PACKAGE VERSION, V2, P5; Illian JB, 2012, J ENV STAT, V3, P1; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Kober K., 2012, 461 JNCC; KOMDEUR J, 1992, IWRB SPECIAL PUBLICA, V19; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Arcos JM, 2012, BIOL CONSERV, V156, P30, DOI 10.1016/j.biocon.2011.12.011; Matthiopoulos J, 2011, ECOLOGY, V92, P583, DOI 10.1890/10-0751.1; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Natural England, 2015, DEP BRIEF NORTH MAR; Oppel S, 2012, BIOL CONSERV, V156, P94, DOI 10.1016/j.biocon.2011.11.013; Perez-Ortega M, 2017, DEEP-SEA RES PT II, V141, P237, DOI 10.1016/j.dsr2.2016.07.007; Peron C, 2013, BIOL CONSERV, V168, P210, DOI 10.1016/j.biocon.2013.09.006; Perrow MR, 2015, BIOL CONSERV, V191, P729, DOI 10.1016/j.biocon.2015.08.031; Proctor R, 1998, FISH OCEANOGR, V7, P347, DOI 10.1046/j.1365-2419.1998.00077.x; Reid J.B., 1998, BIOL CONSERVATION FA, V102, P291; Scottish Natural Heritage, 2016, UK9020316 SCOTT NAT; Scottish Natural Heritage, 2016, UK9020313 SCOTT NAT; Soanes LM, 2013, J APPL ECOL, V50, P671, DOI 10.1111/1365-2664.12069; TASKER ML, 1984, AUK, V101, P567, DOI 10.1093/auk/101.3.567; Thaxter C.B., 2009, HIGH DEFINITION IMAG; Thaxter CB, 2012, BIOL CONSERV, V156, P53, DOI 10.1016/j.biocon.2011.12.009; The Crown Estate, 2016, OFFSH WIND OP REP JA; Thiers L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115057; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Wakefield ED, 2017, ECOL APPL, V27, P2074, DOI 10.1002/eap.1591; Wakefield ED, 2009, MAR ECOL PROG SER, V391, P165, DOI 10.3354/meps08203; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yamamoto T, 2015, ECOL APPL, V25, P2394, DOI 10.1890/15-0142.1.sm	49	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201797	10.1371/journal.pone.0201797	http://dx.doi.org/10.1371/journal.pone.0201797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157191	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400017
J	Singh, S; Fatima, Z; Ahmad, K; Hameed, S				Singh, Shweta; Fatima, Zeeshan; Ahmad, Kamal; Hameed, Saif			Fungicidal action of geraniol against Candida albicans is potentiated by abrogated CaCdr1p drug efflux and fluconazole synergism	PLOS ONE			English	Article							ABC MULTIDRUG TRANSPORTERS; PROTEIN-STRUCTURE; I-TASSER; RESISTANCE; MECHANISMS; ANTIBACTERIAL; MITOCHONDRIA; HOMEOSTASIS; DISRUPTION; INHIBITORS	Among the several mechanisms of multidrug resistance (MDR), overexpression of drug efflux pumps CaCdr1p and CaMdr1p belonging to ATP binding cassette (ABC) and major facilitator superfamily (MFS) respectively remain the predominant mechanisms of candidal infections. Therefore inhibiting or modulating the function of these transporters continues to draw attention as effective strategy to combat MDR. We have previously reported the antifungal potential of Geraniol (Ger), a natural monoterpenoid from Palmarosa oil, against Candida albicans. Herein, we explored the fungicidal nature of Ger. The Rhodamine 6G (R6G) and Nile red accumulation confirms the specific effect on CaCdr1p. Mechanistic insights with Candida cells overexpressing CaCdr1p and CaMdr1p revealed that Ger specifically modulates CaCdr1p activity. Kinetic studies further unraveled the competitive inhibition of Ger for R6G efflux as evident from increased apparent Km without affecting V-max value. The effect of Ger on CaCdr1p was substantiated by molecular docking analyses, which depicted in-silico binding affinity of Ger with CaCdr1p and explored that Ger binds to the active site of CaCdr1p with higher binding energy. Although RT-PCR and western blot revealed no change in expressions of CDR1 and CaCdr1p, confocal microscopy images however depicted CaCdr1p mislocalization in presence of Ger. Interestingly, Ger was synergistic (FICI<0.5) with fluconazole (FLC) which is a well known antifungal drug. Furthermore, Ger sensitizes the FLC sensitive and resistant clinical matched pair of isolates Gu4/Gu5 and led to abrogated R6G efflux and depleted ergosterol. Furthermore, Rhodamine B labeling demonstrates altered mitochondrial potential with Ger which suggest possible linkage of dysfunctional mitochondria with CaCdr1p activity. We also estimated phenotypic virulence marker extracellular phospholipase activity which was considerably diminished along with inhibited cell adherence and biofilm biomass. Lastly, antifungal efficacy of Ger was demonstrated by enhanced survival of Caenorhabditis elegans model and negligible hemolytic activity (20%). Together, modulation of efflux pump activity by Ger and FLC synergism represent a promising approach for combinatorial treatment of candidiasis.	[Singh, Shweta; Fatima, Zeeshan; Hameed, Saif] Amity Univ Haryana, Amity Inst Biotechnol, Gurugram, Manesar, India; [Ahmad, Kamal] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India	Jamia Millia Islamia	Fatima, Z; Hameed, S (corresponding author), Amity Univ Haryana, Amity Inst Biotechnol, Gurugram, Manesar, India.	drzeeshanfatima@gmail.com; saifhameed@yahoo.co.in		ahmad, kamal/0000-0003-1744-6554				Ahmad K, 2017, LETT DRUG DES DISCOV, V14, P488, DOI 10.2174/1570180814666161214114322; [Anonymous], 2008, M27A3 NAT COMM CLIN; Ansari MA, 2018, BIOCHEM BIOPH RES CO, V495, P560, DOI 10.1016/j.bbrc.2017.11.064; Ansari MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162465; Ansari MA, 2016, MICROB PATHOGENESIS, V98, P140, DOI 10.1016/j.micpath.2016.07.004; Asthana N, 2004, J BIOL CHEM, V279, P55042, DOI 10.1074/jbc.M408881200; Baghel P, 2017, BBA-BIOMEMBRANES, V1859, P1778, DOI 10.1016/j.bbamem.2017.05.011; Bambach A, 2009, EUKARYOT CELL, V8, P1706, DOI 10.1128/EC.00066-09; Berkow EL, 2017, INFECT DRUG RESIST, V10, P237, DOI 10.2147/IDR.S118892; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Franz R, 1999, MYCOSES, V42, P453, DOI 10.1046/j.1439-0507.1999.00498.x; Franz R, 1998, ANTIMICROB AGENTS CH, V42, P3065, DOI 10.1128/AAC.42.12.3065; Garcia-Gomes AS, 2012, MED MYCOL, V50, P26, DOI 10.3109/13693786.2011.578156; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gu WR, 2016, ANTIMICROB AGENTS CH, V60, P6179, DOI 10.1128/AAC.03046-15; Guo XL, 2008, J APPL MICROBIOL, V104, P831, DOI 10.1111/j.1365-2672.2007.03617.x; Hameed Saif, 2013, Int J Microbiol, V2013, P240209, DOI 10.1155/2013/240209; Karacaer Z, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.398.4960; Lacka I, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00783; Misra LN, 2013, J ETHNOPHARMACOL, V148, P74, DOI 10.1016/j.jep.2013.03.069; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nailis H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-114; Nim S, 2016, PLANTA MED, V82, P1180, DOI 10.1055/s-0042-106169; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Pasrija R, 2007, EUKARYOT CELL, V6, P443, DOI 10.1128/EC.00315-06; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prasad R., 2006, Infectious Disorders - Drug Targets, V6, P69, DOI 10.2174/187152606784112164; Prasad R, 2002, ADV MICROB PHYSIOL, V46, P155, DOI 10.1016/S0065-2911(02)46004-3; Prasad R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00202; Qu Y, 2012, EUKARYOT CELL, V11, P532, DOI 10.1128/EC.05292-11; Repasky M.P., 2007, CURR PROTOC HUM GENE, V18, P1; Reungpatthanaphong P, 2003, J BIOCHEM BIOPH METH, V57, P1, DOI 10.1016/S0165-022X(03)00032-0; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sharma M, 2011, ANTIMICROB AGENTS CH, V55, P4834, DOI 10.1128/AAC.00344-11; Sharma M, 2009, ANTIMICROB AGENTS CH, V53, P3256, DOI 10.1128/AAC.01497-08; Shukla S, 2003, EUKARYOT CELL, V2, P1361, DOI 10.1128/EC.2.6.1361-1375.2003; Singh S., 2017, FRONT ANTIINFECT DRU, V7, P1; Singh S, 2016, REV SOC BRAS MED TRO, V49, P465, DOI 10.1590/0037-8682-0190-2016; Singh S, 2016, ARCH MICROBIOL, V198, P459, DOI 10.1007/s00203-016-1205-9; Singh Shweta, 2015, Infez Med, V23, P211; Sun WW, 2017, INT J ANTIMICROB AG, V50, P399, DOI 10.1016/j.ijantimicag.2017.03.015; Szczepaniak J, 2017, INT J ANTIMICROB AG, V50, P171, DOI 10.1016/j.ijantimicag.2017.01.044; Tanwar Jyoti, 2014, Interdiscip Perspect Infect Dis, V2014, P541340, DOI 10.1155/2014/541340; Thomas E, 2013, ANTIMICROB AGENTS CH, V57, P5580, DOI 10.1128/AAC.00889-13; Tong YJ, 2016, SYN SYST BIOTECHNO, V1, P158, DOI 10.1016/j.synbio.2016.10.001; Tran-Nguyen VK, 2017, CURR MED CHEM, V24, P3242, DOI 10.2174/0929867324666170523102244; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xie F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33687; Yamamoto S, 2005, BIOCHEM BIOPH RES CO, V330, P622, DOI 10.1016/j.bbrc.2005.03.009; Yan HB, 2014, FEMS YEAST RES, V14, P614, DOI 10.1111/1567-1364.12148; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yousuf S, 2011, MED MYCOL, V49, P444, DOI 10.3109/13693786.2010.539629; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhao LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079671	59	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203079	10.1371/journal.pone.0203079	http://dx.doi.org/10.1371/journal.pone.0203079			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157240	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400087
J	Spindler, J; Zandi, S; Pfister, IB; Gerhardt, C; Garweg, JG				Spindler, Jan; Zandi, Souska; Pfister, Isabel B.; Gerhardt, Christin; Garweg, Justus G.			Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BIOMARKERS; EXPRESSION; CHEMOKINE; ANGIOGENESIS; INFLAMMATION; RANIBIZUMAB; PROGRESSION; MECHANISMS; SENESCENCE	Purpose To identify disease-specific cytokine profile differences in the aqueous humor (AH) (other than the vascular endothelial growth factor) between patients with dry and treated wet age-related macular degeneration (AMD) and healthy controls. Methods This retrospective study drew on a case-series of patients diagnosed with dry AMD (n=25) and treated wet AMD (n=19), as well as on healthy controls (no systemic therapy; n=20) undergoing phacoemulsification or vitrectomy. Samples of AH and serum were collected in parallel at the beginning of surgery. The levels of 43 cytokines were simultaneously determined using the Bio-Plex (R) multiplex beads system. Differences between the three groups were statistically compared using the Kruskal-Wallis H-Test after applying the Bonferroni correction for multiple comparisons (p<0.0012). Results The concentrations of three cytokines were elevated in the AH of patients with dry AMD (CXCL6; p=0.00067) and treated wet AMD (CXCL5, CXCL6, MIG/XCXL; all p<0.001) relative to those in the healthy controls. No other differences between the three groups were identified. The AH levels of seven cytokines (16%), including CXCL6, ranged below the lower limit of quantitation of the assay. Without the correction for multiple comparisons (p<0.05), the levels of 31 of the 43 cytokines in the AH of patients with AMD would have differed significantly from those in the control. The systemic cytokine profiles (serum) were similar in all three groups. Conclusions No systematic differences in the AH cytokine environment were identified between patients with dry AMD and those with treated wet AMD. This finding might indicate that AMD is either the result of a persistent imbalance in the physiological tissue milieu, or that the localized process induces no significant change in the cytokine environment of the anterior ocular segment.	[Spindler, Jan; Zandi, Souska; Pfister, Isabel B.; Gerhardt, Christin; Garweg, Justus G.] Swiss Eye Inst, Bern, Switzerland; [Spindler, Jan; Zandi, Souska; Pfister, Isabel B.; Gerhardt, Christin; Garweg, Justus G.] Berner Augenklin Lindenhofspital, Bern, Switzerland; [Spindler, Jan; Pfister, Isabel B.; Gerhardt, Christin; Garweg, Justus G.] Univ Bern, Bern, Switzerland	University of Bern	Garweg, JG (corresponding author), Swiss Eye Inst, Bern, Switzerland.; Garweg, JG (corresponding author), Berner Augenklin Lindenhofspital, Bern, Switzerland.; Garweg, JG (corresponding author), Univ Bern, Bern, Switzerland.	garweg@swiss-eye-institute.com		Zandi, Souska/0000-0001-9351-4278	Scientific Funds of the Lindenhof Foundation	Scientific Funds of the Lindenhof Foundation	The manuscript was partially funded by a grant from the Scientific Funds of the Lindenhof Foundation without commercial interests. There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Anand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049905; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Bartlett DB, 2012, AGING CELL, V11, P912, DOI 10.1111/j.1474-9726.2012.00849.x; Bauer ME, 2016, MECH AGEING DEV, V158, P27, DOI 10.1016/j.mad.2016.01.001; Bird AC, 2014, JAMA OPHTHALMOL, V132, P338, DOI 10.1001/jamaophthalmol.2013.5799; Camelo S, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/532487; Campagne MV, 2014, J PATHOL, V232, P151, DOI 10.1002/path.4266; Cao SJ, 2013, AM J OPHTHALMOL, V156, P1176, DOI 10.1016/j.ajo.2013.08.003; Cha DM, 2013, INVEST OPHTH VIS SCI, V54, P7038, DOI 10.1167/iovs.13-12730; Chaudhary V, 2016, CAN J OPHTHALMOL, V51, P302, DOI 10.1016/j.jcjo.2016.04.020; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Danis RP, 2015, CLIN OPHTHALMOL, V9, P2159, DOI 10.2147/OPTH.S92359; Falk MK, 2014, INVEST OPHTH VIS SCI, V55, P4050, DOI 10.1167/iovs.14-14107; Fauser S, 2016, BRIT J OPHTHALMOL, V100, P1494, DOI 10.1136/bjophthalmol-2015-308264; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; Fox SE, 2005, CYTOKINE, V29, P135, DOI 10.1016/j.cyto.2004.10.007; FRASCA D, 2016, BIOGERONTOLOGY, V17, P7, DOI [DOI 10.1007/S10522-015-9578-8, 10.1007/s10522-015-9578-8]; Fujimura S, 2012, INVEST OPHTH VIS SCI, V53, P1999, DOI 10.1167/iovs.11-8232; Gallenga CE, 2014, INFLAMM RES, V63, P105, DOI 10.1007/s00011-013-0684-2; Garweg JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182571; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hong HS, 2015, WOUND REPAIR REGEN, V23, P268, DOI 10.1111/wrr.12264; Hooks JJ, 2008, J IMMUNOL, V180, P3789, DOI 10.4049/jimmunol.180.6.3789; Huang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173716; Jonas JB, 2007, OPHTHAL RES, V39, P139, DOI 10.1159/000102935; Jonas JB, 2012, ACTA OPHTHALMOL, V90, pe381, DOI 10.1111/j.1755-3768.2012.02414.x; Juel HB, 2012, INVEST OPHTH VIS SCI, V53, P8472, DOI 10.1167/iovs.12-9963; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kawai M, 2012, INVEST OPHTH VIS SCI, V53, P7951, DOI 10.1167/iovs.12-10231; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Knickelbein Jared E, 2015, Int Ophthalmol Clin, V55, P63, DOI 10.1097/IIO.0000000000000073; Kutty RK, 2015, CYTOKINE, V74, P335, DOI 10.1016/j.cyto.2015.03.016; Torres KCL, 2018, EXP GERONTOL, V103, P47, DOI 10.1016/j.exger.2017.12.006; Lin Tony, 2013, Cytokine, V62, P369, DOI 10.1016/j.cyto.2013.03.027; Liu F, 2016, MOL VIS, V22, P352; Ma YG, 2018, TRANSL RES, V191, P15, DOI 10.1016/j.trsl.2017.10.001; Machado-Silva W, 2016, J STROKE CEREBROVASC, V25, P2851, DOI 10.1016/j.jstrokecerebrovasdis.2016.07.047; Marquioni-Ramella MD, 2015, PHOTOCH PHOTOBIO SCI, V14, P1560, DOI 10.1039/c5pp00188a; Marshall A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172821; Martinez-Cengotitabengoa M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122022; Miao H, 2012, MOL VIS, V18, P574; Miller Jr R. G, 1981, SIMULTANEOUS STAT IN, P67; Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3; Nakamura R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8847; Nassar K, 2015, GRAEF ARCH CLIN EXP, V253, P699, DOI 10.1007/s00417-014-2738-8; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Parmar T, 2016, INVEST OPHTH VIS SCI, V57, P3257, DOI 10.1167/iovs.15-18993; PENFOLD P, 1984, AUST J OPHTHALMOL, V12, P23; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; Rutar M, 2016, ADV EXP MED BIOL, V854, P11, DOI 10.1007/978-3-319-17121-0_2; Sakamoto S, 2017, BR J OPHTHALMOL; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Sharma R, 2014, NUTR RES, V34, P968, DOI 10.1016/j.nutres.2014.09.006; Shen DF, 2011, INVEST OPHTH VIS SCI, V52, P2897, DOI 10.1167/iovs.10-6114; Shevchenko A V, 2016, Vestn Oftalmol, V132, P8, DOI 10.17116/oftalma201613228-13; Shi G, 2008, INVEST OPHTH VIS SCI, V49, P4620, DOI 10.1167/iovs.08-1816; Shurin GV, 2007, CYTOKINE, V39, P123, DOI 10.1016/j.cyto.2007.06.006; Shwu-Jiuan S, 2012, TAIWAN J OPHTHALMOLO, V2, P51, DOI [10.1016/j.tjo.2012.02.002, DOI 10.1016/J.TJO.2012.02.002]; Silvestre JS, 2000, CIRC RES, V87, P448; van der Kraan P, 2017, GERONTOLOGY, V63, P29, DOI 10.1159/000448711; Ventura Maria Teresa, 2017, Clin Mol Allergy, V15, P21, DOI 10.1186/s12948-017-0077-0; Wuyts A, 2000, BIOCHEMISTRY-US, V39, P14549, DOI 10.1021/bi0011227; Zandi S, 2016, INVEST OPHTH VIS SCI, V57, P6320, DOI 10.1167/iovs.16-20657; Zandi S, 2015, CELL REP, V10, P1173, DOI 10.1016/j.celrep.2015.01.050; Zehetner C, 2014, INVEST OPHTH VIS SCI, V55, P337, DOI 10.1167/iovs.13-12978; Zhu DH, 2009, AGING-US, V1, P740, DOI 10.18632/aging.100078	69	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203337	10.1371/journal.pone.0203337	http://dx.doi.org/10.1371/journal.pone.0203337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157273	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400103
J	Yuan, AL; Ricks, CB; Bohm, AK; Lun, XQ; Maxwell, L; Safdar, S; Bukhari, S; Gerber, A; Sayeed, W; Bering, EA; Pedersen, H; Chan, JA; Shen, YQ; Marra, M; Kaplan, DR; Mason, W; Goodman, LD; Ezhilarasan, R; Kaufmann, AB; Cabral, M; Robbins, SM; Senger, DL; Cahill, DP; Sulman, EP; Cairncross, JG; Blough, MD				Yuan, Alice L.; Ricks, Christian B.; Bohm, Alexandra K.; Lun, Xueqing; Maxwell, Lori; Safdar, Shahana; Bukhari, Shazreh; Gerber, Amanda; Sayeed, Wajid; Bering, Elizabeth A.; Pedersen, Haley; Chan, Jennifer A.; Shen, Yaoqing; Marra, Marco; Kaplan, David R.; Mason, Warren; Goodman, Lindsey D.; Ezhilarasan, Ravesanker; Kaufmann, Ascher B.; Cabral, Matthew; Robbins, Steve M.; Senger, Donna L.; Cahill, Daniel P.; Sulman, Erik P.; Cairncross, J. Gregory; Blough, Michael D.			ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts	PLOS ONE			English	Article							ADP-RIBOSE POLYMERASE; MISMATCH REPAIR-DEFICIENT; BASE EXCISION-REPAIR; ADJUVANT TEMOZOLOMIDE; MSH6 MUTATIONS; CLINICAL-TRIAL; GLIOBLASTOMA; INHIBITOR; MGMT; THERAPY	Background Temozolomide (TMZ) is active against glioblastomas (GBM) in which the O6-methylguanine-DNA methyltransferase (MGMT) gene is silenced. However, even in responsive cases, its beneficial effect is undermined by the emergence of drug resistance. Here, we tested whether inhibition of poly (ADP-ribose) polymerase-1 and -2 (PARP) enhanced the effectiveness of TMZ. Methods Using patient derived brain tumor initiating cells (BTICs) and orthotopic xenografts as models of newly diagnosed and recurrent high-grade glioma, we assessed the effects of TMZ, ABT-888, and the combination of TMZ and ABT-888 on the viability of BTICs and survival of tumor-bearing mice. We also studied DNA damage repair, checkpoint protein phosphorylation, and DNA replication in mismatch repair (MMR) deficient cells treated with TMZ and TMZ plus ABT-888. Results Cells and xenografts derived from newly diagnosed MGMT methylated high-grade gliomas were sensitive to TMZ while those derived from unmethylated and recurrent gliomas were typically resistant. ABT-888 had no effect on the viability of BTICs or tumor bearing mice, but co-treatment with TMZ restored sensitivity in resistant cells and xenografts from newly diagnosed unmethylated gliomas and recurrent gliomas with MSH6 mutations. In contrast, the addition of ABT-888 to TMZ had little sensitizing effect on cells and xenografts derived from newly diagnosed methylated gliomas. In a model of acquired TMZ resistance mediated by loss of MMR gene MSH6, re-sensitization to TMZ by ABT-888 was accompanied by persistent DNA strand breaks, re-engagement of checkpoint kinase signaling, and interruption of DNA synthesis. Conclusion In laboratory models, the addition of ABT-888 to TMZ overcame resistance to TMZ.	[Yuan, Alice L.; Bohm, Alexandra K.; Lun, Xueqing; Maxwell, Lori; Safdar, Shahana; Bukhari, Shazreh; Gerber, Amanda; Sayeed, Wajid; Bering, Elizabeth A.; Pedersen, Haley; Chan, Jennifer A.; Robbins, Steve M.; Senger, Donna L.; Cairncross, J. Gregory; Blough, Michael D.] Univ Calgary, Clark H Smith Brain Tumour Ctr, Calgary, AB, Canada; [Yuan, Alice L.; Bohm, Alexandra K.; Lun, Xueqing; Maxwell, Lori; Safdar, Shahana; Bukhari, Shazreh; Gerber, Amanda; Sayeed, Wajid; Bering, Elizabeth A.; Pedersen, Haley; Chan, Jennifer A.; Robbins, Steve M.; Senger, Donna L.; Cairncross, J. Gregory; Blough, Michael D.] Univ Calgary, Charbonneau Canc Inst, Calgary, AB, Canada; [Ricks, Christian B.; Goodman, Lindsey D.; Ezhilarasan, Ravesanker; Kaufmann, Ascher B.; Sulman, Erik P.] MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA; [Sayeed, Wajid; Robbins, Steve M.; Senger, Donna L.; Cairncross, J. Gregory] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Chan, Jennifer A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Shen, Yaoqing; Marra, Marco] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Kaplan, David R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kaplan, David R.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Mason, Warren] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Cabral, Matthew] MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX USA; [Cahill, Daniel P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Cairncross, J. Gregory; Blough, Michael D.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Cairncross, J. Gregory] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Texas System; UTMD Anderson Cancer Center; University of Calgary; University of Calgary; British Columbia Cancer Agency; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; University of Calgary; University of Calgary	Blough, MD (corresponding author), Univ Calgary, Clark H Smith Brain Tumour Ctr, Calgary, AB, Canada.; Blough, MD (corresponding author), Univ Calgary, Charbonneau Canc Inst, Calgary, AB, Canada.; Blough, MD (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.	mdblough@ucalgary.edu	Marra, Marco A/B-5987-2008; Ezhilarasan, Ravesanker/AAC-9750-2022	Marra, Marco A/0000-0001-7146-7175; Senger, Donna/0000-0003-2403-3395; Robbins, Stephen/0000-0001-7475-1665; Goodman, Lindsey/0000-0002-9255-3811; Ezhilarasan, Ravesanker/0000-0002-1353-8307; Sulman, Erik/0000-0003-4933-9120	Terry Fox Research Institute and Foundation (CA); Alberta Cancer Foundation; Genome Canada; Alberta Innovates Health Solutions; family of Clark H. Smith; Burroughs Wellcome Career Award	Terry Fox Research Institute and Foundation (CA); Alberta Cancer Foundation; Genome Canada(Genome Canada); Alberta Innovates Health Solutions; family of Clark H. Smith; Burroughs Wellcome Career Award(Burroughs Wellcome Fund)	This work was supported by the Terry Fox Research Institute and Foundation (CA), the Alberta Cancer Foundation, Genome Canada, Alberta Innovates Health Solutions all to MDB, and the family of Clark H. Smith. DPC is the recipient of a Burroughs Wellcome Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata CM, 2010, CLIN CANCER RES, V16, P4517, DOI 10.1158/1078-0432.CCR-10-0526; Balvers RK, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0427-y; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Blough MD, 2010, NEURO-ONCOLOGY, V12, P756, DOI 10.1093/neuonc/noq032; Butowski NA, 2006, J CLIN ONCOL, V24, P1273, DOI 10.1200/JCO.2005.04.7522; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Cheng CL, 2005, MOL CANCER THER, V4, P1364, DOI 10.1158/1535-7163.MCT-05-0128; Clarke MJ, 2009, MOL CANCER THER, V8, P407, DOI 10.1158/1535-7163.MCT-08-0854; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; del Alcazar CRG, 2016, MOL CANCER RES, V14, P928, DOI 10.1158/1541-7786.MCR-16-0125; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Gupta SK, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv369; Gupta SK, 2014, CLIN CANCER RES, V20, P3730, DOI 10.1158/1078-0432.CCR-13-3446; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Huambachano O, 2011, J BIOL CHEM, V286, P7149, DOI 10.1074/jbc.M110.175190; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; Kelly JJP, 2010, NEURO-ONCOLOGY, V12, P745, DOI 10.1093/neuonc/noq031; Kummar S, 2009, J CLIN ONCOL, V27, P2705, DOI 10.1200/JCO.2008.19.7681; Lemasson B, 2016, NEOPLASIA, V18, P82, DOI 10.1016/j.neo.2015.11.014; Liu L, 1999, CLIN CANCER RES, V5, P2908; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Nguyen SA, 2014, CLIN CANCER RES, V20, P4894, DOI 10.1158/1078-0432.CCR-13-1856; Palma JP, 2009, CLIN CANCER RES, V15, P7277, DOI 10.1158/1078-0432.CCR-09-1245; Robins HI, 2016, J NEURO-ONCOL, V126, P309, DOI 10.1007/s11060-015-1966-z; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Su JM, 2014, NEURO-ONCOLOGY, V16, P1661, DOI 10.1093/neuonc/nou103; Tentori L, 2003, CLIN CANCER RES, V9, P5370; Tentori L, 2002, GLIA, V40, P44, DOI 10.1002/glia.10113; Tentori L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-151; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; van den Bent MJ, 2007, NEUROL CLIN, V25, P1089, DOI 10.1016/j.ncl.2007.07.013; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Woodhouse BC, 2008, DNA REPAIR, V7, P932, DOI 10.1016/j.dnarep.2008.03.017; Yip S, 2013, CLIN CANCER RES, V19, P4543, DOI 10.1158/1078-0432.CCR-13-1821; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102	43	20	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202860	10.1371/journal.pone.0202860	http://dx.doi.org/10.1371/journal.pone.0202860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153289	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700028
J	Choi, SM; Sum, RKW; Leung, EFL; Ng, RSK				Choi, Siu Ming; Sum, Raymond Kim Wai; Leung, Elean Fung Lin; Ng, Robert Siu Kuen			Relationship between perceived physical literacy and physical activity levels among Hong Kong adolescents	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; EUROPEAN ADOLESCENTS; GENDER-DIFFERENCES; IPAQ-A; SCHOOL; ASSOCIATIONS; FITNESS; PERFORMANCE; CHILDREN; AGE	This study explores the relationship between the perceived physical literacy (PL) and physical activity (PA) levels of Hong Kong adolescents by using a cross-sectional study design. A total of 1,945 adolescents aged between 12 and 18, (1,028 male and 917 female) with a mean age of 14.98 (+/- 1.65 years), took part in this study. A Perceived Physical Literacy Instrument (PPLI) and an International Physical Activity Questionnaire for Adolescents (IPAQ-A) were distributed to the participants within the first 15 minutes of PE lessons at their schools. The correlation between perceived PL and PA levels was low but significant (r = 0.227, p < 0.01), as was the correlation between the attributes of PL and PA intensity and the domains of PA (r = 0.067-0.292, p < 0.01). A significant linear equation was computed (F (3, 1941) = 35.679, p < 0.01), with an R-2 of 0.052. The metabolic equivalent (MET) minutes representing participants' predicted PA levels were -5490 + 366.1 (sense of self and self-confidence) + 221.866 (self-expression and communication with others) + 287.748 (knowledge and understanding). Looking at individual factors, the correlation between perceived PL and PA levels showed no significant difference across gender (r(male) = 0.234; r(female) = 0.198) but showed a significant difference across grade level (r(junior) = 0.302; r (senior) = 0.197), school bands (r(band 1) = 0.31; r(band 2) = 0.263; r(band 3) = 0.191) and socio-economic status (SES) (r(low) = 0.225; r(medium) = 0.35; r(high) = 0.191). The relationship between perceived PL and PA levels was significantly low but was closely related to the recreational PA, including individual factors such as gender, grade levels, school band and SES. Future studies could focus on school-based PA intervention programmes for perceived PL and the relationship between perceived PL and objective PA levels.	[Choi, Siu Ming; Sum, Raymond Kim Wai] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Shatin, Hong Kong, Peoples R China; [Leung, Elean Fung Lin; Ng, Robert Siu Kuen] Chinese Univ Hong Kong, Phys Educ Unit, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Sum, RKW (corresponding author), Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Shatin, Hong Kong, Peoples R China.	kwsum@cuhk.edu.hk	Choi, Siu Ming/AAY-3451-2021; Sum, Raymond/ABA-1210-2020; Choi, Siu Ming/P-3418-2018	Choi, Siu Ming/0000-0002-0716-699X; Sum, Raymond/0000-0002-4051-9945; Choi, Siu Ming/0000-0002-0716-699X	Chinese University of Hong Kong [4058033]	Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was funded by the direct grant for research (Grant Number: 4058033) of the Chinese University of Hong Kong (http://www.orkts.cuhk.edu.hk/research-and-funding/overview). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, QUALITY PHYS ED POLI; Booth M, 2000, Res Q Exerc Sport, V71 Suppl 2, P114, DOI 10.1080/02701367.2000.11082794; Castelli DM, 2014, PREV MED, V66, P95, DOI 10.1016/j.ypmed.2014.06.007; Census and Statistics Department (CSD), 2013, HONG KONG MONTHLY DI; Census and Statistics Department (CSD), 2016, HONG KONG 2016 POP C; Corbin CB, 2016, RES Q EXERCISE SPORT, V87, P14, DOI 10.1080/02701367.2016.1124722; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Curriculum Development Council (CDC), 2002, PHYS ED KEY LEARN AR; Dmitruk A., 2014, Polish Journal of Sport and Tourism, V21, P240; Education Bureau (EDB), 2017, GEN INF SEC SCH PLAC; Edwards JU, 2011, J SCHOOL HEALTH, V81, P65, DOI 10.1111/j.1746-1561.2010.00562.x; Edwards LC, 2017, SPORTS MED, V47, P113, DOI 10.1007/s40279-016-0560-7; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fox CK, 2010, J SCHOOL HEALTH, V80, P31, DOI 10.1111/j.1746-1561.2009.00454.x; Giblin S, 2014, SPORTS MED, V44, P1177, DOI 10.1007/s40279-014-0205-7; Ha AS, 2010, SPORT EDUC SOC, V15, P331, DOI 10.1080/13573322.2010.493313; Hagstromer M, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.182; Hagstromer M, 2010, J PHYS ACT HEALTH, V7, P541, DOI 10.1123/jpah.7.4.541; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hui SC, 2004, J PHYS ACT HEALTH, V1; Ingram DK, 2000, MED SCI SPORT EXER, V32, P1623; Keegan R., 2013, GETTING AUSTR MOVING; Keeley T.J.H., 2009, INT REV SPORT EXER P, V2, P198, DOI [10.1080/17509840903233822, DOI 10.1080/17509840903233822]; Kwak L, 2009, J PEDIATR-US, V155, P914, DOI 10.1016/j.jpeds.2009.06.019; Lloyd M, 2010, PEDIATR EXERC SCI, V22, P176, DOI 10.1123/pes.22.2.176; Longmuir PE, 2016, RES Q EXERCISE SPORT, V87, P28, DOI 10.1080/02701367.2016.1124671; Ottevaere C, 2011, J SCI MED SPORT, V14, P317, DOI 10.1016/j.jsams.2011.02.008; Singh A, 2012, ARCH PEDIAT ADOL MED, V166, P49, DOI 10.1001/archpediatrics.2011.716; Srikanth S, 2015, J EARLY ADOLESCENCE, V35, P353, DOI 10.1177/0272431614530807; Sum RKW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155610; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; United Nations Educational Scientific and Cultural Organization (UNESCO), 2013, WORLD WID SURV SCH P; USDHHS, 2008, PHYS ACT GUID AM; Vickerman P, 2010, PHYS LITERACY LIFECO; Vilhjalmsson R, 2003, SOC SCI MED, V56, P363, DOI 10.1016/S0277-9536(02)00042-4; Whitehead M., 2001, European Journal of Physical Education, V6, P127; Whitehead M., 2006, PE MATTERS, V1, P6; Whitehead M., 2013, INT COUNCIL SPORT SC, V65, P29; Whitehead M., 2016, INT PHYS LITERACY AS; Whitehead M., 2010, PHYS LITERACY, DOI DOI 10.4324/9780203881903; Whitehead M., 2013, J SPORT SCI PHYS ED, P52; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	43	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203105	10.1371/journal.pone.0203105	http://dx.doi.org/10.1371/journal.pone.0203105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148876	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200047
J	Fitzpatrick, KR; Cucak, A; McLoon, LK				Fitzpatrick, Krysta R.; Cucak, Anja; McLoon, Linda K.			Changing muscle function with sustained glial derived neurotrophic factor treatment of rabbit extraocular muscle	PLOS ONE			English	Article							LATERAL RECTUS MUSCLE; GROWTH-FACTOR-I; MYOSIN HEAVY; SKELETAL-MUSCLE; ADULT-RABBIT; MOTOR UNIT; NEUROMUSCULAR-JUNCTION; CONTRACTILE PROPERTIES; OCULOMOTOR NEURONS; GENE-EXPRESSION	Recent microarray and RNAseq experiments provided evidence that glial derived neurotrophic factor (GDNF) levels were decreased in extraocular muscles from human strabismic subjects compared to age-matched controls. We assessed the effect of sustained GDNF treatment of the superior rectus muscles of rabbits on their physiological and morphological characteristics, and these were compared to naive control muscles. Superior rectus muscles of rabbits were implanted with a sustained release pellet of GDNF to deliver 2 mu g/day, with the contralateral side receiving a placebo pellet. After one month, the muscles were assessed using in vitro physiological methods. The muscles were examined histologically for alteration in fiber size, myosin expression patterns, neuromuscular junction size, and stem cell numbers and compared to age-matched naive control muscles. GDNF resulted in decreased force generation, which was also seen on the untreated contralateral superior rectus muscles. Muscle relaxation times were increased in the GDNF treated muscles. Myofiber mean cross-sectional areas were increased after the GDNF treatment, but there was a compensatory increase in expression of developmental, neonatal, and slow tonic myosin heavy chain isoforms. In addition, in the GDNF treated muscles there was a large increase in Pitx2-positive myogenic precursor cells. One month of GDNF resulted in significant extraocular muscle adaptation. These changes are interesting relative to the decreased levels of GDNF in the muscles from subjects with strabismus and preliminary data in infant non-human primates where sustained GDNF treatment produced a strabismus. These data support the view that GDNF has the potential for improving eye alignment in subjects with strabismus.	[Fitzpatrick, Krysta R.; Cucak, Anja; McLoon, Linda K.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA; [McLoon, Linda K.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	McLoon, LK (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.; McLoon, LK (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	mcloo001@umn.edu		McLoon, LInda/0000-0001-9714-4681	NIH from the National Eye Institute [R01EY15313, P30 EY11375]; Minnesota Lions Foundation; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [R01EY015313] Funding Source: NIH RePORTER	NIH from the National Eye Institute; Minnesota Lions Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by NIH R01EY15313 (LKM) and NIH P30 EY11375 from the National Eye Institute, the Minnesota Lions Foundation, and an unrestricted grant to the Department of Ophthalmology and Visual Neurosciences from Research to Prevent Blindness, Inc. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAOGLU MN, 2015, INVEST OPHTH VIS SCI, V56; Agarwal AB, 2016, INVEST OPHTH VIS SCI, V57, P5576, DOI 10.1167/iovs.16-20294; Ahn AN, 2003, J PHYSIOL-LONDON, V549, P877, DOI 10.1113/jphysiol.2002.038018; Altick AL, 2012, INVEST OPHTH VIS SCI, V53, P5168, DOI 10.1167/iovs.12-9785; Anderson BC, 2008, INVEST OPHTH VIS SCI, V49, P221, DOI 10.1167/iovs.07-0600; Baumgartner BJ, 1998, J NEUROSCI RES, V54, P766, DOI 10.1002/(SICI)1097-4547(19981215)54:6<766::AID-JNR4>3.0.CO;2-A; Belair EL, 2005, J PHYSIOL-LONDON, V569, P163, DOI 10.1113/jphysiol.2005.094805; Chen J, 2004, INVEST OPHTH VIS SCI, V45, P3538, DOI 10.1167/iovs.04-0393; Chen J, 2003, MOL CELL NEUROSCI, V24, P41, DOI 10.1016/S1044-7431(03)00098-8; Christiansen SP, 2010, INVEST OPHTH VIS SCI, V51, P5646, DOI 10.1167/iovs.10-5523; Glat MJ, 2016, J MOL NEUROSCI, V58, P39, DOI 10.1007/s12031-015-0648-9; Goldberg SJ, 1998, J NEUROSCI, V18, P10629; Goldberg SJ, 1997, MUSCLE NERVE, V20, P1229, DOI 10.1002/(SICI)1097-4598(199710)20:10<1229::AID-MUS4>3.0.CO;2-E; Harandi VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109833; Hebert SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058405; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; HUGHES A, 1982, J COMP NEUROL, V204, P151, DOI 10.1002/cne.902040205; JOHNSON BD, 1994, J APPL PHYSIOL, V77, P481, DOI 10.1152/jappl.1994.77.1.481; Kallestad KM, 2011, EXP CELL RES, V317, P873, DOI 10.1016/j.yexcr.2011.01.018; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Li TA, 2011, PFLUG ARCH EUR J PHY, V461, P373, DOI 10.1007/s00424-011-0925-6; Li T, 2010, INVEST OPHTH VIS SCI, V51, P2479, DOI 10.1167/iovs.09-4414; LOWEY S, 1993, J BIOL CHEM, V268, P20414; Mantilla CB, 2004, MUSCLE NERVE, V29, P381, DOI 10.1002/mus.10558; McLoon LK, 2006, J AAPOS, V10, P424, DOI 10.1016/j.jaapos.2006.06.011; McLoon LK, 2018, INVEST OPHTH VIS SCI, V59, P322, DOI 10.1167/iovs.17-23003; McLoon LK, 2016, INVEST OPHTH VIS SCI, V57, P6070, DOI 10.1167/iovs.16-19739; McLoon LK, 2011, J APPL PHYSIOL, V111, P1178, DOI 10.1152/japplphysiol.00368.2011; McLoon LK, 2004, MUSCLE NERVE, V29, P707, DOI 10.1002/mus.20012; McLoon LK, 2003, INVEST OPHTH VIS SCI, V44, P3866, DOI 10.1167/iovs.03-0223; McLoon LK, 2002, MUSCLE NERVE, V25, P348, DOI 10.1002/mus.10056; McLoon LK, 2016, INVEST OPHTH VIS SCI, V57, P1395; Morcuende S, 2013, NEUROSCIENCE, V250, P31, DOI 10.1016/j.neuroscience.2013.06.050; NELSON AG, 1994, AM J PHYSIOL, V266, pC919, DOI 10.1152/ajpcell.1994.266.4.C919; Nelson KR, 2016, INVEST OPHTH VIS SCI, V57, P5834, DOI 10.1167/iovs.16-19679; Park JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090245; PATTON JF, 1990, EUR J APPL PHYSIOL O, V60, P222, DOI 10.1007/BF00839163; Pawlikowski B, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0067-1; PULLELA M, 2015, INVEST OPHTH VIS SCI, V56; Pullela M, 2016, INVEST OPHTH VIS SCI, V57, P6040, DOI 10.1167/iovs.16-20481; REISER PJ, 1988, DEV BIOL, V129, P400, DOI 10.1016/0012-1606(88)90387-9; Rubinstein NA, 2000, INVEST OPHTH VIS SCI, V41, P3391; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Seale Patrick, 2000, Cell, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sendtner M, 1998, CYTOKINE GROWTH F R, V9, P1, DOI 10.1016/S1359-6101(97)00033-6; Steljes TPV, 1999, J NEUROBIOL, V41, P295, DOI 10.1002/(SICI)1097-4695(19991105)41:2<295::AID-NEU11>3.0.CO;2-W; Suzuki H, 1998, NEUROSCI LETT, V257, P165, DOI 10.1016/S0304-3940(98)00817-9; Thalhammer A, 2014, NEUROPHARMACOLOGY, V78, P23, DOI 10.1016/j.neuropharm.2013.03.015; Verma Mayank, 2017, Curr Ophthalmol Rep, V5, P207, DOI 10.1007/s40135-017-0141-4; WIECZOREK DF, 1985, J CELL BIOL, V101, P618, DOI 10.1083/jcb.101.2.618; Willoughby CL, 2015, INVEST OPHTH VIS SCI, V56, P3467, DOI 10.1167/iovs.15-16852; Willoughby CL, 2015, INVEST OPHTH VIS SCI, V56, P3484, DOI 10.1167/iovs.15-16761; Yang LX, 2004, NEUROSCIENCE, V128, P497, DOI 10.1016/j.neuroscience.2004.06.067; Zwick M, 2001, EXP NEUROL, V171, P342, DOI 10.1006/exnr.2001.7753	54	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202861	10.1371/journal.pone.0202861	http://dx.doi.org/10.1371/journal.pone.0202861			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142211	gold, Green Published, Green Submitted			2022-12-27	WOS:000442722500042
J	Krekula, LG; Forinder, U; Tibell, A				Krekula, Linda Gyllstrom; Forinder, Ulla; Tibell, Annika			What do people agree to when stating willingness to donate? On the medical interventions enabling organ donation after death	PLOS ONE			English	Article							BRAIN-DEATH; EXPERIENCES; ATTITUDES; FAMILIES; LIFE	Purpose of the study The purpose of this study is to explore donor relatives' experiences of the medical interventions enabling organ donation, as well as to examine the donor relatives' attitudes towards donating their own organs, and whether or not their experiences have influenced their own inclination to donate. Methods The experiences of donor relatives were explored via in-depth interviews. The interviews covered every step from the deceased family member being struck by a severe bleeding in the brain till after the organ recovery, including the medical interventions enabling organ donation. The interviews were analysed through qualitative and quantitative content analysis. Results Brain death and organ donation proved to be hard to understand for many donor relatives. The prolonged interventions provided after death in order to enable organ donation misled some relatives to believe that their family member still was alive. In general, the understanding for what treatment aimed at saving the family member and what interventions aimed at maintaining organ viability was low. However, most donor relatives were either inspired to, or reinforced in their willingness to, donate their own organs after having experienced the loss of a family member who donated organs. Conclusions There is a need for greater transparency regarding the whole chain of events during the donation process. Yet, having experienced the donation process closely did not discourage the donor relatives from donating their own organs-but rather inspired a willingness to donate. This indicates an acceptance of the medical procedures necessary in order to enable organ donation after death.	[Krekula, Linda Gyllstrom] Karolinska Univ Hosp, Funct Area Social Work Hlth Care, Stockholm, Sweden; [Krekula, Linda Gyllstrom; Tibell, Annika] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Forinder, Ulla] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Forinder, Ulla] Univ Gavle, Dept Social Work & Psychol, Gavle, Sweden; [Tibell, Annika] Karolinska Univ Hosp, New Karolinska, PMO, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; University of Gavle; Karolinska Institutet; Karolinska University Hospital	Krekula, LG (corresponding author), Karolinska Univ Hosp, Funct Area Social Work Hlth Care, Stockholm, Sweden.; Krekula, LG (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden.	linda.gyllstrom-krekula@sll.se			Svensk Njurmedicinsk Forening, Patient Organisation; Stiftelsen Professor Lars-Erik Gelins, Minnesfond; Foundation in memory of Professor Lars-Erik Gelin; Stiftelsen Stig och Gunborg Westman	Svensk Njurmedicinsk Forening, Patient Organisation; Stiftelsen Professor Lars-Erik Gelins, Minnesfond; Foundation in memory of Professor Lars-Erik Gelin; Stiftelsen Stig och Gunborg Westman	LGK received financial support from: Svensk Njurmedicinsk Forening, Patient Organisation, www.njurmed.se; Stiftelsen Professor Lars-Erik Gelins, Minnesfond, Foundation in memory of Professor Lars-Erik Gelin, www.gelinfonden.org; L. Jacobssons testamente, foundation in memory of L. Jacobsson; and Stiftelsen Stig och Gunborg Westman, private foundation, www.stiftelsemedel.se/stiftelsen-stig-och-gunborg-westman-fr-forskning-kring-njursjukdomar-organtransplantation-och-organdonation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, 201584 SOU, P84; [Anonymous], 2011, 20117 SOSFS, P7; Berntzen H, 2014, INTENS CRIT CARE NUR, V30, P266, DOI 10.1016/j.iccn.2014.03.001; Burroughs TE, 1998, PSYCHOSOM MED, V60, P156, DOI 10.1097/00006842-199803000-00007; Camut S, 2014, NURS ETHICS; Cohen J, 2008, CLIN TRANSPLANT, V22, P211, DOI 10.1111/j.1399-0012.2007.00776.x; Commission E, 2010, ORG DON TRANSPL DIR; de Groot J, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-52; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Floden Anne, 2009, Intensive Crit Care Nurs, V25, P306, DOI 10.1016/j.iccn.2009.06.002; Floden Anne, 2011, Intensive Crit Care Nurs, V27, P305, DOI 10.1016/j.iccn.2011.08.002; Fridh I, 2014, INTENS CRIT CARE NUR, V30, P306, DOI 10.1016/j.iccn.2014.07.004; General Medical Council U, TREATM CAR END LIF G; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hynninen M, 2008, ACTA ANAESTH SCAND, V52, P1081, DOI 10.1111/j.1399-6576.2008.01636.x; Kazdin A. E, 2016, RES DESIGN CLIN PSYC, DOI 10.1017/9781108993647; Kilcullen JK, 2014, J CRIT CARE, V29, P872, DOI 10.1016/j.jcrc.2014.06.018; Krippendorff K., 2012, CONTENT ANAL INTRO I; Long T, 2008, PROG TRANSPLANT, V18, P118, DOI 10.7182/prtr.18.2.07707n0107q43781; National Institute for Health and Clinical Exellence U, QUICK REF GUID ORG D; Oroy A, 2014, NURS ETHICS, P1; Pearson A, 2001, J CLIN NURS, V10, P132, DOI 10.1046/j.1365-2702.2001.00447.x; PEARSON IY, 1995, ANAESTH INTENS CARE, V23, P88, DOI 10.1177/0310057X9502300116; Polit DF., 2008, NURSING RES GENERATI; Ralph A, 2014, AM J TRANSPLANT, V14, P923, DOI 10.1111/ajt.12660; Sadala MLA, 2006, HEART LUNG, V35, P190, DOI 10.1016/j.hrtlng.2005.12.004; Sandelowski M, 2001, RES NURS HEALTH, V24, P230, DOI 10.1002/nur.1025; Sharp T., 2009, JICS, V10; Shemie SD, 2014, ANN NY ACAD SCI, V1330, P101, DOI 10.1111/nyas.12564; Yaguchi A, 2009, ARCH INTERN MED, V165	30	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202544	10.1371/journal.pone.0202544	http://dx.doi.org/10.1371/journal.pone.0202544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142168	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500017
J	Ma, MX; Proffitt, R; Skubic, M				Ma, Mengxuan; Proffitt, Rachel; Skubic, Marjorie			Validation of a Kinect V2 based rehabilitation game	PLOS ONE			English	Article							VIRTUAL-REALITY; IN-HOME; RELIABILITY; MOVEMENT; EFFICACY; VALIDITY; MOTION; RANGE; WII	Interactive technologies are beneficial to stroke recovery as rehabilitation interventions; however, they lack evidence for use as assessment tools. Mystic Isle is a multi-planar full-body rehabilitation game developed using the Microsoft Kinect (R) V2. It aims to help stroke patients improve their motor function and daily activity performance and to assess the motions of the players. It is important that the assessment results generated from Mystic Isle are accurate. The Kinect V2 has been validated for tracking lower limbs and calculating gait-specific parameters. However, few studies have validated the accuracy of the Kinect (R) V2 skeleton model in upper-body movements. In this paper, we evaluated the spatial accuracy and measurement validity of a Kinect-based game Mystic Isle in comparison to a gold-standard optical motion capture system, the Vicon system. Thirty participants completed six trials in sitting and standing. Game data from the Kinect sensor and the Vicon system were recorded simultaneously, then filtered and sample rate synchronized. The spatial accuracy was evaluated using Pearson's r correlation coefficient, signal to noise ratio (SNR) and 3D distance difference. Each arm-joint signal had an average correlation coefficient above 0.9 and a SNR above 5. The hip joints data had less stability and a large variation in SNR. Also, the mean 3D distance difference of joints were less than 10 centimeters. For measurement validity, the accuracy was evaluated using mean and standard error of the difference, percentage error, Pearson's r correlation coefficient and intra-class correlation (ICC). Average errors of maximum hand extent of reach were less than 5% and the average errors of mean and maximum velocities were about 10% and less than 5%, respectively. We have demonstrated that Mystic Isle provides accurate measurement and assessment of movement relative to the Vicon system.	[Ma, Mengxuan; Skubic, Marjorie] Univ Missouri, Dept Elect Engn & Comp Sci, Columbia, MO 65211 USA; [Proffitt, Rachel] Univ Missouri, Dept Occupat Therapy, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ma, MX (corresponding author), Univ Missouri, Dept Elect Engn & Comp Sci, Columbia, MO 65211 USA.	mmrnc@mail.missouri.edu	Proffitt, Rachel M/B-6179-2016	Proffitt, Rachel M/0000-0002-7357-6495	Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC) [W911NF-04-D-0005]; NIH National Center for Advancing Translational Sciences (NCATS), components of the National Institutes of Health (NIH) [UL1 TR000448]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, KL2TR002346] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024994] Funding Source: NIH RePORTER	Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NIH National Center for Advancing Translational Sciences (NCATS), components of the National Institutes of Health (NIH); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC) (W911NF-04-D-0005) (PI: Lange) and by Grant Number UL1 TR000448 from the NIH National Center for Advancing Translational Sciences (NCATS), components of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsatar F, 2013, J PEDIATR REHAB MED, V6, P193, DOI 10.3233/PRM-130260; Acar G, 2016, J PHYS THER SCI, V28, P774, DOI 10.1589/jpts.28.774; Alexandrova Ivelina V, 2012, Stud Health Technol Inform, V173, P16; Anderson Kelly R, 2015, Arch Phys Med Rehabil, V96, P973, DOI 10.1016/j.apmr.2014.09.008; Baheux Kenji, 2005, Technol Health Care, V13, P245; BOONE DC, 1978, PHYS THER, V58, P1355, DOI 10.1093/ptj/58.11.1355; Brennan DM, 2009, STUD HEALTH TECHNOL, V145, P231, DOI 10.3233/978-1-60750-018-6-231; Broeren J, 2002, CYBERPSYCHOL BEHAV, V5, P207, DOI 10.1089/109493102760147196; Chanpimol Shane, 2017, Arch Physiother, V7, DOI 10.1186/s40945-017-0033-9; Chien-Yen Chang, 2012, 2012 6th International Conference on Pervasive Computing Technologies for Healthcare, P159, DOI 10.4108/icst.pervasivehealth.2012.248714; Chow Y. W., 2017, J WIRELESS MOBILE NE, V8, P18; Geerse DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139913; Guess TM, 2017, J APPL BIOMECH, V33, P176, DOI 10.1123/jab.2016-0107; Hartmann M, 2014, GAIT POSTURE, V39, pS109, DOI [10.1016/j.gaitpost.2014.04.150, DOI 10.1016/J.GAITPOST.2014.04.150]; HORGER MM, 1990, AM J OCCUP THER, V44, P342, DOI 10.5014/ajot.44.4.342; Hotrabhavananda B, 2016, IEEE ENG MED BIO, P2274, DOI 10.1109/EMBC.2016.7591183; Kurillo G, 2013, TECHNOL HEALTH CARE, V21, P641, DOI 10.3233/THC-130764; Lange B, 2012, DISABIL REHABIL, V34, P1863, DOI 10.3109/09638288.2012.670029; LifeModeler, MARK PLAC PROT LIFEM; Ma MX, 2017, 2017 IEEE/ACM SECOND INTERNATIONAL CONFERENCE ON CONNECTED HEALTH - APPLICATIONS, SYSTEMS AND ENGINEERING TECHNOLOGIES (CHASE), P255, DOI 10.1109/CHASE.2017.90; Mentiplay BF, 2015, J BIOMECH, V48, P2166, DOI 10.1016/j.jbiomech.2015.05.021; Microsoft, REFL HLTH; Mitchell K, 2014, PHYSIOTHER THEOR PR, V30, P521, DOI 10.3109/09593985.2014.900593; Motiian S, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0102-9; Mousavi Hondori Hossein, 2014, J Med Eng, V2014, P846514, DOI 10.1155/2014/846514; Muller B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175813; Nixon ME, 2011, 2013 INT C VIRT REH, P222; Otte K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166532; Pathirana PN, 2016, IEEE T IND ELECTRON, V63, P1822, DOI 10.1109/TIE.2015.2497662; Pourmand A, 2017, GAMES HEALTH J, V6, P263, DOI 10.1089/g4h.2017.0046; Proffitt R, 2015, INT J TELEREHABILITA, V7, P23, DOI 10.5195/ijt.2015.6177; Proffitt R, 2015, PHYS THER, V95, P441, DOI 10.2522/ptj.20130571; Springer S, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16020194; Stone E, 2011, J AMB INTEL SMART EN, V3, P349, DOI 10.3233/AIS-2011-0124; Sugarman H., 2011, VIRTUAL REHABILITATI, P1; Therapy P., MAKING PHYS THERAPY; van de Pol RJ, 2010, J PHYSIOTHER, V56, P7, DOI 10.1016/S1836-9553(10)70049-7; Vicon Motion Systems, FULL BOD MOD PLUG GA; Wilson JD, 2017, J SHOULDER ELB SURG, V26, pE382, DOI 10.1016/j.jse.2017.06.004	39	35	35	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202338	10.1371/journal.pone.0202338	http://dx.doi.org/10.1371/journal.pone.0202338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142631	gold, Green Published, Green Submitted			2022-12-27	WOS:000442722500011
J	van Rijssen, TJ; Mohabati, D; Dijkman, G; Theelen, T; de Jong, EK; van Dijk, EHC; Boon, CJF				van Rijssen, Thomas J.; Mohabati, Daniel; Dijkman, Greet; Theelen, Thomas; de Jong, Eiko K.; van Dijk, Elon H. C.; Boon, Camiel J. F.			Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy	PLOS ONE			English	Article							FOVEAL PHOTORECEPTOR LAYER; THICKNESS; DENSITY; SEGMENT	Purpose To assess parameters on optical coherence tomography (OCT), and their correlation with best-corrected visual acuity (BCVA) in patients with non-resolving central serous chorioretinopathy (CSC). Methods For 25 non-resolving CSC patients treated with photodynamic therapy (PDT), the thickness of retinal layers was assessed on the foveal spectral-domain (SD) OCT scan. Evaluated OCT parameters included the central retinal thickness (CRT), defined as the internal limiting membrane (ILM) to ellipsoid zone (EZ) distance, and the second band thickness (SBT), defined as the EZ to hyperreflective subretinal accumulation distance. Integrity of the external limiting membrane (ELM) and the EZ bands was also determined. These parameters, along with BCVA and CRT measured automatically by SD-OCT device software were obtained before PDT, after PDT, and at final visit. After Bonferroni correction, a p-value <0.007 was considered statistically significant. Results Twenty-five patients could be included at last visit before PDT and first visit after PDT. At final visit, 24 patients could be included, since 1 patients was lost to follow-up. Mean CRT was 112 mu m at last visit before PDT, 118 mu m at first visit after PDT (p = 0.030), and 127 mu m at final visit (p<0.001 compared to baseline). Mean SBT was 74 mu m, 26 mu m (p<0.001 compared to baseline), and 21 mu m (p<0.001 compared to baseline), respectively. Mean BCVA in Early Treatment of Diabetic Retinopathy Study letters was 79 at baseline, 85 at first visit after PDT (p = 0.005 compared to baseline), and 87 at final visit (p = 0.001 compared to baseline). BCVA had an estimated correlation of beta = 0.103 (p = 0.114) with CRT, beta = -0.051 (p = 0.014) with SBT, beta = 0.615 (p = 0.600) with the integrity of the ELM, and beta = 4.917 with the integrity of the EZ (p = 0.001). Conclusions In non-resolving CSC patients treated with half-dose PDT, the CRT increased at final visit in comparison to the last visit before PDT. The continuity of the EZ on SD-OCT was positively correlated with BCVA. We propose that the distance between ILM and EZ should be used as a reliable CRT measurement in non-resolving CSC patients treated with half-dose PDT.	[van Rijssen, Thomas J.; Mohabati, Daniel; Dijkman, Greet; van Dijk, Elon H. C.; Boon, Camiel J. F.] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands; [Theelen, Thomas; de Jong, Eiko K.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Ophthalmol, Med Ctr, Nijmegen, Netherlands; [Boon, Camiel J. F.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Boon, CJF (corresponding author), Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands.; Boon, CJF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands.	c.j.f.boon@lumc.nl	Theelen, Thomas/A-3192-2012; Boon, CJF/P-7534-2014	Theelen, Thomas/0000-0001-9067-1171; Boon, CJF/0000-0002-6737-7932	Macula Fonds; Retina Netherlands, BlindenPenning; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Rotterdamse Stichting Blindenbelangen, Stichting Leids Oogheelkundig Ondersteuningsfonds; Haagse Stichting Blindenhulp; Gisela Thier Fellowship of Leiden University; VENI grant of Netherlands Organization for Scientific Research (NWO)	Macula Fonds; Retina Netherlands, BlindenPenning; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Landelijke Stichting voor Blinden en Slechtzienden; Rotterdamse Stichting Blindenbelangen, Stichting Leids Oogheelkundig Ondersteuningsfonds; Haagse Stichting Blindenhulp; Gisela Thier Fellowship of Leiden University; VENI grant of Netherlands Organization for Scientific Research (NWO)	This research was supported by the following foundations: Macula Fonds (http://maculafonds.nl/), Retina Netherlands, BlindenPenning (http://www.blinden-penning.nl/), Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (http://www.anvvb.nl/), and Landelijke Stichting voor Blinden en Slechtzienden (https://www.lsbs.nl/), which contributed through UitZicht (https://www.uitzicht.nl/), as well as Rotterdamse Stichting Blindenbelangen, Stichting Leids Oogheelkundig Ondersteuningsfonds (http://stichtingloof.nl/), and Haagse Stichting Blindenhulp (http://www.blindenhulp.nl/). Prof. Camiel J.F. Boon was supported by a Gisela Thier Fellowship of Leiden University, and a VENI grant of Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arf S, 2016, INT OPHTHALMOLOGY; Breukink MB, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0939-z; Cakir B, 2016, GRAEF ARCH CLIN EXP, V254, P2151, DOI 10.1007/s00417-016-3373-3; Cheng C, 2016, RETINA-J RET VIT DIS, V36, P717, DOI 10.1097/IAE.0000000000000757; Choi KE, 2017, RETINA-J RET VIT DIS, V37, P568, DOI 10.1097/IAE.0000000000001170; Daruich A, 2015, PROG RETIN EYE RES, V48, P82, DOI 10.1016/j.preteyeres.2015.05.003; de Jong EK, 2015, OPHTHALMOLOGY, V122, P562, DOI 10.1016/j.ophtha.2014.09.026; Dhirani NA, 2017, CLIN OPHTHALMOL, V11, DOI 10.2147/OPTH.S151933; Furuta M, 2009, OPHTHALMOLOGICA, V223, P28, DOI 10.1159/000161880; Ghadiali Q, 2016, RETINA-J RET VIT DIS, V36, P611, DOI 10.1097/IAE.0000000000000748; Haga F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181479; Haimovici R, 2004, OPHTHALMOLOGY, V111, P244, DOI 10.1016/j.ophtha.2003.09.024; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Lai FHP, 2016, AM J OPHTHALMOL, V170, P91, DOI 10.1016/j.ajo.2016.07.026; Matsumoto H, 2008, AM J OPHTHALMOL, V145, P162, DOI 10.1016/j.ajo.2007.08.024; Nakamura T, 2016, GRAEF ARCH CLIN EXP, V254, P2347, DOI 10.1007/s00417-016-3403-1; Ohkuma Y, 2013, GRAEF ARCH CLIN EXP, V251, P1909, DOI 10.1007/s00417-013-2289-4; Ojima Y, 2007, OPHTHALMOLOGY, V114, P2197, DOI 10.1016/j.ophtha.2007.02.015; Ojima Y, 2010, JPN J OPHTHALMOL, V54, P55, DOI 10.1007/s10384-009-0766-4; Piccolino FC, 2005, AM J OPHTHALMOL, V139, P87, DOI 10.1016/j.ajo.2004.08.037; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Salehi M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011841.pub2; Sayanagi K, 2009, OPHTHALMOLOGY, V116, P947, DOI 10.1016/j.ophtha.2008.11.002; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Tao LW, 2016, CLIN EXP OPHTHALMOL, V44, P422, DOI 10.1111/ceo.12685; Tzekov R, 2006, INVEST OPHTH VIS SCI, V47, P377, DOI 10.1167/iovs.05-0838; Wang JS, 2009, NAT NEUROSCI, V12, P295, DOI 10.1038/nn.2258; Wang M, 2005, ACTA OPHTHALMOL SCAN, V83, P691, DOI 10.1111/j.1600-0420.2005.00582.x; Williamson TH, 2013, EYE, V27, P1063, DOI 10.1038/eye.2013.136; Yalcinbayir O, 2014, RETINA-J RET VIT DIS, V34, P705, DOI 10.1097/IAE.0000000000000001; Yannuzzi LA, 2003, RETINA-J RET VIT DIS, V23, P288, DOI 10.1097/00006982-200306000-00002	32	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202549	10.1371/journal.pone.0202549	http://dx.doi.org/10.1371/journal.pone.0202549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142176	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500019
J	Xu, BH; Lu, YQ; Ye, ZW; Zheng, QW; Wei, T; Lin, JF; Guo, LQ				Xu, Ben-Hong; Lu, Ya-Qin; Ye, Zhi-Wei; Zheng, Qian-Wang; Wei, Tao; Lin, Jun-Fang; Guo, Li-Qiong			Genomics-guided discovery and structure identification of cyclic lipopeptides from the Bacillus siamensis JFL15	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; BACILLOMYCIN-D; SUBTILIS SPB1; AMYLOLIQUEFACIENS; PURIFICATION; SURFACTIN; FENGYCIN; ITURIN; GENES; BIOSYNTHESIS	In this research, a strain with broad-spectrum antimicrobial activities was isolated from the gastrointestinal tract of hairtail (Trichiurus haumela) and identified as Bacillus siamensis JFL15 through morphological, 16S rRNA, and average nucleotide identity analyses. The genome of B. siamensis JFL15 was sequenced, and three gene clusters involved in the biosynthesis of surfactin (srf), bacillibactin (dhb), and fengycin (fen) were predicted through antiSMASH analysis. The combined genomics-metabolics profiling of the strain revealed 20 active compounds, which belong to four main types of cyclic lipopeptides produced by Bacillus species: bacillibactin, iturin, fengycin, and surfactin. Among these lipopeptides, two highpurity antifungal components, namely, components b and c, were successfully identified as iturin A and bacillomycin F. The minimum inhibitory concentrations (MICs) of iturin A for Magnapothe grisea, Rhizoctorzia solani, and Colletotrichum gloeosporioides were 125.00, 62.50, and 125.00 mu g/ml, respectively, whereas the MICs of bacillomycin F for these three organisms were 62.50, 31.25, and 62.50 mu g/ml, respectively. The mechanism of bacillomycin F and iturin A against M. grisea was also investigated. Scanning electron microscopy (SEM) indicated that the surface of the hypha treated with iturin A or bacillomycin F became sunk, lumpy, and wrinkled. The diversity of the identified and predicted compounds from B. siamensis JFL15 suggested that this strain might be a promising biocontrol agent for an effective and environmentally friendly control of pathogenic microorganisms. To the best of our knowledge, this study is the first to describe cyclic lipopeptides purified and identified from B. siamensis.	[Xu, Ben-Hong; Lu, Ya-Qin; Ye, Zhi-Wei; Zheng, Qian-Wang; Wei, Tao; Lin, Jun-Fang; Guo, Li-Qiong] South China Agr Univ, Coll Food Sci, Guangzhou, Guangdong, Peoples R China; [Xu, Ben-Hong; Lu, Ya-Qin; Ye, Zhi-Wei; Zheng, Qian-Wang; Wei, Tao; Lin, Jun-Fang; Guo, Li-Qiong] South China Agr Univ, Inst Food Biotechnol, Guangzhou, Guangdong, Peoples R China; [Xu, Ben-Hong; Lu, Ya-Qin; Ye, Zhi-Wei; Zheng, Qian-Wang; Wei, Tao; Lin, Jun-Fang; Guo, Li-Qiong] Res Ctr Microecol Agent Engn & Technol Guangdong, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Lin, JF; Guo, LQ (corresponding author), South China Agr Univ, Coll Food Sci, Guangzhou, Guangdong, Peoples R China.; Lin, JF; Guo, LQ (corresponding author), South China Agr Univ, Inst Food Biotechnol, Guangzhou, Guangdong, Peoples R China.; Lin, JF; Guo, LQ (corresponding author), Res Ctr Microecol Agent Engn & Technol Guangdong, Guangzhou, Guangdong, Peoples R China.	linjf@scau.edu.cn; guolq@scau.edu.cn	tao, wei/GXN-4445-2022	Lin, Jun-Fang/0000-0002-2981-5188; Ye, Zhi-Wei/0000-0001-7537-2739	National Natural Science Foundation of China [31372116]; Projects of Science and Technology of Guangdong Province [2015A020209121, 2014B050505018]; Project of Science and Technology of Guangzhou City [201607010197]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of Science and Technology of Guangdong Province; Project of Science and Technology of Guangzhou City	This work was supported by the National Natural Science Foundation of China (Grant Number 31372116)(LQG), the Projects of Science and Technology of Guangdong Province (Grant Numbers 2015A020209121 and 2014B050505018)(JFL), the Project of Science and Technology of Guangzhou City (Grant Number 201607010197)(JFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltz RH, 2017, J IND MICROBIOL BIOT, V44, P573, DOI 10.1007/s10295-016-1815-x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; [陈倩倩 Chen Qianqian], 2016, [农业生物技术学报, Journol of Agricultural Biotechnology], V24, P261; Chiou AL, 2003, J PHYTOPATHOL, V151, P13, DOI 10.1046/j.1439-0434.2003.00669.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dunlap CA, 2015, INT J SYST EVOL MICR, V65, P3507, DOI 10.1099/ijsem.0.000444; Falardeau J, 2013, J CHEM ECOL, V39, P869, DOI 10.1007/s10886-013-0319-7; Galica T, 2017, J PHYCOL, V53, P985, DOI 10.1111/jpy.12555; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gong AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116871; Gong QW, 2014, FOOD CONTROL, V36, P8, DOI 10.1016/j.foodcont.2013.07.034; Jasim B, 2016, MICROB ECOL, V72, P106, DOI 10.1007/s00248-016-0753-5; Jeong H, 2012, J BACTERIOL, V194, P4148, DOI 10.1128/JB.00805-12; Kamysz E, 2015, INT J PEPT RES THER, V21, P39, DOI 10.1007/s10989-014-9423-y; Kim YO, 2014, J KOREAN SOC APPL BI, V57, P605, DOI 10.1007/s13765-014-4174-1; Kreutzer MF, 2012, ORG BIOMOL CHEM, V10, P9338, DOI 10.1039/c2ob26296g; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee H, 2008, J APPL MICROBIOL, V105, P663, DOI 10.1111/j.1365-2672.2008.03797.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mnif I, 2016, ENVIRON SCI POLLUT R, V23, P6690, DOI 10.1007/s11356-015-5826-3; Mnif I, 2015, ENVIRON SCI POLLUT R, V22, P18137, DOI 10.1007/s11356-015-5005-6; Moyne AL, 2001, J APPL MICROBIOL, V90, P622, DOI 10.1046/j.1365-2672.2001.01290.x; Naughton LM, 2017, FRONT MICROBIOL, V8, P1, DOI [10.3389/fmicb.2017.00001, DOI 10.3389/FMICB.2017.00001]; Niazi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104651; Paulus C, 2017, SCI REP-UK, V7, DOI 10.1038/srep42382; Ramarathnam R, 2007, CAN J MICROBIOL, V53, P901, DOI 10.1139/W07-049; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roongsawang N, 2002, EXTREMOPHILES, V6, P499, DOI 10.1007/s00792-002-0287-2; Sharma SCD, 2013, J MICROB BIOTEC FOOD, V2, P2293; Shrestha BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146764; Singh RK, 2014, PLANT GROWTH REGUL, V73, P91, DOI 10.1007/s10725-013-9870-z; Song B, 2013, APPL MICROBIOL BIOT, V97, P7141, DOI 10.1007/s00253-013-5000-0; Tani H, 2005, J NAT PROD, V68, P1768, DOI 10.1021/np0503855; Wang NN, 2015, GENET MOL RES, V14, P15488, DOI 10.4238/2015.November.30.27; Xu Benhong, 2018, Fisheries Science (Liaoning), V37, P193; Xu ZH, 2013, APPL ENVIRON MICROB, V79, P808, DOI 10.1128/AEM.02645-12; Yang H, 2015, ANAL BIOANAL CHEM, V407, P2529, DOI 10.1007/s00216-015-8486-8; Zhang B, 2013, APPL BIOCHEM BIOTECH, V171, P2262, DOI 10.1007/s12010-013-0424-7; Zhang B, 2013, BBA-BIOMEMBRANES, V1828, P2230, DOI 10.1016/j.bbamem.2013.05.033; Zhao JF, 2014, INT J MOL SCI, V15, P19847, DOI 10.3390/ijms151119847; Zhao JF, 2012, J IND MICROBIOL BIOT, V39, P889, DOI 10.1007/s10295-012-1098-9	41	20	24	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202893	10.1371/journal.pone.0202893	http://dx.doi.org/10.1371/journal.pone.0202893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169540	Green Published, Green Submitted, gold			2022-12-27	WOS:000443374400016
J	Adekpedjou, R; Stacey, D; Briere, N; Freitas, A; Garvelink, MM; Turcotte, S; Menear, M; Bourassa, H; Fraser, K; Durand, PJ; Dumont, S; Roy, L; Legere, F				Adekpedjou, Rheda; Stacey, Dawn; Briere, Nathalie; Freitas, Adriana; Garvelink, Mirjam M.; Turcotte, Stephane; Menear, Matthew; Bourassa, Henriette; Fraser, Kimberley; Durand, Pierre J.; Dumont, Serge; Roy, Lise; Legere, France			"Please listen to me": A cross-sectional study of experiences of seniors and their caregivers making housing decisions	PLOS ONE			English	Article							RESIDENTIAL-MOBILITY; FAMILY CAREGIVERS; HEALTH-STATUS; ZARIT-BURDEN; CARE; SUPPORT; RELIABILITY; VALIDATION; NEEDS; RELOCATION	Background Little is known about the decision-making experiences of seniors and informal caregivers facing decisions about seniors' housing decisions when objective decision making measures are used. Objectives To report on seniors' and caregivers' experiences of housing decisions. Design A cross-sectional study with a quantitative approach supplemented by qualitative data. Setting Sixteen health jurisdictions providing home care services, Quebec province, Canada. Participants Two separate samples of seniors aged > 65 years and informal caregivers of cognitively impaired seniors who had made a decision about housing. Measurements Information on preferred choice and actual choice about housing, role assumed in the decision, decisional conflict and decision regret was obtained through closed-ended questionnaires. Research assistants paraphrased participants' narratives about their decision-making experiences and made other observations in standardized logbooks. Results Thirty-one seniors (median age: 85.5 years) and 48 caregivers (median age: 65.1 years) were recruited. Both seniors and caregivers preferred that the senior stay at home (64.5% and 71.7% respectively). Staying home was the actual choice for only 32.2% of participating seniors and 36.2% of the seniors cared for by the participating caregivers. Overall, 93% seniors and 71% caregivers reported taking an active or collaborative role in the decisionmaking process. The median decisional conflict score was 23/100 for seniors and 30/100 for caregivers. The median decision regret score was the same for both (10/100). Qualitative analysis revealed that the housing decision was influenced by factors such as seniors' health and safety concerns and caregivers' burden of care. Some caregivers felt sad and guilty when the decision did not match the senior's preference. Conclusion The actual housing decision made for seniors frequently did not match their preferred housing option. Advanced care planning regarding housing and better decision support are needed for these difficult decisions.	[Adekpedjou, Rheda; Freitas, Adriana; Garvelink, Mirjam M.; Menear, Matthew; Bourassa, Henriette; Roy, Lise; Legere, France] Univ Laval, Ctr Rech Soins & Serv Premiere Ligne, Quebec City, PQ, Canada; [Stacey, Dawn] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Stacey, Dawn] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Briere, Nathalie] Univ Laval, Ctr Integre Univ Sante & Serv Sociaux Capitale Na, Quebec City, PQ, Canada; [Turcotte, Stephane] Ctr Integre Sante & Serv Sociaux Chaudiere Appala, St Marie, ON, Canada; [Fraser, Kimberley] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Durand, Pierre J.] Univ Laval, Fac Med, Quebec City, PQ, Canada; [Dumont, Serge] Univ Laval, Fac Social Sci, Quebec City, PQ, Canada; [Legere, France] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada	Laval University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Laval University; University of Alberta; Laval University; Laval University; Laval University	Legere, F (corresponding author), Univ Laval, Ctr Rech Soins & Serv Premiere Ligne, Quebec City, PQ, Canada.; Legere, F (corresponding author), Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada.	france.legare@mfa.ulaval.ca		Legare, France/0000-0002-2296-6696; Stacey, Dawn/0000-0002-2681-741X	Canadian Frailty Network [MFE-140842]; Ministere de la Sante et des Services, Sociaux (MSSS) du Quebec [13-SS-00431]	Canadian Frailty Network; Ministere de la Sante et des Services, Sociaux (MSSS) du Quebec	This work was supported by the Canadian Frailty Network (http://www.cfn-nce.ca/), Grant number: MFE-140842, to FL; and by Ministere de la Sante et des Services (http://www.msss.gouv.qc.ca/), Sociaux (MSSS) du Quebec, Grant number: 13-SS-00431, to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson M, 2012, HOUSING STUD, V27, P582, DOI 10.1080/02673037.2012.697553; Association CHPC, 2009, NAT ROUNDT P ADV CAR; Brehaut JC, 2003, MED DECIS MAKING, V23, P281, DOI 10.1177/0272989X03256005; Canadian Institute for Health Information [CIHI], 2011, HLTH CAR CAN 2011 FO; Caron CD, DECIDING I RELATIVE; Cavalieri Thomas A., 2002, Journal of the American Osteopathic Association, V102, P541; Cepoiu-Martin M, 2016, INT J GERIATR PSYCH, V31, P1151, DOI 10.1002/gps.4449; D'Amour Danielle, 2005, J Interprof Care, V19 Suppl 1, P116, DOI 10.1080/13561820500082529; D'Amour Danielle, 2005, J Interprof Care, V19 Suppl 1, P8; DEGNER LF, 1992, J CLIN EPIDEMIOL, V45, P941, DOI 10.1016/0895-4356(92)90110-9; Dixon J, 2017, J PAIN SYMPTOM MANAG; Ducharme Francine, 2012, Home Health Care Serv Q, V31, P197, DOI 10.1080/01621424.2012.681572; Edmonston B, 2014, CAN J AGING, V33, P378, DOI 10.1017/S071498081400035X; Garvelink Mirjam M, 2015, BMC Res Notes, V8, P751, DOI 10.1186/s13104-015-1743-2; Garvelink MM, 2016, HEALTH AFFAIR, V35, P619, DOI 10.1377/hlthaff.2015.1375; Glisczinski D, 2018, J TRANSFORM EDUC, V16, P175, DOI 10.1177/1541344618777367; Hamilton IJ, 2017, BRIT J GEN PRACTICE; HEBERT R, 1993, CAN J AGING, V12, P324, DOI 10.1017/S0714980800013726; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Hoover M, 2012, HEALTH REP, V23, P55; HUNT SM, 1980, J EPIDEMIOL COMMUN H, V34, P281, DOI 10.1136/jech.34.4.281; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; Institut de la statistique du Quebec, 2014, PERSP DEM QUEB REG 2; Institut de la statistique du Quebec, 2013, ENQ QUEB LIM ACT MAL; Jacobsen MJ, 1999, DECISIONAL NEEDS ASS; Jungers CM, 2010, J COUNS DEV, V88, P416, DOI 10.1002/j.1556-6678.2010.tb00041.x; Kremer H, 2008, MED DECIS MAKING, V28, P899, DOI 10.1177/0272989X08317014; Lefebvre C, 2003, PORTRAIT SANTE QUEBE; Legare F, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0567-7; Legare F, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-83; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Nolan M, 1996, J ADV NURS, V24, P265, DOI 10.1046/j.1365-2648.1996.01966.x; Northcott HC, 2011, CAN J AGING, V30, P311, DOI 10.1017/S0714980811000262; O'Connor AM, 1998, PATIENT EDUC COUNS, V33, P267, DOI 10.1016/S0738-3991(98)00026-3; O'Connor AM, 2008, BMJ-BRIT MED J, V336, P228, DOI 10.1136/bmj.39435.643275.BE; O'Connor Annette M, 2003, Health Expect, V6, P97, DOI 10.1046/j.1369-6513.2003.00215.x; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Oswald F., 2013, ENV GERONTOLOGY MAKI, P53; Perks T, 2010, CAN J AGING, V29, P445, DOI 10.1017/S0714980810000413; REINARDY JR, 1995, HEALTH SOC WORK, V20, P31, DOI 10.1093/hsw/20.1.31; Reuss GF, 2005, J GERONTOL SOC WORK, V46, P17, DOI 10.1300/J083v46n01_03; Scholl I, 2011, Z EVIDENZ FORTBILD Q, V105, P313, DOI 10.1016/j.zefq.2011.04.012; Seng BK, 2010, ANN ACAD MED SINGAP, V39, P758; Sepucha K, 2009, MED CARE RES REV, V66, p53S, DOI 10.1177/1077558708325511; STRULL WM, 1984, JAMA-J AM MED ASSOC, V252, P2990, DOI 10.1001/jama.252.21.2990; Sung VW, 2010, INT UROGYNECOL J, V21, P1071, DOI 10.1007/s00192-010-1155-8; Thompson GN, 2014, PALLIAT SUPPORT CARE, V12, P223, DOI 10.1017/S1478951513000461; Toma A, 2015, HEALTH PLACE, V34, P46, DOI 10.1016/j.healthplace.2015.03.014; Wackerbarth SB, 2002, J APPL GERONTOL, V21, P314, DOI 10.1177/073346480202100303; Waekerbarth S, 1999, QUAL HEALTH RES, V9, P294; Wan H, 2014, AM COMMUNITY SURVEY; Woodhead C, 2015, HEALTH PLACE, V32, P19, DOI 10.1016/j.healthplace.2014.12.013; Zar J.H., 1996, BIOSTAT ANAL	53	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202975	10.1371/journal.pone.0202975	http://dx.doi.org/10.1371/journal.pone.0202975			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161238	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900057
J	Arnold, WK; Savage, CR; Lethbridge, KG; Smith, TC; Brissette, CA; Seshu, J; Stevenson, B				Arnold, William K.; Savage, Christina R.; Lethbridge, Kathryn G.; Smith, Trever C.; Brissette, Catherine A.; Seshu, Janakiram; Stevenson, Brian			Transcriptomic insights on the virulence-controlling CsrA, BadR, RpoN, and RpoS regulatory networks in the Lyme disease spirochete	PLOS ONE			English	Article							BORRELIA-BURGDORFERI OSPC; DECORIN-BINDING-PROTEIN; CARBON STORAGE REGULATOR; GENE-EXPRESSION; CARBOHYDRATE UTILIZATION; PLASMID CONTENT; SMALL RNA; INFECTION; SEQUENCE; DISSECTION	Borrelia burgdorferi, the causative agent of Lyme disease, survives in nature through a cycle that alternates between ticks and vertebrates. To facilitate this defined lifestyle, B. burgdorferi has evolved a gene regulatory network that ensures transmission between those hosts, along with specific adaptations to niches within each host. Several regulatory proteins are known to be essential for the bacterium to complete these critical tasks, but interactions between regulators had not previously been investigated in detail, due to experimental uses of different strain backgrounds and growth conditions. To address that deficit in knowledge, the transcriptomic impacts of four critical regulatory proteins were examined in a uniform strain background. Pairs of mutants and their wild-type parent were grown simultaneously under a single, specific culture condition, permitting direct comparisons between the mutant strains. Transcriptomic analyses were strand-specific, and assayed both coding and noncoding RNAs. Intersection analyses identified regulatory overlaps between regu-Ions, including transcripts involved in carbohydrate and polyamine metabolism. In addition, it was found that transcriptional units such as ospC and dbpBA, which were previously observed to be affected by alternative sigma factors, are transcribed by RNA polymerase using the housekeeping sigma factor, RpoD.	[Arnold, William K.; Savage, Christina R.; Lethbridge, Kathryn G.; Stevenson, Brian] Univ Kentucky, Sch Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Smith, Trever C.; Seshu, Janakiram] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Brissette, Catherine A.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND USA; [Stevenson, Brian] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Arnold, William K.] Addgene, Cambridge, MA USA; [Smith, Trever C.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	University of Kentucky; University of Texas System; University of Texas at San Antonio (UTSA); University of North Dakota Grand Forks; University of Kentucky; Tufts University	Stevenson, B (corresponding author), Univ Kentucky, Sch Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA.; Stevenson, B (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	brian.stevenson@uky.edu		Lethbridge, Kathryn/0000-0002-7160-7358; Brissette, Catherine/0000-0003-0792-1403; Arnold, Will/0000-0003-2447-3489; Smith II, Trever/0000-0002-1651-313X	National Institutes of Health [R03 AI113648]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, R03 AI113648 (BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PP, 2017, NUCLEIC ACIDS RES, V45, P775, DOI 10.1093/nar/gkw1180; Arnold WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164165; Babb K, 2001, INFECT IMMUN, V69, P4146, DOI 10.1128/IAI.69.6.4146-4153.2001; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bontemps-Gallo S, 2018, MOL MICROBIOL, V108, P350, DOI 10.1111/mmi.13940; Bontemps-Gallo S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005791; Brissette CA, 2008, INT J MED MICROBIOL, V298, P257, DOI 10.1016/j.ijmm.2007.09.004; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; Burke TP, 2016, MBIO, V7, DOI 10.1128/mBio.00240-16; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Bykowski T, 2006, J BACTERIOL, V188, P4879, DOI 10.1128/JB.00229-06; Caimano MJ, 2005, J BACTERIOL, V187, P7845, DOI 10.1128/JB.187.22.7845-7852.2005; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Casjens S, 1997, J BACTERIOL, V179, P217, DOI 10.1128/jb.179.1.217-227.1997; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Crother TR, 2004, INFECT IMMUN, V72, P5063, DOI 10.1128/IAI.72.9.5063-5072.2004; Drecktrah D, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00231; Drecktrah D, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1005160, 10.1371/journal.ppat.1005242]; Drecktrah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068799; Dulebohn DP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01734; Eggers CH, 2004, J BACTERIOL, V186, P7390, DOI 10.1128/JB.186.21.7390-7402.2004; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Esquerre A T, 2016, SCI REP, V6, P250; Esteve-Gassent MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136707; Feng SL, 1998, INFECT IMMUN, V66, P2827, DOI 10.1128/IAI.66.6.2827-2835.1998; Fikrig E, 2004, J CLIN MICROBIOL, V42, P1243, DOI 10.1128/JCM.42.3.1243-1246.2004; Fischer JR, 2006, INFECT IMMUN, V74, P435, DOI 10.1128/IAI.74.1.435-441.2006; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Garcia BL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005404; Grove AP, 2017, MBIO, V8, DOI [10.1128/mbio.01204-17, 10.1128/mBio.01204-17]; Hagman KE, 1998, INFECT IMMUN, V66, P2674, DOI 10.1128/IAI.66.6.2674-2683.1998; He M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002133; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Imai D, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-100; Indest KJ, 1997, INFECT IMMUN, V65, P1165, DOI 10.1128/IAI.65.4.1165-1171.1997; Iyer Radha, 2016, Microarrays (Basel), V5, DOI 10.3390/microarrays5020009; Jain S, 2015, INFECT IMMUN, V83, P2224, DOI 10.1128/IAI.02859-14; Jewett MW, 2009, J BACTERIOL, V191, P6231, DOI 10.1128/JB.00450-09; Jutras BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066683; Jutras BL, 2013, J BIOL CHEM, V288, P26220, DOI 10.1074/jbc.M113.491357; Jutras BL, 2013, J BACTERIOL, V195, P757, DOI 10.1128/JB.01956-12; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Karna SLR, 2013, INFECT IMMUN, V81, P2972, DOI 10.1128/IAI.00494-13; Karna SLR, 2011, INFECT IMMUN, V79, P732, DOI 10.1128/IAI.00882-10; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P1409, DOI 10.1128/IAI.69.3.1409-1419.2001; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YH, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00684-16, 10.1128/iai.00684-16]; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Livny J, 2014, NUCLEIC ACIDS RES, V42, P12212, DOI 10.1093/nar/gku891; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Miller JC, 2005, CURRENT PROTOCOLS D, V1D, P3; Ouyang ZM, 2015, MOL MICROBIOL, V98, P1147, DOI 10.1111/mmi.13206; Ouyang ZM, 2014, INFECT IMMUN, V82, P1511, DOI 10.1128/IAI.01555-13; Ouyang ZM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001272; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pappas CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002102; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Popitsch N, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3398-3; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Sanjuan E, 2009, INFECT IMMUN, V77, P5149, DOI 10.1128/IAI.00673-09; Savage CR, 2018, J BACTERIOL, V200, DOI [10.1128/JB.00033-18, 10.1128/jb.00033-18]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Shishkin AA, 2015, NAT METHODS, V12, P323, DOI [10.1038/NMETH.3313, 10.1038/nmeth.3313]; Smith AH, 2007, J BACTERIOL, V189, P2139, DOI 10.1128/JB.01653-06; Soneson C., 2016, F1000RES, V4, DOI [10.12688/F1000RESEARCH.7563.2. F1000Research, DOI 10.12688/F1000RESEARCH.7563.2]; Stevenson B, 2001, SPIROCHETES: MOLECULAR AND CELLULAR BIOLOGY, P87; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Stevenson B, 2018, SPIROCHETE BIOL POST; Stevenson B, 2006, WIEN KLIN WOCHENSCHR, V118, P643, DOI 10.1007/s00508-006-0690-2; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Strother KO, 2005, VECTOR-BORNE ZOONOT, V5, P237, DOI 10.1089/vbz.2005.5.237; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Sze CW, 2011, INFECT IMMUN, V79, P1270, DOI 10.1128/IAI.00871-10; Tilly K, 2004, VECTOR-BORNE ZOONOT, V4, P159, DOI 10.1089/1530366041210738; Tilly K, 1997, MOL MICROBIOL, V25, P361, DOI 10.1046/j.1365-2958.1997.4711838.x; Tilly K, 2001, J BACTERIOL, V183, P5544, DOI 10.1128/JB.183.19.5544-5553.2001; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Troy EB, 2016, MOL MICROBIOL, V101, P1003, DOI 10.1111/mmi.13437; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; von Lackum K, 2005, FEMS MICROBIOL LETT, V243, P173, DOI 10.1016/j.femsle.2004.12.002; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2008, MICROB PATHOGENESIS, V45, P70, DOI 10.1016/j.micpath.2008.03.002; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	105	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203286	10.1371/journal.pone.0203286	http://dx.doi.org/10.1371/journal.pone.0203286			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161198	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900102
J	Chiba, Y; Suto, W; Sakai, H				Chiba, Yoshihiko; Suto, Wataru; Sakai, Hiroyasu			Augmented Pla2g4c/Ptgs2/Hpgds axis in bronchial smooth muscle tissues of experimental asthma	PLOS ONE			English	Article							IVC PHOSPHOLIPASE A(2); BETA(2)-ADRENERGIC RECEPTOR DESENSITIZATION; NF-KAPPA-B; AIRWAY HYPERRESPONSIVENESS; TNF-ALPHA; TRANSCRIPTIONAL REGULATION; LUNG INFLAMMATION; CD38 EXPRESSION; CELLS; RELEASE	Rationale Augmented smooth muscle contractility of the airways is one of the causes of airway hyperresponsiveness in asthmatics. However, the mechanism of the altered properties of airway smooth muscle cells is not well understood. Objectives To identify differentially expressed genes (DEGs) related to the bronchial smooth muscle (BSM) hypercontractility in a murine asthma model. Methods The ovalbumin (OA)-sensitized mice were repeatedly challenged with aerosolized OA to induce asthmatic reaction. Transcriptomic profiles were generated by microarray analysis of BSM tissues from the OA-challenged and control animals, and KEGG (Kyoto Encyclopedia of Genes and Genomes) Pathway Analysis was applied. Measurements and main results Tension study showed a BSM hyperresponsiveness to acetylcholine (ACh) in the OA-challenged mice. A total of 770 genes were differentially expressed between the OA-challenged and control animals. Pathway analysis showed a significant change in arachidonic acid (AA) metabolism pathway in BSM tissues of the OA-challenged mice. Validation of DEGs by quantitative RT-PCR showed a significant increase in PLA 2 group 4c (Pla2g4c)/C0X-2 (Ptgs2)/PGD(2) synthase 2 (Hpgds) axis. PGD(2) level in bronchoalveolar fluids of the OAchallenged mice was significantly increased. A 24-h incubation of BSM tissues with PGD(2) caused a hyperresponsiveness to ACh in naive control mice. Conclusions AA metabolism is shifted towards PGD(2) production in BSM tissues of asthma. Increased PGD(2) level in the airways might be a cause of the BSM hyperresponsiveness in asthma.	[Chiba, Yoshihiko; Suto, Wataru] Hoshi Univ, Sch Pharm, Dept Physiol & Mol Sci, Tokyo, Japan; [Sakai, Hiroyasu] Hoshi Univ, Sch Pharm, Dept Analyt Pathophysiol, Tokyo, Japan	Hoshi University; Hoshi University	Chiba, Y (corresponding author), Hoshi Univ, Sch Pharm, Dept Physiol & Mol Sci, Tokyo, Japan.	chiba@hoshi.ac.jp		Chiba, Yoshihiko/0000-0002-7342-4491; Sakai, Hiroyasu/0000-0002-4501-2836	Japan Society for the Promotion of Science (JSPS) [15K08248]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grant-in-Aid for Scientific Research (C) Grant Number 15K08248 (YC) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMOUR CL, 1988, PROSTAGLANDINS, V35, P959, DOI 10.1016/0090-6980(88)90119-0; Asai K, 2003, J BIOL CHEM, V278, P8809, DOI 10.1074/jbc.M212117200; Bickford JS, 2012, BIOCHEM J, V442, P127, DOI 10.1042/BJ20111269; BJORCK T, 1992, AM REV RESPIR DIS, V145, P1087; Bowton DL, 1997, AM J RESP CRIT CARE, V155, P421, DOI 10.1164/ajrccm.155.2.9032172; Calzetta L, 2014, AM J RESP CELL MOL, V50, P493, DOI 10.1165/rcmb.2013-0119OC; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cheng Z, 2017, ONCOTARGET, V8, P67933, DOI 10.18632/oncotarget.18913; Chiba Y, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-4; Chiba Yoshihiko, 2004, Journal of Smooth Muscle Research, V40, P155, DOI 10.1540/jsmr.40.155; Chiba Y, 2009, AM J RESP CRIT CARE, V180, P713, DOI 10.1164/rccm.200903-0325OC; Clarke DL, 2009, PULM PHARMACOL THER, V22, P426, DOI 10.1016/j.pupt.2008.12.003; Comer BS, 2015, AM J RESP CELL MOL, V52, P438, DOI 10.1165/rcmb.2014-0129OC; Dahan D, 2014, AM J PHYSIOL-CELL PH, V307, pC1093, DOI 10.1152/ajpcell.00250.2014; Damera G, 2009, AM J PHYSIOL-LUNG C, V296, pL674, DOI 10.1152/ajplung.90585.2008; Fajt ML, 2013, J ALLERGY CLIN IMMUN, V131, P1504, DOI 10.1016/j.jaci.2013.01.035; Ishimura Masakazu, 2006, Allergol Int, V55, P403, DOI 10.2332/allergolint.55.403; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Jude JA, 2012, AM J RESP CELL MOL, V47, P427, DOI 10.1165/rcmb.2012-0025OC; Jude JA, 2012, AM J PHYSIOL-LUNG C, V303, pL460, DOI 10.1152/ajplung.00041.2012; Kato Y, 1999, J IMMUNOL, V162, P7470; Lambert JA, 2015, AM J PHYSIOL-LUNG C, V309, pL1394, DOI 10.1152/ajplung.00353.2015; Lortie K, 2018, AM J RESP CELL MOL, V58, P79, DOI 10.1165/rcmb.2017-0008OC; Lucas KK, 2004, BBA-MOL CELL BIOL L, V1636, P213, DOI 10.1016/j.bbalip.2003.12.009; Ma XF, 2002, AM J PHYSIOL-LUNG C, V283, pL1181, DOI 10.1152/ajplung.00389.2001; Martin JG, 2000, EUR RESPIR J, V16, P349, DOI 10.1034/j.1399-3003.2000.16b25.x; Morin C, 2013, CLIN EXP ALLERGY, V43, P1071, DOI 10.1111/cea.12162; Morin C, 2008, AM J RESP CELL MOL, V38, P192, DOI 10.1165/rcmb.2007-0232OC; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Murakami M, 2003, BIOCHEM J, V372, P695, DOI 10.1042/BJ20030061; Nie M, 2003, MOL CELL BIOL, V23, P9233, DOI 10.1128/MCB.23.24.9233-9244.2003; OMINI C, 1986, J AUTON PHARMACOL, V6, P181, DOI 10.1111/j.1474-8673.1986.tb00643.x; Paez-Cortez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074469; Pickard RT, 1999, J BIOL CHEM, V274, P8823, DOI 10.1074/jbc.274.13.8823; Rumzhum NN, 2016, ALLERGY, V71, P387, DOI 10.1111/all.12810; Rumzhum NN, 2016, AM J RESP CELL MOL, V54, P128, DOI 10.1165/rcmb.2014-0443OC; Sanak M, 2016, ALLERGY ASTHMA IMMUN, V8, P481, DOI 10.4168/aair.2016.8.6.481; Santus P, 2016, EXPERT OPIN INV DRUG, V25, P1083, DOI 10.1080/13543784.2016.1212838; Seow CY, 1998, AM J RESP CRIT CARE, V158, pS179, DOI 10.1164/ajrccm.158.supplement_2.13tac160; Singer CA, 2003, AM J PHYSIOL-LUNG C, V285, pL1087, DOI 10.1152/ajplung.00409.2002; Singh SR, 2014, ALLERGY, V69, P1189, DOI 10.1111/all.12444; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Sun MY, 2016, BIOL CHEM, V397, P507, DOI 10.1515/hsz-2015-0298; Sun QZ, 2017, J ALLERGY CLIN IMMUN, V140, P510, DOI 10.1016/j.jaci.2016.11.013; Sutcliffe A, 2012, AM J RESP CRIT CARE, V185, P267, DOI 10.1164/rccm.201107-1281OC; Sutcliffe AM, 2009, BRIT J PHARMACOL, V157, P436, DOI 10.1111/j.1476-5381.2009.00143.x; TAMAOKI J, 1987, J APPL PHYSIOL, V63, P1396, DOI 10.1152/jappl.1987.63.4.1396; TAMAOKI J, 1993, PROSTAGLANDINS, V45, P363, DOI 10.1016/0090-6980(93)90113-L; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Underwood KW, 1998, J BIOL CHEM, V273, P21926, DOI 10.1074/jbc.273.34.21926; Vanaudenaerde BM, 2007, AM J TRANSPLANT, V7, P76, DOI 10.1111/j.1600-6143.2006.01586.x; Yamabayashi C, 2012, AM J RESP CELL MOL, V47, P170, DOI 10.1165/rcmb.2011-0350OC; Zaslona Z, 2015, CHEST, V148, P1300, DOI 10.1378/chest.15-1029; Zhou WS, 2016, J IMMUNOL, V197, P1577, DOI 10.4049/jimmunol.1501063	54	9	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202623	10.1371/journal.pone.0202623	http://dx.doi.org/10.1371/journal.pone.0202623			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161143	gold, Green Submitted, Green Published			2022-12-27	WOS:000443388900034
J	Malfacini, D; Simon, K; Trapella, C; Guerrini, R; Zaveri, NT; Kostenis, E; Calo, G				Malfacini, Davide; Simon, Katharina; Trapella, Claudio; Guerrini, Remo; Zaveri, Nurulain T.; Kostenis, Evi; Calo, Girolamo			NOP receptor pharmacological profile - A dynamic mass redistribution study	PLOS ONE			English	Article							NOCICEPTIN/ORPHANIN FQ RECEPTOR; PROTEIN-COUPLED RECEPTOR; LABEL-FREE; IN-VITRO; OPIOID RECEPTOR; ORL1 RECEPTOR; SELECTIVE ANTAGONIST; BINDING REGION; HIGH-AFFINITY; LIVING CELLS	The Nociceptin/Orphanin FQ (N/OFQ) peptide NOP receptor is coupled to pertussis toxin (PTX)-sensitive G proteins (G(i/o)) whose activation leads to the inhibition of both cAMP production and calcium channel activity, and to the stimulation of potassium currents. The label free dynamic mass redistribution (DMR) approach has been demonstrated useful for investigating the pharmacological profile of G protein-coupled receptors. Herein, we employ DMR technology to systematically characterize the pharmacology of a large panel of NOP receptor ligands. These are of peptide and non-peptide nature and display varying degrees of receptor efficacy, ranging from full agonism to pure antagonism. Using Chinese hamster ovary (CHO) cells expressing the human NOP receptor we provide rank orders of potency for full and partial agonists as well as apparent affinities for selective antagonists. We find the pharmacological profile of NOP receptor ligands to be similar but not identical to values reported in the literature using canonical assays for G(i/o)-coupled receptors. Our data demonstrate that holistic label-free DMR detection can be successfully used to investigate the pharmacology of the NOP receptor and to characterize the cellular effects of novel NOP receptor ligands.	[Malfacini, Davide; Simon, Katharina; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany; [Malfacini, Davide; Calo, Girolamo] Univ Ferrara, Sect Pharmacol, Dept Med Sci, Ferrara, Italy; [Malfacini, Davide; Calo, Girolamo] Univ Ferrara, Natl Inst Neurosci, Ferrara, Italy; [Trapella, Claudio; Guerrini, Remo] Univ Ferrara, Dept Chem & Pharmaceut Sci, Ferrara, Italy; [Trapella, Claudio; Guerrini, Remo] Univ Ferrara, LTTA, Ferrara, Italy; [Zaveri, Nurulain T.] Astraea Therapeut LLC, Mountain View, CA USA	University of Bonn; University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Malfacini, D (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Bonn, Germany.; Malfacini, D (corresponding author), Univ Ferrara, Sect Pharmacol, Dept Med Sci, Ferrara, Italy.; Malfacini, D (corresponding author), Univ Ferrara, Natl Inst Neurosci, Ferrara, Italy.	dmalfaci@uni-bonn.de	Trapella, Claudio/I-2128-2012	Trapella, Claudio/0000-0002-6666-143X; Malfacini, Davide/0000-0003-4562-9550	5x1000 Giovani Ricercatori (University of Ferrara, IT); German Academic Exchange Service (DAAD) Short-Term Grants, 2015; FAR grant	5x1000 Giovani Ricercatori (University of Ferrara, IT); German Academic Exchange Service (DAAD) Short-Term Grants, 2015; FAR grant	This work was supported by 5x1000 Giovani Ricercatori (University of Ferrara, IT) and German Academic Exchange Service (DAAD) Short-Term Grants, 2015 to DM. Both funders provided support in the form of salary for DM. This work was also supported by a FAR grant to GC (University of Ferrara, IT). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu JM, 2016, METHODS, V92, P64, DOI 10.1016/j.ymeth.2015.08.018; Bes B, 2003, BIOCHEM BIOPH RES CO, V310, P992, DOI 10.1016/j.bbrc.2003.09.113; Calo G, 2002, BRIT J PHARMACOL, V136, P303, DOI 10.1038/sj.bjp.0704706; Calo G, 1998, BRIT J PHARMACOL, V125, P373, DOI 10.1038/sj.bjp.0702087; Calo' G, 2000, BRIT J PHARMACOL, V129, P1183, DOI 10.1038/sj.bjp.0703169; Calo G, 2018, PEPTIDES, V99, P195, DOI 10.1016/j.peptides.2017.10.004; Calo' G, 2013, ACS SYM SER, V1131, P275; Camarda V, 2009, N-S ARCH PHARMACOL, V379, P599, DOI 10.1007/s00210-009-0396-x; Carter RL, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.24; Chan JSC, 1998, J NEUROCHEM, V71, P2203; Chang SD, 2015, MOL PHARMACOL, V88, P502, DOI 10.1124/mol.115.099150; Christensen HB, 2017, J PHARMACOL TOX MET, V88, P72, DOI 10.1016/j.vascn.2017.07.003; Deng HY, 2013, J PHARMACOL TOX MET, V68, P323, DOI 10.1016/j.vascn.2013.07.005; Dooley CT, 1997, J PHARMACOL EXP THER, V283, P735; Eichel K, 2018, NATURE, V557, P381, DOI 10.1038/s41586-018-0079-1; Fang Y, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-24; Ferrari F, 2016, EUR J PHARMACOL, V793, P1, DOI 10.1016/j.ejphar.2016.10.025; Ferrie AM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00033; Gestwicki JE, 2002, J AM CHEM SOC, V124, P14922, DOI 10.1021/ja027184x; Goto Y, 2006, J MED CHEM, V49, P847, DOI 10.1021/jm0509851; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Grundmann M, 2015, METHODS MOL BIOL, V1272, P199, DOI 10.1007/978-1-4939-2336-6_14; Guerrini R, 1997, J MED CHEM, V40, P1789, DOI 10.1021/jm970011b; Guerrini R, 1998, BRIT J PHARMACOL, V123, P163, DOI 10.1038/sj.bjp.0701640; Guerrini R, 2014, BIOORGAN MED CHEM, V22, P3703, DOI 10.1016/j.bmc.2014.05.005; Homberg JR, 2009, NEUROSCIENCE, V163, P308, DOI 10.1016/j.neuroscience.2009.06.021; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P81, DOI 10.1016/B978-0-12-374585-9.00005-0; Koster A, 1999, P NATL ACAD SCI USA, V96, P10444, DOI 10.1073/pnas.96.18.10444; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; Lee MY, 2014, ASSAY DRUG DEV TECHN, V12, P361, DOI 10.1089/adt.2014.590; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Lieb S, 2016, PHARMACOL RES, V114, P13, DOI 10.1016/j.phrs.2016.10.010; Lieb S, 2016, PHARMACOL RES, V108, P65, DOI 10.1016/j.phrs.2016.04.026; Madeddu P, 1999, HYPERTENSION, V33, P914, DOI 10.1161/01.HYP.33.3.914; Mahmoud S, 2010, MOL PHARMACOL, V77, P804, DOI 10.1124/mol.109.062208; Malfacini D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132865; Mangmool S, 2011, TOXINS, V3, P884, DOI 10.3390/toxins3070884; Marti M, 2013, BRIT J PHARMACOL, V168, P863, DOI 10.1111/j.1476-5381.2012.02219.x; McDonald J, 2003, BRIT J PHARMACOL, V140, P61, DOI 10.1038/sj.bjp.0705401; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Miller RL, 2015, STRUCTURE, V23, P2291, DOI 10.1016/j.str.2015.07.024; Morse M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-17; Morse M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025643; Mouledous L, 2000, J BIOL CHEM, V275, P29268, DOI 10.1074/jbc.M004971200; Mustazza C, 2011, MED RES REV, V31, P605, DOI 10.1002/med.20197; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Nishi M, 1997, EMBO J, V16, P1858, DOI 10.1093/emboj/16.8.1858; Okada K, 2000, BIOCHEM BIOPH RES CO, V278, P493, DOI 10.1006/bbrc.2000.3822; Ozaki S, 2000, EUR J PHARMACOL, V402, P45, DOI 10.1016/S0014-2999(00)00520-3; Ozawa A, 2015, J NEUROSCI, V35, P11682, DOI 10.1523/JNEUROSCI.5122-14.2015; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Rizzi A, 2015, BRIT J PHARMACOL, V172, P3661, DOI 10.1111/bph.13150; Rizzi A, 2014, BRIT J PHARMACOL, V171, P4138, DOI 10.1111/bph.12799; Rizzi A, 1999, EUR J PHARMACOL, V385, pR3, DOI 10.1016/S0014-2999(99)00730-X; Rizzi A, 2001, N-S ARCH PHARMACOL, V363, P161, DOI 10.1007/s002100000358; Rizzi A, 2007, PEPTIDES, V28, P1240, DOI 10.1016/j.peptides.2007.04.020; Rover S, 2000, J MED CHEM, V43, P1329, DOI 10.1021/jm991129q; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Spagnolo B, 2007, J PHARMACOL EXP THER, V321, P961, DOI 10.1124/jpet.106.116764; Staus DP, 2016, NATURE, V535, P448, DOI 10.1038/nature18636; Tang WW, 2017, RSC ADV, V7, P43005, DOI 10.1039/c7ra07927c; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Toll L, 2016, PHARMACOL REV, V68, P419, DOI 10.1124/pr.114.009209; Tran E, 2012, ASSAY DRUG DEV TECHN, V10, P37, DOI 10.1089/adt.2011.0392; Trapella C, 2009, BIOORGAN MED CHEM, V17, P5080, DOI 10.1016/j.bmc.2009.05.068; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x; Witkin JM, 2014, PHARMACOL THERAPEUT, V141, P283, DOI 10.1016/j.pharmthera.2013.10.011; Yung LY, 1999, J PHARMACOL EXP THER, V288, P232; Zaratin PF, 2004, J PHARMACOL EXP THER, V308, P454, DOI 10.1124/jpet.103.055848; Zaveri NT, 2016, J MED CHEM, V59, P7011, DOI 10.1021/acs.jmedchem.5b01499	74	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203021	10.1371/journal.pone.0203021	http://dx.doi.org/10.1371/journal.pone.0203021			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161182	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900068
J	Sonnweber, T; Nairz, M; Theurl, I; Petzer, V; Tymoszuk, P; Haschka, D; Rieger, E; Kaessmann, B; Deri, M; Watzinger, K; Steringer-Mascherbauer, R; Tancevski, I; Weiss, G; Loffler-Ragg, J				Sonnweber, Thomas; Nairz, Manfred; Theurl, Igor; Petzer, Verena; Tymoszuk, Piotr; Haschka, David; Rieger, Eva; Kaessmann, Birgit; Deri, Miriam; Watzinger, Kathrin; Steringer-Mascherbauer, Regina; Tancevski, Ivan; Weiss, Guenter; Loeffler-Ragg, Judith			The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; ARTERIAL-HYPERTENSION; CHRONIC DISEASE; FERRIC CARBOXYMALTOSE; HEPCIDIN EXPRESSION; THERAPEUTIC TARGET; ANEMIA; HOMEOSTASIS; METABOLISM; HYPOXIA	Imbalances of iron homeostasis are associated with an adverse clinical outcome of pulmonary hypertension (PH). Herein, we aimed to analyze the impact of iron deficiency (ID) in a real-life PH patient cohort according to different currently used ID definitions. In a retrospective study including 153 precapillary PH patients followed over a mean period of five years, iron deficiency was assessed according to five clinical definitions used in previous trials. The impact of ID on clinical, hematological and hemodynamic parameters was investigated. Depending on the different cutoff levels for serum ferritin and transferrin saturation, currently used ID definitions indicated a prevalence of either true or functional ID in 11 to 75 percent of PH patients. A good diagnostic accuracy was achieved by using the sTFRF/log ferritin (sTFRF) index, which identified 33 to 42 percent of PH patients as being iron deficient. The sTFRF index had the best prediction for the association between ID and clinical outcome. Iron deficient patients with precapillary PH had a significantly higher mortality as compared to non-iron deficiency subjects, which was true for both, PH patients with and without anemia. Although levels of the iron hormone hepcidin were rather affected by ID than by inflammation, they were not associated with the clinical course or mortality of PH subjects. To conclude, ID had a significant impact on the clinical course of precapillary PH patients. The appropriate use of robust biomarkers to define ID is a prerequisite to further evaluate the role of ID and the potential benefit of iron supplementation in precapillary PH patients.	[Sonnweber, Thomas; Nairz, Manfred; Theurl, Igor; Petzer, Verena; Tymoszuk, Piotr; Haschka, David; Rieger, Eva; Kaessmann, Birgit; Deri, Miriam; Watzinger, Kathrin; Tancevski, Ivan; Weiss, Guenter; Loeffler-Ragg, Judith] Med Univ Innsbruck, Dept Internal Med 2, Innsbruck, Austria; [Steringer-Mascherbauer, Regina] Elisabethinen Hosp, Dept Internal Med 2, Linz, Austria; [Weiss, Guenter] Med Univ Innsbruck, Christian Doppler Lab Iron Metab & Anemia Res, Innsbruck, Austria	Medical University of Innsbruck; Ordensklinikum Linz Elisabethinen; Medical University of Innsbruck	Weiss, G; Loffler-Ragg, J (corresponding author), Med Univ Innsbruck, Dept Internal Med 2, Innsbruck, Austria.; Weiss, G (corresponding author), Med Univ Innsbruck, Christian Doppler Lab Iron Metab & Anemia Res, Innsbruck, Austria.	guenter.weiss@i-med.ac.at; judith.loeffler@i-med.ac.at	Tancevski, Ivan/AID-5169-2022; Loeffler-Ragg, Judith/ABG-3407-2020	Tancevski, Ivan/0000-0001-5116-8960; Tymoszuk, Piotr/0000-0002-0398-6034; Petzer, Verena/0000-0002-9205-1440; Theurl, Igor/0000-0003-3180-4784; Loeffler-Ragg, Judith/0000-0003-0873-7501	Austrian National bank Fund [17271]; Verein zur Forderung von Forschung und Weiterbildung in Infektiologie und Immunologie, Innsbruck; Christian Doppler Society, Austria	Austrian National bank Fund; Verein zur Forderung von Forschung und Weiterbildung in Infektiologie und Immunologie, Innsbruck; Christian Doppler Society, Austria	This work was supported by the Austrian National bank Fund (Project 17271, J.LR.), the "Verein zur Forderung von Forschung und Weiterbildung in Infektiologie und Immunologie, Innsbruck" (G.W.) and the Christian Doppler Society, Austria (G.W.).	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Brugnara C, 2013, CLIN CHEM, V59, P740, DOI 10.1373/clinchem.2012.182071; Camaschella C, 2015, NEW ENGL J MED, V373, P485, DOI 10.1056/NEJMc1507104; Filippatos G, 2013, EUR J HEART FAIL, V15, P1267, DOI 10.1093/eurjhf/hft099; Frise MC, 2016, J CLIN INVEST, V126, P2139, DOI 10.1172/JCI85715; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; Krasuski RA, 2011, INT J CARDIOL, V150, P291, DOI 10.1016/j.ijcard.2010.04.038; Lasocki S, 2010, INTENS CARE MED, V36, P1044, DOI 10.1007/s00134-010-1794-8; Levi S, 2009, BBA-GEN SUBJECTS, V1790, P629, DOI 10.1016/j.bbagen.2008.09.008; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; Loreal O, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00128; Mleczko-Sanecka K, 2017, HAEMATOLOGICA, V102, P1173, DOI 10.3324/haematol.2016.162917; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Nairz M, 2017, PFLUG ARCH EUR J PHY, V469, P397, DOI 10.1007/s00424-017-1944-8; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Oexle H, 1999, BBA-BIOENERGETICS, V1413, P99, DOI 10.1016/S0005-2728(99)00088-2; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pietrangelo A, 2016, LIVER INT, V36, P116, DOI 10.1111/liv.13020; Rhodes CJ, 2011, EUR RESPIR J, V38, P1453, DOI 10.1183/09031936.00037711; Rhodes CJ, 2011, J AM COLL CARDIOL, V58, P300, DOI 10.1016/j.jacc.2011.02.057; Ruiter G, 2011, EUR RESPIR J, V37, P1386, DOI 10.1183/09031936.00100510; Ruiter G, 2014, RHEUMATOLOGY, V53, P285, DOI 10.1093/rheumatology/ket331; Sitbon O, 2015, EUR RESPIR J, V46, P152, DOI 10.1183/09031936.00004414; Skikne BS, 2011, AM J HEMATOL, V86, P923, DOI 10.1002/ajh.22108; Sonnweber T, 2014, GUT, V63, P1951, DOI 10.1136/gutjnl-2013-305317; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Sutendra G, 2015, CIRC RES, V116, P1636, DOI 10.1161/CIRCRESAHA.115.306440; Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Theurl I, 2011, HAEMATOL-HEMATOL J, V96, P1761, DOI 10.3324/haematol.2011.048926; Theurl I, 2009, BLOOD, V113, P5277, DOI 10.1182/blood-2008-12-195651; Tuder RM, 2009, J AM COLL CARDIOL, V54, pS3, DOI 10.1016/j.jacc.2009.04.009; van Veldhuisen DJ, 2017, CIRCULATION, V136, P1374, DOI 10.1161/CIRCULATIONAHA.117.027497; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Weiss G, 2015, SEMIN HEMATOL, V52, P313, DOI 10.1053/j.seminhematol.2015.07.004	43	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203396	10.1371/journal.pone.0203396	http://dx.doi.org/10.1371/journal.pone.0203396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161261	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900119
J	Trevisi, P; Priori, D; Jansman, AJM; Luise, D; Koopmans, SJ; Hynonen, U; Palva, A; Van Der Meulen, J; Bosi, P				Trevisi, Paolo; Priori, Davide; Jansman, Alfons J. M.; Luise, Diana; Koopmans, Sietse-Jan; Hynonen, Ulla; Palva, Airi; Van Der Meulen, Jan; Bosi, Paolo			Molecular networks affected by neonatal microbial colonization in porcine jejunum, luminally perfused with enterotoxigenic Escherichia coli, F4ac fimbria or Lactobacillus amylovorus	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; VANIN INHIBITORS; BARRIER FUNCTION; DENDRITIC CELLS; REGIII-GAMMA; WEANED PIGS; PIGLETS; GUT; EXPRESSION; INFECTION	The development of an early complex gut microbiota may play an important role in the protection against intestinal dysbiosis later in life. The significance of the developed microbiota for gut barrier functionality upon interaction with pathogenic or beneficial bacteria is largely unknown. The transcriptome of differently perfused jejunal loops of 12 caesarian-derived pigs, neonatally associated with microbiota of different complexity, was studied. Piglets received pasteurized sow colostrum at birth (d0), a starter microbiota (Lactobacillus amylovorus (LAM), Clostridium glycolicum, and Parabacteroides) on d1-d3, and a placebo inoculant (simple association, SA) or an inoculant consisting of sow's diluted feces (complex association, CA) on d3-d4. On d 26-37, jejunal loops were perfused for 8 h with either enterotoxigenic Escherichia coli F4 (ETEC), purified F4 fimbriae, LAM or saline control (CTRL). Gene expression of each intestinal loop was analyzed by Affymetrix Porcine Gene 1.1_ST array strips. Gene Set Enrichment Analysis was performed on expression values. Compared to CTRL, 184 and 74; 2 and 139; 2 and 48 gene sets, were up- and down-regulated by ETEC, F4 and LAM, respectively. ETEC up-regulated networks related to inflammatory and immune responses, RNA processing, and mitosis. There was a limited overlap in up-regulated gene sets between ETEC and F4 fimbriae. LAM down-regulated genes related to inflammatory and immune responses, as well as to cellular compound metabolism. In CA pigs, 57 gene sets were up-regulated by CA, while 73 were down-regulated compared to SA. CA up-regulated gene sets related to lymphocyte modulation and to cellular defense in all loop perfusions. In CA pigs, compared to SA pigs, genes for chemokine and cytokine activity and for response to external stimuli were down-regulated in ETEC-perfused loops and up-regulated in CTRL. The results highlight the importance of the nature of neonatal microbial colonization in the response to microbial stimuli later in life.	[Trevisi, Paolo; Priori, Davide; Luise, Diana; Bosi, Paolo] Univ Bologna, DISTAL, Bologna, Italy; [Jansman, Alfons J. M.; Koopmans, Sietse-Jan; Van Der Meulen, Jan] Wageningen UR Livestock Res, Wageningen, Netherlands; [Hynonen, Ulla; Palva, Airi] Univ Helsinki, Dept Vet Biosci, Div Microbiol & Epidemiol, Helsinki, Finland	University of Bologna; Wageningen University & Research; University of Helsinki	Bosi, P (corresponding author), Univ Bologna, DISTAL, Bologna, Italy.	paolo.bosi@unibo.it	Luise, Diana/AAR-6903-2020	van der Meulen, Jan/0000-0002-9451-2335; Hynonen, Ulla/0000-0002-2002-7804; BOSI, PAOLO/0000-0002-0755-8002; Luise, Diana/0000-0001-7864-7822	European Union [227549]	European Union(European Commission)	This research was funded by the European Union, Interplay project, Grant agreement no. 227549. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekiaris V, 2014, IMMUNOL REV, V260, P86, DOI 10.1111/imr.12194; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Canani RB, 2011, CURR OPIN GASTROEN, V27, P8, DOI 10.1097/MOG.0b013e32833fd48a; Danabassis MS, 2006, THESIS; Dawson PA, 2009, GUT, V58, P910, DOI 10.1136/gut.2007.147595; Elizondo-Salazar JA, 2009, J DAIRY SCI, V92, P4565, DOI 10.3168/jds.2009-2188; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Ghose Romi, 2004, Nucl Recept, V2, P4, DOI 10.1186/1478-1336-2-4; Goc J, 2015, INT IMMUNOL; Godden S, 2006, J DAIRY SCI, V89, P3476, DOI 10.3168/jds.S0022-0302(06)72386-4; Gronke K, 2015, NATURE, V528, P488, DOI 10.1038/nature16325; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; HOWELL S, 1992, BIOCHEM J, V284, P595, DOI 10.1042/bj2840595; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jansen PAM, 2013, ANTIMICROB AGENTS CH, V57, P4794, DOI 10.1128/AAC.00603-13; Jansen PAM, 2013, ACS CHEM BIOL, V8, P530, DOI 10.1021/cb3006424; Jansman AJM, 2012, J ANIM SCI, V90, P433, DOI 10.2527/jas.53850; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kaskow BJ, 2012, BIOCHEM BIOPH RES CO, V417, P653, DOI 10.1016/j.bbrc.2011.11.099; Kiers JL, 2006, RES VET SCI, V81, P274, DOI 10.1016/j.rvsc.2005.12.007; Kim HB, 2015, VET MICROBIOL, V177, P242, DOI 10.1016/j.vetmic.2015.03.014; Konstantinov SR, 2008, FEMS MICROBIOL ECOL, V66, P599, DOI 10.1111/j.1574-6941.2008.00517.x; Konstantinov SR, 2004, ANIM RES, V53, P317, DOI 10.1051/animres:2004019; Konstantinov SR, 2004, APPL ENVIRON MICROB, V70, P3821, DOI 10.1128/AEM.70.7.3821-3830.2004; Koopmans SJ, 2016, 41 ANIMAL NUTR RES F, P16; Kraan CTMV, 2012, HUM IMMUNOL, V73, P912, DOI 10.1016/j.humimm.2012.06.004; Kumar A, 2014, AM J PHYSIOL-CELL PH, V307, pC1084, DOI 10.1152/ajpcell.00194.2014; Lalles JP, 2011, J ANIM PHYSIOL AN N, V95, P478, DOI 10.1111/j.1439-0396.2010.01075.x; Laycock G, 2012, VET IMMUNOL IMMUNOP, V149, P216, DOI 10.1016/j.vetimm.2012.07.004; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Loos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041041; Luo Y, 2015, VET RES, V46, DOI 10.1186/s13567-015-0264-2; NABUURS MJA, 1993, RES VET SCI, V55, P108, DOI 10.1016/0034-5288(93)90043-F; Niewold TA, 2005, VET IMMUNOL IMMUNOP, V105, P317, DOI 10.1016/j.vetimm.2005.02.010; Niewold TA, 2010, VET MICROBIOL, V141, P110, DOI 10.1016/j.vetmic.2009.08.014; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Orrhage K, 1999, ACTA PAEDIATR, V88, P47; Oshida K, 2015, NUCL RECEPTOR SIGNAL, V13; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Priori D, 2016, J ANIM SCI, V94, P592, DOI 10.2527/jas.2015-9948; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Rothkotter HJ, 2009, DEV COMP IMMUNOL, V33, P267, DOI 10.1016/j.dci.2008.06.016; Rothkotter HJ, 1999, SCAND J IMMUNOL, V50, P31; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Snoeck V, 2008, VET IMMUNOL IMMUNOP, V124, P29, DOI 10.1016/j.vetimm.2006.10.014; Soler L, 2015, VET IMMUNOL IMMUNOP, V167, P51, DOI 10.1016/j.vetimm.2015.07.006; Trevisi P, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0213-1; Trevisi P, 2017, ITAL J ANIM SCI, V16, P101, DOI 10.1080/1828051X.2016.1260499; Trevisi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081473; Van den Broeck W, 1999, INFECT IMMUN, V67, P520, DOI 10.1128/IAI.67.2.520-526.1999; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780	53	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202160	10.1371/journal.pone.0202160	http://dx.doi.org/10.1371/journal.pone.0202160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161141	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900022
J	van Schadewijk, R; van den Berg, TE; Gupta, KBSS; Ronen, I; de Groot, HJM; Alia, A				van Schadewijk, Remco; van den Berg, Tomas E.; Gupta, Karthick B. Sai Sankar; Ronen, Itamer; de Groot, Huub J. M.; Alia, A.			Non-invasive magnetic resonance imaging of oils in Botryococcus braunii green algae: Chemical shift selective and diffusion-weighted imaging	PLOS ONE			English	Article							RACE B; HYDROCARBON PRODUCTION; CULTURE; BIOSYNTHESIS; ACCUMULATION; SPECTROSCOPY; BIODIESEL; STRAIN; GROWTH; MEDIA	Botryococcus braunii is an oleaginous green algae with the distinctive property of accumulating high quantities of hydrocarbons per dry weight in its colonies. Large variation in colony structure exists, yet its implications and influence of oil distribution and diffusion dynamics are not known and could not be answered due to lack of suitable in vivo methods. This publication seeks to further the understanding on oil dynamics, by investigating naturally relevant large (700-1500 mu m) and extra-large (1500-2500 mu m) sized colonies of Botryococcus braunii (race B, strain Showa) in vivo, using a comprehensive approach of chemical shift selective imaging, chemical shift imaging and spin echo diffusion measurements at high magnetic field (17.6T). Hydrocarbon distribution in large colonies was found to be localised in two concentric oil layers with different thickness and concentration. Extra-large colonies were highly unstructured and oil was spread throughout colonies, but with large local variations. Interestingly, fluid channels were observed in extra-large colonies. Diffusion-weighted MRI revealed a strong correlation between colony heterogeneity, oil distribution, and diffusion dynamics in different parts of Botryococcus colonies. Differences between large and extra-large colonies were characterised by using T-2 weighted MRI along with relaxation measurements. Our result, therefore, provides first non-invasive MRI means to obtain spatial information on oil distribution and diffusion dynamics in Botryococcus braunii colonies.	[van Schadewijk, Remco; Gupta, Karthick B. Sai Sankar; de Groot, Huub J. M.; Alia, A.] Leiden Univ, Leiden Inst Chem, Leiden, Netherlands; [van den Berg, Tomas E.] Vrije Univ Amsterdam, Dept Phys & Astron, Biophys Photosynth, Amsterdam, Netherlands; [Ronen, Itamer] Leiden Univ, Med Ctr, Radiol Dept, Leiden, Netherlands; [Alia, A.] Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leipzig University	Alia, A (corresponding author), Leiden Univ, Leiden Inst Chem, Leiden, Netherlands.; Alia, A (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany.	a.alia@chem.leidenuniv.nl	de Groot, Huub J. M./J-4741-2012; de Groot, Huub/GXV-7380-2022	de Groot, Huub J. M./0000-0002-8796-1212; van den Berg, Tomas/0000-0002-7202-4699; van Schadewijk, Remco/0000-0002-7821-3853; Ronen, Itamar/0000-0002-6872-4895	Foundation for Fundamental Research on Matter (FOM) within BioSolar Cells program [10TBSC23]; BioSolar Cell [C2.2, U2.3]	Foundation for Fundamental Research on Matter (FOM) within BioSolar Cells program; BioSolar Cell	This work was funded by the Foundation for Fundamental Research on Matter (FOM) within BioSolar Cells program (grant no. 10TBSC23) and grants from BioSolar Cell (C2.2 &U2.3).	BROWN TR, 1992, NMR BIOMED, V5, P238, DOI 10.1002/nbm.1940050508; BROWNSTEIN KR, 1979, PHYS REV A, V19, P2446, DOI 10.1103/PhysRevA.19.2446; Chiang IZ, 2004, J PHYCOL, V40, P474, DOI 10.1111/j.1529-8817.2004.03096.x; Chu SP, 1942, J ECOL, V30, P284, DOI 10.2307/2256574; Demirbas A, 2011, ENERG CONVERS MANAGE, V52, P163, DOI 10.1016/j.enconman.2010.06.055; Bayona KCD, 2014, J APPL PHYCOL, V26, P2087, DOI 10.1007/s10811-014-0242-5; DUBREUIL C, 1989, ORG GEOCHEM, V14, P543, DOI 10.1016/0146-6380(89)90034-X; Eroglu E, 2011, J APPL PHYCOL, V23, P763, DOI 10.1007/s10811-010-9577-8; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Furuhashi K, 2016, ALGAL RES, V16, P160, DOI 10.1016/j.algal.2016.02.021; GLIKSON M, 1989, ORG GEOCHEM, V14, P595, DOI 10.1016/0146-6380(89)90039-9; Guy-Ohlson D, 1998, PALAEOGEOGR PALAEOCL, V140, P347, DOI 10.1016/S0031-0182(98)00019-4; HAASE A, 1985, PHYS MED BIOL, V30, P341, DOI 10.1088/0031-9155/30/4/008; HILLEN LW, 1982, BIOTECHNOL BIOENG, V24, P193, DOI 10.1002/bit.260240116; Hirose M, 2013, EUKARYOT CELL, V12, P1132, DOI 10.1128/EC.00088-13; Hoh D, 2016, CHEM ENG J, V287, P466, DOI 10.1016/j.cej.2015.11.062; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P3043, DOI 10.1016/0031-9422(89)80276-6; Jin J, 2016, PROCESS BIOCHEM, V51, P1866, DOI 10.1016/j.procbio.2015.11.026; Kaufmann I, 2008, J MAGN RESON, V192, P139, DOI 10.1016/j.jmr.2008.02.008; Khatri W, 2014, BIOTECHNOL BIOENG, V111, P493, DOI 10.1002/bit.25126; Kumar M, 2017, PALYNOLOGY, V41, P462, DOI 10.1080/01916122.2016.1259667; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1081, DOI 10.1016/0031-9422(80)83060-3; Metzger P, 2007, ORG GEOCHEM, V38, P566, DOI 10.1016/j.orggeochem.2006.12.003; Meyer L, 2014, CLIMATE CHANGE 2014; Nonomura A., 1988, JPN J PHYCOL, V36, P285; Rivas MO, 2010, MICROB ECOL, V60, P628, DOI 10.1007/s00248-010-9686-6; Ruhl ID, 2011, ORG GEOCHEM, V42, P1, DOI 10.1016/j.orggeochem.2010.09.004; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Shen Y, 2015, BIOPROC BIOSYST ENG, V38, P481, DOI 10.1007/s00449-014-1287-1; Simpson AJ, 2003, PHYTOCHEMISTRY, V62, P783, DOI 10.1016/S0031-9422(02)00628-3; Suzuki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081626; Tanoi T, 2014, J APPL PHYCOL, V26, P1, DOI 10.1007/s10811-013-0026-3; Uno Y, 2015, ALGAL RES, V8, P214, DOI 10.1016/j.algal.2015.02.015; WAKE LV, 1980, BIOTECHNOL BIOENG, V22, P1637, DOI 10.1002/bit.260220808; WAKE LV, 1983, AUST J BOT, V31, P605, DOI 10.1071/BT9830605; Weiss TL, 2012, EUKARYOT CELL, V11, P1424, DOI 10.1128/EC.00184-12; Weiss TL, 2010, J BIOL CHEM, V285, P32458, DOI 10.1074/jbc.M110.157230; Wijihastuti RS, 2017, J APPL PHYCOL, V29, P1123, DOI 10.1007/s10811-016-1032-z; WOLF FR, 1985, J PHYCOL, V21, P388; Yoshimura T, 2013, BIORESOURCE TECHNOL, V133, P232, DOI 10.1016/j.biortech.2013.01.095	40	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203217	10.1371/journal.pone.0203217	http://dx.doi.org/10.1371/journal.pone.0203217			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161202	gold, Green Published			2022-12-27	WOS:000443388900092
J	Amnie, AG				Amnie, Asrat Genet			An impact evaluation of two rounds of mass drug administration on the prevalence of active trachoma: A clustered cross sectional survey	PLOS ONE			English	Article							NIGERIA	Introduction We investigated the impact of two round of mass drug administration on trachoma prevalence in Plateau and Nasarawa States of Nigeria. The mass drug administration was conducted as a component of the SAFE Strategy, a combination of interventions recommended for the global elimination of blinding trachoma. Methods The study consisted of a two-stage cross-sectional clustered sample survey in which 3990 people from 793 households were screened for clinical signs of trachoma. Results Of the total 3990 people examined, 1530 were children, of which 808 (53%) were boys and 704 (47%) were girls. The impact of intervention as measured by the changes in overall prevalence of follicular trachoma were as follows: At baseline the overall prevalence of follicular trachoma among children 1 +/- 9 years of age was 6.4%, 95% CI [5.8, 7.0]; the overall prevalence of trachomatous trichiasis in the total population was 0.20%, 95% CI [0.16, 0.25]. At follow up, the overall prevalence of follicular trachoma among children 1 +/- 9 years of age was 3.4%, 95% CI [1.9, 4.9]; the overall prevalence of trachomatous trichiasis in the total population was 0.20%, 95% CI [0.00, 0.05]. The highest statistically significant reduction (96%) in follicular trachoma prevalence was observed in Doma Local Government Area of Nasarawa State from baseline prevalence of 13.6%, 95% CI [9.7, 17.5] to follow-up prevalence of 0.5%, 95% CI [0.0, 1.5] and the lowest reduction (58%) in follicular trachoma prevalence was observed in Langtang North Local Government Area of Plateau State from baseline prevalence of 15.8%, 95% CI [9.3, 22.3] to 6.6%, 95% CI [1.6, 11.6], (p< 0.05). Conclusion A significant reduction in the overall prevalence of follicular trachoma was achieved after two rounds of mass drug administration. In the absence of significant activities pertaining to facial cleanliness and environmental sanitation components of the SAFE strategy in the intervention areas, the observed deep reductions in prevalence could mainly be attributed to mass drug administration. Therefore, two rounds of mass azithromycin administration may be as effective as guideline-recommended three or more rounds in reducing active trachoma prevalence but findings should be replicated in more robustly designed studies.	[Amnie, Asrat Genet] CUNY, Eugenio Maria de Hostos Community Coll, Dept Educ, Hlth Educ Unit, New York, NY 10021 USA	City University of New York (CUNY) System	Amnie, AG (corresponding author), CUNY, Eugenio Maria de Hostos Community Coll, Dept Educ, Hlth Educ Unit, New York, NY 10021 USA.	aamnie@hostos.cuny.edu						[Anonymous], 2013, SAS COMP PROGR VERS; [Anonymous], 2013, MICROSOFT EXCEL; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Emerson PM, 2006, B WORLD HEALTH ORGAN, V84, P613, DOI 10.2471/BLT.05.28696; Hopkins DR, 2008, ANN NY ACAD SCI, V1136, P45, DOI 10.1196/annals.1425.015; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001600; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hu VH, 2010, TROP MED INT HEALTH, V15, P673, DOI 10.1111/j.1365-3156.2010.02521.x; King JD, 2010, BRIT J OPHTHALMOL, V94, P14, DOI 10.1136/bjo.2009.165282; King JD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002732; Kyari F, 2009, INVEST OPHTH VIS SCI, V50, P2033, DOI 10.1167/iovs.08-3133; Mariotti SP, 2008, BRIT J OPHTHALMOLOGY; Mathew AA, 2009, DRUGS, V69, P953, DOI 10.2165/00003495-200969080-00002; Means AR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005085; Ngondi J, 2008, T ROY SOC TROP MED H, V102, P432, DOI 10.1016/j.trstmh.2008.02.014; Oswald .WE, 2017, B WORLD HEALTH ORGAN, V95, P250, DOI [10.2471/BLT.16.177758, 10.2471/blt.16.177758]; Rabiu M, 2012, COCHRANE LIB, DOI [10.1002/14651858.CD010274, DOI 10.1002/14651858.CD010274]; Rabiu MM, 2011, MIDDLE EAST AFR J OP, V18, P115, DOI 10.4103/0974-9233.80699; Roba AA, 2011, J EPIDEMIOL COMMUN H, V65, P626, DOI 10.1136/jech.2009.094763; Stocks ME, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001605; The Carter Center, 2010, SUMM P 11 ANN TRACH; The World Health Organization, 2006, TRACH CONTR GUID PRO, P34; WHO, 2016, GUID TREATM CHLAM TR; World Health Organization, 2008, HUM RES HLTH COUNTR; World Health Organization, 2008, PREV BLINDN VIS IMP	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201911	10.1371/journal.pone.0201911	http://dx.doi.org/10.1371/journal.pone.0201911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157193	Green Published, gold			2022-12-27	WOS:000443071400019
J	Brun, C; Gagne, M; McCabe, CS; Mercier, C				Brun, Clementine; Gagne, Martin; McCabe, Candida S.; Mercier, Catherine			Motor and sensory disturbances induced by sensorimotor conflicts during passive and active movements in healthy participants	PLOS ONE			English	Article							ONE ARM; VISUAL FEEDBACK; INCONGRUENCE; SYMPTOMS; POSITION; DISPLACEMENT; INFORMATION; INTEGRATION; VOLUNTEERS; PERCEPTION	Sensorimotor conflict induces both sensory and motor disturbances, but the specific factors playing a role in conflict-induced disturbances are still misunderstood. For example, we still do not know the role played by motor intention (vs. a purely visuo-proprioceptive conflict) or the influence of specific types of incongruent visual feedback. The objective of this study was threefold: 1- to compare the effect of passive and active movement during sensorimotor conflict on sensory disturbances measured with a questionnaire; 2- to compare the effect of three incongruent visual feedback conditions on sensory and motor (mediolateral drift and movement amplitude) disturbances; 3- to test whether conflict-induced sensory and motor disturbances were stable over time. 20 healthy participants realized active or passive cyclic upper limb movements while viewing either congruent or incongruent visual feedback about their movement using a robotized exoskeleton combined with 2D virtual reality interface. First, results showed that in condition of conflict, participants reported higher sensory disturbances during active movements compared to passive movements (p = 0.034), suggesting that the efference copy reinforces the conflict between vision and proprioception. Second, the three conditions of incongruence in the active condition induced similar sensory (all p>0.45) and motor disturbances (medio-lateral drift: all p>0.59 and amplitude: all p>0.25), suggesting that conflict induced motor disturbances could be related more to the observation of another movement rather than to a detection of conflict between motor intention and sensory feedback. Finally, both sensory and motor disturbances were stable over time (all ICCs between 0.76 and 0.87), demonstrating low variability within participants. Overall, our results suggest that the efference copy is more involved in sensory disturbances than in motor disturbances, suggesting that they might rely on independent processes.	[Brun, Clementine; Gagne, Martin; Mercier, Catherine] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Brun, Clementine; Mercier, Catherine] Laval Univ, Dept Rehabil, Quebec City, PQ, Canada; [McCabe, Candida S.] Royal United Hosp NHS Fdn Trust, Bath, Avon, England; [McCabe, Candida S.] Univ West England, Bristol, Avon, England; [McCabe, Candida S.] Florence Nightingale Fdn, London, England	Laval University; Laval University; University of West England	Mercier, C (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.; Mercier, C (corresponding author), Laval Univ, Dept Rehabil, Quebec City, PQ, Canada.	Catherine.mercier@rea.ulaval.ca		Mercier, Catherine/0000-0002-2037-6916	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 355896-2012]; Centre interdisciplinaire de recherche en readaptation et en integration sociale (CIRRIS); Centre thematique de recherche en neurosciences (CTRN); Faculte de medecine de l'Universite Laval; Fonds de Recherche Quebec - Nature et Technologies (FRQNT); Fonds de recherche Quebec-Sante (FRQS) [29251]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre interdisciplinaire de recherche en readaptation et en integration sociale (CIRRIS); Centre thematique de recherche en neurosciences (CTRN); Faculte de medecine de l'Universite Laval; Fonds de Recherche Quebec - Nature et Technologies (FRQNT); Fonds de recherche Quebec-Sante (FRQS)	We thank Nicolas Robitaille, eng. Ph.D. for his help in the development of the task and technical support. This study was supported by a Discovery grant from Natural Sciences and Engineering Research Council of Canada (NSERC, RGPIN 355896-2012, www.nserc-crsng.gc.ca). C. Brun was supported by fellowships from Centre interdisciplinaire de recherche en readaptation et en integration sociale (CIRRIS, www.cirris.ulaval.ca), from Centre thematique de recherche en neurosciences (CTRN, www.neuro.ulaval.ca), from the Faculte de medecine de l'Universite Laval (www.fmed.ulaval.ca) and from the Fonds de Recherche Quebec - Nature et Technologies (FRQNT, www.frqnt.gouv.qc.ca). C. Mercier is supported by a salary award from Fonds de recherche Quebec-Sante (FRQS, no. 29251, www.frqs.gouv.qc.ca).	Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Blanchard C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062475; Brun C, 2015, NEUROSCIENCE, V310, P268, DOI 10.1016/j.neuroscience.2015.09.052; Brun C, 2015, NEUROSCIENCE, V285, P343, DOI 10.1016/j.neuroscience.2014.11.036; Brun C, SENSORY DISTUR UNPUB; Brun C, 2017, FRONT INTEGR NEUROSC, V11, P1, DOI [10.3389/fnint.2017.00001, DOI 10.3389/FNINT.2017.00001]; Chancel M, 2016, EXP BRAIN RES, V234, P1, DOI [10.1007/s00221-015-4432-4, DOI 10.1007/S00221-015-4432-4]; Coslett HB, 2008, BEHAV NEUROL, V19, P117, DOI 10.1155/2008/972542; Daenen L, 2012, PAIN PHYSICIAN, V15, P405; Daenen L, 2012, RHEUMATOLOGY, V51, P1492, DOI 10.1093/rheumatology/kes050; Daenen L, 2010, RHEUMATOLOGY, V49, P1281, DOI 10.1093/rheumatology/keq067; De Kooning M, 2017, PAIN PRACT, V17, P156, DOI 10.1111/papr.12439; Don S, 2017, PAIN PRACT, V17, P115, DOI 10.1111/papr.12456; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Foell J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00310; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Gritsenko V, 2007, J NEUROPHYSIOL, V98, P1140, DOI 10.1152/jn.00162.2007; Guerraz M, 2012, NEUROSCIENCE, V223, P258, DOI 10.1016/j.neuroscience.2012.07.059; Gullaud-Toussaint L, 2003, PSYCHOL RES-PSYCH FO, V67, P291, DOI 10.1007/s00426-002-0129-y; Harris AJ, 1999, LANCET, V354, P1464, DOI 10.1016/S0140-6736(99)05003-5; Holmes NP, 2004, COGN AFFECT BEHAV NE, V4, P193, DOI 10.3758/CABN.4.2.193; Howell DC, 2008, FUNDAMENTALS STAT BE; Izumizaki M, 2010, J PHYSIOL-LONDON, V588, P2789, DOI 10.1113/jphysiol.2010.192336; Katayama O, 2016, J PAIN RES, V9, P1197, DOI 10.2147/JPR.S122564; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; LAJOIE Y, 1992, NEUROLOGY, V42, P1104, DOI 10.1212/WNL.42.5.1104; Laufer Y, 2001, Physiother Res Int, V6, P65, DOI 10.1002/pri.215; McCabe CS, 2007, RHEUMATOLOGY, V46, P1587, DOI 10.1093/rheumatology/kem204; McCabe CS, 2005, RHEUMATOLOGY, V44, P509, DOI 10.1093/rheumatology/keh529; McCabe CS, 2000, LANCET, V355, P318, DOI 10.1016/S0140-6736(05)72316-3; Metral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080360; Miall RC, 2007, EXP BRAIN RES, V176, P432, DOI 10.1007/s00221-006-0626-0; Moseley GL, 2006, RHEUMATOLOGY, V45, P196, DOI 10.1093/rheumatology/kei119; Roussel NA, 2015, MOTOR CONTROL, V19, P271, DOI 10.1123/ijsnem.2013-0074; Smith JL, 2009, J APPL PHYSIOL, V106, P950, DOI 10.1152/japplphysiol.91365.2008; Snijders HJ, 2007, NEUROPSYCHOLOGIA, V45, P496, DOI 10.1016/j.neuropsychologia.2006.01.003; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tsuge M, 2012, EXP BRAIN RES, V223, P541, DOI 10.1007/s00221-012-3281-7	38	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203206	10.1371/journal.pone.0203206	http://dx.doi.org/10.1371/journal.pone.0203206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157264	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400100
J	Deng, KH; Chen, H; Zhao, YJ; Zhou, YS; Wang, Y; Sun, YC				Deng, Kehui; Chen, Hu; Zhao, Yijiao; Zhou, Yongsheng; Wang, Yong; Sun, Yuchun			Evaluation of adaptation of the polylactic acid pattern of maxillary complete dentures fabricated by fused deposition modelling technology: A pilot study	PLOS ONE			English	Article								Objective To quantitatively evaluate maxillary complete dentures fabricated from polylactic acid (PLA) using fused deposition modelling (FDM) technology. Methods A digital maxillary complete denture was prepared based on a standard maxillary edentulous plaster model. The PLA pattern was printed by a FDM machine, with 5 repetitions, while another 5 wax patterns were printed as control group, using a high accuracy threedimensional (3D) wax printer. The patterns were scanned with a 3D scanner. A light-body silicone film was made after each denture pattern had been totally seated on the plaster model, and was scanned to determine its thickness, which reflected the 3D space between the plaster model and the tissue surface of the denture pattern. The overall area was separated into four parts: primary stress-bearing area, secondary stress-bearing area, border seal area and relief area, and the average deviation of these four parts were measured. The values were analyzed by independent t-test. Results The overall mean value and standard deviation of space between PLA denture patterns and plaster model was 0.277 +/- 0.021 mm, while that of the wax denture patterns was 0.279 +/- 0.045 mm, which showed a good fit overall. No statistically significant (P > 0.05) difference was observed between the PLA patterns and wax patterns. Conclusions The adaptation of the PLA pattern of maxillary complete denture printed by FDM technology is comparable to that prepared by wax printer, and can satisfy the accuracy requirements.	[Deng, Kehui; Chen, Hu; Zhao, Yijiao; Wang, Yong; Sun, Yuchun] Peking Univ, Sch & Hosp Stomatol, Ctr Digital Dent, Beijing, Peoples R China; [Deng, Kehui; Chen, Hu; Zhao, Yijiao; Zhou, Yongsheng; Wang, Yong; Sun, Yuchun] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing, Peoples R China; [Deng, Kehui; Chen, Hu; Zhao, Yijiao; Zhou, Yongsheng; Wang, Yong; Sun, Yuchun] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Deng, Kehui; Chen, Hu; Zhao, Yijiao; Wang, Yong; Sun, Yuchun] Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China; [Deng, Kehui; Chen, Hu; Zhao, Yijiao; Zhou, Yongsheng; Wang, Yong; Sun, Yuchun] Beijing Key Lab Digital Stomatol, Beijing, Peoples R China	Peking University; Peking University	Wang, Y; Sun, YC (corresponding author), Peking Univ, Sch & Hosp Stomatol, Ctr Digital Dent, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Beijing Key Lab Digital Stomatol, Beijing, Peoples R China.	kqcadc@bjmu.edu.cn; polarshining@163.com	, 孙玉春/AAX-5280-2020		National Natural Science Foundation of China [81271181]; Capital Health Research and Development of Special [2016-1-4101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Health Research and Development of Special	This work was supported by the National Natural Science Foundation of China (grant no. 81271181) to YS and The Capital Health Research and Development of Special (grant no. 2016-1-4101) to YSZ.	Ahn SH, 2002, RAPID PROTOTYPING J, V8, P248, DOI 10.1108/13552540210441166; Anitha R, 2001, J MATER PROCESS TECH, V118, P385, DOI 10.1016/S0924-0136(01)00980-3; Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1; Baba Nadim Z, 2016, Gen Dent, V64, P23; Bae EJ, 2015, J ADV PROSTHODONT, V7, P312, DOI 10.4047/jap.2015.7.4.312; Bassoli E, 2007, RAPID PROTOTYPING J, V13, P148, DOI 10.1108/13552540710750898; Bidra AS, 2013, J PROSTHET DENT, V109, P361, DOI 10.1016/S0022-3913(13)60318-2; Chen H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19207; Gibson I., 2021, POWDER BED FUSION AD, P125, DOI [10.1016/j.addma.2020.101465, DOI 10.1016/J.ADDMA.2020.101465]; Goodacre BJ, 2016, J PROSTHET DENT, V116, P249, DOI 10.1016/j.prosdent.2016.02.017; Han WL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005435; Hu C-Y, 2015, BIOMED RES INT, V2015, P1; Ishida Y, 2016, DENT MATER J, V35, P250, DOI 10.4012/dmj.2015-278; Ishinabe S., 1991, J JPN PROSTHODONT SO, V35, P111, DOI DOI 10.2186/JJPS.35.111; Kattadiyil Mathew T, 2013, J Calif Dent Assoc, V41, P407; Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004; Oksman K, 2003, COMPOS SCI TECHNOL, V63, P1317, DOI 10.1016/S0266-3538(03)00103-9	17	10	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201777	10.1371/journal.pone.0201777	http://dx.doi.org/10.1371/journal.pone.0201777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157184	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400014
J	Hunt, EA; Evans, TC; Tanner, NA				Hunt, Eric A.; Evans, Thomas C., Jr.; Tanner, Nathan A.			Single-stranded binding proteins and helicase enhance the activity of prokaryotic argonautes in vitro	PLOS ONE			English	Article							THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; DEPENDENT AMPLIFICATION; BACTERIAL ARGONAUTE; SILENCING COMPLEX; DEFENSE SYSTEMS; SLICER ACTIVITY; PIWI PROTEIN; GUIDE-DNA; RNA	Prokaryotic argonautes are a unique class of nucleic acid-guided endonucleases putatively involved in cellular defense against foreign genetic elements. While their eukaryotic homologs and Cas protein counterparts require single-stranded RNAs as guides, some prokaryotic argonautes are able to utilize short single-stranded DNAs as guides for sequence-specific endonuclease activity. Many complications currently prevent the use of prokaryotic argonautes for in vivo gene-editing applications; however, they do exhibit potential as a new class of in vitro molecular tools if certain challenges can be overcome, specifically the limitations on substrate accessibility which leads to unequal levels of activity across a broad palate of substrates and the inability to act on double-stranded DNA substrates. Here we demonstrate the use of accessory factors, including thermostable single-stranded DNA binding proteins and UvrD-like helicase, in conjunction with prokaryotic argonautes to significantly improve enzymatic activity and enable functionality with a broader range of substrates, including linear double-stranded DNA substrates. We also demonstrate the use of Thermus thermophilus argonaute with accessory factors as a programmable restriction enzyme to generate long, unique single-stranded overhangs from linear double-stranded substrates compatible with downstream ligation.	[Hunt, Eric A.; Evans, Thomas C., Jr.; Tanner, Nathan A.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Tanner, NA (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	tanner@neb.com		Hunt, Eric/0000-0002-6891-8294	New England Biolabs, Inc.; New England Biolabs	New England Biolabs, Inc.; New England Biolabs	This project was funded internally by New England Biolabs, Inc. (http://www.neb.com). Eric A. Hunt, Thomas C. Evans Jr., and Nathan A. Tanner are employees of New England Biolabs, a manufacturer and vendor of molecular biology reagents. All authors were employees of New England Biolabs at the time the work was performed. New England Biolabs funded the work and paid the salaries of all authors. Members of New England Biolabs is not on the author list had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LX, 2005, J BIOL CHEM, V280, P28952, DOI 10.1074/jbc.M503096200; Azlan A, 2016, J GENET GENOMICS, V43, P481, DOI 10.1016/j.jgg.2016.06.002; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Dickey TH, 2013, STRUCTURE, V21, P1074, DOI 10.1016/j.str.2013.05.013; Enghiad B, 2017, ACS SYNTH BIOL, V6, P752, DOI 10.1021/acssynbio.6b00324; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Gilhooly Neville Surain, 2013, Front Biosci (Schol Ed), V5, P206; Goldmeyer J, 2007, J MOL DIAGN, V9, P639, DOI 10.2353/jmoldx.2007.070012; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Greenough L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv899; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Hegge JW, 2017, NAT REV MICROBIOL, V434, P356; Hiramatsu Y, 1997, GENE, V199, P77, DOI 10.1016/S0378-1119(97)00349-1; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Javidi-Parsijani P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177444; Jeon JH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.208101; Klein M, 2017, SEMIN CELL DEV BIOL, V65, P20, DOI 10.1016/j.semcdb.2016.05.017; Koonin EV, 2017, ANNU REV MICROBIOL, V71, P233, DOI 10.1146/annurev-micro-090816-093830; Koonin EV, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-017-0177-2; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lapinaite A, 2018, P NATL ACAD SCI USA, V115, P3368, DOI 10.1073/pnas.1717725115; Lee SH, 2017, NAT BIOTECHNOL, V35, P17, DOI 10.1038/nbt.3753; LILLEY DMJ, 1988, TRENDS GENET, V4, P111, DOI 10.1016/0168-9525(88)90099-6; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Meyer R, 1990, MICROBIOL REV; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Olszewski M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126563; OSHIMA RG, 1992, BIOTECHNIQUES, V13, P188; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Rapley Ralph, 1994, Molecular Biotechnology, V2, P295, DOI 10.1007/BF02745882; Richard DJ, 2004, NUCLEIC ACIDS RES, V32, P1065, DOI 10.1093/nar/gkh259; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Sheu-Gruttadauria J, 2017, J MOL BIOL, V429, P2619, DOI 10.1016/j.jmb.2017.07.018; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sunghyeok Y, 2017, DNA DEPENDENT RNA CL; Swarts DC, 2017, MOL CELL, V65, P985, DOI 10.1016/j.molcel.2017.01.033; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124880; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tanner NA, REDUCING TEMPLATE IN; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Tsai Y, 2017, AMPLIFICATION FREE C; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Willkomm S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.35; Willkomm Sarah, 2015, Life-Basel, V5, P538, DOI 10.3390/life5010538; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zander A, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.34; Zhang JC, 2014, NUCLEIC ACIDS RES, V42, P3821, DOI 10.1093/nar/gkt1316; Zhang YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09063-x; Zhu LZ, 2017, PROG BIOPHYS MOL BIO, V128, P39, DOI 10.1016/j.pbiomolbio.2016.09.008; Zhu LZ, 2016, J PHYS CHEM B, V120, P2709, DOI 10.1021/acs.jpcb.5b12426	64	10	12	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203073	10.1371/journal.pone.0203073	http://dx.doi.org/10.1371/journal.pone.0203073			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157272	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400086
J	Marchenkov, AM; Petrova, DP; Morozov, AA; Zakharova, YR; Grachev, MA; Bondar, AA				Marchenkov, Artyom M.; Petrova, Darya P.; Morozov, Alexey A.; Zakharova, Yulia R.; Grachev, Michael A.; Bondar, Alexander A.			A family of silicon transporter structural genes in a pennate diatom Synedra ulna subsp danica (Kutz.) Skabitsch	PLOS ONE			English	Article							GENOME; ACUS; DATABASE; PROTEIN; MARINE; CYCLE	Silicon transporters (SIT) are the proteins, which capture silicic acid in the aquatic environment and direct it across the plasmalemma to the cytoplasm of diatoms. Diatoms utilize silicic acid to build species-specific ornamented exoskeletons and make a significant contribution to the global silica cycle, estimated at 240 +/- 40 Tmol a year. Recently SaSIT genes of the freshwater araphid pennate diatom Synedra acus subsp. radians are found to be present in the genome as a cluster of two structural genes (SaSIT-TD and SaSIT-TRI) encoding several concatenated copies of a SIT protein each. These structural genes could potentially be transformed into "mature" SIT proteins by means of posttranslational proteolytic cleavage. In the present study, we discovered three similar structural SuSIT genes in the genome of a closely related freshwater diatom Synedra ulna subsp. danica. Structural gene SuSIT1 is identical to structural gene SuSIT2, and the two are connected by a non-coding nucleotide DNA sequence. All the putative "mature" SITs contain conserved amino acid motifs, which are believed to be important in silicon transport. The data obtained suggest that the predicted "mature" SIT proteins may be the minimal units necessary for the transport of silicon is S. ulna subsp. danica. The comparative analysis of all available multi-SITs has allowed us to detect two conservative motifs YQXDXVYL and DXDID, located between the "mature" proteins. Aspartic acid-rich DXDID motif can, in our opinion, serve as a proteolysis site during the multi-SIT cleavage. The narrow distribution of the distances between CMLD and DXDID motifs can serve as additional evidence to the conservation of their function.	[Marchenkov, Artyom M.; Petrova, Darya P.; Morozov, Alexey A.; Zakharova, Yulia R.; Grachev, Michael A.] Russian Acad Sci, Limnol Inst, Dept Cell Ultrastruct, Siberian Branch, Irkutsk, Russia; [Bondar, Alexander A.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Genom Core Facil, Siberian Branch, Novosibirsk, Russia	Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Petrova, DP (corresponding author), Russian Acad Sci, Limnol Inst, Dept Cell Ultrastruct, Siberian Branch, Irkutsk, Russia.	daryapetr@lin.irk.ru	Morozov, Alexey Anatolievich/J-4630-2018; Bondar, Alexander/AAA-7087-2020; Marchenkov, Artyom M/J-4652-2018	Morozov, Alexey Anatolievich/0000-0003-1925-0045; Bondar, Alexander/0000-0001-9181-0487; Marchenkov, Artyom M/0000-0002-4820-9394	FASO Russia [0345-2015-0031, AAAA-A15-115122810221-8, 0345-2016-0005, AAAA-A16-116122110068-5]	FASO Russia	This study was supported by government projects (FASO Russia) "Molecular and Cell Biology" (0345-2015-0031, state registration No AAAA-A15-115122810221-8) (MAG) and (FASO Russia) "Experimental studies of genomes and proteomes" (0345-2016-0005, state registration No AAAA-A16-116122110068-5) (MAG).	Alverson AJ, 2007, LIMNOL OCEANOGR, V52, P1420, DOI 10.4319/lo.2007.52.4.1420; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Basu S, 2017, NEW PHYTOL, V215, P140, DOI 10.1111/nph.14557; Bidle KD, 2008, EUKARYOT CELL, V7, P223, DOI 10.1128/EC.00296-07; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bukhtiyarova L. N., 2006, ALGOLOGIA, V16, P280; Carlisle E.M., 1981, P69; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Durak GM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10543; Durkin CA, 2012, LIMNOL OCEANOGR, V57, P1619, DOI 10.4319/lo.2012.57.6.1619; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Frings PJ, 2016, CHEM GEOL, V425, P12, DOI 10.1016/j.chemgeo.2016.01.020; Galachyants YP, 2015, DOKL BIOCHEM BIOPHYS, V461, P84, DOI 10.1134/S1607672915020064; Grachev MA, 2002, MOL BIOL+, V36, P534, DOI 10.1023/A:1019860628910; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hastings PJ, 2010, GENES-BASEL, V1, P427, DOI 10.3390/genes1030427; Hildebrand M, 2003, PROG ORG COAT, V47, P256, DOI 10.1016/S0300-9440(03)00142-5; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Iler, 1979, CHEM SILICA SOLUBILI; JACOBS JD, 1992, MOL GEN GENET, V233, P302, DOI 10.1007/BF00587592; Kang LK, 2015, MAR BIOL, V162, P1511, DOI 10.1007/s00227-015-2687-8; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Knight MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11926; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Korunes KL, 2017, MOL ECOL, V26, P351, DOI 10.1111/mec.13736; Kulikovskiy M, 2016, FOTTEA, V16, P34, DOI 10.5507/fot.2015.011; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Likhoshway Ye V, 2006, Dokl Biol Sci, V408, P256, DOI 10.1134/S001249660603015X; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Marchenkov AM, 2016, DOKL BIOCHEM BIOPHYS, V471, P407, DOI 10.1134/S1607672916060089; Marron AO, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2543; Mock T, 2017, NATURE, V541, P536, DOI 10.1038/nature20803; Monroe J.S., 2011, CHANGING EARTH EXPLO, V6th; Mukherjee S, 2017, NUCLEIC ACIDS RES, V45, pD446, DOI 10.1093/nar/gkw992; Petrova DP, 2007, DOKL BIOCHEM BIOPHYS, V417, P295, DOI 10.1134/S1607672907060014; Pondaven P, 2000, NATURE, V405, P168, DOI 10.1038/35012046; Round F. E., 1990, DIATOMS BIOL MORPHOL; Sapriel G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007458; Sherbakova TA, 2005, MOL BIOL+, V39, P269, DOI 10.1007/s11008-005-0038-4; Skabichevskii AP, 1960, PLANCTONIC DIATOMS F; Skabichevskii AP, 1959, URSS, V12, p46 ; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sutton JN, 2018, FRONT EARTH SC-SWITZ, V5, DOI 10.3389/feart.2017.00112; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka T, 2015, PLANT CELL, V27, P162, DOI 10.1105/tpc.114.135194; Thamatrakoln K, 2007, EUKARYOT CELL, V6, P271, DOI 10.1128/EC.00235-06; Thamatrakoln K, 2006, J PHYCOL, V42, P822, DOI 10.1111/j.1529-8817.2006.00233.x; Thompson A.S., 1988, CULTURE COLLECTION A; Traller JC, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0670-3; Treguer P, 2018, NAT GEOSCI, V11, P27, DOI 10.1038/s41561-017-0028-x; Treguer PJ, 2013, ANNU REV MAR SCI, V5, P477, DOI 10.1146/annurev-marine-121211-172346; Wil liams D.M., 1987, DIATOM RES, V2, P267, DOI DOI 10.1080/0269249X.1987.9705004; ZUCKERKANDL EMILE, 1965, P97	56	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203161	10.1371/journal.pone.0203161	http://dx.doi.org/10.1371/journal.pone.0203161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157241	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400098
J	Murillo-Barroso, M; Penalver, E; Bueno, P; Barroso, R; de Balbin, R; Martinon-Torres, M				Murillo-Barroso, Mercedes; Penalver, Enrique; Bueno, Primitiva; Barroso, Rosa; de Balbin, Rodrigo; Martinon-Torres, Marcos			Amber in prehistoric Iberia: New data and a review	PLOS ONE			English	Review							LA CONCEPCIN SEVILLE; BRONZE-AGE; NORTHERN SPAIN; ARTIFACTS; COPPER; INCLUSIONS; VALENCINA	Provenancing exotic raw materials and reconstructing the nature and routes of exchange is a major concern of prehistoric archaeology. Amber has long been recognised as a key commodity of prehistoric exchange networks in Europe. However, most science-based studies so far have been localised and based on few samples, hence making it difficult to observe broad geographic and chronological trends. This paper concentrates on the nature, distribution and circulation of amber in prehistoric Iberia. We present new standardised FTIR analyses of 22 archaeological and geological samples from a large number of contexts across Iberia, as well as a wide scale review of all the legacy data available. On the basis of a considerable body of data, we can confirm the use of local amber resources in the Northern area of the Iberian Peninsula from the Palaeolithic to the Bronze Age; we push back the arrival of Sicilian amber to at least the 4th Millennium BC, and we trace the appearance of Baltic amber since the last quarter of the 2nd Millennium BC, progressively replacing Sicilian simetite. Integrating these data with other bodies of archaeological information, we suggest that the arrival of Baltic amber was part of broader Mediterranean exchange networks, and not necessarily the result of direct trade with the North. From a methodological perspective, thanks to the analyses carried out on both the vitreous core and the weathered surfaces of objects made of Sicilian simetite, we define the characteristic FTIR bands that allow the identification of Sicilian amber even in highly deteriorated archaeological samples.	[Murillo-Barroso, Mercedes] Univ Granada, Dept Prehist & Arqueol, Granada, Spain; [Penalver, Enrique] Geominer Museum, Inst Geol & Minero Espana, Valencia, Spain; [Bueno, Primitiva; Barroso, Rosa; de Balbin, Rodrigo] Univ Alcala de Henares, Dept Hist & Filosofia, Madrid, Spain; [Martinon-Torres, Marcos] Univ Cambridge, Dept Archaeol, Cambridge, England	University of Granada; Universidad de Alcala; University of Cambridge	Murillo-Barroso, M (corresponding author), Univ Granada, Dept Prehist & Arqueol, Granada, Spain.	murillobarroso@ugr.es	Murillo-Barroso, Mercedes/Y-6357-2019; Barroso Bermejo, Rosa/H-5996-2015; Peñalver, Enrique/AAB-5470-2022; Bueno Ramirez, Primitiva/R-7474-2018	Murillo-Barroso, Mercedes/0000-0002-2271-291X; Barroso Bermejo, Rosa/0000-0003-3129-4497; Peñalver, Enrique/0000-0001-8312-6087; Martinon-Torres, Marcos/0000-0003-2124-2837; Bueno Ramirez, Primitiva/0000-0001-8958-8928	7th Framework Programme of the European Commission under a Marie Curie Intra-European Fellowship at UCL Institute of Archaeology (London, UK); University of Granada under the programme Captacion de Talento UGRFellows; Spanish Ministry of Economy and Competitiveness [HAR2017-82685-R]; Spanish AEI/FEDER, UE [CGL2017-84419]	7th Framework Programme of the European Commission under a Marie Curie Intra-European Fellowship at UCL Institute of Archaeology (London, UK); University of Granada under the programme Captacion de Talento UGRFellows; Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish AEI/FEDER, UE	This work was supported by the 7th Framework Programme of the European Commission under a Marie Curie Intra-European Fellowship at UCL Institute of Archaeology (London, UK); by the University of Granada under the programme Captacion de Talento UGRFellows; by the Spanish Ministry of Economy and Competitiveness under the R&D projects: Metal y Ambar: Modelos de Circulacion de Materias Primas en la Prehistoria Reciente de la Peninsula Iberica (HAR2017-82685-R) and the project CRE: Global bioevent of massive resin production at the initial diversification of modern forest ecosystems, funded by the Spanish AEI/FEDER, UE Grant CGL2017-84419.	Almagro Basch M, 1963, POBLADO NECROPOLIS M, V3; Alonso J, 2000, J PALEONTOL, V74, P158, DOI 10.1666/0022-3360(2000)074<0158:ANFRWB>2.0.CO;2; Alvarez-Fernandez E, 2005, ZEPHYRUS, V58, P147; Angelini I, 2017, ARCHAEOL ANTHROP SCI, V9, P673, DOI 10.1007/s12520-016-0452-7; Jimenez GA, 2015, TRABAJOS PREHIST, V72, P126, DOI 10.3989/tp.2015.12147; Arbizu M., 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P245; ARRUDA A. M., 2008, CONTACTO CULTURAL EN, P16; Barron E, 2015, CRETACEOUS RES, V52, P292, DOI 10.1016/j.cretres.2014.10.003; Barros L., 2000, THESIS; Barros L, 1997, SETUB ARQUEOL, V11-12, P217; BECK C, 1965, ARCHAEOMETRY, V8, P96, DOI 10.1111/j.1475-4754.1965.tb00896.x; BECK CW, 1964, NATURE, V201, P256, DOI 10.1038/201256a0; BECK CW, 1982, PHYS CHEM MINER, V8, P146, DOI 10.1007/BF00311286; Beck CW, 1990, P 2 INT C AMB ARCH L, P36; Bernardez Rodroguez, 1994, CUADERNOS GEOLOGIA I, V18, P11; Bueno Ramirez P., 2016, MONTELIRIO GRAN MONU, P365; Bueno Ramorez P, 2012, AGR METALURGICOS VAL; Bueno-Ramirez P., 2005, TRABAJOS PREHIST, V62, P67, DOI [DOI 10.3989/TP.2005.V62.I2.69, 10.3989/tp.2005.v62.i2.69]; Calderon S., 1910, MINERALES ESPANA; Cardoso JL, 1999, EST ARQUEOL OEIR, V7, P355; Celestino Perez S, 2008, CONTACTO CULTURAL EN; Chaves F., 1902, B R SOC HIST NAT, VII, P301; Civilyte A, 2015, GERMANIA, V93, P97; Costa M. E., 2011, MENGA REV PREHISTORI, V1, P253; Cultraro M., AEGEAN BALTIC SEAS P; Czebreszuk J., 2013, COUNTERPOINT ESSAYS, P557; Dominguez-Bella S., 2010, MINERALES ROCAS SOC, P275; Dominguez-Bella S., 1995, ZEPHYRUS, VXLVIII, P129; Dominguez-Bella S, 1998, WORLD C AM INCL VIT, P153; Dominguez-Bella S, 2016, ARCHAEOL ANTHROP SCI, V8, P205, DOI 10.1007/s12520-015-0232-9; Dominguez-Bella S, 2011, TRABAJOS PREHIST, V68, P369, DOI 10.3989/tp.2011.11075; Domonguez-Bella S, 2001, 3 C NAC ARQ SEV U SE, P621; Fernandez Flores A., 2016, MONTELIRIO GRAN MONU; Freund KP, 2017, LITHIC TECHNOL, V42, P35, DOI 10.1080/01977261.2017.1290335; Gallart i Fernandez JR, 2006, COTA ZERO, V21, P10; Garcia Sanjuan L, MEGALITHS SOC LANDSC; Sanjuan LG, 2018, J WORLD PREHIST, V31, P179, DOI 10.1007/s10963-018-9114-2; Sanjuan LG, 2017, J WORLD PREHIST, V30, P239, DOI 10.1007/s10963-017-9107-6; GarcYa SanjuSSn L., 2013, PREHISTORY IBERIA DE, P119, DOI DOI 10.4324/9780203072035; Gil O., 1947, ADQUISICIONES MUSEO; Goncalves VS, 2004, REV PORT ARQUEOL, V7, P73; Gonzalez Fernandez B., 2004, Trabajos de Geologia, V24, P43; Guiliano M, 2007, SPECTROCHIM ACTA A, V67, P1407, DOI 10.1016/j.saa.2006.10.033; Gutierrez Morillo A., 2003, C A E A P 25 INVESTI, P137; Harding A, 1975, AMBER MYCEANEAN WORL, V69, P145; Herbaut F., 2004, B SOC PREHISTORIQUE, V101, P497, DOI [10.3406/bspf.2004.13029, DOI 10.3406/BSPF.2004.13029]; Khanjian H, 2013, E PRESERVATION SCI, V10, P66; Leisner G, 1943, MEGALITHGRABER IBERI, V17; Liesau von Lettow-Vorbeck C, 2012, CPA UAM, V37-38, P209; Ling J, 2014, J ARCHAEOL SCI, V41, P106, DOI 10.1016/j.jas.2013.07.018; Lorrio A., 2008, QURENIMA BRONCE FINA, V25-26, P119; Cerdeno ML, 2012, TRABAJOS PREHIST, V69, P375, DOI 10.3989/tp.2012.12098; Maran J., 2013, MOBILITY MEANING TRA, P147; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; Melheim L, 2018, J ARCHAEOL SCI, V96, P85, DOI 10.1016/j.jas.2018.04.003; Melheim L, 2018, METALS MINDS MOBILIT; Menor-Salvan C, 2010, ORG GEOCHEM, V41, P1089, DOI 10.1016/j.orggeochem.2010.06.013; Mora Molina C, 2013, ASENTAMIENTO PREHIST, P261; Mujika J. A., 1991, MUNIBE, V43, P105; Murillo-Barroso M., 2016, MONTELIRIO GRAN MONU, P311; Murillo-Barroso M., 2013, ASENTAMIENTO PREHIST, P511; Murillo-Barroso M, 2018, TRAB PREHIST, V75; Murillo-Barroso M, 2015, J ARCHAEOL SCI, V57, P322, DOI 10.1016/j.jas.2015.03.013; Murillo-Barroso M, 2012, EUR J ARCHAEOL, V15, P187, DOI 10.1179/1461957112Y.0000000009; Najarro M, 2009, GEOL ACTA, V7, P363, DOI 10.1344/105.000001443; Nieto-Albert LM, 2015, MESOZOICO PREBETICO; Odriozola CP, 2019, ARCHAEOL ANTHROP SCI, V11, P567, DOI 10.1007/s12520-017-0549-7; Penalver E, 2007, J ARCHAEOL SCI, V34, P843, DOI 10.1016/j.jas.2006.03.006; Penalver E, 2007, CRETACEOUS RES, V28, P791, DOI 10.1016/j.cretres.2006.12.004; Penalver Enrique, 2010, P236; Penalver Enrique, 1999, Revista Espanola de Paleontologia, V14, P231; Petrequin P, 2015, CONNECTING NETWORKS, P83; Petrequin P., 2016, INTANGIBLE ELEMENTS, P47, DOI DOI 10.1007/978-3-319-23153-2_3; Rafel N., 2008, CONTACTO CULTURAL EN; Rodriguez O., 2013, THESIS; Rovira i Port J, 1994, QUADERNS PREHISTORIA, V16, P67; Sabatini S., 2017, NEW PERSPECTIVES BRO, P355, DOI [10.2307/j.ctv1pzk2c1.32, DOI 10.2307/J.CTV1PZK2C1.32]; Salas R., 1996, GEOGACETA, V20, P1704; Schuhmacher TX, 2009, ANTIQUITY, V83, P983, DOI 10.1017/S0003598X00099294; Silva A. M., 2003, ANTHROPOL, VXLI, P55; Siret L., 1909, ANTHROPOL, VXX, P129; Torres Ortiz M., 2008, CONTACTA CULTURAL ME, P59; Tykot RH, 1995, THESIS; Tykot RH, 2013, ACS SYM SER, V1147, P195; Vila EV, 2015, CR PALEVOL, V14, P147, DOI 10.1016/j.crpv.2014.11.004; Vilaca R., 2002, MADRIDER MITTEILUNGE, V43, P61; Vilaca R, 2006, COMPLUTUM, V17, P81; Zapatero P., 2015, THESIS; Zapatero P, 2017, BSAA ARQUEOL, VLXXXIII, P71	89	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202235	10.1371/journal.pone.0202235	http://dx.doi.org/10.1371/journal.pone.0202235			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157208	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400046
J	Bosschieter, J; Bach, S; Bijnsdorp, IV; Segerink, LI; Rurup, WF; van Splunter, AP; Bahce, I; Novianti, PW; Kazemier, G; van Moorselaar, RJA; Steenbergen, RDM; Nieuwenhuijzen, JA				Bosschieter, J.; Bach, S.; Bijnsdorp, I., V; Segerink, L., I; Rurup, W. F.; van Splunter, A. P.; Bahce, I; Novianti, P. W.; Kazemier, G.; van Moorselaar, R. J. A.; Steenbergen, R. D. M.; Nieuwenhuijzen, J. A.			A protocol for urine collection and storage prior to DNA methylation analysis	PLOS ONE			English	Article							EDTA	Background Urine poses an attractive non-invasive means for obtaining liquid biopsies for oncological diagnostics. Especially molecular analysis on urinary DNA is a rapid growing field. However, optimal and practical storage conditions that result in preservation of urinary DNA, and in particular hypermethylated DNA (hmDNA), are yet to be determined. Aim To determine the most optimal and practical conditions for urine storage that result in adequate preservation of DNA for hmDNA analysis. Methods DNA yield for use in methylation analysis was determined by quantitative methylation specific PCR (qMSP) targeting the ACTB and RASSF1A genes on bisulfite modified DNA. First, DNA yield (ACTB qMSP) was determined in a pilot study on urine samples of healthy volunteers using two preservatives (Ethylenediaminetetraacetic acid (EDTA) and Urine Conditioning Buffer, Zymo Research) at four different temperatures (room temperature (RT), 4 degrees C, -20 degrees C, -80 degrees C) for four time periods (1, 2, 7, 28 days). Next, hmDNA levels (RASSF1A qMSP) in stored urine samples of patients suffering from bladder cancer (n = 10) or non-small cell lung cancer (NSCLC; n = 10) were measured at day 0 and 7 upon storage with and without the addition of 40mM EDTA and/ or 20 mu l/ml Penicillin Streptomycin (PenStrep) at RT and 4 degrees C. Results In the pilot study, DNA for methylation analysis was only maintained at RT upon addition of preserving agents. In urine stored at 4 degrees C for a period of 7 days or more, the addition of either preserving agent yielded a slightly better preservation of DNA. When urine was stored at -20 degrees C or -80 degrees C for up to 28 days, DNA was retained irrespective of the addition of preserving agents. In bladder cancer and NSCLC samples stored at RT loss of DNA was significantly less if EDTA was added compared to no preserving agents (p<0.001). Addition of PenStrep did not affect DNA preservation (p>0.99). Upon storage at 4 degrees C, no difference in DNA preservation was found after the addition of preserving agents (p = 0.18). The preservation of methylated DNA (RASSF1A) was strongly correlated to that of unmethylated DNA (ACTB) in most cases, except when PCR values became inaccurate. Conclusions Addition of EDTA offers an inexpensive preserving agent for urine storage at RT up to seven days allowing for reliable hmDNA analysis. To avoid bacterial overgrowth PenStrep can be added without negatively affecting DNA preservation.	[Bosschieter, J.; Bijnsdorp, I., V; van Moorselaar, R. J. A.; Nieuwenhuijzen, J. A.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Urol, Med Ctr, Amsterdam, Netherlands; [Bach, S.; Kazemier, G.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Med Ctr, Amsterdam, Netherlands; [Segerink, L., I; Rurup, W. F.] Univ Twente, BIOS Lab Chip Grp, Enschede, Netherlands; [van Splunter, A. P.; Novianti, P. W.; Steenbergen, R. D. M.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Pathol & Mol Biol, Med Ctr, Amsterdam, Netherlands; [Bahce, I] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Pulmonol, Med Ctr, Amsterdam, Netherlands; [Novianti, P. W.] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Twente; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Bosschieter, J (corresponding author), Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Urol, Med Ctr, Amsterdam, Netherlands.	j.bosschieter@vumc.nl	Segerink, Loes/L-8229-2018; Bahce, Idris/AAZ-5501-2021	Bahce, Idris/0000-0002-1111-608X; Steenbergen, Renske/0000-0002-2327-9839; Bach, Sander/0000-0003-1711-6619; Nieuwenhuijzen, Jakko/0000-0002-8977-5501	Edli Foundations	Edli Foundations	Part of this research was funded by Edli Foundations.	Barra GB, 2015, CLIN BIOCHEM, V48, P976, DOI 10.1016/j.clinbiochem.2015.02.014; Bryzgunova OE, 2015, ACTA NATURAE, V7, P48, DOI 10.32607/20758251-2015-7-3-48-54; Cannas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006985; Cerchietti L, 2017, J CLIN ONCOL, V35, P793, DOI 10.1200/JCO.2016.71.0616; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Clozel T, 2013, CANCER DISCOV, V3, P1002, DOI 10.1158/2159-8290.CD-13-0117; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Hubers AJ, 2014, LUNG CANCER, V84, P127, DOI 10.1016/j.lungcan.2014.01.019; Mell JC, 2014, J BACTERIOL, V196, P1471, DOI 10.1128/JB.01293-13; Milde A, 1999, INT J LEGAL MED, V112, P209, DOI 10.1007/s004140050237; Reckamp KL, 2016, J THORAC ONCOL, V11, P1690, DOI 10.1016/j.jtho.2016.05.035; Uijterwaal MH, 2016, GYNECOL ONCOL, V143, P135, DOI 10.1016/j.ygyno.2016.07.089; van Kessel KEM, 2017, J UROLOGY, V197, P590, DOI 10.1016/j.juro.2016.09.118; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilting SM, 2016, ONCOTARGET, V7, P43805, DOI 10.18632/oncotarget.9698; Yokoi K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040735	16	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0200906	10.1371/journal.pone.0200906	http://dx.doi.org/10.1371/journal.pone.0200906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142219	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500002
J	Jung, H; Kim, JY; Kim, KB; Chae, YC; Hahn, Y; Kim, JW; Seo, SB				Jung, Hyeonsoo; Kim, Ji-Young; Kim, Kee-Beom; Chae, Yun-Cheol; Hahn, Yoonsoo; Kim, Jung-Woong; Seo, Sang-Beom			Deacetylase activity-independent transcriptional activation by HDAC2 during TPA-induced HL-60 cell differentiation	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; H3K9 METHYLTRANSFERASE G9A; TRANS-RETINOIC ACID; VALPROIC ACID; B-CELLS; PAX5 EXPRESSION; CANCER; GENE; LSD1; THERAPY	The human myeloid leukemia cell line HL-60 differentiate into monocytes following treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA). However, the mechanism underlying the differentiation of these cells in response to TPA has not been fully elucidated. In this study, we performed ChIP-seq profiling of RNA Pol II, HDAC2, Acetyl H3 (AcH3), and H3K27me3 and analyzed differential chromatin state changes during TPA-induced differentiation of HL-60 cells. We focused on atypically active genes, which showed enhanced H3 acetylation despite increased HDAC2 recruitment. We found that HDAC2 positively regulates the expression of these genes in a histone deacetylase activity-independent manner. HDAC2 interacted with and recruited paired box 5 (PAX5) to the promoters of the target genes and regulated HL-60 cell differentiation by PAX5-mediated gene activation. Taken together, these data elucidated the specific-chromatin status during HL-60 cell differentiation following TPA exposure and suggested that HDAC2 can activate transcription of certain genes through interactions with PAX5 in a deacetylase activity-independent pathway.	[Jung, Hyeonsoo; Kim, Ji-Young; Kim, Kee-Beom; Chae, Yun-Cheol; Hahn, Yoonsoo; Kim, Jung-Woong; Seo, Sang-Beom] Chung Ang Univ, Dept Life Sci, Coll Nat Sci, Seoul, South Korea	Chung Ang University	Seo, SB (corresponding author), Chung Ang Univ, Dept Life Sci, Coll Nat Sci, Seoul, South Korea.	sangbs@cau.ac.kr	Kim, Kee-Beom/AAG-9225-2022; Kim, Kee-Beom/AFL-8804-2022	Kim, Kee-Beom/0000-0003-0132-8924; Kim, Kee-Beom/0000-0003-0132-8924; Seo, Sang Beom/0000-0003-4709-6022	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016R1A4A1008035, NRF-2017R1A2B4004407]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2016R1A4A1008035 and NRF-2017R1A2B4004407).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baijun Fang QL., 2015, J LEUKEMIA, V03, DOI [10.4172/2329-6917.1000168, DOI 10.4172/2329-6917.1000168]; Beguelin W, 2015, LEUKEMIA, V29, P1684, DOI 10.1038/leu.2015.57; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Blagitko-Dorfs N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075258; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; COLLINS SJ, 1987, BLOOD, V70, P1233; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hurtz C, 2011, J EXP MED, V208, P2163, DOI 10.1084/jem.20110304; Jiang H, 1999, MOL CELL BIOL, V19, P8136; Jung H, 2017, SCI REP-UK, V7, DOI 10.1038/srep46182; Kanteti R, 2009, LAB INVEST, V89, P301, DOI 10.1038/labinvest.2008.168; Kim JY, 2012, MOL CELL BIOL, V32, P2917, DOI 10.1128/MCB.00133-12; Kim KB, 2015, NUCLEIC ACIDS RES, V43, P3509, DOI 10.1093/nar/gkv183; Kimbrel EA, 2009, BLOOD, V114, P4804, DOI 10.1182/blood-2009-04-217794; Kuendgen A, 2006, CANCER-AM CANCER SOC, V106, P112, DOI 10.1002/cncr.21552; Kupsa T, 2012, BIOMED PAP, V156, P291, DOI 10.5507/bp.2012.108; Laurent B, 2015, MOL CELL, V57, P957, DOI 10.1016/j.molcel.2015.01.010; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Miccadei S, 2005, ONCOGENE, V24, P6993, DOI 10.1038/sj.onc.1208861; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Plass C, 2008, SEMIN ONCOL, V35, P378, DOI 10.1053/j.seminoncol.2008.04.008; Quintas-Cardama A, 2011, LEUKEMIA, V25, P226, DOI 10.1038/leu.2010.276; Ramirez RN, 2017, CELL SYST, V4, P416, DOI 10.1016/j.cels.2017.03.005; Ray D, 2013, BLOOD, V122, P759, DOI 10.1182/blood-2013-02-482497; Rucker FG, 2016, EPIGENETICS-US, V11, P517, DOI 10.1080/15592294.2016.1187350; Savickiene J, 2012, CELL MOL BIOL LETT, V17, P501, DOI 10.2478/s11658-012-0024-5; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Son HJ, 2012, MOL CELL BIOL, V32, P3681, DOI 10.1128/MCB.00673-12; Tegla CA, 2015, EXP MOL PATHOL, V98, P328, DOI 10.1016/j.yexmp.2015.03.011; Tiacci E, 2004, CANCER RES, V64, P7399, DOI 10.1158/0008-5472.CAN-04-1865; Verma M., 2018, EPIGENETICS AGING LO, P439, DOI DOI 10.1016/B978-0-12-811060-7.00021-8; Vlaicu SI, 2013, IMMUNOL RES, V56, P109, DOI 10.1007/s12026-012-8381-8	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202935	10.1371/journal.pone.0202935	http://dx.doi.org/10.1371/journal.pone.0202935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142192	Green Submitted, Green Published, gold			2022-12-27	WOS:000442722500050
J	Huang, HM; Zhao, YL; Xu, ZG; Ding, Y; Zhang, W; Wu, L				Huang, Huimin; Zhao, Yunlin; Xu, Zhenggang; Ding, Yi; Zhang, Wan; Wu, Liang			Biosorption characteristics of a highly Mn(II)-resistant Ralstonia pickettii strain isolated from Mn ore	PLOS ONE			English	Article							HEAVY-METAL POLLUTION; AQUEOUS-SOLUTION; LEAD; BACTERIA; CADMIUM; REMOVAL; COPPER; BIOREMEDIATION; EQUILIBRIUM; ADSORPTION	Microorganisms play an important role in immobilizing and detoxifying excessive Mn; however, there is so far a lack of sufficient information concerning highly Mn(II)-tolerant bacteria. The present study was conducted to analyze the bio-sorption characteristics of a strain (HM8) isolated from manganese ore wastes. Analytical data from the 16S rDNA sequence determination showed that the species, HM8, had a 99% similarity to Ralstonia pickettii. Results from the designed physiological, biochemical and isothermal adsorption tests indicated that HM8 did not only grow well at a Mn(II) concentration level of 10,000 mg/L but also removed 1,002.83 mg/L of Mn(II) from the bulk solution of the culture, showing that the isolated strain possessed strong capabilities to tolerate and remove Mn(II). In the isothermal bio-sorption experiments performed to investigate the effects of relevant factors on Mn(II) sorption, the highest Mn(II) removal rate was obtained at the contact time 72 h, temperature 40 degrees C, and pH 6.0, while the differences in both strain growth and Mn(II) removal rate between different inoculated HM8 doses were found to be insignificant within the tested range. Scanning electron microscopy showed that, under Mn(II) stress, HM8 cells appeared irregular and cracked, with apparent wrinkles on the surface. The peaks in the Fourier transform infrared spectra showed that hydroxyl and carboxyl groups were the main functional groups for Mn(II) adsorption. The experimental data supported the practical application of HM8 as a biological adsorbent for remediation of heavily Mn contaminated sites.	[Huang, Huimin; Zhao, Yunlin] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Huang, Huimin; Zhao, Yunlin; Xu, Zhenggang; Ding, Yi; Zhang, Wan; Wu, Liang] Cent South Univ Forestry & Technol, Hunan Res Ctr Engn Technol Utilizat Environm & Re, Changsha, Hunan, Peoples R China; [Xu, Zhenggang] Hunan City Univ, Sch Mat & Chem Engn, Yiyang, Hunan, Peoples R China	Hunan Agricultural University; Central South University of Forestry & Technology; Hunan City University	Xu, ZG (corresponding author), Cent South Univ Forestry & Technol, Hunan Res Ctr Engn Technol Utilizat Environm & Re, Changsha, Hunan, Peoples R China.; Xu, ZG (corresponding author), Hunan City Univ, Sch Mat & Chem Engn, Yiyang, Hunan, Peoples R China.	rssq198677@163.com	Zhenggang, Xu/ABE-9095-2020	Zhenggang, Xu/0000-0002-7401-5163	Forestry science and technology project of Hunan Province [XLK201825, XKL201731]; Key Technology R&D Program of Hunan Province [2016TP2007, 2016TP1014, 2016TP1022]	Forestry science and technology project of Hunan Province; Key Technology R&D Program of Hunan Province	This work was supported by Forestry science and technology project of Hunan Province (XLK201825, XKL201731), Yunlin Zhao, Key Technology R&D Program of Hunan Province (2016TP2007, 2016TP1014, 2016TP1022), Zhenggang Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hasan H, 2016, J IND ENG CHEM, V37, P295, DOI 10.1016/j.jiec.2016.03.038; Acosta JA, 2011, J GEOCHEM EXPLOR, V109, P8, DOI 10.1016/j.gexplo.2011.01.004; AIKING H, 1985, APPL ENVIRON MICROB, V50, P1262, DOI 10.1128/AEM.50.5.1262-1267.1985; [Anonymous], 1990, BIOSORPTION HEAVY ME; BROWN MJ, 1982, WATER RES, V16, P1539, DOI 10.1016/0043-1354(82)90206-8; Burger MS, 2008, WATER RES, V42, P4733, DOI 10.1016/j.watres.2008.08.024; CHANMUGATHAS P, 1987, SOIL SCI SOC AM J, V51, P1184, DOI 10.2136/sssaj1987.03615995005100050017x; Chen BY, 2000, INT BIODETER BIODEGR, V46, P11, DOI 10.1016/S0964-8305(00)00054-8; Chen HM, 1999, AMBIO, V28, P130; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Deng PY, 2013, INT J ENVIRON SCI TE, V10, P559, DOI 10.1007/s13762-013-0186-3; Divekar M., 2010, ISOLATION CHARACTERI; Dong J, 2011, ENVIRON EARTH SCI, V64, P1317, DOI 10.1007/s12665-011-0992-1; El Aafi N, 2012, INT J PHYTOREMEDIAT, V14, P261, DOI 10.1080/15226514.2011.604693; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Fan T, 2008, J HAZARD MATER, V160, P655, DOI 10.1016/j.jhazmat.2008.03.038; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Figueira MM, 1999, ENVIRON SCI TECHNOL, V33, P1840, DOI 10.1021/es981111p; Forstner U, 1990, SEDIMENT CRITERIA DE, DOI [10.1016/j.scitotenv.2013.08.090, DOI 10.1016/J.SCITOTENV.2013.08.090]; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Govarthanan M, 2013, CHEMOSPHERE, V90, P2267, DOI 10.1016/j.chemosphere.2012.10.038; Han RP, 2005, J HAZARD MATER, V125, P266, DOI 10.1016/j.jhazmat.2005.05.031; Hasan Hassimi Abu, 2012, J Environ Manage, V111, P34, DOI 10.1016/j.jenvman.2012.06.027; Holt John G., 1994, BERGEYS MANUAL DETER, P520; Hynes RK, 2008, CAN J MICROBIOL, V54, P248, DOI [10.1139/W08-008, 10.1139/w08-008]; Iqbal M, 2009, J HAZARD MATER, V164, P161, DOI 10.1016/j.jhazmat.2008.07.141; Jebeli MA, 2017, CHEMOSPHERE, V169, P636, DOI 10.1016/j.chemosphere.2016.11.129; [金羽 Jin Yu], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P2248; Kang CH, 2015, ECOL ENG, V74, P402, DOI 10.1016/j.ecoleng.2014.10.009; Khalilnezhad R, 2014, APPL BIOCHEM BIOTECH, V174, P1919, DOI 10.1007/s12010-014-1076-y; Khani MH, 2008, J HAZARD MATER, V150, P612, DOI 10.1016/j.jhazmat.2007.05.010; Klein R, 2014, ADV BIOCHEM ENG BIOT, V141, P109, DOI 10.1007/10_2013_265; Kuffner M, 2010, J APPL MICROBIOL, V108, P1471, DOI 10.1111/j.1365-2672.2010.04670.x; Learman DR, 2011, GEOCHIM COSMOCHIM AC, V75, P6048, DOI 10.1016/j.gca.2011.07.026; Li DD, 2017, J ENVIRON MANAGE, V196, P8, DOI 10.1016/j.jenvman.2017.02.076; Li FT, 2007, CHINESE CHEM LETT, V18, P325, DOI 10.1016/j.cclet.2007.01.034; [李会东 Li Huidong], 2014, [环境工程学报, Chinese Journal of Environmental Engineering], V8, P5022; Li XA, 2010, STAT RES; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; [凌薇薇 LING Weiwei], 2011, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V31, P152; Lu WB, 2006, J HAZARD MATER, V134, P80, DOI 10.1016/j.jhazmat.2005.10.036; Mijnendonckx K, 2013, MICROB ECOL, V65, P347, DOI 10.1007/s00248-012-0139-2; Narayani M, 2013, CRIT REV ENV SCI TEC, V43, P955, DOI 10.1080/10643389.2011.627022; Nelson YM, 2002, ENVIRON SCI TECHNOL, V36, P421, DOI 10.1021/es010907c; Ouyang LN, 2016, CHINA ENV SCI; Oves M, 2013, SAUDI J BIOL SCI, V20, P121, DOI 10.1016/j.sjbs.2012.11.006; Oyetibo GO, 2014, INT BIODETER BIODEGR, V91, P37, DOI 10.1016/j.ibiod.2014.03.004; Pardo R, 2003, ANAL BIOANAL CHEM, V376, P26, DOI 10.1007/s00216-003-1843-z; Paul Dipak, 2017, Annals of Agrarian Science, V15, P278, DOI 10.1016/j.aasci.2017.04.001; Peres TV, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0099-0; POPP JL, 1990, BIOCHEMISTRY-US, V29, P10475, DOI 10.1021/bi00498a008; Rai UN, 2008, ENVIRON MONIT ASSESS, V144, P469, DOI 10.1007/s10661-007-0010-y; Rajkumar M, 2010, TRENDS BIOTECHNOL, V28, P142, DOI 10.1016/j.tibtech.2009.12.002; [任立民 Ren Limin], 2007, [生态学报, Acta Ecologica Sinica], V27, P357; Ryan MP, 2013, J MED MICROBIOL, V62, P1025, DOI 10.1099/jmm.0.054759-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sana Ehsan, 2013, Ecoterra, P37; Saygideger S, 2005, J HAZARD MATER, V126, P96, DOI 10.1016/j.jhazmat.2005.06.012; Sen SK, 2014, J HAZARD MATER, V265, P47, DOI 10.1016/j.jhazmat.2013.11.036; Shiller AM, 2005, GEOMICROBIOL J, V22, P117, DOI 10.1080/01490450590945924; Silva AM, 2012, J CLEAN PROD, V29-30, P11, DOI 10.1016/j.jclepro.2012.01.032; Sun ZhongXing, 2011, Journal of Environmental & Occupational Medicine, V28, P379; Tang WW, 2016, CHEMOSPHERE, V165, P277, DOI 10.1016/j.chemosphere.2016.08.134; Tani Y, 2004, J ENVIRON SCI HEAL A, V39, P2641, DOI [10.1081/ESE-200027021, 10.1081/LESA-200027021]; Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002; Wang L, 2018, J HAZARD MATER, V341, P1, DOI 10.1016/j.jhazmat.2017.07.036; Wang PF, 2015, POL J ENVIRON STUD, V24, P339; Wang T, 2017, ENV SCI POLLUTION RE, V1, P1; Weyens N, 2009, CURR OPIN BIOTECH, V20, P248, DOI 10.1016/j.copbio.2009.02.012; Xie XH, 2010, AFR J BIOTECHNOL, V9, P4056; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x; Yang F, 2010, ENVIRON TECHNOL, V31, P1045, DOI 10.1080/09593330.2010.487290; Zeng Xian-Cai, 2016, China Environmental Science, V36, P293; Zhang P, 2014, CHINA RURAL WATER HY, P35; ZHAO Han XW-j, 2016, ENV HLTH, P303; Zhongxing S., 2017, SHANGHAI J PREV MED, V29, P288; Zouboulis AI, 2004, PROCESS BIOCHEM, V39, P909, DOI 10.1016/S0032-9592(03)00200-0	77	24	26	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203285	10.1371/journal.pone.0203285	http://dx.doi.org/10.1371/journal.pone.0203285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169522	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400032
J	Liang, H; Estes, MK; Zhang, HL; Du, GW; Zhou, Y				Liang, Hong; Estes, Mary K.; Zhang, Huiling; Du, Guangwei; Zhou, Yong			Bile acids target proteolipid nano-assemblies of EGFR and phosphatidic acid in the plasma membrane for stimulation of MAPK signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LIGAND-INDEPENDENT ACTIVATION; MODEL MEMBRANES; CHOLESTEROL; KINASE; DOMAIN; HEPATOCYTES; INHIBITION; ENTEROIDS; DYNAMICS	Bile acids are critical biological detergents in the gastrointestinal tract and also act as messengers to regulate a multitude of intracellular signaling events, including mitogenic signaling, lipid metabolism and endo/exocytosis. In particular, bile acids stimulate many receptors and ion channels on the cell surface, the mechanisms of which are still poorly understood. Membrane-associating proteins depend on the local spatial distribution of lipids in the plasma membrane (PM) for their function. Here, we report that the highly amphipathic secondary bile acid deoxycholic acid (DCA), a major constituent in the human bile, at doses <1 mu M enhances the nanoclustering and the PM localization of phosphatidic acid (PA) but disrupts the local segregation of phosphatidylserine in the basolateral PM of the human colorectal adenocarcinoma Caco-2 cells. PA is a key structural component of the signaling nano-domains of epidermal growth factor receptor (EGFR) on the cell surface. We show that DCA promotes the co-localization between PA and EGFR, the PA-driven EGFR dimerization/oligomerization and EGFR signaling. Depletion of PA abolishes the stimulatory effects of DCA on the EGFR oligomerization and signaling. This effect occurs in the cultured Caco-2 cells and the ex vivo human intestinal enteroids. We propose a novel mechanism, where the amphiphilic DCA monomers alter the nano-assemblies of anionic phospholipids and in turn change the dynamic structural integrity of the lipid-driven oligomerization of cell surface receptors and their signal transduction.	[Liang, Hong; Du, Guangwei; Zhou, Yong] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Zhang, Huiling] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Soochow University - China	Zhou, Y (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	yong.zhou@uth.tmc.edu	zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022	Du, Guangwei/0000-0003-4193-6975; Zhou, Yong/0000-0002-0214-8151	National Institute of Diabetes and Digestive and Kidney Diseases grant [DK056338]; National Institute of Aging [A157788]; National Institute of Heart, Lung and Blood Institute [HL119478]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases grant; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The National Institute of Diabetes and Digestive and Kidney Diseases grant no. DK056338 to MKE and YZ, The National Institute of Aging grant no. A157788 to MKE, and The National Institute of Heart, Lung and Blood Institute grant no. HL119478 to GD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Halim KB, 2015, BBA-GEN SUBJECTS, V1850, P1017, DOI 10.1016/j.bbagen.2014.09.006; Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; Chen X, 2002, J BIOL CHEM, V277, P49631, DOI 10.1074/jbc.M208327200; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Esteves M, 2015, LANGMUIR, V31, P8901, DOI 10.1021/acs.langmuir.5b01702; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fuentes NR, 2018, CANCER RES, V78, P3899, DOI 10.1158/0008-5472.CAN-18-0324; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; GARRY FB, 1994, J VET INTERN MED, V8, P432, DOI 10.1111/j.1939-1676.1994.tb03263.x; Hofmann AF, 2014, J LIPID RES, V55, P1553, DOI 10.1194/jlr.R049437; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Jean-Louis S, 2006, J BIOL CHEM, V281, P14948, DOI 10.1074/jbc.M506710200; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Lieu T, 2014, GASTROENTEROLOGY, V147, P1417, DOI 10.1053/j.gastro.2014.08.042; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Mello-Vieira J, 2013, BBA-BIOMEMBRANES, V1828, P2152, DOI 10.1016/j.bbamem.2013.05.021; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; Nagathihalli NS, 2014, CANCER RES, V74, P2062, DOI 10.1158/0008-5472.CAN-13-2329; Natalini B, 2014, J PHARMACEUT BIOMED, V87, P62, DOI 10.1016/j.jpba.2013.06.029; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Rao YP, 2002, HEPATOLOGY, V35, P307, DOI 10.1053/jhep.2002.31104; Saxena K, 2016, J VIROL, V90, P43, DOI 10.1128/JVI.01930-15; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Taberner FJ, 2015, BBA-BIOMEMBRANES, V1848, P1818, DOI 10.1016/j.bbamem.2015.03.022; Wilken JA, 2011, CANCER-AM CANCER SOC, V117, P2358, DOI 10.1002/cncr.25805; Wilson SR, 2013, J NEUROSCI, V33, P9283, DOI 10.1523/JNEUROSCI.5318-12.2013; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619; Zhou Y, 2013, J BIOL CHEM, V288, P35660, DOI 10.1074/jbc.M113.519116; Zou WY, 2019, METHODS MOL BIOL, V1576, P229, DOI 10.1007/7651_2017_1	39	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0198983	10.1371/journal.pone.0198983	http://dx.doi.org/10.1371/journal.pone.0198983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169511	gold, Green Published, Green Submitted			2022-12-27	WOS:000443374400001
J	Adam, KCS; Vogel, EK				Adam, Kirsten C. S.; Vogel, Edward K.			Improvements to visual working memory performance with practice and feedback	PLOS ONE			English	Article							SHORT-TERM-MEMORY; CAPACITY; INTELLIGENCE; MOTIVATION; ATTENTION; LAPSES; GOALS; TASK	Visual working memory capacity is estimated to be around 3-4 items, but on some trials participants fail to correctly report even a single item from the memory array. Such failures of working memory performance are surprisingly common, and participants have poor self-awareness of them. Previous work has shown that behavioral feedback can reduce the frequency of working memory failures, but the benefits of feedback disappeared immediately after it was taken away. Here, we tested whether extended practice with or without trial-bytrial feedback would lead to persistent improvements in working memory performance. Participants were assigned to one of four groups: (1) Working memory practice with feedback (2) Working memory practice without feedback (3) Crossword puzzle active control (4) No contact control. Consistent with previous work, simple practice with a visual working memory task robustly improved working memory performance across practice sessions. However, we found only partial support for the efficacy of feedback in improving working memory performance. Practicing with feedback improved working memory performance relative to a no-feedback group for some practice sessions. However, the feedback benefits did not persist across all training sessions and did not transfer to a final test session without the feedback. Thus, the benefits of performance feedback did not persist over time. Further, we found only stimulus-specific transfer of visual working memory practice benefits. We also found that participants' metaknowledge improved with practice, but that receiving feedback about task accuracy actually slightly harmed the accuracy of concurrent metaknowledge ratings. Finally, we discuss important design considerations for future work in this area (e.g. power, expectations, and "spacing effects"). For example, we found that achieved statistical power to detect a between-groups effect declined with practice. This finding has potentially critical implications for any study using a 1-session study to calculate power for a planned multi-session study.	[Adam, Kirsten C. S.; Vogel, Edward K.] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Adam, Kirsten C. S.; Vogel, Edward K.] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA; [Vogel, Edward K.] Univ Chicago, Grossman Inst Neurosci Quantitat Biol & Human Beh, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Adam, KCS (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.; Adam, KCS (corresponding author), Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA.	kadam1@uchicago.edu	Vogel, Edward K/AAW-9466-2021; Adam, Kirsten/I-3691-2019	Adam, Kirsten/0000-0002-4950-327X	National Institute of Mental Health [MH087214]; Office of Naval Research [N00014-12-1-0972]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087214] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research was supported by National Institute of Mental Health grant MH087214 to E.V. (https://www.nimh.nih.gov) and by Office of Naval Research grant N00014-12-1-0972 to E.V. (https:// www.onr.navy.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam KCS, 2017, ATTEN PERCEPT PSYCHO, V79, P1506, DOI 10.3758/s13414-017-1331-8; Adam KCS, 2016, PSYCHON B REV, V23, P1520, DOI 10.3758/s13423-016-1019-4; Adam KCS, 2015, J COGNITIVE NEUROSCI, V27, P1601, DOI 10.1162/jocn_a_00811; Blacker KJ, 2017, J COGN ENHANCE, V1, P434, DOI 10.1007/s41465-017-0044-1; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burke Jennifer L, 2006, ICMI 06 P 8 INT C MU, P108, DOI DOI 10.1145/1180995.1181017; Buschkuehl M, 2017, J COGN ENHANCE, V1, P419, DOI 10.1007/s41465-017-0055-y; Buschkuehl M, 2014, COGN AFFECT BEHAV NE, V14, P147, DOI 10.3758/s13415-013-0244-9; Cepeda NJ, 2008, PSYCHOL SCI, V19, P1095, DOI 10.1111/j.1467-9280.2008.02209.x; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Debettencourt MT, 2018, PSYCHON B REV, V25, P605, DOI 10.3758/s13423-017-1309-5; Debettencourt MT, 2015, NAT NEUROSCI, V18, P470, DOI 10.1038/nn.3940; Dweck C., 2000, SELF THEORIES THEIR; DWECK CS, 1988, PSYCHOL REV, V95, P256, DOI 10.1037/0033-295X.95.2.256; ELLIOTT ES, 1988, J PERS SOC PSYCHOL, V54, P5, DOI 10.1037/0022-3514.54.1.5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fukuda K, 2015, PSYCHOL SCI, V26, P1026, DOI 10.1177/0956797615578122; Gaspar JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067781; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hambrick DZ, 1999, J EXP PSYCHOL GEN, V128, P131, DOI 10.1037/0096-3445.128.2.131; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Huang LQ, 2010, J VISION, V10, DOI 10.1167/10.14.8; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2014, MEM COGNITION, V42, P464, DOI 10.3758/s13421-013-0364-z; Johnson MK, 2013, NEUROPSYCHOLOGY, V27, P220, DOI 10.1037/a0032060; Jones PR, 2019, BEHAV RES METHODS, V51, P28, DOI 10.3758/s13428-018-1045-4; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Kane MJ, 2017, PSYCHOL SCI, V28, P1271, DOI 10.1177/0956797617706086; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; LaConte SM, 2011, NEUROIMAGE, V56, P440, DOI 10.1016/j.neuroimage.2010.06.052; Lam CF, 2011, ORGAN BEHAV HUM DEC, V116, P217, DOI 10.1016/j.obhdp.2011.05.002; Lieberman DA, 2008, Q J EXP PSYCHOL, V61, P194, DOI 10.1080/17470210701557506; Lovden M, 2010, PSYCHOL BULL, V136, P659, DOI 10.1037/a0020080; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Mathot S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148805; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Miran S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00262; Miranda AT, 2014, BEHAV RES METHODS, V46, P159, DOI 10.3758/s13428-013-0357-7; Olson IR, 2004, MEM COGNITION, V32, P1326, DOI 10.3758/BF03206323; Opitz B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rademaker RL, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00224; Raven J. C., 1965, ADV PROGR MATRICES S; Reason J, 1984, VARIETIES ATTENTION, P515; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Rohrer D, 2007, CURR DIR PSYCHOL SCI, V16, P183, DOI 10.1111/j.1467-8721.2007.00500.x; Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105; Salthouse TA, 2006, PERSPECT PSYCHOL SCI, V1, P68, DOI 10.1111/j.1745-6916.2006.00005.x; Shea CH, 2000, HUM MOVEMENT SCI, V19, P737, DOI 10.1016/S0167-9457(00)00021-X; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Sigrist R, 2013, PSYCHON B REV, V20, P21, DOI 10.3758/s13423-012-0333-8; Simons DJ, 2016, PSYCHOL SCI PUBL INT, V17, P103, DOI 10.1177/1529100616661983; Souza AS, 2016, J EXP PSYCHOL HUMAN, V42, P890, DOI 10.1037/xhp0000192; UNDERWOOD BJ, 1961, PSYCHOL REV, V68, P229, DOI 10.1037/h0047516; Unsworth N, 2011, ACTA PSYCHOL, V137, P90, DOI 10.1016/j.actpsy.2011.03.004; von Bastian CC, 2016, PSYCHOL RES-PSYCH FO, V80, P181, DOI 10.1007/s00426-015-0655-z; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Xie WZ, 2017, MEM COGNITION, V45, P677, DOI 10.3758/s13421-016-0679-7; Xu Z, 2018, BEHAV RES METHODS, V50, P576, DOI 10.3758/s13428-017-0886-6	62	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203279	10.1371/journal.pone.0203279	http://dx.doi.org/10.1371/journal.pone.0203279			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161210	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900101
J	Ayieko, J; Brown, L; Anthierens, S; Van Rie, A; Getahun, M; Charlebois, ED; Petersen, ML; Clark, TD; Kamya, MR; Cohen, CR; Bukusi, EA; Havlir, DV; Camlin, CS				Ayieko, James; Brown, Lillian; Anthierens, Sibyl; Van Rie, Annelies; Getahun, Monica; Charlebois, Edwin D.; Petersen, Maya L.; Clark, Tamara D.; Kamya, Moses R.; Cohen, Craig R.; Bukusi, Elizabeth A.; Havlir, Diane, V; Camlin, Carol S.			"Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; STIGMA; PREVENTION; HEALTH; FACILITATORS; TRANSMISSION; POPULATION; ADULTS	Background Despite substantial progress, gaps in the HIV care cascade remain large: globally, while about 36.7 million people were living with HIV in 2015, 11.9 million of these individuals did not know their HIV status, 12.7 million were in need of antiretroviral therapy (ART) and 13.0 million were not virally suppressed. We sought to deepen understanding of the barriers to care engagement at three critical steps of the care cascade proposed to make greatest impact for attaining the UNAIDS 90-90-90 targets aimed at shutting down the HIV epidemic. Methods Analyses were conducted among HIV-infected adults in rural East Africa. Qualitative data were collected using in-depth interviews among 63 individuals participating in an ongoing test-and treat trial (NCT01864683) in its baseline year (July 2013-June 2014). Audio recordings were transcribed, translated into English, and coded using Atlas.ti software. Data were analyzed using a thematic framework for explaining barriers to care engagement that drew upon both theory and prior empirical research in similar settings. Results Multiple barriers to engagement in care were observed. HIV-related stigma across dimensions of anticipated, internalized and enacted stigma manifested in denial and fears of disclosure, and influenced lapses in care engagement across multiple steps in the cascade. Poverty (lack of food and transport), lack of social support, work interference, prior negative experiences with health services, drug side effects, and treatment fatigue also negatively affected ART adherence and viral suppression. Gender differences were observed, with work interference and denial disproportionately affecting men compared to women. Conclusion Multiple barriers to HIV care engagement still pervade rural sub-Saharan settings threatening the realization of the UNAIDS 90-90-90 targets. To control the epidemic, efforts need to be accelerated to combat stigma. Patient economic empowerment, innovative drug formulations, as well as more patient-responsive health systems, may help overcome barriers to engagement in care.	[Ayieko, James; Bukusi, Elizabeth A.] Ctr Microbiol Res, Kenya Med Res Inst, Nairobi, Kenya; [Brown, Lillian; Charlebois, Edwin D.; Clark, Tamara D.; Havlir, Diane, V] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA; [Anthierens, Sibyl; Van Rie, Annelies] Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium; [Getahun, Monica; Cohen, Craig R.; Camlin, Carol S.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Petersen, Maya L.] Univ Calif Berkeley, Dept Biostat & Epidemiol, Berkeley, CA 94720 USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	Kenya Medical Research Institute; University of California System; University of California San Francisco; University of Antwerp; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Makerere University	Ayieko, J (corresponding author), Ctr Microbiol Res, Kenya Med Res Inst, Nairobi, Kenya.	jimayieko@gmail.com		Anthierens, Sibyl/0000-0003-4762-1907	National Institutes of Health [UA101099959]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by National Institutes of Health, grant number UA101099959. The Grant was awarded to DVH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS85, DOI 10.1089/apc.2007.9983; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Bronfenbrenner U., 1989, ANN CHILD DEV, V6, P87; Camlin CS, 2016, AIDS, V30, P495, DOI 10.1097/QAD.0000000000000931; Chamie G, 2016, LANCET HIV, V3, pE111, DOI 10.1016/S2352-3018(15)00251-9; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cunningham CO, 2007, AIDS PATIENT CARE ST, V21, P177, DOI 10.1089/apc.2006.103; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Eldred L, 2007, AIDS PATIENT CARE ST, V21, pS1, DOI 10.1089/apc.2007.9993; Emlet CA, 2013, AIDS CARE, V25, P1330, DOI 10.1080/09540121.2013.774317; Erving Goffman, 1963, STIGMA NOTES MANAGEM; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinsztejn B, 2014, LANCET INFECT DIS; Grov C, 2010, AIDS CARE, V22, P630, DOI 10.1080/09540120903280901; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Karim SSA, 2011, LANCET, V378, pE23, DOI 10.1016/S0140-6736(11)61136-7; Kuznetsova AV, 2016, AIDS BEHAV, V20, P2433, DOI 10.1007/s10461-015-1282-9; Kwarisiima Dalsone, 2017, J Int AIDS Soc, V20, P21673, DOI 10.7448/IAS.20.5.21673; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Maeri I, 2016, AIDS CARE, V28, P59, DOI 10.1080/09540121.2016.1168917; Nachega JB, 2011, PATIENT PREFER ADHER, V5, P357, DOI 10.2147/PPA.S22771; Parker R.G., 2002, HIV AIDS RELATED STI; Ritchie J., 1994, ANAL QUALITATIVE DAT, P173, DOI [10.4324/9780203413081, DOI 10.4324/9780203413081_CHAPTER_9]; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; UNAIDS, 90 90 90 AMB TREATM; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; WHO, GLOB UPD HIV TREATM; Yehia BR, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0990-0	33	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202990	10.1371/journal.pone.0202990	http://dx.doi.org/10.1371/journal.pone.0202990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161172	Green Published, gold			2022-12-27	WOS:000443388900062
J	Lin, JB; Cui, X; Dai, XY; Chen, YJ; Mo, L				Lin, Jiabao; Cui, Xuan; Dai, Xiaoying; Chen, Yajue; Mo, Lei			Neural correlates of creative insight: Amplitude of low-frequency fluctuation of resting-state brain activity predicts creative insight	PLOS ONE			English	Article							SUPERIOR FRONTAL GYRUS; CHUNK DECOMPOSITION; CHINESE CHARACTERS; ANGULAR GYRUS; FMRI; EEG; LOCALIZATION; SUBDIVISIONS; NEUROSCIENCE; FLEXIBILITY	Creative insight has attracted much attention across cultures. Although previous studies have explored the neural correlates of creative insight by functional magnetic resonance imaging (fMRI), little is known about intrinsic resting-state brain activity associated with creative insight. In the present study, we used amplitude of low-frequency fluctuation (ALFF) as an index in resting-state fMRI (rs-fMRI) to identify brain regions involved in individual differences in creative insight, which was measured by the response time of creative Chinese character chunk decomposition. Our results showed that ALFF in the superior frontal gyrus (SFG) positively predicted creative insight, while ALFF in the middle cingulate cortex/insula cortex (MCC/IC), superior temporal gyrus/angular gyrus (STG/AG), anterior cingulate cortex/caudate nucleus (ACC/CN), and culmen/declive (CU/DC) negatively predicted creative insight. Moreover, these findings indicate that spontaneous brain activity in multiple regions related to breaking mental sets, solutions exploring, evaluation of novel solutions, forming task-related associations, and emotion experience contributes to creative insight. In conclusion, the present study provides new evidence to further understand the cognitive processing and neural correlates of creative insight.	[Lin, Jiabao; Cui, Xuan; Dai, Xiaoying; Chen, Yajue; Mo, Lei] South China Normal Univ, Ctr Studies Psychol Applicat, Sch Psychol, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China; [Lin, Jiabao; Cui, Xuan; Dai, Xiaoying; Chen, Yajue; Mo, Lei] South China Normal Univ, Guangdong Prov Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Mo, L (corresponding author), South China Normal Univ, Ctr Studies Psychol Applicat, Sch Psychol, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China.; Mo, L (corresponding author), South China Normal Univ, Guangdong Prov Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China.	molei@m.scnu.edu.cn			National Social Science Foundation of China [14ZDB159]; Key Institute of Humanities and Social Sciences, Ministry of Education, China [16JJD880025]	National Social Science Foundation of China; Key Institute of Humanities and Social Sciences, Ministry of Education, China(Ministry of Education, China)	This work was supported by grants from the National Social Science Foundation of China (Grant NO.14ZDB159 URL:http://www.npopss-cn.gov.cn/) and Project of the Key Institute of Humanities and Social Sciences, Ministry of Education, China (Grant NO.16JJD880025 URL:https://www.sinoss.net/). The funders had no role in study design, data collection and analysis,	AMABILE TM, 1988, RES ORGAN BEHAV, V10, P123; Chavez RA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00351; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bowden EM, 2007, METHODS, V42, P87, DOI 10.1016/j.ymeth.2006.11.007; Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; DREU CKW, 2011, SOCIAL PSYCHOL PERSO, V2, P72, DOI DOI 10.1177/1948550610381789; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Ellison A, 2004, BRAIN, V127, P2307, DOI 10.1093/brain/awh244; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frith C, 2001, NEUROPSYCHOLOGIA, V39, P1367, DOI 10.1016/S0028-3932(01)00124-5; Goldman-Rakic P S, 1987, COMPREHENSIVE PHYSL; Gonen-Yaacovi G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00465; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Huang FR, 2015, NEUROIMAGE, V113, P122, DOI 10.1016/j.neuroimage.2015.03.030; Huang XQ, 2010, NEUROIMAGE, V49, P2901, DOI 10.1016/j.neuroimage.2009.11.072; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Kershaw TC, 2004, J EXP PSYCHOL LEARN, V30, P3, DOI 10.1037/0278-7393.30.1.3; Knoblich G, 2001, MEM COGNITION, V29, P1000, DOI 10.3758/BF03195762; Knoblich G, 1999, J EXP PSYCHOL LEARN, V25, P1534, DOI 10.1037/0278-7393.25.6.1534; Kounios J, 2006, PSYCHOL SCI, V17, P882, DOI 10.1111/j.1467-9280.2006.01798.x; Kounios J, 2009, CURR DIR PSYCHOL SCI, V18, P210, DOI 10.1111/j.1467-8721.2009.01638.x; Kulkarni B, 2005, EUR J NEUROSCI, V21, P3133, DOI 10.1111/j.1460-9568.2005.04098.x; Kumari V, 2004, J NEUROSCI, V24, P10636, DOI 10.1523/JNEUROSCI.3206-04.2004; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Luo J, 2006, BRAIN RES BULL, V70, P430, DOI 10.1016/j.brainresbull.2006.07.005; Marcoulides G.A., 1997, MULTIVARIATE STAT ME; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Nijstad BA, 2010, EUR REV SOC PSYCHOL, V21, P34, DOI 10.1080/10463281003765323; Ollinger M, 2008, EXP PSYCHOL, V55, P269, DOI 10.1027/1618-3169.55.4.269; Ohlsson S., 1992, ADV PSYCHOL THINKING, V1, DOI DOI 10.1017/CB09780511780295; Pernet CR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-67; Qiu J, 2010, CORTEX, V46, P397, DOI 10.1016/j.cortex.2009.06.006; Radua J, 2012, NEUROSCI BIOBEHAV R, V36, P2325, DOI 10.1016/j.neubiorev.2012.07.012; Rose JE, 2011, BIOL PSYCHIAT, V70, P794, DOI 10.1016/j.biopsych.2011.05.031; SCOTT WA, 1962, SOCIOMETRY, V25, P405, DOI 10.2307/2785779; Seger CA, 2006, NEUROSCIENTIST, V12, P285, DOI 10.1177/1073858405285632; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Smith S. M., 1995, GETTING OUT MENTAL R; Sternberg R. J, 1995, NATURE INSIGHT; Subramaniam K, 2009, J COGNITIVE NEUROSCI, V21, P415, DOI 10.1162/jocn.2009.21057; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tang XC, 2016, CEREB CORTEX, V26, P2991, DOI 10.1093/cercor/bhv113; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Webb ME, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01424; Wu LL, 2013, HUM BRAIN MAPP, V34, P1173, DOI 10.1002/hbm.21501; Wu LL, 2009, BRAIN RES, V1296, P104, DOI 10.1016/j.brainres.2009.08.023; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang WJ, 2016, CREATIVITY RES J, V28, P67, DOI 10.1080/10400419.2016.1125274; Yin Y, 2011, NEUROSCI LETT, V498, P185, DOI 10.1016/j.neulet.2011.02.069; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhao Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082503, 10.1371/journal.pone.0059351]; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009	60	5	7	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203071	10.1371/journal.pone.0203071	http://dx.doi.org/10.1371/journal.pone.0203071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161187	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900075
J	Miyara, M; Charuel, JL; Mudumba, S; Wu, A; Ghillani-Dalbin, P; Amoura, Z; Burlingame, RW; Musset, L				Miyara, Makoto; Charuel, Jean-Luc; Mudumba, Sasi; Wu, Alice; Ghillani-Dalbin, Pascale; Amoura, Zahir; Burlingame, Rufus W.; Musset, Lucile			Detection in whole blood of autoantibodies for the diagnosis of connective tissue diseases in near patient testing condition	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; POINT-OF-CARE; CLASSIFICATION CRITERIA; RHEUMATIC-DISEASES; AMERICAN-COLLEGE; ANTIBODIES	A novel technology, photonic ring immunoassay (PRI), for detecting 12 autoantibodies simultaneously in whole blood in less than 15 minutes was evaluated by comparing results from 235 clinically diagnosed patients with standard laboratory tests. The overall agreement was greater than 91% for 10 of the 12 assays, with positive percent agreement greater than 89% for 9 of the assays and negative percent agreement greater than 91% for 10 of them. Thus, the clinical sensitivities and specificities were similar for the 2 methods. In addition, 199 normal blood donors were tested on the ANA 12 PRI, yielding specificities greater than 97.5% for all assays. This proof of concept study shows that this new system is suitable for point of care testing for clinically useful autoantibodies, allowing the doctor to have test results in minutes rather than days.	[Miyara, Makoto; Charuel, Jean-Luc; Ghillani-Dalbin, Pascale; Musset, Lucile] Hop La Pitie Salpetriere, AP HP, Immunol Dept, Paris, France; [Miyara, Makoto; Amoura, Zahir] Sorbonne Univ, CIMI, INSERM U1135, Paris, France; [Mudumba, Sasi; Wu, Alice; Burlingame, Rufus W.] Genalyte Inc, San Diego, CA USA; [Amoura, Zahir] Hop Pitie Salpetriere Hosp, AP HP, Serv Med Interne 2, Inst E3M,Ctr Reference Natl Lupus & Syndrome Anti, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Miyara, M (corresponding author), Hop La Pitie Salpetriere, AP HP, Immunol Dept, Paris, France.; Miyara, M (corresponding author), Sorbonne Univ, CIMI, INSERM U1135, Paris, France.	makoto.miyara@aphp.fr	Miyara, Makoto/P-4491-2017	Miyara, Makoto/0000-0001-8743-8846	Genalyte Inc.	Genalyte Inc.	Funding for the study (materials, arrays etc.) was provided by Genalyte Inc. SM, AW and RB are Genalyte Inc employees. The funder provided support in the form of salaries for authors SM, AW and RB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agmon-Levin N, 2014, ANN RHEUM DIS, V73, P17, DOI 10.1136/annrheumdis-2013-203863; Amigues JM, 1996, J RHEUMATOL, V23, P2055; Bhansing KJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4562; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Fritzler MJ, 1996, MOL BIOL REP, V23, P133, DOI 10.1007/BF00351161; Goddard GZ, 2017, IMMUNOL RES, V65, P363, DOI 10.1007/s12026-016-8846-2; Iqbal M, 2010, IEEE J SEL QUANTUM E, V16; Konstantinov KN, 2013, AUTOIMMUN HIGHLIGHTS, V4, P55, DOI 10.1007/s13317-013-0052-9; Luchansky MS, 2010, BIOSENS BIOELECTRON, V26, P1283, DOI 10.1016/j.bios.2010.07.010; Mahler M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/315179; Mudumba S, 2017, J IMMUNOL METHODS; Pasoto SG, 2014, EXPERT REV CLIN IMMU, V10, P1493, DOI 10.1586/1744666X.2014.966692; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pisetsky DS, 2016, NAT REV RHEUMATOL, V12, P102, DOI 10.1038/nrrheum.2015.151; Respaldiza N, 2006, SCAND J RHEUMATOL, V35, P290, DOI 10.1080/03009740600588376; Rubin RL, 2016, BIOSENS BIOELECTRON, V83, P306, DOI 10.1016/j.bios.2016.04.048; Scholz J, 2015, CLIN CHEM LAB MED, V53, P1991, DOI 10.1515/cclm-2015-0083; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; SMEENK R, 1990, CLIN RHEUMATOL, V9, P63, DOI 10.1007/BF02205553; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; WERLE E, 1992, LUPUS, V1, P369, DOI 10.1177/096120339200100606; Willems P, 2018, CLIN CHEM LAB MED	24	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202736	10.1371/journal.pone.0202736	http://dx.doi.org/10.1371/journal.pone.0202736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161159	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900042
J	Nagano, N; Saito, M; Sugiura, T; Miyahara, F; Namba, F; Ota, E				Nagano, Nobuhiko; Saito, Makoto; Sugiura, Takahiro; Miyahara, Fumiko; Namba, Fumihiko; Ota, Erika			Benefits of umbilical cord milking versus delayed cord clamping on neonatal outcomes in preterm infants: A systematic review and meta-analysis	PLOS ONE			English	Review							RED-CELL TRANSFUSIONS; PLACENTAL TRANSFUSION; NEURODEVELOPMENTAL OUTCOMES; RANDOMIZED-TRIAL; RESUSCITATION; ADAPTATION; NEED	Background Optimum timing of umbilical cord clamping has not been established in preterm infants. Objectives We compared the short- and long-term effects of umbilical cord milking (UCM) versus delayed cord clamping (DCC) on infants born at less than 37 weeks of gestation. Search methods A systematic review and meta-analysis was conducted according to the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" statement. We searched CINAHL, CENTRAL, EMBASE, MEDLINE, PubMed and ClinicalTrials.gov for relevant randomized controlled trials (RCTs). Selection criteria We included individual and clustered RCTs comparing UCM to DCC for infants born before 37 weeks of gestation. Data collection and analysis Four reviewers independently assessed trial quality and eligibility for inclusion. Main results Two trials (255 preterm infants, 23 0/7 to 32 6/7 weeks of gestation) were included in the analysis. UCM was associated with fewer intraventricular hemorrhages (IVHs) (two trials, 255 infants; relative risk [RR] 0.45, 95% confidence interval [CI] 0.20 to 0.98, low quality of evidence) and UCM was an increased proportion of infants with a Bayley score at 2 years of age (two trials, 174 infants; Cognitive: RR 1.14, 95% CI 1.03 to 1.26, Language: RR 1.24, 95% CI 1.03 to 1.49, low quality of evidence) compared to DCC. Conclusions UCM wasn't reduced in-hospital mortality and need for transfusion compared to DCC. But our study suggests that UCM may lower the risk of IVH and improve certain neurodevelopmental outcomes compared to DCC in preterm infants.	[Nagano, Nobuhiko] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, Tokyo, Japan; [Saito, Makoto] Univ Tsukuba, Dept Pediat, Tsukuba, Ibaraki, Japan; [Sugiura, Takahiro] Toyohashi Municipal Hosp, Dept Pediat, Toyohashi, Aichi, Japan; [Miyahara, Fumiko] Tottori Univ, Fac Med, Div Pediat & Perinatol, Yonago, Tottori, Japan; [Namba, Fumihiko] Saitama Med Univ, Saitama Med Ctr, Dept Pediat, Kawagoe, Saitama, Japan; [Ota, Erika] St Lukes Int Univ, Global Hlth Nursing, Grad Sch Nursing Sci, Chuo Ku, Tokyo, Japan	Nihon University; University of Tsukuba; Tottori University; Saitama Medical University; St. Luke's International Hospital	Nagano, N (corresponding author), Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, Tokyo, Japan.	nagana.nobuhiko@rihon-u.ac.jp	Nagano, Nobuhiko/H-3478-2017	Nagano, Nobuhiko/0000-0002-0890-1626	Japan Agency for Medical Research and Development (AMED); Neonatal Research Network (NRN) Japan	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Neonatal Research Network (NRN) Japan	This research was supported by the Project for Baby and Infant in Research of health and Development to Adolescent and Young adult (BIRTHDAY) from the Japan Agency for Medical Research and Development (AMED) (EO) and a grant from the Neonatal Research Network (NRN) Japan (FN).	Agarwal Shivam, 2016, Acta Paediatr, V105, pe526, DOI 10.1111/apa.13559; Aladangady N, 2006, PEDIATRICS, V117, P93, DOI 10.1542/peds.2004-1773; Backes CH, 2014, OBSTET GYNECOL, V124, P47, DOI 10.1097/AOG.0000000000000324; Banerjee J, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0247-6; Brune T, 2002, BIOL NEONATE, V81, P236, DOI 10.1159/000056754; Dang D, 2015, J OBSTET GYNAECOL RE, V41, P890, DOI 10.1111/jog.12657; Duley L, 2018, ARCH DIS CHILD-FETAL, V103, pF6, DOI 10.1136/archdischild-2016-312567; Fogarty M, 2018, AM J OBSTET GYNECOL, V218, P1, DOI 10.1016/j.ajog.2017.10.231; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hosono S, 2008, ARCH DIS CHILD-FETAL, V93, pF14, DOI 10.1136/adc.2006.108902; Katheria A, 2018, J PEDIATR-US, V194, P76, DOI 10.1016/j.jpeds.2017.10.037; Katheria AC, 2015, PEDIATRICS, V136, P61, DOI 10.1542/peds.2015-0368; Krueger MS, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.017; Mercer JS, 2014, J MIDWIFERY WOM HEAL, V59, P635, DOI 10.1111/jmwh.12206; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Polglase GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117504; Popat H, 2016, J PEDIATR-US, V178, P81, DOI 10.1016/j.jpeds.2016.08.004; Rabe H, 2016, NEONATOLOGY, V109, P113, DOI 10.1159/000441891; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Rabe H, 2011, OBSTET GYNECOL, V117, P205, DOI 10.1097/AOG.0b013e3181fe46ff; The World Health Organization, 2017, GUID DEL UMB CORD CL; Wyckoff MH, 2015, CIRCULATION, V132, pS543, DOI 10.1161/CIR.0000000000000267	23	26	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201528	10.1371/journal.pone.0201528	http://dx.doi.org/10.1371/journal.pone.0201528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161139	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900009
J	Naidoo, N; Zuma, N; Khosa, NS; Marincowitz, G; Railton, J; Matlakala, N; Jobson, GA; Igumbor, JO; McIntyre, JA; Struthers, HE; Peters, RPH				Naidoo, Nireshni; Zuma, Nkosinathi; Khosa, N. Sellina; Marincowitz, Gert; Railton, Jean; Matlakala, Nthabiseng; Jobson, Geoffrey A.; Igumbor, Jude O.; McIntyre, James A.; Struthers, Helen E.; Peters, Remco P. H.			Qualitative assessment of facilitators and barriers to HIV programme implementation by community health workers in Mopani district, South Africa	PLOS ONE			English	Article							MODEL; CARE	South Africa has implemented a community-based HIV programme (CBHP) in its primary healthcare (PHC) re-engineering strategy that aims to improve public healthcare delivery. This CBHP is delivered by ward-based outreach teams (WBOTs); provision of community HIV services comprises an important component of this programme. We conducted an exploratory study to determine the facilitators and barriers to successful implementation of this CBHP in rural Mopani District, South Africa. Focus group discussions were conducted with the community health workers (CHWs) and PHC nurses; participant interviews were conducted with community members who access these health services, community leaders, and social workers. We conducted a thematic content analysis and based on the key themes reported, we identified the Consolidated Framework for Implementation Research, consisting of five domains, as the most appropriate model to interpret our findings. First, in terms of intervention characteristics, community members generally valued the HIV services provided, but the variable needs impacted on programme implementation. Outer setting challenges include inability to meet the need of patients as a result of stigma, nondisclosure of HIV status and social factors. In terms of the inner setting, CHWs were grateful for the equipment and training received but expressed the need for better support of management and the provision of additional resources. With regard to characteristics of the implementers, the CHWs expressed the desire for further training despite reporting having sufficient knowledge to conduct their HIV work. Finally, in terms of the implementation process, the importance of relationship building between CHWs and community members was emphasised. In conclusion, these data underline the positive receipt and potential of the CBHP in this rural district and identify areas to further strengthen the programme. The success and sustainability of the CBHP requires ongoing commitment of resources, training, supervision, and organisational support in order to operate effectively and efficiently.	[Naidoo, Nireshni; Zuma, Nkosinathi; Khosa, N. Sellina; Railton, Jean; Matlakala, Nthabiseng; Jobson, Geoffrey A.; McIntyre, James A.; Struthers, Helen E.; Peters, Remco P. H.] Anova Hlth Inst, Johannesburg, South Africa; [Naidoo, Nireshni; Igumbor, Jude O.; Peters, Remco P. H.] Univ Witwatersrand, Div Epidemiol & Biostat, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Marincowitz, Gert] Mopani DCST, Dept Hlth, Giyani, Limpopo Provinc, South Africa; [McIntyre, James A.] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Struthers, Helen E.] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, Cape Town, South Africa; [Peters, Remco P. H.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands	University of Witwatersrand; University of Cape Town; University of Cape Town; Maastricht University	Peters, RPH (corresponding author), Anova Hlth Inst, Johannesburg, South Africa.; Peters, RPH (corresponding author), Univ Witwatersrand, Div Epidemiol & Biostat, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.; Peters, RPH (corresponding author), MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands.	peters@anovahealth.co.za	Igumbor, Jude Ofuzinim/AAJ-2802-2020	Igumbor, Jude Ofuzinim/0000-0002-3324-7654; Peters, Remco Petrus Hendricus/0000-0003-2124-7275	US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) [674-A-12-00015]; Fogarty and NIAID, The UNC-Wits AIDS Implementation Science and Cohort Analyses Training Grant [5D43TW009774-02]; FOGARTY INTERNATIONAL CENTER [D43TW009774] Funding Source: NIH RePORTER	US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty and NIAID, The UNC-Wits AIDS Implementation Science and Cohort Analyses Training Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study is made possible by the generous support of the American people through the US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) under Cooperative Agreement number 674-A-12-00015 to the Anova Health Institute. The contents are the responsibility of Anova Health Institute and do not necessarily reflect the views of USAID or the United States Government. The funding body did not play a role in the design of the study, data collection, analysis, interpretation of data, or in writing the manuscript. This research project was supported by a postgraduate training scholarship from the Fogarty and NIAID, The UNC-Wits AIDS Implementation Science and Cohort Analyses Training Grant (Grant number: 5D43TW009774-02 to N.N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty or NIAID.	[Anonymous], NVIVO QUAL DAT AN SO; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Condo J, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-71; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; De Neve JW, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002374; Feldstein AC, 2008, JT COMM J QUAL PATIE, V34, P228, DOI 10.1016/S1553-7250(08)34030-6; Geldsetzer P, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0236-x; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Gustafson DH, 2003, HEALTH SERV RES, V38, P751, DOI 10.1111/1475-6773.00143; Javanparast S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-291; Johnson CD, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-25; Klein KJ, 2005, CURR DIR PSYCHOL SCI, V14, P243, DOI 10.1111/j.0963-7214.2005.00373.x; Liu A, 2011, MT SINAI J MED, V78, P419, DOI 10.1002/msj.20260; Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140; Marincowitz G, 2016, COMMUNICATION; Mendel P, 2008, ADM POLICY MENT HLTH, V35, P21, DOI 10.1007/s10488-007-0144-9; Naledi TBP, 2011, PRIMARY HLTH CARE SA; National Department of Health, 2011, PROV GUID IMPL 3 STR; Pettigrew AM, 2001, ACAD MANAGE J, V44, P697, DOI 10.2307/3069411; Pillay Y., 2011, IMPLEMENTATION PHC R; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Rachlis B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149412; Saint S, 2009, JT COMM J QUAL PATIE, V35, P239, DOI 10.1016/S1553-7250(09)35032-1; Schneider H, 2016, HEALTH SYST REFORM, V2, P112, DOI 10.1080/23288604.2016.1166307; Wajid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075476	26	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203081	10.1371/journal.pone.0203081	http://dx.doi.org/10.1371/journal.pone.0203081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161208	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900079
J	Affenzeller, S; Cerveau, N; Jackson, DJ				Affenzeller, Susanne; Cerveau, Nicolas; Jackson, Daniel John			Identification and validation of reference genes for qPCR in the terrestrial gastropod Cepaea nemoralis	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; SHELL COLOR; POLYMORPHISM; EXPRESSION; SELECTION; GENETICS	Identifying and understanding mechanisms that generate phenotypic diversity is a fundamental goal of evolutionary biology. With a diversity of pigmented shell morphotypes governed by Mendelian patterns of inheritance, the common grove snail Cepaea nemoralis (Linnaeus, 1758) has been a model for evolutionary biologists and population geneticists for decades. However, the genetic mechanisms by which C. nemoralis generates this pigmented shell diversity remain unknown. An important first step in investigating this pigmentation pattern is to establish a set of validated reference genes for differential gene expression assays. Here we have evaluated eleven candidate genes for reverse transcription quantitative polymerase chain reaction (qPCR) in C. nemoralis. Five of these were housekeeping genes traditionally employed as qPCR reference genes in other species, while six alternative genes were selected de novo from C. nemoralis transcriptome data based on the stability of their expression levels. We tested all eleven candidates for expression stability in four sub-adult tissues of C. nemoralis: pigmented mantle, unpigmented mantle, head and foot. We find that two commonly employed housekeeping genes (alpha tubulin, glyceraldehyde 3-phosphate dehydrogenase) are unsuitable for use as qPCR reference genes in C. nemoralis. The traditional housekeeping gene UBIquitin on the other hand performed very well. Additionally, an RNAdirected DNA polymerase (RNAP), a Potassium Channel Protein (KCHP) and a Prenylated Rab acceptor protein 1 (PRAP), identified de novo from transcriptomic data, were the most stably expressed genes in different tissue combinations. We also tested expression stability over two seasons and found that, although other genes are more stable within a single season, beta actin (BACT) and elongation factor 1 alpha (EF1a) were the most reliable reference genes across seasons.	[Affenzeller, Susanne; Cerveau, Nicolas; Jackson, Daniel John] Georg August Univ Gottingen, Dept Geobiol, Gottingen, Germany	University of Gottingen	Jackson, DJ (corresponding author), Georg August Univ Gottingen, Dept Geobiol, Gottingen, Germany.	djackso@uni-goettingen.de		Affenzeller, Susanne/0000-0003-4554-7651	Deutsche Forschungsgemeinschaft [JA 2108/2-1, JA 2108/6-1]; DFG [JA 2108/2-1, JA 2108/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grants (JA 2108/2-1 and JA 2108/6-1) to Daniel J. Jackson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Gabriela Salinas-Riester and her team at the TAL laboratory (University Medical Centre Gottingen) are acknowledged for NGS sequencing. This work was supported by DFG grants (JA 2108/2-1 and JA 2108/6-1) to DJJ.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CAIN AJ, 1950, HEREDITY, V4, P275, DOI 10.1038/hdy.1950.22; CAIN AJ, 1960, GENETICS, V45, P393; CAIN AJ, 1952, HEREDITY, V6, P217, DOI 10.1038/hdy.1952.22; CAIN AJ, 1954, GENETICS, V39, P89; Cerveau N, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1406-x; Chapman JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149454; COOK LM, 1967, HEREDITY, V22, P397, DOI 10.1038/hdy.1967.49; Cubero-Leon E, 2012, ENVIRON SCI POLLUT R, V19, P2728, DOI 10.1007/s11356-012-0772-9; Cuthill IC, 2017, SCIENCE, V357, DOI 10.1126/science.aan0221; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Fisher RA, 1934, NATURE, V133, P834, DOI 10.1038/133834b0; Garcia-Fernandez P, 2016, J INVERTEBR PATHOL, V138, P57, DOI 10.1016/j.jip.2016.06.003; GREENWOOD JJ, 1974, HEREDITY, V33, P17, DOI 10.1038/hdy.1974.61; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; JONES JS, 1977, ANNU REV ECOL SYST, V8, P109, DOI 10.1146/annurev.es.08.110177.000545; Kerkvliet J, 2017, PEERJ, V5, DOI 10.7717/peerj.3715; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; LAMOTTE M, 1959, COLD SPRING HARB SYM, V24, P65, DOI 10.1101/SQB.1959.024.01.009; Liu Q, 2016, ENVIRON TOXICOL PHAR, V43, P120, DOI 10.1016/j.etap.2016.03.007; Mann K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-249; Nowicka A, 2013, NATURWISSENSCHAFTEN, V100, P1, DOI [10.1007/s00114-012-1000-7, DOI 10.1007/S00114-012-1000-7]; Peng Y, 2013, BIOINFORMATICS, V29, P326, DOI 10.1093/bioinformatics/btt219; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Richards PM, 2013, MOL ECOL, V22, P3077, DOI 10.1111/mec.12262; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter Jan M, 2015, Biomol Detect Quantif, V5, P10, DOI 10.1016/j.bdq.2015.07.001; Schwander T, 2014, CURR BIOL, V24, pR288, DOI 10.1016/j.cub.2014.01.056; Sirakov M, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-70; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan Q, 2011, COMP BIOCHEM PHYS C, V153, P259, DOI 10.1016/j.cbpc.2010.11.009; WILLIAMSON P, 1976, J ANIM ECOL, V45, P875, DOI 10.2307/3586	38	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201396	10.1371/journal.pone.0201396	http://dx.doi.org/10.1371/journal.pone.0201396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157182	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400008
J	Guerra, TJ; Messeder, JVS; Arruda, AAJ; Fuzessy, LF; Dayrell, RLC; Neves, FS; Silveira, FAO				Guerra, Tadeu J.; Messeder, Joao V. S.; Arruda, Andre A. J.; Fuzessy, Lisieux F.; Dayrell, Roberta L. C.; Neves, Frederico S.; Silveira, Fernando A. O.			Handling by avian frugivores affects diaspore secondary removal	PLOS ONE			English	Article							SEED DISPERSAL EFFECTIVENESS; FRUIT-EATING BIRDS; GUT PASSAGE; MICONIA MELASTOMATACEAE; PLANT INTERACTIONS; MICROHABITAT USE; ANTS; GERMINATION; PREDATION; TROPIDURIDAE	The balance between the costs and benefits of fleshy fruit production depends on the feeding behavior of their seed dispersers, which might effectively disperse seeds to farther areas or drop beneath parent plants some diaspores they handle during frugivory bouts. Nevertheless, the consequences of variation in fruit handling by primary seed dispersers on the secondary removal of diaspores remains poorly understood. We conducted a field study to determine how variation in fruit handling by avian frugivores affects short-term secondary removal of Miconia irwinii (Melastomataceae) diaspores by the ground-dwelling fauna in campo rupestre vegetation, southeastern Brazil. We conducted factorial experiments manipulating: (1) different outcomes of primary fruit/seed removal by birds, (2) distances of diaspore deposition from conspecifics, and (3) the access of ants and vertebrates to diaspores. We showed that secondary removal of diaspores was highly variable at the population scale, with an overall low removal rate by the ground-dwelling fauna (13% seeds, 19% fruits). However, we found that gut-passed seeds embedded in bird feces were less removed than seeds expelled from fruits. Gut-passed seeds were more likely to be removed by ant species acting as secondary dispersers, whereas pulp-free seeds dropped by birds were likely to interact with potential seed predators, including ants and rodents. We found no clear effect of dispersal from parent plant vicinity on seed removal, but fruit removal was significantly higher near parent plants. Partially defleshed fruits were more removed than intact fruits. The removal of fruits by ant and vertebrate rescuers, including lizards and birds, might reduce the costs of interactions with less effective dispersers that drop partially defleshed fruits under parent plants. Our study highlights that variation in fruit handling by primary avian seed dispersers mediate subsequent interactions among discarded diaspores and ground-dwelling animals, potentially affecting final seed fates. Moreover, we argue that escape-related benefits of dispersal can be contingent on how primary dispersers handle and discard seeds.	[Guerra, Tadeu J.; Messeder, Joao V. S.; Arruda, Andre A. J.; Fuzessy, Lisieux F.; Dayrell, Roberta L. C.; Silveira, Fernando A. O.] Univ Fed Minas Gerais Belo Horizonte, Dept Bot, Belo Horizonte, MG, Brazil; [Neves, Frederico S.] Univ Fed Minas Gerais Belo Horizonte, Dept Biol Geral, Belo Horizonte, MG, Brazil		Guerra, TJ (corresponding author), Univ Fed Minas Gerais Belo Horizonte, Dept Bot, Belo Horizonte, MG, Brazil.	guerra.tj@gmail.com	Arruda, André/ABC-2514-2021; Neves, Frederico/E-5777-2013; Fuzessy, Lisieux/G-2488-2017; Guerra, Tadeu J./O-2320-2013; Dayrell, Roberta LC/L-7063-2016; Messeder, João Vitor S/F-2809-2019	Arruda, André/0000-0001-8894-2585; Neves, Frederico/0000-0002-2691-3743; Fuzessy, Lisieux/0000-0001-9599-9782; Guerra, Tadeu J./0000-0003-1247-365X; Dayrell, Roberta LC/0000-0002-4770-9100; Messeder, João Vitor S/0000-0001-9161-0274; Silveira, Fernando/0000-0001-9700-7521	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais FAPEMIG [APQ00382-17]; CAPES; FAPEMIG; FAO Silveira; CNPq	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAO Silveira; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais FAPEMIG (Grant#: APQ00382-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also that TJ Guerra, AJ Arruda, LF Fuzessy and RLC Dayrell received scholarships from CAPES, JVS Messeder received a scholarship from FAPEMIG and FAO Silveira and FS Neves received a research productivity grant from CNPq.	Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Bates D, 2014, DRUG INF J, V35, P1215; Bieber AGD, 2013, ECOSCIENCE, V20, P85, DOI 10.2980/20-1-3573; Brito VLG, 2017, PLANT BIOLOGY, V19, P806, DOI 10.1111/plb.12591; BYRNE MM, 1993, VEGETATIO, V108, P363; Camargo PHSA, 2016, OECOLOGIA, V181, P507, DOI 10.1007/s00442-016-3571-z; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Christianini AV, 2007, J TROP ECOL, V23, P343, DOI 10.1017/S0266467407004087; Christianini AV, 2010, J ECOL, V98, P573, DOI 10.1111/j.1365-2745.2010.01653.x; Christianini AV, 2009, OECOLOGIA, V160, P735, DOI 10.1007/s00442-009-1349-2; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Costa FV, 2015, SOCIOBIOLOGY, V62, P228; Costa FV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167161; Crawley M. J., 2013, R BOOK; Dalling JW, 1998, J TROP ECOL, V14, P705, DOI 10.1017/S0266467498000492; Palacio RD, 2016, BIOTROPICA, V48, P349, DOI 10.1111/btp.12290; Duncan RS, 2002, ECOLOGY, V83, P2630, DOI 10.1890/0012-9658(2002)083[2630:DHSBSR]2.0.CO;2; Fedriani JM, 2013, J ECOL, V101, P1581, DOI 10.1111/1365-2745.12146; Filogonio R, 2010, IHERINGIA SER ZOOL, V100, P336, DOI 10.1590/S0073-47212010000400008; Fornara DA, 2005, J TROP ECOL, V21, P79, DOI 10.1017/S026646740400197X; Fricke EC, 2016, OECOLOGIA, V181, P905, DOI 10.1007/s00442-016-3612-7; Fricke EC, 2013, ECOL LETT, V16, P1031, DOI 10.1111/ele.12134; Gallegos SC, 2014, J ECOL, V102, P659, DOI 10.1111/1365-2745.12226; Genrich CM, 2017, OIKOS, V126, P361, DOI 10.1111/oik.03825; Goldenberg R, 2013, PHYTOTAXA, V106, P1, DOI 10.11646/phytotaxa.106.1.1; Gomes VGN, 2014, PLANT BIOLOGY, V16, P315, DOI 10.1111/plb.12063; Guerra TJ, 2011, J NAT HIST, V45, P1101, DOI 10.1080/00222933.2011.552800; Guerra TJ, 2017, OECOLOGIA, V185, P233, DOI 10.1007/s00442-017-3943-z; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; KASPARI M, 1993, OECOLOGIA, V95, P81, DOI 10.1007/BF00649510; Labecca, 2012, ORNITOL NEOTROP, V23, P9; Leal IR, 1998, BIOTROPICA, V30, P170, DOI 10.1111/j.1744-7429.1998.tb00052.x; Lessa LG, 2013, ACTA BOT BRAS, V27, P519, DOI 10.1590/S0102-33062013000300009; LEVEY DJ, 1993, ECOLOGY, V74, P1802, DOI 10.2307/1939938; LEVEY DJ, 1987, AM NAT, V129, P471, DOI 10.1086/284652; Lima MHC, 2013, BIOTROPICA, V45, P217, DOI 10.1111/j.1744-7429.2012.00910.x; Loiselle BA, 1999, ECOLOGY, V80, P330, DOI 10.1890/0012-9658(1999)080[0330:DOMSBF]2.0.CO;2; MAGNUSSON WE, 1987, J TROP ECOL, V3, P277, DOI 10.1017/S0266467400002169; Maruyama PK, 2013, J TROP ECOL, V29, P99, DOI 10.1017/S0266467413000138; Murakami T, 1997, J ETHOL, V15, P17, DOI 10.1007/BF02767322; Noss CF, 2014, SOUTHEAST NAT, V13, P475, DOI 10.1656/058.013.0308; Silveira FAO, 2012, PLANT ECOL EVOL, V145, P350, DOI 10.5091/plecevo.2012.706; Orivel J, 2018, BIOTROPICA, V50, P641, DOI 10.1111/btp.12539; Pan Y, 2016, INTEGR ZOOL, V11, P191, DOI 10.1111/1749-4877.12189; Pietczak C, 2013, HERPETOL J, V23, P75; Pizo MA, 1999, CAN J ZOOL, V77, P1595, DOI 10.1139/cjz-77-10-1595; R Core Team, 2015, R LANGUAGE ENV STAT; ROBERTS JT, 1986, ECOLOGY, V67, P1046, DOI 10.2307/1939827; Sahley CT, 2016, J TROP ECOL, V32, P125, DOI 10.1017/S0266467416000043; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; Santos AMO, 2017, SEED SCI RES, V27, P65, DOI 10.1017/S0960258517000071; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Silveira FAO, 2012, SEED SCI RES, V22, P37, DOI 10.1017/S0960258511000286; Silvius KM, 2002, J ECOL, V90, P1024, DOI 10.1046/j.1365-2745.2002.00728.x; STILES FG, 1993, VEGETATIO, V108, P57; TRAVESET A, 1994, EVOL ECOL, V8, P618, DOI 10.1007/BF01237845; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Van Sluys M, 2004, J HERPETOL, V38, P606, DOI 10.1670/218-03N; Vander Wall SB, 2005, ECOLOGY, V86, P801, DOI 10.1890/04-0847; Vander Wall SB, 2004, TRENDS ECOL EVOL, V19, P155, DOI 10.1016/j.tree.2003.12.004	61	11	11	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202435	10.1371/journal.pone.0202435	http://dx.doi.org/10.1371/journal.pone.0202435			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157261	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400057
J	Liu, YF; Pencheon, E; Hunter, RM; Moncrieff, J; Freemantle, N				Liu, Yifeng; Pencheon, Emma; Hunter, Rachael Maree; Moncrieff, Joanna; Freemantle, Nick			Recruitment and retention strategies in mental health trials - A systematic review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; PLACEBO-RESPONSE; CLINICAL-TRIALS; DEPRESSION; SCHIZOPHRENIA; INTERVENTION; RATES; WOMEN	Background Recruitment and retention challenges are very common in mental health randomised trials. Investigators utilise different methods to improve recruitment or retention. However, evidence of the effectiveness and efficiency of these strategies in mental health has not been synthesised. This systematic review is to investigate and assess the effectiveness and cost-effectiveness of different strategies to improve recruitment and retention in mental health randomised trials. Methods and materials MEDLINE, EMBASE, the Cochrane Methodology Register and PsycINFO were searched from beginning of record up to July 2016. Randomised trials involving participants with mental health problems which compared different strategies for recruitment or retention were selected. Two authors independently screened identified studies for eligibility. Results A total of 5,157 citations were identified. Thirteen articles were included, 11 on recruitment and 2 on retention. Three randomised controlled trials compared different recruitment strategies, none of which found statistically significant differences between the interventional recruitment strategies and the routine recruitment methods. Retrospective comparisons of recruitment methods showed that non-web-based advertisement and recruitment by clinical research staff each have advantages in efficiency. Web-based adverts had the lowest cost per person recruited (13.41 pound per person recruited). Specialised care referral cost 183.24 pound per person, non-web-based adverts cost 372.03 pound per patient and recruitment via primary care cost 407.65 pound for each patient. Financial incentives, abridged questionnaires and prenotification had a positive effect on retention rates. Conclusion The recruitment studies included showed differences in strategies, clinical settings, mental health conditions and study design. It is difficult to assess the overall effectiveness of any particular recruitment strategy as some strategies that worked well for a particular population may not work as well for others. Paying attention to the accessibility of information and consent materials may help improve recruitment. More research in this area is needed given its important implications.	[Liu, Yifeng; Hunter, Rachael Maree] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Pencheon, Emma] Chelsea & Westminster NHS Fdn Trust, London, England; [Moncrieff, Joanna] UCL, Div Psychiat, London, England; [Freemantle, Nick] UCL, Inst Clin Trials & Methodol, London, England	University of London; University College London; Imperial College London; University of London; University College London; University of London; University College London	Freemantle, N (corresponding author), UCL, Inst Clin Trials & Methodol, London, England.	nicholas.freemantle@ucl.ac.uk	Hunter, Rachael Maree/H-7846-2019; liu, yi/GXE-9662-2022	Hunter, Rachael Maree/0000-0002-7447-8934; Liu, Yifeng/0000-0002-8875-2375; Moncrieff, Joanna/0000-0003-1214-6974				Brueton VC, 2013, DATABASE SYST REV; Daley AJ, 2008, BRIT J GEN PRACT, V58, P178, DOI 10.3399/bjgp08X277195; Debar LL, 2009, CONTEMP CLIN TRIALS, V30, P326, DOI 10.1016/j.cct.2009.02.007; Dirmaier J, 2007, J CLIN EPIDEMIOL, V60, P1263, DOI 10.1016/j.jclinepi.2007.04.006; Furlong EMJRP, 2015, BARRIERS CLIN TRIAL; Howard L, 2009, CONTEMP CLIN TRIALS, V30, P40, DOI 10.1016/j.cct.2008.07.007; Hughes-Morley A, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1718-1; Jeste DV, 2009, SCHIZOPHRENIA BULL, V35, P719, DOI 10.1093/schbul/sbm148; Kearney Anna, 2017, ONLINE RESOURCE RECR; Kinon BJ, 2011, CURR OPIN PSYCHIATR, V24, P107, DOI 10.1097/YCO.0b013e32834381b0; Krusche A, 2014, CLIN TRIALS, V11, P141, DOI 10.1177/1740774514521905; Le HN, 2008, ARCH WOMEN MENT HLTH, V11, P159, DOI 10.1007/s00737-008-0009-6; Madurasinghe VW, 2016, TRIALS, V17, DOI 10.1186/s13063-015-1126-y; Man MS, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0820-0; Mason VL, 2007, FAM PRACT, V24, P518, DOI 10.1093/fampra/cmm047; McLean SA, 2014, J CLIN EPIDEMIOL, V67, P870, DOI 10.1016/j.jclinepi.2013.10.013; Morgan AJ, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2262; Palmer BA, 2005, ARCH GEN PSYCHIAT, V62, P247, DOI 10.1001/archpsyc.62.3.247; Rollman BL, 2008, J GEN INTERN MED, V23, P447, DOI 10.1007/s11606-007-0449-0; Rutherford BR, 2014, JAMA PSYCHIAT, V71, P1409, DOI 10.1001/jamapsychiatry.2014.1319; Schlernitzauer M, 1998, AM J GERIAT PSYCHIAT, V6, P67; Schulz KF, 2002, LANCET, V359, P781, DOI 10.1016/S0140-6736(02)07882-0; Speich B, 2018, J CLIN EPIDEMIOL, V96, P1, DOI 10.1016/j.jclinepi.2017.12.018; Spineli LM, 2013, EUR NEUROPSYCHOPHARM, V23, P1010, DOI 10.1016/j.euroneuro.2013.03.006; Treweek S, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000013.pub6; Treweek S, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2535-5; Treweek S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002360; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Weisfeld V, 2012, PUBLIC ENGAGEMENT CL; Woolhouse H, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0369-z	30	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203127	10.1371/journal.pone.0203127	http://dx.doi.org/10.1371/journal.pone.0203127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157250	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400092
J	Zhang, J; Jiang, Y; Wang, Y; Guo, YL; Long, H; Deng, GB; Chen, Q; Xuan, P				Zhang, Jie; Jiang, Yun; Wang, Ying; Guo, Yuanlin; Long, Hai; Deng, Guangbing; Chen, Qian; Xuan, Pu			Molecular markers and cytogenetics to characterize a wheat-Dasypyrum villosum 3V (3D) substitution line conferring resistance to stripe rust	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; F-SP TRITICI; CHROMOSOMAL-ABERRATIONS; CEREAL EYESPOT; GENUS SECALE; HETEROCHROMATIN; IDENTIFICATION; REARRANGEMENTS; SEQUENCES; CHROMATIN	Dasypyrum villosum has been used as a valuable gene resource for disease resistances, yield increase and quality improvement in wheat. A novel wheat-D. villosum alien introgression line CD-3 was generated through hybridization between the common wheat Chinese Spring (CS) and a CS-D. villosum 3V addition line having considerably high stripe rust resistance, which enable the characterization of a potential new stripe rust resistance gene (s) derived from D. villosum. The results of non-denaturing fluorescent in situ hybridization (ND-FISH) showed that CD-3 contained 42 chromosomes, including a 3V chromosome pair, and the absence of both of the 3D chromosomes. PCR-based Landmark Unique Gene (PLUG) molecular marker analysis supported results from the FISH analysis, revealing CD-3 was a wheat-D. villosum 3V (3D) disomic substitution line. Resistant test of stripe rust on 52 plants of F2 generation (CD-3/CS), CD-3, CS and D. villosum have been conducted at seedling stage. 7 plants of F2 generation possessing two 3V chromosomes exhibited high resistance to stripe rust as CD-3 and D. villosum, 10 plants carrying one 3V chromosome and 35 plants without 3V chromosome were susceptive to stripe rust as CS. The result implied the high stripe rust resistance of CD-3 should be controlled by recessive gene(s) originating from D. villosum. To rapidly detect chromosome 3V in the genetic background of wheat, we developed a novel Sequence Characterized Amplified Region (SCAR) marker specific for 3V chromosome based on the sequence of a grain size-related gene DvGS5 in D. villosum, an orthologue of TaGS5 from wheat. The SCAR marker was designated DvGS5-1443, which could successfully amplify a unique 3V-specific fragment in CD-3 and D. villosum, suggesting that this SCAR marker could facilitate targeting the chromosome 3V in the genetic background of wheat for wheat improvement.	[Zhang, Jie; Jiang, Yun; Wang, Ying; Guo, Yuanlin; Chen, Qian] Sichuan Acad Agr Sci, Inst Biotechnol & Nucl Technol Res, Chengdu, Sichuan, Peoples R China; [Zhang, Jie] Minist Agr, Key Lab Wheat Biol & Genet Improvement Southweste, Chengdu, Sichuan, Peoples R China; [Long, Hai; Deng, Guangbing] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Xuan, Pu] Sichuan Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Chengdu, Sichuan, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS); Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan Academy of Agricultural Sciences (SAAS)	Xuan, P (corresponding author), Sichuan Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Chengdu, Sichuan, Peoples R China.	xuanpu@hotmail.com	Guo, Yuan-Lin/K-4887-2019	Guo, Yuan-Lin/0000-0002-7159-0189	National Key R&D Program of China [2016YFD0102101, 2016YFD0102002]; Foundation for Excellent Thesis of Sichuan Academy of Agricultural Sciences [2017LWJJ-001]; Sichuan Wheat Breeding Community [2016NYZ0030]; Project of Innovation Ability Improvement, Sichuan Province [2016ZYPZ-004]; Applied Basic Research Programs of Science and Technology Department, Sichuan Province (Key Project) [2018JY0629]	National Key R&D Program of China; Foundation for Excellent Thesis of Sichuan Academy of Agricultural Sciences; Sichuan Wheat Breeding Community; Project of Innovation Ability Improvement, Sichuan Province; Applied Basic Research Programs of Science and Technology Department, Sichuan Province (Key Project)	This work was supported by National Key R&D Program of China (No. 2016YFD0102101, http://www.most.gov.cn/), YG received the funding; National Key R&D Program of China (No2016YFD0102002, http://www.most.gov.cn/), HL received the funding; Foundation for Excellent Thesis of Sichuan Academy of Agricultural Sciences (No. 2017LWJJ-001, http://www.chinawestagr.com/), JZ received the funding; Sichuan Wheat Breeding Community (No. 2016NYZ0030, http://www.scst.gov.cn/), YG received the funding; Project of Innovation Ability Improvement, Sichuan Province (No. 2016ZYPZ-004, http://www.sccz.gov.cn/new_web/new_index.jsp), YG received the funding; Applied Basic Research Programs of Science and Technology Department, Sichuan Province (Key Project) grant 2018JY0629 to YG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; Arzani A, 2016, CRIT REV PLANT SCI, V35, P146, DOI 10.1080/07352689.2016.1245056; Bariana H, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0528-1; Bento M, 2010, THEOR APPL GENET, V121, P489, DOI 10.1007/s00122-010-1325-6; Bizzarri M, 2009, P 53 IT SOC AGR GEN, P16; CHEN PD, 1995, THEOR APPL GENET, V91, P1125, DOI 10.1007/BF00223930; Chen PD, 2013, MOL BREEDING, V31, P477, DOI 10.1007/s11032-012-9804-x; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Danilova TV, 2017, THEOR APPL GENET, V130, P549, DOI 10.1007/s00122-016-2834-8; Danilova TV, 2012, CHROMOSOMA, V121, P597, DOI 10.1007/s00412-012-0384-7; De Pace C, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P185, DOI 10.1007/978-3-642-14228-4_4; Dong ZZ, 2017, THEOR APPL GENET, V130, P2127, DOI 10.1007/s00122-017-2946-9; Fu SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10552; Fu SL, 2013, J GENET GENOMICS, V40, P413, DOI 10.1016/j.jgg.2013.05.005; Fu SL, 2010, J GENET, V89, P489, DOI 10.1007/s12041-010-0070-6; Gradzielewska A, 2006, EUPHYTICA, V152, P441, DOI 10.1007/s10681-006-9245-x; GUSTAFSON JP, 1983, CHROMOSOMA, V88, P293, DOI 10.1007/BF00292906; He H., 2017, BIORXIV, DOI [10.1101/177857, DOI 10.1101/177857]; He HG, 2018, MOL PLANT, V11, P879, DOI 10.1016/j.molp.2018.03.004; Huang DaHui, 2007, Agricultural Sciences in China, V6, P513, DOI 10.1016/S1671-2927(07)60077-7; Ishikawa G, 2009, THEOR APPL GENET, V118, P499, DOI 10.1007/s00122-008-0916-y; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Kato A, 2004, P NATL ACAD SCI USA, V101, P13554, DOI 10.1073/pnas.0403659101; Kim W, 2004, CROP SCI, V44, P1254, DOI 10.2135/cropsci2004.1254; Li GR, 2014, CYTOGENET GENOME RES, V143, P280, DOI 10.1159/000366051; Li GR, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0217-0; Li Q, 2011, THEOR APPL GENET, V122, P189, DOI 10.1007/s00122-010-1435-1; LINE RF, 1995, PLANT DIS, V79, P1254; Line RF, 1992, US DEP AGR TECH B, P1968; Liu Shou-Bin, 2003, Acta Genetica Sinica, V30, P350; MCINTOSH RA, 2001, CATALOGUE GENE SYMBO; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; PUMPHREY M, 2008, P 11 INT WHEAT GEN S; Randhawa MS, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0270-0; Roebbelen G, 1978, ADV PLANT BREEDING S, V9, P1; SEARS ER, 1953, AM J BOT, V40, P168, DOI 10.2307/2438774; Sears ER, 1939, GENETICS, V24, P509; Tang ZX, 2014, J APPL GENET, V55, P313, DOI 10.1007/s13353-014-0215-z; Tang ZuQiang, 2007, Journal of Agricultural Biotechnology, V15, P799; Uslu E, 1998, EUPHYTICA, V103, P203, DOI 10.1023/A:1018340018838; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Wan AM, 2004, PLANT DIS, V88, P896, DOI 10.1094/PDIS.2004.88.8.896; Wang SS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01166; Xiang C, 2016, PHYTOPATHOLOGY, V106, P1186, DOI 10.1094/PHYTO-01-16-0045-FI; Xing L, 2018, MOL PLANT, V11, P847; Yildirim A, 1998, GENOME, V41, P1, DOI 10.1139/gen-41-1-1; Yildirim A, 2000, PLANT DIS, V84, P40, DOI 10.1094/PDIS.2000.84.1.40; Zhang J, 2017, GENETICA, V145, P371, DOI 10.1007/s10709-017-9972-z; Zhang J, 2015, INT J MOL SCI, V16, P29787, DOI 10.3390/ijms161226134; Zhang J, 2013, J GENET, V92, P103, DOI 10.1007/s12041-013-0218-2; Zhang QP, 2005, EUPHYTICA, V145, P317, DOI 10.1007/s10681-005-1743-8; Zhang RQ, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0549-9; Zhang RQ, 2016, THEOR APPL GENET, V129, P1975, DOI 10.1007/s00122-016-2753-8; Zhang RQ, 2015, THEOR APPL GENET, V128, P2415, DOI 10.1007/s00122-015-2596-8; Zhao WC, 2010, EUPHYTICA, V175, P343, DOI 10.1007/s10681-010-0177-0; Zheng SG, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1828-6	56	10	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202033	10.1371/journal.pone.0202033	http://dx.doi.org/10.1371/journal.pone.0202033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157196	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400028
J	Cuneo, F; Antonietti, JP; Mohr, C				Cuneo, Felix; Antonietti, Jean-Philippe; Mohr, Christine			Unkept promises of cognitive styles: A new look at old measurements	PLOS ONE			English	Article							EMBEDDED FIGURES TEST; FIELD-DEPENDENCE; VALIDITY; RELIABILITY; INDEPENDENCE; PERSONALITY; INNOVATORS; BUSINESS	Cognitive style is thought to be a stable marker of one's way to approach mental operations. While of wide interest over the last decades, its operationalization remains a challenge. The literature indicates that cognitive styles assessed via i) questionnaires are predicted by personality and ii) performance tests (e.g., Group Embedded Figures Test; GEFT) are related to general intelligence. In the first study, we tested the psychometric relationship between the Cognitive Style Index questionnaire (CSI) and personality inventories (NEO Five Factor Inventory; NEO-FFI, HEXACO Personality Inventory Revised; HEXACO-PI-R). In the second study, we assessed the CSI, NEO-FFI, GEFT and a general intelligence test (Raven's Standard Progressive Matrices Test; RSMT). We found that CSI scores were largely predicted by personality and that CSI was uncorrelated with GEFT performance. Instead, better performance on the GEFT was associated with better performance on the RSMT. We conclude that i) cognitive style questionnaires overlap with personality inventories, ii) cognitive style performance tests do not measure cognitive styles and should not be used as such and iii) the cognitive style concept needs to be assessed with alternative measurement types. We discuss possible future directions.	[Cuneo, Felix; Antonietti, Jean-Philippe; Mohr, Christine] Univ Lausanne, Inst Psychol, Lausanne, Vaud, Switzerland	University of Lausanne	Cuneo, F (corresponding author), Univ Lausanne, Inst Psychol, Lausanne, Vaud, Switzerland.	felix.cuneo@unil.ch		Mohr, Christine/0000-0002-3720-7115				Allinson CW, 1996, J MANAGE STUD, V33, P119, DOI 10.1111/j.1467-6486.1996.tb00801.x; Antonakis J, 2011, PERS INDIV DIFFER, V50, P409, DOI 10.1016/j.paid.2010.09.014; Ashton MC, 2009, J PERS ASSESS, V91, P340, DOI 10.1080/00223890902935878; Bendall RCA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01786; Boccia M, 2016, EXP BRAIN RES, V234, P2799, DOI 10.1007/s00221-016-4682-9; Campbell DT, 1959, PSYCHOL BULL, V11, P413; Cassidy S., 2004, ED PSYCHOL, V24, P419, DOI DOI 10.1080/0144341042000228834; Cheng HY, 2017, EUR J PSYCHOL EDUC, V32, P271, DOI 10.1007/s10212-016-0289-6; Cools E., 2009, REFLECTION ED, V5, P19; Cools E, 2007, J PSYCHOL, V141, P359, DOI 10.3200/JRLP.141.4.359-388; Cools E, 2014, EUR J WORK ORGAN PSY, V23, P627, DOI 10.1080/1359432X.2013.788245; COOPERMAN EW, 1980, J PSYCHOL, V105, P29, DOI 10.1080/00223980.1980.9915128; Costa PT., 1992, REVISED NEO PERSONAL; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dimov D, 2007, ENTREP THEORY PRACT, V31, P561, DOI 10.1111/j.1540-6520.2007.00188.x; Evans C, 2012, HDB INTELLECTUAL STY, P295; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Fuermaier ABM, 2015, NEUROPSYCHOLOGY, V29, P45, DOI 10.1037/neu0000108; GOODENOUGH D, 1961, J ABNORM SOC PSYCH, V63, P241, DOI 10.1037/h0046524; Hayes J, 1998, BR J MANAG, V51, P847; Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8; Hittner JB, 2003, J GEN PSYCHOL, V130, P149, DOI 10.1080/00221300309601282; Huang JL, 2015, J BUS PSYCHOL, V30, P299, DOI 10.1007/s10869-014-9357-6; Huang JL, 2012, J BUS PSYCHOL, V27, P99, DOI 10.1007/s10869-011-9231-8; Huteau M, 1975, ANNEE PSYCHOL; Jackson DN., 1976, M SOC MULT EXP PSYCH; Johnson JA, 2005, J RES PERS, V39, P103, DOI 10.1016/j.jrp.2004.09.009; KAGAN J, 1964, PSYCHOL MONOGR, V78, P1; KIRTON M, 1976, J APPL PSYCHOL, V61, P622, DOI 10.1037/0021-9010.61.5.622; KIRTON M, 1978, PSYCHOL REP, V42, P695, DOI 10.2466/pr0.1978.42.3.695; Koc-Januchta M, 2017, COMPUT HUM BEHAV, V68, P170, DOI 10.1016/j.chb.2016.11.028; Kozhevnikov M, 2007, PSYCHOL BULL, V133, P464, DOI 10.1037/0033-2909.133.3.464; Kozhevnikov M, 2014, PSYCHOL SCI PUBL INT, V15, P3, DOI 10.1177/1529100614525555; McDonald RP, 1999, TEST THEORY UNIFIED; MCKENNA FP, 1984, J PERS SOC PSYCHOL, V47, P593, DOI 10.1037/0022-3514.47.3.593; Messick S., 1984, ED PSYCHOL, V19, P59, DOI DOI 10.1080/00461528409529283; O'Brien TP, 2001, INT J ENG EDUC, V17, P89; Parkinson A, 2004, PERS INDIV DIFFER, V37, P1273, DOI 10.1016/j.paid.2003.12.012; Peterson ER, 2015, LEARN INDIVID DIFFER, V38, P115, DOI 10.1016/j.lindif.2015.01.011; Peterson ER, 2009, LEARN INDIVID DIFFER, V19, P518, DOI 10.1016/j.lindif.2009.06.003; Peterson ER, 2003, PERS INDIV DIFFER, V34, P881, DOI 10.1016/S0191-8869(02)00116-2; Raptis George E., 2016, Digital Heritage. Progress in Cultural Heritage: Documentation, Preservation and Protection. 6th International Conference, EuroMed 2016. Proceedings: LNCS 10059, P199, DOI 10.1007/978-3-319-48974-2_22; Raven JC, 1941, BRIT J MED PSYCHOL, V19, P137, DOI 10.1111/j.2044-8341.1941.tb00316.x; Rezaei AR, 2004, PERS INDIV DIFFER, V36, P1317, DOI 10.1016/S0191-8869(03)00219-8; Riding R.J., 1991, COGNITIVE STYLES ANA; Riding R. J., 1997, EDUC PSYCHOL-UK, V17, P29; Riding R. J., 1991, EDUC PSYCHOL, V11, P193, DOI DOI 10.1080/0144341910110301; Rolland JP, 1998, J PERS ASSESS, V71, P269, DOI 10.1207/s15327752jpa7102_13; Salthouse TA, 2005, AGING NEUROPSYCHOL C, V12, P89, DOI 10.1080/13825580590925143; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Sternberg R.J., 1995, EUROPEAN J HIGH ABIL, V6, P201, DOI [10.1080/0937445940060211, DOI 10.1080/0937445940060211]; Sternberg RJ, 1997, AM PSYCHOL, V52, P700, DOI 10.1037/0003-066X.52.7.700; Strine TW, 2008, PSYCHIAT SERV, V59, P1383, DOI 10.1176/appi.ps.59.12.1383; Volkova EV, 2016, PERS INDIV DIFFER, V99, P266, DOI 10.1016/j.paid.2016.04.097; von Wittich D, 2011, PERS INDIV DIFFER, V50, P1044, DOI 10.1016/j.paid.2011.01.022; Voorhees CM, 2016, J ACAD MARKET SCI, V44, P119, DOI 10.1007/s11747-015-0455-4; WEISZ JR, 1975, DEV PSYCHOL, V11, P539, DOI 10.1037/h0076673; Wise SL, 2006, APPL MEAS EDUC, V19, P95, DOI 10.1207/s15324818ame1902_2; Witkin, 1971, MANUAL GROUP EMBEDDE; Witkin H. A., 1954, PERSONALITY PERCEPTI; Witkin H. A., 1981, COGNITIVE STYLE ESSE; Witkin H.A., 1962, PSYCHOL DIFFERENTIAT, DOI DOI 10.1037/13128-000; Witkin HA, 1974, COGNITIVE STYLE PERS; Witkin HA, 1948, J EXP PSYCHOL, V43, P5; Zhang LF, 2005, EDUC PSYCHOL REV, V17, P1, DOI 10.1007/s10648-005-1635-4	67	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203115	10.1371/journal.pone.0203115	http://dx.doi.org/10.1371/journal.pone.0203115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153302	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700044
J	Inomata, M; Horie, T; Into, T				Inomata, Megumi; Horie, Toshi; Into, Takeshi			OmpA-like proteins of Porphyromonas gingivalis contribute to serum resistance and prevent Toll-like receptor 4-mediated host cell activation	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; MANNOSE-BINDING LECTIN; CYSTEINE PROTEINASES; INNATE IMMUNITY; COMPLEMENT; LIPOPOLYSACCHARIDE; GINGIPAINS; PERIODONTITIS; PROTEASE; OPSONOPHAGOCYTOSIS	Porphyromonas gingivalis possesses various abilities to evade and disrupt host immune responses, by which it acts as an important periodontal pathogen. P. gingivalis produces outer membrane protein A (OmpA)-like proteins (OmpALPs), Pgm6 and Pgm7, as major O-linked glycoproteins, but their pathological roles in P. gingivalis infection are largely unknown. Here, we report that OmpALP-deficient strains of P. gingivalis show an enhanced stimulatory activity in coculture with host cells. Such an altered ability of the OmpALP-deficient strains was found to be due to their impaired survival in coculture and the release of LPS from dead bacterial cells to stimulate Toll-like receptor 4 (TLR4). Further analyses revealed that the OmpALP-deficient strains were inviable in serum-containing media although they grew normally in the bacterial medium. The wild-type strain was able to grow in 90% normal human serum, while the OmpALP-deficient strains did not survive even at 5%. The OmpALP-deficient strains did not survive in heat-inactivated serum, but they gained the ability to survive and grow in proteinase K-treated serum. Of note, the sensitivity of the OmpALP-deficient strains to the bactericidal activity of human beta-defensin 3 was increased as compared with the WT. Thus, this study suggests that OmpALPs Pgm6 and Pgm7 are important for serum resistance of P. gingivalis. These proteins prevent bacterial cell destruction by serum and innate immune recognition by TLR4; this way, P. gingivalis may adeptly colonize serum-containing gingival crevicular fluids and subgingival environments.	[Inomata, Megumi; Horie, Toshi; Into, Takeshi] Asahi Univ, Sch Dent, Div Oral Infect & Hlth Sci, Dept Oral Microbiol,Mizuho Ku, Gifu, Japan	Asahi University	Inomata, M; Into, T (corresponding author), Asahi Univ, Sch Dent, Div Oral Infect & Hlth Sci, Dept Oral Microbiol,Mizuho Ku, Gifu, Japan.	inomata@dent.asahi-u.ac.jp; into@dent.asahi-u.ac.jp		Inomata, Megumi/0000-0003-2409-2694	 [15K11094];  [17K17114];  [26462803]	; ; 	This work was supported by Grant-in-Aid for Scientific Research (C), 15K11094 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15K11094/) to MI; Grant-in-Aid for Young Scientists (B), 17K17114, (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17K17114/) to TH; Grant-in-Aid for Scientific Research (C) 26462803, (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-26462803/) to TI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Asai Y, 2005, INFECT IMMUN, V73, P2157, DOI 10.1128/IAI.73.4.2157-2163.2005; Brown L J, 1993, Periodontol 2000, V2, P57; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Dasanayake Ananda P, 2003, Dent Clin North Am, V47, P115, DOI 10.1016/S0011-8532(02)00056-3; DEMOT R, 1994, MOL MICROBIOL, V12, P333; GANT VA, 1993, J MED MICROBIOL, V39, P147, DOI 10.1099/00222615-39-2-147; Genco R, 2002, J AM DENT ASSOC, V133, p14S, DOI 10.14219/jada.archive.2002.0375; Gorr SU, 2012, FRONT ORAL BIOL, V15, P84, DOI 10.1159/000329673; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Hajishengallis G, 2008, J IMMUNOL, V181, P4141, DOI 10.4049/jimmunol.181.6.4141; Hajishengallis G, 2009, J IMMUNOL, V182, P6690, DOI 10.4049/jimmunol.0900524; Horie T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163974; Inomata M, 2007, MICROBES INFECT, V9, P1500, DOI 10.1016/j.micinf.2007.08.005; Inomata M, 2010, EUR J ORAL SCI, V118, P574, DOI 10.1111/j.1600-0722.2010.00775.x; Into T, 2006, CLIN EXP IMMUNOL, V145, P545, DOI 10.1111/j.1365-2249.2006.03156.x; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Iwami J, 2007, ORAL MICROBIOL IMMUN, V22, P356, DOI 10.1111/j.1399-302X.2007.00363.x; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; Maisetta G, 2003, ANTIMICROB AGENTS CH, V47, P3349, DOI 10.1128/AAC.47.10.3349-3351.2003; Maisetta G, 2011, PEPTIDES, V32, P1073, DOI 10.1016/j.peptides.2011.02.003; March C, 2011, J BIOL CHEM, V286, P9956, DOI 10.1074/jbc.M110.181008; McCrudden MTC, 2013, J CLIN PERIODONTOL, V40, P933, DOI 10.1111/jcpe.12141; Murakami Y, 2002, EUR J ORAL SCI, V110, P157, DOI 10.1034/j.1600-0722.2002.11171.x; Murakami Y, 2014, INFECT IMMUN, V82, P4563, DOI 10.1128/IAI.02069-14; Nagano K, 2005, J BACTERIOL, V187, P902, DOI 10.1128/JB.187.3.902-911.2005; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Ogawa T, 2002, EUR J IMMUNOL, V32, P2543, DOI 10.1002/1521-4141(200209)32:9<2543::AID-IMMU2543>3.0.CO;2-2; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.33029; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.30936; Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Potempa M, 2008, J IMMUNOL, V181, P5537, DOI 10.4049/jimmunol.181.8.5537; Scannapleco FA, 1999, J PERIODONTAL RES, V34, P340, DOI 10.1111/j.1600-0765.1999.tb02263.x; SCHENKEIN HA, 1977, J PERIODONTOL, V48, P772, DOI 10.1902/jop.1977.48.12.772; Slaney JM, 2006, INFECT IMMUN, V74, P5352, DOI 10.1128/IAI.00304-06; SUNDQVIST G, 1985, J MED MICROBIOL, V19, P85, DOI 10.1099/00222615-19-1-85; Tabeta K, 2000, INFECT IMMUN, V68, P3731, DOI 10.1128/IAI.68.6.3731-3735.2000; Wilensky A, 2015, J INNATE IMMUN, V7, P127, DOI 10.1159/000365970; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202791	10.1371/journal.pone.0202791	http://dx.doi.org/10.1371/journal.pone.0202791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153274	gold, Green Submitted, Green Published			2022-12-27	WOS:000443001700026
J	Young, CR; Kaida, A; Kabakyenga, J; Muyindike, W; Musinguzi, N; Martin, JN; Hunt, PW; Bangsberg, DR; Haberer, JE; Matthews, LT				Young, Cynthia R.; Kaida, Angela; Kabakyenga, Jerome; Muyindike, Winnie; Musinguzi, Nicholas; Martin, Jeffrey N.; Hunt, Peter W.; Bangsberg, David R.; Haberer, Jessica E.; Matthews, Lynn T.			Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda	PLOS ONE			English	Article							DAR-ES-SALAAM; PRIMARY-CARE; RISK-FACTORS; TANZANIA; AUDIT	Background Intimate partner violence (IPV) is a significant global health problem. Women who experience IPV have increased HIV incidence, reduced antiretroviral adherence, and a lower likelihood of viral load suppression. There is a lack of evidence regarding how to effectively identify and support women living with HIV (WLWH) experiencing IPV, including uncertainty whether universal or targeted screening is most appropriate for lower-resourced settings. We examined physical and sexual IPV prevalence and correlates among WLWH in Uganda to understand the burden of IPV and factors that could help identify women at risk. Methods We utilized data from women receiving ART and enrolled in the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort study between 2011 and 2015. Bloodwork and interviewer-administered questionnaires were completed every 4 months. IPV was assessed annually or with any new pregnancy. Multivariate models assessed independent socio-demographic and clinical factors correlated with IPV, at baseline and follow-up visits. Results 455 WLWH were included. Median age was 36 years, 43% were married, and median follow-up was 2.8 years. At baseline 131 women (29%) reported any experience of past or current IPV. In the adjusted models, being married was associated with a higher risk of baseline IPV (ARR 2.33, 95% CI 1.13-4.81) and follow-up IPV (ARR 2.43, 95% CI 1.334.45). Older age (ARR 0.96, 95% CI 0.94-0.99) and higher household asset index score (ARR 0.81, 95% CI 0.68-0.96) were associated with lower risk of IPV during follow-up. Conclusion There was a high prevalence of physical and sexual IPV amongst WLWH, and many women experienced both types of violence. These findings suggest the need for clinic-based screening for IPV. If universal screening is not feasible, correlates of having experienced IPV can inform targeted approaches.	[Young, Cynthia R.] Brigham & Womens Hosp, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA; [Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Kabakyenga, Jerome] Mbarara Univ Sci & Technol, Maternal Newborn & Child Hlth Inst, Mbarara, Uganda; [Muyindike, Winnie] Mbarara Univ Sci & Technol, Dept Internal Med, Mbarara, Uganda; [Musinguzi, Nicholas] Mbarara Univ Sci & Technol, Global Hlth Collaborat, Mbarara, Uganda; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hunt, Peter W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bangsberg, David R.] Portland State Univ, Sch Publ Hlth, Oregon Hlth & Sci Univ, Portland, OR USA; [Haberer, Jessica E.; Matthews, Lynn T.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Haberer, Jessica E.; Matthews, Lynn T.] Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Simon Fraser University; Mbarara University of Science & Technology; Mbarara University of Science & Technology; Mbarara University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University; Portland State University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Young, CR (corresponding author), Brigham & Womens Hosp, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA.	cyoung2@bwh.harvard.edu	Hunt, Peter W./P-2976-2017; Muyindike, Winnie/W-2892-2019; Haberer, Jessica/AAH-7976-2019	Hunt, Peter W./0000-0002-4571-4870; Haberer, Jessica/0000-0001-5845-3190	National Institutes of Health [R21 HD069194, R01 MH054907, K23 MH095655, P30 AI027763, U01 CA066529, T32 AI007433]; Sullivan Family Foundation; Global Women's Health Fellowship at the Connor's Center for Women's Health and Gender Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433, P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sullivan Family Foundation; Global Women's Health Fellowship at the Connor's Center for Women's Health and Gender Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the National Institutes of Health (R21 HD069194, R01 MH054907, K23 MH095655, P30 AI027763, U01 CA066529, T32 AI007433), the Sullivan Family Foundation, and the Global Women's Health Fellowship at the Connor's Center for Women's Health and Gender Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; [Anonymous], 2013, WORLD FACTB 2013 14; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Bair-Merritt MH, 2014, AM J PREV MED, V46, P188, DOI 10.1016/j.amepre.2013.10.001; Bolton P, 2000, CROSS CULTURAL ASSES; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Ellsberg M., 2005, RES VIOLENCE WOMEN P; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Folayan MO, 2016, PLOS ONE, V11, P16; Geng EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014098; Hampanda KM, 2016, SOC SCI MED, V153, P123, DOI 10.1016/j.socscimed.2016.02.011; Hatcher AM, 2015, AIDS, V29, P2183, DOI 10.1097/QAD.0000000000000842; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Joyner K, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-399; Joyner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029540; Joyner K, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000254; Kayibanda JF, 2012, JAIDS-J ACQ IMM DEF, V59, P300, DOI 10.1097/QAI.0b013e31823dc634; Koenig MA, 2004, SOC SCI MED, V58, P787, DOI 10.1016/S0277-9536(03)00244-2; Kouyoumdjian FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081044; Kouyoumdjian FG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-566; Kouyoumdjian FG, 2013, AIDS, V27, P1331, DOI 10.1097/QAD.0b013e32835fd851; Machtinger EL, 2015, WOMEN HEALTH ISS, V25, P193, DOI 10.1016/j.whi.2015.03.008; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Ministry of Health, 2016, CONS GUID PREV TREAT; O'Doherty L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007007.pub3; Organization WH, 2010, PREV INT PARTN SEX V, DOI [10.1136/ip.2010.029629, DOI 10.1136/IP.2010.029629]; Rees K, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24588; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Taillieu TL, 2010, AGGRESS VIOLENT BEH, V15, P14, DOI 10.1016/j.avb.2009.07.013; UBOS ICF, 2018, UGANDA DEMOGRAPHIC H; Uganda Bureau of Statistics, 2012, UG DEM HLTH SURV 201; WINOKUR A, 1984, BRIT J PSYCHIAT, V144, P395, DOI 10.1192/bjp.144.4.395; World Health Organisation, 2013, RESPONDING INTIMATE; World Health Organization, 2005, WHO MULT STUD WOM HL	38	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202992	10.1371/journal.pone.0202992	http://dx.doi.org/10.1371/journal.pone.0202992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148854	Green Published, gold, Green Submitted			2022-12-27	WOS:000442804200042
J	Schall, M; Zimmermann, M; Iordanishvili, E; Gu, Y; Shah, NJ; Oros-Peusquens, AM				Schall, Melissa; Zimmermann, Markus; Iordanishvili, Elene; Gu, Yun; Shah, N. Jon; Oros-Peusquens, Ana-Maria			A 3D two-point method for whole-brain water content and relaxation time mapping: Comparison with gold standard methods	PLOS ONE			English	Article							HIGH-RESOLUTION T-1; MAGNETIC-FIELD; QUANTITATIVE T-1; SPOILED FLASH; TISSUE; ACCURACY; BIAS	Quantitative imaging of the human brain is of great interest in clinical research as it enables the identification of a range of MR biomarkers useful in diagnosis, treatment and prognosis of a wide spectrum of diseases. Here, a 3D two-point method for water content and relaxation time mapping is presented and compared to established gold standard methods. The method determines free water content, H2O, and the longitudinal relaxation time, T-1, quantitatively from a two-point fit to the signal equation including corrections of the transmit and receive fields. In addition, the effective transverse relaxation time, T-2*, is obtained from an exponential fit to the multi-echo signal train and its influence on H2O values is corrected. The phantom results obtained with the proposed method show good agreement for H2O and T-1 values with known and spectroscopically measured values, respectively. The method is compared in vivo to already established gold standard quantitative methods. For H2O and T-2* mapping, the 3D two-point results were compared to a measurement conducted with a multiple-echo GRE with long TR and T-1 is compared to results from a Look-Locker method, TAPIR. In vivo results show good overall agreement between the methods, but some systematic deviations are present. Besides an expected dependence of T-2* on voxel size, T-1 values are systematically larger in the 3D approach than those obtained with the gold standard method. This behaviour might be due to imperfect spoiling, influencing each method differently. Results for H2O differ due to differences in the saturation of cerebrospinal fluid and partial volume effects. In addition, ground truth values of in vivo studies are unknown, even when comparing to in vivo gold standard methods. A detailed region-of-interest analysis for H2O and T-1 matches well published literature values.	[Schall, Melissa; Zimmermann, Markus; Iordanishvili, Elene; Gu, Yun; Shah, N. Jon; Oros-Peusquens, Ana-Maria] Res Ctr Julich, INM 4, Julich, Germany; [Shah, N. Jon] Res Ctr Julich, INM 11, Julich, Germany; [Shah, N. Jon] Julich Aachen Res Alliance JARA BRAIN Translat Me, Aachen, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; RWTH Aachen University	Oros-Peusquens, AM (corresponding author), Res Ctr Julich, INM 4, Julich, Germany.	a.m.oros-peusquens@fz-juelich.de	Shah, N. Jon/H-5849-2013; Iordanishvili, Elene/AAK-6121-2020	Shah, N. Jon/0000-0002-8151-6169; Iordanishvili, Elene/0000-0001-5937-3790; Zimmermann, Markus/0000-0003-1273-5218; Oros-Peusquens, Ana-Maria/0000-0003-1869-3354	Shota Rustaveli National Science Foundation [PhD2016_235]	Shota Rustaveli National Science Foundation	The authors acknowledge Shota Rustaveli National Science Foundation for its support in the framework of the PhD grant No. PhD2016_235. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, 2017, ISMRM HONOLULU, V25; Abbas Z, 2015, NEUROIMAGE, V106, P404, DOI 10.1016/j.neuroimage.2014.11.017; Abbas Z, 2014, MAGN RESON MED, V72, P1735, DOI 10.1002/mrm.25086; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Badve C, 2017, AM J NEURORADIOL, V38, P492, DOI 10.3174/ajnr.A5035; Baudrexel S, 2016, NMR BIOMED, V29, P349, DOI 10.1002/nbm.3460; Cheng K, 2006, MICRON, V37, P566, DOI 10.1016/j.micron.2005.11.014; Deichmann R, 2005, MAGNET RESON MED, V54, P20, DOI 10.1002/mrm.20552; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Dmitry A, 1994, MAGN RESON MED, P749; Fatouros PP, 1999, J NEUROSURG, V90, P109, DOI 10.3171/jns.1999.90.1.0109; Friston KJ, 2006, STAT PARAMETRIC MAPP; Gelman N., 2013, NEUROIMAGE, V44, P137, DOI [10. 1016/j. neuroimage. 2009. 09. 037, DOI 10.1016/J.NEUROIMAGE.2009.09.037]; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Gras V, 2013, CONCEPT MAGN RESON A, V42, P89, DOI 10.1002/cmr.a.21264; Helms G, 2011, MAGN RESON MED, V66, P669, DOI 10.1002/mrm.22849; Hoeks CMA, 2011, RADIOLOGY, V261, P46, DOI 10.1148/radiol.11091822; Ma D, 2013, NATURE, V495, P187, DOI 10.1038/nature11971; Millman KJ, 2011, COMPUT SCI ENG, V13, P9, DOI 10.1109/MCSE.2011.36; Oros-Peusquens AM, 2008, MAGN RESON MATER PHY, V21, P131, DOI 10.1007/s10334-008-0107-5; Oros-Peusquens AM, 2014, NUCL INSTRUM METH A, V734, P185, DOI 10.1016/j.nima.2013.09.045; Palma G, 2015, PLOS ONE, V10, P1; Preibisch C, 2009, MAGN RESON MED, V61, P125, DOI 10.1002/mrm.21776; Preibisch C, 2008, MAGN RESON MED, V60, P908, DOI 10.1002/mrm.21730; Reetz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122188; Rooney WD, 2007, MAGN RESON MED, V57, P308, DOI 10.1002/mrm.21122; Sabati M, 2013, MAGN RESON IMAGING, V31, P1752, DOI 10.1016/j.mri.2013.08.001; Shah NJ, 2008, NEUROIMAGE, V41, P706, DOI 10.1016/j.neuroimage.2008.02.057; Shah NJ, 2003, HEPATOLOGY, V38, P1219, DOI 10.1053/jhep.2003.50477; Shah NJ, 2001, NEUROIMAGE, V14, P1175, DOI 10.1006/nimg.2001.0886; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Steinhoff S, 2001, MAGN RESON MED, V46, P131, DOI 10.1002/mrm.1168; Stikov N, 2015, MAGN RESON MED, V73, P514, DOI 10.1002/mrm.25135; Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV; Turner R, 2008, MAGN RESON IMAGING, V26, P935, DOI 10.1016/j.mri.2008.01.043; Volz S, 2012, NEUROIMAGE, V63, P540, DOI 10.1016/j.neuroimage.2012.06.076; Warntjes JBM, 2007, MAGN RESON MED, V57, P528, DOI 10.1002/mrm.21165; Weiskopf N, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00095; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Yablonskiy DA, 2013, MAGN RESON MED, V70, P1283, DOI 10.1002/mrm.24585; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201013	10.1371/journal.pone.0201013	http://dx.doi.org/10.1371/journal.pone.0201013			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161125	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900007
J	Avenarius, MR; Jung, JY; Askew, C; Jones, SM; Hunker, KL; Azaiez, H; Rehman, AU; Schraders, M; Najmabadi, H; Kremer, H; Smith, RJH; Geleoc, GSG; Dolan, DF; Raphael, Y; Kohrman, DC				Avenarius, Matthew R.; Jung, Jae-Yun; Askew, Charles; Jones, Sherri M.; Hunker, Kristina L.; Azaiez, Hela; Rehman, Atteeq U.; Schraders, Margit; Najmabadi, Hossein; Kremer, Hannie; Smith, Richard J. H.; Geleoc, Gwenaelle S. G.; Dolan, David F.; Raphael, Yehoash; Kohrman, David C.			Grxcr2 is required for stereocilia morphogenesis in the cochlea	PLOS ONE			English	Article							PLANAR CELL POLARITY; AUDITORY HAIR-CELLS; PROTEIN-STRUCTURE PREDICTION; NONSYNDROMIC HEARING-LOSS; MOUSE INNER-EAR; SENSORY TRANSDUCTION; DEVELOPMENTAL ACQUISITION; SECONDARY STRUCTURE; GENE-EXPRESSION; USHER-SYNDROME	Hearing and balance depend upon the precise morphogenesis and mechanosensory function of stereocilia, the specialized structures on the apical surface of sensory hair cells in the inner ear. Previous studies of Grxcr1 mutant mice indicated a critical role for this gene in control of stereocilia dimensions during development. In this study, we analyzed expression of the paralog Grxcr2 in the mouse and evaluated auditory and vestibular function of strains carrying targeted mutations of the gene. Peak expression of Grxcr2 occurs during early postnatal development of the inner ear and GRXCR2 is localized to stereocilia in both the cochlea and in vestibular organs. Homozygous Grxcr2 deletion mutants exhibit significant hearing loss by 3 weeks of age that is associated with developmental defects in stereocilia bundle orientation and organization. Despite these bundle defects, the mechanotransduction apparatus assembles in relatively normal fashion as determined by whole cell electrophysiological evaluation and FM1-43 uptake. Although Grxcr2 mutants do not exhibit overt vestibular dysfunction, evaluation of vestibular evoked potentials revealed subtle defects of the mutants in response to linear accelerations. In addition, reduced Grxcr2 expression in a hypomorphic mutant strain is associated with progressive hearing loss and bundle defects. The stereocilia localization of GRXCR2, together with the bundle pathologies observed in the mutants, indicate that GRXCR2 plays an intrinsic role in bundle orientation, organization, and sensory function in the inner ear during development and at maturity.	[Avenarius, Matthew R.; Jung, Jae-Yun; Hunker, Kristina L.; Dolan, David F.; Raphael, Yehoash; Kohrman, David C.] Univ Michigan, Kresge Hearing Res Inst, Sch Med, Dept Otolaryngol, 1301 E Ann St, Ann Arbor, MI 48109 USA; [Avenarius, Matthew R.; Kohrman, David C.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Askew, Charles] Univ Virginia, Neurosci Grad Program, Charlottesville, VA USA; [Askew, Charles; Geleoc, Gwenaelle S. G.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA; [Jones, Sherri M.] East Carolina Univ, Dept Commun Sci & Disorders, Greenville, NC USA; [Azaiez, Hela; Smith, Richard J. H.] Univ Iowa, Carver Coll Med, Mol Otolaryngol & Renal Res Labs, Iowa City, IA USA; [Rehman, Atteeq U.] NIDCD, Sect Human Genet, Mol Genet Lab, NIH, Rockville, MD USA; [Schraders, Margit; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, Hearing & Genes Div, Nijmegen, Netherlands; [Schraders, Margit; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Schraders, Margit; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran; [Avenarius, Matthew R.] Nationwide Childrens Hosp, Inst Genom Med, Columbus, OH USA; [Jung, Jae-Yun] Dankook Univ, Dept Otolaryngol Head & Neck Surg, Cheonan, South Korea; [Askew, Charles] Univ North Carolina Chapel Hill, Gene Therapy Ctr, Chapel Hill, NC USA; [Jones, Sherri M.] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Virginia; Harvard University; Boston Children's Hospital; Harvard Medical School; University of North Carolina; East Carolina University; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Dankook University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Nebraska System; University of Nebraska Lincoln	Kohrman, DC (corresponding author), Univ Michigan, Kresge Hearing Res Inst, Sch Med, Dept Otolaryngol, 1301 E Ann St, Ann Arbor, MI 48109 USA.; Kohrman, DC (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	dkohrman@umich.edu	Kremer, Hannie/F-5126-2010; Azaiez, Hela/AAQ-7011-2020; Najmabadi, Hossein/P-8182-2017; Rehman, Atteeq/AAG-8342-2020	Kremer, Hannie/0000-0002-0841-8693; Azaiez, Hela/0000-0002-2863-6970; Geleoc, Gwenaelle/0000-0002-2825-6521; Avenarius, Matthew/0000-0001-9516-5163; Askew, Charles/0000-0002-6131-6602; Smith, Richard/0000-0003-1201-6731	NIH-NIDCD [DC003049, DC005188, DC006443, DC008853, DC002842, DC000011]; Margaret G. Bertsch Endowed Research Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000011, P30DC005188, R01DC006443, R01DC003049, R01DC008853, R01DC002842] Funding Source: NIH RePORTER	NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Margaret G. Bertsch Endowed Research Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	These studies were supported by NIH-NIDCD grants DC003049 (DCK), DC005188 (DCK and YR), DC006443 (SMJ), DC008853 (GSGG), DC002842 (RJHS), and DC000011 (MRA) and by the Margaret G. Bertsch Endowed Research Fund (DCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arany ZP, 2008, CURR PROTOC HUM GENE, DOI DOI 10.1002/0471142905.HG1110S58; Barr-Gillespie PG, 2015, MOL BIOL CELL, V26, P2727, DOI 10.1091/mbc.E14-04-0940; Bartles JR, 1996, J CELL SCI, V109, P1229; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beyer LA, 2000, J NEUROCYTOL, V29, P227, DOI 10.1023/A:1026515619443; Bonthuis PJ, 2015, CELL REP, V12, P979, DOI 10.1016/j.celrep.2015.07.017; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dallos P., 1973, AUDITORY PERIPHERY, P548; Daudet N, 2002, CELL MOTIL CYTOSKEL, V53, P326, DOI 10.1002/cm.10092; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Erven A, 2002, EUR J NEUROSCI, V16, P1433, DOI 10.1046/j.1460-9568.2002.02213.x; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Friedman TB, 2011, ADV OTO-RHINO-LARYNG, V70, P56, DOI 10.1159/000322473; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Goodyear RJ, 2012, J NEUROSCI, V32, P2762, DOI 10.1523/JNEUROSCI.3635-11.2012; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Grimsley-Myers CM, 2009, J NEUROSCI, V29, P15859, DOI 10.1523/JNEUROSCI.3998-09.2009; Gurtler N, 2004, J MOL MED, V82, P775, DOI 10.1007/s00109-004-0597-1; Horwitz GC, 2011, J NEUROSCI, V31, P16814, DOI 10.1523/JNEUROSCI.3064-11.2011; Imtiaz A, 2014, HUM MUTAT, V35, P618, DOI 10.1002/humu.22545; Jagger D, 2011, HUM MOL GENET, V20, P466, DOI 10.1093/hmg/ddq493; Jeong D, 2008, CIRC RES, V102, P711, DOI 10.1161/CIRCRESAHA.107.165985; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Jones SM, 1999, HEARING RES, V135, P56, DOI 10.1016/S0378-5955(99)00090-8; Jones TA, 1999, HEARING RES, V136, P75, DOI 10.1016/S0378-5955(99)00110-0; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Lu XW, 2016, WIRES DEV BIOL, V5, P85, DOI 10.1002/wdev.202; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Martinez-Yamout M, 2000, J MOL BIOL, V300, P805, DOI 10.1006/jmbi.2000.3923; McCormack EA, 2009, J MOL BIOL, V391, P192, DOI 10.1016/j.jmb.2009.06.003; McGee DJ, 2006, J BIOL CHEM, V281, P3290, DOI 10.1074/jbc.M506139200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mchugh RK, 2006, ANAT REC PART A, V288A, P370, DOI 10.1002/ar.a.20297; Meyers JR, 2003, J NEUROSCI, V23, P4054; Mianne J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0273-4; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Mustapha M, 2009, J NEUROSCI, V29, P1212, DOI 10.1523/JNEUROSCI.4957-08.2009; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Nayak GD, 2007, INT J DEV BIOL, V51, P597, DOI 10.1387/ijdb.072392gn; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Noguchi S, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.112; Odeh H, 2004, AUDIOL NEURO-OTOL, V9, P303, DOI 10.1159/000080701; Odeh H, 2010, AM J HUM GENET, V86, P148, DOI 10.1016/j.ajhg.2010.01.016; OSBORNE MP, 1991, SCANNING MICROSCOPY, V5, P555; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Papadopoulos JS, 2007, CONSTRAINT BASED MUL; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Raphael Y, 2001, HEARING RES, V151, P237, DOI 10.1016/S0378-5955(00)00233-1; Rida PCG, 2009, SEMIN CELL DEV BIOL, V20, P978, DOI 10.1016/j.semcdb.2009.02.007; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sabag Adi D., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P101; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Scheffer DI, 2015, GENE EXPRESSION MOUS; Schraders M, 2010, AM J HUM GENET, V86, P138, DOI 10.1016/j.ajhg.2009.12.017; Sipe CW, 2011, DEVELOPMENT, V138, P3441, DOI 10.1242/dev.065961; SOBKOWICZ HM, 1995, J NEUROCYTOL, V24, P633, DOI 10.1007/BF01179815; Steel KP, 1995, ANNU REV GENET, V29, P675; Van Laer L, 2003, EAR HEARING, V24, P275, DOI 10.1097/01.AUD.0000079805.04016.03; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Xia JH, 2002, J HUM GENET, V47, P635, DOI 10.1007/s100380200098; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng QY, 2001, HEARING RES, V154, P45, DOI 10.1016/S0378-5955(01)00215-5; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	96	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201713	10.1371/journal.pone.0201713	http://dx.doi.org/10.1371/journal.pone.0201713			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157177	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400011
J	Edwards, HA; Schroeder, J; Dugdale, HL				Edwards, Hannah A.; Schroeder, Julia; Dugdale, Hannah L.			Gender differences in authorships are not associated with publication bias in an evolutionary journal	PLOS ONE			English	Article							DOUBLE-BLIND; WOMEN; PATTERNS; OUTCOMES; SCIENCE; JOB	The loss of talented women from senior academic positions has partly resulted from a lower number of published papers and the accompanying reduced visibility of female compared to male scientists. The reasons for these gender-differences in authorship is unclear. One potential reason is a bias in the editorial and review process of scientific journals. We investigated whether patterns of authorship and editorial outcome were biased according to gender and geographic location in the Journal of Evolutionary Biology. Such potential bias may contribute to inequality in the field. We found patterns of gender differences in authorship, but this was unrelated to the editorial decision of whether to publish the manuscript. Female first-authors (the lead role) were six times less likely to be named as the corresponding author than male first-authors, and female first-authors were more likely to be displaced as corresponding authors by female co-authors than were male first-authors. We found an under-representation of female first-and last-authors compared to baseline populations of members of the European Society for Evolutionary Biology (which publishes the Journal of Evolutionary Biology) and of Evolutionary Biology faculty at the world top-10 universities for the Life Sciences. Also, manuscripts from Asia were five times more likely to be rejected on the final decision, independent of gender. Overall our results suggest that the peer review processes we investigated at the Journal of Evolutionary Biology are predominately genderneutral, but not neutral to geographic location. Editorial gender-bias is thus unlikely to be a contributing factor to differences in authorship in this journal.	[Edwards, Hannah A.; Dugdale, Hannah L.] Univ Leeds, Sch Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Schroeder, Julia] Imperial Coll London, Dept Life Sci, Ascot, Berks, England	University of Leeds; Imperial College London	Edwards, HA (corresponding author), Univ Leeds, Sch Biol, Fac Biol Sci, Leeds, W Yorkshire, England.	hannah.a.edwards@outlook.com	Schroeder, Julia/B-1436-2010; Dugdale, Hannah L/C-7138-2008	Schroeder, Julia/0000-0002-4136-843X; Dugdale, Hannah L/0000-0001-8769-0099	European Society of Evolutionary Biology (ESEB); JEB (the society journal for the ESEB); JEB; ESEB Equal Opportunities Fund 2017	European Society of Evolutionary Biology (ESEB); JEB (the society journal for the ESEB); JEB; ESEB Equal Opportunities Fund 2017	HAE was supported by a (sic)1000 European Society of Evolutionary Biology (ESEB) Equal Opportunities Fund 2017. The editorial office of the Journal of Evolutionary Biology, the society journal for the ESEB, provided data on the reviewing requests and publication decisions of manuscripts submitted to the journal between January 2012 and February 2016.; We thank Mike Ritchie, former Editor-in-Chief of the JEB (the society journal for the ESEB), and Lianne Baker, Managing Editor of the JEB, for their support and for providing data on the reviewing requests and publication decisions of manuscripts submitted to the journal. We also thank Ute Friedrich from the ESEB office for providing membership data and three anonymous reviewers for their constructive comments. HAE was supported by the ESEB Equal Opportunities Fund 2017.	Ali J, 2010, J YOUNG PHARM, V2, P3, DOI [10.4103/0975-1483.62205, 10.4103/0975-1483.51868]; Amrein K, 2011, GENDER MED, V8, P378, DOI 10.1016/j.genm.2011.10.007; [Anonymous], 2015, SHE FIGURES 2015 EUR; Barrett SCH, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2553; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake-Beard S, 2011, J SOC ISSUES, V67, P622, DOI 10.1111/j.1540-4560.2011.01717; BLANK RM, 1991, AM ECON REV, V81, P1041; Bonnet X. R., 2004, J WOM MINOR SCI ENG, V10, P353; Burgman M, 2015, CONSERV BIOL, V29, P1255, DOI 10.1111/cobi.12589; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Cho AH, 2014, PEERJ, V2, DOI 10.7717/peerj.542; Cole J.R., 1984, ADV MOTIVATION ACHIE, V2, P217; Committee on Science Engineering and Public Policy (COSE-PUP), 2007, BIAS BARR FULF POT W; Damschen EI, 2005, FRONT ECOL ENVIRON, V3, P212, DOI 10.2307/3868465; Dugdale HL, 2011, TRENDS ECOL EVOL, V26, P622, DOI 10.1016/j.tree.2011.07.005; Fox CW, 2017, FUNCT ECOL, V31, P270, DOI 10.1111/1365-2435.12665; Fox CW, 2016, FUNCT ECOL, V30, P140, DOI 10.1111/1365-2435.12529; Fox CW, 2016, FUNCT ECOL, V30, P126, DOI 10.1111/1365-2435.12587; Fyfe A, 2018, TIME HIGHER ED  0212; Garcia-Carpintero E, 2010, SCIENTOMETRICS, V84, P799, DOI 10.1007/s11192-010-0199-3; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Grod ON, 2010, FRONT ECOL ENVIRON, V8, P187, DOI 10.1890/090048; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Heckenberg A, 2010, WIEN KLIN WOCHENSCHR, V122, P141, DOI 10.1007/s00508-010-1302-8; Herrera AJ, 1999, NATURE, V397, P467, DOI 10.1038/17194; Kamalski J, 2011, RISE ASIA RES PROFIL; Knapp S, 2005, TRENDS ECOL EVOL, V20, P55, DOI 10.1016/j.tree.2004.11.016; Lee CJ, 2013, J AM SOC INF SCI TEC, V64, P2, DOI 10.1002/asi.22784; Long MT, 2015, GASTROINTEST ENDOSC, V81, P1440, DOI 10.1016/j.gie.2015.01.032; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P177, DOI 10.1890/12.WB.011; Mason M. A., 2004, DO BABIES MATTER 2; Mauleon E, 2013, SCIENTOMETRICS, V95, P87, DOI 10.1007/s11192-012-0824-4; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Morton MJ, 2007, J NATL MED ASSOC, V99, P764; Moss-Racusin CA, 2010, PSYCHOL WOMEN QUART, V34, P186, DOI 10.1111/j.1471-6402.2010.01561.x; Pasterkamp G, 2007, SCIENTOMETRICS, V70, P153, DOI 10.1007/s11192-007-0109-5; R Development Core Team, 2017, R LANG ENV STAT COMP; Rammstedt B, 2001, Z PADAGOG PSYCHOL, V15, P207, DOI 10.1024//1010-0652.15.34.207; Roberts SG, 2016, J LANG EVOL, V1, P163, DOI 10.1093/jole/lzw009; Schroeder J, 2013, J EVOLUTION BIOL, V26, P2063, DOI 10.1111/jeb.12198; Shah Deepika N, 2013, Digit J Ophthalmol, V19, P50, DOI 10.5693/djo.01.2013.07.002; Shen H, 2013, NATURE, V495, P22, DOI [10.1038/495022a, 10.1038/495021a]; Sieverding M, 2003, Z SOZIALPSYCHOL, V34, P147, DOI 10.1024//0044-3514.34.3.147; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Symonds MRE, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000127; Topaz CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161357; Uzun A, 2004, SCIENTOMETRICS, V61, P457, DOI 10.1023/B:SCIE.0000045121.26810.35; Valian V., 1999, WHY SO SLOW ADV WOME, V1 1st; Wais K, 2016, GENDERIZER GENDER PR; Webb TJ, 2008, TRENDS ECOL EVOL, V23, P351, DOI 10.1016/j.tree.2008.03.003; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Willett Peter, 2013, International Journal of Knowledge Content Development & Technology, V3, P5, DOI 10.5865/IJKCT.2013.3.1.005	53	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201725	10.1371/journal.pone.0201725	http://dx.doi.org/10.1371/journal.pone.0201725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157231	Green Published, gold			2022-12-27	WOS:000443071400012
J	Nilsson, E; King, SE; McBirney, M; Kubsad, D; Pappalardo, M; Beck, D; Sadler-Riggleman, I; Skinner, MK				Nilsson, Eric; King, Stephanie E.; McBirney, Margaux; Kubsad, Deepika; Pappalardo, Michelle; Beck, Daniel; Sadler-Riggleman, Ingrid; Skinner, Michael K.			Vinclozolin induced epigenetic transgenerational inheritance of pathologies and sperm epimutation biomarkers for specific diseases	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; DNA METHYLATION; READ ALIGNMENT; ADIPOSE-TISSUE; EXPOSURE; OBESITY; CLASSIFICATION; INDUCTION; PACKAGE; GENES	Exposure to vinclozolin has been shown to induce the epigenetic transgenerational inheritance of increased susceptibility to disease, and to induce transgenerational changes to the epigenome. In the current study, gestating F0 generation rats were exposed to vinclozolin, and the subsequent F1, F2 and transgenerational F3 generations were evaluated for diseases and pathologies. F1 and F2 generation rats exhibited few abnormalities. However, F3 generation rats showed transgenerational increases in testis, prostate, and kidney disease, changes in the age of puberty onset in males, and an increased obesity rate in females. Overall there was an increase in the rate of animals with disease, and in the incidence of animals with multiple diseases. The objective of the current study was to analyze the sperm epigenome of F3 generation rats with specific abnormalities and compare them to rats without those abnormalities, in an effort to find epigenetic biomarkers of transgenerational disease. Unique signatures of differential DNA methylation regions (DMRs) in sperm were found that associated with testis disease, prostate disease and kidney disease. Confounding factors identified were the presence of multiple diseases in the analysis and the limited number of animals without disease. These results further our understanding of the mechanisms governing epigenetic transgenerational inheritance, and may lead in the future to the use of epigenetic biomarkers that will help predict an individual's susceptibility for specific diseases.	[Nilsson, Eric; King, Stephanie E.; McBirney, Margaux; Kubsad, Deepika; Pappalardo, Michelle; Beck, Daniel; Sadler-Riggleman, Ingrid; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020	King, Stephanie Evelyn/0000-0002-0970-6355; Kubsad, Deepika/0000-0002-3830-1808	John Templeton Foundation [50183]; NIH [ES012974]	John Templeton Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a John Templeton Foundation (50183) (https://www.templeton.org/) grant to MKS and NIH (ES012974) (https://www.nih.gov/) grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baker TR, 2014, MOL CELL ENDOCRINOL, V398, P36, DOI 10.1016/j.mce.2014.08.011; Ben Maamar M, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvy010; Berger A, 2016, REPROD TOXICOL, V60, P39, DOI 10.1016/j.reprotox.2015.12.004; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Bruner-Tran KL, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.138370; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Carvan MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176155; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Guerrero-Bosagna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059922; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Knecht AL, 2017, TOXICOL APPL PHARM, V329, P148, DOI 10.1016/j.taap.2017.05.033; Kress A, 2017, J INSECT PHYSIOL, V99, P113, DOI 10.1016/j.jinsphys.2017.04.003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leroux S, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0292-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Manikkam M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102091; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McBirney M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184306; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Pocar P, 2017, TOXICOL APPL PHARM, V322, P113, DOI 10.1016/j.taap.2017.03.008; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; Santi D, 2017, ANDROLOGY-US, V5, P695, DOI 10.1111/andr.12379; Schneider P, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00043; Schuster A, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvw001; Shnorhavorian M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170085; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0178-0; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P4, DOI 10.1016/j.mce.2014.07.019; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P1, DOI 10.1016/j.mce.2014.07.017; Skinner MK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-692; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Taylor JA, 2011, J STEROID BIOCHEM, V127, P83, DOI 10.1016/j.jsbmb.2011.07.005; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; WONG CI, 1995, J BIOL CHEM, V270, P19998, DOI 10.1074/jbc.270.34.19998; Xie F, 2012, CELL PHYSIOL BIOCHEM, V29, P111, DOI 10.1159/000337592; 2000, ARCH INTERN MED, V160, P898	72	50	50	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202662	10.1371/journal.pone.0202662	http://dx.doi.org/10.1371/journal.pone.0202662			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157260	gold, Green Published, Green Submitted			2022-12-27	WOS:000443071400067
J	Yi, Y; Li, FJ; Zhang, MW; Yuan, Y; Zhu, M; Guo, WS; Zhu, XK; Li, CY				Yi, Yuan; Li, Fujian; Zhang, Mingwei; Yuan, Yi; Zhu, Min; Guo, Wenshan; Zhu, Xinkai; Li, Chunyan			Is there a nitrogen fertilizer threshold emitting less N2O with the prerequisite of high wheat production?	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; USE EFFICIENCY; CROPPING SYSTEMS; OXIDE EMISSIONS; RICE PRODUCTION; GRAIN PRODUCTION; EASTERN CHINA; MANAGEMENT; REGION; SOILS	Excessive use of synthetic nitrogen (N) fertilizer and lower nitrogen use efficiency (NUE) are threatening the wheat production in the middle and lower reaches of Yangtze River. Excess input of N fertilizers also results in severe environmental pollution, climate change and biodiversity loss. However, the study on reasonable nitrogen application and NUE improvement with the prerequisite of stable and high yield remains unexplored. In our study, the four different levels of nitrogen were applied to find out the nitrogen threshold which could be both friendly to environment and promise the stable and high yield. The experiment was carried out in Yangzhou University (Yangzhou, China). The wheat cultivar Yangmai 23 was selected as the research material. The four nitrogen levels were as follows: 0, 189, 229.5, and 270 kg ha(-1). The results showed that the grain yield under the application of 229.5 kg ha(-1) N was as high as that under 270 kg ha(-1) N level, with the observation of 20.3% increase in agronomic efficiency. The N2O emission of 229.5 kg ha(-1) N application was as low as that of 189 kg ha(-1) N, but the grain yield and agronomic efficiency were significantly higher (11.9%) under 229.5 kg ha(-1) treatment than the lower one. Taken together, this indicated the nitrogen level at 229.5 kg ha(-1) could be identified as the fertilizer threshold, which will be beneficial for the future fieldwork.	[Yi, Yuan; Li, Fujian; Zhang, Mingwei; Zhu, Min; Guo, Wenshan; Zhu, Xinkai; Li, Chunyan] Yangzhou Univ, Wheat Res Inst, Coinnovat Ctr Modern Prod Technol Grain Crops, Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China; [Yuan, Yi] Zhenjiang Agrotech Extens Stn 97, Zhenjiang City, Jiangsu, Peoples R China	Yangzhou University	Guo, WS; Zhu, XK (corresponding author), Yangzhou Univ, Wheat Res Inst, Coinnovat Ctr Modern Prod Technol Grain Crops, Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China.	guows@yze.edu.cn; xkzhu@yzu.edu.cn		yi, yuan/0000-0002-8795-6261	National Key Research and Development Program of China - Ministry of Science and Technology of the People's Republic of China [2016YFD0300107]; National Natural Science Foundation of China by the committee of National Natural Science Foundation of China [31771711]; Science and Technology Innovation Group of Yangzhou University; Innovation Program of Jiangsu Province [CX(16)1001]; Yangzhou Science Foundation for Excellent Youths - Yangzhou Science and Technology Bureau [YZ2017098]	National Key Research and Development Program of China - Ministry of Science and Technology of the People's Republic of China; National Natural Science Foundation of China by the committee of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Group of Yangzhou University; Innovation Program of Jiangsu Province; Yangzhou Science Foundation for Excellent Youths - Yangzhou Science and Technology Bureau	This work was supported by the National Key Research and Development Program of China (2016YFD0300107), which was funded by the Ministry of Science and Technology of the People's Republic of China (http://www.most.gov.cn/) and the receiver is Li CY. It was also supported by the National Natural Science Foundation of China (31771711), which was provided by the committee of National Natural Science Foundation of China (http://www.nsfc.gov.cn/) with the receiver Guo WS. In addition, it was sponsored by Science and Technology Innovation Group of Yangzhou University (2016) with the receiver Zhu XK. It was also funded by the Innovation Program of Jiangsu Province (CX(16)1001) with the receiver Li CY. It was also supported by the Yangzhou Science Foundation for Excellent Youths (YZ2017098), which was funded by the Yangzhou Science and Technology Bureau (http://kjj.yangzhou.gov.cn/yzkjj/index.shtml) with the receiver Li CY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Chem A, 1980, OFFICIAL METHODS ANA; Chen J, 2011, AGR ECOSYST ENVIRON, V142, P195, DOI 10.1016/j.agee.2011.05.005; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chuan LM, 2013, FIELD CROP RES, V140, P1, DOI 10.1016/j.fcr.2012.09.020; Cui ZL, 2010, AMBIO, V39, P376, DOI 10.1007/s13280-010-0076-6; Dobermann A, 2002, PLANT SOIL, V247, P153, DOI 10.1023/A:1021197525875; Dyson T, 1999, P NATL ACAD SCI USA, V96, P5929, DOI 10.1073/pnas.96.11.5929; EICHNER MJ, 1990, J ENVIRON QUAL, V19, P272, DOI 10.2134/jeq1990.00472425001900020013x; European Environmental Agency, 2013, ANN EUR UN GREENH GA, DOI [10.2800/92220, DOI 10.2800/92220]; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Grant B, 2004, CLIMATIC CHANGE, V65, P315, DOI 10.1023/B:CLIM.0000038226.60317.35; Gray V, 2010, S AFR GEOGR J, V92, P86; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo Q, 2013, SPAN J AGRIC RES, V11, P980, DOI 10.5424/sjar/2013114-4373; Jia XC, 2014, AGR WATER MANAGE, V137, P92, DOI 10.1016/j.agwat.2014.02.010; Johnson JMF, 2007, ENVIRON POLLUT, V150, P107, DOI 10.1016/j.envpol.2007.06.030; Ju XT, 2004, AMBIO, V33, P300, DOI 10.1639/0044-7447(2004)033[0300:NFSNAA]2.0.CO;2; Kahrl F, 2010, ENVIRON SCI POLICY, V13, P688, DOI 10.1016/j.envsci.2010.07.006; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Kumar A, 2015, J PURE APPL MICROBIO, V9, P1487; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; Li CS, 2006, J ENVIRON QUAL, V35, P1554, DOI 10.2134/jeq2005.0208; Li CS, 2001, NUTR CYCL AGROECOSYS, V60, P159, DOI 10.1023/A:1012642201910; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Lu R, 1999, SOIL AGROCHEMISTRY A, V15; Ma L, 2014, LAND USE POLICY, V37, P52, DOI 10.1016/j.landusepol.2013.01.008; Manna MC, 2005, FIELD CROP RES, V93, P264, DOI 10.1016/j.fcr.2004.10.006; Meng QF, 2012, AGR ECOSYST ENVIRON, V146, P93, DOI 10.1016/j.agee.2011.10.015; Mosier A, 1998, NUTR CYCL AGROECOSYS, V52, P225, DOI 10.1023/A:1009740530221; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Nouriyani H, 2012, RES CROP, V13, P439; Peng SB, 2006, FIELD CROP RES, V96, P37, DOI 10.1016/j.fcr.2005.05.004; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Raun WR, 2002, AGRON J, V94, P815; Richard B, 2011, ENVIRON PLANN A, V43, P431, DOI [10.1007/978-94-007-6208-4_2, DOI 10.1007/978-94-007-6208-4_2]; Roelcke M, 2004, PEDOSPHERE, V14, P449; Roelcke M, 2002, NUTR CYCL AGROECOSYS, V63, P255, DOI 10.1023/A:1021115218531; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Sheoran P, 2016, INT J PLANT PROD, V10, P109; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; Solomon S, 2007, CLIMATE CHANGE 2007, V18, P95; Tian HQ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044020; Wang DJ, 2004, ENVIRON GEOCHEM HLTH, V26, P221, DOI 10.1023/B:EGAH.0000039584.35434.e0; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yan J, 2009, SOILS; Yao ZS, 2010, PLANT SOIL, V327, P315, DOI 10.1007/s11104-009-0056-4; Zhang JH, 2013, PEDOSPHERE, V23, P59, DOI 10.1016/S1002-0160(12)60080-0; Zhao X, 2009, PLANT SOIL, V319, P225, DOI 10.1007/s11104-008-9865-0; Zheng J, 2000, RICE WHEAT CROPPING; Zhu XinKai, 2003, Agricultural Sciences in China, V2, P609; Zou JW, 2009, GLOBAL CHANGE BIOL, V15, P229, DOI 10.1111/j.1365-2486.2008.01775.x	55	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202343	10.1371/journal.pone.0202343	http://dx.doi.org/10.1371/journal.pone.0202343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153270	Green Published, Green Submitted, gold			2022-12-27	WOS:000443001700014
J	Hopker, A; Pandey, N; Dhamorikar, A; Hopker, S; Gautam, P; Pandey, S; Kumar, S; Rahangadale, N; Mehta, P; Marsland, R; Sargison, N				Hopker, Andy; Pandey, Naveen; Dhamorikar, Aniruddha; Hopker, Sophie; Gautam, Pradeep; Pandey, Subash; Kumar, Sharad; Rahangadale, Narendra; Mehta, Prakash; Marsland, Rebecca; Sargison, Neil			Delivery and evaluation of participatory education for animal keepers led by veterinarians and para-veterinarians around the Kanha Tiger Reserve, Madhya Pradesh, India (vol 13, e0200999, 2018)	PLOS ONE			English	Correction													Marsland, Rebecca/AAW-4407-2020	Marsland, Rebecca/0000-0002-0512-0955	BBSRC; BBSRC through the Institute Strategic Programme funding [BB/J004235/1, BB/P013740/1]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC through the Institute Strategic Programme funding(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was conducted using the facilities of the Roslin Institute funded by the BBSRC. NS is supported by BBSRC through the Institute Strategic Programme funding (BB/J004235/1 and BB/P013740/1).	Hopker A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200999	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203299	10.1371/journal.pone.0203299	http://dx.doi.org/10.1371/journal.pone.0203299			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148892	gold, Green Submitted, Green Published			2022-12-27	WOS:000442804200056
J	Lesieur, E; Blanc, J; Loundou, A; Claquin, A; Marcot, M; Heckenroth, H; Bretelle, F				Lesieur, Emmanuelle; Blanc, Julie; Loundou, Anderson; Claquin, Arnaud; Marcot, Michele; Heckenroth, Helene; Bretelle, Florence			Teaching and performing audits on caesarean delivery reduce the caesarean delivery rate	PLOS ONE			English	Article							CLUSTER-RANDOMIZED TRIAL; ROBSON CLASSIFICATION; PLACENTA-ACCRETA; SECTION RATE; LABOR; RISK; POPULATION; INDUCTION; FRANCE; QUEBEC	Aim To assess the factors associated with lower rate of caesarean deliveries in the South of France, based on the characteristics and organisation of the region's 40 maternity facilities and the characteristics of the practitioners in these facilities. Method A retrospective study from 1 January 2012 to 31 December 2015. Data were collected by the Mediterranean network and a declarative survey was completed by each maternity facility in the region to study factor which could be associated with lower caesarean rate by univariate and multivariate analysis. Results 250 564 women gave birth during this period, of which 55 097 by caesarean section. The mean caesarean delivery rate over the four years was 22.0%. The rate was significantly higher in private maternity facilities [23.9% (21.9%- 25.8%), p<0.05] and type I I I (maximum care level) maternity facilities [24.2% (21.3%- 27.1%), p<0.05]. After a step-wise regression, the factors associated with a decrease in the caesarean delivery rate were audits concerning caesarean delivery (19.83%, beta = - 2.48, p = 0.03 over the four years) and the provision of training to trainee doctors at the maternity facility (20.28%, beta = - 1.08, p = 0.04 over the four years). Conclusion Performing audits in relation to caesarean deliveries could affect the caesarean. Teaching trainee doctors could be an indicator of quality of caesarean practices. They should be encouraged in maternity facilities to reduce the rate of caesareans.	[Lesieur, Emmanuelle; Blanc, Julie; Heckenroth, Helene; Bretelle, Florence] AMU, AP HM, Dept Obstet & Gynaecol, Gynepole, Marseille, France; [Blanc, Julie; Loundou, Anderson] Aix Marseille Univ, Publ Hlth Chron Dis & Qual Life Res Unit, EA 3279, Marseille, France; [Claquin, Arnaud; Marcot, Michele; Bretelle, Florence] Reseau Mediterannee PACA Corse Monaco, Mediterannee Perinatal Networks, Marseille, France; [Bretelle, Florence] Aix Marseille Univ, CNRS 7278, INSERM 1095, Clin Infect Dis,Res Unit,IRD 198,UM63, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lesieur, E (corresponding author), AMU, AP HM, Dept Obstet & Gynaecol, Gynepole, Marseille, France.	emmanuelle.lesieur@ap-hm.fr			a *MIDEX project "CREER" - "Investissements d'Avenir" French Government program [ANR-11-IDEX-0001-02]	a *MIDEX project "CREER" - "Investissements d'Avenir" French Government program(French National Research Agency (ANR))	This work was supported by a *MIDEX project "CREER" (No. ANR-11-IDEX-0001-02) funded by the "Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR) (FB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolo S, 2016, BJOG-INT J OBSTET GY, V123, P1664, DOI 10.1111/1471-0528.14056; Blomberg M, 2016, ACTA OBSTET GYN SCAN, V95, P580, DOI 10.1111/aogs.12872; Blondel B, 2012, J Gynecol Obstet Biol Reprod (Paris), V41, pe1, DOI 10.1016/j.jgyn.2012.04.014; Chaillet N, 2015, NEW ENGL J MED, V372, P1710, DOI 10.1056/NEJMoa1407120; Deneux-Tharaux C, 2012, J GYNECOL OBST BIO R, V41, P697, DOI 10.1016/j.jgyn.2012.09.022; Janoudi G, 2015, J OBSTET GYNAECOL CA, V37, P517, DOI 10.1016/S1701-2163(15)30228-0; Jauniaux E, 2016, BJOG-INT J OBSTET GY, V123, P438, DOI 10.1111/1471-0528.13618; Jayot A, 2016, J OBSTET GYNAECOL RE, V42, P648, DOI 10.1111/jog.12964; Johri M, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0859-8; Lasnet A, 2015, J GYNECOL OBST BIO R, V44, P550, DOI 10.1016/j.jgyn.2014.08.003; Le Ray C, 2007, ACTA OBSTET GYN SCAN, V86, P657, DOI 10.1080/00016340701245427; Le Ray C, 2015, J GYNECOL OBST BIO R, V44, P605, DOI 10.1016/j.jgyn.2015.02.001; Le Ray C, 2015, BJOG-INT J OBSTET GY, V122, P690, DOI 10.1111/1471-0528.13199; Lembrouck C, 2016, J GYNECOL OBST BIO R, V45, P641, DOI 10.1016/j.jgyn.2015.08.002; Mazzoni A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0824-0; mondiale de la Sante O, 2015, DECL OMS TAUX CES; Robson M, 2015, INT J GYNECOL OBSTET, V131, pS23, DOI 10.1016/j.ijgo.2015.04.026; Sholapurkar SL, 2015, BJOG-INT J OBSTET GY, V122, P143, DOI 10.1111/1471-0528.13017; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; Tourette C, 2014, J GYNECOL OBST BIO R, V43, P322, DOI 10.1016/j.jgyn.2013.03.005; Triunfo S, 2015, EUR J OBSTET GYN R B, V189, P91, DOI 10.1016/j.ejogrb.2015.03.030; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Ye J, 2016, BJOG-INT J OBSTET GY, V123, P745, DOI 10.1111/1471-0528.13592; Zelli P, 2016, J GYNECOL OBST BIO R, V45, P841, DOI 10.1016/j.jgyn.2016.06.001	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202475	10.1371/journal.pone.0202475	http://dx.doi.org/10.1371/journal.pone.0202475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148837	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200010
J	Oda, Y; Sasaki, H; Miura, T; Takanashi, T; Furuya, Y; Yoshinari, M; Yajima, Y				Oda, Yukari; Sasaki, Hodaka; Miura, Tadashi; Takanashi, Takuya; Furuya, Yoshitaka; Yoshinari, Masao; Yajima, Yasutomo			Bone marrow stromal cells from low-turnover osteoporotic mouse model are less sensitive to the osteogenic effects of fluvastatin	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; IN-VITRO; SIMVASTATIN; EXPRESSION; STATINS; SAMP6; MICE; OSTEOCALCIN; INHIBITION; HYDROGEL	This study aimed to investigate the effects of fluvastatin on the differentiation of bone marrow stromal cells (BMSCs) into osteoblasts in senescence-accelerated mouse prone 6 (SAMP6) compared with that in the normal senescence-accelerated-resistant mouse (SAMR1) model. SAMP strains arose spontaneously from the AKR/J background and display shortened life span and an array of signs of accelerated aging, compared with control SAMR strains. The dose effects of fluvastatin were also evaluated. BMSCs were cultured with/without fluvastatin (0 mu M, 0.1 mu M, 0.5 mu M, and 1.0 mu M). WST-1-based colorimetry was performed to evaluate cell proliferation. To evaluate cell differentiation, gene expression levels of bmp2 and runx2 were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR), and protein expression levels were determined using enzyme-linked immunosorbent assay (BMP2) and immunofluorescence staining (BMP2 and Runx2). Alkaline phosphatase (ALP) activity assay and histochemical detection were determined; the effect of noggin, a BMP-specific antagonist, was examined using ALP histochemical detection. To assess for mature osteogenic marker, gene expression levels of bglap2 were determined by qRT-PCR and mineralization was determined by alizarin red staining. RhoA activity was also examined by Western blotting. In SAMP6, BMP2, Runx2 and Bglap2 mRNA and protein expressions were significantly increased by fluvastatin, and ALP activity was increased by BMP2 action. RhoA activity was also inhibited by fluvastatin. The concentration of fluvastatin sufficient to increase BMP2 and Runx2 expression and ALP activity was 0.5 mu M in SAMP6 and 0.1 mu M in SAMR1. In conclusion, the present study revealed that fluvastatin promoted BMSC differentiation into osteoblasts by RhoA-BMP2 pathway in SAMP6. BMSCs of SAMP6 are less sensitive to the osteogenic effects of fluvastatin than SAMR1.	[Oda, Yukari; Sasaki, Hodaka; Miura, Tadashi; Yoshinari, Masao; Yajima, Yasutomo] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan; [Oda, Yukari; Sasaki, Hodaka; Takanashi, Takuya; Furuya, Yoshitaka; Yajima, Yasutomo] Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College	Oda, Y (corresponding author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan.; Oda, Y (corresponding author), Tokyo Dent Coll, Dept Oral & Maxillofacial Implantol, Tokyo, Japan.	takahashiyukari@tdc.ac.jp		Oda, Yukari/0000-0003-3419-9217				Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x; Auer J, 2002, CURR MED CHEM, V9, P1831, DOI 10.2174/0929867023369024; Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031; Beppu K, 2013, CLIN IMPLANT DENT R, V15, P217, DOI 10.1111/j.1708-8208.2011.00350.x; Bryant S Ross, 2002, J Can Dent Assoc, V68, P97; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Chen PY, 2010, NUTR RES, V30, P191, DOI 10.1016/j.nutres.2010.03.004; Duque G, 2008, J AM GERIATR SOC, V56, P935, DOI 10.1111/j.1532-5415.2008.01764.x; Fukui T, 2012, J BONE MINER RES, V27, P1118, DOI 10.1002/jbmr.1558; Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Horiuchi N, 2006, ORAL DIS, V12, P85, DOI 10.1111/j.1601-0825.2005.01172.x; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kasai S, 2004, J BONE MINER METAB, V22, P207, DOI 10.1007/s00774-003-0471-1; Kupcsik L, 2009, J CELL MOL MED, V13, P4465, DOI 10.1111/j.1582-4934.2008.00545.x; Maeda T, 2004, J CELL BIOCHEM, V92, P458, DOI 10.1002/jcb.20074; Moriyama Y, 2008, CLIN ORAL IMPLAN RES, V19, P600, DOI 10.1111/j.1600-0501.2007.01508.x; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; O'Sullivan RP, 2012, EXP HEMATOL, V40, P499, DOI 10.1016/j.exphem.2012.01.019; Ohira T, 2015, J HARD TISSUE BIOL, V24, P147, DOI 10.2485/jhtb.24.147; Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597; PARFITT AM, 1995, J BONE MINER RES, V10, P466; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Ruiz-Gaspa S, 2007, J CELL BIOCHEM, V101, P1430, DOI 10.1002/jcb.21259; Shao HW, 2008, STEM CELLS, V26, P1376, DOI 10.1634/stemcells.2007-0785; Silva MJ, 2004, J BIOMECH, V37, P1639, DOI 10.1016/j.jbiomech.2004.02.018; Song CL, 2003, BIOCHEM BIOPH RES CO, V308, P458, DOI 10.1016/S0006-291X(03)01408-6; Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1; Yamashita M, 2008, J ENDOCRINOL, V196, P601, DOI 10.1677/JOE-07-0532; Zhou YS, 2010, BIOMATERIALS, V31, P5325, DOI 10.1016/j.biomaterials.2010.03.037	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202857	10.1371/journal.pone.0202857	http://dx.doi.org/10.1371/journal.pone.0202857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142209	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500041
J	Wysocki, MA; Tseng, ZJ				Wysocki, M. Aleksander; Tseng, Z. Jack			Allometry predicts trabecular bone structural properties in the carnivoran jaw joint	PLOS ONE			English	Article							R PACKAGE	Because overall cranial morphology-biomechanics linkage in carnivorans is significantly influenced by both feeding and non-feeding ecological variables, whole-skull mechanical performance measures may be less sensitive to feeding ecology than regional characteristics within the skull. The temporomandibular joint could be one regional characteristic that is highly sensitive to feeding ecology considering that this joint is used in prey capture, food processing, and experiences compressive loading during mastication. Through 3D model construction, 3D printing, and compression tests, morphological and mechanical performance measures were determined for the temporomandibular joint trabecular bone structure of 40 species representative of the phylogenetic and ecology diversity of Carnivora. Remarkably, the results indicate that relative fill volume, relative structural complexity, elastic modulus, and relative maximum compressive strength of trabecular bone structure are not significantly related to phylogeny or ecology. The results reveal that morphological and mechanical performance attributes of trabecular bone structure are primarily influenced by body size, and that positive centroid size allometry and positive body mass allometry are present for structural complexity. The lack of feeding ecological signal in dorso-ventral compressive loading of temporomandibular joint models indicates that carnivoran temporomandibular joint trabecular structures may not undergo significant differential remodeling as an evolutionary response to different mechanically demanding feeding tasks.	[Wysocki, M. Aleksander; Tseng, Z. Jack] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pathol & Anat Sci, Grad Program Computat Cell Biol Anat & Pathol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wysocki, MA (corresponding author), Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Pathol & Anat Sci, Grad Program Computat Cell Biol Anat & Pathol, Buffalo, NY 14260 USA.	research.wysocki@gmail.com			National Science Foundation [DEB-1257572]	National Science Foundation(National Science Foundation (NSF))	This project is funded by National Science Foundation grant DEB-1257572 to Z.J.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alexander R., 1983, ANIMAL MECH; [Anonymous], 2018, MESQUITE MODULAR SYS; [Anonymous], 2018, 3D SYST VISIJET M2R; Askeland D. R., 2013, SCI ENG MAT; Beaulieu J, 2014, OUWIE ANAL EVOLUTION, P1; Boughner JC, 2017, J EXP ZOOL PART B, V328, P321, DOI 10.1002/jez.b.22734; Diaz-Uriarte R, 2005, PHYLOGR FUNCTIONS PH; FAY F H, 1985, Mammalian Species, P1, DOI 10.2307/3503810; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey KB, 2005, J BIOMECH, V38, P2143, DOI 10.1016/j.jbiomech.2005.06.007; Herring SW, 2001, CELLS TISSUES ORGANS, V169, P193, DOI 10.1159/000047882; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Orme D., 2013, CAPER PACKAGE COMP A, V5, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pasitschniak- Arts M, 1995, MAMMALIAN SPECIES, P1; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Ravosa MJ, 2007, J EXP BIOL, V210, P628, DOI 10.1242/jeb.02683; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ryan TM, 2010, AM J PHYS ANTHROPOL, V141, P583, DOI 10.1002/ajpa.21178; Schlager S, 2017, MORPHO RVCG SHAPE AN, P217; Team RC, 2014, R LANG ENV STAT COMP; Tseng ZJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao5441; van Ruijven LJ, 2007, J BIOMECH, V40, P1211, DOI 10.1016/j.jbiomech.2006.06.004	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202824	10.1371/journal.pone.0202824	http://dx.doi.org/10.1371/journal.pone.0202824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142221	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500038
J	Abel, S; Cuzin, L; Da Cunha, S; Bolivard, JM; Fagour, L; Miossec, C; Pircher, M; Thioune, M; Cesaire, R; Cabie, A				Abel, Sylvie; Cuzin, Lise; Da Cunha, Severine; Bolivard, Jean-Marie; Fagour, Laurence; Miossec, Charline; Pircher, Mathilde; Thioune, Mareme; Cesaire, Raymond; Cabie, Andre			Reaching the WHO target of testing persons in jails in prisons will need diverse efforts and resources	PLOS ONE			English	Article							INCARCERATED MEN; HIV; STIGMA; WOMEN	Background The Caribbean is the second most affected region in the world by human immunodeficiency virus (HIV), and HIV prevalence is significantly higher among persons in jails and prisons than in the free population. The aim of our study was to assess the screening rates of HIV, hepatitis B and C, syphilis and human T cell leukaemia virus type 1 among newly-arrived persons in 2014, at Ducos facility in Martinique and the testing process performance. Methods This is an observational monocentric study conducted within the prison's health unit. The study population consisted of all individuals incarcerated between 01/01/14 and 31/12/14. At the initial medical visit, HIV and STI testing were proposed to every newcomer. The rate of acceptance was calculated, as well as the screening process performance. Results In 2014 778 new persons were incarcerated, among those, 461 (59.3%) were tested. The main reasons for missing the testing opportunity were due to organization of the judiciary system (persons on electronic monitoring or day parole, transferred or quickly released before completion of the process) or to individual refusal. Finally, 75 persons did not get their results (all of them negative), 41 of them due to the medical staff work overload. Conclusions HIV and STI testing rates among newcomers at Ducos have notable room for improvement. The future availability of combined (HIV, HBV, HCV and syphilis) rapid tests may be very useful in case of short term incarceration, if their cost is not prohibitive. Reaching higher levels of testing will also require more resources.	[Abel, Sylvie; Da Cunha, Severine; Bolivard, Jean-Marie; Pircher, Mathilde; Thioune, Mareme] Martinique Univ Hosp, Prison Med Unit, Fort De France, Martinique, France; [Abel, Sylvie; Cuzin, Lise; Pircher, Mathilde; Thioune, Mareme; Cabie, Andre] Martinique Univ Hosp, Infect & Trop Dis Unit, Fort De France, Martinique, France; [Cuzin, Lise] INSERM, UMR 1027, Toulouse, France; [Fagour, Laurence; Cesaire, Raymond] Martinique Univ Hosp, Virol Lab, Fort De France, Martinique, France; [Miossec, Charline] Martinique Univ Hosp, Parasitol Lab, Fort De France, Martinique, France; [Cesaire, Raymond; Cabie, Andre] Antilles Univ, EA4537, Fort De France, Martinique, France; [Cabie, Andre] Martinique Univ Hosp, INSERM, CIC1424, Fort De France, Martinique, France	CHU Martinique; CHU Martinique; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU Martinique; CHU Martinique; CHU Martinique; Institut National de la Sante et de la Recherche Medicale (Inserm)	Cuzin, L (corresponding author), Martinique Univ Hosp, Infect & Trop Dis Unit, Fort De France, Martinique, France.; Cuzin, L (corresponding author), INSERM, UMR 1027, Toulouse, France.	lise.cuzin@chu-martinique.fr	Cuzin, Lise/AAF-8812-2020	Cuzin, Lise/0000-0002-6345-497X; Cabie, Andre/0000-0003-0117-3061; ABEL, Sylvie/0000-0002-3351-0547				Andrinopoulos K, 2010, INT J STD AIDS, V21, P114, DOI 10.1258/ijsa.2009.008416; Andrinopoulos K, 2010, AIDS CARE, V22, P339, DOI 10.1080/09540120903193633; Beckwith C, 2014, AIDS PATIENT CARE ST, V28, P183, DOI 10.1089/apc.2013.0357; Cazein F, 2016, B EPIDEMIOL HEBD, V41-42, P745; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Institute for Criminal Policy Research, WORLD PRIS BRIEF DAT; MacGowan R, 2009, SEX TRANSM DIS, V36, pS9, DOI 10.1097/OLQ.0b013e318148b6b1; Mansuy JM, 1999, AM J TROP MED HYG, V61, P598, DOI 10.4269/ajtmh.1999.61.598; Ministere de la Justice Ministere des affaires sociales et de la Sante A, 2012, NON TRADITIONAL REF; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Muessig KE, 2016, AIDS EDUC PREV, V28, P103, DOI 10.1521/aeap.2016.28.2.103; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Rumble C, 2015, EUR J PUBLIC HEALTH, V25, P1078, DOI 10.1093/eurpub/ckv133; Semaille C, 2013, EURO SURVEILL, V18; Simonsen KA, 2015, J PRIM PREV, V36, P427, DOI 10.1007/s10935-015-0408-1; World Health Organization, AIDS IN NUMB 2016	16	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202985	10.1371/journal.pone.0202985	http://dx.doi.org/10.1371/journal.pone.0202985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161176	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900061
J	Duranti, S; Vivo, V; Zini, I; Milani, C; Mangifesta, M; Anzalone, R; Mancabelli, L; Viappiani, A; Cantoni, AM; Barocelli, E; van Sinderen, D; Bertoni, S; Turroni, F				Duranti, Sabrina; Vivo, Valentina; Zini, Irene; Milani, Christian; Mangifesta, Marta; Anzalone, Rosaria; Mancabelli, Leonardo; Viappiani, Alice; Cantoni, Anna Maria; Barocelli, Elisabetta; van Sinderen, Douwe; Bertoni, Simona; Turroni, Francesca			Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusion injury	PLOS ONE			English	Article							REPERFUSION INJURY; GUT; INFLAMMATION; ISCHEMIA; IDENTIFICATION; PROBIOTICS; MICROBIOTA; BACTERIA; ASSAY; PCR	Mesenteric ischemia/reperfusion is a clinical emergency with high morbidity and mortality due to the transient reduction of blood supply to the bowel. In recent years, the critical contribution of gut microbiome to human health and proper gastrointestinal functions has gradually emerged. In the current study, we investigated the protective effects of five days supplementation with Bifidobacterium bifidum PRL2010 in a murine model of gut ischemia/reperfusion. Our findings indicate that animals pretreated with B. bifidum PRL2010 showed lower neutrophil recruitment in the lungs, remarkably reduced bacterial translocation and decreased transcription levels of TNFalpha and IL-10 both in liver and kidneys, at the same time increasing those of IL-12 in kidneys. Inhibiting the adhesion of pathogenic bacteria and boosting host innate immunity responses are among the possible protective mechanisms enacted by the probiotic. These results demonstrate that short-period treatment with B. bifidum PRL2010 is a potential strategy to dampen remote organ injury due to mesenteric ischemia/reperfusion.	[Duranti, Sabrina; Milani, Christian; Anzalone, Rosaria; Mancabelli, Leonardo; Viappiani, Alice; Barocelli, Elisabetta; Turroni, Francesca] Univ Parma, Dept Chem Sci Life Sci & Environm Sustainabil, Lab Probiogen, Parma, Italy; [Vivo, Valentina; Zini, Irene; Bertoni, Simona] Univ Parma, Food & Drug Dept, Parma, Italy; [Mangifesta, Marta] GenProbio Srl, Parma, Italy; [Cantoni, Anna Maria] Univ Parma, Dept Vet Sci, Parma, Italy; [van Sinderen, Douwe] Natl Univ Ireland, APC Microbiome Inst, Cork, Ireland; [van Sinderen, Douwe] Natl Univ Ireland, Sch Microbiol, Biosci Inst, Cork, Ireland; [Turroni, Francesca] Univ Parma, Microbiome Res Hub, Parma, Italy	University of Parma; University of Parma; University of Parma; University College Cork; University College Cork; University of Parma	Bertoni, S (corresponding author), Univ Parma, Food & Drug Dept, Parma, Italy.	simona.bertoni@uni.it	Bertoni, Simona/AAJ-8961-2020; mangifesta, marta/AAW-1521-2020; Mancabelli, Leonardo/AAV-5147-2021; Turroni, Francesca/K-9660-2016; Milani, Christian/ABA-8160-2020; Van Sinderen, Douwe/A-6778-2015; Duranti, Sabrina/AAI-7916-2020	mangifesta, marta/0000-0002-0933-1071; Mancabelli, Leonardo/0000-0002-1744-2214; Turroni, Francesca/0000-0001-5363-0231; Van Sinderen, Douwe/0000-0003-1823-7957; Duranti, Sabrina/0000-0002-7724-5669	GenProbio srl; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [SFI/12/RC/2273]	GenProbio srl; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland)	We thank GenProbio srl for financial support of the Laboratory of Probiogenomics. The funder provided support in the form of salaries for L.M., M.M. and A.V. and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DvS is a member of The APC Microbiome Institute funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (Grant number SFI/12/RC/2273). Part of this research was conducted using the High Performance Computing (HPC) facility of the University of Parma.	Aviello G, 2017, BRIT J PHARMACOL, V174, P1704, DOI 10.1111/bph.13428; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Batt RM, 1996, J SMALL ANIM PRACT, V37, P261, DOI 10.1111/j.1748-5827.1996.tb02376.x; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bertoni S, 2018, DRUG DISCOV TODAY, V23, P1416, DOI 10.1016/j.drudis.2018.05.034; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Carver TW, 2016, CRIT CARE CLIN, V32, P155, DOI 10.1016/j.ccc.2015.11.001; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Duranti S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw191; Fedorak RN, 2015, CLIN GASTROENTEROL H, V13, P928, DOI 10.1016/j.cgh.2014.10.031; Guarner F, 2012, J CLIN GASTROENTEROL, V46, P468, DOI 10.1097/MCG.0b013e3182549092; Gueimonde M, 2004, APPL ENVIRON MICROB, V70, P4165, DOI 10.1128/AEM.70.7.4165-4169.2004; Hollister EB, 2014, GASTROENTEROLOGY, V146, P1449, DOI 10.1053/j.gastro.2014.01.052; Isolauri E, 2002, GUT, V50, P54, DOI 10.1136/gut.50.suppl_3.iii54; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Milani C, 2017, ISME J, V11, P2834, DOI 10.1038/ismej.2017.138; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Moore-Olufemi SD, 2005, SHOCK, V23, P258, DOI 10.1097/01.shk.0000155195.17687.00; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pires Ana L.G., 2003, J. Pediatr. (Rio J.), V79, P329, DOI 10.1590/S0021-75572003000400011; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Serafini F, 2013, ANAEROBE, V21, P9, DOI 10.1016/j.anaerobe.2013.03.003; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Turroni F, 2016, ISME J, V10, P1656, DOI 10.1038/ismej.2015.236; Turroni F, 2014, APPL ENVIRON MICROB, V80, P730, DOI 10.1128/AEM.03313-13; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Turroni F, 2011, APPL ENVIRON MICROB, V77, P8578, DOI 10.1128/AEM.06352-11; Wang HG, 2013, BRIT J NUTR, V109, P1990, DOI 10.1017/S0007114512004308	33	13	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202670	10.1371/journal.pone.0202670	http://dx.doi.org/10.1371/journal.pone.0202670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161157	Green Submitted, Green Published, gold			2022-12-27	WOS:000443388900037
J	Dzhonova, D; Olariu, R; Leckenby, J; Dhayani, A; Vemula, PK; Prost, JC; Banz, Y; Taddeo, A; Rieben, R				Dzhonova, Dzhuliya; Olariu, Radu; Leckenby, Jonathan; Dhayani, Ashish; Vemula, Praveen Kumar; Prost, Jean-Christophe; Banz, Yara; Taddeo, Adriano; Rieben, Robert			Local release of tacrolimus from hydrogel-based drug delivery system is controlled by inflammatory enzymes in vivo and can be monitored non-invasively using in vivo imaging	PLOS ONE			English	Article							REJECTION	Background Local drug delivery systems that adjust the release of immunosuppressive drug in response to the nature and intensity of inflammation represent a promising approach to reduce systemic immunosuppression and its side effects in allotransplantation. Here we aimed to demonstrate that release of tacrolimus from triglycerol monostearate hydrogel is inflammationdependent in vivo. We further report that by loading the hydrogel with a near-infrared dye, it is possible to monitor drug release non-invasively in an in vivo model of vascularized composite allotransplantation. Materials and methods Inflammation was induced by local challenge with lipopolysaccharides in naive rats 7 days after injection of tacrolimus-loaded hydrogel in the hind limb. Tacrolimus levels in blood and tissues were measured at selected time points. A near-infrared dye was encapsulated in the hydrogel together with tacrolimus in order to monitor hydrogel deposits and drug release in vitro and in vivo in a model of vascularized composite allotransplantation. Results Injection of lipopolysaccharides led to increased blood and skin tacrolimus levels (p = 0.0076, day 7 vs. day 12 in blood, and p = 0.0007 in treated limbs, 48 h after injection compared to controls). Moreover, lipopolysaccharides-injected animals had higher tacrolimus levels in treated limbs compared to contralateral limbs (p = 0.0003 for skin and p = 0.0053 for muscle). Imaging of hydrogel deposits and tacrolimus release was achieved by encapsu-lating near-infrared dye in the hydrogel for 160 days. The correlation of tacrolimus and near infrared dye release from hydrogel was R-2 = 0.6297 and R-2 = 0.5619 in blood and grafts of transplanted animals respectively and R-2 = 0.6066 in vitro. Conclusions Here we demonstrate the inflammation-responsiveness of a tacrolimus-loaded hydrogel in vivo. Moreover, we show that encapsulating a near-infrared dye in the hydrogel provides a reliable correlation of tacrolimus and dye release from the hydrogel, and an accessible noninvasive method for monitoring drug release from hydrogel deposits.	[Dzhonova, Dzhuliya; Taddeo, Adriano; Rieben, Robert] Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland; [Dzhonova, Dzhuliya] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Olariu, Radu; Leckenby, Jonathan; Taddeo, Adriano] Bern Univ Hosp, Inselspital, Dept Plast & Hand Surg, Bern, Switzerland; [Dhayani, Ashish; Vemula, Praveen Kumar] Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India; [Dhayani, Ashish] SASTRA Univ, Sch Chem & Biotechnol, Thanjavur, Tamil Nadu, India; [Prost, Jean-Christophe] Univ Hosp, Univ Inst Clin Chem, Ctr Lab Med, Bern, Switzerland; [Banz, Yara] Univ Bern, Inst Pathol, Bern, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Shanmugha Arts, Science, Technology & Research Academy (SASTRA); University of Bern; University Hospital of Bern; University of Bern	Taddeo, A; Rieben, R (corresponding author), Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland.; Taddeo, A (corresponding author), Bern Univ Hosp, Inselspital, Dept Plast & Hand Surg, Bern, Switzerland.	adriano.taddeo@dbmr.unibe.ch; robert.rieben@dbmr.unibe.ch	Taddeo, Adriano/AAW-3861-2021; Rieben, Robert/D-7044-2017	Taddeo, Adriano/0000-0003-3281-1548; Bovet, Cedric/0000-0002-1600-3818; Dzhonova, Dzhuliya/0000-0001-5196-5417; Rieben, Robert/0000-0003-4179-8891; Prost, Jean-Christophe/0000-0002-8820-706X; Dhayani, Ashish/0000-0002-5488-8952; Olariu, Radu/0000-0002-0204-4432	Indo-Swiss Joint Research Program of the Swiss National Science Foundation (SNF) [156773]; Department of Science and Technology, Govt. of India [INT/SWISS/SNSFP-51/2015]; University Grant Commission	Indo-Swiss Joint Research Program of the Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); University Grant Commission(University Grants Commission, India)	This work was supported by Indo-Swiss Joint Research Program of the Swiss National Science Foundation (SNF, grant 156773) and the Department of Science and Technology, Govt. of India (grant INT/SWISS/SNSFP-51/2015) to R.R. and P.V. respectively. A.D. thanks the University Grant Commission for the senior research fellowship.	Asai D, 2012, BIOMATERIALS, V33, P5451, DOI 10.1016/j.biomaterials.2012.03.083; Bloch S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2070148; Capron A, 2012, TRANSPL INT, V25, P41, DOI 10.1111/j.1432-2277.2011.01365.x; Dzhonova DV, 2018, TRANSPLANTATION, P1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gajanayake T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008778; Gharb BB, 2013, TRANSPLANTATION, V95, P1197, DOI 10.1097/TP.0b013e31828bca61; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Mieog JSD, 2011, ANN SURG ONCOL, V18, P2483, DOI 10.1245/s10434-011-1566-x; Olariu R, 2017, J SURG RES, V218, P49, DOI 10.1016/j.jss.2017.05.046; Petrou P, 2018, CULT HEALTH SEX, V20, P640, DOI 10.1080/13691058.2017.1368710; Petruzzo P, 2017, CURRENT TRANSPLANTAT, P1; Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020; Solari MG, 2009, PLAST RECONSTR SURG, V123, p17S, DOI 10.1097/PRS.0b013e318191bcbd; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Taddeo A, 2018, CURRENT OPINION ORGA, V1; Unadkat JV, 2017, PLAST RECONSTR SURG, V139, p403E, DOI 10.1097/PRS.0000000000002951; Wang T, 2010, AM J TRANSPLANT, V10, P1524, DOI 10.1111/j.1600-6143.2010.03066.x	18	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203409	10.1371/journal.pone.0203409	http://dx.doi.org/10.1371/journal.pone.0203409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161258	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900123
J	Hu, YR; Yang, XB; Zhang, L; Wu, XR; Liu, AY; Boscarino, JA; Kirchner, HL; Casale, AS; Zhang, XP				Hu, Yirui; Yang, Xinbei; Zhang, Li; Wu, Xianren; Liu, Anastasia Yian; Boscarino, Joseph A.; Kirchner, H. Lester; Casale, Alfred S.; Zhang, Xiaopeng			Perioperative diltiazem or nitroglycerin in on-pump coronary artery bypass: A systematic review and network meta-analysis	PLOS ONE			English	Review							INTERNAL MAMMARY ARTERY; MYOCARDIAL-ISCHEMIA; INTRAVENOUS NITROGLYCERIN; GRAFT-SURGERY; CALCIUM-ANTAGONISTS; CARDIAC-SURGERY; NITRIC-OXIDE; INFUSION; FLOW; VASODILATORS	Background Arterial graft spasm is a severe complication after coronary artery bypass graft (CABG). Among numerous potential antispasmodic agents, systemic application of diltiazem and nitroglycerin had been investigated most frequently over the past three decades. However, it remains inconclusive if either or both agents could improve patient outcomes by preventing graft spasm when applied perioperatively, and, if so, which one would be a better choice. The current systematic review and network meta-analysis aims to summarize the data from all available randomized clinical trials of perioperative continuous intravenous infusion of diltiazem and/or nitroglycerin in patients undergoing on-pump CABG in order to define and compare their roles in graft spasm prevention and their impacts on perioperative outcomes. Methods We searched Ovid Medline, PubMed, CINAHL, Google Scholar and Cochrane Center for randomized controlled trials that reported outcome effects of perioperative continuous intravenous infusion of diltiazem and/or nitroglycerin in patients undergoing elective on-pump CABG. Conventional meta-analyses were conducted to evaluate the pairwise comparisons (diltiazem vs. placebo; nitroglycerin vs. placebo; diltiazem vs. nitroglycerin) on perioperative outcomes. Network meta-analyses were implemented to compare the three regimens through direct and indirect comparison. Results Twenty-seven studies involving 1,660 patients were included. Pairwise and network meta analyses found no significant difference in mortality among the groups. There are four studies that reported blood flow measurements of internal mammary artery grafts intraoperatively after dissecting or immediately after distal anastomosis while patients were on continuous intravenous infusion of diltiazem and nitroglycerin. Although insufficient for data synthesis, the measured results from all four studies suggest that both diltiazem and nitroglycerin significantly increased blood flow of arterial grafts compared to placebo. For other perioperative outcomes, compared to diltiazem, patients that received nitroglycerin had higher odds of postoperative atrial fibrillation (OR = 2.67, 95% CI: 1.15 to 6.24) and higher peak serum cardiac enzymes. Patients that received placebo had higher odds of atrial fibrillation (OR = 3.00, 95% CI: 1.18 to 7.63) and lower odds of requiring inotrope support (OR = 0.19, 95% CI: 0.04 to 0.73) compared to diltiazem. Data from the network meta-analysis indicated that diltiazem had significantly lower odds of postoperative atrial fibrillation compared to nitroglycerin (OR = 0.39, 95% CI: 0.18 to 0.85). In fact, the rank from highest to lowest rates of postoperative atrial fibrillation was placebo>nitroglycerin>diltiazem. The rank from highest to lowest odds of requiring inotropic support is nitroglycerin>diltiazem>placebo. However, placebo had significantly higher odds of postoperative myocardial infarction than diltiazem (OR = 4.51, 95% CI: 1.34 to 15.25). The rank from highest to lowest odds of postoperative myocardial infarction, transient cardiac ischemic event and atrial fibrillation is placebo>nitroglycerin>diltiazem. Conclusion Compared to nitroglycerin and placebo, perioperative continuous intravenous infusion of diltiazem had stronger protective effects against postoperative ischemic cardiac injuries and atrial fibrillation although patients may need more inotropic support. The increased blood flow from diltiazem use in arterial grafts may potentially contribute to the drug's outcome benefits.	[Hu, Yirui; Yang, Xinbei; Kirchner, H. Lester] Geisinger Med Ctr, Biomed & Translat Informat, Danville, PA 17822 USA; [Zhang, Li; Wu, Xianren; Zhang, Xiaopeng] Geisinger Med Ctr, Div Anesthesiol, Danville, PA 17822 USA; [Liu, Anastasia Yian] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Boscarino, Joseph A.] Geisinger Med Ctr, Dept Epidemiol & Hlth Serv Res, Danville, PA 17822 USA; [Casale, Alfred S.] Geisinger Wyoming Valley Med Ctr, Geisinger Heart Inst, Wilkes Barre, PA USA	Geisinger Medical Center; Geisinger Medical Center; University of Toronto; Geisinger Medical Center	Zhang, XP (corresponding author), Geisinger Med Ctr, Div Anesthesiol, Danville, PA 17822 USA.	xzhang1@geisinger.edu	Zhang, Xiaopeng/GSN-8426-2022	Zhang, Xiaopeng/0000-0003-0854-4742				Abramov D, 2000, ANN THORAC SURG, V70, P84, DOI 10.1016/S0003-4975(00)01249-2; Ali IS, 2004, AM HEART J, V148, P727, DOI 10.1016/j.ahj.2004.04.003; AMANO J, 1995, CHEST, V107, P1260, DOI 10.1378/chest.107.5.1260; ANDREWS TC, 1991, CIRCULATION, V84, P236; Apostolidou IA, 1999, ANN THORAC SURG, V67, P417, DOI 10.1016/S0003-4975(98)01039-X; Arnaudov D, 1996, ANN THORAC SURG, V62, P1816, DOI 10.1016/S0003-4975(96)00741-2; Asrress KN, 2017, CIRCULATION, V136, P24, DOI 10.1161/CIRCULATIONAHA.116.025856; BabinEball J, 1996, EUR J CARDIO-THORAC, V10, P412, DOI 10.1016/S1010-7940(96)80107-2; Battaloglu B, 2007, HEART SURG FORUM, V10, pE136, DOI 10.1532/HSF98.20061166; Chanda J, 2001, ANN THORAC SURG, V72, P476, DOI 10.1016/S0003-4975(01)02799-0; Chen X, 2000, Zhonghua Wai Ke Za Zhi, V38, P669; Chung JH, 2013, KOREAN J UROL, V54, P289, DOI 10.4111/kju.2013.54.5.289; Colson P, 1992, J Cardiothorac Vasc Anesth, V6, P424, DOI 10.1016/1053-0770(92)90007-T; Cornwell LD, 2015, JAMA SURG, V150, P308, DOI 10.1001/jamasurg.2014.1700; Ding YX, 2000, J PHARMACOL EXP THER, V292, P606; DONEGANI E, 1986, THORAC CARDIOV SURG, V34, P168, DOI 10.1055/s-2007-1020402; Ege T, 2010, J INT MED RES, V38, P1759, DOI 10.1177/147323001003800521; Erdem O, 2015, REV BRAS CIR CARDIOV, V30, P459, DOI 10.5935/1678-9741.20150045; Erdil N, 2010, TEX HEART I J, V37, P301; Ertuna E, 2016, FUND CLIN PHARMACOL, V30, P226, DOI 10.1111/fcp.12185; Fansa I, 2003, MED SCI MONITOR, V9, pI30; GALLAGHER JD, 1986, ANESTHESIOLOGY, V64, P785, DOI 10.1097/00000542-198606000-00018; Garaliene V, 2014, J Physiol Pharmacol, V65, P35; HAAK T, 1995, J CARDIOVASC PHARM, V26, pS494; HANNES W, 1995, EUR HEART J, V16, P87, DOI 10.1093/eurheartj/16.1.87; HANNES W, 1993, EUR J CARDIO-THORAC, V7, P239, DOI 10.1016/1010-7940(93)90211-S; He GW, 1996, J CARDIOVASC PHARM, V28, P208, DOI 10.1097/00005344-199608000-00005; He GW, 1997, BRIT J CLIN PHARMACO, V44, P353, DOI 10.1046/j.1365-2125.1997.00640.x; HE GW, 1994, J THORAC CARDIOV SUR, V107, P1440, DOI 10.1016/S0022-5223(94)70420-1; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Hirnle T, 2000, KARDIOL POL, V52, P277; Hou HT, 2016, ANN THORAC SURG, V101, P1789, DOI 10.1016/j.athoracsur.2015.10.029; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Ignarro LJ, 2002, P NATL ACAD SCI USA, V99, P7816, DOI 10.1073/pnas.132271799; Keilich M, 1997, INT J ANGIOL, V6, P8; KNOTHE C, 1993, HERZ, V18, P379; Lassnigg A, 2001, WIEN KLIN WOCHENSCHR, V113, P439; Le J, 2015, J CARDIOTHORAC SURG, V10, DOI 10.1186/s13019-014-0203-8; LELL W, 1993, J CARDIAC SURG, V8, P228; LISCHKE V, 1995, ANAESTHESIST, V44, P92, DOI 10.1007/s001010050136; Liu JJ, 1997, J THORAC CARDIOV SUR, V113, P108, DOI 10.1016/S0022-5223(97)70405-7; Locker C, 2002, ANN THORAC SURG, V74, pS1368; Malhotra R, 1997, EUR J CARDIO-THORAC, V12, P420, DOI 10.1016/S1010-7940(97)00140-1; Nakamura Y, 1999, AM HEART J, V138, P577, DOI 10.1016/S0002-8703(99)70163-8; NOMURA F, 1991, J CARDIOVASC SURG, V32, P26; ROUBOS N, 1995, CIRCULATION, V92, P31, DOI 10.1161/01.CIR.92.9.31; SARABU MR, 1987, ANN THORAC SURG, V44, P199, DOI 10.1016/S0003-4975(10)62041-3; SEITELBERGER R, 1994, J THORAC CARDIOV SUR, V107, P811; Serebruany VL, 1998, PHARMACOL RES, V38, P165, DOI 10.1006/phrs.1998.0349; Shapira OM, 2000, ANN THORAC SURG, V70, P883, DOI 10.1016/S0003-4975(00)01628-3; SIEVERT H, 1989, EUR HEART J, V10, P134, DOI 10.1093/eurheartj/10.suppl_F.134; Steinhorn BS, 2015, NEW ENGL J MED, V373, P277, DOI 10.1056/NEJMsr1503311; Szabo C, 1997, SHOCK, V7, P304, DOI 10.1097/00024382-199704000-00011; Tabel Y, 2004, EUR J CARDIO-THORAC, V25, P553, DOI 10.1016/j.ejcts.2004.01.004; Tatoulis James, 2013, Multimed Man Cardiothorac Surg, V2013, pmmt017, DOI 10.1093/mmcts/mmt017; THOMSON IR, 1984, ANESTHESIOLOGY, V61, P385, DOI 10.1097/00000542-198410000-00005; Trinquart L, 2016, ANN INTERN MED, V164, P666, DOI 10.7326/M15-2521; Wenzel RR, 1996, CIRCULATION, V94, P316, DOI 10.1161/01.CIR.94.3.316; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; Wijeysundera DN, 2003, J AM COLL CARDIOL, V41, P1496, DOI 10.1016/S0735-1097(03)00191-8; WITHINGTON PS, 1988, EUR HEART J, V9, P187, DOI 10.1093/eurheartj/9.suppl_A.187; Yaliniz H, 2004, HEART SURG FORUM, V7, pE434, DOI 10.1532/HSF98.20041074; Yavuz S, 2002, MED SCI MONITOR, V8, pPI45; Zabeeda D, 2001, ANN THORAC SURG, V71, P138, DOI 10.1016/S0003-4975(00)02227-X; Zanardo G, 1993, J Cardiothorac Vasc Anesth, V7, P711, DOI 10.1016/1053-0770(93)90057-R; Zhang Peng, 2003, Zhonghua Yi Xue Za Zhi, V83, P1387; Zvara DA, 2000, J CARDIOTHOR VASC AN, V14, P571, DOI 10.1053/jcan.2000.9445	68	3	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203315	10.1371/journal.pone.0203315	http://dx.doi.org/10.1371/journal.pone.0203315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161246	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900108
J	O'Sullivan, NP; Lelijveld, N; Rutishauser-Perera, A; Kerac, M; James, P				O'Sullivan, Natasha Phillipa; Lelijveld, Natasha; Rutishauser-Perera, Alexandra; Kerac, Marko; James, Philip			Follow-up between 6 and 24 months after discharge from treatment for severe acute malnutrition in children aged 6-59 months: A systematic review	PLOS ONE			English	Review							NUTRITION; MORTALITY; GROWTH; UNDERNUTRITION; INTERVENTIONS; KWASHIORKOR; MANAGEMENT; EFFICACY; TRIAL; DHAKA	Background Severe acute malnutrition (SAM) is a major global health problem affecting some 16.9 million children under five. Little is known about what happens to children 6-24 months post discharge as this window often falls through the gap between studies on SFPs and those focusing on longer-term effects. Methods A protocol was registered on PROSPERO (PROSPERO 2017:CRD42017065650). Embase, Global Health and MEDLINE In-Process and Non-Indexed Citations were systematically searched with terms related to SAM, nutritional intervention and follow-up between June and August 2017. Studies were selected if they included children who experienced an episode of SAM, received a therapeutic feeding intervention, were discharged as cured and presented any outcome from follow-up between 6-24 months later. Results 3,691 articles were retrieved from the search, 55 full-texts were screened and seven met the inclusion criteria. Loss-to-follow-up, mortality, relapse, morbidity and anthropometry were outcomes reported. Between 0.0% and 45.1% of cohorts were lost-to-follow-up. Of those discharged as nutritionally cured, mortality ranged from 0.06% to 10.4% at an average of 12 months post-discharge. Relapse was inconsistently defined, measured, and reported, ranging from 0% to 6.3%. Two studies reported improved weight-for-height z-scores, whilst three studies that reported height-for-age z-scores found either limited or no improvement. Conclusions Overall, there is a scarcity of studies that follow-up children 6-24 months post-discharge from SAM treatment. Limited data that exists suggest that children may exhibit sustained vulnerability even after achieving nutritional cure, including heightened mortality and morbidity risk and persistent stunting. Prospective cohort studies assessing a wider range of outcomes in children post-SAM treatment are a priority, as are intervention studies exploring how to improve post-SAM outcomes and identify high-risk children.	[O'Sullivan, Natasha Phillipa; Lelijveld, Natasha; Kerac, Marko] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [O'Sullivan, Natasha Phillipa] Brighton & Sussex Med Sch, Falmer, E Sussex, England; [Lelijveld, Natasha; Rutishauser-Perera, Alexandra] Act Hunger, London, England; [Kerac, Marko] London Sch Hyg & Trop Med, Ctr Maternal Adolescent Reprod & Child Hlth MARCH, London, England; [James, Philip] London Sch Hyg & Trop Med, Med Res Council MRC Unit Gambia, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Brighton; University of Sussex; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	O'Sullivan, NP (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London, England.; O'Sullivan, NP (corresponding author), Brighton & Sussex Med Sch, Falmer, E Sussex, England.	bsms3556@uni.bsms.ac.uk	Kerac, Marko/G-1777-2010; James, Philip/AAG-4618-2020; Kerac, Marko/GQR-1136-2022	Kerac, Marko/0000-0002-3745-7317; James, Philip/0000-0001-5448-8193; O'Sullivan, Natasha/0000-0002-4429-2901; Lelijveld, Natasha/0000-0002-8452-0198				Annan RA., 2014, CMAM FORUM TECHNICAL; Aprameya H. S., 2015, International Journal of Health and Allied Sciences, V4, P148; Ashraf H, 2012, J TROP PEDIATRICS, V58, P253, DOI 10.1093/tropej/fmr083; Bahwere P., 2012, Journal of Public Health and Epidemiology, V4, P215; Bahwere Paluku, 2017, BMC Res Notes, V10, P570, DOI 10.1186/s13104-017-2909-x; Bahwere P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-106; Bailey J., 2016, Field Exchange - Emergency Nutrition Network ENN, P44; Banapurmath C R, 1999, Indian Pediatr, V36, P139; BARTEL PR, 1979, AM J CLIN NUTR, V32, P753, DOI 10.1093/ajcn/32.4.753; Bhandari N, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000144; Bhutta ZA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.67; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brennhofer S, 2017, PUBLIC HEALTH NURS, V34, P401, DOI 10.1111/phn.12273; Briend A., 2016, BMC NUTR, V2, P63, DOI [10.1186/s40795-016-0101-7, DOI 10.1186/S40795-016-0101-7, 10.1186/s40795-016, DOI 10.1186/S40795-016]; Burza S, 2016, EUR J CLIN NUTR, V70, P437, DOI 10.1038/ejcn.2015.140; CARVALHO NM, 1992, REV SAUDE PUBL, V26, P223, DOI 10.1590/S0034-89101992000400003; Collins S, 2006, FOOD NUTR B, V27; Collins S., 2004, COMMUNITY BASED THER; Council of Research & Technical Advice on Acute Malnutrition (CORTASAM), 2017, RES AG AC MALN; Council of Research & Technical Advice on Acute Malnutrition (CORTASAM), 2017, STAT COUNC RES RECHN; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Fergusson P, 2009, ARCH DIS CHILD, V94, P512, DOI 10.1136/adc.2008.142646; Grellety E., 2016, BMC NUTR, V2, P1173, DOI [10.1038/ng.3097, DOI 10.1038/NG.3097, DOI 10.1186/S40795-016-0049-7]; Grellety E, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0848-y; Guerrero Saul, 2013, IS COMMUNITY BASED T, V1; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; HENNART P, 1987, J TROP PEDIATRICS, V33, P10, DOI 10.1093/tropej/33.1.10; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hure A, 2016, AM J EPIDEMIOL, V184, P870, DOI 10.1093/aje/kww131; Idohou-Dossou N, 2003, BRIT J NUTR, V90, P1123, DOI 10.1079/BJN2003990; Keenan JD, 2018, NEW ENGL J MED, V378, P1583, DOI [10.1056/nejmoa1715474, 10.1056/NEJMoa1715474]; Kerac M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096030; Kerac M, 2009, LANCET, V374, P136, DOI 10.1016/S0140-6736(09)60884-9; Khanum S, 1998, AM J CLIN NUTR, V67, P940, DOI 10.1093/ajcn/67.5.940; Khara T, 2014, TECHNICAL BRIEFING P; KHARE RD, 1976, INDIAN J MED RES, V64, P1119; Lelijveld N, 2016, LANCET GLOB HEALTH, V4, pE654, DOI 10.1016/S2214-109X(16)30133-4; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Mann J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6851; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Meghji J, 2016, AM J RESP CRIT CARE, V194, P67, DOI 10.1164/rccm.201509-1807OC; National Institute for Health and Care Excellence, 2012, METH DEV NICE PUBL H; National Institute of Health and Care Excellence, 2017, FALT GROWTH REC MAN; National Statistical Office (NSO) [Malawi] and ICF, 2017, MALAWI DEMOGRAPHIC H; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; Patel D, 2010, INDIAN PEDIATR, V47, P694, DOI 10.1007/s13312-010-0102-6; PECOUL B, 1992, ANN TROP PAEDIATR, V12, P47, DOI 10.1080/02724936.1992.11747546; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Project Sphere, 2018, HUM CHART MIN STAND; Sadler K, 2008, J TROP PEDIATRICS, V54, P364, DOI 10.1093/tropej/fmn029; Seal A, 2007, BMJ-BRIT MED J, V334, P733, DOI 10.1136/bmj.39101.664109.AE; Singhal Atul, 2014, Nestle Nutr Inst Workshop Ser, V78, P123, DOI 10.1159/000354951; Somasse YE, 2016, MATERN CHILD NUTR, V12, P908, DOI 10.1111/mcn.12197; Tadesse E, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12519; United Nations Children's Fund World Health Organization World Bank Group, 2017, LEV TRENDS CHILD MAL; VANROOSMALENWIEBENGA MW, 1987, J TROP PEDIATRICS, V33, P24, DOI 10.1093/tropej/33.1.24; WHO, 2013, GUID UPD MAN SEV AC; World Health Organization , 2007, COMM BAS MAN SEV AC; World Health Organization, 2013, CHILDH STUNT CONT CA; World Health Organization, 2006, WHO CHILD GROWTH STA	61	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202053	10.1371/journal.pone.0202053	http://dx.doi.org/10.1371/journal.pone.0202053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161151	Green Published, Green Accepted, gold			2022-12-27	WOS:000443388900019
J	Abd El Kader, NA; Farghali, HA; Abu-Seida, AM; Salem, NY; Khattab, MS				Abd El Kader, Naglaa A.; Farghali, Haithem A.; Abu-Seida, Ashraf M.; Salem, Noha Y.; Khattab, Marwa S.			Evaluation of chromocystoscopy in the diagnosis of cystitis in female donkeys	PLOS ONE			English	Article							CHROMOENDOSCOPY; MANAGEMENT; ENDOSCOPY; HORSES; TRACT	Early detection of cystitis in equine is essential to improve the prognosis and outcome of therapy. However, the conventional white light endoscopy is not sufficiently accurate for this purpose. Hence, this study evaluated chromoendoscopy as a recent diagnostic tool for cystitis in female donkeys. For this purpose, 5 apparently normal donkeys (control group) and 5 female donkeys with cystitis (diseased group) were used. Physical and rectal examinations, urine analysis, white light cystoscopy, methylene blue-based chromoendoscopy and histopathology were performed in all animals. Turbid urine exhibiting an alkaline pH and a significant (P = .02) increase in the numbers of RBCs and WBCs was observed in the diseased group compared to the control one. In the control group, white light cystoscopy showed a smooth pale pink glistening mucosa with two openings of the ureters and visible submucosal blood vessels. During chromocystoscopy, faint bluish discoloration of the mucosal surface with clearly visible submucosal blood vessels was detectable. These findings were correlated with the histopathological findings of the biopsies collected from the urinary bladder. In the diseased group, white-light cystoscopy showed clearly visible blood vessels, mildly hyperaemic mucosa in focal or diffuse forms and small vesicle formation. Chromocystoscopy revealed dark bluish oedematous and irregular mucosa either in a focal form or a diffuse form (marbled appearance) with deeply stained submucosal blood vessels. Histopathologically, the urothelium was hyperplastic with squamous metaplasia and the lamina propria was infiltrated with few leukocytes and congested blood vessels. Small bluish dots representing the absorbed methylene blue dye were seen in the inflamed areas against the lightly stained mucosa of the bladder. Severe diffuse necrotic cystitis was also seen with bacterial aggregations on the surface. Gram's staining revealed both gram positive bacilli and Gram positive coccobacilli. In conclusion, chromoendoscopy is a helpful tool for early diagnosis of cystitis in female donkeys and enables targeted biopsies, which improves the prognosis and outcome of therapy.	[Abd El Kader, Naglaa A.; Farghali, Haithem A.; Abu-Seida, Ashraf M.] Cairo Univ, Fac Vet Med, Dept Surg Anaesthesiol & Radiol, Giza, Egypt; [Salem, Noha Y.] Cairo Univ, Fac Vet Med, Dept Internal Med & Infect Dis, Giza, Egypt; [Khattab, Marwa S.] Cairo Univ, Fac Vet Med, Dept Pathol, Giza, Egypt; [Abd El Kader, Naglaa A.; Farghali, Haithem A.; Abu-Seida, Ashraf M.; Salem, Noha Y.; Khattab, Marwa S.] Cairo Univ, Fac Vet Med, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Abu-Seida, AM (corresponding author), Cairo Univ, Fac Vet Med, Dept Surg Anaesthesiol & Radiol, Giza, Egypt.; Abu-Seida, AM (corresponding author), Cairo Univ, Fac Vet Med, Giza, Egypt.	ashrafseida@cu.edu.eg	Abu-Seida, A.M./F-7771-2011; Farghali, Haithem/AAH-8288-2021	Abu-Seida, A.M./0000-0001-5466-2016; Salem, Noha/0000-0002-3376-8695; Khattab, Marwa/0000-0002-8068-6094; Ali Mohamed Ahmed Farghali, Haithem/0000-0002-3311-1335				Boeriu AM, 2009, J GASTROINTEST LIVER, V18, P109; Divers TJ, 2006, LARGE ANIMAL INTERNA, P937; Frye MA, 2006, VET CLIN N AM-EQUINE, V22, P497, DOI 10.1016/j.cveq.2006.03.004; Higgens AG, 2006, EQUINE MANUAL, P123; JOHNSON PJ, 1987, J AM VET MED ASSOC, V191, P973; Kida M, 2003, ENDOSCOPY, V35, P590; Kiesslich R, 2001, ENDOSCOPY, V33, P1001, DOI 10.1055/s-2001-18932; Kim C, 2011, OPT LETT, V36, P3599, DOI 10.1364/OL.36.003599; Knottenbelt DC, 2006, THE EQUINE MANUAL; Kumas C, 2014, J EQUINE VET SCI, V34, P329, DOI 10.1016/j.jevs.2013.07.003; Martov A. G., 2015, Urologiya (Moscow), P55; Nessa K, 2014, J ENAM MED COLL, V4, P39; Onmaz AC, 2013, KAFKAS UNIV VET FAK, V19, pA203, DOI 10.9775/kvfd.2012.7656; Pohl J, 2011, GUT, V60, P485, DOI 10.1136/gut.2010.229534; Pohl J, 2010, AM J GASTROENTEROL, V105, P2350, DOI 10.1038/ajg.2010.280; Ratiu Nadia, 2005, Rom J Gastroenterol, V14, P239; Rendle DI, 2008, VET REC, V162, P783, DOI 10.1136/vr.162.24.783; Schott H.C., 2004, EQUINE INTERNAL MED; Schott HC, 1997, URINARY TRACT EQUINE, P187; Sellon DC, 2004, EQUINE INTERNAL MED; Sellors John, 2003, Asian Pac J Cancer Prev, V4, P277; Sprayberry K., 2004, ATLAS EQUINE ENDOSCO, P169; Squinas SC, 2013, CAN VET J, V54, P690; Sullins KE, 1988, COMP CONT EDUC PRACT, V4, P339; Suvarna SK, 2012, BANCROFTS THEORY PRA, P234; Tatsuta M, 1985, GASTROENTEROL ENDOSC, V27, P924; Traub-Dargatz JL, 1987, VET CLIN N AM-EQUINE, V3, P585; Trivedi PJ, 2013, QJM-INT J MED, V106, P117, DOI 10.1093/qjmed/hcs186; YOSHIDA S, 1981, JPN J CLIN ONCOL, V11, P495; YOSHIDA S, 1984, JPN J CLIN ONCOL, V14, P225	30	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202596	10.1371/journal.pone.0202596	http://dx.doi.org/10.1371/journal.pone.0202596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157228	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400064
J	Zhao, M; Yuan, MM; Yuan, L; Huang, LL; Liao, JH; Yu, XL; Su, C; Chen, YH; Yang, YY; Yu, H; Xu, DX				Zhao, Mei; Yuan, Man Man; Yuan, Li; Huang, Li Li; Liao, Jian Hong; Yu, Xiao Ling; Su, Chang; Chen, Yuan Hua; Yang, Yu Ying; Yu, Huan; Xu, De Xiang			Chronic folate deficiency induces glucose and lipid metabolism disorders and subsequent cognitive dysfunction in mice	PLOS ONE			English	Article							HIGH-FAT DIET; HEPATIC INSULIN-RESISTANCE; FED ICR MICE; HOMOCYSTEINE-THIOLACTONE; METHYL DONOR; MODEL; RATS; HYPERHOMOCYSTEINEMIA; DIFFERENTIATION; GLYCOGEN	Previous studies have shown that folate levels were decreased in patients with type 2 diabetes (T2D) and further lowered in T2D patients with cognitive impairment. However, whether folate deficiency could cause T2D and subsequent cognitive dysfunction is still unknown. The present study aimed to explore the effects of chronic folate deficiency (CFD) on glucose and lipid metabolism and cognitive function in mice. Seven-week-old mice were fed with either a CFD or control diet for 25 weeks. Serum folate was significantly reduced, whereas serum total homocysteine was significantly increased in the CFD group. Moreover, CFD induced obesity after a 6-week diet treatment, glucose intolerance and insulin resistance after a 16-week-diet treatment. In addition, CFD reduced the hepatic p-Akt/Akt ratio in response to acute insulin administration. Moreover, CFD increased serum triglyceride levels, upregulated hepatic Acct and Fasn mRNA expression, and downregulated hepatic Cd36 and ApoB mRNA expression. After a 24-week diet treatment, CFD induced anxietyrelated activities and impairment of spatial learning and memory performance. This study demonstrates that folate deficiency could induce obesity, glucose and lipid metabolism disorders and subsequent cognitive dysfunction.	[Zhao, Mei; Yuan, Man Man; Yuan, Li; Huang, Li Li; Liao, Jian Hong; Yu, Xiao Ling; Su, Chang; Yang, Yu Ying; Yu, Huan] Anhui Med Univ, Sch Nursing, Hefei, Anhui, Peoples R China; [Zhao, Mei; Chen, Yuan Hua; Xu, De Xiang] Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Anhui, Peoples R China; [Chen, Yuan Hua] Anhui Med Univ, Dept Histol & Embryol, Hefei, Anhui, Peoples R China; [Xu, De Xiang] Anhui Med Univ, Dept Toxicol, Hefei, Anhui, Peoples R China; [Yuan, Man Man] Anhui Med Univ, Sch Int Educ, Hefei, Anhui, Peoples R China; [Yuan, Li] Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp USTC 1, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhao, M (corresponding author), Anhui Med Univ, Sch Nursing, Hefei, Anhui, Peoples R China.; Zhao, M (corresponding author), Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Anhui, Peoples R China.	zhaomei@ahmu.edu.cn		Zhao, Mei/0000-0003-3530-0233	National Natural Science Foundation of China [81671471, 81630084]; Key University Science Research Project of Anhui Provincial [KJ2016A360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key University Science Research Project of Anhui Provincial	This project was supported by National Natural Science Foundation of China (81671471 and 81630084) and Key University Science Research Project of Anhui Provincial (KJ2016A360).	Akchiche N, 2012, FASEB J, V26, P3980, DOI 10.1096/fj.12-205757; Al-Maskari Masoud Y, 2012, Nutrition, V28, pe23, DOI 10.1016/j.nut.2012.01.005; Araujo JR, 2015, AGEING RES REV, V22, P9, DOI 10.1016/j.arr.2015.04.005; Aydin O, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1020-6; Berglund SK, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2809-3; Bernardo A, 2007, NEUROBIOL AGING, V28, P1195, DOI 10.1016/j.neurobiolaging.2006.05.035; Bharathselvi M, 2016, INDIAN J MED RES, V143, P756, DOI 10.4103/0971-5916.192026; Champier J, 2012, NUTR RES, V32, P124, DOI 10.1016/j.nutres.2011.12.012; Chew TW, 2011, J NUTR, V141, P1475, DOI 10.3945/jn.111.138859; Choi Sun-Il, 2012, Lab Anim Res, V28, P155, DOI 10.5625/lar.2012.28.3.155; Dekel Y, 2009, LAB ANIMAL, V38, P55, DOI 10.1038/laban0209-55; Demakakos P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175827; EVENSON A, 1946, J BACTERIOL, V51, P513, DOI 10.1128/JB.51.4.513-521.1946; Fu L, 2017, PHYSIOL BEHAV, V179, P333, DOI 10.1016/j.physbeh.2017.07.017; Geijselaers SLC, 2015, LANCET DIABETES ENDO, V3, P75, DOI 10.1016/S2213-8587(14)70148-2; Helm S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00161; Hong SM, 2017, BRIT J NUTR, V118, P1078, DOI 10.1017/S0007114517003087; Hrncic D, 2016, CAN J PHYSIOL PHARM, V94, P1074, DOI 10.1139/cjpp-2015-0581; Hsu HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077931; Javelot H, 2014, BEHAV BRAIN RES, V261, P8, DOI 10.1016/j.bbr.2013.11.047; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kang S, 2017, NEUROPHARMACOLOGY, V113, P467, DOI 10.1016/j.neuropharm.2016.10.029; Kim Ji Eun, 2017, Lab Anim Res, V33, P171, DOI 10.5625/lar.2017.33.2.171; Liu XJ, 2015, ENDOCRINOLOGY, V156, P2103, DOI 10.1210/en.2014-2037; Liu XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114780; Liu ZX, 2016, MOL MED REP, V14, P1323, DOI 10.3892/mmr.2016.5393; Macklin L, 2017, EXP GERONTOL, V88, P9, DOI 10.1016/j.exger.2016.12.019; Najib S, 2005, J MOL ENDOCRINOL, V34, P119, DOI 10.1677/jme.1.01581; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Niedowicz DM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-64; Nilsson E, 2015, J CLIN ENDOCR METAB, V100, pE1491, DOI 10.1210/jc.2015-3204; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Palta P, 2018, J GERONTOL A-BIOL, V73, P123, DOI 10.1093/gerona/glx076; Rector RS, 2013, HEPATOLOGY, V57, P2213, DOI 10.1002/hep.26285; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shea TB, 2004, J ALZHEIMERS DIS, V6, P269; Sickmann HM, 2015, METAB BRAIN DIS, V30, P335, DOI 10.1007/s11011-014-9546-z; Sironi AM, 2011, CURR PHARM DESIGN, V17, P3074, DOI 10.2174/138161211798157720; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wang D, 2017, MOL CELL ENDOCRINOL, V443, P72, DOI 10.1016/j.mce.2017.01.006; Wang XXX, 2011, AM J PHYSIOL-RENAL, V300, pF801, DOI 10.1152/ajprenal.00338.2010; Wee AKH, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0208-3; Wierzbicki Anthony S, 2007, Diab Vasc Dis Res, V4, P143; Yu XQ, 2014, POULTRY SCI, V93, P2596, DOI 10.3382/ps.2014-04027; Yuan HD, 2012, BIOMOL THER, V20, P220, DOI 10.4062/biomolther.2012.20.2.220; Zhang F, 2017, J DAIRY SCI, V100, P1618, DOI 10.3168/jds.2016-11870; Zhang HS, 2005, PHARMACOLOGY, V74, P57, DOI 10.1159/000083684; Zhang ZH, 2015, EXP ANIM TOKYO, V64, P435, DOI 10.1538/expanim.14-0086; Zhao Y, 2009, ARTERIOSCL THROM VAS, V29, P1349, DOI 10.1161/ATVBAHA.109.188672; Zheng MY, 2014, J CLIN BIOCHEM NUTR, V54, P122, DOI 10.3164/jcbn.13-89; Zheng YQ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0223-5; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	53	16	16	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202910	10.1371/journal.pone.0202910	http://dx.doi.org/10.1371/journal.pone.0202910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153273	gold, Green Submitted, Green Published			2022-12-27	WOS:000443001700031
J	Jin, S; Lee, MY				Jin, Solee; Lee, Mi-Young			The ameliorative effect of hemp seed hexane extracts on the Propionibacterium acnes-induced inflammation and lipogenesis in sebocytes	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; HUMAN KERATINOCYTES; PROTEIN EXPRESSION; MAMMALIAN TARGET; CELLS; AKT; MACROPHAGES; SUPPRESSION; ACTIVATION	In this study, we investigated the anti-microbial, anti-inflammatory, and anti-lipogenic effects of hemp (Cannabis sativa L.) seed hexane extracts, focusing on the Propionibacterium acnes-triggered inflammation and lipogenesis. Hemp seed hexane extracts (HSHE) showed anti-microbial activity against P. acnes. The expression of iNOS, COX-2, and the subsequent production of nitric oxide and prostaglandin increased after infection of P. acnes in HaCaT cells, however, upon treating with HSHE, their expressions were reduced. P. acnes induced expressions of IL-1 beta and IL-8 were also reduced. HSHE exerted anti-inflammatory effects by regulating NF-kappa B and MAPKs signaling and blunting the translocation of p-NF-kappa B to the nucleus in P. acnes-stimulated HaCaT cells. Moreover, P. acnes-induced phosphorylation of ERK and JNK, and their downstream targets c-Fos and c-Jun, was also inhibited by HSHE. In addition, the transactivation of AP-1 induced by P. acnes infection was also downregulated by HSHE. Notably, HSHE regulated inflammation and lipid biosynthesis via regulating AMPK and AKT/FoxO1 signaling in IGF-1-induced inflammation and lipogenesis of sebocytes. In addition, HSHE inhibited 5-lipoxygenase level and P. acnes-induced MMP-9 activity, and promoted collagen biosynthesis in vitro. Thus, HSHE could be utilized to treat acne vulgaris, through its anti-microbial, anti-inflammatory, anti-lipogenic, and collagen-promoting properties.	[Jin, Solee; Lee, Mi-Young] SoonChunHyang Univ, Coll Med Sci, Dept Med Sci, Asan, Chungnam, South Korea; [Lee, Mi-Young] SoonChunHyang Univ, Coll Med Sci, Dept Med Biotechnol, Asan, Chungnam, South Korea	Soonchunhyang University; Soonchunhyang University	Lee, MY (corresponding author), SoonChunHyang Univ, Coll Med Sci, Dept Med Sci, Asan, Chungnam, South Korea.; Lee, MY (corresponding author), SoonChunHyang Univ, Coll Med Sci, Dept Med Biotechnol, Asan, Chungnam, South Korea.	miyoung@sch.ac.kr			Soonchunhyang University	Soonchunhyang University	This work was supported by Soonchunhyang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Soonchunhyang University.	Al-Mariri A, 2013, IRAN J MED SCI, V38, P44; Amar MB, 2006, J ETHNOPHARMACOL, V105, P1, DOI 10.1016/j.jep.2006.02.001; Badowski M, 2017, CANCER CHEMOTH PHARM, V80, P441, DOI 10.1007/s00280-017-3387-5; Bai S, 2005, MATRIX BIOL, V24, P247, DOI 10.1016/j.matbio.2005.03.007; Byrum RS, 1999, J IMMUNOL, V163, P6810; Chang CS, 2010, INFLAMMATION, V33, P46, DOI 10.1007/s10753-009-9157-8; Croxford JL, 2008, J NEUROIMMUNOL, V193, P120, DOI 10.1016/j.jneuroim.2007.10.024; Deferne J.L, 1996, J INT HEMP ASS, V3, P4; Dhupal M, 2017, MOL CELL TOXICOL, V13, P115, DOI 10.1007/s13273-017-0012-y; Gao YL, 2012, TOXICOL IN VITRO, V26, P1, DOI 10.1016/j.tiv.2011.09.019; Ge YJ, 2012, J BIOL CHEM, V287, P43928, DOI 10.1074/jbc.R112.406942; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hirayama K, 2002, J COMP PATHOL, V127, P249, DOI 10.1053/jcpa.2002.0590; Jeon YM, 2015, LIFE SCI, V124, P56, DOI 10.1016/j.lfs.2014.12.029; Jeong JW, 2017, MOL CELL TOXICOL, V13, P405, DOI 10.1007/s13273-017-0045-2; Jeong M, 2014, J ETHNOPHARMACOL, V154, P745, DOI 10.1016/j.jep.2014.04.052; Jung JY, 2014, ACTA DERM-VENEREOL, V94, P521, DOI 10.2340/00015555-1802; Kim JH, 2016, MOL CELL TOXICOL, V12, P53, DOI 10.1007/s13273-016-0008-z; Kim M, 2015, ARCH BIOCHEM BIOPHYS, V583, P79, DOI 10.1016/j.abb.2015.07.007; Kim SY, 2015, INT J MOL MED, V35, P1042, DOI 10.3892/ijmm.2015.2098; Ko JW, 2017, MOL CELL TOXICOL, V13, P295, DOI 10.1007/s13273-017-0033-6; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lee H, 2016, MOL CELL TOXICOL, V12, P337, DOI 10.1007/s13273-016-0038-6; Lee H, 2016, MOL CELL TOXICOL, V12, P273, DOI 10.1007/s13273-016-0032-z; Lee NR, 2016, MOL CELL TOXICOL, V12, P371, DOI 10.1007/s13273-016-0041-y; Leizer C., 2000, Journal of Nutraceuticals, Functional & Medical Foods, V2, P35, DOI 10.1300/J133v02n04_04; Levy LL, 2012, AM J CLIN DERMATOL, V13, P331, DOI 10.2165/11631410-000000000-00000; Luo Q, 2017, MOL CELL BIOCHEM, V428, P129, DOI 10.1007/s11010-016-2923-7; McCusker MM, 2010, CLIN DERMATOL, V28, P440, DOI 10.1016/j.clindermatol.2010.03.020; Nissen L, 2010, FITOTERAPIA, V81, P413, DOI 10.1016/j.fitote.2009.11.010; Ottaviani M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/858176; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park JY, 2014, EVID-BASED COMPL ALT, V2014, P11; Ryu AR, 2017, PHOTODIAGN PHOTODYN, V20, P71, DOI 10.1016/j.pdpdt.2017.08.002; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Sato T, 2012, J DERMATOL, V39, P774, DOI 10.1111/j.1346-8138.2012.01525.x; Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011; Shibata M, 2009, J INVEST DERMATOL, V129, P375, DOI 10.1038/jid.2008.237; Tsai HH, 2013, J DERMATOL SCI, V69, P122, DOI 10.1016/j.jdermsci.2012.10.009; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Wang YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170599; Won J, 2016, MOL CELL TOXICOL, V12, P37, DOI 10.1007/s13273-016-0006-1; Wu WJ, 2015, INT J MOL MED, V35, P1734, DOI 10.3892/ijmm.2015.2187; Yoon JY, 2013, J INVEST DERMATOL, V133, P429, DOI 10.1038/jid.2012.292; Zhang JH, 2016, DRUG DES DEV THER, V10, P1829, DOI 10.2147/DDDT.S104602; Zouboulis CC, 2010, EXP DERMATOL, V19, P148, DOI 10.1111/j.1600-0625.2009.00929.x; Zouboulis CC, 2009, DERM-ENDOCRINOL, V1, P188, DOI 10.4161/derm.1.3.8368; Zuardi AW, 2006, REV BRAS PSIQUIATR, V28, P153, DOI 10.1590/S1516-44462006000200015	48	19	21	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202933	10.1371/journal.pone.0202933	http://dx.doi.org/10.1371/journal.pone.0202933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148860	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200035
J	Lee, DH; Tsao, MS; Kambartel, KO; Isobe, H; Huang, MS; Barrios, CH; Khattak, A; de Marinis, F; Kothari, S; Arunachalam, A; Cao, XT; Burke, T; Valladares, A; de Castro, J				Lee, Dae Ho; Tsao, Ming-Sound; Kambartel, Karl-Otto; Isobe, Hiroshi; Huang, Ming-Shyan; Barrios, Carlos H.; Khattak, Adnan; de Marinis, Filippo; Kothari, Smita; Arunachalam, Ashwini; Cao, Xiting; Burke, Thomas; Valladares, Amparo; de Castro, Javier			Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PlvOTAL observational study	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; 1ST-LINE TREATMENT; 2ND-LINE THERAPY; NSCLC PATIENTS; RESOURCE USE; MUTATIONS; EGFR; ASSOCIATION; MANAGEMENT; DIAGNOSIS	Background The goals of this multinational retrospective study were to describe treatment patterns and survival outcomes by receipt of molecular testing and molecular status of patients with advanced non-small cell lung cancer (NSCLC). Methods This chart review study, conducted in Italy, Spain, Germany, Australia, Japan, Korea, Taiwan, and Brazil, included 1440 patients with newly diagnosed advanced (stage IIIB/IV) NSCLC initiating systemic therapy from January 2011 through June 2013, with follow-up until July 2016. We evaluated treatment patterns and survival by histology, line of therapy, molecular testing, and test results for epidermal growth factor receptor (EGFR) mutation and/or anaplastic lymphoma kinase (ALK) rearrangement. Country-specific data were analyzed descriptively and presented as ranges (lowest to highest country). Overall survival (OS) was estimated using Kaplan-Meier method. Results Patients with >= 1 molecular test varied from 43% (Brazil) to 85% (Taiwan). Numerically greater proportions of patients who were female, Asian, or never/former-smokers, and those with nonsquamous histology or stage-IV NSCLC, received a test. Testing was common for nonsquamous NSCLC (54%, Brazil, to 91%, Taiwan), with positive EGFR and ALK tests from 17% (Brazil and Spain) to 67% (Taiwan) and from 0% (Brazil) to 60% (Taiwan), respectively. First-line treatment regimens for nonsquamous NSCLC with positive EGFR/ ALKtests included targeted therapy for 30% (Germany) to 89% (Japan); with negative/ inconclusive test results, platinum-based combinations for 88% (Japan) to 98% (Brazil); and if not tested, platinum-based combinations for 80% (Australia) to 95% (Japan), except in Taiwan, where 44% received single agents. Median OS from first-line therapy initiation was 10.0 (Japan) to 26.7 (Taiwan) months for those tested and 7.6 (Australia/Brazil) to 19.3 (Taiwan) months for those not tested. Conclusions We observed substantial variation among countries in testing percentages, treatment patterns, and survival outcomes. Efforts to optimize molecular testing rates should be implemented in the context of each country's health care scenario.	[Lee, Dae Ho] Asan Med Ctr, Seoul, South Korea; [Tsao, Ming-Sound] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Kambartel, Karl-Otto] Krankenhaus Bethanien, Moers, Germany; [Isobe, Hiroshi] KKR Sapporo Med Ctr, Sapporo, Hokkaido, Japan; [Huang, Ming-Shyan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Kaohsiung, Taiwan; [Barrios, Carlos H.] Hosp Canc Mae Deus, Porto Alegre, RS, Brazil; [Khattak, Adnan] Fiona Stanley Hosp, Murdoch, WA, Australia; [de Marinis, Filippo] IRCCS, European Inst Oncol, Milan, Italy; [Kothari, Smita; Arunachalam, Ashwini; Cao, Xiting; Burke, Thomas] Merck & Co Inc, Ctr Observat & Real World Evidence CORE, Kenilworth, NJ USA; [Valladares, Amparo] Merck Sharp & Dohme Espana, Outcomes Res, Madrid, Spain; [de Castro, Javier] Hosp Univ La Paz IDIPAZ, Madrid, Spain; [Huang, Ming-Shyan] I Shou Univ, Sch Med, E DA Canc Hosp, Kaohsiung, Taiwan	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Kaohsiung Medical University; Kaohsiung Medical University Hospital; IRCCS European Institute of Oncology (IEO); Merck & Company; Hospital Universitario La Paz; E-Da Hospital; I Shou University	Arunachalam, A (corresponding author), Merck & Co Inc, Ctr Observat & Real World Evidence CORE, Kenilworth, NJ USA.	ashwini.arunachalam@merck.com	Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017; de Marinis, Filippo/AAR-2826-2020	Tsao, Ming Sound/0000-0002-9160-5405; De Castro, Javier/0000-0002-3622-6306	Merck & Co., Inc., Kenilworth, NJ, USA; Merck Sharp Dohme Corp.	Merck & Co., Inc., Kenilworth, NJ, USA; Merck Sharp Dohme Corp.(Merck & Company)	This work was supported by Merck & Co., Inc., Kenilworth, NJ, USA. The funder of the study participated in the study design and data analysis. Medical writing and editorial assistance was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA. All authors, including those employed by the funder of the study, participated in the data interpretation, decision to publish, and preparation of the manuscript.	American Cancer Society, NON SMALL CELL LUNG; [Anonymous], 2017, NCCN GUID NON SMALL; Carrato A, 2014, CURR MED RES OPIN, V30, P447, DOI 10.1185/03007995.2013.860372; Cheema PK, 2017, CURR ONCOL, V24, P16, DOI 10.3747/co.24.3266; Cheng TYD, 2016, J THORAC ONCOL, V11, P1653, DOI 10.1016/j.jtho.2016.05.021; de Castro J, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12734; De Geer Anna, 2013, J Med Econ, V16, P134, DOI 10.3111/13696998.2012.703631; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Greenhalgh J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010383.pub2; Gridelli C, 2014, J CANCER RES CLIN, V140, P1783, DOI 10.1007/s00432-014-1715-2; Hiley CT, 2016, LANCET, V388, P1002, DOI 10.1016/S0140-6736(16)31340-X; International Agency for Research on Cancer, CANC TOD; Isobe H, 2017, LUNG CANCER-TARGETS, V8, P191, DOI 10.2147/LCTT.S140491; Jain A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123587; Japan Lung Cancer Society, TREATM GUID LUNG CAN; Kerr KM, 2012, HISTOPATHOLOGY, V60, P531, DOI 10.1111/j.1365-2559.2011.03854.x; Kim Hyojin, 2014, Korean J Pathol, V48, P1, DOI 10.4132/KoreanJPathol.2014.48.1.1; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lee DH, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2946-8; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Lim C, 2015, ANN ONCOL, V26, P1415, DOI 10.1093/annonc/mdv208; Moro-Sibilot D, 2015, LUNG CANCER, V88, P215, DOI 10.1016/j.lungcan.2015.02.011; Moro-Sibilot D, 2010, CURR MED RES OPIN, V26, P2661, DOI 10.1185/03007995.2010.525489; Novello S, 2016, ANN ONCOL, V27, pv1, DOI 10.1093/annonc/mdw326; Reck M, 2011, LUNG CANCER, V74, P1, DOI 10.1016/j.lungcan.2011.05.002; Sacher AG, 2016, JAMA ONCOL, V2, P313, DOI 10.1001/jamaoncol.2015.4482; Salto-Tellez M, 2011, J THORAC ONCOL, V6, P1663, DOI 10.1097/JTO.0b013e318227816a; Schnabel PA, 2012, LUNG CANCER, V78, P263, DOI 10.1016/j.lungcan.2012.09.001; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Solomon B, 2017, LANCET, V389, P884, DOI 10.1016/S0140-6736(17)30124-1; Tanner NT, 2012, LUNG CANCER, V76, P131, DOI 10.1016/j.lungcan.2011.11.013; The World Health Organization, 2018, FACT SHEETS CANC; Thunnissen E, 2012, LUNG CANCER, V76, P1, DOI 10.1016/j.lungcan.2011.10.017; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Vergnenegre A, 2012, CURR MED RES OPIN, V28, P1253, DOI 10.1185/03007995.2012.703133; von Verschuer U, 2017, LUNG CANCER, V112, P216, DOI 10.1016/j.lungcan.2017.07.031; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; Yatabe Y, 2015, J THORAC ONCOL, V10, P438, DOI 10.1097/JTO.0000000000000422	39	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202865	10.1371/journal.pone.0202865	http://dx.doi.org/10.1371/journal.pone.0202865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148862	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200029
J	Ma, DJ; Park, UC; Kim, ET; Yu, HG				Ma, Dae Joong; Park, Un Chul; Kim, Ei Tae; Yu, Hyeong Gon			Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SPECTRAL-DOMAIN; ANGIOGRAPHY; THICKNESS; EYES; VASCULATURE; VERTEPORFIN	Purpose This study evaluated changes in choroidal vascularity after half-fluence photodynamic therapy (HF-PDT) in patients with central serous chorioretinopathy (CSC) using swept-source optical coherence tomography (SS-OCT) en face imaging. Methods This retrospective comparative case series included 50 eyes of 25 patients with unilateral CSC who underwent HF-PDT and 50 age-and sex-matched normal healthy control eyes. En face SS-OCT images of the choriocapillaris, Sattler's layer, and Haller's layer were converted into binary images. The vascular proportions were defined as the percentage of the area of vascular lumen against the area of the 3.0-mm-diameter circular area. The main outcome measures were the vascular proportions before HF-PDT and at 6 weeks, 6 months, and 12 months after HF-PDT. Results At baseline, the vascular proportions in the CSC eyes were significantly greater than those in the control eyes in all layers (choriocapillaris: 51.8%+/- 15.5% vs. 41.3 +/- 18.7%, P = 0.018; Sattler's: 58.6% +/- 13.4% vs. 49.7% +/- 15.7%, P = 0.017; Haller's: 65.3% +/- 15.3% vs. 53.0% +/- 13.4%, P= 0.001). In the CSC eyes, the vascular proportion in the choriocapillaris significantly decreased at 6 weeks (36.6% +/- 16.9%, P< 0.001), 6 months (34.0% +/- 12.3%, P< 0.001), and 12 months (34.8% +/- 17.6%, P< 0.001) after HF-PDT compared with baseline. The vascular proportions in Sattler's and Haller's layers did not show a significant decrease at 6 weeks (Sattler's: 49.7% +/- 17.3%, P = 0.052 and Haller's: 58.3% +/- 12.9%, P= 0.558) but decreased significantly at 6 months (Sattler's: 48.9% +/- 12.4%, P< 0.001 and Haller's: 57.7% +/- 15.7%, P= 0.027) and 12 months after HF-PDT from the baseline values (Sattler's: 45.8% +/- 10.4%, P< 0.001 and Haller's: 56.8% +/- 15.7%, P< 0.001). Conclusion After HF-PDT, the choriocapillaris showed the earliest decrease in vascular proportion of en face images, Sattler's and Haller's layers showed later decreases. The temporal differences in the response of each layer may reflect the pathophysiology of CSC and the therapeutic mechanism of HF-PDT.	[Ma, Dae Joong; Park, Un Chul; Kim, Ei Tae; Yu, Hyeong Gon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Ma, Dae Joong; Park, Un Chul; Yu, Hyeong Gon] Seoul Natl Univ Hosp, Retinal Degenerat Res Lab, Biomed Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Yu, HG (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.; Yu, HG (corresponding author), Seoul Natl Univ Hosp, Retinal Degenerat Res Lab, Biomed Res Inst, Seoul, South Korea.	hgonyu@snu.ac.kr		MA, DAE JOONG/0000-0001-9322-5898; Yu, Hyeong Gon/0000-0002-1795-202X				Agrawal R, 2016, RETINA-J RET VIT DIS, V36, P1646, DOI 10.1097/IAE.0000000000001040; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Chan SY, 2016, RETINA-J RET VIT DIS, V36, P2051, DOI 10.1097/IAE.0000000000001064; Chan WM, 2003, BRIT J OPHTHALMOL, V87, P1453, DOI 10.1136/bjo.87.12.1453; Dansingani KK, 2016, RETINA-J RET VIT DIS, V36, P499, DOI 10.1097/IAE.0000000000000742; Donald J, 1967, AM J OPHTHALMOL, V63, DOI [10.1016/0002-9394(67)90027-X, DOI 10.1016/0002-9394(67)90027-X]; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; Hennessy S, 1999, AM J EPIDEMIOL, V149, P195; Hua R, 2014, PHOTODIAGN PHOTODYN, V11, P565, DOI 10.1016/j.pdpdt.2014.07.002; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Izumi T, 2017, BRIT J OPHTHALMOL, V101, P433, DOI 10.1136/bjophthalmol-2016-308921; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Kim YT, 2011, EYE, V25, P1635, DOI 10.1038/eye.2011.258; Kuroda Y, 2016, AM J OPHTHALMOL, V169, P199, DOI 10.1016/j.ajo.2016.06.043; Manayath GJ, 2018, RETINA-J RET VIT DIS, V38, P1195, DOI 10.1097/IAE.0000000000001665; Mansouri K, 2013, OPHTHALMOLOGY, V120, P2508, DOI 10.1016/j.ophtha.2013.07.040; MARMOR MF, 1988, GRAEF ARCH CLIN EXP, V226, P548, DOI 10.1007/BF02169203; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1603, DOI 10.1097/IAE.0b013e31820f4b39; Mori K, 1999, OPHTHALMOLOGY, V106, P1384, DOI 10.1016/S0161-6420(99)00729-0; Nicholson B, 2013, SURV OPHTHALMOL, V58, P103, DOI 10.1016/j.survophthal.2012.07.004; Prunte C, 1996, AM J OPHTHALMOL, V121, P26; Reibaldi M, 2010, AM J OPHTHALMOL, V149, P307, DOI 10.1016/j.ajo.2009.08.026; Salehi M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011841.pub2; Schlotzer-Schrehardt U, 2002, GRAEF ARCH CLIN EXP, V240, P748, DOI 10.1007/s00417-002-0517-4; Shin JY, 2011, RETINA-J RET VIT DIS, V31, P119, DOI 10.1097/IAE.0b013e3181e378f2; Sonoda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157190; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Su GL, 2017, CLIN OPHTHALMOL, V11, P889, DOI 10.2147/OPTH.S135479; Tsujikawa A, 2010, RETINA-J RET VIT DIS, V30, P801, DOI 10.1097/IAE.0b013e3181c72068; Yang LH, 2013, ACTA OPHTHALMOL, V91, pE358, DOI 10.1111/aos.12059	30	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202930	10.1371/journal.pone.0202930	http://dx.doi.org/10.1371/journal.pone.0202930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148858	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200033
J	Stipdonk, LW; Franken, MCJP; Dudink, J				Stipdonk, Lottie W.; Franken, Marie-Christine J. P.; Dudink, Jeroen			Language outcome related to brain structures in school-aged preterm children: A systematic review (vol 13, e0196607, 2018)	PLOS ONE			English	Correction																		Stipdonk LW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196607	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0203298	10.1371/journal.pone.0203298	http://dx.doi.org/10.1371/journal.pone.0203298			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148897	Green Submitted, Green Published, gold			2022-12-27	WOS:000442804200055
J	Tran, VN; Dasagrandhi, C; Truong, VG; Kim, YM; Kang, HW				Van Nam Tran; Dasagrandhi, Chakradhar; Van Gia Truong; Kim, Young-Mog; Kang, Hyun Wook			Antibacterial activity of Staphylococcus aureus biofilm under combined exposure of glutaraldehyde, near-infrared light, and 405-nm laser	PLOS ONE			English	Article							ANTIMICROBIAL PHOTODYNAMIC THERAPY; BACTERIAL BIOFILMS; ESCHERICHIA-COLI; IN-VITRO; GOLD NANOPARTICLES; RESISTANCE; EFFICACY; AGENTS; DECONTAMINATION; DISINFECTION	Healthcare-associated infections have increasingly become problematic in the endoscopic procedures resulting in several severe diseases such as carbapenem-resistant Enterobacteriaceae (CRE)-related infections, pneumonia, and bacteremia. Especially, some bacterial strains are resistant to traditional antimicrobials. Therefore, the necessity of developing new antibiotics or management to deal with bacterial infections has been increasing. The current study combined a low concentration of glutaraldehyde (GTA) with near-infrared (NIR) light and 405-nm laser to entail antibacterial activity on Staphylococcus aureus biofilm. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and colony forming unit (CFU) counting were used to quantify the viable cells while fluorescent and scanning electron microscopic images were used to qualitatively evaluate the cell membrane integrity and structural deformation, respectively. Practically, S. aureus biofilm was highly susceptible (7% cell viability and 6.8-log CFU/cm(2) bacterial reduction for MTT assay and CFU analysis, respectively) to the combination of GTA (0.1%), NIR light (270 J/cm(2)), and 405-nm laser (288 J/cm(2)) exposure. GTA could form either DNA-protein or protein-protein crosslinks to inhibit DNA and protein synthesis. The NIR light induced the thermal damage on protein/ enzymes while 405-nm laser could induce reactive oxygen species (ROS) to damage the bacterial membrane. Thus, the proposed technique may be a feasible modality for endoscope cleaning to prevent any secondary infection in the healthcare industry.	[Van Nam Tran; Van Gia Truong; Kang, Hyun Wook] Pukyong Natl Univ, Dept Biomed Engn, Busan, South Korea; [Dasagrandhi, Chakradhar] Pukyong Natl Univ, Marine Integrated Bion Res Ctr, Busan, South Korea; [Kim, Young-Mog] Pukyong Natl Univ, Dept Food Sci & Technol, Busan, South Korea; [Kang, Hyun Wook] Pukyong Natl Univ, Ctr Marine Integrated Biomed Technol, Busan, South Korea	Pukyong National University; Pukyong National University; Pukyong National University; Pukyong National University	Kang, HW (corresponding author), Pukyong Natl Univ, Dept Biomed Engn, Busan, South Korea.; Kim, YM (corresponding author), Pukyong Natl Univ, Dept Food Sci & Technol, Busan, South Korea.; Kang, HW (corresponding author), Pukyong Natl Univ, Ctr Marine Integrated Biomed Technol, Busan, South Korea.	ymkim@pknu.ac.kr; wkang@pukyong.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C1017]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C1017).; This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C1017).	Abee T, 2011, CURR OPIN BIOTECH, V22, P172, DOI 10.1016/j.copbio.2010.10.016; Abreu AC, 2013, J ANTIMICROB CHEMOTH, V68, P2718, DOI 10.1093/jac/dkt281; Alkawareek MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044289; Astafyeva LG, 2012, OPT SPECTROSC+, V112, P642, DOI 10.1134/S0030400X12040030; Aumeran C, 2012, J CLIN MICROBIOL, V50, P938, DOI 10.1128/JCM.06221-11; Bruenke J, 2016, MACROMOL BIOSCI, V16, P647, DOI 10.1002/mabi.201500266; Chua SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5462; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cotton P., 2003, PRACTICAL GASTROINTE; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Gao Q, 2017, ACTA BIOMATER, V51, P112, DOI 10.1016/j.actbio.2017.01.061; Gu HW, 2003, NANO LETT, V3, P1261, DOI 10.1021/nl034396z; Guffey JS, 2006, PHOTOMED LASER SURG, V24, P684, DOI 10.1089/pho.2006.24.684; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Ha JW, 2015, APPL ENVIRON MICROB, V81, P2, DOI 10.1128/AEM.01862-14; Ha JW, 2013, APPL ENVIRON MICROB, V79, P6568, DOI 10.1128/AEM.02249-13; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hu DF, 2017, ACS NANO, V11, P9330, DOI 10.1021/acsnano.7b04731; Ju EG, 2013, CHEM COMMUN, V49, P9048, DOI 10.1039/c3cc45290e; Juan MR, 2015, GASTROENTEROL NURS, V38, P70, DOI 10.1097/SGA.0000000000000092; Kim SY, 2011, CLIN ENDOSC, V44, P109, DOI 10.5946/ce.2011.44.2.109; Kim SH, 2016, RSC ADV, V6, P61482, DOI 10.1039/c6ra08196g; Kim SH, 2015, ACS APPL MATER INTER, V7, P15600, DOI 10.1021/acsami.5b04321; Kovaleva J, 2013, CLIN MICROBIOL REV, V26, P231, DOI 10.1128/CMR.00085-12; Krespi YP, 2011, AM J OTOLARYNG, V32, P198, DOI 10.1016/j.amjoto.2010.01.010; Kumar A, 2015, J PHOTOCH PHOTOBIO B, V149, P37, DOI 10.1016/j.jphotobiol.2015.05.005; Lei WX, 2016, ADV MATER INTERFACES, V3, DOI 10.1002/admi.201600767; Li M, 2017, RSC ADV, V7, P40734, DOI 10.1039/c7ra06073d; Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]; MACLEAN M, 2009, J APPL ENV MICROBIOL, V75, P1932, DOI DOI 10.1128/AEM.01892-08; Maillard JY, 2002, J APPL MICROBIOL, V92, p16S, DOI 10.1046/j.1365-2672.92.5s1.3.x; Marion-Ferey K, 2003, J HOSP INFECT, V53, P64, DOI 10.1053/jhin.2002.1320; Martinez SR, 2016, RSC ADV, V6, P101023, DOI 10.1039/c6ra19670e; Mattheis C, 2013, MACROMOL BIOSCI, V13, P242, DOI 10.1002/mabi.201200217; MCGUCKEN PV, 1973, J APPL BACTERIOL, V36, P419, DOI 10.1111/j.1365-2672.1973.tb04123.x; Mirzaie M, 2016, PHOTODIAGN PHOTODYN, V14, P115, DOI 10.1016/j.pdpdt.2016.03.005; Murdoch LE, 2012, SCI WORLD J, DOI 10.1100/2012/137805; Pajkos A, 2004, J HOSP INFECT, V58, P224, DOI 10.1016/j.jhin.2004.06.023; Park SB, 2013, CLIN ENDOSC, V46, P403, DOI 10.5946/ce.2013.46.4.403; Pineau L, 2008, J HOSP INFECT, V68, P171, DOI 10.1016/j.jhin.2007.10.021; Pires RH, 2013, ANTIMICROB AGENTS CH, V57, P2417, DOI 10.1128/AAC.01308-12; Psaltikidis EM, 2014, COGITARE ENFERMAGEM, V19; Ramakrishnan P, 2016, TOXICOL IN VITRO, V33, P54, DOI 10.1016/j.tiv.2016.02.011; Rutala WA, 2013, AM J INFECT CONTROL, V41, pS2, DOI 10.1016/j.ajic.2012.11.005; Saravanan R, 2014, BIOTECHNOL BIOENG, V111, P37, DOI 10.1002/bit.25003; Su YJ, 2017, POLYM CHEM-UK, V8, P3788, DOI 10.1039/c7py00528h; Su YJ, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601173; Traba C, 2015, BIOFOULING, V31, P39, DOI 10.1080/08927014.2014.995643; USA- Environmental Protection Agency, 2012, DIS US HARD SURF EFF; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Venkatesan N, 2015, FUTURE MICROBIOL, V10, P1743, DOI 10.2217/fmb.15.69; Wang HW, 2010, J MICROBIOL METH, V82, P330, DOI 10.1016/j.mimet.2010.06.014; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wu MC, 2013, ACS NANO, V7, P1281, DOI 10.1021/nn304782d; Yang L, 2012, FEMS IMMUNOL MED MIC, V65, P146, DOI 10.1111/j.1574-695X.2011.00858.x; Zhang J, 2018, J HAZARD MATER, V342, P121, DOI 10.1016/j.jhazmat.2017.07.053; Zhao YY, 2010, J AM CHEM SOC, V132, P12349, DOI 10.1021/ja1028843	57	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202821	10.1371/journal.pone.0202821	http://dx.doi.org/10.1371/journal.pone.0202821			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148865	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200026
J	Kim, HN; Han, K; Song, SW; Lee, JH				Kim, Ha-Na; Han, Kyungdo; Song, Sang-Wook; Lee, Ji Hyun			Hypertension and risk of psoriasis incidence: An 11-year nationwide population-based cohort study	PLOS ONE			English	Article							II-INDUCED HYPERTENSION; ANGIOTENSIN-II; VASCULAR DYSFUNCTION; EPIDEMIOLOGY; PREVALENCE; DISEASE; ASSOCIATION; MECHANISMS; SEVERITY; GENES	Psoriasis is a chronic inflammatory skin disease that is characterized by T-cell mediated immune response, and has been known to increase the risk of developing hypertension. However, the risk of psoriasis in patients with hypertension is not clear. Therefore, we investigated the risk of psoriasis in patients with hypertension. A total of 256,356 adults (42,726 in the hypertension group and 213,630 in the control group) were followed from 2003 to 2013 in a nationwide population-based cohort study. During the follow-up, 9,254 participants (3.6%) were found to have psoriasis (2,152 [5.0%] in the hypertension group and 7,102 [3.3%] in the control group). The hypertension group had a higher risk of psoriasis incidence (hazard ratio [HR] 1.54, 95% confidence interval [CI] 1.47-1.61, P < 0.001), and the association remained significant after adjusting for comorbidities of diabetes and dyslipidemia, antihypertensive medication and nonsteroidal anti-inflammatory drug use, and sociodemo-graphic factors (HR 1.18, 95% CI 1.08-1.28, P < 0.001). In conclusion, hypertension was significantly associated with an increased risk of psoriasis incidence. Further studies are needed to confirm whether hypertension is associated with the incidence of psoriasis.	[Kim, Ha-Na; Song, Sang-Wook] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Family Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Lee, Ji Hyun] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Dermatol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Lee, JH (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Dermatol, Seoul, South Korea.	ejee@catholic.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2015R1C1A2A01054767]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2015R1C1A2A01054767) to JHL, http://www.nrf.re.kr/index.	Armesto S, 2012, J EUR ACAD DERMATOL, V26, P785, DOI 10.1111/j.1468-3083.2011.04108.x; Armstrong AW, 2013, J HYPERTENS, V31, P433, DOI 10.1097/HJH.0b013e32835bcce1; Armstrong AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018227; Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Chang YT, 2009, ACTA DERM-VENEREOL, V89, P262, DOI 10.2340/00015555-0642; Cheng H, 2014, J INVEST DERMATOL, V134, P359, DOI 10.1038/jid.2013.317; Cohen AD, 2005, ACTA DERM-VENEREOL, V85, P299, DOI 10.1080/00015550510032823; Cohen AD, 2001, ACTA DERM-VENEREOL, V81, P347; Cohen AD, 2010, ACTA DERM-VENEREOL, V90, P23, DOI 10.2340/00015555-0741; De Venecia T, 2016, POSTGRAD MED, V128, P201, DOI 10.1080/00325481.2016.1147927; Ding XL, 2012, EUR J DERMATOL, V22, P663, DOI 10.1684/ejd.2012.1802; Elder JT, 2009, GENES IMMUN, V10, P201, DOI 10.1038/gene.2009.11; ENA P, 1985, ACTA CARDIOL, V40, P199; Esteban V, 2005, CIRC RES, V96, P965, DOI 10.1161/01.RES.0000166326.91395.74; Franklin SS, 2012, J CLIN HYPERTENS, V14, P779, DOI 10.1111/j.1751-7176.2012.00703.x; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Han JH, 2018, ACTA DERM-VENEREOL, V98, P396, DOI 10.2340/00015555-2877; Karbach S, 2014, ARTERIOSCL THROM VAS, V34, P2658, DOI 10.1161/ATVBAHA.114.304108; Kitamura A, 2017, CIRC J, V81, P1022, DOI 10.1253/circj.CJ-16-1129; Kubota K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006450; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Michalek IM, 2017, J EUR ACAD DERMATOL, V31, P205, DOI 10.1111/jdv.13854; Morris BJ, 2015, HYPERTENSION, V65, P956, DOI 10.1161/HYPERTENSIONAHA.114.04366; Nakada TA, 2011, CHEST, V139, P1042, DOI 10.1378/chest.10-2517; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Phan C, 2016, ANN DERMATOL VENER, V143, P264, DOI 10.1016/j.annder.2015.06.024; Qureshi AA, 2009, ARCH DERMATOL, V145, P379, DOI 10.1001/archdermatol.2009.48; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Sowers JR, 2002, NEW ENGL J MED, V346, P1999, DOI 10.1056/NEJMe020054; Sriramula S, 2008, HYPERTENSION, V51, P1345, DOI 10.1161/HYPERTENSIONAHA.107.102152; Takeshita J, 2017, J AM ACAD DERMATOL, V76, P377, DOI 10.1016/j.jaad.2016.07.064; Takeshita J, 2015, JAMA DERMATOL, V151, P161, DOI 10.1001/jamadermatol.2014.2094; Wu SW, 2014, JAMA DERMATOL, V150, P957, DOI 10.1001/jamadermatol.2013.9957; Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015	35	25	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202854	10.1371/journal.pone.0202854	http://dx.doi.org/10.1371/journal.pone.0202854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142208	Green Submitted, Green Published, gold			2022-12-27	WOS:000442722500040
J	Hou, JH; Li, JJ; Huang, JJ; Lu, CH; Zhou, J; Liu, Y; Wu, SL; Wei, F; Wang, LH; Chen, HY; Yu, HB; Wang, Z; Jiang, AL				Hou, Jinhong; Li, Junjuan; Huang, Jinjie; Lu, Chunhong; Zhou, Jing; Liu, Yang; Wu, Shouling; Wei, Fang; Wang, Lihua; Chen, Haiyan; Yu, Haibo; Wang, Zhe; Jiang, Aili			Relationship between the exposure to cumulative cardiovascular health behaviors and factors and chronic kidney disease-The Kailuan study	PLOS ONE			English	Article							BLOOD-PRESSURE; HYPERTENSION; RISK; ASSOCIATION; PATHOPHYSIOLOGY; METAANALYSIS; PREVALENCE; MANAGEMENT; MORTALITY	It is unclear whether ideal cardiovascular health (CVH) behaviors and factors, particularly cumulative exposure to ideal CVH (cumCVH), is associated with chronic kidney disease (CKD). The aim of the study was to examine the effect of cumCVH on CKD using the data from the Kailuan study. The study included the 27,970 (21,199 males) of the Kailuan community (China). The participants were 19 to 98 years of age. They were followed in 2008-2009, 2010-2011, and 2012-2013 by the same medical staff that did the initial physical examinations in 2006-2007. Participants were censored on the visit reporting CKD. A CVH score was created based on the seven AHA health metrics. The cumCVH score was CVH(1)xtime(v1-v2)+CVH(2)xtime(v2-v3)+CVH(3)xtime(v3-v4). In the fully adjusted model, compared with the lowest quintile of cumCVH, individuals in the highest quintile had a 75% lower risk of CKD (95% confidence interval (CI): 66-82%). Every additional year lived with a 1-unit increase in ideal CVH was associated with an 11% (95% CI: 9-13%) reduction in the incidence of CKD. Furthermore, when we excluded each of the six metrics from the cumCVH score in turn, the association was unaffected after the exclusion of individual risk factors. Ideal CVH is associated with a reduced incidence of CKD. Measurements of cumCVH are more likely to reflect the lifetime risk of CKD and possibly of other health outcomes.	[Hou, Jinhong; Wei, Fang; Wang, Lihua; Chen, Haiyan; Yu, Haibo; Wang, Zhe; Jiang, Aili] Tianjin Med Univ, Hosp 2, Kidney Dis & Blood Purificat Dept, Tianjin, Peoples R China; [Hou, Jinhong; Li, Junjuan; Huang, Jinjie; Lu, Chunhong; Zhou, Jing; Liu, Yang] Kailuan Gen Hosp, Dept Nephrol, Tangshan, Peoples R China; [Wu, Shouling] Kailuan Gen Hosp, Dept Cardiol, Tangshan, Peoples R China	Tianjin Medical University	Jiang, AL (corresponding author), Tianjin Med Univ, Hosp 2, Kidney Dis & Blood Purificat Dept, Tianjin, Peoples R China.; Wu, SL (corresponding author), Kailuan Gen Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; carlos_j@126.com	Chen, Haiyan/HGB-6216-2022		National Key Research and Development Program [2016YFC1305401]	National Key Research and Development Program	This study was funded by the National Key Research and Development Program (2016YFC1305401).	Agarwal R, 2005, CARDIOL CLIN, V23, P237, DOI 10.1016/j.ccl.2005.03.003; Campese VM, 2014, SEMIN NEPHROL, V34, P571, DOI 10.1016/j.semnephrol.2014.08.011; Dorresteijn JAN, 2012, HYPERTENSION, V59, P14, DOI 10.1161/HYPERTENSIONAHA.111.179143; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; Hamrahian SM, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0739-9; Han QL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012486; Huai PC, 2013, HYPERTENSION, V62, P1021, DOI 10.1161/HYPERTENSIONAHA.113.01965; Huang QF, 2016, CURR HYPERTENS REV, V12, P181, DOI 10.2174/1573402113666161122114854; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Johansen MY, 2017, JAMA-J AM MED ASSOC, V318, P637, DOI 10.1001/jama.2017.10169; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu F, 2016, CARDIOL PLUS, V1, P33; Liu XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004132; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Michishita R, 2017, CLIN EXP HYPERTENS, V39, P645, DOI 10.1080/10641963.2017.1306541; Navar-Boggan AM, 2015, CIRCULATION, V131, P451, DOI 10.1161/CIRCULATIONAHA.114.012477; Qi CC, 2013, CHIN J HYPERTENSION, V21, P765; Sullivan CA, 2015, HYPERTENSION, V66, P134, DOI 10.1161/HYPERTENSIONAHA.114.04990; Townsend RR, 2015, NAT REV NEPHROL, V11, P555, DOI 10.1038/nrneph.2015.114; Yamamoto-Kabasawa K, 2015, CLIN EXP NEPHROL, V19, P1079, DOI 10.1007/s10157-015-1103-5; Yan N, 2016, J STROKE CEREBROVASC, V25, P41, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.031; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19673; Yu JX, 2017, J STROKE CEREBROVASC, V26, P2501, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.037; Zemaitis P, 2014, CLIN J AM SOC NEPHRO, V9, P1922, DOI 10.2215/CJN.02450314; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhao HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005415; Zheng XM, 2017, ATHEROSCLEROSIS, V260, P56, DOI 10.1016/j.atherosclerosis.2017.03.018	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203171	10.1371/journal.pone.0203171	http://dx.doi.org/10.1371/journal.pone.0203171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169509	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400024
J	Penzias, G; Singanamalli, A; Elliott, R; Gollamudi, J; Shih, N; Feldman, M; Stricker, PD; Delprado, W; Tiwari, S; Bohm, M; Haynes, AM; Ponsky, L; Fu, PF; Tiwari, P; Viswanath, S; Madabhushi, A				Penzias, Gregory; Singanamalli, Asha; Elliott, Robin; Gollamudi, Jay; Shih, Natalie; Feldman, Michael; Stricker, Phillip D.; Delprado, Warick; Tiwari, Sarita; Bohm, Maret; Haynes, Anne-Maree; Ponsky, Lee; Fu, Pingfu; Tiwari, Pallavi; Viswanath, Satish; Madabhushi, Anant			Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings	PLOS ONE			English	Article							WHOLE HISTOLOGICAL SECTIONS; TEXTURE ANALYSIS; TISSUE COMPOSITION; CENTRAL GLAND; IMAGES; ADENOCARCINOMA; HISTOPATHOLOGY; CLASSIFICATION; SEGMENTATION; MODELS	Translation of radiomics into the clinic may require a more comprehensive understanding of the underlying morphologic tissue characteristics they reflect. In the context of prostate cancer (PCa), some studies have correlated gross histological measurements of gland lumen, epithelium, and nuclei with disease appearance on MRI. Quantitative histomorphometry (QH), like radiomics for radiologic images, is the computer based extraction of features for describing tumor morphology on digitized tissue images. In this work, we attempt to establish the histomorphometric basis for radiomic features for prostate cancer by (1) identifying the radiomic features from T2w MRI most discriminating of low vs. intermediate/high Gleason score, (2) identifying QH features correlated with the most discriminating radiomic features previously identified, and (3) evaluating the discriminative ability of QH features found to be correlated with spatially co-localized radiomic features. On a cohort of 36 patients (23 for training, 13 for validation), Gabor texture features were identified as being most predictive of Gleason grade on MRI (AUC of 0.69) and gland lumen shape features were identified as the most predictive QH features (AUC = 0.75). Our results suggest that the PCa grade discriminability of Gabor features is a consequence of variations in gland shape and morphology at the tissue level.	[Penzias, Gregory; Singanamalli, Asha; Tiwari, Pallavi; Viswanath, Satish; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Elliott, Robin; Gollamudi, Jay; Ponsky, Lee] Univ Hosp, Cleveland, OH USA; [Shih, Natalie; Feldman, Michael] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Stricker, Phillip D.] St Vincents Prostate Canc Clin, Darlinghurst, NSW, Australia; [Delprado, Warick] Douglass Hanly Moir Pathol, Macquarie Pk, NSW, Australia; [Tiwari, Sarita; Bohm, Maret; Haynes, Anne-Maree] Kinghorn Canc Ctr, Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Fu, Pingfu] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland; University of Pennsylvania; Garvan Institute of Medical Research; Case Western Reserve University	Penzias, G; Madabhushi, A (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	gregory.penzias@case.edu; anant.madabhushi@case.edu	Madabhushi, Anant/AAG-2908-2019; Fu, Pingfu/O-5415-2019	Madabhushi, Anant/0000-0002-5741-0399; Fu, Pingfu/0000-0002-2334-5218; Viswanath, Satish/0000-0003-4550-8337; Stricker, Phillip/0000-0002-0934-0656	National Cancer Institute of the National Institutes of Health [1U24CA199374-01, R01CA202752-01A1, R01CA208236-01M, R01 CA216579-01A1, R01 CA220581-01A1, R21CA179327-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R21CM 95152-01, R01DK098503-02]; National Center for Research Resources [1 C06 RR12463-01]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Prostate Cancer Idea Development Award; DOD career development award [W81XWH-16-1-0329]; Ohio Third Frontier Technology Validation Fund; Case Comprehensive Cancer Center Pilot Grant VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering; Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University; NIH [RO1]; NATIONAL CANCER INSTITUTE [R01CA202752, R01CA208236, U24CA199374, R01CA216579, R21CA195152, R01CA220581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098503] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOD Prostate Cancer Synergistic Idea Development Award; DOD Lung Cancer Idea Development New Investigator Award; DOD Prostate Cancer Idea Development Award; DOD career development award; Ohio Third Frontier Technology Validation Fund; Case Comprehensive Cancer Center Pilot Grant VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering; Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers 1U24CA199374-01, R01CA202752-01A1, R01CA208236-01M, R01 CA216579-01A1, R01 CA220581-01A1, R21CA179327-01; R21CM 95152-01 the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, National Center for Research Resources under award number 1 C06 RR12463-01 the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Lung Cancer Idea Development New Investigator Award (LC130463), the DOD Prostate Cancer Idea Development Award; the DOD career development award W81XWH-16-1-0329; the Ohio Third Frontier Technology Validation Fund, the Case Comprehensive Cancer Center Pilot Grant VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering and the Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University. Case Urology Translational Research Training Program (CUTRTP), the I-Corps Ohio Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health nor the Department of Defense. Author Anant Madabhushi is a co-founder and stake holder in Ibris Inc., a cancer diagnostics company. Additionally he is also an equity holder in Elucid Bioimaging and in Inspirata. He is also a scientific advisory consultant for Inspirata, and holds a joint NIH RO1 grant with them. Author Satish Viswanath is a scientific advisory board member and equity holder in Virbio, Inc. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2016, JAMA ONCOL, V2, P1636, DOI 10.1001/jamaoncol.2016.2631; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Ali S, 2015, COMPUT MED IMAG GRAP, V41, P3, DOI 10.1016/j.compmedimag.2014.11.001; Ali Sahirzeeshan, 2013, Med Image Comput Comput Assist Interv, V16, P412; Allsbrook WC, 2001, HUM PATHOL, V32, P81, DOI 10.1053/hupa.2001.21135; Antunes J, 2016, TRANSL ONCOL, V9, P155, DOI 10.1016/j.tranon.2016.01.008; Basavanhally AN, 2010, IEEE T BIO-MED ENG, V57, P642, DOI 10.1109/TBME.2009.2035305; Bhargava R, 2016, ANNU REV BIOMED ENG, V18, P387, DOI 10.1146/annurev-bioeng-112415-114722; Bhatnagar G, 2016, ABDOM RADIOL, V41, P1261, DOI 10.1007/s00261-016-0657-3; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; BOVIK AC, 1990, IEEE T PATTERN ANAL, V12, P55, DOI 10.1109/34.41384; Bunyak F, 2015, IEEE INT C BIOINFORM, P450, DOI 10.1109/BIBM.2015.7359726; Bunyak F, 2011, ADV EXP MED BIOL, V696, P413, DOI 10.1007/978-1-4419-7046-6_41; Chappelow J, 2011, COMPUT MED IMAG GRAP, V35, P557, DOI 10.1016/j.compmedimag.2011.01.010; Chatterjee A, 2015, RADIOLOGY, V277, P751, DOI 10.1148/radiol.2015142414; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; Depeursinge A, 2015, MED PHYS, V42, P2054, DOI 10.1118/1.4916088; Doyle S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-282; Doyle S, 2008, I S BIOMED IMAGING, P496, DOI 10.1109/ISBI.2008.4541041; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Fehr D, 2015, P NATL ACAD SCI USA, V112, pE6265, DOI 10.1073/pnas.1505935112; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Ganeshan B, 2013, RADIOLOGY, V266, P326, DOI 10.1148/radiol.12112428; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Ginsburg SB, 2015, J MAGN RESON IMAGING, V41, P1383, DOI 10.1002/jmri.24676; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Gnep K, 2017, J MAGN RESON IMAGING, V45, P103, DOI 10.1002/jmri.25335; Gunduz-Demir C, 2010, MED IMAGE ANAL, V14, P1, DOI 10.1016/j.media.2009.09.001; Hafiane A, 2008, LECT NOTES COMPUT SC, V5259, P903, DOI 10.1007/978-3-540-88458-3_82; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Huang YQ, 2016, J CLIN ONCOL, V34, P2157, DOI 10.1200/JCO.2015.65.9128; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; Khalvati F, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0069-9; Kickingereder P, 2016, RADIOLOGY, V280, P880, DOI 10.1148/radiol.2016160845; Kien Nguyen, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P1497, DOI 10.1109/ICPR.2010.370; Kobus T, 2016, RADIOLOGY, V278, P801, DOI 10.1148/radiol.2015142889; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Langer DL, 2010, RADIOLOGY, V255, P485, DOI 10.1148/radiol.10091343; Laws KI., 1980, TEXTURED IMAGE SEGME, V940, P188; Lee G, 2015, IEEE T MED IMAGING, V34, P284, DOI 10.1109/TMI.2014.2355175; Lee G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097954; Leo P, 2016, J MED IMAGING, V3, DOI 10.1117/1.JMI.3.4.047502; Li H, 2016, RADIOLOGY, V281, P382, DOI 10.1148/radiol.2016152110; Liang CS, 2016, ONCOTARGET, V7, P31401, DOI 10.18632/oncotarget.8919; Litjens GJS, 2016, RADIOLOGY, V278, P135, DOI 10.1148/radiol.2015142856; Madabhushi A, 2010, CLIN CHEM LAB MED, V48, P989, DOI 10.1515/CCLM.2010.193; Mattonen SA, 2014, MED PHYS, V41, DOI 10.1118/1.4866219; Miles KA, 2014, J NUCL MED, V55, P386, DOI 10.2967/jnumed.113.120485; Monaco JP, 2010, MED IMAGE ANAL, V14, P617, DOI 10.1016/j.media.2010.04.007; Naik S, 2008, I S BIOMED IMAGING, P284, DOI 10.1109/ISBI.2008.4540988; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Pallavi T, 2014, INT SOC OPTICAL ENG, V9035; Parmar C, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00272; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13087; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Penzias G, 2016, SCI REP-UK, V6, DOI 10.1038/srep29906; Prasath VS, 2012, 1 IEEE HEALTHC TECHN, P40; Rahbar H, 2016, ACAD RADIOL, V23, P768, DOI 10.1016/j.acra.2016.02.008; Singanamalli A, 2016, J MAGN RESON IMAGING, V43, P149, DOI 10.1002/jmri.24975; Sirinukunwattana K, 2015, IEEE T MED IMAGING, V34, P2366, DOI 10.1109/TMI.2015.2433900; Sparks R, 2013, COMPUT VIS IMAGE UND, V117, P1138, DOI 10.1016/j.cviu.2012.11.011; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tiwari P, 2013, MED IMAGE ANAL, V17, P219, DOI 10.1016/j.media.2012.10.004; Toth Robert J, 2014, J Pathol Inform, V5, P8, DOI 10.4103/2153-3539.129441; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Vignati A, 2015, PHYS MED BIOL, V60, P2685, DOI 10.1088/0031-9155/60/7/2685; Viswanath SE, 2012, J MAGN RESON IMAGING, V36, P213, DOI 10.1002/jmri.23618; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143308; Wibmer A, 2015, EUR RADIOL, V25, P2840, DOI 10.1007/s00330-015-3701-8; Wu WM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00071	73	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0200730	10.1371/journal.pone.0200730	http://dx.doi.org/10.1371/journal.pone.0200730			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169514	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400004
J	Li, Y; Wu, CJ; Yang, EJ; Li, K				Li, Yang; Wu, Chaojiang; Yang, Erjia; Li, Kai			Will open access increase journal CiteScores? An empirical investigation over multiple disciplines	PLOS ONE			English	Article							IN-DIFFERENCES; PROPENSITY-SCORE; CITATION; SCIENCE; IMPACT; SELECTION; RETURNS; PANEL	This paper empirically studies the effect of Open Access on journal CiteScores. We have found that the general effect is positive but not uniform across different types of journals. In particular, we investigate two types of heterogeneous treatment effect: (1) the differential treatment effect among journals grouped by academic field, publisher, and tier; and (2) differential treatment effects of Open Access as a function of propensity to be treated. The results are robust to a number of sensitivity checks and falsification tests. Our findings shed new light on Open Access effect on journals and can help stakeholders of journals in the decision of adopting the Open Access policy.	[Li, Yang; Wu, Chaojiang] Drexel Univ, LeBow Coll Business, Philadelphia, PA 19104 USA; [Yang, Erjia; Li, Kai] Drexel Univ, Coll Comp & Informat, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Wu, CJ (corresponding author), Drexel Univ, LeBow Coll Business, Philadelphia, PA 19104 USA.	cw578@drexel.edu	Li, Kai/N-3209-2013	Li, Kai/0000-0002-7264-365X				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Abadie A, 2005, REV ECON STUD, V72, P1, DOI 10.1111/0034-6527.00321; Anderson C., 2004, WIRED MAGAZINE, V12, P170, DOI DOI 10.3359/OZ0912041; Antelman K, 2004, COLL RES LIBR, V65, P372, DOI 10.5860/crl.65.5.372; ASHENFELTER O, 1985, REV ECON STAT, V67, P648, DOI 10.2307/1924810; Atchison A, 2015, PS-POLIT SCI POLIT, V48, P129, DOI 10.1017/S1049096514001668; Averett SL, 1996, ECON EDUC REV, V15, P37, DOI 10.1016/0272-7757(95)00027-5; Baumgartner H, 2003, J MARKETING, V67, P123, DOI 10.1509/jmkg.67.2.123.18610; Bethesda Statement, 2003, BETHESDA STATEMENT O; Bjork Bo-Christer, 2010, PLoS One, V5, pe11273, DOI 10.1371/journal.pone.0011273; BOAI, 2002, BUDAPEST OPEN ACCESS; Bond S, 2003, REV ECON STAT, V85, P153, DOI 10.1162/003465303762687776; Brand JE, 2010, AM SOCIOL REV, V75, P273, DOI 10.1177/0003122410363567; Brand JE, 2007, SOCIOL METHODOL, V37, P393, DOI 10.1111/j.1467-9531.2007.00185.x; Breen R, 2015, SOCIOL SCI, V2, P351, DOI 10.15195/v2.a17; Carneiro P, 2011, AM ECON REV, V101, P2754, DOI 10.1257/aer.101.6.2754; Crown WH, 2014, APPL HEALTH ECON HEA, V12, P7, DOI 10.1007/s40258-013-0075-4; Cumming D, 2017, STRATEG ENTREP J, V11, P357, DOI 10.1002/sej.1265; David PA, 1998, AM ECON REV, V88, P15; Davis PM, 2008, J AM SOC INF SCI TEC, V59, P2186, DOI 10.1002/asi.20943; Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Davis PM, 2007, SCIENTOMETRICS, V71, P203, DOI 10.1007/s11192-007-1661 -8; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Evans JA, 2009, SCIENCE, V323, P1025, DOI 10.1126/science.1154562; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; FAZZARI SM, 1988, BROOKINGS PAP ECO AC, P141; Gargouri Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013636; Gormley TA, 2016, J FINANC ECON, V122, P431, DOI 10.1016/j.jfineco.2016.08.002; Gormley TA, 2014, REV FINANC STUD, V27, P617, DOI 10.1093/rfs/hht047; Hajjem C, 2006, CS0606079 ARXIV; Harnad S., 2004, D LIB MAGAZINE, V10, DOI DOI 10.1045/JUNE2004-HARNAD; Henneken EA, 2006, CS0604061 ARXIV; Hicks Diana, 2015, Nature, V520, P429, DOI 10.1038/520429a; Hitchcock S, 2004, EFFECT OPEN ACCESS D; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Koler-Povh T, 2014, SCIENTOMETRICS, V98, P1033, DOI 10.1007/s11192-013-1101-x; Laakso M, 2016, J INFORMETR, V10, P919, DOI 10.1016/j.joi.2016.08.002; Laakso M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020961; Lawrence S, 2001, NATURE, V411, P521, DOI 10.1038/35079151; Mann F, 2009, COMMUN ACM, V52, P135, DOI 10.1145/1467247.1467279; McCabe MJ, 2015, REV ECON STAT, V97, P144, DOI 10.1162/REST_a_00437; McCabe MJ, 2014, ECON INQ, V52, P1284, DOI 10.1111/ecin.12064; McKiernan G., 2000, INT J GREY LIT, V1, P127, DOI [10.1108/14666180010345564, DOI 10.1108/14666180010345564]; Merton R.K., 1968, SOCIAL THEORY SOCIAL; Moed HF, 2007, J AM SOC INF SCI TEC, V58, P2047, DOI 10.1002/asi.20663; Pinfield S, 2014, J ASSOC INF SCI TECH, V65, P2404, DOI 10.1002/asi.23131; Redalyc L, 2003, BERLIN DECLARATION O; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Straumann T, 2001, CS0111035 ARXIV; Swan A, 2001, NATURE; Tennant Jonathan P, 2016, F1000Res, V5, P632; Wang XW, 2015, SCIENTOMETRICS, V103, P555, DOI 10.1007/s11192-015-1547-0; Wing C, 2014, J HEALTH ECON, V34, P131, DOI 10.1016/j.jhealeco.2013.12.001; Wohlrabe K, 2014, DO OPEN ACCESS ARTIC; Xie Y, 2012, SOCIOL METHODOL, V42, P314, DOI 10.1177/0081175012452652; Xu L, 2011, P 2011 ICONFERENCE, P426, DOI DOI 10.1145/1940761; Yan EJ, 2017, J ASSOC INF SCI TECH, V68, P1090, DOI 10.1002/asi.23670	60	26	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201885	10.1371/journal.pone.0201885	http://dx.doi.org/10.1371/journal.pone.0201885			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161156	Green Submitted, gold, Green Published			2022-12-27	WOS:000443388900015
J	Ma, SS; Ning, TG; Pei, L; Li, J; Zheng, JJ; He, XQ; Wen, X				Ma, Shaoshuo; Ning, Tigang; Pei, Li; Li, Jing; Zheng, Jingjing; He, Xueqing; Wen, Xiaodong			Bend-resistant leaky multi-trench fiber with large mode area and single-mode operation	PLOS ONE			English	Article							OPTICAL-FIBER; LASERS; AMPLIFIERS; DESIGN; INDEX; PERFORMANCE; DISPERSION	A novel structure of modified multi-trench fiber (MTF) with characteristics of bend-resistance and large mode-area is proposed. In this structure, each low refractive-index trench of traditional MTF is broken by two gaps up and down. Numerical investigations show that the mode field area of 840 mu m(2) can be achieved with effective single-mode (SM) operation when the bending radius is 15 cm. Moreover, the high order mode (HOM) suppression of the proposed design is better than that of standard MTF. The SM operation property can be enhanced with the decreases of bending radius. The proposed design shows great potential in high power fiber lasers with compact structure.	[Ma, Shaoshuo; Ning, Tigang; Pei, Li; Li, Jing; Zheng, Jingjing; He, Xueqing] Beijing Jiaotong Univ, Key Lab All Opt Network & Adv Telecommun Network, Inst Lightwave Technol, Beijing, Peoples R China; [Wen, Xiaodong] Qufu Normal Univ, Coll Phys & Engn, Qufu, Peoples R China	Beijing Jiaotong University; Qufu Normal University	Pei, L (corresponding author), Beijing Jiaotong Univ, Key Lab All Opt Network & Adv Telecommun Network, Inst Lightwave Technol, Beijing, Peoples R China.	lipei@bjtu.edu.cn			National Natural Science Foundation of China [NSFC-61525501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC-61525501), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dussardier B, 2011, APPL OPTICS, V50, P3118, DOI 10.1364/AO.50.003118; Eidam T, 2011, OPT EXPRESS, V19, P13218, DOI 10.1364/OE.19.013218; Jain D, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2014.2301412; Jain D, 2013, OPT EXPRESS, V21, P26663, DOI 10.1364/OE.21.026663; Jain D, 2013, OPT EXPRESS, V21, P1448, DOI 10.1364/OE.21.001448; Kim G, 2010, ADV SOLID; Kumar A, 2007, J OPT A-PURE APPL OP, V10; Kumar A, 2011, APPL OPTICS, V50, pE119, DOI 10.1364/AO.50.00E119; Li MJ, 2009, J LIGHTWAVE TECHNOL, V27, P3010, DOI 10.1109/JLT.2009.2020682; Limpert J, 2004, OPT EXPRESS, V12, P1313, DOI 10.1364/OPEX.12.001313; Ma SS, 2016, APPL OPTICS, V55, P9954, DOI 10.1364/AO.55.009954; Ma XQ, 2014, OPT EXPRESS, V22, P9206, DOI 10.1364/OE.22.009206; Machewirth D, 2004, P SOC PHOTO-OPT INS, V5335, P140, DOI 10.1117/12.528056; Molardi C, 2017, OPT EXPRESS, V25, P29013, DOI 10.1364/OE.25.029013; NAGANO K, 1978, APPL OPTICS, V17, P2080, DOI 10.1364/AO.17.002080; Nilsson J, 2011, SCIENCE, V332, P921, DOI 10.1126/science.1194863; PETERMANN K, 1983, ELECTRON LETT, V19, P712, DOI 10.1049/el:19830485; Rastogi V, 2004, J OPT SOC AM B, V21, P258, DOI 10.1364/JOSAB.21.000258; Richardson DJ, 2010, J OPT SOC AM B, V27, pB63, DOI 10.1364/JOSAB.27.000B63; Saitoh K, 2003, OPT EXPRESS, V11, P3100, DOI 10.1364/OE.11.003100; Smith AV, 2011, OPT EXPRESS, V19, P10180, DOI 10.1364/OE.19.010180; Sun J, 2015, J LIGHTWAVE TECHNOL, V33, P4908, DOI 10.1109/JLT.2015.2491651; Sun J, 2015, APPL OPTICS, V54, P8271, DOI 10.1364/AO.54.008271; Tsuchida Y, 2005, OPT EXPRESS, V13, P4770, DOI 10.1364/OPEX.13.004770; Wang LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2015.2427746; Wang X, 2015, IEEE J SEL TOP QUANT, V22, DOI [10.1109/JSTQE.2015.2461456, 10.1109/JSTQE.2015.2456108]; Zervas MN, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2014.2321279	27	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203047	10.1371/journal.pone.0203047	http://dx.doi.org/10.1371/journal.pone.0203047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161209	gold, Green Submitted, Green Published			2022-12-27	WOS:000443388900072
J	Drews, HJ; Wiesner, CD; Bethke-Jaenicke, C; Weinhold, SL; Baier, PC; Goder, R				Drews, Henning Johannes; Wiesner, Christian Dirk; Bethke-Jaenicke, Christina; Weinhold, Sara Lena; Baier, Paul Christian; Goeder, Robert			Slow-wave sleep predicts long-term social functioning in severe mental illness	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; SCHIZOPHRENIA; MEMORY; CONSOLIDATION; DISORDERS; DEFICITS; OUTCOMES	Sleep's relevance for long-term social functioning in psychiatric disorders has been widely overlooked so far. Here, we investigate social functioning in a transdiagnostic sample of 31 patients with severe mental illness, namely schizophrenia (n = 15) or major depression (n = 16), in relation to their polysomnographic sleep characteristics 6 (+/- 2.4) years earlier. In addition, cognitive performance at follow-up and clinical characteristics (i.e., severity of disorder-related symptoms and number of hospitalizations between baseline and follow-up) are assessed. Multiple regression analysis results in a model with slow-wave sleep (SWS) and number of hospitalizations as significant predictors accounting for 50% (R-2 = 0.507; p<0.001) of the variance in social functioning. SWS remains a significant predictor of long-term social functioning throughout a series of refining analyses which also identify baseline functioning as an additional significant predictor, whereas diagnosis is non-significant. Also, the effect of SWS on social functioning is not mediated by number of hospitalizations as assessed by a bootstrapped mediation analysis. We thus conclude that duration of slow-wave sleep is a powerful predictor of long-term social outcome in psychiatric disorders. Also, we discuss the relevance of verbal memory, symptom severity, and diagnostic category for social functioning. Future studies should test this finding by using a prospective design, a bigger sample, optimized predictor variables, and a more diverse set of diagnoses. Moreover, it should be explored whether or not treating sleep disturbances in psychiatric illnesses independently improves long-term social functioning.	[Drews, Henning Johannes; Bethke-Jaenicke, Christina; Weinhold, Sara Lena; Baier, Paul Christian; Goeder, Robert] Christian Albrechts Univ Kiel, Dept Psychiat & Psychotherapy, Kiel, Schleswig Holst, Germany; [Wiesner, Christian Dirk] Christian Albrechts Univ Kiel, Dept Psychol, Kiel, Schleswig Holst, Germany	University of Kiel; University of Kiel	Drews, HJ (corresponding author), Christian Albrechts Univ Kiel, Dept Psychiat & Psychotherapy, Kiel, Schleswig Holst, Germany.	henning.drews@uksh.de	Baier, Paul Christian/H-7919-2014	Weinhold, Sara Lena/0000-0002-7606-3492; Drews, Henning Johannes/0000-0002-9929-3194	Dpt. of Psychiatry and Psychotherapy, Christian-Albrechts-University, Kiel and Land Schleswig-Holstein within the funding program Open Access Publikationsfonds	Dpt. of Psychiatry and Psychotherapy, Christian-Albrechts-University, Kiel and Land Schleswig-Holstein within the funding program Open Access Publikationsfonds	The present study was funded by own resources of the Dpt. of Psychiatry and Psychotherapy, Christian-Albrechts-University, Kiel and Land Schleswig-Holstein within the funding program Open Access Publikationsfonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Baglioni C, 2016, PSYCHOL BULL, V142, P969, DOI 10.1037/bul0000053; Bonnin CM, 2010, J AFFECT DISORDERS, V121, P156, DOI 10.1016/j.jad.2009.05.014; Bryson G, 2003, J NERV MENT DIS, V191, P87, DOI 10.1097/01.NMD.0000050937.06332.3C; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Feld GB, 2017, CURR OPIN NEUROBIOL, V44, P20, DOI 10.1016/j.conb.2017.02.012; Fusar-Poli P, 2010, J PSYCHIATR RES, V44, P294, DOI 10.1016/j.jpsychires.2009.08.016; Giugiario M, 2012, SOC PSYCH PSYCH EPID, V47, P553, DOI 10.1007/s00127-011-0367-7; Goder R, 2008, PHARMACOPSYCHIATRY, V41, P92, DOI 10.1055/s-2007-1004592; Goder R, 2004, J PSYCHIATR RES, V38, P591, DOI 10.1016/j.jpsychires.2004.04.005; Goder R, 2011, J SLEEP RES, V20, P544, DOI 10.1111/j.1365-2869.2011.00914.x; Goldman M, 1996, SCHIZOPHR RES, V21, P65, DOI 10.1016/0920-9964(96)00021-7; Gonzalez-Ortega I, 2013, PSYCHIAT RES, V206, P8, DOI 10.1016/j.psychres.2012.08.025; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 2016, J CLIN PSYCHIAT, V77, P8, DOI 10.4088/JCP.14074su1c.02; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Harvey AG, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1690-9; Harvey AG, 2011, CLIN PSYCHOL REV, V31, P225, DOI 10.1016/j.cpr.2010.04.003; Hayes A. F., 2012, PROCESS VERSATILE CO; Helmstaedter C, 1990, Schweiz Arch Neurol Psychiatr (1985), V141, P21; Hofer A, 2007, PHARMACOPSYCHIATRY, V40, P1, DOI 10.1055/s-2007-958520; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Krystal AD, 2012, NEUROL CLIN, V30, P1389, DOI 10.1016/j.ncl.2012.08.018; Lee RSC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058176; Leger D, 2018, SLEEP MED REV; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Nordt C, 2007, SOC SCI MED, V65, P1420, DOI 10.1016/j.socscimed.2007.05.024; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; Raven F, 2018, SLEEP MED REV, V39, P3, DOI 10.1016/j.smrv.2017.05.002; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sanchez-Torres AM, 2017, SCHIZOPHR RES, V179, P30, DOI 10.1016/j.schres.2016.10.002; Sara SJ, 2017, J NEUROSCI, V37, P457, DOI 10.1523/JNEUROSCI.0297-16.2017; Simonsen C, 2010, J INT NEUROPSYCH SOC, V16, P771, DOI 10.1017/S1355617710000573; STRAUSS JS, 1972, ARCH GEN PSYCHIAT, V27, P739; WHO, 2013, EUR MENT HLTH ACT PL; Woo YS, 2016, CLIN PSYCHOPHARM NEU, V14, P1, DOI 10.9758/cpn.2016.14.1.1	38	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202198	10.1371/journal.pone.0202198	http://dx.doi.org/10.1371/journal.pone.0202198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157190	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400043
J	Koike, S; Nakamaru, M; Otaka, T; Shimao, H; Shimomura, KI; Yamato, T				Koike, Shimpei; Nakamaru, Mayuko; Otaka, Tokinao; Shimao, Hajime; Shimomura, Ken-Ichi; Yamato, Takehiko			Reciprocity and exclusion in informal financial institutions: An experimental study of rotating savings and credit associations	PLOS ONE			English	Article							PUBLIC-GOODS EXPERIMENTS; ALTRUISTIC PUNISHMENT; HUMAN COOPERATION; EVOLUTION; PROVISION; ECONOMICS; SELECTION; GOSSIP; GAMES	Group cooperation is fundamental to human society. The public goods game is often used to describe the difficulty of group cooperation. However, there are other structures of institutions to maintain group cooperation such as Rotating savings and credit associations (ROSCAs). ROSCAs are informal financial institutions that exist worldwide, in which all participants contribute to a common fund and take turns to receive a return. ROSCAs are common in developing countries and among migrant groups in developed countries. There are various types of ROSCAs, and they share a crucial problem in that participants whose turn to receive a return has passed have an incentive to default on their contributions. We conducted a laboratory experiment to investigate the mechanisms that can prevent default in a fixed ROSCA, in which the order of receipt of returns is determined before starting and is also known to members. The findings are as follows. (i) Excluding low contributors from ROSCA groups by voting increased contribution rates both before and after the receipt of returns. (ii) ROSCA members exhibited reciprocity and a sense of revenge: that is, members contributed to the returns payments of other members who had contributed to them, and did not contribute to the returns payments of non-contributors. Voluntary behaviors thus sustained ROSCAs. Meanwhile, an exogenous punishment whereby subjects were prevented from receiving returns payments unless they had themselves contributed previously did not increase contribution rates.	[Koike, Shimpei; Nakamaru, Mayuko; Shimao, Hajime] Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo, Japan; [Nakamaru, Mayuko; Yamato, Takehiko] Tokyo Inst Technol, Sch Environm & Soc, Tokyo, Japan; [Otaka, Tokinao] Tokyo Inst Technol, Dept Social Engn, Tokyo, Japan; [Shimomura, Ken-Ichi] Kobe Univ, Res Inst Econ & Business Adm, Kobe, Hyogo, Japan; [Yamato, Takehiko] Tokyo Inst Technol, Sch Engn, Tokyo, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Tokyo Institute of Technology; Kobe University; Tokyo Institute of Technology	Nakamaru, M (corresponding author), Tokyo Inst Technol, Dept Value & Decis Sci, Tokyo, Japan.; Nakamaru, M (corresponding author), Tokyo Inst Technol, Sch Environm & Soc, Tokyo, Japan.	nakamaru.m.aa@m.titech.ac.jp	Nakamaru, Mayuko/N-9127-2013; Yamato, Takehiko/B-7240-2015	Nakamaru, Mayuko/0000-0003-2116-1711; Yamato, Takehiko/0000-0001-7552-865X	JSPS KAKENHI [21770016, 26440236, 26285045, 24310110, 25380228]; Zengin Foundation for Studies on Economics and Finance	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Zengin Foundation for Studies on Economics and Finance	This work was supported by JSPS KAKENHI Grant Numbers 21770016, 26440236 and 26285045 for MN; JSPS KAKENHI Grant Numbers 24310110, 25380228 and 26285045 for KS and the Zengin Foundation for Studies on Economics and Finance for TY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambec S, 2007, J DEV ECON, V82, P120, DOI 10.1016/j.jdeveco.2005.09.005; Anderson S, 2009, J DEV ECON, V90, DOI [10.1016/j.jdeveco.2008.12.001, DOI 10.1016/J.JDEVECO.2008.12.001]; Ardener S., 1964, J R ANTHROPOL INST G, V94, P201, DOI DOI 10.2307/2844382; Ardener Shirley, 1995, MONEY GO ROUNDS IMPO; Armendaris B, 2010, EC MICROFINANCE; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Besley T, 1996, ECON J, V106, P39, DOI 10.2307/2234930; BESLEY T, 1993, AM ECON REV, V83, P792; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; Bonnett AW, 1981, I ADAPTATIONS W INDI; Bouman F. J. A., 1977, SAVINGS DEV, V1, P181; BOUMAN FJA, 1995, WORLD DEV, V23, P371, DOI 10.1016/0305-750X(94)00141-K; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Carpenter JP, 2007, GAME ECON BEHAV, V60, P31, DOI 10.1016/j.geb.2006.08.011; Chamlee-Wright E, 2002, ECON DEV CULT CHANGE, V50, P979, DOI 10.1086/343134; Charness G, 2014, GAME ECON BEHAV, V87, P322, DOI 10.1016/j.geb.2014.05.002; Charness G, 2014, J ECON BEHAV ORGAN, V102, P119, DOI 10.1016/j.jebo.2014.03.005; Cinyabuguma M, 2005, J PUBLIC ECON, V89, P1421, DOI 10.1016/j.jpubeco.2004.05.011; Coleman JS., 1990, FDN SOCIAL THEORY; Croson R, 2015, J ECON BEHAV ORGAN, V114, P13, DOI 10.1016/j.jebo.2015.03.005; DIEKMANN A, 1985, J CONFLICT RESOLUT, V29, P605, DOI 10.1177/0022002785029004003; Ehrhart KM, 1999, CIRANO SCI SERIES S, V99s, P24; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Feinberg M, 2014, PSYCHOL SCI, V25, P656, DOI 10.1177/0956797613510184; Gachter S, 2011, EUR ECON REV, V55, P193, DOI 10.1016/j.euroecorev.2010.04.003; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; GEERTZ C, 1962, ECON DEV CULT CHANGE, V10, P241, DOI 10.1086/449960; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Handa S, 1999, J DEV ECON, V60, P173, DOI 10.1016/S0304-3878(99)00040-1; Hechter Michael, 1988, PRINCIPLES GROUP SOL; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Koike S, 2010, J THEOR BIOL, V264, P143, DOI 10.1016/j.jtbi.2009.12.030; LEVIN BR, 1974, EVOLUTION, V28, P527, DOI 10.1111/j.1558-5646.1974.tb00787.x; Light Ivan H., 1972, ETHNIC ENTERPRISE AM; Maier-Rigaud FP, 2010, J ECON BEHAV ORGAN, V73, P387, DOI 10.1016/j.jebo.2009.11.001; Morduch J, 2009, PORTFOLIOS POOR; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; Nakamaru M, 2004, EVOL ECOL RES, V6, P261; Nakamaru M, 2006, J THEOR BIOL, V240, P475, DOI 10.1016/j.jtbi.2005.10.011; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Page T, 2005, ECON J, V115, P1032, DOI 10.1111/j.1468-0297.2005.01031.x; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Schreiner M, 2010, DEV PRACTICE, V10, P229; Seki M, 2016, J THEOR BIOL, V407, P90, DOI 10.1016/j.jtbi.2016.07.001; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sober E., 1999, OTHERS EVOLUTION PSY; Sugden R, 1986, EC RIGHTS COOPERATIO; Trivers R. L., 1985, SOCIAL EVOLUTION; YAMAGISHI T, 1993, SOC PSYCHOL QUART, V56, P235, DOI 10.2307/2786661	58	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202878	10.1371/journal.pone.0202878	http://dx.doi.org/10.1371/journal.pone.0202878			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157222	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400073
J	Landman, C; Grill, JP; Mallet, JM; Marteau, P; Humbert, L; Le Balc'h, E; Maubert, MA; Perez, K; Chaara, W; Brot, L; Beaugerie, L; Sokol, H; Thenet, S; Rainteau, D; Seksik, P; Quevrain, E				Landman, Cecilia; Grill, Jean-Pierre; Mallet, Jean-Maurice; Marteau, Philippe; Humbert, Lydie; Le Balc'h, Eric; Maubert, Marie-Anne; Perez, Kevin; Chaara, Wahiba; Brot, Loic; Beaugerie, Laurent; Sokol, Harry; Thenet, Sophie; Rainteau, Dominique; Seksik, Philippe; Quevrain, Elodie		St Antoine IBD Network	Inter-kingdom effect on epithelial cells of the N-Acyl homoserine lactone 3-oxo-C12:2, a major quorum-sensing molecule from gut microbiota	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RESONANCE MASS-SPECTROMETRY; ACTIVE ULCERATIVE-COLITIS; LINEAR ION-TRAP; FECAL MICROBIOTA; CROHNS-DISEASE; PSEUDOMONAS-AERUGINOSA; FAECALIBACTERIUM-PRAUSNITZII; ELECTROSPRAY-IONIZATION; CONTROLLED-TRIAL	Background and aims N-acyl homoserine lactones (AHLs), which are autoinducer quorum-sensing molecules involved in the bacterial communication network, also interact with eukaryotic cells. Searching for these molecules in the context of inflammatory bowel disease (IBD) is appealing. The aims of our study were to look for AHL molecules in faecal samples from healthy subjects (HS) and IBD patients to correlate AHL profiles with the microbiome and investigate the effect of AHLs of interest on epithelial cells. Methods Using mass spectrometry, we characterised AHL profiles in faecal samples from HS (n = 26) and IBD patients in remission (n = 24) and in flare (n = 25) and correlated the presence of AHLs of interest with gut microbiota composition obtained by real-time qPCR and 16S sequencing. We synthesised AHLs of interest to test the inflammatory response after IL1 beta stimulation and paracellular permeability on Caco-2 cells. Results We observed 14 different AHLs, among which one was prominent. This AHL corresponded to 3-oxo-C12:2 and was found significantly less frequently in IBD patients in flare (16%) and in remission (37.5%) versus HS (65.4%) (p = 0.001). The presence of 3-oxo-C12:2 was associated with significantly higher counts of Firmicutes, especially Faecalbacterium prausnitzii, and lower counts of Escherichia coli. In vitro, 3-oxo-C12:2 exerted an anti-inflammatory effect on Caco-2 cells. Interestingly, although 3-oxo-C12, the well-known AHL from Pseudomonas aeruginosa, increased paracellular permeability, 3-oxo-C12:2 did not. Conclusions We identified AHLs in the human gut microbiota and discovered a new and prominent AHL, 3-oxo-C12:2, which correlates with normobiosis and exerts a protective effect on gut epithelial cells.	[Landman, Cecilia; Grill, Jean-Pierre; Mallet, Jean-Maurice; Marteau, Philippe; Humbert, Lydie; Le Balc'h, Eric; Maubert, Marie-Anne; Perez, Kevin; Brot, Loic; Beaugerie, Laurent; Sokol, Harry; Rainteau, Dominique; Seksik, Philippe; Quevrain, Elodie] Sorbonne Univ, PSL Univ, Ecole Normale Super, CNRS,INSERM,AP HP,Hop St Antoine,Lab Biomol,LBM, Paris, France; [Chaara, Wahiba] Sorbonne Univ, INSERM, i3, Paris, France; [Thenet, Sophie] Sorbonne Univ, PSL Univ, Ctr Rech Cordeliers, Paris, France	Arts et Metiers Institute of Technology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Universite Paris Cite	Seksik, P (corresponding author), Sorbonne Univ, PSL Univ, Ecole Normale Super, CNRS,INSERM,AP HP,Hop St Antoine,Lab Biomol,LBM, Paris, France.	philippe.seksik@aphp.fr	Thenet, Sophie/GQY-5726-2022; SEKSIK, Philippe/ABE-2962-2020; Mallet, Jean-Maurice/H-2113-2011; Perez, Kevin/AAM-3763-2021; Sokol, Harry/E-2290-2019; sokol, harry/ABA-8991-2020	Thenet, Sophie/0000-0002-0336-2942; Mallet, Jean-Maurice/0000-0001-8570-9542; Perez, Kevin/0000-0002-1802-185X; Sokol, Harry/0000-0002-2914-1822; sokol, harry/0000-0002-2914-1822; philippe, marteau/0000-0002-7621-6719	Biocodex; ECCO (European Crohn's and Colitis Organization); Association Francois Aupetit; Fondation pour la recherche medicale; SNFGE (Societe nationale francaise de gastroenterologie)	Biocodex; ECCO (European Crohn's and Colitis Organization); Association Francois Aupetit; Fondation pour la recherche medicale(Fondation pour la Recherche Medicale); SNFGE (Societe nationale francaise de gastroenterologie)	This study was supported by grants from Biocodex https://www.snfge.org/content/bourse-biocodex (CL), ECCO (European Crohn's and Colitis Organization) https://www.ecco-ibd.eu/science/fellowships-and-grants.html (PS), the Association Francois Aupetit https://www.afa.asso.fr/categorie/la-recherche/bourses-de-recherche.html (CL), Fondation pour la recherche medicale https://www.frm.org/chercheurs/les-appels-doffre/programme-espoirs-de-la-recherche (ELB, CL) and SNFGE (Societe nationale francaise de gastroenterologie) https://www.snfge.org/content/fare-nouvelles-modalites-pour-lappel-projet (PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand X, 2001, INTENS CARE MED, V27, P1263, DOI 10.1007/s001340100979; Boehm D, 2009, INFLAMM BOWEL DIS, V15, P93, DOI 10.1002/ibd.20582; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; Cataldi TRI, 2008, J MASS SPECTROM, V43, P82, DOI 10.1002/jms.1275; Cataldi TRI, 2011, RAPID COMMUN MASS SP, V25, P1817, DOI 10.1002/rcm.5054; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Chakrabarti S, 2003, PROTEIN ENG, V16, P271, DOI 10.1093/proeng/gzg031; Chhabra SR, 2003, J MED CHEM, V46, P97, DOI 10.1021/jm020909n; Cooley M, 2008, CHEM BIOL, V15, P1141, DOI 10.1016/j.chembiol.2008.10.010; Cooley MA, 2010, MICROBES INFECT, V12, P231, DOI 10.1016/j.micinf.2009.12.009; Derwa Y, 2017, ALIMENT PHARM THER, V46, P389, DOI 10.1111/apt.14203; Doberva M, 2015, AQUAT MICROB ECOL, V74, P107, DOI 10.3354/ame01734; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Eum SY, 2014, AM J PHYSIOL-GASTR L, V306, pG992, DOI 10.1152/ajpgi.00016.2014; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Glucksam-Galnoy Y, 2013, J IMMUNOL, V191, P337, DOI 10.4049/jimmunol.1300368; Hawver LA, 2016, FEMS MICROBIOL REV, V40, P738, DOI 10.1093/femsre/fuw014; Holm A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00309; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karban A, 2007, DIGEST DIS SCI, V52, P2707, DOI 10.1007/s10620-006-9700-5; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Mitchell RJ, 2011, BMB REP, V44, P1, DOI 10.5483/BMBRep.2011.44.1.1; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; MOSS CW, 1989, J CLIN MICROBIOL, V27, P1467, DOI 10.1128/JCM.27.7.1467-1470.1989; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; Pascal V, 2017, GUT, V66, P813, DOI 10.1136/gutjnl-2016-313235; Pigneur B, 2016, MUCOSAL IMMUNOL, V9, P1360, DOI 10.1038/mi.2016.67; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Quigley EMM, 2016, CURR OPIN GASTROEN, V32, P74, DOI 10.1097/MOG.0000000000000243; Ritchie AJ, 2005, INFECT IMMUN, V73, P1648, DOI 10.1128/IAI.73.3.1648-1655.2005; Sartor RB, 2017, GASTROENTEROLOGY, V152, P327, DOI 10.1053/j.gastro.2016.10.012; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Soares JA, 2011, CURR OPIN MICROBIOL, V14, P188, DOI 10.1016/j.mib.2011.01.006; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Sokol H, 2014, DIGEST DIS, V32, P10, DOI 10.1159/000367820; Swearingen MC, 2013, J BACTERIOL, V195, P173, DOI 10.1128/JB.01341-12; Teplitski M, 2011, CHEM REV, V111, P100, DOI 10.1021/cr100045m; Teshima CW, 2017, CLIN GASTROENTEROL H, V15, P1413, DOI 10.1016/j.cgh.2017.02.028; Varela E, 2013, ALIMENT PHARM THER, V38, P151, DOI 10.1111/apt.12365; Vikstrom E, 2009, EXP CELL RES, V315, P313, DOI 10.1016/j.yexcr.2008.10.044	46	24	24	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202587	10.1371/journal.pone.0202587	http://dx.doi.org/10.1371/journal.pone.0202587			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157234	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400063
J	Fu, LY; Wang, XX; Wu, X; Li, B; Huang, LL; Li, BB; Du, QF; Wang, PX				Fu, Li-Ying; Wang, Xiao-Xiao; Wu, Xiao; Li, Bo; Huang, Ling-Ling; Li, Bing-Bing; Du, Qing-Feng; Wang, Pei-Xi			Association between obesity and sickness in the past two weeks among middle-aged and elderly women: A cross-sectional study in Southern China	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; CHRONIC DISEASES; OVERWEIGHT; MORTALITY; DEPRESSION; PREVALENCE; WEIGHT; COHORT	Objectives Sickness situation in the past two weeks, an indicator of health service needs, is an increasing major health concern. However, data on the relationship between obesity and two-week morbidity in the female population, particularly in middle-aged and elderly women, is sparse. The present study aimed to examine the association between obesity and two-week morbidity among middle-aged and elderly women in Southern China, and to explore the independent contributions of socio-demographic variables, health-related factors, and obesity to two-week morbidity. Methods In total, 2364 middle-aged and elderly women were included in this cross-sectional, community-based survey. Obesity was assessed using body mass index (BMI). The outcome variable was sickness situation over the past two weeks (two-week morbidity). Clustered logistic regression was applied to analyze the independent contribution of obesity to two-week morbidity. Results Approximately 14.6% of participants experienced sickness in the past two weeks. Obesity (odds ratio [OR] = 1.47, 95% confidence interval [CI] = 1.02-2.12) was significantly associated with two-week morbidity and its independent contribution accounted for 3.7%, lower than that of socio-demographic variables (73.7%) and health-related factors(22.6%). Conclusions Some degree of correlation was observed between obesity and two-week morbidity among middle-aged and elderly women in Southern China, which can be used as a reference for health-related decision-making.	[Fu, Li-Ying; Wang, Xiao-Xiao; Wu, Xiao; Li, Bo; Huang, Ling-Ling; Li, Bing-Bing; Wang, Pei-Xi] Henan Univ, Sch Nursing & Hlth, Inst Chron Dis Risks Assessment, Kaifeng, Henan, Peoples R China; [Fu, Li-Ying; Du, Qing-Feng; Wang, Pei-Xi] Southern Med Univ, Nanhai Hosp, Gen Practice Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Xiao-Xiao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Nursing Dept, Wuhan, Hubei, Peoples R China; [Wang, Pei-Xi] Guangzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou, Guangdong, Peoples R China	Henan University; Southern Medical University - China; Huazhong University of Science & Technology; Guangzhou Medical University	Wang, PX (corresponding author), Henan Univ, Sch Nursing & Hlth, Inst Chron Dis Risks Assessment, Kaifeng, Henan, Peoples R China.; Du, QF; Wang, PX (corresponding author), Southern Med Univ, Nanhai Hosp, Gen Practice Ctr, Guangzhou, Guangdong, Peoples R China.; Wang, PX (corresponding author), Guangzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou, Guangdong, Peoples R China.	nhyyqk@126.com; 18317856338@163.com			Science and Technology Program of Guangzhou [201607010136]; Guangzhou 121 Talents program	Science and Technology Program of Guangzhou; Guangzhou 121 Talents program	This work was supported by the Science and Technology Program of Guangzhou [201607010136] and the Guangzhou 121 Talents program to PXW.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Barcelos-Ferreira R, 2013, J AFFECT DISORDERS, V150, P616, DOI 10.1016/j.jad.2013.02.024; Center for Health Statistics and Information the Ministry of Health of China, 2009, REP NAT HLTH SERV SU; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen J, 2016, CHINESE MED CLIN, V16, P1573; Chen L., 2016, THESIS; Cohen YC, 1999, J CLIN EPIDEMIOL, V52, P1031, DOI 10.1016/S0895-4356(99)00079-7; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Ferrie JE, 2007, OBESITY, V15, P1554, DOI 10.1038/oby.2007.184; Gazmararian JA, 2015, J OBES, V2015, DOI 10.1155/2015/298698; Gong YL, 2002, HLTH SERVICE REASEAR; Hajek A, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0081-5; Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317; Huang X, 2015, INT J ENV RES PUB HE, V12, P13209, DOI 10.3390/ijerph121013209; Jing MJ, 2015, J PSYCHOSOM RES, V79, P288, DOI 10.1016/j.jpsychores.2015.05.009; Khongsdier R, 2005, BRIT J NUTR, V93, P101, DOI 10.1079/BJN20041316; Korpela K, 2013, SCAND J PUBLIC HEALT, V41, P25, DOI 10.1177/1403494812468965; Lin YY, 2017, J PUBLIC HLTH PREVEN, V28, P133; Liu L., 2018, HLTH EC RES, P39, DOI [10.14055/j.cnki.33-1056/f.20180109.010, DOI 10.14055/J.CNKI.33-1056/F.20180109.010]; Mao Y, 2013, CHINESE MED J-PEKING, V126, P2510, DOI 10.3760/cma.j.issn.0366-6999.20123001; Moore SC, 2008, INT J OBESITY, V32, P730, DOI 10.1038/sj.ijo.0803801; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Qin XZ, 2016, HEALTH ECON, V25, P1291, DOI 10.1002/hec.3217; Roos E, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4997-x; Roos E, 2015, EUR J PUBLIC HEALTH, V25, P263, DOI 10.1093/eurpub/cku087; Rossi AP, 2017, J GERONTOL A-BIOL, V72, P1098, DOI 10.1093/gerona/glw203; Salguero A, 2011, ARCH GERONTOL GERIAT, V53, P152, DOI 10.1016/j.archger.2010.10.005; Song T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2238-8; Tian DP, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0330-z; Wardell S, 2015, CAN RESPIR J, V22, P23, DOI 10.1155/2015/938930; Wen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043081; World Health Organization, GLOBAL STATUS REPORT; Xu LT, 2016, CHINESE COMMUNITY PH, V32, P184; Zhao W, 2008, OBES REV, V9, P62, DOI 10.1111/j.1467-789X.2007.00440.x; Zhu CY, 2012, QUAL LIFE RES, V21, P495, DOI 10.1007/s11136-011-9950-3; Zhu Yan-Bo, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P687; 何利平, 2017, [中国卫生统计, Chinese Journal of Health Statistics], V34, P104; 高忠飞, 2016, [中国卫生统计, Chinese Journal of Health Statistics], V33, P800	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203034	10.1371/journal.pone.0203034	http://dx.doi.org/10.1371/journal.pone.0203034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153292	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700038
J	Gao, X; Yang, X; Noll, L; Shi, XR; Worley, J; Allard, M; Brown, E; Nagaraja, TG; Meng, JH				Gao, Xin; Yang, Xun; Noll, Lance; Shi, Xiaorong; Worley, Jay; Allard, Marc; Brown, Eric; Nagaraja, T. G.; Meng, Jianghong			Whole genome shotgun sequencing revealed highly polymorphic genome regions and genes in Escherichia coli O157:H7 isolates collected from a single feedlot	PLOS ONE			English	Article							UNITED-STATES; OUTBREAK DATA; O157-H7; VIRULENCE; CATTLE; INFECTION; MICROBIOLOGY; EPIDEMIOLOGY; SURVEILLANCE; PREVALENCE	Escherichia coli serotype O157:H7 continues to pose a serious health threat to human beings. Cattle, a major reservoir of the pathogen, harbor E. coli O157:H7 in their gastrointestinal tract and shed variable concentrations of E. coli O157:H7 into the environment. Genetic characterization of cattle-shed E. coli O157 strains is of interest to the livestock industry, food business, and public health community. The present study applied whole genome shotgun sequencing (WGS) and single nucleotide variant (SNV) calling to characterize 279 cattle-shed E. coli O157:H7 strains isolated from a single feedlot located in southwestern region of the US. More than 4,000 SNVs were identified among the strains and the resultant phylogenomic tree revealed three major groups. Using the Sakai strain genome as reference, more than 2,000 SNVs were annotated and a detailed SNV map generated. Results clearly revealed highly polymorphic loci along the E. coli O157:H7 genome that aligned with the prophage regions and highly variant genes involved in processing bacterial genetic information. The WGS data were further profiled against a comprehensive virulence factor database (VFDB) for virulence gene identification. Among the total 285 virulence genes identified, only 132 were present in all the strains. There were six virulence genes unique to single isolates. Our findings suggested that the genome variations of the E. coli O157:H7 were mainly attributable to dynamics of certain phages, and the bacterial strains have variable virulence gene profiles, even though they came from a single cattle population, which may explain the differences in pathogenicity, host prevalence, and transmissibility by E. coli O157:H7.	[Gao, Xin; Yang, Xun; Worley, Jay; Meng, Jianghong] Univ Maryland, Ctr Food Safety & Secur Syst, Joint Inst Food Safety & Appl Nutr, College Pk, MD 20742 USA; [Noll, Lance; Shi, Xiaorong; Nagaraja, T. G.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Allard, Marc; Brown, Eric] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); Kansas State University; US Food & Drug Administration (FDA)	Meng, JH (corresponding author), Univ Maryland, Ctr Food Safety & Secur Syst, Joint Inst Food Safety & Appl Nutr, College Pk, MD 20742 USA.	jmeng@umd.edu		Worley, Jay/0000-0002-5923-1159	National Institute of Food and Agriculture, U. S. Department of Agriculture [2012-68003-30155]; Joint Institute for Food Safety and Applied Nutrition (JIFSAN), University of Maryland	National Institute of Food and Agriculture, U. S. Department of Agriculture(United States Department of Agriculture (USDA)); Joint Institute for Food Safety and Applied Nutrition (JIFSAN), University of Maryland	This material is based upon work that is supported by the National Institute of Food and Agriculture (https://nifa.usda.gov/), U. S. Department of Agriculture, under award number 2012-68003-30155 and in part by the Joint Institute for Food Safety and Applied Nutrition (JIFSAN), University of Maryland (http://jifsan.umd.edu/).	Ambroise J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-413; Amigo N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127710; Avery LM, 2005, J APPL MICROBIOL, V98, P814, DOI 10.1111/j.1365-2672.2004.02524.x; Bai JF, 2010, J MICROBIOL METH, V82, P85, DOI 10.1016/j.mimet.2010.05.003; Bankevich A, 2012, JCOMPUTBIOL, V19; Beutin L, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-4; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown CA, 1997, APPL ENVIRON MICROB, V63, P27, DOI 10.1128/AEM.63.1.27-32.1997; Callaway TR, 2006, FOODBORNE PATHOG DIS, V3, P234, DOI 10.1089/fpd.2006.3.234; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Chui HX, 2015, J CLIN MICROBIOL, V53, P2480, DOI 10.1128/JCM.00593-15; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CRAY WC, 1995, APPL ENVIRON MICROB, V61, P1586, DOI 10.1128/AEM.61.4.1586-1590.1995; Dallman TJ, 2015, CLIN INFECT DIS, V61, P305, DOI 10.1093/cid/civ318; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Eppinger M, 2011, APPL ENVIRON MICROB, V77, P2916, DOI 10.1128/AEM.02554-10; Gardner SN, 2015, BIOINFORMATICS, V31, P2877, DOI 10.1093/bioinformatics/btv271; Greig JD, 2009, INT J FOOD MICROBIOL, V130, P77, DOI 10.1016/j.ijfoodmicro.2008.12.031; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hirvonen JJ, 2012, J CLIN MICROBIOL, V50, P3586, DOI 10.1128/JCM.01754-12; Holmes A, 2015, J CLIN MICROBIOL, V53, P3565, DOI 10.1128/JCM.01066-15; Kaminski J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004557; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Laing C, 2008, APPL ENVIRON MICROB, V74, P6606, DOI 10.1128/AEM.00985-08; LeJeune JT, 2001, APPL ENVIRON MICROB, V67, P3053, DOI 10.1128/AEM.67.7.3053-3057.2001; Leung KT, 2004, FEMS MICROBIOL ECOL, V47, P111, DOI 10.1016/S0168-6496(03)00254-X; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Manges AR, 2015, FOODBORNE PATHOG DIS, V12, P302, DOI 10.1089/fpd.2014.1860; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Mayo B, 2014, CURR GENOMICS, V15, P293, DOI 10.2174/1389202915666140616233211; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Reinstein S, 2007, J FOOD PROTECT, V70, P2555, DOI 10.4315/0362-028X-70.11.2555; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Ronholm J, 2016, CLIN MICROBIOL REV, V29, P837, DOI 10.1128/CMR.00056-16; Rusconi B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00985; Salipante SJ, 2015, J CLIN MICROBIOL, V53, P1072, DOI 10.1128/JCM.03385-14; Sargeant JM, 2007, ZOONOSES PUBLIC HLTH, V54, P260, DOI 10.1111/j.1863-2378.2007.01059.x; Sheng HQ, 2006, INFECT IMMUN, V74, P4685, DOI 10.1128/IAI.00406-06; Teunis P, 2004, RISK ANAL, V24, P401, DOI 10.1111/j.0272-4332.2004.00441.x; Trees E, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00718-14; Vernozy-Rozand C, 2004, APPL ENVIRON MICROB, V70, P2556, DOI 10.1128/AEM.70.4.2556-2559.2004; WELLS JG, 1983, J CLIN MICROBIOL, V18, P512, DOI 10.1128/JCM.18.3.512-520.1983; Worley JN, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00734-17; Yang SC, 2017, ARCH MICROBIOL, V199, P811, DOI 10.1007/s00203-017-1393-y; Zhang DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep33235; Zhou MX, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-32; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	54	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202775	10.1371/journal.pone.0202775	http://dx.doi.org/10.1371/journal.pone.0202775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153286	Green Published, gold, Green Submitted			2022-12-27	WOS:000443001700025
J	Kumari, S; Kumar, M; Khandelwal, NK; Kumari, P; Varma, M; Vishwakarma, P; Shahi, G; Sharma, S; Lynn, AM; Prasad, R; Gaur, NA				Kumari, Sonam; Kumar, Mohit; Khandelwal, Nitesh Kumar; Kumari, Priya; Varma, Mahendra; Vishwakarma, Poonam; Shahi, Garima; Sharma, Suman; Lynn, Andrew M.; Prasad, Rajendra; Gaur, Naseem A.			ABC transportome inventory of human pathogenic yeast Candida glabrata: Phylogenetic and expression analysis	PLOS ONE			English	Article							NUCLEOTIDE-BINDING DOMAIN; MULTIDRUG-RESISTANCE; AZOLE RESISTANCE; SACCHAROMYCES-CEREVISIAE; FLUCONAZOLE RESISTANCE; CASSETTE PROTEIN; GENE FAMILY; EVOLUTION; ALBICANS; COMPLEX	ATP-binding cassette (ABC) is one of the two major superfamilies of transporters present across the evolutionary scale. ABC superfamily members came to prominence due to their ability to extrude broad spectrum of substrates and to confer multi drug resistance (MDR). Overexpression of some ABC transporters in clinical isolates of Candida species was attributed to the development of MDR phenotypes. Among Candida species, Candida glabrata is an emerging drug resistant species in human fungal infections. A comprehensive analysis of such proteins in C. glabrata is required to untangle their role not only in MDR but also in other biological processes. Bioinformatic analysis of proteins encoded by genome of human pathogenic yeast C. glabrata identified 25 putative ABC protein coding genes. On the basis of phylogenetic analysis, domain organization and nomenclature adopted by the Human Genome Organization (HUGO) scheme, these proteins were categorized into six subfamilies such as Pleiotropic Drug Resistance (PDR)/ABCG, Multi Drug Resistance (MDR)/ABCB, Multi Drug Resistance associated Protein (MRP)/ABCC, Adrenoleukodystrophy protein (ALDp)/ABCD, RNase L Inhibitor (RLI)/ABCE and Elongation Factor 3 (EF3)/ABCF. Among these, only 18 ABC proteins contained transmembrane domains (TMDs) and were grouped as membrane proteins, predominantly belonging to PDR, MDR, MRP, and ALDp subfamilies. A comparative phylogenetic analysis of these ABC proteins with other yeast species revealed their orthologous relationship and pointed towards their conserved functions. Quantitative real time PCR (qRT-PCR) analysis of putative membrane localized ABC protein encoding genes of C. glabrata confirmed their basal expression and showed variable transcriptional response towards antimycotic drugs. This study presents first comprehensive overview of ABC superfamily proteins of a human fungal pathogen C. glabrata, which is expected to provide an important platform for in depth analysis of their physiological relevance in cellular processes and drug resistance.	[Kumari, Sonam; Kumar, Mohit; Khandelwal, Nitesh Kumar; Kumari, Priya; Varma, Mahendra; Gaur, Naseem A.] Int Ctr Genet Engn & Biotechnol, Yeast Biofuel Grp, New Delhi, India; [Kumar, Mohit; Shahi, Garima; Sharma, Suman; Prasad, Rajendra] Amity Univ Gurgaon, Amity Inst Integrat Sci & Hlth, Gurgaon, Haryana, India; [Vishwakarma, Poonam; Lynn, Andrew M.] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jawaharlal Nehru University, New Delhi	Gaur, NA (corresponding author), Int Ctr Genet Engn & Biotechnol, Yeast Biofuel Grp, New Delhi, India.; Prasad, R (corresponding author), Amity Univ Gurgaon, Amity Inst Integrat Sci & Hlth, Gurgaon, Haryana, India.	rprasad@amity.ggn.amity.edu; naseem@icgeb.res.in	Khandelwal, Nitesh Kumar/AAX-6273-2021	Khandelwal, Nitesh Kumar/0000-0002-6319-8048; Varma, Mahendra/0000-0003-0271-4958; Gaur, Naseem/0000-0002-1224-8789; Sharma, Suman/0000-0003-3398-3245	Department of Biotechnology DBT [BT/01/CEIB/10/III/02, BT/PR7392/MED/29/652/2012, BT/PR14117/BRB/10/1420/2015]; DST [SR/S2/RJN-07/2012]; DBT [BT/PR10684/PBD/26/403/2013, BT/PB/Centre/03/2011]	Department of Biotechnology DBT(Department of Biotechnology (DBT) India); DST(Department of Science & Technology (India)); DBT(Department of Biotechnology (DBT) India)	The work has been supported in parts by grants to R.P. from the Department of Biotechnology DBT [No. BT/01/CEIB/10/III/02], DBT [No. BT/PR7392/MED/29/652/2012] and DBT [No. BT/PR14117/BRB/10/1420/2015] and in parts by grants to N.A.G. by DST Ramanujan Fellowship grant [SR/S2/RJN-07/2012], DBT grants [No. BT/PR10684/PBD/26/403/2013] and DBT [No. BT/PB/Centre/03/2011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Ben-Ami R, 2016, MBIO, V7, DOI 10.1128/mBio.00655-16; Birchler JA, 2010, NEW PHYTOL, V186, P54, DOI 10.1111/j.1469-8137.2009.03087.x; Brun S, 2004, SOCIETY, P1788, DOI [10.1128/AAC.48.5.1788, DOI 10.1128/AAC.48.5.1788]; Cui ZF, 1996, J BIOL CHEM, V271, P14712, DOI 10.1074/jbc.271.25.14712; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; Dean M, 2001, J LIPID RES, V42, P1007; DEAN M, 1994, YEAST, V10, P377, DOI 10.1002/yea.320100310; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Ferrari S, 2011, ANTIMICROB AGENTS CH, V55, P1852, DOI 10.1128/AAC.01271-10; Gaur M, 2005, J MOL MICROB BIOTECH, V9, P3, DOI 10.1159/000088141; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Izumikawa K, 2003, YEAST, V20, P249, DOI 10.1002/yea.962; Jeong CB, 2017, AQUAT TOXICOL, V183, P144, DOI 10.1016/j.aquatox.2016.12.022; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Khandelwal NK, 2018, J BIOL CHEM, V293, P412, DOI [10.1074/jbc.M117.807032, 10.1074/jbc.m117.807032]; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Khunweeraphong N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11794-w; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Klein C, 2011, ESSAYS BIOCHEM, V50, P101, DOI [10.1042/bse0500101, 10.1042/BSE0500101]; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Kovalchuk A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-177; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Liu HY, 2001, J BIOL CHEM, V276, P7541, DOI 10.1074/jbc.M009112200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miyazaki H, 1998, ANTIMICROB AGENTS CH, V42, P1695, DOI 10.1128/AAC.42.7.1695; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Nagi M, 2013, J INFECT CHEMOTHER, V19, P138, DOI 10.1007/s10156-012-0531-3; Nakayama H, 1998, MICROBIOL-UK, V144, P2407, DOI 10.1099/00221287-144-9-2407; Nakayama H, 2007, J ANTIMICROB CHEMOTH, V60, P1264, DOI 10.1093/jac/dkm321; Oxman DA, 2010, J ANTIMICROB CHEMOTH, V65, P1460, DOI 10.1093/jac/dkq136; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Piper P, 1998, EMBO J, V17, P4257, DOI 10.1093/emboj/17.15.4257; Prasad R, 2016, FUNGAL GENET BIOL, V93, P25, DOI 10.1016/j.fgb.2016.05.008; Prasad R, 2015, EUKARYOT CELL, V14, P1154, DOI 10.1128/EC.00137-15; Prasad R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00202; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Rai V, 2006, BIOCHEMISTRY-US, V45, P14726, DOI 10.1021/bi061535t; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Samaranayake YH, 2013, J MED MICROBIOL, V62, P303, DOI 10.1099/jmm.0.044123-0; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Sanglard D, 2001, ANTIMICROB AGENTS CH, V45, P1174, DOI 10.1128/AAC.45.4.1174-1183.2001; Sanguinetti M, 2005, ANTIMICROB AGENTS CH, V49, P668, DOI 10.1128/AAC.49.2.668-679.2005; Schmidt P, 2008, PROTEOMICS, V8, P534, DOI 10.1002/pmic.200700845; Schwarzmuller T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004211; Shani N, 1996, P NATL ACAD SCI USA, V93, P11901, DOI 10.1073/pnas.93.21.11901; Slomka M, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0271-3; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Theodoulou FL, 2006, FEBS LETT, V580, P1139, DOI 10.1016/j.febslet.2005.12.095; Tian LX, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3706-6; Torelli R, 2008, MOL MICROBIOL, V68, P186, DOI 10.1111/j.1365-2958.2008.06143.x; Tsai HF, 2010, ANTIMICROB AGENTS CH, V54, P3308, DOI 10.1128/AAC.00535-10; Vale-Silva L, 2013, INFECT IMMUN, V81, P1709, DOI 10.1128/IAI.00074-13; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Vernon RM, 2017, J BIOL CHEM, V292, P14147, DOI 10.1074/jbc.M116.772335; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Whaley SG, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02173; Whaley SG, 2016, CURRENT INFECT DIS R, V18, P19, DOI [10.1007/s11908-016-0525-x, DOI 10.1007/S11908-016-0525-X]; Wilkens Stephan, 2015, F1000Prime Rep, V7, P14, DOI 10.12703/P7-14; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Xiong J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16724	72	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202993	10.1371/journal.pone.0202993	http://dx.doi.org/10.1371/journal.pone.0202993			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153284	Green Submitted, Green Published, gold			2022-12-27	WOS:000443001700036
J	Konno, S; Banno, T; Takagi, H; Honda, S; Toyota, T				Konno, Shota; Banno, Taisuke; Takagi, Hideaki; Honda, Satoshi; Toyota, Taro			Irreversible aggregation of alternating tetra- block-like amphiphile in water	PLOS ONE			English	Article							STATE NMR-SPECTROSCOPY; MAGIC-ANGLE; X-RAY; MODEL; PROTEINS; BACTERIORHODOPSIN; KINETICS; BEHAVIOR; SYSTEM	As a frontier topic of soft condensed matter physics, irreversible aggregation has drawn attention for a better understanding of the complex behavior of biomaterials. In this study, we have described the synthesis of an artificial amphiphilic molecule, an alternating tetrablock-like amphiphile, which was able to diversify its aggregate structure in water. The aggregated state of its aqueous dispersion was obtained by slow evaporation of the organic solvent at room temperature, and it collapsed irreversibly at - 50 degrees C. By using a cryo-transmission electron microscope and a differential scanning calorimeter, it was revealed that two types of molecular nanostructures were formed and developed into submicro- and micrometer-sized fibrils in the aggregated material.	[Konno, Shota; Honda, Satoshi; Toyota, Taro] Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo, Japan; [Banno, Taisuke] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa, Japan; [Takagi, Hideaki] High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki, Japan	University of Tokyo; Keio University; High Energy Accelerator Research Organization (KEK)	Toyota, T (corresponding author), Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo, Japan.	cttoyota@mail.ecc.u-tokyo.ac.jp	Honda, Satoshi/E-9072-2016; Banno, Taisuke/AAB-3702-2019	Honda, Satoshi/0000-0001-5289-5078; Takagi, Hideaki/0000-0003-3389-7945	KAKENHI of Japan Society for the Promotion of Science [16K14074, 16H04032]; Izumi Science and Technology Foundation	KAKENHI of Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Izumi Science and Technology Foundation(Izumi Science and Technology Foundation)	This work was partially supported by KAKENHI of Japan Society for the Promotion of Science (Grant Numbers 16K14074 S.H. and 16H04032 T.T.) [see https://www.jsps.go.jp/]and the Izumi Science and Technology Foundation (S.H.) [see http://www.izumi-zaidan.jp/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work benefited from fruitful discussions with Prof. Hideki Seto (High Energy Accelerator Research Organization, KEK, Japan), Dr. Taku Ogura (Lion Corp., Japan) and Prof. Atsushi Ikeda (The University of Tokyo, Japan). Synchrotron radiation-SAXS measurements were performed under the approval of the Photon Factory Program Advisory Committee (Proposal No. 2016PF-02 H.T.). Cryo-TEM measurements were conducted under the approval of the Advanced Characterization Nanotechnology Platform of the University of Tokyo, supported by the "Nanotechnology Platform" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (Proposal No. A-16-UT-0225 S.H.). The authors acknowledge Ms. Misuzu Konishi and Mr. Hiroshi Ohki (Mettler-Toledo Japan) for support with DSC measurements and Dr. Shunji Yunoki and Mr. Hirosuke Hatayama (Tokyo Metropolitan Industrial Technology Research Institute) for support with DMA. This work was partially supported by KAKENHI of Japan Society for the Promotion of Science (Grant Numbers 16K14074 S.H. and 16H04032 T.T.) and the Izumi Science and Technology Foundation (S.H.).	Bedard AC, 2013, ACS CATAL, V3, P773, DOI 10.1021/cs400050g; Berthelot J.-M, 2012, COMPOSITE MAT MECH B; Bourriot S, 1999, FOOD HYDROCOLLOID, V13, P43, DOI 10.1016/S0268-005X(98)00068-X; Corezzi S, 2010, J PHYS CHEM B, V114, P3769, DOI 10.1021/jp911165b; Craievich A.F., 2002, Mat. Res., V5, P1, DOI 10.1590/S1516-14392002000100002; Fameau AL, 2011, ANGEW CHEM INT EDIT, V50, P8264, DOI 10.1002/anie.201102115; Gennes P. G. D., 1990, INTRO POLYM DYNAMICS; GREST GS, 1985, PHYS REV B, V32, P3014, DOI 10.1103/PhysRevB.32.3014; He JT, 2017, CARBOHYD POLYM, V164, P364, DOI 10.1016/j.carbpol.2017.01.080; Helvig S, 2015, AIMS BIOPHYS, V2, P116, DOI 10.3934/biophy.2015.2.116; Henrich B, 2009, NUCL INSTRUM METH A, V607, P247, DOI 10.1016/j.nima.2009.03.200; HIGUCHI WI, 1963, J PHARM SCI, V52, P49, DOI 10.1002/jps.2600520110; Hu ZB, 2010, SOFT MATTER, V6, P2115, DOI 10.1039/b921150k; Igarashi N, 2011, J PHYS CONF SER, V272, DOI 10.1088/1742-6596/272/1/012026; Ikkala O, 2004, CHEM COMMUN, P2131, DOI 10.1039/b403983a; Knyazev A, 2011, CHEM-EUR J, V17, P14663, DOI 10.1002/chem.201101182; Lee CY, 2005, LANGMUIR, V21, P5134, DOI 10.1021/la0472302; Lee MJ, 2015, PROC SPIE, V9565, DOI 10.1117/12.2187818; Liu JQ, 2012, J MATER CHEM, V22, P12435, DOI 10.1039/c2jm31218b; Mezzenga R, 2005, NAT MATER, V4, P729, DOI 10.1038/nmat1496; Mushi NE, 2016, CHEMSUSCHEM, V9, P989, DOI 10.1002/cssc.201501697; Pavisic R, 2010, EUR J PHARM BIOPHARM, V76, P357, DOI 10.1016/j.ejpb.2010.09.006; Pham KN, 2002, SCIENCE, V296, P104, DOI 10.1126/science.1068238; Prasad V, 2003, FARADAY DISCUSS, V123, P1, DOI 10.1039/b211107c; Ravula T, 2017, ANGEW CHEM INT EDIT, V56, P11466, DOI 10.1002/anie.201705569; Rest C, 2015, CHEM SOC REV, V44, P2543, DOI 10.1039/c4cs00497c; Royall CP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.258302; SAEKI S, 1976, POLYMER, V17, P685, DOI 10.1016/0032-3861(76)90208-1; Saito H, 2007, BBA-BIOMEMBRANES, V1768, P3145, DOI 10.1016/j.bbamem.2007.08.026; SCHAEFER J, 1976, J AM CHEM SOC, V98, P1031, DOI 10.1021/ja00420a036; Shih WY, 1999, J AM CERAM SOC, V82, P616, DOI 10.1111/j.1151-2916.1999.tb01809.x; Shimizu N, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952937; Trappe V, 2004, CURR OPIN COLLOID IN, V8, P494, DOI 10.1016/j.cocis.2004.01.002; Wang AD, 2014, SOFT MATTER, V10, P3362, DOI 10.1039/c3sm53214c; Winter R, 2002, BBA-PROTEIN STRUCT M, V1595, P160, DOI 10.1016/S0167-4838(01)00342-9; WU CH, 1994, J MAGN RESON SER A, V109, P270, DOI 10.1006/jmra.1994.1169; Xuan Y, 2004, MACROMOLECULES, V37, P7301, DOI 10.1021/ma0497761; Zaccarelli E, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/32/323101; Zhang H, 2016, RSC ADV, V6, P9186, DOI 10.1039/c5ra25437j; Zhang RC, 2017, ACCOUNTS CHEM RES, V50, P1105, DOI 10.1021/acs.accounts.7b00082; Zhou YL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02579-w	42	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202816	10.1371/journal.pone.0202816	http://dx.doi.org/10.1371/journal.pone.0202816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR6UK	30148887	Green Published, Green Submitted, gold			2022-12-27	WOS:000442804200025
J	Chong, WT; Tang, CP; Cheah, YK; Lajis, AFB; Dian, NLHM; Kanagaratnam, S; Lai, OM				Chong, Wai-Ting; Tang, Chin-Ping; Cheah, Yoke-Kqueen; Lajis, Ahmad Firdaus B.; Dian, Noor Lida Habi Mat; Kanagaratnam, Sivaruby; Lai, Oi-Ming			Optimization of process parameters in preparation of tocotrienol-rich red palm oil-based nanoemulsion stabilized by Tween80-Span 80 using response surface methodology	PLOS ONE			English	Article							HIGH-PRESSURE HOMOGENIZATION; FOOD-GRADE MICROEMULSIONS; NANO-EMULSION FORMATION; IN-WATER NANOEMULSIONS; ALPHA-TOCOPHEROL; PHASE-BEHAVIOR; SPONTANEOUS EMULSIFICATION; ULTRASONIC EMULSIFICATION; PROPYLENE-GLYCOL; REQUIRED HLB	Red palm oil (RPO) is a natural source of Vitamin E (70-80% tocotrienol). It is a potent natural antioxidant that can be used in skin-care products. Its antioxidant property protects skin from inflammation and aging. In our work, a tocotrienol-rich RPO-based nanoemulsion formulation was optimized using response surface methodology (RSM) and formulated using high pressure homogenizer. Effect of the concentration of three independent variables [surfactant (5-15 wt%), co-solvent (10-30 wt%) and homogenization pressure (500-700 bar)] toward two response variables (droplet size, polydispersity index) was studied using central composite design (CCD) coupled to RSM. RSM analysis showed that the experimental data could be fitted into a second-order polynomial model and the coefficients of multiple determination (R-2) is 0.9115. The optimized formulation of RPO-based nanoemulsion consisted of 6.09 wt% mixed surfactant [Tween 80/Span 80 (63: 37, wt)], 20 wt% glycerol as a co-solvent via homogenization pressure (500 bar). The optimized tocotrienol-rich RPO-based nanoemulsion response values for droplet size and polydispersity index were 119.49nm and 0.286, respectively. The actual values of the formulated nanoemulsion were in good agreement with the predicted values obtained from RSM, thus the optimized compositions have the potential to be used as a nanoemulsion for cosmetic formulations.	[Chong, Wai-Ting; Lajis, Ahmad Firdaus B.; Lai, Oi-Ming] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia; [Tang, Chin-Ping] Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Technol, Serdang, Selangor, Malaysia; [Cheah, Yoke-Kqueen] Univ Putra Malaysia, Dept Biomed Sci, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Dian, Noor Lida Habi Mat; Kanagaratnam, Sivaruby] Malaysian Palm Oil Board, Prot & Food Technol Unit, Kajang, Selangor, Malaysia; [Lai, Oi-Ming] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Bioproc Technol, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Malaysian Palm Oil Board; Universiti Putra Malaysia	Lai, OM (corresponding author), Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia.; Lai, OM (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Bioproc Technol, Serdang, Selangor, Malaysia.	omlai@upm.edu.my	Tan, Chin-Ping/A-8130-2008; Lajis, Ahmad Firdaus B./T-7088-2018; Lajis, Ahmad Firdaus B./AAD-3717-2020	Tan, Chin-Ping/0000-0003-4177-4072; Lajis, Ahmad Firdaus B./0000-0003-2766-8986; Lajis, Ahmad Firdaus B./0000-0003-2766-8986	Universiti Putra Malaysia, Malaysia (Putra Grant-Putra Graduate Initiative) [9622900]	Universiti Putra Malaysia, Malaysia (Putra Grant-Putra Graduate Initiative)	This project was financially supported by Universiti Putra Malaysia, Malaysia (Putra Grant-Putra Graduate Initiative, Grant No.: 9622900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta E, 2009, CURR OPIN COLLOID IN, V14, P3, DOI 10.1016/j.cocis.2008.01.002; Ali A, 2016, INT J PHARMACEUT, V500, P291, DOI 10.1016/j.ijpharm.2016.01.035; Anarjan N, 2010, FOOD CHEM, V123, P477, DOI 10.1016/j.foodchem.2010.05.036; Aramaki K, 1999, LANGMUIR, V15, P6226, DOI 10.1021/la9900573; Ayeleso A. O., 2012, African Journal of Biotechnology, V11, P8275; Benichou A, 2001, J DISPER SCI TECHNOL, V22, P269, DOI 10.1081/DIS-100105214; Bergstrom M, 2000, LANGMUIR, V16, P7173, DOI 10.1021/la000397k; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bouchemal K, 2004, INT J PHARM, V280, P241, DOI 10.1016/j.ijpharm.2004.05.016; Cavalli R, 1996, J DISPER SCI TECHNOL, V17, P717, DOI 10.1080/01932699608943535; Chaturvedi PA, 2000, PLANT FOOD HUM NUTR, V55, P147, DOI 10.1023/A:1008197931085; Che HL, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/357609; Cheong JN, 2008, J FOOD ENG, V89, P204, DOI 10.1016/j.jfoodeng.2008.04.018; Choo YM, 1993, PORIM INF SER, V11; Choo YM, 1995, PALM OIL DEV, V22, P1; Chu BS, 2007, J AM OIL CHEM SOC, V84, P1053, DOI 10.1007/s11746-007-1132-7; Edem DO, 2009, EUR J SCI RES, P32; Eqbal Dauqan, 2011, American Journal of Applied Sciences, V8, P407; Fan YR, 2010, COLLOID SURFACE A, V366, P120, DOI 10.1016/j.colsurfa.2010.05.034; Fanun M, 2007, J DISPER SCI TECHNOL, V28, P1244, DOI 10.1080/01932690701528159; Floury J, 2003, J FOOD ENG, V58, P227, DOI 10.1016/S0260-8774(02)00372-2; Floury J., 2000, Innovative Food Science & Emerging Technologies, V1, P127, DOI 10.1016/S1466-8564(00)00012-6; Fu ZS, 2010, FUEL, V89, P2838, DOI 10.1016/j.fuel.2010.05.031; Garti N, 2001, J AGR FOOD CHEM, V49, P2552, DOI 10.1021/jf001390b; Genot C, 2013, WOODHEAD PUBL FOOD S, V252, P150, DOI 10.1533/9780857098863.2.150; GENSLER HL, 1991, NUTR CANCER, V15, P97, DOI 10.1080/01635589109514117; Gharibzahedi SMT, 2013, FOOD BIOPROCESS TECH, V6, P456, DOI 10.1007/s11947-011-0763-8; Gutierrez JM, 2008, CURR OPIN COLLOID IN, V13, P245, DOI 10.1016/j.cocis.2008.01.005; Hatanaka J, 2010, INT J PHARMACEUT, V396, P188, DOI 10.1016/j.ijpharm.2010.06.017; He J, 2016, INT J PSYCHOL, V51, P445, DOI 10.1002/ijop.12263; Hecht LL, 2011, LANGMUIR, V27, P2279, DOI 10.1021/la104480s; Hsieh CW, 2012, J OLEO SCI, V61, P483, DOI 10.5650/jos.61.483; Izquierdo P, 2005, J COLLOID INTERF SCI, V285, P388, DOI 10.1016/j.jcis.2004.10.047; Izquierdo P, 2004, LANGMUIR, V20, P6594, DOI 10.1021/la049566h; Jiang Q, 2014, FREE RADICAL BIO MED, V72, P76, DOI 10.1016/j.freeradbiomed.2014.03.035; Keck CM, 2006, EUR J PHARM BIOPHARM, V62, P3, DOI 10.1016/j.ejpb.2005.05.009; Kommuru TR, 2001, INT J PHARM, V212, P233, DOI 10.1016/S0378-5173(00)00614-1; Kosmadaki MG, 2004, MICRON, V35, P155, DOI 10.1016/j.micron.2003.11.002; Lee Junsoo, 2000, Journal of Food Composition and Analysis, V13, P45, DOI 10.1006/jfca.1999.0845; Li PH, 2012, ULTRASON SONOCHEM, V19, P192, DOI 10.1016/j.ultsonch.2011.05.017; Li QH, 2005, FOOD CHEM, V92, P701, DOI 10.1016/j.foodchem.2004.08.042; Lietz G, 2001, AM J CLIN NUTR, V74, P501; Liyana-Pathirana C, 2005, FOOD CHEM, V93, P47, DOI 10.1016/j.foodchem.2004.08.050; Maindarkar SN, 2013, CHEM ENG SCI, V89, P102, DOI 10.1016/j.ces.2012.12.001; Mao LK, 2009, FOOD TECHNOL BIOTECH, V47, P336; Mba OI, 2015, FOOD BIOSCI, V10, P26, DOI 10.1016/j.fbio.2015.01.003; McClements D. J., 2015, Food emulsions: principles, practices, and techniques; McClements DJ, 2018, ADV COLLOID INTERFAC, V251, P55, DOI 10.1016/j.cis.2017.12.001; McClements DJ, 2011, CRIT REV FOOD SCI, V51, P285, DOI 10.1080/10408398.2011.559558; McClements DJ, 2011, SOFT MATTER, V7, P2297, DOI 10.1039/c0sm00549e; Meganathan P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111682; Mohan S, 1997, J COLLOID INTERF SCI, V192, P1, DOI 10.1006/jcis.1997.5012; Morales D, 2003, LANGMUIR, V19, P7196, DOI 10.1021/la0300737; Nagendran B., 2000, Food and Nutrition Bulletin, V21, P189; Niemann B, 2010, J COLLOID INTERF SCI, V342, P361, DOI 10.1016/j.jcis.2009.10.066; Oguntibeju OO, 2009, BRIT J BIOMED SCI, V66, P216, DOI 10.1080/09674845.2009.11730279; Orafidiya LO, 2002, INT J PHARMACEUT, V237, P241, DOI 10.1016/S0378-5173(02)00051-0; Peh HY, 2016, PHARMACOL THERAPEUT, V162, P152, DOI 10.1016/j.pharmthera.2015.12.003; Petrovic LB, 2010, J COLLOID INTERF SCI, V342, P333, DOI 10.1016/j.jcis.2009.10.077; Pey CM, 2006, COLLOID SURFACE A, V288, P144, DOI 10.1016/j.colsurfa.2006.02.026; Pinheiro-Santana HMF, 1998, SOC BRAS CIENC E; Poletto FS, 2009, J NANOSCI NANOTECHNO, V9, P4933, DOI 10.1166/jnn.2009.1270; PORRETTA S, 1995, FOOD CHEM, V52, P35, DOI 10.1016/0308-8146(94)P4178-I; Preetz C, 2010, EUR J PHARM SCI, V39, P141, DOI 10.1016/j.ejps.2009.11.009; Qian C, 2011, FOOD HYDROCOLLOID, V25, P1000, DOI 10.1016/j.foodhyd.2010.09.017; Rao J, 2012, FOOD HYDROCOLLOID, V29, P326, DOI 10.1016/j.foodhyd.2012.04.008; Rebolleda S, 2015, FOOD CHEM, V167, P16, DOI 10.1016/j.foodchem.2014.06.097; Saberi AH, 2013, FOOD RES INT, V54, P812, DOI 10.1016/j.foodres.2013.08.028; Scamehorn JF, 1986, ANAL CHEM, V58, p1250A, DOI [10.1021/BK-1986-0311, DOI 10.1021/BK-1986-0311]; Schmidts T, 2010, COLLOID SURFACE A, V372, P48, DOI 10.1016/j.colsurfa.2010.09.025; SERBINOVA E, 1991, FREE RADICAL BIO MED, V10, P263, DOI 10.1016/0891-5849(91)90033-Y; Shi AM, 2011, CARBOHYD POLYM, V83, P1604, DOI 10.1016/j.carbpol.2010.10.011; Shibata A, 2010, J AGR FOOD CHEM, V58, P7013, DOI 10.1021/jf100691g; Solans C, 2005, CURR OPIN COLLOID IN, V10, P102, DOI 10.1016/j.cocis.2005.06.004; Sole I, 2006, COLLOID SURFACE A, V288, P138, DOI 10.1016/j.colsurfa.2006.02.013; Sun MH, 2011, DRUG DEV IND PHARM, V37, P986, DOI 10.3109/03639045.2011.553618; SUNDRAM K, 1992, BRIT J NUTR, V68, P677, DOI 10.1079/BJN19920125; Sundram K, 2003, ASIA PAC J CLIN NUTR, V12, P355; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023; Tan SF, 2016, ULTRASON SONOCHEM, V29, P299, DOI 10.1016/j.ultsonch.2015.09.015; Uskokovic V, 2005, SURF REV LETT, V12, P239, DOI 10.1142/S0218625X05007001; Wang LJ, 2009, J COLLOID INTERF SCI, V330, P443, DOI 10.1016/j.jcis.2008.10.077; Wooster TJ, 2008, LANGMUIR, V24, P12758, DOI 10.1021/la801685v; Yaghmur A, 2002, COLLOID SURFACE A, V209, P71, DOI 10.1016/S0927-7757(02)00168-1; Yamada Y, 2008, J NUTR SCI VITAMINOL, V54, P117, DOI 10.3177/jnsv.54.117; Yuan Y, 2008, FOOD RES INT, V41, P61, DOI 10.1016/j.foodres.2007.09.006	86	32	33	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202771	10.1371/journal.pone.0202771	http://dx.doi.org/10.1371/journal.pone.0202771			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142164	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500030
J	Correa-Rocha, R; Lopez-Abente, J; Gutierrez, C; Perez-Fernandez, VA; Prieto-Sanchez, A; Moreno-Guillen, S; Munoz-Fernandez, MA; Pion, M				Correa-Rocha, Rafael; Lopez-Abente, Jacobo; Gutierrez, Carolina; Astrid Perez-Fernandez, Veronica; Prieto-Sanchez, Adrian; Moreno-Guillen, Santiago; Munoz-Fernandez, Maria-Angeles; Pion, Marjorie			CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1(+) viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion	PLOS ONE			English	Article							LYMPHOCYTE SEMAPHORIN; CD100-CD72 INTERACTION; DENDRITIC CELLS; IMMUNE-SYSTEM; HIV-INFECTION; REGULATORY T; CD72; SURFACE; PD-1; SEMA4D/CD100	In our work, we analyzed the role of the CD100/CD72 and PD-1/PD-L1 axes in immune response dysfunction in human immunodeficiency virus (HIV)-1 infection in which high expressions of PD-1 and PD-L1 were associated with an immunosuppressive state via limitation of the HIV-1-specific T-cell responses. CD100 was demonstrated to play a relevant role in immune responses in various pathological processes and may be responsible for immune dysregulation during HIV-1 infection. We investigated the function of CD72/CD100, and PD-1/PDL-1 axes on T and B cells in HIV-infected individuals and in healthy individuals. We analyzed the frequencies and fluorescence intensities of these four markers on CD4(+), CD8(+) T and B cells. Marker expressions were increased during active HIV-1 infection. CD100 frequency on T cells was positively associated with the expression of PD-1 and PDL1 on T cells from HIV-infected treatment-naive individuals. In addition, the frequency of CD72-expressing T cells was associated with interferon gamma (IFN-gamma) production in HIV-infected treatment-naive individuals. Our data suggest that the CD72/CD100 and PD-1/PDL1 axes may jointly participate in dysregulation of immunity during HIV-1 infection and could partially explain the immune systems' hyper-activation and exhaustion.	[Correa-Rocha, Rafael; Lopez-Abente, Jacobo; Astrid Perez-Fernandez, Veronica; Prieto-Sanchez, Adrian; Pion, Marjorie] Gregorio Maranon Univ Gen Hosp, Gregorio Maranon Hlth Res Inst IiSGM, Immuno Regulat Lab, Madrid, Spain; [Gutierrez, Carolina; Moreno-Guillen, Santiago] Alcala de Henares Univ, Hosp Ramon y Cajal, IRYCIS, Dept Infect Dis, Madrid, Spain; [Munoz-Fernandez, Maria-Angeles; Pion, Marjorie] Gregorio Maranon Univ, Immuno Biol Mol Lab, Gregorio Maranon Hlth Res Inst IiSGM, Gen Hosp,Spanish HIV HGM BioBank, Madrid, Spain; [Munoz-Fernandez, Maria-Angeles] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain	General University Gregorio Maranon Hospital; Hospital Universitario Ramon y Cajal; Universidad de Alcala; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Pion, M (corresponding author), Gregorio Maranon Univ Gen Hosp, Gregorio Maranon Hlth Res Inst IiSGM, Immuno Regulat Lab, Madrid, Spain.; Pion, M (corresponding author), Gregorio Maranon Univ, Immuno Biol Mol Lab, Gregorio Maranon Hlth Res Inst IiSGM, Gen Hosp,Spanish HIV HGM BioBank, Madrid, Spain.	marjorie.pion@iisgm.com	Pion, Marjorie/AAB-5812-2022; Correa-Rocha, Rafael/C-8213-2011; Pion, Marjorie/D-8139-2012; Pion, Marjorie/D-8139-2012	Correa-Rocha, Rafael/0000-0003-3456-9986; Pion, Marjorie/0000-0003-1828-4745; Lopez-Abente, Jacobo/0000-0003-3640-4077; Pion, Marjorie/0000-0002-6406-747X; Munoz-Fernandez/0000-0002-0813-4500	Ministry of Economy and Competitiveness ISCIII-FIS [PI12/01763, PI12/00934, PI15/00923]; ERDF (FEDER) Funds from the European Commission; IiSGM; Youth Employment Program; Madrid community; FEDER Founds; Spanish AIDS Research Network; "Miguel Servet" program [CPII13/00033]; Spanish MICINN through the Ramon y Cajal [RYC-2009-05486]	Ministry of Economy and Competitiveness ISCIII-FIS; ERDF (FEDER) Funds from the European Commission; IiSGM; Youth Employment Program; Madrid community; FEDER Founds(European Commission); Spanish AIDS Research Network; "Miguel Servet" program; Spanish MICINN through the Ramon y Cajal	This work was partially supported by the Ministry of Economy and Competitiveness ISCIII-FIS grants PI12/01763, PI12/00934 and PI15/00923, co-financed by ERDF (FEDER) Funds from the European Commission, "A way of making Europe". JL-A was supported by a grant from IiSGM. AP-S and VP-F were supported by the Youth Employment Program co-financed by the Madrid community and FEDER Founds. CG was supported by the Spanish AIDS Research Network. RC-R was supported by "Miguel Servet" program (CPII13/00033), and MP by the Spanish MICINN through the Ramon y Cajal (RYC-2009-05486).; We acknowledge Dr. Laura Doaz from Cytometry Unit of IiSGM for samples analysis, Dr. Maribel Clemente from Cell Culture Unit of IiSGM and Jose-Maria Bellon from the Unit of Methodology and Biostatistics of IiSGM. This work was partially supported by the Ministry of Economy and Competitiveness ISCIII-FIS grants PI12/01763, PI12/00934 and PI15/00923, co-financed by ERDF (FEDER) Funds from the European Commission, "A way of making Europe". J.L-A. was supported by a Grant from IiSGM. A.P-S and V.A. P-F were supported by the Youth Employment Program co-financed by the Madrid community and FEDER Founds. C.G. was supported by the Spanish AIDS Research Network. R.C-R was supported by "Miguel Servet" program (CPII13/00033), and M.P by the Spanish MICINN through the Ramon y Cajal (RYC-2009-05486). All this work was performed in the Laboratorio de Inmuno-Biologia Molecular, Department of Immunology (HGUG and IiSGM) lead by M-A.M-F.	Adachi T, 2000, J IMMUNOL, V164, P1223, DOI 10.4049/jimmunol.164.3.1223; Ahmad F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00338; Barathan M, 2016, EUR J CLIN INVEST, V46, P170, DOI 10.1111/eci.12581; Bardhan K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00550; Besliu A, 2011, AUTOIMMUNITY, V44, P427, DOI 10.3109/08916934.2010.541171; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Ellegard R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00899; Eriksson EM, 2012, BLOOD, V119, P745, DOI 10.1182/blood-2010-12-324848; Granziero L, 2003, BLOOD, V101, P1962, DOI 10.1182/blood-2002-05-1339; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; He Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113338; Ishida I, 2003, INT IMMUNOL, V15, P1027, DOI 10.1093/intimm/dxg098; Jiang XJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00765; Kuklina EM, 2017, B EXP BIOL MED; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Larsson M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-31; Li BJ, 2017, J INT MED RES, V45, P89, DOI 10.1177/0300060516676136; Li T, 2018, MOL IMMUNOL, V94, P98, DOI 10.1016/j.molimm.2017.12.020; Liu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073958; Lopez-Abente J, 2017, CELL MOL IMMUNOL; Maleki KT, 2016, CLIN IMMUNOL, V163, P52, DOI 10.1016/j.clim.2015.12.012; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meier A, 2008, AIDS, V22, P655, DOI 10.1097/QAD.0b013e3282f4de23; Mizrahi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000818; Moir S, 2014, CURR OPIN HIV AIDS, V9, P472, DOI 10.1097/COH.0000000000000092; Peretz Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002840; Rosignoli G, 2009, CLIN EXP IMMUNOL, V157, P90, DOI 10.1111/j.1365-2249.2009.03960.x; Rothstein TL, 2013, ANN NY ACAD SCI, V1285, P97, DOI 10.1111/nyas.12137; Saeidi A, 2015, CELL IMMUNOL, V297, P19, DOI 10.1016/j.cellimm.2015.05.005; Saeidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124659; Schweneker M, 2008, J IMMUNOL, V180, P6490, DOI 10.4049/jimmunol.180.10.6490; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Suzuki K, 2003, CYTOKINE GROWTH F R, V14, P17, DOI 10.1016/S1359-6101(02)00073-4; Thibult ML, 2013, INT IMMUNOL, V25, P129, DOI 10.1093/intimm/dxs098; Trabattoni D, 2003, BLOOD, V101, P2514, DOI 10.1182/blood-2002-10-3065; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Vadasz Z, 2018, CLIN IMMUNOL, V191, P88, DOI 10.1016/j.clim.2017.09.010; Wang L, 2015, DIGEST DIS SCI, V60, P405, DOI 10.1007/s10620-014-3372-3; Wu HJ, 2002, IMMUNOL RES, V25, P155, DOI 10.1385/IR:25:2:155; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826; Zheng MK, 2014, IMMUNOL INVEST, V43, P705, DOI 10.3109/08820139.2014.917096	46	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203419	10.1371/journal.pone.0203419	http://dx.doi.org/10.1371/journal.pone.0203419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161254	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900124
J	Hosseinpourfeizi, H; Sadeghi-Bazargani, H; Hassanzadeh, K; Salarilak, S; Abedi, L; Basirat, SB; Abdolahi, HM; Khorasani-Zavareh, D				Hosseinpourfeizi, Hojjat; Sadeghi-Bazargani, Homayoun; Hassanzadeh, Kamal; Salarilak, Shaker; Abedi, Leili; Basirat, Shahryar Behzad; Abdolahi, Hossein Mashhadi; Khorasani-Zavareh, Davoud			The short Persian version of motorcycle riding behavior questionnaire and its interchangeability with the full version	PLOS ONE			English	Article							RIDER-BEHAVIOR; RISK-FACTORS; AGREEMENT; ACCIDENTS; IRAN	The aim of current study was to develop a valid and reliable short motorcycle riding behavior questionnaire (SMRBQ) and assess its interchangeability with the original 48-item tool. Through a psychometric study in Bukan district of Iran in 2015, the most recent available Persian version of the motorcycle riding behavior questionnaire (MRBQ) was used as a reference to develop its short version, the SMRBQ. The preliminary version was prepared through expert reviews, and its dimension was further reduced through principal component analysis (PCA). An exploratory factor analysis (EFA) was then applied on the remaining items and the final version was developed with 23 items. The validity, consistency, agreement and interchangeability of the SMRBQ were assessed in parallel with the MRBQ using several statistical methods including Kendall's Tau, intra-class correlation coefficient (ICC), Bland-Altman plot and receiver operating characteristics (ROC) curve analysis. All the 340 participants were males. The mean age of the participants was 30.2 (SD = 9.1). SMRBQ was developed including 23 items. The mean normalized score for the full version was 30.5 (SD = 11.2) and it was 30 (SD = 13.9) for the short version. There was a high correlation between the normalized scores of MRBQ and SMRBQ (Kendall's Tau = 0.82). The ICC of the interchangeability of the full version and short version scales was as high as 0.92 (95% CI: 90.2-93.5). The scale had adequate internal consistency based on the calculated Cronbach's alpha which was 0.85 for the scale. Bland-Altman and ROC curve analysis confirmed the interchangeability and criterion validity of the SMRBQ. The Persian version of SMRBQ was found to be a valid, reliable and feasible tool for assessing motorcycle riding behavior in the studied population.	[Hosseinpourfeizi, Hojjat] Tabriz Univ Med Sci, Dept Orthoped, Tabriz, Iran; [Sadeghi-Bazargani, Homayoun] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran; [Hassanzadeh, Kamal] Tabriz Univ Med Sci, Dept Stat & Epidemiol, Tabriz, Iran; [Salarilak, Shaker] Islamic Azad Univ Tabriz, Med Sch, Dept Publ Hlth, Tabriz, Iran; [Abedi, Leili] Kerman Univ Med Sci, Dept Epidemiol, Kerman, Iran; [Basirat, Shahryar Behzad] Traff Police Appl Res Ctr, Tehran, Iran; [Abdolahi, Hossein Mashhadi] Tabriz Univ Med Sci, Tabriz Hlth Serv Management Res Ctr, Tabriz, Iran; [Khorasani-Zavareh, Davoud] Safety Promot & Injury Prevent Res Ctr, Tehran, Iran; [Khorasani-Zavareh, Davoud] Shahid Beheshti Univ Med Sci, Sch Hlth Safety & Environm, Tehran, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Islamic Azad University; Kerman University of Medical Sciences; Tabriz University of Medical Science; Shahid Beheshti University Medical Sciences	Sadeghi-Bazargani, H (corresponding author), Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran.	homayoun.sadeghi@gmail.com	abedi, leili/ABF-1896-2021; abedi, leili/AAD-8685-2019; Mashhadi Abdolahi, Hossein/A-4174-2017	abedi, leili/0000-0003-2115-9777; Sadeghibazargani, Homayoun/0000-0003-4309-7933; Mashhadi Abdolahi, Hossein/0000-0002-1843-817X				Abedi L, 2015, J ANAL RES CLIN MED, V3; Abedi L, 2017, INT J INJ CONTROL SA, V24, P263, DOI 10.1080/17457300.2015.1080729; Agency IN, 2016, BUK TRAFF CRASH; [Anonymous], 2017, PCA PRINCIPAL COMPON; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brancato G., 2006, HDB RECOMMENDED PRAC; Cheng ASK, 2010, ACCIDENT ANAL PREV, V42, P1250, DOI 10.1016/j.aap.2010.01.018; Chumpawadee U, 2015, SE ASIAN J TROP MED, V46, P805; Cliff N, 2003, ORDINAL MEASUREMENT, Vx; Elliott MA, 2007, ACCIDENT ANAL PREV, V39, P491, DOI 10.1016/j.aap.2006.08.012; Hutcheson G, 1999, MULTIVARIATE SOCIAL, Vxii; Jama HH, 2011, ACCIDENT ANAL PREV, V43, P652, DOI 10.1016/j.aap.2010.10.008; Kim Hae-Young, 2013, Restor Dent Endod, V38, P98, DOI 10.5395/rde.2013.38.2.98; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; Moskal A, 2012, ACCIDENT ANAL PREV, V49, P5, DOI 10.1016/j.aap.2010.08.021; Motevalian Seyed Abbas, 2011, Ann Adv Automot Med, V55, P91; Ozkan T, 2012, ACCIDENT ANAL PREV, V49, P124, DOI 10.1016/j.aap.2011.03.009; Rahimi H, 2010, VALIDATION MOTORCYCL; Reeder AI, 1997, SOC SCI MED, V45, P1357, DOI 10.1016/S0277-9536(97)00061-0; Sadeghi-Bazargani H, 2017, TRAFFIC SAFETY; Sadeghi-Bazargani O, 2015, NEUROPSYCH DIS TREAT, V11, P2049, DOI [10.2147/NDT.587614, 10.2147/NDT.S87614]; Sakashita C, 2014, TRANSPORT RES F-TRAF, V22, P126, DOI 10.1016/j.trf.2013.10.005; Satiennam W, 2018, TRANSPORT RES F-TRAF, V55, P234, DOI 10.1016/j.trf.2018.03.007; Sisimwo PK, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.296.4885; Teoh ER, 2010, J SAFETY RES, V41, P507, DOI 10.1016/j.jsr.2010.10.005; World Health Organisation, 2018, NONC DIS COUNTR PROF; Wu D, 2018, TRAFFIC INJ PREV, V19, P433, DOI 10.1080/15389588.2017.1410145; Zamani-Alavijeh F, 2009, TRAFFIC INJ PREV, V10, P237, DOI 10.1080/15389580902822717	31	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201946	10.1371/journal.pone.0201946	http://dx.doi.org/10.1371/journal.pone.0201946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161204	Green Published, gold, Green Submitted			2022-12-27	WOS:000443388900017
J	Maduranga, K; Attanayake, RN; Santhirasegaram, S; Weerakoon, G; Paranagama, PA				Maduranga, Kasun; Attanayake, Renuka Nilmini; Santhirasegaram, Sinthujah; Weerakoon, Gothamie; Paranagama, Priyani Ashoka			Molecular phylogeny and bioprospecting of Endolichenic Fungi (ELF) inhabiting in the lichens collected from a mangrove ecosystem in Sri Lanka	PLOS ONE			English	Article							NATURAL-PRODUCTS; ERYSIPHE-TRIFOLII; POWDERY MILDEW; REGION; DIVERSITY; DNA	Endolichenic fungi (ELF) are unexplored group of organisms as a source for the production of bioactive secondary metabolites with radical scavenging activity, antilipase and amylase inhibitory activities. Endolichenic fungi in lichens collected from mangrove or mangrove associated plants are least known for their fungal diversity and potential to produce bioactive compounds. A total of 171 ELF strains were isolated from the lichens collected from mangrove and mangrove associated plants in Puttalam lagoon. Out of this collection, 70 isolates were identified using rDNA-ITS region sequence homology to the GenBank accessions and a phylogenetic analysis was performed. Commonly isolated genera of ELF from lichens were Aspergillus, Byssochlamys, Talaromyces, Diaporthe, Phomopsis, Endomelanconiopsis, Schizophyllum, Cerrena, Trichoderma, Xylaria, Hypoxylon, Daldinia, Preussia, Sordaria, Neurospora, and Lasiodiplodia. In the present study, the effectiveness of ethyl acetate extracts of the ELF isolates were investigated against antioxidant activity, antilipase activity and a-amylase inhibition activity in in-vitro conditions. The results revealed that the extracts of Daldinia eschscholtzii, Diaporthe musigena and Sordaria sp. had the highest radical scavenging activity with smaller IC50 values (25 mu g/mL to 31 mu g/mL) compared to the IC50 values of BHT (76.50 +/- 1.47 mu g/mL). Antilipase assay revealed that 13 extracts from ELF showed promising antiobesity activity ranged between 25% to 40%. Amylase inhibitory assay indicated that the test extracts do not contain antidiabetic secondary metabolites.	[Maduranga, Kasun; Santhirasegaram, Sinthujah; Paranagama, Priyani Ashoka] Univ Kelaniya, Dept Chem, Kelaniya, Sri Lanka; [Attanayake, Renuka Nilmini] Univ Kelaniya, Dept Bot, Kelaniya, Sri Lanka; [Weerakoon, Gothamie] Field Museum Nat Hist, Dept Sci & Educ, Integrat Res Ctr, Chicago, IL 60605 USA; [Weerakoon, Gothamie] Nat Hist Museum, Dept Life Sci, Algae Fungi & Plants Div, London, England	University Kelaniya; University Kelaniya; Field Museum of Natural History (Chicago); Natural History Museum London	Paranagama, PA (corresponding author), Univ Kelaniya, Dept Chem, Kelaniya, Sri Lanka.	priyani@kln.ac.lk	Weerakoon, Gothamie/AAJ-3035-2021	Paranagama, Priyani/0000-0001-5489-081X	National Research Council, Sri Lanka [NRC/15-08]	National Research Council, Sri Lanka	This research project was funded by National Research Council, Sri Lanka under the grant number NRC/15-08 to PAP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Arnold AE, 2009, SYST BIOL, V58, P283, DOI 10.1093/sysbio/syp001; Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Attanayake RN, 2010, PLANT PATHOL, V59, P712, DOI 10.1111/j.1365-3059.2010.02306.x; Attanayake RN, 2009, PLANT DIS, V93, P797, DOI 10.1094/PDIS-93-8-0797; Bhutkar M. A., 2012, International Journal of Chemical Sciences, V10, P457; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chatatikun M., 2013, Journal of Chemical and Pharmaceutical Research, V5, P97; Chowdhary K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141444; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Dias ACF, 2009, WORLD J MICROB BIOT, V25, P1305, DOI 10.1007/s11274-009-0013-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gilham D, 2005, METHODS, V36, P139, DOI 10.1016/j.ymeth.2004.11.003; Gupta M, 2015, J ENZYM INHIB MED CH, V30, P15, DOI 10.3109/14756366.2013.871007; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Jayakumar K, 2016, RES J PHARM BIOL CHE, V7, P1412; Khan AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158207; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Manthrirathna MATP, 2018, J NATN SCI FDN SRI L; Muggia L, 2016, FUNGAL DIVERS, V76, P119, DOI 10.1007/s13225-015-0343-8; Nielsen JC, 2017, SYN SYST BIOTECHNO, V2, P5, DOI 10.1016/j.synbio.2017.02.002; Orange A., 2001, MICROCHEMICAL METHOD; Paranagama PA, 2007, J NAT PROD, V70, P1700, DOI 10.1021/np070466w; Pinto L., 1986, PUBLICATION NATL RES; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Raja HA, 2017, J NAT PROD, V80, P756, DOI 10.1021/acs.jnatprod.6b01085; Reynolds CL, 2017, PLOS ONE, V12, P180; Samanthi KAU, 2015, J NATL SCI FOUND SRI, V43, P217, DOI 10.4038/jnsfsr.v43i3.7950; Samanthi KAU, 2015, J NATL SCI FOUND SRI, V43, P119, DOI 10.4038/jnsfsr.v43i2.7939; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Upreti D. K., 1999, Tropical Ecology, V40, P41; Weerakoon G, 2016, PHYTOTAXA, V280, P152, DOI 10.11646/phytotaxa.280.2.5; Zhang T, 2016, EXTREMOPHILES, V20, P461, DOI 10.1007/s00792-016-0836-8; Zhao Q, 2015, J NAT PROD, V78, P1221, DOI 10.1021/np500912t	38	16	20	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0200711	10.1371/journal.pone.0200711	http://dx.doi.org/10.1371/journal.pone.0200711			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157176	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400005
J	Shumilov, K; Real, MA; Valderrama-Carvajal, A; Rivera, A				Shumilov, Kirill; Angeles Real, M.; Valderrama-Carvajal, Alejandra; Rivera, Alicia			Selective ablation of striatal striosomes produces the deregulation of dopamine nigrostriatal pathway	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; IN-SITU HYBRIDIZATION; CHOLINERGIC INTERNEURONS; PATCH COMPARTMENT; DORSAL STRIATUM; SUBSTANCE-P; RAT-BRAIN; NEURONS; EXPRESSION; PROJECTIONS	The striatum is a complex structure in which the organization in two compartments (striosomes and matrix) have been defined by their neurochemical profile and their input-output connections. The striosomes receive afferences from the limbic brain areas and send projections to the dopamine neurons of the substantia nigra pars compacta. Thereby, it has been suggested that the striosomes exert a limbic control over the motor function mediated by the surrounding matrix. However, the functionality of the striosomes are not completely understood. To elucidate the role of the striosomes on the regulation of the nigral dopamine neurons, we have induced specific ablation of this compartment by striatal injections of the neurotoxin dermorphin-saporin (DS) and dopamine neurotransmission markers have been analyzed by immunohistochemistry. The degeneration of the striosomes resulted in a nigrostriatal projections imbalance between the two striatal compartments, with an increase of the dopamine neurotransmission in the striosomes and a decrease in the matrix. The present results highlight the key function of the striosomes for the maintenance of the striatal dopamine tone and would contribute to the understanding of their involvement in some neurological disorders such as Huntington's disease.	[Shumilov, Kirill; Angeles Real, M.; Valderrama-Carvajal, Alejandra; Rivera, Alicia] Univ Malaga, Dept Cell Biol, Inst Invest Biomed, Malaga, Spain	Universidad de Malaga	Rivera, A (corresponding author), Univ Malaga, Dept Cell Biol, Inst Invest Biomed, Malaga, Spain.	arivera@uma.es	Rivera, Alicia/L-2098-2014; Valderrama-Carvajal, Alejandra/F-3852-2016; Valderrama-Carvajal, Alejandra/AAB-4325-2020; Real/L-2950-2014; Shumilov, Kirill/J-2190-2018	Rivera, Alicia/0000-0002-7282-0441; Valderrama-Carvajal, Alejandra/0000-0002-9412-1713; Valderrama-Carvajal, Alejandra/0000-0002-9412-1713; Real/0000-0001-8823-9419; Shumilov, Kirill/0000-0001-8961-1702	Junta de Andalucia [CTS-0161, BIO121]; Universidad de Malaga	Junta de Andalucia(Junta de Andalucia); Universidad de Malaga	This work was supported by Junta de Andalucia (grant numbers CTS-0161 to A.R. and BIO121 to M.A.R) and Universidad de Malaga.	ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; Austin S, 2014, STRIATAL CHOLINERGIC; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Beste C, 2017, MOVEMENT DISORD, V32, P576, DOI 10.1002/mds.26895; Brimblecombe KR, 2017, ACS CHEM NEUROSCI, V8, P235, DOI 10.1021/acschemneuro.6b00333; Brown LL, DIFFERENTIAL METABOL; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Crittenden JR, 2016, P NATL ACAD SCI USA; Cui YJ, 2014, NAT NEUROSCI, V17, P254, DOI 10.1038/nn.3622; DELFS JM, 1994, J COMP NEUROL, V345, P46, DOI 10.1002/cne.903450104; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Friedman A, 2015, CELL, V161, P1320, DOI 10.1016/j.cell.2015.04.049; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Gago B, 2007, J COMP NEUROL, V502, P358, DOI 10.1002/cne.21327; GERFEN CR, 1984, NATURE, V311, P461, DOI 10.1038/311461a0; GIAGNONI G, 1984, NEUROPEPTIDES, V5, P157, DOI 10.1016/0143-4179(84)90051-9; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; Graybiel AM, 2015, COLD SPRING HARB PER, V7; Guttenberg ND, 1996, NEUROREPORT, V7, P2119, DOI 10.1097/00001756-199609020-00011; HERKENHAM M, 1981, NATURE, V291, P415, DOI 10.1038/291415a0; HERSCH SM, 1994, J NEUROSCI, V14, P3351; Hontanilla B, 1998, BRAIN RES BULL, V47, P107, DOI 10.1016/S0361-9230(98)00035-5; Jabourian M, 2005, EUR J NEUROSCI, V21, P3301, DOI 10.1111/j.1460-9568.2005.04154.x; Jabourian M, 2007, EUR J NEUROSCI, V25, P1546, DOI 10.1111/j.1460-9568.2007.05375.x; JIMENEZCASTELLANOS J, 1989, NEUROSCIENCE, V32, P297, DOI 10.1016/0306-4522(89)90080-8; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Lanciego JL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009621; Lawhorn C, 2009, NEUROSCIENCE, V163, P109, DOI 10.1016/j.neuroscience.2009.05.021; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; McMahon A, 1998, MOL BRAIN RES, V54, P56, DOI 10.1016/S0169-328X(97)00305-7; Murray RC, 2015, BRAIN RES, V1618, P286, DOI 10.1016/j.brainres.2015.06.012; Murray RC, 2014, BRAIN STRUCT FUNCT, V219, P1213, DOI 10.1007/s00429-013-0559-x; OLSON L, 1972, BRAIN RES, V44, P283, DOI 10.1016/0006-8993(72)90385-X; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ponterio G, 2013, NEUROPHARMACOLOGY, V75, P78, DOI 10.1016/j.neuropharm.2013.07.006; Porreca F, 2001, J NEUROSCI, V21, P5281, DOI 10.1523/JNEUROSCI.21-14-05281.2001; Rivera A, 2002, J NEUROCHEM, V80, P219, DOI 10.1046/j.0022-3042.2001.00702.x; Rivera A, 2017, ADDICT BIOL, V22, P1232, DOI 10.1111/adb.12407; Smith JB, 2016, NEURON, V91, P1069, DOI 10.1016/j.neuron.2016.07.046; Tajima K, 2013, NEUROSCIENCE, V241, P215, DOI 10.1016/j.neuroscience.2013.03.012; Tippett LJ, 2007, BRAIN, V130, P206, DOI 10.1093/brain/awl243; Tokuno H, 2002, NEUROSCI LETT, V332, P5, DOI 10.1016/S0304-3940(02)00837-6; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wang H, 1999, J COMP NEUROL, V412, P132, DOI 10.1002/(SICI)1096-9861(19990913)412:1<132::AID-CNE10>3.0.CO;2-B; Wang HB, 2007, NEUROSCI LETT, V425, P195, DOI 10.1016/j.neulet.2007.08.033; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wiley RG, 2000, J NEUROSCI METH, V103, P73, DOI 10.1016/S0165-0270(00)00297-1; Winzer-Serhan UH, 2003, J CHEM NEUROANAT, V26, P17, DOI 10.1016/S0891-0618(03)00031-0; Wirtshafter D, 2004, J CHEM NEUROANAT, V28, P107, DOI 10.1016/j.jchemneu.2004.05.007; Xu MY, 2015, P NATL ACAD SCI USA, V112, P893, DOI 10.1073/pnas.1419533112; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203135	10.1371/journal.pone.0203135	http://dx.doi.org/10.1371/journal.pone.0203135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157254	Green Published, Green Submitted, gold			2022-12-27	WOS:000443071400094
J	Hsi, RS; Schlunk, SG; Tierney, JE; Dei, K; Jones, R; George, M; Karve, P; Duddu, R; Byram, BC				Hsi, Ryan S.; Schlunk, Siegfried G.; Tierney, Jaime E.; Dei, Kazuyuki; Jones, Rebecca; George, Mark; Karve, Pranav; Duddu, Ravindra; Byram, Brett C.			Feasibility of non-linear beamforming ultrasound methods to characterize and size kidney stones	PLOS ONE			English	Article							SONOGRAPHIC TWINKLING ARTIFACT; LAG SPATIAL COHERENCE; PULSE ARRIVAL-TIME; COMPUTED-TOMOGRAPHY; MEDICAL ULTRASOUND; CLINICAL EFFECTIVENESS; CLUTTER REDUCTION; RENAL-CALCULUS; ABDOMINAL-WALL; ULTRASONOGRAPHY	Purpose Ultrasound methods for kidney stone imaging suffer from poor sensitivity and size overestimation. The study objective was to demonstrate feasibility of non-linear ultrasound beamforming methods for stone imaging, including plane wave synthetic focusing (PWSF), short-lag spatial coherence (SLSC) imaging, mid-lag spatial coherence (MLSC) imaging with incoherent compounding, and aperture domain model image reconstruction (ADMIRE). Materials and methods The ultrasound techniques were evaluated in an in vitro kidney stone model and in a pilot study of 5 human stone formers (n = 6 stones). Stone contrast, contrast-to-noise ratio (CNR), sizing, posterior shadow contrast, and shadow width sizing were compared among the different techniques and to B-mode. CT imaging within 60 days was considered the gold standard stone size. Paired t-tests using Bonferroni correction were performed to evaluate comparing each technique with B-mode. Results Mean CT measured stone size was 6.0mm (range 2.9-12.2mm) with mean skin-to-stone distance 10.2cm (range 5.4-16.3cm). Compared to B-mode, stone contrast was best with ADMIRE (mean +12.2dB), while SLSC and MLSC showed statistically improved CNR. Sizing was best with ADMIRE (mean +1.3mm error), however this was not significantly improved over B-mode (+2.4mm). PWSF performed similarly to B-mode for stone contrast, CNR, SNR, and stone sizing. In the in vitro model, the shadow contrast was highest with ADMIRE (mean 10.5 dB vs 3.1 dB with B-mode). Shadow sizing was best with SLSC (mean error +0.9mm +/- 2.9), however the difference compared to B-mode was not significant. Conclusions The detection and sizing of stones are feasible with advanced beamforming methods with ultrasound. ADMIRE, SLSC, and MLSC hold promise for improving stone detection, shadow contrast, and sizing.	[Hsi, Ryan S.] Vanderbilt Univ, Med Ctr, Dept Urol, Nashville, TN 37232 USA; [Schlunk, Siegfried G.; Tierney, Jaime E.; Dei, Kazuyuki; Jones, Rebecca; George, Mark; Byram, Brett C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Karve, Pranav; Duddu, Ravindra] Vanderbilt Univ, Dept Civil & Environm Engn, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Hsi, RS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Urol, Nashville, TN 37232 USA.	ryan.hsi@vanderbilt.edu	Karve, Pranav/AAN-2258-2021; Byram, Brett/B-3559-2016; Duddu, Ravindra/A-6854-2015	Byram, Brett/0000-0003-3693-1459; Hsi, Ryan/0000-0003-1652-694X; Duddu, Ravindra/0000-0002-4205-0247	Vanderbilt Institute of Surgery and Engineering (VISE); VISE Surgeon in Residence Award [R01EB020040]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB020040] Funding Source: NIH RePORTER	Vanderbilt Institute of Surgery and Engineering (VISE); VISE Surgeon in Residence Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was received from Vanderbilt Institute of Surgery and Engineering (VISE) Pilot and Feasibility Award, VISE Surgeon in Residence Award, R01EB020040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aja-Fernandez S, 2015, KNOWL-BASED SYST, V83, P1, DOI 10.1016/j.knosys.2015.02.029; Anderson ME, 1998, J ACOUST SOC AM, V104, P3099, DOI 10.1121/1.423889; Anderson ME, 2000, J ACOUST SOC AM, V107, P3540, DOI 10.1121/1.429422; BLY SHP, 1985, ULTRASOUND MED BIOL, V11, P99, DOI 10.1016/0301-5629(85)90012-2; Bottenus N, 2013, IEEE T ULTRASON FERR, V60, P1816, DOI 10.1109/TUFFC.2013.2768; Brisbane W, 2016, NAT REV UROL, V13, P654, DOI 10.1038/nrurol.2016.154; Byram B., 2015, P INT ULTR S IUS OCT, P1; Byram B, 2016, ULTR S IUS 2016 IEEE; Byram B, 2015, IEEE T ULTRASON FERR, V62, P1913, DOI 10.1109/TUFFC.2015.007004; Byram B, 2014, IEEE T ULTRASON FERR, V61, P428, DOI 10.1109/TUFFC.2014.2928; CARSON PL, 1977, RADIOLOGY, V122, P765, DOI 10.1148/122.3.765; Dai JC, 2018, WORLD J UROL, V36, P727, DOI 10.1007/s00345-017-2156-8; Dei K, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.2.027001; Dei K, 2018, ULTRASONICS, V89, P34, DOI 10.1016/j.ultras.2018.04.011; Dillman JR, 2011, RADIOLOGY, V259, P911, DOI 10.1148/radiol.11102128; Dunmire B, 2016, J UROLOGY, V195, P171, DOI 10.1016/j.juro.2015.05.111; Dunmire B, 2015, J ENDOUROL, V29, P147, DOI 10.1089/end.2014.0332; FLAX SW, 1988, IEEE T ULTRASON FERR, V35, P758, DOI 10.1109/58.9333; Fowler KAB, 2002, RADIOLOGY, V222, P109, DOI 10.1148/radiol.2221010453; Fulgham PF, 2013, J UROLOGY, V189, P1203, DOI 10.1016/j.juro.2012.10.031; Ganesan V, 2017, BJU INT, V119, P464, DOI 10.1111/bju.13605; HINKELMAN LM, 1994, J ACOUST SOC AM, V95, P530, DOI 10.1121/1.408347; Hyun D, 2017, IEEE T ULTRASON FERR, V64, P500, DOI 10.1109/TUFFC.2016.2634004; Kruizinga P, 2012, IEEE T ULTRASON FERR, V59, P2684, DOI 10.1109/TUFFC.2012.2509; Lediju MA, 2011, IEEE T ULTRASON FERR, V58, P1377, DOI 10.1109/TUFFC.2011.1957; Lediju MA, 2008, ULTRASONIC IMAGING, V30, P151, DOI 10.1177/016173460803000302; LO T, 1991, ELECTRON LETT, V27, P350, DOI 10.1049/el:19910222; Masch WR, 2016, AM J ROENTGENOL, V206, P326, DOI 10.2214/AJR.15.14998; Mitterberger M, 2009, INT BRAZ J UROL, V35, P532, DOI 10.1590/S1677-55382009000500004; Montaldo G, 2009, IEEE T ULTRASON FERR, V56, P489, DOI 10.1109/TUFFC.2009.1067; Nicolau C, 2015, INSIGHTS IMAGING, V6, P441, DOI 10.1007/s13244-015-0396-y; Omar M, 2015, J ENDOUROL, V29, P1122, DOI 10.1089/end.2015.0088; Pinton GF, 2011, IEEE T ULTRASON FERR, V58, P1272, DOI 10.1109/TUFFC.2011.1938; Ray AA, 2010, UROLOGY, V76, P295, DOI 10.1016/j.urology.2009.12.015; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Semins MJ, 2014, NAT REV UROL, V11, P163, DOI 10.1038/nrurol.2014.17; SMITH SW, 1986, ULTRASOUND MED BIOL, V12, P229, DOI 10.1016/0301-5629(86)90314-5; SMITH SW, 1983, IEEE T SON ULTRASON, V30, P164, DOI 10.1109/T-SU.1983.31405; Smith-Bindman R, 2014, NEW ENGL J MED, V371, P1100, DOI 10.1056/NEJMoa1404446; Sternberg KM, 2016, UROLOGY, V95, P67, DOI 10.1016/j.urology.2016.06.002; SUMINO Y, 1991, J ACOUST SOC AM, V90, P2924, DOI 10.1121/1.401766; Tabei M, 2003, J ACOUST SOC AM, V113, P1166, DOI 10.1121/1.1531986; Tierney JE, 2019, UROLITHIASIS, V47, P181, DOI 10.1007/s00240-018-1036-z; Turk C, 2016, EUR UROL, V69, P468, DOI 10.1016/j.eururo.2015.07.040; Ulusan S, 2007, J CLIN ULTRASOUND, V35, P256, DOI 10.1002/jcu.20347; Unal D, 2003, UROL INT, V70, P31, DOI 10.1159/000067702; Vouras P, 2016, CONF REC ASILOMAR C, P669, DOI 10.1109/ACSSC.2016.7869128; Waag RC, 1986, SONICS ULTRASONICS I, V32, P36; Wang LT, 2012, SENSORS-BASEL, V12, P12424, DOI 10.3390/s120912424; Winkel RR, 2012, ULTRASOUND MED BIOL, DOI [10.1016/j.ultrasmedbio.2012.03, DOI 10.1016/J.ULTRASMEDBIO.2012.03]; ZHU Q, 1992, ULTRASONIC IMAGING, V14, P276, DOI 10.1016/0161-7346(92)90067-6	51	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0203138	10.1371/journal.pone.0203138	http://dx.doi.org/10.1371/journal.pone.0203138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153279	Green Published, gold			2022-12-27	WOS:000443001700047
J	Milner, GR; Boldsen, JL; Ousley, SD; Getz, SM; Weise, S; Tarp, P; Steadman, DW				Milner, George R.; Boldsen, Jesper L.; Ousley, Stephen D.; Getz, Sara M.; Weise, Svenja; Tarp, Peter; Steadman, Dawnie W.			Selective mortality in middle-aged American women with Diffuse Idiopathic Skeletal Hyperostosis (DISH)	PLOS ONE			English	Article							HYPER-OSTOSIS DISH; ANKYLOSING SPINAL-DISORDERS; OF-THE-LITERATURE; RISK-FACTORS; EXTRASPINAL MANIFESTATIONS; CLASSIFICATION CRITERIA; CARDIOVASCULAR-DISEASES; SPONDYLOSIS DEFORMANS; METABOLIC SYNDROME; PREVALENCE	Objective A mortality sample of white American male and female skeletons was examined to illustrate a simple means of identifying skeletal conditions associated with an increased risk of dying relatively early in adulthood and to determine if males and females with Diffuse Idiopathic Skeletal Hyperostosis (DISH) displayed the same general age-specific pattern of mortality. Methods Age-specific probability distributions for DISH were generated from 416 white Americans who died from the 1980s to the present, and whose remains were donated to the University of Tennessee Forensic Anthropology Center. The age-specific frequency of DISH is analyzed using an empirical smoothing algorithm. Doing so allows for the identification of deviations (i.e., local maxima) from monotonically increasing age-specific probabilities. Results In females (N = 199), there is a peak in the frequency of individuals with DISH around 60 years of age where 37.0% of the individuals have DISH. It is matched only by the frequency (38.7%) in the oldest females, those over 85 years old. In contrast, DISH frequencies for males (N = 217) increase monotonically with advancing age, reaching 62.5% in the >86 years age group. There was an association between DISH and high body weight in women, particularly those who died before they reached the age of 75. Conclusions Early-onset DISH in white American women is associated with an increased risk of dying indicated by a local maximum in the probability curve. Should this finding be replicated in additional mortality samples and the reason DISH is associated with early death is established, beyond being heavy, this radiologically visible ossification of the spine could be a potential component of health-monitoring programs for middle-aged women.	[Milner, George R.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Boldsen, Jesper L.; Weise, Svenja; Tarp, Peter] Univ Southern Denmark, Dept Forens Med, Unit Anthropol, ADBOU, Odense, Denmark; [Ousley, Stephen D.] Mercyhurst Univ, Dept Math & Informat Sci, Erie, PA USA; [Getz, Sara M.] Idaho State Univ, Dept Anthropol, Pocatello, ID 83209 USA; [Steadman, Dawnie W.] Univ Tennessee, Dept Anthropol, Forens Anthropol Ctr, Knoxville, TN 37996 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Southern Denmark; Idaho; Idaho State University; University of Tennessee System; University of Tennessee Knoxville	Milner, GR (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	ost@psu.edu	Steadman, Dawnie/AAG-4216-2020	Steadman, Dawnie/0000-0003-0812-0739	National Institute of Justice (NIJ) [2014-DN-BX-K007]	National Institute of Justice (NIJ)	This work was funded by a National Institute of Justice (NIJ) grant, 2014-DN-BX-K007, awarded to GRM, JLB, and SDO. The NIJ had no role in data collection, analysis, or manuscript preparation.	Aceves-Avila FJ, 1998, J RHEUMATOL, V25, P776; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], R LANG ENV STAT COMP; ARRIAZA BT, 1993, AM J PHYS ANTHROPOL, V92, P243, DOI 10.1002/ajpa.1330920302; ARRIAZA BT, 1993, AM J PHYS ANTHROPOL, V91, P263, DOI 10.1002/ajpa.1330910302; Bazzocchi A, 2017, RADIOL CLIN N AM, V55, P943, DOI 10.1016/j.rcl.2017.04.003; BLOOM RA, 1984, SCAND J RHEUMATOL, V13, P181, DOI 10.3109/03009748409100384; Caron T, 2010, SPINE, V35, pE458, DOI 10.1097/BRS.0b013e3181cc764f; CASSIM B, 1990, BRIT J RHEUMATOL, V29, P131; Connell B., 2012, MOLA MONOGRAPH, V60; Crawley M.J., 2007, R BOOK; Crubezy E, 1993, REV RHUM, V60, P489; Denko CW, 2006, RHEUMATOL INT, V26, P292, DOI 10.1007/s00296-005-0588-8; Diederichs G, 2011, OSTEOPOROSIS INT, V22, P1789, DOI 10.1007/s00198-010-1409-9; Faccia K, 2016, QUATERN INT, V405, P66, DOI 10.1016/j.quaint.2015.10.011; FORESTIER J, 1950, ANN RHEUM DIS, V9, P321, DOI 10.1136/ard.9.4.321; FORESTIER J, 1971, CLIN ORTHOP RELAT R, P65; Foster A, 2018, J ARCHAEOL SCI-REP, V18, P408, DOI 10.1016/j.jasrep.2018.01.002; Giuffra V, 2010, EUR SPINE J, V19, pS103, DOI 10.1007/s00586-009-1125-3; GRAN JT, 1993, SEMIN ARTHRITIS RHEU, V22, P319, DOI 10.1016/S0049-0172(05)80011-3; Hartmann S, 2017, GLOB SPINE J, V7, P469, DOI 10.1177/2192568217700108; HENDRIX RW, 1994, AM J ROENTGENOL, V162, P899, DOI 10.2214/ajr.162.4.8141015; Hirasawa A, 2016, J ORTHOP SCI, V21, P287, DOI 10.1016/j.jos.2016.02.001; Hlavenkova L, 2013, ANTHROPOL ANZ, V70, P261, DOI 10.1127/0003-5548/2013/0309; Holgate RLV, 2016, CLIN ANAT, V29, P870, DOI 10.1002/ca.22716; Jankauskas R, 2003, INT J OSTEOARCHAEOL, V13, P289, DOI 10.1002/oa.697; JULKUNEN H, 1981, SCAND J RHEUMATOL, V10, P193, DOI 10.3109/03009748109095298; JULKUNEN H, 1975, SCAND J RHEUMATOL, V4, P23; JULKUNEN H, 1981, SCAND J RHEUMATOL, V10, P241, DOI 10.3109/03009748109095306; JULKUNEN H, 1971, ANN RHEUM DIS, V30, P605, DOI 10.1136/ard.30.6.605; Kagotani R, 2015, J BONE MINER METAB, V33, P221, DOI 10.1007/s00774-014-0583-9; Katzman WB, 2017, J AM GERIATR SOC, V65, P1476, DOI 10.1111/jgs.14810; Kim MJ, 2012, INT J OSTEOARCHAEOL, V22, P235, DOI 10.1002/oa.1203; Kim SK, 2004, J RHEUMATOL, V31, P2032; Kiss C, 2002, RHEUMATOLOGY, V41, P27, DOI 10.1093/rheumatology/41.1.27; Kiss C, 2002, SCAND J RHEUMATOL, V31, P226, DOI 10.1080/030097402320318422; KRAMAR C, 1990, SCAND J RHEUMATOL, V19, P163, DOI 10.3109/03009749009102121; Kuperus JS, 2017, RHEUMATOLOGY, V56, P1123, DOI 10.1093/rheumatology/kex056; LITTLEJOHN GO, 1985, CLIN RHEUMATOL, V4, P294, DOI 10.1007/BF02031611; MAAT GJR, 1995, INT J OSTEOARCHAEOL, V5, P289, DOI 10.1002/oa.1390050308; Mader R, 2009, OSTEOARTHR CARTILAGE, V17, P825, DOI 10.1016/j.joca.2008.12.004; Mader R, 2013, NAT REV RHEUMATOL, V9, P741, DOI 10.1038/nrrheum.2013.165; Mader R, 2013, RHEUMATOLOGY, V52, P326, DOI 10.1093/rheumatology/kes257; Mader R, 2012, NAT REV RHEUMATOL, V8, P10, DOI 10.1038/nrrheum.2011.189; Mader R, 2010, J RHEUMATOL, V37, P1911, DOI 10.3899/jrheum.091008; Mader R, 2009, RHEUMATOLOGY, V48, P1478, DOI 10.1093/rheumatology/kep308; Mader R, 2009, SEMIN ARTHRITIS RHEU, V38, P361, DOI 10.1016/j.semarthrit.2008.01.010; MAERTENS M, 1992, CLIN RHEUMATOL, V11, P551, DOI 10.1007/BF02283118; Mata S, 1998, SEMIN ARTHRITIS RHEU, V28, P88, DOI 10.1016/S0049-0172(98)80041-3; Mays S., 2000, J PATHOL, V12, P25; Mays S, 2016, AM J PHYS ANTHROPOL, V159, P577, DOI 10.1002/ajpa.22912; Milner GR, 2017, INT J PALEOPATHOL, V17, P26, DOI 10.1016/j.ijpp.2017.03.007; Miyazawa N, 2006, SPINE, V31, pE225, DOI 10.1097/01.brs.0000214949.75361.f4; Mori K, 2017, J ORTHOP SCI, V22, P38, DOI 10.1016/j.jos.2016.09.003; Okada E, 2017, J ORTHOP SCI, V22, P3, DOI 10.1016/j.jos.2016.09.011; Olivieri I, 2013, J RHEUMATOL, V40, P1251, DOI 10.3899/jrheum.130647; Olivieri Ignazio, 2009, Curr Rheumatol Rep, V11, P321; Osz Brigitta, 2009, Acta Biologica Szegediensis, V53, P125; Oudkerk SF, 2017, EUR RADIOL, V27, P188, DOI 10.1007/s00330-016-4355-x; Oxenham MF, 2006, INT J OSTEOARCHAEOL, V16, P34, DOI 10.1002/oa.803; Paja Laszio, 2010, Acta Biologica Szegediensis, V54, P75; PALEY D, 1991, CLIN ORTHOP RELAT R, P22; Pillai Sruti, 2014, Open Rheumatol J, V8, P116, DOI 10.2174/1874312901408010116; Quintelier K, 2014, AM J PHYS ANTHROPOL, V153, P203, DOI 10.1002/ajpa.22420; Reale B, 1999, INT J OSTEOARCHAEOL, V9, P369; RESNICK D, 1976, RADIOLOGY, V119, P559, DOI 10.1148/119.3.559; RESNICK D, 1975, RADIOLOGY, V115, P513, DOI 10.1148/15.3.513; RESNICK D, 1978, SEMIN ARTHRITIS RHEU, V7, P153, DOI 10.1016/0049-0172(78)90036-7; ROGERS J, 1990, BRIT MED J, V300, P367, DOI 10.1136/bmj.300.6721.367; ROGERS J, 1985, ANN RHEUM DIS, V44, P113, DOI 10.1136/ard.44.2.113; Rogers J, 2001, INT J OSTEOARCHAEOL, V11, P357, DOI 10.1002/oa.574; Rustagi T, 2017, J ORTHOP TRAUMA, V31, pS57, DOI 10.1097/BOT.0000000000000953; Smith MO, 2013, INT J PALEOPATHOL, V3, P11, DOI 10.1016/j.ijpp.2013.03.001; Stroud G, 1993, CEMETERIES ST ANDREW; SUZUKI T, 1993, ANTHROPOL SCI, V101, P273, DOI 10.1537/ase.101.273; Toyoda H, 2017, ASIAN SPINE J, V11, P63, DOI 10.4184/asj.2017.11.1.63; UTSINGER PD, 1985, CLIN RHEUM DIS, V11, P325; van der Merwe AE, 2012, HOMO, V63, P202, DOI 10.1016/j.jchb.2012.03.005; Venables WN., 2002, MODERN APPL STAT S; Verlaan JJ, 2007, EUR SPINE J, V16, P1129, DOI 10.1007/s00586-007-0342-x; Verlaan JJ, 2011, EUR SPINE J, V20, P1474, DOI 10.1007/s00586-011-1719-4; Vezyroglou G, 1996, J RHEUMATOL, V23, P672; Vidal P, 2000, JOINT BONE SPINE, V67, P210; WALDRON T, 1985, BRIT MED J, V291, P1762, DOI 10.1136/bmj.291.6511.1762; Waldron T., 1991, INT J OSTEOARCHAEOL, V1, P103, DOI DOI 10.1002/0A.1390010206; Waldron T, 2007, ST PETERS BARTON UPO, V2; Weinfeld RM, 1997, SKELETAL RADIOL, V26, P222, DOI 10.1007/s002560050225; Weisz GM, 2011, RHEUMATOL INT, V31, P1649, DOI 10.1007/s00296-010-1563-6; Westerveld LA, 2014, SPINE J, V14, P729, DOI 10.1016/j.spinee.2013.06.038; Westerveld LA, 2009, EUR SPINE J, V18, P145, DOI 10.1007/s00586-008-0764-0; Westerveld LA, 2008, J RHEUMATOL, V35, P1635; William M., BASS DONATED SKELETA; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; Zincarelli C, 2012, ARTHRIT CARE RES, V64, P1765, DOI 10.1002/acr.21742	94	5	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202283	10.1371/journal.pone.0202283	http://dx.doi.org/10.1371/journal.pone.0202283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR8TH	30153267	Green Submitted, Green Published, gold			2022-12-27	WOS:000443001700012
J	Pandey, K; Lahiani, MH; Hicks, VK; Hudson, MK; Green, MJ; Khodakovskaya, M				Pandey, Kamal; Lahiani, Mohamed H.; Hicks, Victoria K.; Hudson, M. Keith; Green, Micah J.; Khodakovskaya, Mariya			Effects of carbon-based nanomaterials on seed germination, biomass accumulation and salt stress response of bioenergy crops	PLOS ONE			English	Article							AQUAPORIN GENE; GROWTH; WATER; SALINITY; NANOTUBES; PLANTS; DESALINATION; IRRIGATION; POTENTIALS; TOLERANCE	Bioenergy crops are an attractive option for use in energy production. A good plant candidate for bioenergy applications should produce a high amount of biomass and resist harsh environmental conditions. Carbon-based nanomaterials (CBNs) have been described as promising seed germination and plant growth regulators. In this paper, we tested the impact of two CBNs: graphene and multi-walled carbon nanotubes (CNTs) on germination and biomass production of two major bioenergy crops (sorghum and switchgrass). The application of graphene and CNTs increased the germination rate of switchgrass seeds and led to an early germination of sorghum seeds. The exposure of switchgrass to graphene (200 mg/l) resulted in a 28% increase of total biomass produced compared to untreated plants. We tested the impact of CBNs on bioenergy crops under salt stress conditions and discovered that CBNs can significantly reduce symptoms of salt stress imposed by the addition of NaCl into the growth medium. Using an ion selective electrode, we demonstrated that the concentration of Na+ ions in NaCl solution can be significantly decreased by the addition of CNTs to the salt solution. Our data confirmed the potential of CBNs as plant growth regulators for non-food crops and demonstrated the role of CBNs in the protection of plants against salt stress by desalination of saline growth medium.	[Pandey, Kamal; Lahiani, Mohamed H.; Khodakovskaya, Mariya] Univ Arkansas, Dept Biol, Little Rock, AR 72204 USA; [Hicks, Victoria K.; Green, Micah J.] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX USA; [Hudson, M. Keith] Univ Arkansas, Dept Chem, Little Rock, AR 72204 USA; [Khodakovskaya, Mariya] Russian Acad Sci, Far Eastern Branch, Fed Sci Ctr East Asia Terr Biodivers, Vladivostok, Russia	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Texas A&M University System; Texas A&M University College Station; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Russian Academy of Sciences; Federal Scientific Center of the East Asia Terrestrial Biodiversity, Far Eastern Branch of the Russian Academy of Sciences	Khodakovskaya, M (corresponding author), Univ Arkansas, Dept Biol, Little Rock, AR 72204 USA.; Khodakovskaya, M (corresponding author), Russian Acad Sci, Far Eastern Branch, Fed Sci Ctr East Asia Terr Biodivers, Vladivostok, Russia.	mvkhodakovsk@ualr.edu	; Green, Micah/C-7647-2011	Lahiani, Mohamed H./0000-0003-0551-2606; Green, Micah/0000-0001-5691-0861	Arkansas Science and Technology Authority [15-B-24]	Arkansas Science and Technology Authority	This study was supported by the Arkansas Science and Technology Authority (Award 15-B-24 to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimohammadi M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295101; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Cohen-Tanugi D, 2012, NANO LETT, V12, P3602, DOI 10.1021/nl3012853; Das R, 2014, DESALINATION, V336, P97, DOI 10.1016/j.desal.2013.12.026; Demirbas AH, 2007, ENERG CONVERS MANAGE, V48, P2386, DOI 10.1016/j.enconman.2007.03.005; Dipti P, 2013, INT J ENV ENG MANAG, V4, P265; Erb KH, 2012, ENERG POLICY, V47, P260, DOI 10.1016/j.enpol.2012.04.066; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Hu W, 2012, PLANT CELL PHYSIOL, V53, P2127, DOI 10.1093/pcp/pcs154; Irin F, 2012, CARBON, V50, P4441, DOI 10.1016/j.carbon.2012.05.022; Johnson J.M.F., 2007, AM J PLANT SCI BIOTE, V1, P1; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Khodakovskaya M, 2009, ACS NANO, V3, P3221, DOI 10.1021/nn900887m; Khodakovskaya MV, 2013, SMALL, V9, P115, DOI 10.1002/smll.201201225; Khodakovskaya MV, 2012, ACS NANO, V6, P2128, DOI 10.1021/nn204643g; Khodakovskaya MV, 2011, P NATL ACAD SCI USA, V108, P1028, DOI 10.1073/pnas.1008856108; Lahiani MH, 2017, J APPL TOXICOL, V37, P1305, DOI 10.1002/jat.3477; Lahiani MH, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/26/265102; Lahiani MH, 2015, CARBON, V81, P607, DOI 10.1016/j.carbon.2014.09.095; Lahiani MH, 2013, ACS APPL MATER INTER, V5, P7965, DOI 10.1021/am402052x; Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393; Li GW, 2014, BBA-GEN SUBJECTS, V1840, P1574, DOI 10.1016/j.bbagen.2013.11.004; Martinez-Alvarez V, 2016, DESALINATION, V381, P58, DOI 10.1016/j.desal.2015.11.032; McKendry P, 2002, BIORESOURCE TECHNOL, V83, P47, DOI 10.1016/S0960-8524(01)00119-5; Moser LE, 1995, FORAGES INTRO GRASSL, V1, P409; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Netondo GW, 2004, CROP SCI, V44, P797, DOI 10.2135/cropsci2004.0797; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Shrivastava P, 2015, SAUDI J BIOL SCI, V22, P123, DOI 10.1016/j.sjbs.2014.12.001; Silber A, 2015, WATER RESOUR RES, V51, P450, DOI 10.1002/2014WR016398; Skoog MA, 1971, PRINCIPLES INSTRUMEN, P473; Smeets EMW, 2007, PROG ENERG COMBUST, V33, P56, DOI 10.1016/j.pecs.2006.08.001; Stavridou E, 2017, GCB BIOENERGY, V9, P92, DOI 10.1111/gcbb.12351; Tofighy MA, 2010, DESALINATION, V258, P182, DOI 10.1016/j.desal.2010.03.017; Torney F, 2007, CURR OPIN BIOTECH, V18, P193, DOI 10.1016/j.copbio.2007.03.006; Vadez V., 2015, PLANT GENE, V1, P18, DOI DOI 10.1016/J.PLGENE.2014.12.002; Villagarcia H, 2012, SMALL, V8, P2328, DOI 10.1002/smll.201102661; Volkmar KM, 1998, CAN J PLANT SCI, V78, P19, DOI 10.4141/P97-020; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Yang Hui Ying, 2013, Nat Commun, V4, P2220, DOI 10.1038/ncomms3220; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001	43	55	56	10	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2018	13	8							e0202274	10.1371/journal.pone.0202274	http://dx.doi.org/10.1371/journal.pone.0202274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR8TH	30153261	gold, Green Published, Green Submitted			2022-12-27	WOS:000443001700011
J	Liu, AR; Hildebrand, AM; Dixon, S; Sontrop, JM; Clark, WF; Lazo-Langner, A; Nash, D; Garg, AX				Liu, Aiden R.; Hildebrand, Ainslie M.; Dixon, Stephanie; Sontrop, Jessica M.; Clark, William F.; Lazo-Langner, Alejandro; Nash, Danielle; Garg, Amit X.			A matched case-control study to assess the association between non-steroidal anti-inflammatory drug use and thrombotic microangiopathy	PLOS ONE			English	Article							THROMBOCYTOPENIC PURPURA; VALIDATION; DIAGNOSIS	Several case reports suggest that non-steroidal anti-inflammatory drug (NSAID) use is associated with development of thrombotic microangiopathy (TMA). We conducted a matched population-based case-control study using linked administrative healthcare data in Ontario, Canada to assess the relationship between TMA hospitalization and recent exposure to prescription NSAIDs versus acetaminophen (acetaminophen was chosen as the referent drug because it has no known association with TMA). Cases and controls were drawn from a source population of adults who filled a prescription for either NSAIDs or acetaminophen between 1991 and 2015 (restricted to adults with prescription drug benefits [n = 3.6 million]). We identified 44 eligible cases with a hospital admission for incident TMA and a recent prescription for NSAIDs or acetaminophen. We successfully matched 38 cases (1: 4) to 152 controls without TMA on demographics, risk factors for TMA, and indications for NSAID use. Cases and controls were similar with respect to age (71 years) and sex (63% women); however, on average, cases had more comorbidities than controls (12 vs. 14; p<0.05) and more primary care visits in the year before the index date (19 vs. 12; p<0.05). Cases were significantly less likely than controls to have received a recent prescription for NSAIDs (19/38 [50%] vs. 115/152 [76%], respectively; adjusted odds ratio 0.37, 95% confidence interval: 0.16 to 0.84). Results were similar in several sensitivity analyses. Overall, the results of this study do not support a harmful association between NSAID use and the development of TMA.	[Liu, Aiden R.; Dixon, Stephanie; Sontrop, Jessica M.; Garg, Amit X.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Liu, Aiden R.; Dixon, Stephanie; Sontrop, Jessica M.; Nash, Danielle; Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Hildebrand, Ainslie M.] Univ Alberta, Dept Med, Div Nephrol, Edmonton, AB, Canada; [Clark, William F.; Garg, Amit X.] Western Univ, Dept Med, Div Nephrol, London, ON, Canada; [Lazo-Langner, Alejandro] Western Univ, Dept Med, Div Hematol, London, ON, Canada	Western University (University of Western Ontario); University of Toronto; University of Alberta; Western University (University of Western Ontario); Western University (University of Western Ontario)	Liu, AR (corresponding author), Western Univ, Dept Epidemiol & Biostat, London, ON, Canada.; Liu, AR (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	aidenxliu@gmail.com	Lazo-Langner, Alejandro/G-3318-2011; Lazo-Langner, Alejandro/E-6993-2011; Garg, Amit X/G-3295-2011; Clark, Bill/G-3287-2011	Lazo-Langner, Alejandro/0000-0001-6869-8431; Lazo-Langner, Alejandro/0000-0001-6869-8431; Sontrop, Jessica M./0000-0001-7784-2028	Canadian Institute of Health Research; Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry at Western University; Lawson Health Research Institute; Lilibeth Caberto Kidney Clinical Research Unit; Ontario Drug Policy Research Network; Canadian Institute for Health Research Drug Safety and Effectiveness Cross-Disciplinary Training Program; Dr. Adam Linton Chair in Kidney Health Analytics; Opportunities Fund of the Academic Health Sciences Centre Alternative Funding Plan of AMOSO; Academic Medical Organization of South Western Ontario (AMOSO) Opportunities fund; Institute for Clinical Evaluative Sciences Western Faculty Scholars program	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry at Western University; Lawson Health Research Institute; Lilibeth Caberto Kidney Clinical Research Unit; Ontario Drug Policy Research Network; Canadian Institute for Health Research Drug Safety and Effectiveness Cross-Disciplinary Training Program; Dr. Adam Linton Chair in Kidney Health Analytics; Opportunities Fund of the Academic Health Sciences Centre Alternative Funding Plan of AMOSO; Academic Medical Organization of South Western Ontario (AMOSO) Opportunities fund; Institute for Clinical Evaluative Sciences Western Faculty Scholars program	This study was funded by the Canadian Institute of Health Research and supported by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The study was conducted by the Kidney, Dialysis and Transplantation program at the ICES Western facility, which received financial support from Academic Medical Organization of Southwestern Ontario (AMOSO), the Schulich School of Medicine and Dentistry at Western University and the Lawson Health Research Institute. The Thrombotic Microangiopathy Database created under the efforts of Ainslie Hildebrand provided the laboratory values for this study. Aiden Liu was a trainee on this project, and was supported by the Lilibeth Caberto Kidney Clinical Research Unit, the Ontario Drug Policy Research Network, and the Canadian Institute for Health Research Drug Safety and Effectiveness Cross-Disciplinary Training Program. Amit Garg was supported by the Dr. Adam Linton Chair in Kidney Health Analytics, and the Opportunities Fund of the Academic Health Sciences Centre Alternative Funding Plan of AMOSO. The opinions, results and conclusions are those of the authors and are independent from the funding sources. Dr. Lazo-Langner was supported in part by a grant from the Academic Medical Organization of South Western Ontario (AMOSO) Opportunities fund and by the Institute for Clinical Evaluative Sciences Western Faculty Scholars program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nouri ZL, 2015, BLOOD, V125, P616, DOI 10.1182/blood-2014-11-611335; Benmoussa J, 2016, AM J EMERG MED, V34, DOI 10.1016/j.ajem.2015.10.044; Catizone L, 1974, Minerva Nefrol, V21, P439; Conaghan PG, 2012, RHEUMATOL INT, V32, P1491, DOI 10.1007/s00296-011-2263-6; Goel V, 1996, PATTERNS HLTH CARE O; GONZALEZ IC, 1989, MED CLIN-BARCELONA, V92, P396; Hazra A, 2016, INDIAN J DERMATOL, V61, P137, DOI 10.4103/0019-5154.177775; Hussain MA, 2016, CLIN INVEST MED, V39, pE73; Nissen Trygve, 2014, BMC Res Notes, V7, P264, DOI 10.1186/1756-0500-7-264; Odueyungbo A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-28; Okura H, 1999, Rinsho Ketsueki, V40, P663; Oregel KZ, 2013, CLIN MED INSIGHTS-BL, V6, P19, DOI 10.4137/CMBD.S12843; Radhi M, 2012, INT SCH RES NOT INT, V2012, DOI [10.5402/2012/310596, DOI 10.5402/2012/310596]; RANDI ML, 1993, BRIT MED J, V306, P186, DOI 10.1136/bmj.306.6871.186-b; Schoenmaker NJ, 2007, CLIN NEPHROL, V68, P177; Schwartz KL, 2015, HUM VACC IMMUNOTHER, V11, P1840, DOI 10.1080/21645515.2015.1043499; Scully M, 2012, BRIT J HAEMATOL, V158, P323, DOI 10.1111/j.1365-2141.2012.09167.x; Shenkman B, 2014, AUTOIMMUN REV, V13, P584, DOI 10.1016/j.autrev.2014.01.004; Singh G, 2000, Am J Ther, V7, P115, DOI 10.1097/00045391-200007020-00008; TRICE JM, 1983, ARCH INTERN MED, V143, P1487, DOI 10.1001/archinte.143.7.1487; Zheng XL, 2008, ANNU REV PATHOL-MECH, V3, P249, DOI 10.1146/annurev.pathmechdis.3.121806.154311	21	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202801	10.1371/journal.pone.0202801	http://dx.doi.org/10.1371/journal.pone.0202801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142223	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500035
J	Power, J; Westle, A; Dowsett, GW; Lucke, J; Tucker, JD; Sugarman, J; Lewin, SR; Hill, S; Brown, G; Wallace, J; Richmond, J				Power, Jennifer; Westle, Andrew; Dowsett, Gary W.; Lucke, Jayne; Tucker, Joseph D.; Sugarman, Jeremy; Lewin, Sharon R.; Hill, Sophie; Brown, Graham; Wallace, Jack; Richmond, Jacqui			Perceptions of HIV cure research among people living with HIV in Australia	PLOS ONE			English	Article							CONTEXT	Participation in HIV cure-related clinical trials that involve antiretroviral treatment (ART) interruption may pose substantial individual risks for people living with HIV (PLHIV) without any therapeutic benefit. As such, it is important that the views of PLHIV are considered in the design of HIV cure research trials. Examining the lived experience of PLHIV provides unique and valuable perspectives on the risks and benefits of HIV cure research. In this study, we interviewed 20 PLHIV in Australia about their knowledge and attitudes toward clinical HIV cure research and explored their views regarding participation in HIV cure clinical trials, including those that involve ART interruption. Data were analysed thematically, using both inductive and deductive coding techniques, to identity themes related to perceptions of HIV cure research and PLHIV's assessment of the possible risks and benefits of trial participation. Study findings revealed interviewees were willing to consider participation in HIV cure research for social reasons, most notably the opportunity to help others. Concerns raised about ART interruption related to the social and emotional impact of viral rebound, including fear of onward HIV transmission and anxiety about losing control. These findings reveal the ways in which PLHIV perspectives deepen our understanding of HIV cure research, moving beyond a purely clinical assessment of risks and benefits in order to consider the social context.	[Power, Jennifer; Westle, Andrew; Dowsett, Gary W.; Lucke, Jayne; Brown, Graham; Wallace, Jack; Richmond, Jacqui] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Dowsett, Gary W.; Brown, Graham] Univ NSW, Ctr Social Res Hlth, Sydney, NSW, Australia; [Lucke, Jayne] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Tucker, Joseph D.] Univ N Carolina, UNC Project China, Guangzhou, Guangdong, Peoples R China; [Tucker, Joseph D.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Tucker, Joseph D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Lewin, Sharon R.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Lewin, Sharon R.] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic, Australia; [Hill, Sophie] La Trobe Univ, Ctr Hlth Commun & Participat, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Richmond, Jacqui] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia	La Trobe University; University of New South Wales Sydney; University of Queensland; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins University; University of Melbourne; Royal Melbourne Hospital; Monash University; La Trobe University; University of Melbourne	Power, J (corresponding author), La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia.	jennifer.power@latrobe.edu.au	Wallace, Jack/ABE-3351-2021; Lucke, Jayne C/A-5538-2008; Lewin, Sharon/Z-3297-2019	Wallace, Jack/0000-0002-4738-7316; Lucke, Jayne C/0000-0002-2885-5292; Dowsett, Gary W./0000-0002-0841-3964; Brown, Graham/0000-0003-4901-0974; Power, Jennifer/0000-0002-6566-3214; Sugarman, Jeremy/0000-0001-7022-8332; Lewin, Sharon Ruth/0000-0002-0330-8241	La Trobe University Building Healthy Communities Research Focus Area (GWD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, R01AI108366, U19AI096113] Funding Source: NIH RePORTER	La Trobe University Building Healthy Communities Research Focus Area (GWD); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a seeding grant from the La Trobe University Building Healthy Communities Research Focus Area (GWD).	Anderson JL, 2015, AIDS RES HUM RETROV, V31, P36, DOI [10.1089/aid.2014.0236, 10.1089/AID.2014.0236]; Arnold MP, 2015, J VIRUS ERAD, V1, P43; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Burt R.S., 2005, BROKERAGE CLOSURE IN; Charmaz, 2007, SAGE HDB GROUNDED TH, P97; Clarridge KE, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006792; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Dube K, 2018, AIDS RES HUM RETROV, V34, P67, DOI [10.1089/aid.2017.0067, 10.1089/AID.2017.0067]; Dube K, 2018, J EMPIR RES HUM RES, V13, P3, DOI 10.1177/1556264617734061; Dube K, 2017, J VIRUS ERAD, V3, P40; Dube K, 2015, J VIRUS ERAD, V1, P250; Dube K, 2014, TRENDS MICROBIOL, V22, P547, DOI 10.1016/j.tim.2014.08.003; Epstein Steven., 1996, IMPURE SCI; Eshleman SH, 2017, JAIDS-J ACQ IMM DEF, V74, P112, DOI 10.1097/QAI.0000000000001158; Evans D, 2017, J MED ETHICS, V43, P100, DOI 10.1136/medethics-2015-103120; Garner SA, 2017, J VIRUS ERAD, V3, P82; Grace D, 2015, AIDS EDUC PREV, V27, P333, DOI 10.1521/aeap.2015.27.4.333; Grossman CI, 2016, TRENDS MICROBIOL, V24, P5, DOI 10.1016/j.tim.2015.10.011; Henderson GE, 2017, J MED ETHICS; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hyde K.F., 2000, QUAL MARK RES, V3, P82, DOI [10.1108/13522750010322089, DOI 10.1108/13522750010322089]; Jenkins N, 2010, QUAL RES, V10, P175, DOI 10.1177/1468794109356737; Kippax S, 2011, AIDS EDUC PREV, V23, P393, DOI 10.1521/aeap.2011.23.5.393; Kirby Institute, 2017, VIR HEP MAPP PROJ NA; Lo B, 2013, CURR OPIN AIDS, V8; Lo YR, 2015, AIDS PATIENT CARE ST, V29, P389, DOI 10.1089/apc.2014.0348; McIntosh MJ, 2015, GLOB QUALIT NURS RES, V2, DOI 10.1177/2333393615597674; McMahon JH, 2015, AIDS, V29, P248, DOI 10.1097/QAD.0000000000000534; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Muir-Cochrane E., 2006, INT J QUAL METH, V5, P15, DOI DOI 10.1177/160940690600500107; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Persson A, 2003, HEALTH, V7, P397, DOI 10.1177/13634593030074002; Power J, 2011, MOVEMENT KNOWLEDGE E; Power J., 2014, COLLABORATIVE PROJEC; Power J, 2017, J VIRUS ERAD, V3, P229; Power J, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00050; Rendina HJ, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25055; Sendziuk P., 2003, LEARNING TRUST AUSTR; Simmons R, 2017, HIV MED, V18, P73, DOI 10.1111/hiv.12391; Stecher M, 2016, OPEN FORUM INFECT DI; Sylla L, 2018, AIDS RES HUM RETROV, V34, P56, DOI [10.1089/aid.2017.0178, 10.1089/AID.2017.0178]; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Treatment Action Group, 2018, RES CUR TRIALS TREAT; UNAIDS, 2007, POL BRIEF GREAT INV, P4; Volberding Paul A, 2017, Top Antivir Med, V25, P17	47	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202647	10.1371/journal.pone.0202647	http://dx.doi.org/10.1371/journal.pone.0202647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR5ZQ	30142171	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000442722500022
J	Partridge, DR; Clark, JA				Partridge, Dustin R.; Clark, J. Alan			Urban green roofs provide habitat for migrating and breeding birds and their arthropod prey	PLOS ONE			English	Article							SPECIES RICHNESS; CONSERVATION IMPLICATIONS; SPRING MIGRATION; STOPOVER SITES; LAND-USE; URBANIZATION; BIODIVERSITY; DIVERSITY; CONNECTIVITY; COMMUNITIES	The world is rapidly urbanizing, and many previously biodiverse areas are now mostly composed of impervious surface. This loss of natural habitat causes local bird communities to become dominated by urban dweller and urban utilizer species and reduces the amount of habitat available for migrating and breeding birds. Green roofs can increase green space in urban landscapes, potentially providing new habitat for wildlife. We surveyed birds and arthropods, an important food source for birds, on green roofs and nearby comparable conventional (non-green) roofs in New York City during spring migration and summer breeding seasons. We predicted that green roofs would have a greater abundance and richness of both birds and arthropods than conventional roofs during both migration and the breeding season for birds. Furthermore, we predicted we would find more urban avoider and urban utilizer bird species on green roofs than conventional roofs. We found that both birds and arthropods were more abundant and rich on green roofs than conventional roofs. In addition, green roofs hosted more urban avoider and utilizer bird species than conventional roofs. Our study shows that birds use green roofs as stopover habitat during migration and as foraging habitat during the breeding season. Establishing green roofs in urban landscapes increases the amount of habitat available for migrating and breeding birds and can partially mitigate the loss of habitat due to increasing urbanization.	[Partridge, Dustin R.; Clark, J. Alan] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA	Fordham University	Partridge, DR (corresponding author), Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA.	DPartridge@fordham.edu						ABLE K. P., 1999, GATHERINGS ANGELS MI; Alquezar RD, 2015, WILSON J ORNITHOL, V127, P712, DOI 10.1676/14-104.1; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Baumann Nathalie, 2006, Urban Habitats, V4, P37; BEISSINGER SR, 1982, CONDOR, V84, P75, DOI 10.2307/1367825; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; BLAKE JG, 1986, AUK, V103, P328, DOI 10.1093/auk/103.2.328; Bonter DN, 2009, CONSERV BIOL, V23, P440, DOI 10.1111/j.1523-1739.2008.01085.x; Braaker S, 2014, ECOLOGY, V95, P1010, DOI 10.1890/13-0705.1; Braaker S, 2017, J ANIM ECOL, V86, P521, DOI 10.1111/1365-2656.12648; Brenneisen Stephan, 2006, Urban Habitats, V4, P27; Bricklin RB, 2016, URBAN NATURALIST, V11, P1; Buchholz S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137723; Buler JJ, 2011, J ORNITHOL, V152, P101, DOI 10.1007/s10336-010-0640-7; Calvert AM, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00581-080211; Cam E, 2000, ECOL APPL, V10, P1196, DOI 10.1890/1051-0761(2000)010[1196:RSRACC]2.0.CO;2; Carbo-Ramirez P, 2011, LANDSCAPE URBAN PLAN, V100, P213, DOI 10.1016/j.landurbplan.2010.12.008; Catry P, 2004, J AVIAN BIOL, V35, P170, DOI 10.1111/j.0908-8857.2004.03112.x; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chernetsov N., 2012, PASSERINE MIGRATION; Chernetsov N, 2006, WILSON J ORNITHOL, V118, P364, DOI 10.1676/04-134.1; Chong KY, 2014, BIOL CONSERV, V171, P299, DOI 10.1016/j.biocon.2014.01.037; Chown SL, 2003, ECOL APPL, V13, P1233, DOI 10.1890/02-5105; Cochran William W., 2005, P274; Cohen EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041818; Colla S.H.R., 2009, CITIES ENV CATE, V2, P4; Concepcion ED, 2015, OIKOS, V124, P1571, DOI 10.1111/oik.02166; DeSante DF, 2008, MAPS MANUAL; Digby A, 2013, METHODS ECOL EVOL, V4, P675, DOI 10.1111/2041-210X.12060; Drent RJ, 2006, J ORNITHOL, V147, P122, DOI 10.1007/s10336-006-0066-4; Eakin CJ, 2015, WILDLIFE SOC B, V39, P574, DOI 10.1002/wsb.566; Evans BS, 2015, ECOLOGY, V96, P1631, DOI 10.1890/14-0171.1; Evans KL, 2006, GLOBAL ECOL BIOGEOGR, V15, P625, DOI 10.1111/j.1466-8238.2006.00253.x; Evans KL, 2009, IBIS, V151, P19, DOI 10.1111/j.1474-919X.2008.00898.x; Evans KL, 2005, GLOBAL ECOL BIOGEOGR, V14, P187, DOI 10.1111/j.1466-822X.2004.00139.x; Evans Ogden LJ, 1996, FATAL LIGHT AWARE PR, V1, P3; Farnsworth G, 2011, BIRDS N AM ONLINE; Ferenc M, 2016, URBAN ECOSYST, V19, P1265, DOI 10.1007/s11252-016-0558-9; Ferenc M, 2014, URBAN ECOSYST, V17, P625, DOI 10.1007/s11252-013-0328-x; Fernandez-Canero R, 2010, J ANIM VET ADV, V9, P2041; Fernandez-Juricic E, 2001, BIODIVERS CONSERV, V10, P2023, DOI 10.1023/A:1013133308987; Fischer JD, 2015, CONSERV BIOL, V29, P1246, DOI 10.1111/cobi.12451; Fornal-Pieniak B., 2012, EKOLOGIA BRATISLAVA, V31, P379; Forys EA, 2013, SOUTHEAST NAT, V12, P238, DOI 10.1656/058.012.0119; Fowle M. T., 2001, NEW YORK CITY AUDUBO; Galbrun L, 2017, BUILD ENVIRON, V116, P130, DOI 10.1016/j.buildenv.2017.02.008; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Gonsalves S, 2016, THESIS; Greenewalt C.H., 1968, BIRD SONG ACOUSTICS; Gregoire BG, 2011, ECOL ENG, V37, P963, DOI 10.1016/j.ecoleng.2011.02.004; Grootaert P., 2010, MANUAL FIELD RECORDI, P377, DOI 10.1128/AEM.00759-10; HAGAN JM, 1991, ORNIS SCAND, V22, P129, DOI 10.2307/3676543; Hager SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053371; Hall-Karlsson K. Susanna S., 2008, Ringing & Migration, V24, P95; Huang Y, 2015, URBAN FOR URBAN GREE, V14, P1027, DOI 10.1016/j.ufug.2015.09.010; Huff MH, 2000, PNWGTR501 US FOR SER; Hutto RL, 2009, J FIELD ORNITHOL, V80, P387, DOI 10.1111/j.1557-9263.2009.00245.x; Hutto RL, 1998, AUK, V115, P823, DOI 10.2307/4089500; Jim CY, 2011, URBAN FOR URBAN GREE, V10, P19, DOI 10.1016/j.ufug.2010.11.001; Johnston Richard F., 2001, P49; Jokimaki J., 2014, URBAN ECOSYST, P1; Jokimaki Jukka, 2000, Urban Ecosystems, V3, P21, DOI 10.1023/A:1009505418327; Kang W, 2015, URBAN ECOSYST, V18, P857, DOI 10.1007/s11252-014-0433-5; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Keller JK, 2003, FOREST ECOL MANAG, V174, P541, DOI 10.1016/S0378-1127(02)00074-9; Kelly JF, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1434; Kimsey LS, 2009, ZOOTAXA, P30, DOI 10.11646/zootaxa.2224.1.2; KING AP, 1983, NATURE, V305, P704, DOI 10.1038/305704a0; Klingbeil BT, 2015, PEERJ, V3, DOI 10.7717/peerj.973; Ksiazek K, 2012, LANDSCAPE URBAN PLAN, V107, P401, DOI 10.1016/j.landurbplan.2012.07.008; Ksiazek-Mikenas K., 2018, URBAN NATURALIST, V1, P52; Ktitorov P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1135, DOI 10.1007/s00265-010-0929-9; Larsen R.J., 2012, INTRO MATH STAT ITS; LODGE DM, 1985, FRESHWATER BIOL, V15, P695, DOI 10.1111/j.1365-2427.1985.tb00243.x; Loss SR, 2015, ANNU REV ECOL EVOL S, V46, P99, DOI 10.1146/annurev-ecolsys-112414-054133; Lowther P.E., 2006, BIRDS N AM ONLINE, DOI 10.2173/bna.12; Lowther PE, 2014, BIRDS N AM ONLINE; Luckett K., 2009, GREEN ROOF CONSTRUCT; Machtans CS, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00568-080206; Maciejowski JM, 2013, CONF CONTR FAULT-TOL, P1, DOI 10.1109/SysTol.2013.6693820; MacIvor JS, 2015, ECOL STUD-ANAL SYNTH, V223, P333, DOI 10.1007/978-3-319-14983-7_14; MacIvor JS, 2011, URBAN ECOSYST, V14, P225, DOI 10.1007/s11252-010-0149-0; Madre F, 2013, ECOL ENG, V57, P109, DOI 10.1016/j.ecoleng.2013.04.029; Magura T, 2009, CONTRIBUTIONS SOIL Z, P97; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marzluff JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167829; Marzluff JM, 2016, URBAN ECOSYST, V19, P1597, DOI 10.1007/s11252-015-0483-3; Mason J, 2007, LANDSCAPE URBAN PLAN, V80, P153, DOI 10.1016/j.landurbplan.2006.07.002; Matteson KC, 2007, THESIS; Matthews SN, 2010, CONDOR, V112, P96, DOI 10.1525/cond.2010.090049; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney M.L., 2018, URBAN NATURALIST, VSI, P73; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McWilliams G. M., 2000, BIRDS PENNSYLVANIA; Mehlman DW, 2005, AUK, V122, P1281, DOI 10.1642/0004-8038(2005)122[1281:CSSFFM]2.0.CO;2; Moore F.R., 2005, BIRD CONSERVATION IM, P684; Moore Frank R., 1995, P121; Moorman CE, 2012, WILSON J ORNITHOL, V124, P31, DOI 10.1676/11-020.1; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Nichols J.D., 1993, ECOLOGY MANAGEMENT M, P576; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; NOWICKI S, 1988, MUSIC PERCEPT, V5, P391; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; Oliver AJ, 2011, LANDSCAPE URBAN PLAN, V102, P215, DOI 10.1016/j.landurbplan.2011.04.007; Parkins KL, 2015, GLOB ECOL CONSERV, V4, P349, DOI 10.1016/j.gecco.2015.07.011; Pautasso M, 2007, ECOL LETT, V10, P16, DOI 10.1111/j.1461-0248.2006.00993.x; Paxton KL, 2008, CONDOR, V110, P672, DOI 10.1525/cond.2008.8602; Poole A., 2005, BIRDS N AM ONLINE; Rega CC, 2015, J URBAN PLANNING DEV, V141, DOI [10.1061/(ASCE)UP.943-5444.0000279, DOI 10.1061/(ASCE)UP.943-5444.0000279]; Rempel RS, 2013, J FIELD ORNITHOL, V84, P86, DOI 10.1111/jofo.12008; Richmond M. E., 2008, 2 ATLAS BREEDING BIR, P258; Robbins M.B., 1992, BIRDS MISSOURI THEIR; Robbins S., 1991, WISCONSIN BIRDLIFE P; Sadler JP, 2006, J BIOGEOGR, V33, P1126, DOI 10.1111/j.1365-2699.2006.01476.x; Sandstrom UG, 2006, LANDSCAPE URBAN PLAN, V77, P39, DOI 10.1016/j.landurbplan.2005.01.004; Santamouris M, 2014, SOL ENERGY, V103, P682, DOI 10.1016/j.solener.2012.07.003; Schrader S, 2006, PEDOBIOLOGIA, V50, P347, DOI 10.1016/j.pedobi.2006.06.003; Seewagen CL, 2008, NORTHEAST NAT, V15, P87, DOI 10.1656/1092-6194(2008)15[87:LCONMP]2.0.CO;2; Seewagen CL, 2011, CONDOR, V113, P284, DOI 10.1525/cond.2011.100136; Seewagen CL, 2010, ACTA OECOL, V36, P484, DOI 10.1016/j.actao.2010.06.005; Smith RJ, 2007, AUK, V124, P107, DOI 10.1642/0004-8038(2007)124[107:SHATSO]2.0.CO;2; Soldatini C, 2008, ITAL J ZOOL, V75, P295, DOI 10.1080/11250000701884805; Southwood T.R.E., 2009, ECOLOGICAL METHODS; Speak AF, 2012, ATMOS ENVIRON, V61, P283, DOI 10.1016/j.atmosenv.2012.07.043; Spiers J. D., 2004, Small Fruits Review, V3, P361, DOI 10.1300/J301v03n03_13; Staicer Cynthia A., 1996, P426; Starry O, 2018, URBAN NATURALIST, V1, P1, DOI DOI 10.1016/J.ECOLENG.2018.04.002; Stephen WP, 2005, J KANSAS ENTOMOL SOC, V78, P373, DOI 10.2317/0410.03.1; Stracey CM, 2012, J AVIAN BIOL, V43, P50, DOI 10.1111/j.1600-048X.2011.05520.x; STRICKLAND A. H., 1954, PLANT PATHOL, V3, P73, DOI 10.1111/j.1365-3059.1954.tb00698.x; Strohbach MW, 2013, LANDSCAPE URBAN PLAN, V114, P69, DOI 10.1016/j.landurbplan.2013.02.007; Taylor PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027054; Tonietto R, 2011, LANDSCAPE URBAN PLAN, V103, P102, DOI 10.1016/j.landurbplan.2011.07.004; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; United Nations, 2014, DEMOGR RES; Vergnes A, 2014, BIODIVERS CONSERV, V23, P1859, DOI 10.1007/s10531-014-0689-3; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Wang JW, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1905; Washburn BE, 2016, ENVIRON MANAGE, V57, P1230, DOI 10.1007/s00267-016-0687-1; White C.M., 2020, BIRDS OF THE WORLD; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Williams NSG, 2014, J APPL ECOL, V51, P1643, DOI 10.1111/1365-2664.12333	144	16	16	8	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202298	10.1371/journal.pone.0202298	http://dx.doi.org/10.1371/journal.pone.0202298			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR9JD	30157217	gold, Green Submitted, Green Published			2022-12-27	WOS:000443071400051
J	Macala, KF; Khadaroo, RG; Panahi, S; Gragasin, FS; Bourque, SL				Macala, Kimberly F.; Khadaroo, Rachel G.; Panahi, Sareh; Gragasin, Ferrante S.; Bourque, Stephane L.			Low dose Intralipid resuscitation improves survival compared to ClinOleic in propranolol overdose in rats	PLOS ONE			English	Article							INTRAVENOUS LIPID EMULSION; LOCAL-ANESTHETIC TOXICITY; BUPIVACAINE TOXICITY; PARENTERAL-NUTRITION; FAT EMULSION; INFUSION; THERAPY; BINDING; PHARMACOTOXICITY; HEMODYNAMICS	Background Medication overdose is a prevalent issue and despite mixed reports of efficacy, the use of intravenous lipid emulsions, notably Intralipid (R), for the management of toxicity from lipid-soluble drugs is becoming increasingly prevalent. Whether alternative lipid emulsion formulations have similar efficacy for resuscitation compared to Intralipid is not known. Here, we compared the efficacy of Intralipid and ClinOleic (R) for resuscitation following overdose with the lipid-soluble beta-adrenergic antagonist propranolol. Methods Male Sprague-Dawley rats (age 3-4 months) were anesthetized with isoflurane and instrumented for direct hemodynamic assessments. In Study One, rats (n = 22) were pre-treated with Intralipid 20% (n = 12) or ClinOleic 20% (n = 10) to determine whether the hemodynamic effects of propranolol could be prevented. In Study Two, rats were randomly assigned to Intralipid 20% (1, 2, or 3 mUkg IV, n = 21) or ClinOleic 20% (1, 2, or 3 mUkg IV, n = 20) resuscitation groups following propranolol overdose (15 mg/kg IV). In Study Three the effect of Intralipid 20% (1 mL/kg IV, n = 3) and ClinOleic 20% (1 mL/kg IV, n = 3) in the absence of propranolol was investigated. The primary endpoint in all studies was survival time (up to a maximum of 120 minutes), and secondary endpoints were time to achieve 50%, 75%, and 90% of baseline hemodynamic parameters. Results In Study One, pre-treatment with Intralipid prior to propranolol administration resulted in prolonged survival compared to pre-treatment with ClinOleic at low doses (1 mL/kg; P = 0.002), but provided no benefit at higher doses (3 mL/kg; P = 0.95). In Study Two, Intralipid conferred a survival advantage over ClinOleic, with 18/21 rats surviving 120 minutes in the Intralipid group and only 4/20 survivors in the ClinOleic group (P<0.0001). Median survival times (with interquartile ranges) for rats treated with Intralipid, and ClinOleic, and saline were 120 (80.5-120) min, 21.5 (3.25-74.5) min, and 1 (0.25-2.5) min respectively (P<0.001). Only 3/21 rats in the Intralipid group survived less than 30 minutes, whereas 12/ 20 ClinOleic treated rats had survival times of less than 30 minutes. The number of rats achieving 75%, and 90% of baseline mean arterial pressure was also greater in the Intralipid group (P<0.05 for both values). Treatment in Study Three did not alter survival times. Conclusions Low-dose Intralipid (1, 2, or 3 mL/kg IV) confers a survival advantage up to 120 minutes post-propranolol overdose (the end-point of the experiment) and better hemodynamic recovery compared to ClinOleic (1, 2, or 3 mL/kg IV) in rats with propranolol overdose. As health care centres choose alternate intravenous lipid emulsions, limited availability of Intralipid could impact efficacy and success of overdose treatment for lipid-soluble drugs.	[Macala, Kimberly F.; Khadaroo, Rachel G.] Univ Alberta, Dept Crit Care Med, Edmonton, AB, Canada; [Macala, Kimberly F.; Panahi, Sareh; Gragasin, Ferrante S.; Bourque, Stephane L.] Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada; [Macala, Kimberly F.; Khadaroo, Rachel G.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Bourque, Stephane L.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Bourque, SL (corresponding author), Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada.; Bourque, SL (corresponding author), Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada.	sborque@ualberta.ca		Bourque, Stephane/0000-0001-6375-7404	Canadian Institutes of Health Research [MOP 142396, MOP 142446]; Stollery Children's Hospital Foundation; Lois Hole Hospital for Women through the Women and Children's Health Research Institute; Canadian Critical Care Trials Group; Canadian Institutes for Health Research New Investigator Salary Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stollery Children's Hospital Foundation; Lois Hole Hospital for Women through the Women and Children's Health Research Institute; Canadian Critical Care Trials Group; Canadian Institutes for Health Research New Investigator Salary Award	This work was supported by funding from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (MOP 142396 to S.L.B and MOP 142446 to F.S.G) and the generous support of the Stollery Children's Hospital Foundation and the Lois Hole Hospital for Women through the Women and Children's Health Research Institute (http://www.wchri.org/). K.M. is supported by a fellowship from the Canadian Critical Care Trials Group (http://www.ccctg.ca/); S. L.B is supported by a Canadian Institutes for Health Research New Investigator Salary Award.	Agarwala R, 2014, J MED TOXICOL, V10, P210, DOI 10.1007/s13181-013-0353-4; Amer Coll Med Toxicology, 2017, J MED TOXICOL, V13, P124, DOI 10.1007/s13181-016-0550-z; Cao DZ, 2015, J EMERG MED, V48, P387, DOI 10.1016/j.jemermed.2014.10.009; Cave G, 2006, J MED TOXICOL, V2, P4, DOI 10.1007/BF03161005; Cave G, 2009, J MED TOXICOL, V5, P50, DOI 10.1007/BF03160983; Cave G, 2009, ACAD EMERG MED, V16, P815, DOI 10.1111/j.1553-2712.2009.00499.x; Chenoweth JA, 2017, AM J EMERG MED, V35, DOI 10.1016/j.ajem.2017.07.023; Dureau P, 2016, ANESTHESIOLOGY, V125, P474, DOI 10.1097/ALN.0000000000001230; Evans JA, 2013, ANAESTH INTENS CARE, V41, P618, DOI 10.1177/0310057X1304100507; Fettiplace MR, 2017, CLIN TOXICOL, V55, P1021, DOI 10.1080/15563650.2017.1325490; Fettiplace MR, 2015, J CONTROL RELEASE, V198, P62, DOI 10.1016/j.jconrel.2014.11.018; Fettiplace MR, 2014, ANESTHESIOLOGY, V120, P915, DOI 10.1097/ALN.0000000000000142; Fettiplace MR, 2013, CRIT CARE MED, V41, pE156, DOI 10.1097/CCM.0b013e318287f874; Flood P, 2015, STOELTINGS PHARM PHY; Gosselin S, 2016, CLIN TOXICOL, V54, P899, DOI 10.1080/15563650.2016.1214275; Hayes BD, 2016, CLIN TOXICOL, V54, P365, DOI 10.3109/15563650.2016.1151528; Hoegberg LCG, 2016, CLIN TOXICOL, V54, P167, DOI 10.3109/15563650.2015.1121270; Lampropoulos KM, 2012, HELL J CARDIOL, V53, P101; Lavonas EJ, 2015, CIRCULATION, V132, pS501, DOI 10.1161/CIR.0000000000000264; Levine M, 2014, J MED TOXICOL, V10, P10, DOI 10.1007/s13181-013-0356-1; Li ZQ, 2011, ANESTHESIOLOGY, V115, P1219, DOI 10.1097/ALN.0b013e318238be73; Macala K, 2014, ACAD EMERG MED, V21, P1220, DOI 10.1111/acem.12511; Mazoit JX, 2009, ANESTHESIOLOGY, V110, P380, DOI 10.1097/ALN.0b013e318194b252; Mowry JB, 2014, CLIN TOXICOL, V52, P1032, DOI 10.3109/15563650.2014.987397; Partownavid P, 2012, CRIT CARE MED, V40, P2431, DOI 10.1097/CCM.0b013e3182544f48; Ruan WM, 2012, ANESTHESIOLOGY, V116, P334, DOI 10.1097/ALN.0b013e318242a5f1; Ruhm CJ, 2017, SSM-POPUL HLTH, V3, P219, DOI 10.1016/j.ssmph.2017.01.009; Siqueira J, 2011, J CLIN ENDOCR METAB, V96, P3207, DOI 10.1210/jc.2011-0480; St-Onge M, 2014, CLIN TOXICOL, V52, P926, DOI 10.3109/15563650.2014.965827; Stehr SN, 2007, ANESTH ANALG, V104, P186, DOI 10.1213/01.ane.0000248220.01320.58; Takahashi H, 2002, CLIN EXP PHARMACOL P, V29, P198, DOI 10.1046/j.1440-1681.2002.03629.x; Tang W, 2016, ANESTH ANALG, V123, P1116, DOI 10.1213/ANE.0000000000001410; VAGO T, 1984, BIOCHEM BIOPH RES CO, V121, P346, DOI 10.1016/0006-291X(84)90729-0; Vinnars E, 2003, JPEN-PARENTER ENTER, V27, P225, DOI 10.1177/0148607103027003225; Weinberg G, 2003, REGION ANESTH PAIN M, V28, P198, DOI 10.1053/rapm.2003.50041; Weinberg GL, 2012, ANESTHESIOLOGY, V117, P180, DOI 10.1097/ALN.0b013e31825ad8de; Young AC, 2009, RESUSCITATION, V80, P591, DOI 10.1016/j.resuscitation.2009.01.023	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202871	10.1371/journal.pone.0202871	http://dx.doi.org/10.1371/journal.pone.0202871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161186	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900047
J	El Zant, S; Jaffres-Runser, K; Shepelyansky, DL				El Zant, Samer; Jaffres-Runser, Katia; Shepelyansky, Dima L.			Capturing the influence of geopolitical ties from Wikipedia with reduced Google matrix	PLOS ONE			English	Article								Interactions between countries originate from diverse aspects such as geographic proximity, trade, socio-cultural habits, language, religions, etc. Geopolitics studies the influence of a country's geographic space on its political power and its relationships with other countries. This work reveals the potential of Wikipedia mining for geopolitical study. Actually, Wikipedia offers solid knowledge and strong correlations among countries by linking web pages together for different types of information (e.g. economical, historical, political, and many others). The major finding of this paper is to show that meaningful results on the influence of country ties can be extracted from the hyperlinked structure of Wikipedia. We leverage a novel stochastic matrix representation of Markov chains of complex directed networks called the reduced Google matrix theory. For a selected small size set of nodes, the reduced Google matrix concentrates direct and indirect links of the million-node sized Wikipedia network into a small Perron-Frobenius matrix keeping the PageRank probabilities of the global Wikipedia network. We perform a novel sensitivity analysis that leverages this reduced Google matrix to characterize the influence of relationships between countries from the global network. We apply this analysis to two chosen sets of countries (i.e. the set of 27 European Union countries and a set of 40 top worldwide countries). We show that with our sensitivity analysis we can exhibit easily very meaningful information on geopolitics from five different Wikipedia editions (English, Arabic, Russian, French and German).	[El Zant, Samer; Jaffres-Runser, Katia] Univ Toulouse, Inst Rech Informat Toulouse Toulouse INP, Toulouse, France; [Shepelyansky, Dima L.] Univ Toulouse, CNRS IRSAMC, Lab Phys Theor, Toulouse, France	Universite de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Jaffres-Runser, K (corresponding author), Univ Toulouse, Inst Rech Informat Toulouse Toulouse INP, Toulouse, France.	kjr@enseeiht.fr		Jaffres-Runser, Katia/0000-0002-1851-6131; EL ZANT, SAMER/0000-0001-8419-396X	APR 2015 call of University of Toulouse; ReAgion Occitanie (project GOMOBILE); MASTODONS-2017 CNRS project APLIGOOGLE; EU CHISTERA MACACO project [ANR-13-CHR2-0002-06]	APR 2015 call of University of Toulouse; ReAgion Occitanie (project GOMOBILE); MASTODONS-2017 CNRS project APLIGOOGLE; EU CHISTERA MACACO project	This work was supported by APR 2015 call of University of Toulouse and by ReAgion Occitanie (project GOMOBILE), MASTODONS-2017 CNRS project APLIGOOGLE, and EU CHISTERA MACACO project ANR-13-CHR2-0002-06.	[Anonymous], ITALY SLOVENIA 20 YE; [Anonymous], 2015, SLOVENIA BUSINESS LA; Bastian M., 2009, ICWSM, V3, P361, DOI 10.13140/2.1.1341.1520; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; British Broadcasting Corporation (BBC), 2016, WHATS CHIN TAIW DIV; Center for International Development, GLOB EC COMPL; Chepelianskii A.D., 2010, ARXIV10035455CSSE; Cyprus Ministry of Foreign Affairs, CYPR UK REL; Eom Y-H, 2013, WIKIPEDIA NETWORKS D; Eom YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114825; Eom YH, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40432-5; Eom YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074554; Ermann L, 2015, REV MOD PHYS, V87, P1261, DOI 10.1103/RevModPhys.87.1261; Federal Foreign Office, BIL REL LUX; Frahm K.M., 2016, ARXIV160202394; Frahm KM, 2017, PHYS LETT A, V381, P2677, DOI 10.1016/j.physleta.2017.06.021; Frahm KM, 2016, EUR PHYS J B, V89, DOI 10.1140/epjb/e2016-70526-3; French Ministry of Economy D Treasurer, ECH COMM ENTR FRANCL; Fukuyama F., 2016, COURRIER INT; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Haagensen K. M., 2014, NORDIC STAT YB 2014; Hart MH, 1992, 100 RANKING MOST INF; Hu Yifan, 2006, MATH J, V10, P1; Hunt A, 2017, BRIT BROADCASTI 0327; Israel Ministry of Foreign Affairs, ISR EG PEAC; Israel Ministry of Foreign Affairs, CAMP DAV ACC; Javanmardi S., 2010, P 1 WORKSH SOC MED A, P132, DOI DOI 10.1145/1964858.1964876; Jones E.L., 1981, EUROPEAN MIRACLE ENV, V2nd; Korosi I., 2013, AUSTRIAN HUNGARIAN R; Lages J, 2016, EUR PHYS J B, V89, DOI 10.1140/epjb/e2016-60922-0; Langville A., 2006, GOOGLES PAGERANK SCI; Ottaviano Gianmarco, 2016, LONDON SCH EC POLITI; Pakistan Today, 2016, PAKISTAN TODAY  0515; Pasquariello Mariano KL, 2013, BRAZILIAN POLITICAL, V7, P1; Price I., 2016, THE DIPLOMAT; Rajagopalan M.S., 2010, J CLIN ONCOL, V28, P6058, DOI DOI 10.1200/JC0.2010.28.15_; Sharp JM, 2016, US FOREIGN AID  1222; Singh A, 2017, INDEPENDENT; Stevens A, 2015, CNN MONEY; Zhirov AO, 2010, EUR PHYS J B, V77, P523, DOI 10.1140/epjb/e2010-10500-7	40	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0201397	10.1371/journal.pone.0201397	http://dx.doi.org/10.1371/journal.pone.0201397			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142201	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500003
J	Collins, M; Pellat, A; Antoni, G; Agostini, H; Labeyrie, C; Adams, D; Carbonnel, F				Collins, Michael; Pellat, Anna; Antoni, Guillemette; Agostini, Helene; Labeyrie, Celine; Adams, David; Carbonnel, Franck			Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; TRANSTHYRETIN AMYLOIDOSIS; GASTROINTESTINAL-TRACT; LIVER-TRANSPLANTATION; OCTREOTIDE; THERAPY; MANAGEMENT; DIAGNOSIS; MOTILITY; TRIAL	Introduction Familial amyloid polyneuropathy (FAP) is a genetic disease leading to the production of a variant transthyretin (TTR) or a beta variant beta 2-microglobulin. FAP may be associated with refractory diarrhoea. In this study, we assessed the efficacy and tolerance of somatostatin analogues in refractory diarrhoea associated with FAP. Methods FAP patients from the French national referral center who received somatostatin analogues for a refractory diarrhoea were retrospectively studied. We assessed remission of diarrhoea, as defined by a stool consistence of five or less on the Bristol stool scale, assessed after three to six months of follow-up. Stool frequency and continence before and after three to six months of treatment were also compared by the means of Wilcoxon and McNemar's exact tests, respectively. Results Fourteen patients treated with somatostatin analogues were evaluable. After three to six months of follow-up, 9/14 patients (64% 95%CI = [35%; 87%]) had remission of diarrhoea. This was significantly higher than a theoretical remission rate of 20% (p = 0.0004). There was a significant decrease of daily bowel movement from 6 to 2.5 per day (p = 0.002). Twelve/14 (85%) patients had incontinence at baseline vs 8/14 (57%) after three to six months of follow-up (p = 0.134). Three out of 14 patients (21%) had a severe adverse event; two patients had hypoglycaemia, and one had endocarditis due to an injection-site bacterial infection. Conclusion This study suggests that somatostatin analogues may benefit to patients with FAP and refractory diarrhoea. Approximately 20% of patients had severe adverse events, including hypoglycaemia.	[Collins, Michael; Pellat, Anna; Carbonnel, Franck] Hop Bicetre, AP HP, Dept Gastroenterol, Le Kremlin Bicetre, France; [Antoni, Guillemette] INSERM SC10 US19, Villejuif, France; [Agostini, Helene] Hop Bicetre, AP HP, Unite Rech Clin Paris Sud, Le Kremlin Bicetre, France; [Labeyrie, Celine; Adams, David; Carbonnel, Franck] French Natl Reference Ctr FAP NNERF, Le Kremlin Bicetre, France; [Labeyrie, Celine; Adams, David] Hop Bicetre, AP HP, Dept Neurol, Le Kremlin Bicetre, France; [Adams, David] Paris Sud Univ, INSERM UMR 1195, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Collins, M (corresponding author), Hop Bicetre, AP HP, Dept Gastroenterol, Le Kremlin Bicetre, France.	michael.collins@aphp.fr	Pellat, Anna/AAD-2847-2021	COLLINS, Michael/0000-0002-5785-722X				Adams D, 2000, BRAIN, V123, P1495, DOI 10.1093/brain/123.7.1495; Adams D, 2016, CURR OPIN NEUROL, V29, pS14, DOI 10.1097/WCO.0000000000000289; Anan I, 1999, ACTA NEUROPATHOL, V98, P48, DOI 10.1007/s004010051050; Anan I, 2001, ACTA NEUROPATHOL, V102, P227; Ando Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-31; Barreiros AP, 2013, DIGEST DIS, V31, P170, DOI 10.1159/000347214; Caplin ME, 2014, NEW ENGL J MED, V371, P224, DOI 10.1056/NEJMoa1316158; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; COMPEAN DG, 1994, AIDS, V8, P1563, DOI 10.1097/00002030-199411000-00007; Cruz MW, 2015, NEUROL THER, V4, P61, DOI 10.1007/s40120-015-0031-3; Dyck PJ, 2017, MUSCLE NERVE, V56, P901, DOI 10.1002/mus.25563; ElSalhy M, 1997, SCAND J GASTROENTERO, V32, P849, DOI 10.3109/00365529709011190; Gertz MA, 2015, J AM COLL CARDIOL, V66, P2451, DOI 10.1016/j.jacc.2015.09.075; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; IKEDA SI, 1987, BRAIN, V110, P315, DOI 10.1093/brain/110.2.315; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; Nikou GC, 2007, JCR-J CLIN RHEUMATOL, V13, P119, DOI 10.1097/RHU.0b013e3180645d2a; Nyhlin N, 1999, AMYLOID, V6, P192, DOI 10.3109/13506129909007326; Parman Y, 2016, CURR OPIN NEUROL, V29, pS3, DOI 10.1097/WCO.0000000000000288; SIMON DM, 1995, GASTROENTEROLOGY, V108, P1753, DOI 10.1016/0016-5085(95)90137-X; SOUDAH HC, 1991, NEW ENGL J MED, V325, P1461, DOI 10.1056/NEJM199111213252102; Szilagyi A, 2001, ALIMENT PHARM THERAP, V15, P1889, DOI 10.1046/j.1365-2036.2001.01114.x; Takahashi S, 2017, BRIT MED J, DOI [10.1136/bmjopen-2017-018445, DOI 10.1136/BMJOPEN-2017-018445]; Topkan E, 2006, ONCOLOGY-BASEL, V71, P354, DOI 10.1159/000108593; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Wixner J, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0284-4; Wixner J, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-61; Yarandi SS, 2014, NEUROGASTROENT MOTIL, V26, P611, DOI 10.1111/nmo.12330	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0201869	10.1371/journal.pone.0201869	http://dx.doi.org/10.1371/journal.pone.0201869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161158	gold, Green Submitted, Green Published			2022-12-27	WOS:000443388900014
J	Ponnan, SM; Swaminathan, S; Tiruvengadam, K; Vidyavijayan, KK; Cheedarla, N; Nesakumar, M; Kathirvel, S; Goyal, R; Singla, N; Mukherjee, J; Bergin, P; Kopycinski, JT; Gilmour, J; Tripathy, SP; Elizabeth, LH				Ponnan, Sivasankaran Munusamy; Swaminathan, Soumya; Tiruvengadam, Kannan; Vidyavijayan, K. K.; Cheedarla, Narayana; Nesakumar, Manohar; Kathirvel, Sujitha; Goyal, Rajat; Singla, Nikhil; Mukherjee, Joyeeta; Bergin, Philip; Kopycinski, Jakub T.; Gilmour, Jill; Tripathy, Srikanth Prasad; Elizabeth, Luke Hanna			Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TFH CELLS; RESPONSES; NEUTRALIZATION; EPITOPES; GLYCOPROTEINS; INFECTION; DYNAMICS; MEMORY; V1/V2	A Phase I HIV-1 vaccine trial sponsored by the International AIDS Vaccine Initiative (IAVI) was conducted in India in 2009 to test a subtype C prophylactic vaccine in a prime-boost regimen comprising of a DNA prime (ADVAX) and MVA (TBC-M4) boost. The trial demonstrated that the regimen was safe and well tolerated and resulted in enhancement of HIV-specific immune responses. Preliminary observations on vaccine-induced immune responses were limited to analysis of neutralizing antibodies and IFN-gamma ELISPOT response. The present study involves a more detailed analysis of the nature of the vaccine-induced humoral immune response using specimens that were archived from the volunteers at the time of the trial. Interestingly, we found vaccine induced production of V1/V2 and V3 region-specific antibodies in a significant proportion of vaccinees. Variable region antibody levels correlated directly with the frequency of circulating T follicular helper cells (Tfh) and regulatory T cells (Treg). Our findings provide encouraging evidence to demonstrate the immunogenicity of the tested vaccine. Better insights into vaccine-induced immune responses can aid in informing future design of a successfulHIV-1 vaccine.	[Ponnan, Sivasankaran Munusamy; Swaminathan, Soumya; Tiruvengadam, Kannan; Vidyavijayan, K. K.; Cheedarla, Narayana; Nesakumar, Manohar; Kathirvel, Sujitha; Tripathy, Srikanth Prasad; Elizabeth, Luke Hanna] Indian Council Med Res, Natl Inst Res TB, Chennai, Tamil Nadu, India; [Goyal, Rajat; Singla, Nikhil; Mukherjee, Joyeeta] Int AIDS Vaccine Initiat, New Delhi, India; [Bergin, Philip; Kopycinski, Jakub T.; Gilmour, Jill] Imperial Coll, IAVI Human Immunol Lab, London, England; [Ponnan, Sivasankaran Munusamy; Elizabeth, Luke Hanna] Natl Inst Res TB, Dept HIV AIDS, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); International AIDS Vaccine Initiative; Imperial College London; International AIDS Vaccine Initiative; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Elizabeth, LH (corresponding author), Indian Council Med Res, Natl Inst Res TB, Chennai, Tamil Nadu, India.; Elizabeth, LH (corresponding author), Natl Inst Res TB, Dept HIV AIDS, Chennai, Tamil Nadu, India.	hanna@nirt.res.in	Thiruvengadam, Kannan/AAQ-8532-2021	Thiruvengadam, Kannan/0000-0002-3758-1094; , MANOHAR/0000-0002-6041-5107; Tripathy, Srikanth/0000-0002-8363-2606	International AIDS Vaccine Initiative (IAVI); United States Agency for International Development (USAID) [2233]; Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; World Bank; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); USAID	International AIDS Vaccine Initiative (IAVI); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; World Bank(The World Bank India); Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); USAID(United States Agency for International Development (USAID))	The vaccine trial and the present study were supported and coordinated by the International AIDS Vaccine Initiative (IAVI). IAVI's work is made possible by generous support from many donors including the Bill & Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of Finance of Japan in partnership with The World Bank, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation (NORAD), the United Kingdom Department for International Development (DFID), and the USAID. The full list of IAVI donors is available at www.iavi.org. This study was made possible by the generous support of the American people through funding from United States Agency for International Development (USAID; Grant ID: 2233). The content is the responsibility of the authors and does not necessarily reflect the views of USAID or the United States Government.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Amara RR, 2002, J VIROL, V76, P7625, DOI 10.1128/JVI.76.15.7625-7631.2002; Baecher-Allan C, 2004, SEMIN IMMUNOL, V16, P89, DOI 10.1016/j.smim.2003.12.005; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Berinyuy E, 2016, J RECEPT SIG TRANSD, V36, P119, DOI 10.3109/10799893.2015.1056307; Boer MC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00217; Brezar V, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030030; Brezar V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004752; Buranapraditkun S, 2017, J VIROL, V91, DOI 10.1128/JVI.00497-17; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Chevalier N, 2011, J IMMUNOL, V6; Chowdhury A, 2015, J IMMUNOL, V21; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Ferrantelli F, 2002, VACCINE, V20, pA61, DOI 10.1016/S0264-410X(02)00389-4; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Hammarlund E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01901-w; Hayes P, 2013, CLIN VACCINE IMMUNOL, V23; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Hessell AJ, 2012, CURR HIV-AIDS REP, V9, P64, DOI [10.1007/s11904-011-0105-5, 10.1007/s11904-011-0105]; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kared H, 2008, AIDS, V22, P2451, DOI 10.1097/QAD.0b013e328319edc0; KAYMAN SC, 1994, J VIROL, V68, P400, DOI 10.1128/JVI.68.1.400-410.1994; KENT KA, 1992, AIDS RES HUM RETROV, V8, P1147, DOI 10.1089/aid.1992.8.1147; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kramski M, 2015, AIDS, V29, P137, DOI 10.1097/QAD.0000000000000523; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Lewis GK, 2014, P NATL ACAD SCI USA, V111, P15614, DOI 10.1073/pnas.1413550111; Li G, 2017, J IMMUNOL S, V1, P198; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; McCoy LE, 2012, J EXP MED, V209, P1091, DOI 10.1084/jem.20112655; MCKEATING JA, 1993, J VIROL, V67, P4932, DOI 10.1128/JVI.67.8.4932-4944.1993; Mehendale S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055831; Mills KHG, 2004, SEMIN IMMUNOL, V16, P107, DOI 10.1016/j.smim.2003.12.006; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Ndure J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00477; O'Connell RJ, 2014, EXPERT REV VACCINES, V13, P1489, DOI 10.1586/14760584.2014.951335; Overbaugh J, 2011, COLD SPRING HARB PER, V1; Pallikkuth S, 2013, IMMUNOL RES, V57, P279, DOI 10.1007/s12026-013-8457-0; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Pissani F, 2014, TRENDS IMMUNOL, V35, P278, DOI 10.1016/j.it.2014.02.010; Rao M, 2013, CURR HIV RES, V11, P427, DOI 10.2174/1570162X113116660064; Recher M, 2011, BLOOD, V118, P6824, DOI 10.1182/blood-2011-06-362533; Rouse BT, 2004, J IMMUNOL, V173, P2211, DOI 10.4049/jimmunol.173.4.2211; Schaerli P, 2001, J IMMUNOL, V167, P6082, DOI 10.4049/jimmunol.167.11.6082; Schiffner T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-72; Schultz BT, 2016, IMMUNITY, V44, P167, DOI 10.1016/j.immuni.2015.12.011; Simonetta F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00215; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Su HB, 2012, METHODS MOL BIOL, V806, P287, DOI 10.1007/978-1-61779-367-7_20; Ueno H, 2016, J CLIN IMMUNOL, V36, pS34, DOI 10.1007/s10875-016-0268-3; UNAIDS, 2016, PREV GAP REP; Wang HB, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/503978; Wang YP, 2017, GPS SOLUT, V21, P523, DOI 10.1007/s10291-016-0543-z; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Zolla-Pazner S, 2014, EBIOMEDICINE, V1, P37, DOI 10.1016/j.ebiom.2014.10.022; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629	68	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203037	10.1371/journal.pone.0203037	http://dx.doi.org/10.1371/journal.pone.0203037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157242	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400083
J	Park, YS; Jun, IG; Go, Y; Song, JG; Hwang, GS				Park, Yong-Seok; Jun, In-Gu; Go, Yonji; Song, Jun-Gol; Hwang, Gyu-Sam			Comparison of acute kidney injury between open and laparoscopic pylorus-preserving pancreaticoduodenectomy: Propensity score analysis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; HYDROXYETHYL STARCH; CARDIAC-SURGERY; NONCARDIAC SURGERY; CLINICAL-OUTCOMES; PNEUMOPERITONEUM; CHOLECYSTECTOMY; MORTALITY; CANCER; RISK	Laparoscopic pylorus-preserving pancreaticoduodenectomy is being performed more frequently because of improved surgical techniques. Although several studies have demonstrated safety and favourable outcomes of laparoscopic pylorus-preserving pancreaticoduodenectomy compared to open pylorus-preserving pancreaticoduodenectomy, few studies have focused on the development of postoperative acute kidney injury. This retrospective study compared the prevalence and risk factors of acute kidney injury following laparoscopic and open pylorus-preserving pancreaticoduodenectomy. Data from 809 patients who underwent pylorus-preserving pancreaticoduodenectomy between February 2012 and September 2016 were analysed. Patients were divided into two groups according to the surgical procedure (open pylorus-preserving pancreaticoduodenectomy [n = 632] vs laparoscopic pylorus-preserving pancreaticoduodenectomy [n = 177]). The Kidney Disease: Improving Global Outcomes criteria were used to define postoperative acute kidney injury and risk factors were investigated using multivariable logistic regression analysis with propensity score matching analysis and standardized mortality ratio weighting to compare outcomes. No significant differences were found in the occurrence of postoperative acute kidney injury and incidence of postoperative ICU admission between open and laparoscopic pylorus-preserving pancreaticoduodenectomy groups after propensity score matching (p = 1.000, p = 0.999, respectivelyand standardized mortality ratio weighted analysis (p = 0.619, p = 0.982, respectively). Hospital stay was significantly shorter in the laparoscopic pylorus-preserving pancreaticoduodenectomy group (propensity matched set, mean [SD], 16.7 [10.0] vs. 18.7 [9.6] days, p = 0.004; standardized mortality ratio, 16.6 [9.9] vs. 18.1 [8.8] days, p = 0.001). There was no significant difference in postoperative acute kidney injury incidence between both groups. Laparoscopic pylorus-preserving pancreaticoduodenectomy is promising with comparable postoperative outcomes to open pylorus-preserving pancreaticoduodenectomy and has the advantage of shorter hospital stay.	[Park, Yong-Seok; Jun, In-Gu; Go, Yonji; Song, Jun-Gol; Hwang, Gyu-Sam] Univ Ulsan, Coll Med, Asan Med Ctr, Lab Cardiovasc Dynam,Dept Anesthesiol & Pain Med, Seoul, South Korea	University of Ulsan; Asan Medical Center	Jun, IG (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Lab Cardiovasc Dynam,Dept Anesthesiol & Pain Med, Seoul, South Korea.	igjun@amc.seoul.kr	Hwang, Gyu-Sam/AAX-1937-2021	Park, Yong-Seok/0000-0002-3752-2211				Barrantes F, 2008, CRIT CARE MED, V36, P1397, DOI 10.1097/CCM.0b013e318168fbe0; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Bouma HR, 2018, ANN THORAC SURG, V106, P92, DOI 10.1016/j.athoracsur.2018.01.066; Boyle JM, 2006, AM J KIDNEY DIS, V48, P787, DOI 10.1053/j.ajkd.2006.08.002; Brown JR, 2006, CIRCULATION, V114, pI409, DOI 10.1161/CIRCULATIONAHA.105.000596; Campbell GA, 2014, ADV CHRONIC KIDNEY D, V21, P64, DOI 10.1053/j.ackd.2013.08.002; Cho A, 2009, AM J SURG, V198, P445, DOI 10.1016/j.amjsurg.2008.12.025; Cisek LJ, 1998, J ENDOUROL, V12, P95, DOI 10.1089/end.1998.12.95; Cohen EP, 2015, AM J KIDNEY DIS, V66, P869, DOI 10.1053/j.ajkd.2015.04.042; Correa-Gallego C, 2014, J AM COLL SURGEONS, V218, P129, DOI 10.1016/j.jamcollsurg.2013.09.005; Doshi SM, 2012, AM J KIDNEY DIS, V59, P222, DOI 10.1053/j.ajkd.2011.08.029; Frenette AJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0602-1; Grande M, 2002, SURG ENDOSC, V16, P313, DOI 10.1007/s00464-001-9042-5; Hoste EAJ, 2017, BEST PRACT RES-CLIN, V31, P299, DOI 10.1016/j.bpa.2017.11.001; Howell NJ, 2008, EUR J CARDIO-THORAC, V34, P390, DOI 10.1016/j.ejcts.2008.04.017; Humphreys BD, 2005, J AM SOC NEPHROL, V16, P151, DOI 10.1681/ASN.2004100843; IWASE K, 1993, EUR SURG RES, V25, P203, DOI 10.1159/000129279; James MT, 2015, AM J KIDNEY DIS, V66, P602, DOI 10.1053/j.ajkd.2015.02.338; Johannes T, 2007, AM J PHYSIOL-RENAL, V292, pF796, DOI 10.1152/ajprenal.00206.2006; Joo EY, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002650; Karas PL, 2015, INTERACT CARDIOV TH, V21, P777, DOI 10.1093/icvts/ivv247; Karkouti K, 2005, J THORAC CARDIOV SUR, V129, P391, DOI 10.1016/j.jtcvs.2004.06.028; Kashy BK, 2014, ANESTHESIOLOGY, V121, P730, DOI 10.1097/ALN.0000000000000375; Kheterpal S, 2007, ANESTHESIOLOGY, V107, P892, DOI 10.1097/01.anes.0000290588.29668.38; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kim HJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004489; Kim SK, 2016, TRANSPL P, V48, P102, DOI 10.1016/j.transproceed.2015.12.016; Kim SC, 2013, SURG ENDOSC, V27, P95, DOI 10.1007/s00464-012-2427-9; Lee BR, 1999, J ENDOUROL, V13, P279, DOI 10.1089/end.1999.13.279; McDougall EM, 1996, J AM COLL SURGEONS, V182, P317; Micali S, 1999, SURG ENDOSC-ULTRAS, V13, P503, DOI 10.1007/s004649901022; Miki Y, 1997, SURG ENDOSC, V11, P838, DOI 10.1007/s004649900466; Momeni M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186403; Moon YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186336; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Nishio S, 1999, BJU INT, V83, P944; Raiman M, 2016, EUR J ANAESTH, V33, P42, DOI 10.1097/EJA.0000000000000328; Romagnoli S, 2015, MINERVA ANESTESIOL, V81, P684; Rosner MH, 2014, ADV CHRONIC KIDNEY D, V21, P7, DOI 10.1053/j.ackd.2013.05.005; Seguro AC, 2012, J SURG RES, V175, P312, DOI 10.1016/j.jss.2011.05.052; Song KB, 2015, ANN SURG, V262, P146, DOI 10.1097/SLA.0000000000001079	42	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202980	10.1371/journal.pone.0202980	http://dx.doi.org/10.1371/journal.pone.0202980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142190	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500056
J	Long, JJ; Jahn, CE; Sanchez-Hidalgo, A; Wheat, W; Jackson, M; Gonzalez-Juarrero, M; Leach, JE				Long, John J.; Jahn, Courtney E.; Sanchez-Hidalgo, Andrea; Wheat, William; Jackson, Mary; Gonzalez-Juarrero, Mercedes; Leach, Jan E.			Interactions of free-living amoebae with rice bacterial pathogens Xanthomonas oryzae pathovars oryzae and oryzicola	PLOS ONE			English	Article							ACANTHAMOEBA-CASTELLANII; COMMUNITY COMPOSITION; BIOFILM FORMATION; PLANT-GROWTH; SOIL; PROTOZOA; RHIZOSPHERE; WATER; SECRETION; GRANULES	Background Free-living amoebae (FLA) are voracious feeders, consuming bacteria and other microbes during colonization of the phytobiome. FLA are also known to secrete bacteriocidal or bacteriostatic compounds into their growth environment. Methodology and principal findings Here, we explore the impacts of co-cultivation of five FLA species, including Acanthamoeba castellanii, A. lenticulata, A. polyphaga, Dictyostelium discoideum and Vermamoeba vermiformis, on survival of two devastating bacterial pathogens of rice, Xanthomonas oryzae pathovars (pv.) oryzae and oryzicola. In co-cultivation assays, the five FLA species were either bacteriostatic or bactericidal to X. oryzae pv. oryzae and X. oryzae pv. oryzicola. Despite these effects, bacteria were rarely detected inside amoebal cells. Furthermore, amoebae did not disrupt X. oryzae biofilms. The bactericidal effects persisted when bacteria were added to a cell-free supernatant from amoebal cultures, suggesting some amoebae produce an extracellular bactericidal compound. Conclusions/Significance This work establishes novel, basal dynamics between important plant pathogenic bacteria and diverse amoebae, and lays the framework for future mechanistic studies.	[Long, John J.; Jahn, Courtney E.; Leach, Jan E.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Sanchez-Hidalgo, Andrea; Wheat, William; Jackson, Mary; Gonzalez-Juarrero, Mercedes] Colorado State Univ, Dept Microbiol Immunol &Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Leach, JE (corresponding author), Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA.	Jan.Leach@colostate.edu	Jackson, Mary/D-5345-2017	Jackson, Mary/0000-0002-9212-0258; gonzalez-juarrero, mercedes/0000-0002-4045-2365; Leach, Jan/0000-0001-7252-4397	Defense Advanced Research Projects Agency (DARPA) [DARPA-BAA-15-35]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was funded by the Defense Advanced Research Projects Agency (DARPA) under project number: DARPA-BAA-15-35. The funders had no role in study design, data collection and analysis, decision to p ublish, or preparation of the manuscript.	Benavides-Montano JA, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00593-17; Bonkowski M, 2002, SOIL BIOL BIOCHEM, V34, P1709, DOI 10.1016/S0038-0717(02)00157-8; Bonkowski M, 2004, NEW PHYTOL, V162, P617, DOI 10.1111/j.1469-8137.2004.01066.x; Chavez-Munguia B, 2014, EXP PARASITOL, V142, P1, DOI 10.1016/j.exppara.2014.03.027; Cho JH, 2000, IUBMB LIFE, V50, P209, DOI 10.1080/152165400300001534; Clarke M, 2006, EUR J CELL BIOL, V85, P1001, DOI 10.1016/j.ejcb.2006.05.004; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Dillon A, 2009, FEMS MICROBIOL ECOL, V69, P106, DOI 10.1111/j.1574-6941.2009.00690.x; El-Etr SH, 2009, APPL ENVIRON MICROB, V75, P7488, DOI 10.1128/AEM.01829-09; Fouque E, 2015, J EUKARYOT MICROBIOL, V62, P327, DOI 10.1111/jeu.12185; Gourabathini P, 2008, APPL ENVIRON MICROB, V74, P2518, DOI 10.1128/AEM.02709-07; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2003, ANN NY ACAD SCI, V990, P628, DOI 10.1111/j.1749-6632.2003.tb07437.x; Griffiths BS, 1999, PEDOBIOLOGIA, V43, P297; GRiSP, RICE ALMANAC; HABTE M, 1975, APPL MICROBIOL, V29, P159, DOI 10.1128/AEM.29.2.159-164.1975; HARF C, 1994, ENDOCYTOBIOSIS CELL, V10, P167; Jousset A, 2010, APPL ENVIRON MICROB, V76, P5263, DOI 10.1128/AEM.02941-09; Kreuzer K, 2006, SOIL BIOL BIOCHEM, V38, P1665, DOI 10.1016/j.soilbio.2005.11.027; LEIGH JA, 1992, ANNU REV MICROBIOL, V46, P307, DOI 10.1146/annurev.mi.46.100192.001515; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Matz C, 2008, ISME J, V2, P843, DOI 10.1038/ismej.2008.47; MEW TW, 1993, PLANT DIS, V77, P5, DOI 10.1094/PD-77-0005; NAPOLITANO JJ, 1982, APPL ENVIRON MICROB, V44, P255, DOI 10.1128/AEM.44.1.255-257.1982; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Pagnier I, 2008, ENVIRON MICROBIOL, V10, P1135, DOI 10.1111/j.1462-2920.2007.01530.x; Plasson F., 2017, WILLAERTIA MAGNA BIO; Pradhan BB, 2012, MOL PLANT MICROBE IN, V25, P1157, DOI 10.1094/MPMI-02-12-0049-R; Riekenberg S, 2004, MOL BIOCHEM PARASIT, V138, P217, DOI 10.1016/j.molbiopara.2004.09.003; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Rosenberg K, 2009, ISME J, V3, P675, DOI 10.1038/ismej.2009.11; ROSENTHAL S, 1969, J BACTERIOL, V98, P182, DOI 10.1128/JB.98.1.182-189.1969; Siddiqui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-6; Thomas V, 2010, FEMS MICROBIOL REV, V34, P231, DOI 10.1111/j.1574-6976.2009.00190.x; Verdier V, 2012, J BIOTECHNOL, V159, P320, DOI 10.1016/j.jbiotec.2011.09.020; Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405; Zhang HT, 2013, CURR OPIN PLANT BIOL, V16, P188, DOI 10.1016/j.pbi.2013.02.008; Zhou XH, 2007, ENVIRON MICROBIOL, V9, P913, DOI 10.1111/j.1462-2920.2006.01213.x	39	13	14	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202941	10.1371/journal.pone.0202941	http://dx.doi.org/10.1371/journal.pone.0202941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142182	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500052
J	Hagege, J; Chammat, M; Tandetnik, C; Naccache, L				Hagege, Joshua; Chammat, Mariam; Tandetnik, Caroline; Naccache, Lionel			Suggestion of self-(in)coherence modulates cognitive dissonance	PLOS ONE			English	Article								While cognitive dissonance is an influential concept of social psychology, its relations with consciousness and episodic memory remain strongly debated. We recently used the free-choice paradigm (FCP) to demonstrate the crucial role of conscious memory of previous choices on choice-induced preference change (CIPC). After choosing between two similarly rated items, subjects reevaluated chosen items as more attractive, and rejected items as less attractive. However such a CIPC was present exclusively for items that were correctly remembered as chosen or rejected during the choice stage, both in healthy controls and in amnesic patients. In the present work, we show that CIPC can be modulated by suggestive quotes promoting self-coherence or self-incoherence. In addition to the crucial role of memory of previous choices, we discovered that memory of the suggestive quotes was correlated to the modulation of CIPC. Taken together these results suggest that CIPC reflects a dynamic homeostatic regulation of self-coherence.	[Hagege, Joshua; Chammat, Mariam; Tandetnik, Caroline; Naccache, Lionel] dINSERM, U1127, Paris, France; [Hagege, Joshua; Chammat, Mariam; Tandetnik, Caroline; Naccache, Lionel] Inst Cerveau & Moelle Epiniere, PICNIC Lab, ICM, Paris, France; [Naccache, Lionel] UPMC Univ Paris 06, Sorbonne Univ, Fac Med Pitie Salpetriere, Paris, France; [Naccache, Lionel] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, Paris, France; [Naccache, Lionel] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurophysiol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Naccache, L (corresponding author), dINSERM, U1127, Paris, France.; Naccache, L (corresponding author), Inst Cerveau & Moelle Epiniere, PICNIC Lab, ICM, Paris, France.; Naccache, L (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Fac Med Pitie Salpetriere, Paris, France.; Naccache, L (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, Paris, France.; Naccache, L (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Dept Neurophysiol, Paris, France.	lionel.naccache@aphp.fr		naccache, lionel/0000-0002-2874-1009	Fondation pour la Recherche Medicale (FRM); Academie des Sciences - Grand Prix Lamonica de Neurologie; program 'Investissements d'avenir' [ANR-10-IAIHU-06]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Academie des Sciences - Grand Prix Lamonica de Neurologie; program 'Investissements d'avenir'(French National Research Agency (ANR))	This work was supported by the 'Equipe FRM 2015' grant of Fondation pour la Recherche Medicale (FRM) (LN), by the Academie des Sciences - Grand Prix Lamonica de Neurologie (LN), and by the program 'Investissements d'avenir' ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Imen El Karoui for helpful discussions.	[Anonymous], 1962, EXPLORATIONS COGNITI; Baayen R, MIXED EFFECTS MODELI; Bator R, 2007, SOC INFLUENCE, V1, P208; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; Chammat M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41320; Chen MK, 2010, J PERS SOC PSYCHOL, V99, P573, DOI 10.1037/a0020217; CIALDINI RB, 1991, ADV EXP SOC PSYCHOL, V24, P201; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Harmon-Jones E, 2008, J PERS SOC PSYCHOL, V94, P1, DOI 10.1037/0022-3514.94.1.1; Izuma K, 2015, J NEUROSCI, V35, P3598, DOI 10.1523/JNEUROSCI.4591-14.2015; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Kitayama S, 2013, NEUROIMAGE, V69, P206, DOI 10.1016/j.neuroimage.2012.11.034; Mengarelli F, 2013, CEREB CORTEX; Risen JL, 2010, SOC PERSONAL PSYCHOL, V4, P1151, DOI 10.1111/j.1751-9004.2010.00323.x; Salti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108579; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; van Veen V, 2009, NAT NEUROSCI, V12, P1469, DOI 10.1038/nn.2413	17	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0202204	10.1371/journal.pone.0202204	http://dx.doi.org/10.1371/journal.pone.0202204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161218	gold, Green Published, Green Submitted			2022-12-27	WOS:000443388900025
J	Pulido, CM; Redondo-Sama, G; Sorde-Marti, T; Flecha, R				Pulido, Cristina M.; Redondo-Sama, Gisela; Sorde-Marti, Teresa; Flecha, Ramon			Social impact in social media: A new method to evaluate the social impact of research	PLOS ONE			English	Article							SCIENCE	The social impact of research has usually been analysed through the scientific outcomes produced under the auspices of the research. The growth of scholarly content in social media and the use of altmetrics by researchers to track their work facilitate the advancement in evaluating the impact of research. However, there is a gap in the identification of evidence of the social impact in terms of what citizens are sharing on their social media platforms. This article applies a social impact in social media methodology (SISM) to identify quantitative and qualitative evidence of the potential or real social impact of research shared on social media, specifically on Twitter and Facebook. We define the social impact coverage ratio (SICOR) to identify the percentage of tweets and Facebook posts providing information about potential or actual social impact in relation to the total amount of social media data found related to specific research projects. We selected 10 projects in different fields of knowledge to calculate the SICOR, and the results indicate that 0.43% of the tweets and Facebook posts collected provide linkages with information about social impact. However, our analysis indicates that some projects have a high percentage (4.98%) and others have no evidence of social impact shared in social media. Examples of quantitative and qualitative evidence of social impact are provided to illustrate these results. A general finding is that novel evidences of social impact of research can be found in social media, becoming relevant platforms for scientists to spread quantitative and qualitative evidence of social impact in social media to capture the interest of citizens. Thus, social media users are showed to be intermediaries making visible and assessing evidence of social impact.	[Pulido, Cristina M.] Univ Autonoma Barcelona, Dept Journalism & Commun Studies, Barcelona, Spain; [Redondo-Sama, Gisela] Univ Zaragoza, Dept Psychol & Sociol, Zaragoza, Spain; [Sorde-Marti, Teresa] Univ Autonoma Barcelona, Dept Sociol, Barcelona, Spain; [Flecha, Ramon] Univ Barcelona, Dept Sociol, Barcelona, Spain	Autonomous University of Barcelona; University of Zaragoza; Autonomous University of Barcelona; University of Barcelona	Pulido, CM (corresponding author), Univ Autonoma Barcelona, Dept Journalism & Commun Studies, Barcelona, Spain.	cristina.pulido@uab.cat	Redondo-Sama, Gisela/ABG-3130-2020; Sorde-Marti, Teresa/AAM-5709-2020; Flecha, Ramon/AAA-9414-2019; Martí, Teresa/GZM-0890-2022; Redondo-Sama, Gisela/AAX-8825-2020; Sorde, Teresa/AAK-5873-2021; Pulido, Cristina/AAM-9712-2020	Flecha, Ramon/0000-0001-7230-516X; Redondo-Sama, Gisela/0000-0003-2240-7795; Sorde, Teresa/0000-0003-0336-3061; Pulido, Cristina/0000-0001-8630-7529	European Commission [613202]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The research leading to these results has received funding from the 7th Framework Programme of the European Commission under the Grant Agreement no 613202 P.I. Ramon Flecha, https://ec.europa.eu/research/fp7/index_en.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, EUROPEAN 2020 STRATE; [Anonymous], 1855, RICHMOND DAILY 0706; Bornmann L, 2015, ASLIB J INFORM MANAG, V67, P305, DOI 10.1108/AJIM-09-2014-0115; Bornmann L, 2013, J AM SOC INF SCI TEC, V64, P217, DOI 10.1002/asi.22803; Cabre-Olive A J, 2017, J SOCIAL SCI, V6, P70, DOI [10.17583/rimcis.2017.2652, DOI 10.17583/RIMCIS.2017.2652]; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Crooks A, 2013, T GIS, V17, P124, DOI 10.1111/j.1467-9671.2012.01359.x; EC Research & Innovation, 2017, SUCC STOR; Economic and Social Research Council, 2017, SOC MED BEST PRACT G; EuroFIT, 2016, EUR INT PP YOUT; Euronews, 2016, BIG FARM IS WATCH SU; European Commission, 2012, WORK PROGR 2013 COOP; European Commission, 2013, WORK PROGR 2013 COOP; European Commission, 2017, BETT REG TOOLB, P129; Flecha R, 2016, SISM METHODOLOGY SOC; Flecha R, 2015, NATURE, V528, P193, DOI 10.1038/528193d; FoodRisc Consortium European Commission, 2017, FOODR RES BRIEF 7 FR; Fresco LO, 2015, CURR SCI INDIA, V109, P430; Godin B, 2005, INRS URBANISATION CU; Haustein S, 2014, J ASSOC INF SCI TECH, V65, P656, DOI 10.1002/asi.23101; Hayes A, 2016, AM J CLIN NUTR, V104, P629, DOI 10.3945/ajcn.116.132530; HELMING K, 2011, ECOL SOC, V0016; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491; Maitre L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46082; Martinello N, 2012, INFORM HEALTH SOC CA, V37, P177, DOI 10.3109/17538157.2012.678448; Murphy L., Q3Q4 GRIT, V3-4; PhysOrg, 2016, REUS FOOD WAST AN FE; Poppy G, 2015, NATURE, V526, P7, DOI 10.1038/526007a; Reale E, 2018, RES EVALUAT, V27, P298, DOI 10.1093/reseval/rvx025; Research Information Center, 2016, TECHN TRIALL FIGHT A; Shuai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047523; Statistica, 2017, STAT FACTS SOC MED U; Townsend L., 2016, SOCIAL MEDIA RES GUI; Wilder L, 2008, ORYX, V42, P529, DOI 10.1017/S0030605307000671; Xia F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165997	36	67	71	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0203117	10.1371/journal.pone.0203117	http://dx.doi.org/10.1371/journal.pone.0203117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157262	gold, Green Published			2022-12-27	WOS:000443071400091
J	Zhao, ZL; Zhang, YL; Liu, LS; Hu, ZZ				Zhao, Zhilong; Zhang, Yili; Liu, Linshan; Hu, Zengzeng			The impact of drought on vegetation conditions within the Damqu River Basin, Yangtze River Source Region, China	PLOS ONE			English	Article							REMOTE-SENSING DATA; CLIMATE-CHANGE; TIBETAN PLATEAU; SOIL-MOISTURE; TREND; DESERTIFICATION; VARIABILITY; INDEX	Drought and vegetation conditions within the Damqu River Basin, part of the Yangtze River Source Region (YRSR), are assessed here using the standardized precipitation index (SPI), the standardized precipitation evapotranspiration index (SPEI), the normalized difference vegetation index (NDVI), and the leaf area index (LAI). We utilized Sen's method, least squares regression method, linear regression and Pearson's correlation analysis to study variations in drought and vegetation indices and the drought effect on vegetation between 1988 and 2015. Results reveal that droughts occurred at a 25% frequency over this period; SPI and SPEI analyses show that 1994, 1999, 2005, and 2010 were change points and that the basin was characterized by varying drought and humidity trends. Subsequent to 2010, both SPI and SPEI decreased within the basin, while 1995, 2000, 2004, and 2010 were change points for NDVI and LAI while the watershed exhibited variable trends in vegetation reduction and increase. The NDVI-annual values of 63.36% regions and the LAI-summer values of 68.39% areas within the basin were decreased during 1988 +/- 2015 and 2000 +/- 2015, respectively. Subsequent to 2010, both NDVI and LAI decreased within the basin and significant positive correlations at inter-annual and inter-summer time scales were seen in both drought and vegetation indices; drought has exerted a lag effect on vegetation as shown by significant positive correlations between annual SPI/SPEI values and following year NDVI/LAI values.	[Zhao, Zhilong; Zhang, Yili; Liu, Linshan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China; [Zhao, Zhilong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Yili] CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Hu, Zengzeng] Capital Univ Econ & Business, Coll Urban Econ & Publ Adm, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital University of Economics & Business	Liu, LS (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China.	liuls@igsnrr.ac.cn		zhang, yili/0000-0002-9474-1664; Liu, Linshan/0000-0002-0194-2214	Key Foundation Project of Basic Work of the Ministry of Science and Technology of China [2012FY111400]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA20040200]; National Natural Science Foundation of China [41671104]	Key Foundation Project of Basic Work of the Ministry of Science and Technology of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by: 1) the Key Foundation Project of Basic Work of the Ministry of Science and Technology of China (2012FY111400), to LSL [http://program.most.gov.cn/]; 2) the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA20040200), to YLZ [http://www.bmrdp.cas.cn/alzx/]; 3) National Natural Science Foundation of China (No. 41671104), to LSL [http://www.nsfc.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai HY, 2015, ECOL ENG, V83, P112, DOI 10.1016/j.ecoleng.2015.06.031; Chen T, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8101069; [陈燕丽 CHEN Yanli], 2011, [遥感学报, Journal of Remote Sensing], V15, P831; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Deng LC, 2015, CHINA SCI PAPER, V10, P1822; Hao C, 2015, INT J APPL EARTH OBS, V35, P270, DOI 10.1016/j.jag.2014.09.011; [何娇楠 He Jiaonan], 2016, [山地学报, Mountain Research], V34, P19; Hua YY, 2016, ECOL INDIC, V71, P438, DOI 10.1016/j.ecolind.2016.07.036; Huang WanHua, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P50; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; IPCCWGII, 2014, CONTR IPCCS 5 ASS RE; Ivits E, 2014, REMOTE SENS-BASEL, V6, P4266, DOI 10.3390/rs6054266; Ivits E, 2014, GLOBAL CHANGE BIOL, V20, P581, DOI 10.1111/gcb.12393; Kahya E, 2004, J HYDROL, V289, P128, DOI 10.1016/j.jhydrol.2003.11.006; Li BQ, 2015, WATER-SUI, V7, P5474, DOI 10.3390/w7105474; Li XL, 2018, APPL GEOGR, V97, P176, DOI 10.1016/j.apgeog.2018.06.011; Li Y, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4182; Li Z, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-4781-0; Li Z, 2015, INT J ENV RES PUB HE, V12, P7615, DOI 10.3390/ijerph120707615; Liu PL, 2017, SCI TOTAL ENVIRON, V589, P73, DOI 10.1016/j.scitotenv.2017.02.210; Liu XF, 2014, J GEOGR SCI, V24, P288, DOI 10.1007/s11442-014-1088-0; Liu XF, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/950262; Lu X., 1996, CHINESE GEOGR SCI, V6, P15; MCKEE TB, 1993, P 8 C APPL CLIM AN C; Meng LK, 2016, NAT HAZARDS, V80, P1135, DOI 10.1007/s11069-015-2014-1; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Mondol MAH, 2017, ADV METEOROL, V2017, DOI 10.1155/2017/4642060; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nicholson SE, 1998, B AM METEOROL SOC, V79, P815, DOI 10.1175/1520-0477(1998)079<0815:DDASVA>2.0.CO;2; Palmer W.C., 1965, 45 US DEP COMM WEATH, P45; Pan BT., 1996, J LANZHOU UNIV NAT S, V32, P108, DOI [10.13885/j.issn.0455-2059.1996.01.024, DOI 10.13885/J.ISSN.0455-2059.1996.01.024]; Pang GJ, 2017, QUATERN INT, V444, P87, DOI 10.1016/j.quaint.2016.08.038; Piao SL, 2015, GLOBAL CHANGE BIOL, V21, P1601, DOI 10.1111/gcb.12795; Pickup G, 1998, CLIMATE RES, V11, P51, DOI 10.3354/cr011051; Preethi B, 2017, CLIM DYNAM, V48, P2489, DOI 10.1007/s00382-016-3218-0; Ren XB, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8080626; Shah SU, 2016, J APPL REMOTE SENS, V10, DOI 10.1117/1.JRS.10.036005; Sheffield J, 2008, J CLIMATE, V21, P432, DOI 10.1175/2007JCLI1822.1; Smol JP, 2014, LAKES CLIMATE CHANGE; [孙鸿烈 Sun Honglie], 2012, [地理学报, Acta Geographica Sinica], V67, P3; Sun JN, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5440-9; Tabari H, 2011, J HYDROL, V396, P313, DOI 10.1016/j.jhydrol.2010.11.034; Tornros T, 2014, HYDROL EARTH SYST SC, V18, P305, DOI 10.5194/hess-18-305-2014; Tome AR, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019100; Tong SQ, 2017, MATH PROBL ENG, V2017, DOI 10.1155/2017/5209173; Vicente-Serrano SM, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI000434.1; Vicente-Serrano SM, 2015, REMOTE SENS-BASEL, V7, P4391, DOI 10.3390/rs70404391; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; [王敏 Wang Min], 2013, [干旱区地理, Arid Land Geography], V36, P49; Wang W, 2016, INT GEOSCI REMOTE SE, P1374, DOI 10.1109/IGARSS.2016.7729351; Wu Zhifeng, 2014, Journal of Natural Disasters, V23, P94, DOI 10.13577/j.jnd.2014.0213; [徐维新 Xu Weixin], 2012, [干旱区地理, Arid Land Geography], V35, P46; YANAI MH, 1992, J METEOROL SOC JPN, V70, P319, DOI 10.2151/jmsj1965.70.1B_319; [姚檀栋 Yao Tandong], 2014, [地理科学进展, Progress in Geography], V33, P884; Yao TD, 2012, ENVIRON DEV, V3, P52, DOI 10.1016/j.envdev.2012.04.002; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/nclimate1580, 10.1038/NCLIMATE1580]; [于秀娟 Yu Xiujuan], 2013, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V22, P66; Zeng XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141648; Zhang YJ, 2012, IEEE INFOCOM SER, P10, DOI 10.1109/INFCOM.2012.6195468; [赵静 ZHAO Jing], 2008, [世界地质, World Geology], V27, P427; Zhao ZhiLong, 2017, Journal of Resources and Ecology, V8, P67, DOI 10.5814/j.issn.1674-764x.2017.01.009; Zhao ZL, 2017, DYNAMIC WETLAND DAMQ; Zhu ZC, 2016, NAT CLIM CHANGE, V6, P791, DOI [10.1038/NCLIMATE3004, 10.1038/nclimate3004]	64	16	16	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202966	10.1371/journal.pone.0202966	http://dx.doi.org/10.1371/journal.pone.0202966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142183	Green Published, gold, Green Submitted			2022-12-27	WOS:000442722500055
J	Cobo-Cuenca, AI; Martin-Espinosa, NM; Sampietro-Crespo, A; Rodriguez-Borrego, MA; Carmona-Torres, JM				Isabel Cobo-Cuenca, Ana; Maria Martin-Espinosa, Noelia; Sampietro-Crespo, Antonio; Aurora Rodriguez-Borrego, Maria; Manuel Carmona-Torres, Juan			Sexual dysfunction in Spanish women with breast cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; MASTECTOMY; CHEMOTHERAPY; SURVIVORS; ISSUE	Purpose To determine whether there are changes in sexuality after breast cancer, to better understand the sexual function of women with breast cancer, and to investigate the potential relationship between sexual dysfunction and socio-demographic and clinical variables. Methods A cross-sectional study. This study included 514 women with breast cancer between 21-and 66-years-old. The cases were gathered between June 2016 and January 2017. The instruments used were the questionnaire on Women's Sexual Function and a questionnaire to collect socio-demographic and clinical data. Results The average age (+/- standard deviation, SD) of participants was 46.34 +/- 8.28 years. Their average age at date of diagnosis was 42.26 +/- 8.56 years, and the average time suffering from cancer was 4.05 +/- 5.23 years. There were significant differences (p = 0.002) in the presence of sexual dysfunction before (32.1%) and after (91.2%) cancer. The primary sexual dysfunctions were due to penetration pain (50.6%), lubrication (50.6%), dysfunctional desire (44.6%), and dysfunctional excitement (44.6%). Two-thirds of participants were satisfied with their sexual relations. The women who presented most sexual dysfunction were those that had a bilateral mastectomy (p = 0.009) and those who received chemotherapy, radiotherapy and hormonal-therapy (p < 0.001. Conclusion Sexual function was changed in women with breast cancer. The main problems included penetration pain, desire, lubrication, and dysfunctional excitement. It is important that Health professionals recognize which circumstances influence the sexual function of women with breast cancer and to make interventions that facilitate sexual adjustment.	[Isabel Cobo-Cuenca, Ana; Maria Martin-Espinosa, Noelia; Manuel Carmona-Torres, Juan] UCLM, EU Enfermeria & Fisioterapia Toledo, Dept Enfermeria Fisioterapia & Terapia Ocupac, Toledo, Spain; [Isabel Cobo-Cuenca, Ana; Aurora Rodriguez-Borrego, Maria; Manuel Carmona-Torres, Juan] Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Sampietro-Crespo, Antonio] Hosp Virgen de la Salud, Toledo, Spain; [Aurora Rodriguez-Borrego, Maria] Univ Cordoba, Fac Med & Enfermeria, Dept Enfermeria, Cordoba, Spain; [Aurora Rodriguez-Borrego, Maria] Hosp Univ Reina Sofia Cordoba, Cordoba, Spain	Universidad de Castilla-La Mancha; Complejo Hospitalario de Toledo; Universidad de Cordoba; Hospital Universitario Reina Sofia - Cordoba	Cobo-Cuenca, AI (corresponding author), UCLM, EU Enfermeria & Fisioterapia Toledo, Dept Enfermeria Fisioterapia & Terapia Ocupac, Toledo, Spain.; Cobo-Cuenca, AI (corresponding author), Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain.	anaisabel.cobo@uclm.es	Cuenca, Ana Isabel Cobo/AAE-5569-2019; Carmona-Torres, Juan Manuel/E-1579-2018	Cuenca, Ana Isabel Cobo/0000-0001-7873-3835; Carmona-Torres, Juan Manuel/0000-0002-7781-872X; Martin Espinosa, Noelia Maria/0000-0002-1298-6976				Aerts L, 2014, BREAST, V23, P629, DOI 10.1016/j.breast.2014.06.012; Alder J, 2008, J SEX MED, V5, P1898, DOI 10.1111/j.1743-6109.2008.00893.x; Alicikus ZA, 2009, TUMORI J, V95, P212; Andrzejczak E, 2013, PSYCHO-ONCOLOGY, V22, P1653, DOI 10.1002/pon.3197; Biglia N, 2010, J SEX MED, V7, P1891, DOI 10.1111/j.1743-6109.2010.01725.x; Burwell SR, 2006, J CLIN ONCOL, V24, P2815, DOI 10.1200/JCO.2005.04.2499; Carmona-Torres JM, 2017, ATENCION PRIMARIA; Cavalheiro JAC, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-28; de Morais FD, 2016, J CLIN NURS, V25, P1557, DOI 10.1111/jocn.13125; de Oncolog oA a Me A dica (SEOM), 2017, CIFR CANC SEOM; Dizon DS, 2014, ONCOLOGIST, V19, P202, DOI 10.1634/theoncologist.2013-0302; Emilee G, 2010, MATURITAS, V66, P397, DOI 10.1016/j.maturitas.2010.03.027; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Galceran J, 2017, CLIN TRANSL ONCOL, V19, P799, DOI 10.1007/s12094-016-1607-9; Ganz PA, 2004, JNCI-J NATL CANCER I, V96, P376, DOI 10.1093/jnci/djh060; Gilbert E, 2016, EUR J CANCER CARE, V25, P280, DOI 10.1111/ecc.12216; Kedde H, 2013, SUPPORT CARE CANCER, V21, P271, DOI 10.1007/s00520-012-1521-9; Kirshbaum MN, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12577; Lopes Juliane da Silveira Ortiz de Camargo, 2016, Enferm. glob., V15, P350; Malinovszky KM, 2006, BRIT J CANCER, V95, P1626, DOI 10.1038/sj.bjc.6603454; Notari SC, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12607; Ochsenkuhn R, 2011, J SEX MED, V8, P1486, DOI 10.1111/j.1743-6109.2011.02220.x; Panjari M, 2011, J SEX MED, V8, P294, DOI 10.1111/j.1743-6109.2010.02034.x; Raggio GA, 2014, PSYCHOL HEALTH, V29, P632, DOI 10.1080/08870446.2013.879136; Sadovsky R, 2010, J SEX MED, V7, P349, DOI 10.1111/j.1743-6109.2009.01620.x; Safarinejad MR, 2013, PSYCHO-ONCOLOGY, V22, P1242, DOI 10.1002/pon.3130; Sanchez F, 2004, Aten Primaria, V34, P286, DOI 10.1157/13067028; Ussher JM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1243-8; Ussher JM, 2012, CANCER NURS, V35, P456, DOI 10.1097/NCC.0b013e3182395401; Vaidakis D, 2014, EUR J GYNAECOL ONCOL, V35, P635; Wang FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074473; Webber K, 2011, ONCOLOGIST, V16, P1333, DOI 10.1634/theoncologist.2011-0100	32	13	14	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203151	10.1371/journal.pone.0203151	http://dx.doi.org/10.1371/journal.pone.0203151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169506	Green Submitted, gold, Green Published			2022-12-27	WOS:000443374400023
J	Yoder, N; Gouaux, E				Yoder, Nate; Gouaux, Eric			Divalent cation and chloride ion sites of chicken acid sensing ion channel 1a elucidated by x-ray crystallography	PLOS ONE			English	Article							INHIBITION; RECEPTOR; PROTONS; ION-CHANNEL-1; EXPRESSION; PLASTICITY; MEMBRANE; AMYGDALA; NEURONS; FAMILY	Acid sensing ion channels (ASICs) are proton-gated ion channels that are members of the degenerin/epithelial sodium channel superfamily and are expressed throughout central and peripheral nervous systems. ASICs have been implicated in multiple physiological processes and are subject to numerous forms of endogenous and exogenous regulation that include modulation by Ca2+ and Cl- ions. However, the mapping of ion binding sites as well as a structure-based understanding of the mechanisms underlying ionic modulation of ASICs have remained elusive. Here we present ion binding sites of chicken ASIC1a in resting and desensitized states at high and low pH, respectively, determined by anomalous diffraction x-ray crystallography. The acidic pocket serves as a nexus for divalent cation binding at both low and high pH, while we observe divalent cation binding within the central vestibule on the resting channel at high pH only. Moreover, neutralization of residues positioned to coordinate divalent cations via individual and combined Glu to Gln substitutions reduced, but did not extinguish, modulation of proton-dependent gating by Ca2+. Additionally, we demonstrate that anion binding at the canonical thumb domain site is state-dependent and present a previously undetected anion site at the mouth of the extracellular fenestrations on the resting channel. Our results map anion and cation sites on ASICs across multiple functional states, informing possible mechanisms of modulation and providing a blueprint for the design of therapeutics targeting ASICs.	[Yoder, Nate; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.; Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	National Institute of General Medical Sciences [5T32DK007680]; National Institute of Neurological Disorders and Stroke [5F31NS096782, 5R01NS038631]; ARCS Foundation; Tartar Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS096782, R37NS038631, R01NS038631] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ARCS Foundation; Tartar Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this research was provided by the National Institute of General Medical Sciences (5T32DK007680, https://www.nigms.nih.gov), and the National Institute of Neurological Disorders and Stroke (5F31NS096782 to N.Y. and 5R01NS038631 to E.G., https://www.ninds.nih.gov/). Additional support was provided by ARCS Foundation (https://www.arcsfoundation.org/) and Tartar Trust fellowships. E.G. is an Investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Coryell MW, 2009, J NEUROSCI, V29, P5381, DOI 10.1523/JNEUROSCI.0360-09.2009; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HILLE B, 2001, ION CHANNELS EXCITAB, V18; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; JIANG C, 1992, J PHYSIOL-LONDON, V448, P697, DOI 10.1113/jphysiol.1992.sp019065; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Lynagh T, 2017, J MED CHEM, V60, P8192, DOI 10.1021/acs.jmedchem.7b01072; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mukhopadhyay M, 2017, NEUROSCIENCE, V348, P264, DOI 10.1016/j.neuroscience.2017.02.025; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Pidoplichko VI, 2014, J NEUROSCI, V34, P3130, DOI 10.1523/JNEUROSCI.4009-13.2014; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Vullo S, 2017, P NATL ACAD SCI USA, V114, P3768, DOI 10.1073/pnas.1620560114; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Yoder N, 2018, NATURE, V555, P397, DOI 10.1038/nature25782; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; Zhang P, 2002, J GEN PHYSIOL, V120, P553, DOI 10.1085/jgp.20028574; Zuo ZC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04424-0	36	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202134	10.1371/journal.pone.0202134	http://dx.doi.org/10.1371/journal.pone.0202134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157194	Green Submitted, Green Published, gold			2022-12-27	WOS:000443071400038
J	Zoccolotti, JD; Tasso, CO; Arbelaez, MIA; Malavolta, IF; Pereira, ECD; Esteves, CSG; Jorge, JH				Zoccolotti, Jacqueline de Oliveira; Tasso, Camilla Olga; Amaya Arbelaez, Maria Isabel; Malavolta, Isadore Ferreira; da Silva Pereira, Eduarda Carolina; Gomes Esteves, Caroline Stefanie; Jorge, Janaina Habib			Properties of an acrylic resin after immersion in antiseptic soaps: Low-cost, easy-access procedure for the prevention of denture stomatitis	PLOS ONE			English	Article							COLOR STABILITY; SURFACE-ROUGHNESS; CANDIDA-ALBICANS; BIOFILM FORMATION; HYGIENE HABITS; BASE MATERIALS; WOUND CARE; WATER BATH; IN-VITRO; DISINFECTION	Denture stomatitis triggered by Candida species requires better preventive measures. This study evaluated the physical and biological properties of a denture base acrylic resin after immersion in antiseptic soaps. Acrylic resin specimens were prepared and stored in distinct solutions for 0, 7, 14, 21, and 28 days. The solutions were as follows: DW: distilled water at 37 degrees C (control group); DS: cycles of daily immersion in Dettol soap for 8 hours at room temperature, followed by immersion in distilled water for 16 hours at 37 degrees C; PS: cycles of daily immersion in Protex soap, as described for the previous group; LS: cycles of daily immersion in Lifebuoy soap, as described for the DS group. The parameters evaluated at each time point were the following: biofilm formation capacity by Candida albicans and reduction of preformed fungal biofilms, cytotoxicity, surface roughness, hardness, and color change. For the fungal adhesion phase, the type of soap had a statistically significant effect (p = 0.0292), but after 24 hours, no differences were found between solutions or between storage times. Regarding the efficacy of biofilm reduction, there was a significant difference when the groups were compared to each other (p = 0.014). Dettol and Lifebuoy eliminated the preformed biofilm on the specimens. Moreover, all the soaps were classified as noncytotoxic (on HaCaT cell line) because there was no difference in cell viability between the different groups, except after 21 days, when a decrease in cell viability occurred, regardless of the type of soap. Regarding the roughness, there was no statistically significant difference (p > 0.05) between the groups. Lifebuoy decreased resin hardness regardless of storage time (p = 0.003). After 21 and 28 days of storage, there was an increase in hardness value, regardless of the type of soap. The specimens' color, according to the National Bureau of Standards values, ranged from 0.27 to 0.58 (i.e., imperceptible or mild color changes). In general, the disinfectant soaps were not able to prevent biofilm formation, but all the soaps were effective in reducing the preformed biofilm. In addition, all soaps were non-cytotoxic and did not change surface roughness, hardness (except Lifebuoy), and color (except Lifebuoy). Therefore, immersion in two antiseptic soaps (Protex and Dettol) may be a cheap and easy procedure for preventing denture stomatitis.	[Zoccolotti, Jacqueline de Oliveira; Tasso, Camilla Olga; Amaya Arbelaez, Maria Isabel; Malavolta, Isadore Ferreira; da Silva Pereira, Eduarda Carolina; Gomes Esteves, Caroline Stefanie; Jorge, Janaina Habib] Sao Paulo State Univ UNESP, Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil	Universidade Estadual Paulista	Jorge, JH (corresponding author), Sao Paulo State Univ UNESP, Dent Sch, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil.	janainahj@foar.unesp.br	Jorge, Janaina Habib/H-7896-2013; Jorge, Janaina Habib/Q-2197-2019	Jorge, Janaina Habib/0000-0002-9135-3455; Jorge, Janaina Habib/0000-0002-9135-3455	Sao Paulo Research Foundation (FAPESP) [2014/22055-4, 2014/22875-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo Research Foundation (FAPESP) [grants number 2014/22055-4 and 2014/22875-1].	Altieri Karen Tereza, 2013, Braz. Dent. J., V24, P487, DOI 10.1590/0103-6440201302289; Asad Tehmina, 1993, International Journal of Prosthodontics, V6, P9; Bagheri R, 2005, J DENT, V33, P389, DOI 10.1016/j.jdent.2004.10.018; BELL JA, 1989, J PROSTHET DENT, V61, P580, DOI 10.1016/0022-3913(89)90280-1; Bettencourt AF, 2010, DENT MATER, V26, pE171, DOI 10.1016/j.dental.2010.01.006; BUDTZJORGENSEN E, 1979, J PROSTHET DENT, V42, P619, DOI 10.1016/0022-3913(79)90190-2; Cakan U, 2015, NIGER J CLIN PRACT, V18, P511, DOI 10.4103/1119-3077.154224; Ciancio Sebastian, 2010, J Clin Dent, V21, P93; da Silva Francine Cristina, 2008, J Prosthodont, V17, P627, DOI 10.1111/j.1532-849X.2008.00358.x; Devine DA, 2007, J APPL MICROBIOL, V103, P2516, DOI 10.1111/j.1365-2672.2007.03491.x; Panariello BHD, 2015, AM J DENT, V28, P150; DorockaBobkowska B, 1996, J ORAL PATHOL MED, V25, P411, DOI 10.1111/j.1600-0714.1996.tb00288.x; Estrela Cyntia R.A., 2003, Braz. Dent. J., V14, P187, DOI 10.1590/S0103-64402003000300009; Faot F, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-77; Farzana K, 2011, SCI RES ESSAYS, V6, P3514; Fernandes FHCN, 2013, GERODONTOLOGY, V30, P18, DOI 10.1111/j.1741-2358.2012.00640.x; Finnegan S, 2015, ADV WOUND CARE, V4, P415, DOI 10.1089/wound.2014.0577; Goiato MC, 2013, GERODONTOLOGY, V30, P276, DOI 10.1111/j.1741-2358.2012.00676.x; Goiato MC, 2014, J PROSTHODONT, V23, P559, DOI 10.1111/jopr.12151; Hollis S, 2015, J PROSTHET DENT, V114, P709, DOI 10.1016/j.prosdent.2015.06.001; International Standard, 2007, 109935 ISO; Izumida FE, 2014, J PROSTHET DENT, V112, P1523, DOI 10.1016/j.prosdent.2014.06.001; Javed F, 2017, J BIOL REG HOMEOS AG, V31, P343; JOHNSTON WM, 1989, J DENT RES, V68, P819, DOI 10.1177/00220345890680051301; Jorge Janaina Habib, 2009, Quintessence Int, V40, pe93; Jorge Janaina Habib, 2006, J. Appl. Oral Sci., V14, P203, DOI 10.1590/S1678-77572006000300011; Jorge JH, 2004, INT J PROSTHODONT, V17, P340; Kellesarian SV, 2017, PHOTODIAGN PHOTODYN, V17, P103, DOI 10.1016/j.pdpdt.2016.12.001; Kulak-Ozkan Y, 2002, J ORAL REHABIL, V29, P300, DOI 10.1046/j.1365-2842.2002.00816.x; Larson EL, 2004, ANN INTERN MED, V140, P321, DOI 10.7326/0003-4819-140-5-200403020-00007; Lefebvre C A, 1995, Int J Prosthodont, V8, P122; Low IM, 1998, MATER RES BULL, V33, P1753, DOI 10.1016/S0025-5408(98)00179-2; Machado AL, 2012, GERODONTOLOGY, V29, pE375, DOI 10.1111/j.1741-2358.2011.00484.x; Machado AL, 2009, J PROSTHET DENT, V102, P115, DOI 10.1016/S0022-3913(09)60120-7; Marcos-Arias C, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-119; MCCOURTIE J, 1985, J MED MICROBIOL, V20, P97, DOI 10.1099/00222615-20-1-97; Minnich KE, 2012, OSTOMY WOUND MANAG, V58, P32; Moffa EB, 2011, J DENT, V39, pE65, DOI 10.1016/j.jdent.2011.10.008; MOLINARI J A, 1991, Dental Clinics of North America, V35, P323; Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x; Neppelenbroek KH, 2005, J PROSTHET DENT, V93, P171, DOI 10.1016/j.prosdent.2004.10.020; Nikawa H, 1999, INT J PROSTHODONT, V12, P153; Nimeroff I, 1968, NBS MONOGRAPH, V104, P47; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Patel SB, 2004, J AM DENT ASSOC, V135, P587, DOI 10.14219/jada.archive.2004.0246; Pavarina AC, 2003, J ORAL REHABIL, V30, P532, DOI 10.1046/j.1365-2842.2003.01093.x; Bianchi CMPD, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-9946201658017, 10.1590/s1678-9946201658017]; Radford DR, 1998, J DENT, V26, P577, DOI 10.1016/S0300-5712(97)00034-1; Rawlf HR, 2005, PHILLIPS DENT MAT, P135; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Sagripanti J L, 2000, Surg Infect (Larchmt), V1, P3, DOI 10.1089/109629600321245; Schuster G S, 1995, Int J Prosthodont, V8, P580; Shay K, 2000, J CONT DENT PRACT, V1, P15; Sheridan PJ, 1997, INT J PROSTHODONT, V10, P73; Smith K, 2008, J MED MICROBIOL, V57, P966, DOI 10.1099/jmm.0.47668-0; Vallittu PK, 1995, DENT MATER, V11, P338, DOI 10.1016/0109-5641(95)80031-X; Verran J, 1997, J PROSTHET DENT, V77, P535, DOI 10.1016/S0022-3913(97)70148-3; Villalta P, 2006, J PROSTHET DENT, V95, P137, DOI 10.1016/j.prosdent.2005.11.019; Webb BC, 1998, AUST DENT J, V43, P160, DOI 10.1111/j.1834-7819.1998.tb00157.x; Webb BC, 1998, AUST DENT J, V43, P45, DOI 10.1111/j.1834-7819.1998.tb00152.x; Webb BC, 1998, AUST DENT J, V43, P244, DOI 10.1111/j.1834-7819.1998.tb00172.x; WENNBERG A, 1979, J BIOMED MATER RES, V13, P109, DOI 10.1002/jbm.820130112; Wiegand C, 2008, GMS HYG INFECT CONTR, V3	63	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203187	10.1371/journal.pone.0203187	http://dx.doi.org/10.1371/journal.pone.0203187			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161256	Green Published, Green Submitted, gold			2022-12-27	WOS:000443388900087
J	Zhang, N; Wu, YZ; Huang, ZL; Zhang, CZ; Zhang, LF; Cai, QR; Shen, XG; Jiang, HX; Ding, HZ				Zhang, Nan; Wu, Yuzhi; Huang, Zilong; Zhang, Chuanzhen; Zhang, Longfei; Cai, Qinren; Shen, Xiangguang; Jiang, Hongxia; Ding, Huanzhong			Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model	PLOS ONE			English	Article							MUTANT SELECTION WINDOW; EFFLUX-MEDIATED RESISTANCE; TOPOISOMERASE-IV; DYNAMIC-MODEL; DNA GYRASE; QUINOLONE; PHARMACOKINETICS; FLUOROQUINOLONES; MUTATIONS; MOXIFLOXACIN	Mycoplasma gallisepticum is a serious pathogen for poultry that causes chronic respiratory disease in chickens. Increased embryonic mortality, as well as reduced weight gain and egg production have been found in infected chickens, which can lead to considerable economic losses in poultry production. Increased antibiotic resistance compromises the use of tetracyclines, macrolides and quinolones in the farm environment. In the present study, danofloxacin concentrations were simulated below the MIC99, between the MIC99 and MPC (the mutant prevention concentration), and above the MPC in an in vitro dynamic model against M. gallisepticum. The relationship between the simulated danofloxacin pharmacokinetics, pharmacodynamics (PK/PD) parameters and development of resistance for M. gallisepticum was explored based on the available data obtained from various dosing regimens in the in vitro model. Danofloxacin concentration, counts of viable cell and susceptibility were determined during the experiment. The mutations in gyrA, gyrB, parC and parE as well as efflux pumps were examined. The MIC of danofloxacin against M. gallisepticum was increased when drug concentrations were between the lower and upper boundaries of the mutant selection window. The upper boundary of the selection window in vitro was estimated as a C-max/MPC value of 1. The lower boundary was estimated as C-max/MPC value of 0.05. Both in terms of the MIC and resistance frequency, M. gallisepticum resistance was developed when danofloxacin concentrations fell inside the mutant selection window (ratios of C-max to MPC between 0.05 and 1). The single mutation in gyrA (Ser-83! Arg) was found in all mutants, while double mutations in gyrA and parC (Ala-64! Ser) were observed only in the mutant with the highest MIC. In addition, no change of susceptibility in the mutants was observed in the presence of reserpine and carbonyl cyanide 3-chlorophenylhydrazone (CCCP). This suggested that ATP-binding cassette superfamily (ABC transporter) and major facilitator superfamily (MFS transporter) did not play a role in danofloxacin efflux.	[Zhang, Nan] Foshan Univ, Sch Life Sci & Engn, Foshan, Peoples R China; [Zhang, Nan; Wu, Yuzhi; Huang, Zilong; Zhang, Chuanzhen; Zhang, Longfei; Cai, Qinren; Shen, Xiangguang; Ding, Huanzhong] South China Agr Univ, Guangdong Key Lab Vet Drug Dev & Safety Evaluat, Guangzhou, Guangdong, Peoples R China; [Cai, Qinren; Jiang, Hongxia] Zhuhai Entry Exit Inspect & Quarantine Bur, Tech Ctr Inspect & Quarantine, Zhuhai, Peoples R China	Foshan University; South China Agricultural University	Ding, HZ (corresponding author), South China Agr Univ, Guangdong Key Lab Vet Drug Dev & Safety Evaluat, Guangzhou, Guangdong, Peoples R China.	hzding@scau.edu.cn		Zhang, Chuan-Zhen/0000-0001-7029-0021	National Key Research and Development Program of China [2016YFD0501300/2016YFD0501310]; Special Program for Science and Technology Development of Gaungdong Province [2015A020209130]	National Key Research and Development Program of China; Special Program for Science and Technology Development of Gaungdong Province	This study is supported financially by National Key Research and Development Program of China (2016YFD0501300/2016YFD0501310) and Special Program for Science and Technology Development of Gaungdong Province (2015A020209130).	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Bebear CM, 1999, ANTIMICROB AGENTS CH, V43, P954, DOI 10.1128/AAC.43.4.954; Bebear CM, 1998, ANTIMICROB AGENTS CH, V42, P2304, DOI 10.1128/AAC.42.9.2304; BRADBURY JM, 1994, AVIAN PATHOL, V23, P105, DOI 10.1080/03079459408418978; Cui JC, 2006, J INFECT DIS, V194, P1601, DOI 10.1086/508752; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Ferguson NA, 2003, AVIAN DIS, V47, P523, DOI 10.1637/6059; Ferran AA, 2009, ANTIMICROB AGENTS CH, V53, P3384, DOI 10.1128/AAC.01347-08; Firsov AA, 2003, ANTIMICROB AGENTS CH, V47, P1604, DOI 10.1128/AAC.47.5.1604-1613.2003; FRIIS C, 1993, AM J VET RES, V54, P1122; GREENBERGOFRATH N, 1993, APPL ENVIRON MICROB, V59, P547, DOI 10.1128/AEM.59.2.547-551.1993; HANNAN PCT, 1989, RES VET SCI, V46, P202, DOI 10.1016/S0034-5288(18)31146-9; Hannan PCT, 1997, ANTIMICROB AGENTS CH, V41, P2037, DOI 10.1128/AAC.41.9.2037; Hooper D.C., 2003, QUINOLONE ANTIMICROB, V3rd ed., P41, DOI [10.1128/9781555817817.ch3, DOI 10.1128/9781555817817.CH3]; Hooper DC, 1998, CLIN INFECT DIS, V27, pS54, DOI 10.1086/514923; Join-Lamberti OF, 2001, ANTIMICROB AGENTS CH, V45, P571, DOI 10.1128/AAC.45.2.571-576.2001; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Kenny GE, 1999, ANTIMICROB AGENTS CH, V43, P2493, DOI 10.1128/AAC.43.10.2493; Kleven S., 1989, SUMMARY DISCUSSIONS; Knoll U, 1999, J VET PHARMACOL THER, V22, P239, DOI 10.1046/j.1365-2885.1999.00217.x; Lauerman, 1998, MYCOPLASMA PCR ASSAY; Levisohn S, 2000, REV SCI TECH OIE, V19, P425, DOI 10.20506/rst.19.2.1232; Ley DH, 1997, EMERG INFECT DIS, V3, P375, DOI 10.3201/eid0303.970318; Liang BB, 2011, ANTIMICROB AGENTS CH, V55, P2409, DOI 10.1128/AAC.00975-10; Lu T, 2003, J ANTIMICROB CHEMOTH, V52, P61, DOI 10.1093/jac/dkg268; LYNCH MJ, 1994, J AGR FOOD CHEM, V42, P289, DOI 10.1021/jf00038a012; Marquez B, 2005, PHYTOCHEMISTRY, V66, P1804, DOI 10.1016/j.phytochem.2005.06.008; McKellar QA, 1998, BIOPHARM DRUG DISPOS, V19, P123, DOI 10.1002/(SICI)1099-081X(199803)19:2<123::AID-BDD89>3.0.CO;2-G; Meletiadis J, 2012, ANTIMICROB AGENTS CH, V56, P403, DOI 10.1128/AAC.00662-11; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2595, DOI 10.1128/AAC.44.10.2595-2599.2000; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2233, DOI 10.1128/AAC.44.9.2233-2241.2000; Ramon-Garcia S, 2006, J ANTIMICROB CHEMOTH, V57, P252, DOI 10.1093/jac/dki436; RAZIN S, 1970, J BACTERIOL, V102, P306, DOI 10.1128/JB.102.2.306-310.1970; Reinhardt AK, 2002, ANTIMICROB AGENTS CH, V46, P590, DOI 10.1128/AAC.46.2.590-593.2002; Ricci V, 2003, J ANTIMICROB CHEMOTH, V52, P605, DOI 10.1093/jac/dkg418; Scheffer GL, 2002, J CLIN PATHOL, V55, P332, DOI 10.1136/jcp.55.5.332; Schrickx JA, 2007, BRIT J PHARMACOL, V150, P463, DOI 10.1038/sj.bjp.0706974; Zeng Z, 2011, J VET PHARMACOL THER, V34, P101, DOI 10.1111/j.1365-2885.2010.01223.x; Zhang BX, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0297-1; Zhang N, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00926; Zhang N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169134; Zhang N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00653; Zhao XL, 2001, CLIN INFECT DIS, V33, pS147, DOI 10.1086/321841; Zinner SH, 2003, J ANTIMICROB CHEMOTH, V52, P616, DOI 10.1093/jac/dkg401; Zinner SH, 2008, J ANTIMICROB CHEMOTH, V61, P629, DOI 10.1093/jac/dkm542	46	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202070	10.1371/journal.pone.0202070	http://dx.doi.org/10.1371/journal.pone.0202070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157201	Green Published, gold, Green Submitted			2022-12-27	WOS:000443071400030
J	Ma, CX; He, RC; Zhang, W				Ma, Changxi; He, Ruichun; Zhang, Wei			Path optimization of taxi carpooling	PLOS ONE			English	Article								The problem that passengers are hard to take taxis while empty driving rate is high widely exists under the traditional taxi operation mode. The implementation of taxi carpooling mode can alleviate the problem in a certain extent. The objective of this study is to optimize the taxi carpooling path. Firstly, the taxi carpooling path optimization model with single objective and its extended model with multiple objectives are built respectively. Then, the single objective path optimization model of taxi carpooling is solved based on the improved single objective genetic algorithm, and the multiple-objective path optimization model of taxi carpooling is solved based on the improved multiple-objective genetic algorithm. Finally, a case study is carried out based on a road network with 24 nodes. The case study results show the path optimization models and algorithms of taxi carpooling proposed in the paper can quickly get the taxi carpooling path, and can increase the income of taxi driver while reduce the cost for passengers.	[Ma, Changxi; He, Ruichun; Zhang, Wei] Lanzhou Jiaotong Univ, Sch Traff & Transportat, Lanzhou, Gansu, Peoples R China	Lanzhou Jiaotong University	Ma, CX (corresponding author), Lanzhou Jiaotong Univ, Sch Traff & Transportat, Lanzhou, Gansu, Peoples R China.	machangxi@mail.lzjtu.cn	Ma, Changxi/AAM-5322-2020					Ardekani SA, 1986, TRANSPORT RES REC, V1103, P33; Chen Y. T., 2013, INT J SOCIAL SCI HUM, V3, P87, DOI DOI 10.7763/IJSSH.2013.V3.201; Cheng J., 2013, J WUHAN UNIV TECHNOL, V37, P187; d'Orey P. M., 2012, 2012 12th International Conference on ITS Telecommunications (ITST 2012), P319, DOI 10.1109/ITST.2012.6425191; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Galland S, 2014, TRANSPORT RES C-EMER, V45, P83, DOI 10.1016/j.trc.2013.12.012; Guo RJ, 2011, J DALIAN JIAOTONG U, V32, P28; He ZB, 2017, COMPUT-AIDED CIV INF, V32, P252, DOI 10.1111/mice.12251; He ZB, 2013, TRANSPORT RES C-EMER, V32, P89, DOI 10.1016/j.trc.2013.04.005; Kammerdiener T, 2011, J COMPUTING SCI COLL, V26, P95; Ma XL, 2013, TRANSPORT RES C-EMER, V36, P1, DOI 10.1016/j.trc.2013.07.010; Manzini R., 2012, J TRANSPORTATION TEC, DOI [10.4236/jtts.2012.22011, DOI 10.4236/JTTS.2012.22011]; Morisugi H., 1997, J E ASIA SOC TRANSPO, V2, P1547; Tang JJ, 2018, PHYSICA A, V506, P566, DOI 10.1016/j.physa.2018.04.073; Tang JJ, 2018, PHYSICA A, V493, P430, DOI 10.1016/j.physa.2017.11.114; Tang-Hsien Chang, 2004, 2004 IEEE International Conference on Networking, Sensing and Control (IEEE Cat. No.04EX761), P1335; Wang L., 2012, THESIS; Wang Y, 2017, APPL SOFT COMPUT, V56, P143, DOI 10.1016/j.asoc.2017.02.025; Wang Y, 2017, J CLEAN PROD, V144, P203, DOI 10.1016/j.jclepro.2017.01.001; Yan SY, 2012, TRANSPORTATION, V39, P723, DOI 10.1007/s11116-011-9354-9; Yang X, 2019, TRANSPORTMETRICA B, V7, P386, DOI 10.1080/21680566.2017.1421109; Zhou Heping, 2011, J CHANGSHA U SCI TEC, V08, P20; Zou X. D., 2002, J HIGHWAY TRANSPORTA, V19, P82	23	94	99	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203221	10.1371/journal.pone.0203221	http://dx.doi.org/10.1371/journal.pone.0203221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161199	Green Submitted, gold, Green Published			2022-12-27	WOS:000443388900093
J	Vedrine, M; Berthault, C; Leroux, C; Reperant-Ferter, M; Gitton, C; Barbey, S; Rainard, P; Gilbert, FB; Germon, P				Vedrine, Megane; Berthault, Camille; Leroux, Cindy; Reperant-Ferter, Maryline; Gitton, Christophe; Barbey, Sarah; Rainard, Pascal; Gilbert, Florence B.; Germon, Pierre			Sensing of Escherichia coli and LPS by mammary epithelial cells is modulated by O-antigen chain and CD14	PLOS ONE			English	Article							COMPLEMENT FRAGMENT C5A; BOVINE MASTITIS; INTRAMAMMARY INFECTIONS; INFLAMMATORY CYTOKINES; STAPHYLOCOCCUS-AUREUS; POLYACRYLAMIDE GELS; SIGNALING PATHWAYS; REDUCES SEVERITY; KAPPA-B; LIPOPOLYSACCHARIDE	Escherichia coli is one of the major pathogens causing mastitis in dairy cattle. Yet, the factors which mediate the ability for E. coli to develop in the bovine mammary gland remain poorly elucidated. In a mouse model, infections induced by the reference mastitis E. coli P4 showed a strong colonisation of the mammary gland, while this strain had a low stimulating power on cells of the PS bovine mammary epithelial cell line. In order to understand if such a reduced response contributes to the severity of infection, a library of random mutants of P4 strain was screened to identify mutants inducing stronger response of PS cells. Among hyper-stimulating mutants, six were altered in genes involved in biosynthesis of lipopolysaccharide (LPS) and had lost their O-polysaccharide region, suggesting that the presence of O-antigen impairs the response of PS cells to LPS. Using purified smooth (S) and rough (R) fractions of LPS, we showed that the R-LPS fraction induced a stronger response from PS cells than the smooth LPS fraction. Biological activity of the S-LPS fraction could be restored by the addition of recombinant bovine CD14 (rbCD14), indicating a crucial role of CD14 in the recognition of S-LPS by Mammary Epithelial Cells (MEC). When S-LPS and R-LPS were injected in udder quarters of healthy lactating cows, an inflammation developed in all infused quarters, but the S-LPS induced a more intense pro-inflammatory response, possibly in relation to sizeable concentrations of CD14 in milk. Altogether, our results demonstrate that the O-antigen modulates the pro-inflammatory response of MEC to LPS, that SLPS and R-LPS trigger different responses of MEC and that these responses depend on the presence of CD14.	[Vedrine, Megane; Berthault, Camille; Leroux, Cindy; Reperant-Ferter, Maryline; Gitton, Christophe; Rainard, Pascal; Gilbert, Florence B.; Germon, Pierre] Univ Francois Rabelais Tours, ISP UMR 1282, INRA, Nouzilly, France; [Barbey, Sarah] INRA, UE Domaine Expt Pin Au Haras 0326, Le Pin Au Haras, France	INRAE; INRAE	Germon, P (corresponding author), Univ Francois Rabelais Tours, ISP UMR 1282, INRA, Nouzilly, France.	pierre.germon@inra.fr	GERMON, Pierre/M-5264-2019	GERMON, Pierre/0000-0003-3078-876X	Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation; project KOlimastIR of the Animal Health and Welfare (ANIHWA) Era-Net; GISA metaprogram (RUMINFLAME project)	Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation; project KOlimastIR of the Animal Health and Welfare (ANIHWA) Era-Net; GISA metaprogram (RUMINFLAME project)	M. Vedrine was recipient of a grant from the Ministere de l'Enseignement superieur, de la Recherche et de l'Innovation. This work has been supported by the project KOlimastIR of the Animal Health and Welfare (ANIHWA) Era-Net (www.anihwa.eu) and by grants from the GISA metaprogram (RUMINFLAME project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bougarn S, 2011, J DAIRY SCI, V94, P2425, DOI 10.3168/jds.2010-3859; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; CARROLL EJ, 1964, AM J VET RES, V25, P720; de Barros JPP, 2015, J LIPID RES, V56, P1363, DOI 10.1194/jlr.D059725; Dosogne H, 2002, INFLAMM RES, V51, P201, DOI 10.1007/PL00000293; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Eckersall PD, 2001, VET REC, V148, P35, DOI 10.1136/vr.148.2.35; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gilbert FB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-40; Godowski PJ, 2005, NAT IMMUNOL, V6, P544, DOI 10.1038/ni0605-544; Gunther J, 2011, INFECT IMMUN, V79, P695, DOI 10.1128/IAI.01071-10; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Han Y, 2014, VET MICROBIOL, V172, P486, DOI 10.1016/j.vetmic.2014.05.029; HILL AW, 1981, RES VET SCI, V31, P107, DOI 10.1016/S0034-5288(18)32532-3; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Horvath DJ, 2016, J BACTERIOL, V198, P964, DOI 10.1128/JB.00664-15; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; Iwaki T, 2008, CYTOTECHNOLOGY, V57, P45, DOI 10.1007/s10616-008-9129-0; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JW, 2006, VET RES, V37, P219, DOI 10.1051/vetres:2005051; Lee JW, 2003, VET RES, V34, P307, DOI 10.1051/vetres:2003006; Lee JW, 2003, INFECT IMMUN, V71, P4034, DOI 10.1128/IAI.71.7.4034-4039.2003; LINTON AH, 1984, BRIT VET J, V140, P368, DOI 10.1016/0007-1935(84)90128-3; LINTON AH, 1979, J APPL BACTERIOL, V46, P585, DOI 10.1111/j.1365-2672.1979.tb00859.x; Lopez-Meza JE, 2009, RES VET SCI, V87, P59, DOI 10.1016/j.rvsc.2008.12.005; MCDERMOTT CM, 1991, J DAIRY SCI, V74, P1227, DOI 10.3168/jds.S0022-0302(91)78278-7; Molenaar AJ, 2009, BIOMARKERS, V14, P26, DOI 10.1080/13547500902730714; MUNFORD RS, 1986, SCIENCE, V234, P203, DOI 10.1126/science.3529396; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Pupo E, 2013, FEBS J, V280, P1095, DOI 10.1111/febs.12104; Rainard P, 2008, MOL IMMUNOL, V45, P4020, DOI 10.1016/j.molimm.2008.06.010; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; REEVES P, 1995, TRENDS MICROBIOL, V3, P381, DOI 10.1016/S0966-842X(00)88983-0; Rendueles O, 2014, ISME J, V8, P1275, DOI 10.1038/ismej.2013.238; Ridley BL, 2000, GLYCOBIOLOGY, V10, P1013, DOI 10.1093/glycob/10.10.1013; Riollet C, 2000, CLIN DIAGN LAB IMMUN, V7, P161, DOI 10.1128/CDLI.7.2.161-167.2000; Roosen S, 2004, MAMM GENOME, V15, P834, DOI 10.1007/s00335-004-2387-z; Roussel P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178285; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; Shuster DE, 1997, INFECT IMMUN, V65, P3286, DOI 10.1128/IAI.65.8.3286-3292.1997; Spears PA, 2000, MOL MICROBIOL, V36, P1425, DOI 10.1046/j.1365-2958.2000.01963.x; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Swanson K, 2004, INFECT IMMUN, V72, P7311, DOI 10.1128/IAI.72.12.7311-7314.2004; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Wang JJ, 2016, J DAIRY SCI, V99, P3016, DOI 10.3168/jds.2015-10330; Wells SJ, 1998, J DAIRY SCI, V81, P3029, DOI 10.3168/jds.S0022-0302(98)75867-9; Zanoni I, 2012, IMMUNOL LETT, V142, P41, DOI 10.1016/j.imlet.2011.12.002	56	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2018	13	8							e0202664	10.1371/journal.pone.0202664	http://dx.doi.org/10.1371/journal.pone.0202664			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR5ZQ	30142177	Green Published, Green Submitted, gold			2022-12-27	WOS:000442722500024
J	Borst, ACW; Verberk, WCEP; Angelini, C; Schotanus, J; Wolters, JW; Christianen, MJA; van der Zee, EM; Derksen-Hooijberg, M; van der Heide, T				Borst, Annieke C. W.; Verberk, Wilco C. E. P.; Angelini, Christine; Schotanus, Jildou; Wolters, Jan-Willem; Christianen, Marjolijn J. A.; van der Zee, Els M.; Derksen-Hooijberg, Marlous; van der Heide, Tjisse			Foundation species enhance food web complexity through non-trophic facilitation	PLOS ONE			English	Article							ECOLOGICAL NETWORKS; HABITAT STRUCTURE; BIODIVERSITY; STABILITY; CONSEQUENCES; ORGANIZATION; COMMUNITIES; DIVERSITY; INCREASES; CASCADE	Food webs are an integral part of every ecosystem on the planet, yet understanding the mechanisms shaping these complex networks remains a major challenge. Recently, several studies suggested that non-trophic species interactions such as habitat modification and mutual isms can be important determinants of food web structure. However, it remains unclear whether these findings generalize across ecosystems, and whether non-trophic interactions affect food webs randomly, or affect specific trophic levels or functional groups. Here, we combine analyses of 58 food webs from seven terrestrial, freshwater and coastal systems to test (1) the general hypothesis that non-trophic facilitation by habitat-forming foundation species enhances food web complexity, and (2) whether these enhancements have either random or targeted effects on particular trophic levels, functional groups, and linkages throughout the food web. Our empirical results demonstrate that foundation species consistently enhance food web complexity in all seven ecosystems. Further analyses reveal that 15 out of 19 food web properties can be well-approximated by assuming that foundation species randomly facilitate species throughout the trophic network. However, basal species are less strongly, and carnivores are more strongly facilitated in foundation species' food webs than predicted based on random facilitation, resulting in a higher mean trophic level and a longer average chain length. Overall, we conclude that foundation species strongly enhance food web complexity through non-trophic facilitation of species across the entire trophic network. We therefore suggest that the structure and stability of food webs often depends critically on non-trophic facilitation by foundation species.	[Borst, Annieke C. W.; Verberk, Wilco C. E. P.; Derksen-Hooijberg, Marlous; van der Heide, Tjisse] Radboud Univ Nijmegen, Inst Water & Wetland Res, Nijmegen, Netherlands; [Angelini, Christine] Univ Florida, Dept Environm Engn Sci, Gainesville, FL 32611 USA; [Schotanus, Jildou] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, Ctr Estuarine & Marine Ecol, Yerseke, Netherlands; [Schotanus, Jildou] HZ Univ Appl Sci, Vlissingen, Netherlands; [Wolters, Jan-Willem] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Christianen, Marjolijn J. A.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [van der Zee, Els M.] Altenburg & Wymenga Ecol Res, Feanwalden, Netherlands; [van der Heide, Tjisse] NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, Den Burg, Texel, Netherlands; [van der Heide, Tjisse] Univ Utrecht, Den Burg, Texel, Netherlands; [van der Heide, Tjisse] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands	Radboud University Nijmegen; State University System of Florida; University of Florida; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Antwerp; Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; University of Groningen	Borst, ACW (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Nijmegen, Netherlands.	Anniekeborst@outlook.com	Verberk, Wilco/E-6337-2011; Christianen, Marjolijn J. A./AAD-3865-2021; van der Heide, Tjisse/M-3000-2013	Verberk, Wilco/0000-0002-0691-583X; Christianen, Marjolijn J. A./0000-0001-5839-2981; Borst, Annieke/0000-0001-7362-5990	Biology Department of the University of Antwerp	Biology Department of the University of Antwerp	Jan-Willem Wolters would like to thank the Biology Department of the University of Antwerp for providing a doctoral grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Altieri AH, 2007, AM NAT, V169, P195, DOI 10.1086/510603; Angelini C, 2014, ECOLOGY, V95, P185, DOI 10.1890/13-0496.1; Angelini C, 2011, BIOSCIENCE, V61, P782, DOI 10.1525/bio.2011.61.10.8; [Anonymous], 1972, P C CONSERVATION PRO; Avin C, 2015, THEOR COMPUT SCI, V584, P91, DOI 10.1016/j.tcs.2014.11.036; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.2307/177252; Bologna PAX, 1999, J EXP MAR BIOL ECOL, V242, P21, DOI 10.1016/S0022-0981(99)00092-1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bulleri F, 2016, FUNCT ECOL, V30, P70, DOI 10.1111/1365-2435.12528; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Christianen MJA, 2017, BIOL CONSERV, V213, P317, DOI 10.1016/j.biocon.2016.09.028; Donadi S, 2013, ECOLOGY, V94, P489, DOI 10.1890/12-0048.1; Donker JJA, 2013, J SEA RES, V82, P54, DOI 10.1016/j.seares.2012.08.010; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Elton C.S., 1927, ANIMAL ECOLOGY, P1, DOI 10.5962/bhl.title.7435; Filazzola A, 2017, BASIC APPL ECOL, V20, P51, DOI 10.1016/j.baae.2017.01.002; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Gilad E, 2007, J THEOR BIOL, V244, P680, DOI 10.1016/j.jtbi.2006.08.006; Gilad E, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098105; Govenar B, 2010, TOP GEOBIOL, V33, P403, DOI 10.1007/978-90-481-9572-5_13; Grutters BMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124455; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Jaschinski S, 2011, AQUAT SCI, V73, P91, DOI 10.1007/s00027-010-0163-6; Jeppesen E., 1992, STRUCTURING ROLE SUB; Jones CG, 2010, OIKOS, V119, P1862, DOI 10.1111/j.1600-0706.2010.18782.x; Kefi S, 2015, ECOLOGY, V96, P291, DOI 10.1890/13-1424.1; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; Klecka J, 2014, OECOLOGIA, V176, P183, DOI 10.1007/s00442-014-3007-6; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Kuiper JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8727; LODGE DM, 1991, AQUAT BOT, V41, P195, DOI 10.1016/0304-3770(91)90044-6; MEA, 2005, MILL ASS EC HUM WELL; Miller RJ, 2015, OECOLOGIA, V179, P1199, DOI 10.1007/s00442-015-3441-0; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Mulder C, 2012, ADV ECOL RES, V46, P1, DOI 10.1016/B978-0-12-396992-7.00001-0; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Olff H, 2009, PHILOS T R SOC B, V364, P1755, DOI 10.1098/rstb.2008.0222; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Pilosof S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0101; PIMM SL, 1979, THEOR POPUL BIOL, V16, P144, DOI 10.1016/0040-5809(79)90010-8; Reid AM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00106.1; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Saint-Beat B, 2015, ECOL INDIC, V52, P458, DOI 10.1016/j.ecolind.2014.12.017; Sanders D, 2014, OIKOS, V123, P513, DOI 10.1111/j.1600-0706.2013.01011.x; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; van der Zee EM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2326; van der Zee EM, 2015, J EXP MAR BIOL ECOL, V465, P41, DOI 10.1016/j.jembe.2015.01.001; Verdonschot RCM, 2012, LIMNOLOGICA, V42, P31, DOI 10.1016/j.limno.2011.07.004; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wright JT, 2017, ECOLOGY, V98, P2425, DOI 10.1002/ecy.1932; Wright JT, 2014, ECOLOGY, V95, P2699, DOI 10.1890/14-0127.1; Zhao QH, 2016, FRESHWATER BIOL, V61, P693, DOI 10.1111/fwb.12739	60	26	26	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0199152	10.1371/journal.pone.0199152	http://dx.doi.org/10.1371/journal.pone.0199152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169517	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400002
J	Snasel, V; Drazdilova, P; Platos, J				Snasel, Vaclav; Drazdilova, Pavla; Platos, Jan			Closed trail distance in a biconnected graph	PLOS ONE			English	Article							NETWORKS; TOPOLOGY	Graphs describe and represent many complex structures in the field of social networks, biological, chemical, industrial and transport systems, and others. These graphs are not only connected but often also k-connected (or at least part of them). Different metrics are used to determine the distance between two nodes in the graph. In this article, we propose a novel metric that takes into account the higher degree of connectivity on the part of the graph (for example, biconnected fullerene graphs and fulleroids). Designed metric reflects the cyclical interdependencies among the nodes of the graph. Moreover, a new component model is derived, and the examples of various types of graphs are presented.	[Snasel, Vaclav; Drazdilova, Pavla; Platos, Jan] VSB Tech Univ Ostrava, Fac Elect Engn & Comp Sci, Dept Comp Sci, 17 Listopadu 15-2172, Ostrava 70833, Czech Republic	Technical University of Ostrava	Platos, J (corresponding author), VSB Tech Univ Ostrava, Fac Elect Engn & Comp Sci, Dept Comp Sci, 17 Listopadu 15-2172, Ostrava 70833, Czech Republic.	jan.platos@vsb.cz	Dráždilová, Pavla/ABB-7673-2020; Snasel, Vaclav/B-8094-2009; Dráždilová, Pavla/GLU-4058-2022; Platoš, Jan/F-4563-2012	Snasel, Vaclav/0000-0002-9600-8319; Dráždilová, Pavla/0000-0001-6668-9187; Platoš, Jan/0000-0002-8481-0136	Student Grant System, VSB-Technical University of Ostrava [SP2018/126]	Student Grant System, VSB-Technical University of Ostrava	This work was supported by the project SP2018/126 "Parallel processing of Big Data V' received by P. Drazdilova of the Student Grant System, VSB-Technical University of Ostrava.	Andova V, 2016, ARS MATH CONTEMP, V11, P353, DOI 10.26493/1855-3974.834.b02; [Anonymous], 2010, ADV NEURAL INF PROCE; Ashrafi A. R., 2016, Distance, Symmetry, and Topology in Carbon Nanomaterials, V9; Bader DA, 2008, 2008 IEEE INTERNATIONAL SYMPOSIUM ON PARALLEL & DISTRIBUTED PROCESSING, VOLS 1-8, P1291; Bader DA, 2008, PARALLEL COMPUT, V34, P627, DOI 10.1016/j.parco.2008.04.002; Bakry R, 2007, INT J NANOMED, V2, P639; Balaban AT, 2006, CHEM TOPOLOGY 3 DIME; Boruvka O., 1926, JISTEM PROBLEMU MINI, P37; Carlsson G, 2014, ACTA NUMER, V23, P289, DOI 10.1017/S0962492914000051; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Chebotarev P, 2012, DISCRETE APPL MATH, V160, P1484, DOI 10.1016/j.dam.2012.02.015; De Silva V., 2005, ROBOTICS SCI SYSTEMS, P335; de Silva V., 2007, NOT AM MATH SOC, V54, P10; Derenyi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160202; Deza MM, 2009, ENCY DISTANCES, P1, DOI DOI 10.1007/978-3-642-00234-2; Ding ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24115; Edachery J, 1999, LECT NOTES COMPUT SC, V1731, P98; Estrada E, 2012, LINEAR ALGEBRA APPL, V436, P4317, DOI 10.1016/j.laa.2012.01.017; Everett M.G., 1998, CONNECTIONS, V21, P49; Gobel F., 1974, Stochastic Processes & their Applications, V1, P311, DOI 10.1016/0304-4149(74)90001-5; Goddard W, 2011, STRUCTURAL ANALYSIS OF COMPLEX NETWORKS, P49, DOI 10.1007/978-0-8176-4789-6_3; Gross J.L., 2003, HDB GRAPH THEORY; Hirsch A, 2010, NAT MATER, V9, P868, DOI 10.1038/nmat2885; Jariwala D, 2013, CHEM SOC REV, V42, P2824, DOI 10.1039/c2cs35335k; Kivimaki I, 2014, PHYSICA A, V393, P600, DOI 10.1016/j.physa.2013.09.016; Klymko Christine, 2014, CORR; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Levorato V., 2011, 2011 International Conference on Computational Aspects of Social Networks (CASoN 2011), P211, DOI 10.1109/CASON.2011.6085946; Nesetril J, 2001, DISCRETE MATH, V233, P3, DOI 10.1016/S0012-365X(00)00224-7; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Sattler K.D, 2010, HDB NANOPHYSICS CLUS; Schwerdtfeger P, 2015, WIRES COMPUT MOL SCI, V5, P96, DOI 10.1002/wcms.1207; Snasel V, 2017, FUTURE GENER COMP SY, V67, P286, DOI 10.1016/j.future.2016.06.005; Spanier Edwin H, 1994, ALGEBRAIC TOPOLOGY, V55; Vazquez A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.025103; Yang Y, 2014, PHYSICA A, V397, P129, DOI 10.1016/j.physa.2013.11.034	36	6	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0202181	10.1371/journal.pone.0202181	http://dx.doi.org/10.1371/journal.pone.0202181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169516	Green Published, gold, Green Submitted			2022-12-27	WOS:000443374400007
J	Cavazzana, A; Rohrborn, A; Garthus-Niegel, S; Larsson, M; Hummel, T; Croy, I				Cavazzana, Annachiara; Rohrborn, Anja; Garthus-Niegel, Susan; Larsson, Maria; Hummel, Thomas; Croy, Ilona			Sensory-specific impairment among older people. An investigation using both sensory thresholds and subjective measures across the five senses	PLOS ONE			English	Article							AGE-RELATED-CHANGES; ODOR DISCRIMINATION; HEARING IMPAIRMENT; VISUAL IMPAIRMENT; VISION IMPAIRMENT; ADULTS; HEALTH; TASTE; LIFE; DECLINE	Age-related sensory impairment is a slow and gradual progress, which affects multiple modalities. Two contradictory hypotheses exist about the age-related decline of sensory thresholds. The common factor theory assumes one underlying factor-which accounts for the loss of several sensory modalities simultaneously-and the specific factor theory predicts that the sensory decline is uncorrelated between different modalities. In this study, we aimed to explore whether (i) there is a common factor of sensory thresholds in older people, (ii) older people assume that sensory decline in one modality also affects other modalities, (iii) there is a relation between sensory threshold and the subjective assessment of sensory function. This was accomplished by collecting both threshold measures and self-reported ratings for smell, hearing, taste, vision, and touch function in a group of 104 older people (mean age: 67.2 years; SD: 9.85; range: 50-100 years). Results indicated that there was no common factor of sensory thresholds, hence an impairment in one modality did not necessarily imply a shortfall in other modalities. In contrast, our results suggested one or two common factor(s) for the participants' ratings. Participants who reported a diminished function in one sense tended to generalize this rating to the other senses as well. The correspondence between subjective ratings and sensory thresholds was relatively good for vision and audition, although no correlations were observed for the other domains. These findings have implications for clinicians, suggesting that subjective measures should be combined with sensory threshold measurements when evaluating sensory dysfunction. Also, these data convey a positive message for older people and their physicians by showing that loss in one sensory modality does not necessarily generalize to losses across all sensory modalities.	[Cavazzana, Annachiara; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Cavazzana, Annachiara; Larsson, Maria] Stockholm Univ, Dept Psychol, Gosta Ekman Lab, Stockholm, Sweden; [Rohrborn, Anja; Garthus-Niegel, Susan; Croy, Ilona] Tech Univ Dresden, Dept Psychotherapy & Psychosomat Med, Fac Med, Dresden, Germany; [Garthus-Niegel, Susan] Norwegian Inst Publ Hlth, Dept Child Hlth, Oslo, Norway	Technische Universitat Dresden; Stockholm University; Technische Universitat Dresden; Norwegian Institute of Public Health (NIPH)	Cavazzana, A (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany.; Cavazzana, A (corresponding author), Stockholm Univ, Dept Psychol, Gosta Ekman Lab, Stockholm, Sweden.	annachiara.cavazzana@gmail.com		Croy, Ilona/0000-0002-0361-5559	Deutsche Froschungsgemeinschaft [DFG HU 411/18-1]; Swedish Foundation for Humanities and Social Sciences [M14-0375:1]; Open Access Publishing Funds of the SLUB / TU Dresden	Deutsche Froschungsgemeinschaft(German Research Foundation (DFG)); Swedish Foundation for Humanities and Social Sciences; Open Access Publishing Funds of the SLUB / TU Dresden	This research was supported by a grant from the Deutsche Froschungsgemeinschaft (http://www.dfg.de) to TH (DFG HU 411/18-1) and by the The Swedish Foundation for Humanities and Social Sciences (https://rio.jrc.ec.europa.eu/en/organisations/swedish-foundation-humanities-and-social-sciences) to ML (M14-0375:1). We acknowledge support by the Open Access Publishing Funds of the SLUB / TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Bazargan M, 2001, J GERONTOL B-PSYCHOL, V56, pP268, DOI 10.1093/geronb/56.5.P268; Berardi A, 2001, EXP AGING RES, V27, P19, DOI 10.1080/03610730126014; Bollen K., 1989, STRUCTURAL EQUATIONS; Bourque P, 2007, CAN J NURS RES, V39, P154; Bowden JL, 2013, AGE, V35, P1077, DOI 10.1007/s11357-012-9429-3; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brennan M, 2005, GERONTOLOGIST, V45, P337, DOI 10.1093/geront/45.3.337; Caban AJ, 2005, AM J PUBLIC HEALTH, V95, P1940, DOI 10.2105/AJPH.2004.056671; CAUNA N, 1958, J ANAT, V92, P1; CERIMELE D, 1990, BRIT J DERMATOL, V122, P13, DOI 10.1111/j.1365-2133.1990.tb16120.x; Chou KL, 2008, J AFFECT DISORDERS, V106, P191, DOI 10.1016/j.jad.2007.05.028; Correia C, 2016, J AM GERIATR SOC, V64, P306, DOI 10.1111/jgs.13955; Crews JE, 2004, AM J PUBLIC HEALTH, V94, P823, DOI 10.2105/AJPH.94.5.823; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Cruickshanks Karen J., 2012, Seminars in Hearing, V33, P217, DOI 10.1055/s-0032-1315720; Decorps J, 2014, AGEING RES REV, V13, P90, DOI 10.1016/j.arr.2013.12.003; Deshpande N, 2008, NEUROBIOL AGING, V29, P765, DOI 10.1016/j.neurobiolaging.2006.12.002; Doty RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00020; Farage MA, 2008, AGING CLIN EXP RES, V20, P195; Fischer ME, 2009, OPHTHAL EPIDEMIOL, V16, P346, DOI 10.3109/09286580903312236; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fozard J.L., 1990, HDB PSYCHOL AGING, V3, P143; Fukunaga A, 2005, J GERONTOL A-BIOL, V60, P109, DOI 10.1093/gerona/60.1.109; Gadkaree SK, 2016, DOES SENSORY FUNCTIO, V2016; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GILMORE MM, 1989, PERCEPT PSYCHOPHYS, V46, P555, DOI 10.3758/BF03208152; Guergova S, 2011, AGEING RES REV, V10, P80, DOI 10.1016/j.arr.2010.04.009; Heft MW, 2017, J ORAL REHABIL, V44, P327, DOI 10.1111/joor.12488; Heft MW, 2014, AGE, V36, P1, DOI 10.1007/s11357-013-9536-9; Heine C, 2004, AGEING SOC, V24, P113, DOI 10.1017/S0144686X03001491; Hofer SM, 2003, PSYCHOL AGING, V18, P285, DOI 10.1037/0882-7974.18.2.285; Hofer SM, 2006, MULTIVARIATE BEHAV R; HOLLAND CA, 1992, APPL COGNITIVE PSYCH, V6, P217, DOI 10.1002/acp.2350060304; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Humes LE, 2013, ATTEN PERCEPT PSYCHO, V75, P508, DOI 10.3758/s13414-012-0406-9; Humes LE, 2009, ATTEN PERCEPT PSYCHO, V71, P860, DOI 10.3758/APP.71.4.860; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2011, INT J PSYCHOPHYSIOL, V80, P69, DOI 10.1016/j.ijpsycho.2011.01.012; Kaneda H, 2000, CHEM SENSES, V25, P331, DOI 10.1093/chemse/25.3.331; Keller BK, 1999, J AM GERIATR SOC, V47, P1319, DOI 10.1111/j.1532-5415.1999.tb07432.x; Khil L, 2015, OTOLARYNG HEAD NECK, V153, P364, DOI 10.1177/0194599815588913; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; Li KZH, 2002, NEUROSCI BIOBEHAV R, V26, P777, DOI 10.1016/S0149-7634(02)00073-8; LIGHT LL, 1991, ANNU REV PSYCHOL, V42, P333, DOI 10.1146/annurev.ps.42.020191.002001; Lin YH, 2005, J PERIPHER NERV SYST, V10, P269, DOI 10.1111/j.1085-9489.2005.10305.x; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Liu ZY, 2016, ARCH GERONTOL GERIAT, V62, P30, DOI 10.1016/j.archger.2015.10.011; Lupsakko T, 2002, INT J GERIATR PSYCH, V17, P808, DOI 10.1002/gps.689; Mueller C, 2003, RHINOLOGY, V41, P2; Muthen LK., 2017, MPLUS, VEight; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; PAUSE M, 1989, BRAIN, V112, P1599, DOI 10.1093/brain/112.6.1599; Pinto JM, 2017, J AM GERIATR SOC, V65, P2587, DOI 10.1111/jgs.15031; Pinto JM, 2014, J GERONTOL B-PSYCHOL, V69, pS144, DOI 10.1093/geronb/gbu102; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reuben DB, 1999, J AM GERIATR SOC, V47, P930, DOI 10.1111/j.1532-5415.1999.tb01286.x; Ro T, 2009, EXP BRAIN RES, V195, P135, DOI 10.1007/s00221-009-1759-8; Roth Thomas Nicolas, 2015, Handb Clin Neurol, V129, P357, DOI 10.1016/B978-0-444-62630-1.00020-2; Schiffman SS, 2009, ANN NY ACAD SCI, V1170, P725, DOI 10.1111/j.1749-6632.2009.03924.x; SCHLAUCH RS, 1990, J ACOUST SOC AM, V88, P732, DOI 10.1121/1.399776; Schubert CR, 2017, J GERONTOL A-BIOL, V72, P710, DOI 10.1093/gerona/glw036; Seubert J, 2017, PREVALENCE CORRELATE, P1; STEVENS JC, 1995, CHEM SENSES, V20, P451, DOI 10.1093/chemse/20.4.451; Stevens JC, 1998, J GERONTOL B-PSYCHOL, V53, pP263, DOI 10.1093/geronb/53B.4.P263; Stuart Meg, 2003, BMC Geriatr, V3, P1, DOI 10.1186/1471-2318-3-1; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Wallhagen MI, 2001, J AM GERIATR SOC, V49, P1086, DOI 10.1046/j.1532-5415.2001.49213.x; Warren DE, 2013, INVEST OPHTH VIS SCI, V54, P5778, DOI 10.1167/iovs.13-12032; Wegener BA, 2015, CHEM SENSES, V40, P667	71	48	50	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2018	13	8							e0202969	10.1371/journal.pone.0202969	http://dx.doi.org/10.1371/journal.pone.0202969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GR6UK	30148857	gold, Green Published, Green Submitted			2022-12-27	WOS:000442804200039
J	Gu, W; Christian, JK; Woodson, CB				Gu, Wen; Christian, Jason K.; Woodson, C. Brock			A novel coupled fluid-behavior model for simulating dynamic huddle formation	PLOS ONE			English	Article							SMOOTHED PARTICLE HYDRODYNAMICS; FINITE-VOLUME METHOD; EMPEROR PENGUINS; INCOMPRESSIBLE FLOWS; AGGREGATION	A coupled numerical model is developed to examine aggregative behavior in instances where the behavior not only responds to the environment, but the environment responds to the behavior such as fish schooling and penguin huddling. In the coupled model, the full Navier-Stokes equations are solved for the wind field using a finite difference method (FDM), and coupled to a smoothed particle hydrodynamics (SPH) model adapted to simulate animal behavior (penguins are individual particles in the SPH). We use the model to examine the dynamics of penguin huddling as a purely individual fitness maximizing behavior. SPH is a mesh-free Lagrangian method driven by local interactions between neighboring fluid particles and their environment allowing particles to act as free ranging 'animals' unconstrained by a computational grid that implicitly interact with one another (a critical element of aggregative behavior). The coupled model is recomputed simultaneously as the huddle evolves over time to update individual particle positions, redefine the properties of the developing huddle (i.e., shape and density), and adjust the wind field flowing through and around the dynamic huddle. This study shows the ability of a coupled model to predict the dynamic properties of penguin huddling, to quantify biometrics of individual particle "penguins", and to confirm communal penguin huddling behavior as an individualistic behavior.	[Gu, Wen; Christian, Jason K.; Woodson, C. Brock] Univ Georgia, Coll Engn, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Woodson, CB (corresponding author), Univ Georgia, Coll Engn, Athens, GA 30602 USA.	bwoodson@uga.edu		Woodson, C. Brock/0000-0003-1325-3667				Ancel A, 2015, ANIM BEHAV, V110, P91, DOI 10.1016/j.anbehav.2015.09.019; Bluestein M, 2002, ENCY ATMOSPHERIC SCI; Canals M, 2011, COMPLEXITY, V17, P35, DOI 10.1002/cplx.20370; Chen FZ, 2015, COMPUT CHEM ENG, V77, P135, DOI 10.1016/j.compchemeng.2015.04.002; Duarte M, 2014, ALIFE 2014: THE FOURTEENTH INTERNATIONAL CONFERENCE ON THE SYNTHESIS AND SIMULATION OF LIVING SYSTEMS, P785, DOI 10.7551/978-0-262-32621-6-ch127; Ellero M, 2007, J COMPUT PHYS, V226, P1731, DOI 10.1016/j.jcp.2007.06.019; Gerum RC, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/125022; Gilbert C, 2008, J EXP BIOL, V211, P1, DOI 10.1242/jeb.005785; Gilbert C, 2008, POLAR BIOL, V31, P163, DOI 10.1007/s00300-007-0343-6; Gilbert C, 2006, PHYSIOL BEHAV, V88, P479, DOI 10.1016/j.physbeh.2006.04.024; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Glancy J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160553; Griffin TM, 2000, NATURE, V408, P929, DOI 10.1038/35050167; Ianniello S, 2010, J COMPUT PHYS, V229, P1353, DOI 10.1016/j.jcp.2009.10.034; Inada Y, 2002, J THEOR BIOL, V214, P371, DOI 10.1006/jtbi.2001.2449; KRAUSE J, 1994, ANIM BEHAV, V48, P353, DOI 10.1006/anbe.1994.1248; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; LunaJorquera G, 1997, POLAR BIOL, V17, P69, DOI 10.1007/s003000050106; Marrone S, 2016, J COMPUT PHYS, V310, P161, DOI 10.1016/j.jcp.2015.11.059; Morrell LJ, 2008, BEHAV ECOL, V19, P193, DOI 10.1093/beheco/arm122; MORTON TL, 1994, J THEOR BIOL, V167, P73, DOI 10.1006/jtbi.1994.1051; Napoli E, 2016, COMPUT METHOD APPL M, V310, P674, DOI 10.1016/j.cma.2016.07.034; Seibold B., 2008, COMPACT FAST MATLAB; Waters A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050277; Wilson SP, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005378	27	0	0	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2018	13	8							e0203231	10.1371/journal.pone.0203231	http://dx.doi.org/10.1371/journal.pone.0203231			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2JK	30169532	Green Published, Green Submitted, gold			2022-12-27	WOS:000443374400027
J	Nemeh, F; Humberstone, J; Yates, MJ; Reeve, RA				Nemeh, Fiona; Humberstone, Judi; Yates, Mark J.; Reeve, Robert A.			Non-symbolic magnitudes are represented spatially: Evidence from a non-symbolic SNARC task	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; PARIETAL CORTEX; NUMERICAL ASSOCIATIONS; VISUOSPATIAL ABILITIES; MENTAL REPRESENTATION; COMPARATIVE JUDGMENTS; RESPONSE SELECTION; NUMBER MAGNITUDE; SINGLE-DIGIT; SPACE	A core proposition in numerical cognition is numbers are represented spatially. Evidence for this proposition comes from the "spatial numerical association of response codes" effect (SNARC) in which faster responses are made by the left/right hand judging whether one of a pair of Arabic digits is smaller/larger than the other. Less is known if a similar SNARC effect exists for non-symbolic magnitudes; and research that has been conducted used stimuli which could be translated into symbolic terms. To overcome this limitation, we employed a referent-to-target judgment paradigm in which a referent dot array (n = 30 dots) was follow by a second array of dots (e.g., n = 45 or 15 dots)-participants judged if the second array contained fewer or more dots than the referent array. Dot arrays with fewer dots were judged more quickly with the left hand compared to the right hand (i.e., a SNARC effect). Not all participants demonstrated a SNARC effect, however. Neither visuospatial working memory nor math ability was associated with the presence/absence of a non-symbolic SNARC effect. Implications of the non-symbolic SNARC effect for accounts of numerical cognition are discussed.	[Nemeh, Fiona; Humberstone, Judi; Reeve, Robert A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Yates, Mark J.] Columbia Univ, Dept Neurol Surg, New York, NY USA	University of Melbourne; Columbia University	Reeve, RA (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	r.reeve@unimelb.edu.au		Nemeh, Fiona/0000-0001-9412-1732	Australian Government Research Training Program (RTP) Scholarship	Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This research was supported by an Australian Government Research Training Program (RTP) Scholarship to Ms Fiona Nemeh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalric M, 2016, P NATL ACAD SCI USA, V113, P4909, DOI 10.1073/pnas.1603205113; Bachot J., 2005, PSYCHOL SCI, V47, P172, DOI DOI 10.1016/0010-0277(92)90049-N; Beecham R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005543; Beran MJ, 2017, BEHAV BRAIN SCI, V40, P17, DOI 10.1017/S0140525X16002065; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Burr DC, 2017, BEHAV BRAIN SCI, V40, P18, DOI 10.1017/S0140525X16002077; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Chew CS, 2016, J EXP CHILD PSYCHOL, V152, P173, DOI 10.1016/j.jecp.2016.07.001; Cipora K, 2016, PSYCHOL RES-PSYCH FO, V80, P710, DOI 10.1007/s00426-015-0677-6; Cipora K, 2013, Q J EXP PSYCHOL, V66, P1974, DOI 10.1080/17470218.2013.772215; Cornu V, 2016, WORKSH DOM GEN DOM S, DOI 10993/28747; Crollen V, 2015, J EXP CHILD PSYCHOL, V132, P84, DOI 10.1016/j.jecp.2014.12.006; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S., 2011, NUMBER SENSE MIND CR; Dehaene Stanislas, 2011, SPACE TIME NUMBER BR; Dowker A, 2008, DEVELOPMENTAL SCI, V11, P650, DOI 10.1111/j.1467-7687.2008.00713.x; Fattorini E, 2015, CORTEX, V73, P298, DOI 10.1016/j.cortex.2015.09.007; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2006, CORTEX, V42, P1066, DOI 10.1016/S0010-9452(08)70218-1; Fischer MH, 2010, BRAIN COGNITION, V72, P333, DOI 10.1016/j.bandc.2009.10.010; Fischer MH, 2004, EXP PSYCHOL, V51, P91, DOI 10.1027/1618-3169.51.2.91; FISCHER MH, 2005, PSYCHOL SCI, V47, P22; Formoso J, 2017, SPAN J PSYCHOL, V20, DOI 10.1017/sjp.2017.23; Gebuis T, 2017, BEHAV BRAIN SCI, V40, P23, DOI 10.1017/S0140525X16002107; Gebuis T, 2016, ACTA PSYCHOL, V171, P17, DOI 10.1016/j.actpsy.2016.09.003; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Gevers W, 2006, ACTA PSYCHOL, V122, P221, DOI 10.1016/j.actpsy.2005.11.004; Gevers W, 2006, EXP PSYCHOL, V53, P58, DOI 10.1027/1618-3169.53.1.58; Gevers W, 2010, J EXP PSYCHOL GEN, V139, P180, DOI 10.1037/a0017688; Gibson LC, 2016, J EXP CHILD PSYCHOL, V150, P301, DOI 10.1016/j.jecp.2016.05.009; Gray SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094428; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; Holmes KJ, 2011, BRAIN COGNITION, V77, P315, DOI 10.1016/j.bandc.2011.07.002; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Huber S, 2015, RES DEV DISABIL, V43-44, P32, DOI 10.1016/j.ridd.2015.06.003; Hyde DC, 2011, DEVELOPMENTAL SCI, V14, P360, DOI 10.1111/j.1467-7687.2010.00987.x; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Keus IM, 2005, COGNITIVE BRAIN RES, V24, P48, DOI 10.1016/j.cogbrainres.2004.12.005; Krause F, 2014, J COGNITIVE NEUROSCI, V26, P768, DOI 10.1162/jocn_a_00518; Leibovich T, 2017, BEHAV BRAIN SCI, V40, P1, DOI 10.1017/S0140525X16000960; Lourenco SF, 2017, BEHAV BRAIN SCI, V40, P29, DOI 10.1017/S0140525X16002156; Macnamara A, 2018, EXP BRAIN RES, V236, P335, DOI 10.1007/s00221-017-5154-6; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; Mitchell T, 2012, Q J EXP PSYCHOL, V65, P1945, DOI 10.1080/17470218.2012.673631; Myers T, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01646; Nishimura A, 2009, PSYCHON B REV, V16, P666, DOI 10.3758/PBR.16.4.666; Nuerk HC, 2005, EXP PSYCHOL, V52, P187, DOI 10.1027/1618-3169.52.3.187; Odic D, 2017, BEHAV BRAIN SCI, V40, P34, DOI 10.1017/S0140525X1600220X; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patro K, 2012, J EXP CHILD PSYCHOL, V111, P534, DOI 10.1016/j.jecp.2011.09.006; Paul JM, 2016, LEARN INSTR, V42, P113, DOI 10.1016/j.learninstruc.2016.01.011; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023553; Reynvoet B, 1999, COGNITION, V72, P191, DOI 10.1016/S0010-0277(99)00048-7; Robertson G, 2006, WIDE RANGE ACHIEVEME; Rusconi E., 2006, COGNITION, V99, P113, DOI [10. 1016/j. cognition. 2005. 01. 004, DOI 10.1016/J.C0GNITI0N.2005.01.004]; Schwarz W, 2006, EXP PSYCHOL, V53, P4, DOI 10.1027/1618-3169.53.1.4; Schwarz W, 2004, PERCEPT PSYCHOPHYS, V66, P651, DOI 10.3758/BF03194909; Sella F, 2016, TRENDS NEUROSCI EDUC, V5, P20, DOI 10.1016/j.tine.2016.02.002; Shaki S, 2005, PSYCHON B REV, V12, P931, DOI 10.3758/BF03196788; Shaki S, 2012, J EXP PSYCHOL HUMAN, V38, P515, DOI 10.1037/a0026729; Shaki S, 2011, J CROSS CULT PSYCHOL, V42, P639, DOI 10.1177/0022022111406100; Tosto MG, 2017, DEV PSYCHOL, V53, P1924, DOI 10.1037/dev0000331; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; Viarouge A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095756; Vicario CM, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00016; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wood G., 2008, PSYCHOL SCI Q, V50, P489; Zhou XL, 2016, EXP PSYCHOL, V63, P169, DOI 10.1027/1618-3169/a000324	70	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203019	10.1371/journal.pone.0203019	http://dx.doi.org/10.1371/journal.pone.0203019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GS2NZ	30161171	Green Published, gold			2022-12-27	WOS:000443388900066
J	Taller, D; Balint, J; Gyula, P; Nagy, T; Barta, E; Baksa, I; Szittya, G; Taller, J; Havelda, Z				Taller, Denes; Balint, Jeannette; Gyula, Peter; Nagy, Tibor; Barta, Endre; Baksa, Ivett; Szittya, Gyorgy; Taller, Janos; Havelda, Zoltan			Expansion of Capsicum annum fruit is linked to dynamic tissue-specific differential expression of miRNA and siRNA profiles (vol 13, e0200207, 2018)	PLOS ONE			English	Correction													Szittya, Gyorgy/M-9199-2019; Taller, Janos/ABB-9586-2021; Barta, Endre/B-1166-2008; Szittya, Gyorgy/A-2905-2012; Gyula, Péter/N-4445-2014	Szittya, Gyorgy/0000-0003-2040-2851; Barta, Endre/0000-0002-6753-0714; Szittya, Gyorgy/0000-0003-2040-2851; Gyula, Péter/0000-0002-3574-2827; Havelda, Zoltan/0000-0002-6349-7646; Nagy, Tibor/0000-0002-4451-0796				Taller D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200207	1	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2018	13	8							e0203582	10.1371/journal.pone.0203582	http://dx.doi.org/10.1371/journal.pone.0203582			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS2NZ	30161235	Green Published, gold			2022-12-27	WOS:000443388900133
J	Beddek, M; Zenboudji-Beddek, S; Geniez, P; Fathalla, R; Sourouille, P; Arnal, V; Dellaoui, B; Koudache, F; Telailia, S; Peyre, O; Crochet, PA				Beddek, Menad; Zenboudji-Beddek, Saliha; Geniez, Philippe; Fathalla, Raouaa; Sourouille, Patricia; Arnal, Veronique; Dellaoui, Boualem; Koudache, Fatiha; Telailia, Salah; Peyre, Olivier; Crochet, Pierre-Andre			Comparative phylogeography of amphibians and reptiles in Algeria suggests common causes for the east-west phylogeographic breaks in the Maghreb	PLOS ONE			English	Article							MEDITERRANEAN-ATLANTIC CONNECTIONS; NATRIX-MAURA SERPENTES; MITOCHONDRIAL-DNA; LATE MIOCENE; EVOLUTIONARY HISTORY; PHENOTYPIC VARIATION; GENETIC-VARIABILITY; NORTH-AFRICA; PATTERNS; LIZARD	A series of phylogeographic studies in the Maghreb identified a repeated pattern of deep genetic divergence between an eastern (Tunisia) and western (Morocco) lineage for several taxa but lack of sampling in Algeria made it difficult to know if the range limits between the eastern and western lineages were shared among taxa or not. To address this question, we designed a comparative phylogeographic study using 8 reptile and 3 amphibian species with wide distribution in the Maghreb as models. We selected species where previous studies had identified an East-West phylogeographic divide and collected sampled in Algeria to 1) examine whether the simple East-West divergence pattern still holds after filling the sampling gap in Algeria or if more complex diversity patterns emerge; 2) if the E-W pattern still holds, test whether the limits between the E and W clades are shared between species, suggesting that common historical process caused the E-W divergences; 3) if E-W limits are shared between species, use information on the age of the divergence to identify possible geological or climatic events that could have triggered these E-W differentiations. We found that the E-W pattern was generally maintained after additional sampling in Algeria and identified two common disjunction areas, one around the Algeria-Morocco border, the other one in Kabylia (central Algeria), suggesting that common historical mechanisms caused the EW-divergences in the Maghreb. Our estimates for the times to most common recent ancestors to the E and Wclades span a wide range between the Messinian salinity crisis and the Plio-Pleistocene limit (except for one older split), suggesting different origins for the initial divergences and subsequent preservation of the E and Wlineages in common climatic refugia in the west and the east of the Maghreb.	[Beddek, Menad; Zenboudji-Beddek, Saliha; Geniez, Philippe; Fathalla, Raouaa; Sourouille, Patricia; Arnal, Veronique; Crochet, Pierre-Andre] Univ Montpellier, Univ Paul Valery Montpellier 3, INRA, CEFE,CNRS,EPHE,IRD, Montpellier, France; [Beddek, Menad; Peyre, Olivier] Naturalia Environm, Site Agroparc, Avignon, France; [Fathalla, Raouaa] Univ Tunis Elmanar, Fac Sci Tunis, Unite Rech Biodiversite & Biol Populat, Tunis, Tunisia; [Dellaoui, Boualem; Koudache, Fatiha] Univ Djillali Liabes Sidi Bel Abbes, Fac Sci, Dept Environm, Sidi Bel Abbes, Bel Abbes, Algeria; [Telailia, Salah] Univ Chadli Bendjedid, Fac Sci Nat & Vie, Dept Sci Agron, El Tarf, Algeria	INRAE; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); University Djillali Liabes Sidi Bel Abbes	Beddek, M (corresponding author), Univ Montpellier, Univ Paul Valery Montpellier 3, INRA, CEFE,CNRS,EPHE,IRD, Montpellier, France.; Beddek, M (corresponding author), Naturalia Environm, Site Agroparc, Avignon, France.	menad.beddek@hotmail.com	Telailia, Salah/AAA-9396-2022; BEDDEK, Menad/AAF-4503-2021	BEDDEK, Menad/0000-0001-9246-730X; ARNAL, VERONIQUE/0000-0002-4037-490X; TELAILIA, Salah/0000-0002-4653-3764	Naturalia-Environnement/ANRT CIFRE [2013/0145]; Naturalia Environnement; ANRT CIFRE	Naturalia-Environnement/ANRT CIFRE; Naturalia Environnement; ANRT CIFRE(French National Research Agency (ANR))	Menad BEDDEK received a Ph.D grant from Naturalia-Environnement/ANRT CIFRE convention No 2013/0145. Naturalia Environnement: http://www.naturalia-environnement.fr/; ANRT CIFRE: http://www.anrt.asso.fr/fr/cifre-7843. The funder "Naturalia Environnement" reprsented by Olivier Peyre has participated to the study design and manuscript preparation.	Achalhi M, 2016, PALAEOGEOGR PALAEOCL, V459, P131, DOI 10.1016/j.palaeo.2016.06.040; Ahmadzadeh F, 2016, SEPARATE HIST BOTH S, DOI [10.1111/jbi.12703, DOI 10.1111/JBI.12703]; Ahmadzadeh F, 2016, J BIOGEOGR, V43, P1242, DOI 10.1111/jbi.12703; Allen H.D., 2001, MEDITERRANEAN ECOGEO; Arano B, 1998, HERPETOL J, V8, P57; Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; Avise J.C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bachiri TN, 2008, GEODIVERSITAS, V30, P41; Barata M, 2008, AFR ZOOL, V43, P1, DOI 10.3377/1562-7020(2008)43[1:CPONAN]2.0.CO;2; Barata M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-167; Barhoun N, 2008, GEODIVERSITAS, V30, P21; Ben Faleh AR, 2012, J ZOOL, V286, P208, DOI 10.1111/j.1469-7998.2011.00868.x; Ben Hassine J, 2016, J ZOOL SYST EVOL RES, V54, P116, DOI 10.1111/jzs.12123; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; BUSACK SD, 1986, NATL GEOGR RES, V2, P17; Carranza S, 2006, MOL PHYLOGENET EVOL, V40, P532, DOI 10.1016/j.ympev.2006.03.028; Carranza S, 2006, J BIOGEOGR, V33, P1279, DOI 10.1111/j.1365-2699.2006.01491.x; Cosson JF, 2005, MOL ECOL, V14, P1151, DOI 10.1111/j.1365-294X.2005.02476.x; COX N, 2006, STATUS DISTRIBUTION; Cuttelod A, 2009, WILDLIFE CHANGING WO, V89, P1; Denton RD, 2014, MOL ECOL, V23, P2811, DOI 10.1111/mec.12775; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; Fonseca MM, 2009, MOL PHYLOGENET EVOL, V51, P131, DOI 10.1016/j.ympev.2008.11.021; Fritz U, 2006, ZOOL SCR, V35, P97, DOI 10.1111/j.1463-6409.2005.00218.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garcia JT, 2008, MOL PHYLOGENET EVOL, V46, P237, DOI 10.1016/j.ympev.2007.06.022; Garcia-Alix A, 2016, J BIOGEOGR, V43, P1336, DOI 10.1111/jbi.12732; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Gracia E, 2017, BIOL J LINN SOC, V121, P641, DOI 10.1093/biolinnean/blx007; Guarnizo CE, 2009, MOL PHYLOGENET EVOL, V50, P84, DOI 10.1016/j.ympev.2008.10.005; Guicking D, 2006, BIOL J LINN SOC, V87, P127, DOI 10.1111/j.1095-8312.2006.00561.x; Guicking D, 2008, ORG DIVERS EVOL, V8, P130, DOI 10.1016/j.ode.2007.05.001; Guillaumet A, 2005, MOL ECOL, V14, P3809, DOI 10.1111/j.1365-294X.2005.02696.x; Guiller A, 2001, MOL ECOL, V10, P81, DOI 10.1046/j.1365-294X.2001.01145.x; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guo XG, 2011, MOL PHYLOGENET EVOL, V61, P400, DOI 10.1016/j.ympev.2011.06.022; Habel JC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-215; Harris DJ, 2009, BIOLOGIA, V64, P356, DOI 10.2478/s11756-009-0042-6; Harris DJ, 2005, TRENDS ECOL EVOL, V20, P6, DOI 10.1016/j.tree.2004.11.004; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Husemann M, 2014, J BIOGEOGR, V41, P81, DOI 10.1111/jbi.12180; Kaliontzopoulou A, 2011, BIOL J LINN SOC, V103, P779, DOI 10.1111/j.1095-8312.2011.01703.x; Kerr KCR, 2007, MOL ECOL NOTES, V7, P535, DOI 10.1111/j.1471-8286.2006.01670.x; Kornilios P, 2010, MOL PHYLOGENET EVOL, V54, P445, DOI 10.1016/j.ympev.2009.09.015; Kouwenhoven TJ, 2006, PALAEOGEOGR PALAEOCL, V238, P373, DOI 10.1016/j.palaeo.2006.03.035; Kouwenhoven TJ, 2003, PALAEOGEOGR PALAEOCL, V198, P303, DOI 10.1016/S0031-0182(03)00472-3; Kumar S., 2016, MOL BIOL EVOLUTION, DOI [DOI 10.1093/M0LBEV/MSW054, 10.1093/molbev/msw054]; Lalis A, 2016, BIOL J LINN SOC, V118, P262, DOI 10.1111/bij.12725; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li ZF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028806, 10.1371/journal.pone.0052388]; Lima A, 2009, AMPHIBIA-REPTILIA, V30, P483, DOI 10.1163/156853809789647103; Lindell J, 2008, BIOL J LINN SOC, V94, P89, DOI 10.1111/j.1095-8312.2008.00976.x; Lomolino M. V., 2006, BIOGEOGRAPHY; Lomolino M.V., 2004, FDN BIOGEOGRAPHY CLA; Martinez-Freiria F, 2017, BIOL J LINN SOC, V122, P366, DOI 10.1093/biolinnean/blx038; Medail F, 1997, JSTOR, P112, DOI [10.2307/239995, DOI 10.2307/239995]; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Mendoca B, 2007, BELG J ZOOL, V137, P239; Merabet K, 2016, AMPHIBIA-REPTILIA, V37, P1, DOI 10.1163/15685381-00003025; Metallinou M, 2015, MOL PHYLOGENET EVOL, V85, P208, DOI 10.1016/j.ympev.2015.02.010; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicolas V, 2018, J ZOOL SYST EVOL RES, V56, P102, DOI 10.1111/jzs.12185; Nicolas V, 2015, J ZOOL SYST EVOL RES, V53, P239, DOI 10.1111/jzs.12094; Nicolas V, 2014, J MAMMAL, V95, P241, DOI 10.1644/13-MAMM-A-241; Feliner GN, 2014, PERSPECT PLANT ECOL, V16, P265, DOI 10.1016/j.ppees.2014.07.002; Paulo OS, 2008, MOL ECOL, V17, P1535, DOI 10.1111/j.1365-294X.2008.03706.x; Perera A, 2010, AFR ZOOL, V45, P321, DOI 10.3377/004.045.0211; Perera A, 2010, MOL PHYLOGENET EVOL, V54, P634, DOI 10.1016/j.ympev.2009.10.020; Pfenninger M, 2010, MOL PHYLOGENET EVOL, V54, P427, DOI 10.1016/j.ympev.2009.09.024; Pinho C, 2007, MOL ECOL, V16, P1191, DOI 10.1111/j.1365-294X.2007.03230.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rambaut A, 2013, LOGCOMBINER V1 8 0; Randi E, 2007, Phylogeography of Southern European Refugia, P101, DOI 10.1007/1-4020-4904-8_3; Rato C, 2016, MOL PHYLOGENET EVOL, V94, P271, DOI 10.1016/j.ympev.2015.09.008; Recuero E, 2007, J BIOGEOGR, V34, P1207, DOI 10.1111/j.1365-2699.2007.01688.x; Renoult JP, 2010, AMPHIB REPTIL, V31, DOI [10.1163/156853810791069074, DOI 10.1163/156853810791069074]; Reyjol Y, 2007, GLOBAL ECOL BIOGEOGR, V16, P65, DOI 10.1111/j.1466-8238.2006.00264.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salvi D, 2018, MOL PHYLOGENET EVOL, V120, P118, DOI 10.1016/j.ympev.2017.11.013; Schmitt T, 2007, J BIOGEOGR, V34, P939, DOI 10.1111/j.1365-2699.2006.01684.x; Sousa P, 2012, J ZOOL, V288, P66, DOI 10.1111/j.1469-7998.2012.00925.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stock M, 2008, MOL PHYLOGENET EVOL, V49, P1019, DOI 10.1016/j.ympev.2008.08.029; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Vea E, 2007, CR BIOL, V330, P589, DOI 10.1016/j.crvi.2007.04.006; Verissimo J, 2016, BIOL J LINN SOC, V119, P943, DOI 10.1111/bij.12849; Yahi N., 2012, Journal of Threatened Taxa, V4, P2753; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	93	25	26	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0201218	10.1371/journal.pone.0201218	http://dx.doi.org/10.1371/journal.pone.0201218			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	30157236	Green Published, gold			2022-12-27	WOS:000443071400007
J	Nikolaidis, PT; Di Gangi, S; de Sousa, CV; Valeri, F; Rosemann, T; Knechtle, B				Nikolaidis, Pantelis Theodoros; Di Gangi, Stefania; de Sousa, Caio Victor; Valeri, Fabio; Rosemann, Thomas; Knechtle, Beat			Sex difference in open-water swimming-The Triple Crown of Open Water Swimming 1875-2017	PLOS ONE			English	Article							PERFORMANCE; MEN; SWIMMERS	The aim of the present study was to compare swimming performances of successful finishers of the ' Triple Crown of Open Water Swimming' from 1875 to 2017, assessing the effects of sex, the place of event and the nationality of swimmers. Data from 535 finishers in ` Catalina Channel Swim', 1,606 finishers in ` English Channel Swim' and 774 finishers in ` Manhattan Island Marathon Swim' were analysed. We performed different analyses and regression model fittings for all swimmers and annual top-5 finishers. Effects (sex, event, time, nationality) and interaction terms (event D time) were examined through a multi-variable spline mixed regression model. Considering all swimmers, we found that (i) women were approximately 0.06 km/h faster than men (p = 0.011) and (ii) Australians were 0.13 km/h faster than Americans (p = 0.004) and Americans were 0.19 km/h faster than British (p< 0.001) and 0.21 km/h faster than Canadians (p = 0.015). When considering annual top-5 finishers, we found that (i) women were 0.07 km/h slower than men (p = 0.042) and (ii) Australians were not faster than Americans (p = 0.149) but Americans were 0.21 km/h faster than British (p< 0.001). Our findings improved the knowledge about swim performances over time, in the three events, considering the effects of sex and the nationality of swimmers.	[Nikolaidis, Pantelis Theodoros] Exercise Physiol Lab, Nikaia, Greece; [Di Gangi, Stefania; Valeri, Fabio; Rosemann, Thomas; Knechtle, Beat] Univ Zurich, Inst Primary Care, Zurich, Switzerland; [de Sousa, Caio Victor] Univ Catolica Brasilia, Grad Program Phys Educ, Brasilia, DF, Brazil; [Knechtle, Beat] Medbase St Gallen Vadianpl, St Gallen, Switzerland	University of Zurich; Universidade Catolica de Brasilia	Knechtle, B (corresponding author), Univ Zurich, Inst Primary Care, Zurich, Switzerland.; Knechtle, B (corresponding author), Medbase St Gallen Vadianpl, St Gallen, Switzerland.	beat.knechtle@hispeed.ch	Sousa, Caio Victor/D-7060-2016; Knechtle, Beat/ABC-5529-2020; Sharma, Alok/AAE-4725-2022; Nikolaidis, Pantelis Theodoros/K-8664-2017; Tsunoda, Tatsuhiko/K-2061-2014	Sousa, Caio Victor/0000-0002-0499-2372; Knechtle, Beat/0000-0002-2412-9103; Sharma, Alok/0000-0002-7668-3501; Nikolaidis, Pantelis Theodoros/0000-0001-8030-7122; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Sattar, Abdul/0000-0002-2567-2052; Di Gangi, Stefania/0000-0002-2847-6399	Grants-in-Aid for Scientific Research [15F15385] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bam J, 1997, MED SCI SPORT EXER, V29, P244, DOI 10.1097/00005768-199702000-00013; Beneke R, 2005, BRIT J SPORT MED, V39, P410, DOI 10.1136/bjsm.2004.017574; Coast JR, 2004, CAN J APPL PHYSIOL, V29, P139, DOI 10.1139/h04-010; Dahler P, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-16; Eichenberger E, 2013, J STRENGTH COND RES, V27, P1362, DOI 10.1519/JSC.0b013e318265a3e9; Eichenberger E, 2012, J SPORT SCI, V30, P1295, DOI 10.1080/02640414.2012.709264; Fischer G, 2013, SCAND J MED SCI SPOR, V23, pe48, DOI 10.1111/sms.12008; Gerrard DF, 1999, CLIN SPORT MED, V18, P337, DOI 10.1016/S0278-5919(05)70149-6; Knechtle B, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1086-4; Knechtle B, 2014, INT J SPORT PHYSIOL, V9, P913, DOI 10.1123/ijspp.2013-0375; Knechtle B, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-34; Nikolaidis PT, 2018, RES SPORTS MED, V26, P332, DOI 10.1080/15438627.2018.1447471; Pyne DB, 2004, J SPORT SCI, V22, P613, DOI 10.1080/02640410310001655822; Rust CA, 2014, APPL PHYSIOL NUTR ME, V39, P270, DOI 10.1139/apnm-2013-0222; Rust CA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-86; Trewin CB, 2004, J SPORT SCI, V22, P339, DOI 10.1080/02640410310001641610; Vogt P, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-603; Zingg MA, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-7; Zingg MA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-2	19	55	56	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2018	13	8							e0202003	10.1371/journal.pone.0202003	http://dx.doi.org/10.1371/journal.pone.0202003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR9JD	29432431	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000443071400024
J	Abdollah, D; Lopez, Y; Lal, SP; Taherzadeh, G; Sattar, A; Tsunoda, T; Sharma, A				Dehzangi, Abdollah; Lopez, Yosvany; Lal, Sunil Pranit; Taherzadeh, Ghazaleh; Sattar, Abdul; Tsunoda, Tatsuhiko; Sharma, Alok			Improving succinylation prediction accuracy by incorporating the secondary structure via helix, strand and coil, and evolutionary information from profile bigrams	PLOS ONE			English	Article							ACCESSIBLE SURFACE-AREA; AMINO-ACID-COMPOSITION; LYSINE SUCCINYLATION; SUBCELLULAR-LOCALIZATION; SCORING MATRIX; POSTTRANSLATIONAL MODIFICATION; PSEUDO COMPONENTS; WEB SERVER; K-TUPLE; SITES	Post-translational modification refers to the biological mechanism involved in the enzymatic modification of proteins after being translated in the ribosome. This mechanism comprises a wide range of structural modifications, which bring dramatic variations to the biological function of proteins. One of the recently discovered modifications is succinylation. Although succinylation can be detected through mass spectrometry, its current experimental detection turns out to be a timely process unable to meet the exponential growth of sequenced proteins. Therefore, the implementation of fast and accurate computational methods has emerged as a feasible solution. This paper proposes a novel classification approach, which effectively incorporates the secondary structure and evolutionary information of proteins through profile bigrams for succinylation prediction. The proposed predictor, abbreviated as SSEvol-Suc, made use of the above features for training an AdaBoost classifier and consequently predicting succinylated lysine residues. When SSEvol-Suc was compared with four benchmark predictors, it outperformed them in metrics such as sensitivity (0.909), accuracy (0.875) and Matthews correlation coefficient (0.75).	[Dehzangi, Abdollah] Morgan State Univ, Dept Comp Sci, Baltimore, MD 21239 USA; [Lopez, Yosvany; Tsunoda, Tatsuhiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo, Japan; [Lopez, Yosvany; Tsunoda, Tatsuhiko; Sharma, Alok] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Lal, Sunil Pranit] Massey Univ, Sch Engn & Adv Technol, Palmerston North, New Zealand; [Taherzadeh, Ghazaleh; Sattar, Abdul] Griffith Univ, Sch Informat & Commun Technol, Nathan, Qld, Australia; [Sattar, Abdul; Sharma, Alok] Griffith Univ, Inst Integrated & Intelligent Syst, Nathan, Qld, Australia; [Tsunoda, Tatsuhiko] JST, CREST, Tokyo, Japan; [Sharma, Alok] Univ South Pacific, Sch Phys & Engn, Suva, Fiji	Morgan State University; Tokyo Medical & Dental University (TMDU); RIKEN; Massey University; Griffith University; Griffith University; Japan Science & Technology Agency (JST); University of the South Pacific	Lopez, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo, Japan.; Lopez, Y (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan.	yosvany.lopez.alvarez@gmail.com	Sousa, Caio Victor/D-7060-2016; Knechtle, Beat/ABC-5529-2020; Sharma, Alok/AAE-4725-2022; Nikolaidis, Pantelis Theodoros/K-8664-2017; Tsunoda, Tatsuhiko/K-2061-2014	Sousa, Caio Victor/0000-0002-0499-2372; Knechtle, Beat/0000-0002-2412-9103; Sharma, Alok/0000-0002-7668-3501; Nikolaidis, Pantelis Theodoros/0000-0001-8030-7122; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Sattar, Abdul/0000-0002-2567-2052; Di Gangi, Stefania/0000-0002-2847-6399	Grants-in-Aid for Scientific Research [15F15385] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2017, NAT SCI, DOI DOI 10.4236/NS.2017.99032; Ansari NA, 2011, DIS MARKERS, V30, P317, DOI [10.3233/DMA-2011-0791, 10.1155/2011/718694]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen W, 2017, ONCOTARGET, V8, P4208, DOI 10.18632/oncotarget.13758; Chen W, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.37; Chen W, 2015, ANAL BIOCHEM, V490, P26, DOI 10.1016/j.ab.2015.08.021; Chen W, 2014, ANAL BIOCHEM, V456, P53, DOI 10.1016/j.ab.2014.04.001; Cheng X, 2018, GENOMICS, V110, P231, DOI 10.1016/j.ygeno.2017.10.002; Cheng X, 2018, GENOMICS, V110, P50, DOI 10.1016/j.ygeno.2017.08.005; Chou K.-C., 2009, NAT SCI, V1, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2017, CURR TOP MED CHEM, V17, P2337, DOI 10.2174/1568026617666170414145508; Chou KC, 2015, MED CHEM, V11, P218, DOI 10.2174/1573406411666141229162834; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; COMB DG, 1966, J BIOL CHEM, V241, P1857; Dehzangi Abdollah, 2013, Pattern Recognition in Bioinformatics. 8th IAPR International Conference, PRIB 2013. Proceedings: LNCS 7986, P208, DOI 10.1007/978-3-642-39159-0_19; Dehzangi Abdollah, 2013, Pattern Recognition in Bioinformatics. 8th IAPR International Conference, PRIB 2013. Proceedings: LNCS 7986, P196, DOI 10.1007/978-3-642-39159-0_18; Dehzangi A, 2010, AUSTR J INTELLIGENT, V10, P32; Dehzangi A, 2017, J THEOR BIOL, V425, P97, DOI 10.1016/j.jtbi.2017.05.005; Dehzangi A, 2015, INT J DATA MIN BIOIN, V11, P115, DOI 10.1504/IJDMB.2015.066359; Dehzangi A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S4-S1; Dehzangi A, 2015, J THEOR BIOL, V364, P284, DOI 10.1016/j.jtbi.2014.09.029; Dehzangi A, 2014, IEEE ACM T COMPUT BI, V11, P510, DOI 10.1109/TCBB.2013.2296317; Dehzangi A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S2; Dehzangi A, 2013, IEEE ACM T COMPUT BI, V10, P564, DOI 10.1109/TCBB.2013.65; Ding H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/286419; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; Feng PM, 2017, MOL THER-NUCL ACIDS, V7, P155, DOI 10.1016/j.omtn.2017.03.006; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Hajisharifi Z, 2014, J THEOR BIOL, V341, P34, DOI 10.1016/j.jtbi.2013.08.037; Hall M., 2009, SIGKDD EXPLOR NEWSL, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hasan MM, 2016, MOL BIOSYST, V12, P786, DOI 10.1039/c5mb00853k; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; Jia JH, 2016, BIOINFORMATICS, V32, P3133, DOI 10.1093/bioinformatics/btw387; Jia JH, 2016, ONCOTARGET, V7, P34558, DOI 10.18632/oncotarget.9148; Jia JH, 2016, J THEOR BIOL, V394, P223, DOI 10.1016/j.jtbi.2016.01.020; Jia JH, 2016, ANAL BIOCHEM, V497, P48, DOI 10.1016/j.ab.2015.12.009; Knorre DG, 2009, ACTA NATURAE, V1, P29, DOI 10.32607/20758251-2009-1-3-29-51; Lamoliatte F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6409; Liu B., 2017, NAT SCI, V09, P67, DOI [10.4236/ns.2017.94007, DOI 10.4236/NS.2017.94007]; Liu B, 2017, MOL THER-NUCL ACIDS, V7, P267, DOI 10.1016/j.omtn.2017.04.008; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, J THEOR BIOL, V385, P153, DOI 10.1016/j.jtbi.2015.08.025; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu LM, 2017, MED CHEM, V13, P552, DOI 10.2174/1573406413666170515120507; Liu ZX, 2014, NUCLEIC ACIDS RES, V42, pD531, DOI 10.1093/nar/gkt1093; Liu ZX, 2011, NUCLEIC ACIDS RES, V39, pD1029, DOI 10.1093/nar/gkq939; Liu Z, 2015, ANAL BIOCHEM, V474, P69, DOI 10.1016/j.ab.2014.12.009; Lopez Y, 2017, ANAL BIOCHEM, V527, P24, DOI 10.1016/j.ab.2017.03.021; Lyons J, 2014, J COMPUT CHEM, V35, P2040, DOI 10.1002/jcc.23718; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Niu B, 2017, ONCOTARGET, V8, P57149, DOI 10.18632/oncotarget.19169; Paliwal KK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S12; Paliwal KK, 2014, IEEE T NANOBIOSCI, V13, P44, DOI 10.1109/TNB.2013.2296050; Qiu WR, 2017, MED CHEM, V13, P734, DOI 10.2174/1573406413666170623082245; Qiu WR, 2017, MOL INFORM, V36, DOI 10.1002/minf.201600010; Qiu WR, 2017, ONCOTARGET, V8, P41178, DOI 10.18632/oncotarget.17104; Qiu WR, 2016, ONCOTARGET, V7, P51270, DOI 10.18632/oncotarget.9987; Qiu WR, 2016, ONCOTARGET, V7, P44310, DOI 10.18632/oncotarget.10027; Qiu WR, 2016, BIOINFORMATICS, V32, P3116, DOI 10.1093/bioinformatics/btw380; Qiu WR, 2015, J BIOMOL STRUCT DYN, V33, P1731, DOI 10.1080/07391102.2014.968875; Qiu WR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/947416; Saini H, 2015, J THEOR BIOL, V380, P291, DOI 10.1016/j.jtbi.2015.05.030; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089890; Sharma A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-233; Sharma A, 2013, J THEOR BIOL, V320, P41, DOI 10.1016/j.jtbi.2012.12.008; Sharma R, 2015, IEEE T NANOBIOSCI, V14, P915, DOI 10.1109/TNB.2015.2500186; Su Q, 2017, ONCOTARGET, V8, P49359, DOI 10.18632/oncotarget.17210; Xiao X, 2015, J BIOMOL STRUCT DYN, V33, P2221, DOI 10.1080/07391102.2014.998710; Xu HD, 2015, BIOINFORMATICS, V31, P3748, DOI 10.1093/bioinformatics/btv439; Xu MF, 2016, MOLECULES, V21, DOI 10.3390/molecules21010086; Xu Y, 2017, MED CHEM, V13, P544, DOI 10.2174/1573406413666170419150052; Xu Y, 2016, CURR TOP MED CHEM, V16, P591, DOI 10.2174/1568026615666150819110421; Xu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10184; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105018; Xu Y, 2014, INT J MOL SCI, V15, P7594, DOI 10.3390/ijms15057594; Xu Y, 2013, PEERJ, V1, DOI 10.7717/peerj.171; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yang YD, 2017, METHODS MOL BIOL, V1484, P55, DOI 10.1007/978-1-4939-6406-2_6; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zhao XW, 2015, J THEOR BIOL, V374, P60, DOI 10.1016/j.jtbi.2015.03.029	87	55	56	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2018	13	2							e0191900	10.1371/journal.pone.0191900	http://dx.doi.org/10.1371/journal.pone.0191900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV8DE	29432431	Green Published, gold, Green Submitted			2022-12-27	WOS:000424814300013
